PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hashizume, K; Chaussidon, M; Marty, B; Robert, F				Hashizume, K; Chaussidon, M; Marty, B; Robert, F			Solar wind record on the moon: Deciphering presolar from planetary nitrogen	SCIENCE			English	Article							ISOTOPIC COMPOSITION; CORPUSCULAR RADIATION; ENERGETIC PARTICLES; ORDINARY CHONDRITES; LUNAR ILMENITES; FRACTIONATION; GRAINS; AR; NUCLEOSYNTHESIS; ABUNDANCES	Ion microprobe analyses show that solar wind nitrogen associated with solar wind hydrogen implanted in the first tens of nanometers of Lunar regolith grains is depleted in N-15 by at least 24% relative to terrestrial atmosphere, whereas a nonsolar component associated with deuterium-rich hydrogen, detected in silicon-bearing coatings at the surface of some ilmenite grains, is enriched in N-15. Systematic enrichment of N-15 in terrestrial planets and bulk meteorites relative to the protosolar gas cannot be explained by isotopic fractionation in nebular or planetary environments but requires the contribution of N-15-rich compounds to the total nitrogen in planetary materials. Most of these compounds are possibly of an interstellar origin and never equilibrated with the N-15-depleted protosolar nebula.	Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Nancy, France; Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Osaka 5600043, Japan; INPL, Ecole Natl Super Geol, F-54501 Vandoeuvre Nancy, France; Museum Natl Hist Nat, Lab Mineral, F-75005 Paris, France	Universite de Lorraine; Osaka University; Universite de Lorraine; Museum National d'Histoire Naturelle (MNHN)	Hashizume, K (corresponding author), Ctr Rech Petrog & Geochim, BP 20, F-54501 Vandoeuvre Nancy, France.		Chaussidon, Marc/E-7067-2017					ADAMS NG, 1981, ASTROPHYS J, V247, pL123, DOI 10.1086/183604; BECKER RH, 1989, GEOCHIM COSMOCHIM AC, V53, P1135, DOI 10.1016/0016-7037(89)90219-6; BENKERT JP, 1993, J GEOPHYS RES-PLANET, V98, P13147, DOI 10.1029/93JE01460; BOCHSLER P, 1994, METEORITICS, V29, P653, DOI 10.1111/j.1945-5100.1994.tb00780.x; Chaussidon M, 1999, NATURE, V402, P270, DOI 10.1038/46235; Fouchet T, 2000, ICARUS, V143, P223, DOI 10.1006/icar.1999.6255; Frick U., 1988, P LUNAR PLANET SCI, P87; GEISS J, 1994, PHILOS T R SOC A, V349, P213, DOI 10.1098/rsta.1994.0126; Geiss J., 1991, SUN TIME, P98; GRADY MM, 1993, EARTH PLANET SC LETT, V116, P165, DOI 10.1016/0012-821X(93)90052-B; GRADY MM, 1986, GEOCHIM COSMOCHIM AC, V50, P2799, DOI 10.1016/0016-7037(86)90228-0; HASHIZUME K, 1995, GEOCHIM COSMOCHIM AC, V59, P4057, DOI 10.1016/0016-7037(95)00236-S; HASHIZUME K, 1999, LUNAR PLANET SCI, V30; Humbert F., 1998, THESIS U H POINCARE; Jewitt DC, 1997, SCIENCE, V278, P90, DOI 10.1126/science.278.5335.90; Kallenbach R, 1998, ASTROPHYS J, V507, pL185, DOI 10.1086/311702; Keller LP, 1997, GEOCHIM COSMOCHIM AC, V61, P2331, DOI 10.1016/S0016-7037(97)00085-9; KERRIDGE JF, 1993, REV GEOPHYS, V31, P423, DOI 10.1029/93RG01953; KERRIDGE JF, 1985, GEOCHIM COSMOCHIM AC, V49, P1707, DOI 10.1016/0016-7037(85)90141-3; Marty B, 1999, GEOCHIM COSMOCHIM AC, V63, P3619, DOI 10.1016/S0016-7037(99)00169-6; MCELROY MB, 1976, SCIENCE, V194, P70, DOI 10.1126/science.194.4260.70; MESSENGER S, 1997, AIP C P, V402, P545; PROMBO CA, 1993, GEOCHIM COSMOCHIM AC, V57, P3749, DOI 10.1016/0016-7037(93)90153-N; SUGIURA N, 1992, EARTH PLANET SC LETT, V111, P441, DOI 10.1016/0012-821X(92)90195-2; WIELER R, 1995, ASTROPHYS J, V453, P987, DOI 10.1086/176458; Wieler R, 1999, EARTH PLANET SC LETT, V167, P47, DOI 10.1016/S0012-821X(99)00012-6; Wieler R, 1996, NATURE, V384, P46, DOI 10.1038/384046a0; Ziegler J.F, 1985, STOPPING RANGE IONS; Zinner E, 1998, ANNU REV EARTH PL SC, V26, P147, DOI 10.1146/annurev.earth.26.1.147	29	130	131	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2000	290	5494					1142	1145		10.1126/science.290.5494.1142	http://dx.doi.org/10.1126/science.290.5494.1142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	372HL	11073449				2022-12-01	WOS:000165228200042
J	Yamashita, J; Itoh, H; Hirashima, M; Ogawa, M; Nishikawa, S; Yurugi, T; Naito, M; Nakao, K; Nishikawa, S				Yamashita, J; Itoh, H; Hirashima, M; Ogawa, M; Nishikawa, S; Yurugi, T; Naito, M; Nakao, K; Nishikawa, S			Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSEL FORMATION; SMOOTH-MUSCLE CELLS; PDGF-B; HEMATOPOIETIC LINEAGES; MESODERMAL CELLS; IN-VITRO; RECEPTOR; BETA; VASCULOGENESIS	Interaction between endothelial cells and mural cells (pericytes and vascular smooth muscle) is essential for vascular development and maintenance(1-4). Endothelial cells arise from Flk1-expressing (Flk1(+)) mesoderm cells(5), whereas mural cells are believed to derive from mesoderm, neural crest or epicardial cells and migrate to form the vessel wall(6-8). Difficulty in preparing pure populations of these lineages has hampered dissection of the mechanisms underlying vascular formation. Here we show that Flk1(+) cells derived from embryonic stem cells can differentiate into both endothelial and mural cells and can reproduce the vascular organization process. Vascular endothelial growth factor promotes endothelial cell differentiation, whereas mural cells are induced by platelet-derived growth factor-BB. Vascular cells derived from Flk1(+) cells can organize into vessel-like structures consisting of endothelial tubes supported by mural cells in three-dimensional culture. Injection of Flk1(+) cells into chick embryos showed that they can incorporate as endothelial and mural cells and contribute to the developing vasculature in vivo. Our findings indicate that Flk1(+) cells can act as `vascular progenitor cells' to form mature vessels and thus offer potential for tissue engineering of the vascular system.	Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto 6068509, Japan; Kyoto Univ, Grad Sch Med, Dept Mol Genet, Sakyo Ku, Kyoto 6068509, Japan; Niigata Univ, Sch Med, Dept Pathol 2, Niigata 9518510, Japan	Kyoto University; Kyoto University; Niigata University	Yamashita, J (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068509, Japan.		Hirashima, Masanori/ABC-9204-2021	Hirashima, Masanori/0000-0002-0190-4381				Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Choi K, 1998, DEVELOPMENT, V125, P725; CUEVAS P, 1984, ANAT EMBRYOL, V170, P155, DOI 10.1007/BF00319000; Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127; DeRuiter MC, 1997, CIRC RES, V80, P444, DOI 10.1161/01.RES.80.4.444; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; ISOBE Y, 1977, ACTA HISTOCHEM CYTOC, V10, P161, DOI 10.1267/ahc.10.161; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Matsuyoshi N, 1997, P ASSOC AM PHYSICIAN, V109, P362; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Ogawa M, 1999, BLOOD, V93, P1168, DOI 10.1182/blood.V93.4.1168.404k12_1168_1177; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIRAYOSHI Y, 1986, CELL STRUCT FUNCT, V11, P245, DOI 10.1247/csf.11.245; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takakura N, 1996, J EXP MED, V184, P2301, DOI 10.1084/jem.184.6.2301; Topouzis S, 1996, DEV BIOL, V178, P430, DOI 10.1006/dbio.1996.0229; UEDA M, 1995, CORONARY ARTERY DIS, V6, P71, DOI 10.1097/00019501-199501000-00011; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamamoto T, 1996, AM J PATHOL, V149, P1271; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	30	1026	1129	1	48	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2000	408	6808					92	96		10.1038/35040568	http://dx.doi.org/10.1038/35040568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081514				2022-12-01	WOS:000165050400058
J	Vance, JC				Vance, JC			A degree of vision	LANCET			English	Editorial Material							OPHTHALMOLOGISTS		Mater Childrens Hosp, Dept Paediat & Child Hlth, S Brisbane, Qld 4101, Australia		Vance, JC (corresponding author), Mater Childrens Hosp, Dept Paediat & Child Hlth, S Brisbane, Qld 4101, Australia.							ADAMS GL, 1970, PSYCHIAT MED, V1, P233, DOI 10.2190/R0G9-95LE-8NK7-YBHE; Burgoon J. K., 1985, HDB INTERPERSONAL CO, P344; CARPENTER JO, 1974, ARCH PHYS MED REHAB, V55, P272; DAVIS L, 1996, NAT FED BLIND CIT AU, P20; FITZGERALD RG, 1970, ARCH GEN PSYCHIAT, V22, P370; FRIEDMAN DB, 1994, PRINCIPLES PRACTICE, P3722; GOLDBERG MF, 1994, OPHTHALMIC GENET, V15, P47, DOI 10.3109/13816819409098863; GREENBLATT SL, 1988, SOC SCI MED, V26, P393, DOI 10.1016/0277-9536(88)90307-3; HALLAHAN D, 1997, EXCEPT CHILDREN, P343; HERSHBERGER PJ, 1992, PERCEPT MOTOR SKILL, V74, P509, DOI 10.2466/PMS.74.2.509-510; HUBER A, 1994, CURR OPIN NEUROL, V7, P65, DOI 10.1097/00019052-199402000-00012; Keeffe JE, 1996, AUST NZ J OPHTHALMOL, V24, P207, DOI 10.1111/j.1442-9071.1996.tb01582.x; Kubler-Ross E., 1970, DEATH DYING; LAMPERT J, 1995, AM J OCCUP THER, V49, P885, DOI 10.5014/ajot.49.9.885; Lindsay S, 1992, CURR OPIN GENET DEV, V2, P459, DOI 10.1016/S0959-437X(05)80158-3; Lovie-Kitchin JE., 1996, CLIN EXP OPTOM, V79, P227; NEMSHICK LA, 1986, J VISUAL IMPAIR BLIN, V80, P859; PARRISH RK, 1988, ARCH OPHTHALMOL-CHIC, V106, P31; SHIPSEY SM, 1994, PRINCIPLES PRACTICE, P3717; STETTEN D, 1981, NEW ENGL J MED, V305, P458, DOI 10.1056/NEJM198108203050811	20	5	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 28	2000	356	9240					1517	1519		10.1016/S0140-6736(00)02888-9	http://dx.doi.org/10.1016/S0140-6736(00)02888-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367NA	11081552				2022-12-01	WOS:000090067300043
J	Brand, JG				Brand, JG			Within reach of an end to unnecessary bitterness?	LANCET			English	Editorial Material							TASTE; GUSTDUCIN		Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; Vet Affairs Med Ctr, Philadelphia, PA USA; Univ Penn, Philadelphia, PA 19104 USA	Monell Chemical Senses Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Brand, JG (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.							Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Barlow LA, 1999, NEURON, V22, P209, DOI 10.1016/S0896-6273(00)81081-8; Brand JG, 2000, J NUTR, V130, p942S, DOI 10.1093/jn/130.4.942S; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Hoffman HJ, 1998, ANN NY ACAD SCI, V855, P716, DOI 10.1111/j.1749-6632.1998.tb10650.x; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Krizhanovsky V, 2000, AM J PHYSIOL-CELL PH, V279, pC120, DOI 10.1152/ajpcell.2000.279.1.C120; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Peri I, 2000, AM J PHYSIOL-CELL PH, V278, pC17, DOI 10.1152/ajpcell.2000.278.1.C17; Rossler P, 2000, CHEM SENSES, V25, P413, DOI 10.1093/chemse/25.4.413; Spielman AI, 1996, AM J PHYSIOL-CELL PH, V270, pC926, DOI 10.1152/ajpcell.1996.270.3.C926; SPIELMAN AI, 1992, SOC GEN PHY, V47, P307; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; YAN W, 1999, CHEM SENSES, V24, P595; YEE KK, IN PRESS DEV BRAIN R	20	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2000	356	9239					1371	1372		10.1016/S0140-6736(00)02836-1	http://dx.doi.org/10.1016/S0140-6736(00)02836-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052575				2022-12-01	WOS:000089976100005
J	Mehta, SH; Brancati, FL; Sulkowski, MS; Strathdee, SA; Szklo, M; Thomas, DL				Mehta, SH; Brancati, FL; Sulkowski, MS; Strathdee, SA; Szklo, M; Thomas, DL			Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							ASSOCIATION; GLUCOSE; CIRRHOSIS	Background: Hepatitis C virus (HCV) infection may contribute to the development of diabetes mellitus. This relationship has not been investigated at the population level, and its biological mechanism remains unknown. Objective: To examine the prevalence of type 2 diabetes among persons with HCV infection in a representative sample of the general adult population of the United States. Design: Cross-sectional national survey. Setting: The Third National Health and Nutrition Examination Survey, 1988-1994. Participants: 9841 persons older than 20 years of age for whom data on HCV infection and diabetes were complete. Measurements: The presence of diabetes was ascertained by using American Diabetes Association guidelines based on fasting plasma glucose measurement and medication history. Presence of HCV infection was assessed by testing for serum HCV-specific antibodies (anti-HCV). Results: of the 9841 persons evaluated, 8.4% had type 2 diabetes and 2.1% were anti-HCV positive. Type 2 diabetes occurred more often in persons who were older, were nonwhite, had a high body mass index, and had low socioeconomic status. Type 2 diabetes was less common in persons who acknowledged previous illicit drug use. After adjustment for these factors, persons 40 years of age or older with HCV infection were more than three times more likely than those without HCV infection to have type 2 diabetes (adjusted odds ratio, 3.77 [95% CI, 1.80 to 7.87]). None of the 19 persons with type 1 diabetes were anti-HCV positive. Conclusion: In the United States, type 2 diabetes occurs more often in persons with HCV infection who are older than 40 years of age.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Thomas, DL (corresponding author), Johns Hopkins Med Inst, 1147 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.		Strathdee, Steffanie A/B-9042-2009	Szklo, Moyses/0000-0001-9433-6266	NATIONAL INSTITUTE ON DRUG ABUSE [F31DA006007, R01DA010627] Funding Source: NIH RePORTER; NIDA NIH HHS [1 F31 DA06007, 1 R01 DA10627] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALLISON MED, 1994, J HEPATOL, V21, P1135, DOI 10.1016/S0168-8278(05)80631-2; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bonkovsky HL, 1998, HEPATOLOGY, V27, P1661, DOI 10.1002/hep.510270627; Caronia S, 1999, HEPATOLOGY, V30, P1059, DOI 10.1002/hep.510300416; GRAY H, 1995, DIABETIC MED, V12, P244, DOI 10.1111/j.1464-5491.1995.tb00466.x; Grimbert S, 1996, GASTROEN CLIN BIOL, V20, P544; Haffner SM, 1998, DIABETES CARE, V21, pC3, DOI 10.2337/diacare.21.3.C3; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Knobler H, 1998, J CLIN GASTROENTEROL, V26, P30, DOI 10.1097/00004836-199801000-00009; Mangia A, 1998, AM J GASTROENTEROL, V93, P2363, DOI 10.1111/j.1572-0241.1998.00688.x; Mason AL, 1999, HEPATOLOGY, V29, P328, DOI 10.1002/hep.510290235; Merli M, 1999, HEPATOLOGY, V30, P649, DOI 10.1002/hep.510300306; *NAT CTR HLTH STAT, 1994, DHHS PUBL; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; NELSON KE, 1991, JAMA-J AM MED ASSOC, V266, P2259, DOI 10.1001/jama.266.16.2259; NHLBI Obesity Education Initiative Expert Panel on the Identi-fication E and T of O in A (US), 1998, CLIN GUID ID EV TREA; Ozyilkan E, 1996, AM J GASTROENTEROL, V91, P1480; PETRIDES AS, 1989, J HEPATOL, V8, P107, DOI 10.1016/0168-8278(89)90169-4; Prior M J, 1993, Ann Epidemiol, V3, P9; Simo R, 1996, DIABETES CARE, V19, P998, DOI 10.2337/diacare.19.9.998; Strassburg CP, 1996, J VIRAL HEPATITIS, V3, P49, DOI 10.1111/j.1365-2893.1996.tb00081.x; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; TRAN A, 1993, HEPATOLOGY, V18, P253, DOI 10.1002/hep.1840180205	26	531	545	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					592	599		10.7326/0003-4819-133-8-200010170-00009	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033586				2022-12-01	WOS:000089906300003
J	Filchak, KE; Roethele, JB; Feder, JL				Filchak, KE; Roethele, JB; Feder, JL			Natural selection and sympatric divergence in the apple maggot Rhagoletis pomonella	NATURE			English	Article							HOST RACES; TRADE-OFFS; FIELD-TEST; FLY; TEPHRITIDAE; DIPTERA; SPECIATION; FLIES	In On the Origin of Species, Darwin proposed that natural selection had a fundamental role in speciation(1). But this view receded during the Modern Synthesis when allopatric (geographic) models of speciation were integrated with genetic studies of hybrid sterility and inviability(2,3). The sympatric hypothesis posits that ecological specialization after a host shift can result in speciation in the absence of complete geographic isolation(4,5). The apple maggot, Rhagoletis pomonella, is a model for sympatric speciation in progress(4,5). Hawthorn (Crataegus spp.) is the native host for R. pomonella in N. America(5). But in the mid-1800s, a new population formed on introduced, domesticated apple (Malus pumila)(4,5). Recent studies(6-10) have conferred `host race' status on apple flies as a potentially incipient species, partially isolated from haw flies owing to host-related adaptation. However, the source of selection that differentiates apple and haw flies is unresolved. Here we document a gene-environment interaction (fitness trade-off) that is related to host phenology and that genetically differentiates the races.	Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr, Notre Dame, IN 46556 USA	University of Notre Dame	Filchak, KE (corresponding author), Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr, Notre Dame, IN 46556 USA.							ABRAHAMSON WG, 1994, GALL FORMING INSECTS, P208; Bush G.L., 1975, P187; Bush G. L., 1966, TAXONOMY CYTOLOGY EV; Craig TP, 1997, EVOLUTION, V51, P1552, DOI 10.1111/j.1558-5646.1997.tb01478.x; Darwin C., 1859, ORIGIN SPECIES MEANS; Dobzhansky T., 1937, GENETICS ORIGINS SPE; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; FEDER JL, 1995, ECOLOGY, V76, P801, DOI 10.2307/1939346; FEDER JL, 1989, EVOLUTION, V43, P1813, DOI [10.2307/2409398, 10.1111/j.1558-5646.1989.tb02632.x]; Feder JL, 1999, ENTOMOL EXP APPL, V91, P211, DOI 10.1023/A:1003603918154; FEDER JL, 1988, NATURE, V336, P61, DOI 10.1038/336061a0; Feder JL, 1998, ENDLESS FORMS, P130; Filchak KE, 1999, EVOLUTION, V53, P187, DOI 10.1111/j.1558-5646.1999.tb05344.x; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; LATHROP FH, 1932, TECH B USDA, V275; Mayr E., 1942, SYSTEMATICS ORIGIN S, DOI 10.2307/1790142; MCPHERON BA, 1988, NATURE, V336, P64, DOI 10.1038/336064a0; PROKOPY RJ, 1988, OECOLOGIA, V76, P138, DOI 10.1007/BF00379612; PROKOPY RJ, 1971, CAN ENTOMOL, V103, P1405, DOI 10.4039/Ent1031405-10; REID JA, 1976, P ENT SOC ONTARIO, V197, P19; Roethele JB, 1997, ANN ENTOMOL SOC AM, V90, P470, DOI 10.1093/aesa/90.4.470; Tauber C.A., 1989, P307; Thompson J.N., 1994, COEVOLUTIONARY PROCE; Via Sara, 1994, P58; WOOD TK, 1990, EVOLUTION, V44, P619, DOI [10.2307/2409439, 10.1111/j.1558-5646.1990.tb05942.x]	26	292	298	0	163	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					739	742		10.1038/35037578	http://dx.doi.org/10.1038/35037578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048719				2022-12-01	WOS:000089773900041
J	Allen, GJ; Chu, SP; Schumacher, K; Shimazaki, CT; Vafeados, D; Kemper, A; Hawke, SD; Tallman, G; Tsien, RY; Harper, JF; Chory, J; Schroeder, JI				Allen, GJ; Chu, SP; Schumacher, K; Shimazaki, CT; Vafeados, D; Kemper, A; Hawke, SD; Tallman, G; Tsien, RY; Harper, JF; Chory, J; Schroeder, JI			Alteration of stimulus-specific guard cell calcium oscillations and stomatal closing in Arabidopsis det3 mutant	SCIENCE			English	Article							CYTOSOLIC-FREE CALCIUM; ABSCISIC-ACID; CYTOPLASMIC CALCIUM; GENE-EXPRESSION; CLOSURE; DICTYOSTELIUM; SENSITIVITY; FREQUENCY; ELEVATION; STRESS	Cytosolic calcium oscillations control signaling in animal cells, whereas in plants their importance remains Largely unknown. In wild-type Arabidopsis guard cells abscisic acid, oxidative stress, cold, and external calcium elicited cytosolic calcium oscillations of differing amplitudes and frequencies and induced stomatal closure. In guard cells of the V-ATPase mutant det3, external calcium and oxidative stress elicited prolonged calcium increases, which did not oscillate, and stomatal closure was abolished. Conversely, cold and abscisic acid elicited calcium oscillations in det3, and stomatal closure occurred normally. Moreover, in det3 guard cells, experimentally imposing external calcium-induced oscillations rescued stomatal closure. These data provide genetic evidence that stimulus-specific calcium oscillations are necessary for stomatal closure.	Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA; Salk Inst, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst, Plant Biol Lab, La Jolla, CA 92037 USA; Willamette Univ, Dept Biol, Salem, OR 97301 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Pharmacol & Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Cellular & Mol Med, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute; Salk Institute; Willamette University; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Allen, GJ (corresponding author), Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA.		Schumacher, Karin/E-8500-2014	Schumacher, Karin/0000-0001-6484-8105; Schroeder, Julian/0000-0002-3283-5972	NIGMS NIH HHS [R01 GM60396-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Camello-Almaraz C, 2000, BIOCHEM BIOPH RES CO, V271, P311, DOI 10.1006/bbrc.2000.2633; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; Grabov A, 1998, P NATL ACAD SCI USA, V95, P4778, DOI 10.1073/pnas.95.8.4778; Hirschi KD, 1999, PLANT CELL, V11, P2113, DOI 10.1105/tpc.11.11.2113; HoldawayClarke TL, 1997, PLANT CELL, V9, P1999, DOI 10.1105/tpc.9.11.1999; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; McAinsh MR, 1996, PLANT PHYSIOL, V111, P1031, DOI 10.1104/pp.111.4.1031; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; McAinsh MR, 1998, TRENDS PLANT SCI, V3, P32, DOI 10.1016/S1360-1385(97)01150-3; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; ROONEY EK, 1994, CELL CALCIUM, V16, P509, DOI 10.1016/0143-4160(94)90081-7; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; Xie YY, 1996, J CELL SCI, V109, P489	27	357	394	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2338	2342		10.1126/science.289.5488.2338	http://dx.doi.org/10.1126/science.289.5488.2338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009417				2022-12-01	WOS:000089593500049
J	Wosten, MMSM; Kox, LFF; Chamnongpol, S; Soncini, FC; Groisman, EA				Wosten, MMSM; Kox, LFF; Chamnongpol, S; Soncini, FC; Groisman, EA			A signal transduction system that responds to extracellular iron	CELL			English	Article							2-COMPONENT REGULATORY SYSTEM; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; LIPID-A; POLYMYXIN RESISTANCE; METAL-CATIONS; PMRA MUTANTS; LIPOPOLYSACCHARIDE; TRANSPORT; GENES	Iron is essential for all organisms but can be toxic in excess. Iron homeostasis is typically regulated by cytoplasmic iron binding proteins, but here we describe a signal transduction system (PmrA/PmrB) that responds to extracytoplasmic ferric iron. Iron promoted transcription of PmrA-activated genes and resistance to the antibiotic polymyxin in Salmonella. The PmrB protein bound iron via its periplasmic domain which harbors two copies of the sequence ExxE, a motif present in the Saccharomyces FTR1 iron transporter and in mammalian ferritin light chain. A pmrA mutant was hypersensitive to killing by iron but displayed wild-type resistance to a variety of oxidants, suggesting PmrA/PmrB controls a novel pathway mediating the avoidance of iron toxicity.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Groisman, EA (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA.	groisman@borcim.wustl.edu		Soncini, Fernando/0000-0002-8925-7763; Wosten, Marc/0000-0002-7464-7232	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042236] Funding Source: NIH RePORTER; NIAID NIH HHS [AI42236] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; Askwith CC, 1996, MOL MICROBIOL, V20, P27, DOI 10.1111/j.1365-2958.1996.tb02485.x; Braun V, 1997, ARCH MICROBIOL, V167, P325, DOI 10.1007/s002030050451; Braun V, 1997, BIOL CHEM, V378, P779; BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209; Cammack R, 1990, IRON TRANSPORT STORA, P17; Davies RH, 1996, J VET MED B, V43, P119, DOI 10.1111/j.1439-0450.1996.tb00295.x; Davis R., 1980, ADV BACTERIAL GENETI; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Dunning JC, 1998, APPL ENVIRON MICROB, V64, P27; ETTNER N, 1995, BIOCHEMISTRY-US, V34, P22, DOI 10.1021/bi00001a004; Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999; FERRIS FG, 1986, CAN J MICROBIOL, V32, P52, DOI 10.1139/m86-010; FOSTER JW, 1992, J BACTERIOL, V174, P4317, DOI 10.1128/JB.174.13.4317-4323.1992; Goddard WP, 1997, J NUTR, V127, P177, DOI 10.1093/jn/127.1.177; Godson GN, 2000, BIOCHEMISTRY-US, V39, P332, DOI 10.1021/bi9916628; GROISMAN EA, 1993, P NATL ACAD SCI USA, V90, P1033, DOI 10.1073/pnas.90.3.1033; GROISMAN EA, 1992, J BACTERIOL, V174, P486, DOI 10.1128/jb.174.2.486-491.1992; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Gunn JS, 1998, MICROB PATHOGENESIS, V25, P77, DOI 10.1006/mpat.1998.0217; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Halliwell B., 1991, FREE RADICALS BIOL M; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HASIN M, 1982, J BIOL CHEM, V257, P2475; Heithoff DM, 1999, J BACTERIOL, V181, P799, DOI 10.1128/JB.181.3.799-807.1999; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hoch JA, 1995, 2 COMPONENT SIGNAL T; JOSHI J G, 1988, Biofactors, V1, P207; Kaplan J, 1996, SCIENCE, V271, P1510, DOI 10.1126/science.271.5255.1510; KARLIN KD, 1993, SCIENCE, V261, P701, DOI 10.1126/science.7688141; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; Langley S, 1999, APPL ENVIRON MICROB, V65, P489; Lucassen ECHET, 2000, AQUAT BOT, V66, P321, DOI 10.1016/S0304-3770(99)00083-2; MAKELA PH, 1978, FEMS MICROBIOL LETT, V3, P323; MILLER DD, 1989, BIOL TRACE ELEM RES, V19, P11, DOI 10.1007/BF02925446; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; MUSZYNSKA G, 1992, J CHROMATOGR, V604, P19, DOI 10.1016/0021-9673(92)85524-W; Nelson N, 1999, EMBO J, V18, P4361, DOI 10.1093/emboj/18.16.4361; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Ratering S, 2000, BIOGEOCHEMISTRY, V48, P341, DOI 10.1023/A:1006252315427; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Sambrook J., 1989, MOL CLONING LAB MANU, V3; SANDERSON KE, 1995, MICROBIOL REV, V59, P241, DOI 10.1128/MMBR.59.2.241-303.1995; SHAFER WM, 1984, INFECT IMMUN, V43, P834, DOI 10.1128/IAI.43.3.834-838.1984; SHAFER WM, 1986, INFECT IMMUN, V53, P651, DOI 10.1128/IAI.53.3.651-655.1986; SIMPSON RJ, 1990, BRIT J NUTR, V63, P79, DOI 10.1079/BJN19900093; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; Soncini FC, 1996, J BACTERIOL, V178, P6796, DOI 10.1128/jb.178.23.6796-6801.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Sparling DW, 1996, REV ENVIRON CONTAM T, V145, P1; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; STORM DR, 1977, ANNU REV BIOCHEM, V46, P723, DOI 10.1146/annurev.bi.46.070177.003451; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Wosten MMSM, 1999, J BIOL CHEM, V274, P27185, DOI 10.1074/jbc.274.38.27185; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999	66	273	278	5	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2000	103	1					113	125		10.1016/S0092-8674(00)00092-1	http://dx.doi.org/10.1016/S0092-8674(00)00092-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051552	Bronze			2022-12-01	WOS:000089636400013
J	Garcia-Tsao, G; Korzenik, JR; Young, L; Henderson, KJ; Jain, D; Byrd, B; Pollak, JS; White, RI				Garcia-Tsao, G; Korzenik, JR; Young, L; Henderson, KJ; Jain, D; Byrd, B; Pollak, JS; White, RI			Liver disease in patients with hereditary hemorrhagic telangiectasia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	49th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases	NOV 04-11, 1998	CHICAGO, IL	Amer Assoc Study Liver Dis			WEBER-RENDU DISEASE; HEPATIC ARTERIOVENOUS-MALFORMATIONS; TRANSCATHETER EMBOLIZATION; ARTERIAL EMBOLIZATION; DOPPLER SONOGRAPHY; FAILURE; TRANSPLANTATION; INVOLVEMENT; MANIFESTATIONS; TRANSFORMATION	Background: Hereditary hemorrhagic telangiectasia, or Rendu-Osler-Weber disease, is an autosomal dominant disorder characterized by angiodysplastic lesions (telangiectases and arteriovenous malformations) that affect many organs. Liver involvement in patients with this disease has not been fully characterized. Methods: We studied the clinical findings and results of hemodynamic, angiographic, and imaging studies in 19 patients with hereditary hemorrhagic telangiectasia and symptomatic liver involvement. Results: We evaluated 14 women and 5 men who ranged in age from 34 to 74 years. All but one of the patients had a hyperdynamic circulation (cardiac index, 4.2 to 7.3 liters per minute per square meter of body-surface area). In eight patients, the clinical findings were consistent with the presence of high-output heart failure. The cardiac index and pulmonary-capillary wedge pressure were elevated in the six patients in whom these measurements were performed. After a median period of 24 months, the condition of three of the eight patients had improved, four were in stable condition with medical therapy, and one had died. Six patients had manifestations of portal hypertension such as ascites or variceal bleeding. The hepatic sinusoidal pressure was elevated in the four patients in whom it was measured. After a median period of 19 months, the condition of two of the six patients had improved, and the other four had died. Five patients had manifestations of biliary disease, such as an elevated alkaline phosphatase level and abnormalities on bile duct imaging. After a median period of 30 months, the condition of two of the five had improved, the condition of one was unchanged, heart failure had developed in one, and one had died after an unsuccessful attempt at liver transplantation. Conclusions: In patients with hereditary hemorrhagic telangiectasia and symptomatic liver involvement, the typical clinical presentations include high-output heart failure, portal hypertension, and biliary disease. (N Engl J Med 2000;343:931-6.) (C)2000, Massachusetts Medical Society.	Yale Univ, Sch Med, Div Digest Dis, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Div Cardiol, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Garcia-Tsao, G (corresponding author), Yale Univ, Sch Med, Div Digest Dis, Dept Internal Med, 333 Cedar St,POB 3333, New Haven, CT 06520 USA.	guadalupe.garcia-tsao@yale.edu	Garcia-Tsao, Guadalupe/ABF-7374-2020					BALL NJ, 1990, ARCH PATHOL LAB MED, V114, P423; BAUER T, 1995, J HEPATOL, V22, P586, DOI 10.1016/0168-8278(95)80455-2; BERNARD G, 1993, GASTROENTEROLOGY, V105, P482, DOI 10.1016/0016-5085(93)90723-P; BJORO K, 1995, SCAND J GASTROENTERO, V30, P92, DOI 10.3109/00365529509093242; Boillot O, 1999, GASTROENTEROLOGY, V116, P187, DOI 10.1016/S0016-5085(99)70243-X; BOURGEOIS N, 1990, J CLIN GASTROENTEROL, V12, P236; BROHEE D, 1984, ARCH INTERN MED, V144, P1282, DOI 10.1001/archinte.144.6.1282; Buscarini E, 1997, J HEPATOL, V26, P111, DOI 10.1016/S0168-8278(97)80017-7; Caselitz M, 1998, GUT, V42, P123, DOI 10.1136/gut.42.1.123; CLOOGMAN HM, 1984, RADIOLOGY, V150, P521, DOI 10.1148/radiology.150.2.6691112; COHEN N, 1994, J CLIN GASTROENTEROL, V18, P172, DOI 10.1097/00004836-199403000-00026; COONEY T, 1977, J CLIN PATHOL, V30, P1134, DOI 10.1136/jcp.30.12.1134; DAGATA IDA, 1994, SEMIN LIVER DIS, V14, P215, DOI 10.1055/s-2007-1007313; DANCHIN N, 1983, AM HEART J, V105, P856, DOI 10.1016/0002-8703(83)90253-3; DERAUF BJ, 1987, CARDIOVASC INTER RAD, V10, P80, DOI 10.1007/BF02577971; FAGEL WJ, 1988, AM J MED, V85, P858; GOTHLIN JH, 1982, EUR J RADIOL, V2, P27; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; HENDERSON JM, 1981, J COMPUT ASSIST TOMO, V5, P773, DOI 10.1097/00004728-198110000-00037; Lee JY, 1998, J VASC INTERV RADIOL, V9, P994, DOI 10.1016/S1051-0443(98)70439-7; LIVNEH A, 1988, SOUTHERN MED J, V81, P1047, DOI 10.1097/00007611-198808000-00026; LUDWIG J, 1989, HEPATOLOGY, V9, P215, DOI 10.1002/hep.1840090209; MARTINI GA, 1978, GUT, V19, P531, DOI 10.1136/gut.19.6.531; McInroy B, 1998, AM J ROENTGENOL, V170, P413, DOI 10.2214/ajr.170.2.9456956; MENDOZA A, 1995, EUR J GASTROEN HEPAT, P999; Mukasa C, 1998, AM J GASTROENTEROL, V93, P471, DOI 10.1016/S0002-9270(98)80052-X; NAGANUMA H, 1995, AM J ROENTGENOL, V165, P1421, DOI 10.2214/ajr.165.6.7484577; Neumann UP, 1998, TRANSPL INT, V11, P323, DOI 10.1007/s001470050152; NIKOLOPOULOS N, 1988, HEPATO-GASTROENTEROL, V35, P167; Odorico JS, 1998, LIVER TRANSPLANT SUR, V4, P483, DOI 10.1002/lt.500040609; OUCHI K, 1994, AM J GASTROENTEROL, V89, P425; Peh WCG, 1996, BRIT J RADIOL, V69, P281, DOI 10.1259/0007-1285-69-819-281; PEPPER GM, 1981, NEW YORK STATE J MED, V81, P209; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; RADTKE WE, 1978, AM HEART J, V95, P235, DOI 10.1016/0002-8703(78)90468-4; RALLS PW, 1992, AM J ROENTGENOL, V159, P59, DOI 10.2214/ajr.159.1.1609722; REILLY PJ, 1984, AM J GASTROENTEROL, V79, P363; REWANE I, 1983, BRIT J RADIOL, V56, P207, DOI 10.1259/0007-1285-56-663-207; ROMAN CF, 1987, ANGIOLOGY, V38, P484, DOI 10.1177/000331978703800610; Saxena R, 1998, AM J SURG PATHOL, V22, P368, DOI 10.1097/00000478-199803000-00013; SCHWARTZ SI, 1961, SURGERY, V49, P611; Shimamatsu K, 1997, HEPATOLOGY, V26, P343, DOI 10.1002/hep.510260214; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; TRELL E, 1972, AM J MED, V53, P50, DOI 10.1016/0002-9343(72)90115-5; Trotter JF, 1998, AM J GASTROENTEROL, V93, P1569, DOI 10.1111/j.1572-0241.1998.00486.x; VILGRAIN V, 1991, AM J ROENTGENOL, V157, P413, DOI 10.2214/ajr.157.2.1853834; WANLESS IR, 1990, HEPATOLOGY, V11, P787, DOI 10.1002/hep.1840110512; WANLESS IR, 1986, ARCH PATHOL LAB MED, V110, P331; WHITING JH, 1992, J NUCL MED, V33, P260; ZAJKO AB, 1987, AM J ROENTGENOL, V149, P485, DOI 10.2214/ajr.149.3.485; ZENTLERMUNRO PL, 1989, GUT, V30, P1293, DOI 10.1136/gut.30.9.1293	51	243	259	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2000	343	13					931	936		10.1056/NEJM200009283431305	http://dx.doi.org/10.1056/NEJM200009283431305			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	357KT	11006369	Bronze			2022-12-01	WOS:000089501400005
J	Joazeiro, CAP; Hunter, T				Joazeiro, CAP; Hunter, T			Ubiquitination - More than two to tango	SCIENCE			English	Article							C-CBL; LIGASE; RBX1; SCF; PROTEIN; SUBUNIT; ENZYME		Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA	Salk Institute	Joazeiro, CAP (corresponding author), Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA.							Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Huang HK, 2000, J BIOL CHEM, V275, P26661; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	15	35	35	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2061	2062		10.1126/science.289.5487.2061	http://dx.doi.org/10.1126/science.289.5487.2061			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11032556				2022-12-01	WOS:000089430900028
J	Schulze, ED; Wirth, C; Heimann, M				Schulze, ED; Wirth, C; Heimann, M			Climate change - managing forests after Kyoto	SCIENCE			English	Article							CARBON SINK; CO2		Max Planck Inst Biogeochem, D-07701 Jena, Germany	Max Planck Society	Schulze, ED (corresponding author), Max Planck Inst Biogeochem, POB 100164, D-07701 Jena, Germany.	Detlef.Schulze@bgc-jena.mpg.de	Schulze, Ernst-Detlef/K-9627-2014; Heimann, Martin/H-7807-2016; Wirth, Christian/A-4446-2016	Heimann, Martin/0000-0001-6296-5113; 				Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; Bousquet P, 1999, J GEOPHYS RES-ATMOS, V104, P26161, DOI 10.1029/1999JD900342; Buchmann N, 1999, GLOBAL BIOGEOCHEM CY, V13, P751, DOI 10.1029/1999GB900016; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; Martin PH, 1998, AMBIO, V27, P582; MELILLO J, 1996, IPCC, P445; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; SCHIMEL D, 1996, IPCC WGI, P65; Schulze E.D., 1998, IGBP SERIES, P145; Schulze ED, 1999, GLOBAL CHANGE BIOL, V5, P703, DOI 10.1046/j.1365-2486.1999.00266.x; Schulze ED, 2000, ECOL STU AN, V142, P468; SHVIDENKO A, 1994, AMBIO, V23, P396; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; WIRTH C, IN PRESS PLANT SOIL; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314	16	312	355	10	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2058	2059		10.1126/science.289.5487.2058	http://dx.doi.org/10.1126/science.289.5487.2058			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11032555				2022-12-01	WOS:000089430900027
J	Allen, TM; O'Connor, DH; Jing, PC; Dzuris, JL; Mothe, BR; Vogel, TU; Dunphy, E; Liebl, ME; Emerson, C; Wilson, N; Kunstman, KJ; Wang, XC; Allison, DB; Hughes, AL; Desrosiers, RC; Altman, JD; Wolinsky, SM; Sette, A; Watkins, DI				Allen, TM; O'Connor, DH; Jing, PC; Dzuris, JL; Mothe, BR; Vogel, TU; Dunphy, E; Liebl, ME; Emerson, C; Wilson, N; Kunstman, KJ; Wang, XC; Allison, DB; Hughes, AL; Desrosiers, RC; Altman, JD; Wolinsky, SM; Sette, A; Watkins, DI			Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; PRIMARY INFECTION; GENETIC-VARIATION; NEF PROTEIN; EPITOPE; AIDS; CTL; MAMU-A-ASTERISK-01; RECOGNITION; PROGRESSION	Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections are characterized by early peaks of viraemia that decline as strong cellular immune responses develop(1,2). Although it has been shown that virus-specific CD8-positive cytotoxic T lymphocytes (CTLs) exert selective pressure during HIV and SIV infection(3-11), the data have been controversial(12,13). Here we show that Tat-specific CD8-positive T-lymphocyte responses select for new viral escape variants during the acute phase of infection. We sequenced the entire virus immediately after the acute phase, and found that amino-acid replacements accumulated primarily in Tat CTL epitopes. This implies that Tat-specific CTLs may be significantly involved in controlling wild-type virus replication, and suggests that responses against viral proteins that are expressed early during the viral life cycle might be attractive targets for HIV vaccine development.	Univ Wisconsin, Wisconsin Reg Primate Res Ctr, Madison, WI 53715 USA; Epimmune, San Diego, CA 92121 USA; Northwestern Univ, Sch Med, Chicago, IL 60611 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; New England Reg Primate Res Ctr, Southborough, MA 01772 USA; Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Emory University; Mount Sinai St. Luke's; Mount Sinai West; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Wisconsin System; University of Wisconsin Madison	Watkins, DI (corresponding author), Univ Wisconsin, Wisconsin Reg Primate Res Ctr, 1220 Capitol Court, Madison, WI 53715 USA.		Allen, Todd/F-5473-2011; Wolinsky, Steven/B-2893-2012; Sette, Alessandro/AFO-8916-2022	Allen, Todd/0000-0002-6609-1318; o'connor, david/0000-0003-2139-470X; Dzuris, John/0000-0002-0046-8426; Allison, David/0000-0003-3566-9399; Wolinsky, Steven/0000-0002-9625-6697				Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; Allen TM, 1998, J IMMUNOL, V160, P6062; ALLEN TM, IN PRESS J VIROL; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Balter M, 1998, SCIENCE, V280, P1860, DOI 10.1126/science.280.5371.1860; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; COUILLIN I, 1994, J EXP MED, V180, P1129, DOI 10.1084/jem.180.3.1129; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Knapp LA, 1997, TISSUE ANTIGENS, V50, P657, DOI 10.1111/j.1399-0039.1997.tb02927.x; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; MEYERHANS A, 1991, EUR J IMMUNOL, V21, P2637, DOI 10.1002/eji.1830211051; Mortara L, 1998, J VIROL, V72, P1403, DOI 10.1128/JVI.72.2.1403-1410.1998; NEI M, 1986, MOL BIOL EVOL, V3, P418; Osterhaus ADME, 1999, VACCINE, V17, P2713, DOI 10.1016/S0264-410X(98)00498-8; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Price GE, 2000, J EXP MED, V191, P1853, DOI 10.1084/jem.191.11.1853; REGIER DA, 1990, AIDS RES HUM RETROV, V6, P1221, DOI 10.1089/aid.1990.6.1221; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; YASUTOMI Y, 1993, J VIROL, V67, P1707, DOI 10.1128/JVI.67.3.1707-1711.1993	28	612	625	0	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					386	390		10.1038/35030124	http://dx.doi.org/10.1038/35030124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014195	Bronze			2022-12-01	WOS:000089390700049
J	Eisenberg, MS				Eisenberg, MS			Is it time for over-the-counter defibrillators?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AUTOMATIC EXTERNAL DEFIBRILLATOR; HOSPITAL CARDIAC-ARREST; VENTRICULAR-FIBRILLATION; SURVIVAL; CPR; RESUSCITATION; PROFESSIONALS; INSTRUCTION; COMMUNITY		Univ Washington, Med Ctr, Dept Med, Div Emergency Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eisenberg, MS (corresponding author), Univ Washington, Med Ctr, Dept Med, Div Emergency Med, Box 356123, Seattle, WA 98195 USA.							Atkins DL, 1998, PEDIATRICS, V101, P393, DOI 10.1542/peds.101.3.393; BANDINI F, 1997, G ITAL CARDIOL, V11, P1121; Becker L, 1999, Prehosp Emerg Care, V3, P353, DOI 10.1080/10903129908958968; Becker L, 1998, CIRCULATION, V97, P2106, DOI 10.1161/01.CIR.97.21.2106; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; Braslow A, 1997, RESUSCITATION, V34, P207, DOI 10.1016/S0300-9572(97)01096-4; CHADDA KD, 1987, AM J CARDIOL, V60, P732, DOI 10.1016/0002-9149(87)90396-1; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; EISENBERG M, 1995, ANN EMERG MED, V25, P198, DOI 10.1016/S0196-0644(95)70324-1; EISENBERG MS, 1989, AM J CARDIOL, V63, P443, DOI 10.1016/0002-9149(89)90316-0; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; EISENBERG MS, 1979, JAMA-J AM MED ASSOC, V241, P1905, DOI 10.1001/jama.241.18.1905; Gundry JW, 1999, CIRCULATION, V100, P1703, DOI 10.1161/01.CIR.100.16.1703; Hossack KF, 1982, J CARDIAC REHABIL, V2, P402; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; LITWIN PE, 1987, ANN EMERG MED, V16, P787, DOI 10.1016/S0196-0644(87)80576-0; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; Stolberg S G, 2000, N Y Times Web, pA15; Todd KH, 1998, ANN EMERG MED, V31, P364, DOI 10.1016/S0196-0644(98)70348-8; WEAVER WD, 1990, PROGR CLIN PACING 19, P47; WEINSTEIN MC, 1995, VALUING HLTH CARE CO, P77, DOI DOI 10.1017/CBO9780511625817.005; 2000, EM TODAY        0614, P1	22	21	22	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2000	284	11					1435	1438		10.1001/jama.284.11.1435	http://dx.doi.org/10.1001/jama.284.11.1435			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352WN	10989409				2022-12-01	WOS:000089242500041
J	van der Laan, LJW; Lockey, C; Griffeth, BC; Frasier, FS; Wilson, CA; Onions, DE; Hering, BJ; Long, ZF; Otto, E; Torbett, BE; Salomon, DR				van der Laan, LJW; Lockey, C; Griffeth, BC; Frasier, FS; Wilson, CA; Onions, DE; Hering, BJ; Long, ZF; Otto, E; Torbett, BE; Salomon, DR			Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice	NATURE			English	Article							HUMAN-CELLS; ENGRAFTMENT; PIGS	Animal donors such as pigs could provide an alternative source of organs for transplantation. However, the promise of xenotransplantation is offset by the possible public health risk of a cross-species infection(1,2). All pigs contain several copies of porcine endogenous retroviruses (PERV)(3,4), and at least three variants of PERV can infect human cell lines in vitro in co-culture, infectivity and pseudotyping experiments(3,5-7). Thus, if xenotransplantation of pig tissues results in PERV viral replication, there is a risk of spreading and adaptation of this retrovirus to the human host. C-type retroviruses related to PERV are associated with malignancies of haematopoietic lineage cells in their natural hosts(8). Here we show that pig pancreatic islets produce PERV and can infect human cells in culture. After transplantation into NOD/SCID (non-obese diabetic, severe combined immunodeficiency) mice, we detect ongoing viral expression and several tissue compartments become infected. This is the first evidence that PERV is transcriptionally active and infectious cross-species in vivo after transplantation of pig tissues. These results show that a concern for PERV infection risk associated with pig islet xenotransplantation in immunosuppressed human patients may be justified.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Genet Therapy Inc, Gaithersburg, MD 20878 USA; US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; Univ Glasgow, Dept Vet Pathol, Glasgow G61 1QH, Lanark, Scotland; Q One Biotech Ltd, Glasgow G20 OXA, Lanark, Scotland; Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA	Scripps Research Institute; Novartis; US Food & Drug Administration (FDA); University of Glasgow; University of Minnesota System; University of Minnesota Twin Cities	Salomon, DR (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Salomon, Daniel/E-9380-2012; van der Laan, Luc/M-5495-2019	van der Laan, Luc/0000-0002-0651-5334				Akiyoshi DE, 1998, J VIROL, V72, P4503, DOI 10.1128/JVI.72.5.4503-4507.1998; BEATTIE GM, 1994, TRANSPLANT P, V26, P3299; CHAPMAN LE, 1995, NEW ENGL J MED, V333, P1498, DOI 10.1056/NEJM199511303332211; Crisa L, 1999, BLOOD, V94, P3928, DOI 10.1182/blood.V94.11.3928.423k02_3928_3940; Heneine W, 1998, LANCET, V352, P1478; HESSELTON RM, 1995, J INFECT DIS, V172, P974, DOI 10.1093/infdis/172.4.974; LAMONT C, 1991, J VIROL, V65, P4619, DOI 10.1128/JVI.65.9.4619-4628.1991; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; LEVY JA, 1973, SCIENCE, V182, P1151, DOI 10.1126/science.182.4117.1151; Liu X, 1997, TRANSPL P, V29, P768, DOI 10.1016/S0041-1345(96)00476-9; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Patience C, 1998, LANCET, V352, P699, DOI 10.1016/S0140-6736(98)04369-4; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Sandrin MS, 1999, CURR OPIN IMMUNOL, V11, P527, DOI 10.1016/S0952-7915(99)00011-4; Stoye JP, 1997, NATURE, V386, P126, DOI 10.1038/386126b0; Takeuchi Y, 1998, J VIROL, V72, P9986, DOI 10.1128/JVI.72.12.9986-9991.1998; TOTH SR, 1986, VET PATHOL, V23, P462, DOI 10.1177/030098588602300417; Weiss RA, 1998, NATURE, V391, P327, DOI 10.1038/34772; Wilson CA, 2000, J VIROL, V74, P49, DOI 10.1128/JVI.74.1.49-56.2000; Wilson CA, 1998, J VIROL, V72, P3082, DOI 10.1128/JVI.72.4.3082-3087.1998	22	292	304	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					90	94		10.1038/35024089	http://dx.doi.org/10.1038/35024089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993079				2022-12-01	WOS:000089124000048
J	Liu, Z; Zhou, XY; Shapiro, SD; Shipley, JM; Twining, SS; Diaz, LA; Senior, RM; Werb, Z				Liu, Z; Zhou, XY; Shapiro, SD; Shipley, JM; Twining, SS; Diaz, LA; Senior, RM; Werb, Z			The serpin alpha 1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo	CELL			English	Article							BULLOUS PEMPHIGOID AUTOANTIGEN; RESPIRATORY-DISTRESS SYNDROME; HUMAN-LEUKOCYTE ELASTASE; BLISTER FLUIDS; MACROPHAGE ELASTASE; IV COLLAGENASE; SYNOVIAL-FLUID; HOST-DEFENSE; INACTIVATION; NEUTROPHILS	We have identified the key protein substrate of gelatinase B/MMP-9 (GB) that is cleaved in vivo during dermal-epidermal separation triggered by antibodies to the hemidesmosomal protein BP180 (collagen XVII, BPAG2). Mice deficient in either GB or neutrophil elastase (NE) are resistant to blister formation in response to these antibodies in a mouse model of the autoimmune disease bullous pemphigoid. Disease develops upon complementation of GB(-/-) mice with NE-/- neutrophils or NE-/- mice with GB(-/-) neutrophils. Only NE degrades BP180 and produces dermal-epidermal separation in vivo and in culture. Instead, GB acts upstream to regulates NE activity by inactivating alpha 1-proteinase inhibitor (alpha 1-PI). Excess NE produces lesions in GB(-/-) mice without cleaving alpha 1-PI. Excess alpha 1-PI phenocopies GB and NE deficiency in wild-type mice.	Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Medical College of Wisconsin; University of California System; University of California San Francisco	Liu, Z (corresponding author), Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA.	zhillu@med.unc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040768, R01AI040768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR032081, R01AR032081, R01AR032599] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40768] Funding Source: Medline; NIAMS NIH HHS [AR32081, AR32599, R01 AR032081] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BANDA MJ, 1988, J EXP MED, V167, P1608, DOI 10.1084/jem.167.5.1608; BANDA MJ, 1980, J EXP MED, V152, P1563, DOI 10.1084/jem.152.6.1563; BANDA MJ, 1987, J CLIN INVEST, V79, P1314, DOI 10.1172/JCI112955; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Betsuyaku T, 1999, AM J RESP CELL MOL, V20, P1303, DOI 10.1165/ajrcmb.20.6.3558; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Bullard KM, 1999, ANN SURG, V230, P260, DOI 10.1097/00000658-199908000-00017; COCHRANE CG, 1983, J CLIN INVEST, V71, P754, DOI 10.1172/JCI110823; COLIGAN JE, 1994, CURR PROTOCOLS IMMUN, V3; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; DVORAK AM, 1982, J INVEST DERMATOL, V78, P91, DOI 10.1111/1523-1747.ep12505711; Gammon W R, 1989, Immunol Ser, V46, P509; GISSLER HM, 1992, BRIT J DERMATOL, V127, P272, DOI 10.1111/j.1365-2133.1992.tb00127.x; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; GRANDO SA, 1989, INT J TISSUE REACT, V11, P195; GRANDO SA, 1989, ARCH DERMATOL, V125, P925, DOI 10.1001/archderm.125.7.925; JANOFF A, 1983, AM REV RESPIR DIS, V127, P782; JORDON RE, 1985, J INVEST DERMATOL, V85, pS72, DOI 10.1111/1523-1747.ep12275497; KNAUPER V, 1990, FEBS LETT, V263, P355, DOI 10.1016/0014-5793(90)81412-H; KRAMER MD, 1993, J CLIN INVEST, V92, P978, DOI 10.1172/JCI116674; LIU Z, 1995, J IMMUNOL, V155, P5449; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; LIU Z, 1995, J CLIN INVEST, V95, P1539, DOI 10.1172/JCI117826; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Liu Z, 1998, J EXP MED, V188, P475, DOI 10.1084/jem.188.3.475; Liu Z, 2000, J CLIN INVEST, V105, P113, DOI 10.1172/JCI3693; MAST AE, 1991, J BIOL CHEM, V266, P15810; MORIHARA K, 1984, J BIOCHEM, V95, P795, DOI 10.1093/oxfordjournals.jbchem.a134671; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; OIKARINEN AI, 1983, J INVEST DERMATOL, V81, P261; OKADA Y, 1992, J BIOL CHEM, V267, P21712; OSSANNA PJ, 1986, J CLIN INVEST, V77, P1939, DOI 10.1172/JCI112523; PEI DQ, 1994, J BIOL CHEM, V269, P25849; POTEMPA J, 1986, J BIOL CHEM, V261, P14330; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; SAWAMURA D, 1991, J BIOL CHEM, V266, P17784; SCHAUMBURGLEVER G, 1972, ARCH DERMATOL, V106, P662, DOI 10.1001/archderm.106.5.662; STAHLEBACKDAHL M, 1994, J CLIN INVEST, V93, P2022, DOI 10.1172/JCI117196; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; TANAKA T, 1991, J BIOL CHEM, V266, P12555; Twining SS, 1996, INVEST OPHTH VIS SCI, V37, P511; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Vu TH, 1998, BIOL EXTRAC, P115; WEILAND JE, 1986, AM REV RESPIR DIS, V133, P218; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WELGUS HG, 1986, J INVEST DERMATOL, V87, P592, DOI 10.1111/1523-1747.ep12455837; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; WONG PS, 1980, BIOCHEM BIOPH RES CO, V96, P1449, DOI 10.1016/0006-291X(80)90113-8; Yu Q, 2000, GENE DEV, V14, P163; ZHANG Z, 1990, BIOCHEM SOC T, V18, P898, DOI 10.1042/bst0180898	51	292	301	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					647	655		10.1016/S0092-8674(00)00087-8	http://dx.doi.org/10.1016/S0092-8674(00)00087-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007483	Bronze			2022-12-01	WOS:000089105200013
J	Hankey, GJ				Hankey, GJ			Clopidogrel and thrombotic thrombocytopenic purpura	LANCET			English	Editorial Material							TICLOPIDINE		Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia	Royal Perth Hospital; University of Western Australia	Hankey, GJ (corresponding author), Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia.		Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Bennett CL, 1999, ARCH INTERN MED, V159, P2524, DOI 10.1001/archinte.159.21.2524; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Bennett CL, 1998, ANN INTERN MED, V128, P541, DOI 10.7326/0003-4819-128-7-199804010-00004; Bennett CL, 1998, LANCET, V352, P1036, DOI 10.1016/S0140-6736(05)60079-7; Bertrand ME, 1999, CIRCULATION, V100, P620; CARWILE JM, 1999, BLOOD S, V94, P78; Connors JM, 1999, TRANSFUSION, V39, p56S; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gordon LI, 1997, SEMIN HEMATOL, V34, P140; McCarthy LJ, 1998, LANCET, V352, P1284, DOI 10.1016/S0140-6736(05)70492-X; Moussa I, 1999, CIRCULATION, V99, P2364, DOI 10.1161/01.CIR.99.18.2364; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Steinhubl SR, 1999, JAMA-J AM MED ASSOC, V281, P806, DOI 10.1001/jama.281.9.806; TOROK TJ, 1995, AM J HEMATOL, V50, P84, DOI 10.1002/ajh.2830500203; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203	15	30	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2000	356	9226					269	270		10.1016/S0140-6736(00)02498-3	http://dx.doi.org/10.1016/S0140-6736(00)02498-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MJ	11071178				2022-12-01	WOS:000088305900004
J	Fussmann, GF; Ellner, SP; Shertzer, KW; Hairston, NG				Fussmann, GF; Ellner, SP; Shertzer, KW; Hairston, NG			Crossing the Hopf bifurcation in a live predator-prey system	SCIENCE			English	Article							CHEMOSTAT CULTURE; ESCHERICHIA-COLI; COMPLEX DYNAMICS; FOOD-CHAINS; CYCLES; CHAOS; TIME	Population biologists have Long been interested in the oscillations in population size displayed by many organisms in the field and Laboratory. A wide range of deterministic mathematical models predict that these fluctuations can be generated internally by nonlinear interactions among species and, if correct, would provide important insights for understanding and predicting the dynamics of interacting populations. We studied the dynamical behavior of a two-species aquatic Laboratory community encompassing the interactions between a demographically structured herbivore population, a primary producer, and a mineral resource, yet still amenable to description and parameterization using a mathematical model. The qualitative dynamical behavior of our experimental system, that is, cycles, equilibria, and extinction, is highly predictable by a simple nonlinear model.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; N Carolina State Univ, Dept Stat, Biomath Program, Raleigh, NC 27695 USA	Cornell University; University of North Carolina; North Carolina State University	Fussmann, GF (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Corson Hall, Ithaca, NY 14853 USA.			Fussmann, Gregor/0000-0001-9576-0122; Shertzer, Kyle/0000-0001-7196-5959				Aoki S, 1996, FISHERIES SCI, V62, P8, DOI 10.2331/fishsci.62.8; BORAAS ME, 1980, AM SOC LIMNOL OCEANO, V3, P173; Constantino R.F, 1995, NATURE, V375, P227; DENT VE, 1976, ARCH MICROBIOL, V109, P187, DOI 10.1007/BF00425134; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; Elton C, 1942, J ANIM ECOL, V11, P215, DOI 10.2307/1358; Gragnani A, 1998, B MATH BIOL, V60, P703, DOI 10.1006/bulm.1997.0039; HALBACH U, 1970, OECOLOGIA, V4, P176, DOI 10.1007/BF00377100; HALBACH U, 1974, ARCH HYDROBIOL, V73, P273; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; JOST JL, 1973, J THEOR BIOL, V41, P461, DOI 10.1016/0022-5193(73)90056-8; JOST JL, 1973, J BACTERIOL, V113, P834, DOI 10.1128/JB.113.2.834-840.1973; Khibnik AI, 1997, P ROY SOC B-BIOL SCI, V264, P1049, DOI 10.1098/rspb.1997.0145; KOT M, 1992, B MATH BIOL, V54, P619, DOI 10.1016/S0092-8240(05)80079-5; LUCKINBILL LS, 1973, ECOLOGY, V54, P1320, DOI 10.2307/1934194; MAY RM, 1972, SCIENCE, V177, P900, DOI 10.1126/science.177.4052.900; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; NISBET RM, 1983, BIOTECHNOL BIOENG, V25, P301, DOI 10.1002/bit.260250122; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Strogatz S. H, 1994, NONLINEAR DYNAMICS C, V1st; TISCHNER R, 1979, PLANTA, V146, P287, DOI 10.1007/BF00387800	23	281	291	3	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2000	290	5495					1358	1360		10.1126/science.290.5495.1358	http://dx.doi.org/10.1126/science.290.5495.1358			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375BN	11082063				2022-12-01	WOS:000165379800049
J	Wolfe, J; Klar, N; Grier, HE; Duncan, J; Salem-Schatz, S; Emanuel, EJ; Weeks, JC				Wolfe, J; Klar, N; Grier, HE; Duncan, J; Salem-Schatz, S; Emanuel, EJ; Weeks, JC			Understanding of prognosis among parents of children who died of cancer - Impact on treatment goals and integration of palliative care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PEDIATRIC ONCOLOGY; PERSPECTIVES; PREFERENCES; GUIDELINES; PATIENT	Context Parents' understanding of prognosis or decision making about palliative care for children who die of cancer is largely unknown. However, a more accurate under standing of prognosis could alter treatment goals and expectations and lead to more effective care. Objectives To evaluate parental understanding of prognosis in children who die of cancer and to assess the association of this factor with treatment goals and the palliative care received by children. Design, Setting, and Participants Survey, conducted between September 1997 and August 1998, of 103 parents of children who received treatment at the Dana-Farber Cancer Institute and Children's Hospital, Boston, Mass, and who died of cancer between 1990 and 1997 (72 % of those eligible and those located) and 42 pediatric oncologists. Main Outcome Measure Timing of parental understanding that the child had no realistic chance for cure compared with the timing of physician understanding of this prognosis, as documented in the medical record. Results Parents first recognized that the child had no realistic chance for cure a mean (SD) of 106 (150) days before the child's death, while physician recognition occurred earlier at 206 (330) days before death. Among children who died of progressive disease, the group characterized by earlier recognition of this prognosis by both parents and physicians had earlier discussions of hospice care (odds ratio [OR], 1.03; 95% confidence interval [CI], 1.01 -1.06; P=.01), better parental ratings of the quality of home care (OR, 3.31; 95% CI, 1.15-9.54; P=.03), earlier institution of a do-not-resuscitate order (OR, 1.03; 95% CI, 1.00-1.06; P=.02), less use of cancer-directed therapy during the last month of life (OR, 2.80; 95% CI, 1.05-7.50; P=.04), and higher likelihood that the goal of cancer-directed therapy identified by both physician and parent was to lessen suffering (OR, 5.17; 95% CI, 1.86-14.4; P=.002 for physician and OR, 6.56; 95% CI, 1.54-27.86; P=.01 for parents). Conclusion Considerable delay exists in parental recognition that children have no realistic chance for cure, but earlier recognition of this prognosis by both physicians and parents is associated with a stronger emphasis on treatment directed at lessening suffering and greater integration of palliative care.	Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Div Prevent Oncol Canc Care Ontario, Toronto, ON, Canada; NIH, Dept Clin Bioeth, Bethesda, MD 20892 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Cancer Care Ontario; National Institutes of Health (NIH) - USA	Wolfe, J (corresponding author), Dana Farber Canc Inst, Ctr Outcomes & Policy Res, 44 Binney St, Boston, MA 02115 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000063] Funding Source: NIH RePORTER; AHRQ HHS [5 T32 HS00063] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; [Anonymous], 1996, JAMA-J AM MED ASSOC, V275, P1232; Billings J A, 1998, J Palliat Med, V1, P73, DOI 10.1089/jpm.1998.1.73; Cherny NI, 1996, HEMATOL ONCOL CLIN N, V10, P261, DOI 10.1016/S0889-8588(05)70338-5; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Frager G, 1996, J PALLIATIVE CARE, V12, P9; Houston K, 1995, Continuum, V15, P9; James L, 1997, J Pediatr Oncol Nurs, V14, P83, DOI 10.1177/104345429701400207; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; LEWIS C, 1988, J PEDIATR-US, V112, P378, DOI 10.1016/S0022-3476(88)80316-0; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Masera G, 1999, MED PEDIATR ONCOL, V32, P44, DOI 10.1002/(SICI)1096-911X(199901)32:1<44::AID-MPO9>3.0.CO;2-P; MAUER AM, 1987, AM J PEDIAT HEMATOL, V9, P58; PRONZATO P, 1994, SUPPORT CARE CANCER, V2, P242, DOI 10.1007/BF00365729; Pyke-Grimm K A, 1999, J Pediatr Oncol Nurs, V16, P13, DOI 10.1177/104345429901600103; Rosner B., 2011, FUNDAMENTALS BIOSTAT, P352; Ross LF, 1997, HASTINGS CENT REP, V27, P41, DOI 10.2307/3527717; Rothenbacher D, 1997, EUR J CANCER, V33, P1184, DOI 10.1016/S0959-8049(97)00034-8; Sanders J, 1997, PEDIATRICS, V99, P139; Saunders C, 1979, OMEGA, V10, P302; Schnipper L, 1998, J CLIN ONCOL, V16, P1986; Schroeder M. R., 1997, CONTINUUM, V17, P3; Shelton TL, 1999, J DEV BEHAV PEDIATR, V20, P117, DOI 10.1097/00004703-199904000-00008; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Streiner DL, 1995, HLTH MEASUREMENT SCA; TULSKY JA, 1995, J GEN INTERN MED, V10, P436, DOI 10.1007/BF02599915; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wolfe J, 2000, NEW ENGL J MED, V342, P326, DOI 10.1056/NEJM200002033420506	31	326	326	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2000	284	19					2469	2475		10.1001/jama.284.19.2469	http://dx.doi.org/10.1001/jama.284.19.2469			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	371MY	11074776	Bronze			2022-12-01	WOS:000165183800020
J	Sickles, EA				Sickles, EA			Galactography and other imaging investigations of nipple discharge	LANCET			English	Editorial Material							EXCISION		Univ Calif San Francisco, Sch Med, Dept Radiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sickles, EA (corresponding author), Univ Calif San Francisco, Sch Med, Dept Radiol, San Francisco, CA 94143 USA.							CARDENOSA G, 1991, RADIOLOGY, V181, P751, DOI 10.1148/radiology.181.3.1947092; Dawes LG, 1998, SURGERY, V124, P685, DOI 10.1067/msy.1998.91362; Dennis MA, 2000, AM J ROENTGENOL, V174, P1263, DOI 10.2214/ajr.174.5.1741263; Dinkel HP, 2000, BRIT J RADIOL, V73, P706, DOI 10.1259/bjr.73.871.11089460; Hild F, 1998, EUR J CANCER PREV, V7, pS57, DOI 10.1097/00008469-199802001-00011; LEIS HP, 1989, WORLD J SURG, V13, P736, DOI 10.1007/BF01658424; LOGANYOUNG W, 1994, BREAST CANC PRACTICA, P193; NEWMAN HF, 1983, NEW YORK STATE J MED, V83, P928; Orel SG, 2000, RADIOLOGY, V216, P248, DOI 10.1148/radiology.216.1.r00jn28248; RISSANEN T, 1993, J CLIN ULTRASOUND, V21, P497, DOI 10.1002/jcu.1870210804; Rovno HDS, 1999, AM J ROENTGENOL, V172, P151, DOI 10.2214/ajr.172.1.9888758; TABAR L, 1983, RADIOLOGY, V149, P31, DOI 10.1148/radiology.149.1.6611939; Van Zee KJ, 1998, CANCER, V82, P1874	13	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2000	356	9242					1622	1623		10.1016/S0140-6736(00)03150-0	http://dx.doi.org/10.1016/S0140-6736(00)03150-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372TB	11089815				2022-12-01	WOS:000165249200004
J	Esteller, M; Garcia-Foncillas, J; Andion, E; Goodman, SN; Hidalgo, OF; Vanaclocha, V; Baylin, SB; Herman, JG				Esteller, M; Garcia-Foncillas, J; Andion, E; Goodman, SN; Hidalgo, OF; Vanaclocha, V; Baylin, SB; Herman, JG			Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; ALKYLTRANSFERASE; METHYLATION; O-6-BENZYLGUANINE; CHEMOTHERAPY; SURVIVAL; PROTEIN; BRAIN	Background: The DNA-repair enzyme O(sup 6)-methylguanine-DNA methyltransferase (MGMT) inhibits the killing of tumor cells by alkylating agents. MGMT activity is controlled by a promoter; methylation of the promoter silences the gene in cancer, and the cells no longer produce MGMT. We examined gliomas to determine whether methylation of the MGMT promoter is related to the responsiveness of the tumor to alkylating agents. Methods: We analyzed the MGMT promoter in tumor DNA by a methylation-specific polymerase-chain-reaction assay. The gliomas were obtained from patients who had been treated with carmustine (1,3-bis(2-chloroethyl)-1-nitrosourea, or BCNU). The molecular data were correlated with the clinical outcome. Results: The MGMT promoter was methylated in gliomas from 19 of 47 patients (40 percent). This finding was associated with regression of the tumor and prolonged overall and disease-free survival. It was an independent and stronger prognostic factor than age, stage, tumor grade, or performance status. Conclusions: Methylation of the MGMT promoter in gliomas is a useful predictor of the responsiveness of the tumors to alkylating agents. (N Engl J Med 2000;343:1350-4.) (C) 2000, Massachusetts Medical Society.	Johns Hopkins Oncol Ctr, Div Canc Biol, Baltimore, MD 21231 USA; Johns Hopkins Oncol Ctr, Div Biostat, Baltimore, MD 21231 USA; Clin Univ, Dept Oncol, Cell Therapy Area, Biotechnol Lab, Pamplona, Spain	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Navarra	Herman, JG (corresponding author), Johns Hopkins Oncol Ctr, Div Canc Biol, 1650 Orleans, Baltimore, MD 21231 USA.		Garcia-Foncillas, Jesus/E-6857-2010; Esteller, Manel/L-5956-2014	Esteller, Manel/0000-0003-4490-6093; Goodman, Steven/0000-0002-3872-5723; J, Garcia-Foncillas/0000-0002-7591-8006				Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Belanich M, 1996, CANCER RES, V56, P783; COLVIN M, 1981, CANCER TREAT REP, V65, P89; Danam RP, 1999, MOL CARCINOGEN, V24, P85, DOI 10.1002/(SICI)1098-2744(199902)24:2<85::AID-MC2>3.0.CO;2-C; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; Dolan ME, 1997, CLIN CANCER RES, V3, P837; Esteller M, 1999, CANCER RES, V59, P793; Esteller M, 2000, CANCER RES, V60, P2368; Friedman HS, 1998, J CLIN ONCOL, V16, P3570, DOI 10.1200/JCO.1998.16.11.3570; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jaeckle KA, 1998, J CLIN ONCOL, V16, P3310, DOI 10.1200/JCO.1998.16.10.3310; LUDLUM DB, 1990, MUTAT RES, V233, P117, DOI 10.1016/0027-5107(90)90156-X; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; Qian XLC, 1997, CANCER RES, V57, P3672; Silber JR, 1999, CLIN CANCER RES, V5, P807; Silber JR, 1998, CANCER RES, V58, P1068; SILBER JR, 1993, CANCER RES, V53, P3416; Teicher Beverly A., 1997, P405; Watts GS, 1997, MOL CELL BIOL, V17, P5612, DOI 10.1128/MCB.17.9.5612	19	1649	1730	1	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2000	343	19					1350	1354		10.1056/NEJM200011093431901	http://dx.doi.org/10.1056/NEJM200011093431901			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZH	11070098	Bronze, Green Published			2022-12-01	WOS:000165152800001
J	Bath, J; Wu, LJ; Errington, J; Wang, JC				Bath, J; Wu, LJ; Errington, J; Wang, JC			Role of Bacillus subtilis SpoIIIE in DNA transport across the mother cell-prespore division septum	SCIENCE			English	Article							ESCHERICHIA-COLI; PARTITIONING PROTEIN; CHROMOSOME; SEGREGATION; TEMPLATE; TRANSCRIPTION; LOCALIZATION; REPLICATION; REGIONS	The SpoIIIE protein of Bacillus subtilis is required for chromosome segregation during spore formation. The COOH-terminal cytoplasmic part of SpoIIIE was shown to be a DNA-dependent adenosine triphosphatase (ATPase) capable of tracking along DNA in the presence of ATP, and the NH2-terminal part of the protein was found to mediate its Localization to the division septum. Thus, during sporulation, SpoIIIE appears to act as a DNA pump that actively moves one of the replicated pair of chromosomes into the prespore. The presence of SpoIIIE homologs in a broad range of bacteria suggests that this mechanism for active transport of DNA may be widespread.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Harvard University; University of Oxford	Wang, JC (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.		Errington, Jeff/G-1832-2011; Bath, Jonathan/E-9569-2011	Errington, Jeff/0000-0002-6977-9388; Bath, Jonathan/0000-0002-7144-662X; Wu, Ling Juan/0000-0003-2432-8820	NATIONAL CANCER INSTITUTE [R01CA047958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024544, R37GM024544] Funding Source: NIH RePORTER; NCI NIH HHS [CA47958] Funding Source: Medline; NIGMS NIH HHS [GM24544] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHAMPOUX JJ, 1972, P NATL ACAD SCI USA, V69, P143, DOI 10.1073/pnas.69.1.143; Gordon GS, 1997, CELL, V90, P1113, DOI 10.1016/S0092-8674(00)80377-3; KOO HS, 1991, P NATL ACAD SCI USA, V88, P1212, DOI 10.1073/pnas.88.4.1212; Lewis PJ, 1997, MOL MICROBIOL, V25, P945, DOI 10.1111/j.1365-2958.1997.mmi530.x; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; OSTRANDER EA, 1990, SCIENCE, V249, P1261, DOI 10.1126/science.2399463; SHARPE ME, 1995, P NATL ACAD SCI USA, V92, P8630, DOI 10.1073/pnas.92.19.8630; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; WANG JC, 1971, J MOL BIOL, V55, P523, DOI 10.1016/0022-2836(71)90334-2; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161; YANG L, 1989, P NATL ACAD SCI USA, V86, P6121, DOI 10.1073/pnas.86.16.6121	14	158	160	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2000	290	5493					995	997		10.1126/science.290.5493.995	http://dx.doi.org/10.1126/science.290.5493.995			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062134				2022-12-01	WOS:000165103200053
J	Howard, SC; Gajjar, A; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sandlund, JT; Harrison, PL; de Armendi, A; Dahl, GV; Pui, CH				Howard, SC; Gajjar, A; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sandlund, JT; Harrison, PL; de Armendi, A; Dahl, GV; Pui, CH			Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPINAL SUBARACHNOID HEMATOMA; REVERSIBLE PARAPLEGIA; PLATELET TRANSFUSIONS; THERAPY; ANTICOAGULATION; COMPLICATIONS; THRESHOLD	Context Patients with thrombocytopenia are at risk for spontaneous or procedure-related hemorrhage. Whether such patients can safely undergo lumbar puncture (LP) without prophylactic platelet transfusion is unknown. Objective To determine whether an association exists between thrombocytopenia and LP complications among children with acute lymphoblastic leukemia. Design, Setting, and Patients Retrospective review of the records of 958 consecutive children (median age, 5.5 years) with newly diagnosed acute lymphoblastic leukemia who were treated at a pediatric cancer center between February 1984 and July 1998. Interventions All patients underwent a diagnostic LP followed by a median of 4 LPs to instill intrathecal chemotherapy. Main Outcome Measure Serious complications of LP occurring during the remission induction and consolidation treatment periods (when thrombocytopenia is likely to occur), defined as any neurologic, infectious, or hemorrhagic problems related to the procedure, reported by platelet count at the time of the procedure. Results Of the 5223 LPs evaluated, 29 were performed at platelet counts of 10 x 10(9)/L or less, 170 at platelet counts of 11 to 20 x 10(9)/L, and 742 at platelet counts of 21 to 50 x 10(9)/L. No serious complications were encountered, regardless of the platelet count. The 95% confidence interval for the proportion of serious complications in the 199 patients with platelet counts of 20 x 10(9)/L or less was 0% to 1.75% and that for the 941 patients with platelet counts of 50 x 10(9)/L or less was 0% to 0.37%. Conclusions In our study of children undergoing remission induction or consolidation therapy for acute lymphoblastic leukemia, serious complications of LP were not observed, regardless of platelet count. Prophylactic platelet transfusion is not necessary in children with platelet counts higher than 10 x 10(9)/L. Due to the small number of patients in our study with platelet counts of 10 x 10(9)/L or less, conclusions cannot yet be drawn for such patients.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat & Epidemiol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Anesthesiol, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Stanford University	Howard, SC (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, ALSAC Bldg,Room C6005,332 N Lauderdale St, Memphis, TN 38105 USA.		Pui, Ching-Hon/N-8076-2018; Rubnitz, Jeffrey E/N-2619-2018; Gajjar, Amar/N-8059-2018; Howard, Scott C/K-3401-2013	Pui, Ching-Hon/0000-0003-0303-5658; Rubnitz, Jeffrey E/0000-0001-9885-3527; Howard, Scott C/0000-0003-2244-1686	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA-21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS RD, 1999, PRINCIPLES NEUROLOGY; BLADE J, 1983, J NEUROSURG, V58, P438, DOI 10.3171/jns.1983.58.3.0438; BREM SS, 1981, NEW ENGL J MED, V304, P1020, DOI 10.1056/NEJM198104233041705; CASELLA G, 1986, CAN J STAT, V14, P113, DOI 10.2307/3314658; DZIK S, 1999, TRANSFUSION THERAPY, P151; Evans RW, 1998, NEUROL CLIN, V16, P83, DOI 10.1016/S0733-8619(05)70368-6; FISHMAN RA, 1995, MERRITS TXB NEUROLOG, P93; HART IK, 1988, BRIT MED J, V296, P51, DOI 10.1136/bmj.296.6614.51; Heckman KD, 1997, J CLIN ONCOL, V15, P1143, DOI 10.1200/JCO.1997.15.3.1143; Kruskall MS, 1997, NEW ENGL J MED, V337, P1914, DOI 10.1056/NEJM199712253372609; Lederle FA, 1996, AM J MED, V100, P237, DOI 10.1016/S0002-9343(97)89465-X; MALNWARING C, 1998, BR J HAEMATOL S1, V101, P73; MAYUMI T, 1983, ANESTH ANALG, V62, P777; OWENS EL, 1986, ANESTH ANALG, V65, P1201; Peltola J, 1996, LANCET, V347, P131, DOI 10.1016/S0140-6736(96)90262-7; PUI CH, 1983, J CLIN ONCOL, V1, P380, DOI 10.1200/JCO.1983.1.6.380; PUI CH, IN PRESS LEUKEMIA; RASMUS KT, 1989, OBSTET GYNECOL, V73, P943; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; RIBEIRO RC, 1986, J CLIN ONCOL, V4, P1212, DOI 10.1200/JCO.1986.4.8.1212; RUFF RL, 1981, STROKE, V12, P879, DOI 10.1161/01.STR.12.6.879; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; SCOTT EW, 1989, NEUROSURGERY, V25, P287, DOI 10.1227/00006123-198908000-00022; Van Schaeybroeck P, 1998, CLIN NEUROL NEUROSUR, V100, P283, DOI 10.1016/S0303-8467(98)00044-4; WULF H, 1988, Regional-Anaesthesie, V11, P26	25	111	115	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2222	2224		10.1001/jama.284.17.2222	http://dx.doi.org/10.1001/jama.284.17.2222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056594	Bronze			2022-12-01	WOS:000090052600031
J	Maclean, N; Pound, P; Wolfe, C; Rudd, A				Maclean, N; Pound, P; Wolfe, C; Rudd, A			Qualitative analysis of stroke patients' motivation for rehabilitation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ILLNESS	Objective To explore the attitudes and beliefs of stroke patients identified by professionals as having either "high" or "low" motivation for rehabilitation. Design Qualitative study with semistructured interviews. Setting The stroke unit of an inner city teaching hospital. Participants 22 patients with stroke who were undergoing rehabilitation; 14 with high motivation for rehabilitation and eight with low motivation. Results All patients thought rehabilitation was important for recovery. High motivation patients were more likely to view rehabilitation as the most important means of recovery and to accord themselves an active role in rehabilitation. These patients were also more likely to understand rehabilitation and in particular to understand the specialist role of the nursing staff, Many patients reported independence at home as a personal goal, though few low motivation patients related this goal to success in rehabilitation. Information from professionals about rehabilitation, favourable comparisons with Other stroke patients, and the desire to leave hospital had a positive effect on motivation. Conversely overprotection from family members and professionals, lack of information or the receipt of "mixed messages" from professionals, and unfavourable comparisons with other patients had a negative effect. Conclusions There are some differences in beliefs between stroke patients identified as having low or high motivation for rehabilitation. These beliefs seem to be influenced by the environment in which the patient is rehabilitated. Professionals and carers should be made a aware of the ways in which their behaviour can positively and negatively affect motivation.	Kings Coll London, Guys Sch Med & Dent, Dept Publ Hlth Sci, London SE1 3QD, England; Kings Coll London, St Thomass Hosp Sch Med & Dent, Dept Publ Hlth Sci, London SE1 3QD, England; Kings Coll London, Kins Coll Sch Med & Dent, Dept Publ Hlth Sci, London SE1 3QD, England; St Thomas Hosp, Elderly Care Unit, London SE1 7EH, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Maclean, N (corresponding author), Kings Coll London, Guys Sch Med & Dent, Dept Publ Hlth Sci, London SE1 3QD, England.	macleanniall@hotmail.com						ANDERSON R, 1992, AFTERMATH STROKE; BECKER G, 1995, MED ANTHROPOL Q, V9, P165, DOI 10.1525/maq.1995.9.2.02a00040; Clark MS, 1997, CLIN REHABIL, V11, P162, DOI 10.1177/026921559701100210; Fitzpatrick R, 1994, Qual Health Care, V3, P107; Gold S, 1983, QUAL SOCIOL, V6, P238, DOI [10.1007/BF00987448, DOI 10.1007/BF00987448]; GRIFFITHS L, 1993, SOCIOL REV, V41, P415, DOI 10.1111/j.1467-954X.1993.tb00072.x; GUBRIUM J, 1982, DESCRIBING CARE IMAG; HOFFMAN JE, 1981, HLTH CANADIAN SOC; IBBOTSON J, 1978, PHYSIOTHERAPY, V61, P189; KAUFMAN S, 1986, SOC SCI MED, V22, P983, DOI 10.1016/0277-9536(86)90171-1; KAUFMAN S, 1988, J AGING STUD, V2, P217, DOI 10.1016/0890-4065(88)90002-3; KAUFMAN S R, 1988, Medical Anthropology Quarterly, V2, P338, DOI 10.1525/maq.1988.2.4.02a00040; KING P, 1939, CLIN REHABIL, V3, P289; Maclean N, 2000, SOC SCI MED, V50, P495; NIGEL G, 1993, RES SOCIAL LIFE; O'Gorman G, 1975, Physiotherapy, V61, P176; Patton M.Q., 1987, USE QUALITATIVE METH; Strauss A., 1998, BASICS QUALITATIVE R; TUPPER A, 1987, International Journal of Rehabilitation Research, V10, P119, DOI 10.1097/00004356-198700105-00024; WADE DT, 1987, BRIT J HOSP MED, V37, P200; Weber RP., 1990, BASIC CONTENT ANAL; WOLFE B B, 1969, Pennsylvania Medicine, V72, P68	22	249	250	1	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2000	321	7268					1051	1054		10.1136/bmj.321.7268.1051	http://dx.doi.org/10.1136/bmj.321.7268.1051			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	369PU	11053175	Green Published, Bronze			2022-12-01	WOS:000165076800024
J	Gamlin, PD; Yoon, K				Gamlin, PD; Yoon, K			An area for vergence eye movement in primate frontal cortex	NATURE			English	Article							OCULAR ACCOMMODATION; SMOOTH-PURSUIT; MACAQUE; FIELD; NEURONS; MONKEY; NUCLEUS; RESPONSES; PATHWAYS; CELLS	To view objects at different distances, humans rely on vergence eye movements to appropriately converge or diverge the eyes and on ocular accommodation to focus the object(1,2). Despite the importance of these coordinated eye movements (the 'near response') very little is known about the role of the cerebral cortex in their control. As near-response neurons exist within the nucleus reticularis tegmenti pontis(3), which receives input from the frontal eye field region of frontal cortex(4-6), and this cortical region is known to be involved in saccadic(7-9) and smooth-pursuit eye movements(10-12), we propose that a nearby region might play a role in vergence and ocular accommodation. Here we provide evidence from rhesus monkeys that a region of frontal cortex located immediately anterior to the saccade-related frontal eye field region is involved in vergence and ocular accommodation, and in the sensorimotor transformations required for these eye movements. We conclude that the macaque frontal cortex is involved in the control of all voluntary eye movements, and suggest that the definition of the frontal eye fields should be expanded to include this region.	Univ Alabama, Vis Sci Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Gamlin, PD (corresponding author), Univ Alabama, Vis Sci Res Ctr, Birmingham, AL 35294 USA.		Gamlin, Paul/W-2169-2019	Gamlin, Paul/0000-0002-2966-4762				BIZZI E, 1968, EXP BRAIN RES, V6, P69; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Dias EC, 1995, J NEUROPHYSIOL, V74, P2744, DOI 10.1152/jn.1995.74.6.2744; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; FISCHER B, 1979, PROC R SOC SER B-BIO, V204, P409, DOI 10.1098/rspb.1979.0036; GAMLIN PDR, 1994, J NEUROPHYSIOL, V72, P2368, DOI 10.1152/jn.1994.72.5.2368; Gamlin PDR, 1999, OPHTHAL PHYSL OPT, V19, P81, DOI 10.1046/j.1475-1313.1999.00434.x; GAMLIN PDR, 1995, J NEUROPHYSIOL, V73, P2115, DOI 10.1152/jn.1995.73.5.2115; Gamlin PDR, 1996, EYE, V10, P167, DOI 10.1038/eye.1996.42; GAMLIN PDR, 1992, J NEUROPHYSIOL, V67, P64, DOI 10.1152/jn.1992.67.1.64; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOTTLIEB JP, 1994, J NEUROPHYSIOL, V72, P1634, DOI 10.1152/jn.1994.72.4.1634; HUERTA MF, 1986, J COMP NEUROL, V253, P415, DOI 10.1002/cne.902530402; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; LEICHNETZ GR, 1984, J COMP NEUROL, V228, P388, DOI 10.1002/cne.902280307; LYNCH JC, 1987, EXP BRAIN RES, V68, P437; MacAvoy MG, 1991, CEREB CORTEX, V1, P95, DOI 10.1093/cercor/1.1.95; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; MUSTARI MJ, 1988, J NEUROPHYSIOL, V60, P664, DOI 10.1152/jn.1988.60.2.664; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P339, DOI 10.1113/jphysiol.1961.sp006812; SCHOR CM, 1992, OPTOMETRY VISION SCI, V69, P258, DOI 10.1097/00006324-199204000-00002; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; Zee DS., 1999, NEUROLOGY EYE MOVEME; Zhang HY, 1998, J NEUROPHYSIOL, V79, P1255, DOI 10.1152/jn.1998.79.3.1255; ZHANG Y, 1992, J NEUROPHYSIOL, V67, P944, DOI 10.1152/jn.1992.67.4.944	28	144	145	2	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2000	407	6807					1003	1007		10.1038/35039506	http://dx.doi.org/10.1038/35039506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069179				2022-12-01	WOS:000090032500043
J	Hendry, AP; Wenburg, JK; Bentzen, P; Volk, EC; Quinn, TP				Hendry, AP; Wenburg, JK; Bentzen, P; Volk, EC; Quinn, TP			Rapid evolution of reproductive isolation in the wild: Evidence from introduced salmon	SCIENCE			English	Article							ONCORHYNCHUS-NERKA; SOCKEYE-SALMON; LAKE-WASHINGTON; BODY-SIZE; ECOLOGICAL SPECIATION; NATURAL-SELECTION; SYMPATRIC RACES; LIFE-HISTORY; GENE FLOW; REINFORCEMENT	Colonization of new environments should promote rapid speciation as a byproduct of adaptation to divergent selective regimes. Although this process of ecological speciation is known to have occurred over millennia or centuries, nothing is known about how quickly reproductive isolation actually evolves when new environments are first colonized. Using DNA microsatellites, population-specific natural tags, and phenotypic variation, we tested for reproductive isolation between two adjacent salmon populations of a common ancestry that colonized divergent reproductive environments (a river and a lake beach). We found evidence for the evolution of reproductive isolation after fewer than 13 generations.	Univ Massachusetts, Organism & Evolutionary Biol Program, Amherst, MA 01003 USA; Univ Washington, Marine Mol Biotechnol Lab, Seattle, WA 98105 USA; Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; Washington Dept Fish & Wildlife, Olympia, WA 98501 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington Department of Fish & Wildlife (WDFW)	Hendry, AP (corresponding author), Univ Massachusetts, Organism & Evolutionary Biol Program, Amherst, MA 01003 USA.	ahendry@bio.umass.edu	Hendry, Andrew/C-5765-2008; Wenburg, John/Y-4373-2019; Langerhans, R. Brian/A-7205-2009; Ebersole, Joseph L/A-8371-2009	Hendry, Andrew/0000-0002-4807-6667; Wenburg, John/0000-0001-9831-1672; Bentzen, Paul/0000-0003-4288-7730				BLAIR GR, 1993, T AM FISH SOC, V122, P550, DOI 10.1577/1548-8659(1993)122&lt;0550:VILHCA&gt;2.3.CO;2; BUTLIN RK, 1995, TRENDS ECOL EVOL, V10, P432, DOI 10.1016/S0169-5347(00)89173-9; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; Hendry AP, 1997, CAN J FISH AQUAT SCI, V54, P75, DOI 10.1139/f96-257; Hendry AP, 1996, CAN J FISH AQUAT SCI, V53, P823, DOI 10.1139/cjfas-53-4-823; Hendry AP, 1998, CAN J FISH AQUAT SCI, V55, P1387, DOI 10.1139/cjfas-55-6-1387; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; LANDE R, 1988, J THEOR BIOL, V133, P85, DOI 10.1016/S0022-5193(88)80026-2; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; Miller M, 1997, TOOLS POPULATION GEN; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Olsen JB, 1996, MOL MAR BIOL BIOTECH, V5, P259; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; *PERK CORP, 1993, GEN 67I SOFTW US MAN; *PERK CORP, 1996, GEN 2 0 US MAN; QUINN TP, 1994, ANIM BEHAV, V48, P751, DOI 10.1006/anbe.1994.1300; Quinn TP, 1999, CAN J ZOOL, V77, P766, DOI 10.1139/cjz-77-5-766; Quinn TP, 2000, EVOLUTION, V54, P1372, DOI 10.1111/j.0014-3820.2000.tb00569.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schluter D, 1998, ENDLESS FORMS, P114; SCHLUTER D, 1996, AM NAT, V148, P540; Steen RP, 1999, CAN J ZOOL, V77, P836, DOI 10.1139/cjz-77-5-836; Taylor EB, 1997, MOL ECOL, V6, P503, DOI 10.1046/j.1365-294X.1997.00213.x; Taylor EB, 1999, REV FISH BIOL FISHER, V9, P299, DOI 10.1023/A:1008955229420; Via S, 1999, EVOLUTION, V53, P1446, DOI [10.1111/j.1558-5646.1999.tb05409.x, 10.2307/2640891]; Volk EC, 1999, FISH RES, V43, P205, DOI 10.1016/S0165-7836(99)00073-9; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wood CC, 1995, AM FISH S S, V17, P195	32	414	428	1	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					516	518		10.1126/science.290.5491.516	http://dx.doi.org/10.1126/science.290.5491.516			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039932				2022-12-01	WOS:000089946000051
J	Johanson, U; West, J; Lister, C; Michaels, S; Amasino, R; Dean, C				Johanson, U; West, J; Lister, C; Michaels, S; Amasino, R; Dean, C			Molecular analysis of FRIGIDA, a major determinant of natural variation in Arabidopsis flowering time	SCIENCE			English	Article							THALIANA BRASSICACEAE ECOTYPES; VERNALIZATION; REPRESSOR	Vernalization, the acceleration of flowering by a long period of cold temperature, ensures that many plants overwinter vegetatively and flower in spring. In Arabidopsis, allelic variation at the FRIGIDA (FRI) locus is a major determinant of natural variation in flowering time. Dominant alleles of FRI confer Late flowering, which is reversed to earliness by vernalization. We cloned FRI and analyzed the molecular basis of the allelic variation, Most of the early-flowering ecotypes analyzed carry FRI alleles containing one of two different deletions that disrupt the open reading frame. Loss-of-function mutations at FRI have thus provided the basis for the evolution of many early-flowering ecotypes.	John Innes Ctr Plant Sci Res, Dept Mol Genet, Norwich NR4 7UH, Norfolk, England; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Wisconsin System; University of Wisconsin Madison	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Mol Genet, Norwich NR4 7UH, Norfolk, England.		Michaels, Scott/D-5458-2009; Johanson, Urban/AHE-8231-2022; Johanson, Urban/D-4344-2015	Johanson, Urban/0000-0001-8862-128X; Johanson, Urban/0000-0001-8862-128X				Alonso-Urmeneta B, 1998, CLIN DIAGN LAB IMMUN, V5, P749, DOI 10.1128/CDLI.5.6.749-754.1998; Bergelson J, 1998, GENETICS, V148, P1311; BURN JE, 1993, GENETICA, V90, P145; CLARKE JH, 1994, MOL GEN GENET, V242, P81, DOI 10.1007/BF00277351; HAGENBLAD J, UNPUB; KARLSSON BH, 1993, AM J BOT, V80, P646, DOI 10.2307/2445435; KHURMATOV KK, 1982, ARAB INF SERV, V19, P63; Koomneef M., 1994, PLANT J, V6, P911; Kuittinen H, 1997, THEOR APPL GENET, V95, P573, DOI 10.1007/s001220050598; LEE I, 1993, MOL GEN GENET, V237, P171, DOI 10.1007/BF00282798; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI 10.1111/j.1558-5646.1996.tb04480.x; NAPPZINN K, 1957, Z INDUKT ABSTAMM VER, V88, P253, DOI 10.1007/BF00308342; NAPPZINN K, 1955, NATURWISSENSCHAFTEN, V42, P650, DOI 10.1007/BF00622395; Nordborg M, 1999, AM J BOT, V86, P470, DOI 10.2307/2656807; Sanda S, 1997, J HERED, V88, P69, DOI 10.1093/oxfordjournals.jhered.a023061; Schmidt R, 1996, PLANT J, V9, P755, DOI 10.1046/j.1365-313X.1996.9050755.x; SHARBEL TF, IN PRESS MOL ECOL; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519	21	757	808	13	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					344	347		10.1126/science.290.5490.344	http://dx.doi.org/10.1126/science.290.5490.344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030654				2022-12-01	WOS:000089818100046
J	Zornberg, GL; Jick, H				Zornberg, GL; Jick, H			Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study	LANCET			English	Article							PRACTICE RESEARCH DATABASE; SUDDEN-DEATH; THROMBOSIS; CLOZAPINE	Background Antipsychotic drugs have been associated with an increased risk of adverse events such as venous thromboembolism. Our aim was to assess this risk in users of conventional antipsychotic drugs who had been diagnosed with first-time, idiopathic venous thromboembolism. Methods From a baseline population of 29 952 recipients of conventional and atypical antipsychotic drugs aged younger than 60 years, we identified 42 individuals with idiopathic venous thromboembolism and 172 matched controls. We compared risk of current and recent use of antipsychotic drugs with non-use before the index date in cases and controls. Findings Current exposure to conventional antipsychotic drugs was associated with a significantly increased risk of idiopathic venous thromboembolism compared with nonuse (adjusted odds ratio 7.1 [95% CI 2.3-21.97]). Although we found no difference between phenothiazines, thioxanthenes, or other conventional antipsychotic drugs, low potency antipsychotic drugs drugs such as chlorpromazine and thioridazine were more strongly associated with venous thromboembolism (odds ratio 24.1 [3.3-172.7]) than were high potency antipsychotic drugs such as haloperidol (3.3 [0.8-13.2]). The risk for Venous thrombosis was highest during the first few months of conventional antipsychotic drug use. Interpretation Current exposure to conventional antipsychotic drugs significantly increases the risk of idiopathic Venous thromboembolism in men and women younger than 60 years of age.	Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA	Boston University	Zornberg, GL (corresponding author), Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA.			Jick, Hershel/0000-0003-4270-5992				BOULLIN DJ, 1978, PLATELETS MULTODICIP, P389; CANOSO RT, 1988, AM J HEMATOL, V27, P272, DOI 10.1002/ajh.2830270408; HAFNER H, 1965, COMPR PSYCHIAT, V6, P25, DOI 10.1016/S0010-440X(65)80005-0; Hagg S, 2000, LANCET, V355, P1155, DOI 10.1016/S0140-6736(00)02066-3; HOLLISTER LE, 1965, JAMA-J AM MED ASSOC, V192, P93; Jick H, 1997, LANCET, V350, P1045, DOI 10.1016/S0140-6736(05)70451-7; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; KETAI R, 1979, AM J PSYCHIAT, V136, P112; Lacika S, 1999, CAN J PSYCHIAT, V44, P396; Lilleng Peer, 1995, Tidsskrift for den Norske Laegeforening, V115, P3026; Marder SR, 1998, AM PSYCHIAT PRESS TX, P309; MEIEREWERT K, 1967, DEUT MED WOCHENSCHR, V92, P2174, DOI 10.1055/s-0028-1106111; ORR MW, 1976, BRIT J CLIN PHARMACO, V3, P925, DOI 10.1111/j.1365-2125.1976.tb00648.x; ROCHEBAYARD P, 1990, CHEST, V6, P1545; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Suttmann I, 2000, LANCET, V355, P842, DOI 10.1016/S0140-6736(05)72453-3; TURBOTT J, 1984, AUST NZ J PSYCHIAT, V18, P91, DOI 10.3109/00048678409161042; UNGVARI G, 1980, PHARMACOPSYCHIATRY, V113, P29; Vandenbroucke JP, 1998, THROMB HAEMOSTASIS, V79, P511; VARIA I, 1983, PSYCHOSOMATICS, V24, P1097, DOI 10.1016/S0033-3182(83)73114-2; Walker AM, 1997, EPIDEMIOLOGY, V8, P671, DOI 10.1097/00001648-199710000-00010; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7	23	198	204	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2000	356	9237					1219	1223		10.1016/S0140-6736(00)02784-7	http://dx.doi.org/10.1016/S0140-6736(00)02784-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	361LQ	11072939				2022-12-01	WOS:000089724900010
J	Seddon, B; Legname, G; Tomlinson, P; Zamoyska, R				Seddon, B; Legname, G; Tomlinson, P; Zamoyska, R			Long-term survival but impaired homeostatic proliferation of naive T cells in the absence of p56(lck)	SCIENCE			English	Article							LIGANDS; RECEPTOR; ACTIVATION; MICE; LCK	Interactions between the T cell receptor (TCR) and major histocompatibility complex antigens are essential for the survival and homeostasis of peripheral T lymphocytes, However, little is known about the TCR signaling events that result from these interactions. The peripheral T cell pool of p56(lck) (lck)-deficient mice was reconstituted by the expression of an inducible lck transgene. Continued survival of peripheral naive T cells was observed for long periods after switching off the transgene, Adoptive transfer of T cells from these mice into T lymphopoienic hosts confirmed that T cell survival was independent of lck but revealed its essential role in TCR-driven homeostatic proliferation of naive T cells in response to the T cell-deficient host environment. These data suggest that survival and homeostatic expansion depend on different signals.	Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England; Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	MRC National Institute for Medical Research; University of California System; University of California San Francisco	Zamoyska, R (corresponding author), Natl Inst Med Res, Div Mol Immunol, Mill Hill, London NW7 1AA, England.		Legname, Giuseppe/C-1723-2012	Legname, Giuseppe/0000-0003-0716-4393; Seddon, Benedict/0000-0003-4352-3373; Zamoyska, Rose/0000-0001-9816-2638				Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; CASABO LG, 1994, J IMMUNOL, V152, P397; Chau LA, 1998, J EXP MED, V187, P1699, DOI 10.1084/jem.187.10.1699; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Ferreira C, 2000, J IMMUNOL, V165, P3689, DOI 10.4049/jimmunol.165.7.3689; Freitas AA, 1999, CURR OPIN IMMUNOL, V11, P152, DOI 10.1016/S0952-7915(99)80026-0; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SEDDON B, UNPUB; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355	28	104	110	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					127	131		10.1126/science.290.5489.127	http://dx.doi.org/10.1126/science.290.5489.127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021796				2022-12-01	WOS:000089724800049
J	Levchenko, I; Seidel, M; Sauer, RT; Baker, TA				Levchenko, I; Seidel, M; Sauer, RT; Baker, TA			A specificity-enhancing factor for the ClpXP degradation machine	SCIENCE			English	Article							ESCHERICHIA-COLI; DEPENDENT PROTEASES; TAGGING SYSTEM; CLPAP; PROTEINS; CHAPERONE	Events that stall bacterial protein, synthesis activate the ssrA-tagging machinery, resulting in resumption of translation and addition of an 11-residue peptide to the carboxyl terminus of the nascent chain. This ssrA-encoded peptide tag marks the incomplete protein for degradation by the energy-dependent ClpXP protease. Here, a ribosome-associated protein, SspB, was found to bind specifically to ssrA-tagged proteins and to enhance recognition of these proteins by ClpXP. Cells with an sspB mutation are defective in degrading ssrA-tagged proteins, demonstrating that SspB is a specificity-enhancing factor for ClpXP that controls substrate choice.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Dept Biol, Bldg 68,Room 523,77 Massachusetts Ave, Cambridge, MA 02139 USA.			Sauer, Robert/0000-0002-1719-5399	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-16892] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Gonciarz-Swiatek M, 1999, J BIOL CHEM, V274, P13999, DOI 10.1074/jbc.274.20.13999; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Hoskins JR, 1998, P NATL ACAD SCI USA, V95, P12135, DOI 10.1073/pnas.95.21.12135; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Laachouch JE, 1996, EMBO J, V15, P437, DOI 10.1002/j.1460-2075.1996.tb00374.x; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; MILLER MJ, 1974, J BIOL CHEM, V249, P3803; PARCELL DA, 1994, J BIOL CHEM, V269, P4480; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; WILLIAMS MD, 1994, MOL MICROBIOL, V11, P1029, DOI 10.1111/j.1365-2958.1994.tb00381.x; WOJTKOWIAK D, 1993, J BIOL CHEM, V268, P22609; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	20	255	263	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2354	2356		10.1126/science.289.5488.2354	http://dx.doi.org/10.1126/science.289.5488.2354			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009422				2022-12-01	WOS:000089593500054
J	Mao, CD; LaBean, TH; Reif, JH; Seeman, NC				Mao, CD; LaBean, TH; Reif, JH; Seeman, NC			Logical computation using algorithmic self-assembly of DNA triple-crossover molecules	NATURE			English	Article							CRYSTALS	Recent work(1-3) has demonstrated the self-assembly of designed periodic two-dimensional arrays composed of DNA tiles, in which the intermolecular contacts are directed by 'sticky' ends. In a mathematical context, aperiodic mosaics may be formed by the self-assembly of 'Wang' tiles(4), a process that emulates the operation of a Turing machine. Macroscopic self-assembly has been used to perform computations(5); there is also a logical equivalence between DNA sticky ends and Wang tile edges(6,7). This suggests that the self-assembly of DNA-based tiles could be used to perform DNA-based computation(8). Algorithmic aperiodic self-assembly requires greater fidelity than periodic self-assembly, because correct tiles must compete with partially correct tiles. Here we report a one-dimensional algorithmic self-assembly of DNA triple-crossover molecules(9) that can be used to execute four steps of a logical (cumulative XOR) operation on a string of binary bits.	NYU, Dept Chem, New York, NY 10003 USA; Duke Univ, Dept Comp Sci, Durham, NC 27707 USA	New York University; Duke University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.		Mao, Chengde/GPP-1546-2022; LaBean, Thomas H/G-2859-2011	LaBean, Thomas H/0000-0002-6739-2059				ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; GEHANI A, IN PRESS DIMACS SERI; HARADA K, 1993, NUCLEIC ACIDS RES, V21, P2287, DOI 10.1093/nar/21.10.2287; LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e; Liu FR, 1999, J AM CHEM SOC, V121, P917, DOI 10.1021/ja982824a; Liu QH, 2000, NATURE, V403, P175, DOI 10.1038/35003155; Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398; Pirrung MC, 2000, J AM CHEM SOC, V122, P1873, DOI 10.1021/ja992392j; Reif J., 1997, DNA BASED COMPUTERS, P217; Rothemund PWK, 2000, P NATL ACAD SCI USA, V97, P984, DOI 10.1073/pnas.97.3.984; Sakamoto K, 2000, SCIENCE, V288, P1223, DOI 10.1126/science.288.5469.1223; Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C; Wang H., 1963, P S MATH THEOR AUT, P23; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Winfree E., 1996, DNA BASED COMPUTERS, P199; Winfree E., 1998, THESIS CALTECH; WINFREE E, 1999, DNA BASED COMPUTERS, V2, P217	18	538	571	2	181	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					493	496		10.1038/35035038	http://dx.doi.org/10.1038/35035038			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028996	Green Submitted			2022-12-01	WOS:000089727400044
J	Bousquet-Antonelli, C; Presutti, C; Tollervey, D				Bousquet-Antonelli, C; Presutti, C; Tollervey, D			Identification of a regulated pathway for nuclear pre-mRNA turnover	CELL			English	Article							MESSENGER-RNA TURNOVER; 5.8S RIBOSOMAL-RNA; HUMAN PM-SCL; SACCHAROMYCES-CEREVISIAE; DECAPPING ENZYME; YEAST-CELLS; GENE; EXOSOME; SPLICEOSOME; MUTATIONS	We have identified a nuclear pathway that rapidly degrades unspliced pre-mRNAs in yeast. This involves 3'-->5' degradation by the exosome complex and 5'-->3' degradation by the exonuclease Rat1p. 3'-->5' degradation is normally the major pathway and is regulated in response to carbon source. Inhibition of pre-mRNA degradation resulted in increased levels of pre-mRNAs and spliced mRNAs. When splicing was inhibited by mutation of a splicing factor, inhibition of turnover resulted in 20- to 50-fold accumulation of pre-mRNAs, accompanied by increased mRNA production. Splicing of a reporter construct with a 3' splice site mutation was also increased on inhibition of turnover, showing competition between degradation and splicing. We propose that nuclear pre-mRNA turnover represents a novel step in the regulation of gene expression.	Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Tollervey, D (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.		Tollervey, David/AAR-6662-2020; Bousquet-Antonelli, Cécile/O-3898-2018	Tollervey, David/0000-0003-2894-2772; Bousquet-Antonelli, Cécile/0000-0002-3909-7976; PRESUTTI, Carlo/0000-0003-3837-2275				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Baker RE, 1998, GENETICS, V149, P73; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; BELTRAME M, 1992, EMBO J, V11, P1531, DOI 10.1002/j.1460-2075.1992.tb05198.x; Benard L, 1998, MOL CELL BIOL, V18, P2688, DOI 10.1128/MCB.18.5.2688; BRANDHORST BP, 1974, J MOL BIOL, V85, P451, DOI 10.1016/0022-2836(74)90444-6; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; CHANFREAU G, 1994, NUCLEIC ACIDS RES, V22, P1981, DOI 10.1093/nar/22.11.1981; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; ENG FJ, 1991, CELL, V65, P797, DOI 10.1016/0092-8674(91)90387-E; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; KADOWAKI T, 1995, MOL BIOL CELL, V6, P1103, DOI 10.1091/mbc.6.9.1103; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; Kim SH, 1996, MOL CELL BIOL, V16, P6810; KING DS, 1990, NUCLEIC ACIDS RES, V18, P6556; Klein CJL, 1998, MICROBIOL-SGM, V144, P13, DOI 10.1099/00221287-144-1-13; Lafontaine D, 1996, NUCLEIC ACIDS RES, V24, P3469, DOI 10.1093/nar/24.17.3469; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; LESSER CF, 1993, GENETICS, V133, P851; MAQUAT LE, 1995, RNA, V1, P453; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; PLUMPTON M, 1994, EMBO J, V13, P879, DOI 10.1002/j.1460-2075.1994.tb06331.x; Rain JC, 1997, EMBO J, V16, P1759, DOI 10.1093/emboj/16.7.1759; Shiomi T, 1998, J BIOCHEM-TOKYO, V123, P883; SHOBUIKE T, 1995, NUCLEIC ACIDS RES, V23, P357, DOI 10.1093/nar/23.3.357; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; TUNG KS, 1992, MOL CELL BIOL, V12, P2673, DOI 10.1128/MCB.12.6.2673; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Venema J, 1996, EMBO J, V15, P5701, DOI 10.1002/j.1460-2075.1996.tb00954.x; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; VIJAYRAGHAVAN U, 1986, EMBO J, V5, P1683, DOI 10.1002/j.1460-2075.1986.tb04412.x; VILARDELL J, 1994, GENE DEV, V8, P211, DOI 10.1101/gad.8.2.211; WARNER JR, 1989, MICROBIOL REV, V53, P256, DOI 10.1128/MMBR.53.2.256-271.1989	51	314	317	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 15	2000	102	6					765	775		10.1016/S0092-8674(00)00065-9	http://dx.doi.org/10.1016/S0092-8674(00)00065-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030620	Bronze, Green Published			2022-12-01	WOS:000089395200008
J	Hoppe, T; Matuschewski, K; Rape, M; Schlenker, S; Ulrich, HD; Jentsch, S				Hoppe, T; Matuschewski, K; Rape, M; Schlenker, S; Ulrich, HD; Jentsch, S			Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing	CELL			English	Article							UBIQUITIN-PROTEIN LIGASE; NF-KAPPA-B; CEREVISIAE OLE1 GENE; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL INHERITANCE; TRANSMEMBRANE PROTEIN; INDUCED DEGRADATION; YEAST; PROTEASOME; PROTEOLYSIS	Processing of integral membrane proteins in order to liberate active proteins is of exquisite cellular importance. Examples are the processing events that govern sterol regulation, Notch signaling, the unfolded protein response, and APP fragmentation linked to Alzheimer's disease. In these cases, the proteins are thought to be processed by regulated intramembrane proteolysis, involving site-specific, membrane-localized proteases. Here we show that two homologous yeast transcription factors SPT23 and MGA2 are made as dormant ER/nuclear membrane-localized precursors and become activated by a completely different mechanism that involves ubiquitin/proteasome-dependent processing. SPT23 and MGA2 are relatives of mammalian NF-kappa B and control unsaturated fatty acid levels. Intriguingly, proteasome-dependent processing of SPT23 is regulated by fatty acid pools, suggesting that the precursor itself or interacting partners are sensors of membrane composition or fluidity.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Hoppe, Thorsten/AAC-7880-2020	Rape, Michael/0000-0003-4849-6343; Matuschewski, Kai/0000-0001-6147-8591; Hoppe, Thorsten/0000-0002-4734-9352; Ulrich, Helle D./0000-0003-0431-2223				Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; BURKETT TJ, 1994, YEAST, V10, P81, DOI 10.1002/yea.320100108; Choi JY, 1996, J BIOL CHEM, V271, P3581; De Strooper B, 2000, NATURE, V405, P627, DOI 10.1038/35015193; DeHoratius C, 1996, MOL BIOL CELL, V7, P1835, DOI 10.1091/mbc.7.11.1835; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gonzalez CI, 1996, J BIOL CHEM, V271, P25801, DOI 10.1074/jbc.271.42.25801; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guthrie C, 1991, GUIDE YEAST GENETICS; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; James P, 1996, GENETICS, V144, P1425; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kanda T, 1996, GENES GENET SYST, V71, P75, DOI 10.1266/ggs.71.75; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Knop M, 1997, EMBO J, V16, P1550, DOI 10.1093/emboj/16.7.1550; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; LIU HP, 1992, GENETICS, V132, P665; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; MCCONNELL SJ, 1990, J CELL BIOL, V111, P967, DOI 10.1083/jcb.111.3.967; MCDONOUGH VM, 1992, J BIOL CHEM, V267, P5931; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; Springael JY, 1999, BIOCHEM BIOPH RES CO, V257, P561, DOI 10.1006/bbrc.1999.0505; STEWART LC, 1991, J CELL BIOL, V115, P1249, DOI 10.1083/jcb.115.5.1249; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wang GL, 1999, MOL CELL BIOL, V19, P342; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wolfe D, 1999, MOL CELL BIOL, V19, P8254; Zhang SR, 1999, GENETICS, V151, P473; Zoladek T, 1997, GENETICS, V145, P595	49	465	475	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 1	2000	102	5					577	586		10.1016/S0092-8674(00)00080-5	http://dx.doi.org/10.1016/S0092-8674(00)00080-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007476	hybrid			2022-12-01	WOS:000089105200006
J	Schluenzen, F; Tocilj, A; Zarivach, R; Harms, J; Gluehmann, M; Janell, D; Bashan, A; Bartels, H; Agmon, I; Franceschi, F; Yonath, A				Schluenzen, F; Tocilj, A; Zarivach, R; Harms, J; Gluehmann, M; Janell, D; Bashan, A; Bartels, H; Agmon, I; Franceschi, F; Yonath, A			Structure of functionally activated small ribosomal subunit at 3.3 angstrom resolution	CELL			English	Article							ESCHERICHIA-COLI RIBOSOME; DIRECTED CROSS-LINKING; MESSENGER-RNA ANALOGS; THERMUS-THERMOPHILUS; PROTEIN S20; CRYOELECTRON MICROSCOPY; CONFORMATIONAL SWITCH; CRYSTAL-STRUCTURE; SITE; 16-S	The small ribosomal subunit performs the decoding of genetic information during translation. The structure of that from Thermus thermophilus shows that the decoding center, which positions mRNA and three tRNAs, is constructed entirely of RNA. The entrance to the mRNA channel will encircle the message when a latch-like contact closes and contributes to processivity and fidelity. Extended RNA helical elements that run longitudinally through the body transmit structural changes, correlating events at the particle's far end with the cycle of mRNA translocation at the decoding region. 96% of the nucleotides were traced and the main fold of all proteins was determined. The latter are either peripheral or appear to serve as linkers. Some may assist the directionality of translocation.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Max Planck Res Unit Ribosomal Struct, D-22603 Hamburg, Germany; Weizmann Inst Sci, IL-76100 Rehovot, Israel	Max Planck Society; Max Planck Society; Weizmann Institute of Science	Franceschi, F (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	franceschi@molgen.mpg.de	ZARIVACH, RAZ/F-1671-2012; Schluenzen, Frank/H-6274-2014; Schluenzen, Frank/P-9177-2019; Harms, Joerg/K-8786-2012; Franceschi, Francois/AAF-5860-2021	ZARIVACH, RAZ/0000-0001-6543-0296; Schluenzen, Frank/0000-0003-2849-0542; Schluenzen, Frank/0000-0003-2849-0542; Harms, Joerg/0000-0002-9442-8264; Franceschi, Francois/0000-0002-1554-7944	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034360] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34360] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; ALKSNE LE, 1993, P NATL ACAD SCI USA, V90, P9538, DOI 10.1073/pnas.90.20.9538; ARAD T, 1987, BIOCHIMIE, V69, P1001, DOI 10.1016/0300-9084(87)90234-3; Auerbach T, 2000, J BIOMOL STRUCT DYN, V17, P617, DOI 10.1080/07391102.2000.10506553; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Baranov PV, 1999, NUCLEIC ACIDS RES, V27, P184, DOI 10.1093/nar/27.1.184; Bashan A, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P21; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bullard JM, 1998, BIOCHEMISTRY-US, V37, P1350, DOI 10.1021/bi9720540; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHOLI T, 1993, BIOL CHEM H-S, V374, P377, DOI 10.1515/bchm3.1993.374.1-6.377; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Culver GM, 1998, RNA, V4, P1471, DOI 10.1017/S1355838298981201; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DONTSOVA O, 1992, EMBO J, V11, P3105, DOI 10.1002/j.1460-2075.1992.tb05383.x; DONTSOVA O, 1991, EMBO J, V10, P2613, DOI 10.1002/j.1460-2075.1991.tb07803.x; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; Gabashvili IS, 1999, J MOL BIOL, V286, P1285, DOI 10.1006/jmbi.1999.2538; GOTZ F, 1990, BIOCHIM BIOPHYS ACTA, V1050, P93, DOI 10.1016/0167-4781(90)90147-T; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GUTELL RR, 1999, COMP SEQUENCE ANAL P; Harms J, 1999, STRUCTURE, V7, P931, DOI 10.1016/S0969-2126(99)80120-8; Helgstrand M, 1999, J MOL BIOL, V292, P1071, DOI 10.1006/jmbi.1999.3122; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kim YC, 1999, P NATL ACAD SCI USA, V96, P14234, DOI 10.1073/pnas.96.25.14234; Leontis NB, 1998, J MOL BIOL, V283, P571, DOI 10.1006/jmbi.1998.2106; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MONTESANORODITIS L, 1993, J BIOL CHEM, V268, P18701; Mueller F, 1997, J MOL BIOL, V271, P566, DOI 10.1006/jmbi.1997.1212; Mueller F, 1997, J MOL BIOL, V271, P524, DOI 10.1006/jmbi.1997.1210; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; MURZINA NV, 1988, NUCLEIC ACIDS RES, V16, P8172, DOI 10.1093/nar/16.16.8172; Muth GW, 2000, BIOCHEMISTRY-US, V39, P4068, DOI 10.1021/bi992362t; Newcomb LF, 1999, RNA, V5, P849, DOI 10.1017/S1355838299990192; Nikulin A, 2000, NAT STRUCT BIOL, V7, P273; OAKES M, 1986, STRUCTURE FUNCTION G, P47; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILIPPSEN A, 2000, DINO VISUALIZING STR; POHL T, 1988, J BIOL CHEM, V263, P4293; Poot RA, 1998, NUCLEIC ACIDS RES, V26, P549, DOI 10.1093/nar/26.2.549; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; POWERS T, 1988, J MOL BIOL, V201, P697, DOI 10.1016/0022-2836(88)90468-8; Ramakrishnan V, 1998, TRENDS BIOCHEM SCI, V23, P208, DOI 10.1016/S0968-0004(98)01214-6; RYDENAULIN M, 1993, MOL MICROBIOL, V7, P983, DOI 10.1111/j.1365-2958.1993.tb01190.x; SCHWEDLER G, 1993, EUR J BIOCHEM, V217, P361, DOI 10.1111/j.1432-1033.1993.tb18254.x; Spickler C, 1997, J MOL BIOL, V273, P586, DOI 10.1006/jmbi.1997.1323; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; STARK H, 1995, STRUCTURE, V3, P815, DOI 10.1016/S0969-2126(01)00216-7; STOFFLER G, 1986, STRUCTURE FUNCTION G, P28; SZEWCZAK AA, 1993, P NATL ACAD SCI USA, V90, P9581, DOI 10.1073/pnas.90.20.9581; Tocilj A, 1999, P NATL ACAD SCI USA, V96, P14252, DOI 10.1073/pnas.96.25.14252; TSIBOLI P, 1994, EUR J BIOCHEM, V226, P169, DOI 10.1111/j.1432-1033.1994.tb20038.x; VANACKEN U, 1975, MOL GEN GENET, V140, P61, DOI 10.1007/BF00268989; VanLoock MS, 1999, J MOL BIOL, V285, P2069, DOI 10.1006/jmbi.1998.2442; Weinstein S, 1999, J STRUCT BIOL, V127, P141, DOI 10.1006/jsbi.1999.4135; Wilson KS, 1998, CELL, V92, P131, DOI 10.1016/S0092-8674(00)80905-8; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WITTMANNLIEBOLD B, 1978, FEBS LETT, V95, P91, DOI 10.1016/0014-5793(78)80059-3; ZAMIR A, 1971, J MOL BIOL, V60, P347, DOI 10.1016/0022-2836(71)90299-3	69	791	844	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					615	623		10.1016/S0092-8674(00)00084-2	http://dx.doi.org/10.1016/S0092-8674(00)00084-2			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007480	Bronze			2022-12-01	WOS:000089105200010
J	Nosten, F; van Vugt, M; Price, R; Luxemburger, C; Thway, KL; Brockman, A; McGready, R; ter Kuile, F; Looareesuwan, S; White, NJ				Nosten, F; van Vugt, M; Price, R; Luxemburger, C; Thway, KL; Brockman, A; McGready, R; ter Kuile, F; Looareesuwan, S; White, NJ			Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study	LANCET			English	Article							BURMESE BORDER; MONOCLONAL-ANTIBODIES; ELISA DEVELOPMENT; BED NETS; SPOROZOITES; EPIDEMIOLOGY; PREVENTION; PREGNANCY; AREA	Background Worsening drug resistance in Plasmodium falciparum malaria is a major threat to health in tropical countries. We did a prospective study of malaria incidence and treatment in an area of highly multidrug-resistant P falciparum malaria. Methods We assessed incidence of P falciparum malaria and the in-vivo responses to mefloquine treatment over 13 years in two large camps for displaced Karen people on the northwest border of Thailand. During this time, the standard mefloquine dose was first increased, and then combined artesunate and mefloquine was introduced as first-line treatment for uncomplicated P falciparum malaria. Findings Early detection and treatment controlled P falciparum malaria initially while mefloquine was effective (cure rate with mefloquine [15 mg/kg] and sulphadoxine-pyrimethamine in 1985, 98% [95% CI 97-100]), but as mefloquine resistance developed, the cure rate fell (71% [67-77] in 1990). A similar pattern was seen for high-dose (25 mg/kg) mefloquine monotherapy from 1990-94. Since the general deployment of the artesunate-mefloquine combination in 1994, the cure rate increased again to almost 100% from 1998 onwards, and there has been a sustained decline in the incidence of P falciparum malaria in the study area. In-vitro susceptibility of P falciparum to mefloquine has improved significantly (p=0.003). Interpretation In this area of low malaria transmission, early diagnosis and treatment with combined artesunate and mefloquine has reduced the incidence of P falciparum malaria and halted the progression of mefloquine resistance. We recommend that antimalarial drugs should be combined with artemisinin or a derivative to protect them against resistance.	Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand; Shoklo Malaria Res Unit, Mae Sot, Thailand; Amsterdam Med Ctr, Dept Infect Dis Trop Med & AIDS, Amsterdam, Netherlands; John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England; Ctr Dis Control & Prevent, Div Parasit Dis, Atlanta, GA USA	Mahidol University; Mahidol University; University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford; Centers for Disease Control & Prevention - USA	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.		White, Nick/AAC-6527-2019; Kuile, Feiko ter/ABD-6681-2020; Nosten, Francois/AAC-5509-2019; White, Nicholas J/I-4629-2012; McGready, Rose/A-3290-2014	White, Nick/0000-0002-1897-1978; Kuile, Feiko ter/0000-0003-3663-5617; Nosten, Francois/0000-0002-7951-0745; McGready, Rose/0000-0003-1621-3257; Price, Richard/0000-0003-2000-2874	Wellcome Trust [091625] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; BROCKMAN A, 2000, IN PRESS T R SOC MED; CHILDS G E, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P438; DOLAN G, 1993, T ROY SOC TROP MED H, V87, P620, DOI 10.1016/0035-9203(93)90262-O; LUXEMBURGER C, 1994, T ROY SOC TROP MED H, V88, P155, DOI 10.1016/0035-9203(94)90273-9; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; NOSTEN F, 1994, J INFECT DIS, V170, P971, DOI 10.1093/infdis/170.4.971; Nosten F, 1998, Med Trop (Mars), V58, P45; NOSTEN F, 1987, B WORLD HEALTH ORGAN, V65, P891; NOSTEN F, 1991, T ROY SOC TROP MED H, V85, P424, DOI 10.1016/0035-9203(91)90205-D; NOSTEN F, 1991, LANCET, V337, P1140, DOI 10.1016/0140-6736(91)92798-7; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; Sharma YD, 1996, ACTA TROP, V62, P135, DOI 10.1016/S0001-706X(96)00031-9; TERKUILE FO, 1992, J INFECT DIS, V166, P1393, DOI 10.1093/infdis/166.6.1393; TERKUILE FO, 1993, LANCET, V341, P1044, DOI 10.1016/0140-6736(93)92409-M; von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X; WEBSTER HK, 1985, AM J TROP MED HYG, V34, P228, DOI 10.4269/ajtmh.1985.34.228; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; White NJ, 1998, DRUG RESIST UPDATE, V1, P3, DOI 10.1016/S1368-7646(98)80208-2; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; WIRTZ RA, 1991, MED VET ENTOMOL, V5, P17, DOI 10.1111/j.1365-2915.1991.tb00515.x; WIRTZ RA, 1992, J MED ENTOMOL, V29, P854, DOI 10.1093/jmedent/29.5.854	24	382	397	0	38	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2000	356	9226					297	302		10.1016/S0140-6736(00)02505-8	http://dx.doi.org/10.1016/S0140-6736(00)02505-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MJ	11071185				2022-12-01	WOS:000088305900011
J	Relling, MV; Pui, CH; Sandlund, JT; Rivera, GK; Hancock, ML; Boyett, JM; Schuetz, EG; Evans, WE				Relling, MV; Pui, CH; Sandlund, JT; Rivera, GK; Hancock, ML; Boyett, JM; Schuetz, EG; Evans, WE			Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia	LANCET			English	Article							ACUTE LYMPHOCYTIC-LEUKEMIA; DOSE METHOTREXATE; CHILDREN; THERAPY; PHARMACODYNAMICS; PHARMACOKINETICS; 6-MERCAPTOPURINE; TRANSPLANTATION; IDENTIFICATION; INHIBITION	Background Many antileukaemic agents or their metabolites are inactivated by liver enzymes. Most anticonvulsant drugs induce drug-metabolising enzymes and thereby increase the clearance of anticancer agents. We investigated whether anticonvulsants compromise the efficacy of cancer chemotherapy. Methods We identified whom of 716 children treated consecutively for acute lymphoblastic leukaemia at a single academic hospital in the USA between 1984 and 1994 received treatment for 30 days or longer with anticonvulsants (phenytoin, phenobarbital, carbamazepine, or a combination) at the same time as antileukaemic therapy. Cox's proportional-hazards models were used to assess the prognostic significance of anticonvulsants on event-free survival and risk of haematological and central-nervous-system (CNS) relapse, with stratification for treatment protocol. Findings 40 (5.6%) of 716 patients received anticonvulsants. Use of these drugs was associated with age over 10 years (p=0.003), non-hyperdiploid leukaemia (p=0.031), and T-cell immunophenotype (p=0.022), After adjustment for age and ploidy, anticonvulsant therapy was significantly related to worse event-free survival (hazard ratio 2.67 [95% CI 1.50-4.76]; p=0.0009), haematological relapse (3.40 [1.69-6.88]; p=0.0006), and CNS relapse (2.90 [1.01-8.28]; p=0.047) among the 566 patients with B-lineage leukaemia, No such associations were seen among the 114 patients with T-cell leukaemia (p=0.61, 0.35, and 0.53, respectively). Faster clearance of teniposide (p=0.0001) and methotrexate (p=0.051), but not cytarabine (p=0.26) was found among patients receiving anticonvulsants. Interpretation Long-term anticonvulsant therapy increases the systemic clearance of several antileukaemic agents and is associated with lower efficacy of chemotherapy. Alternatives to enzyme;inducing anticonvulsants should be prescribed for patients receiving chemotherapy for acute lymphoblastic leukaemia.	St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Univ Tennessee, Coll Pharm, Memphis, TN 38163 USA; Univ Tennessee, Coll Med, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Relling, MV (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.		Pui, Ching-Hon/N-8076-2018; Relling, Mary/N-5032-2018; Schuetz, Erin/N-8087-2018; Evans, William E./C-2069-2012	Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322	NATIONAL CANCER INSTITUTE [R01CA036401, R37CA036401, P01CA020180, R01CA051001, R29CA051001] Funding Source: NIH RePORTER; NCI NIH HHS [CA36401, CA20180, CA51001] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER DK, 1992, J CLIN ONCOL, V10, P311, DOI 10.1200/JCO.1992.10.2.311; CAMITTA B, 1994, J CLIN ONCOL, V12, P1383, DOI 10.1200/JCO.1994.12.7.1383; Chessells JM, 2000, BRIT J HAEMATOL, V108, P204; CONNEY AH, 1967, PHARMACOL REV, V19, P317; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; EVANS WE, 1983, CLIN PHARMACOL THER, V33, P301, DOI 10.1038/clpt.1983.37; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; EVANS WE, 1986, NEW ENGL J MED, V314, P471, DOI 10.1056/NEJM198602203140803; FREY BM, 1984, EUR J CLIN INVEST, V14, P1, DOI 10.1111/j.1365-2362.1984.tb00695.x; Gentile DM, 1996, J PHARMACOL EXP THER, V277, P105; KATKI AG, 1987, CHEM-BIOL INTERACT, V62, P237, DOI 10.1016/0009-2797(87)90025-1; Kivisto KT, 1995, BRIT J CLIN PHARMACO, V40, P523, DOI 10.1111/j.1365-2125.1995.tb05796.x; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; MURPHY JA, 1995, LANCET, V346, P443, DOI 10.1016/S0140-6736(95)92816-2; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; OCHS JJ, 1984, LANCET, V2, P1422; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 1998, BLOOD, V92, P411, DOI 10.1182/blood.V92.2.411.414k34_411_415; REICH SD, 1976, CANCER RES, V36, P3803; Relling MV, 1999, BLOOD, V93, P2817; RELLING MV, 1994, MOL PHARMACOL, V45, P352; RIVERA GK, 1991, LANCET, V337, P61, DOI 10.1016/0140-6736(91)90733-6; RODMAN JH, 1994, J CLIN ONCOL, V12, P2390, DOI 10.1200/JCO.1994.12.11.2390; SCHUETZ EG, 1993, HEPATOLOGY, V18, P1254; Smith M, 1996, J CLIN ONCOL, V14, P18, DOI 10.1200/JCO.1996.14.1.18; Steinherz PG, 1996, J CLIN ONCOL, V14, P389, DOI 10.1200/JCO.1996.14.2.389; Stram DO, 1996, BIOMETRICS, V52, P1079, DOI 10.2307/2533069; Veerman AJP, 1996, J CLIN ONCOL, V14, P911, DOI 10.1200/JCO.1996.14.3.911; Villikka K, 1999, CLIN PHARMACOL THER, V66, P589, DOI 10.1016/S0009-9236(99)90067-X; WASSNER SJ, 1976, J PEDIATR-US, V88, P134, DOI 10.1016/S0022-3476(76)80745-7; WINICK NJ, 1992, J NATL CANCER I, V84, P252, DOI 10.1093/jnci/84.4.252	31	130	134	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2000	356	9226					285	290		10.1016/S0140-6736(00)02503-4	http://dx.doi.org/10.1016/S0140-6736(00)02503-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MJ	11071183				2022-12-01	WOS:000088305900009
J	Grinspoon, S; Thomas, E; Pitts, S; Gross, E; Mickley, D; Miller, K; Herzog, D; Klibanski, A				Grinspoon, S; Thomas, E; Pitts, S; Gross, E; Mickley, D; Miller, K; Herzog, D; Klibanski, A			Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa	ANNALS OF INTERNAL MEDICINE			English	Article							BONE TURNOVER; OSTEOPOROSIS; DENSITY	Background: Anorexia nervosa is highly prevalent among young women. Objective: To determine prevalence and predictive factors for regional bone loss. Design: Prospective cohort analysis. Setting: University hospital. Patients: 130 women with anorexia nervosa. Measurements: Dual-energy x-ray absorptiometry. Results: The prevalence of osteopenia (-1.0 SD greater than or equal to T-score > -2.5 SD) and osteoporosis (T-score less than or equal to -2.5 SD) was 50% and 13% for the anterior-posterior spine, 57% and 24% for the lateral spine, and 47% and 16% for the total hip, respectively. Bone mineral density (BMD) was reduced by at least 1.0 SD at one or more skeletal sites in 92% of patients and by at least 2.5 SD in 38% of patients. Weight was the most consistent predictor of BMD at all skeletal sites. Twenty-three percent of patients were current estrogen users, and 58% were previous estrogen users. Bone mineral density did not differ by history of estrogen use at any site. Conclusions: Bone mineral density is reduced at several skeletal sites in most women with anorexia nervosa. Weight, but not estrogen use, is a significant predictor of BMD in this population at all skeletal sites.	Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Wilkins Ctr, Greenwich, CT USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Grinspoon, S (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Bulfinch 457B, Boston, MA 02114 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, T32DK007028, R01DK052625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038333] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR001066, MO1-RR01066] Funding Source: Medline; NIDDK NIH HHS [R01-DK52625, P30 DK040561-06, P30 DK040561, T32 DK007028, R01 DK052625] Funding Source: Medline; NIMH NIH HHS [R01 MH038333, R01-MH38333] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; BILLER BMK, 1989, J CLIN ENDOCR METAB, V68, P548, DOI 10.1210/jcem-68-3-548; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; FINKELSTEIN JS, 1994, J CLIN ENDOCR METAB, V78, P724, DOI 10.1210/jc.78.3.724; FRISANCHO AR, 1983, AM J CLIN NUTR, V37, P311, DOI 10.1093/ajcn/37.2.311; Frisancho AR., 1990, ANTHROPOMETRIC STAND; Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P3864, DOI 10.1210/jc.81.11.3864; Grinspoon S, 1999, J CLIN ENDOCR METAB, V84, P2049, DOI 10.1210/jc.84.6.2049; HERZOG W, 1993, J BONE MINER RES, V8, P597; Hotta M, 2000, J CLIN ENDOCR METAB, V85, P200, DOI 10.1210/jc.85.1.200; KLIBANSKI A, 1995, J CLIN ENDOCR METAB, V80, P898, DOI 10.1210/jc.80.3.898; LUCAS AR, 1991, AM J PSYCHIAT, V148, P917; POPE HG, 1984, INT J EAT DISORDER, V3, P45, DOI 10.1002/1098-108X(198421)3:3<45::AID-EAT2260030304>3.0.CO;2-G; RIGOTTI NA, 1984, NEW ENGL J MED, V311, P1601, DOI 10.1056/NEJM198412203112503; RIGOTTI NA, 1991, JAMA-J AM MED ASSOC, V265, P1133, DOI 10.1001/jama.265.9.1133; SEEMAN E, 1992, J BONE MINER RES, V7, P1467; Soyka LA, 1999, J CLIN ENDOCR METAB, V84, P4489, DOI 10.1210/jc.84.12.4489; 1959, STAT B METROPOL INSU, V40, P1	18	260	267	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2000	133	10					790	794		10.7326/0003-4819-133-10-200011210-00011	http://dx.doi.org/10.7326/0003-4819-133-10-200011210-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374AA	11085841	Green Accepted			2022-12-01	WOS:000165321200004
J	Giasson, BI; Duda, JE; Murray, IVJ; Chen, QP; Souza, JM; Hurtig, HI; Ischiropoulos, H; Trojanowski, JQ; Lee, VMY				Giasson, BI; Duda, JE; Murray, IVJ; Chen, QP; Souza, JM; Hurtig, HI; Ischiropoulos, H; Trojanowski, JQ; Lee, VMY			Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions	SCIENCE			English	Article							MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; LEWY BODIES; ALZHEIMERS-DISEASE; NITRIC-OXIDE; TYROSINE NITRATION; PEROXYNITRITE; DEMENTIA; INCLUSIONS; STRESS	Aggregated alpha -synuclein proteins form brain Lesions that are hallmarks of neurodegenerative synucleinopathies, and oxidative stress has been implicated in the pathogenesis of some of these disorders. Using antibodies to specific nitrated tyrosine residues in alpha -synuclein, we demonstrate extensive and widespread accumulations of nitrated alpha -synuclein in the signature inclusions of Parkinson's disease, dementia with Lewy bodies, the Lewy body variant of Alzheimer's disease, and multiple system atrophy brains. We also show that nitrated alpha -synuclein is present in the major filamentous building blocks of these inclusions, as well as in the insoluble fractions of affected brain regions of synucleinopathies. The selective and specific nitration of alpha -synuclein in these disorders provides evidence to directly link oxidative and nitrative damage to the onset and progression of neurodegenerative synucleinopathies.	Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Stokes Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Giasson, BI (corresponding author), Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu	Murray, Ian/O-5983-2015	Murray, Ian/0000-0003-1196-1360				Arawaka S, 1998, NEUROLOGY, V51, P887, DOI 10.1212/WNL.51.3.887; Baba M, 1998, AM J PATHOL, V152, P879; Browne SE, 1999, BRAIN PATHOL, V9, P147; Cookson MR, 1999, BRAIN PATHOL, V9, P165; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; DUDA JE, UNPUB; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; GIASSON BI, UNPUB; Good PF, 1996, AM J PATHOL, V149, P21; Good PF, 1998, J NEUROPATH EXP NEUR, V57, P338, DOI 10.1097/00005072-199804000-00006; Gow A, 1996, ARCH BIOCHEM BIOPHYS, V333, P42, DOI 10.1006/abbi.1996.0362; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Jenner P, 1998, MOVEMENT DISORD, V13, P24; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Lyras L, 1998, J NEUROCHEM, V71, P302; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RODRIGUEZ EM, 1984, HISTOCHEMISTRY, V81, P253, DOI 10.1007/BF00495636; SCHMIDT ML, 1991, AM J PATHOL, V139, P53; Smith MA, 1997, J NEUROSCI, V17, P2653; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; White CR, 1999, METHOD ENZYMOL, V301, P288; Ye YZ, 1996, METHOD ENZYMOL, V269, P201	36	1268	1307	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2000	290	5493					985	989		10.1126/science.290.5493.985	http://dx.doi.org/10.1126/science.290.5493.985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062131				2022-12-01	WOS:000165103200050
J	Goss, DA				Goss, DA			Nearwork and myopia	LANCET			English	Editorial Material									Indiana Univ, Sch Optometry, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Goss, DA (corresponding author), Indiana Univ, Sch Optometry, Bloomington, IN 47405 USA.							Bear JC, 1991, REFRACTIVE ANOMALIES, P57; CURTIN BJ, 1985, MYOPIAS BASIC SCI CL, P120; Fulk GW, 2000, OPTOMETRY VISION SCI, V77, P395, DOI 10.1097/00006324-200008000-00006; GROSVENOR T, 1999, CLIN MANAGEMENT MYOP, P113; JIANG BC, 2000, MYOPIA 2000, P291; Kroger RHH, 2000, BRIT J OPHTHALMOL, V84, P890, DOI 10.1136/bjo.84.8.890; Leung JTM, 1999, OPTOMETRY VISION SCI, V76, P346, DOI 10.1097/00006324-199906000-00013; Rosenfield M, 1998, MYOPIA NEARWORK, P91; SCHAEFFEL F, 1990, VISUAL NEUROSCI, V4, P177, DOI 10.1017/S0952523800002327; Smith EL, 1998, MYOPIA NEARWORK, P57; *WORK GROUP MYOP P, 1989, MYOP PREV PROGR, P1; Zadnik K., 1998, BORISHS CLIN REFRACT, P30	12	60	65	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 28	2000	356	9240					1456	1457		10.1016/S0140-6736(00)02864-6	http://dx.doi.org/10.1016/S0140-6736(00)02864-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367NA	11081523				2022-12-01	WOS:000090067300004
J	de la Iglesia, HO; Meyer, J; Carpino, A; Schwartz, WJ				de la Iglesia, HO; Meyer, J; Carpino, A; Schwartz, WJ			Antiphase oscillation of the left and right suprachiasmatic nuclei	SCIENCE			English	Article							ACTIVITY RHYTHMS; CIRCADIAN OSCILLATORS; GOLDEN-HAMSTER; INTERNAL DESYNCHRONIZATION; UNILATERAL LESIONS; FIRING RHYTHMS; DARK PULSES; EXPRESSION; LIGHT; CLOCK	An unusual property of the circadian timekeeping systems of animals is rhythm "splitting," in which a single daily period of physical activity (usually measured as wheel running) dissociates into two stably coupled components about 12 hours apart; this behavior has been ascribed to a clock composed of two circadian oscillators cycling in antiphase. We analyzed gene expression in the hypothalamic circadian clock, the suprachiasmatic nucleus (SCN), of behaviorally "split" hamsters housed in constant Light. The results show that the two oscillators underlying the split condition correspond to the Left and right sides of the bilaterally paired SCN.	Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	de la Iglesia, HO (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, 55 Lake Ave N, Worcester, MA 01655 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024542] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS24542] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; BOULOS Z, 1986, J BIOL RHYTHM, V1, P1; CHAMBILLE I, 1993, BRAIN RES, V612, P138, DOI 10.1016/0006-8993(93)91654-B; DAAN S, 1978, J THEOR BIOL, V70, P297, DOI 10.1016/0022-5193(78)90378-8; Davis FC, 1996, J BIOL RHYTHM, V11, P291, DOI 10.1177/074873049601100402; DAVIS FC, 1984, J COMP PHYSIOL, V154, P221, DOI 10.1007/BF00604987; Guido ME, 1999, NEUROSCIENCE, V90, P555, DOI 10.1016/S0306-4522(98)00467-9; HARRINGTON ME, 1990, BRAIN RES BULL, V24, P593, DOI 10.1016/0361-9230(90)90164-U; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; HUDSON DJ, 1980, BRAIN RES, V183, P481, DOI 10.1016/0006-8993(80)90485-0; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KALSBEEK A, 1993, J COMP NEUROL, V332, P293, DOI 10.1002/cne.903320304; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KOEHLER WK, 1978, NATURE, V274, P708, DOI 10.1038/274708a0; LEES JG, 1983, J COMP PHYSIOL, V153, P123, DOI 10.1007/BF00610349; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; MEIJER JH, 1990, J BIOL RHYTHM, V5, P1, DOI 10.1177/074873049000500101; PAGE TL, 1978, J COMP PHYSIOL, V124, P225, DOI 10.1007/BF00657054; Palmer JD, 2000, BIOESSAYS, V22, P32, DOI 10.1002/(SICI)1521-1878(200001)22:1<32::AID-BIES7>3.3.CO;2-L; PICKARD GE, 1984, PHYSIOL BEHAV, V32, P763, DOI 10.1016/0031-9384(84)90191-4; PICKARD GE, 1982, SCIENCE, V215, P1119, DOI 10.1126/science.7063843; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; REPPERT SM, 1987, TRENDS NEUROSCI, V10, P76, DOI 10.1016/0166-2236(87)90029-4; Schwartz WJ, 2000, NEUROSCIENCE, V98, P535, DOI 10.1016/S0306-4522(00)00140-8; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; SHIBUYA CA, 1980, NATURWISSENSCHAFTEN, V67, P45, DOI 10.1007/BF00424511; Sumova A, 1998, AM J PHYSIOL-REG I, V274, pR857, DOI 10.1152/ajpregu.1998.274.3.R857; SWANN JM, 1985, SCIENCE, V228, P898, DOI 10.1126/science.4001926; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; WIEDENMANN G, 1983, J COMP PHYSIOL, V150, P51, DOI 10.1007/BF00605287; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; ZLOMANCZUK P, 1991, BRAIN RES, V559, P94, DOI 10.1016/0006-8993(91)90291-3	36	223	228	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					799	801		10.1126/science.290.5492.799	http://dx.doi.org/10.1126/science.290.5492.799			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052942				2022-12-01	WOS:000090067600047
J	Horner, PJ; Gage, FH				Horner, PJ; Gage, FH			Regenerating the damaged central nervous system	NATURE			English	Review							SPINAL-CORD INJURY; PARTIAL FUNCTIONAL RECOVERY; SCHWANN-CELL GRAFTS; ADULT-MOUSE BRAIN; AXONAL REGENERATION; STEM-CELLS; REACTIVE ASTROCYTES; NEURITE OUTGROWTH; GROWTH-FACTOR; PROMOTES REGENERATION	It is self-evident that the adult mammalian brain and spinal cord do not regenerate after injury, but recent discoveries have forced a reconsideration of this accepted principle. Advances in our understanding of how the brain develops have provided a rough blueprint for how we may bring about regeneration in the damaged brain. Studies in developmental neurobiology, intracellular signalling and neuroimmunology are bringing the regeneration field closer to success. Notwithstanding these advances, clear and indisputable evidence for adult functional regeneration remains to be shown.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Horner, Philip J./AAF-7012-2021					Aubert I, 1998, J COMP NEUROL, V399, P1; Bahr M, 1997, ADV NEUROL, V73, P83; BARTLETT PF, 1982, P NATL ACAD SCI-BIOL, V79, P2722, DOI 10.1073/pnas.79.8.2722; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bernhardt RR, 1999, EXP NEUROL, V157, P223, DOI 10.1006/exnr.1999.7059; BISBY MA, 1992, MOL NEUROBIOL, V6, P107, DOI 10.1007/BF02780547; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Blomer U, 1998, P NATL ACAD SCI USA, V95, P2603, DOI 10.1073/pnas.95.5.2603; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Cajal R.S., 1928, DEGENERATION REGENER; CARONI P, 1988, PROG BRAIN RES, V78, P363; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; DAVIES AM, 1995, TRENDS NEUROSCI, V18, P355, DOI 10.1016/0166-2236(95)93928-Q; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DiProspero NA, 1997, EXP NEUROL, V148, P628, DOI 10.1006/exnr.1997.6700; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gaiano N, 1998, J NEUROBIOL, V36, P152, DOI 10.1002/(SICI)1097-4695(199808)36:2<152::AID-NEU4>3.0.CO;2-0; Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.3.CO;2-B; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Grill R, 1997, J NEUROSCI, V17, P5560; Haas CA, 1999, J NEUROSCI, V19, P9953; Harvey N L, 1998, Adv Biochem Eng Biotechnol, V62, P107; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Horner PJ, 2000, J NEUROSCI, V20, P2218; Houle JD, 1999, NEUROSCIENCE, V94, P929, DOI 10.1016/S0306-4522(99)00359-0; Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; Jaworski DM, 1999, EXP NEUROL, V157, P327, DOI 10.1006/exnr.1999.7062; KAWAJA MD, 1991, NEURON, V7, P1019, DOI 10.1016/0896-6273(91)90346-2; Keirstead HS, 1999, EXP NEUROL, V159, P225, DOI 10.1006/exnr.1999.7100; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KORDOWER JH, 1999, CNS REGENERATION BAS, P159; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Lemons ML, 1999, EXP NEUROL, V160, P51, DOI 10.1006/exnr.1999.7184; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Liu Y, 1999, J NEUROSCI, V19, P4370; Liu Y, 1999, EXP NEUROL, V158, P9, DOI 10.1006/exnr.1999.7079; Logan A, 1999, EUR J NEUROSCI, V11, P2367, DOI 10.1046/j.1460-9568.1999.00654.x; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Matyszak MK, 1998, PROG NEUROBIOL, V56, P19, DOI 10.1016/S0301-0082(98)00014-8; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Menei P, 1998, EUR J NEUROSCI, V10, P607, DOI 10.1046/j.1460-9568.1998.00071.x; Ono K, 1999, BIOCHEM BIOPH RES CO, V262, P610, DOI 10.1006/bbrc.1999.1223; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Pettigrew DB, 1999, J NEUROSCI, V19, P8358; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Ribotta MGY, 2000, J NEUROSCI, V20, P5144; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Roitbak T, 1999, GLIA, V28, P40, DOI 10.1002/(SICI)1098-1136(199910)28:1<40::AID-GLIA5>3.0.CO;2-6; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stichel CC, 1999, EUR J NEUROSCI, V11, P632, DOI 10.1046/j.1460-9568.1999.00466.x; Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1; Stichel CC, 1999, GLIA, V28, P156, DOI 10.1002/(SICI)1098-1136(199911)28:2<156::AID-GLIA7>3.0.CO;2-Z; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z; Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951	90	622	666	6	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2000	407	6807					963	970		10.1038/35039559	http://dx.doi.org/10.1038/35039559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069169				2022-12-01	WOS:000090032500033
J	Yan, MH; Wang, LC; Hymowitz, SG; Schilbach, S; Lee, J; Goddard, A; de Vos, AM; Gao, WQ; Dixit, VM				Yan, MH; Wang, LC; Hymowitz, SG; Schilbach, S; Lee, J; Goddard, A; de Vos, AM; Gao, WQ; Dixit, VM			Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors	SCIENCE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; ECTODYSPLASIN-A; EDA GENE; PROTEIN; HOMOLOG; RESOLUTION; MUTATIONS; MEMBRANE; ENCODES; DOMAIN	Ectodysplasin, a member of the tumor necrosis factor family, is encoded by the anhidrotic ectodermal dysplasia (EDA) gene. Mutations in EDA give rise to a clinical syndrome characterized by loss of hair, sweat glands, and teeth. EDA-A1 and EDA-A2 are two isoforms of ectodysplasin that differ only by an insertion of two amino acids. This insertion functions to determine receptor binding specificity, such that EDA-A1 binds only the receptor EDAR, whereas EDA-A2 binds only the related, but distinct, X-linked ectodysplasin-A2 receptor (XEDAR). In situ binding and organ culture studies indicate that EDA-A1 and EDA-A2 are differentially expressed and play a role in epidermal morphogenesis.	Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, S San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, S San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, S San Francisco, CA 94080 USA.		dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; ECK MJ, 1992, J BIOL CHEM, V267, P2119; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Freire-Maia N, 1988, Birth Defects Orig Artic Ser, V24, P3; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Mikkola ML, 1999, MECH DEVELOP, V88, P133, DOI 10.1016/S0925-4773(99)00180-X; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Wang LC, 2000, J NEUROSCI RES, V61, P1; WILSONRAWLS J, 1994, VIROLOGY, V201, P66, DOI 10.1006/viro.1994.1266; Yan M., UNPUB; ZONANA J, 1992, AM J HUM GENET, V51, P1036	20	223	364	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					523	527		10.1126/science.290.5491.523	http://dx.doi.org/10.1126/science.290.5491.523			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039935				2022-12-01	WOS:000089946000054
J	[Anonymous]				[Anonymous]			Desperately seeking a syndrome	NATURE			English	Editorial Material																		Wadman M, 2000, NATURE, V407, P121, DOI 10.1038/35025263; Wadman M, 1997, NATURE, V385, P187, DOI 10.1038/385187a0	2	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					819	819						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057624				2022-12-01	WOS:000089901900001
J	Anandalakshmi, R; Marathe, R; Ge, X; Herr, JM; Mau, C; Mallory, A; Pruss, G; Bowman, L; Vance, VB				Anandalakshmi, R; Marathe, R; Ge, X; Herr, JM; Mau, C; Mallory, A; Pruss, G; Bowman, L; Vance, VB			A calmodulin-related protein that suppresses posttranscriptional gene silencing in plants	SCIENCE			English	Article							RNA; VIRUSES; EXPRESSION; STRATEGY	Posttranscriptional gene silencing (PTGS) is an ancient eukaryotic regulatory mechanism in which a particular RNA sequence is targeted and destroyed. The helper component-proteinase (HC-Pro) of plant potyviruses suppresses PTGS in plants; Using a yeast two-hybrid system, we identified a calmodulin-related protein (termed rgs-CaM) that interacts with HC-Pro. Here we report that rgs-CaM, like HC-Pro itself, suppresses gene silencing. Our work is the first report identifying a cellular suppressor of PTGS.	Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Univ Calif Davis, CEPRAP, Davis, CA 95616 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California Davis	Vance, VB (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.							AN G, 1987, PLANT MOL BIOL MANUA, pA3; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Beclin C, 1998, VIROLOGY, V252, P313, DOI 10.1006/viro.1998.9457; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; CARRINGTON JC, 1990, EMBO J, V9, P1347, DOI 10.1002/j.1460-2075.1990.tb08249.x; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; English JJ, 1996, PLANT CELL, V8, P179, DOI 10.1105/tpc.8.2.179; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Grant SR, 1999, CELL, V96, P303, DOI 10.1016/S0092-8674(00)80541-3; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Montgomery MK, 1998, TRENDS GENET, V14, P255, DOI 10.1016/S0168-9525(98)01510-8; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Sharp PA, 2000, SCIENCE, V287, P2431, DOI 10.1126/science.287.5462.2431; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; SNEDDEN WA, 1999, PLANT SCI, V3, P299; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	25	255	298	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					142	144		10.1126/science.290.5489.142	http://dx.doi.org/10.1126/science.290.5489.142			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021800				2022-12-01	WOS:000089724800053
J	Voinnet, O; Lederer, C; Baulcombe, DC				Voinnet, O; Lederer, C; Baulcombe, DC			A viral movement protein prevents spread of the gene silencing signal in Nicotiana benthamiana	CELL			English	Article							PLANTS; VIRUSES; RNA; DNA; SUPPRESSION; STRATEGY; CELL	In plants, viruses induce an RNA-mediated defense that is similar to posttranscriptional gene silencing (PTGS) of transgenes. Here we demonstrate with potato virus X (PVX) that PTGS operates as a systemic, sequence-specific defense system. However, in grafting experiments or with movement defective forms of PVX, we could not detect systemic silencing unless the 25 kDa viral movement protein (p25) was made nonfunctional. Investigation of p25 revealed two branches to the PTGS pathway that converge in the production of 25 nucleotide RNAs corresponding to the target RNA. One of these branches is unique to virus-induced PTGS and is not affected by p25. The second branch is common to both virus- and transgene-induced PTGS, is blocked by p25, and is likely to generate the systemic silencing signal.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baulcombe, DC (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	david.baulcombe@bbsrc.ac.uk	Lederer, Carsten W./GXN-3171-2022	Voinnet, Olivier/0000-0001-6982-9544; Baulcombe, David/0000-0003-0780-6878				Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Angell SM, 1996, VIROLOGY, V216, P197, DOI 10.1006/viro.1996.0046; Atabekov J G, 1990, Adv Virus Res, V38, P201, DOI 10.1016/S0065-3527(08)60863-5; Baulcombe D, 1999, ARCH VIROL, P189; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Carrington JC, 1999, TRENDS MICROBIOL, V7, P312, DOI 10.1016/S0966-842X(99)01559-0; Carrington JC, 1996, PLANT CELL, V8, P1669, DOI 10.1105/tpc.8.10.1669; Chisholm ST, 2000, P NATL ACAD SCI USA, V97, P489, DOI 10.1073/pnas.97.1.489; Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Jorgensen RA, 1998, SCIENCE, V279, P1486, DOI 10.1126/science.279.5356.1486; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Lucas WJ, 1999, CURR OPIN PLANT BIOL, V2, P192, DOI 10.1016/S1369-5266(99)80035-1; Matthews REF., 2002, PLANT VIROLOGY; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Ruiz F, 1998, MOL BIOL CELL, V9, P931, DOI 10.1091/mbc.9.4.931; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; Verchot J, 1998, J VIROL, V72, P8316, DOI 10.1128/JVI.72.10.8316-8320.1998; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Whitham SA, 1999, P NATL ACAD SCI USA, V96, P772, DOI 10.1073/pnas.96.2.772; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	33	511	572	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2000	103	1					157	167		10.1016/S0092-8674(00)00095-7	http://dx.doi.org/10.1016/S0092-8674(00)00095-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051555	Bronze			2022-12-01	WOS:000089636400016
J	Burmester, T; Weich, B; Reinhardt, S; Hankeln, T				Burmester, T; Weich, B; Reinhardt, S; Hankeln, T			A vertebrate globin expressed in the brain	NATURE			English	Article							AMINO-ACID-SEQUENCE; GLYCERA-DIBRANCHIATA; INTRACELLULAR HEMOGLOBIN; INTRON GAIN; GENE; MYOGLOBIN; EVOLUTION; TISSUE; RNA	Haemoglobins and myoglobins constitute related protein families that function in oxygen transport and storage in humans and other vertebrates(1,2). Here we report the identification of a third globin type in man and mouse. This protein is predominantly expressed in the brain, and therefore we have called it neuroglobin. Mouse neuroglobin is a monomer with a high oxygen affinity (half saturation pressure, P(50) approximate to 2 torr). Analogous to myoglobin, neuroglobin may increase the availability of oxygen to brain tissue. The human neuroglobin gene (NGB), located on chromosome 14q24, has a unique exon-intron structure. Neuroglobin represents a distinct protein family that diverged early in metazoan evolution, probably before the Protostomia/Deuterostomia split.	Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Mol Genet Biosafety Res & Consulting, D-55099 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Physiol Chem, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Burmester, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany.	burmeste@mail.uni-mainz.de	Burmester, Thorsten/I-7225-2013	Burmester, Thorsten/0000-0002-5772-7863				BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Burmester T, 1999, MOL BIOL EVOL, V16, P1809, DOI 10.1093/oxfordjournals.molbev.a026093; Dewilde S, 1996, J BIOL CHEM, V271, P19865, DOI 10.1074/jbc.271.33.19865; Dickerson RE, 1983, HEMOGLOBIN STRUCTURE; DIXON B, 1992, TRENDS BIOCHEM SCI, V17, P486; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELSENSTEIN J, 1993, PHYLIP VERSION 3 5C; GO M, 1981, NATURE, V291, P90, DOI 10.1038/291090a0; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; GOODMAN M, 1975, NATURE, V253, P603, DOI 10.1038/253603a0; Hankeln T, 1997, GENE, V205, P151, DOI 10.1016/S0378-1119(97)00518-0; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; KRAUS DW, 1986, SCIENCE, V232, P90, DOI 10.1126/science.232.4746.90; Logsdon JM, 1998, CURR BIOL, V8, pR560, DOI 10.1016/S0960-9822(07)00361-2; Makalowski W, 1996, GENOME RES, V6, P846, DOI 10.1101/gr.6.9.846; RENTROP M, 1986, HISTOCHEM J, V18, P271, DOI 10.1007/BF01676237; Schmidt R. F., 1997, PHYSL MENSCHEN, V27; SIMONS PC, 1989, BIOCHEMISTRY-US, V28, P8525, DOI 10.1021/bi00447a038; STRITTMATTER P, 1963, BIOCHIM BIOPHYS ACTA, V78, P562, DOI 10.1016/0006-3002(63)90928-4; Stryer L, 1995, BIOCHEMISTRY; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vandergon TL, 1998, J BIOL CHEM, V273, P16998, DOI 10.1074/jbc.273.27.16998; Waterman M R, 1978, Methods Enzymol, V52, P456; WITTENBERG BA, 1965, BIOCHEM J, V96, P363, DOI 10.1042/bj0960363; ZAFAR RS, 1990, BIOCHIM BIOPHYS ACTA, V1041, P117, DOI 10.1016/0167-4838(90)90053-I; ZAFAR RS, 1990, J BIOL CHEM, V265, P21843; [No title captured]	28	838	1003	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					520	523		10.1038/35035093	http://dx.doi.org/10.1038/35035093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029004				2022-12-01	WOS:000089727400052
J	Mullikin, JC; Hunt, SE; Cole, CG; Mortimore, BJ; Rice, CM; Burton, J; Matthews, LH; Pavitt, R; Plumb, RW; Sims, SK; Ainscough, RMR; Attwood, J; Bailey, JM; Barlow, K; Bruskiewich, RMM; Butcher, PN; Carter, NP; Chen, Y; Clee, CM; Coggill, PC; Davies, J; Davies, RM; Dawson, E; Francis, MD; Joy, AA; Lamble, RG; Langford, CF; Macarthy, J; Mall, V; Moreland, A; Overton-Larty, EK; Ross, MT; Smith, LC; Steward, CA; Sulston, JE; Tinsley, EJ; Turney, KJ; Willey, DL; Wilson, GD; McMurray, AA; Dunham, I; Rogers, J; Bentley, DR				Mullikin, JC; Hunt, SE; Cole, CG; Mortimore, BJ; Rice, CM; Burton, J; Matthews, LH; Pavitt, R; Plumb, RW; Sims, SK; Ainscough, RMR; Attwood, J; Bailey, JM; Barlow, K; Bruskiewich, RMM; Butcher, PN; Carter, NP; Chen, Y; Clee, CM; Coggill, PC; Davies, J; Davies, RM; Dawson, E; Francis, MD; Joy, AA; Lamble, RG; Langford, CF; Macarthy, J; Mall, V; Moreland, A; Overton-Larty, EK; Ross, MT; Smith, LC; Steward, CA; Sulston, JE; Tinsley, EJ; Turney, KJ; Willey, DL; Wilson, GD; McMurray, AA; Dunham, I; Rogers, J; Bentley, DR			An SNP map of human chromosome 22	NATURE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DNA-SEQUENCE; GEL-ELECTROPHORESIS; HUMAN GENOME; GENES; IDENTIFICATION; MUTATION; QUALITY	The human genome sequence will provide a reference for measuring DNA sequence variation in human populations. Sequence variants are responsible for the genetic component of individuality, including complex characteristics such as disease susceptibility and drug response. Most sequence variants are single nucleotide polymorphisms (SNPs), where two alternate bases occur at one position (1-3). Comparison of any two genomes reveals around 1 SNP per kilobase(1,3). A sufficiently dense map of SNPs would allow the detection of sequence variants responsible for particular characteristics on the basis that they are associated with a specific SNP allele(4-6). Here we have evaluated large-scale sequencing approaches to obtaining SNPs, and have constructed a map of 2,730 SNPs on human chromosome 22. Most of the SNPs are within 25 kilobases of a transcribed exon, and are valuable for association studies. We have scaled up the process, detecting over 65,000 SNPs in the genome as part of The SNP Consortium programme, which is on target to build a map of 1 SNP every 5 kilobases that is integrated with the human genome sequence and that is freely available in the public domain.	Sanger Ctr, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Bentley, DR (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.			Hunt, Sarah/0000-0002-8350-1235; Davies, Robert/0000-0002-9983-1378; Steward, Charles/0000-0001-8829-5349; Carter, Emma/0000-0002-0825-2793; Dunham, Ian/0000-0003-2525-5598				Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bouck J, 1998, GENOME RES, V8, P1074, DOI 10.1101/gr.8.10.1074; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Felsenfeld A, 1999, GENOME RES, V9, P1; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kwok PY, 1996, GENOMICS, V31, P123, DOI 10.1006/geno.1996.0019; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; *SANG CTR WASH U G, 1998, GENOME RES, V8, P1097; Taillon-Miller P, 1998, GENOME RES, V8, P748, DOI 10.1101/gr.8.7.748; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	25	103	128	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					516	520		10.1038/35035089	http://dx.doi.org/10.1038/35035089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029003	hybrid			2022-12-01	WOS:000089727400051
J	Wang, MH; vom Saal, FS				Wang, MH; vom Saal, FS			Maternal age and traits in offspring - The timing of a mouse's first litter influences the development of her pups.	NATURE			English	Article							ESTRADIOL; PREGNANCY; EXPOSURE		Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Wang, MH (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	vomsaalf@missouri.edu						BERNSTEIN L, 1986, J NATL CANCER I, V76, P1035; BERNSTEIN L, 1988, BRIT J CANCER, V58, P379, DOI 10.1038/bjc.1988.223; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Finch C., 2000, CHANCE DEV AGING; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Key TJA, 1996, BRIT J CANCER, V73, P698, DOI 10.1038/bjc.1996.121; MATT DW, 1986, BIOL REPROD, V34, P478, DOI 10.1095/biolreprod34.3.478; SAAL FSV, 1989, J ANIM SCI, V67, P1824; Vom Saal FS, 1994, PHYSL REPRODUCTION, P1213; vomSaal FS, 1997, P NATL ACAD SCI USA, V94, P2056	11	57	58	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					469	470		10.1038/35035156	http://dx.doi.org/10.1038/35035156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028989				2022-12-01	WOS:000089727400037
J	Olowokure, B; Hawker, J; Blair, I; Spencer, N				Olowokure, B; Hawker, J; Blair, I; Spencer, N			Decrease in effectiveness of routine surveillance of Haemophilus influenzae disease after introduction of conjugate vaccine: comparison of routine reporting with active surveillance system	BRITISH MEDICAL JOURNAL			English	Article								In October 1992 routine immunisation with Haemophilus influenzae type b conjugate vaccine was introduced in the United Kingdom, and the incidence of disease was subsequently reported to have decreased 15-fold.(1) The surveillance systems in place were primarily routine and were known to underestimate the burden of invasive H influenzae disease.(2) This study aimed to determine whether underreporting continued after introduction of the conjugate vaccine, and how this might affect the reported success of the vaccine. Results of routine surveillance were compared with active surveillance for invasive H influenzae disease in the West Midlands health region of England.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Sandwell Hlth Author, Dept Publ Hlth, W Bromwich B70 9LD, W Midlands, England; Univ Warwick, Postgrad Med Sch, Sect Child Hlth, Coventry CV4 7AL, W Midlands, England	University of Birmingham; University of Warwick	Olowokure, B (corresponding author), W Midlands Heartlands Hosp, Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Birmingham B9 5SS, W Midlands, England.							Hargreaves RM, 1996, BRIT MED J, V312, P160; Macleod C A, 1994, Commun Dis Rep CDR Rev, V4, pR13; Nazareth B, 1992, Commun Dis Rep CDR Rev, V2, pR13; Salisbury DM, 1998, PEDIATR INFECT DIS J, V17, pS136, DOI 10.1097/00006454-199809001-00009; Wise J, 1999, BRIT MED J, V319, P278, DOI 10.1136/bmj.319.7205.278	5	11	11	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					731	732		10.1136/bmj.321.7263.731	http://dx.doi.org/10.1136/bmj.321.7263.731			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999903	Green Published, Bronze			2022-12-01	WOS:000089546600020
J	Seale, P; Sabourin, LA; Girgis-Gabardo, A; Mansouri, A; Gruss, P; Rudnicki, MA				Seale, P; Sabourin, LA; Girgis-Gabardo, A; Mansouri, A; Gruss, P; Rudnicki, MA			Pax7 is required for the specification of myogenic satellite cells	CELL			English	Article							SKELETAL-MUSCLE REGENERATION; HEMATOPOIETIC STEM-CELLS; ADHESION MOLECULE; MDX MOUSE; IN-VIVO; EXPRESSION; DIFFERENTIATION; GENES; MYOD; MICE	The paired box transcription factor Pax7 was isolated by representational difference analysis as a gene specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization revealed that Pax7 was also expressed in satellite cells residing in adult muscle. Cell culture and electron microscopic analysis revealed a complete absence of satellite cells in Pax7(-/-) skeletal muscle. Surprisingly, fluorescence-activated cell sorting analysis indicated that the proportion of muscle-derived stem cells was unaffected. Importantly, stem cells from Pax7(-/-) muscle displayed almost a 10-fold increase in their ability to form hematopoietic colonies. These results demonstrate that satellite cells and muscle-derived stem cells represent distinct cell populations. Together these studies suggest that induction of Pax7 in muscle-derived stem cells induces satellite cell specification by restricting alternate developmental programs.	McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; McMaster Univ, Dept Pathol, Hamilton, ON L8S 4K1, Canada; McMaster Univ, Inst Mol Biol & Biotechnol, Hamilton, ON L8S 4K1, Canada; Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	McMaster University; McMaster University; McMaster University; Max Planck Society	Rudnicki, MA (corresponding author), Ottawa Hosp Res Inst, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ottawahospital.on.ca						ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211; APPELL HJ, 1988, INT J SPORTS MED, V9, P297, DOI 10.1055/s-2007-1025026; Bancroft JD, 1990, THEORY PRACTICE HIST; Bennicelli JL, 1999, ONCOGENE, V18, P4348, DOI 10.1038/sj.onc.1202812; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; Borycki AG, 1997, CURR BIOL, V7, pR620, DOI 10.1016/S0960-9822(06)00317-4; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Daston G, 1996, DEVELOPMENT, V122, P1017; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; GEORGEWEINSTEIN M, 1993, DEV BIOL, V156, P209, DOI 10.1006/dbio.1993.1071; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Grounds M D, 1993, Mol Cell Biol Hum Dis Ser, V3, P210; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Holst BD, 1997, P NATL ACAD SCI USA, V94, P1465, DOI 10.1073/pnas.94.4.1465; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; HURKO O, 1983, NEUROLOGY, V33, P737, DOI 10.1212/WNL.33.6.737; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; KABLAR B, 1995, TISSUE CELL, V27, P309, DOI 10.1016/S0040-8166(95)80051-4; Kay PH, 1998, INT J BIOCHEM CELL B, V30, P261, DOI 10.1016/S1357-2725(97)00108-8; KAY PH, 1995, GENE, V163, P171, DOI 10.1016/0378-1119(95)00368-G; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Maniatis T, 1982, MOL CLONING; Mansouri A, 1996, DEVELOPMENT, V122, P831; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; Mansouri A, 1999, CANCER RES, V59, p1707S; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; MORLET K, 1989, ANAT EMBRYOL, V180, P471, DOI 10.1007/BF00305122; NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Relaix F, 1999, GENE DEV, V13, P3171, DOI 10.1101/gad.13.24.3171; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; SCHAFER BW, 1994, NUCLEIC ACIDS RES, V22, P4574, DOI 10.1093/nar/22.22.4574; SCHULTZ E, 1985, MECH AGEING DEV, V30, P63, DOI 10.1016/0047-6374(85)90059-4; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tremblay P, 1998, DEV BIOL, V203, P49, DOI 10.1006/dbio.1998.9041; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785	56	1541	1608	3	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					777	786		10.1016/S0092-8674(00)00066-0	http://dx.doi.org/10.1016/S0092-8674(00)00066-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030621	Green Published, Bronze			2022-12-01	WOS:000089395200009
J	Stewart, PM				Stewart, PM			Dexamethasone-suppressible hypertension	LANCET			English	Editorial Material							APPARENT MINERALOCORTICOID EXCESS; GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; GENE; PHENOTYPE		Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Stewart, PM (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England.							AGARWAL AK, IN PRESS HYPERTENSIO; Davies E, 1999, HYPERTENSION, V33, P703, DOI 10.1161/01.HYP.33.2.703; DLUHY RG, 1995, STEROIDS, V60, P48, DOI 10.1016/0039-128X(94)00010-A; Funder JW, 2000, J CLIN ENDOCR METAB, V85, P2158, DOI 10.1210/jc.85.6.2158; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; HAMILTON BP, 1979, J CLIN ENDOCR METAB, V48, P848, DOI 10.1210/jcem-48-5-848; JAMIESON A, 1995, CLIN SCI, V88, P563, DOI 10.1042/cs0880563; Li A, 1998, AM J HUM GENET, V63, P370, DOI 10.1086/301955; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Litchfield WR, 1998, HYPERTENSION, V31, P445, DOI 10.1161/01.HYP.31.1.445; Nunez BS, 1999, HYPERTENSION, V34, P638, DOI 10.1161/01.HYP.34.4.638; RUPPRECHT R, 1993, EUR J PHARM-MOLEC PH, V247, P145, DOI 10.1016/0922-4106(93)90072-H; Stewart PM, 1996, LANCET, V347, P88, DOI 10.1016/S0140-6736(96)90211-1; Stowasser M, 2000, J CLIN ENDOCR METAB, V85, P2160, DOI 10.1210/jc.85.6.2160; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135	15	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 26	2000	356	9231					697	699		10.1016/S0140-6736(00)02624-6	http://dx.doi.org/10.1016/S0140-6736(00)02624-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347UU	11085685				2022-12-01	WOS:000088948200005
J	Crowley, JC; Katz, LC				Crowley, JC; Katz, LC			Early development of ocular dominance columns	SCIENCE			English	Article							FERRET VISUAL-CORTEX; MONKEY STRIATE CORTEX; BINOCULAR IMPULSE BLOCKADE; SUBPLATE NEURONS; THALAMOCORTICAL CONNECTIONS; OPTIC CHIASM; CAT; ORIENTATION; PLASTICITY; ORGANIZATION	The segregation of Lateral geniculate nucleus (LGN) axons into ocular dominance columns is believed to involve a prolonged, activity-dependent sorting process. However, visualization of early postnatal ferret LGN axons by direct LGN tracer injections revealed segregated ocular dominance columns <7 days after innervation of Layer 4. These early columns were unaffected by experimentally induced imbalances in retinal activity, implying that different mechanisms govern initial column formation and their modification during the subsequent critical period. Instead of activity-dependent plasticity, we propose that ocular dominance column formation relies on the targeting of distinct axonal populations to defined Locales in cortical Layer 4.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Crowley, JC (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH012359] Funding Source: NIH RePORTER; NEI NIH HHS [EY07690] Funding Source: Medline; NIMH NIH HHS [MH12359] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANTONINI A, 1993, J NEUROSCI, V13, P3549; Antonini A, 1996, J COMP NEUROL, V369, P64; BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; CROWLEY JC, UNPUB; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; Erwin E, 1998, J NEUROSCI, V18, P9870; Finney EM, 1998, J NEUROSCI, V18, P8826; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; HERRMANN K, 1994, EUR J NEUROSCI, V6, P1729, DOI 10.1111/j.1460-9568.1994.tb00565.x; Horton JC, 1996, J NEUROSCI, V16, P1791; Horton JC, 1998, VISUAL NEUROSCI, V15, P289, DOI 10.1017/S0952523898152124; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; HUBEL DH, 1972, J COMP NEUROL, V146, P421, DOI 10.1002/cne.901460402; HUBEL DH, 1969, NATURE, V221, P747, DOI 10.1038/221747a0; Hubener M, 1997, J NEUROSCI, V17, P9270; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; JACKSON CA, 1989, J NEUROSCI, V9, P1242; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LeVay S., 1979, SOC NEUROSCI S, V4, P83; Mason CA, 1997, CURR OPIN NEUROBIOL, V7, P647, DOI 10.1016/S0959-4388(97)80084-0; Meissirel C, 1997, P NATL ACAD SCI USA, V94, P5900, DOI 10.1073/pnas.94.11.5900; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; NELSON DA, 1995, NEURON, V15, P23, DOI 10.1016/0896-6273(95)90061-6; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; PURVES D, 1988, BODY BRAIN; RAKIC P, 1981, SCIENCE, V214, P928, DOI 10.1126/science.7302569; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; Rathjen S, 2000, NEUROREPORT, V11, P2363, DOI 10.1097/00001756-200008030-00006; REDIES C, 1990, J NEUROSCI, V10, P2791; Ruthazer ES, 1999, J COMP NEUROL, V407, P151; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; WIESEL TN, 1974, BRAIN RES, V79, P273, DOI 10.1016/0006-8993(74)90416-8; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410	48	213	217	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2000	290	5495					1321	1324		10.1126/science.290.5495.1321	http://dx.doi.org/10.1126/science.290.5495.1321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375BN	11082053				2022-12-01	WOS:000165379800039
J	Confavreux, C; Vukusic, S; Moreau, T; Adeleine, P				Confavreux, C; Vukusic, S; Moreau, T; Adeleine, P			Relapses and progression of disability in multiple sclerosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATURAL-HISTORY; CLINICAL COURSE; PROGNOSIS	Background: The influence of the patterns of onset of multiple sclerosis and relapses of the disease on the time course of irreversible disability is controversial. Methods: In 1844 patients who had had multiple sclerosis for a mean (+/-SD) of 11+/-10 years, we determined the time of the clinical onset of the disease, the initial course (relapsing-remitting or progressive) and the subsequent course (relapsing-remitting, secondary progressive, or primary progressive), the times of relapses, the time to the onset of irreversible disability, and the time course of progressive, irreversible disability. We used three scores on the Kurtzke Disability Status Scale (range, 0 to 10, with higher scores indicating more severe disability) as measures of the severity and progression of disability: a score of 4 (limited walking ability but able to walk more than 500 m without aid or rest), a score of 6 (ability to walk with unilateral support no more than 100 m without rest), and a score of 7 (ability to walk no more than 10 m without rest while leaning against a wall or holding onto furniture for support). We used Kaplan-Meier analyses to determine the influence of relapses on the time to the onset of irreversible disability. Results: The median times from the onset of multiple sclerosis to the assignment of a score of 4, a score of 6, and a score of 7 on the disability scale were longer among the 1562 patients with a relapsing-remitting onset of disease (11.4, 23.1, and 33.1 years, respectively) than among the 282 patients who had progressive disease from the onset (0.0, 7.1, and 13.4 years, respectively; P<0.001 for all comparisons). In contrast, the times from the assignment of a score of 4 to a score of 6 were similar in the two groups (5.7 and 5.4 years, P=0.74). The time course of progressive, irreversible disease among patients with the primary progressive type of multiple sclerosis was not affected by the presence or absence of superimposed relapses. Conclusions: Among patients with multiple sclerosis, relapses do not significantly influence the progression of irreversible disability. (N Engl J Med 2000; 343:1430-8.) (C) 2000, Massachusetts Medical Society.	Hop Neurol, EDMUS Coordinating Ctr, F-69394 Lyon 03, France; Hop Neurol, Serv Neurol A, F-69394 Lyon 03, France; Hospices Civils Lyon, Unite Biostat & Informat Med, Lyon, France	CHU Lyon; CHU Lyon; CHU Lyon	Confavreux, C (corresponding author), Hop Neurol, EDMUS Coordinating Ctr, 59 Pinel Bvd, F-69394 Lyon 03, France.							Andersson PB, 1999, ARCH NEUROL-CHICAGO, V56, P1138, DOI 10.1001/archneur.56.9.1138; BERGER JR, 1989, NEUROLOGY, V39, P324, DOI 10.1212/WNL.39.3.324; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; CONFAVREUX C, 1992, J NEUROL NEUROSUR PS, V55, P671, DOI 10.1136/jnnp.55.8.671; CONFAVREUX C, 1980, BRAIN, V103, P281, DOI 10.1093/brain/103.2.281; Cottrell DA, 1999, BRAIN, V122, P625, DOI 10.1093/brain/122.4.625; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers GC, 1999, LANCET, V353, P678; Jacobs LD, 1996, ANN NEUROL, V40, P480; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Kremenchutzky M, 1999, BRAIN, V122, P1941, DOI 10.1093/brain/122.10.1941; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; PHADKE JG, 1990, BRAIN, V113, P1597, DOI 10.1093/brain/113.6.1597; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rudick RA, 1997, NEW ENGL J MED, V337, P1604, DOI 10.1056/NEJM199711273372207; RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117; SADOVNICK AD, 1993, CAN J NEUROL SCI, V20, P17, DOI 10.1017/S0317167100047351; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; SPSS, 1999, STAT PACK SOC SCI RE; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133	25	905	930	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2000	343	20					1430	1438		10.1056/NEJM200011163432001	http://dx.doi.org/10.1056/NEJM200011163432001			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373CR	11078767				2022-12-01	WOS:000165271300001
J	Emanuel, EJ; Fairclough, DL; Emanuel, LL				Emanuel, EJ; Fairclough, DL; Emanuel, LL			Attitudes and desires related to euthanasia and physician-assisted suicide among terminally ill patients and their caregivers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ONCOLOGY PATIENTS; CARE GIVERS; FAMILIES; HEALTH; BURDEN; DEATH	Context Euthanasia and physician-assisted suicide (PAS) are highly controversial is' sues. While there are studies of seriously ill patients' interest in euthanasia and PAS, there are no data on the attitudes and desires of terminally ill patients regarding these issues. Objective To determine the attitudes of terminally ill patients toward euthanasia and PAS, whether they seriously were considering euthanasia and PAS for themselves, the stability of their desires, factors associated with their desires, and the proportion of patients who die from these interventions. Design Prospective cohort of terminally ill patients and their primary caregivers surveyed twice between March 1996 and July 1997. Setting Outpatient settings in 5 randomly selected metropolitan statistical areas and 1 rural county. Participants A total of 988 patients identified by their physicians to be terminally ill with any disease except for human immunodeficiency virus infection (response ratel 87.4%) and 893 patient-designated primary caregivers (response rate, 97.6%). Main Outcome Measures Support for euthanasia or PAS in standard scenarios; patient-expressed considerations and discussions of their desire for euthanasia or PAS; hoarding of drugs for suicide; patient death by euthanasia or PAS; and patient-reported sociodemographic factors and symptoms related to these outcomes. Results Of the 988 terminally ill patients, a total of 60.2% supported euthanasia or PAS in a hypothetical situation, but only 10.6% reported seriously considering euthanasia or PAS for themselves. Factors associated with being less likely to consider euthanasia or PAS were feeling appreciated (odds ratio [OR], 0.65; 95% confidence interval [CI], 0.52-0.82), being aged 65 years or older (OR, 0.52; 95% CI, 0.34-0.82), and being African American (OR, 0.39; 95 % CI, 0.18-0.84). Factors associated with being more likely to consider euthanasia or PAS were depressive symptoms (OR, 1.25; 95 % Clr 1.05-1.49), substantial caregiving needs (OR, 1.09; 95 % CI, 1.01 - 1.17), and pain (OR, 1.26; 95% CI, 1.02-1.56). At the follow-up interview, half of the terminally ill patients who had considered euthanasia or PAS for themselves changed their minds, while an almost equal number began considering these interventions. Patients with depressive symptoms (OR, 5.29; 95% CI, 1.21-23.2) and dyspnea (OR, 1.68; 95% CI, 1.26-2.22) were more likely to change their minds to consider euthanasia or PAS. According to the caregivers of the 256 decedents, 14 patients (5.6%) had discussed asking the physician for euthanasia or PAS and 6 (2.5%) had hoarded drugs. Ultimately, of the 256 decedents 1 (0.4%) died by euthanasia or PAS, 1 unsuccessfully attempted suicide, and 1 repeatedly requested for her life to be ended but the family and physicians refused. Conclusions In this survey, a small proportion of terminally ill patients seriously considered euthanasia or PAS for themselves. Over a few months, half the patients changed their minds. Patients with depressive symptoms were more likely to change their minds;about desiring euthanasia or PAS.	NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; Amer Med Ctr, Canc Res Ctr, Ctr Res Methodol & Biometr, Denver, CO USA; Northwestern Univ, Sch Med, Interdisciplinary Program Professionalism & Human, Chicago, IL USA	National Institutes of Health (NIH) - USA; Northwestern University	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.							BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V267, P2658, DOI 10.1001/jama.267.19.2658; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; BROCK DW, 1992, HASTINGS CENT REP, V22, P10, DOI 10.2307/3562560; Brown J, 1995, AM J PSYCHIAT, V152, P1185; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Emanuel EJ, 2000, ANN INTERN MED, V133, P527, DOI 10.7326/0003-4819-133-7-200010030-00011; Emanuel EJ, 1998, JAMA-J AM MED ASSOC, V280, P507, DOI 10.1001/jama.280.6.507; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Emanuel EJ, 1999, ETHICS, V109, P629, DOI 10.1086/233925; EMANUEL L, IN PRESS J PALLIAT M; EPSTEIN AM, 1995, INQUIRY-J HEALTH CAR, V32, P211; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Kissane DW, 1998, LANCET, V352, P1097, DOI 10.1016/S0140-6736(98)05406-3; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Koenig HG, 1996, ARCH INTERN MED, V156, P2240, DOI 10.1001/archinte.156.19.2240; Nuland SB, 2000, NEW ENGL J MED, V342, P583, DOI 10.1056/NEJM200002243420811; Owen C., 1992, PSYCHO-ONCOLOGY, V1, P79, DOI [10.1002/pon.2960010205, DOI 10.1002/PON.2960010205]; Quill TE, 1993, DEATH DIGNITY MAKING; RICE DP, 1993, HEALTH AFFAIR, V12, P164, DOI 10.1377/hlthaff.12.2.164; Rosenfeld B, 1999, AM J PSYCHIAT, V156, P94, DOI 10.1176/ajp.156.1.94; SHERBOURNE CD, 1993, SOC SCI MED, V12, P164; SIEGEL K, 1991, CANCER, V68, P1131, DOI 10.1002/1097-0142(19910901)68:5<1131::AID-CNCR2820680541>3.0.CO;2-N; SuarezAlmazor ME, 1997, J CLIN ONCOL, V15, P418, DOI 10.1200/JCO.1997.15.2.418; SUBROD C, 1960, J CHRON DIS, V11, P7; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; Ware J.E., 1993, LINC RI QUAL METR IN; Willems DL, 2000, ARCH INTERN MED, V160, P63, DOI 10.1001/archinte.160.1.63; Wolfe J, 1999, J CLIN ONCOL, V17, P1274, DOI 10.1200/JCO.1999.17.4.1274; [No title captured]	38	235	236	2	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2000	284	19					2460	2468		10.1001/jama.284.19.2460	http://dx.doi.org/10.1001/jama.284.19.2460			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	371MY	11074775	Bronze			2022-12-01	WOS:000165183800019
J	Steinhauser, AE; Christakis, NA; Clipp, EC; McNeilly, M; McIntyre, L; Tulsky, JA				Steinhauser, AE; Christakis, NA; Clipp, EC; McNeilly, M; McIntyre, L; Tulsky, JA			Factors considered important at the end of life by patients, family, physicians, and other care providers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUSTAINING TREATMENTS; PREFERENCES; SAMPLE; PEOPLE; DEATH	Context A clear understanding of what patients, families, and health care practitioners view as important at the end of life is integral to the success of improving care of dying patients. Empirical evidence de fining such factors, however, is lacking. Objective To determine the factors considered important at the end of life by patients, their families, physicians, and other care providers. Design and Setting Cross-sectional, stratified random national survey conducted in March-August 1999. Participants Seriously ill patients (n = 340), recently bereaved family (n = 332), physicians (n = 361), and other care providers (nurses, social workers, chaplains, and hospice volunteers; n = 429). Main Outcome Measures Importance of 44 attributes of quality at the end of life (5-point scale) and rankings of 9 major attributes, compared in the 4 groups. Results Twenty-six items consistently were rated as being important (>70% responding that item is important) across all 4 groups, including pain and symptom management, preparation for death, achieving a sense of completion, decisions about treatment preferences, and being treated as a "whole person." Eight items received strong importance ratings from patients but less from physicians (P<.001), including being mentally aware, having funeral arrangements planned, not being a burden, helping others, and coming to peace with Clod. Ten items had broad variation within as well as among the 4 groups, including decisions about life-sustaining treatments, dying at home, and talking about the meaning of death. Participants ranked freedom from pain most important and dying at home least important among 9 major attributes. Conclusions Although pain and symptom management, communication with;one's physician, preparation for death, and the opportunity to achieve a sense of completion are important to most, other factors important to quality at the end of life differ by role and by individual. Efforts to evaluate and improve patients' and families' experiences at the end of life must account for diverse perceptions of quality.	Program Med Encounter & Palliat Care, Durham, NC USA; Vet Adm Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC 27705 USA; Durham Vet Affairs Med Ctr, Dept Med, Durham, NC USA; Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; Duke Univ, Inst Care End Life, Durham, NC USA; Inst Multiculturalism, Durham, NC USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Sociol, Chicago, IL 60637 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; University of Chicago; University of Chicago	Steinhauser, AE (corresponding author), Vet Affairs Med Ctr 152, 508 Fulton St, Durham, NC 27705 USA.	karensteinhauser@mindspring.com	Christakis, Nicholas A/C-3205-2009; Christakis, Nicholas A/B-6690-2008	McIntyre, Lauren/0000-0002-0077-3359				ADDINGTON-HALL J M, 1991, Palliative Medicine, V5, P207, DOI 10.1177/026921639100500305; Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; [Anonymous], 1997, APPROACHING DEATH, DOI [10.17226/5801, DOI 10.17226/5801]; CHILDERS TL, 1979, J MARKETING RES, V16, P429, DOI 10.2307/3150720; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Christakis Nicholas, 1999, DEATH FORETOLD PROPH; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Erikson EH., 1982, LIFE CYCLE COMPLETED; Fried TR, 1999, ANN INTERN MED, V131, P109, DOI 10.7326/0003-4819-131-2-199907200-00006; GARRETT JM, 1993, J GEN INTERN MED, V8, P361, DOI 10.1007/BF02600073; GARVIN J, 1995, W J MED, V163, P268; GIBSON R, 1998, J PALLIAT MED, V1, P415; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; HENDRICK C, 1972, PSYCHON SCI, V26, P349; KING DE, 1994, J FAM PRACTICE, V39, P349; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Martin DK, 1999, ARCH INTERN MED, V159, P86, DOI 10.1001/archinte.159.1.86; *NAT HOSP ORG, 1996, NEW FINDINGS ADDRESS; OBRIEN LA, 1995, JAMA-J AM MED ASSOC, V274, P1775, DOI 10.1001/jama.274.22.1775; SCHMIDT TA, 1995, ACAD EMERG MED, V2, P513, DOI 10.1111/j.1553-2712.1995.tb03250.x; SEALE C, 1991, SOC SCI MED, V32, P943, DOI 10.1016/0277-9536(91)90249-C; SEALE C, 1995, SOC SCI MED, V40, P589, DOI 10.1016/0277-9536(94)E0119-D; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Solomon MZ, 1995, HASTINGS CENT REP, V25, pS28, DOI 10.2307/3527856; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; TULSKY J, 1997, J CLIN ETHIC, V126, P381; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306	27	1605	1624	10	106	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2000	284	19					2476	2482		10.1001/jama.284.19.2476	http://dx.doi.org/10.1001/jama.284.19.2476			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	371MY	11074777	Green Published			2022-12-01	WOS:000165183800021
J	Weichenrieder, O; Wild, K; Strub, K; Cusack, S				Weichenrieder, O; Wild, K; Strub, K; Cusack, S			Structure and assembly of the Alu domain of the mammalian signal recognition particle	NATURE			English	Article							SRP-RNA; PROTEIN TRANSLOCATION; CRYSTAL-STRUCTURE; ENDOPLASMIC-RETICULUM; HAMMERHEAD RIBOZYME; ELONGATION ARREST; SRP9/14 SUBUNIT; BINDING-SITES; 7SL RNA; ELEMENTS	The Alu domain of the mammalian signal recognition particle (SRP) comprises the heterodimer of proteins SRP9 and SRP14 bound to the 5' and 3' terminal sequences of SRP RNA. It retards the ribosomal elongation of signal-peptide-containing proteins before their engagement with the translocation machinery in the endoplasmic reticulum. Here we report two crystal structures of the heterodimer SRP9/14 bound either to the 5' domain or to a construct containing both 5' and 3' domains. We present a model of the complete Alu domain that is consistent with extensive biochemical data. SRP9/14 binds strongly to the conserved core of the 5' domain, which forms a U-turn connecting two helical stacks. Reversible docking of the more weakly bound 3' domain might be functionally important in the mechanism of translational regulation. The Alu domain structure is probably conserved in other cytoplasmic ribonucleoprotein particles and retroposition intermediates containing SRP9/14-bound RNAs transcribed from Alu repeats or related elements in genomic DNA.	European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; Univ Geneva, Dept Biol Cellulaire, CH-1211 Geneva, Switzerland	European Molecular Biology Laboratory (EMBL); University of Geneva	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, BP 156X, F-38042 Grenoble 9, France.			Cusack, Stephen/0000-0002-9324-0796; Weichenrieder, Oliver/0000-0001-5818-6248				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; ANDREWS DW, 1987, EMBO J, V6, P3471, DOI 10.1002/j.1460-2075.1987.tb02671.x; Birse DEA, 1997, EMBO J, V16, P3757, DOI 10.1093/emboj/16.13.3757; Bovia F, 1997, NUCLEIC ACIDS RES, V25, P318, DOI 10.1093/nar/25.2.318; BOVIA F, 1995, MOL BIOL CELL, V6, P471, DOI 10.1091/mbc.6.4.471; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chang DY, 1997, NUCLEIC ACIDS RES, V25, P1117, DOI 10.1093/nar/25.6.1117; Chang DY, 1996, NUCLEIC ACIDS RES, V24, P4165, DOI 10.1093/nar/24.21.4165; Chen YH, 1998, J BIOL CHEM, V273, P35023, DOI 10.1074/jbc.273.52.35023; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Cusack S, 1998, NAT STRUCT BIOL, V5, P634, DOI 10.1038/1325; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Emde G, 1997, RNA, V3, P538; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; GUNDELFINGER ED, 1983, NUCLEIC ACIDS RES, V11, P7363, DOI 10.1093/nar/11.21.7363; Jacobson MR, 1998, P NATL ACAD SCI USA, V95, P7981, DOI 10.1073/pnas.95.14.7981; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; Kremerskothen J, 1998, NEUROSCI LETT, V245, P123, DOI 10.1016/S0304-3940(98)00215-8; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mighell AJ, 1997, FEBS LETT, V417, P1, DOI 10.1016/S0014-5793(97)01259-3; Nakamura K, 1999, J BIOL CHEM, V274, P13569, DOI 10.1074/jbc.274.19.13569; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; RAPOPORT TA, 1987, J MOL BIOL, V195, P621, DOI 10.1016/0022-2836(87)90186-0; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; SIEGEL V, 1988, P NATL ACAD SCI USA, V85, P1801, DOI 10.1073/pnas.85.6.1801; STRUB K, 1990, MOL CELL BIOL, V10, P777, DOI 10.1128/MCB.10.2.777; STRUB K, 1989, P NATL ACAD SCI USA, V86, P9747, DOI 10.1073/pnas.86.24.9747; Strub K, 1999, RNA, V5, P1333, DOI 10.1017/S1355838299991045; STRUB K, 1991, MOL CELL BIOL, V11, P3949, DOI 10.1128/MCB.11.8.3949; Thomas Y, 1997, NUCLEIC ACIDS RES, V25, P1920, DOI 10.1093/nar/25.10.1920; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cellbio.10.1.87; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Weichenrieder O, 1997, RNA, V3, P1262; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.biochem.55.1.631; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Zwieb C, 1996, FOLD DES, V1, P315, DOI 10.1016/S1359-0278(96)00044-2	47	137	143	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					167	173		10.1038/35041507	http://dx.doi.org/10.1038/35041507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089964	Green Published			2022-12-01	WOS:000165180400036
J	Calverley, PMA				Calverley, PMA			Oxygen-induced hypercapnia revisited	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; ACUTE RESPIRATORY-FAILURE; VENTILATION		Aintree Univ Hosp NHS Fdn Trust, Dept Med, Liverpool L9 7AL, Merseyside, England	Aintree University Hospitals NHS Foundation Trust; University of Liverpool	Calverley, PMA (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Dept Med, Liverpool L9 7AL, Merseyside, England.							AUBIER M, 1980, AM REV RESPIR DIS, V122, P747, DOI 10.1164/arrd.1980.122.5.747; BAZUAYE EA, 1992, THORAX, V47, P609, DOI 10.1136/thx.47.8.609; BONE RC, 1978, AM J MED, V65, P896, DOI 10.1016/0002-9343(78)90740-4; CAMPBELL EJ, 1967, AM REV RESPIR DIS, V96, P626; COSTELLO RW, 1995, THORAX, V50, P405, DOI 10.1136/thx.50.4.405; Dick CR, 1997, AM J RESP CRIT CARE, V155, P609, DOI 10.1164/ajrccm.155.2.9032202; DONALD K, 1949, LANCET, V257, P1056; DUNN WF, 1991, AM REV RESPIR DIS, V144, P526, DOI 10.1164/ajrccm/144.3_Pt_1.526; Gorini M, 1996, THORAX, V51, P677, DOI 10.1136/thx.51.7.677; LOPEZMAJ.V, 1973, AM REV RESPIR DIS, V108, P232; MCNICOL MW, 1965, LANCET, V1, P336; Plant PK, 2000, THORAX, V55, P550, DOI 10.1136/thorax.55.7.550; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Robinson TD, 2000, AM J RESP CRIT CARE, V161, P1524, DOI 10.1164/ajrccm.161.5.9904119	14	19	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2000	356	9241					1538	1539		10.1016/S0140-6736(00)03119-6	http://dx.doi.org/10.1016/S0140-6736(00)03119-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370QV	11075762				2022-12-01	WOS:000165134500004
J	Chow, WH; Gridley, G; Fraumeni, JF; Jarvholm, B				Chow, WH; Gridley, G; Fraumeni, JF; Jarvholm, B			Obesity, hypertension, and the risk of kidney cancer in men.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-CELL CANCER; GROWTH-FACTOR; PREDICTORS; CARCINOMA; HORMONE	Background: Obesity and hypertension have been implicated as risk factors for the development of renal-cell cancer. Methods: We examined the health records of 363,992 Swedish men who underwent at least one physical examination from 1971 to 1992 and were followed until death or the end of 1995. Men with cancer (renal-cell cancer in 759 and renal-pelvis cancer in 136) were identified by cross-linkage of data with the nationwide Swedish Cancer Registry. Poisson regression analysis was used to estimate relative risks, with adjustments for age, smoking status, body-mass index, and diastolic blood pressure. Results: As compared with men in the lowest three eighths of the cohort for body-mass index, men in the middle three eighths had a 30 to 60 percent greater risk of renal-cell cancer, and men in the highest two eighths had nearly double the risk (P for trend, <0.001). There was also a direct association between higher blood pressures and a higher risk of renal-cell cancer (P for trend, <0.001 for diastolic pressure; P for trend, 0.007 for systolic pressure). After the first five years of follow-up had been excluded to reduce possible effects of preclinical disease, the risk of renal-cell cancer was still consistently higher in men with a higher body-mass index or higher blood pressure. At the sixth-year follow-up, the risk rose further with increasing blood pressures and decreased with decreasing blood pressures, after adjustment for base-line measurements. Men who were current or former smokers had a greater risk of both renal-cell cancer and renal-pelvis cancer than men who were not smokers. There was no relation between body-mass index or blood pressure and the risk of renal-pelvis cancer. Conclusions: Higher body-mass index and elevated blood pressure independently increase the long-term risk of renal-cell cancer in men. A reduction in blood pressure lowers the risk. (N Engl J Med 2000;343:1305-11.) (C) 2000, Massachusetts Medical Society.	NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Umea University	Chow, WH (corresponding author), NCI, Div Canc Epidemiol & Genet, 6120 Execut Blvd,EPS 8100, Bethesda, MD 20892 USA.				NCI NIH HHS [N02-CP-71100] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Chow WH, 2000, COMPREHENSIVE TXB GE, P101; Cohen PG, 1999, MED HYPOTHESES, V52, P49, DOI 10.1054/mehy.1997.0624; Coughlin SS, 1997, CANCER-AM CANCER SOC, V79, P2171, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2171::AID-CNCR15>3.0.CO;2-T; Cowley AW, 1996, JAMA-J AM MED ASSOC, V275, P1581, DOI 10.1001/jama.275.20.1581; ENGHOLM G, 1987, ANN OCCUP HYG, V31, P663, DOI 10.1093/annhyg/31.4B.663; Gago-Dominguez M, 1999, CANCER EPIDEM BIOMAR, V8, P999; Giovannucci E, 1999, HORM RES, V51, P34, DOI 10.1159/000053160; GROVE JS, 1991, AM J EPIDEMIOL, V134, P942, DOI 10.1093/oxfordjournals.aje.a116178; Hodgson AV, 1998, CARCINOGENESIS, V19, P2169, DOI 10.1093/carcin/19.12.2169; Hsieh CC, 1998, J CLIN EPIDEMIOL, V51, P837, DOI 10.1016/S0895-4356(98)00069-9; Klahr S, 1999, J NEPHROL, V12, pS53; Liaw KL, 1997, INT J CANCER, V70, P265, DOI 10.1002/(SICI)1097-0215(19970127)70:3<265::AID-IJC3>3.3.CO;2-H; LINDBLAD P, 1994, CANCER EPIDEM BIOMAR, V3, P631; LINDBLAD P, 1995, INT J CANCER, V61, P192, DOI 10.1002/ijc.2910610209; Matsumoto K, 1999, HYPERTENSION, V34, P279, DOI 10.1161/01.HYP.34.2.279; MATTSSON B, 1985, INT J EPIDEMIOL, V14, P64, DOI 10.1093/ije/14.1.64; MCCREDIE M, 1992, EUR J CANCER, V28A, P2050, DOI 10.1016/0959-8049(92)90254-Y; McLaughlin J. K., 1996, CANC EPIDEMIOLOGY PR, P1142; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; *NAT BOARD HLTH WE, 1995, SWED CANC REG CANC I; OSTLUND E, 1971, WORK ENV HLTH, V8, P27; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Schena FP, 1999, AM J NEPHROL, V19, P308, DOI 10.1159/000013466; Shapiro JA, 1999, AM J EPIDEMIOL, V149, P521; STEFFENS J, 1992, UROL RES, V20, P111, DOI 10.1007/BF00296521; WHITTEMORE AS, 1984, J UROLOGY, V132, P1256, DOI 10.1016/S0022-5347(17)50118-4	27	460	477	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2000	343	18					1305	1311		10.1056/NEJM200011023431804	http://dx.doi.org/10.1056/NEJM200011023431804			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368RP	11058675				2022-12-01	WOS:000090131600004
J	Cook, A; Sheikh, A				Cook, A; Sheikh, A			Trends in serious head injuries among cyclists in England: analysis of routinely collected data	BRITISH MEDICAL JOURNAL			English	Article							HELMETS		Imperial Coll Sch Med, Dept Primary Hlth Care & Gen Practice, London W2 1PG, England	Imperial College London	Cook, A (corresponding author), Imperial Coll Sch Med, Dept Primary Hlth Care & Gen Practice, London W2 1PG, England.		Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; MCCARTHY M, 1992, BRIT MED J, V305, P881, DOI 10.1136/bmj.305.6858.881; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Wardle S, 1998, J PUBLIC HEALTH MED, V20, P70, DOI 10.1093/oxfordjournals.pubmed.a024722	4	25	26	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1055	1055		10.1136/bmj.321.7268.1055	http://dx.doi.org/10.1136/bmj.321.7268.1055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	369PU	11053177	Green Published, Bronze			2022-12-01	WOS:000165076800025
J	Becker, KM; Moe, CL; Southwick, KL; MacCormack, JN				Becker, KM; Moe, CL; Southwick, KL; MacCormack, JN			Transmission of norwalk virus during a football game.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVERSE TRANSCRIPTION-PCR; VIRAL GASTROENTERITIS; OUTBREAKS; SPECIMENS	Background: During a college football game in Florida, diarrhea and vomiting developed in many of the members of a North Carolina team. The next day, similar symptoms developed in some of the players on the opposing team. Methods: We interviewed those who ate the five meals served to the North Carolina team before the game and some of the players on the opposing team who became ill. Patients with primary cases were members or staff of the team who had vomiting or diarrhea at least 10 hours after but no more than 50 hours after eating a box lunch served the day before the game. Patients with secondary cases had a later onset of symptoms or had symptoms without having eaten the box lunch. Stool samples were examined by electron microscopy and by a reverse-transcription-polymerase-chain-reaction (RT-PCR) assay. Results: The two football teams shared no food or beverages and had no contact off the playing field. Of five meals served to the North Carolina team before the game, only the box lunch was associated with a significant risk of illness (relative risk of illness, 4.1; 95 percent confidence interval, 1.6 to 10.0). The rate of attack among those who ate the box lunch was 62 percent. There were 11 secondary cases among the members and staff of the North Carolina team and 11 such cases among the Florida players. All four stool samples obtained from North Carolina patients were positive for Norwalk-like virus on electron microscopy. All four samples as well as one of two stool samples from players on the Florida team were positive for a Norwalk-like virus of genogroup I on RT-PCR assay; the RT-PCR products had identical sequences. Conclusions: This investigation documents person-to-person transmission of Norwalk virus among players during a football game. Persons with acute gastroenteritis should be excluded from playing contact sports.	Dept Hlth & Human Serv, Off Int & Refugee Hlth, Rockville, MD 20857 USA; Ctr Dis Control & Prevent, Epidemiol Intelligence Serv, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA; Univ N Carolina, Chapel Hill, NC USA; N Carolina Dept Hlth & Human Serv, Raleigh, NC USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill	Becker, KM (corresponding author), Dept Hlth & Human Serv, Off Int & Refugee Hlth, Rm 18-105,Parklawn Bldg,5600 Fischers Ln, Rockville, MD 20857 USA.	kbecker@osophs.dhhs.gov	Moe, Christine L/G-6118-2012					ANDO T, 1995, J CLIN MICROBIOL, V33, P64, DOI 10.1128/JCM.33.1.64-71.1995; [Anonymous], 1995, CONTROL COMMUNICABLE; Daniels NA, 2000, J INFECT DIS, V181, P1467, DOI 10.1086/315365; DEAN A, 1995, EPI INFO VERSION 6 W; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; GELLERT GA, 1990, INFECT CONT HOSP EP, V11, P459; GOODMAN RA, 1994, JAMA-J AM MED ASSOC, V271, P862, DOI 10.1001/jama.271.11.862; GREENBERG HB, 1979, LANCET, V1, P55; GRIFFIN MR, 1982, AM J EPIDEMIOL, V115, P178, DOI 10.1093/oxfordjournals.aje.a113289; HO MS, 1989, LANCET, V2, P961; JIANG X, 1993, VIROLOGY, V195, P51, DOI 10.1006/viro.1993.1345; KAPIKIAN AZ, 1996, FIELDS VIROLOGY, V1, P783; MILLER SE, 1986, J ELECTRON MICR TECH, V4, P265, DOI 10.1002/jemt.1060040305; MOE C, 1998, 98 ANN M AM SOC MICR, P15; MOE CL, 1994, J CLIN MICROBIOL, V32, P642, DOI 10.1128/JCM.32.3.642-648.1994; MONROE SS, 1993, J CLIN MICROBIOL, V31, P2866, DOI 10.1128/JCM.31.11.2866-2872.1993; REMINGTON JS, 1981, NEW ENGL J MED, V304, P433, DOI 10.1056/NEJM198102123040730; Schwab KJ, 1997, J CLIN MICROBIOL, V35, P511, DOI 10.1128/JCM.35.2.511-514.1997; TAYLOR JW, 1981, AM J EPIDEMIOL, V114, P584, DOI 10.1093/oxfordjournals.aje.a113224; XI J, 1992, J CLIN MICROBIOL, V30, P2529, DOI 10.1128/JCM.30.10.2529-2534.1992; XI JA, 1990, SCIENCE, V250, P1580, DOI 10.1126/science.2177224; 1987, MMWR MORB MORTAL WKL, V36, P709	22	81	87	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2000	343	17					1223	1227		10.1056/NEJM200010263431704	http://dx.doi.org/10.1056/NEJM200010263431704			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366PQ	11071673	Bronze			2022-12-01	WOS:000090014100004
J	Wauters, H; Van Casteren, V; Buntinx, F				Wauters, H; Van Casteren, V; Buntinx, F			Rectal bleeding and colorectal cancer in general practice: diagnostic study	BRITISH MEDICAL JOURNAL			English	Article									Catholic Univ Louvain, Dept Gen Practice, B-3000 Louvain, Belgium; Sci Inst Publ Hlth, Dept Epidemiol, B-1050 Brussels, Belgium	Universite Catholique Louvain	Buntinx, F (corresponding author), Catholic Univ Louvain, Dept Gen Practice, B-3000 Louvain, Belgium.		Buntinx, Frank/E-4950-2011					BUNTINX F, 2000, INCIDENCE CANC BELGI; FIJTEN GH, 1993, THESIS U LIMBURG NET; GOULSTON KJ, 1986, LANCET, V2, P261; LOBET MP, 1987, INT J EPIDEMIOL, V16, P612, DOI 10.1093/ije/16.4.612; MANT A, 1989, DIS COLON RECTUM, V32, P191, DOI 10.1007/BF02554525	5	48	49	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					998	999		10.1136/bmj.321.7267.998	http://dx.doi.org/10.1136/bmj.321.7267.998			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039968	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000090035600028
J	Packard, CJ; O'Reilly, DSJ; Caslake, MJ; McMahon, AD; Ford, I; Cooney, J; Macphee, CH; Suckling, KE; Krishna, M; Wilkinson, FE; Rumley, A; Lowe, GDO				Packard, CJ; O'Reilly, DSJ; Caslake, MJ; McMahon, AD; Ford, I; Cooney, J; Macphee, CH; Suckling, KE; Krishna, M; Wilkinson, FE; Rumley, A; Lowe, GDO		W Scotland Coronary Prevention Stu	Lipoprotein-associated phospholipase A(2) as an independent predictor of coronary heart disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; ACTIVATING-FACTOR ACETYLHYDROLASE; LOW-DENSITY LIPOPROTEINS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; RISK-FACTORS; ATHEROSCLEROSIS; INFLAMMATION; ATHEROGENESIS	Background: Chronic inflammation is believed to increase the risk of coronary events by making atherosclerotic plaques in coronary vessels prone to rupture. We examined blood constituents potentially affected by inflammation as predictors of risk in men with hypercholesterolemia who were enrolled in the West of Scotland Coronary Prevention Study, a trial that evaluated the value of pravastatin in the prevention of coronary events. Methods: A total of 580 men who had had a coronary event (nonfatal myocardial infarction, death from coronary heart disease, or a revascularization procedure) were each matched for age and smoking status with 2 control subjects (total, 1160) from the same cohort who had not had a coronary event. Lipoprotein-associated phospholipase A(2), C-reactive protein, and fibrinogen levels and the white-cell count were measured at base line, along with other traditional risk factors. The association of these variables with the risk of coronary events was tested in regression models and by dividing the range of values according to quintiles. Results: Levels of C-reactive protein, the white-cell count, and fibrinogen levels were strong predictors of the risk of coronary events; the risk in the highest quintile of the study cohort for each variable was approximately twice that in the lowest quintile. However, the association of these variables with risk was markedly attenuated when age, systolic blood pressure, and lipoprotein levels were included in multivariate models. Levels of lipoprotein-associated phospholipase A(2) (platelet-activating factor acetylhydrolase), the expression of which is regulated by mediators of inflammation, had a strong, positive association with risk that was not confounded by other factors. It was associated with almost a doubling of the risk in the highest quintile as compared with the lowest quintile. Conclusions: Inflammatory markers are predictors of the risk of coronary events, but their predictive ability is attenuated by associations with other coronary risk factors. Elevated levels of lipoprotein-associated phospholipase A(2) appear to be a strong risk factor for coronary heart disease, a finding that has implications for atherogenesis and the assessment of risk. (N Engl J Med 2000;343:1148-55.) (C) 2000 Massachusetts Medical Society.	Glasgow Royal Infirm Univ NHS Trust, Glasgow Royal Infirm, Dept Pathol Biochem, Glasgow G31 2ER, Lanark, Scotland; Glasgow Royal Infirm, Dept Med, Glasgow G31 2ER, Lanark, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; SmithKline Beecham Pharmaceut, Harlow CM19 5AD, Essex, England; diaDexus, Santa Clara, CA USA	University of Glasgow; University of Glasgow; University of Glasgow; GlaxoSmithKline	Packard, CJ (corresponding author), Glasgow Royal Infirm Univ NHS Trust, Glasgow Royal Infirm, Dept Pathol Biochem, 4th Fl Queen Elizabeth Bldg,10 Alexandra Parade, Glasgow G31 2ER, Lanark, Scotland.		Ford, Ian/ABE-6145-2020; McMahon, Alex D/C-4304-2008					Berliner J, 1997, THROMB HAEMOSTASIS, V78, P195; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Cao Y, 1998, J BIOL CHEM, V273, P4012, DOI 10.1074/jbc.273.7.4012; Caslake MJ, 2000, ATHEROSCLEROSIS, V150, P413, DOI 10.1016/S0021-9150(99)00406-2; Danesh J, 1999, EUR HEART J, V20, P954, DOI 10.1053/euhj.1998.1309; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DAVIES MJ, 1993, BRIT HEART J, V69, P377; Elinder LS, 1997, ARTERIOSCL THROM VAS, V17, P2257, DOI 10.1161/01.ATV.17.10.2257; Hak AE, 1999, ARTERIOSCL THROM VAS, V19, P1986, DOI 10.1161/01.ATV.19.8.1986; Hakkinen T, 1999, ARTERIOSCL THROM VAS, V19, P2909, DOI 10.1161/01.ATV.19.12.2909; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Leitinger N, 1999, ARTERIOSCL THROM VAS, V19, P1291, DOI 10.1161/01.ATV.19.5.1291; LOWE GDO, IN PRESS THROMB HAEM; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sartipy P, 1999, J BIOL CHEM, V274, P25913, DOI 10.1074/jbc.274.36.25913; SHEPHERD J, 1995, AM J CARDIOL, V76, P485; Shepherd J, 1997, AM J CARDIOL, V79, P756; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SNYDER E, 1995, BIOCHIM BIOPHYS ACTA, V1254, P231; SNYDER F, 1995, BBA-LIPID LIPID MET, V1259, P121; SNYDER F, 1995, BIOCHIM BIOPHYS ACTA, V1257, P2977; Tew DG, 1996, ARTERIOSCL THROM VAS, V16, P591, DOI 10.1161/01.ATV.16.4.591; Tracy RP, 1999, CURR OPIN LIPIDOL, V10, P435, DOI 10.1097/00041433-199910000-00008; YARNELL JWG, 1991, CIRCULATION, V83, P836, DOI 10.1161/01.CIR.83.3.836; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	32	691	748	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2000	343	16					1148	1155		10.1056/NEJM200010193431603	http://dx.doi.org/10.1056/NEJM200010193431603			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364FY	11036120				2022-12-01	WOS:000089882800003
J	Pestic-Dragovich, L; Stojiljkovic, L; Philimonenko, AA; Nowak, G; Ke, Y; Settlage, RE; Shabanowitz, J; Hunt, DF; Hozak, P; de Lanerolle, P				Pestic-Dragovich, L; Stojiljkovic, L; Philimonenko, AA; Nowak, G; Ke, Y; Settlage, RE; Shabanowitz, J; Hunt, DF; Hozak, P; de Lanerolle, P			A myosin I isoform in the nucleus	SCIENCE			English	Article							RNA-POLYMERASE-II; UNCONVENTIONAL MYOSINS; LARGEST SUBUNIT; PHOSPHORYLATION; TRANSCRIPTION; LOCALIZATION; CLONING; MUSCLE; ALPHA; CELL	A nuclear isoform of myosin I beta that contains a unique 16-amino acid aminoterminal extension has been identified. An affinity-purified antibody to the 16-amino acid peptide demonstrated nuclear staining. Confocal and electron microscopy revealed that nuclear myosin I beta colocalized with RNA polymerase II in an alpha-amanitin- and actinomycin D-sensitive manner. The antibody coimmunoprecipitated RNA polymerase II and blocked in vitro RNA synthesis. This isoform of myosin I beta appears to be in a complex with RNA polymerase II and may affect transcription.	Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; Acad Sci Czech Republ, Inst Expt Med, Dept Cell Ultrastruct & Mol Biol, Prague, Czech Republic; Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22901 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; University of Virginia; University of Virginia	de Lanerolle, P (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA.	primal@uic.edu	Hozak, Pavel/J-4182-2014; Hunt, Donald F/I-6936-2012; Hozak, Pavel/AAB-5359-2021	Hozak, Pavel/0000-0003-1901-1394; Hunt, Donald F/0000-0003-2815-6368; Hozak, Pavel/0000-0003-1901-1394	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056489, R01GM037537] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 37537, GM 56489] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Alberts B., 1994, MOL BIOL CELL 2, V3rd ed.; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Crozet F, 1997, GENOMICS, V40, P332, DOI 10.1006/geno.1996.4526; DELANEROLLE P, 1982, NATURE, V298, P871, DOI 10.1038/298871a0; FUKUI Y, 1989, NATURE, V341, P328, DOI 10.1038/341328a0; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; Iborra FJ, 1996, J CELL SCI, V109, P1427; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lavoie SB, 1999, BIOCHEM CELL BIOL, V77, P367, DOI 10.1139/bcb-77-4-367; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Nowak G, 1997, J BIOL CHEM, V272, P17176, DOI 10.1074/jbc.272.27.17176; PHILIMONENKO AA, UNPUB; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; RUPPERT C, 1995, J CELL SCI, V108, P3775; Shabanowitz J, 2000, MASS SPECTROMETRY IN BIOLOGY & MEDICINE, P163; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653	24	202	213	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2000	290	5490					337	341		10.1126/science.290.5490.337	http://dx.doi.org/10.1126/science.290.5490.337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030652				2022-12-01	WOS:000089818100044
J	Foster, KR; Ratnieks, FLW				Foster, KR; Ratnieks, FLW			Social insects - Facultative worker policing in a wasp	NATURE			English	Article							HYMENOPTERA; BEES		Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Western Bank, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Foster, KR (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Western Bank, Sheffield S10 2TN, S Yorkshire, England.			Foster, Kevin/0000-0003-4687-6633				ESTOUP A, 1995, MOL ECOL, V4, P89, DOI 10.1111/j.1365-294X.1995.tb00195.x; Foster KR, 2000, MOL ECOL, V9, P735, DOI 10.1046/j.1365-294x.2000.00920.x; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Keller L, 1999, LEVELS SELECTION EVO; Peters JM, 1999, P ROY SOC B-BIOL SCI, V266, P379, DOI 10.1098/rspb.1999.0648; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Starr C.K., 1984, P427; THOREN PA, 1995, INSECT MOL BIOL, V4, P141, DOI 10.1111/j.1365-2583.1995.tb00019.x	9	115	119	0	56	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					692	693		10.1038/35037665	http://dx.doi.org/10.1038/35037665			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048706				2022-12-01	WOS:000089773900027
J	Hong, L; Koelsch, G; Lin, XL; Wu, SL; Terzyan, S; Ghosh, AK; Zhang, XC; Tang, J				Hong, L; Koelsch, G; Lin, XL; Wu, SL; Terzyan, S; Ghosh, AK; Zhang, XC; Tang, J			Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; ASPARTIC PROTEINASE; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; CANDIDA-ALBICANS; RESOLUTION; PEPSTATIN; SYSTEM; GENE	Memapsin 2 (beta-secretase) is a membrane-associated aspartic protease involved in the production of beta-amyloid peptide in Alzheimer's disease and is a major target for drug design. We determined the crystal structure of the protease domain of human memapsin 2 complexed to an eight-residue inhibitor at 1.9 angstrom resolution. The active site of memapsin 2 is more open and less hydrophobic than that of other human aspartic proteases. The subsite locations from S-4 to S-2' are well defined. A kink of the inhibitor chain at P-2' and the change of chain direction of P-3' and P-4' may be mimicked to provide inhibitor selectivity.	Oklahoma Med Res Fdn, Prot Studies Program, Oklahoma City, OK 73104 USA; Oklahoma Med Res Fdn, Crystallog Program, Oklahoma City, OK 73104 USA; Univ Illinois, Dept Chem, Chicago, IL 60607 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center	Tang, J (corresponding author), Oklahoma Med Res Fdn, Prot Studies Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	jordan-tang@omrf.ouhsc.edu						AbadZapatero C, 1996, PROTEIN SCI, V5, P640; BAILEY D, 1994, PROTEIN SCI, V3, P2129, DOI 10.1002/pro.5560031126; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUTFIELD SM, 1995, STRUCTURE, V3, P1261, DOI 10.1016/S0969-2126(01)00261-1; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; DEALWIS CG, 1994, J MOL BIOL, V236, P342, DOI 10.1006/jmbi.1994.1139; ERMOLIEFF J, IN PRESS BIOCHEMISTR; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fujinaga M, 2000, ACTA CRYSTALLOGR D, V56, P272, DOI 10.1107/S0907444999016376; FUJINAGA M, 1995, PROTEIN SCI, V4, P960; Ghosh AK, 2000, J AM CHEM SOC, V122, P3522, DOI 10.1021/ja000300g; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kearney BP, 1999, NEUROL CLIN, V17, P883, DOI 10.1016/S0733-8619(05)70171-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; LIN XL, 1994, METHOD ENZYMOL, V241, P195; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SIELECKI AR, 1990, J MOL BIOL, V214, P143, DOI 10.1016/0022-2836(90)90153-D; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Symersky J, 1997, BIOCHEMISTRY-US, V36, P12700, DOI 10.1021/bi970613x; TANG J, 1978, NATURE, V271, P618, DOI 10.1038/271618a0; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WLODAWER A, 1993, ANNU REV BIOCHEM, V62, P543, DOI 10.1146/annurev.bi.62.070193.002551; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang J, 1999, ACTA CRYSTALLOGR D, V55, P625, DOI 10.1107/S0907444998013961	32	651	730	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					150	153		10.1126/science.290.5489.150	http://dx.doi.org/10.1126/science.290.5489.150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021803				2022-12-01	WOS:000089724800056
J	Helgason, S; Petursson, G; Gudmundsson, S; Sigurdsson, JA				Helgason, S; Petursson, G; Gudmundsson, S; Sigurdsson, JA			Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up	BRITISH MEDICAL JOURNAL			English	Article							ORAL ACYCLOVIR; CHRONIC PAIN; TRIALS; RISK	Objective To estimate the frequency, duration, and clinical importance of postherpetic neuralgia after a first episode of herpes tester. Design Prospective cohort study with long term follow up. Setting Primary health care in Iceland. Participants 421 patients with a first episode of herpes tester. Main outcome measures Age and sex distribution of patients with herpes tester, point prevalence or postherpetic neuralgia, and severity of pain at 1, 3, 6, and 12 months and up to 7.6 years after the outbreak of zoster. Results Among patients) younger than 60 years, the risk of postherpetic neuralgia three months after the start of the tester rash was 1.8% (95% confidence interval 0.59% to 4.18%) and pain was mild in all cases. In patients 60 years and older, the risk of postherpetic neuralgia increased but the pain was usually mild or moderate. After three months severe pain was recorded in two patients older than 60 years (1.7%, 2.14% to 6.15%). After 12 months no patient reported severe pain and 14 patients (3.3%) had mild or moderate pain. Seven of these became pain free within two to seven years, and five reported mild pain and one moderate pain after 7.6 years of follow up. Sex was not a predictor of postherpetic neuralgia. Possible immunomodulating comorbidity (such as malignancy, systemic steroid use, diabetes) was present in It patients. Conclusions The probability of longstanding pain of clinical importance after herpes tester is lo it in an unselected population of primary care patients essentially untreated with antiviral drugs.	Arbaer Hlth Care Ctr, IS-110 Reykjavik, Iceland; Univ Iceland, Dept Family Med, IS-105 Reykjavik, Iceland; Directorate Hlth, IS-150 Reykjavik, Iceland	University of Iceland	Helgason, S (corresponding author), Arbaer Hlth Care Ctr, IS-110 Reykjavik, Iceland.			Sigurdsson, Johann Agust/0000-0002-5646-6411	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEUTNER KR, 1995, ANTIMICROB AGENTS CH, V39, P1546, DOI 10.1128/AAC.39.7.1546; Bowsher D, 1999, EUR J PAIN-LONDON, V3, P335, DOI 10.1016/S1090-3801(99)90015-0; Christensen P, 1985, Ugeskr Laeger, V147, P3401; DWORKIN RH, 1992, J ABNORM PSYCHOL, V101, P200, DOI 10.1037/0021-843X.101.1.200; Dworkin RH, 1997, ANTIVIR RES, V33, P73, DOI 10.1016/S0166-3542(96)01007-8; Gardner M. J., 1989, STAT CONFIDENCE; GEBSKY V, 1992, SPIDA USERS MANUAL; HARDING SP, 1991, CURR EYE RES, V10, P177, DOI 10.3109/02713689109020376; HAYENS B, 1998, EVIDENCE BASED MED, V3, P130; HELGASON S, 1996, EUR J GEN PRACT, V2, P12; Hope-Simpson R E, 1975, J R Coll Gen Pract, V25, P571; Jackson JL, 1997, ARCH INTERN MED, V157, P909, DOI 10.1001/archinte.157.8.909; Johnson RW, 1997, ANTIVIR CHEM CHEMOTH, V8, P19, DOI 10.1177/09563202970080S606; Johnstone B, 1997, NEUROREHABILITATION, V8, P1, DOI 10.3233/NRE-1997-8101; KAY R, 1995, ANTIVIR CHEM CHEMOTH, V6, P28, DOI 10.1177/09563202950060S607; Knottnerus JA, 1997, BRIT MED J, V315, P1109; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; LANCASTER T, 1995, BRIT J GEN PRACT, V45, P39; LYDICK E, 1995, NEUROLOGY S8, V45, P52; MCKENDRICK MW, 1989, BRIT MED J, V298, P431, DOI 10.1136/bmj.298.6671.431; McQuay HJ, 1997, BRIT MED J, V314, P763, DOI 10.1136/bmj.314.7083.763; Petursson G, 1998, PEDIATR INFECT DIS J, V17, P905, DOI 10.1097/00006454-199810000-00011; RAGOZZINO MW, 1982, NEW ENGL J MED, V307, P393, DOI 10.1056/NEJM198208123070701; SACKETT DL, 1991, CLIN EPIDEMIOLOGY BA, P318; SANDERS HWA, 1968, THESIS U NIJMEGEN NI	25	164	173	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					794	796A		10.1136/bmj.321.7264.794	http://dx.doi.org/10.1136/bmj.321.7264.794			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009518	Green Published, Bronze			2022-12-01	WOS:000089696600022
J	Irmay, F; Merzouga, B; Vettorel, D				Irmay, F; Merzouga, B; Vettorel, D			The Krukenberg procedure: a surgical option for the treatment of double hand amputees in Sierra Leone	LANCET			English	Article								Background For the past 9 years, Sierra Leone has struggled with a cruel civil war in which the civilian population has been the principal target. The International Committee of the Red Cross established a surgical mission in Netland Hospital, Freetown, and during this surgical mission, we treated crippled individuals who had had one or both hands amputated. We assessed the benefit of the Krukenberg procedure to restore manual dexterity in this group.:ln this operation, radius and ulna are separated and a: pincer-like grasp is created. Methods From July 15, 1998, to Sept 9, 1998, we carried out the Krukenberg procedure on a group of double and single hand amputees. The main target group was double hand amputees, however, the procedure was initially done on three single hand amputees to assess the functional result. Between the original trauma and the operation, there had been an interval of 3 months or longer in all patients. Patients were followed up for 3 months after the procedure to assess gripping strength and self-sufficiency (feeding, personal hygiene, dressing, and manual dexterity). Findings 15 Kruhenberg procedures were done on 11 patients: eight men and three women (mean age 42 years). Three had single hand amputation and eight had double hand amputation. In only two patients had sufficient time passed for the stumps to heal. Of ten patients who were followed up at 3 months, all could eat and drink by themselves. The simple dressing test was passed by all patients and 75% of the patients had recovered some dexterity. Interpretation The Kruhenberg procedure is a surgical option to achieve some manual dexterity in double hand amputees, where resources for sophisticated hand prostheses are lacking.	Univ Hosp Geneva, Dept Surg, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Div Anaesthesiol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Irmay, F (corresponding author), Univ Hosp Geneva, Dept Surg, Rue Micheli du Crest 24, CH-1211 Geneva 14, Switzerland.							BAUMGARTNER R, 1994, Z ORTHOP GRENZGEB, V132, P180, DOI 10.1055/s-2008-1039960; CALANDRUCCIO JH, 1998, CAMPBELLS OPERATIVE, P3517; *CICR, 1977, PROT ADD CONV GEN 12, P136; *CICR, 1949, CONV GEN 12 AOUT 194, P256; Colp R, 1933, J BONE JOINT SURG, V15, P439; *COM INT CROIX ROU, 1999, ACT CICR SIERR LEON; GARST RJ, 1991, J BONE JOINT SURG BR, V73, P385, DOI 10.1302/0301-620X.73B3.1670433; GOSSET J, 1975, ANN CHIR, V29, P1073; Krukenberg H, 1931, ARCH KLIN CHIR, V165, P191; LESCOEUR JE, 1979, AMPUTES MEMBRES SUPE, P112; Lob A, 1970, Hefte Unfallheilkd, V105, P1; Loosli-Guignard R M, 1983, Ann Chir Main, V2, P154, DOI 10.1016/S0753-9053(83)80095-7; MATHUR BP, 1981, PROSTHET ORTHOT INT, V5, P135; RICHARDS P, 1996, FIGHTING RAIN FOREST, P182; SINAKI M, 1982, CLIN ORTHOP RELAT R, P163; SWANSON DB, 1980, CLIN ORTHOP RELAT R, V148, P55; TUBIANA R, 1981, ORTHOP CLIN N AM, V12, P819; United Nations, 1996, WORLD POP PROSP; 1998, UN CONS INT AG APP H, P62; 1998, AFRICA S SAHARA 1999, P928	20	17	17	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1072	1075		10.1016/S0140-6736(00)02731-8	http://dx.doi.org/10.1016/S0140-6736(00)02731-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009143				2022-12-01	WOS:000089430500012
J	Michael, WM; Ott, R; Fanning, E; Newport, J				Michael, WM; Ott, R; Fanning, E; Newport, J			Activation of the DNA replication checkpoint through RNA synthesis by primase	SCIENCE			English	Article							POLYMERASE-ALPHA; PROTEIN-KINASE; FISSION YEAST; S-PHASE; INITIATION; INHIBITOR; MITOSIS; DAMAGE; CDK	When DNA replication is inhibited during the synthesis (S) phase of the cell cycle, a signaling pathway (checkpoint) is activated that serves to prevent mitosis from initiating before completion of replication. This replication checkpoint acts by down-regulating the activity of the mitotic inducer cdc2-cyclin B. Here, we report the relation between chromatin structure and induction of the replication checkpoint. Chromatin was competent to initiate a checkpoint response only after the DNA was unwound and DNA polymerase or had been Loaded. Checkpoint induction did not require new DNA synthesis on the unwound template strand but did require RNA primer synthesis by primase. These findings Identify the RNA portion of the primer as an important component of the signal that activates the replication checkpoint.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Vanderbilt Univ, Dept Mol Biol, Nashville, TN 37235 USA	University of California System; University of California San Diego; Harvard University; Vanderbilt University	Michael, WM (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.	matt@mcb.harvard.edu	McDermott, Michael Francis/GZM-5330-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033523] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM33523-16] Funding Source: Medline; PHS HHS [52948] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bhaumik D, 1998, MOL BIOL CELL, V9, P2107, DOI 10.1091/mbc.9.8.2107; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; DURSO G, 1995, J CELL SCI, V108, P3109; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; GROSSE F, 1985, J BIOL CHEM, V260, P1881; Kirk BW, 1999, BIOCHEMISTRY-US, V38, P7727, DOI 10.1021/bi990247c; KORNBERG A, 1992, DNA REPLICATION, P466; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MICHAEL WM, UNPUB; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; MURRAY GB, 1995, PSYCHOSOMATICS, V36, P581, DOI 10.1016/S0033-3182(95)71616-4; Rhind N, 1998, CURR OPIN CELL BIOL, V10, P749, DOI 10.1016/S0955-0674(98)80118-X; Russell P, 1998, TRENDS BIOCHEM SCI, V23, P399, DOI 10.1016/S0968-0004(98)01291-2; Schneider A, 1998, J BIOL CHEM, V273, P21608, DOI 10.1074/jbc.273.34.21608; SHEAFF R, 1991, BIOCHEMISTRY-US, V30, P8590, DOI 10.1021/bi00099a014; TANAKA S, 1982, J BIOL CHEM, V257, P8386; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1999, PRACT APPROACH SER, V199, P201; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wang TSF, 1995, METHOD ENZYMOL, V262, P77; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189	24	162	166	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2133	2137		10.1126/science.289.5487.2133	http://dx.doi.org/10.1126/science.289.5487.2133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000117				2022-12-01	WOS:000089430900047
J	Farrison, PJH				Farrison, PJH			Dopamine and schizophrenia - proof at last?	LANCET			English	Editorial Material							RELEASE		Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England	University of Oxford	Farrison, PJH (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Neurosci Bldg, Oxford OX3 7JX, England.			Harrison, Paul/0000-0002-6719-1126				Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Bennett MR, 1998, J PSYCHOPHARMACOL, V12, P289, DOI 10.1177/026988119801200310; Bertolino A, 1999, BIOL PSYCHIAT, V45, P660, DOI 10.1016/S0006-3223(98)00380-1; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; DEUTCH AY, 1992, J NEURAL TRANSM-GEN, P61; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; HIETALA J, 1995, LANCET, V346, P1130, DOI 10.1016/S0140-6736(95)91801-9; Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; Kerwin RW, 1996, PSYCHOL MED, V26, P221, DOI 10.1017/S0033291700034619; Laruelle M, 1999, J PSYCHOPHARMACOL, V13, P358, DOI 10.1177/026988119901300405; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Seeman P, 2000, P NATL ACAD SCI USA, V97, P7673, DOI 10.1073/pnas.97.14.7673; Seeman P, 1998, MOL PSYCHIATR, V3, P123, DOI 10.1038/sj.mp.4000336; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012	15	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					958	959		10.1016/S0140-6736(00)02710-0	http://dx.doi.org/10.1016/S0140-6736(00)02710-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041394				2022-12-01	WOS:000089293600007
J	Kleemann, R; Hausser, A; Geiger, G; Mischke, R; Burger-Kentischer, A; Flieger, O; Johannes, FJ; Roger, T; Calandra, T; Kapurniotu, A; Grell, M; Finkelmeier, D; Brunner, H; Bernhagen, J				Kleemann, R; Hausser, A; Geiger, G; Mischke, R; Burger-Kentischer, A; Flieger, O; Johannes, FJ; Roger, T; Calandra, T; Kapurniotu, A; Grell, M; Finkelmeier, D; Brunner, H; Bernhagen, J			Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1	NATURE			English	Article							MIGRATION-INHIBITORY FACTOR; PROTEIN; GENES; EXPRESSION; SUBUNITS; BINDING; REVEALS	Cytokines are multifunctional mediators that classically modulate immune activity by receptor-mediated pathways. Macrophage migration inhibitory factor (MIF) is a cytokine that has a critical role in several inflammatory conditions(1-3) but that also has endocrine(4,5) and enzymatic functions(6,7). The molecular targets of MIF action have so far remained unclear. Here we show that MIF specifically interacts with an intracellular protein, Jab1, which is a coactivator of AP-1 transcription(8,9) that also promotes degradation of the cyclin-dependent kinase inhibitor p27(Kip1) (ref. 10). MIF colocalizes with Jab1 in the cytosol, and both endogenous and exogenously added MIF following endocytosis bind Jab1. MIF inhibits Jab1- and stimulus-enhanced AP-1 activity, but does not interfere with the induction of the transcription factor NF kappaB. Jab1 activates c-Jun amino-terminal kinase (JNK) activity and enhances endogenous phospho-c-Jun levels, and MIF inhibits these effects. MIF also antagonizes Jab1-dependent cell-cycle regulation by increasing p27(Kip1) expression through stabilization of p27(Kip1) protein. Consequently, Jab1-mediated rescue of fibroblasts from growth arrest is blocked by MIF. Amino acids 50-65 and Cys 60 of MIF are important for Jab1 binding and modulation. We conclude that MIF may act broadly to negatively regulate Jab1-controlled pathways and that the MIF-Jab1 interaction may provide a molecular basis for key activities of MIF.	Univ Stuttgart, Biochem Lab, Inst Interfacial Engn, D-70569 Stuttgart, Germany; Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; Fraunhofer IGB, D-70569 Stuttgart, Germany; CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland; Univ Tubingen, Inst Physiol Chem, D-72076 Tubingen, Germany	University of Stuttgart; University of Stuttgart; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Eberhard Karls University of Tubingen	Bernhagen, J (corresponding author), Univ Stuttgart, Biochem Lab, Inst Interfacial Engn, Nobelstr 12, D-70569 Stuttgart, Germany.		Hausser, Angelika/AAC-4531-2021; Roger, Thierry/G-2007-2012; Calandra, Thierry/D-9017-2015	Roger, Thierry/0000-0002-9358-0109; Calandra, Thierry/0000-0003-3051-1285				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; Bacher M, 1998, MOL MED, V4, P217, DOI 10.1007/BF03401919; Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chauchereau A, 2000, J BIOL CHEM, V275, P8540, DOI 10.1074/jbc.275.12.8540; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Dedio J, 1998, J IMMUNOL, V160, P3534; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Johannes FJ, 1998, EUR J BIOCHEM, V257, P47, DOI 10.1046/j.1432-1327.1998.2570047.x; KARIN M, 1995, J BIOL CHEM, V270; Kleemann R, 1999, EUR J BIOCHEM, V261, P753, DOI 10.1046/j.1432-1327.1999.00327.x; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; Roger T, 1998, BIOCHEM J, V330, P429, DOI 10.1042/bj3300429; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782; WISTOW GJ, 1993, P NATL ACAD SCI USA, V90, P1271	30	486	519	0	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					211	216		10.1038/35041591	http://dx.doi.org/10.1038/35041591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089976				2022-12-01	WOS:000165180400048
J	McKinsey, TA; Zhang, CL; Lu, JR; Olson, EN				McKinsey, TA; Zhang, CL; Lu, JR; Olson, EN			Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation	NATURE			English	Article							TRANSCRIPTION FACTOR MEF2C; PROTEIN-KINASE; GENE-EXPRESSION; ACTIVATION; PHOSPHORYLATION; CALCINEURIN; SURVIVAL; DOMAIN; CRM1	Members of the myocyte enhancer factor-2 (MEF2) family of transcription factors associate with myogenic basic helix-loop-helix transcription factors such as MyoD to activate skeletal myogenesis(1). MEF2 proteins also interact with the class II histone deacetylases HDAC4 and HDAC5, resulting in repression of MEF2-dependent genes(2-4). Execution of the muscle differentiation program requires release of MEF2 from repression by HDACs, which are expressed constitutively in myoblasts and myotubes(5). Here we show that HDAC5 shuttles from the nucleus to the cytoplasm when myoblasts are triggered to differentiate. Calcium/calmodulin-dependent protein kinase (CaMK) signalling, which stimulates myogenesis(5) and prevents formation of MEF2-HDAC complexes(4), also induces nuclear export of HDAC4 and HDAC5 by phosphorylation of these transcriptional repressors. An HDAC5 mutant lacking two CaMK phosphorylation sites is resistant to CaMK-mediated nuclear export and acts as a dominant inhibitor of skeletal myogenesis, whereas a cytoplasmic HDAC5 mutant is unable to block efficiently the muscle differentiation program. Our results highlight a mechanism for transcriptional regulation through signal- and differentiation-dependent nuclear export of a chromatin-remodelling enzyme, and suggest that nucleo-cytoplasmic trafficking of HDACs is involved in the control of cellular differentiation.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	eolson@hamon.swmed.edu	Lu, Jianrong/F-5240-2013	Lu, Jianrong/0000-0002-4969-6040	NHLBI NIH HHS [R01 HL053351] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053351] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; English JM, 1999, J BIOL CHEM, V274, P31588, DOI 10.1074/jbc.274.44.31588; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NISHI K, 1994, J BIOL CHEM, V269, P6320; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Rybkin II, 2000, J BIOL CHEM, V275, P5460, DOI 10.1074/jbc.275.8.5460; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963	30	835	875	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2000	408	6808					106	111		10.1038/35040593	http://dx.doi.org/10.1038/35040593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081517	Green Accepted			2022-12-01	WOS:000165050400061
J	Henney, JE				Henney, JE			Challenges in regulating direct-to-consumer advertising	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									US FDA, Washington, DC 20204 USA	US Food & Drug Administration (FDA)	Henney, JE (corresponding author), US FDA, Washington, DC 20204 USA.							Bradley LR, 1997, MED CARE, V35, P86, DOI 10.1097/00005650-199701000-00008; Food and Drug Administration Center for Drug Evaluation and Research (CDER), 1999, FED REG, V64, P43197; *FOOD DRUG ADM, 1997, DRAFT GUID IND CONS; *FOOD DRUG ADM, 1984, PRESCR DRUG ADV CONS; WILES MS, 2000, HLTH AFF MILLWOOD, V10, P110; 1999, FED REG, V50, P36677	6	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2242	2242		10.1001/jama.284.17.2242	http://dx.doi.org/10.1001/jama.284.17.2242			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056601	hybrid			2022-12-01	WOS:000090052600037
J	Mer, G; Bochkarev, A; Gupta, R; Bochkareva, E; Frappier, L; Ingles, CJ; Edwards, AM; Chazin, WJ				Mer, G; Bochkarev, A; Gupta, R; Bochkareva, E; Frappier, L; Ingles, CJ; Edwards, AM; Chazin, WJ			Structural basis for the recognition of DNA repair proteins UNG2, XPA, and RAD52 by replication factor RPA	CELL			English	Article							SINGLE-STRANDED-DNA; NUCLEOTIDE EXCISION-REPAIR; A COMPLEMENTING PROTEIN; BINDING DOMAIN; CRYSTAL-STRUCTURE; NMR; COMPLEX; RECOMBINATION; GLYCOSYLASE; MECHANISM	Replication protein A (RPA), the nuclear ssDNA-binding protein in eukaryotes, is essential to DNA replication, recombination, and repair. We have shown that a globular domain at the C terminus of subunit RPA32 contains a specific surface that interacts in a similar manner with the DNA repair enzyme UNG2 and repair factors XPA and RAD52, each of which functions in a different repair pathway. NMR structures of the RPA32 domain, free and in complex with the minimal interaction domain of UNG2, were determined, defining a common structural basis for linking RPA to the nucleotide excision, base excision, and recombinational pathways of repairing damaged DNA. Our findings support a hand-off model for the assembly and coordination of different components of the DNA repair machinery.	Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Scripps Research Institute; University of Toronto; University of Toronto; University of Oklahoma System; University of Oklahoma Health Sciences Center; Vanderbilt University	Edwards, AM (corresponding author), Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada.	aled.edwards@utoronto.ca; walter.chazin@vanderbilt.edu	Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578; Edwards, Aled/0000-0002-4782-6016				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; Buchko GW, 1999, BIOCHEMISTRY-US, V38, P15116, DOI 10.1021/bi991755p; COVERLEY D, 1991, NATURE, V349, P538, DOI 10.1038/349538a0; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; DeMott MS, 1998, J BIOL CHEM, V273, P27492, DOI 10.1074/jbc.273.42.27492; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Ikegami T, 1998, NAT STRUCT BIOL, V5, P701, DOI 10.1038/1400; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lee BE, 1999, MOL CELLS, V9, P185; LONGHESE MP, 1994, MOL CELL BIOL, V14, P7884, DOI 10.1128/MCB.14.12.7884; Macke TJ, 1998, ACS SYM SER, V682, P379; Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047; Mer G, 2000, J BIOMOL NMR, V17, P179, DOI 10.1023/A:1008306832408; MIYAMOTO I, 1992, J BIOL CHEM, V267, P12182; Nagelhus TA, 1997, J BIOL CHEM, V272, P6561, DOI 10.1074/jbc.272.10.6561; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; OTTING G, 1990, Q REV BIOPHYS, V23, P39, DOI 10.1017/S0033583500005412; Parikh Sudip S., 1999, Current Opinion in Structural Biology, V9, P37, DOI 10.1016/S0959-440X(99)80006-2; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; PEARLMAN DA, 1995, AMBER 4 1; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Saijo M, 1996, NUCLEIC ACIDS RES, V24, P4719, DOI 10.1093/nar/24.23.4719; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; SENN H, 1989, FEBS LETT, V249, P113, DOI 10.1016/0014-5793(89)80027-4; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Stigger E, 1998, J BIOL CHEM, V273, P9337, DOI 10.1074/jbc.273.15.9337; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; ZWALEN C, 1997, J AM CHEM SOC, V119, P6711; [No title captured]	43	193	197	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 27	2000	103	3					449	456		10.1016/S0092-8674(00)00136-7	http://dx.doi.org/10.1016/S0092-8674(00)00136-7			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081631	Bronze			2022-12-01	WOS:000090144100010
J	Thompson, SA; Duncan, JS; Smith, SJM				Thompson, SA; Duncan, JS; Smith, SJM			Partial seizures presenting as panic attacks	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LOBE SEIZURES; EPILEPSY; PREVALENCE; DIAGNOSIS; DISORDERS		MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Thompson, SA (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England.	SianAT@aol.com		Duncan, John S/0000-0002-1373-0681				ALEMAYEHU S, 1995, EPILEPSIA, V36, P824, DOI 10.1111/j.1528-1157.1995.tb01621.x; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P393; Duncan JS, 1995, CLIN EPILEPSY, P29; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; KERANEN T, 1988, EPILEPSIA, V29, P1, DOI 10.1111/j.1528-1157.1988.tb05089.x; Lagerlund TD, 1996, MAYO CLIN PROC, V71, P1000; LAIDLAW JDD, 1993, BRIT MED J, V306, P709, DOI 10.1136/bmj.306.6879.709; LOGAR C, 1994, EUR NEUROL, V34, P29, DOI 10.1159/000119506; ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949; STAHL SM, 1995, SEMIN NEUROL, V15, P126, DOI 10.1055/s-2008-1041016; YOUNG GB, 1995, J NEUROPSYCH CLIN N, V7, P352	11	36	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2000	321	7267					1002	1003		10.1136/bmj.321.7267.1002	http://dx.doi.org/10.1136/bmj.321.7267.1002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039971	Green Published			2022-12-01	WOS:000090035600030
J	Simeonov, A; Matsushita, M; Juban, EA; Thompson, EHZ; Hoffman, TZ; Beuscher, AE; Taylor, MJ; Wirsching, P; Rettig, W; McCusker, JK; Stevens, RC; Millar, DP; Schultz, PG; Lerner, RA; Janda, KD				Simeonov, A; Matsushita, M; Juban, EA; Thompson, EHZ; Hoffman, TZ; Beuscher, AE; Taylor, MJ; Wirsching, P; Rettig, W; McCusker, JK; Stevens, RC; Millar, DP; Schultz, PG; Lerner, RA; Janda, KD			Blue-fluorescent antibodies	SCIENCE			English	Article							COHERENT REACTION DYNAMICS; CIS-STILBENE FLUORESCENCE; EXCIMER FLUORESCENCE; TRANS-STILBENE; QUANTUM YIELDS; PHOTOISOMERIZATION; PHOTOCHEMISTRY; ISOMERIZATION; CYCLODEXTRIN; PHOTOPHYSICS	The forte of catalytic antibodies has resided in the control of the ground-state reaction coordinate. A principle and method are now described in which antibodies can direct the outcome of photophysical and photochemical events that take place on excited-state potential energy surfaces. The key component is a chemically reactive optical sensor that provides a direct report of the dynamic interplay between protein and Ligand at the active site. To illustrate the concept, we used a trans-stilbene hapten to elicit a panel of monoclonal antibodies that displayed a range of fluorescent spectral behavior when bound to a trans-stilbene substrate. Several antibodies yielded a blue fluorescence indicative of an excited-state complex or "exciplex" between trans-stilbene and the antibody. The antibodies controlled the isomerization coordinate of trans-stilbene and dynamically coupled this manifold with an active-site residue. A step was taken toward the use of antibody-based photochemical sensors for diagnostic and clinical applications.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Humboldt Univ, Inst Phys & Theoret Chem, D-10117 Berlin, Germany	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Berkeley; Scripps Research Institute; Humboldt University of Berlin	Simeonov, A (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Stevens, Raymond/K-7272-2015	Stevens, Raymond/0000-0002-4522-8725	NCI NIH HHS [P01CA27489] Funding Source: Medline; NIAID NIH HHS [AI39089] Funding Source: Medline; NIGMS NIH HHS [GM43858] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA027489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039089, R01AI039089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM043858, R01GM043858] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGBARIA RA, 1995, J PHYS CHEM-US, V99, P10056, DOI 10.1021/j100024a057; BIRKS JB, 1975, CHEM PHYS LETT, V31, P608, DOI 10.1016/0009-2614(75)85098-6; COURTNEIDGE JL, 1987, J CHEM SOC PERK T 2, P1527, DOI 10.1039/p29870001527; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; DUVENECK GL, 1989, J PHYS CHEM-US, V93, P7166, DOI 10.1021/j100357a028; Exner O., 1988, CORRELATION ANAL CHE; GOMER H, 1995, ADV PHOTOCHEM, V19, P1; GUEST CR, 1991, BIOCHEMISTRY-US, V30, P3271, DOI 10.1021/bi00227a015; Kistiakowsky GB, 1934, J AM CHEM SOC, V56, P638, DOI 10.1021/ja01318a029; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LAARHOVEN WH, 1990, PHOTOCHROMISM MOL SY, P282; LEWIS FD, 1995, J AM CHEM SOC, V117, P8785, DOI 10.1021/ja00139a011; LEWIS FD, 1995, J AM CHEM SOC, V117, P660, DOI 10.1021/ja00107a010; Liebl U, 1999, NATURE, V401, P181, DOI 10.1038/43699; MALKIN S, 1964, J PHYS CHEM-US, V68, P1153, DOI 10.1021/j100787a032; OGAWA K, 1988, J CHEM SOC PERK T 2, P39, DOI 10.1039/p29880000039; PALMANS JP, 1984, J AM CHEM SOC, V106, P7721, DOI 10.1021/ja00337a014; PETEK H, 1990, J PHYS CHEM-US, V94, P7539, DOI 10.1021/j100382a043; RETTIG W, 1993, PURE APPL CHEM, V65, P1699, DOI 10.1351/pac199365081699; SALTIEL J, 1972, J AM CHEM SOC, V94, P6445, DOI 10.1021/ja00773a031; SALTIEL J, 1990, J AM CHEM SOC, V112, P4580, DOI 10.1021/ja00167a086; SALTIEL J, 1967, J AM CHEM SOC, V89, P1036, DOI 10.1021/ja00980a057; SALTIEL J, 1993, J AM CHEM SOC, V115, P2453, DOI 10.1021/ja00059a047; SALTIEL J, 1979, J AM CHEM SOC, V101, P2982, DOI 10.1021/ja00505a027; SALTIEL J, 1993, J PHYS CHEM-US, V97, P2516, DOI 10.1021/j100113a009; SALTIEL J, 1990, STUD ORG CHEM, V40, P64; SALTIEL J, 1968, J AM CHEM SOC, V90, P4759, DOI 10.1021/ja01019a063; SCHULTZ PG, 1995, SCIENCE, V269, P1835, DOI 10.1126/science.7569920; SIMEONOV AM, UNPUB; SYAMALA MS, 1986, J PHOTOCHEM, V34, P219, DOI 10.1016/0047-2670(86)85021-3; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; WALDECK DH, 1991, CHEM REV, V91, P415, DOI 10.1021/cr00003a007; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; Wentworth P, 1998, CURR OPIN CHEM BIOL, V2, P138, DOI 10.1016/S1367-5931(98)80046-X; ZHU LY, 1994, SCIENCE, V266, P629, DOI 10.1126/science.7939716	36	94	99	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					307	313		10.1126/science.290.5490.307	http://dx.doi.org/10.1126/science.290.5490.307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030644				2022-12-01	WOS:000089818100036
J	Choi, SB; Wang, CL; Muench, DG; Ozawa, K; Franceschi, VR; Wu, YJ; Okita, TW				Choi, SB; Wang, CL; Muench, DG; Ozawa, K; Franceschi, VR; Wu, YJ; Okita, TW			Messenger RNA targeting of rice seed storage proteins to specific ER subdomains	NATURE			English	Article							EXPRESSION; ENDOSPERM; CELLS; LOCALIZATION	Rice seeds, a rich reserve of starch and protein, are a major food source in many countries. Unlike the seeds of other plants, which typically accumulate one major type of storage protein, rice seeds use two major classes, prolamines and globulin-like glutelins. Both storage proteins are synthesized on the endoplasmic reticulum (ER) and translocated to the ER lumen, but are then sorted into separate intracellular compartments(1,2). Prolamines are retained in the ER lumen as protein bodies whereas glutelins are transported and stored in protein storage vacuoles. Mechanisms responsible for the retention of prolamines within the ER lumen and their assembly into intracisternal inclusion granules are unknown, but the involvement of RNA localization has been suggested(3). Here we show that the storage protein RNAs are localized to distinct ER membranes and that prolamine RNAs are targeted to the prolamine protein bodies by a mechanism based on RNA signal(s), a process that also requires a translation initiation codon. Our results indicate that the ER may be composed of subdomains that specialize in the synthesis of proteins directed to different compartments of the plant endomembrane system.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Natl Inst Agrobiol Resources, Tsukuba, Ibaraki 3058602, Japan	Washington State University; Washington State University; University of Calgary; National Institute of Agrobiological Sciences - Japan	Okita, TW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.			Okita, Tom/0000-0002-2246-0599				Bassell GJ, 1999, FASEB J, V13, P447, DOI 10.1096/fasebj.13.3.447; Dalgleish GD, 1999, NUCLEIC ACIDS RES, V27, P4363, DOI 10.1093/nar/27.22.4363; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Jansen RP, 1999, FASEB J, V13, P455, DOI 10.1096/fasebj.13.3.455; KIM WT, 1988, PLANT PHYSIOL, V88, P649, DOI 10.1104/pp.88.3.649; KIM WT, 1993, PLANT CELL PHYSIOL, V34, P595; KRISHNAN HB, 1986, PLANTA, V169, P471, DOI 10.1007/BF00392095; LI XX, 1993, CELL, V72, P869, DOI 10.1016/0092-8674(93)90576-C; LI XX, 1993, SCIENCE, V262, P1054, DOI 10.1126/science.8235623; MITSUKAWA N, 1991, RICE GENETICS, V2, P503; Muench DG, 1997, PLANT CELL PHYSIOL, V38, P404, DOI 10.1093/oxfordjournals.pcp.a029183; Muench DG, 2000, PLANTA, V211, P227, DOI 10.1007/PL00008159; Okita TW, 1996, ANNU REV PLANT PHYS, V47, P327, DOI 10.1146/annurev.arplant.47.1.327; YAMAGATA H, 1986, PLANT CELL PHYSIOL, V27, P135; YAMAGATA H, 1986, PLANT CELL PHYSIOL, V27, P1419, DOI 10.1093/oxfordjournals.pcp.a077240	15	143	150	1	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					765	767		10.1038/35037633	http://dx.doi.org/10.1038/35037633			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048726				2022-12-01	WOS:000089773900048
J	Christians, E; Davis, AA; Thomas, SD; Benjamin, IJ				Christians, E; Davis, AA; Thomas, SD; Benjamin, IJ			Embryonic development - Maternal effect of Hsf1 on reproductive success	NATURE			English	Article							MOUSE EMBRYO; GENE; TRANSCRIPTION; EXPRESSION; ACTIVATION; PROTECTION; FACTOR-1; MICE		Univ Liege, Fac Vet Med, Dept Histol & Embryol, B-4000 Liege, Belgium; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Div Cell & Mol Biol, Dallas, TX 75390 USA	University of Liege; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Christians, E (corresponding author), Univ Liege, Fac Vet Med, Dept Histol & Embryol, 20 Blvd Colonster, B-4000 Liege, Belgium.	ivor.benjamin@utsouthwestern.edu						BENSAUDE O, 1983, NATURE, V305, P331, DOI 10.1038/305331a0; Bevilacqua A, 2000, DEVELOPMENT, V127, P1541; Christians E, 1997, MOL CELL BIOL, V17, P778, DOI 10.1128/MCB.17.2.778; CHRISTIANS E, 1995, DEVELOPMENT, V121, P113; Davis W, 2000, DEV BIOL, V218, P275, DOI 10.1006/dbio.1999.9486; Greenhouse S, 1998, AM J HUM GENET, V62, P1282, DOI 10.1086/301893; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; LATHAM KE, 1991, DEVELOPMENT, V112, P921; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; SCHUPBACH T, 1989, GENETICS, V121, P101; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943	12	213	228	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					693	694		10.1038/35037669	http://dx.doi.org/10.1038/35037669			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048707				2022-12-01	WOS:000089773900028
J	Gabrick, DM; Hartmann, LC; Cerhan, JR; Vierkant, RA; Therneau, TM; Vachon, CM; Olson, JE; Couch, FJ; Anderson, KE; Pankratz, VS; Sellers, TA				Gabrick, DM; Hartmann, LC; Cerhan, JR; Vierkant, RA; Therneau, TM; Vachon, CM; Olson, JE; Couch, FJ; Anderson, KE; Pankratz, VS; Sellers, TA			Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEREDITARY OVARIAN-CANCER; FINAL REPORT; FOLLOW-UP	Context Oral contraceptive (OC) use is weakly associated with breast cancer risk in the general population, but the association among women with a familial predisposition to breast cancer is less clear. Objective To determine whether the association between OC use and risk of breast cancer is influenced by family history of the disease. Design and Setting Historical cohort study of 426 families of breast cancer probands diagnosed between 1944 and 1952 at the Tumor Clinic of the University of Minnesota Hospital. Follow-up data on families were collected by telephone interview between 1991 and 1996. Participants A total of 394 sisters and daughters of the probands, 3002 grand daughters and nieces, and 2754 women who married into the families. Main Outcome Measure Relative risk (RR) of breast cancer associated with history of OC use by relationship to proband. Results After accounting for age and birth cohort, ever having used OCs was associated with significantly increased risk of breast cancer among sisters and daughters of the probands (RR, 3.3; 95% confidence interval [CI], 1.6-6.7), but not among granddaughters and nieces of the probands (RR, 1.2, 95% CI, 0.8-2.0) or among marry-ins (RR, 1.2, 95% CI, 0.8-1.9). Results were essentially unchanged after adjustment for parity, age at first birth, age at menarche, age at menopause, oophorectomy, smoking, and education. The elevated risk among women with a first-degree family history of breast cancer was most evident for OC use during or prior to 1975, when formulations were likely to contain higher dosages of estrogen and progestins (RR, 3.3; 95% CI, 1.5-7.2). A small number of breast cancer cases (n = 2) limited the statistical power to detect risk among women with a first-degree relative with breast cancer and OC use after 1975. Conclusions These results suggest that women who have ever used earlier formulations of OCs and who also have a first-degree relative with breast cancer may be at particularly high risk for breast cancer. Further studies of women with a strong family history who have used more recent lower-dosage formulations of OCs are needed to determine how women with a familial predisposition to breast cancer should be advised regarding OC use today.	Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin, Dept Med Oncol, Rochester, MN USA; Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; Mayo Clin, Dept Biochem, Rochester, MN USA; Mayo Clin, Dept Mol Biol, Rochester, MN USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Canc, Minneapolis, MN USA; Mayo Clin, Ctr Canc, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Sellers, TA (corresponding author), Mayo Clin, Dept Hlth Sci Res, 200 1st St SW, Rochester, MN 55905 USA.		Vierkant, Robert/AAP-4927-2020	Vierkant, Robert/0000-0001-6242-5221; Cerhan, James/0000-0002-7482-178X	NATIONAL CANCER INSTITUTE [K07CA064220, R01CA055747] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA55747, K07-CA64220] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON VE, 1958, VARIABLES RELATED HU; BLACK MM, 1980, CANCER, V46, P27247; BRINTON LA, 1995, J NATL CANCER I, V87, P827, DOI 10.1093/jnci/87.11.827; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; *CDC CANC STER HOR, 1983, JAMA-J AM MED ASSOC, V249, P1591; CHILVERS CED, 1990, LANCET, V335, P1507, DOI 10.1016/0140-6736(90)93038-Q; Colditz GA, 1996, J NATL CANCER I, V88, P365, DOI 10.1093/jnci/88.6.365; Cox DR, 1972, J ROYAL STAT SOC B, V34, P87; Egan KM, 1998, CANCER EPIDEM BIOMAR, V7, P359; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; HARRIS RE, 1990, INT J EPIDEMIOL, V19, P240, DOI 10.1093/ije/19.2.240; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; LIPNICK RJ, 1986, JAMA-J AM MED ASSOC, V255, P58, DOI 10.1001/jama.255.1.58; Little R.J.A., 1987, STAT ANAL MISSING DA; LITTLE RJA, 1998, ENCY BIOSTATISTICS, P2272; MILLER DR, 1989, AM J EPIDEMIOL, V129, P269, DOI 10.1093/oxfordjournals.aje.a115132; MISHELL DR, 1997, TXB INFERTILITY CONT, P800; MURRAY PP, 1989, OBSTET GYNECOL, V73, P977; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; NISCHAN P, 1993, AM J EPIDEMIOL, V138, P697, DOI 10.1093/oxfordjournals.aje.a116907; PAUL C, 1990, INT J CANCER, V46, P366, DOI 10.1002/ijc.2910460305; PUGH M, 1992, INFERENCE COX PROPOR; RAVNIHAR B, 1988, NEOPLASMA, V35, P109; ROHAN TE, 1988, MED J AUSTRALIA, V149, P520, DOI 10.5694/j.1326-5377.1988.tb120759.x; Rosenberg L, 1996, AM J EPIDEMIOL, V143, P25; Rubin SC, 1998, NEW ENGL J MED, V339, P469, DOI 10.1056/NEJM199808133390710; SELLERS TA, 1995, GENET EPIDEMIOL, V12, P417, DOI 10.1002/gepi.1370120409; TAVANI A, 1993, BRIT J CANCER, V68, P568, DOI 10.1038/bjc.1993.387; Ursin G, 1998, BREAST CANCER RES TR, V50, P175, DOI 10.1023/A:1006037823178; Ursin G, 1997, CANCER RES, V57, P3678; VESSEY M, 1983, BRIT J CANCER, V47, P455, DOI 10.1038/bjc.1983.74	32	143	146	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1791	1798		10.1001/jama.284.14.1791	http://dx.doi.org/10.1001/jama.284.14.1791			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025831	Bronze			2022-12-01	WOS:000089622100030
J	Speed, CA; Shapiro, LM				Speed, CA; Shapiro, LM			Exercise prescription in cardiac disease	LANCET			English	Editorial Material							SUDDEN STRENUOUS EXERCISE; CORONARY-ARTERY DISEASE		Papworth Hosp, Dept Cardiol, Cambridge CB3 8RE, England; Addenbrookes Hosp, Dept Rheumatol & Sports & Exercise Med, Cambridge, England	Papworth Hospital; Addenbrooke's Hospital; University of Cambridge	Shapiro, LM (corresponding author), Papworth Hosp, Dept Cardiol, Cambridge CB3 8RE, England.							BARNARD RJ, 1973, CIRCULATION, V48, P936, DOI 10.1161/01.CIR.48.5.936; BARNARD RJ, 1973, J APPL PHYSIOL, V34, P833, DOI 10.1152/jappl.1973.34.6.833; BETHELL HJN, 1999, BENEFITS HAZARDS EXE, P339; Burrows S, 1999, BRIT J SPORT MED, V33, P287; FLETCHER GF, 1990, CIRCULATION, V82, P2286, DOI 10.1161/01.CIR.82.6.2286; FOSTER C, 1981, CIRCULATION, V63, P592, DOI 10.1161/01.CIR.63.3.592; FRANKLIN BA, 1992, AM J CARDIOL, V69, P1426, DOI 10.1016/0002-9149(92)90895-6; OBERMAN A, 1995, AM J CARDIOL, V76, P643, DOI 10.1016/S0002-9149(99)80189-1; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; POLLOCK ML, 1975, ARCH PHYS MED REHAB, V56, P141; Pollock ML, 2000, CIRCULATION, V101, P828, DOI 10.1161/01.CIR.101.7.828; POLLOCK ML, 1996, US PRESIDENTS COUNCI, V2; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; SIRE S, 1987, EUR HEART J, V8, P1215, DOI 10.1093/oxfordjournals.eurheartj.a062195; SULLIVAN MJ, 1988, CIRCULATION, V78, P506, DOI 10.1161/01.CIR.78.3.506; Swan L, 2000, HEART, V83, P685, DOI 10.1136/heart.83.6.685	16	9	10	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2000	356	9237					1208	1210		10.1016/S0140-6736(00)02778-1	http://dx.doi.org/10.1016/S0140-6736(00)02778-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	361LQ	11072933				2022-12-01	WOS:000089724900004
J	Low, K; Crestani, F; Keist, R; Benke, D; Brunig, I; Benson, JA; Fritschy, JM; Rulicke, T; Bluethmann, H; Mohler, H; Rudolph, U				Low, K; Crestani, F; Keist, R; Benke, D; Brunig, I; Benson, JA; Fritschy, JM; Rulicke, T; Bluethmann, H; Mohler, H; Rudolph, U			Molecular and neuronal substrate for the selective attenuation of anxiety	SCIENCE			English	Article							ALPHA-SUBUNITS; LOCALIZATION; RECEPTORS; MOUSE	Benzodiazepine tranquilizers are used in the treatment of anxiety disorders. To identify the molecular and neuronal target mediating the anxiolytic action of benzodiazepines, we generated and analyzed two mouse lines in which the alpha 2 or alpha 3 GABA(A) (gamma-aminobutyric acid type A) receptors, respectively, were rendered insensitive to diazepam by a knock-in point mutation. The anxiolytic action of diazepam was absent in mice with the alpha 2(H101R) point mutation but present in mice with the alpha 3(H126R) point mutation. These findings indicate that the anxiolytic effect of benzodiazepine drugs is mediated by alpha 2 GABA(A) receptors, which are largely expressed in the limbic system, but not by alpha 3 GABA(A) receptors, which predominate in the reticular activating system.	Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland; Univ Zurich Hosp, Biol Cent Lab, CH-8091 Zurich, Switzerland; F Hoffmann La Roche & Co Ltd, Dept Pharma Res Gene Technol, CH-4002 Basel, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; Roche Holding	Rudolph, U (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.			Low, Karin/0000-0002-5052-3892; Fritschy, Jean-Marc/0000-0002-8552-3702				Benson JA, 1998, FEBS LETT, V431, P400, DOI 10.1016/S0014-5793(98)00803-5; BONETTI EP, 1988, PHARMACOL BIOCHEM BE, V31, P733, DOI 10.1016/0091-3057(88)90259-6; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; MISSLIN R, 1989, BEHAV PROCESS, V18, P119, DOI 10.1016/S0376-6357(89)80010-5; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; SHADER RI, 1993, NEW ENGL J MED, V328, P1398; WIELAND HA, 1992, J BIOL CHEM, V267, P1426	12	740	768	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					131	134		10.1126/science.290.5489.131	http://dx.doi.org/10.1126/science.290.5489.131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021797				2022-12-01	WOS:000089724800050
J	Boetius, A; Ravenschlag, K; Schubert, CJ; Rickert, D; Widdel, F; Gieseke, A; Amann, R; Jorgensen, BB; Witte, U; Pfannkuche, O				Boetius, A; Ravenschlag, K; Schubert, CJ; Rickert, D; Widdel, F; Gieseke, A; Amann, R; Jorgensen, BB; Witte, U; Pfannkuche, O			A marine microbial consortium apparently mediating anaerobic oxidation of methane	NATURE			English	Article							SULFATE-REDUCING BACTERIA; SPATIAL-ORGANIZATION; ACTIVATED-SLUDGE; SEDIMENTS; PROBES; ABUNDANCE; FLOW	A large fraction of globally produced methane is converted to CO2 by anaerobic oxidation in marine sediments(1). Strong geochemical evidence for net methane consumption in anoxic sediments is based on methane profiles(2), radiotracer experiments(3) and stable carbon isotope data(4). But the elusive microorganisms mediating this reaction have not yet been isolated, and the pathway of anaerobic oxidation of methane is insufficiently understood. Recent data suggest that certain archaea reverse the process of methanogenesis by interaction with sulphate-reducing bacteria(5-7). Here we provide microscopic evidence for a structured consortium of archaea and sulphate-reducing bacteria, which we identified by fluorescence in situ hybridization using specific 16S rRNA-targeted oligonucleotide probes. In this example of a structured archaeal-bacterial symbiosis, the archaea grow in dense aggregates of about 100 cells and are surrounded by sulphate-reducing bacteria. These aggregates were abundant in gas-hydrate-rich sediments with extremely high rates of methane-based sulphate reduction, and apparently mediate anaerobic oxidation of methane.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; GEOMAR Res Ctr Marine Geosci, D-24148 Kiel, Germany	Max Planck Society; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Boetius, A (corresponding author), Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany.	aboetius@mpi-bremen.de	Boetius, Antje/D-5459-2013; Schubert, Carsten/GQQ-1673-2022; Jorgensen, Bo B/C-2214-2013; Amann, Rudolf I/C-6534-2014	Boetius, Antje/0000-0003-2117-4176; Jorgensen, Bo B/0000-0001-9398-8027; Amann, Rudolf I/0000-0002-0846-7372				Aharon P, 2000, GEOCHIM COSMOCHIM AC, V64, P233, DOI 10.1016/S0016-7037(99)00292-6; Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; BOHRMANN G, 2000, GEOMAR REP, V93; BOONE DR, 1989, APPL ENVIRON MICROB, V55, P1735, DOI 10.1128/AEM.55.7.1735-1741.1989; DEVEREUX R, 1992, SYST APPL MICROBIOL, V15, P601, DOI 10.1016/S0723-2020(11)80122-0; Elvert M, 1999, NATURWISSENSCHAFTEN, V86, P295, DOI 10.1007/s001140050619; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; Hansen LB, 1998, AQUAT MICROB ECOL, V14, P195, DOI 10.3354/ame014195; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; Koga Y, 1998, BIOSCI BIOTECH BIOCH, V62, P230, DOI 10.1271/bbb.62.230; LINKE P, 1994, DEEP-SEA RES PT I, V41, P721, DOI 10.1016/0967-0637(94)90051-5; Manz W, 1998, FEMS MICROBIOL ECOL, V25, P43; MARTENS CS, 1977, LIMNOL OCEANOGR, V22, P10, DOI 10.4319/lo.1977.22.1.0010; Mobarry BK, 1996, APPL ENVIRON MICROB, V62, P2156, DOI 10.1128/AEM.62.6.2156-2162.1996; Pancost RD, 2000, APPL ENVIRON MICROB, V66, P1126, DOI 10.1128/AEM.66.3.1126-1132.2000; PREUSS A, 1989, Z NATURFORSCH C, V44, P397; Rabus R, 2000, PROKARYOTES EVOLVING; Ravenschlag K, 2000, APPL ENVIRON MICROB, V66, P3592, DOI 10.1128/AEM.66.8.3592-3602.2000; Reerburgh W.S., 1982, DYNAMIC ENV OCEAN FL, P203; Sahm K, 1999, APPL ENVIRON MICROB, V65, P3976; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Stumm W., 1981, AQUAT CHEM; Suess E, 1999, EARTH PLANET SC LETT, V170, P1, DOI 10.1016/S0012-821X(99)00092-8; Thiel V, 1999, GEOCHIM COSMOCHIM AC, V63, P3959, DOI 10.1016/S0016-7037(99)00177-5; VALENTINE DL, IN PRESS ENV MICROB, V2	29	2053	2234	34	980	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2000	407	6804					623	626		10.1038/35036572	http://dx.doi.org/10.1038/35036572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034209				2022-12-01	WOS:000089772800045
J	Lasorella, A; Noseda, M; Beyna, M; Iavarone, A				Lasorella, A; Noseda, M; Beyna, M; Iavarone, A			Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins	NATURE			English	Article							CELL-CYCLE ARREST; C-MYC; HUMAN NEUROBLASTOMA; REGULATORY PATHWAY; GENE; EXPRESSION; FAMILY; MOUSE; PROLIFERATION; GROWTH	In mammalian cells, Id proteins coordinate proliferation and differentiation. Id2 is a dominant-negative antagonist of basic helix- loop-helix transcription factors and proteins of the retinoblastoma (Rb) family. Here we show that Id2-Rb double knockout embryos survive to term with minimal or no defects in neurogenesis and haematopoiesis, but they die at birth from severe reduction of muscle tissue. In neuroblastoma, an embryonal tumour derived from the neural crest, Id2 is overexpressed in cells carrying extra copies of the N-myc gene. In these cells, Id2 is in molar excess of the active form of Rb. The overexpression of Id2 results from transcriptional activation by oncoproteins of the Myc family. Cell-cycle progression induced by Myc oncoproteins requires inactivation of Rb by Id2. Thus, a dual connection links Id2 and Rb: during normal cell-cycle, Rb prohibits the action of Id2 on its natural targets, but oncogenic activation of the Myc-Id2 transcriptional pathway overrides the tumour-suppressor function of Rb.	Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Ctr Comprehens Canc, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Iavarone, A (corresponding author), Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA.		Califano, Andrea/F-7239-2012	Beyna, Mercedes/0000-0003-0603-3981; Noseda, Michela/0000-0002-9553-5029				Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Amati B, 1998, FRONT BIOSCI, V3, pd250, DOI [10.2741/a239, DOI 10.2741/A239]; BELTINGER CP, 1995, CANCER RES, V55, P2053; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Castresana JS, 1997, MOL CARCINOGEN, V18, P129, DOI 10.1002/(SICI)1098-2744(199703)18:3<129::AID-MC1>3.0.CO;2-A; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Cooper CL, 1997, BLOOD, V89, P3155, DOI 10.1182/blood.V89.9.3155; Diccianni MB, 1996, CANCER LETT, V104, P183, DOI 10.1016/0304-3835(96)04250-4; Diccianni MB, 1999, INT J CANCER, V80, P145, DOI 10.1002/(SICI)1097-0215(19990105)80:1<145::AID-IJC26>3.0.CO;2-G; Easton J, 1998, CANCER RES, V58, P2624; Fan X, 1999, ONCOL REP, V6, P647; Florio M, 1998, MOL CELL BIOL, V18, P5435, DOI 10.1128/MCB.18.9.5435; GOODRICH DW, 1992, NATURE, V360, P177, DOI 10.1038/360177a0; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Iavarone A, 1997, NATURE, V387, P417; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jen Y, 1996, DEV DYNAM, V207, P235; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; Kawamata N, 1996, CANCER, V77, P570; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; LUFKIN T, 1992, NATURE, V359, P835, DOI 10.1038/359835a0; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Martinsen BJ, 1998, SCIENCE, V281, P988, DOI 10.1126/science.281.5379.988; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Morrow MA, 1999, MOL IMMUNOL, V36, P491, DOI 10.1016/S0161-5890(99)00071-1; NEUMAN K, 1995, FEBS LETT, V374, P279, DOI 10.1016/0014-5793(95)01128-2; NEUMAN T, 1993, DEV BIOL, V160, P186, DOI 10.1006/dbio.1993.1297; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; ZHU WJ, 1995, MOL BRAIN RES, V30, P312, DOI 10.1016/0169-328X(95)00017-M	41	417	429	1	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					592	598		10.1038/35036504	http://dx.doi.org/10.1038/35036504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034201				2022-12-01	WOS:000089772800037
J	Larson, DG; Tobin, DR				Larson, DG; Tobin, DR			End-of-life conversations - Evolving practice and theory	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVANCE DIRECTIVES; PALLIATIVE MEDICINE; DECISION-MAKING; SELF-EFFICACY; CARE; CANCER; COMMUNICATION; PERSPECTIVES; QUALITY	This article examines the evolution of and need for "end-of-life conversations." Barriers to end-of-life discussions that have been identified in patients and families, health care professionals, and health cave systems can seriously interfere with the quality of remaining life for terminally ill patients. Strategies for enhancing end-of-life discussions are most productively linked to (1) physicians' interpersonal communication skills, (2) a patient-centered model of care, (3) a focus on quality of remaining life, and (4) innovative clinical models for implementing these discussions earlier in the care process. We conclude that end-of-life conversations must become a routine, structured intervention in health care and that advance care planning is best viewed as one component in a series of ongoing end-of-life discussions. Randomized trials are needed to examine new approaches and models for enhancing end-of-life conversations.	Vet Affairs Hlth Care Network Upstate New York, Albany, NY 12208 USA; Santa Clara Univ, Dept Counseling Psychol, Santa Clara, CA 95053 USA	Santa Clara University	Tobin, DR (corresponding author), Vet Affairs Hlth Care Network Upstate New York, 113 Holland Ave,111T, Albany, NY 12208 USA.	daniel.tobin@med.va.gov						Bandura A., 1997, SELF EFFICACY CHANGI; Becker E., 1973, DENIAL DEATH; Beckham JC, 1997, BEHAV MED, V23, P138, DOI 10.1080/08964289709596370; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; Buckman R., 1992, BREAK BAD NEWS GUIDE; BURGER JM, 1989, J PERS SOC PSYCHOL, V56, P246, DOI 10.1037/0022-3514.56.2.246; Byock I., 1997, DYING WELL PEACE POS; Byock IR, 1996, CLIN GERIATR MED, V12, P237; CASSEL EJ, 1989, NEW ENGL J MED, V306, P639; Chen A, 2000, BEST PRACTICES COORD; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Connor S, 1998, HOSPICE PRACTICE PIT; Connor S R, 1999, Hosp J, V14, P193; Cugliari AM, 1999, AM J HEALTH BEHAV, V23, P105, DOI 10.5993/AJHB.23.2.3; EMANUEL L, 1999, ED PHYSICIANS END LI; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; EMANUEL LL, 1995, STRUCTURED DELIBRA S; EPSTEIN RM, 1993, J FAM PRACTICE, V37, P377; FAULKNER A, 1991, PATIENT EDUC COUNS, V18, P3, DOI 10.1016/0738-3991(91)90073-E; Field MJ, 1997, APPROACHING DEATH IM; Fins JJ, 1999, J PAIN SYMPTOM MANAG, V17, P6, DOI 10.1016/S0885-3924(98)00109-2; FORD S, 1994, BRIT J CANCER, V70, P767, DOI 10.1038/bjc.1994.393; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Gallagher TH, 1999, TEACH LEARN MED, V11, P142, DOI 10.1207/S15328015TL110304; GERTEIS M, 1993, PATIENTS EYES, P1; GOLDSTEIN MG, 1998, HDB HLTH BEHAV CHANG, P85; Greene MG, 1996, RES AGING, V18, P84, DOI 10.1177/0164027596181006; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; HAVERMANS T, 1994, CHILD CARE HLTH DEV, V20, P309, DOI 10.1111/j.1365-2214.1994.tb00393.x; Heaven CM, 1997, PALLIATIVE MED, V11, P283, DOI 10.1177/026921639701100404; Hinton J, 1998, J PALLIATIVE CARE, V14, P15, DOI 10.1177/082585979801400305; Hockley JM, 1998, HOSP BASED PALLIATIV; JARRETT N, 1995, J ADV NURS, V22, P72, DOI 10.1046/j.1365-2648.1995.22010072.x; Kleinman A., 1988, ILLNESS NARRATIVES S; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Laine C, 1996, JAMA-J AM MED ASSOC, V275, P152, DOI 10.1001/jama.275.2.152; Larson D. G., 1993, HELPERS JOURNEY WORK; Larson Dale G., 1993, Journal of Psychosocial Oncology, V11, P1; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; LO B, 1995, JAMA-J AM MED ASSOC, V274, P1634, DOI 10.1001/jama.274.20.1634; Lynn J, 2000, J AM GERIATR SOC, V48, pS214, DOI 10.1111/j.1532-5415.2000.tb03135.x; MCCANN R, 1998, GERONTOL GERIATR ED, V18, P3; Merluzzi TV, 1997, HEALTH PSYCHOL, V16, P163, DOI 10.1037/0278-6133.16.2.163; Morrison M. F., 1998, END OF LIFE DECISION, P109; Murphy P, 2000, J AM GERIATR SOC, V48, pS154, DOI 10.1111/j.1532-5415.2000.tb03125.x; National Hospice Organization Standards and Accreditation Committee, 1997, PATHW PAT FAM FAC TE; PEARLMAN RA, 1995, PATIENT EDUC COUNS, V26, P353, DOI 10.1016/0738-3991(95)00739-M; Rabow MW, 2000, JAMA-J AM MED ASSOC, V283, P771, DOI 10.1001/jama.283.6.771; Rando T. A., 2000, CLIN DIMENSIONS ANTI; ROTER D, 1998, PSYCHO-ONCOLOGY, P1074; ROTHCHILD E, 1994, GEN HOSP PSYCHIAT, V16, P251, DOI 10.1016/0163-8343(94)90004-3; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; SMITH RA, 1984, J PERS SOC PSYCHOL, V47, P415, DOI 10.1037/0022-3514.47.2.415; Solomon M Z, 1993, J Law Med Ethics, V21, P231, DOI 10.1111/j.1748-720X.1993.tb01245.x; STRULL WM, 1984, JAMA-J AM MED ASSOC, V252, P2990, DOI 10.1001/jama.252.21.2990; Teno JM, 1999, J PAIN SYMPTOM MANAG, V17, P75, DOI 10.1016/S0885-3924(98)00134-1; TOBIN DR, 2000, ADV ILLNES COORDINAT; TOBIN DR, 1999, PEACEFUL DYING; TOBIN DR, 1999, PATIENT FAMILY ED MA, P193; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; Weissman DE, 1998, J PAIN SYMPTOM MANAG, V15, P195, DOI 10.1016/S0885-3924(97)00265-0; Weissman DE, 1998, J PAIN SYMPTOM MANAG, V15, P82, DOI 10.1016/S0885-3924(97)00253-4; Wilkinson A M, 1998, Hosp J, V13, P165; Yuen K, 1998, J PALLIATIVE CARE, V14, P79, DOI 10.1177/082585979801400316; Zuckerman C, 1999, Hosp J, V14, P85; [No title captured]	67	185	187	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1573	1578		10.1001/jama.284.12.1573	http://dx.doi.org/10.1001/jama.284.12.1573			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355HF	11000655	Bronze			2022-12-01	WOS:000089379700037
J	Buffetaut, E; Suteethorn, V; Cuny, G; Tong, HY; Le Loeuff, J; Khansubha, S; Jongautchariyakul, S				Buffetaut, E; Suteethorn, V; Cuny, G; Tong, HY; Le Loeuff, J; Khansubha, S; Jongautchariyakul, S			The earliest known sauropod dinosaur	NATURE			English	Article							EVOLUTION; THAILAND	Sauropods were a very successful group of dinosaurs during the Jurassic and Cretaceous periods, but their earlier history is poorly known. Until now, the earliest reported sauropod bones were from the Early Jurassic(1-3), and the only tentative evidence of earlier sauropods was in the form of controversial footprints(4,5). Here we report the discovery of an incomplete sauropod skeleton from the Late Triassic period of Thailand, which provides the first osteological evidence of pre-Jurassic sauropods. This dinosaur is markedly different from prosauropods and substantiates theoretical predictions that there was a fairly long period of sauropod evolution during the Triassic.	CNRS, F-75013 Paris, France; Dept Mineral Resources, Geol Survey Div, Bangkok 10400, Thailand; Musee Dinosaures, F-11260 Esperaza, France; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Department of Mineral Resources - Thailand; University of Bristol	Buffetaut, E (corresponding author), CNRS, 16 Cour Liegat, F-75013 Paris, France.	Eric.Buffetaut@wanadoo.fr	Cuny, Gilles/F-8949-2017; Cuny, Gilles/A-4775-2013	Cuny, Gilles/0000-0001-7680-1697; Cuny, Gilles/0000-0001-7680-1697				Avanzini M, 1997, PALAIOS, V12, P538, DOI 10.2307/3515410; Barrett PM, 1999, J VERTEBR PALEONTOL, V19, P785, DOI 10.1080/02724634.1999.10011191; Bonaparte J.F., 1971, OPERA LILLOANA, V22, P1; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; BUFFETAUT E, 1995, GEOL MAG, V132, P739, DOI 10.1017/S0016756800018951; Buffetaut Eric, 1998, P83; Charig A. J., 1965, Proceedings of the Linnean Society of London, V176, P197; COOPER M R, 1984, Palaeontologia Africana, V25, P203; Dong Z., 1983, PALAEONTOLOGICA SI C, V162, P1; Ellenberger F., 1958, C R SOC GEOL FRANCE, V4, P65; Ellenberger P., 1972, PALAEOVERTEBRATA, P1; Galton P.M., 1990, P320; GALTON PM, 1985, GEOBIOS-LYON, V18, P671, DOI 10.1016/S0016-6995(85)80065-6; Gauffre F-X, 1993, NEUES JB GEOLOGIE PA, V11, P648; GIERLINSKI R, 1998, GEOL Q, V42, P477; Haubold H., 1984, SAURIERFAHRTEN; He X. L., 1998, ACTA GEOLOGICA SICHU, V18, P1; JAIN SL, 1979, 4 INT GONDW S, P204; McIntosh J.S., 1990, P345; Racey A, 1996, J PETROL GEOL, V19, P5, DOI 10.1111/j.1747-5457.1996.tb00511.x; Sues H.-D., 1990, P143; Thulborn T., 1990, DINOSAUR TRACKS; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Wellnhofer Peter, 1994, Revue de Paleobiologie Volume Special, V7, P263; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; YADAGIRI P, 1988, RECORDS GEOLOGICAL S, V11, P102; ZHANG FJ, 1989, ACTA MATH APPL SIN-E, V1, P1	28	80	87	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					72	74		10.1038/35024060	http://dx.doi.org/10.1038/35024060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993074				2022-12-01	WOS:000089124000043
J	Earn, DJD; Levin, SA; Rohani, P				Earn, DJD; Levin, SA; Rohani, P			Coherence and conservation	SCIENCE			English	Article							CHAOS; DYNAMICS; ECOLOGY; EXTINCTION; PERSISTENCE; IMMIGRATION; SYNCHRONY; DISPERSAL; RATES	A principal aim of current conservation policy is to reduce the impact of habitat fragmentation. Conservation corridors may achieve this goal by facilitating movement among isolated patches, but there is a risk that increased connectivity could synchronize Local population fluctuations (causing coherent oscillations) and thereby increase the danger of global extinction, We identify general conditions under which populations can or cannot undergo coherent oscillations, and we relate these conditions to Local and global extinction probabilities. We suggest a simple method to explore the potential success of conservation corridors and, more generally, any manipulations of dispersal patterns that aim to protect threatened species or control pests.	McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4K1, Canada; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	McMaster University; Princeton University; University of Cambridge	Earn, DJD (corresponding author), McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4K1, Canada.	earn@math.mcmaster.ca	Levin, Simon A/J-1218-2014	Levin, Simon A/0000-0002-8216-5639; Earn, David/0000-0002-7562-1341; rohani, pejman/0000-0002-7221-3801				ALLEN JC, 1993, NATURE, V364, P229, DOI 10.1038/364229a0; ANDERSON R M, 1991; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Bohr T, 1998, DYNAMICAL SYSTEMS AP; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Earn DJD, 1998, P ROY SOC B-BIOL SCI, V265, P7, DOI 10.1098/rspb.1998.0256; EARN DJD, UNPUB; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Guckenheimer J., 1984, NONLINEAR OSCILLATIO, DOI 10.1115/1.3167759; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I., 1997, METAPOPULATION BIOL; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; HASTINGS A, 1993, ANNU REV ECOL SYST, V24, P1, DOI 10.1146/annurev.es.24.110193.000245; HASTINGS A, 1994, SCIENCE, V263, P1133, DOI 10.1126/science.263.5150.1133; Heino M, 1997, P ROY SOC B-BIOL SCI, V264, P481, DOI 10.1098/rspb.1997.0069; KANEKO K, 1989, PHYS REV LETT, V63, P219, DOI 10.1103/PhysRevLett.63.219; LAURANCE WF, 1997, TROPICAL FOREST REMN; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Pimm SL, 1998, NATURE, V393, P23, DOI 10.1038/29892; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; RUXTON GD, 1994, P ROY SOC B-BIOL SCI, V256, P189, DOI 10.1098/rspb.1994.0069; Silva JAL, 2000, B MATH BIOL, V62, P337, DOI 10.1006/bulm.1999.0157; Sole RV, 1998, J THEOR BIOL, V193, P539, DOI 10.1006/jtbi.1998.0716; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; STONE L, 1993, NATURE, V365, P617, DOI 10.1038/365617a0; [No title captured]	32	231	242	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2000	290	5495					1360	1364		10.1126/science.290.5495.1360	http://dx.doi.org/10.1126/science.290.5495.1360			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375BN	11082064				2022-12-01	WOS:000165379800050
J	Engstrom, DR; Fritz, SC; Almendinger, JE; Juggins, S				Engstrom, DR; Fritz, SC; Almendinger, JE; Juggins, S			Chemical and biological trends during lake evolution in recently deglaciated terrain	NATURE			English	Article							SOUTHEASTERN ALASKA; GLACIER BAY; ACIDIFICATION; HISTORY; WATER; PARK	As newly formed landscapes evolve, physical and biological changes occur that are collectively known as primary succession. Although succession is a fundamental concept in ecology, it is poorly understood in the context of aquatic environments. The prevailing view is that lakes become more enriched in nutrients as they age, leading to increased biological production. Here we report the opposite pattern of lake development, observed from the water chemistry of lakes that formed at various times within the past 10,000 years during glacial retreat at Glacier Bay, Alaska. The lakes have grown more dilute and acidic with time, accumulated dissolved organic carbon and undergone a transient rise in nitrogen concentration, all as a result of successional changes in surrounding vegetation and soils. Similar trends are evident from fossil diatom stratigraphy of lake sediment cores. These results demonstrate a tight hydrologic coupling between terrestrial and aquatic environments during the colonization of newly deglaciated landscapes, and provide a conceptual basis for mechanisms of primary succession in boreal lake ecosystems.	Sci Museum Minnesota, St Croix Watershed Res Stn, Marine On St Croix, MN 55047 USA; Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Newcastle Upon Tyne, Dept Geog, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Newcastle University - UK	Engstrom, DR (corresponding author), Sci Museum Minnesota, St Croix Watershed Res Stn, Marine On St Croix, MN 55047 USA.		Juggins, Stephen/D-1653-2010	Juggins, Stephen/0000-0003-4466-424X; Engstrom, Daniel/0000-0002-8066-029X				ALMENDINGER JE, 1990, P 2 GLAC BAY SCI S, P133; Battarbee Richard W., 1999, P85; Birks HH, 2000, J PALEOLIMNOL, V23, P91, DOI 10.1023/A:1008079725596; BIRKS HJB, 1990, PHILOS T R SOC B, V327, P263, DOI 10.1098/rstb.1990.0062; BORMANN BT, 1990, J ECOL, V78, P561, DOI 10.2307/2260884; BREW DA, 1978, 78494 US GEOL SURV, P1; BROWER WA, 1977, CLIMATIC ATLAS OUTER, V1; Carpenter SR, 1998, NONPOINT POLLUTION S; CHAPIN FS, 1994, J ECOL, V64, P149; CHAPIN FS, 1995, P 3 GLAC BAY SCI S 1, P96; Cooper WS, 1931, ECOLOGY, V12, P61, DOI 10.2307/1932934; Cooper WS, 1923, ECOLOGY, V4, P223, DOI 10.2307/1929047; CROCKER RL, 1955, J ECOL, V43, P427, DOI 10.2307/2257005; CRONAN CS, 1985, GEOCHIM COSMOCHIM AC, V49, P1697, DOI 10.1016/0016-7037(85)90140-1; ENGSTROM DR, 1990, SCIENCE, V250, P1383, DOI 10.1126/science.250.4986.1383; ENGSTROM DR, 1987, CAN J FISH AQUAT SCI, V44, P1306, DOI 10.1139/f87-154; ENGSTROM DR, 1990, P 2 GLAC BAY SCI S, P127; FASTIE CL, 1995, ECOLOGY, V76, P1899, DOI 10.2307/1940722; FORD MSJ, 1990, ECOL MONOGR, V60, P57, DOI 10.2307/1943026; GOLDMAN CR, 1961, ECOLOGY, V42, P282, DOI 10.2307/1932080; Hunter L. E., 1995, P 3 GLAC BAY SCI S 1, P46; Juggins S, 1996, FRESHWATER BIOL, V36, P203, DOI 10.1046/j.1365-2427.1996.00079.x; KORHOLA AA, 1991, BOREAS, V20, P333, DOI 10.1111/j.1502-3885.1991.tb00284.x; Lawrence D. B., 1951, Yearbook, American Philosophical Society, Philadelphia 1950, P175; LAWRENCE DB, 1958, AM SCI, V46, P89; MANN DH, 1985, CAN J EARTH SCI, V22, P913, DOI 10.1139/e85-095; Matthews JA., 1992, ECOLOGY RECENTLY DEG; MCBRIDE MS, 1975, J RES US GEOL SURV, V3, P505; NAUMANN E, 1932, BINNENGEWASSER, V11, P1; NOBLE MG, 1984, BRYOLOGIST, V87, P119, DOI 10.2307/3243117; Olson O. G., 1995, P 3 GLAC BAY SCI S N, P154; OLSON OG, 1998, THESIS LEHIGH U; Pearsall WH, 1921, P R SOC LOND B-CONTA, V92, P259, DOI 10.1098/rspb.1921.0024; RASMUSSEN JB, 1989, LIMNOL OCEANOGR, V34, P1336, DOI 10.4319/lo.1989.34.7.1336; REINERS W A, 1971, Ecology (Washington D C), V52, P55, DOI 10.2307/1934737; RENBERG I, 1993, AMBIO, V22, P264; RODHE W, 1969, EUTROPHICATION CAUSE, P50; Taylor J. K, 1966, AUSTR ENV, P29; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Thienemann A., 1931, Archiv fuer Hydrobiologie Stuttgart Suppl, V9, P205; UGOLINI FC, 1979, NATURE, V281, P366, DOI 10.1038/281366a0; WHITEHEAD D R, 1989, Journal of Paleolimnology, V2, P185; WILLIAMSON CE, IN PRESS ECOLOGY; WINTER TC, 1988, LIMNOL OCEANOGR, V33, P1209, DOI 10.4319/lo.1988.33.5.1209	44	247	252	5	88	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					161	166		10.1038/35041500	http://dx.doi.org/10.1038/35041500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089963	Green Published			2022-12-01	WOS:000165180400035
J	Manfredini, R; Portaluppi, F; Salmi, R; Martini, A; Gallerani, M				Manfredini, R; Portaluppi, F; Salmi, R; Martini, A; Gallerani, M			Circadian variation in onset of epistaxis: analysis of hospital admissions	BRITISH MEDICAL JOURNAL			English	Article							EVENTS		Univ Ferrara, Sch Med, Dept Clin & Expt Med, Internal Med & Hypertens Unit 1, I-44100 Ferrara, Italy; Univ Ferrara, Sch Med, Dept Ear Nose & Throat, I-44100 Ferrara, Italy; St Anna Gen Hosp, Dept Internal Med, Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna	Manfredini, R (corresponding author), Univ Ferrara, Sch Med, Dept Clin & Expt Med, Internal Med & Hypertens Unit 1, I-44100 Ferrara, Italy.		Manfredini, Roberto/N-3859-2019; Portaluppi, Francesco/H-2206-2012; Manfredini, Roberto/AAJ-5442-2020; Manfredini, Roberto/A-3471-2008; Martini, Alessandro/K-2513-2018	Manfredini, Roberto/0000-0002-8364-2601; Portaluppi, Francesco/0000-0002-2948-1579; Manfredini, Roberto/0000-0002-8364-2601; Martini, Alessandro/0000-0002-2003-6348				Gallerani M, 1996, STROKE, V27, P1793, DOI 10.1161/01.STR.27.10.1793; Manfredini R, 1999, LANCET, V353, P643, DOI 10.1016/S0140-6736(98)05653-0; Manfredini R, 1996, ANN NY ACAD SCI, V783, P141, DOI 10.1111/j.1749-6632.1996.tb26713.x; MOJON A, 1992, CHRONOBIOL INT, V9, P403, DOI 10.3109/07420529209064552; Portaluppi F, 1999, CHRONOBIOL INT, V16, P33, DOI 10.3109/07420529908998710	5	12	13	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1112	1112		10.1136/bmj.321.7269.1112	http://dx.doi.org/10.1136/bmj.321.7269.1112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061731	Green Published, Bronze			2022-12-01	WOS:000165219600023
J	Decatur, AL; Portnoy, DA				Decatur, AL; Portnoy, DA			A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity	SCIENCE			English	Article							INFECTED CELLS; GROWTH; DETERMINANTS; PATHOGENESIS; PHAGOSOME	Establishment and maintenance of an intracellular niche are critical to the success of an intracellular pathogen, Here, the pore-forming protein listeriolysin O (LLO), secreted by Listeria monocytogenes, was shown to contain a PEST-like sequence (P, Pro; E, Glu; S, Ser; T, Thr) that is essential for the virulence and intracellular compartmentalization of this pathogen. Mutants lacking the PEST-like sequence entered the host cytosol but subsequently permeabilized and killed the host cell. LLO lacking the PEST-like sequence accumulated in the host-cell cytosol, suggesting that this sequence targets LLO for degradation. Transfer of the sequence to perfringolysin O transformed this toxic cytolysin into a nontoxic derivative that facilitated intracellular growth.	Univ Calif Berkeley, Sch Publ Hlth, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Portnoy, DA (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.				NIAID NIH HHS [R01 AI027655, R37 AI029619, AI10283, AI27655] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029619, R29AI027655, F32AI010283, R01AI027655] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alouf JE, 1991, SOURCEBOOK BACTERIAL, P147; Clemens DL, 1996, TRENDS MICROBIOL, V4, P113, DOI 10.1016/0966-842X(96)81528-9; DECATUR AL, UNPUB; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; FREITAG NE, 2000, GRAM POSITIVE PATHOG, pCH51; GEDDE M, UNPUB; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; HO SN, 1989, GENE, V77, pS1; Jones S, 1996, MOL MICROBIOL, V21, P1219, DOI 10.1046/j.1365-2958.1996.00074.x; JONES S, 1994, METHOD ENZYMOL, V236, P463; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1; Moors MA, 1999, INFECT IMMUN, V67, P131, DOI 10.1128/IAI.67.1.131-139.1999; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; VILLANUEVA MS, 1995, J IMMUNOL, V155, P5227	19	181	221	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2000	290	5493					992	995		10.1126/science.290.5493.992	http://dx.doi.org/10.1126/science.290.5493.992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062133				2022-12-01	WOS:000165103200052
J	Groisman, I; Huang, YS; Mendez, R; Cao, QP; Theurkauf, W; Richter, JD				Groisman, I; Huang, YS; Mendez, R; Cao, QP; Theurkauf, W; Richter, JD			CPEB, maskin, and cyclin B1 mRNA at the mitotic apparatus: Implications for local translational control of cell division	CELL			English	Article							MATERNAL MESSENGER-RNA; XENOPUS OOCYTE MATURATION; ELEMENT-BINDING PROTEIN; CYTOPLASMIC POLYADENYLATION; C-MOS; REGULATED POLYADENYLATION; RIBOSE METHYLATION; SPECIFICITY FACTOR; COILED-COIL; CENTROSOME	In Xenopus development, the expression of several maternal mRNAs is regulated by cytoplasmic polyadenylation. CPEB and maskin, two factors that control polyadenylation-induced translation are present on the mitotic apparatus of animal pole blastomeres in embryos. Cyclin B1 protein and mRNA, whose translation is regulated by polyadenylation, are colocalized with CPEB and maskin. CPEB interacts with microtubules and is involved in the localization of cyclin B1 mRNA to the mitotic apparatus. Agents that disrupt polyadenylation-induced translation inhibit cell division and promote spindle and centrosome defects in injected embryos. Two of these agents inhibit the synthesis of cyclin B1 protein and one, which has little effect on this process, disrupts the localization of cyclin B1 mRNA and protein. These data suggest that CPEB-regulated mRNA translation is important for the integrity of the mitotic apparatus and for cell division.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.		Huang, Yi-Shuian/P-2824-2018	Huang, Yi-Shuian/0000-0001-9000-7748; Mendez, Raul/0000-0002-1952-6905; Theurkauf, William/0000-0001-7342-1912; Groisman, Sonia/0000-0003-1153-3841	NIGMS NIH HHS [GM50898, GM46779] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046779, R01GM050898] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bally-Cuif L, 1998, MECH DEVELOP, V77, P31, DOI 10.1016/S0925-4773(98)00109-9; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; DAVIS CA, 1993, METHOD ENZYMOL, V225, P502; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Dickson KS, 1999, MOL CELL BIOL, V19, P5707; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; GARD DL, 1992, DEV BIOL, V151, P516, DOI 10.1016/0012-1606(92)90190-R; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; GEBAUER F, 1995, MOL CELL BIOL, V15, P1422; Gebauer F, 1996, P NATL ACAD SCI USA, V93, P14602, DOI 10.1073/pnas.93.25.14602; Gergely F, 2000, EMBO J, V19, P241, DOI 10.1093/emboj/19.2.241; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Goto T, 1999, DNA CELL BIOL, V18, P227, DOI 10.1089/104454999315448; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; HIROKAWA N, 1985, J CELL BIOL, V101, P1858, DOI 10.1083/jcb.101.5.1858; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; KLOC M, 1999, ANAL LOCALIZED RNAS; Kuge H, 1998, NUCLEIC ACIDS RES, V26, P3208, DOI 10.1093/nar/26.13.3208; Kuge H, 1995, EMBO J, V14, P6301, DOI 10.1002/j.1460-2075.1995.tb00320.x; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; LANTZ V, 1992, DEVELOPMENT, V115, P75; Macdonald PM, 1996, CURR OPIN GENET DEV, V6, P403, DOI 10.1016/S0959-437X(96)80060-8; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; MENDEZ R, 2000, IN PRESS MOL CELL; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Niessing D, 1999, EMBO J, V18, P1966, DOI 10.1093/emboj/18.7.1966; PARIS J, 1991, GENE DEV, V5, P1697, DOI 10.1101/gad.5.9.1697; RAFF JW, 1990, DEVELOPMENT, V110, P1249; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; RICHTER JD, 2000, TRANSLATIONAL CONTRO; Roghi C, 1998, J CELL SCI, V111, P557; Schnapp BJ, 1997, SEMIN CELL DEV BIOL, V8, P529, DOI 10.1006/scdb.1997.0178; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; STANDART N, 1990, GENE DEV, V4, P2157, DOI 10.1101/gad.4.12a.2157; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; STEBBINSBOAZ B, 1994, MOL CELL BIOL, V14, P5870, DOI 10.1128/MCB.14.9.5870; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Still IH, 1999, ONCOGENE, V18, P4032, DOI 10.1038/sj.onc.1202801; Still IH, 1999, GENOMICS, V58, P165, DOI 10.1006/geno.1999.5829; Stutz A, 1998, GENE DEV, V12, P2535, DOI 10.1101/gad.12.16.2535; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Tatsuka M, 1998, CANCER RES, V58, P4811; Walker J, 1999, RNA, V5, P14, DOI 10.1017/S1355838299981219; WICKENS M, 1996, TRANSLATIONAL CONTRO; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	58	218	223	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 27	2000	103	3					435	447		10.1016/S0092-8674(00)00135-5	http://dx.doi.org/10.1016/S0092-8674(00)00135-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081630	Bronze			2022-12-01	WOS:000090144100009
J	Somers, WS; Tang, J; Shaw, GD; Camphausen, RT				Somers, WS; Tang, J; Shaw, GD; Camphausen, RT			Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1	CELL			English	Article							GLYCOPROTEIN LIGAND-1; TYROSINE SULFATION; AMINO-TERMINUS; BINDING-SITES; RECOGNITION; ADHESION; DOMAINS; OLIGOSACCHARIDE; REPLACEMENT; ANTIBODIES	P-, E- and L-selectin constitute a family of cell adhesion receptors that mediate the initial tethering and rolling of leukocytes on inflamed endothelium as a prelude to their firm attachment and extravasation into tissues. The selectins bind weakly to sialyl Lewis(X) (SLe(X))-like glycans, but with high-affinity to specific glycoprotein counterreceptors, including PSGL-1. Here, we report crystal structures of human P- and E-selectin constructs containing the lectin and EGF (LE) domains co-complexed with SLe(X). We also present the crystal structure of P-selectin LE co-complexed with the N-terminal domain of human PSGL-1 modified by both tyrosine sulfation and SLe(X). These structures reveal differences in how E- and P-selectin bind SLe(X) and the molecular basis of the high-affinity interaction between P-selectin and PSGL-1.	Genet Inst Inc, Wyeth Res, Cambridge, MA 02140 USA	Pfizer	Camphausen, RT (corresponding author), Genet Inst Inc, Wyeth Res, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.	rcamphausen@genetics.com						Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; ASA D, 1992, GLYCOBIOLOGY, V2, P395, DOI 10.1093/glycob/2.5.395; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAJORATH J, 1994, BIOCHEMISTRY-US, V33, P1332, DOI 10.1021/bi00172a007; BERTOZZI CR, 1995, CHEM BIOL, V2, P703, DOI 10.1016/1074-5521(95)90096-9; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen SQ, 1997, P NATL ACAD SCI USA, V94, P3172, DOI 10.1073/pnas.94.7.3172; Croce K, 1998, BIOCHEMISTRY-US, V37, P16472, DOI 10.1021/bi981341g; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Goetz DJ, 1997, J CELL BIOL, V137, P509, DOI 10.1083/jcb.137.2.509; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAVALLIE ER, 1993, J BIOL CHEM, V268, P23311; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; McEver RP, 1997, J CLIN INVEST, V100, pS97; Mehta P, 1997, BLOOD, V90, P2381, DOI 10.1182/blood.V90.6.2381.2381_2381_2389; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MOORE KL, 1994, J BIOL CHEM, V269, P23318; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Poppe L, 1997, J AM CHEM SOC, V119, P1727, DOI 10.1021/ja9610702; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Puri KD, 1998, NATURE, V392, P930, DOI 10.1038/31954; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Varki A, 1997, J CLIN INVEST, V100, pS31; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WILKINS PP, 1995, J BIOL CHEM, V270, P22677, DOI 10.1074/jbc.270.39.22677; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Yang J, 1999, THROMB HAEMOSTASIS, V81, P1; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769	45	600	626	1	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 27	2000	103	3					467	479		10.1016/S0092-8674(00)00138-0	http://dx.doi.org/10.1016/S0092-8674(00)00138-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081633	Bronze			2022-12-01	WOS:000090144100012
J	Griffith, CA; Hall, JL; Geballe, TR				Griffith, CA; Hall, JL; Geballe, TR			Detection of daily clouds on Titan	SCIENCE			English	Article							SURFACE; ATMOSPHERE; TROPOSPHERE; METHANE; TEMPERATURE; REANALYSIS; OCEAN	We have discovered frequent variations in the near-infrared spectrum of Titan, Saturn's largest moon, which are indicative of the daily presence of sparse clouds covering less than 1% of the area of the satellite. The thermodynamics of Titan's atmosphere and the clouds' altitudes suggest that convection governs their evolutions. Their short lives point to the presence of rain. We propose that Titan's atmosphere resembles Earth's, with clouds, rain, and an active weather cycle, driven by latent heat release from the primary condensible species.	No Arizona Univ, Dept Phys & Astron, Flagstaff, AZ 86011 USA; Gemini Observ, Hilo, HI 96720 USA	Northern Arizona University	Griffith, CA (corresponding author), No Arizona Univ, Dept Phys & Astron, Flagstaff, AZ 86011 USA.							AWAL M, 1994, GEOPHYS RES LETT, V21, P2491, DOI 10.1029/94GL01707; Combes M, 1997, ICARUS, V129, P482, DOI 10.1006/icar.1997.5772; COURTIN R, 1995, ICARUS, V114, P144, DOI 10.1006/icar.1995.1050; COUSTENIS A, 1995, ICARUS, V118, P87, DOI 10.1006/icar.1995.1179; ESHLEMAN VR, 1983, SCIENCE, V221, P53, DOI 10.1126/science.221.4605.53; FLASAR FM, 1983, SCIENCE, V221, P55, DOI 10.1126/science.221.4605.55; FLASAR FM, 1981, NATURE, V292, P693, DOI 10.1038/292693a0; GIER HT, 1970, TESTIS, V1, P1; Goody R.M., 1989, ATMOSPHERIC RAD THEO; GRIFFITH CA, 1993, NATURE, V364, P511, DOI 10.1038/364511a0; GRIFFITH CA, 1991, ICARUS, V93, P362, DOI 10.1016/0019-1035(91)90219-J; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; HOLTON JR, 1992, INTRO DYNAMICAL METE; Hunten D.M, 1984, SATURN, P671; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; LEMMON MT, 1995, ICARUS, V113, P27, DOI 10.1006/icar.1995.1003; LEMMON MT, 1993, ICARUS, V103, P329, DOI 10.1006/icar.1993.1074; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; McKay CP, 1997, ICARUS, V129, P498, DOI 10.1006/icar.1997.5751; Samuelson RE, 1997, PLANET SPACE SCI, V45, P959, DOI 10.1016/S0032-0633(97)00090-1; SIMPSON J, 1967, J ATMOS SCI, V24, P508, DOI 10.1175/1520-0469(1967)024<0508:SCSESA>2.0.CO;2; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; STOMMEL H, 1947, J METEOROL, V4, P91, DOI 10.1175/1520-0469(1947)004<0091:EOAIAC>2.0.CO;2; TOON OB, 1988, ICARUS, V75, P255, DOI 10.1016/0019-1035(88)90005-X	24	124	124	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					509	513		10.1126/science.290.5491.509	http://dx.doi.org/10.1126/science.290.5491.509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039930				2022-12-01	WOS:000089946000049
J	Kim, CH; Oda, T; Itoh, M; Jiang, D; Artinger, KB; Chandrasekharappa, SC; Driever, W; Chitnis, AB				Kim, CH; Oda, T; Itoh, M; Jiang, D; Artinger, KB; Chandrasekharappa, SC; Driever, W; Chitnis, AB			Repressor activity of headless/Tcf3 is essential for vertebrate head formation	NATURE			English	Article							HOMEOBOX GENE; SPEMANN ORGANIZER; XENOPUS EMBRYOS; BETA-CATENIN; ZEBRAFISH; WNT; LOCALIZATION; EXPRESSION; ANTAGONIST; INDUCTION	The vertebrate organizer can induce a complete body axis when transplanted to the ventral side of a host embryo(1) by virtue of its distinct head and trunk inducing properties. Wingless/Wnt antagonists secreted by the organizer have been identified as head inducers(2-4). Their ectopic expression can promote head formation, whereas ectopic activation of Wnt signalling during early gastrulation blocks head formation(5-7). These observations suggest that the ability of head inducers to inhibit Wnt signalling during formation of anterior structures is what distinguishes them from trunk inducers that permit the operation of posteriorizing Wnt signals(8). Here we describe the zebrarsh headless (hdl) mutant and show that its severe head defects are due to a mutation in T-cell factor-3 (Tcf3), a member of the Tcf/Lef family(9,10). Loss of Tcf3 function in the hdl mutant reveals that hdl represses Wnt target genes. We provide genetic evidence that a component of the Wnt signalling pathway is essential in vertebrate head formation and patterning.	NICHD, Genet Mol Lab, NIH, Bethesda, MD 20892 USA; NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Freiburg, Inst Zool, D-79104 Freiburg, Germany	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Harvard Medical School; University of Freiburg	Chitnis, AB (corresponding author), NICHD, Genet Mol Lab, NIH, Bethesda, MD 20892 USA.			Kim, Cheol-Hee/0000-0002-3019-0699; Driever, Wolfgang/0000-0002-9551-9141	NICHD NIH HHS [F32 HD008209-04, F32 HD008209] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008209, Z01HD001012] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Artinger KB, 1999, DEVELOPMENT, V126, P3969; BADIANI P, 1994, GENE DEV, V8, P770, DOI 10.1101/gad.8.7.770; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Gates MA, 1999, GENOME RES, V9, P334; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kobayashi M, 1998, DEVELOPMENT, V125, P2973; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; McGrew LL, 1999, MECH DEVELOP, V87, P21, DOI 10.1016/S0925-4773(99)00136-7; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Nieto MA, 1999, CELL, V98, P417, DOI 10.1016/S0092-8674(00)81971-6; Pelegri F, 1998, MECH DEVELOP, V77, P63, DOI 10.1016/S0925-4773(98)00132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; VANDEWETERING M, 1992, J BIOL CHEM, V267, P8530; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	29	315	326	1	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					913	916		10.1038/35038097	http://dx.doi.org/10.1038/35038097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057671	Green Accepted			2022-12-01	WOS:000089901900054
J	Blatchford, O; Murray, WR; Blatchford, M				Blatchford, O; Murray, WR; Blatchford, M			A risk score to predict need for treatment for upper-gastrointestinal haemorrhage	LANCET			English	Article							PROGNOSTIC FACTORS; OUTPATIENT CARE; HEMORRHAGE; ISOLEUCINE; MORTALITY; SYSTEM; RATIO	Background Current risk-stratification systems for patients with acute upper-gastrointestinal bleeding discriminate between patients at high or low risks of dying or rebleeding. We therefore developed and prospectively validated a risk score to identify a patient's need for treatment. Methods Our first study used data from 1748 patients admitted for upper-gastrointestinal haemorrhage. By logistic regression, we derived a risk score that predicts patients' risks of needing blood transfusion or intervention to control bleeding, rebleeding, or dying. From this score, we developed a simplified fast-track screen for use at initial presentation. In a second study, we prospectively Validated this score using receiver operating characteristic (ROC) curves-a measure of the validity of a scoring system-and chi(2) goodness-of-fit testing with data from 197 patients. We also validated the quicker screening tool. Findings We calculated risk scores from patients' admission haemoglobin, blood urea, purse, and systolic brood pressure, as well as presentation with syncope or melaena, and evidence of hepatic disease or cardiac failure. The score discriminated well with a ROC curve area of 0.92 (95% CI 0.88-0.95). The score was well calibrated for patients needing treatment (p-=0.84). Interpretation Our score identified patients at low or high risk of needing treatment to manage their bleeding. This score should assist the clinical management of patients presenting with upper-gastrointestinal haemorrhage, but requires external validation.	Univ Glasgow, Dept Publ Hlth, Glasgow, Lanark, Scotland; Univ Glasgow, Dept Gen Practice, Glasgow, Lanark, Scotland; Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Blatchford, O (corresponding author), Argyll & Clyde Hlth Board, Paisley PA2 7BN, Renfrew, Scotland.							Bhatti N, 1998, CHEST, V114, P1137, DOI 10.1378/chest.114.4.1137; Blatchford O, 1997, BMJ-BRIT MED J, V315, P510, DOI 10.1136/bmj.315.7107.510; BORDLEY DR, 1985, JAMA-J AM MED ASSOC, V253, P3282, DOI 10.1001/jama.253.22.3282; Christiansen T, 1935, ACTA MED SCAND, V85, P0333; CLASON AE, 1986, BRIT J SURG, V73, P985, DOI 10.1002/bjs.1800731213; Dejong CHC, 1996, GUT, V39, P13, DOI 10.1136/gut.39.1.13; Elisaf M. S., 1997, EUR J INTERN MED, V8, P127; FELBER S, 1988, J PEDIATR GASTR NUTR, V7, P685, DOI 10.1097/00005176-198809000-00011; Gunning K, 1999, BRIT MED J, V319, P241, DOI 10.1136/bmj.319.7204.241; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; KATSCHINSKI B, 1994, DIGEST DIS SCI, V39, P706, DOI 10.1007/BF02087411; Longstreth GF, 1998, GASTROINTEST ENDOSC, V47, P219, DOI 10.1016/S0016-5107(98)70316-5; LONGSTRETH GF, 1995, LANCET, V345, P108, DOI 10.1016/S0140-6736(95)90068-3; MAILER C, 1965, BRIT MED J, V2, P784, DOI 10.1136/bmj.2.5465.784; MEYER L, 1935, ACTA MED SCAND, V87, P313; MOSS G, 1975, AM J SURG, V130, P269, DOI 10.1016/0002-9610(75)90382-7; OLSEN LH, 1991, BRIT J SURG, V78, P71, DOI 10.1002/bjs.1800780122; PIMPL W, 1987, ENDOSCOPY, V19, P101, DOI 10.1055/s-2007-1013010; PUMPHREY CW, 1980, BRIT MED J, V280, P527, DOI 10.1136/bmj.280.6213.527-a; Rockall TA, 1996, LANCET, V347, P1138, DOI 10.1016/S0140-6736(96)90607-8; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; SAEED ZA, 1993, AM J GASTROENTEROL, V88, P1842; Schiff L., 1939, AM J DIG DIS, V6, P597; SILVERSTEIN FE, 1981, GASTROINTEST ENDOSC, V27, P80, DOI 10.1016/S0016-5107(81)73156-0; SNOOK JA, 1986, LANCET, V1, P1064; STELLATO T, 1980, AM J GASTROENTEROL, V73, P486; VANBERLO CLH, 1989, HEPATOLOGY, V10, P315, DOI 10.1002/hep.1840100311; Vreeburg EM, 1999, GUT, V44, P331, DOI 10.1136/gut.44.3.331	28	608	661	0	19	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 14	2000	356	9238					1318	1321		10.1016/S0140-6736(00)02816-6	http://dx.doi.org/10.1016/S0140-6736(00)02816-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VL	11073021				2022-12-01	WOS:000089858300013
J	Corset, V; Nguyen-ba-Charvet, KT; Forcet, C; Moyse, E; Chedotal, A; Mehlen, P				Corset, V; Nguyen-ba-Charvet, KT; Forcet, C; Moyse, E; Chedotal, A; Mehlen, P			Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor	NATURE			English	Article							COLORECTAL-CANCER DCC; GROWTH CONE GUIDANCE; NETRIN RECEPTOR; A(2B) RECEPTORS; NERVOUS-SYSTEM; MAST-CELLS; BINDING; ATTRACTION; MECHANISM; REPULSION	The netrins, a family of laminin-related secreted proteins, are critical in controlling axon elongation and pathfinding(1-4). The DCC (for deleted in colorectal cancer) protein was proposed as a receptor for netrin-1 in the light of many observations including the inhibition of netrin-1-mediated axon outgrowth and attraction in the presence of an anti-DCC antiserum(5-7), the similitude of nervous system defects in DCC and netrin-1 knockout mice(4,8) and the results of receptor swapping experiments(9). Previous studies have failed to show a direct interaction of DCC with netrin-1 (ref. 10), suggesting the possibility of an additional receptor or coreceptor. Here we show that DCC interacts with the membrane-associated adenosine A2b receptor, a G-protein-coupled receptor that induces cAMP accumulation on binding adenosine(11). We show that A2b is actually a netrin-1 receptor and induces cAMP accumulation on binding netrin-1. Finally, we show that netrin-1-dependent outgrowth of dorsal spinal cord axons directly involves A2b. Together our results indicate that the growth-promoting function of netrin-1 may require a receptor complex containing DCC and A2b.	Univ Lyon 1, Ctr Genet Mol & Cellulaire, Lab Apoptose & Differenciat, Label Ligue,CNRS,UMR 5534, F-69622 Villeurbanne, France; Hop La Pitie Salpetriere, INSERM, U106, F-75651 Paris 13, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Mehlen, P (corresponding author), Univ Lyon 1, Ctr Genet Mol & Cellulaire, Lab Apoptose & Differenciat, Label Ligue,CNRS,UMR 5534, F-69622 Villeurbanne, France.		MOYSE, Emmanuel/ABE-1819-2021; Nguyen-Ba-Charvet, Kim/J-3507-2017; Chedotal, Alain/F-2750-2017	Nguyen-Ba-Charvet, Kim/0000-0001-5398-0872; Chedotal, Alain/0000-0001-7577-3794; MOYSE, Emmanuel/0000-0002-9590-1367				Bennett KL, 1997, J BIOL CHEM, V272, P26940, DOI 10.1074/jbc.272.43.26940; Boileau AJ, 1999, J NEUROSCI, V19, P4847; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999; de Castro F, 1999, J NEUROSCI, V19, P4428; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEOKTISTOV I, 1993, MOL PHARMACOL, V43, P909; FEOKTISTOV I, 1995, J CLIN INVEST, V96, P1979, DOI 10.1172/JCI118245; Feoktistov I, 1997, PHARMACOL REV, V49, P381; FORCET C, UNPUB P NATL ACAD SC; FREDHOLM BB, 1982, EUR J PHARMACOL, V81, P673, DOI 10.1016/0014-2999(82)90359-4; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Linden J, 1999, MOL PHARMACOL, V56, P705; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Meyerhardt JA, 1999, CELL GROWTH DIFFER, V10, P35; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ralevic V, 1998, PHARMACOL REV, V50, P413; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Squires RF, 1999, NEUROCHEM RES, V24, P1593, DOI 10.1023/A:1021116502548; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; YAKEL JL, 1993, MOL PHARMACOL, V43, P277	29	168	175	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					747	750		10.1038/35037600	http://dx.doi.org/10.1038/35037600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048721				2022-12-01	WOS:000089773900043
J	Boquet, I; Boujemaa, R; Carlier, MF; Preat, T				Boquet, I; Boujemaa, R; Carlier, MF; Preat, T			Ciboulot regulates actin assembly during Drosophila brain metamorphosis	CELL			English	Article							MUSHROOM BODIES; ACANTHAMOEBA ACTOBINDIN; FILAMENT TURNOVER; THYMOSIN BETA-4; CENTRAL COMPLEX; NERVOUS-SYSTEM; GLIAL-CELLS; PROFILIN; MOTILITY; BODY	A dynamic actin cytoskeleton is essential for the remodeling of cell shape during development, but the specific roles of many actin partners remain unclear. Here we characterize a novel actin binding protein, Ciboulot (Cib), which plays a major role in axonal growth during Drosophila brain metamorphosis. Loss of Cib function leads to axonal growth defects in the central brain, while overexpression of the gene during development leads to overgrown projections. The Cib protein displays strong sequence similarity to beta-thymosins but has biochemical properties like profilin: the Cib-actin complex participates in actin filament assembly exclusively at the barbed end, and Cib enhances actin-based motility in vitro. Genetic experiments show that Cib and the Drosophila profilin protein Chickadee (Chic) cooperate in central brain metamorphosis.	CNRS, Inst Neurobiol Alfred Fessard, Lab Dev Evolut & Plast Syst Nerveux, F-91190 Gif Sur Yvette, France; CNRS, Lab Enzymol & Biochim Struct, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), CNRS, Inst Neurobiol Alfred Fessard, Lab Dev Evolut & Plast Syst Nerveux, F-91190 Gif Sur Yvette, France.	preat@iaf.cnrs-gif.fr		Preat, Thomas/0000-0001-9976-1763; Boujemaa-Paterski, Rajaa/0000-0001-9645-387X				Armstrong JD, 1998, LEARN MEMORY, V5, P102; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Boquet I, 2000, J NEUROBIOL, V42, P33; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUBB MR, 1991, J BIOL CHEM, V266, P3820; BUBB MR, 1995, BIOCHEMISTRY-US, V34, P3921, DOI 10.1021/bi00012a008; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Carlsen KH, 1994, EUR RESPIR REV, V4, P5; CASELLA JF, 1995, CELL MOTIL CYTOSKEL, V30, P164, DOI 10.1002/cm.970300208; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; ERICKSONVIITANEN S, 1983, ARCH BIOCHEM BIOPHYS, V221, P570, DOI 10.1016/0003-9861(83)90177-7; Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; HANESCH U, 1986, THESIS J MAXIMILIANS; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; Ito K, 1997, DEVELOPMENT, V124, P761; Korey CA, 2000, J NEUROBIOL, V44, P184, DOI 10.1002/1097-4695(200008)44:2<184::AID-NEU8>3.0.CO;2-N; Kraft R, 1998, J NEUROSCI, V18, P8886; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lee T, 1999, DEVELOPMENT, V126, P4065; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; Nachmias VT, 1993, CURR OPIN CELL BIOL, V5, P56, DOI 10.1016/S0955-0674(05)80008-0; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; POECK B, 1993, DEVELOPMENT, V117, P1017; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; PRING M, 1992, BIOCHEMISTRY-US, V31, P1827, DOI 10.1021/bi00121a035; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Renn SCP, 1999, J NEUROBIOL, V41, P189; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Roth LWA, 1999, DEVELOPMENT, V126, P1365; Safer D, 1997, CELL MOTIL CYTOSKEL, V38, P163, DOI 10.1002/(SICI)1097-0169(1997)38:2<163::AID-CM5>3.0.CO;2-8; Sambrook J., 1989, MOL CLONING LAB MANU, V3; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; Simon AF, 1998, MECH DEVELOP, V76, P45, DOI 10.1016/S0925-4773(98)00104-X; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Tettamanti M, 1997, DEV GENES EVOL, V207, P242, DOI 10.1007/s004270050112; Truman James W., 1993, P1245; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Vaduva G, 1997, J CELL BIOL, V139, P1821, DOI 10.1083/jcb.139.7.1821; Vaduva G, 1999, J BIOL CHEM, V274, P17103, DOI 10.1074/jbc.274.24.17103; VANDEKERCKHOVE J, 1990, J BIOL CHEM, V265, P12801; VanTroys M, 1996, EMBO J, V15, P201, DOI 10.1002/j.1460-2075.1996.tb00350.x; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; YU FX, 1993, J BIOL CHEM, V268, P502	58	98	101	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					797	808		10.1016/S0092-8674(00)00068-4	http://dx.doi.org/10.1016/S0092-8674(00)00068-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030623	Bronze			2022-12-01	WOS:000089395200011
J	Usiello, A; Baik, JH; Rouge-Pont, F; Picetti, R; Dierich, A; LeMeur, M; Piazza, PV; Borrelli, E				Usiello, A; Baik, JH; Rouge-Pont, F; Picetti, R; Dierich, A; LeMeur, M; Piazza, PV; Borrelli, E			Distinct functions of the two isoforms of dopamine D-2 receptors	NATURE			English	Article							DEFICIENT MICE; D2 RECEPTORS; LOCOMOTOR-ACTIVITY; G-PROTEINS; NEURONS; HYPERPLASIA; AGONISTS; RELEASE; GENE	Signalling through dopamine D2 receptors governs physiological functions related to locomotion, hormone production and drug abuse(1-7). D2 receptors are also known targets of antipsychotic drugs that are used to treat neuropsychiatric disorders such as schizophrenia(8). By a mechanism of alternative splicing, the D2 receptor gene encodes two molecularly distinct isoforms(9), D2S and D2L, previously thought to have the same function. Here we show that these receptors have distinct functions in vivo; D2L acts mainly at postsynaptic sites and D2S serves presynaptic autoreceptor functions. The cataleptic effects of the widely used antipsychotic haloperidol(1) are absent in D2L-deficient mice. This suggests that D2L is targeted by haloperidol, with implications for treatment of neuropsychiatric disorders. The absence of D2L reveals that D2S inhibits D1 receptor-mediated functions, uncovering a circuit of signalling interference between dopamine receptors.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; Univ Bordeaux 2, INSERM, U259, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Borrelli, E (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	eb@igbmc.u-strasbg.fr	usiello, alessandro/B-2368-2012; Borrelli, Emiliana/M-8994-2018; Picetti, Roberto/B-9944-2011	Picetti, Roberto/0000-0003-4756-5271; Usiello, Alessandro/0000-0001-9203-853X				Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Boulay D, 2000, EUR J PHARMACOL, V391, P63, DOI 10.1016/S0014-2999(99)00916-4; Boulay D, 1999, NEUROPHARMACOLOGY, V38, P1389, DOI 10.1016/S0028-3908(99)00064-7; Calabresi P, 1997, J NEUROSCI, V17, P4536; CRENSHAW EB, 1987, CELL, V49, P389, DOI 10.1016/0092-8674(87)90291-1; Egan MF, 1997, CURR OPIN NEUROBIOL, V7, P701, DOI 10.1016/S0959-4388(97)80092-X; EILAM D, 1989, EUR J PHARMACOL, V161, P151, DOI 10.1016/0014-2999(89)90837-6; GUIRAMAND J, 1995, J BIOL CHEM, V270, P7354, DOI 10.1074/jbc.270.13.7354; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jung MY, 1999, NEUROSCIENCE, V91, P911, DOI 10.1016/S0306-4522(98)00705-2; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kelly MA, 1998, J NEUROSCI, V18, P3470; Khan ZU, 1998, P NATL ACAD SCI USA, V95, P7731, DOI 10.1073/pnas.95.13.7731; L'hirondel M, 1998, BRAIN RES, V792, P253, DOI 10.1016/S0006-8993(98)00146-2; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; MONTMAYEUR JP, 1993, MOL ENDOCRINOL, V7, P161, DOI 10.1210/me.7.2.161; Nisenbaum ES, 1998, SYNAPSE, V29, P213, DOI 10.1002/(SICI)1098-2396(199807)29:3<213::AID-SYN3>3.0.CO;2-9; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; PROTAIS P, 1983, PSYCHOPHARMACOLOGY, V81, P126, DOI 10.1007/BF00429006; ROUGEPONT F, 1995, J NEUROSCI, V15, P7189; RUBINSTEIN M, 1988, N-S ARCH PHARMACOL, V337, P115; Ruskin DN, 1998, J PHARMACOL EXP THER, V286, P272; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; STARKE K, 1989, PHYSIOL REV, V69, P864, DOI 10.1152/physrev.1989.69.3.864; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; WADDINGTON JL, 1993, DOPAMINE RECEPTOR IN, P52; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839	30	528	549	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2000	408	6809					199	203		10.1038/35041572	http://dx.doi.org/10.1038/35041572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089973				2022-12-01	WOS:000165180400045
J	Cohen, J				Cohen, J			Combination antibiotic therapy for severe peritonitis	LANCET			English	Editorial Material							INFECTIONS; NETILMICIN; GENTAMICIN		Hammersmith Hosp, Imperial Coll Sch Med, Dept Infect Dis & Microbiol, London W12 0NN, England	Imperial College London	Cohen, J (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Dept Infect Dis & Microbiol, London W12 0NN, England.							COMETTA A, 1994, ANTIMICROB AGENTS CH, V38, P1309, DOI 10.1128/AAC.38.6.1309; Del Favero A, 1999, 39 INT C ANT AG CHEM, P722; DONNELLY JP, 1985, J INFECTION, V11, P205, DOI 10.1016/S0163-4453(85)93063-4; Dupont H, 2000, ANTIMICROB AGENTS CH, V44, P2028, DOI 10.1128/AAC.44.8.2028-2033.2000; Falagas ME, 1996, EUR J CLIN MICROBIOL, V15, P913, DOI 10.1007/BF01690508; Johnson CC, 1997, CLIN INFECT DIS, V24, P1035, DOI 10.1086/513658; MARTINO P, 1985, EUR J CANCER CLIN ON, V21, P439, DOI 10.1016/0277-5379(85)90034-3; MOSDELL DM, 1991, ANN SURG, V214, P543, DOI 10.1097/00000658-199111000-00001; ROTSTEIN OD, 1985, REV INFECT DIS, V7, P151; SAUNDERS NJ, 1995, J ANTIMICROB CHEMOTH, V36, P729, DOI 10.1093/jac/36.4.729; VANDERAUWERA P, 1985, J ANTIMICROB CHEMOTH, V16, P581, DOI 10.1093/jac/16.5.581	11	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 4	2000	356	9241					1539	1540		10.1016/S0140-6736(00)03120-2	http://dx.doi.org/10.1016/S0140-6736(00)03120-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370QV	11075763				2022-12-01	WOS:000165134500005
J	Willy, PJ; Kobayashi, R; Kadonaga, JT				Willy, PJ; Kobayashi, R; Kadonaga, JT			A basal transcription factor that activates or represses transcription	SCIENCE			English	Article							II GENE-TRANSCRIPTION; CORE PROMOTER ELEMENT; NEGATIVE COFACTOR; IN-VIVO; BINDING; NC2; DROSOPHILA; MECHANISM; TFIIA; DR1	We have identified an activity that is required for transcription of downstream promoter element (DPE)-containing core promoters in vitro. The purified factor was found to be the Drosophila homolog of the transcriptional repressor known as NC2 or Dr1-Drap1. Purified recombinant dNC2 activates DPE-driven promoters and represses TATA-driven promoters. A mutant version of dNC2 can activate DPE promoters but is unable to repress TATA promoters. Thus, the activation and repression functions are distinct. These studies reveal that NC2 (Dr1-Drap1) is a bifunctional basal transcription factor that differentially regulates gene transcription through DPE or TATA box motifs.	Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory	Kadonaga, JT (corresponding author), Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA.				NCI NIH HHS [CA13106] Funding Source: Medline; NIGMS NIH HHS [GM41249] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Castano E, 2000, P NATL ACAD SCI USA, V97, P7184, DOI 10.1073/pnas.140202297; Gadbois EL, 1997, P NATL ACAD SCI USA, V94, P3145, DOI 10.1073/pnas.94.7.3145; GEISBERG JV, UNPUB; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; INOSTROZA JA, 1992, CELL, V70, P477; Kim J, 1996, J BIOL CHEM, V271, P18405, DOI 10.1074/jbc.271.31.18405; KIM TK, 1995, J BIOL CHEM, V270, P10976, DOI 10.1074/jbc.270.18.10976; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; WILLY PJ, UNPUB; Yeung K, 1997, MOL CELL BIOL, V17, P36, DOI 10.1128/MCB.17.1.36; YEUNG KC, 1994, GENE DEV, V8, P2097, DOI 10.1101/gad.8.17.2097	20	128	136	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2000	290	5493					982	984		10.1126/science.290.5493.982	http://dx.doi.org/10.1126/science.290.5493.982			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062130				2022-12-01	WOS:000165103200049
J	Xu, YW; Tao, X; Shen, BH; Horng, T; Medzhitov, R; Manley, JL; Tong, L				Xu, YW; Tao, X; Shen, BH; Horng, T; Medzhitov, R; Manley, JL; Tong, L			Structural basis for signal transduction by the Toll/interleukin-1 receptor domains	NATURE			English	Article							DIFFRACTION DATA; ADAPTER PROTEIN; DROSOPHILA TOLL; INNATE IMMUNITY; IL-1 RECEPTOR; FAMILY; MYD88; MACROMOLECULES; MUTATIONS; MODELS	Toll-like receptors (TLRs) and the interleukin-1 receptor superfamily (IL-1Rs) are integral to both innate and adaptive immunity for host defence(1-3). These receptors share a conserved cytoplasmic domain(4,5), known as the TIR domain. A single-point mutation in the TIR domain of murine TLR4 (Pro712His, the Lps(d) mutation) abolishes the host immune response to lipopolysaccharide (LPS)(6), and mutation of the equivalent residue in TLR2, Pro681His, disrupts signal transduction in response to stimulation by yeast and Gram-positive bacteria(7). Here we report the crystal structures of the TIR domains of human TLR1 and TLR2 and of the Pro681His mutant of TLR2. The structures have a large conserved surface patch that also contains the site of the Lps(d) mutation. Mutagenesis and functional studies confirm that residues in this surface patch are crucial for receptor signalling. The Lps(d) mutation does not disturb the structure of the TIR domain itself. Instead, structural and functional studies indicate that the conserved surface patch may mediate interactions with the downstream MyD88 adapter molecule(7-11), and that the Lps(d) mutation may abolish receptor signalling by disrupting this recruitment.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Yale Univ, Sch Med, Sect Immunobiol, New Haven, CT 06520 USA	Columbia University; Yale University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.			Manley, James/0000-0002-8341-1459; Tong, Liang/0000-0002-0563-6468				Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mitcham JL, 1996, J BIOL CHEM, V271, P5777, DOI 10.1074/jbc.271.10.5777; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NORRIS JL, 1992, GENE DEV, V6, P1654, DOI 10.1101/gad.6.9.1654; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Shen BH, 1998, DEVELOPMENT, V125, P4719; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; TONG L, 1998, ACTA CRYSTALLOGR A, V52, P905; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1	29	615	657	3	60	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2000	408	6808					111	115		10.1038/35040600	http://dx.doi.org/10.1038/35040600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081518				2022-12-01	WOS:000165050400062
J	Coussens, LM; Tinkle, CL; Hanahan, D; Werb, Z				Coussens, LM; Tinkle, CL; Hanahan, D; Werb, Z			MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis	CELL			English	Article							CAPILLARY ENDOTHELIAL-CELLS; COLLAGENASE GELATINASE-B; MATRIX METALLOPROTEINASES; TRANSGENIC MICE; EXPRESSION; ANGIOGENESIS; INHIBITORS; SECRETION; TUMORIGENESIS; PROGRESSION	The matrix metalloproteinase MMP-9/gelatinase B is upregulated in angiogenic dysplasias and invasive cancers of the epidermis in a mouse model of multistage tumorigenesis elicited by HPV16 oncogenes. Transgenic mice lacking MMP-9 show reduced keratinocyte hyperproliferation at all neoplastic stages and a decreased incidence of invasive tumors. Yet those carcinomas that do arise in the absence of MMP-9 exhibit a greater loss of keratinocyte differentiation, indicative of a more aggressive and higher grade tumor. Notably, MMP-9 is predominantly expressed in neutrophils, macrophages, and mast cells, rather than in oncogene-positive neoplastic cells. Chimeric mice expressing MMP-9 only in cells of hematopoietic origin, produced by bone marrow transplantation, reconstitute the MMP-9-dependent contributions to squamous carcinogenesis. Thus, inflammatory cells can be coconspirators in carcinogenesis.	Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Hormone Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Coussens, LM (corresponding author), Univ Calif San Francisco, Canc Res Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	coussens@cc.ucsf.edu	Tinkle, Christopher/D-4211-2018; Coussens, Lisa/ABH-9834-2020	Tinkle, Christopher/0000-0001-5552-2664; 	NATIONAL CANCER INSTITUTE [R01CA047632, P01CA072006, R37CA037395] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA047632-12, R37 CA037395-18, CA72006, P01 CA072006-020003, CA 47632, R37 CA037395, R37-CA37395, P01 CA072006] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADLER RR, 1990, DEVELOPMENT, V110, P211; ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447; Bergers G, 2000, CURR OPIN GENET DEV, V10, P120, DOI 10.1016/S0959-437X(99)00043-X; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9; Broders AC, 1932, NYJ MED, V32, P667; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Cockett MI, 1998, BIOCHEM SOC SYMP, P295; Cordon-Cardo C, 1999, J EXP MED, V190, P1367, DOI 10.1084/jem.190.10.1367; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 1996, AM J PATHOL, V149, P1899; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; FOSSTIEN E, 2000, ANN CLIN LAB SCI, V1, P3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HERRON GS, 1986, J BIOL CHEM, V261, P2814; HERRON GS, 1986, J BIOL CHEM, V261, P2810; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Lane E B, 1990, Semin Cancer Biol, V1, P165; Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049; Masson R, 1998, J CELL BIOL, V140, P1535, DOI 10.1083/jcb.140.6.1535; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Olumi AF, 1999, CANCER RES, V59, P5002; REPONEN P, 1994, J CELL BIOL, V124, P1091, DOI 10.1083/jcb.124.6.1091; Smits AJ, 1997, EXP THERM FLUID SCI, V14, P1, DOI 10.1016/S0894-1777(96)00189-6; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; TALHOUK RS, 1991, DEVELOPMENT, V112, P439; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Vu TH, 1998, BIOL EXTRAC, P115; WEEKS BS, 1993, J CELL PHYSIOL, V157, P644, DOI 10.1002/jcp.1041570326; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Yu Q, 2000, GENE DEV, V14, P163	37	1070	1111	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 27	2000	103	3					481	490		10.1016/S0092-8674(00)00139-2	http://dx.doi.org/10.1016/S0092-8674(00)00139-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081634	Bronze, Green Accepted			2022-12-01	WOS:000090144100013
J	Reinfelder, JR; Kraepiel, AML; Morel, FMM				Reinfelder, JR; Kraepiel, AML; Morel, FMM			Unicellular C-4 photosynthesis in a marine diatom	NATURE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYLASE; INORGANIC CARBON; PHYTOPLANKTON; LIMITATION	Nearly 50 years ago, inorganic carbon was shown to be fixed in microalgae as the C-3 compound phosphoglyceric acid(1). The enzyme responsible for C-3 carbon fixation, ribulose-1,5-bisphosphate carboxylase (Rubisco), however, requires inorganic carbon in the form of CO2 (ref. 2), and Rubisco enzymes from diatoms have half-saturation constants for CO2 of 30-60 muM (ref. 3). As a result, diatoms growing in seawater that contains about 10 muM CO2 may be CO2 limited(4). Kinetic and growth studies have shown that diatoms can avoid CO2 limitation 5-7, but the biochemistry of the underlying mechanisms remains unknown. Here we present evidence that C-4 photosynthesis supports carbon assimilation in the marine diatom Thalassiosira weissflogii, thus providing a biochemical explanation for CO2-insensitive photosynthesis in marine diatoms. If C-4 photosynthesis is common among marine diatoms, it may account for a significant portion of carbon fixation and export in the ocean, and would explain the greater enrichment of C-13 in diatoms compared with other classes of phytoplankton. Unicellular C-4 carbon assimilation may have predated the appearance of multicellular C-4 plants.	Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08901 USA; Univ Strasbourg 1, Ctr Geochim Surface, F-67084 Strasbourg, France; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Princeton University	Reinfelder, JR (corresponding author), Rutgers State Univ, Dept Environm Sci, 14 Coll Farm Rd, New Brunswick, NJ 08901 USA.		Morel, Francois M M/A-8107-2008; Reinfelder, John/C-7214-2016	Reinfelder, John/0000-0002-3737-604X				AUSENHUS SL, 1992, BIOCHEMISTRY-US, V31, P6427, DOI 10.1021/bi00143a010; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; BERNER RA, 1990, SCIENCE, V249, P1382, DOI 10.1126/science.249.4975.1382; BOYD P, 1995, DEEP-SEA RES PT I, V42, P619, DOI 10.1016/0967-0637(95)00017-Z; CALVIN M, 1951, SYM SOC EXP BIOL, V5, P284; COLMAN B, 1995, PLANT CELL ENVIRON, V18, P919, DOI 10.1111/j.1365-3040.1995.tb00601.x; COOPER TG, 1971, J BIOL CHEM, V246, P5488; COOPER TG, 1969, J BIOL CHEM, V244, P1081; EHLERINGER JR, 1993, ANNU REV ECOL SYST, V24, P411, DOI 10.1146/annurev.es.24.110193.002211; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; FRY B, 1991, MAR ECOL PROG SER, V76, P149, DOI 10.3354/meps076149; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; HATCH MD, 1990, PLANT PHYSIOL, V93, P825, DOI 10.1104/pp.93.2.825; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Korb RE, 1997, J PHYCOL, V33, P433, DOI 10.1111/j.0022-3646.1997.00433.x; Lane TW, 2000, PLANT PHYSIOL, V123, P345, DOI 10.1104/pp.123.1.345; Magnin NC, 1997, PLANT PHYSIOL, V115, P1681, DOI 10.1104/pp.115.4.1681; Medlin LK, 1997, NOVA HEDWIGIA, V65, P1; MOREL FMM, 1994, NATURE, V369, P740, DOI 10.1038/369740a0; MORRIS I, 1980, PRIMARY PRODUCTIVITY, P139; MORTAINBERTRAND A, 1987, PHYCOLOGIA, V26, P262, DOI 10.2216/i0031-8884-26-2-262.1; OLEARY MH, 1981, BIOCHEMISTRY-US, V20, P7308, DOI 10.1021/bi00528a040; PRICE N M, 1988, Biological Oceanography, V6, P443; RIEBESELL U, 1993, NATURE, V361, P249, DOI 10.1038/361249a0; SLACK CR, 1969, BIOCHEM J, V114, P489, DOI 10.1042/bj1140489; STREAMER M, 1993, MAR BIOL, V115, P195, DOI 10.1007/BF00346335; Tortell PD, 1997, NATURE, V390, P243, DOI 10.1038/36765; WILBUR KM, 1948, J BIOL CHEM, V176, P147	28	239	260	10	100	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2000	407	6807					996	999		10.1038/35039612	http://dx.doi.org/10.1038/35039612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069177				2022-12-01	WOS:000090032500041
J	West, SA; Peters, AD				West, SA; Peters, AD			Evolution - Paying for sex is not easy	NATURE			English	Article							RECOMBINATION		Univ Edinburgh, Ashworth Labs, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	West, SA (corresponding author), Univ Edinburgh, Ashworth Labs, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		West, Stuart A/M-3608-2014	West, Stuart A/0000-0003-2152-3153				Begon M., 1996, ECOLOGY; Bell G., 1997, SELECTION MECH EVOLU; Bell G., 1982, MASTERPIECE NATURE E; BURT A, 1987, NATURE, V326, P803, DOI 10.1038/326803a0; Doncaster CP, 2000, NATURE, V404, P281, DOI 10.1038/35005078; Ghiselin M.T., 1974, EC NATURE EVOLUTION; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Maynard-Smith J., 1978, MODELS ECOLOGY; West SA, 1999, J EVOLUTION BIOL, V12, P1003	10	9	9	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2000	407	6807					962	962		10.1038/35039675	http://dx.doi.org/10.1038/35039675			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069168				2022-12-01	WOS:000090032500032
J	Fu, DX; Libson, A; Miercke, LJW; Weitzman, C; Nollert, P; Krucinski, J; Stroud, RM				Fu, DX; Libson, A; Miercke, LJW; Weitzman, C; Nollert, P; Krucinski, J; Stroud, RM			Structure of a glycerol-conducting channel and the basis for its selectivity	SCIENCE			English	Article							WATER CHANNELS; ESCHERICHIA-COLI; XENOPUS-OOCYTES; FUNCTIONAL RECONSTITUTION; ELECTRON CRYSTALLOGRAPHY; MEMBRANE-PROTEINS; HELIX PACKING; MIP FAMILY; AQUAPORIN-1; PERMEABILITY	Membrane channel proteins of the aquaporin family are highly selective for permeation of specific small molecules, with absolute exclusion of ions and charged solutes and without dissipation of the electrochemical potential across the cell membrane. We report the crystal structure of the Escherichia coli glycerol facilitator (GlpF) with its primary permeant substrate glycerol at 2.2 angstrom resolution. Glycerol molecules line up in an amphipathic channel in single file. In the narrow selectivity filter of the channel the glycerol alkyl backbone is wedged against a hydrophobic corner, and successive hydroxyl groups form hydrogen bonds with a pair of acceptor, and donor atoms. Two conserved aspartic acid-proline-alanine motifs form a key interface between two gene-duplicated segments that each encode three-and-one-half membrane-spanning helices around the channel. This structure elucidates the mechanism of selective permeability for linear carbohydrates and suggests how ions and water are excluded.	Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA.		Stroud, Rhonda/GQZ-0151-2022; Stroud, Rhonda M./C-5503-2008	Stroud, Rhonda/0000-0001-5242-8015; Stroud, Rhonda M./0000-0001-5242-8015; Fu, Dax/0000-0002-2663-1316	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024485, R37GM024485] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24485] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agre P, 1999, Methods Enzymol, V294, P550; ANDERSEN OS, 1992, PHYSIOL REV, V72, pS89, DOI 10.1152/physrev.1992.72.suppl_4.S89; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Anthony TL, 2000, MOL PHARMACOL, V57, P576, DOI 10.1124/mol.57.3.576; Bernal JD, 1933, J CHEM PHYS, V1, P515, DOI 10.1063/1.1749327; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; BRUNGER AT, 1996, XPLOR VERSION 3 843; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; DEEN PMT, 1995, J CLIN INVEST, V95, P2291, DOI 10.1172/JCI117920; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Doyle DA, 1997, J MOL BIOL, V266, P963, DOI 10.1006/jmbi.1996.0837; Eisenberg D., 2005, STRUCTURE PROPERTIES; Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800; Finkelstein A., 1987, WATER MOVEMENT LIPID; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; LAFORTELLE ED, 1997, CRYSTALLOGRAPHIC COM, V7; Lagree V, 1998, J BIOL CHEM, V273, P12422, DOI 10.1074/jbc.273.20.12422; LAUGER P, 1982, BIOPHYS CHEM, V16, P209, DOI 10.1016/0301-4622(82)87004-X; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; MALONEY PC, 1989, ARCH BIOCHEM BIOPHYS, V269, P1, DOI 10.1016/0003-9861(89)90080-5; MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x; MAUREL C, 1994, J BIOL CHEM, V269, P11869; Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177; MULLINS LJ, 1959, J GEN PHYSIOL, V42, P817, DOI 10.1085/jgp.42.4.817; PAO GM, 1991, MOL MICROBIOL, V5, P33, DOI 10.1111/j.1365-2958.1991.tb01823.x; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; Ringler P, 1999, J MOL BIOL, V291, P1181, DOI 10.1006/jmbi.1999.3031; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SMITH BL, 1991, J BIOL CHEM, V266, P6407; SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343; Walther D, 1996, J MOL BIOL, V255, P536, DOI 10.1006/jmbi.1996.0044; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; WISTOW GJ, 1991, TRENDS BIOCHEM SCI, V16, P170, DOI 10.1016/0968-0004(91)90065-4; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Yool AJ, 1996, SCIENCE, V273, P1216, DOI 10.1126/science.273.5279.1216	43	815	850	1	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					481	486		10.1126/science.290.5491.481	http://dx.doi.org/10.1126/science.290.5491.481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039922				2022-12-01	WOS:000089946000041
J	Higgie, M; Chenoweth, S; Blows, MW				Higgie, M; Chenoweth, S; Blows, MW			Natural selection and the reinforcement of mate recognition	SCIENCE			English	Article							DROSOPHILA; SPECIATION	Natural selection on mate recognition may often contribute to speciation, resulting in reproductive character displacement. Field populations of Drosophila serrata display reproductive character displacement in cuticular hydrocarbons when sympatric with Drosophila birchii. We exposed field sympatric and allopatric populations of D. serrata to experimental sympatry with D. birchii for nine generations. Cuticular hydrocarbons of field allopatric D. serrata populations evolved to resemble the field sympatric populations, whereas field sympatric D. serrata populations remained unchanged. Our experiment indicates that natural selection on mate recognition resulted in the field pattern of reproductive character displacement.	Univ Queensland, Dept Zool & Entomol, St Lucia, Qld 4072, Australia; Griffith Univ, Fac Environm Sci, Nathan, Qld 4111, Australia	University of Queensland; Griffith University	Higgie, M (corresponding author), Univ Queensland, Dept Zool & Entomol, St Lucia, Qld 4072, Australia.	MHiggie@zoology.uq.edu.au	Chenoweth, Stephen F/A-7211-2012; Higgie, Megan/A-6131-2008; Chenoweth, Steve/AAV-9916-2020; Blows, Mark W/B-6195-2008	Chenoweth, Stephen F/0000-0002-8303-9159; Higgie, Megan/0000-0002-2397-0240; Chenoweth, Steve/0000-0002-8303-9159; Blows, Mark W/0000-0002-1065-5524				AYALA FJ, 1965, GENETICS, V51, P527; AYALA FJ, 1965, EVOLUTION, V19, P538, DOI 10.1111/j.1558-5646.1965.tb03329.x; BIRCH LC, 1963, EVOLUTION, V17, P72, DOI 10.1111/j.1558-5646.1963.tb03255.x; BLAIR WF, 1964, Q REV BIOL, V39, P333, DOI 10.1086/404323; Blows MW, 1998, AM NAT, V152, P826, DOI 10.1086/286211; Blows MW, 1998, AM NAT, V151, P538, DOI 10.1086/286139; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; BUTLIN RK, 1995, TRENDS ECOL EVOL, V10, P432, DOI 10.1016/S0169-5347(00)89173-9; Butlin Roger, 1995, P327; DOBZHANSKY T, 1951, GENETICS ORIGIN SPEC, P206; HICKS CR, 1993, FUNDAMENTAL CONCEPTS, P268; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Kim YK, 1996, BEHAV GENET, V26, P27, DOI 10.1007/BF02361156; KOOPMAN KF, 1950, EVOLUTION, V4, P135, DOI 10.2307/2405390; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; Noor MAF, 1997, AM NAT, V149, P1156, DOI 10.1086/286044; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; Saetre GP, 1997, NATURE, V387, P589	21	242	245	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2000	290	5491					519	521		10.1126/science.290.5491.519	http://dx.doi.org/10.1126/science.290.5491.519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039933				2022-12-01	WOS:000089946000052
J	Frame, PS				Frame, PS			Routine screening for lung cancer? Maybe someday, but not yet	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSTITUTE; MORTALITY; PROGRAM		Tri County Family Med, Cohocton, NY 14826 USA; Univ Rochester, Sch Med & Dent, Rochester, NY USA	University of Rochester	Frame, PS (corresponding author), Tri County Family Med, 25 Park Ave, Cohocton, NY 14826 USA.	psframe@frontiernet.net						BERLIN NI, 1984, AM REV RESPIR DIS, V130, P545; BOUCOT KR, 1959, NEW ENGL J MED, V260, P742, DOI 10.1056/NEJM195904092601503; BOUCOT KR, 1973, JAMA-J AM MED ASSOC, V224, P1361, DOI 10.1001/jama.224.10.1361; BRETT GZ, 1969, BRIT MED J, V4, P260, DOI 10.1136/bmj.4.5678.260; Brownson RC, 1998, EPIDEMIOL REV, V20, P218, DOI 10.1093/oxfordjournals.epirev.a017982; *CONS STAT PREV EA, 1999, ONCOLOGY, V13, P298; Eddy D, 1980, CA Cancer J Clin, V30, P193; FONTANA RS, 1986, J OCCUP ENVIRON MED, V28, P746, DOI 10.1097/00043764-198608000-00038; FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0; Frame P S, 1998, J Am Board Fam Pract, V11, P87; GOHAGAN JK, 1995, CANCER, V75, P1869, DOI 10.1002/1097-0142(19950401)75:7+<1869::AID-CNCR2820751617>3.0.CO;2-7; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; KUBIK A, 1986, CANCER-AM CANCER SOC, V57, P2427, DOI 10.1002/1097-0142(19860615)57:12<2427::AID-CNCR2820571230>3.0.CO;2-M; LILIENFE.A, 1966, CANCER RES, V26, P2083; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; NASH FA, 1968, BRIT MED J, V2, P715, DOI 10.1136/bmj.2.5607.715; *NCI, 1979, NIH CONS DEV C SUMM, V1, P4; Payne PW, 1997, MAYO CLIN PROC, V72, P697; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; TOCKMAN MS, 1986, CHEST, V89, pS324, DOI 10.1378/chest.89.4_Supplement.324S-a; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P135; Wingo PA, 1998, CANCER-AM CANCER SOC, V82, P1197, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1197::AID-CNCR26>3.0.CO;2-0	22	26	26	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1980	1983		10.1001/jama.284.15.1980	http://dx.doi.org/10.1001/jama.284.15.1980			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035899				2022-12-01	WOS:000089774000035
J	Wang, XJ; Moylan, B; Leopold, DA; Kim, J; Rubenstein, RC; Togias, A; Proud, D; Zeitlin, PL; Cutting, GR				Wang, XJ; Moylan, B; Leopold, DA; Kim, J; Rubenstein, RC; Togias, A; Proud, D; Zeitlin, PL; Cutting, GR			Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NASAL POLYPS; CFTR GENE; DISEASE	Context Chronic rhinosinusitis (CRS) is a common condition in the US general population, yet little is known about its underlying molecular cause. Chronic rhinosinusitis is a consistent feature of the autosomal recessive disorder cystic fibrosis (CF). Objective To determine whether mutations in the cystic fibrosis transmembrane regulator (CFTR) gene, which is responsible for CF, predispose to CRS. Design Case-control study conducted from 1996 to 1999 in which the DNA of CRS patients and controls was typed for 16 mutations that account for 85% of CF alleles in the general population. Chronic rhinosinusitis patients with 1 CF mutation were evaluated for a CF diagnosis by sweat chloride testing, nasal potential difference measurement, and DNA analysis for additional mutations. Setting Otolaryngology-head and neck clinic of a US teaching hospital. Participants One hundred forty-seven consecutive adult white patients who met stringent diagnostic criteria for CRS and 123 CRS-free white control volunteers of similar age range, geographic region, and socioeconomic status. Main Outcome Measures Presence of CF mutations by DNA analysis among CRS patients vs controls. Results Eleven CRS patients were found to have a CF mutation (Delta F508, n = 9; G542X, n = 1; and N1303K, n = 1). Diagnostic testing excluded CF in 10 of these patients and led to CF diagnosis in 1. Excluding this patient from the analyses, the proportion of CRS patients who were found to have a CF mutation (7%) was significantly higher than in the control group (n = 2 [2%]; P = .04, both having Delta F508 mutations). Furthermore, 9 of the 10 CF carriers had the polymorphism M470V, and M470V homozygotes were overrepresented in the remaining 136 CRS patients (P = .03). Conclusion These data indicate that mutations in the gene responsible for CF may be associated with the development of CRS in the general population.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cutting, GR (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, CMSC 1004, Baltimore, MD 21287 USA.			Zeitlin, Pamela/0000-0002-2719-1834; Rubenstein, Ronald/0000-0002-3138-4006	NCRR NIH HHS [RR00052] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BURGER J, 1991, LANCET, V337, P974, DOI 10.1016/0140-6736(91)91603-R; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Collins J G, 1993, Vital Health Stat 10, P1; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; CUPPENS H, 1994, HUM MOL GENET, V3, P607, DOI 10.1093/hmg/3.4.607; Cutting GR., 1997, EMERY RIMOINS PRINCI, P2685; CUTTING GR, 2000, DIS SINUSES DIAGNOST; GIBSON LE, 1959, PEDIATRICS, V23, P545; GWALTNEY JM, 1994, NEW ENGL J MED, V330, P25, DOI 10.1056/NEJM199401063300105; Hamosh A, 1998, J PEDIATR-US, V132, P255, DOI 10.1016/S0022-3476(98)70441-X; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; *INT RHIN ADV BOAR, 1997, EAR NOSE THROAT J S, V76, P1; Irving RM, 1997, CLIN OTOLARYNGOL, V22, P519, DOI 10.1046/j.1365-2273.1997.00058.x; Kaliner MA, 1997, J ALLERGY CLIN IMMUN, V99, pS829, DOI 10.1016/S0091-6749(97)70041-1; KAWASAKI E, 1993, METHOD ENZYMOL, V218, P369; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; Lazaro C, 1999, HUM MUTAT, V14, P510, DOI 10.1002/(SICI)1098-1004(199912)14:6<510::AID-HUMU10>3.0.CO;2-O; LEDESMAMEDINA J, 1980, PEDIATR RADIOL, V9, P61, DOI 10.1007/BF00977665; LeGrys V. A., 1994, SWEAT TESTING SAMPLE; Macek M, 1997, HUM MUTAT, V9, P136, DOI 10.1002/(SICI)1098-1004(1997)9:2<136::AID-HUMU6>3.3.CO;2-M; Mak V, 1999, JAMA-J AM MED ASSOC, V281, P2217, DOI 10.1001/jama.281.23.2217; RAMSEY B, 1992, J ALLERGY CLIN IMMUN, V90, P547, DOI 10.1016/0091-6749(92)90183-3; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; STRONG TV, 1991, NEW ENGL J MED, V325, P1630, DOI 10.1056/NEJM199112053252307; VARON R, 1995, HUM MOL GENET, V4, P1463, DOI 10.1093/hmg/4.8.1463; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799	31	181	191	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1814	1819		10.1001/jama.284.14.1814	http://dx.doi.org/10.1001/jama.284.14.1814			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025834	Bronze			2022-12-01	WOS:000089622100033
J	Kovalchuk, O; Dubrova, YE; Arkhipov, A; Hohn, B; Kovalchuk, I				Kovalchuk, O; Dubrova, YE; Arkhipov, A; Hohn, B; Kovalchuk, I			Germline DNA - Wheat mutation rate after Chernobyl	NATURE			English	Article							INDUCTION		Novartis Res Fdn, Friedrich Miescher Inst, CH-4002 Basel, Switzerland; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Chernobyl Sci & Tech Ctr Int Res, UA-255620 Chernobyl, Ukraine	Friedrich Miescher Institute for Biomedical Research; Novartis; University of Leicester	Kovalchuk, O (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst, POB 2543, CH-4002 Basel, Switzerland.	Olga.Kovalchuk@fmi.ch	Dubrova, Yuri/ABA-7148-2020	Dubrova, Yuri/0000-0001-5281-7539				CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dubrova YE, 1998, INT J RADIAT BIOL, V74, P689, DOI 10.1080/095530098140952; FRANKENBERGSCHWAGER M, 1990, RADIAT ENVIRON BIOPH, V29, P273, DOI 10.1007/BF01210408; Kovalchuk I, 1998, NAT BIOTECHNOL, V16, P1054, DOI 10.1038/3505; Kovalchuk O, 2000, MUTAT RES-FUND MOL M, V449, P47, DOI 10.1016/S0027-5107(00)00029-4; MOISEEV A, 1991, DIRECTORY DOSIMETRY; Roder MS, 1998, GENETICS, V149, P2007; SADAMOTO S, 1994, INT J RADIAT BIOL, V65, P549, DOI 10.1080/09553009414550641; SHIELDS R, 1993, NATURE, V365, P297, DOI 10.1038/365297a0	9	108	112	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2000	407	6804					583	584		10.1038/35036692	http://dx.doi.org/10.1038/35036692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034198				2022-12-01	WOS:000089772800034
J	Bisby, FA				Bisby, FA			The quiet revolution: Biodiversity informatics and the internet	SCIENCE			English	Editorial Material									Univ Reading, Sch Plant Sci, Ctr Plant Divers & Systemat, Reading RG6 6AS, Berks, England	University of Reading	Bisby, FA (corresponding author), Univ Reading, Sch Plant Sci, Ctr Plant Divers & Systemat, Reading RG6 6AS, Berks, England.	f.a.bisby@reading.ac.uk						BEACH JH, 1993, ADVANCES IN COMPUTER METHODS FOR SYSTEMATIC BIOLOGY, P241; BERENDSOHN WG, 1995, TAXON, V44, P207, DOI 10.2307/1222443; Bisby FA, 1996, SPECIES 2000 PROJECT; Bisby FA, 1993, DESIGNS GLOBAL PLANT, P145; Edwards JL, 2000, SCIENCE, V289, P2312, DOI 10.1126/science.289.5488.2312; JONES AC, 2000, P 12 INT C SCI STAT, P3; Leow R, 2000, 12TH INTERNATIONAL CONFERENCE ON SCIENTIFIC AND STATISTICAL DATABASE MANAGEMENT, PROCEEDINGS, P25, DOI 10.1109/SSDM.2000.869776; Pullan MR, 2000, TAXON, V49, P55, DOI 10.2307/1223932; YAKOVLEV GP, 1998, LEGUMES NO EURASIA; Zhong Y, 1996, TAXON, V45, P223, DOI 10.2307/1224663	10	151	160	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2000	289	5488					2309	2312		10.1126/science.289.5488.2309	http://dx.doi.org/10.1126/science.289.5488.2309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009408				2022-12-01	WOS:000089593500040
J	Xu, CY; Kauffmann, RC; Zhang, JJ; Kladny, S; Carthew, RW				Xu, CY; Kauffmann, RC; Zhang, JJ; Kladny, S; Carthew, RW			Overlapping activators and repressors delimit transcriptional response to receptor tyrosine kinase signals in the Drosophila eye	CELL			English	Article							EGF RECEPTOR; MAP KINASE; CELL FATE; R7 CELL; PATHWAY; DIFFERENTIATION; LOZENGE; EXPRESSION; PHYLLOPOD; EMBRYO	Regulated transcription of the prospero gene in the Drosophila eye provides a model for how gene expression is specifically controlled by signals from receptor tyrosine kinases. We show that prospero is controlled by signals from the EGF receptor DER and the Sevenless receptor. A direct link is established between DER activation of a transcription enhancer in prospero and binding of two transcription factors that are targets of DER signaling. Binding of the cell-specific Lozenge protein is also required for activation, and overlapping Lozenge protein distribution and DER signaling establishes expression in a subset of equivalent cells competent to respond to Sevenless. We show that Sevenless activates prospero independent of the enhancer and involves targeted degradation of Tramtrack, a transcription repressor.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carthew, RW (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.				NATIONAL EYE INSTITUTE [R01EY010111] Funding Source: NIH RePORTER; NEI NIH HHS [EY10111] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; CHANG HC, 1995, CELL, V80, P463, DOI 10.1016/0092-8674(95)90497-2; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; Crew JR, 1997, DEV GENES EVOL, V206, P481, DOI 10.1007/s004270050079; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; DICKSON BJ, 1995, CELL, V80, P453, DOI 10.1016/0092-8674(95)90496-4; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Flores GV, 1998, DEVELOPMENT, V125, P3681; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Golembo M, 1999, GENE DEV, V13, P158, DOI 10.1101/gad.13.2.158; Greenwood S, 1997, DEVELOPMENT, V124, P4879; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Li LH, 1999, DEVELOPMENT, V126, P3313; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; PERRIMON N, 1994, CURR OPIN CELL BIOL, V6, P260, DOI 10.1016/0955-0674(94)90145-7; Queenan AM, 1997, DEVELOPMENT, V124, P3871; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Rodan GA, 1997, CELL, V89, P677, DOI 10.1016/S0092-8674(00)80249-4; Rogge R, 1995, DEVELOPMENT, V121, P3947; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	32	123	125	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					87	97		10.1016/S0092-8674(00)00107-0	http://dx.doi.org/10.1016/S0092-8674(00)00107-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051550	Bronze			2022-12-01	WOS:000089636400011
J	Weijer, C; Shapiro, SH; Glass, KC; Enkin, MW				Weijer, C; Shapiro, SH; Glass, KC; Enkin, MW			For and against - Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The ethical basis for entering patients in randomised controlled trials is under debate, Some doctors espouse the uncertainty principle whereby randomisation to treatment is acceptable when an individual doctor is genuinely unsure which treatment is best for a patient. Others believe that clinical equipoise, reflecting collective professional uncertainty over treatment, is the soundest ethical criterion. Here doctors from two Canadian centres discuss their positions.	Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 4H7, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3A 1A2, Canada; McGill Univ, Dept Human Genet, Biomed Eth Unit, Montreal, PQ H3A 1A2, Canada; McGill Univ, Dept Pediat, Biomed Eth Unit, Montreal, PQ H3A 1A2, Canada	Dalhousie University; McGill University; McGill University; McGill University	Weijer, C (corresponding author), Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 4H7, Canada.	charles.weijer@dal.ca		Weijer, Charles/0000-0002-5510-1074				COLLINS R, 1992, INTRO NEW TREATMENTS; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Fuks A, 1998, J CLIN EPIDEMIOL, V51, P69, DOI 10.1016/S0895-4356(97)00240-0; HELLMAN S, 1991, NEW ENGL J MED, V324, P1585, DOI 10.1056/NEJM199105303242208; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; TAYLOR KM, 1984, NEW ENGL J MED, V310, P1363, DOI 10.1056/NEJM198405243102106; Weijer C, 1999, SCHIZOPHR RES, V35, P211, DOI 10.1016/S0920-9964(98)00127-3; Weijer C, 1999, J CLIN ETHIC, V10, P100; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	11	115	117	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2000	321	7263					756	758		10.1136/bmj.321.7263.756	http://dx.doi.org/10.1136/bmj.321.7263.756			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999914	Green Published			2022-12-01	WOS:000089546600034
J	Brendza, RP; Serbus, LR; Duffy, JB; Saxton, WM				Brendza, RP; Serbus, LR; Duffy, JB; Saxton, WM			A function for kinesin I in the posterior transport of oskar mRNA and Staufen protein	SCIENCE			English	Article							DROSOPHILA OOGENESIS; ANTERIOR-POSTERIOR; MESSENGER-RNA; EGF RECEPTOR; LOCALIZATION; OOCYTES; ORB; POLARIZATION; MICROTUBULES; COMPONENT	The asymmetric localization of messenger RNA (mRNA) and protein determinants plays an important role in the establishment of complex body plans. In Drosophila oocytes, the anterior localization of bicoid mRNA and the posterior Localization of oskar mRNA are key events in establishing the anterior-posterior axis. Although the mechanisms that drive bicoid and oskar Localization have been elusive, oocyte microtubules are known to be essential. Here we report that the plus end-directed microtubule motor kinesin 1 is required for the posterior Localization of oskar mRNA and an associated protein, Staufen, but not for the anterior-posterior localization of other asymmetric factors. Thus, a complex containing oskar mRNA and Staufen may be transported along microtubules to the posterior pole by kinesin I.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Saxton, WM (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.				NIGMS NIH HHS [R01GM46295, R01 GM046295, R01 GM046295-09] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046295] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brendza RP, 2000, MOL BIOL CELL, V11, P1329, DOI 10.1091/mbc.11.4.1329; BRENDZA RP, 1999, THESIS INDIANA U; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; CHOU TB, 1993, DEVELOPMENT, V119, P1359; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KOCH EA, 1983, CELL TISSUE RES, V228, P21; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; Lasko P, 1999, FASEB J, V13, P421, DOI 10.1096/fasebj.13.3.421; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Martin MAE, 1999, CELL MOL LIFE SCI, V56, P200, DOI 10.1007/s000180050422; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4	26	283	291	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2120	2122		10.1126/science.289.5487.2120	http://dx.doi.org/10.1126/science.289.5487.2120			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000113	Green Accepted			2022-12-01	WOS:000089430900043
J	Zhou, ZL; Luo, M; Straesser, K; Katahira, J; Hurt, E; Reed, R				Zhou, ZL; Luo, M; Straesser, K; Katahira, J; Hurt, E; Reed, R			The protein Aly links pre-messenger-RNA splicing to nuclear export in metazoans	NATURE			English	Article							CONSTITUTIVE TRANSPORT ELEMENT; BINDING-PROTEINS; SPLICEOSOME; RIBONUCLEOPROTEINS; AUTOANTIBODIES; HOMOLOG; INVITRO; PATHWAY; MEX67P; EF-2	In metazoans, most pre-messenger RNAs contain introns that are removed by splicing. The spliced mRNAs are then exported to the cytoplasm. Recent studies showed that splicing promotes efficient mRNA export(1), but the mechanism for coupling these two processes is not known. Here we show that Aly, the metazoan homologue of the yeast mRNA export factor Yra1p (ref. 2), is recruited to messenger ribonucleoprotein (mRNP) complexes generated by splicing. In contrast, Aly does not associate with mRNPs assembled on identical mRNAs that already have no introns or with heterogenous nuclear RNP (hnRNP) complexes. Aly is recruited during spliceosome assembly, and then becomes tightly associated with the spliced mRNP. Aly shuttles between the nucleus and cytoplasm, and excess recombinant Aly increases both the rate and efficiency of mRNA export in vivo. Consistent with its splicing-dependent recruitment, Aly co-localizes with splicing factors in the nucleus. We conclude that splicing is required for efficient mRNA export as a result of coupling between the splicing and the mRNA export machineries.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Heidelberg, BZH, D-69120 Heidelberg, Germany	Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg	Reed, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Katahira, Jun/0000-0001-5188-0368; Strasser, Katja/0000-0003-3533-5516				Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; BENNETT M, 1992, MOL CELL BIOL, V12, P3165, DOI 10.1128/MCB.12.7.3165; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; FU XD, 1995, RNA, V1, P663; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; HABETS WJ, 1989, J IMMUNOL, V143, P2560; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Le Hir H, 2000, GENE DEV, V14, P1098; Lewis JD, 2000, SCIENCE, V288, P1385, DOI 10.1126/science.288.5470.1385; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; NAIELNY S, 1999, CELL, V99, P677; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; PINOLROMA S, 1988, GENE DEV, V2, P490; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; PORTENOY RK, 1997, T PALLIAT CARE, V1, P3; REED R, 1990, P NATL ACAD SCI USA, V87, P8031, DOI 10.1073/pnas.87.20.8031; Saavedra C, 1997, CURR BIOL, V7, P619, DOI 10.1016/S0960-9822(06)00288-0; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cb.09.110193.001405; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Wichmann I, 1999, HUM IMMUNOL, V60, P57, DOI 10.1016/S0198-8859(98)00085-8	31	390	397	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					401	405		10.1038/35030160	http://dx.doi.org/10.1038/35030160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014198				2022-12-01	WOS:000089390700052
J	Gibbs, HL; Sorenson, MD; Marchetti, K; Brooke, MD; Davies, NB; Nakamura, H				Gibbs, HL; Sorenson, MD; Marchetti, K; Brooke, MD; Davies, NB; Nakamura, H			Genetic evidence for female host-specific races of the common cuckoo	NATURE			English	Article							CUCULUS-CANORUS; EGG MIMICRY; DIFFERENTIATION; DISCRIMINATION; MITOCHONDRIAL	The common cuckoo Cuculus canorus is divided into host-specific races (gentes)(1). Females of each race lay a distinctive egg type that tends to match the host's eggs, for instance, brown and spotted for meadow pipit hosts or plain blue for redstart hosts(2-4). The puzzle is how these gentes remain distinct. Here, we provide genetic evidence that gentes are restricted to female lineages, with cross mating by males maintaining the common cuckoo genetically as one species. We show that there is differentiation between gentes in maternally inherited mitochondrial DNA, but not in microsatellite loci of nuclear DNA. This supports recent behavioural evidence that female, but not male, common cuckoos specialize on a particular host(5), and is consistent with the possibility that genes affecting cuckoo egg type are located on the female-specific W sex chromosome(6). Our results also support the ideas that common cuckoos often switched hosts during evolution(7,8), and that some gentes may have multiple, independent origins, due to colonization by separate ancestral lineages.	McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; Boston Univ, Dept Biol, Boston, MA 02215 USA; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Shinshu Univ, Fac Educ, Nagano 380, Japan	McMaster University; Boston University; University of Cambridge; Shinshu University	Gibbs, HL (corresponding author), McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	gibbs@mcmaster.ca	Sorenson, Michael/D-8065-2011	Sorenson, Michael/0000-0001-5375-2917				Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Baker ECS, 1942, CUCKOO PROBLEMS; BROOKE MD, 1991, ETHOLOGY, V89, P154; BROOKE MD, 1988, NATURE, V335, P630; COLLIAS EC, 1993, AUK, V110, P683, DOI 10.2307/4088624; Davies N. B, 2000, COWBIRDS OTHER CHEAT; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; DAWKINS R, 1998, UNWEAVING RAINBOW; EXCOFFIER L, 1992, GENETICS, V131, P479; Gibbs HL, 1996, P ROY SOC B-BIOL SCI, V263, P89, DOI 10.1098/rspb.1996.0015; Gibbs HL, 1998, MOL ECOL, V7, P1437; GOODNIGHT K, 1997, VER 1 2; HUDSON RR, 1992, GENETICS, V132, P583; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Maddison W. P., 1992, MACCLADE ANAL PHYLOG; Marchetti K, 1998, SCIENCE, V282, P471, DOI 10.1126/science.282.5388.471; MOKSNES A, 1995, J ZOOL, V236, P625, DOI 10.1111/j.1469-7998.1995.tb02736.x; Nakamura H, 1998, OX ORN SER, V9, P94; Nakamura Hiroshi, 1997, Japanese Journal of Ornithology, V46, P23, DOI 10.3838/jjo.46.23; Newton A., 1893, DICT BIRDS; Punnett RC, 1933, NATURE, V132, P892, DOI 10.1038/132892b0; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Roldan ERS, 1999, TRENDS ECOL EVOL, V14, P58, DOI 10.1016/S0169-5347(98)01567-5; Schneider S., 1997, ARLEQUIN VER 1 1 SOF; SCHOFFNER RN, 1982, POULTRY SCI, V61, P817; SLATKIN M, 1995, GENETICS, V139, P457; Steel MA, 1996, SYST BIOL, V45, P127, DOI 10.2307/2413610; SWOFFORD D, 1999, PAUP VER 4 0; Teuschl Y, 1998, ANIM BEHAV, V56, P1425, DOI 10.1006/anbe.1998.0931	30	185	193	3	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					183	186		10.1038/35025058	http://dx.doi.org/10.1038/35025058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001055				2022-12-01	WOS:000089241000047
J	Menzies, D; Fanning, A; Yuan, L; FitzGerald, JM				Menzies, D; Fanning, A; Yuan, L; FitzGerald, JM		Canadian Collaborative Grp Nosocom	Hospital ventilation and risk for tuberculous infection in Canadian health care workers	ANNALS OF INTERNAL MEDICINE			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; HUMAN-IMMUNODEFICIENCY-VIRUS; CDC TB SURVEY; SKIN-TEST; NOSOCOMIAL TRANSMISSION; PULMONARY TUBERCULOSIS; YOUNG-ADULTS; OCCUPATIONAL TUBERCULOSIS; DIAGNOSTIC-PROCEDURES; RESPIRATORY ISOLATION	Background: The risk for and determinants of transmission of tuberculosis in hospitals caring for moderate numbers of patients with tuberculosis remain uncertain. Objective: To study the association of tuberculin conversion among health care workers with ventilation of patient care areas. Design: Cross-sectional observational survey. Setting: 17 acute-care community or university hospitals. Participants: All personnel who worked at least 2 days per week in the respiratory and physiotherapy departments or in selected nursing units. Measurements: Participating workers underwent tuberculin skin testing and completed self-administered questionnaires. Previous tuberculin tests and bacille Calmette-Guerin vaccinations were verified. Records of patients with tuberculosis who were hospitalized in the 3 years preceding the study were reviewed. Air exchanges per hour in patient care areas were measured by using a tracer gas technique. Multivariate proportional hazards regression was used to estimate the effect of occupational factors on documented tuberculin conversion, after adjustment for nonoccupational factors, among participants with at least one previous negative result on tuberculin skin testing. Results: Tuberculin conversion was associated with ventilation of general or nonisolation patient rooms of less than 2 air exchanges per hour (adjusted hazard ratio, 3.4 [95% Cl, 2.1 to 5.8]); with work in moderate- to high-risk hospitals (adjusted hazard ratio, 2.2 [Cl, 1.3 to 3.5]); and with work in the nursing (adjusted hazard ratio, 4.3 [Cl, 2.7 to 6.91), respiratory therapy (adjusted hazard ratio, 6.1 [Cl, 3.1 to 12.0]), and physiotherapy (adjusted hazard ratio, 3.3 [Cl, 1.5 to 74) departments or housekeeping (adjusted hazard ratio, 4.2 [Cl, 2.3 to 7.6]). Conversion was not associated with inadequate ventilation of respiratory isolation rooms (adjusted hazard ratio, 1.0 [Cl, 0.8 to 1.3). Conclusion: Tuberculin conversion among health care workers was strongly associated with inadequate ventilation in general patient rooms and with type and duration of work, but not with ventilation of respiratory isolation rooms.	McGill Univ, Montreal Chest Inst, Montreal, PQ H2X 2P4, Canada; Univ Alberta, Edmonton, AB, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	McGill University; University of Alberta; University of British Columbia	Menzies, D (corresponding author), McGill Univ, Montreal Chest Inst, 3650 St Urbain St, Montreal, PQ H2X 2P4, Canada.	menzies@meakins.lan.mcgill.ca						ADAL KA, 1994, NEW ENGL J MED, V331, P169, DOI 10.1056/NEJM199407213310306; *AM STAND TEST MAT, 1988, ANN BOOK ASTM STAND, P568; [Anonymous], 1994, MMWR-MORBID MORTAL W, V43, P1; Bangsberg DR, 1997, INFECT CONT HOSP EP, V18, P566; Barnhart S, 1997, J OCCUP ENVIRON MED, V39, P849, DOI 10.1097/00043764-199709000-00008; BASS JB, 1981, AM REV RESPIR DIS, V123, P394; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; BECKSAGUE C, 1992, JAMA-J AM MED ASSOC, V268, P1280, DOI 10.1001/jama.268.10.1280; BLUMBERG HM, 1995, ANN INTERN MED, V122, P658, DOI 10.7326/0003-4819-122-9-199505010-00003; CATANZARO A, 1982, AM REV RESPIR DIS, V125, P559, DOI 10.1164/arrd.1982.125.5.559; CAUTHEN CM, 1994, AM J RESP CRIT CARE, V149, P1597, DOI 10.1164/ajrccm.149.6.8004319; COUNSELL SR, 1989, ARCH INTERN MED, V149, P1274, DOI 10.1001/archinte.149.6.1274; COX DR, 1972, J R STAT SOC B, V34, P187; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; DAWSONSAUNDERS B, 1990, BASIC CLIN BIOSTATIS; EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302; EDWARDS LB, 1969, AM REV RESPIR DIS, V99, P1; EHRENKRA.NJ, 1972, ANN INTERN MED, V77, P377, DOI 10.7326/0003-4819-77-3-377; Fella P, 1995, AM J INFECT CONTROL, V23, P352, DOI 10.1016/0196-6553(95)90265-1; Fennelly KP, 1998, INFECT CONT HOSP EP, V19, P754; FEREBEE SH, 1963, AM REV RESPIR DIS, V88, P118; FITZGERALD JM, 1996, CANADIAN TUBERCULOSI; FRASER VJ, 1993, INFECT CONT HOSP EP, V14, P623; FRIDKIN SK, 1995, INFECT CONT HOSP EP, V16, P135; FRIDKIN SK, 1995, INFECT CONT HOSP EP, V16, P129; GORDIN FM, 1988, AM REV RESPIR DIS, V137, P153, DOI 10.1164/ajrccm/137.1.153; HALEY CE, 1989, INFECT CONT HOSP EP, V10, P204, DOI 10.1086/646003; Holton D, 1997, Can J Infect Dis, V8, P188; JEANES CWL, 1969, CAN MED ASSOC J, V100, P888; KNIGHT RA, 1963, AM REV RESPIR DIS, V88, P119; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; LINGREENBERG A, 1992, AM J INFECT CONTROL, V20, P16, DOI 10.1016/S0196-6553(05)80119-1; Long R, 1999, CAN MED ASSOC J, V160, P1185; MAGNUS K, 1955, LANCET, V2, P643; MALASKY C, 1990, AM REV RESPIR DIS, V142, P505, DOI 10.1164/ajrccm/142.3.505; MALONEY SA, 1995, ANN INTERN MED, V122, P90, DOI 10.7326/0003-4819-122-2-199501150-00002; MATHUR P, 1994, ARCH INTERN MED, V154, P306, DOI 10.1001/archinte.154.3.306; Menzies D, 1997, AM J RESP CRIT CARE, V156, P1915, DOI 10.1164/ajrccm.156.6.9704017; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; MENZIES R, 1992, AM REV RESPIR DIS, V145, P621, DOI 10.1164/ajrccm/145.3.621; MENZIES R, 1995, AM J RESP CRIT CARE, V152, P1992, DOI 10.1164/ajrccm.152.6.8520767; MENZIES R, 1992, AM REV RESPIR DIS, V146, P752, DOI 10.1164/ajrccm/146.3.752; MENZIES R, 1994, ANN INTERN MED, V120, P190, DOI 10.7326/0003-4819-120-3-199402010-00003; MORSE DL, 1985, AM REV RESPIR DIS, V132, P516; NARDELL EA, 1993, INFECT CONT HOSP EP, V14, P681; NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302; Nicas M, 1998, J OCCUP ENVIRON MED, V40, P648, DOI 10.1097/00043764-199807000-00011; PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191; RAAD I, 1989, INFECT CONT HOSP EP, V10, P465, DOI 10.1086/645922; Rao VK, 1999, ANN INTERN MED, V130, P404, DOI 10.7326/0003-4819-130-5-199903020-00004; RICHARDS NM, 1979, AM REV RESPIR DIS, V120, P59; RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069; Rivest P, 1998, CAN MED ASSOC J, V158, P605; SCOTT B, 1994, ARCH INTERN MED, V154, P326, DOI 10.1001/archinte.154.3.326; SEPKOWITZ KA, 1994, ANN INTERN MED, V120, P71, DOI 10.7326/0003-4819-120-1-199401010-00012; SEPULVEDA RL, 1990, AM REV RESPIR DIS, V142, P24, DOI 10.1164/ajrccm/142.1.24; SLUTKIN G, 1986, AM REV RESPIR DIS, V134, P1048, DOI 10.1164/arrd.1986.134.5.1048; SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013; STEAD WW, 1987, ANN INTERN MED, V107, P837, DOI 10.7326/0003-4819-107-6-837; THOMPSON NJ, 1979, AM REV RESPIR DIS, V119, P587; VANDENBRANDE P, 1992, CHEST, V101, P447, DOI 10.1378/chest.101.2.447; Wells, 1955, AIRBORNE CONTAGION A; WENGER PN, 1995, LANCET, V345, P235, DOI 10.1016/S0140-6736(95)90228-7; Woeltje KF, 1997, INFECT CONT HOSP EP, V18, P548; 1996, CANADIAN COMMUNICABL, P1	65	133	137	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2000	133	10					779	789		10.7326/0003-4819-133-10-200011210-00010	http://dx.doi.org/10.7326/0003-4819-133-10-200011210-00010			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374AA	11085840				2022-12-01	WOS:000165321200003
J	Jick, H; Kaye, JA; Vasilakis-Scaramozza, C; Jick, SS				Jick, H; Kaye, JA; Vasilakis-Scaramozza, C; Jick, SS			Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISEASE; WOMEN	Objective To compare the risk of idiopathic venous thromboembolism among women taking third generation oral contraceptives (with gestodene or desogestrel) with that among women taking oral contraceptives with levonorgestrel. Design Cohort and case-control analyses derived from the General Practice Research Database. Setting UK general practices,January 1993 to December 1999. Participants Women aged 15-39 taking third generation oral contraceptives or oral contraceptives with levonorgestrel. Main outcome measures Relative incidence (cohort study) and odds ratios (case-control study) as measures of the relative risk of venous thromboembolism. Results The adjusted estimates of relative risk for venous thromboembolism associated with third generation oral contraceptives compared with oral contraceptives with levonorgestrel was 1.9 (95% confidence interval 1.3 to 2.8) in the cohort analysis and 2.3 (1.3 to 3.9) in the case-control study. The estimates for the two types of oral contraceptives were similar before and after the warning issued by the Committee on Safety of Medicines in October 1995. A shift away from the use of third generation oral contraceptives after the scare was more pronounced among younger women (who have a lower risk of venous thromboembolism) than among older women. Fewer cases of venous thromboembolism occurred in 1996 and later than would have been expected if the use of oral contraceptives had remained unchanged. Conclusions These findings are consistent with previously reported studies, which found that compared with oral contraceptives with levonorgestrel, third generation oral contraceptives are associated with around twice the risk of venous thromboembolism.	Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA	Boston University	Jick, H (corresponding author), Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA.	hjick@bu.edu		Jick, Hershel/0000-0003-4270-5992; Jick, Susan/0000-0002-2215-1067; Kaye, James A./0000-0002-9357-4227	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersen BS, 1998, THROMB HAEMOSTASIS, V79, P28, DOI 10.1055/s-0037-1614213; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; Farley TMM, 1999, HUM REPROD UPDATE, V5, P721, DOI 10.1093/humupd/5.6.721; FARLEY TMM, 1995, LANCET, V346, P1582; Farmer RDT, 2000, BRIT J CLIN PHARMACO, V49, P580, DOI 10.1046/j.1365-2125.2000.00198.x; Farmer RDT, 2000, BMJ-BRIT MED J, V321, P477, DOI 10.1136/bmj.321.7259.477; Farmer RDT, 1997, LANCET, V349, P83, DOI 10.1016/S0140-6736(96)07496-X; Herings RMC, 1999, LANCET, V354, P127, DOI 10.1016/S0140-6736(99)01257-X; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; Jick SS, 1998, LANCET, V351, P1404, DOI 10.1016/S0140-6736(05)79443-5; Parkin L, 2000, LANCET, V355, P2133, DOI 10.1016/S0140-6736(00)02382-5; STOLLEY PD, 1975, AM J EPIDEMIOL, V102, P197, DOI 10.1093/oxfordjournals.aje.a112148; Vasilakis C, 1999, LANCET, V354, P1610, DOI 10.1016/S0140-6736(99)04394-9; Vasilakis C, 1999, CONTRACEPTION, V59, P79, DOI 10.1016/S0010-7824(99)00011-6; Walker AM, 1998, CONTRACEPTION, V57, P169, DOI 10.1016/S0010-7824(98)00014-6	17	140	141	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2000	321	7270					1190	1195		10.1136/bmj.321.7270.1190	http://dx.doi.org/10.1136/bmj.321.7270.1190			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374RA	11073511	Green Published			2022-12-01	WOS:000165357100028
J	Lanyon, P; Muir, K; Doherty, S; Doherty, M				Lanyon, P; Muir, K; Doherty, S; Doherty, M			Assessment of a genetic contribution to osteoarthritis of the hip: sibling study	BRITISH MEDICAL JOURNAL			English	Article							1ST NATIONAL-HEALTH; FARMERS; JOINT; WOMEN	Objectives To study the influence of genetics on the development of hip osteoarthritis as determined by structural change on plain radiographs. Design Sibling study. Setting Nottinghamshire, England. Participants 392 index participants with hip osteoarthritis of sufficient severity to warrant total hip replacement, 604 siblings of the index participants, and 1718 participants who had undergone intravenous urography. Main outcome measure Odds ratios for hip osteoarthritis in siblings. Results The age adjusted odds ratios in siblings were 4.9 (95% confidence interval, 3.9 to 6.4) for probable hip osteoarthritis and 6.4 (4.5 to 9.1) for definite hip osteoarthritis. These values were not significantly altered by adjusting for other risk factors. Conclusion Siblings have a high risk of hip osteoarthritis as shown by structural changes on plain radiographs. One explanation is that hip osteoarthritis is under strong genetic influence.	Queens Med Ctr, Clin Immunol Unit, Nottingham NG7 2UH, England; Queens Med Ctr, Dept Epidemiol & Publ Hlth Med, Nottingham NG7 2UH, England; City Hosp Nottingham, Acad Rheumatol, Nottingham NG5 1PB, England	University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Lanyon, P (corresponding author), Queens Med Ctr, Clin Immunol Unit, Nottingham NG7 2UH, England.		Lanyon, Peter/K-8100-2019	Lanyon, Peter/0000-0002-9855-6802; Doherty, Michael/0000-0002-5763-8326				ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chitnavis J, 1997, J BONE JOINT SURG BR, V79B, P660, DOI 10.1302/0301-620X.79B4.7437; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cooper C, 1998, AM J EPIDEMIOL, V147, P516; CROFT P, 1990, AM J EPIDEMIOL, V132, P514, DOI 10.1093/oxfordjournals.aje.a115687; CROFT P, 1992, BRIT MED J, V304, P1269, DOI 10.1136/bmj.304.6837.1269; DANIELSSON L, 1984, CLIN ORTHOP RELAT R, P110; DANIELSSON LARS G., 1964, ACTA ORTHOPAED SCAND, V66, P1; Felson DT, 1996, ANN RHEUM DIS, V55, P668, DOI 10.1136/ard.55.9.668; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1064, DOI 10.1002/1529-0131(199806)41:6<1064::AID-ART13>3.0.CO;2-K; Fox KM, 1996, J RHEUMATOL, V23, P693; GABRIEL SE, 1995, J RHEUMATOL, V22, P23; Hirsch R, 1998, ARTHRITIS RHEUM, V41, P1227, DOI 10.1002/1529-0131(199807)41:7<1227::AID-ART13>3.0.CO;2-N; JORRING K, 1980, ACTA ORTHOP SCAND, V51, P253; LINDBERG H, 1986, CLIN ORTHOP RELAT R, P273; O'Reilly S, 1999, OSTEOARTHR CARTILAGE, V7, P461, DOI 10.1053/joca.1999.0240; OBRIEN TM, 1989, IRISH J MED SCI, V158, P63, DOI 10.1007/BF02942144; ROACH KE, 1994, J RHEUMATOL, V21, P2334; SMITH RW, 1995, ANN RHEUM DIS, V54, P179, DOI 10.1136/ard.54.3.179; Spector TD, 1996, BRIT MED J, V312, P940; Stecher RM, 1941, AM J MED SCI, V201, P801, DOI 10.1097/00000441-194106000-00004; TEPPER S, 1993, AM J EPIDEMIOL, V137, P1081, DOI 10.1093/oxfordjournals.aje.a116611; THELIN A, 1990, AM J IND MED, V18, P339, DOI 10.1002/ajim.4700180316	25	90	91	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 11	2000	321	7270					1179	1183		10.1136/bmj.321.7270.1179	http://dx.doi.org/10.1136/bmj.321.7270.1179			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374RA	11073507	Bronze, Green Published			2022-12-01	WOS:000165357100024
J	Weiss, BP; Kirschvink, JL; Baudenbacher, FJ; Vali, H; Peters, NT; Macdonald, FA; Wikswo, JP				Weiss, BP; Kirschvink, JL; Baudenbacher, FJ; Vali, H; Peters, NT; Macdonald, FA; Wikswo, JP			A low temperature transfer of ALH84001 from Mars to Earth	SCIENCE			English	Article							MARTIAN METEORITE ALH84001; MONOCLINIC PYRRHOTITE FE7S8; NOBLE-GASES; ALLAN-HILLS-84001; MAGNETIZATION; PLANETS; SEARCH; EJECTA; ORIGIN; LIFE	The ejection of material from Mars is thought to be caused by Large impacts that would heat much of the ejecta to high temperatures. Images of the magnetic field of martian meteorite ALH84001 reveal a spatially heterogeneous pattern of magnetization associated with fractures and rock fragments. Heating the meteorite to 40 degreesC reduces the intensity of some magnetic features, indicating that the interior of the rock has not been above this temperature since before its ejection from the surface of Mars. Because this temperature cannot sterilize most bacteria or eukarya, these data support the hypothesis that meteorites could transfer Life between planets in the solar system.	CALTECH, Div Geol & Planetary Sci 17025, Pasadena, CA 91125 USA; Vanderbilt Univ, Dept Phys & Astron, Stevenson Ctr 6301, Nashville, TN 37235 USA; McGill Univ, Ctr Electron Microscopy, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ H3A 2B2, Canada	California Institute of Technology; Vanderbilt University; McGill University; McGill University	Weiss, BP (corresponding author), CALTECH, Div Geol & Planetary Sci 17025, Pasadena, CA 91125 USA.	bweiss@gps.caltech.edu	Vali, Hojatollah/F-3511-2012	Vali, Hojatollah/0000-0003-3464-9943				Bada JL, 1998, SCIENCE, V279, P362, DOI 10.1126/science.279.5349.362; BAUDENBACHER FJ, 1999, B AM PHYS SOC, V44, P702; BAUDENBACHER FJ, 2000, B AM PHYS SOC, V45, P651; BINA M, 1994, PHYS EARTH PLANET IN, V85, P83, DOI 10.1016/0031-9201(94)90009-4; Bogard DD, 1999, METEORIT PLANET SCI, V34, P451, DOI 10.1111/j.1945-5100.1999.tb01353.x; Borg LE, 1999, SCIENCE, V286, P90, DOI 10.1126/science.286.5437.90; BREARLEY AJ, 2000, LUNAR PLANET SCI, V31; BRONSHTEN VA, 1983, PHYSICS METEORIC PHE; Collinson DW, 1997, METEORIT PLANET SCI, V32, P803, DOI 10.1111/j.1945-5100.1997.tb01571.x; DiGregorio B.E, 1997, MARS LIVING PLANET; Dunlop D., 1997, ROCK MAGNETISM FUNDA; Fuller M., 1987, GEOMAGN AERON, V2, P307; Gilmour JD, 1998, GEOCHIM COSMOCHIM AC, V62, P2555, DOI 10.1016/S0016-7037(98)00165-3; Gladman B, 1997, ICARUS, V130, P228, DOI 10.1006/icar.1997.5828; Gladman BJ, 1996, SCIENCE, V271, P1387, DOI 10.1126/science.271.5254.1387; Gladman BJ, 1996, SCIENCE, V274, P161; Goswami JN, 1997, METEORIT PLANET SCI, V32, P91, DOI 10.1111/j.1945-5100.1997.tb01244.x; GRATZ AJ, 1993, NATURE, V363, P522, DOI 10.1038/363522a0; HORNECK G, 1994, ADV SPACE RES, V14, P41, DOI 10.1016/0273-1177(94)90448-0; Kirschvink JL, 1997, SCIENCE, V275, P1629, DOI 10.1126/science.275.5306.1629; Kirtley JR, 1999, ANNU REV MATER SCI, V29, P117, DOI 10.1146/annurev.matsci.29.1.117; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; MELOSH HJ, 1988, NATURE, V332, P687, DOI 10.1038/332687a0; MELOSH HJ, 1993, NATURE, V363, P498, DOI 10.1038/363498a0; MELOSH HJ, 1986, IMPACT CRATERING GEO; MENYEH A, 1995, PHYS EARTH PLANET IN, V89, P51, DOI 10.1016/0031-9201(94)02999-R; Menyeh A, 1996, J GEOPHYS RES-SOL EA, V101, P25045, DOI 10.1029/96JB01188; NYQUIST LE, 1995, LUNAR PLANET SCI, V26; PULLAIAH G, 1975, EARTH PLANET SC LETT, V28, P133, DOI 10.1016/0012-821X(75)90221-6; Shearer CK, 1999, METEORIT PLANET SCI, V34, P331, DOI 10.1111/j.1945-5100.1999.tb01343.x; Sugiura N, 2000, METEORIT PLANET SCI, V35, P373, DOI 10.1111/j.1945-5100.2000.tb01783.x; SWINDLE TD, 1995, GEOCHIM COSMOCHIM AC, V59, P793, DOI 10.1016/0016-7037(94)00359-T; THOMAS IM, 1992, GEOPHYS RES LETT, V19, P2139, DOI 10.1029/92GL02322; THOMASKEPRTA KL, IN PRESS GEOCHIM COS; Treiman AH, 1998, METEORIT PLANET SCI, V33, P753, DOI 10.1111/j.1945-5100.1998.tb01681.x; TREIMAN AH, 2000, LUNAR PLANET SCI, V31; Wikswo JP, 1996, NATO ADV SCI I E-APP, V329, P307; ZAPLETAL K, 1992, PHYS EARTH PLANET IN, V70, P302, DOI 10.1016/0031-9201(92)90196-3	38	168	173	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					791	795		10.1126/science.290.5492.791	http://dx.doi.org/10.1126/science.290.5492.791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052940				2022-12-01	WOS:000090067600045
J	Robinson, D; Smith, AMJ; Johnston, GD				Robinson, D; Smith, AMJ; Johnston, GD			Severity of overdose after restriction of paracetamol availability: retrospective study	BRITISH MEDICAL JOURNAL			English	Article									Queens Univ Belfast, Dept Therapeut & Pharmacol, Belfast BT9 7BL, Antrim, North Ireland; Royal Victoria Hosp, Reg Med & Poisons Informat Unit, Belfast BT12 6BA, Antrim, North Ireland	Queens University Belfast	Johnston, GD (corresponding author), Queens Univ Belfast, Dept Therapeut & Pharmacol, Whitla Med Bldg, Belfast BT9 7BL, Antrim, North Ireland.							Fagan E, 1996, BRIT MED J, V313, P1417, DOI 10.1136/bmj.313.7070.1417; Prince MI, 2000, LANCET, V355, P2047, DOI 10.1016/S0140-6736(00)02354-0; Routledge P, 1998, BRIT MED J, V317, P1609; *SECR STAT HLTH, 1999, SAV LIV OUR HLTH NAT; Turvill JL, 2000, LANCET, V355, P2048, DOI 10.1016/S0140-6736(00)02355-2	5	33	34	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					926	927		10.1136/bmj.321.7266.926	http://dx.doi.org/10.1136/bmj.321.7266.926			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030678	Bronze, Green Published			2022-12-01	WOS:000089975100020
J	Smaglik, P; Abbott, A				Smaglik, P; Abbott, A			Project offers free mouse sequence	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					663	664		10.1038/35037772	http://dx.doi.org/10.1038/35037772			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048689	Bronze			2022-12-01	WOS:000089773900007
J	[Anonymous]				[Anonymous]			In defence of animal research	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					659	659						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048683				2022-12-01	WOS:000089773900001
J	Verity, CM; Nicoll, A; Will, RG; Devereux, G; Stellitano, L				Verity, CM; Nicoll, A; Will, RG; Devereux, G; Stellitano, L			Variant Creutzfeldt-Jakob disease in UK children: a national surveillance study	LANCET			English	Article							SPONGIFORM ENCEPHALOPATHY	Background Variant Creutzfeldt-Jakob Disease (vCJD) was first reported in 1996; the youngest patient developed first reported in 1996; the youngest patient developed symptoms at 16 years of age. We have done 3 years of prospective active surveillance for progressive intellectual and neurological deterioration (PIND) in UK children, and have searched for vCJD among the children who were reported. Methods Since May, 1997, there has been active surveillance for patients younger than 16 years old with FIND by means of a monthly card sent to all UK consultant paediatricians by the British Paediatric Surveillance Unit. Clinical details of cases of FIND are obtained from reporting paediatricians by telephone interview or site visit, and an expert group of paediatric neurologists then classifies the cases. Findings After 3 years, 885 patients with suspected FIND have been reported. Among them were two fatal cases of definite vCJD and one case, of probable vCJD; all were reported in 1999. One girl was age 12 years at onset-the youngest ever case of vCJD. No other children with the clinical features of vCJD were identified. The expert group has discussed 655 cases, of which 360 have a confirmed underlying cause, being categorised into 88 known neurodegenerative diseases. Interpretation That this prospective active surveillance in the UK has found few children with suspected vCJD is relatively reassuring, However, 3 years is a short time to survey a disease with an unknown incubation period. Since one probable and two definite cases of vCJD were reported to the study in 1999, there is concern that more childhood cases may appear.	Addenbrookes Hosp, Child Dev Ctr, PIND Surveillance Grp, Cambridge CB2 2QQ, England; PHLS Communicable Dis Surveillance Ctr, London, England; Western Gen Hosp, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh	Verity, CM (corresponding author), Addenbrookes Hosp, Child Dev Ctr, PIND Surveillance Grp, Box 107, Cambridge CB2 2QQ, England.							Gore SM, 1996, BRIT MED J, V312, P791, DOI 10.1136/bmj.312.7034.791; Hall SM, 1998, CHILD CARE HLTH DEV, V24, P129; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Ironside JW, 2000, LANCET, V355, P1693, DOI 10.1016/S0140-6736(00)02243-1; *NAT CREUTZF JAK D, 1999, 8 NAT CREUTZF JAK DI; *ROYAL COLL PAED C, 1999, BRIT PAED SURV UN AN; *TRAG VAR CREUTZF, 1999, LANCET, V353, P939; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; WILESMITH JW, 1988, VET REC, V123, P638; Will RG, 2000, ANN NEUROL, V47, P575; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Will RG, 1996, LANCET, V348, P955, DOI 10.1016/S0140-6736(96)24040-1; Will RG, 1999, LANCET, V353, P979, DOI 10.1016/S0140-6736(99)01160-5; Zeidler M, 2000, LANCET, V355, P1412, DOI 10.1016/S0140-6736(00)02140-1	14	40	41	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2000	356	9237					1224	1227		10.1016/S0140-6736(00)02785-9	http://dx.doi.org/10.1016/S0140-6736(00)02785-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	361LQ	11072940				2022-12-01	WOS:000089724900011
J	Fata, JE; Kong, YY; Li, J; Sasaki, T; Irie-Sasaki, J; Moorehead, RA; Elliott, R; Scully, S; Voura, EB; Lacey, DL; Boyle, WJ; Khokha, R; Penninger, JM				Fata, JE; Kong, YY; Li, J; Sasaki, T; Irie-Sasaki, J; Moorehead, RA; Elliott, R; Scully, S; Voura, EB; Lacey, DL; Boyle, WJ; Khokha, R; Penninger, JM			The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development	CELL			English	Article							T-CELLS; RECEPTOR; MICE; PROLACTIN; PREGNANCY; LACTATION; PROTEIN; MOUSE	Osteoprotegerin-ligand (OPGL) is a key osteoclast differentiation/activation factor essential for bone remodeling. We report that mice lacking OPGL or its receptor RANK fail to form lobulo-alveolar mammary structures during pregnancy, resulting in death of newborns. Transplantation and OPGL-rescue experiments in opgl(-/-) and rank(-/-) pregnant females showed that OPGL acts directly on RANK-expressing mammary epithelial cells. The effects of OPGL are autonomous to epithelial cells. The mammary gland defect in female opgl(-/-) mice is characterized by enhanced apoptosis and failures in proliferation and PKB activation in lobulo-alveolar buds that can be reversed by recombinant OPGL treatment. These data provide a novel paradigm in mammary gland development and an evolutionary rationale for hormonal regulation and gender bias of osteoporosis in females.	Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Ontario Canc Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Amgen Inc, Dept Cell Biol, Thousand Oaks, CA 91320 USA; Amgen Inc, Dept Pathol, Thousand Oaks, CA 91320 USA	Pohang University of Science & Technology (POSTECH); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Amgen; Amgen	Kong, YY (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea.		Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Sasaki, Takehiko/0000-0003-1837-3748; , Roger/0000-0001-9539-6295				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Brisken C, 2000, GENE DEV, V14, P650; Couse JF, 1998, J MOL MED-JMM, V76, P497, DOI 10.1007/s001090050244; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Dunbar ME, 1999, J MAMMARY GLAND BIOL, V4, P21, DOI 10.1023/A:1018700502518; Fata JE, 1999, DEV BIOL, V211, P238, DOI 10.1006/dbio.1999.9313; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Honore P, 2000, NAT MED, V6, P521, DOI 10.1038/74999; Horseman ND, 1999, J MAMMARY GLAND BIOL, V4, P79, DOI 10.1023/A:1018708704335; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Kurihara N, 2000, J CLIN INVEST, V105, P607, DOI 10.1172/JCI8489; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Neville MC, 1999, CLIN PERINATOL, V26, P251, DOI 10.1016/S0095-5108(18)30053-8; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; POLLARD JW, 1994, P NATL ACAD SCI USA, V91, P9312, DOI 10.1073/pnas.91.20.9312; Robinson GW, 1999, J MAMMARY GLAND BIOL, V4, P9, DOI 10.1023/A:1018748418447; Robinson GW, 2000, GENE DEV, V14, P889; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Ross FP, 2000, J CLIN INVEST, V105, P555, DOI 10.1172/JCI9557; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	32	565	595	0	24	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					41	50		10.1016/S0092-8674(00)00103-3	http://dx.doi.org/10.1016/S0092-8674(00)00103-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051546	Bronze			2022-12-01	WOS:000089636400007
J	Pinson, KI; Brennan, J; Monkley, S; Avery, BJ; Skarnes, WC				Pinson, KI; Brennan, J; Monkley, S; Avery, BJ; Skarnes, WC			An LDL-receptor-related protein mediates Wnt signalling in mice	NATURE			English	Article							INT-1 PROTOONCOGENE; MOUSE; DISRUPTION; FAMILY; EMBRYO	Wnt genes comprise a large family of secreted polypeptides that are expressed in spatially and tissue-restricted patterns during vertebrate embryonic development(1). Mutational analysis in mice has shown the importance of Wnts in controlling diverse developmental processes such as patterning of the body axis, central nervous system and limbs, and the regulation of inductive events during organogenesis(2). Although many components of the Wnt signalling pathway have been identified, little is known about how Wnts and their cognate Frizzled receptors signal to downstream effector molecules. Here we present evidence that a new member of the low-density lipoprotein (LDL)-receptor-related protein family, LRP6 (ref. 3), is critical for Wnt signalling in mice. Embryos homozygous for an insertion mutation in the LRP6 gene exhibit developmental defects that are a striking composite of those caused by mutations in individual Wnt genes. Furthermore, we show a genetic enhancement of a Wnt mutant phenotype in mice lacking one functional copy of LRP6. Together, our results support a broad role for LRP6 in the transduction of several Wnt signals in mammals.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Skarnes, WC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	skarnes@socrates.berkeley.edu		Monkley, Susan/0000-0001-9174-6278; Brennan, Jane/0000-0003-3222-5485				BALLYCUIF L, 1995, MECH DEVELOP, V53, P23, DOI 10.1016/0925-4773(95)00421-1; Brennan J, 1999, METH MOL B, V97, P123, DOI 10.1385/1-59259-270-8:123; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; Brown SP, 1998, J AGING PHYS ACTIV, V6, P248, DOI 10.1123/japa.6.3.248; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; HOGAN B, 1994, MANIPULATING MOUSE E, P260; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Uusitalo M, 1999, EXP CELL RES, V253, P336, DOI 10.1006/excr.1999.4710; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Willnow TE, 1999, J MOL MED-JMM, V77, P306, DOI 10.1007/s001090050356; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; YANG Y, CELL, V80, P939; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502	24	854	906	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					535	538		10.1038/35035124	http://dx.doi.org/10.1038/35035124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029008				2022-12-01	WOS:000089727400056
J	Grosberg, RK; Hart, MW				Grosberg, RK; Hart, MW			Mate selection and the evolution of highly polymorphic self/nonself recognition genes	SCIENCE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; ASCIDIAN BOTRYLLUS-SCHLOSSERI; HYDRACTINIA-SYMBIOLONGICARPUS; CLONAL INVERTEBRATES; MATING PREFERENCES; NO EVIDENCE; ALLORECOGNITION; SYSTEM; GERM; HLA	Multicellular organisms use the products of highly polymorphic genes to distinguish self from conspecific nonself cells or tissues. These allorecognition polymorphisms may regulate somatic interactions between hosts and pathogens or between competitors (to avoid various forms of parasitism), as well as reproductive interactions between mates or between gametes (to avoid inbreeding). In both cases, rare alleles may be advantageous, but it remains unclear which mechanism maintains the genetic polymorphism for specificity in self/nonself recognition. Contrary to earlier reports, we show that mate selection cannot be a strong force maintaining allorecognition polymorphism in two colonial marine invertebrates. Instead, the regulation of intraspecific competitive interactions appears to promote the evolution of polymorphisms in these species.	Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada	University of California System; University of California Davis; University of California System; University of California Davis; Dalhousie University	Grosberg, RK (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, 1 Shields Dr, Davis, CA 95616 USA.	rkgrosberg@ucdavis.edu						Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; BROWN JL, 1994, AM NAT, V143, P435, DOI 10.1086/285612; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; Buss L. W., 1987, EVOLUTION INDIVIDUAL; BUSS LW, 1984, BIOL BULL, V167, P139, DOI 10.2307/1541343; BUSS LW, 1985, DEV COMP IMMUNOL, V9, P191, DOI 10.1016/0145-305X(85)90110-7; BUSS LW, 1990, TRENDS ECOL EVOL, V5, P352, DOI 10.1016/0169-5347(90)90093-S; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Cohen CS, 1998, EVOLUTION, V52, P746, DOI 10.1111/j.1558-5646.1998.tb03699.x; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; GRAFEN A, 1990, ANIM BEHAV, V39, P42, DOI 10.1016/S0003-3472(05)80724-9; Grosberg RK, 1996, EVOLUTION, V50, P2221, DOI 10.1111/j.1558-5646.1996.tb03612.x; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; GROSBERG RK, 1991, EVOLUTION, V45, P130, DOI 10.1111/j.1558-5646.1991.tb05272.x; GROSBERG RK, 1987, INVERTEBRATE HISTORE, P157; Hedrick PW, 1997, AM J HUM GENET, V61, P505, DOI 10.1086/515519; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; MATTON DP, 1994, P NATL ACAD SCI USA, V91, P1992, DOI 10.1073/pnas.91.6.1992; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Mokady O, 1996, GENETICS, V143, P823; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Oka H., 1957, Proceedings of the Japan Academy, V33, P657; Oka H., 1970, PROFILES JAPANESE SC, P195; Palumbi SR, 1998, ENDLESS FORMS, P271; Paterson S, 1997, P ROY SOC B-BIOL SCI, V264, P1813, DOI 10.1098/rspb.1997.0250; Penn D, 1998, P ROY SOC B-BIOL SCI, V265, P1299, DOI 10.1098/rspb.1998.0433; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; RINKEVICH B, 1995, P ROY SOC B-BIOL SCI, V259, P319, DOI 10.1098/rspb.1995.0047; SABBADIN A, 1979, J EXP ZOOL, V207, P289, DOI 10.1002/jez.1402070212; SABBADIN A, 1989, Acta Embryologiae et Morphologiae Experimentalis New Series, V10, P205; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087	36	99	100	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2111	2114		10.1126/science.289.5487.2111	http://dx.doi.org/10.1126/science.289.5487.2111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000110				2022-12-01	WOS:000089430900040
J	Malkowski, MG; Ginell, SL; Smith, WL; Garavito, RM				Malkowski, MG; Ginell, SL; Smith, WL; Garavito, RM			The productive conformation of arachidonic acid bound to prostaglandin synthase	SCIENCE			English	Article							CYCLOOXYGENASE ACTIVE-SITE; ENDOPEROXIDE-H SYNTHASE-1; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HUMAN COLON-CANCER; CRYSTAL-STRUCTURE; H-2 SYNTHASE; ASPIRIN; INHIBITION; BINDING; COX-2	Prostaglandin H synthase-1 and -2 (PGHS-1 and -2) catalyze the committed step in prostaglandin synthesis and are targets for nonsteroidal anti-inflammatory drugs (NSAIDs) Like aspirin. We have determined the structure of PGHS-1 at 3 angstrom resolution with arachidonic acid (AA) bound in a chemically productive conformation. The fatty acid adopts an extended L-shaped conformation that positions the 13proS hydrogen of AA for abstraction by tyrosine-385, the Likely radical donor. A space also exists for oxygen addition on the antarafacial surface of the carbon in the 11-position (C-11). While this conformation allows endoperoxide formation between C-11 and C-9, it also implies that a subsequent conformational rearrangement must occur to allow formation of the C-8/C-12 bond and to position C-15 for attack by a second molecule of oxygen.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA	Michigan State University; United States Department of Energy (DOE); Argonne National Laboratory	Garavito, RM (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	garavito@magaera.bch.msu.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Malkowski, Michael/0000-0002-1203-7463	NHLBI NIH HHS [F32 HL10170-01, R01 HL56773] Funding Source: Medline; NIGMS NIH HHS [P01 GM57323] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056773, F32HL010170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057323] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeWitt DL, 1999, MOL PHARMACOL, V55, P625; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Garavito RM, 1996, J BIOENERG BIOMEMBR, V28, P13, DOI 10.1007/BF02150674; Gierse JK, 1996, J BIOL CHEM, V271, P15810, DOI 10.1074/jbc.271.26.15810; HSI LC, 1995, BIOCHEM BIOPH RES CO, V207, P652, DOI 10.1006/bbrc.1995.1237; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; KARGMAN SL, 1995, CANCER RES, V55, P2556; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Levy GN, 1997, FASEB J, V11, P234, DOI 10.1096/fasebj.11.4.9068612; Loll PJ, 1996, BIOCHEMISTRY-US, V35, P7330, DOI 10.1021/bi952776w; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Malkowski MG, 2000, ARCH BIOCHEM BIOPHYS, V380, P39, DOI 10.1006/abbi.2000.1906; Marnett LJ, 1998, CURR OPIN CHEM BIOL, V2, P482, DOI 10.1016/S1367-5931(98)80124-5; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; McGeer PL, 1999, J LEUKOCYTE BIOL, V65, P409, DOI 10.1002/jlb.65.4.409; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; PATRONO C, 1994, NEW ENGL J MED, V330, P1287; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Riendeau D, 1997, BRIT J PHARMACOL, V121, P105, DOI 10.1038/sj.bjp.0701076; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; SMITH P, 1995, INT J ENVIRON HEAL R, V5, P5; SMITH WL, 1992, BIOCHEMISTRY-US, V31, P3, DOI 10.1021/bi00116a001; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; SMITH WW, UNPUB; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; Zhang Y, 1997, J PHARMACOL EXP THER, V283, P1069	40	242	245	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2000	289	5486					1933	1937		10.1126/science.289.5486.1933	http://dx.doi.org/10.1126/science.289.5486.1933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988074				2022-12-01	WOS:000089355800046
J	Sinal, CJ; Tohkin, M; Miyata, M; Ward, JM; Lambert, G; Gonzalez, FJ				Sinal, CJ; Tohkin, M; Miyata, M; Ward, JM; Lambert, G; Gonzalez, FJ			Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis	CELL			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; MICROSOMAL EPOXIDE HYDROLASE; BINDING PROTEIN GENE; RETINOID-X RECEPTOR; SALT EXPORT PUMP; CHOLESTEROL 7-ALPHA-HYDROXYLASE; FUNCTIONAL EXPRESSION; ESTROGEN-RECEPTOR; RESPONSE PATHWAY; HORMONE-RECEPTOR	Mice lacking the nuclear bile acid receptor FXR/BAR developed normally and were outwardly identical to wild-type littermates. RXR/BAR null mice were distinguished from wild-type mice by elevated serum bile acid, cholesterol, and triglycerides, increased hepatic cholesterol and triglycerides, and a proatherogenic serum lipoprotein profile. FXR/BAR null mice also had reduced bile acid pools and reduced fecal bile acid excretion due to decreased expression of the major hepatic canalicular bile acid transport protein. Bile acid repression and induction of cholesterol 7 alpha-hydroxylase and the ileal bile acid binding protein, respectively, did not occur in FXR/BAR null mice, establishing the regulatory role of FXR/BAR for the expression of these genes in vivo. These data demonstrate that FXR/BAR is critical for bile acid and lipid homeostasis by virtue of its role as an intracellular bile acid sensor.	NIH, Lab Metab, Div Basic Sci, Bethesda, MD 20892 USA; NCI, Vet & Tumor Pathol Sect, Off Lab Anim Sci, NIH, Frederick, MD 21702 USA; NHLBI, Metab Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gonzalez, FJ (corresponding author), NIH, Lab Metab, Div Basic Sci, Bldg 10, Bethesda, MD 20892 USA.			Sinal, Christopher/0000-0001-8301-3349; Lambert, Gilles/0000-0001-5632-0685	NATIONAL CANCER INSTITUTE [Z01BC005708, ZIABC005708] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberti S, 2000, GENE, V243, P93, DOI 10.1016/S0378-1119(99)00555-7; Aldini R, 1996, GASTROENTEROLOGY, V110, P459, DOI 10.1053/gast.1996.v110.pm8566593; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Bahar RJ, 1999, GASTROENTEROL CLIN N, V28, P27, DOI 10.1016/S0889-8553(05)70042-X; Balistreri WF, 1999, GASTROENTEROL CLIN N, V28, P145, DOI 10.1016/S0889-8553(05)70048-0; Berard AM, 1997, NAT MED, V3, P744, DOI 10.1038/nm0797-744; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Cattori V, 1999, BBA-GENE STRUCT EXPR, V1445, P154, DOI 10.1016/S0167-4781(99)00029-9; COLEMAN R, 1987, BIOCHEM J, V244, P249, DOI 10.1042/bj2440249; CROSSMAN MW, 1994, J CELL BIOL, V126, P1547, DOI 10.1083/jcb.126.6.1547; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gafvels M, 1999, GENOMICS, V56, P184, DOI 10.1006/geno.1998.5606; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; GOODWIN B, 2000, IN PRESS MOL CELL; Green RM, 2000, GENE, V241, P117, DOI 10.1016/S0378-1119(99)00460-6; Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749; GROS P, 1988, MOL CELL BIOL, V8, P2770, DOI 10.1128/MCB.8.7.2770; GUO YD, 1993, P NATL ACAD SCI USA, V90, P8668, DOI 10.1073/pnas.90.18.8668; Hagenbuch B, 2000, BIOCHEM J, V345, P115, DOI 10.1042/0264-6021:3450115; HARDIKAR W, 1995, J BIOL CHEM, V270, P20841, DOI 10.1074/jbc.270.35.20841; Hylemon P B, 1994, Prog Liver Dis, V12, P99; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Jansen PLM, 1999, GASTROENTEROLOGY, V117, P1370, DOI 10.1016/S0016-5085(99)70287-8; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; Johansson L, 1999, J BIOL CHEM, V274, P345, DOI 10.1074/jbc.274.1.345; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lambert G, 2000, J LIPID RES, V41, P667; Lambert G, 1999, J LIPID RES, V40, P1294; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; LU TT, 2000, IN PRESS MOL CELL; LUND E, 1993, BIOCHIM BIOPHYS ACTA, V1166, P177, DOI 10.1016/0005-2760(93)90094-P; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Miyata M, 1999, J BIOL CHEM, V274, P23963, DOI 10.1074/jbc.274.34.23963; NATHANSON MH, 1991, HEPATOLOGY, V14, P551, DOI 10.1016/0270-9139(91)90198-5; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Osuga J, 1998, J CLIN INVEST, V102, P386, DOI 10.1172/JCI1124; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Rao YP, 1999, J STEROID BIOCHEM, V70, P1, DOI 10.1016/S0960-0760(99)00099-0; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Roberts LR, 1997, GASTROENTEROLOGY, V113, P1714, DOI 10.1053/gast.1997.v113.pm9352877; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Saeki T, 1999, J BIOCHEM-TOKYO, V125, P846, DOI 10.1093/oxfordjournals.jbchem.a022358; Schroeder F, 1998, CHEM PHYS LIPIDS, V92, P1, DOI 10.1016/S0009-3084(98)00003-6; Schwarz M, 1997, J BIOL CHEM, V272, P23995, DOI 10.1074/jbc.272.38.23995; Seel WG, 1998, MOL ENDOCRINOL, V12, P1551, DOI 10.1210/mend.12.10.0184; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Seol W, 1997, MOL CELL BIOL, V17, P7126, DOI 10.1128/MCB.17.12.7126; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; SHAYIQ RM, 1992, J BIOL CHEM, V267, P2421; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; STAPLETON G, 1995, J BIOL CHEM, V270, P29739, DOI 10.1074/jbc.270.50.29739; Strautnieks SS, 1997, AM J HUM GENET, V61, P630, DOI 10.1086/515501; TZUNG KW, 1994, GENOMICS, V21, P244, DOI 10.1006/geno.1994.1250; Vlahcevic ZR, 1999, GASTROENTEROL CLIN N, V28, P1, DOI 10.1016/S0889-8553(05)70041-8; vonDippe P, 1996, J BIOL CHEM, V271, P18176, DOI 10.1074/jbc.271.30.18176; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Yang YZ, 1996, J BIOL CHEM, V271, P28235, DOI 10.1074/jbc.271.45.28235; Zavacki AM, 1997, P NATL ACAD SCI USA, V94, P7909, DOI 10.1073/pnas.94.15.7909; ZHANG XK, 1994, MOL CELL BIOL, V14, P4311, DOI 10.1128/MCB.14.6.4311	74	1323	1387	12	130	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 15	2000	102	6					731	744		10.1016/S0092-8674(00)00062-3	http://dx.doi.org/10.1016/S0092-8674(00)00062-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030617	Bronze			2022-12-01	WOS:000089395200005
J	Bains, S; Norris, RD; Corfield, RM; Faul, KL				Bains, S; Norris, RD; Corfield, RM; Faul, KL			Termination of global warmth at the Palaeocene/Eocene boundary through productivity feedback	NATURE			English	Article							PALEOCENE-EOCENE BOUNDARY; CENTRAL EQUATORIAL PACIFIC; OCEANIC METHANE HYDRATE; LATEST PALEOCENE; MARINE BARITE; EVOLUTIONARY CONSEQUENCES; THERMAL MAXIMUM; CLIMATE; END; DISSOCIATION	The onset of the Palaeocene/Eocene thermal maximum (about 55 Myr ago) was marked by global surface temperatures warming by 5-7 degrees C over approximately 30,000 yr (ref. 1), probably because of enhanced mantle outgassing(2,3) and the pulsed release of similar to 1,500 gigatonnes of methane carbon from decomposing gas-hydrate reservoirs(4-7). The aftermath of this rapid, intense and global warming event may be the best example in the geological record of the response of the Earth to high atmospheric carbon dioxide concentrations and high temperatures. This response has been suggested to include an intensified flux of organic carbon from the ocean surface to the deep ocean and its subsequent burial through biogeochemical feedback mechanisms(8). Here we present firm evidence for this view from two ocean drilling cores, which record the largest accumulation rates of biogenic barium-indicative of export palaeoproductivity-at times of maximum global temperatures and peak excursion values of delta(13)C. The unusually rapid return of delta(13)C to values similar to those before the methane release(7) and the apparent coupling of the accumulation rates of biogenic barium to temperature, suggests that the enhanced deposition of organic matter to the deep sea may have efficiently cooled this greenhouse climate by the rapid removal of excess carbon dioxide from the atmosphere.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02540 USA; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA	University of Oxford; Woods Hole Oceanographic Institution; University of California System; University of California Santa Cruz	Bains, S (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	santo.bains@earth.ox.ac.uk						Bains S, 1999, SCIENCE, V285, P724, DOI 10.1126/science.285.5428.724; Beerling DJ, 2000, GFF, V122, P23, DOI 10.1080/11035890001221023; Bernstein RE, 1998, DEEP-SEA RES PT I, V45, P491, DOI 10.1016/S0967-0637(97)00095-2; Bertram MA, 1997, J MAR RES, V55, P577, DOI 10.1357/0022240973224292; BISHOP JKB, 1988, NATURE, V332, P341, DOI 10.1038/332341a0; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; Budyko M, 1999, GLOBAL PLANET CHANGE, V20, P281, DOI 10.1016/S0921-8181(98)00062-9; CORFIELD RM, 1994, EARTH-SCI REV, V37, P225, DOI 10.1016/0012-8252(94)90030-2; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; DICKENS GR, IN PRESS W N ATLANTI; Dymond J, 1992, PALEOCEANOGRAPHY, V7, P163, DOI 10.1029/92PA00181; ELDHOLM O, 1993, EARTH PLANET SC LETT, V117, P319, DOI 10.1016/0012-821X(93)90087-P; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Kelly DC, 1998, PALAEOGEOGR PALAEOCL, V141, P139, DOI 10.1016/S0031-0182(98)00017-0; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; Kvenvolden KA, 1998, GEOL SOC SPEC PUBL, V137, P9, DOI 10.1144/GSL.SP.1998.137.01.02; Legeleux F, 1996, DEEP-SEA RES PT I, V43, P1857, DOI 10.1016/S0967-0637(96)00086-6; McManus J, 1998, GEOCHIM COSMOCHIM AC, V62, P3453, DOI 10.1016/S0016-7037(98)00248-8; MURRAY RW, 1993, PALEOCEANOGRAPHY, V8, P651, DOI 10.1029/93PA02195; Norris RD, 1999, NATURE, V401, P775, DOI 10.1038/44545; Pak DK, 1992, PALEOCEANOGRAPHY, V7, P405, DOI 10.1029/92PA01234; Paytan A, 1996, EARTH PLANET SC LETT, V142, P439, DOI 10.1016/0012-821X(96)00120-3; PAYTAN A, 1993, NATURE, V366, P445, DOI 10.1038/366445a0; Paytan A, 1996, SCIENCE, V274, P1355, DOI 10.1126/science.274.5291.1355; REA DK, 1990, PALAEOGEOGR PALAEOCL, V79, P117, DOI 10.1016/0031-0182(90)90108-J; ROBERT C, 1994, GEOLOGY, V22, P211, DOI 10.1130/0091-7613(1994)022<0211:ASHEAT>2.3.CO;2; Schmitz B, 1997, TERRA NOVA, V9, P95, DOI 10.1111/j.1365-3121.1997.tb00011.x; Thomas DJ, 1999, PALEOCEANOGRAPHY, V14, P561, DOI 10.1029/1999PA900031; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Zachos JC, 2000, GFF, V122, P188, DOI 10.1080/11035890001221188	32	180	190	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					171	174		10.1038/35025035	http://dx.doi.org/10.1038/35025035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001051				2022-12-01	WOS:000089241000043
J	Crawley, L; Payne, R; Bolden, J; Payne, T; Washington, P; Williams, S				Crawley, L; Payne, R; Bolden, J; Payne, T; Washington, P; Williams, S		Initiative Improve Palliative End	Palliative and end-of-life care in the African American community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE; ADVANCE DIRECTIVES; MEASURING QUALITY; RACIAL VARIATION; PAIN MANAGEMENT; DECISION-MAKING; RACE; ETHNICITY; BLACK; ATTITUDES		Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Balm Gilead End Life Initiat Cooper Green Hosp, Birmingham, AL USA; Harlem Palliat Care Network, New York, NY USA; Univ Texas, MD Anderson Canc Ctr, Dept Pain & Symptom Res, Houston, TX 77030 USA; Tuskegee Univ, Natl Ctr Bioeth Res & Hlth Care, Tuskegee, AL 36088 USA	Stanford University; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tuskegee University	Crawley, L (corresponding author), Stanford Univ, Ctr Biomed Eth, 701 Welch Rd,Bldg A,Suite 1105, Palo Alto, CA 94304 USA.	lcrawley@stanford.edu						Al-Jeilani M, 1987, Acta Neurochir Suppl (Wien), V38, P132; ANGELOU M, 1997, NORTON ANTHOLOGY AFR, P2039; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Blackhall LJ, 1999, SOC SCI MED, V48, P1779, DOI 10.1016/S0277-9536(99)00077-5; Burrs F A, 1995, Hosp J, V10, P15; CARALIS PV, 1993, J CLIN ETHIC, V4, P155; CARLISLE DM, 1995, AM J PUBLIC HEALTH, V85, P352, DOI 10.2105/AJPH.85.3.352; Clayton L A, 1993, J Health Care Poor Underserved, V4, P83; CRAWLEY L, 2000, CTR LIT MED HLTH PRO, V12, P5; CRAWLEY L, 1999, ANN M NAT MED ASS AU; DULA A, 1994, CLIN GERIATR MED, V10, P419, DOI 10.1016/S0749-0690(18)30330-6; DULA A, 1994, CAMB Q HEALTHC ETHIC, V3, P347, DOI 10.1017/S0963180100005168; Fowler FJ, 1999, J PAIN SYMPTOM MANAG, V17, P114, DOI 10.1016/S0885-3924(98)00133-X; Freeman HP, 2000, NEW ENGL J MED, V342, P1045, DOI 10.1056/NEJM200004063421411; Geiger HJ, 1996, NEW ENGL J MED, V335, P815, DOI 10.1056/NEJM199609123351110; GERBNER G, 1981, NEW ENGL J MED, V305, P901, DOI 10.1056/NEJM198110083051530; Gordon A K, 1996, Hosp J, V11, P49, DOI 10.1300/J011v11n01_04; Gordon A K, 1995, Hosp J, V10, P65; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; Hauser JM, 1997, CAMB Q HEALTHC ETHIC, V6, P58, DOI 10.1017/S0963180100007611; Hoffman-Goetz L, 1999, PSYCHO-ONCOL, V8, P36, DOI 10.1002/(SICI)1099-1611(199901/02)8:1<36::AID-PON330>3.0.CO;2-8; HOOKS B, 2000, OTHER SIDE, V36, P43; Horner RD, 1998, CANC TREAT, P99; JOHNSON JW, 1992, TRIALS TRIBULATIONS, P171; Jones MR, 2000, STROKE, V31, P563, DOI 10.1161/01.STR.31.3.563; KAHN KL, 1994, JAMA-J AM MED ASSOC, V271, P1169, DOI 10.1001/jama.271.15.1169; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; KRIEGER N, 1993, AM J PUBLIC HEALTH, V83, P1086, DOI 10.2105/AJPH.83.8.1086; Kumasaka L, 1996, AM J NURS, V96, P45, DOI 10.1097/00000446-199606000-00044; Low JF, 1997, AM J OCCUP THER, V51, P215, DOI 10.5014/ajot.51.3.215; Lynn J, 1997, J AM GERIATR SOC, V45, P526; MARABLE M, 1994, MEDIA STUD J, V8, P11; MBITI JS, 1991, INTRO AFRICAN RELIG, P116; McKinley ED, 1996, J GEN INTERN MED, V11, P651, DOI 10.1007/BF02600155; Mebane EW, 1999, J AM GERIATR SOC, V47, P579, DOI 10.1111/j.1532-5415.1999.tb02573.x; MESSNER SF, 1992, CRIMINOLOGY, V30, P421, DOI 10.1111/j.1745-9125.1992.tb01111.x; Murphy ST, 1996, J LAW MED ETHICS, V24, P108, DOI 10.1111/j.1748-720X.1996.tb01843.x; NHPCO, FACTS FIG HOSP CAR A; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Phillips RS, 1996, J GEN INTERN MED, V11, P387, DOI 10.1007/BF02600183; Reese DJ, 1999, SOC WORK, V44, P549, DOI 10.1093/sw/44.6.549; Rossler D, 1987, Acta Neurochir Suppl (Wien), V38, P127; Signorielli N., 1993, MASS MEDIA IMAGES IM, P37; TODD KH, 1993, JAMA-J AM MED ASSOC, V269, P1537, DOI 10.1001/jama.269.12.1537; Todd KH, 2000, ANN EMERG MED, V35, P11, DOI 10.1016/S0196-0644(00)70099-0; TROPH S, 1999, ST LOUIS J REV, V29, P1; *US DEP HHS, HLTH PEOPL 2010	48	219	219	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2000	284	19					2518	2521		10.1001/jama.284.19.2518	http://dx.doi.org/10.1001/jama.284.19.2518			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	371MY	11074786				2022-12-01	WOS:000165183800029
J	Meisel, A; Snyder, L; Quill, T				Meisel, A; Snyder, L; Quill, T			Seven legal barriers to end-of-life care - Myths, realities, and grains of truth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN-ASSISTED SUICIDE; PALLIATIVE CARE; TERMINAL SEDATION; ADVANCE DIRECTIVES; MALPRACTICE CLAIMS; SLOW EUTHANASIA; DECISION-MAKING; SUPREME-COURT; MANAGEMENT; DIALOGUE	Objective The American College of Physicians-American Society of Internal Medicine (ACP-ASIM) End-of-Life Care Consensus Panel was convened in 1997 to identify clinical, ethical, and policy problems in end-of-life care, to analyze critically the available evidence and guidelines, and to offer consensus recommendations on how to improve care of the dying. Topic selection and content presentation were carefully debated to maximize the project's focus on providing practical clinical and other guidance to clinicians who are not specialists in palliative care. This statement examines current legal myths, realities, and grains of truth in end-of-life care. Participants The Consensus Panel comprises 13 medical and bioethics experts, clinicians, and educators in care at the end of life selected by the Ethics and Human Rights Committee, College leadership, and the Center for Ethics and Professionalism at the ACP-ASIM. Evidence A literature review including a MEDLINE search of articles from 1970-1998 and review of end-of-life care literature and organizational bibliographies was conducted. Unpublished sources were also identified by participants, as was anecdotal clinical experience. Consensus Process The draft statement was debated by panel members over a series of 3 to 4 meetings. For this statement, the initial draft and subsequent revised drafts were discussed in 1998-1999. The statement then underwent external peer review and revision before panel approval and the journal peer review process. Conclusions Legal myths about end-of-life care can undermine good care and ethical medical practice. In addition, at times ethics, clinical judgment, and the law conflict, Patients (or families) and physicians can find themselves considering clinical actions that are ethically appropriate, but raise legal concerns. The 7 major legal myths regarding end-of-life care are: (1) forgoing life-sustaining treatment for patients without decision-making capacity requires evidence that this was the patient's actual wish; (2) withholding or withdrawing of artificial fluids and nutrition from terminally ill or permanently unconscious patients is illegal; (3) risk management personnel must be consulted before life-sustaining medical treatment may be terminated; (4) advance directives must comply with specific forms, are not transferable between states, and govern all future treatment decisions; oral advance directives are unenforceable; (5) if a physician prescribes or administers high doses of medication to relieve pain or other discomfort in a terminally ill patient, resulting in death, he/she will be criminally prosecuted; (6) when a terminally ill patient's suffering is overwhelming despite palliative care, and he/she requests a hastened death, there are no legally permissible options to ease suffering; and (7) the 1997 Supreme Court decisions outlawed physician-assisted suicide. Many legal barriers to end-of-life care are more mythical than real, but sometimes there is a grain of truth. Physicians must know the law of the state in which they practice.	Amer Coll Physicians, Ctr Eth & Professionalism, Amer Soc Internal Med, Philadelphia, PA 19106 USA; Univ Pittsburgh, Sch Law, Ctr Med Eth, Pittsburgh, PA 15260 USA; Genesee Hosp, Dept Med, Rochester, NY 14607 USA	American College of Physicians; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Snyder, L (corresponding author), Amer Coll Physicians, Ctr Eth & Professionalism, Amer Soc Internal Med, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	lsnyder@mail.acponline.org						Alpers A, 1998, J LAW MED ETHICS, V26, P308, DOI 10.1111/j.1748-720X.1998.tb01678.x; Asch DA, 1996, NEW ENGL J MED, V334, P1374, DOI 10.1056/NEJM199605233342106; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; Billings JA, 1996, J PALLIAT CARE, V12, P21, DOI 10.1177/082585979601200404; BREITBART W, 1997, OXFORD TXB PALLIATIV, P437; Burt RA, 1997, NEW ENGL J MED, V337, P1234, DOI 10.1056/NEJM199710233371712; Duffy FD, 1998, ANN INTERN MED, V128, P139, DOI 10.7326/0003-4819-128-2-199801150-00011; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Field MJ, 1997, APPROACHING DEATH IM; Garcia J. L. A., 1995, ENCY BIOETHICS, P636; Goodman MD, 1998, CRIT CARE MED, V26, P701, DOI 10.1097/00003246-199804000-00018; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; Jacobson JA, 1997, J CLIN ETHIC, V8, P359; Johnson SH, 1996, J LAW MED ETHICS, V24, P319, DOI 10.1111/j.1748-720X.1996.tb01874.x; KAPP MB, 1996, J HLTH CARE RISK MAN, V16, P411; Karlawish JHT, 1999, ANN INTERN MED, V130, P835, DOI 10.7326/0003-4819-130-10-199905180-00018; Kitchens LW, 1998, ANN INTERN MED, V128, P576, DOI 10.7326/0003-4819-128-7-199804010-00012; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; Marco CA, 1997, ACAD EMERG MED, V4, P898, DOI 10.1111/j.1553-2712.1997.tb03816.x; Meisel A, 1995, AM J LAW MED, V21, P335; MEISEL A, 1991, ARCH INTERN MED, V151, P1497, DOI 10.1001/archinte.151.8.1497; MEISEL A, 1995, RIGHT DIE; MEISEL A, 1999, U MD J HLTH CARE LAW, V2, P201; Meisel Alan, 1992, Kennedy Institute of Ethics Journal, V2, P309; Miller FG, 2000, ANN INTERN MED, V132, P470, DOI 10.7326/0003-4819-132-6-200003210-00008; Mount B, 1996, J PALLIAT CARE, V12, P31, DOI 10.1177/082585979601200405; Orentlicher D, 1997, NEW ENGL J MED, V337, P1236, DOI 10.1056/NEJM199710233371713; Orentlicher David, 1994, MD Law Rev, V53, P1255; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Rousseau P, 1996, ARCH INTERN MED, V156, P1785, DOI 10.1001/archinte.156.16.1785; Shapiro RS, 1996, J LAW MED ETHICS, V24, P360, DOI 10.1111/j.1748-720X.1996.tb01879.x; SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14, DOI 10.2105/AJPH.83.1.14; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003	37	116	117	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2000	284	19					2495	2501		10.1001/jama.284.19.2495	http://dx.doi.org/10.1001/jama.284.19.2495			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	371MY	11074780				2022-12-01	WOS:000165183800024
J	Mas, P; Devlin, PF; Panda, S; Kay, SA				Mas, P; Devlin, PF; Panda, S; Kay, SA			Functional interaction of phytochrome B and cryptochrome 2	NATURE			English	Article							LIGHT RECEPTOR CRYPTOCHROME-2; SIGNAL-TRANSDUCTION; ARABIDOPSIS; PROTEIN; PHOTORECEPTORS; TRANSLOCATION; NUCLEUS	Light is a crucial environmental signal that controls many photomorphogenic and circadian responses in plants(1). Perception and transduction of light is achieved by at least two principal groups of photoreceptors, phytochromes and cryptochromes(2,3). Phytochromes are red/far-red light-absorbing receptors encoded by a gene family of five members (phyA to phyE)(2,4) in Arabidopsis. Cryptochrome 1 (cry1), cryptochrome 2 (cry2) and phototropin are the blue/ultraviolet-A light receptors that have been characterized in Arabidopsis(5). Previous studies showed that modulation of many physiological responses in plants is achieved by genetic interactions between different photoreceptors(6); however, little is known about the nature of these interactions and their roles in the signal transduction pathway. Here we show the genetic interaction that occurs between the Arabidopsis photoreceptors phyB and cry2 in the control of flowering time, hypocotyl elongation and circadian period by the clock. PhyB interacts directly with cry2 as observed in co-immunoprecipitation experiments with transgenic Arabidopsis plants overexpressing cry2. Using fluorescent resonance energy transfer microscopy, we show that phyB and cry2 interact in nuclear speckles that are formed in a light-dependent fashion.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Natl Sci Fdn, Ctr Biol Timing, La Jolla, CA 92037 USA	Scripps Research Institute; National Science Foundation (NSF); NSF - Center for Biological Timing; Scripps Research Institute	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevek@scripps.edu	Mas, Paloma/B-8215-2016; Kay, Steve A/F-6025-2011; Panda, Satchidananda/J-6891-2012	Mas, Paloma/0000-0002-3780-8041; Kay, Steve A/0000-0002-0402-2878; Devlin, Paul/0000-0002-0168-3793				Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Bastiaens PIH, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P136; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; CARRINGTON JC, 1991, PLANT CELL, V3, P953, DOI 10.1105/tpc.3.9.953; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Choi G, 1999, NATURE, V401, P610, DOI 10.1038/44176; Chory J, 1997, PLANT CELL, V9, P1225, DOI 10.1105/tpc.9.7.1225; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Gadella TWJ, 1999, TRENDS PLANT SCI, V4, P287, DOI 10.1016/S1360-1385(99)01426-0; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Kendric RE, 1994, PHOTOMORPHOGENESIS P; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kleiner O, 1999, PLANT J, V19, P289, DOI 10.1046/j.1365-313X.1999.00535.x; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Mas P, 1999, J CELL BIOL, V147, P945, DOI 10.1083/jcb.147.5.945; MILLAR AJ, 1995, SCIENCE, V267, P1163, DOI 10.1126/science.7855596; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; WHETLAM GC, 1998, PLANT CELL ENVIRON, V20, P752; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	30	311	333	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2000	408	6809					207	211		10.1038/35041583	http://dx.doi.org/10.1038/35041583			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089975				2022-12-01	WOS:000165180400047
J	Engelmann, J; Hanke, W; Mogdans, J; Bleckmann, H				Engelmann, J; Hanke, W; Mogdans, J; Bleckmann, H			Neurobiology - Hydrodynamic stimuli and the fish lateral line	NATURE			English	Article									Univ Bonn, Inst Zool, D-53115 Bonn, Germany	University of Bonn	Engelmann, J (corresponding author), Univ Bonn, Inst Zool, Poppelsdorfer Schloss, D-53115 Bonn, Germany.							[Anonymous], 1994, PROGR ZOOL; BATSCHELET E., 1981, CIRCULAR STAT BIOL M; BLECKMANN H, 1990, BRAIN BEHAV EVOLUT, V35, P240, DOI 10.1159/000115870; Denton E.J., 1989, P229; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; Hanke W, 2000, J EXP BIOL, V203, P1193; JAKUBOWSKI M, 1967, ACTA BIOL CRACOV ZOO, V10, P69; KROESE ABA, 1992, J NEUROPHYSIOL, V68, P2212, DOI 10.1152/jn.1992.68.6.2212; Marshall N. B., 1971, EXPLORATIONS LIFE FI; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Northcutt R.G., 1989, P17	11	162	168	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2000	408	6808					51	52		10.1038/35040706	http://dx.doi.org/10.1038/35040706			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081502				2022-12-01	WOS:000165050400046
J	Smith, SD; Huxman, TE; Zitzer, SF; Charlet, TN; Housman, DC; Coleman, JS; Fenstermaker, LK; Seemann, JR; Nowak, RS				Smith, SD; Huxman, TE; Zitzer, SF; Charlet, TN; Housman, DC; Coleman, JS; Fenstermaker, LK; Seemann, JR; Nowak, RS			Elevated CO2 increases productivity and invasive species success in an arid ecosystem	NATURE			English	Article							NET PRIMARY PRODUCTION; PERFORMANCE; ENRICHMENT	Arid ecosystems, which occupy about 20% of the earth's terrestrial surface area, have been predicted to be one of the most responsive ecosystem types to elevated atmospheric CO2 and associated global climate change(1-3). Here we show, using free-air CO2 enrichment (FACE) technology in an intact Mojave Desert ecosystem(4), that new shoot production of a dominant perennial shrub is doubled by a 50% increase in atmospheric CO2 concentration in a high rainfall year. However, elevated CO2 does not enhance production in a drought year. We also found that aboveground production and seed rain of an invasive annual grass increases more at elevated CO2 than in several species of native annuals. Consequently, elevated CO2 might enhance the longterm success and dominance of exotic annual grasses in the region. This shift in species composition in favour of exotic annual grasses, driven by global change, has the potential to accelerate the fire cycle, reduce biodiversity and alter ecosystem function in the deserts of western North America.	Univ Nevada, Dept Biol Sci, Las Vegas, NV 89154 USA; Univ Nevada, Dept Biochem, Reno, NV 89557 USA; Desert Res Inst, Div Earth & Ecosyst Sci, Reno, NV 89512 USA; Desert Res Inst, Div Earth & Ecosyst Sci, Reno, NV 89119 USA; Univ Nevada, Dept Environm & Resource Sci, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Nevada System of Higher Education (NSHE); University of Nevada Reno	Smith, SD (corresponding author), Univ Nevada, Dept Biol Sci, Las Vegas, NV 89154 USA.			Seemann, Jeffrey/0000-0002-5160-175X				BAZZAZ FA, 1990, ANNU REV ECOL SYST, V21, P167, DOI 10.1146/annurev.es.21.110190.001123; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Hamerlynck EP, 2000, J ARID ENVIRON, V44, P425, DOI 10.1006/jare.1999.0615; HENDREY GR, 1994, AGR FOREST METEOROL, V70, P3, DOI 10.1016/0168-1923(94)90044-2; HUNTER R, 1991, GREAT BASIN NAT, V51, P176; Huxman TE, 1999, FUNCT ECOL, V13, P769, DOI 10.1046/j.1365-2435.1999.00366.x; Huxman TE, 1998, OECOLOGIA, V114, P202, DOI 10.1007/s004420050437; Huxman TE, 1998, PLANT CELL ENVIRON, V21, P1153, DOI 10.1046/j.1365-3040.1998.00379.x; Jordan DN, 1999, GLOB CHANGE BIOL, V5, P659, DOI 10.1046/j.1365-2486.1999.00255.x; Knapp PA, 1998, GLOBAL ECOL BIOGEOGR, V7, P259, DOI 10.2307/2997600; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; MAYEUX HS, 1994, ECOLOGY MANAGEMENT A, P95; MELGOZA G, 1990, OECOLOGIA, V83, P7, DOI 10.1007/BF00324626; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; NOYMEIR I, 1973, ANNU REV ECOL SYST, V4, P51; SAGE RF, 1996, CARBON DIOXIDE POPUL, P231; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; Smith SD, 1987, FUNCT ECOL, V1, P139, DOI 10.2307/2389717; Smith S.D., 1997, PHYSIOLOGICAL ECOLOG; Strain BR, 1983, CO2 PLANTS RESPONSE; YOUNG JA, 1978, J RANGE MANAGE, V31, P283, DOI 10.2307/3897603	23	414	468	8	280	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2000	408	6808					79	82		10.1038/35040544	http://dx.doi.org/10.1038/35040544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081510				2022-12-01	WOS:000165050400054
J	Liedtke, W; Choe, Y; Marti-Renom, MA; Bell, AM; Denis, CS; Sali, A; Hudspeth, AJ; Friedman, JM; Heller, S				Liedtke, W; Choe, Y; Marti-Renom, MA; Bell, AM; Denis, CS; Sali, A; Hudspeth, AJ; Friedman, JM; Heller, S			Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor	CELL			English	Article							CAENORHABDITIS-ELEGANS; LAMINA TERMINALIS; CAPSAICIN-RECEPTOR; ION-CHANNEL; SENSITIVITY; NEURONS; RAT; MECHANOTRANSDUCTION; IDENTIFICATION; TRANSDUCTION	The detection of osmotic stimuli is essential for all organisms, yet few osmoreceptive proteins are known, none of them in vertebrates. By employing a candidate-gene approach based on genes encoding members of the TRP superfamily of ion channels, we cloned cDNAs encoding the vanilloid receptor-related osmotically activated channel (VR-OAC) from the rat, mouse, human, and chicken. This novel cation-selective channel is gated by exposure to hypotonicity within the physiological range. In the central nervous system, the channel is expressed in neurons of the circumventricular organs, neurosensory cells responsive to systemic osmotic pressure. The channel also occurs in other neurosensory cells, including inner-ear hair cells, sensory neurons, and Merkel cells.	Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Heller, S (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, 243 Charles St, Boston, MA 02114 USA.	hellers@epl.meei.harvard.edu	Liedtke, Wolfgang B/G-4633-2011; Liedtke, Wolfgang/GNH-1878-2022; Marti-Renom, Marc A./Y-8803-2019; Marti-Renom, Marc/A-1836-2010	Marti-Renom, Marc A./0000-0002-0151-4279; Marti-Renom, Marc/0000-0002-0151-4279	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054762, R01GM054762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000317, R01DC000241] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [F32 DC000317, DC00317, R01 DC000241, R01 DC000241-26] Funding Source: Medline; NIDDK NIH HHS [R01 DK041096, R01 DK041096-18, DK41096] Funding Source: Medline; NIGMS NIH HHS [R01 GM054762, R29 GM054762, GM54762, R01 GM054762-13] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDRES KH, 1973, HDB SENSORY PHYSIOLO, V2, P3; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Bisley JW, 1996, BRAIN RES, V720, P25, DOI 10.1016/0006-8993(96)00079-0; Bourque CW, 1997, ANNU REV PHYSIOL, V59, P601, DOI 10.1146/annurev.physiol.59.1.601; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dehnhardt G, 1998, J EXP BIOL, V201, P3023; Denton DA, 1996, P NATL ACAD SCI USA, V93, P7397, DOI 10.1073/pnas.93.14.7397; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; FUCCI D, 1976, PERCEPT MOTOR SKILL, V43, P263, DOI 10.2466/pms.1976.43.1.263; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Heller S, 1998, P NATL ACAD SCI USA, V95, P11400, DOI 10.1073/pnas.95.19.11400; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; Kanzaki M, 1999, SCIENCE, V285, P882, DOI 10.1126/science.285.5429.882; KERNAN M, 1995, CURR OPIN NEUROBIOL, V5, P443, DOI 10.1016/0959-4388(95)80003-4; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; McKinley M.J., 1990, HUMAN NERVOUS SYSTEM, P415; McKinley MJ, 1999, AM J PHYSIOL-REG I, V276, pR673, DOI 10.1152/ajpregu.1999.276.3.R673; MCKINLEY MJ, 1992, PROG BRAIN RES, V91, P395; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Meyer J, 1998, J NEUROSCI, V18, P6748; O'Neill R R, 1989, Appl Theor Electrophor, V1, P163; PENNER R, 1989, FEBS LETT, V259, P217, DOI 10.1016/0014-5793(89)81532-7; Retief J D, 2000, Methods Mol Biol, V132, P243; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; SACKIN H, 1995, ANNU REV PHYSIOL, V57, P333, DOI 10.1146/annurev.ph.57.030195.002001; SIBBALD JR, 1988, BRAIN RES, V461, P205, DOI 10.1016/0006-8993(88)90251-X; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; TATE SS, 1992, P NATL ACAD SCI USA, V89, P1, DOI 10.1073/pnas.89.1.1; THRASHER TN, 1982, ENDOCRINOLOGY, V110, P1837, DOI 10.1210/endo-110-5-1837; Touchman JW, 2000, GENOME RES, V10, P165, DOI 10.1101/gr.10.2.165; TRAVIS KA, 1993, AM J PHYSIOL, V264, pR1200, DOI 10.1152/ajpregu.1993.264.6.R1200; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Weitz J, 1941, J EXP PSYCHOL, V28, P21, DOI 10.1037/h0059426; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761; [No title captured]	43	968	1036	0	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 27	2000	103	3					525	535		10.1016/S0092-8674(00)00143-4	http://dx.doi.org/10.1016/S0092-8674(00)00143-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081638	Bronze, Green Accepted			2022-12-01	WOS:000090144100017
J	Xie, T; Spradling, AC				Xie, T; Spradling, AC			A niche maintaining germ line stem cells in the Drosophila ovary	SCIENCE			English	Article							OOCYTE SPECIFICATION; SIGNALING PATHWAY; MAINTENANCE; OOGENESIS; SCHNURRI; ENCODES; FATE	Stromal cells are thought to generate specific regulatory microenviroments or "niches" that control stem cell behavior. Characterizing stem cell niches in vivo remains an important goal that has been difficult to achieve. The individual ovarioles of the Drosophila ovary each contain about two germ line stem cells that maintain oocyte production. Here we show that anterior ovariolar somatic cells comprising three cell types act as a germ line stem cell niche. Germ line stem cells Lost by normal or induced differentiation are efficiently replaced, and the ability to repopulate the niche increases the functional lifetime of ovarioles in vivo. Our studies implicate one of the somatic cell types, the cap cells, as a key niche component.	Carnegie Inst Washington, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD 21210 USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Xie, T (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.				Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Cox DN, 2000, DEVELOPMENT, V127, P503; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FIELDING CJ, 1967, J EMBRYOL EXP MORPH, V17, P375; Forbes AJ, 1996, DEVELOPMENT, V122, P3283; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Fuller Margaret T., 1993, P71; GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5; Jones PH, 1997, BIOESSAYS, V19, P683, DOI 10.1002/bies.950190808; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; King FJ, 1999, DEVELOPMENT, V126, P1833; Lin HF, 1998, CURR OPIN CELL BIOL, V10, P687, DOI 10.1016/S0955-0674(98)80108-7; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Spradling AC, 1997, COLD SPRING HARB SYM, V62, P25; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xie T., UNPUB	27	567	597	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					328	330		10.1126/science.290.5490.328	http://dx.doi.org/10.1126/science.290.5490.328			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030649				2022-12-01	WOS:000089818100041
J	Balabin, IA; Onuchic, JN				Balabin, IA; Onuchic, JN			Dynamically controlled protein tunneling paths in photosynthetic reaction centers	SCIENCE			English	Article							ELECTRON-TRANSFER; PATHWAYS; REDUCTION; MODELS; TUBES	Marcus theory has explained how thermal nuclear motions modulate the energy gap between donor and acceptor sites in protein electron transfer reactions, Thermal motions, however, may also modulate electron tunneling between these reactions. Here we identify a new mechanism of nuclear dynamics amplification that plays a central role when interference among the dominant tunneling pathway tubes is destructive. In these cases, tunneling takes place in protein conformations far from equilibrium that minimize destructive interference. As an example, we demonstrate how this dynamical amplification mechanism affects certain reaction rates in the photosynthetic reaction center and therefore may be critical for biological function.	Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Onuchic, JN (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	jonuchic@ucsd.edu	Balabin, Ilya/B-3967-2013; Balabin, Ilya/P-2421-2019	Balabin, Ilya/0000-0001-6245-3855	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048043] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48043] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; Aquino AJA, 1997, CHEM PHYS LETT, V275, P181, DOI 10.1016/S0009-2614(97)00742-2; Balabin IA, 1998, J PHYS CHEM B, V102, P7497, DOI 10.1021/jp9819442; Balabin IA, 1996, J PHYS CHEM-US, V100, P11573, DOI 10.1021/jp953568g; BENDALL DS, 1996, PROTEIN ELECTRON TRA; Bertini I., 1994, BIOINORGANIC CHEM; BETTS JN, 1992, J AM CHEM SOC, V114, P4043, DOI 10.1021/ja00037a004; Bixon M, 1997, J CHEM PHYS, V107, P5154, DOI 10.1063/1.474878; CURRY WB, 1995, J BIOENERG BIOMEMBR, V27, P285, DOI 10.1007/BF02110098; Daizadeh I, 1997, P NATL ACAD SCI USA, V94, P3703, DOI 10.1073/pnas.94.8.3703; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; Graige MS, 1998, P NATL ACAD SCI USA, V95, P11679, DOI 10.1073/pnas.95.20.11679; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Hyslop AG, 1998, INORG CHIM ACTA, V276, P427; KUKI A, 1987, SCIENCE, V236, P1647, DOI 10.1126/science.3603005; Kuznetsov AM, 1998, SPECTROCHIM ACTA A, V54, P1201, DOI 10.1016/S1386-1425(98)00070-5; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; McMahon BH, 1998, BIOPHYS J, V74, P2567, DOI 10.1016/S0006-3495(98)77964-0; Okamura MY, 2000, BBA-BIOENERGETICS, V1458, P148, DOI 10.1016/S0005-2728(00)00065-7; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PLATO M, 1989, FEBS LETT, V249, P70, DOI 10.1016/0014-5793(89)80018-3; Priyadarshy S, 1998, J BIOL INORG CHEM, V3, P196, DOI 10.1007/s007750050221; Priyadarshy S, 1996, J CHEM PHYS, V104, P9473, DOI 10.1063/1.471690; Regan JJ, 1999, ADV CHEM PHYS, V107, P497; SIGEL H, 1991, ELECTRON TRANSFER RE; Skourtis SS, 1997, J PHYS CHEM B, V101, P1215, DOI 10.1021/jp9619245; Stowell MHB, 1997, SCIENCE, V276, P812, DOI 10.1126/science.276.5313.812; Wolfgang J, 1997, J PHYS CHEM B, V101, P2986, DOI 10.1021/jp963771r	28	242	247	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					114	117		10.1126/science.290.5489.114	http://dx.doi.org/10.1126/science.290.5489.114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021791				2022-12-01	WOS:000089724800044
J	Martinelli, I; Taioli, E; Cetin, I; Marinoni, A; Gerosa, S; Villa, MV; Bozzo, M; Mannucci, PM				Martinelli, I; Taioli, E; Cetin, I; Marinoni, A; Gerosa, S; Villa, MV; Bozzo, M; Mannucci, PM			Mutations in coagulation factors in women with unexplained late fetal loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR-V-LEIDEN; ANTIPHOSPHOLIPID ANTIBODIES; RECURRENT MISCARRIAGE; PREGNANCY LOSS; RISK FACTOR; PROTEIN-C; THROMBOPHILIA; THROMBOSIS; STILLBIRTH; FREQUENCY	Background: The Factor V Leiden and prothrombin-gene mutations are independent risk factors for venous thrombosis; it is debated whether a mutation in the gene encoding methylenetetrahydrofolate reductase, an enzyme involved in homocysteine metabolism, also increases the risk of venous thrombosis. Whether any of these mutations is associated with an increased risk of late fetal death is not known. Methods: We studied 67 women with a first episode of unexplained late fetal loss (fetal death after 20 weeks or more of gestation) and 232 women who had had one or more normal pregnancies and no late fetal losses. All the women were tested for the presence of three gene mutations. Women with other thrombophilic conditions were excluded from the study. Results: Eleven of the 67 women with late fetal loss (16 percent) and 13 of the 232 control women (6 percent) had either the factor V or the prothrombin mutation. The relative risks of late fetal loss in carriers of the factor V and prothrombin mutations were 3.2 (95 percent confidence interval, 1.0 to 10.9) and 3.3 (95 percent confidence interval, 1.1 to 10.3), respectively. Thirteen percent of the women whose fetuses died and 20 percent of the control women were homozygous for the mutation in the methylenetetrahydrofolate reductase gene (relative risk, 0.8; 95 percent confidence interval, 0.5 to 1.2). Conclusions: Both the factor V and the prothrombin mutations are associated with an approximate tripling of the risk of late fetal loss. (N Engl J Med 2000;343:1015-8.) (C) 2000, Massachusetts Medical Society.	Univ Milan, IRCCS Maggiore Hosp, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy; Univ Milan, IRCCS Maggiore Hosp, Epidemiol Unit, I-20122 Milan, Italy; Univ Milan, San Paolo Hosp, Dept Obstet & Gynecol, I-20122 Milan, Italy; Univ Milan, Ist Clin Perfezionamento, Dept Obstet & Gynecol, I-20122 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; San Paolo-Polo Universitaria Hospital; University of Milan; University of Milan	Martinelli, I (corresponding author), Univ Milan, IRCCS Maggiore Hosp, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy.		Martinelli, ida/J-2287-2015; cetin, irene/K-6112-2016; Marinoni, Angela/AAK-9587-2021	Martinelli, ida/0000-0001-9218-3622; cetin, irene/0000-0002-9217-3034; Marinoni, Angela/0000-0002-6580-7126				BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Breart G, 1997, EUR J OBSTET GYN R B, V75, P71, DOI 10.1016/S0301-2115(97)00190-5; Brenner B, 1997, BLOOD REV, V11, P72, DOI 10.1016/S0268-960X(97)90013-8; Cattaneo M, 1999, THROMB HAEMOSTASIS, V81, P165; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; DAVIES BR, 1985, AM J OBSTET GYNECOL, V152, P17, DOI 10.1016/S0002-9378(85)80168-X; DizonTomson DS, 1997, AM J OBSTET GYNECOL, V177, P402, DOI 10.1016/S0002-9378(97)70205-9; Festin Mario R., 1997, Kobe Journal of Medical Sciences, V43, P143; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Grandone E, 1997, THROMB HAEMOSTASIS, V77, P822; Gris JC, 1999, THROMB HAEMOSTASIS, V81, P891; Kupferminc MJ, 1999, NEW ENGL J MED, V341, P384; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; Martinelli I, 1998, BLOOD, V92, P2353, DOI 10.1182/blood.V92.7.2353.2353_2353_2358; Meinardi JR, 1999, ANN INTERN MED, V130, P736, DOI 10.7326/0003-4819-130-9-199905040-00013; OBRIEN WF, 1990, OBSTET GYNECOL, V75, P445; Ogunyemi D, 1998, ACTA OBSTET GYN SCAN, V77, P722, DOI 10.1034/j.1600-0412.1998.770705.x; Oshiro BT, 1996, OBSTET GYNECOL, V87, P489, DOI 10.1016/0029-7844(95)00498-X; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Preston FE, 1996, LANCET, V348, P913, DOI 10.1016/S0140-6736(96)04125-6; Rai R, 1997, BRIT MED J, V314, P253, DOI 10.1136/bmj.314.7076.253; Rai RS, 1995, HUM REPROD, V10, P3301, DOI 10.1093/oxfordjournals.humrep.a135907; Rand JH, 1997, NEW ENGL J MED, V337, P1327; Rand JH, 1997, NEW ENGL J MED, V337, P154, DOI 10.1056/NEJM199707173370303; Rees DC, 1996, BRIT J HAEMATOL, V95, P579, DOI 10.1046/j.1365-2141.1996.d01-1954.x; Ridker PM, 1998, ANN INTERN MED, V128, P1000, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00007; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; Rosendaal FR, 1998, THROMB HAEMOSTASIS, V79, P706; SAMUELOFF A, 1993, J REPROD MED, V38, P883; Sanson BJ, 1996, THROMB HAEMOSTASIS, V75, P387; Sanson BJ, 1999, THROMB HAEMOSTASIS, V81, P668, DOI 10.1055/s-0037-1614550; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; Tormene D, 1999, THROMB HAEMOSTASIS, V82, P1237	35	254	264	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2000	343	14					1015	1018		10.1056/NEJM200010053431405	http://dx.doi.org/10.1056/NEJM200010053431405			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PU	11018168	Bronze			2022-12-01	WOS:000089619900005
J	Guthrie, B; Wyke, S				Guthrie, B; Wyke, S			Controversy in primary care - Does continuity in general practice really matter?	BRITISH MEDICAL JOURNAL			English	Article							PATIENT SATISFACTION; RANDOMIZED TRIAL; PRACTITIONERS; CONSULTATIONS	Continuity is an official core value of general practice in the United Kingdom,(1) but there are at least two potentially conflicting definitions of it Both definitions are powerfully expressed in a recent report from the BMA, entitled Shaping Tomorrow.(2) For general practitioners, continuity of care has traditionally meant that a patient visits the same doctor(3 4) What matters is personal continuity, in which an ongoing doctor-patient relationship ensures that care takes account of the patient's personal and social context By contrast, recent statements from the NHS Executive emphasise the importance of consistency and coordination of care.(5) From this perspective, continuity can be enhanced by appropriate organisation, guidelines, and electronic medical records, irrespective of which doctor is seen.	Univ Edinburgh, Dept Community Hlth Sci, Div Gen Practice, Edinburgh EH8 9DX, Midlothian, Scotland; Royal Coll Gen Practitioners, Scottish Sch Primary Care, Edinburgh EH2 1JX, Midlothian, Scotland	University of Edinburgh	Guthrie, B (corresponding author), Univ Edinburgh, Dept Community Hlth Sci, Div Gen Practice, Edinburgh EH8 9DX, Midlothian, Scotland.			Guthrie, Bruce/0000-0003-4191-4880				BAKER R, 1995, BRIT J GEN PRACT, V45, P654; Baker R, 1996, BRIT J GEN PRACT, V46, P601; BECKER MH, 1974, AM J PUBLIC HEALTH, V64, P1062, DOI 10.2105/AJPH.64.11.1062; *BMA GEN PRACT COM, 2000, PRIM CAR TRUSTS IMPL; *BMA GEN PRACT COM, 2000, SHAP TOM ISS FAC GEN; ETTLINGER PRA, 1981, BRIT MED J, V282, P1192, DOI 10.1136/bmj.282.6271.1192; Flint C, 1989, Midwifery, V5, P11, DOI 10.1016/S0266-6138(89)80059-2; FREEMAN G, 1985, J ROY COLL GEN PRACT, V35, P423; Freeman G, 1997, BRIT MED J, V314, P1870, DOI 10.1136/bmj.314.7098.1870; FREEMAN GK, 1994, BRIT J GEN PRACT, V44, P395; GORDIS L, 1971, PEDIATRICS, V48, P766; HJORTDAHL P, 1992, BRIT MED J, V304, P1287, DOI 10.1136/bmj.304.6837.1287; Howie JGR, 1999, BMJ-BRIT MED J, V319, P738, DOI 10.1136/bmj.319.7212.738; NAZARETH I, 1993, BRIT MED J, V306, P1103, DOI 10.1136/bmj.306.6885.1103; *NHS EX, 2000, PRIM COMM CAR; ROWLEY MJ, 1995, MED J AUSTRALIA, V163, P289, DOI 10.5694/j.1326-5377.1995.tb124592.x; Royal College of General Practitioners, 1972, FUT GEN PRACT; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413	18	44	47	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					734	735		10.1136/bmj.321.7263.734	http://dx.doi.org/10.1136/bmj.321.7263.734			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999906	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000089546600025
J	Wakayama, T; Shinkai, Y; Tamashiro, KLK; Niida, H; Blanchard, DC; Blanchard, RJ; Ogura, A; Tanemura, K; Tachibana, M; Perry, ACF; Colgan, DF; Mombaerts, P; Yanagimachi, R				Wakayama, T; Shinkai, Y; Tamashiro, KLK; Niida, H; Blanchard, DC; Blanchard, RJ; Ogura, A; Tanemura, K; Tachibana, M; Perry, ACF; Colgan, DF; Mombaerts, P; Yanagimachi, R			Ageing - Cloning of mice to six generations	NATURE			English	Article									Rockefeller Univ, New York, NY 10021 USA; Univ Hawaii, John A Burns Sch Med, Dept Anat & Reprod Biol, Honolulu, HI 96822 USA; Kyoto Univ, Inst Virus Res, Dept Cell Biol, Sakyo Ku, Kyoto 6068507, Japan; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Hawaii, Bekesy Lab Neurobiol, Honolulu, HI 96822 USA; Natl Inst Infect Dis, Dept Vet Sci, Tokyo 1628640, Japan	Rockefeller University; University of Hawaii System; Kyoto University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Hawaii System; National Institute of Infectious Diseases (NIID)	Wakayama, T (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Shinkai, Yoichi/N-3909-2014; Ogura, Atsuo/J-3916-2014	Shinkai, Yoichi/0000-0002-6051-2484; Ogura, Atsuo/0000-0003-0447-1988; Perry, Tony/0000-0003-3136-5355; Tamashiro, Kellie/0000-0002-9398-8796				Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Tamashiro KLK, 2000, BIOL REPROD, V63, P328, DOI 10.1095/biolreprod63.1.328; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Wilmut I, 2000, NAT BIOTECHNOL, V18, P599, DOI 10.1038/76430; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	8	165	181	1	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					318	319		10.1038/35030301	http://dx.doi.org/10.1038/35030301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014179				2022-12-01	WOS:000089390700033
J	Ross, EA; Szabo, NJ; Tebbett, IR				Ross, EA; Szabo, NJ; Tebbett, IR			Lead content of calcium supplements	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; DIETARY LEAD; EXPOSURE	Context Substantial quantities of lead have been reported in some over-the-counter calcium supplement preparations, including not only bonemeal and dolomite, but also over-the-counter natural and refined calcium carbonate formulations. Examination of this issue is warranted given recent increases in physician recommendations for calcium supplements for prevention and treatment of osteoporosis. Objectives To determine the lead content of calcium supplements and to quantify the lead exposure from popular brands of calcium in dosages used for childhood recommended daily allowance, osteoporosis, and phosphate binding in dialysis patients. Design and Setting Analysis of lead content in 21 formulations of nonprescription calcium carbonate (including 7 natural [ie, oyster shell] and 14 refined), 1 brand of prescription-only calcium acetate, and 1 noncalcium synthetic phosphate binder conducted in March 2000, Main Outcome Measures Lead content, assayed using electrothermal atomic absorption, expressed as micrograms of lead per 800 mg/d of elemental calcium, per 1500 mg/d of calcium, and for a range of dosages for patients with renal failure. Six mu g/d of lead was considered the absolute dietary limit, with no more than 1 mu g/d being the goal for supplements. Results Four of 7 natural products had measurable lead content, amounting to approximately 1 mu g/d for 800 mg/d of calcium, between 1 and 2 mu g/d for 1500 mg/d of calcium, and up to 10 mu g/d for renal dosages, Four of the 14 refined products had similar lead content, including up to 3 mu g/d of lead in osteoporosis calcium dosages and up to 20 mu g/d in high renal dosages, No lead was detected in the calcium acetate or polymer products. Lead was present even in some brand name products from major pharmaceutical companies not of natural oyster shell derivation. Conclusions Despite increasingly stringent limits of lead exposure, many calcium supplement formulations contain lead and thereby may pose an easily avoidable public health concern.	Univ Florida, Div Nephrol Hypertens & Transplantat, Coll Med, Gainesville, FL 32610 USA; Univ Florida, Coll Vet Med, Dept Physiol Sci, Analyt Toxicol Core Lab, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ross, EA (corresponding author), Univ Florida, Div Nephrol Hypertens & Transplantat, Coll Med, Box 100224, Gainesville, FL 32610 USA.	Rossea@medicine.ufl.edu						Adachi JD, 1998, CALCIFIED TISSUE INT, V63, P429, DOI 10.1007/s002239900552; Bolger PM, 1996, FOOD ADDIT CONTAM A, V13, P53, DOI 10.1080/02652039609374380; BOULOS BM, 1988, AM J HYPERTENS, V1, pS137, DOI 10.1093/ajh/1.3.137S; BOURGOIN BP, 1993, AM J PUBLIC HEALTH, V83, P1155, DOI 10.2105/AJPH.83.8.1155; CARR C J, 1987, American Pharmacy, V27, P49; CARRINGTON CD, 1992, REGUL TOXICOL PHARM, V16, P265, DOI 10.1016/0273-2300(92)90006-U; Carrington CD, 1996, FOOD ADDIT CONTAM, V13, P61, DOI 10.1080/02652039609374381; D'Haese PC, 1999, CLIN CHEM, V45, P1548; Ervin R.B., 1999, VITAL HLTH STAT, V11, P1; NAVARRO JA, 1992, CLIN CHIM ACTA, V211, P133, DOI 10.1016/0009-8981(92)90189-W; ROBERTS HJ, 1983, SOUTHERN MED J, V76, P556, DOI 10.1097/00007611-198305000-00005; Sargent JD, 1999, AM J CLIN NUTR, V69, P1224; SLESINSKI MJ, 1995, J AM DIET ASSOC, V95, P921, DOI 10.1016/S0002-8223(95)00255-3; SLITONEN PH, 1994, J ASSOC OFF ANA CHEM, V77, P1299; SUITOR CW, 1990, J AM DIET ASSOC, V90, P268; *US DEP HHS AG TOX, 1999, TOX PROF LEAD; *US EPA OFF HLTH E, 1999, INT RISK INF SYST; *US FDA, 1990, HFF156 US FDA US PHS; *US FDA, 1981, LEAD BON; *US PHARM CONV INC, 2000, US PHARM NAT FORM, P277; VANDEVYVER FL, 1988, KIDNEY INT, V33, P601, DOI 10.1038/ki.1988.39; WHITING SJ, 1994, NUTR REV, V52, P95, DOI 10.1111/j.1753-4887.1994.tb01396.x; 1999, CONSUMER REPORTS, V64, P9	23	44	47	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2000	284	11					1425	1429		10.1001/jama.284.11.1425	http://dx.doi.org/10.1001/jama.284.11.1425			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352WN	10989406				2022-12-01	WOS:000089242500038
J	Peltola, H; Davidkin, I; Paunio, M; Valle, M; Leinikki, P; Heinonen, OP				Peltola, H; Davidkin, I; Paunio, M; Valle, M; Leinikki, P; Heinonen, OP			Mumps and rubella eliminated from Finland	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VACCINATED CHILDREN; CONGENITAL-RUBELLA; FOLLOW-UP; MEASLES; IMMUNITY; PROGRAM; IMMUNIZATION; INFECTION; IMPACT	Many countries use trivalent measles-mumps-rubella (MMR) vaccine for their mumps and rubella immunization programs. In Finland, a national 2-dose MMR vaccination program for children, free of charge and on a voluntary basis, was launched in 1982, Serological confirmation of all suspected cases of mumps and rubella has been required since 1987, Despite intensive surveillance, no persistent sequelae or deaths attributable to vaccination have been detected. Indigenous mumps and rubella were eliminated in 1996, but 4 imported cases of mumps and 2 of rubella occurred from 1997 to 1999, Lack of secondary cases indicates sufficient immunity in the community. Compared with an epidemic year, up to thousands of cases of mumps meningoencephalitis and orchitis and around 50 cases of congenital rubella syndrome are now avoided annually. A 2-dose vaccine regimen in children during the last 17 years (1983-1999) has interrupted circulation of the target viruses entirely. Finland is the first country documented to be free of indigenous mumps and rubella(measles was eliminated in 1996), Despite the ongoing possibility of imported disease, major outbreaks probably can be avoided by maintaining high vaccination coverage and the 2-dose policy.	Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, FIN-00029 Helsinki, Finland; Natl Publ Hlth Inst, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki	Peltola, H (corresponding author), Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, POB 281, FIN-00029 Helsinki, Finland.							Bang HO, 1943, ACTA MED SCAND, V113, P487; BRISS PA, 1994, J INFECT DIS, V169, P77, DOI 10.1093/infdis/169.1.77; CHARNOW JA, 1993, INFECT DIS CHILD, V6, P31; Davidkin I, 2000, VACCINE, V18, P3106, DOI 10.1016/S0264-410X(00)00139-0; DAVIDKIN I, 1995, VACCINE, V13, P1617, DOI 10.1016/0264-410X(95)00064-8; Davidkin I, 1998, J INFECT DIS, V178, P1567, DOI 10.1086/314513; DESMOND MM, 1978, J PEDIATR-US, V93, P584, DOI 10.1016/S0022-3476(78)80892-0; Galazka AM, 1999, B WORLD HEALTH ORGAN, V77, P3; HEDMAN K, 1988, J CLIN IMMUNOL, V8, P214, DOI 10.1007/BF00917569; JOHANSSON CARL - JOHAN, 1957, ACTA OBSTET ET GYNCEOL SCAND, V36, P1; JUNTUNENBACKMAN K, 1987, AM J DIS CHILD, V141, P1103, DOI 10.1001/archpedi.1987.04460100081032; KNOX EG, 1980, INT J EPIDEMIOL, V9, P13, DOI 10.1093/ije/9.1.13; KOPLAN JP, 1982, AM J DIS CHILD, V136, P362, DOI 10.1001/archpedi.1982.03970400080021; LAITINEN O, 1974, LANCET, V1, P194; LEINEBERG O, 1945, NORD MED, V27, P1901; LEINEBERG O, 1945, ANN MED MILIT FENNIA, V20, P126; MCINTOSH EDG, 1992, LANCET, V340, P414, DOI 10.1016/0140-6736(92)91483-O; NIEMINEN U, 1993, ACTA PAEDIATR, V82, P267, DOI 10.1111/j.1651-2227.1993.tb12657.x; OJALA P, 1973, AM J EPIDEMIOL, V98, P395, DOI 10.1093/oxfordjournals.aje.a121568; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; PAUNIO M, 1991, AM J EPIDEMIOL, V133, P1152, DOI 10.1093/oxfordjournals.aje.a115827; Paunio M, 2000, JAMA-J AM MED ASSOC, V283, P343, DOI 10.1001/jama.283.3.343; Paunio M, 1999, J EPIDEMIOL COMMUN H, V53, P173, DOI 10.1136/jech.53.3.173; PELTOLA H, 1994, NEW ENGL J MED, V331, P1397, DOI 10.1056/NEJM199411243312101; PELTOLA H, 1986, LANCET, V1, P137; Peltola H, 1997, LANCET, V350, P1364, DOI 10.1016/S0140-6736(05)65134-3; PELTOLA H, 1986, LANCET, V1, P939; PENTTINEN K, 1968, AM J EPIDEMIOL, V88, P234, DOI 10.1093/oxfordjournals.aje.a120882; PENTTINEN K, 1954, Ann Med Exp Biol Fenn, V32, P248; PHILIP RN, 1959, AM J HYG, V69, P91; Rabo E, 1981, Lakartidningen, V78, P2840; SOSIN DM, 1989, PEDIATRICS, V84, P779; Ukkonen P, 1996, SCAND J INFECT DIS, V28, P31, DOI 10.3109/00365549609027146; UKKONEN P, 1981, J MED VIROL, V8, P131, DOI 10.1002/jmv.1890080207; VAANANEN P, 1979, J MED VIROL, V3, P245, DOI 10.1002/jmv.1890030402; VIRTANEN M, IN PRESS PEDIATRICS; VUORI M, 1962, Acta Otolaryngol, V55, P231, DOI 10.3109/00016486209127357; WHITE CC, 1985, AM J PUBLIC HEALTH, V75, P739, DOI 10.2105/AJPH.75.7.739; Whittle HC, 1999, LANCET, V353, P98, DOI 10.1016/S0140-6736(98)02364-2	39	87	92	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	2000	284	20					2643	2647		10.1001/jama.284.20.2643	http://dx.doi.org/10.1001/jama.284.20.2643			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373NU	11086376				2022-12-01	WOS:000165296200043
J	Hanevik, K; Kvale, G				Hanevik, K; Kvale, G			Landmine injuries in Eritrea	BRITISH MEDICAL JOURNAL			English	Article							MINES; MOZAMBIQUE		Univ Bergen, Ctr Int Hlth, N-5021 Bergen, Norway	University of Bergen	Hanevik, K (corresponding author), Univ Bergen, Ctr Int Hlth, N-5021 Bergen, Norway.		Hanevik, Kurt/I-1159-2012	Hanevik, Kurt/0000-0002-1466-2326				ANDERSSON N, 1995, BRIT MED J, V311, P718, DOI 10.1136/bmj.311.7007.718; ASCHERIO A, 1995, LANCET, V346, P721, DOI 10.1016/S0140-6736(95)91501-X; COUPLAND RM, 1991, BMJ-BRIT MED J, V303, P1509, DOI 10.1136/bmj.303.6816.1509; TAYLOR C, 1994, NGIC116600494	4	19	19	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 11	2000	321	7270					1189	1189		10.1136/bmj.321.7270.1189	http://dx.doi.org/10.1136/bmj.321.7270.1189			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374RA	11073510	Green Published, Bronze			2022-12-01	WOS:000165357100027
J	Henderson, L; Kitzinger, J; Green, J				Henderson, L; Kitzinger, J; Green, J			Representing infant feeding: content analysis of British media portrayals of bottle feeding and breast feeding	BRITISH MEDICAL JOURNAL			English	Article							RISK	Objective To examine how breast feeding and bottle feeding are represented by the British media. Design Content analysis. Subjects Television programmes and newspaper articles that made reference to infant feeding during March 1999. Setting UK mass media Main outcome measures Visual and verbal references to breast or bottle feeding in newspapers and television programmes. Results Overall, 235 references to infant feeding were identified in the television sample and 38 in the newspaper sample. Bottle feeding was shown more often than breast feeding and was presented as less problematic. Bottle feeding was associated with "ordinary" families whereas breast feeding was associated with middle class or celebrity women. The health risks of formula milk and ale health benefits of breast feeding were rarely mentioned. Conclusions The media rarely present positive information on breast feeding, even though this feeding practice is associated with the most health benefits. Health professionals and policy makers should be aware of patterns in media cover-age and the cultural background within which women make decisions about infant feeding.	Brunel Univ, Dept Human Sci, Ctr Media & Commun Res, Uxbridge UB8 3PH, Middx, England; Univ Leeds, Mother & Infant Res Unit, Leeds LS2 9LN, W Yorkshire, England	Brunel University; University of Leeds	Henderson, L (corresponding author), Brunel Univ, Dept Human Sci, Ctr Media & Commun Res, Uxbridge UB8 3PH, Middx, England.			Kitzinger, Jenny/0000-0002-2593-8033				AMOS A, 1992, BRIT MED J, V304, P99, DOI 10.1136/bmj.304.6819.99; ANIANSSON G, 1994, PEDIATR INFECT DIS J, V13, P183, DOI 10.1097/00006454-199403000-00003; BEGG N, 1999, BRIT MED J, V318, P30; Chapman S. L. D., 1994, FIGHT PUBLIC HLTH; FORD RPK, 1993, INT J EPIDEMIOL, V22, P885, DOI 10.1093/ije/22.5.885; GRILLI R, 1999, COCHRANE LIB; Henderson L, 1999, SOCIOL HEALTH ILL, V21, P560, DOI 10.1111/1467-9566.00173; Hoddinott P, 1999, BRIT MED J, V318, P30, DOI 10.1136/bmj.318.7175.30; HOWIE PW, 1990, BRIT MED J, V300, P11, DOI 10.1136/bmj.300.6716.11; MACLEAN HM, 1989, HLTH PROMOTION, V3, P355; MAYER EJ, 1988, DIABETES, V37, P1625, DOI 10.2337/diabetes.37.12.1625; MILLER D, 1997, CIRCUIT MASS COMMUNI; Philo G, 1996, MEDIA MENTAL DISTRES; PISACANE A, 1990, LANCET, V336, P336	14	83	83	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 11	2000	321	7270					1196	+		10.1136/bmj.321.7270.1196	http://dx.doi.org/10.1136/bmj.321.7270.1196			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374RA	11073512	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000165357100029
J	Holder, HD; Gruenewald, PJ; Ponicki, WR; Treno, AJ; Grube, JW; Saltz, RF; Voas, RB; Reynolds, R; Davis, J; Sanchez, L; Gaumont, G; Roeper, P				Holder, HD; Gruenewald, PJ; Ponicki, WR; Treno, AJ; Grube, JW; Saltz, RF; Voas, RB; Reynolds, R; Davis, J; Sanchez, L; Gaumont, G; Roeper, P			Effect of community-based interventions on high-risk drinking and alcohol-related injuries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY ROOM; AVAILABILITY; VIOLENCE; HEALTH	Context High-risk alcohol consumption patterns, such as binge drinking and drinking before driving, and underage drinking may be lin ked to traffic crashes and violent assaults in community settings. Objectives To determine the effect of community-based environmental interventions in reducing the rate of high-risk drinking and alcohol-related motor vehicle injuries and assaults. Design and Setting A longitudinal multiple time series of 3 matched intervention communities (northern California, southern California, and South Carolina) conducted from April 1992 to December 1996. Outcomes were assessed by 120 general population telephone surveys per month of randomly selected individuals in the intervention and comparison sites, traffic data on motor vehicle crashes, and emergency department surveys in 1 intervention-comparison pair and 1 additional intervention site. Interventions Mobilize the community; encourage responsible beverage service, reduce underage drinking by limiting access to alcohol; increase local enforcement of drinking and driving laws; and limit access to alcohol by using zoning. Main Outcome Measures Self-reported alcohol consumption and driving after drinking; rates of alcohol-related crashes and assault injuries observed in emergency departments and admitted to hospitals. Results Population surveys revealed that the self-reported amount of alcohol consumed per drinking occasion declined 6% from 1.37 to 1.29 drinks. Self-reported rate of "having had too much to drink" declined 49% from 0.43 to 0.22 times per 6-month period. Self-reported driving when "over the legal limit" was 51% lower (0.77 vs 0.38 times) per 6-month period in the intervention communities relative to the comparison communities. Traffic data revealed that, in the intervention vs comparison communities, nighttime injury crashes declined by 10% and crashes in which the driver had been drinking declined by 6%. Assault injuries observed in emergency departments declined by 43% in the intervention communities vs the comparison communities, and all hospitalized assault injuries declined by 2%. Conclusion A coordinated, comprehensive, community-based intervention can reduce high-risk alcohol consumption and alcohol-related injuries resulting from motor vehicle crashes and assaults.	Pacific Inst Res & Evaluat, Prevent Res Ctr, Berkeley, CA 94704 USA; Pacific Inst Res & Evaluat, Landover, MD USA; Pacific Inst Res & Evaluat, Rockville, MD USA; PARTS, Salinas, CA USA; Pacific Inst Res & Evaluat, Prevent Res Ctr, Oceanside, CA USA	Pacific Institute for Research & Evaluation (PIRE); Pacific Institute for Research & Evaluation (PIRE); Pacific Institute for Research & Evaluation (PIRE); Pacific Institute for Research & Evaluation (PIRE)	Holder, HD (corresponding author), Pacific Inst Res & Evaluat, Prevent Res Ctr, 2150 Shattuck Ave,Suite 900, Berkeley, CA 94704 USA.			Grube, Joel/0000-0003-1099-8743; Saltz, Robert/0000-0002-6373-7670	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009146] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA09146] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Borges G, 1998, ADDICTION, V93, P103, DOI 10.1046/j.1360-0443.1998.93110310.x; FELL JC, 1989, HEALTH EDUC QUART, V16, P335, DOI 10.1177/109019818901600303; Grube JW, 1997, ADDICTION, V92, pS251, DOI 10.1111/j.1360-0443.1997.tb02995.x; Gruenewald PJ, 1997, EVALUATION REV, V21, P209, DOI 10.1177/0193841X9702100205; Gruenewald PJ, 1996, ADDICTION, V91, P967, DOI 10.1046/j.1360-0443.1996.9179674.x; GRUENEWALD PJ, 1996, ADDICTION, V91, P1627; Hingson R, 1996, AM J PUBLIC HEALTH, V86, P791, DOI 10.2105/AJPH.86.6.791; Holder HD, 1997, ADDICTION, V92, pS189, DOI 10.1111/j.1360-0443.1997.tb02991.x; Holder HD, 1997, ADDICTION, V92, pS155, DOI 10.1111/j.1360-0443.1997.tb02989.x; KANN L, 1993, PUBLIC HEALTH REP, V108, P47; Kennedy BP, 1996, RISK ANAL, V16, P565, DOI 10.1111/j.1539-6924.1996.tb01101.x; MASSEY JT, 1988, TELEPHONE SURVEY MET; Reynolds RI, 1997, ADDICTION, V92, pS261, DOI 10.1111/j.1360-0443.1997.tb02996.x; Saltz RF, 1997, ADDICTION, V92, pS237, DOI 10.1111/j.1360-0443.1997.tb02994.x; SALTZ RF, 1992, COMMUNITY PREVENTION, P35; SCRIBNER RA, 1995, AM J PUBLIC HEALTH, V85, P335, DOI 10.2105/AJPH.85.3.335; Stout RL, 1994, REPORT NATL I ALCOHO, VII; STOUT RL, 1992, COMMUNITY PREVENTION, P121; Treno AJ, 1997, J STUD ALCOHOL, V58, P372, DOI 10.15288/jsa.1997.58.372; Treno AJ, 1997, EVALUATION REV, V21, P133, DOI 10.1177/0193841X9702100201; Treno AJ, 1998, ADDICTION, V93, P113, DOI 10.1046/j.1360-0443.1998.93111311.x; VALOIS RF, 1995, J ADOLESCENT HEALTH, V16, P26, DOI 10.1016/1054-139X(95)94070-O; Voas RB, 1997, ADDICTION, V92, pS201, DOI 10.1111/j.1360-0443.1997.tb02992.x; Wagenaar AC, 2000, ADDICTION, V95, P209, DOI 10.1046/j.1360-0443.2000.9522097.x; Wagenaar AC, 2000, J STUD ALCOHOL, V61, P85, DOI 10.15288/jsa.2000.61.85; WECHSLER H, 1994, JAMA-J AM MED ASSOC, V272, P1672, DOI 10.1001/jama.272.21.1672; ZADOR P, 1989, ALCOHOL RELATED RISK	27	269	271	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2000	284	18					2341	2347		10.1001/jama.284.18.2341	http://dx.doi.org/10.1001/jama.284.18.2341			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	369NU	11066184	Bronze			2022-12-01	WOS:000165074500028
J	Hill, AA; Hunter, CP; Tsung, BT; Tucker-Kellogg, G; Brown, EL				Hill, AA; Hunter, CP; Tsung, BT; Tucker-Kellogg, G; Brown, EL			Genomic analysis of gene expression in C-elegans	SCIENCE			English	Article								Until now, genome-wide transcriptional profiling has been Limited to single-cell organisms. The nematode Caenorhabditis elegans is a well-characterized metazoan in which the expression of all genes can be monitored by oligonucleotide arrays. We used such arrays to quantitate the expression of C. elegans genes throughout the development of this organism. The results provide an estimate of the number of expressed genes in the nematode, reveal relations between gene function and gene expression that can guide analysis of uncharacterized worm genes, and demonstrate a shift in expression from evolutionarily conserved genes to worm-specific genes over the course of development.	Genet Inst Inc, Dept Genom, Cambridge, MA 02140 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Hill, AA (corresponding author), Genet Inst Inc, Dept Genom, Cambridge, MA 02140 USA.	ahill@genetics.com; hunter@mcb.harvard.edu	Tucker-Kellogg, Greg/G-3344-2012	Tucker-Kellogg, Greg/0000-0001-8407-9251				C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CARTER PW, 1990, MOL GEN GENET, V221, P72, DOI 10.1007/BF00280370; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; HILL AF, UNPUB; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; Priess J. R., 1997, C ELEGANS 2; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wood WB, 1988, NEMATODE CAENORHABDI; XIN JH, 1982, DEV BIOL, V89, P527, DOI 10.1016/0012-1606(82)90342-6	15	244	255	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					809	812		10.1126/science.290.5492.809	http://dx.doi.org/10.1126/science.290.5492.809			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052945				2022-12-01	WOS:000090067600050
J	Kuo, SC; McGrath, JL				Kuo, SC; McGrath, JL			Steps and fluctuations of Listeria monocytogenes during actin-based motility	NATURE			English	Article							PARTICLE TRACKING; INTERFEROMETRY; MECHANICS; FILAMENT; PROTEINS; COMPLEX; DOMAIN	The actin-based motility of the bacterium, Listeria monocytogenes, is a model system for understanding motile cell functions involving actin polymerization(1). Although the biochemical and genetic aspects of Listeria motility have been intensely studied(2-5), biophysical data are sparse(6). Here we have used high-resolution laser tracking to follow the trailing ends of Listeria moving in the lamellae of COS7 cells. We found that pauses during motility occur frequently and that episodes of step-like motion often show pauses spaced at about 5.4 nm, which corresponds to the spatial periodicity of F-actin(7). We occasionally observed smaller steps (<3 nm), as well as periods of motion with no obvious pauses. Clearly, bacteria do not sense cytoplasmic viscoelasticity because they fluctuate 20 times less than adjacent lipid droplets. Instead, bacteria bind their own actin 'tails', and the anchoring proteins can 'step' along growing filaments within the actin tail. Because positional fluctuations are unusually small, the forces of association and propulsion must be very strong. Our data disprove the brownian ratchet model(8) and limit alternative models, such as the 'elastic' brownian ratchet(9) or the 'molecular' ratchet(4,10).	Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University	Kuo, SC (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, 720 Rutland Ave, Baltimore, MD 21205 USA.	skuo@bme.jhu.edu		McGrath, James/0000-0003-2017-8335	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059285] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059285] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; DENK W, 1989, P NATL ACAD SCI USA, V86, P5371, DOI 10.1073/pnas.86.14.5371; Dupuis DE, 1997, J MUSCLE RES CELL M, V18, P17, DOI 10.1023/A:1018672631256; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Gerbal F, 2000, EUR BIOPHYS J BIOPHY, V29, P134, DOI 10.1007/s002490050258; Gerbal F, 1999, PRAMANA-J PHYS, V53, P155, DOI 10.1007/s12043-999-0147-z; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; KUO SC, 1991, J CELL SCI, P135; Lasa I, 1997, EMBO J, V16, P1531, DOI 10.1093/emboj/16.7.1531; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; MCGRATH JL, 2000, IN PRESS BIOPHYS J; Mehta AD, 1997, P NATL ACAD SCI USA, V94, P7927, DOI 10.1073/pnas.94.15.7927; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Olbris DJ, 2000, BBA-MOL CELL RES, V1495, P140, DOI 10.1016/S0167-4889(99)00156-1; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Reif F., 1965, FUNDAMENTALS STAT TH; Smith GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/jcb.135.3.647; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Theriot JA, 2000, TRAFFIC, V1, P19, DOI 10.1034/j.1600-0854.2000.010104.x; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7	28	101	103	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2000	407	6807					1026	1029		10.1038/35039544	http://dx.doi.org/10.1038/35039544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069185				2022-12-01	WOS:000090032500049
J	Chua, JD; Wilkoff, BL; Lee, I; Juratli, N; Longworth, DL; Gordon, SM				Chua, JD; Wilkoff, BL; Lee, I; Juratli, N; Longworth, DL; Gordon, SM			Diagnosis and management of infections involving implantable electrophysiologic cardiac devices	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	North-American-Society-of-Pacing-and-Electrophysiology Meeting	MAY 12-15, 1999	TORONTO, CANADA	N Amer Soc Pacing & Electrophysiol			CARDIOVERTER-DEFIBRILLATORS; PACEMAKER LEADS; REMOVAL; ENDOCARDITIS	Background: Optimal treatment of infections related to implantable electrophysiologic cardiac devices is poorly defined. Objective: To describe the clinical presentation, treatment, and outcome of patients with such infections. Design: Retrospective we series. Setting: The Cleveland Clinic Foundation, Cleveland, Ohio. Patients: 123 patients with infections involving implantable cardiac electrophysiologic devices. Measurements: Demographic characteristics, clinical manifestations, time to diagnosis, management, and outcome. Results: 87 patients with permanent pacemakers and 36 patients with implantable cardioverter defibrillators had infections. The most common signs and symptoms were pocket erythema and local pain. The most common pathogens were coagulase-negative staphylococci (68%) and Staphylococcus aureus (23%). In 117 patients (95%), all equipment was extracted and antibiotic therapy lasted a median of 28 days. Operative mortality was zero. Follow-up showed crude mortality and relapse rates of 8% and 3%, respectively. Conclusion: For infections related to implantable electrophysiologic devices, complete device removal and antimicrobial therapy allow timely, successful reimplantation at a remote anatomic site without substantial risk for operative mortality or recurrent infection.	Cleveland Clin Fdn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Wilkoff, BL (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave,F-15, Cleveland, OH 44195 USA.							ARBER N, 1994, MEDICINE, V73, P299, DOI 10.1097/00005792-199411000-00003; BYRD CL, 2000, CLIN CARDIAC PACING, P669; Cacoub P, 1998, AM J CARDIOL, V82, P480, DOI 10.1016/S0002-9149(98)00365-8; CAMUS C, 1993, CLIN INFECT DIS, V17, P46, DOI 10.1093/clinids/17.1.46; FRAME R, 1993, PACE, V16, P2343, DOI 10.1111/j.1540-8159.1993.tb02348.x; KEARNEY RA, 1994, ANN INTERN MED, V121, P219, DOI 10.7326/0003-4819-121-3-199408010-00010; Klug D, 1997, CIRCULATION, V95, P2098, DOI 10.1161/01.CIR.95.8.2098; Lai KK, 1998, CLIN INFECT DIS, V27, P265, DOI 10.1086/514673; Lee JH, 1996, PACE, V19, P437, DOI 10.1111/j.1540-8159.1996.tb06514.x; Molina JE, 1997, ANN THORAC SURG, V63, P504; ONunain S, 1997, J THORAC CARDIOV SUR, V113, P121, DOI 10.1016/S0022-5223(97)70407-0; POHLMAN JK, 1995, J CLIN MICROBIOL, V33, P2856, DOI 10.1128/JCM.33.11.2856-2858.1995; Samuels LE, 1997, ANN THORAC SURG, V64, P1702, DOI 10.1016/S0003-4975(97)00920-X; Smith PN, 1998, PACE, V21, P42, DOI 10.1111/j.1540-8159.1998.tb01060.x; SPRATT KA, 1993, CLIN INFECT DIS, V17, P679; TRAPPE HJ, 1995, BRIT HEART J, V73, P20; Turkisher V, 1997, PACE, V20, P2268, DOI 10.1111/j.1540-8159.1997.tb04247.x; Victor F, 1999, HEART, V81, P82, DOI 10.1136/hrt.81.1.82; Wilkoff BL, 1999, J AM COLL CARDIOL, V33, P1671, DOI 10.1016/S0735-1097(99)00074-1	19	333	346	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					604	608		10.7326/0003-4819-133-8-200010170-00011	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	364RH	11033588				2022-12-01	WOS:000089906300005
J	Joossens, L; Raw, M				Joossens, L; Raw, M			How can cigarette smuggling be reduced?	BRITISH MEDICAL JOURNAL			English	Article							EUROPE		Int Union Against Canc, EU Liaison Off, B-1040 Brussels, Belgium; Univ London, Guys Kings & St Thomass Sch Med, Dept Publ Hlth Sci, London, England	University of London; King's College London	Joossens, L (corresponding author), Int Union Against Canc, EU Liaison Off, Rue Pascale 33, B-1040 Brussels, Belgium.							[Anonymous], 2000, TOBACCO CONTROL DEV; *ATT GEN CAN, 1999, COMPL DAM INJ DECL R; *BATCO, 1994, GLOB 5 YEAR PLAN; CLARKE K, 2000, GUARDIAN        0203, P19; *COMM EUR COMM, 1999, PROT COMM FIN INT FI; *HLTH CAN, 1994, SURV SMOK CAN CYCL 1; *HM TREAS HM CUST, 2000, TOB SMUGGL TOLD YOUR; *HOUS COMM SEL COM, 2000, 2 HOUS COMM SEL COMM; JOOSSENS L, 1995, BRIT MED J, V310, P1393, DOI 10.1136/bmj.310.6991.1393; Joossens L, 1998, TOB CONTROL, V7, P66, DOI 10.1136/tc.7.1.66; *MARK TRACK INT, 1998, WORLD TOB FIL 1998; MARSDEN W, 1999, GAZETTE         1218, P1; *REUT, 2000, EU WILL SUE AM TOB C; SWEANOR DT, 1997, SMUGGLING TOBACCO PR; 2000, GUARDIAN        0402, P21	15	68	69	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					947	950		10.1136/bmj.321.7266.947	http://dx.doi.org/10.1136/bmj.321.7266.947			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030690	Green Published			2022-12-01	WOS:000089975100029
J	Gibson, MC; Schubiger, G				Gibson, MC; Schubiger, G			Peripodial cells regulate proliferation and patterning of Drosophila imaginal discs	CELL			English	Article							WING DISKS; GENE; EYE; MELANOGASTER; EXPRESSION; DIFFERENTIATION; MORPHOGENESIS; COMPARTMENTS; POLYPEPTIDE; EVAGINATION	Cells employ a diverse array of signaling mechanisms to establish spatial patterns during development. Nowhere is this better understood than in Drosophila, where the limbs and eyes arise from discrete epithelial sacs called imaginal discs. Molecular-genetic analyses of pattern formation have generally treated discs as single epithelial sheets. Anatomically, however, discs comprise a columnar cell monolayer covered by a squamous epithelium known as the peripodial membrane. Here we demonstrate that during development, peripodial cells signal to disc columnar cells via microtubule-based apical extensions. Ablation and targeted gene misexpression experiments demonstrate that peripodial cell signaling contributes to growth control and pattern formation in the eye and wing primordia. These findings challenge the traditional view of discs as monolayers and provide foundational evidence for peripodial cell function in Drosophila appendage development.	Univ Washington, Dept Zool, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Schubiger, G (corresponding author), Univ Washington, Dept Zool, Seattle, WA 98195 USA.	gerold@u.washington.edu			NIGMS NIH HHS [GM58282, T32 GM07270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058282, T32GM007270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agnes F, 1999, DEVELOPMENT, V126, P5453; Allen MJ, 1999, J NEUROSCI, V19, P9374; AUERBACH C, 1936, T R SOC ED 3, V58; Basler K, 2000, EMBO J, V19, P1169, DOI 10.1093/emboj/19.6.1169; BLAIR SS, 1995, BIOESSAYS, V17, P299, DOI 10.1002/bies.950170406; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bryant PJ, 1999, CURR BIOL, V9, pR655, DOI 10.1016/S0960-9822(99)80416-3; BRYANT PJ, 1971, DEV BIOL, V26, P606, DOI 10.1016/0012-1606(71)90146-1; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Cohen S. M., 1993, DEV DROSOPHILA MELAN, P747; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Fan SS, 1997, DEVELOPMENT, V124, P1497; Fawcett DW, 1981, CELL, P410; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Fristrom D., 1993, DEV DROSOPHILA MELAN, P843; Gibson MC, 1999, DEVELOPMENT, V126, P1591; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; GUSTAFSON T, 1961, EXP CELL RES, V24, P64, DOI 10.1016/0014-4827(61)90248-8; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; Ju BG, 2000, NATURE, V405, P191, DOI 10.1038/35012090; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; KOOH PJ, 1993, DEVELOPMENT, V117, P493; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; MADHAVAN MM, 1977, ROUX ARCH DEV BIOL, V183, P269, DOI 10.1007/BF00848459; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.3.CO;2-O; MILLER J, 1995, DEVELOPMENT, V121, P2501; MILNER MJ, 1984, ROUX ARCH DEV BIOL, V193, P180, DOI 10.1007/BF00848893; Montell DJ, 1999, DEVELOPMENT, V126, P3035; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; NARDI JB, 1987, DEV BIOL, V119, P20, DOI 10.1016/0012-1606(87)90202-8; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Plough HH, 1935, GENETICS, V20, P0042; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Schubiger G., 1968, Wilhelm Roux Archiv fur Entwicklungsmechanik der Organismen, V160, P9, DOI 10.1007/BF00573645; SCHUBIGER G, 1971, DEV BIOL, V26, P277, DOI 10.1016/0012-1606(71)90127-8; SPEICHER SA, 1994, DEVELOPMENT, V120, P535; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Sun X, 1997, DEVELOPMENT, V124, P3439; SWAROOP A, 1987, P NATL ACAD SCI USA, V84, P6501, DOI 10.1073/pnas.84.18.6501; THOMAS U, 1991, DEVELOPMENT, V111, P749; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; Vincent S, 1997, DEVELOPMENT, V124, P2741; WatermanStorer CM, 1996, J BIOL CHEM, V271, P1153, DOI 10.1074/jbc.271.2.1153; Wolff Tanya, 1993, P1277; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947	51	80	81	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					343	350		10.1016/S0092-8674(00)00125-2	http://dx.doi.org/10.1016/S0092-8674(00)00125-2			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057906	Bronze			2022-12-01	WOS:000089864300017
J	Ogata, H; Audic, S; Barbe, V; Artiguenave, F; Fournier, PE; Raoult, D; Claverie, JM				Ogata, H; Audic, S; Barbe, V; Artiguenave, F; Fournier, PE; Raoult, D; Claverie, JM			Selfish DNA in protein-coding genes of Rickettsia	SCIENCE			English	Article							GENOME; SEQUENCE	Rickettsia conorii, the aetiological agent of Mediterranean spotted fever, is an intracellular bacterium transmitted by ticks. Preliminary analyses of the nearly complete genome sequence of R. conorii have revealed 44 occurrences of a previously undescribed palindromic repeat (150 base pairs Long) throughout the genome. Unexpectedly, this repeat was found inserted in-frame within 19 different R. conorii open reading frames likely to encode functional proteins. We found the same repeat in proteins of other Rickettsia species. The finding of a mobile element inserted in many unrelated genes suggests the potential role of selfish DNA in the creation of new protein sequences.	CNRS AVENTIS UMR 1889, F-13402 Marseille, France; Ctr Natl Sequencage, F-91000 Evry, France; Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS UPRES A 6020, F-13385 Marseille, France	Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Franche-Comte	Claverie, JM (corresponding author), CNRS AVENTIS UMR 1889, 31 Chemin Joseph Aiguier, F-13402 Marseille, France.		Fournier, Pierre-Edouard/AAC-6155-2021; RAOULT, Didier/A-8434-2008; Claverie, Jean Michel/Z-2183-2019; Claverie, Jean-Michel/AAG-4889-2019	Fournier, Pierre-Edouard/0000-0001-8463-8885; RAOULT, Didier/0000-0002-0633-5974; Claverie, Jean-Michel/0000-0003-1424-0315; Audic, Stephane/0000-0001-6193-4374				Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Audic S, 1998, P NATL ACAD SCI USA, V95, P10026, DOI 10.1073/pnas.95.17.10026; Bachellier S, 1999, RES MICROBIOL, V150, P627, DOI 10.1016/S0923-2508(99)00128-X; Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Kato S, 1998, CURR GENET, V34, P303, DOI 10.1007/s002940050400; MONCHOIS V, COMMUNICATION; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Perler FB, 1999, NUCLEIC ACIDS RES, V27, P346, DOI 10.1093/nar/27.1.346; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; SHARPLES GJ, 1990, NUCLEIC ACIDS RES, V18, P6503, DOI 10.1093/nar/18.22.6503; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443	18	88	106	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					347	350		10.1126/science.290.5490.347	http://dx.doi.org/10.1126/science.290.5490.347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030655				2022-12-01	WOS:000089818100047
J	Lee, EG; Boone, DL; Chai, S; Libby, SL; Chien, M; Lodolce, JP; Ma, A				Lee, EG; Boone, DL; Chai, S; Libby, SL; Chien, M; Lodolce, JP; Ma, A			Failure to regulate TNF-induced NF-kappa B and cell death responses in A20-deficient mice	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; ZINC-FINGER PROTEIN; A20; ACTIVATION; ALPHA; EXPRESSION; APOPTOSIS; INHIBITOR; SIGNAL	A20 is a cytoplasmic zinc finger protein that inhibits nuclear factor kappa B (NF-kappa B) activity and tumor necrosis factor (TNF)-mediated programmed cell death (PCD). TNF dramatically increases A20 messenger RNA expression in all tissues. Mice deficient far A20 develop severe inflammation and cachexia, are hypersensitive to both Lipopolysaccharide and TNF, and die prematurely. A20-deficient cells fail to terminate TNF-induced NF-kappa B responses. These cells are also more susceptible than control cells to undergo TNF-mediated PCD. Thus, AZO is critical for limiting inflammation by terminating TNF-induced NF-kappa B responses in vivo.	Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Ma, A (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 6084, Chicago, IL 60637 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007839, T32GM007183] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI045860] Funding Source: Medline; NIDDK NIH HHS [R01 DK052751] Funding Source: Medline; NIGMS NIH HHS [T32 GM007839, 5T32GM07183, T32 GM007183, T32GM07839] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; GIROIR BP, 1992, P NATL ACAD SCI USA, V89, P4864, DOI 10.1073/pnas.89.11.4864; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; TEWARI M, 1995, J IMMUNOL, V154, P1699; VAN AD, 1996, SCIENCE, V274, P787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WONG GHW, 1994, J IMMUNOL, V152, P1751; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	16	1145	1218	3	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2350	2354		10.1126/science.289.5488.2350	http://dx.doi.org/10.1126/science.289.5488.2350			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009421	Green Accepted			2022-12-01	WOS:000089593500053
J	Miller, JS; Venable, DL				Miller, JS; Venable, DL			Polyploidy and the evolution of gender dimorphism in plants	SCIENCE			English	Article							INBREEDING DEPRESSION; SELF-INCOMPATIBILITY; FLOWERING PLANTS; SEED PLANTS; DIOECY; INHERITANCE; ANGIOSPERMS; GYNODIOECY	Gender dimorphism and polyploidy are important evolutionary transitions that have evolved repeatedly in many plant families. We show that gender dimorphism in North American Lycium (Solanaceae) has evolved in polyploid, self-compatible taxa whose closest relatives are cosexual, self-incompatible diploids. This has occurred independently in South African Lycium. We present additional evidence for this pathway to gender dimorphism from 12 genera involving at Least 20 independent evolutionary events. We propose that polyploidy is a trigger of unrecognized importance for the evolution of gender dimorphism, which operates by disrupting self-incompatibility and leading to inbreeding depression. Subsequently, male sterile mutants invade and increase because they are unable to inbreed.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Miller, JS (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.							BAKER HG, 1984, AM NAT, V124, P149, DOI 10.1086/284260; BAKER HG, 1959, COLD SPRING HARB SYM, V24, P177, DOI 10.1101/SQB.1959.024.01.019; BAWA KS, 1980, ANNU REV ECOL SYST, V11, P15, DOI 10.1146/annurev.es.11.110180.000311; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth D., 1985, EVOLUTION ESSAYS HON, P237; CHARNOV EL, 1976, NATURE, V263, P125, DOI 10.1038/263125a0; Chawla B, 1997, THEOR APPL GENET, V95, P992, DOI 10.1007/s001220050652; Chiang-Cabrera F., 1981, THESIS U TEXAS AUSTI; DENETTANCOURT D, 1977, IMCOMPATIBILITY ANGI; DEWEY DR, 1969, CROP SCI, V9, P592, DOI 10.2135/cropsci1969.0011183X000900050023x; Geber MA, 1999, GENDER SEXUAL DIMORP; Husband BC, 1997, EVOLUTION, V51, P737, DOI 10.1111/j.1558-5646.1997.tb03657.x; JOHNSTON MO, 1994, EVOLUTION, V48, P1735, DOI 10.1111/j.1558-5646.1994.tb02209.x; KOHN JR, 1988, NATURE, V335, P431, DOI 10.1038/335431a0; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LLOYD DG, 1975, GENETICA, V45, P325, DOI 10.1007/BF01508307; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MCCOMB JA, 1968, AUST J BOT, V16, P525, DOI 10.1071/BT9680525; MILLER JA, UNPUB; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Richards A.J, 1997, PLANT BREEDING SYSTE; Richman AD, 1996, SCIENCE, V273, P1212, DOI 10.1126/science.273.5279.1212; Richman AD, 2000, PLANT MOL BIOL, V42, P169, DOI 10.1023/A:1006336206637; Ronfort J, 1999, GENET RES, V74, P31, DOI 10.1017/S0016672399003845; Stout AB, 1941, SCIENCE, V94, P118, DOI 10.1126/science.94.2431.118; SWOFFORD DL, 2000, PHYTOGENETIC ANAL US; THOMSON JD, 1990, TRENDS ECOL EVOL, V5, P11, DOI 10.1016/0169-5347(90)90006-Y; VENTER AM, 1999, 16 INT BOT C ST LOUI; Webb C.J., 1999, GENDER SEXUAL DIMORP, P61, DOI DOI 10.1007/978-3-662-03908-3_3; Wen J, 1996, MOL PHYLOGENET EVOL, V6, P167, DOI 10.1006/mpev.1996.0069	30	153	161	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2335	2338		10.1126/science.289.5488.2335	http://dx.doi.org/10.1126/science.289.5488.2335			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009416				2022-12-01	WOS:000089593500048
J	Hingson, RW; Heeren, T; Jamanka, A; Howland, J				Hingson, RW; Heeren, T; Jamanka, A; Howland, J			Age of drinking onset and unintentional injury involvement after drinking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALCOHOL-USE; ACCIDENTAL FALLS; RISK; INTERVENTIONS; BEHAVIORS; ADULTS; DEATH	Context In 1997, unintentional injury was the leading cause of death for persons aged 1 to 34 years. Approximately one third of deaths due to unintentional injury in the United States are estimated to be alcohol related. Onset of drinking at an early age has been found to be associated with alcohol dependence, but whether early-onset drinking increases risk for unintentional injury while drinking is unknown. Objective To explore whether persons who started drinking at an early age are more likely to have experienced unintentional injuries while under the influence of alcohol. Design and Setting The National Longitudinal Alcohol Epidemiology Survey, a cross-sectional survey conducted in 1992 of a representative sample of the US population. Participants A total of 42 862 randomly selected adults (response rate, 90%; mean age, 44 years). Main Outcome Measures Unintentional injury involvement while under the influence of alcohol by age of drinking onset (categorized as <14 years, each age from 14-20 years, or greater than or equal to 21 years). Results Relative to respondents who began drinking at age 21 years or older, those who started before age 14 years as well as those who started at each intervening age up to 21 years were significantly more likely to have been injured while under the influence of alcohol, even after controlling for history of alcohol dependence, heavy drinking frequency during the period that they drank most, family history of alcoholism, and other characteristics associated with earlier onset of drinking. After adjusting for these variables, odds ratios for having been injured while under the influence of alcohol were as follows: for younger than 14 years, 2.98 (95% confidence interval [CI], 2.29-3.89); age 14 years, 2.96 (95% CI, 2.26-3.88); age 15 years, 3.14 (95% CI, 2.48-3.97); age 16 years, 2.38 (95% CI, 1.90-2.98); age 17 years, 2.12 (95% CI, 1.66-2.71); age 18 years, 1.33 (95% CI, 1.08-1.64); age 19 years, 1.42 (95% CI, 1.07-1.89); and age 20 years, 1.39 (95% CI, 1.01-1.91). Conclusion Drinking onset at ages younger than 21 years is associated with;having experienced alcohol-related injuries.	Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Hingson, RW (corresponding author), Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, 715 Albany St,T 2W, Boston, MA 02118 USA.	rhingson@bu.edu		Howland, Jonathan/0000-0001-8079-1188; Heeren, Timothy/0000-0001-5643-3559				*CDC NAT CTR HLTH, 1999, OFF STAT PROGR DAT; CLAPPER RL, 1995, INT J ADDICT, V30, P507, DOI 10.3109/10826089509048741; Dinh-Zarr T, 1999, ALCOHOL ALCOHOLISM, V34, P609, DOI 10.1093/alcalc/34.4.609; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; *GEN ACC OFF, 1987, DRINK AG LAWS EV SYN; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Grant BF, 1998, ALCOHOL HEALTH RES W, V22, P144; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P37, DOI 10.1016/0376-8716(95)01134-K; HINGSON R, 1993, ADDICTION, V88, P877, DOI 10.1111/j.1360-0443.1993.tb02105.x; HINGSON R, 1987, J STUD ALCOHOL, V48, P212, DOI 10.15288/jsa.1987.48.212; Hingson R., 1990, J TRAFFIC MED, V3, P123; HONKANEN R, 1983, J STUD ALCOHOL, V44, P231, DOI 10.15288/jsa.1983.44.231; HOWLAND J, 1988, ACCIDENT ANAL PREV, V20, P19, DOI 10.1016/0001-4575(88)90011-5; JONES NE, 1992, AM J PUBLIC HEALTH, V82, P112, DOI 10.2105/AJPH.82.1.112; MASSEY JT, 1985, VITAL HLTH STAT REPO, V2; *NAT HIGHW TRAFF S, 1996, US DEP TRANSP PUBL; *NAT HIGHW TRAFF S, 1998, TRAFF SAF FACTS 1997; *NAT HIGHW TRAFF S, 1998, TRAFF SAF FACTS ALC; O'Malley PM, 1999, AM J PUBLIC HEALTH, V89, P678, DOI 10.2105/AJPH.89.5.678; OMALLEY PM, 1991, J STUD ALCOHOL, V52, P478, DOI 10.15288/jsa.1991.52.478; Prescott CA, 1999, ALCOHOL CLIN EXP RES, V23, P101, DOI 10.1111/j.1530-0277.1999.tb04029.x; Robins L. N., 1993, MENTAL DISORDER CRIM, P173; Schuckit MA, 1999, JAMA-J AM MED ASSOC, V281, P1875, DOI 10.1001/jama.281.20.1875; Shah BV, 1996, SUDAAN USERS MANUAL; Smith GS, 1999, ANN EMERG MED, V33, P659, DOI 10.1016/S0196-0644(99)70195-2; Zador PL, 2000, J STUD ALCOHOL, V61, P387, DOI 10.15288/jsa.2000.61.387; ZADOR PL, 1991, J STUD ALCOHOL, V52, P302, DOI 10.15288/jsa.1991.52.302	27	219	219	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1527	1533		10.1001/jama.284.12.1527	http://dx.doi.org/10.1001/jama.284.12.1527			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355HF	11000646	Green Submitted, Bronze			2022-12-01	WOS:000089379700028
J	Lin, SJ; Defossez, PA; Guarente, L				Lin, SJ; Defossez, PA; Guarente, L			Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae	SCIENCE			English	Article							GENE-EXPRESSION; YEAST; PATHWAY; RAS; MECHANISMS; COMPLEX; MUTANTS; STRESS	Calorie restriction extends Life-span in a wide variety of organisms. Although it has been suggested that calorie restriction may work by reducing the levels of reactive oxygen species produced during respiration. the mechanism by which this regimen slows aging is uncertain. Here, we mimicked calorie restriction in yeast by physiological or genetic means and showed a substantial extension in Life-span. This extension was not observed in strains mutant for SIR2 (which encodes the silencing protein Sir2p) or NPT1 (a gene in a pathway in the synthesis of NAD, the oxidized form of nicotinamide adenine dinucleotide), These findings suggest that the increased longevity induced by calorie restriction requires the activation of Sir2p by NAD.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Defossez, Pierre-Antoine/0000-0002-6463-9263	NIA NIH HHS [5-F32-AG05857-02] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [F32AG005857] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BROACH JR, 1991, TRENDS GENET, V7, P28, DOI 10.1016/0168-9525(91)90018-L; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Grubmeyer CT, 1999, METHOD ENZYMOL, V308, P28; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lin S.-T., UNPUB; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Rajavel M, 1998, BIOCHEMISTRY-US, V37, P4181, DOI 10.1021/bi9720134; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; WALSH RB, 1983, J BACTERIOL, V154, P1002, DOI 10.1128/JB.154.2.1002-1004.1983; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; YU BP, 1994, MODULATION AGING PRO	24	1381	1441	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2126	2128		10.1126/science.289.5487.2126	http://dx.doi.org/10.1126/science.289.5487.2126			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000115				2022-12-01	WOS:000089430900045
J	Turner, GC; Varshavsky, A				Turner, GC; Varshavsky, A			Detecting and measuring cotranslational protein degradation in vivo	SCIENCE			English	Article							N-END RULE; SACCHAROMYCES-CEREVISIAE; IN-VITRO; UBIQUITIN; PROTEASOME	Nascent polypeptides emerging from the ribosome and not yet folded may at Least transiently present degradation signals similar to those recognized by the ubiquitin system in misfolded proteins. The ubiquitin sandwich technique was used to detect and measure cotranslational protein degradation in living cells. More than 50 percent of nascent protein molecules bearing an amino-terminal degradation signal can be degraded cotranslationally, never reaching their mature size before their destruction by processive proteolysis. Thus, the folding of nascent proteins, including abnormal ones, may be in kinetic competition with pathways that target these proteins for degradation cotranslationally.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.			Turner, Glenn/0000-0002-5341-2784				BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DEGROOT RJ, 1991, P NATL ACAD SCI USA, V88, P8967, DOI 10.1073/pnas.88.20.8967; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; JOHNSSON N, 1994, EMBO J, V13, P2686, DOI 10.1002/j.1460-2075.1994.tb06559.x; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Liao W, 1998, J BIOL CHEM, V273, P27225, DOI 10.1074/jbc.273.42.27225; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Spirin A, 1986, RIBOSOME STRUCTURE P; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5	19	200	204	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2117	2120		10.1126/science.289.5487.2117	http://dx.doi.org/10.1126/science.289.5487.2117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000112				2022-12-01	WOS:000089430900042
J	Jouven, X; Zureik, M; Desnos, M; Courbon, D; Ducimetiere, P				Jouven, X; Zureik, M; Desnos, M; Courbon, D; Ducimetiere, P			Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; MITRAL-VALVE PROLAPSE; PROGNOSTIC-SIGNIFICANCE; HEART-DISEASE; FOLLOW-UP; HYPERTROPHIC CARDIOMYOPATHY; TREADMILL EXERCISE; HEALTHY-MEN; ARRHYTHMIAS; PREVALENCE	Background: Exercise testing is widely used in the diagnosis of coronary artery disease, but the long-term outcome for asymptomatic persons with exercise-induced premature ventricular depolarizations remains unclear. We used data from the Paris Prospective Study I to assess the long-term outcome of such persons. Methods: A total of 6101 asymptomatic French men (42 to 53 years of age) who were free of clinically detectable cardiovascular disease underwent a standardized graded exercise test between 1967 and 1972. Subjects were prospectively classified as having or not having frequent premature ventricular depolarizations (a run of two or more consecutive premature ventricular depolarizations or premature ventricular depolarizations constituting more than 10 percent of all ventricular depolarizations during any of the 30-second electrocardiographic recordings). Results: During exercise, 138 subjects had frequent premature ventricular depolarizations. After 23 years of follow-up, these subjects had a higher risk of death from cardiovascular causes than the men without frequent premature ventricular depolarizations during exercise (relative risk, 2.67; 95 percent confidence interval, 1.76 to 4.07). In a multivariate model, with adjustment for standard coronary risk factors and the presence or absence of premature ventricular depolarizations before exercise and during recovery from exercise, both exercise-induced ischemia and the occurrence of frequent premature ventricular depolarizations during exercise remained independently associated with an increased risk of death from cardiovascular causes, with similar relative risks (2.63 [95 percent confidence interval, 1.93 to 3.59] and 2.53 [95 percent confidence interval, 1.65 to 3.88], respectively). Conclusions: The occurrence of frequent premature ventricular depolarizations during exercise in asymptomatic middle-aged men is associated with a long-term increase in the risk of death from cardiovascular causes. (N Engl J Med 2000;343:826-33.) (C) 2000, Massachusetts Medical Society.	Univ Paris 05, Serv Cardiol, Hop Europeen Georges Pompidou, Fac Necker Enfants Malad, F-75015 Paris, France; Hop Paul Brousse, INSERM, U258, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jouven, X (corresponding author), Univ Paris 05, Serv Cardiol, Hop Europeen Georges Pompidou, Fac Necker Enfants Malad, 20 Rue Le Blanc, F-75015 Paris, France.	xavier.jouven@bcc.ap-hop-paris.fr	Zureik, Mahmoud/F-7855-2018	Zureik, Mahmoud/0000-0002-8393-4217				BRUCE RA, 1980, AM J CARDIOL, V46, P371, DOI 10.1016/0002-9149(80)90003-X; CALIFF RM, 1983, J AM COLL CARDIOL, V2, P1060, DOI 10.1016/S0735-1097(83)80330-1; DIMSDALE JE, 1984, JAMA-J AM MED ASSOC, V251, P630, DOI 10.1001/jama.251.5.630; DRORY Y, 1990, AM J CARDIOL, V66, P1092, DOI 10.1016/0002-9149(90)90510-8; DUCIMETIERE P, 1980, LANCET, V1, P1346; FARIS JV, 1976, AM J CARDIOL, V37, P617, DOI 10.1016/0002-9149(76)90404-5; FILIPOVSKY J, 1992, HYPERTENSION, V20, P333, DOI 10.1161/01.HYP.20.3.333; FLEG JL, 1984, AM J CARDIOL, V54, P762, DOI 10.1016/S0002-9149(84)80204-0; Fontaine G, 1998, CIRCULATION, V97, P1532, DOI 10.1161/01.CIR.97.16.1532; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Froelicher V F Jr, 1974, Am J Cardiol, V34, P770, DOI 10.1016/0002-9149(74)90694-8; GIAGNONI E, 1983, NEW ENGL J MED, V309, P1085, DOI 10.1056/NEJM198311033091803; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; GORDON DJ, 1986, CIRCULATION, V74, P252, DOI 10.1161/01.CIR.74.2.252; JANSSEN MJA, 1995, EUR HEART J, V16, P674, DOI 10.1093/oxfordjournals.eurheartj.a060972; Kuck KH, 1997, PACE, V20, P2706, DOI 10.1111/j.1540-8159.1997.tb06120.x; La Vecchia L, 1998, CLIN CARDIOL, V21, P731; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; Maron BJ, 1997, LANCET, V350, P1330; MCHENRY PL, 1984, CIRCULATION, V70, P547, DOI 10.1161/01.CIR.70.4.547; Michaelides AP, 1999, NEW ENGL J MED, V340, P340, DOI 10.1056/NEJM199902043400502; MORROW K, 1993, ANN INTERN MED, V118, P689, DOI 10.7326/0003-4819-118-9-199305010-00005; NAIR CK, 1983, J AM COLL CARDIOL, V1, P1201, DOI 10.1016/S0735-1097(83)80130-2; Pogwizd SM, 1998, CIRCULATION, V98, P2404, DOI 10.1161/01.CIR.98.22.2404; Rywik TM, 1998, CIRCULATION, V97, P2117, DOI 10.1161/01.CIR.97.21.2117; SAMI M, 1984, AM J CARDIOL, V54, P1182, DOI 10.1016/S0002-9149(84)80064-8; Shaw LJ, 1998, CIRCULATION, V98, P1622, DOI 10.1161/01.CIR.98.16.1622; SPIRITO P, 1989, NEW ENGL J MED, V320, P749, DOI 10.1056/NEJM198903233201201; TOFF WD, 1988, EUR HEART J SUPPL, V9, pG119; UDALL JA, 1977, CIRCULATION, V56, P985, DOI 10.1161/01.CIR.56.6.985; VEDIN JA, 1972, AM J CARDIOL, V29, P25, DOI 10.1016/0002-9149(72)90120-8; WEINER DA, 1984, J AM COLL CARDIOL, V3, P772, DOI 10.1016/S0735-1097(84)80254-5; *WHO, 1967, INT CLASS DIS MAN IN, V1, P3	33	161	172	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2000	343	12					826	833		10.1056/NEJM200009213431201	http://dx.doi.org/10.1056/NEJM200009213431201			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354XB	10995861				2022-12-01	WOS:000089355600001
J	Lerner, LS				Lerner, LS			Good and bad science in US schools - One-third of US states have unsatisfactory standards for teaching evolution.	NATURE			English	Editorial Material									Calif State Univ Long Beach, Long Beach, CA 90840 USA	California State University System; California State University Long Beach	Lerner, LS (corresponding author), Calif State Univ Long Beach, Long Beach, CA 90840 USA.								0	26	27	1	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					287	290		10.1038/35030204	http://dx.doi.org/10.1038/35030204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014166				2022-12-01	WOS:000089390700019
J	Gigant, B; Curmi, PA; Martin-Barbey, C; Charbaut, E; Lachkar, S; Lebeau, L; Siavoshian, S; Sobel, A; Knossow, M				Gigant, B; Curmi, PA; Martin-Barbey, C; Charbaut, E; Lachkar, S; Lebeau, L; Siavoshian, S; Sobel, A; Knossow, M			The 4 angstrom X-ray structure of a tubulin : stathmin-like domain complex	CELL			English	Article							MICROTUBULE-DESTABILIZING ACTIVITY; NEURON-ENRICHED PHOSPHOPROTEIN; MOLECULAR REPLACEMENT; PROTEIN SCG10; DOUBLE RINGS; IN-VITRO; PHOSPHORYLATION; DYNAMICS; ONCOPROTEIN-18; GROWTH	Phosphoproteins of the stathmin family interact with the alpha beta tubulin heterodimer (tubulin) and hence interfere with microtubule dynamics. The structure of the complex of GDP-tubulin with the stathmin-like domain of the neural protein RB3 reveals a head-to-tail assembly of two tubulins with a 91-residue RB3 alpha helix in which each copy of an internal duplicated sequence interacts with a different tubulin. As a result of the relative orientations adopted by tubulins and by their alpha and beta subunits, the tubulin:RB3 complex forms a curved structure. The RB3 helix thus most likely prevents incorporation of tubulin into microtubules by holding it in an assembly with a curvature very similar to that of the depolymerization products of microtubules.	Lab Enzymol & Biochim Struct, CNRS, UPR 9063, F-91198 Gif Sur Yvette, France; Inst Fer Moulin, INSERM, U440, F-75005 Paris, France; Fac Pharm, CNRS, UMR 7514, F-67401 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Knossow, M (corresponding author), Lab Enzymol & Biochim Struct, CNRS, UPR 9063, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	knossow@lebs.cnrs-gif.fr	Lebeau, Luc/M-9964-2019; CURMI, Patrick/G-4036-2013	CURMI, Patrick A./0000-0001-5045-8501; Gigant, Benoit/0000-0002-5946-6759; Lebeau, Luc/0000-0002-3276-6727				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antonsson B, 1998, J BIOL CHEM, V273, P8439, DOI 10.1074/jbc.273.14.8439; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; CURMI PA, 1994, BIOCHEM J, V300, P331, DOI 10.1042/bj3000331; DIAZ JF, 1994, J MOL BIOL, V238, P214, DOI 10.1006/jmbi.1994.1282; DiPaolo G, 1997, FEBS LETT, V416, P149, DOI 10.1016/S0014-5793(97)01188-5; DOYE V, 1989, J BIOL CHEM, V264, P12134; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gavet O, 1998, J CELL SCI, V111, P3333; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; HAILAT N, 1990, ONCOGENE, V5, P1615; Horwitz SB, 1997, J BIOL CHEM, V272, P8129, DOI 10.1074/jbc.272.13.8129; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Larsson NL, 1999, MOL CELL BIOL, V19, P2242; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; MAUCUER A, 1990, FEBS LETT, V264, P275, DOI 10.1016/0014-5793(90)80266-L; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; MELKI R, 1989, BIOCHEMISTRY-US, V28, P9143, DOI 10.1021/bi00449a028; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; NAVAZA J, 1995, ACTA CRYSTALLOGR A, V51, P445, DOI 10.1107/S0108767394011335; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Redeker V, 2000, J BIOL CHEM, V275, P6841, DOI 10.1074/jbc.275.10.6841; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; SOBEL A, 1989, J BIOL CHEM, V264, P3765; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; Wallon G, 2000, EMBO J, V19, P213, DOI 10.1093/emboj/19.2.213	43	211	217	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					809	816		10.1016/S0092-8674(00)00069-6	http://dx.doi.org/10.1016/S0092-8674(00)00069-6			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030624	Bronze			2022-12-01	WOS:000089395200012
J	Kolesnikova, OA; Entelis, NS; Mireau, H; Fox, TD; Martin, RP; Tarassov, IA				Kolesnikova, OA; Entelis, NS; Mireau, H; Fox, TD; Martin, RP; Tarassov, IA			Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm	SCIENCE			English	Article							TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; YEAST MITOCHONDRIA; TRYPANOSOMA-BRUCEI; PROTEIN; TRNA(LYS); AMINOACYLATION; IDENTITY; INVIVO; LEADER	Mitochondrial import of a cytoplasmic transfer RNA (tRNA) in yeast requires the preprotein import machinery and cytosolic factors. We investigated whether the tRNA import pathway can be used to correct respirator,, deficiencies due to mutations in the mitochondrial DNA and whether this system can be transferred into human cells. We show that cytoplasmic tRNAs with altered aminoacylation identity can be specifically targeted to the mitochondria and participate in mitochondrial translation. We also show that human mitochondria, which do not normally import tRNAs, are able to internalize yeast tRNA derivatives in vitro and that this import requires an essential yeast import factor.	Moscow MV Lomonosov State Univ, Dept Mol Biol, Moscow 119899, Russia; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Lomonosov Moscow State University; Cornell University	Tarassov, IA (corresponding author), Mecan Mol Div Cellulaire & Dev, CNRS, FRE 2168, 21 Rue Rene Descartes, F-57084 Strasbourg, France.	I.Tarassov@ibmc.u-strasbg.fr		Mireau, Hakim/0000-0002-2299-5139; Fox, Thomas/0000-0001-7629-3661	NIGMS NIH HHS [GM29362] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029362] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adhya S, 1997, J BIOL CHEM, V272, P21396, DOI 10.1074/jbc.272.34.21396; Aphasizhev R, 1997, RNA, V3, P489; BEATTIE DS, 1987, MITOCHONDRIA PRACTIC, P283; Dietrich A, 1996, PLANT J, V10, P913, DOI 10.1046/j.1365-313X.1996.10050913.x; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; Entelis NS, 1996, FEBS LETT, V384, P38, DOI 10.1016/0014-5793(96)00259-1; Entelis NS, 1998, P NATL ACAD SCI USA, V95, P2838, DOI 10.1073/pnas.95.6.2838; GAINES G, 1984, MOL CELL BIOL, V4, P1605, DOI 10.1128/MCB.4.8.1605; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Kazakova HA, 1999, FEBS LETT, V442, P193, DOI 10.1016/S0014-5793(98)01653-6; LI K, 1994, J CELL BIOL, V124, P871, DOI 10.1083/jcb.124.6.871; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; MARTIN RP, 1979, BIOCHEMISTRY-US, V18, P4600, DOI 10.1021/bi00588a021; MCKEE EE, 1984, J BIOL CHEM, V259, P9320; Mireau H, 2000, J BIOL CHEM, V275, P13291, DOI 10.1074/jbc.275.18.13291; MULERO JJ, 1993, MOL BIOL CELL, V4, P1327, DOI 10.1091/mbc.4.12.1327; Nabholz CE, 1999, MOL BIOL CELL, V10, P2547, DOI 10.1091/mbc.10.8.2547; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schneider Andre, 1994, Trends in Cell Biology, V4, P282, DOI 10.1016/0962-8924(94)90218-6; TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; TARASSOV IA, 1999, MITOCHONDRIAL DIS MO, P303; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WIESENBERGER G, 1995, MOL CELL BIOL, V15, P3291; Yermovsky-Kammerer AE, 1999, MOL CELL BIOL, V19, P6253	26	119	127	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2000	289	5486					1931	1933		10.1126/science.289.5486.1931	http://dx.doi.org/10.1126/science.289.5486.1931			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988073				2022-12-01	WOS:000089355800045
J	Glotzer, JB; Saltik, M; Chiocca, S; Michou, AI; Moseley, P; Cotten, M				Glotzer, JB; Saltik, M; Chiocca, S; Michou, AI; Moseley, P; Cotten, M			Activation of heat-shock response by an adenovirus is essential for virus replication	NATURE			English	Article							SIMIAN-VIRUS-40 LARGE-T; VIRAL-DNA REPLICATION; ESCHERICHIA-COLI; HUMAN HSP70; J-DOMAIN; TRANSCRIPTIONAL ACTIVATION; HUMAN CYTOMEGALOVIRUS; PROTEIN HSP70; CELL-LINE; GENE	Successful viral infection requires viruses to redirect host biochemistry to replicate the viral genome, and produce and assemble progeny virions. Cellular heat-shock responses, which are characterized as elevation and relocalization of heat-shock proteins, occur during replication of many viruses(1-7). Such responses might be host reactions to the synthesis of foreign protein, or might be irrelevant consequences of the viral need to activate transcription. Alternatively, as heat-shock proteins can facilitate protein folding(8,9), activating a heat-shock response might be a specific virus function ensuring proper synthesis of viral proteins and virions. It is not possible to determine whether heat-shock response is essential for virus replication, because the implicated viral genes (such as Ad5 E1A, ref. 10) also control other essential replication steps. Here we report that expression of Gam1, a protein encoded by the avian virus CELO (ref. 11), elevates and relocalizes hsp70 and hsp40. Gam1-negative CELO is replication-defective; however, Gam1 function can be partially replaced by either heat shock or forced hsp40 expression. Thus, an essential function of Gam1 during virus replication is to activate host heat-shock responses with hsp40 as a primary target.	Inst Mol Pathol, A-1030 Vienna, Austria; European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Univ New Mexico, Dept Med, Albuquerque, NM 87131 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); IRCCS European Institute of Oncology (IEO); University of New Mexico	Cotten, M (corresponding author), Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Chiocca, Susanna/K-5233-2016; Chiocca, Susanna/AAC-8863-2019	Chiocca, Susanna/0000-0002-9721-0850; Cotten, Matthew/0000-0002-3361-3351; Moseley, Pope/0000-0002-3723-9950				Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chiocca S, 1997, J VIROL, V71, P3168, DOI 10.1128/JVI.71.4.3168-3177.1997; Chiocca S, 1996, J VIROL, V70, P2939, DOI 10.1128/JVI.70.5.2939-2949.1996; COLLINS PL, 1982, J VIROL, V44, P703, DOI 10.1128/JVI.44.2.703-707.1982; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Flint J, 1997, ANNU REV GENET, V31, P177, DOI 10.1146/annurev.genet.31.1.177; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HATTORI H, 1992, CELL STRUCT FUNCT, V17, P77, DOI 10.1247/csf.17.77; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; KAO HT, 1983, MOL CELL BIOL, V3, P2058, DOI 10.1128/MCB.3.11.2058; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; Kelley WL, 1999, CURR BIOL, V9, pR305, DOI 10.1016/S0960-9822(99)80185-7; Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679; KOBAYASHI K, 1994, MICROBIOL IMMUNOL, V38, P321, DOI 10.1111/j.1348-0421.1994.tb01785.x; Liu JS, 1998, J BIOL CHEM, V273, P30704, DOI 10.1074/jbc.273.46.30704; Mayer MP, 1998, BIOL CHEM, V379, P261; Michou AI, 1999, J VIROL, V73, P1399, DOI 10.1128/JVI.73.2.1399-1410.1999; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; NEVINS JR, 1982, CELL, V29, P913, DOI 10.1016/0092-8674(82)90453-6; Ohgitani E, 1999, J GEN VIROL, V80, P63, DOI 10.1099/0022-1317-80-1-63; OHTSUKA K, 1993, BIOCHEM BIOPH RES CO, V197, P235, DOI 10.1006/bbrc.1993.2466; PHILLIPS B, 1991, J VIROL, V65, P5680, DOI 10.1128/JVI.65.11.5680-5692.1991; POLISSI A, 1995, FEMS MICROBIOL REV, V17, P159; SANTOMENNA LD, 1990, J VIROL, V64, P2033, DOI 10.1128/JVI.64.5.2033-2040.1990; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; Stubdal H, 1997, MOL CELL BIOL, V17, P4979, DOI 10.1128/MCB.17.9.4979; WELCH WJ, 1984, J BIOL CHEM, V259, P4501	30	145	152	2	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					207	211		10.1038/35025102	http://dx.doi.org/10.1038/35025102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001061				2022-12-01	WOS:000089241000053
J	Akoulitchev, S; Chuikov, S; Reinberg, D				Akoulitchev, S; Chuikov, S; Reinberg, D			TFIIH is negatively regulated by cdk8-containing mediator complexes	NATURE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL ACTIVATION; KINASE-ACTIVITY; PHOSPHORYLATION; CDK7; CTD; SRB; E1A; CAK	The mammalian cyclin-dependent kinase 8 (cdk8)(1) gene has been linked with a subset of acute lymphoblastic leukaemias(2), and its corresponding protein has been functionally implicated in regulation of transcription(3,4). Mammalian cdk8 and cyclin C, and their respective yeast homologues, Srb10 and Srb11, are components of the RNA polymerase II holoenzyme complex(5,6) where they function as a protein kinase that phosphorylates the carboxyterminal domain (CTD) of the largest subunit of RNA polymerase II (ref. 7). The yeast SRB10 and SRB11 genes have been implicated in the negative regulation of transcription(8). The cdk8/cyclin C protein complex is also found in a number of mammalian Mediator-like protein complexes(3,5,9-12), which repress activated transcription independently of the CTD in vitro(9,10). Here we show that cdk8/cyclin C can regulate transcription by targeting the cdk7/cyclin H subunits of the general transcription initiation factor IIH (TFIIH). cdk8 phosphorylates mammalian cyclin H in the vicinity of its functionally unique amino-terminal and carboxy-terminal alpha-helical domains(13). This phosphorylation represses both the ability of TFIIH to activate transcription and its CTD kinase activity. In addition, mimicking cdk8 phosphorylation of cyclin H in vivo has a dominant-negative effect on cell growth. Our results link the Mediator complex and the basal transcription machinery by a regulatory pathway involving two cyclin-dependent kinases. This pathway appears to be unique to higher organisms.	Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Dept Biochem, Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Reinberg, D (corresponding author), Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Dept Biochem, Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA.	reinbedf@umdnj.edu		Reinberg, Danny/0000-0003-4288-2016				Akoulitchev S, 1998, GENE DEV, V12, P3541, DOI 10.1101/gad.12.22.3541; Andersen G, 1997, EMBO J, V16, P958, DOI 10.1093/emboj/16.5.958; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; GE H, 1994, P NATL ACAD SCI USA, V91, P12691, DOI 10.1073/pnas.91.26.12691; Gold MO, 1996, NUCLEIC ACIDS RES, V24, P3771, DOI 10.1093/nar/24.19.3771; Gould K.L., 1994, PROTEIN KINASES, P149; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; Harper JW, 1998, GENE DEV, V12, P285, DOI 10.1101/gad.12.3.285; HAUER CA, 1989, NUCLEIC ACIDS RES, V17, P1989, DOI 10.1093/nar/17.5.1989; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Kazmi MA, 1996, BIOTECHNIQUES, V21, P304; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378; LeRoy G, 1998, J BIOL CHEM, V273, P7134, DOI 10.1074/jbc.273.12.7134; Li HM, 1996, GENOMICS, V32, P253, DOI 10.1006/geno.1996.0112; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Long JJ, 1998, MOL CELL BIOL, V18, P1467, DOI 10.1128/MCB.18.3.1467; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rickert P, 1996, ONCOGENE, V12, P2631; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871	29	290	309	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					102	106		10.1038/35024111	http://dx.doi.org/10.1038/35024111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993082				2022-12-01	WOS:000089124000051
J	Baron, R				Baron, R			Capsaicin and nociception: from basic mechanisms to novel drugs	LANCET			English	Editorial Material							INDUCED SECONDARY HYPERALGESIA; POSTHERPETIC NEURALGIA; TOPICAL CAPSAICIN; EVOKED PAIN; ALLODYNIA; RECEPTOR; TRIAL		Univ Kiel, Neurol Klin, D-24105 Kiel, Germany	University of Kiel	Baron, R (corresponding author), Univ Kiel, Neurol Klin, D-24105 Kiel, Germany.		Baron, Ralf/E-4298-2010					Baron R, 2000, BRAIN RES, V871, P75, DOI 10.1016/S0006-8993(00)02444-6; Baron R, 1999, NEUROLOGY, V53, P548, DOI 10.1212/WNL.53.3.548; BARON R, 1993, BRAIN, V116, P1477, DOI 10.1093/brain/116.6.1477; Baron R, 1999, NEUROLOGY, V52, P923, DOI 10.1212/WNL.52.5.923; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DONOFRIO P, 1991, ARCH INTERN MED, V151, P2225; Fields HL, 1998, NEUROBIOL DIS, V5, P209, DOI 10.1006/nbdi.1998.0204; Iadarola MJ, 1998, BRAIN, V121, P931, DOI 10.1093/brain/121.5.931; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; PARK KM, 1995, PAIN, V63, P163, DOI 10.1016/0304-3959(95)00029-R; Robbins WR, 1998, ANESTH ANALG, V86, P579, DOI 10.1097/00000539-199803000-00027; Sterner O, 1999, TRENDS PHARMACOL SCI, V20, P459, DOI 10.1016/S0165-6147(99)01393-0; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; WATSON CPN, 1993, CLIN THER, V15, P510; WATSON CPN, 1992, PAIN, V51, P375, DOI 10.1016/0304-3959(92)90223-X	18	36	37	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2000	356	9232					785	787		10.1016/S0140-6736(00)02649-0	http://dx.doi.org/10.1016/S0140-6736(00)02649-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022922				2022-12-01	WOS:000089101800005
J	Ma, YC; Huang, JY; All, S; Lowry, W; Huang, XY				Ma, YC; Huang, JY; All, S; Lowry, W; Huang, XY			Src tyrosine kinase is a novel direct effector of G proteins	CELL			English	Article							BETA-GAMMA-SUBUNITS; ADENYLYL-CYCLASE; CRYSTAL-STRUCTURE; MAP KINASE; C-SRC; COUPLED RECEPTORS; ALPHA-SUBUNITS; FAMILY KINASES; FIBROBLAST TRANSFORMATION; REGULATORY INTERACTIONS	Heterotrimeric G proteins transduce signals from cell surface receptors to modulate the activity of cellular effecters. Src, the product of the first characterized proto-oncogene and the first identified protein tyrosine kinase, plays a critical role in the signal transduction of G protein-coupled receptors. However, the mechanism of biochemical regulation of Src by G proteins is not known. Here we demonstrate that G alpha s and G alpha i, but neither G alpha q, G alpha 12 nor G beta gamma, directly stimulate the kinase activity of downregulated c-Src. G alpha s and G alpha i similarly modulate Hck, another member of Src-family tyrosine kinases. G alpha s and G alpha i bind to the catalytic domain and change the conformation of Src, leading to increased accessibility of the active site to substrates. These data demonstrate that the Src family tyrosine kinases are direct effecters of G proteins.	Cornell Univ, Coll Med, Dept Physiol, New York, NY 10021 USA	Cornell University	Huang, XY (corresponding author), Cornell Univ, Coll Med, Dept Physiol, New York, NY 10021 USA.			Ma, Yongchao/0000-0002-2469-4356	NIA NIH HHS [AG14563] Funding Source: Medline; NIGMS NIH HHS [GM56904] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014563] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKIHO H, 1993, ARCH BIOCHEM BIOPHYS, V304, P235, DOI 10.1006/abbi.1993.1344; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; Boerner RJ, 1996, BIOCHEMISTRY-US, V35, P9519, DOI 10.1021/bi960248u; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; BUSHMAN WA, 1990, P NATL ACAD SCI USA, V87, P7462, DOI 10.1073/pnas.87.19.7462; CHEN YH, 1994, J BIOL CHEM, V269, P27372; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.biochem.56.1.615; Grishina G, 1997, J BIOL CHEM, V272, P20619, DOI 10.1074/jbc.272.33.20619; Gu CH, 2000, J BIOL CHEM, V275, P20726, DOI 10.1074/jbc.M000152200; GUPTA SK, 1992, MOL CELL BIOL, V12, P190, DOI 10.1128/MCB.12.1.190; GUPTA SK, 1992, J BIOL CHEM, V267, P7987; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HAUSDORFF WP, 1992, P NATL ACAD SCI USA, V89, P5720, DOI 10.1073/pnas.89.13.5720; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.bi.54.070185.004341; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; ISHIDA M, 1995, CIRC RES, V77, P1053, DOI 10.1161/01.RES.77.6.1053; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; Kleuss C, 1997, P NATL ACAD SCI USA, V94, P6116, DOI 10.1073/pnas.94.12.6116; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LANGHANSRAJASEKARAN SA, 1995, P NATL ACAD SCI USA, V92, P8601, DOI 10.1073/pnas.92.19.8601; LEE E, 1994, METHOD ENZYMOL, V237, P146; LINDER ME, 1991, J BIOL CHEM, V266, P4654; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Ma YC, 1998, P NATL ACAD SCI USA, V95, P12197, DOI 10.1073/pnas.95.21.12197; MAGUIRE ME, 1980, J BIOL CHEM, V255, P1030; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; MOYERS JS, 1995, BIOCHEM J, V305, P411, DOI 10.1042/bj3050411; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; NEER EJ, 1985, P NATL ACAD SCI USA, V82, P6025, DOI 10.1073/pnas.82.18.6025; PACE AM, 1991, P NATL ACAD SCI USA, V88, P7031, DOI 10.1073/pnas.88.16.7031; PACE AM, 1995, MOL BIOL CELL, V6, P1685, DOI 10.1091/mbc.6.12.1685; Postma FR, 1998, J CELL BIOL, V140, P1199, DOI 10.1083/jcb.140.5.1199; PTASZNIK A, 1995, J BIOL CHEM, V270, P19969, DOI 10.1074/jbc.270.34.19969; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; Schieffer B, 1996, J BIOL CHEM, V271, P10329, DOI 10.1074/jbc.271.17.10329; Schieffer B, 1997, AM J PHYSIOL-CELL PH, V272, pC2019, DOI 10.1152/ajpcell.1997.272.6.C2019; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Simonson MS, 1996, J BIOL CHEM, V271, P77, DOI 10.1074/jbc.271.1.77; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Sondhi D, 1998, BIOCHEMISTRY-US, V37, P165, DOI 10.1021/bi9722960; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Sun GQ, 1998, ONCOGENE, V17, P1587, DOI 10.1038/sj.onc.1202076; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TORTI M, 1992, BIOCHEM BIOPH RES CO, V186, P440, DOI 10.1016/S0006-291X(05)80827-7; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; Wan Y, 1997, J BIOL CHEM, V272, P17209, DOI 10.1074/jbc.272.27.17209; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wolfgang WJ, 1996, P NATL ACAD SCI USA, V93, P14542, DOI 10.1073/pnas.93.25.14542; WONG TW, 1984, J BIOL CHEM, V259, P3127; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0	74	357	359	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 1	2000	102	5					635	646		10.1016/S0092-8674(00)00086-6	http://dx.doi.org/10.1016/S0092-8674(00)00086-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007482	Bronze			2022-12-01	WOS:000089105200012
J	Hannah, ME				Hannah, ME			Search for best tocolytic for preterm labour	LANCET			English	Editorial Material							RITODRINE; INDOMETHACIN; NIFEDIPINE; TRIAL		Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Obstet & Gynecol, Toronto, ON M5G 1N8, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Hannah, ME (corresponding author), Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Obstet & Gynecol, Toronto, ON M5G 1N8, Canada.							Abramov Y, 2000, OBSTET GYNECOL, V95, P482, DOI 10.1016/S0029-7844(99)00578-5; Agustines LA, 2000, AM J OBSTET GYNECOL, V182, P1113, DOI 10.1067/mob.2000.105386; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; GYERVAI K, 1999, OBSTET GYNECOL, V94, P869; HANNAH ME, 1995, J SOC OBSTET GYNAECO, V17, P1089; Kok JH, 1998, BRIT J OBSTET GYNAEC, V105, P162, DOI 10.1111/j.1471-0528.1998.tb10046.x; LEVENO KJ, 1990, OBSTET GYNECOL, V76, P12; Lye SJ, 1998, FETAL MATERNAL MED R, V10, P121, DOI DOI 10.1017/S096553959800031X); MOUTQUIN JM, 1992, NEW ENGL J MED, V327, P308; NORTON ME, 1993, NEW ENGL J MED, V329, P1602, DOI 10.1056/NEJM199311253292202; Oei SG, 1999, ACTA OBSTET GYN SCAN, V78, P783, DOI 10.1034/j.1600-0412.1999.780908.x; Panter KR, 1999, BRIT J OBSTET GYNAEC, V106, P467, DOI 10.1111/j.1471-0528.1999.tb08300.x; Papatsonis DNM, 1997, OBSTET GYNECOL, V90, P230, DOI 10.1016/S0029-7844(97)00182-8; Papatsonis DNM, 2000, OBSTET GYNECOL, V95, P477, DOI 10.1016/S0029-7844(99)00596-7; Smith GN, 1999, BRIT J OBSTET GYNAEC, V106, P736, DOI 10.1111/j.1471-0528.1999.tb08376.x	15	11	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 26	2000	356	9231					699	700		10.1016/S0140-6736(00)02626-X	http://dx.doi.org/10.1016/S0140-6736(00)02626-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347UU	11085687				2022-12-01	WOS:000088948200007
J	Deinum, J; Derkx, FHM				Deinum, J; Derkx, FHM			Cystatin for estimation of glomerular filtration rate?	LANCET			English	Editorial Material							SERUM CREATININE; RENAL-FUNCTION		Univ Hosp Dijkzigt, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands; Univ Hosp Dijkzigt, Dept Pharm, NL-3015 GD Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Derkx, FHM (corresponding author), Univ Hosp Dijkzigt, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands.							COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Keevil BG, 1998, CLIN CHEM, V44, P1535; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Randers E, 1999, CLIN CHEM LAB MED, V37, P389, DOI 10.1515/CCLM.1999.064; SIMONSEN O, 1985, SCAND J CLIN LAB INV, V45, P97, DOI 10.3109/00365518509160980; ZIETSE R, 1995, CLIN NEPHROL, V43, P29	7	41	46	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2000	356	9242					1624	1625		10.1016/S0140-6736(00)03152-4	http://dx.doi.org/10.1016/S0140-6736(00)03152-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372TB	11089817				2022-12-01	WOS:000165249200006
J	Caspersen, JP; Pacala, SW; Jenkins, JC; Hurtt, GC; Moorcroft, PR; Birdsey, RA				Caspersen, JP; Pacala, SW; Jenkins, JC; Hurtt, GC; Moorcroft, PR; Birdsey, RA			Contributions of land-use history to carbon accumulation in US forests	SCIENCE			English	Article								Carbon accumulation in forests has been attributed to historical changes in Land use and the enhancement of tree growth by CO2 fertilization, N deposition, and climate change. The relative contribution of land use and growth enhancement is estimated by using inventory data from five states spanning a latitudinal gradient in the eastern United States, Land use is the dominant factor governing the rate of carbon accumulation in these states, with growth enhancement contributing far Less than previously reported. The estimated fraction of aboveground net ecosystem production due to growth enhancement is 2.0 +/- 4.4%, with the remainder due to Land use.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; US Forest Serv, NE Res Stn, USDA, Burlington, VT 05402 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Complex Syst Res Ctr, Durham, NH 03824 USA; US Forest Serv, NE Res Stn, USDA, Newtown Sq, PA 19073 USA	Princeton University; United States Department of Agriculture (USDA); United States Forest Service; University System Of New Hampshire; University of New Hampshire; United States Department of Agriculture (USDA); United States Forest Service	Caspersen, JP (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA.	jpc@eno.princeton.edu	Gutierrez, Emilia/O-7568-2014; Hurtt, George/A-8450-2012	Gutierrez, Emilia/0000-0002-6085-5700; Hurtt, George/0000-0001-7278-202X				BIRDSEY RA, 1992, RM214 USDA FERS SERV; BIRDSEY RA, 1995, PRODUCTIVITY AM FORE, P56; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; HANSEN MH, 1992, NC151 USDA FOR SERV; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Mooney H.A., 1999, TERRESTRIAL BIOSPHER, P141; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Spiecker H., 1996, GROWTH TRENDS EUROPE; Steffen W, 1998, SCIENCE, V280, P1393	9	386	434	7	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2000	290	5494					1148	1151		10.1126/science.290.5494.1148	http://dx.doi.org/10.1126/science.290.5494.1148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	372HL	11073451				2022-12-01	WOS:000165228200044
J	Scully, KM; Jacobson, EM; Jepsen, K; Lunyak, V; Viadiu, H; Carriere, C; Rose, DW; Hooshmand, F; Aggarwal, AK; Rosenfeld, MG				Scully, KM; Jacobson, EM; Jepsen, K; Lunyak, V; Viadiu, H; Carriere, C; Rose, DW; Hooshmand, F; Aggarwal, AK; Rosenfeld, MG			Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification	SCIENCE			English	Article							GROWTH-HORMONE GENE; LOCUS-CONTROL REGION; CRYSTAL-STRUCTURE; TRANSGENIC MICE; PROMOTER ACTIVITY; THYROID-HORMONE; CO-REPRESSOR; OCA-B; BINDING; DOMAIN	Reciprocal gene activation and restriction during cell type differentiation from a common Lineage is a hallmark of mammalian organogenesis. A key question, then, is whether a critical transcriptional activator of cell type-specific gene targets can also restrict expression of the same genes in other cell types. Here, we show that whereas the pituitary-specific POU domain factor Pit-1 activates growth hormone gene expression in one cell type, the somatotrope, it restricts its expression from a second cell type, the lactotrope. This distinction depends on a two-base pair spacing in accommodation of the bipartite POU domains on a conserved growth hormone promoter site. The allosteric effect on Pit-1, in combination with other DNA binding factors, results in the recruitment of a corepressor complex. including nuclear receptor corepressor N-CoR, which, unexpectedly, is required for active Long-term repression of the growth hormone gene in lactotropes.	Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, New York, NY 10029 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Endocrinol & Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Transgen Res Unit, La Jolla, CA 92093 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Aggarwal, AK (corresponding author), Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, New York, NY 10029 USA.	aggarwal@inka.mssm.edu; mrosenfeld@ucsd.edu	Viadiu, Hector/E-7785-2013; lunyak, victoria/R-3765-2017	lunyak, victoria/0000-0001-9093-2714	NIDDK NIH HHS [R01 DK18477, R01 DK54802] Funding Source: Medline; NIGMS NIH HHS [R01 GM49327] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018477, R01DK054802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049327] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; Chasman D, 1999, GENE DEV, V13, P2650, DOI 10.1101/gad.13.20.2650; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CLEARY MA, 1993, GENE DEV, V7, P72, DOI 10.1101/gad.7.1.72; CRENSHAW EB, 1989, GENE DEV, V3, P959, DOI 10.1101/gad.3.7.959; Dasen JS, 1999, CURR OPIN GENET DEV, V9, P566, DOI 10.1016/S0959-437X(99)00015-5; Elefant F, 2000, J BIOL CHEM, V275, P13827, DOI 10.1074/jbc.275.18.13827; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; Glass CK, 2000, GENE DEV, V14, P121; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jin Y, 1999, MOL ENDOCRINOL, V13, P1249, DOI 10.1210/me.13.8.1249; JONES BK, 1995, MOL CELL BIOL, V15, P7010; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LIPKIN SM, 1993, GENE DEV, V7, P1674, DOI 10.1101/gad.7.9.1674; LIRA SA, 1988, P NATL ACAD SCI USA, V85, P4755, DOI 10.1073/pnas.85.13.4755; Liu Y, 1999, GENE DEV, V13, P1692, DOI 10.1101/gad.13.13.1692; LUO Y, 1995, MOL CELL BIOL, V15, P4115; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; SCHAUFELE F, 1990, J BIOL CHEM, V265, P17189; SCULLY KM, UNPUB; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270	33	208	210	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2000	290	5494					1127	1131		10.1126/science.290.5494.1127	http://dx.doi.org/10.1126/science.290.5494.1127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	372HL	11073444				2022-12-01	WOS:000165228200037
J	Girou, E; Schortgen, F; Delclaux, C; Brun-Buisson, C; Blot, F; Lefort, Y; Lemaire, F; Brochard, L				Girou, E; Schortgen, F; Delclaux, C; Brun-Buisson, C; Blot, F; Lefort, Y; Lemaire, F; Brochard, L			Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	International Conference of the American-Thoracic-Society	APR 23-28, 1999	SAN DIEGO, CALIFORNIA	Amer Thoracic Soc			ACUTE RESPIRATORY-FAILURE; POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; INTENSIVE-CARE UNIT; MECHANICAL VENTILATION; FACE MASK; AIRWAY PRESSURE; ATTRIBUTABLE MORTALITY; SUPPORT VENTILATION; ACUTE EXACERBATIONS	Context Invasive life-support techniques are a major risk factor for nosocomial infection. Noninvasive ventilation (NIV) can be used to avoid endotracheal intubation and may reduce morbidity among patients in intensive care units (ICUs). Objective To determine whether the use of NIV is associated with decreased risk of nosocomial infections and improved survival in everyday clinical practice among patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) or hypercapnic cardiogenic pulmonary edema (CPE). Design and setting Matched case-control study conducted in the medical ICU of a French university hospital from January 1996 through March 1998, Patients fifty patients with acute exacerbation of COPD or severe CPE who were treated with NIV for at least 2 hours and 50 patients treated with mechanical ventilation between 1993 and 1998 (controls), matched on diagnosis, Simplified Acute Physiology Score II, Logistic Organ Dysfunction score, age, and no contraindication to NIV. Main Outcome Measures Rates of nosocomial infections, antibiotic use, lengths of ventilatory support and of ICU stay, ICU mortality, compared between cases and controls, Results Rates of nosocomial infections and of nosocomial pneumonia were significantly lower in patients who received NIV than those treated with mechanical ventilation (18% vs 60% and 8% vs 22%; P<.001 and P=.04, respectively). Similarly, the daily risk of acquiring an infection (19 vs 39 episodes per 1000 patient-days; P=.05), proportion of patients receiving antibiotics for nosocomial infection (8% vs 26%, P=.01), mean (SD) duration of ventilation (6 [6] vs 10 [12] days; P=.01), mean (SD) length of ICU stay (9 [7] vs 15 [14] days; P=.02), and crude mortality (4% vs 26%; P=.002) were all lower among patients who received NIV than those treated with mechanical ventilation, Conclusions Use of NIV instead of mechanical ventilation is associated with a lower risk of nosocomial infections, less antibiotic use, shorter length of ICU stay, and lower mortality.	Assistance Publ Hop Paris, Hop Henri Mondor, Unite Hyg & Prevent Infect, F-94010 Creteil, France; Assistance Publ Hop Paris, Hop Henri Mondor, Serv Reanimat Med, F-94010 Creteil, France; Assistance Publ Hop Paris, Hop Henri Mondor, INSERM, U492, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Girou, E (corresponding author), Assistance Publ Hop Paris, Hop Henri Mondor, Unite Hyg & Prevent Infect, F-94010 Creteil, France.			Schortgen, Frederique/0000-0003-1756-7508				Antonelli M, 1998, NEW ENGL J MED, V339, P429, DOI 10.1056/NEJM199808133390703; Antonelli M, 2000, JAMA-J AM MED ASSOC, V283, P235, DOI 10.1001/jama.283.2.235; Barbe F, 1996, EUR RESPIR J, V9, P1240, DOI 10.1183/09031936.96.09061240; BERSTEN AD, 1991, NEW ENGL J MED, V325, P1825, DOI 10.1056/NEJM199112263252601; BOTT J, 1993, LANCET, V341, P1555, DOI 10.1016/0140-6736(93)90696-E; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; BROCHARD L, 1990, NEW ENGL J MED, V323, P1523, DOI 10.1056/NEJM199011293232204; BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873; CHEVROLET JC, 1991, CHEST, V100, P775, DOI 10.1378/chest.100.3.775; Confalonieri M., 1998, European Respiratory Journal, V12, p128S; CRAVEN DE, 1988, ARCH INTERN MED, V148, P1161, DOI 10.1001/archinte.148.5.1161; ELLIOTT M, 1994, PRINCIPLES PRACTICE, P427; Fagon JY, 1996, JAMA-J AM MED ASSOC, V275, P866, DOI 10.1001/jama.275.11.866; FAGON JY, 1993, AM J MED, V94, P281, DOI 10.1016/0002-9343(93)90060-3; Girou E, 1998, AM J RESP CRIT CARE, V157, P1151, DOI 10.1164/ajrccm.157.4.9701129; Guerin C, 1997, INTENS CARE MED, V23, P1024, DOI 10.1007/s001340050452; Guerin C, 1998, INTENS CARE MED, V24, P27, DOI 10.1007/s001340050510; Hillberg RE, 1997, NEW ENGL J MED, V337, P1746, DOI 10.1056/NEJM199712113372407; Kollef MH, 1999, NEW ENGL J MED, V340, P627, DOI 10.1056/NEJM199902253400807; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LIN M, 1995, CHEST, V107, P1379, DOI 10.1378/chest.107.5.1379; MAKI DG, 1989, ARCH INTERN MED, V149, P30, DOI 10.1001/archinte.149.1.30; Meduri GU, 1996, CHEST, V109, P179, DOI 10.1378/chest.109.1.179; Mehta S, 1997, CRIT CARE MED, V25, P620, DOI 10.1097/00003246-199704000-00011; Nava S, 1997, CHEST, V111, P1631, DOI 10.1378/chest.111.6.1631; Nava S, 1998, ANN INTERN MED, V128, P721, DOI 10.7326/0003-4819-128-9-199805010-00004; Nourdine K, 1999, INTENS CARE MED, V25, P567, DOI 10.1007/s001340050904; PHAM LH, 1991, AM REV RESPIR DIS, V143, P1055, DOI 10.1164/ajrccm/143.5_Pt_1.1055; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Rusterholtz T, 1999, INTENS CARE MED, V25, P21, DOI 10.1007/s001340050782; Sznajder M, 1998, INTENS CARE MED, V24, P582, DOI 10.1007/s001340050619; TEASDALE G, 1974, LANCET, V2, P81; Wood KA, 1998, CHEST, V113, P1339, DOI 10.1378/chest.113.5.1339; WYSOCKI M, 1995, CHEST, V107, P761, DOI 10.1378/chest.107.3.761	37	267	287	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2000	284	18					2361	2367		10.1001/jama.284.18.2361	http://dx.doi.org/10.1001/jama.284.18.2361			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369NU	11066187	Bronze			2022-12-01	WOS:000165074500031
J	Schenk, P; Madl, C; Rezaie-Majd, S; Lehr, S; Muller, C				Schenk, P; Madl, C; Rezaie-Majd, S; Lehr, S; Muller, C			Methylene blue improves the hepatopulmonary syndrome	ANNALS OF INTERNAL MEDICINE			English	Article							NITRIC-OXIDE SYNTHESIS; HYPERDYNAMIC CIRCULATION; SEPTIC SHOCK; EXHALED AIR; CIRRHOSIS; INHIBITION; RATS	Background: The hypoxemia of the hepatopulmonary syndrome, seen in patients with severe chronic liver dysfunction, results from widespread pulmonary vasodilation. No established drug therapy is available for this condition. Objective: To study the effect of methylene blue, a potent inhibitor of guanylate cyclase, in patients with severe hepatopulmonary syndrome, Design: Open, uncontrolled trial, Setting: Medical intensive care unit at the university hospital in Vienna, Austria. Patients: 7 patients with advanced cirrhosis and severe hepatopulmonary syndrome with Pao(2) of 60 mm Hg br less, Intervention: Insertion of a pulmonary artery catheter and an arterial indwelling catheter; intravenous administration of methylene blue, 3 mg/kg of body weight, over a 15-minute period. Measurements: Serial measurements of gas exchange and hemodynamic variables, Results: After methylene blue administration, Pao(2) increased in all patients (from a baseline mean +/- SD of 58 +/- 2.5 mm Hg to 74 +/- 11.5 mm Hg 5 hours after infusion; P = 0.006) and the alveolar-arterial difference for partial pressure of oxygen (PAO(2)-Pao(2)) decreased in all patients, with a maximum effect achieved after 5 hours (from 49 +/- 3.3 mm Hg to 30 +/- 10.4 mm Hg; P = 0.003); even after 10 hours, PAO(2)-Pao(2) was still significantly reduced compared with baseline (P = 0.041), Oxygenation improved because of reduction in shunt fraction (from 41% +/- 3.1% to 25% +/- 4.5%; P < 0.001). Mean pulmonary artery pressure increased (from 20 <plus/minus> 5.2 mm Hg to 23 +/- 3.6 mm Hg; P = 0.028), as did pulmonary vascular resistance (from 58 +/- 23 dyne/sec.cm(-5) to 115 +/- 56 dyne/sec.cm(-5); P = 0.012), Arterial blood pressure did not change significantly. Cardiac output decreased (from 10.6 +/- 2.2 L/min to 8.6 +/- 2.7 L/min; P = 0.008) and systemic vascular resistance increased (from 527 +/- 144 dyne/sec.cm(-5) to 729 +/- 222 dyne/sec.cm(-5); P = 0.037), Heart rate, central venous pressure, and pulmonary capillary wedge pressure remained unchanged. Conclusion: Intravenous methylene blue improved hypoxemia and hyperdynamic circulation in patients with liver cirrhosis and severe hepatopulmonary syndrome.	Univ Vienna, A-1090 Vienna, Austria	University of Vienna	Schenk, P (corresponding author), Univ Vienna, Allgemeines Krankenhaus Wien, Dept Internal Med 4, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	peter.schenk@akh-wien.ac.at						CALVER A, 1994, CLIN SCI, V86, P203, DOI 10.1042/cs0860203; CAMPILLO B, 1995, HEPATOLOGY, V22, P1423, DOI 10.1016/0270-9139(95)90147-7; Castro M, 1996, CLIN CHEST MED, V17, P35, DOI 10.1016/S0272-5231(05)70297-5; CREMONA G, 1995, EUR RESPIR J, V8, P1883, DOI 10.1183/09031936.95.08111883; Gachot B, 1995, INTENS CARE MED, V21, P1027, DOI 10.1007/BF01700666; Hori N, 1996, CLIN EXP PHARMACOL P, V23, P30; KROWKA MJ, 1994, CHEST, V105, P1528, DOI 10.1378/chest.105.5.1528; MARCZIN N, 1992, J PHARMACOL EXP THER, V263, P170; MATSUMOTO A, 1995, ANN INTERN MED, V123, P110, DOI 10.7326/0003-4819-123-2-199507150-00005; NIEDERBERGER M, 1995, GASTROENTEROLOGY, V109, P1624, DOI 10.1016/0016-5085(95)90652-5; Pilette C, 1996, J GASTROEN HEPATOL, V11, P1, DOI 10.1111/j.1440-1746.1996.tb00002.x; PREISER JC, 1995, CRIT CARE MED, V23, P259, DOI 10.1097/00003246-199502000-00010; RODRIGUEZROISIN R, 1992, THORAX, V47, P897, DOI 10.1136/thx.47.11.897; ROLLA G, 1994, NEW ENGL J MED, V331, P1098, DOI 10.1056/NEJM199410203311617; Rolla G, 1997, HEPATOLOGY, V26, P842, DOI 10.1002/hep.510260406; SOGNI P, 1995, J HEPATOL, V23, P471, DOI 10.1016/0168-8278(95)80207-X; VALLANCE P, 1991, LANCET, V337, P776, DOI 10.1016/0140-6736(91)91384-7; West JB, 1977, BIOENGINEERING ASPEC, P361; WRIGHT CE, 1992, CARDIOVASC RES, V26, P48, DOI 10.1093/cvr/26.1.48; ZHANG HB, 1995, CRIT CARE MED, V23, P1711, DOI 10.1097/00003246-199510000-00016	20	145	157	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2000	133	9					701	706		10.7326/0003-4819-133-9-200011070-00012	http://dx.doi.org/10.7326/0003-4819-133-9-200011070-00012			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PC	11074903				2022-12-01	WOS:000165075300005
J	Shen, Y; Naujokas, K; Park, M; Ireton, K				Shen, Y; Naujokas, K; Park, M; Ireton, K			InlB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase	CELL			English	Article							HEPATOCYTE GROWTH-FACTOR; PHOSPHOINOSITIDE 3-KINASE; EPITHELIAL MORPHOGENESIS; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; SURFACE PROTEIN; L-MONOCYTOGENES; NK1 FRAGMENT; ENTRY	The Listeria monocytogenes surface protein InlB promotes bacterial entry into mammalian cells. Here, we identify a cellular surface receptor required for InlB-mediated entry. Treatment of mammalian cells with InlB protein or infection with L. monocytogenes induces rapid tyrosine phosphorylation of Met, a receptor tyrosine kinase (RTK) for which the only known ligand is Hepatocyte Growth Factor (HGF). Like HGF, InlB binds to the extracellular domain of Met and induces "scattering" of epithelial cells. Experiments with Met-positive and Met-deficient cell lines demonstrate that Met is required for InlB-dependent entry of L. monocytogenes. InlB is a novel Met agonist that induces bacterial entry through exploitation of a host RTK pathway.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; McGill Univ, Mol Oncol Grp, Royal Victoria Hosp, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Mol Oncol Grp, Royal Victoria Hosp, Dept Oncol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Mol Oncol Grp, Royal Victoria Hosp, Dept Biochem, Montreal, PQ H3A 1A1, Canada	University of Toronto; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital	Ireton, K (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, 100 Coll St, Toronto, ON M5S 1A8, Canada.							Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Eggleton P, 1998, TRENDS CELL BIOL, V8, P428, DOI 10.1016/S0962-8924(98)01373-7; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; Greiffenberg L, 1998, INFECT IMMUN, V66, P5260, DOI 10.1128/IAI.66.11.5260-5267.1998; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; Kilby MD, 1996, GROWTH FACTORS, V13, P133, DOI 10.3109/08977199609034573; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; MARK MR, 1992, J BIOL CHEM, V267, P26166; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; NGUYEN LM, 1997, J BIOL CHEM, V27, P20811; Parida SK, 1998, MOL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2958.1998.00776.x; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Trusolino L, 1998, FASEB J, V12, P1267, DOI 10.1096/fasebj.12.13.1267; Ultsch M, 1998, STRUCT FOLD DES, V6, P1383, DOI 10.1016/S0969-2126(98)00138-5; Virji M, 1996, MICROBIOL-SGM, V142, P3319, DOI 10.1099/13500872-142-12-3319; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; ZHU H, 1994, CELL GROWTH DIFFER, V5, P359	32	386	412	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 27	2000	103	3					501	510		10.1016/S0092-8674(00)00141-0	http://dx.doi.org/10.1016/S0092-8674(00)00141-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081636	Bronze			2022-12-01	WOS:000090144100015
J	Barouch, DH; Santra, S; Schmitz, JE; Kuroda, MJ; Fu, TM; Wagner, W; Bilska, M; Craiu, A; Zheng, XX; Krivulka, GR; Beaudry, K; Lifton, MA; Nickerson, CE; Trigona, WL; Punt, K; Freed, DC; Guan, LM; Dubey, S; Casimiro, D; Simon, A; Davies, ME; Chastain, M; Strom, TB; Gelman, RS; Montefiori, DC; Lewis, MG; Emini, EA; Shiver, JW; Letvin, NL				Barouch, DH; Santra, S; Schmitz, JE; Kuroda, MJ; Fu, TM; Wagner, W; Bilska, M; Craiu, A; Zheng, XX; Krivulka, GR; Beaudry, K; Lifton, MA; Nickerson, CE; Trigona, WL; Punt, K; Freed, DC; Guan, LM; Dubey, S; Casimiro, D; Simon, A; Davies, ME; Chastain, M; Strom, TB; Gelman, RS; Montefiori, DC; Lewis, MG; Emini, EA; Shiver, JW; Letvin, NL			Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; IMMUNE-RESPONSES; CELL RESPONSES; DISEASE PROGRESSION; PROTECTION; INFECTION; MACAQUES; PROTEIN; HIV-1	With accumulating evidence indicating the importance of cytotoxic T Lymphocytes (CTLs) in containing human immunodeficiency virus-1 (HIV-1) replication in infected individuals, strategies are being pursued to elicit virus-specific CTLs with prototype HIV-1 vaccines. Here, we report the protective efficacy of vaccine-elicited immune responses against a pathogenic SHIV-89.6P challenge in rhesus monkeys. Immune responses were elicited by DNA vaccines expressing SIVmac239 Gag and HIV-1 89.6P Env, augmented by the administration of the purified fusion protein IL-2/Ig, consisting of interleukin-2 (IL-2) and the Fc portion of immunoglobulin G (IgG), or a plasmid encoding IL-2/Ig. After SHIV-89.6P infection, sham-vaccinated monkeys developed weak CTL responses, rapid Loss of CD4(+) T cells, no virus-specific CD4(+) T cell responses, high setpoint viral loads, significant clinical disease progression, and death in half of the animals by day 140 after challenge. in contrast, all monkeys that received the DNA vaccines augmented with IL-2/Ig were infected, but demonstrated potent secondary CTL responses, stable CD4(+) T cell counts, preserved virus-specific CD4(+) T cell responses, Low to undetectable setpoint viral Loads, and no evidence of clinical disease or mortality by day 140 after challenge.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Merck Res Labs, West Point, PA 19486 USA; So Res Inst, Frederick, MD 21701 USA; Duke Univ, Med Ctr, Durham, NC 27710 USA; Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Merck & Company; Duke University; Harvard University; Dana-Farber Cancer Institute	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, 330 Brookline Ave, Boston, MA 02215 USA.	dan_barouch@hotmail.com	Schmitz, Joern/A-4929-2018; Barouch, Dan/Y-3918-2019	Schmitz, Joern/0000-0001-8803-0922; 	NCI NIH HHS [CA-50139, R01 CA050139] Funding Source: Medline; NIAID NIH HHS [P01 AI041521, AI-65301, AI-85343] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI041521, N01AI085343] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; Allen TM, 1998, J IMMUNOL, V160, P6062; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barouch DH, 2000, P NATL ACAD SCI USA, V97, P4192, DOI 10.1073/pnas.050417697; Barouch DH, 1998, J IMMUNOL, V161, P1875; BAROUCH DH, UNPUB; Boyer JD, 1997, NAT MED, V3, P526, DOI 10.1038/nm0597-526; CHEN ZW, 1995, J EXP MED, V182, P21, DOI 10.1084/jem.182.1.21; Chow YH, 1997, J VIROL, V71, P169, DOI 10.1128/JVI.71.1.169-178.1997; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; Egan MA, 2000, J VIROL, V74, P7485, DOI 10.1128/JVI.74.16.7485-7495.2000; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Geissler M, 1997, J IMMUNOL, V158, P1231; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kent SJ, 1998, J VIROL, V72, P10180, DOI 10.1128/JVI.72.12.10180-10188.1998; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; LANDOLFI NF, 1991, J IMMUNOL, V146, P915; Letvin NL, 1997, P NATL ACAD SCI USA, V94, P9378, DOI 10.1073/pnas.94.17.9378; Lu S, 1996, J VIROL, V70, P3978, DOI 10.1128/JVI.70.6.3978-3991.1996; McMichael A, 1998, CELL, V93, P673, DOI 10.1016/S0092-8674(00)81428-2; MILLER MD, 1991, J IMMUNOL, V147, P320; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Nickerson P, 1996, Transpl Immunol, V4, P81, DOI 10.1016/S0966-3274(96)80043-8; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Reimann KA, 1999, VIROLOGY, V256, P15, DOI 10.1006/viro.1999.9632; Reimann KA, 1996, J VIROL, V70, P3198, DOI 10.1128/JVI.70.5.3198-3206.1996; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Robinson HL, 1999, NAT MED, V5, P526, DOI 10.1038/8406; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seth A, 2000, J VIROL, V74, P2502, DOI 10.1128/JVI.74.6.2502-2509.2000; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Xin KQ, 1998, IMMUNOLOGY, V94, P438, DOI 10.1046/j.1365-2567.1998.00533.x	41	787	832	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2000	290	5491					486	492		10.1126/science.290.5491.486	http://dx.doi.org/10.1126/science.290.5491.486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039923				2022-12-01	WOS:000089946000042
J	Pinto-Sietsma, SJ; Mulder, J; Janssen, WMT; Hillege, HL; de Zeeuw, D; de Jong, PE				Pinto-Sietsma, SJ; Mulder, J; Janssen, WMT; Hillege, HL; de Zeeuw, D; de Jong, PE			Smoking is related to albuminuria and abnormal renal function in nondiabetic persons	ANNALS OF INTERNAL MEDICINE			English	Article							GLYCOSYLATION END-PRODUCTS; INSULIN-RESISTANCE SYNDROME; CIGARETTE-SMOKING; MANIFEST NEPHROPATHY; DIABETES-MELLITUS; TREATED DIABETICS; SMOKERS; MICROALBUMINURIA; IMPAIRMENT; POPULATION	Background: smoking induces albuminuria and accelerates progression to renal failure in persons with diabetes, but little is known about the relation between smoking and renal function in nondiabetic persons. Objective: To investigate whether smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Design: cross-sectional study. Setting: Groningen, The Netherlands. Participants: 7476 participants in the PREVEND (Prevention of REnal and Vascular ENd stage Disease) Study. Measurements: Microalbuminuria and high normal albuminuria were defined as urinary albumin excretion of 30 to 300 mg/24 h and 15 to 30 mg/24 h, respectively. Elevated or decreased glomerular filtration rate (GFR) was defined as a creatinine clearance that exceeded or was less than two times the standard deviation of the mean value in nondiabetic, nonsmoking participants who had an albumin excretion of 0 to 15 mg/24 h, adjusted for age and sex. Results: current smokers had a higher median albumin excretion than nonsmokers and were more likely to have microalbuminuria and high normal albuminuria with elevated or decreased GFR. After adjustment for several potential confounding factors, persons who smoked 20 or fewer cigarettes/d and persons who smoked more than 20 cigarettes/d, respectively, showed a dose-dependent association between smoking and high normal albuminuria (relative risk, 1.33 [95% CI, 1.10 to 1.61] and 1.98 [CI, 1.49 to 2.64]), microalbuminuria (relative risk, 1.92 [CI, 1.54 to 2.39] and 2.15 [CI, 1.52 to 3.03]), elevated GFR (relative risk, 1.82 [CI, 1.31 to 2.53] and 1.84 [CI, 1.12 to 3.02]), and decreased GFR (relative risk, 1.53 [CI, 1.04 to 2.24] and 1.83 [CI, 1.05 to 3.20]), respectively. Quitting smoking was associated only with microalbuminuria. Conclusions: Smoking is associated with albuminuria and abnormal renal function. However, these associations are less pronounced or absent in former smokers.	Univ Groningen Hosp, Dept Internal Med, Div Nephrol, NL-9713 GZ Groningen, Netherlands; Univ Groningen, Inst Drug Explorat, Groningen, Netherlands	University of Groningen; University of Groningen	Pinto-Sietsma, SJ (corresponding author), Univ Groningen Hosp, Dept Internal Med, Div Nephrol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.		SJ, Pinto-Sietsma/AAI-3207-2021; de Zeeuw, Dick/E-9080-2014	de Zeeuw, Dick/0000-0003-3434-7777; Mulder, Jaap/0000-0001-5404-9203				ATTVALL S, 1993, J INTERN MED, V233, P327, DOI 10.1111/j.1365-2796.1993.tb00680.x; BIESENBACH G, 1994, NEPHROL DIAL TRANSPL, V9, P1097, DOI 10.1093/ndt/9.8.1097; BLACK HR, 1983, NEPHRON, V34, P173, DOI 10.1159/000183005; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Christiansen J S, 1978, Diabetes Care, V1, P146, DOI 10.2337/diacare.1.3.146; Cirillo M, 1998, ARCH INTERN MED, V158, P1933, DOI 10.1001/archinte.158.17.1933; COUPER JJ, 1994, DIABETIC MED, V11, P666, DOI 10.1111/j.1464-5491.1994.tb00330.x; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; EKBERG G, 1991, J INTERN MED, V230, P435, DOI 10.1111/j.1365-2796.1991.tb00469.x; EKBERG G, 1990, J INTERN MED, V228, P211; ELIASSON B, 1994, ARTERIOSCLER THROMB, V14, P1946, DOI 10.1161/01.ATV.14.12.1946; ESPOSITO C, 1989, J EXP MED, V170, P1387, DOI 10.1084/jem.170.4.1387; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Fliser D, 1998, KIDNEY INT, V53, P1343, DOI 10.1046/j.1523-1755.1998.00898.x; FORSBLOM CM, 1995, DIABETOLOGIA, V38, P363, DOI 10.1007/BF00400643; Gambaro G, 1998, J AM SOC NEPHROL, V9, P562; HAFFNER SM, 1993, DIABETOLOGIA, V36, P1002, DOI 10.1007/BF02374491; HAMMOND EC, 1966, EPIDEMIOLOGICAL APPR, P127; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; JANZON L, 1983, DIABETOLOGIA, V25, P86; Jarrett R J, 1984, Diabet Med, V1, P17; Karter AJ, 1996, DIABETES, V45, P1547, DOI 10.2337/diabetes.45.11.1547; KIOWSKI W, 1994, CIRCULATION, V90, P27, DOI 10.1161/01.CIR.90.1.27; Kubo M, 1999, KIDNEY INT, V55, P2450, DOI 10.1046/j.1523-1755.1999.00458.x; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; MAKITA Z, 1994, LANCET, V343, P1519, DOI 10.1016/S0140-6736(94)92935-1; METCALF PA, 1993, CLIN CHEM, V39, P1793; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; MUHLHAUSER I, 1986, DIABETOLOGIA, V29, P500, DOI 10.1007/BF00453501; NITENBERG A, 1993, AM J MED, V95, P71, DOI 10.1016/0002-9343(93)90234-G; Orth SR, 1997, KIDNEY INT, V51, P1669, DOI 10.1038/ki.1997.232; Park Sung Kwang, 1995, Korean Journal of Internal Medicine (English Edition), V10, P48; PINTOSIETSMA SJ, 2000, IN PRESS J AM SOC NE, V11; Remuzzi G, 1999, AM J KIDNEY DIS, V33, P807, DOI 10.1016/S0272-6386(99)70241-6; Ritz E, 1998, J AM SOC NEPHROL, V9, P1798; SELL DR, 1990, J CLIN INVEST, V85, P380, DOI 10.1172/JCI114449; TELMER S, 1984, ACTA MED SCAND, V215, P63; *US DHEW, 1973, PHS PUBL; VLASSARA H, 1992, P NATL ACAD SCI USA, V89, P12043, DOI 10.1073/pnas.89.24.12043; VORA JP, 1992, KIDNEY INT, V41, P829, DOI 10.1038/ki.1992.127	42	213	232	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					585	591		10.7326/0003-4819-133-8-200010170-00008	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033585				2022-12-01	WOS:000089906300002
J	Cho, KO; Chern, J; Izaddoost, S; Choi, KW				Cho, KO; Chern, J; Izaddoost, S; Choi, KW			Novel signaling from the peripodial membrane is essential for eye disc patterning in Drosophila	CELL			English	Article							SEGMENT POLARITY GENE; RETINAL DIFFERENTIATION; MORPHOGENETIC FURROW; IMAGINAL DISKS; ADULT HEAD; WINGLESS; HEDGEHOG; MELANOGASTER; EXPRESSION; INDUCTION	The Drosophila eye disc is a sac of single layer epithelium with two opposing sides, the peripodial membrane (PM) and the disc proper (DP). Retinal morphogenesis is organized by Notch signaling at the dorsoventral (DV) boundary in the DP. Functions of the PM in coordinating growth and patterning of the DP are unknown. We show that the secreted proteins, Hedgehog, Wingless, and Decapentaplegic, are expressed in the PM, yet they control DP expression of Notch ligands, Delta and Serrate. Peripodial clones expressing Hedgehog induce Serrate in the DP while loss of peripodial Hedgehog disrupts disc growth. Furthermore, PM cells extend cellular processes to the DP. Therefore, peripodial signaling is critical for eye pattern formation and may be mediated by peripodial processes.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Choi, KW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.		Cho, Kyung-Ok/C-1705-2011; Choi, Kwang-Wook/C-1707-2011	Choi, Kwang-Wook/0000-0002-8997-3065; Cho, Kyung-Ok/0000-0002-0760-2560				Agnes F, 1999, DEVELOPMENT, V126, P5453; BAKER NE, 1987, EMBO J, V6, P1765, DOI 10.1002/j.1460-2075.1987.tb02429.x; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Brennan CA, 2000, CELL MOL LIFE SCI, V57, P195, DOI 10.1007/PL00000684; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; BROWER DL, 1987, DEVELOPMENT, V101, P83; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; BRYANT PJ, 1975, J EXP ZOOL, V193, P49, DOI 10.1002/jez.1401930106; CARROLL SB, 1989, GENE DEV, V3, P905, DOI 10.1101/gad.3.6.905; Cavodeassi F, 1999, DEVELOPMENT, V126, P4933; Chen HX, 1999, CELL TISSUE RES, V296, P67, DOI 10.1007/s004410051267; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Cohen Stephen M., 1993, P747; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Fristrom Dianne, 1993, P843; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Gibson MC, 2000, CELL, V103, P343, DOI 10.1016/S0092-8674(00)00125-2; Gibson MC, 1999, DEVELOPMENT, V126, P1591; HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; Heberlein U, 1998, DEVELOPMENT, V125, P567; HEBERLEIN U, 1995, NATURE, V373, P709, DOI 10.1038/373709a0; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; JACOBSON AG, 1988, DEVELOPMENT, V104, P341; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; Ju BG, 2000, NATURE, V405, P191, DOI 10.1038/35012090; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919; Kehl BT, 1998, DEVELOPMENT, V125, P1217; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lindsley D.L., 1992, GENOME DROSOPHILA ME; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; MA CY, 1995, DEVELOPMENT, V121, P2279; McNeill H, 1997, GENE DEV, V11, P1073, DOI 10.1101/gad.11.8.1073; MILNER M J, 1984, Wilhelm Roux's Archives of Developmental Biology, V193, P406, DOI 10.1007/BF00848232; MILNER M J, 1983, Wilhelm Roux's Archives of Developmental Biology, V192, P164, DOI 10.1007/BF00848686; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Murone M, 1999, EXP CELL RES, V253, P25, DOI 10.1006/excr.1999.4676; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Netter S, 1998, GENETICS, V149, P257; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; Obara-Ishihara T, 1999, DEVELOPMENT, V126, P1103; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; PARKS AL, 1995, MECH DEVELOP, V50, P201, DOI 10.1016/0925-4773(94)00336-L; Penton A, 1996, NATURE, V382, P162, DOI 10.1038/382162a0; Pignoni F, 1997, DEVELOPMENT, V124, P271; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Reifegerste R, 1999, BIOESSAYS, V21, P275, DOI 10.1002/(SICI)1521-1878(199904)21:4<275::AID-BIES3>3.0.CO;2-5; Royet J, 1997, DEVELOPMENT, V124, P4793; Royet J, 1996, DEVELOPMENT, V122, P1849; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; STJOHNSTON RD, 1990, GENE DEV, V4, P1114, DOI 10.1101/gad.4.7.1114; Theisen H, 1996, DEVELOPMENT, V122, P3939; Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 1999, DEVELOPMENT, V126, P5857; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8	65	100	103	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 13	2000	103	2					331	342		10.1016/S0092-8674(00)00124-0	http://dx.doi.org/10.1016/S0092-8674(00)00124-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057905	Bronze			2022-12-01	WOS:000089864300016
J	Boucher, TJ; Okuse, K; Bennett, DLH; Munson, JB; Wood, JN; McMahon, SB				Boucher, TJ; Okuse, K; Bennett, DLH; Munson, JB; Wood, JN; McMahon, SB			Potent analgesic effects of GDNF in neuropathic pain states	SCIENCE			English	Article							NERVE INJURY; NEUROTROPHIC FACTOR; SENSORY NEURONS; DRG NEURONS; RAT MODEL; AFFERENTS; LIGATION	Neuropathic pain arises as a debilitating consequence of nerve injury. The etiology of such pain is poorly understood, and existing treatment is largely ineffective. We demonstrate here that glial cell line-derived neurotrophic factor (GDNF) both prevented and reversed sensory abnormalities that developed in neuropathic pain models, without affecting pain-related behavior in normal animals. GDNF reduces ectopic discharges within sensory neurons after nerve injury. This may arise as a consequence of the reversal by GDNF of the injury-induced plasticity of several sodium channel subunits. Together these findings provide a rational basis for the use of GDNF as a therapeutic treatment for neuropathic pain states.	Kings Coll London, Ctr Res Neurosci, London SE1 7EH, England; UCL, Dept Biol, London WC1E 6BT, England	University of London; King's College London; University of London; University College London	McMahon, SB (corresponding author), Kings Coll London, Ctr Res Neurosci, London SE1 7EH, England.	stephen.mcmahon@kcl.ac.uk		McMahon, Stephen/0000-0003-4656-5536; Bennett, David/0000-0002-7996-2696				Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bian D, 1998, NEUROSCI LETT, V241, P79, DOI 10.1016/S0304-3940(98)00051-2; Black JA, 1999, J NEUROPHYSIOL, V82, P2776, DOI 10.1152/jn.1999.82.5.2776; Boucher TJ, 2000, PROG PAIN RES MANAG, V16, P175; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; Gold MS, 2000, PAIN, V84, P117, DOI 10.1016/S0304-3959(99)00309-7; KERR BJ, UNPUB; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Lai J, 2000, METHOD ENZYMOL, V314, P201; Leclere P, 1998, NEUROSCIENCE, V82, P545; Li YB, 2000, PAIN, V85, P493, DOI 10.1016/S0304-3959(00)00250-5; Liu XG, 2000, PAIN, V84, P309, DOI 10.1016/S0304-3959(99)00211-0; Michaelis M, 2000, J NEUROSCI, V20, P2742; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Ogun-Muyiwa P, 1999, NEUROREPORT, V10, P2107, DOI 10.1097/00001756-199907130-00021; OmanaZapata I, 1997, PAIN, V72, P41, DOI 10.1016/S0304-3959(97)00012-2; Ossipov MH, 1999, PAIN, V79, P127, DOI 10.1016/S0304-3959(98)00187-0; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; SHEEN K, 1993, BRAIN RES, V610, P62, DOI 10.1016/0006-8993(93)91217-G; Waxman SG, 1999, PAIN, pS133, DOI 10.1016/S0304-3959(99)00147-5; Yoon YW, 1996, PAIN, V64, P27, DOI 10.1016/0304-3959(95)00096-8	25	414	452	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					124	127		10.1126/science.290.5489.124	http://dx.doi.org/10.1126/science.290.5489.124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021795				2022-12-01	WOS:000089724800048
J	Johansson, LC; Norberg, UML				Johansson, LC; Norberg, UML			Biomechanics - Asymmetric toes aid underwater swimming	NATURE			English	Article									Gothenburg Univ, Dept Zool, S-41390 Gothenburg, Sweden	University of Gothenburg	Johansson, LC (corresponding author), Gothenburg Univ, Dept Zool, S-41390 Gothenburg, Sweden.		Johansson, Christoffer/B-2189-2013	Johansson, Christoffer/0000-0002-1851-3635				Braun J., 1985, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V169, P307; EBB P, 1985, FUNCTIONAL VERTEBRAT, P110; Norberg, 1990, VERTEBRATE FLIGHT; NORBERG RA, 1973, BIOL REV, V48, P561, DOI 10.1111/j.1469-185X.1973.tb01569.x; NORBERG RA, 1985, BEGINNINGS BIRDS; Smith AMO, 1975, J AIRCRAFT, V12, P501, DOI DOI 10.2514/3.59830; [No title captured]	7	18	18	15	75	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					582	583		10.1038/35036689	http://dx.doi.org/10.1038/35036689			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034197				2022-12-01	WOS:000089772800033
J	Okuda, M; Horn, HF; Tarapore, P; Tokuyama, Y; Smulian, AG; Chan, PK; Knudsen, ES; Hofmann, IA; Snyder, JD; Bove, KE; Fukasawa, K				Okuda, M; Horn, HF; Tarapore, P; Tokuyama, Y; Smulian, AG; Chan, PK; Knudsen, ES; Hofmann, IA; Snyder, JD; Bove, KE; Fukasawa, K			Nucleophosmin/B23 is a target of CDK2/Cyclin E in centrosome duplication	CELL			English	Article							CELL-CYCLE; MAMMALIAN-CELLS; MOS ONCOGENE; S-PHASE; PROTEINS; B23; OVEREXPRESSION; INSTABILITY; ACTIVATION; KINASES	In animal cells, duplication of centrosomes and DNA is coordinated. Since CDK2/cyclin E triggers initiation of both events, activation of CDK2/cyclin E is thought to link these two events. We identified nucleophosmin (NPM/B23) as a substrate of CDK2/cyclin E in centrosome duplication. NPM/B23 associates specifically with unduplicated centrosomes, and NPM/B23 dissociates from centrosomes by CDK2/cyclin E-mediated phosphorylation. An anti-NPM/B23 antibody, which blocks this phosphorylation, suppresses the initiation of centrosome duplication in vivo. Moreover, expression of a nonphosphorylatable mutant NPM/ B23 in cells effectively blocks centrosome duplication. Thus, NPM/B23 is a target of CDK2/cyclin E in the initiation of centrosome duplication.	Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Div Infect Dis, Cincinnati, OH 45267 USA; Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Fukasawa, K (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA.	kenji.fukasawa@uc.edu	Tarapore, Pheruza/A-8876-2013	Tarapore, Pheruza/0000-0003-0911-3661; Horn, Henning/0000-0002-5885-8996; Okuda, Masaru/0000-0003-4690-8244	NCI NIH HHS [R01 CA090522-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090522] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Brinkley BR, 1998, CELL MOTIL CYTOSKEL, V41, P281, DOI 10.1002/(SICI)1097-0169(1998)41:4<281::AID-CM1>3.0.CO;2-C; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; CHAN WY, 1989, BIOCHEMISTRY-US, V28, P1033, DOI 10.1021/bi00429a017; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FUKASAWA K, 1995, ONCOGENE, V10, P1; FUKASAWA K, 1994, CELL GROWTH DIFFER, V5, P1093; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; HEICHMAN KA, 1994, CELL, V79, P557, DOI 10.1016/0092-8674(94)90541-X; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; JOSHI HC, 1994, CURR OPIN CELL BIOL, V6, P55, DOI 10.1016/0955-0674(94)90116-3; Keryer G, 1995, BIOL CELL, V84, P155, DOI 10.1016/0248-4900(96)89425-1; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Lange BMH, 1996, TRENDS CELL BIOL, V6, P348, DOI 10.1016/0962-8924(96)10033-7; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; Moudjou M, 1996, J CELL SCI, V109, P875; MOUDJOU M, 1994, METHOD CENTROSOME IS; Mussman JG, 2000, ONCOGENE, V19, P1635, DOI 10.1038/sj.onc.1203460; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Nigg E A, 1988, Int Rev Cytol, V110, P27; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Pihan GA, 1998, CANCER RES, V58, P3974; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; SPECTOR DL, 1984, CHROMOSOMA, V90, P139, DOI 10.1007/BF00292451; Szebeni A, 1999, PROTEIN SCI, V8, P905; TOURNIER F, 1994, CELL CYCLE REGULATIO; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; VANDRE DD, 1989, CENTROSOME CYCLE ANI; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; YUNG BYM, 1985, BIOCHIM BIOPHYS ACTA, V826, P167, DOI 10.1016/0167-4781(85)90002-8; Zatsepina OV, 1999, J CELL SCI, V112, P455	38	545	563	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2000	103	1					127	140		10.1016/S0092-8674(00)00093-3	http://dx.doi.org/10.1016/S0092-8674(00)00093-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051553	Bronze			2022-12-01	WOS:000089636400014
J	Pham, AD; Sauer, F				Pham, AD; Sauer, F			Ubiquitin-activating/conjugating activity of TAF(II)250, a mediator of activation of gene expression in Drosophila	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVATION; MACRONUCLEI; NUCLEOSOME; SUBUNIT; PROTEIN; TAFS	Ubiquitination of histones has been linked to the complex processes that regulate the activation of eukaryotic transcription. However, the cellular factors that interpose this histone modification during the processes of transcriptional activation are not well characterized. A biochemical approach identified the Drosophila coactivator TAF(II)250, the central subunit within the general transcription factor TFIID, as a histone-specific ubiquitin-activating/conjugating enzyme (ubac). TAF(II)250 mediates monoubiquitination of histone H1 in vitro. Point mutations within the putative ubac domain of TAF(II)250 abolished H1-specific ubiquitination in vitro. In the Drosophila embryo, inactivation of the TAF(II)250 ubac activity reduces the cellular level of monoubiquitinated histone H1 and the expression of genes targeted by the maternal activator Dorsal. Thus, coactivator-mediated ubiquitination of proteins within the transactivation pathway may contribute to the processes directing activation of eukaryotic transcription.	Univ Heidelberg ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sauer, F (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.							Austin RJ, 1996, P NATL ACAD SCI USA, V93, P5788, DOI 10.1073/pnas.93.12.5788; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; DAVIE JR, 1991, BIOCHEM CELL BIOL, V69, P66, DOI 10.1139/o91-009; DAVIE JR, 1990, BIOCHEMISTRY-US, V29, P4752, DOI 10.1021/bi00472a002; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; Georgel PT, 1997, EMBO J, V16, P4717, DOI 10.1093/emboj/16.15.4717; HANSEN SK, 1995, CELL, V82, P565, DOI 10.1016/0092-8674(95)90029-2; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Howe L, 1999, CRIT REV EUKAR GENE, V9, P231, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.80; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Pham AD, 1999, MECH DEVELOP, V84, P3, DOI 10.1016/S0925-4773(99)00051-9; PHARN AD, UNPUB; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; VANHOLDE KE, 1988, CHROMATIN, P111; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; Wassarman DA, 2000, P NATL ACAD SCI USA, V97, P1154, DOI 10.1073/pnas.97.3.1154; WEINZIERL ROJ, 1993, NATURE, V362, P511, DOI 10.1038/362511a0; Wimmer EA, 1996, MECH DEVELOP, V59, P53, DOI 10.1016/0925-4773(96)00575-8	21	190	200	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2357	2360		10.1126/science.289.5488.2357	http://dx.doi.org/10.1126/science.289.5488.2357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009423				2022-12-01	WOS:000089593500055
J	Neumann, CJ; Nuesslein-Volhard, C				Neumann, CJ; Nuesslein-Volhard, C			Patterning of the zebrafish retina by a wave of sonic hedgehog activity	SCIENCE			English	Article							POLARITY GENE HEDGEHOG; TRANSGENIC ZEBRAFISH; DROSOPHILA EYE; FLOOR PLATE; DIFFERENTIATION; EXPRESSION; ACTIVATION; INDUCTION; TISSUES; CELLS	The Drosophila retina is patterned by a morphogenetic wave driven by the Hedgehog signaling protein. Hedgehog, secreted by the first neurons, induces neuronal differentiation and hedgehog expression in nearby uncommitted cells, thereby propagating the wave. Evidence is presented here that the zebrafish Hedgehog homolog, Sonic Hedgehog, is also expressed in the first retinal neurons, and that Sonic Hedgehog drives a wave of neurogenesis across the retina, strikingly similar to the wave in Drosophila. The conservation of this patterning mechanism is unexpected, given the highly divergent structures of vertebrate and invertebrate eyes, and supports a common evolutionary origin of the animal visual system.	Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany	Max Planck Society	Neumann, CJ (corresponding author), Max Planck Inst Entwicklungsbiol, Spemannstr 35-III, D-72076 Tubingen, Germany.							Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Greenwood S, 1999, DEVELOPMENT, V126, P5795; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; HEBERLEIN U, 1995, NATURE, V373, P709, DOI 10.1038/373709a0; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jensen AM, 1997, DEVELOPMENT, V124, P363; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Levine EM, 1997, J NEUROSCI, V17, P6277; Long QM, 1997, DEVELOPMENT, V124, P4105; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Malicki J, 1996, DEVELOPMENT, V123, P263; McCabe KL, 1999, DEVELOPMENT, V126, P5713; Muller F, 1999, DEVELOPMENT, V126, P2103; Neumann C.C M., UNPUB; Neumann CJ, 1999, DEVELOPMENT, V126, P4817; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Stenkamp DL, 2000, DEV BIOL, V220, P238, DOI 10.1006/dbio.2000.9629; Takabatake T, 1997, FEBS LETT, V410, P485, DOI 10.1016/S0014-5793(97)00645-5; Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8; WESTERFIELD M, 1992, GENE DEV, V6, P591, DOI 10.1101/gad.6.4.591	26	282	284	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2137	2139		10.1126/science.289.5487.2137	http://dx.doi.org/10.1126/science.289.5487.2137			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000118				2022-12-01	WOS:000089430900048
J	Parlati, F; McNew, JA; Fukuda, R; Miller, R; Sollner, TH; Rothman, JE				Parlati, F; McNew, JA; Fukuda, R; Miller, R; Sollner, TH; Rothman, JE			Topological restriction of SNARE-dependent membrane fusion	NATURE			English	Article							YEAST SECRETORY PATHWAY; GOLGI-COMPLEX; V-SNARE; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; PROTEIN; VESICLES; IDENTIFICATION; ACTIVATION; ENCODES	To fuse transport vesicles with target membranes, proteins of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) complex must be located on both the vesicle (v-SNARE) and the target membrane (t-SNARE)(1). In yeast, four integral membrane proteins, Sed5, Bos1, Sec22 and Bet1 (refs 2-6), each probably contribute a single helix to form the SNARE complex that is needed for transport from endoplasmic reticulum to Golgi(7-11). This generates a four-helix bundle(12), which ultimately mediates the actual fusion event(13). Here we explore how the anchoring arrangement of the four helices affects their ability to mediate fusion. We reconstituted two populations of phospholipid bilayer vesicles, with the individual SNARE proteins distributed in all possible combinations between them. Of the eight non-redundant permutations of four subunits distributed over two vesicle populations, only one results in membrane fusion. Fusion only occurs when the v-SNARE Bet1 is on one membrane and the syntaxin heavy chain Sed5 and its two light chains, Bos1 and Sec22, are on the other membrane where they form a functional t-SNARE. Thus, each SNARE protein is topologically restricted by design to function either as a v-SNARE or as part of a t-SNARE complex.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Rothman, JE (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave,Box 251, New York, NY 10021 USA.		McNew, James/ABD-8081-2020; McNew, James/AAV-4911-2020	McNew, James/0000-0001-8459-3664				Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; BOEHM J, 1994, EMBO J, V13, P3696, DOI 10.1002/j.1460-2075.1994.tb06679.x; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; NEWMAN AP, 1987, J CELL BIOL, V105, P1587, DOI 10.1083/jcb.105.4.1587; NEWMAN AP, 1990, MOL CELL BIOL, V10, P3405, DOI 10.1128/MCB.10.7.3405; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Sacher M, 1997, J BIOL CHEM, V272, P17134, DOI 10.1074/jbc.272.27.17134; SHIM J, 1991, J CELL BIOL, V113, P55, DOI 10.1083/jcb.113.1.55; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stone S, 1997, MOL BIOL CELL, V8, P1175, DOI 10.1091/mbc.8.7.1175; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEBER T, 2000, J CELL BIOL, V149; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	30	195	206	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					194	198		10.1038/35025076	http://dx.doi.org/10.1038/35025076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001058				2022-12-01	WOS:000089241000050
J	Pittet, D; Bonten, MJM				Pittet, D; Bonten, MJM			Towards invasive diagnostic techniques as standard management of ventilator-associated pneumonia	LANCET			English	Editorial Material									Univ Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland; Univ Utrecht Hosp, Dept Internal Med, Utrecht, Netherlands	University of Geneva; Utrecht University; Utrecht University Medical Center	Pittet, D (corresponding author), Univ Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland.							Bonten MJM, 1997, AM J RESP CRIT CARE, V156, P1820, DOI 10.1164/ajrccm.156.6.9610117; Campbell GD, 1996, AM J RESP CRIT CARE, V153, P1711; CHASTRE J, 1994, AM J RESP CRIT CARE, V150, P570, DOI 10.1164/ajrccm.150.2.8049850; Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004; FAGON JY, 1993, AM J MED, V94, P281, DOI 10.1016/0002-9343(93)90060-3; KOLLEF MH, 1995, ANN INTERN MED, V122, P743, DOI 10.7326/0003-4819-122-10-199505150-00002; NIEDERMAN MS, 1994, AM J RESP CRIT CARE, V150, P565, DOI 10.1164/ajrccm.150.2.8049849; Pittet D, 1998, LANCET, V352, P83, DOI 10.1016/S0140-6736(98)85005-8; Sanchez-Nieto JM, 1998, AM J RESP CRIT CARE, V157, P371, DOI 10.1164/ajrccm.157.2.97-02039; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639	10	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					874	874		10.1016/S0140-6736(00)02675-1	http://dx.doi.org/10.1016/S0140-6736(00)02675-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036890				2022-12-01	WOS:000089259800007
J	Shapiro, E; Krivit, W; Lockman, L; Jambaque, I; Peters, C; Cowan, M; Harris, R; Blanche, S; Bordigoni, P; Loes, D; Ziegler, R; Crittenden, M; Ris, D; Berg, B; Cox, C; Moser, H; Fischer, A; Aubourg, P				Shapiro, E; Krivit, W; Lockman, L; Jambaque, I; Peters, C; Cowan, M; Harris, R; Blanche, S; Bordigoni, P; Loes, D; Ziegler, R; Crittenden, M; Ris, D; Berg, B; Cox, C; Moser, H; Fischer, A; Aubourg, P			Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy	LANCET			English	Article							BRAIN MR OBSERVATIONS; FATTY-ACIDS; GENE; MUTATIONS; THERAPY; PROGRESSION; PHENOTYPES; ADRENOMYELONEUROPATHY; IMMUNOSUPPRESSION; PROTEIN	Background The childhood-onset cerebral form of X-linked adrenoleukodystrophy, a demyelinating disorder of the central nervous system, leads to a vegetative state and death within 3-5 years once clinical symptoms are detectable. The hypothesis to be tested was whether bone-marrow transplantation can over an extended period of time halt the inexorable progressive demyelination and neurological deterioration. Methods 12 patients with childhood onset of cerebral X-linked adrenoleukodystrophy have been followed for 5-10 years after bone-marrow transplantation. Magnetic resonance imaging (MRI), neurological, neuropsychological, electrophysiological, and plasma very-long-chain fatty acid (VLCFA) measurements were used to evaluate the effect of this treatment. Findings MRI showed complete reversal of abnormalities in two patients and improvement in one. One patient showed no change from baseline to last follow-up. All eight patients who showed an initial period of continued demyelination stabilised and remained unchanged thereafter. Motor function remained normal or improved after bone-marrow transplantation in ten patients. Verbal intelligence remained within the normal range for 11 patients. Performance (non-verbal) abilities were improved or were stable in seven patients. Decline in performance abilities followed by stability occurred in five patients. Plasma VLCFA concentrations decreased by 55% and remained slightly above the upper limits of normal. Interpretation 5-10-year follow-up of 12 patients with childhood-onset cerebral X-linked adrenoleukodystrophy shows the long-term beneficial effect of bone marrow transplantation when the procedure is done at an early stage of the disease.	Univ Minnesota, Div Paediat Neurol, Minneapolis, MN 55455 USA; Hop St Vincent de Paul, INSERM, F-75674 Paris, France; Univ Calif San Francisco, San Francisco, CA 94143 USA; Cincinnati Childrens Hosp, Cincinnati, OH USA; Hop Brabois, Nancy, France; Johns Hopkins Hosp, Kennedy Krieger Inst, Baltimore, MD 21287 USA; Hop Necker Enfants Malad, Paris, France	University of Minnesota System; University of Minnesota Twin Cities; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; Cincinnati Children's Hospital Medical Center; CHU de Nancy; Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Shapiro, E (corresponding author), Univ Minnesota, Div Paediat Neurol, Mayo Mail Code 486,420 Delaware St SE, Minneapolis, MN 55455 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029099] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29099] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUBOURG P, 1993, NEW ENGL J MED, V329, P745, DOI 10.1056/NEJM199309093291101; AUBOURG P, 1990, NEW ENGL J MED, V322, P1860, DOI 10.1056/NEJM199006283222607; AUBOURG P, 1985, J LIPID RES, V26, P263; AUBOURG P, 1997, HDB CLIN NEUROLOGY N, P447; Bezman L, 1998, AM J MED GENET, V76, P415, DOI 10.1002/(SICI)1096-8628(19980413)76:5<415::AID-AJMG9>3.3.CO;2-J; BRAUN A, 1995, AM J HUM GENET, V56, P854; Doerflinger N, 1998, HUM GENE THER, V9, P1025, DOI 10.1089/hum.1998.9.7-1025; FANEN P, 1994, J CLIN INVEST, V94, P516, DOI 10.1172/JCI117363; Feigenbaum V, 1996, AM J HUM GENET, V58, P1135; FUCHS S, 1994, HUM MOL GENET, V3, P1903, DOI 10.1093/hmg/3.10.1903; Kemp S, 1998, NAT MED, V4, P1261, DOI 10.1038/3242; KOK F, 1995, HUM MUTAT, V6, P104, DOI 10.1002/humu.1380060203; Korenke GC, 1997, J INHERIT METAB DIS, V20, P59, DOI 10.1023/A:1005361607523; KRIVIT W, 1990, NEW ENGL J MED, V322, P28, DOI 10.1056/NEJM199001043220106; KRIVIT W, 1996, CORRECTION CERTAIN G, P48; LIGTENBERG MJL, 1995, AM J HUM GENET, V56, P44; LOES DJ, 1994, AM J NEURORADIOL, V15, P1761; LOES DJ, 1994, AM J NEURORADIOL, V15, P1767; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Moser HW, 2000, J INHERIT METAB DIS, V23, P273, DOI 10.1023/A:1005688130338; MOSER HW, 1984, NEUROLOGY, V34, P1410, DOI 10.1212/WNL.34.11.1410; Moser HW, 1997, BRAIN, V120, P1485, DOI 10.1093/brain/120.8.1485; Moser HW, 1991, TECHNIQUES DIAGNOSTI, P177; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; NAIDU S, 1988, ARCH NEUROL-CHICAGO, V45, P846, DOI 10.1001/archneur.1988.00520320032011; PETERS C, CORRECTION GENETIC D, V5; RIZZO WB, 1989, NEUROLOGY, V39, P1415, DOI 10.1212/WNL.39.11.1415; SHAPIRO EG, 1995, J INHERIT METAB DIS, V18, P413, DOI 10.1007/BF00710053; Singh I, 1998, NEW ENGL J MED, V339, P702, DOI 10.1056/NEJM199809033391012; Smith KD, 1999, NEUROCHEM RES, V24, P521, DOI 10.1023/A:1022535930009; STUMPF DA, 1981, ARCH NEUROL-CHICAGO, V38, P48, DOI 10.1001/archneur.1981.00510010074014; UZIEL G, 1991, DEV NEUROSCI-BASEL, V13, P274, DOI 10.1159/000112173; Wechsler D., 1989, WECHSLER PRESCHOOL P; Wechsler D, 1991, WECHSLER INTELLIGENC, V3rd	34	202	217	1	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 26	2000	356	9231					713	718		10.1016/S0140-6736(00)02629-5	http://dx.doi.org/10.1016/S0140-6736(00)02629-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347UU	11085690				2022-12-01	WOS:000088948200010
J	Anand, SS; Yusuf, S; Vuksan, V; Devanesen, S; Teo, KK; Montague, PA; Kelemen, L; Yi, CL; Lonn, E; Gerstein, H; Hegele, RA; McQueen, M				Anand, SS; Yusuf, S; Vuksan, V; Devanesen, S; Teo, KK; Montague, PA; Kelemen, L; Yi, CL; Lonn, E; Gerstein, H; Hegele, RA; McQueen, M		SHARE Investigators	Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)	LANCET			English	Article							DENSITY LIPOPROTEIN CHOLESTEROL; BASE-LINE CHARACTERISTICS; INTIMA-MEDIA THICKNESS; CORONARY HEART-DISEASE; MYOCARDIAL-INFARCTION; DESIGN; PREVALENCE; MECHANISMS; RATIONALE; STROKE	Background Cardiovascular disease rates vary greatly between ethnic groups in Canada. To establish whether this variation can be explained by differences in disease risk factors and subclinical atherosclerosis, we undertook a population-based study of three ethnic groups in Canada: South Asians, Chinese, and Europeans. Methods 985 participants were recruited from three cities (Hamilton, Toronto, and Edmonton) by stratified random sampling. Clinical cardiovascular disease was defined by history or electrocardiographic findings. Carotid atherosclerosis was measured with B-mode ultrasonography. Conventional (smoking, hypertension, diabetes, raised cholesterol) and novel risk factors (markers of a prothrombotic state) were measured. Findings Within each ethnic group and overall, the degree of carotid atherosclerosis was associated with a higher prevalence of cardiovascular disease. South Asians had the highest prevalence of this condition compared with Europeans and Chinese (11%, 5%, and 2%, respectively, p=0.0004): Despite this finding, Europeans had more atherosclerosis (mean of the maximum intimal medial thickness 0.75 [0.16] mm) than South Asians (0.72 [0.15] mm), and Chinese (0.69 [0.16] mm). South Asians had an increased prevalence of glucose intolerance, higher total and LDL cholesterol, higher triglycerides, and lower HDL cholesterol, and much greater abnormalities in novel risk factors including higher concentrations of fibrinogen, homocysteine, lipoprotein (a), and plasminogen activator homocysteine, inhibitor-1. Interpretation Although there are differences in conventional and novel risk factors between ethnic groups, this variation and the degree of atherosclerosis only partly explains the higher rates of cardiovascular disease among South Asians compared with Europeans and Chinese. The increased risk of cardiovascular events could be due to factors affecting plaque rupture, the interaction between prothrombotic factors and atherosclerosis, or as yet undiscovered risk factors.	McMaster Univ, HGH McMaster Clin, Prevent Cardiol & Therapeut Res Program, Dept Med, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Alberta, Dept Med, Edmonton, AB T6G 2M7, Canada; Univ Western Ontario, John P Robarts Res Inst, London, ON N6A 3K7, Canada	McMaster University; McMaster University; University of Toronto; University of Alberta; Western University (University of Western Ontario)	Anand, SS (corresponding author), McMaster Univ, HGH McMaster Clin, Prevent Cardiol & Therapeut Res Program, Dept Med, Hamilton, ON L8L 2X2, Canada.		Hegele, Robert/AAF-6482-2020; Gerstein, Hertzel/ABB-8781-2020; Hegele, Robert/G-3301-2011; Gerstein, Hertzel C/B-1235-2013	Hegele, Robert/0000-0003-2861-5325; Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836				ALLAIN CC, 1974, CLIN CHEM, V20, P470; Anand SS, 1998, CAN J CARDIOL, V14, P1349; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Armitage P, 1994, STAT METHODS MED RES; BHOPAL R, 1999, BRIT MED J, P319; BLACKBURN H, 1982, MINNESOTA CODE MANUA; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Byington RP, 1997, AM J CARDIOL, V80, P1087, DOI 10.1016/S0002-9149(97)00611-5; Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; CROUSE JR, 1995, AM J CARDIOL, V75, P455, DOI 10.1016/S0002-9149(99)80580-3; ERIKSSON E, 1988, THROMB RES, V50, P91, DOI 10.1016/0049-3848(88)90177-6; FORTIN LJ, 1995, CLIN BIOCHEM, V28, P155, DOI 10.1016/0009-9120(94)00073-5; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Harland JO, 1997, PUBLIC HEALTH, V111, P331, DOI 10.1016/S0033-3506(97)00064-4; Harland JO, 1997, J EPIDEMIOL COMMUN H, V51, P636, DOI 10.1136/jech.51.6.636; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Libby P, 1998, Vasc Med, V3, P225, DOI 10.1177/1358836X9800300309; Lonn EM, 1996, AM J CARDIOL, V78, P914, DOI 10.1016/S0002-9149(96)00467-5; MCGOWAN MW, 1983, CLIN CHEM, V29, P538; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; NEELEY WE, 1972, CLIN CHEM, V18, P509; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Reddy KS, 1998, CIRCULATION, V97, P596; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sheth T, 1999, CAN MED ASSOC J, V161, P132; Sheth T, 1997, Ethn Health, V2, P287; WARNICK GR, 1985, CLIN CHEM, V31, P217; Woo KS, 1997, INT J CARDIOL S1, V62, P639	33	621	630	0	43	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2000	356	9226					279	284		10.1016/S0140-6736(00)02502-2	http://dx.doi.org/10.1016/S0140-6736(00)02502-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MJ	11071182				2022-12-01	WOS:000088305900008
J	Cohen, MS; Shugars, DC; Fiscus, SA				Cohen, MS; Shugars, DC; Fiscus, SA			Limits on oral transmission of HIV-1	LANCET			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-FREE SIV; INFECTION		Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Dent Ecol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cohen, MS (corresponding author), Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27599 USA.		Abrams, William R/A-5782-2008					BABA TW, 1994, AIDS RES HUM RETROV, V10, P351, DOI 10.1089/aid.1994.10.351; Baba TW, 1996, SCIENCE, V272, P1486, DOI 10.1126/science.272.5267.1486; Baron S, 2000, J INFECT DIS, V181, P498, DOI 10.1086/315251; DILLON B, 2000, 7 C RETR OPP INF SAN; McNeely TB, 1997, BLOOD, V90, P1141, DOI 10.1182/blood.V90.3.1141.1141_1141_1149; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Rothenberg RB, 1998, AIDS, V12, P2095, DOI 10.1097/00002030-199816000-00004; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Shugars DC, 2000, ORAL SURG ORAL MED O, V89, P432, DOI 10.1016/S1079-2104(00)70124-7; Shugars DC, 1998, J AM DENT ASSOC, V129, P851, DOI 10.14219/jada.archive.1998.0349; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261	13	27	29	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2000	356	9226					272	272		10.1016/S0140-6736(00)02500-9	http://dx.doi.org/10.1016/S0140-6736(00)02500-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MJ	11071180				2022-12-01	WOS:000088305900006
J	Nakayama, T; Yonekura-Sakakibara, K; Sato, T; Kikuchi, S; Fukui, Y; Fukuchi-Mizutani, M; Ueda, T; Nakao, M; Tanaka, Y; Kusumi, T; Nishino, T				Nakayama, T; Yonekura-Sakakibara, K; Sato, T; Kikuchi, S; Fukui, Y; Fukuchi-Mizutani, M; Ueda, T; Nakao, M; Tanaka, Y; Kusumi, T; Nishino, T			Aureusidin synthase: A polyphenol oxidase homolog responsible for flower coloration	SCIENCE			English	Article							CLONING; EXPRESSION; CLEAVAGE	Aurones are plant flavonoids that provide yellow color to the flowers of some popular ornamental plants, such as snapdragon and cosmos. In this study, we have identified an enzyme responsible for the synthesis of aurone from chalcones in the yellow snapdragon flower, The enzyme (aureusidin synthase) is a 39-kilodalton, copper-containing glycoprotein catalyzing the hydroxylation and/or oxidative cyclization of the precursor chalcones, 2',4',6',4-tetrahydroxychalcone and 2',4',6',3,4-pentahydroxychalcone. The complementary DNA encoding aureusidin synthase is expressed in the petals of aurone-containing varieties, DNA sequence analysis revealed that aureusidin synthase belongs to the plant polyphenol oxidase family, providing an unequivocal example of the function of the polyphenol oxidase homolog in plants, i.e., flower coloration.	Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; Suntory Ltd, Inst Fundamental Res, Shimamoto, Osaka 6188503, Japan; Kobe Gakuin Univ, Kobe, Hyogo 6512180, Japan	Tohoku University; Suntory Holdings Ltd; Kobe Gakuin University	Nakayama, T (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Yama 07, Sendai, Miyagi 9808579, Japan.		Yonekura-Sakakibara, Keiko/J-8749-2014	Yonekura-Sakakibara, Keiko/0000-0002-0409-1523				BATESMITH EC, 1951, NATURE, V167, P688, DOI 10.1038/167688a0; Brouillard R., 1993, FLAVONOIDS ADV RES 1, P565; CLARKE JT, 1964, ANN NY ACAD SCI, V121, P428, DOI 10.1111/j.1749-6632.1964.tb14214.x; DRY IB, 1994, PLANT MOL BIOL, V26, P495, DOI 10.1007/BF00039560; Fujiwara H, 1998, PLANT J, V16, P421, DOI 10.1046/j.1365-313x.1998.00312.x; JOY RW, 1995, PLANT PHYSIOL, V107, P1083, DOI 10.1104/pp.107.4.1083; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; RATHMELL WG, 1972, BIOCHEM J, V127, P125, DOI 10.1042/bj1270125; ROBINSON SP, 1992, PLANT PHYSIOL, V99, P317, DOI 10.1104/pp.99.1.317; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; SATO T, IN PRESS PLANT SCI; SHIMOKORIYAMA M, 1953, J AM CHEM SOC, V75, P2277, DOI 10.1021/ja01105a532; Tanaka Y, 1998, PLANT CELL PHYSIOL, V39, P1119, DOI 10.1093/oxfordjournals.pcp.a029312; THYGESEN PW, 1995, PLANT PHYSIOL, V109, P525, DOI 10.1104/pp.109.2.525; VAUGHN KC, 1988, PHYSIOL PLANTARUM, V72, P659, DOI 10.1111/j.1399-3054.1988.tb09180.x; YONEKURASAKAKIB.K, UNPUB	17	156	185	6	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2000	290	5494					1163	1166		10.1126/science.290.5494.1163	http://dx.doi.org/10.1126/science.290.5494.1163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	372HL	11073455				2022-12-01	WOS:000165228200048
J	Pauk, J; Huang, ML; Brodie, SJ; Wald, A; Koelle, DM; Schacker, T; Celum, C; Selke, S; Corey, L				Pauk, J; Huang, ML; Brodie, SJ; Wald, A; Koelle, DM; Schacker, T; Celum, C; Selke, S; Corey, L			Mucosal shedding of human herpesvirus 8 in men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; KAPOSIS-SARCOMA; HUMAN-HERPESVIRUS-8 DNA; SEXUAL TRANSMISSION; PERIPHERAL-BLOOD; INFECTED PERSONS; GENE-EXPRESSION; HOMOSEXUAL MEN; IN-VIVO	Background: Epidemiologic studies suggest that human herpesvirus 8 (HHV-8) is sexually transmitted among men who have sex with men; however, the mode of transmission is unclear. Methods: To evaluate the patterns of shedding of HHV-8, we obtained mucosal-secretion samples from a cohort of HHV-8-seropositive men who had sex with men and had no clinical evidence of Kaposi's sarcoma. Quantitative polymerase-chain-reaction (PCR) assays, in situ PCR assays, and in situ RNA hybridization were used to identify potential sources of infectious HHV-8. Results: We detected HHV-8 in at least one mucosal sample from 30 of 50 men who were seropositive for HHV-8 (60 percent). Overall, HHV-8 was detected in 30 percent of oropharyngeal samples, as compared with 1 percent of anal and genital samples (P<0.001). In 39 percent of the HHV-8-seropositive men, HHV-8 was detected in saliva on more than 35 percent of the consecutive days on which samples were obtained. The median log titer of HHV-8 from the oral cavity was approximately 2.5 times as high as the titer at all other sites. In situ hybridization studies indicated that HHV-8 DNA and messenger RNA were present in oral epithelial cells. Among 92 men who had sex with men and who were seronegative for the human immunodeficiency virus (HIV), a history of sex with a partner who had Kaposi's sarcoma, deep kissing with an HIV-positive partner, and the use of amyl nitrite capsules ("poppers'') or inhaled nitrites were independent risk factors for infection with HHV-8. Conclusions: Oral exposure to infectious saliva is a potential risk factor for the acquisition of HHV-8 among men who have sex with men. Hence, currently recommended safer sex practices may not protect against HHV-8 infection. (N Engl J Med 2000;343:1369-77.) (C) 2000, Massachusetts Medical Society.	Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98109 USA; Univ Washington, Dept Med, Seattle, WA USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities	Corey, L (corresponding author), Fred Hutchinson Canc Res Ctr, Program Infect Dis, 1100 Fairview Ave N D3-100, Seattle, WA 98109 USA.		Wald, Anna/B-6272-2012; Koelle, David/Q-6529-2016	Wald, Anna/0000-0003-3486-6438; Koelle, David/0000-0003-1255-9023	NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER; NCI NIH HHS [CA18029] Funding Source: Medline; NIAID NIH HHS [AI31576, AI30731] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Angeloni A, 1998, J INFECT DIS, V177, P1715, DOI 10.1086/517429; BERREY MM, IN PRESS J INFECT DI; Blackbourn DJ, 1999, J INFECT DIS, V179, P237, DOI 10.1086/314570; Blackbourn DJ, 1997, AIDS, V11, P249, DOI 10.1097/00002030-199702000-00016; Boldogh I, 1996, CLIN INFECT DIS, V23, P406, DOI 10.1093/clinids/23.2.406; Bosch ML, 1999, J GEN VIROL, V80, P467, DOI 10.1099/0022-1317-80-2-467; Brodie Scott J., 2000, P97; Brodie SJ, 1999, AM J PATHOL, V154, P1453, DOI 10.1016/S0002-9440(10)65400-4; Brodie SJ, 1998, J VIROL, V72, P5599, DOI 10.1128/JVI.72.7.5599-5609.1998; Brodie SJ, 2000, J CLIN INVEST, V105, P1407, DOI 10.1172/JCI8707; BRODIE SJ, 1995, AM J PATHOL, V146, P250; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Calabro M L, 1998, J Hum Virol, V1, P207; Calabro ML, 1999, J INFECT DIS, V179, P1534, DOI 10.1086/314765; Chandran B, 1998, VIROLOGY, V243, P208, DOI 10.1006/viro.1998.9055; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; CONE RW, 1993, J CLIN MICROBIOL, V31, P1262, DOI 10.1128/JCM.31.5.1262-1267.1993; CONE RW, 1994, J CLIN MICROBIOL, V32, P2633; Corbellino M, 1996, NEW ENGL J MED, V335, P1237, DOI 10.1056/NEJM199610173351614; DiAlberti L, 1997, J INFECT DIS, V175, P703, DOI 10.1093/infdis/175.3.703; Diamond C, 1997, J INFECT DIS, V176, P775, DOI 10.1086/517299; Diamond C, 1998, J VIROL, V72, P6223, DOI 10.1128/JVI.72.7.6223-6227.1998; Dukers NHTM, 2000, AM J EPIDEMIOL, V151, P213, DOI 10.1093/oxfordjournals.aje.a010195; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kedes DH, 1996, NAT MED, V2, P1041; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Koelle DM, 1997, J INFECT DIS, V176, P94, DOI 10.1086/514045; Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403; O'Brien TR, 1999, J INFECT DIS, V180, P1010, DOI 10.1086/315039; Oksenhendler E, 1998, NEW ENGL J MED, V338, P1585, DOI 10.1056/NEJM199805283382204; Olsen SJ, 1998, AIDS, V12, P1921, DOI 10.1097/00002030-199814000-00024; Pellett PE, 1999, J CLIN MICROBIOL, V37, P1298, DOI 10.1128/JCM.37.5.1298-1301.1999; RABKIN CS, 1991, INT J CANCER, V47, P692, DOI 10.1002/ijc.2910470511; Renwick N, 1998, AIDS, V12, P2481, DOI 10.1097/00002030-199818000-00018; REYNOLDS P, 1993, AM J EPIDEMIOL, V137, P19, DOI 10.1093/oxfordjournals.aje.a116598; Rezza G, 1998, INT J CANCER, V77, P361, DOI 10.1002/(SICI)1097-0215(19980729)77:3&lt;361::AID-IJC9&gt;3.0.CO;2-M; Ryncarz AJ, 1999, J CLIN MICROBIOL, V37, P1941, DOI 10.1128/JCM.37.6.1941-1947.1999; Schacker T, 1998, ANN INTERN MED, V128, P21, DOI 10.7326/0003-4819-128-1-199801010-00004; Sitas F, 1999, NEW ENGL J MED, V340, P1863, DOI 10.1056/NEJM199906173402403; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; Smith NA, 1999, J INFECT DIS, V180, P600, DOI 10.1086/314926; Staskus KA, 1997, J VIROL, V71, P715, DOI 10.1128/JVI.71.1.715-719.1997; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Vieira J, 1997, J VIROL, V71, P7083, DOI 10.1128/JVI.71.9.7083-7087.1997; VIEIRA J, IN PRESS J VIROL; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9; Whitby D, 2000, BRIT J CANCER, V82, P702, DOI 10.1054/bjoc.1999.0983; Zerr DM, 2000, J CLIN MICROBIOL, V38, P1981, DOI 10.1128/JCM.38.5.1981-1983.2000; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641	50	328	339	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2000	343	19					1369	1377		10.1056/NEJM200011093431904	http://dx.doi.org/10.1056/NEJM200011093431904			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZH	11070101				2022-12-01	WOS:000165152800004
J	Vergunst, AC; Schrammeijer, B; den Dulk-Ras, A; de Vlaam, CMT; Regensburg-Tuink, TJG; Hooykaas, PJJ				Vergunst, AC; Schrammeijer, B; den Dulk-Ras, A; de Vlaam, CMT; Regensburg-Tuink, TJG; Hooykaas, PJJ			VirB/D4-dependent protein translocation from Agrobacterium into plant cells	SCIENCE			English	Article							VIRULENCE SYSTEM; DNA TRANSFER; T-DNA; TUMEFACIENS; TRANSFORMATION; GENE; VIRF	The Agrobacterium VirB/D4 transport system mediates the transfer of a nucleoprotein T complex into plant cells, Leading to crown gall disease. In addition, several Virulence proteins must somehow be transported to fulfill a function in planta. Here, we used fusions between Cre recombinase and VirE2 or VirF to directly demonstrate protein translocation into plant cells. Transport of the proteins was monitored by a Cre-mediated in planta recombination event resulting in a selectable phenotype and depended on the VirB/D4 transport system but did not require transferred DNA.	Leiden State Univ, Inst Mol Plant Sci, Clusius Lab, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Hooykaas, PJJ (corresponding author), Leiden State Univ, Inst Mol Plant Sci, Clusius Lab, Wassenaarseweg 64, NL-2333 AL Leiden, Netherlands.	hooykaas@rulbim.leidenuniv.nl	Hooykaas, Paul JJ/S-4256-2017; Vergunst, Annette C./O-5139-2017	Hooykaas, Paul JJ/0000-0002-9736-6927; Vergunst, Annette C./0000-0002-4359-1491				BEIJERSBERGEN A, 1992, SCIENCE, V256, P1324, DOI 10.1126/science.256.5061.1324; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Gelvin SB, 2000, ANNU REV PLANT PHYS, V51, P223, DOI 10.1146/annurev.arplant.51.1.223; Hansen G, 1999, CURR TOP MICROBIOL, V240, P21; Hooykaas PJJ, 2000, BIOLOGY OF PLANT-MICROBE INTERACTIONS, VOL 2, P159; HOOYKAAS PJJ, 1994, ANNU REV PHYTOPATHOL, V32, P157, DOI 10.1146/annurev.py.32.090194.001105; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lai EM, 2000, TRENDS MICROBIOL, V8, P361, DOI 10.1016/S0966-842X(00)01802-3; MOZO T, 1992, MOL GEN GENET, V236, P1; OTTEN L, 1985, MOL GEN GENET, V199, P189, DOI 10.1007/BF00330258; OW DW, 1995, CRIT REV PLANT SCI, V14, P239, DOI 10.1080/713608117; REGENSBURGTUINK AJG, 1993, NATURE, V363, P69, DOI 10.1038/363069a0; Schrammeijer B, 1998, MOL PLANT MICROBE IN, V11, P429, DOI 10.1094/MPMI.1998.11.5.429; Vergunst AC, 1998, PLANT MOL BIOL, V38, P393, DOI 10.1023/A:1006024500008; Vergunst AC, 1998, METH MOL B, V82, P227; VERGUNST AC, UNPUB; Zupan JR, 1998, CURR OPIN MICROBIOL, V1, P649, DOI 10.1016/S1369-5274(98)80110-0	21	298	337	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2000	290	5493					979	982		10.1126/science.290.5493.979	http://dx.doi.org/10.1126/science.290.5493.979			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062129				2022-12-01	WOS:000165103200048
J	Ismail, W; Taylor, SJC; Beddow, E				Ismail, W; Taylor, SJC; Beddow, E			Advice on driving after groin hernia surgery in the United Kingdom: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article									Harold Wood Hosp, Havering Hosp NHS Trust, Romford RM3 0BE, Essex, England; Univ London Queen Mary & Westfield Coll, Dept Gen Practice & Primary Care, London E1 4NS, England; St Bartholomews Hosp, Dept Cardiothorac Surg, London EC1A 7BE, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Ismail, W (corresponding author), Harold Wood Hosp, Havering Hosp NHS Trust, Romford RM3 0BE, Essex, England.		TAYLOR, STEPHANIE/GYV-4768-2022					AMID PK, 1993, AM J SURG, V165, P369, DOI 10.1016/S0002-9610(05)80847-5; Giddins GEB, 1996, INJURY, V27, P495, DOI 10.1016/0020-1383(96)00054-X; ROBERTSON GSM, 1993, ANN ROY COLL SURG, V75, P30; The Royal College of Surgeons of England, 1993, CLIN GUID MAN GROIN; Wright DM, 1999, SURG ENDOSC-ULTRAS, V13, P332, DOI 10.1007/s004649900983	5	15	15	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1056	1056		10.1136/bmj.321.7268.1056	http://dx.doi.org/10.1136/bmj.321.7268.1056			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053178	Green Published, Bronze			2022-12-01	WOS:000165076800026
J	Seemann, J; Jokitalo, E; Pypaert, M; Warren, G				Seemann, J; Jokitalo, E; Pypaert, M; Warren, G			Matrix proteins can generate the higher order architecture of the Golgi apparatus	NATURE			English	Article							COILED-COIL PROTEINS; BREFELDIN-A; ENDOPLASMIC-RETICULUM; TRANSPORT; ER; DOMAIN; CELLS; REDISTRIBUTION; CISTERNAE; MEMBRANES	The Golgi apparatus in animal cells comprises a reticulum of linked stacks in the pericentriolar and often in the juxtanuclear regions of the cell(1). The unique architecture of this organelle is thought to depend on the cytoskeleton(2) and cytoplasmic matrix proteins(3,4)-the best characterized being the golgin family of fibrous, coiled-coil proteins and the GRASP family of stacking proteins(5-10). Here we show that these matrix proteins can be separated from oligosaccharide-modifying enzymes in the Golgi stack without affecting their ability to form a ribbon-like reticulum in the correct location near to the nucleus. Our data suggest that the Golgi is a structural scaffold that can exist independently of, but is normally populated by, the enzyme-containing membranes that modify transiting cargo. This new concept of the Golgi further indicates that the Golgi may be an autonomous organelle rather than one that is in simple dynamic equilibrium with the endoplasmic reticulum.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Bioctr, Inst Biotechnol, Electron Microscopy Unit, Helsinki 00014, Finland	Yale University	Warren, G (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.		Jokitalo, Eija/C-8375-2009	Jokitalo, Eija/0000-0002-4159-6934				ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; CLUETT EB, 1992, J CELL SCI, V103, P773; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; De Matteis MA, 1998, CURR OPIN CELL BIOL, V10, P542, DOI 10.1016/S0955-0674(98)80071-9; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; Farquhar MG, 1998, TRENDS CELL BIOL, V8, P2, DOI 10.1016/S0962-8924(97)01187-2; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; HENDRICKS LC, 1992, EUR J CELL BIOL, V58, P202; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Linstedt AD, 1999, CURR BIOL, V9, pR893, DOI 10.1016/S0960-9822(00)80077-9; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Pepperkok R, 1998, J CELL SCI, V111, P1877; REAVES B, 1992, J CELL BIOL, V116, P85, DOI 10.1083/jcb.116.1.85; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; ROWE PM, 1995, MOL MED TODAY, V1, P257, DOI 10.1016/S1357-4310(95)90961-3; SANDVIG K, 1991, J CELL BIOL, V115, P971, DOI 10.1083/jcb.115.4.971; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2	29	206	212	2	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2000	407	6807					1022	1026		10.1038/35039538	http://dx.doi.org/10.1038/35039538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069184				2022-12-01	WOS:000090032500048
J	Sun, LG; Xie, ZQ; Zhao, JL				Sun, LG; Xie, ZQ; Zhao, JL			Palaeoecology - A 3,000-year record of penguin populations	NATURE			English	Article							LAKE-SEDIMENTS		Univ Sci & Technol China, Inst Polar Environm, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Sun, LG (corresponding author), Univ Sci & Technol China, Inst Polar Environm, Hefei 230026, Anhui, Peoples R China.		xie, zhouqing/P-9661-2019					CLAPPERTON CM, 1989, QUATERNARY RES, V31, P210, DOI 10.1016/0033-5894(89)90006-9; Hodgson DA, 1997, NATURE, V387, P30, DOI 10.1038/387030a0; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; STUIVER M, 1975, QUATERNARY RES, V5, P251, DOI 10.1016/0033-5894(75)90027-7; TAYLOR R H, 1990, Polar Record, V26, P293; TEDROW J. C. F., 1966, Publ. natn. Acad. Sci. natn. Res-Com., Wash., P161; UGOLINI FC, 1966, NATURE, V211, P440, DOI 10.1038/211440a0; WANG G, 1998, ACTA GEOGRAPH SINICA, V53, P538; XU ZB, 1994, ELEMENTS MATH GEOLOG, P226; ZHANG J, 1995, COMPUT MATH APPL, V30, P15, DOI 10.1016/0898-1221(95)00121-E; ZHAO JL, 1991, CHARACTERISTICS MODE	11	167	226	5	60	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					858	858		10.1038/35038163	http://dx.doi.org/10.1038/35038163			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057656	Bronze			2022-12-01	WOS:000089901900039
J	Kraynov, VS; Chamberlain, C; Bokoch, GM; Schwartz, MA; Slabaugh, S; Hahn, KM				Kraynov, VS; Chamberlain, C; Bokoch, GM; Schwartz, MA; Slabaugh, S; Hahn, KM			Localized Rac activation dynamics visualized in living cells	SCIENCE			English	Article							GTP-BINDING-PROTEIN; RHO-GTPASES; FLUORESCENCE; CDC42; EXCHANGE; KINASE	Signaling proteins are thought to be tightly regulated spatially and temporally in order to generate specific and Localized effects. For Rac and other small guanosine triphosphatases, binding to guanosine triphosphate Leads to interaction with downstream targets and regulates subcellular localization. A method called FLAIR (fluorescence activation indicator for Rho proteins) was developed to quantify the spatio-temporal dynamics of the Rad nucleotide state in Living cells. FLAIR revealed precise spatial control of growth factor-induced Rac activation, in membrane ruffles and in a gradient of activation at the leading edge of motile cells. FLAIR exemplifies a generally applicable approach for examining spatio-temporal control of protein activity.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Hahn, KM (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.			Hahn, Klaus/0000-0002-1970-7562; schwartz, martin/0000-0002-2071-1243	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057464, R01GM039434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015430] Funding Source: NIH RePORTER; NIA NIH HHS [AG15430] Funding Source: Medline; NIGMS NIH HHS [R01 GM-57464, GM39434] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; CASTLEMAN K. R., 1996, DIGITAL IMAGE PROCES, P207; CHAMBERLAIN CE, IN PRESS METHODS ENZ; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; DEBIASIO R, 1987, J CELL BIOL, V105, P1613, DOI 10.1083/jcb.105.4.1613; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Joneson T, 1999, MOL CELL BIOL, V19, P5892; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Lakowicz J. R., 1983, PRINCIPLES FLUORESCE, P305; Leonard DA, 1997, BIOCHEMISTRY-US, V36, P1173, DOI 10.1021/bi9622837; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MENARD L, 1992, EUR J BIOCHEM, V206, P537, DOI 10.1111/j.1432-1033.1992.tb16957.x; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nomanbhoy TK, 1996, BIOCHEMISTRY-US, V35, P4602, DOI 10.1021/bi951743d; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Zhou KM, 1998, J BIOL CHEM, V273, P16782, DOI 10.1074/jbc.273.27.16782	24	540	558	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					333	337		10.1126/science.290.5490.333	http://dx.doi.org/10.1126/science.290.5490.333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030651				2022-12-01	WOS:000089818100043
J	Kiger, AA; White-Cooper, H; Fuller, MT				Kiger, AA; White-Cooper, H; Fuller, MT			Somatic support cells restrict germline stem cell self-renewal and promote differentiation	NATURE			English	Article							BAG-OF-MARBLES; EGF RECEPTOR; DROSOPHILA-MELANOGASTER; GENE; MORPHOGENESIS; PROLIFERATION; MAINTENANCE; ACTIVATION; OOGENESIS; FUSOME	Stem cells maintain populations of highly differentiated, short-lived cell-types, including blood, skin and sperm, throughout adult life(1). Understanding the mechanisms that regulate stem cell behaviour is crucial for realizing their potential in regenerative medicine(2). A fundamental characteristic of stem cells is their capacity for asymmetric division: daughter cells either retain stem cell identity or initiate differentiation. However, stem cells are also capable of symmetric division where both daughters remain stem cells(3-6), indicating that mechanisms must exist to balance self-renewal capacity with differentiation. Here we present evidence that support cells surrounding the stem cells restrict self-renewal and control stem cell number by ensuring asymmetric division. Loss of function of the Drosophila Epidermal growth factor receptor in somatic cells disrupted the balance of self-renewal versus differentiation in the male germline, increasing the number of germline stem cells. We propose that activation of this receptor specifies normal behaviour of somatic support cells; in turn, the somatic cells play a guardian role, providing information that prevents self-renewal of stem cell identity by the germ cell they enclose.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Stanford University; Stanford University; University of Oxford	Fuller, MT (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.		White-Cooper, Helen/A-4633-2010	White-Cooper, Helen/0000-0002-3373-8023; Fuller, Margaret T/0000-0002-3804-4987	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078176] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078176] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; BRAND AH, 1994, GENE DEV, V8, P629, DOI 10.1101/gad.8.5.629; CLIFFORD RJ, 1989, GENETICS, V123, P771; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Gabay L, 1997, DEVELOPMENT, V124, P3535; Golembo M, 1999, GENE DEV, V13, P158, DOI 10.1101/gad.13.2.158; Gonczy P, 1997, DEVELOPMENT, V124, P4361; GONCZY P, 1995, THESIS ROCKEFELLER U; GREEN H, 1991, Scientific American, V265, P96; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hime GR, 1996, J CELL SCI, V109, P2779; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; King FJ, 1999, DEVELOPMENT, V126, P1833; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEFFLER M, 1997, STEM CELLS, P1; LIN HF, 1994, DEVELOPMENT, V120, P947; LINDSLEY DL, 1980, GENETICS BIOL DROSOP, P00225, DOI DOI 10.1111/J.1601-5223.1952.TB02915.X; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Parreira GG, 1998, BIOL REPROD, V59, P1360, DOI 10.1095/biolreprod59.6.1360; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wessells RJ, 1999, DEV BIOL, V216, P243, DOI 10.1006/dbio.1999.9459; WHITELEY M, 1992, MECH DEVELOP, V36, P117, DOI 10.1016/0925-4773(92)90063-P; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	29	261	279	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					750	754		10.1038/35037606	http://dx.doi.org/10.1038/35037606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048722				2022-12-01	WOS:000089773900044
J	Grosset, C; Chen, CYA; Xu, NH; Sonenberg, N; Jacquemin-Sablon, H; Shyu, AB				Grosset, C; Chen, CYA; Xu, NH; Sonenberg, N; Jacquemin-Sablon, H; Shyu, AB			A mechanism for translationally coupled mRNA turnover: Interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex	CELL			English	Article							MYC MESSENGER-RNA; AU-RICH ELEMENTS; COLD SHOCK DOMAINS; DESTABILIZING ELEMENTS; BINDING SPECIFICITY; DECAY; DEGRADATION; REGION; DEADENYLATION; INITIATION	mRNA turnover mediated by the major protein-coding-region determinant of instability (mCRD) of the c-fos proto-oncogene transcript illustrates a functional interplay between mRNA turnover and translation. We show that the function of mCRD depends on its distance from the poly(A)tail. Five mCRD-associated proteins were identified: Unr, a purine-rich RNA binding protein; PABP, a poly(A) binding protein; PAIP-1, a poly(A) binding protein interacting protein; hnRNP D, an AU-rich element binding protein; and NSAP1, an hnRNP R-like protein. These proteins form a multiprotein complex. Overexpression of these proteins stabilized mCRD-containing mRNA by impeding deadenylation. We propose that a bridging complex forms between the poly(A) tail and the mCRD and ribosome transit disrupts or reorganizes the complex, leading to rapid RNA deadenylation and decay.	Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; Inst Rech Canc, CNRS, UPR Genet Mol & Integrat Fonct Cellulaires 9044, F-94801 Villejuif, France	University of Texas System; McGill University; Centre National de la Recherche Scientifique (CNRS)	Shyu, AB (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.		Grosset, Christophe/I-5059-2016; Grosset, Christophe/P-9864-2019	Grosset, Christophe/0000-0002-0479-6291; Grosset, Christophe/0000-0002-0479-6291	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046454, R01GM059211] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 59211, GM 46454] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARUCCIO N, 1994, J BIOL CHEM, V269, P31814; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; CHEN CYA, 1994, MOL CELL BIOL, V14, P416, DOI 10.1128/MCB.14.1.416; CHEN CYA, 1992, MOL CELL BIOL, V12, P5748, DOI 10.1128/MCB.12.12.5748; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; Greenberg ME, 1993, CONTROL MESSENGER RN, P199, DOI 10.1016/B978-0-08-091652-1.50013-X; Harris CE, 1999, J VIROL, V73, P72, DOI 10.1128/JVI.73.1.72-80.1999; Hassfeld W, 1998, NUCLEIC ACIDS RES, V26, P439, DOI 10.1093/nar/26.2.439; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HERRICK DJ, 1994, MOL CELL BIOL, V14, P2119, DOI 10.1128/MCB.14.3.2119; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hunt SL, 1999, GENE DEV, V13, P437, DOI 10.1101/gad.13.4.437; Jacobson A., 1996, TRANSLATIONAL CONTRO, P451; JACQUEMINSABLON H, 1994, NUCLEIC ACIDS RES, V22, P2643, DOI 10.1093/nar/22.13.2643; Korner CG, 1997, J BIOL CHEM, V272, P10448; LAIRDOFFRINGA IA, 1991, NUCLEIC ACIDS RES, V19, P2387, DOI 10.1093/nar/19.9.2387; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; MANLEY JL, 1994, GENE DEV, V8, P259, DOI 10.1101/gad.8.3.259; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Preiss T, 1998, NATURE, V392, P516, DOI 10.1038/33192; Preiss T, 1999, CURR OPIN GENET DEV, V9, P515, DOI 10.1016/S0959-437X(99)00005-2; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SCHIAVI SC, 1994, J BIOL CHEM, V269, P3441; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; SHYU AB, 1996, ANAL MRNA DECAY MAMM; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Triqueneaux G, 1999, NUCLEIC ACIDS RES, V27, P1926, DOI 10.1093/nar/27.8.1926; WELLINGTON CL, 1993, MOL CELL BIOL, V13, P5034, DOI 10.1128/MCB.13.8.5034; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; Yeakley JM, 1996, P NATL ACAD SCI USA, V93, P7582, DOI 10.1073/pnas.93.15.7582; Yeilding NM, 1998, J BIOL CHEM, V273, P15749, DOI 10.1074/jbc.273.25.15749; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0; ZAPP ML, 1989, NUCLEIC ACIDS RES, V17, P2655, DOI 10.1093/nar/17.7.2655; Zhang SA, 1997, RNA, V3, P234	45	244	256	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					29	40		10.1016/S0092-8674(00)00102-1	http://dx.doi.org/10.1016/S0092-8674(00)00102-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051545	Bronze			2022-12-01	WOS:000089636400006
J	Kikyo, N; Wade, PA; Guschin, D; Ge, H; Wolffe, AP				Kikyo, N; Wade, PA; Guschin, D; Ge, H; Wolffe, AP			Active remodeling of somatic nuclei in egg cytoplasm by the nucleosomal ATPase ISWI	SCIENCE			English	Article							RNA-POLYMERASE-II; XENOPUS-LAEVIS; HISTONE DEACETYLASE; CHROMATIN; PROTEIN; TRANSCRIPTION; BINDING; CELLS; NUCLEOPLASMIN; EXTRACTS	Cloning by the transplantation of somatic nuclei into unfertilized eggs requires a dramatic remodeling of chromosomal architecture. Many proteins are specifically Lost from nuclei, and others are taken up from the egg cytoplasm. Recreating this exchange in vitro, we identified the chromatin-remodeling nucleosomal adenosine triphosphatase (ATPase) ISWI as a key molecule in this process. ISWI actively erases the TATA binding protein from association with the nuclear matrix. Defining the biochemistry of global nuclear remodeling may facilitate the efficiency of cloning and other dedifferentiation events that establish new stem cell lineages.	NIH, Mol Embryol Lab, Bethesda, MD 20892 USA; Sangarno BioSci, Point Richmond Tech Ctr, Richmond, CA 94804 USA	National Institutes of Health (NIH) - USA	Wolffe, AP (corresponding author), Sangarno BioSci, Point Richmond Tech Ctr, Richmond, CA 94804 USA.	awolffe@sangamo.com	Wade, Paul A/D-2374-2019; Guschin, Dmitry/U-3731-2019; Guschin, Dmitry/O-7594-2018	Wade, Paul A/0000-0002-6042-357X; Guschin, Dmitry/0000-0002-4184-0001; Guschin, Dmitry/0000-0002-4184-0001				ADAM SA, 1992, METHOD ENZYMOL, V219, P97; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Dimitrov S, 1996, EMBO J, V15, P5897, DOI 10.1002/j.1460-2075.1996.tb00976.x; Gurdon J.B., 1979, International Review of Cytology Supplement, P161; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Gurdon JB, 1999, NATURE, V402, P743, DOI 10.1038/45429; Guschin D, 2000, BIOCHEMISTRY-US, V39, P5238, DOI 10.1021/bi000421t; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kimura H, 1999, MOL CELL BIOL, V19, P5383; Li W, 1996, BIOCHEM J, V314, P631, DOI 10.1042/bj3140631; NEWMEYER DD, 1986, J CELL BIOL, V103, P2091, DOI 10.1083/jcb.103.6.2091; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PUDNEY M, 1973, EXPERIENTIA, V29, P466, DOI 10.1007/BF01926785; SEALY L, 1989, METHOD ENZYMOL, V170, P612; SPECTOR DL, 1997, CELLS LAB MANUAL, P105; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Veenstra GJC, 1999, MOL CELL BIOL, V19, P7972, DOI 10.1128/mcb.19.12.7972; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Weitzel JM, 1997, MOL CELL BIOL, V17, P5656, DOI 10.1128/MCB.17.9.5656; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	28	185	205	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2000	289	5488					2360	2362		10.1126/science.289.5488.2360	http://dx.doi.org/10.1126/science.289.5488.2360			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009424				2022-12-01	WOS:000089593500056
J	Altshuler, D; Pollara, VJ; Cowles, CR; Van Etten, WJ; Baldwin, J; Linton, L; Lander, ES				Altshuler, D; Pollara, VJ; Cowles, CR; Van Etten, WJ; Baldwin, J; Linton, L; Lander, ES			An SNP map of the human genome generated by reduced representation shotgun sequencing	NATURE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CANDIDATE GENES; IDENTIFICATION; DIVERSITY; DISCOVERY	Most genomic variation is attributable to single nucleotide polymorphisms (SNPs), which therefore offer the highest resolution for tracking disease genes and population history(1-3). It has been proposed that a dense map of 30,000-500,000 SNPs can be used to scan the human genome for haplotypes associated with common diseases(4-6). Here we describe a simple but powerful method, called reduced representation shotgun (RRS) sequencing, for creating SNP maps. RRS re-samples specific subsets of the genome from several individuals, and compares the resulting sequences using a highly accurate SNP detection algorithm. The method can be extended by alignment to available genome sequence, increasing the yield of SNPs and providing map positions. These methods are being used by The SNP Consortium, an international collaboration of academic centres, pharmaceutical companies and a private foundation, to discover and release at least 300,000 human SNPs. We have discovered 47,172 human SNPs by RRS, and in total the Consortium has identified 148,459 SNPs. More broadly, RRS facilitates the rapid, inexpensive construction of SNP maps in biomedically and agriculturally important species. SNPs discovered by RRS also offer unique advantages for large-scale genotyping.	MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Diabet Unit, Boston, MA 02114 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), MIT, Whitehead Inst, Ctr Genome Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gu ZJ, 1998, HUM MUTAT, V12, P221, DOI 10.1002/(SICI)1098-1004(1998)12:4<221::AID-HUMU1>3.0.CO;2-I; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Landegren U, 1998, GENOME RES, V8, P769, DOI 10.1101/gr.8.8.769; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Li W.H., 1997, MOL EVOLUTION; LI WH, 1991, GENETICS, V129, P513; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401	22	525	579	1	95	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					513	516		10.1038/35035083	http://dx.doi.org/10.1038/35035083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029002				2022-12-01	WOS:000089727400050
J	Hibbett, DS; Gilbert, LB; Donoghue, MJ				Hibbett, DS; Gilbert, LB; Donoghue, MJ			Evolutionary instability of ectomycorrhizal symbioses in basidiomycetes	NATURE			English	Article							HOST SPECIFICITY; YUCCA MOTHS; FUNGI; EUCALYPTUS; PLANTS	Mycorrhizae, the symbiotic associations of plant roots and fungal hyphae, are classic examples of mutualisms. In these ecologically important associations, the fungi derive photosynthetic sugars from their plant hosts, which in turn benefit from fungus-mediated uptake of mineral nutrients. Early views on the evolution of symbioses suggested that all long-term, intimate associations tend to evolve toward mutualism. Following this principle, it has been suggested that mycorrhizal symbioses are the stable derivatives of ancestral antagonistic interactions involving plant parasitic fungi(1). Alternatively, mutualisms have been interpreted as inherently unstable reciprocal parasitisms, which can be disrupted by conflicts of interest among the partners(2-5). To determine the number of origins of mycorrhizae, and to assess their evolutionary stability, it is necessary to understand the phylogenetic relationships of the taxa involved. Here we present a broad phylogenetic analysis of mycorrhizal and free-living homobasidiomycetes (mushroom-forming fungi). Our results indicate that mycorrhizal symbionts with diverse plant hosts have evolved repeatedly from saprotrophic precursors, but also that there have been multiple reversals to a free-living condition. These findings suggest that mycorrhizae are unstable, evolutionarily dynamic associations.	Harvard Univ Herbaria, Cambridge, MA 02138 USA	Harvard University	Hibbett, DS (corresponding author), Clark Univ, Dept Biol, 950 Main St, Worcester, MA 01610 USA.	dhibbett@black.clarku.edu						ASHTON DH, 1976, AUST J BOT, V24, P723, DOI 10.1071/BT9760723; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; BRUNS TD, 1995, PLANT SOIL, V170, P63, DOI 10.1007/BF02183055; COOK RC, 1984, ECOLOGY SAPROTROPHIC; DANIELSON RM, 1984, CAN J BOT, V62, P932, DOI 10.1139/b84-132; Fitter AH, 1996, PHILOS T R SOC B, V351, P1367, DOI 10.1098/rstb.1996.0120; HAWKSWORTH DL, 1996, DICT FUNGI; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; HIBBETT DS, MYCOTA, V7; KROPP BR, 1982, MYCOLOGIA, V74, P479, DOI 10.2307/3792970; LAMB RJ, 1974, T BRIT MYCOL SOC, V63, P295, DOI 10.1016/S0007-1536(74)80176-2; Maddison WP, 1992, MACCLADE VERSION 3 A; MALAJCZUK N, 1982, NEW PHYTOL, V91, P467, DOI 10.1111/j.1469-8137.1982.tb03325.x; MALLOCH DW, 1980, P NATL ACAD SCI-BIOL, V77, P2113, DOI 10.1073/pnas.77.4.2113; MOLINA R, 1982, FOREST SCI, V28, P423; NUHAMARA ST, 1985, P 6 N AM C MYC, P439; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; Pellmyr O, 1996, NATURE, V380, P155, DOI 10.1038/380155a0; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; Price P.W., 1991, SYMBIOSIS SOURCE EVO, P262; Smith S. E., 2010, MYCORRHIZAL SYMBIOSI; SMITS WTM, 1994, DIPTEROCARPACEAE MYC; SWANN EC, 1993, MYCOLOGIA, V85, P923, DOI 10.2307/3760675; SWOFFORD DL, 1999, PAUP; Thompson J.N., 1994, COEVOLUTIONARY PROCE; TRAPPE JM, 1962, BOT REV, V28, P538, DOI 10.1007/BF02868758; [No title captured]; [No title captured]	29	289	308	1	116	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					506	508		10.1038/35035065	http://dx.doi.org/10.1038/35035065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029000				2022-12-01	WOS:000089727400048
J	Mathias, CJ				Mathias, CJ			A 21st century water cure	LANCET			English	Editorial Material							POSTURAL HYPOTENSION; AUTONOMIC FAILURE; DRINKING		UCL, Natl Hosp Neurol & Neurosurg, Univ Dept Clin Neurol, Autonom Unit, London WC1E 6BT, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Mathias, CJ (corresponding author), St Marys, Imperial Coll Sch Med, Neurovasc Med Unit, London W2 1NY, England.							Cariga P, 2000, CLIN AUTON RES, V10, P89; CORBETT JL, 1971, J PHYSIOL-LONDON, V215, P395, DOI 10.1113/jphysiol.1971.sp009476; DIBONA GF, 1999, AUTONOMIC FAILURE TX, P143; Jordan J, 1999, LANCET, V353, P723, DOI 10.1016/S0140-6736(99)99015-3; Jordan J, 2000, CIRCULATION, V101, P504, DOI 10.1161/01.CIR.101.5.504; KOONER JS, 1987, J HYPERTENS       S5, V5, P327; Mathias CJ, 1998, J NEUROL NEUROSUR PS, V65, P285, DOI 10.1136/jnnp.65.3.285; MATHIAS CJ, 1991, J NEUROL NEUROSUR PS, V54, P726, DOI 10.1136/jnnp.54.8.726; MATHIAS CJ, 1986, BRIT MED J, V293, P353, DOI 10.1136/bmj.293.6543.353; PUVIRAJASINGHAM S, 1997, J PHYSL, V505, P481; Rossi P, 1998, J NEUROL SCI, V161, P148, DOI 10.1016/S0022-510X(98)00276-7; Senard JM, 1999, LANCET, V353, P1971, DOI 10.1016/S0140-6736(05)77182-8	12	23	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1046	1048		10.1016/S0140-6736(00)02723-9	http://dx.doi.org/10.1016/S0140-6736(00)02723-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009136				2022-12-01	WOS:000089430500004
J	Akhtar, A; Zink, D; Becker, PB				Akhtar, A; Zink, D; Becker, PB			Chromodomains are protein-RNA interaction modules	NATURE			English	Article							MALE X-CHROMOSOME; DOSAGE COMPENSATION; DROSOPHILA-MELANOGASTER; CHROMATIN; GENES; COMPLEX; DOMAIN; ASSOCIATION; YEAST; ROX1	In Drosophila, compensation for the reduced dosage of genes located on the single male X chromosome involves doubling their expression in relation to their counterparts on female X chromosomes(1). Dosage compensation is an epigenetic process involving the specific acetylation of histone H4 at lysine 16 by the histone acetyltransferase MOF2-5. Although MOF is expressed in both sexes, it only associates with the X chromosome in males. Its absence causes male-specific lethality(6). MOF is part of a chromosome-associated complex comprising male-specific lethal (MSL) proteins and at least one non-coding roX RNA(7). How MOF is integrated into the dosage compensation complex is unknown. Here we show that association of MOF with the male X chromosome depends on its interaction with RNA. MOF specifically binds through its chromodomain to roX2 RNA in vivo. In vitro analyses of the MOF and MSL-3 chromodomains indicate that these chromodomains may function as RNA interaction modules. Their interaction with non-coding RNA may target regulators to specific chromosomal sites.	Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; Univ Munich, Inst Anthropol & Humangenet, D-80336 Munich, Germany	University of Munich; University of Munich	Becker, PB (corresponding author), Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany.		Zink, Daniele/A-8181-2015	Becker, Peter/0000-0001-7186-0372				Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Amrein H, 1997, CELL, V88, P459, DOI 10.1016/S0092-8674(00)81886-3; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; Eddy SR, 1999, CURR OPIN GENET DEV, V9, P695, DOI 10.1016/S0959-437X(99)00022-2; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Gu WG, 1998, DEV GENET, V22, P56, DOI 10.1002/(SICI)1520-6408(1998)22:1<56::AID-DVG6>3.0.CO;2-6; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lucchesi JC, 1999, CURR BIOL, V9, pR807, DOI 10.1016/S0960-9822(99)80495-3; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Richter L, 1996, GENES CELLS, V1, P325, DOI 10.1046/j.1365-2443.1996.26027.x; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Stuckenholz C, 1999, TRENDS GENET, V15, P454, DOI 10.1016/S0168-9525(99)01855-7; Turner BM, 1998, CELL MOL LIFE SCI, V54, P21, DOI 10.1007/s000180050122; Weeks KM, 1997, CURR OPIN STRUC BIOL, V7, P336, DOI 10.1016/S0959-440X(97)80048-6	30	299	310	3	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					405	409		10.1038/35030169	http://dx.doi.org/10.1038/35030169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014199				2022-12-01	WOS:000089390700053
J	Yasunari, T; Shiraki, K; Hattori, H; Miki, T				Yasunari, T; Shiraki, K; Hattori, H; Miki, T			Frequency of choroidal abnormalities in neurofibromatosis type 1	LANCET			English	Article							INDOCYANINE GREEN ANGIOGRAPHY; MALIGNANT-MELANOMA; DYE	Background Choroidal neurofibromatosis is thought to be a rare form of neurofibromatosis that involves the eyes. The development of infrared light examination with a scanning laser ophthalmoscope (SLO) and indocyanine-green fundus angiography has allowed examination of the choroid. We studied choroidal abnormalities in patients with neurofibromatosis 1 and compared their frequency with that of other ocular abnormalities. Methods We examined 33 eyes of 17 consecutive patients diagnosed with neurofibromatosis 1 by conventional ophthalmoscopy and by non-invasive infrared monochromatic light with confocal SLO. 76 eyes of 39 age-matched controls were examined similarly by confocal SLO. 21 digital fluorescein and indocyanine-green angiographies were obtained from 11 adult patients, and 77 angiograms were obtained from age-matched controls. Findings Infrared monochromatic light examination by confocal SLO showed bright multiple patchy regions at and around the entire posterior pole of all 33 eyes examined. All bright patchy regions seen in adult patients corresponded to hypofluorescent areas on their indocyanine-green angiograms. However, no abnormalities were noted in any patient at corresponding areas under conventional ophthalmoscopic examination or fluorescein angiography. In SLO and indocyanine-green studies, controls and control angiograms showed no choroidal abnormalities. Iris nodules were noted in 25 eyes (76%) of 14 patients (82%) and eyelid neurofibroma in five patients (29%). Interpretation The bright patchy regions noted under infrared fundus examination and the corresponding hypofluorescent areas seen on indocyanine-green angiograms are probably of choroidal origin. The high frequency (100%) of these abnormalities suggests that the choroid is one of the structures most commonly affected by neurofibromatosis 1.	Osaka City Univ, Sch Med, Dept Ophthalmol, Abeno Ku, Osaka 5458585, Japan; Osaka City Univ, Sch Med, Dept Pediat, Abeno Ku, Osaka 5458585, Japan	Osaka Metropolitan University; Osaka Metropolitan University	Yasunari, T (corresponding author), Osaka City Univ, Sch Med, Dept Ophthalmol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	taka@med.osaka-cu.ac.jp						ALBERT DM, 1982, PATHOLOGY OCULAR DIS, V1, P590; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; BISCHOFF PM, 1985, DOC OPHTHALMOL, V60, P235, DOI 10.1007/BF00157827; Chang AA, 1998, OPHTHALMOLOGY, V105, P1060, DOI 10.1016/S0161-6420(98)96008-0; DESTRO M, 1989, OPHTHALMOLOGY, V96, P846; FERRY AP, 1994, RETINA, V1, P650; FLOWER RW, 1994, RETINA-J RET VIT DIS, V14, P283, DOI 10.1097/00006982-199414030-00019; FLOWER RW, 1973, INVEST OPHTH VISUAL, V12, P248; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; HAYASHI K, 1985, OPHTHALMOLOGICA, V190, P20, DOI 10.1159/000309488; Kissel P, 1981, NEUROCRISTOPATHIES, P223; KLEIN RM, 1985, AM J OPHTHALMOL, V99, P367, DOI 10.1016/0002-9394(85)90376-9; KUROSAWA A, 1982, ARCH OPHTHALMOL-CHIC, V100, P1939; Rescaldani C, 1998, OPHTHALMOLOGICA, V212, P99, DOI 10.1159/000027287; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; SHIKISHIMA K, 1997, JPN J CLIN OPHTHAL, V51, P1090; Shiraki K, 1998, INT OPHTHALMOL, V21, P245; SHIRAKI K, 1996, FOLIA OPHTHALMOL JPN, V47, P629; TO KW, 1989, SURV OPHTHALMOL, V33, P373, DOI 10.1016/0039-6257(89)90014-3; VONRECKLINGHAUS.FD, 1982, MULTIPHEN FIBROME HA; Warwar RE, 1998, ARCH OPHTHALMOL-CHIC, V116, P1241, DOI 10.1001/archopht.116.9.1241; WOLTER JR, 1962, AM J OPHTHALMOL, V54, P217, DOI 10.1016/0002-9394(62)93279-8; WOLTER JR, 1965, ARCH OPHTHALMOL-CHIC, V73, P696, DOI 10.1001/archopht.1965.00970030698019; WOOG JJ, 1983, GRAEF ARCH CLIN EXP, V220, P25, DOI 10.1007/BF02307012	24	76	77	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2000	356	9234					988	992		10.1016/S0140-6736(00)02716-1	http://dx.doi.org/10.1016/S0140-6736(00)02716-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041400				2022-12-01	WOS:000089293600013
J	Neuberger, MS; Scott, J				Neuberger, MS; Scott, J			Immunology - RNA editing AIDs antibody diversification?	SCIENCE			English	Editorial Material									MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Med, London W12 0NN, England	MRC Laboratory Molecular Biology; Imperial College London	Neuberger, MS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; MUTO T, IN PRESS GENOMICS; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9	7	9	9	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1705	1706		10.1126/science.289.5485.1705	http://dx.doi.org/10.1126/science.289.5485.1705			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	11001738				2022-12-01	WOS:000089195200035
J	Minor, DL; Lin, YF; Mobley, BC; Avelar, A; Jan, YN; Jan, LY; Berger, JM				Minor, DL; Lin, YF; Mobley, BC; Avelar, A; Jan, YN; Jan, LY; Berger, JM			The polar T1 interface is linked to conformational changes that open the voltage-gated potassium channel	CELL			English	Article							SHAKER K+ CHANNEL; ALANINE-SCANNING MUTAGENESIS; GCN4 LEUCINE-ZIPPER; CRYSTAL-STRUCTURE; ACETYLCHOLINE-RECEPTOR; TETRAMERIZATION DOMAIN; PROTEIN STABILITY; MOLECULAR-BASIS; N-TERMINUS; ACTIVATION	Kv voltage-gated potassium channels share a cytoplasmic assembly domain, T1. Recent mutagenesis of two T1 C-terminal loop residues implicates T1 in channel gating. However, structural alterations of these mutants leave open the question concerning direct involvement of T1 in gating. We find in mammalian Kv1.2 that gating depends critically on residues at complementary T1 surfaces in an unusually polar interface. An isosteric mutation in this interface causes surprisingly little structural alteration while stabilizing the dosed channel and increasing the stability of T1 tetramers. Replacing T1 with a tetrameric coiled-coil destabilizes the closed channel. Together, these data suggest that structural changes involving the buried polar T1 surfaces play a key role in the conformational changes leading to channel opening.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Minor, DL (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	minor@itsa.ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Lin, Yu-Fung/0000-0003-1471-949X				ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; ASCHER P, 1992, CURR OPIN NEUROBIOL, V2, P241; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Cachero TG, 1998, CELL, V93, P1077, DOI 10.1016/S0092-8674(00)81212-X; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; CHANDY KG, 1995, HDB RECEPTORS CHANNE, P1; Chiara MD, 1999, J NEUROSCI, V19, P6865, DOI 10.1523/JNEUROSCI.19-16-06865.1999; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Creighton TE, 1993, PROTEINS STRUCTURES; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Elkes DA, 1997, NEURON, V19, P165, DOI 10.1016/S0896-6273(00)80356-6; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hendsch ZS, 1999, PROTEIN SCI, V8, P1381, DOI 10.1110/ps.8.7.1381; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hille B., 1992, IONIC CHANNELS EXCIT; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; HUANG XY, 1994, P NATL ACAD SCI USA, V91, P624, DOI 10.1073/pnas.91.2.624; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Johnstone DB, 1997, NEURON, V19, P151, DOI 10.1016/S0896-6273(00)80355-4; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; McPherson A., 1999, CRYSTALLIZATION BIOL; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; SHEN NV, 1993, NEURON, V11, P67; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	68	159	165	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					657	670		10.1016/S0092-8674(00)00088-X	http://dx.doi.org/10.1016/S0092-8674(00)00088-X			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007484	Bronze			2022-12-01	WOS:000089105200014
J	London, SJ; Yuan, JM; Chung, FL; Gao, YT; Coetzee, GA; Ross, RK; Yu, MC				London, SJ; Yuan, JM; Chung, FL; Gao, YT; Coetzee, GA; Ross, RK; Yu, MC			Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China	LANCET			English	Article							DIETARY ISOTHIOCYANATES; GSTT1 POLYMORPHISMS; CIGARETTE-SMOKING; NULL GENOTYPE; GSTM1; VEGETABLES; METABOLISM; SINGAPORE; BROCCOLI; SPROUTS	Background Dietary isothiocyanates inhibit lung carcinogenesis in laboratory animals but human data are limited. Glutathione S-transferases M1 and T1 (GSTM1 and GSTT1) conjugate isothiocyanates leading to more rapid elimination, Common deletion polymorphisms of GSTM1 and GSTT1 abolish enzyme activity. We hypothesised that chemopreventive effects of isothiocyanates might be heightened when enzymes that enhance their elimination are lacking. Methods We examined the relation between total isothiocyanate concentrations in urine, collected before diagnosis, and the subsequent risk of lung cancer among 232 incident cases of lung cancer and 710 matched controls from a cohort of 18 244 men in Shanghai, China, followed from 1986 to 1997. Homozygous deletion of the GSTM1 and GSTT1 genes were determined by PCR. Findings Individuals with detectable isothiocyanates in the urine were at decreased risk of lung cancer (smoking-adjusted relative risk for lung cancer=0.65 [95% CI 0.43-0.97]). This protective effect of isothiocyanates was seen primarily among individuals with homozygous deletion of GSTT1 (0.36 [0.20-0.63]) and particularly with deletion of both GSTM1 and GSTT1 (0.28 [0.13-0.57]). Interpretation Isothiocyanates appeared to reduce lung-cancer risk in this cohort of Chinese men. Reduction in risk was strongest among persons genetically deficient in enzymes that rapidly eliminate these chemopreventive compounds.	NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA USA; Amer Hlth Fdn, Div Carcinogenesis & Mol Epidemiol, Valhalla, NY 10595 USA; Shanghai Canc Inst, Shanghai, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Southern California; American Health Foundation; Shanghai Jiao Tong University	London, SJ (corresponding author), NIEHS, Epidemiol Branch, POB 12233,MD A3-05, Res Triangle Pk, NC 27709 USA.		London, Stephanie/C-3734-2019; coetzee, Gerhard/AAT-6203-2020; Coetzee, Gerhard/AAG-8439-2019	London, Stephanie/0000-0003-4911-5290; Coetzee, Gerhard/0000-0001-8820-8364; Yuan, Jian-Min/0000-0002-4620-3108	NCI NIH HHS [R01 CA043092-20, R35 CA53890, R01 CA043092, R01 CA43092] Funding Source: Medline; NIEHS NIH HHS [5P30 ES07048] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA053890, R01CA043092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048, Z01ES043012, Z01ES025045, Z01ES049017, Z01ES049018, Z01ES049019] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arand M, 1996, ANAL BIOCHEM, V236, P184, DOI 10.1006/abio.1996.0153; CHUNG FL, 1992, CANCER EPIDEM BIOMAR, V1, P383; Chung FL, 1998, CANCER EPIDEM BIOMAR, V7, P103; Chung FL, 1997, J CELL BIOCHEM, P76; CHUNG FL, 1992, CANC CHEMOPREVENTION; DAVIS FG, 1993, NUTR CANCER, V20, P241, DOI 10.1080/01635589309514292; Fahey JW, 1999, FOOD CHEM TOXICOL, V37, P973, DOI 10.1016/S0278-6915(99)00082-4; Hecht SS, 1999, J NUTR, V129, p768S, DOI 10.1093/jn/129.3.768S; Kelsey KT, 1997, CANCER CAUSE CONTROL, V8, P554, DOI 10.1023/A:1018434027502; Ketterer B, 1998, FREE RADICAL RES, V28, P647, DOI 10.3109/10715769809065820; Ketterer B, 1998, CANCER EPIDEM BIOMAR, V7, P645; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; Lampe J. W., 1999, Proceedings of the American Association for Cancer Research Annual Meeting, V40, P213; LEE EJD, 1995, PHARMACOGENETICS, V5, P332, DOI 10.1097/00008571-199510000-00010; Lin HJ, 1998, CANCER EPIDEM BIOMAR, V7, P647; LONDON SJ, 1995, J NATL CANCER I, V87, P1246, DOI 10.1093/jnci/87.16.1246; MEYER DJ, 1995, BIOCHEM J, V306, P565, DOI 10.1042/bj3060565; Nestle M, 1997, P NATL ACAD SCI USA, V94, P11149, DOI 10.1073/pnas.94.21.11149; POTTER JD, 1996, IARC SCI PUBL, V139, P61; PRE J, 1991, CLIN CHIM ACTA, V204, P87, DOI 10.1016/0009-8981(91)90220-7; ROSS RK, 1992, LANCET, V339, P943, DOI 10.1016/0140-6736(92)91528-G; Rothman N, 1996, CANCER EPIDEM BIOMAR, V5, P979; Seow A, 1998, CANCER EPIDEM BIOMAR, V7, P775; Shapiro TA, 1998, CANCER EPIDEM BIOMAR, V7, P1091; STEINMETZ KA, 1991, CANCER CAUSE CONTROL, V2, P427, DOI 10.1007/BF00054304; ToFigueras J, 1997, CARCINOGENESIS, V18, P1529, DOI 10.1093/carcin/18.8.1529; Van Lieshout EMM, 1998, ONCOL REP, V5, P959; Verhagen H, 1997, CANCER LETT, V114, P127, DOI 10.1016/S0304-3835(97)04641-7; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733; Woodson K, 1999, CANCER EPIDEM BIOMAR, V8, P965; Yu R, 1998, CANCER RES, V58, P402; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646; ZHANG YS, 1995, BIOCHEM BIOPH RES CO, V206, P748, DOI 10.1006/bbrc.1995.1106	33	337	349	0	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 26	2000	356	9231					724	729		10.1016/S0140-6736(00)02631-3	http://dx.doi.org/10.1016/S0140-6736(00)02631-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347UU	11085692				2022-12-01	WOS:000088948200012
J	Jick, H; Zornberg, GL; Jick, SS; Seshadri, S; Drachman, DA				Jick, H; Zornberg, GL; Jick, SS; Seshadri, S; Drachman, DA			Statins and the risk of dementia	LANCET			English	Article							ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; FRONTOTEMPORAL DEMENTIA; INTERNATIONAL WORKSHOP; VASCULAR DEMENTIA; TOTAL CHOLESTEROL; DIAGNOSIS; ASSOCIATION; PREVALENCE; EPSILON-4	Background Dementia affects an estimated 10% of the population older than 65 years. Because vascular and lipid-related mechanisms are thought to have a role in the pathogenesis of Alzheimer's disease and vascular dementia, we did an epidemiological study of the potential effect of HMGCoA (3 hydroxy-3 methylglutaryl-coenzyme A) reductase inhibitors (statins) and other lipid-lowering agents on dementia, Methods We used a nested case-control design with information derived from 368 practices which contribute to the UK-based General Practice Research Database. The base study population included three groups of patients age 50 years and older: all individuals who had received lipid-lowering agents (LLAs); all individuals with a clinical diagnosis of untreated hyperlipidaemia: and a randomly selected group of other individuals. From this base population, all cases with a computer-recorded clinical diagnosis of dementia were identified. Each case was matched with up to four controls derived from the base population on age, sex, practice, and index date of case. Findings The study encompassed 284 cases with dementia and 1 080 controls. Among controls 13% had untreated hyperlipidaemia, 11% were prescribed statins, 7% other LLAs, and 69% had no hyperlipidaemia or LLA exposure. The relative risk estimates of dementia adjusted for ape, sex, history of coronary-artery disease, hypertension, coronary-bypass surgery and cerebral ischaemia, smoking and body mass index for individuals with untreated hyperlipidaemia (odds ratio 0.72 [95% CI 0.45-1.14]), or treated with non-statin LLAs (0.96 [0.47-1.97], was close to 1.0 and not significant compared with people who had no diagnosis of hyperlipidaemia or exposure to other lipid-lowering drugs. The adjusted relative risk for those prescribed statins was 0.29 (0.13-0.63; p=0.002). Interpretation Individuals of 50 years and older who were prescribed statins had a substantially lowered risk of developing dementia, independent of the presence or absence of untreated hyperlipidaemia, or exposure to non-statin LLAs. The available data do not distinguish between Alzheimer's disease and other forms of dementia.	Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA; Boston Univ, Sch Med, Framingham Heart Study, Framingham, MA 01702 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Boston University; Boston University; Framingham Heart Study; Harvard University; Harvard T.H. Chan School of Public Health	Drachman, DA (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA.	david.drachman@umassmed.edu		Seshadri, Sudha/0000-0001-6135-2622; Jick, Hershel/0000-0003-4270-5992; Jick, Susan/0000-0002-2215-1067	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS017950] Funding Source: Medline; PHS HHS [AC05134] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BRAYNE C, 1995, BRIT J PSYCHIAT, V167, P255, DOI 10.1192/bjp.167.2.255; Buee L, 1997, ANN NY ACAD SCI, V826, P7, DOI 10.1111/j.1749-6632.1997.tb48457.x; Chow TW, 1999, ARCH NEUROL-CHICAGO, V56, P817, DOI 10.1001/archneur.56.7.817; Chun MR, 1998, NEUROBIOLOGY OF PRIMARY DEMENTIA, P1; Dahiyat M, 1999, ANN NEUROL, V46, P664, DOI 10.1002/1531-8249(199910)46:4<664::AID-ANA18>3.0.CO;2-J; Davignon J, 1999, CURR OPIN LIPIDOL, V10, P543, DOI 10.1097/00041433-199912000-00010; de la Monte SM, 2000, NEUROBIOL AGING, V21, P309, DOI 10.1016/S0197-4580(99)00108-6; DRACHMAN D, 1998, TXB NEUROLOGY, P389; DRACHMAN DA, 1993, NEUROLOGY, V43, P243, DOI 10.1212/WNL.43.2.243; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Hachinski V, 1997, ANN NY ACAD SCI, V826, P1, DOI 10.1111/j.1749-6632.1997.tb48456.x; Hess DC, 2000, NEUROLOGY, V54, P790, DOI 10.1212/WNL.54.4.790; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Hyman BT, 2000, ARCH NEUROL-CHICAGO, V57, P646, DOI 10.1001/archneur.57.5.646; Jagust WJ, 1997, ANN NY ACAD SCI, V826, P254, DOI 10.1111/j.1749-6632.1997.tb48477.x; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Jick H, 1998, LANCET, V352, P1767, DOI 10.1016/S0140-6736(98)04350-5; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; Kaesemeyer WH, 1999, J AM COLL CARDIOL, V33, P234, DOI 10.1016/S0735-1097(98)00514-2; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MILUNSKY A, 1989, JAMA-J AM MED ASSOC, V262, P2847, DOI 10.1001/jama.262.20.2847; Neary D, 1996, BRAIN COGNITION, V31, P176, DOI 10.1006/brcg.1996.0041; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; *PROGR BCDS, 1974, BRIT MED J, V1, P440; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Sackett D.L., 1997, EVIDENCE BASED MED P; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SESHADRI S, 2000, IN PRESS ARCH NEUROL; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.1997.03540340047031; St George-Hyslop P, 1995, Prog Clin Biol Res, V393, P139; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439	34	1327	1382	1	108	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 11	2000	356	9242					1627	1631		10.1016/S0140-6736(00)03155-X	http://dx.doi.org/10.1016/S0140-6736(00)03155-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372TB	11089820				2022-12-01	WOS:000165249200009
J	Finnell, RH; Burn, J				Finnell, RH; Burn, J			Effect of anti-epileptic drugs on intrauterine growth	LANCET			English	Editorial Material							ANTIEPILEPTIC DRUGS		Univ Nebraska, Med Ctr, Ctr Human Mol Genet, Omaha, NE 68198 USA; Univ Newcastle Upon Tyne, No Reg Genet Serv, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Nebraska System; University of Nebraska Medical Center; Newcastle University - UK	Finnell, RH (corresponding author), Univ Nebraska, Med Ctr, Ctr Human Mol Genet, 600 S 42nd St, Omaha, NE 68198 USA.		Finnell, Richard/D-8174-2018	Finnell, Richard/0000-0002-5962-8754				Fairgrieve SD, 2000, BRIT MED J, V321, P674, DOI 10.1136/bmj.321.7262.674; Finnell RH, 1997, DRUG TOXICITY EMBRYO, P121; James F, 2000, J MED GENET, V37, pS67; Janz D.J.G.M.M., 1964, GER MED MON, V9, P20; KANEKO S, 1992, NEUROLOGY, V42, P68; LINDHOUT D, 1992, NEUROLOGY, V42, P94; Lundberg YW, 2000, AM J HUM GENET, V67, P20; Wide K, 2000, EPILEPSIA, V41, P854, DOI 10.1111/j.1528-1157.2000.tb00253.x	8	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 4	2000	356	9241					1537	1538		10.1016/S0140-6736(00)03118-4	http://dx.doi.org/10.1016/S0140-6736(00)03118-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370QV	11075761				2022-12-01	WOS:000165134500003
J	Blackburn, EH				Blackburn, EH			Telomere states and cell fates	NATURE			English	Article							TO-END FUSIONS; SACCHAROMYCES-CEREVISIAE; LACKING TELOMERASE; HUMAN FIBROBLASTS; MOUSE TELOMERASE; LIFE-SPAN; IN-VITRO; LENGTH; YEAST; RNA	Telomere length has frequently been used as a means to predict the future life of cells. But by itself it can be a poor indicator of ageing or cell viability. What, then, is the important property of a telomere? Here recent findings are integrated into a new, probabilistic view of the telomere to explain how and when it can signal not only its own fate but also that of a cell.	Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blackburn, EH (corresponding author), Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA.	telomer@itsa.ucsf.edu						Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Bassham S, 1998, MOL CELL BIOL, V18, P269, DOI 10.1128/MCB.18.1.269; Bertuch A, 1998, TRENDS CELL BIOL, V8, P339, DOI 10.1016/S0962-8924(98)01331-2; Blackburn E, 1999, MT SINAI J MED, V66, P292; BLACKBURN EH, IN PRESS COLD SPRING; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; di Fagagna FD, 1999, NAT GENET, V23, P76; Ducray C, 1999, ONCOGENE, V18, P4211, DOI 10.1038/sj.onc.1202797; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harley CB, 1997, CIBA F SYMP, V211, P129; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; Holliday R, 1996, BIOESSAYS, V18, P3, DOI 10.1002/bies.950180103; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; JONES RB, 1985, MECH AGEING DEV, V29, P143, DOI 10.1016/0047-6374(85)90014-4; KARATZA C, 1984, J CELL SCI, V65, P163; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; Kondo S, 1998, FASEB J, V12, P801, DOI 10.1096/fasebj.12.10.801; Krauskopf A, 1996, NATURE, V383, P354, DOI 10.1038/383354a0; Krauskopf A, 1998, P NATL ACAD SCI USA, V95, P12486, DOI 10.1073/pnas.95.21.12486; Le S, 1999, GENETICS, V152, P143; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; PONTEN J, 1983, J CELL PHYSIOL, V117, P342, DOI 10.1002/jcp.1041170309; Prescott J, 1997, GENE DEV, V11, P528, DOI 10.1101/gad.11.4.528; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Roy J, 1998, GENE DEV, V12, P3286, DOI 10.1101/gad.12.20.3286; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Smith CD, 1999, J CELL BIOL, V145, P203, DOI 10.1083/jcb.145.2.203; Sprung CN, 1997, MUTAT RES-FUND MOL M, V379, P177, DOI 10.1016/S0027-5107(97)00119-X; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Weng NP, 1998, IMMUNITY, V9, P151, DOI 10.1016/S1074-7613(00)80597-X; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	48	1019	1077	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2000	408	6808					53	56		10.1038/35040500	http://dx.doi.org/10.1038/35040500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081503				2022-12-01	WOS:000165050400047
J	Fernandez-Funez, P; Nino-Rosales, ML; de Gouyon, B; She, WC; Luchak, JM; Martinez, P; Turiegano, E; Benito, J; Capovilla, M; Skinner, PJ; McCall, A; Canal, I; Orr, HT; Zoghbi, HY; Botas, J				Fernandez-Funez, P; Nino-Rosales, ML; de Gouyon, B; She, WC; Luchak, JM; Martinez, P; Turiegano, E; Benito, J; Capovilla, M; Skinner, PJ; McCall, A; Canal, I; Orr, HT; Zoghbi, HY; Botas, J			Identification of genes that modify ataxin-1-induced neurodegeneration	NATURE			English	Article							SCA1 TRANSGENIC MICE; DROSOPHILA-MELANOGASTER; BINDING PROTEIN; POLYGLUTAMINE; DISEASE; HUNTINGTIN; ENCODES	A growing number of human neurodegenerative diseases result from the expansion of a glutamine repeat in the protein that causes the disease(1). Spinocerebellar ataxia type 1 (SCA1) is one such disease-caused by expansion of a polyglutamine tract in the protein ataxin-1. To elucidate the genetic pathways and molecular mechanisms underlying neuronal degeneration in this group of diseases, we have created a model system for SCA1 by expressing the full-length human SCA1 gene in Drosophila. Here we show that high levels of wild-type ataxin-1 can cause degenerative phenotypes similar to those caused by the expanded protein. We conducted genetic screens to identify genes that modify SCA1-induced neurodegeneration. Several modifiers highlight the role of protein folding and protein clearance in the development of SCA1. Furthermore, new mechanisms of polyglutamine pathogenesis were revealed by the discovery of modifiers that are involved in RNA processing, transcriptional regulation and cellular detoxification. These findings may be relevant to the treatment of polyglutamine diseases and, perhaps, to other neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Autonoma Madrid, Dept Biol, Madrid, Spain; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Autonomous University of Madrid; University of Minnesota System; University of Minnesota Twin Cities	Botas, J (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.		Capovilla, Maria/O-8483-2016; Turiegano, Enrique/M-8679-2013	Turiegano, Enrique/0000-0003-4620-7894; Capovilla, Maria/0000-0002-1308-7964; Zoghbi, Huda/0000-0002-0700-3349; Skinner, Pamela/0000-0003-3388-1687; Orr, Harry/0000-0001-6118-741X				Bodoor K, 1999, BIOCHEM CELL BIOL, V77, P321, DOI 10.1139/bcb-77-4-321; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; BRAND AH, 1993, DEVELOPMENT, V118, P401; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chai YH, 1999, J NEUROSCI, V19, P10338; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Grams R, 1998, GENE, V215, P191, DOI 10.1016/S0378-1119(98)00251-0; HAREL A, 1989, J CELL SCI, V94, P463; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Lin X, 1999, NEURON, V24, P499, DOI 10.1016/S0896-6273(00)81104-6; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Rorth P, 1998, DEVELOPMENT, V125, P1049; Salinas AE, 1999, CURR MED CHEM, V6, P279; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532	21	500	531	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2000	408	6808					101	106		10.1038/35040584	http://dx.doi.org/10.1038/35040584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081516				2022-12-01	WOS:000165050400060
J	Urban, FE; Cole, JE; Overpeck, JT				Urban, FE; Cole, JE; Overpeck, JT			Influence of mean climate change on climate variability from a 155-year tropical Pacific coral record	NATURE			English	Article							SOUTHERN-OSCILLATION; GALAPAGOS CORALS; ENSO; TEMPERATURE; OCCURRENCES; CENTURIES; INDEX	Today, the El Nino/Southern Oscillation (ENSO) system is the primary driver of interannual variability in global climate, but its long-term behaviour is poorly understood. Instrumental observations reveal a shift in 1976 towards warmer and wetter conditions in the tropical Pacific, with widespread climatic and ecological consequences(1-3). This shift, unique over the past century(4), has prompted debate over the influence of increasing atmospheric concentrations of greenhouse gases on ENSO variability(5-7). Here we present a 155-year ENSO reconstruction from a central tropical Pacific coral that provides new evidence for long-term changes in the regional mean climate and its variability. A gradual transition in the early twentieth century and the abrupt change in 1976, both towards warmer and wetter conditions, co-occur with changes in variability. In the mid-late nineteenth century, cooler and drier background conditions coincided with prominent decadal variability; in the early twentieth century, shorter-period (similar to2.9 years) variability intensified. After 1920, variability weakens and becomes focused at interannual timescales; with the shift in 1976, variability with a period of about 4 years becomes prominent. Our results suggest that variability in the tropical Pacific is linked to the region's mean climate, and that changes in both have occurred during periods of natural as well as anthropogenic climate forcing.	Univ Colorado, PAOS, INSTAAR, Dept Geol Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Cole, JE (corresponding author), Univ Colorado, PAOS, INSTAAR, Dept Geol Sci, Box 450, Boulder, CO 80309 USA.	jcole@geo.arizona.edu	Cole, Julia/ABA-5759-2020	Cole, Julia/0000-0002-3389-7809				ALLAN R., 1997, NINO SO OSCILLATION; Cole JE, 2000, SCIENCE, V287, P617, DOI 10.1126/science.287.5453.617; COLE JE, 1993, SCIENCE, V260, P1790, DOI 10.1126/science.260.5115.1790; Cole JE, 1990, PALEOCEANOGRAPHY, V5, P669, DOI 10.1029/PA005i005p00669; DUNBAR RB, 1994, PALEOCEANOGRAPHY, V9, P291, DOI 10.1029/93PA03501; EBBESMEYER CC, 1991, P 7 ANN PAC CLIM PAC, P120; Evans MN, 1998, NATURE, V394, P732, DOI 10.1038/29424; Fairbanks RG, 1997, CORAL REEFS, V16, pS93, DOI 10.1007/s003380050245; GAGAN MK, 1994, EARTH PLANET SC LETT, V121, P549, DOI 10.1016/0012-821X(94)90090-6; GRAHAM NE, 1995, SCIENCE, V267, P666, DOI 10.1126/science.267.5198.666; Guilderson TP, 1999, PALEOCEANOGRAPHY, V14, P457, DOI 10.1029/1999PA900024; Hughen KA, 1999, GEOPHYS RES LETT, V26, P3129, DOI 10.1029/1999GL006062; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI [10.1029/97JC01736, 10.1029/97JC01734]; KENNEDY JA, 1992, NATURE, V357, P62, DOI 10.1038/357062a0; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; MANN ME, NINO SO OSCILLATION, P321; Picaut J, 1996, SCIENCE, V274, P1486, DOI 10.1126/science.274.5292.1486; QUINN WH, 1987, J GEOPHYS RES-OCEANS, V92, P14449, DOI 10.1029/JC092iC13p14449; Rajagopalan B, 1997, J CLIMATE, V10, P2351, DOI 10.1175/1520-0442(1997)010<2351:AEOAAV>2.0.CO;2; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P2161, DOI 10.1175/1520-0493(1987)115<2161:AEOTTS>2.0.CO;2; Stahle DW, 1998, B AM METEOROL SOC, V79, P2137, DOI 10.1175/1520-0477(1998)079<2137:EDROTS>2.0.CO;2; TRENBERTH KE, 1987, MON WEATHER REV, V115, P3078, DOI 10.1175/1520-0493(1987)115<3078:OTEOTS>2.0.CO;2; Trenberth KE, 1996, GEOPHYS RES LETT, V23, P57, DOI 10.1029/95GL03602; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Tudhope AW, 1995, EARTH PLANET SC LETT, V136, P575, DOI 10.1016/0012-821X(95)00156-7; Wellington GM, 1996, PALEOCEANOGRAPHY, V11, P467, DOI 10.1029/96PA01023; Wolter K, 1993, P 17 CLIM DIAGN WORK, P52; WOODRUFF SD, 1987, B AM METEOROL SOC, V68, P1239, DOI 10.1175/1520-0477(1987)068<1239:ACOADS>2.0.CO;2; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2	30	233	239	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2000	407	6807					989	993		10.1038/35039597	http://dx.doi.org/10.1038/35039597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069175				2022-12-01	WOS:000090032500039
J	Keeling, MJ; Gilligan, CA				Keeling, MJ; Gilligan, CA			Metapopulation dynamics of bubonic plague	NATURE			English	Article							INFECTIOUS-DISEASES	Bubonic plague is widely regarded as a disease of mainly historical importance; however, with increasing reports of incidence(1-3) and the discovery of antibiotic-resistant strains of the plague bacterium Yersinia pestis(4), it is re-emerging as a significant health concern(5,6). Here we bypass the conventional human-disease models, and propose that bubonic plague is driven by the dynamics of the disease in the rat population. Using a stochastic, spatial metapopulation model, we show that bubonic plague can persist in relatively small rodent populations from which occasional human epidemics arise, without the need for external imports. This explains why historically the plague persisted despite long disease-free periods, and how the disease re-occurred in cities with tight quarantine control. In a contemporary setting, we show that human vaccination cannot eradicate the plague, and that culling of rats may prevent or exacerbate human epidemics, depending on the timing of the cull. The existence of plague reservoirs in wild rodent populations has important public-health implications for the transmission to urban rats and the subsequent risk of human outbreaks.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge; University of Cambridge	Keeling, MJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	matt@zoo.cam.ac.uk	Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765				ANDERSON R M, 1991; APPLEBY AB, 1980, ECON HIST REV, V33, P161; BACOT AW, 1915, J HYG, V6, P770; BARRETO A, 1995, LANCET, V345, P983, DOI 10.1016/S0140-6736(95)90730-0; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Boisier P, 1997, TROP MED INT HEALTH, V2, P422, DOI 10.1046/j.1365-3156.1997.d01-292.x; BOLKER B, 1995, PHILOS T R SOC B, V348, P309, DOI 10.1098/rstb.1995.0070; Buckle A.P., 1994, RODENT PESTS THEIR C; Busvine JR, 1993, DIS TRANSMISSION INS; CURSON P, 1986, PLAGUE SYDNEY ANATOM; FOX JP, 1971, AM J EPIDEMIOL, V94, P179, DOI 10.1093/oxfordjournals.aje.a121310; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; GRAUNT J, 1996, NATURAL POLITICAL OB; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Hanski I., 1997, METAPOPULATION BIOL; Hirst L.F., 1938, BRIT ENCY MEDICAL PR, P675; Keeling MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2219, DOI 10.1098/rspb.2000.1272; Keeling MJ, 1997, TRENDS MICROBIOL, V5, P513, DOI 10.1016/S0966-842X(97)01147-5; KUMAR S, 1995, LANCET, V345, P714, DOI 10.1016/S0140-6736(95)90876-5; Macchiavello A., 1954, J TROP MED HYG, V57, P1; McCormick JB, 1998, CURR OPIN MICROBIOL, V1, P125, DOI 10.1016/S1369-5274(98)80152-5; NOBLE JV, 1974, NATURE, V250, P726, DOI 10.1038/250726a0; Pinner RW, 1996, AM J MED SCI, V311, P3, DOI 10.1097/00000441-199601000-00002; Poland J. D., 1979, CRC Handbook Series in Zoonoses. Section A: bacterial, rickettsial, and mycotic diseases. Volume I., P515; Raggett GF., 1982, IMA J, V18, P221; Renshaw E., 1991, MODELLING BIOL POPUL, DOI 10.1017/CBO9780511624094; Scott S, 1996, ANN HUM BIOL, V23, P1, DOI 10.1080/03014469600004232; Shrewsbury JFD, 1970, HIST BUBONIC PLAGUE; SLACK P, 1981, ECON HIST REV, V34, P469	30	176	180	2	62	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					903	906		10.1038/35038073	http://dx.doi.org/10.1038/35038073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057668				2022-12-01	WOS:000089901900051
J	Wolkow, CA; Kimura, KD; Lee, MS; Ruvkun, G				Wolkow, CA; Kimura, KD; Lee, MS; Ruvkun, G			Regulation of C-elegans life-span by insulinlike signaling in the nervous system	SCIENCE			English	Article							AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; METABOLIC-RATE; LONGEVITY; DIAPAUSE; RECEPTOR; DAF-2	An insulinlike signaling pathway controls Caenorhabditis elegans aging. metabolism, and development. Mutations in the daf-2 insulin receptor-like gene or the downstream age-1 phosphoinositide 3-kinase gene extend adult life-span by two- to threefold. To identify tissues where this pathway regulates aging and metabolism, we restored daf-2 pathway signaling to only neurons, muscle, or intestine. Insulinlike signaling in neurons alone was sufficient to specify wild-type life-span, but muscle or intestinal signaling was not. However, restoring daf-2 pathway signaling to muscle rescued metabolic defects, thus decoupling regulation of life-span and metabolism. These findings point to the nervous system as a central regulator of animal longevity.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Nagoya Univ, Div Biol Sci, Nagoya, Aichi 4648602, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Nagoya University	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@frodo.mgh.harvard.edu	Kimura, Koutarou D./T-9645-2019	Kimura, Koutarou D./0000-0002-3359-1578	NIA NIH HHS [AG14161] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG014161, R37AG014161] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Finch CE., 1990, LONGEVITY SENESCENCE; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; HSU DR, 1995, DEVELOPMENT, V121, P3323; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIMURA K, UNPUB; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LARSEN PL, 1995, GENETICS, V139, P1567; MADURO M, 1995, GENETICS, V141, P977; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; OKKEMA PG, 1993, GENETICS, V135, P385; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; WOLKOW CA, UNPUB	27	501	526	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					147	150		10.1126/science.290.5489.147	http://dx.doi.org/10.1126/science.290.5489.147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021802				2022-12-01	WOS:000089724800055
J	Rickwood, AMK; Kenny, SE; Donnell, SC				Rickwood, AMK; Kenny, SE; Donnell, SC			Towards evidence based circumcision of English boys: survey of trends in practice	BRITISH MEDICAL JOURNAL			English	Article							PHIMOSIS		Childrens Hosp, Dept Paediat Surg, Birmingham B16 8ET, W Midlands, England; Alder Hey Childrens Hosp, Dept Urol, Liverpool L12 2AP, Merseyside, England; Univ Liverpool, Alder Hey Childrens Hosp, Inst Child Hlth, Dept Child Hlth, Liverpool L69 3BX, Merseyside, England	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool	Rickwood, AMK (corresponding author), Alder Hey Childrens Hosp, Dept Urol, Liverpool L12 2AP, Merseyside, England.			Kenny, Simon/0000-0002-5917-8554				ESCALA JM, 1989, BRIT J UROL, V63, P196, DOI 10.1111/j.1464-410X.1989.tb05164.x; FRISCH M, 1995, BRIT MED J, V311, P1471, DOI 10.1136/bmj.311.7018.1471; Kenney N, 1999, BRIT MED J, V319, P619, DOI 10.1136/bmj.319.7210.619; RICKWOOD AMK, 1989, ANN ROY COLL SURG, V71, P275; Shankar KR, 1999, BJU INT, V84, P101	5	44	44	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					792	793		10.1136/bmj.321.7264.792	http://dx.doi.org/10.1136/bmj.321.7264.792			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009516	Bronze, Green Published			2022-12-01	WOS:000089696600021
J	Wang, SS; Yue, HW; Derin, RB; Guggino, WB; Lit, M				Wang, SS; Yue, HW; Derin, RB; Guggino, WB; Lit, M			Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; ELECTRON-MICROSCOPY; EPITHELIAL-CELLS; PDZ DOMAINS; IDENTIFICATION; LOCALIZATION; EXPRESSION; BINDING; FAMILY	The cystic fibrosis transmembrane conductance regulator (CFTR) gene encodes a chloride channel protein that belongs to the superfamily of ATP binding cassette (ABC) transporters. Phosphorylation by protein kinase A in the presence of ATP activates the CFTR-mediated chloride conductance of the apical membranes. We have identified a novel hydrophilic CFTR binding protein, CAP70, which is also concentrated on the apical surfaces. CAP70 consists of four PDZ domains, three of which are capable of binding to the CFTR C terminus. Linking at least two CFTR molecules via cytoplasmic C-terminal binding by either multivalent CAP70 ora bivalent monoclonal antibody potentiates the CFTR chloride channel activity. Thus, the CFTR channel can be switched to a more active conducting state via a modification of intermolecular CFTR-CFTR contact that is enhanced by an accessory protein.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Lit, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	minli@jhmi.edu	Eckhardt, Erik/G-1567-2010					ALAWQATI Q, 1995, SCIENCE, V269, P805, DOI 10.1126/science.7543697; ARMSTRONG S, 1998, PEDIAT PULMONOL, V17, P91; AUSUBEL FM, 1993, CURRENT PROTOCOLS MO, V8; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; Devidas S, 1998, J BIOL CHEM, V273, P29373, DOI 10.1074/jbc.273.45.29373; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; GADSBY DC, 1995, ANNU REV PHYSIOL, V57, P387; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kocher O, 1998, LAB INVEST, V78, P117; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; MARSHALL J, 1994, J BIOL CHEM, V269, P2987; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wine JJ, 1995, CURR BIOL, V5, P1357, DOI 10.1016/S0960-9822(95)00269-7; Zerhusen B, 1999, J BIOL CHEM, V274, P7627, DOI 10.1074/jbc.274.12.7627; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	33	248	255	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2000	103	1					169	179		10.1016/S0092-8674(00)00096-9	http://dx.doi.org/10.1016/S0092-8674(00)00096-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051556	Bronze			2022-12-01	WOS:000089636400017
J	Piccirillo, JF; Duntley, S; Schotland, H				Piccirillo, JF; Duntley, S; Schotland, H			Obstructive sleep apnea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSITIVE AIRWAY PRESSURE; DAYTIME SLEEPINESS; THERAPY; FRAGMENTATION; DEPRIVATION; DIAGNOSIS; OBESITY; ADULTS		Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Clin Outcomes Res Off, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Piccirillo, JF (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Clin Outcomes Res Off, Campus Box 8115,660 Euclid Ave, St Louis, MO 63110 USA.							*AG HLTHCAR POL RE, 1999, 1 US DEP HLTH HUM SE; Ball EM, 1997, ARCH INTERN MED, V157, P419, DOI 10.1001/archinte.157.4.419; CHARUZI I, 1992, American Journal of Clinical Nutrition, V55, p594S, DOI 10.1093/ajcn/55.2.594s; Cohen R, 1998, ORAL SURG ORAL MED O, V85, P388, DOI 10.1016/S1079-2104(98)90062-2; Conradt R, 1998, J SLEEP RES, V7, P217, DOI 10.1046/j.1365-2869.1998.00116.x; Douketis JD, 1999, CAN MED ASSOC J, V160, P513; GUILLEMINAULT C, 1981, CLIN RES PROC, V17, P341; GUILLEMINAULT C, 1993, CHEST, V104, P781, DOI 10.1378/chest.104.3.781; Haponik EF, 1996, J GEN INTERN MED, V11, P759, DOI 10.1007/BF02598994; Hoy CJ, 1999, AM J RESP CRIT CARE, V159, P1096, DOI 10.1164/ajrccm.159.4.9808008; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jokic R, 1999, CHEST, V115, P771, DOI 10.1378/chest.115.3.771; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; KRIEGER J, 1983, LANCET, V2, P1429; Li KK, 2000, OTOLARYNG HEAD NECK, V122, P410, DOI 10.1016/S0194-5998(00)70057-X; Loube DI, 1999, CHEST, V115, P863, DOI 10.1378/chest.115.3.863; Man GCW, 1996, MED CLIN N AM, V80, P803, DOI 10.1016/S0025-7125(05)70468-5; Marklund M, 1998, CHEST, V113, P707, DOI 10.1378/chest.113.3.707; Mickelson SA, 1996, LARYNGOSCOPE, V106, P10, DOI 10.1097/00005537-199601000-00003; NINOMURCIA G, 1989, WESTERN J MED, V150, P165; PACK AI, 1994, ADV INTERNAL MED, V39, P517; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Persson HE, 1996, CHEST, V109, P645, DOI 10.1378/chest.109.3.645; Powell NB, 1998, CLIN CHEST MED, V19, P77, DOI 10.1016/S0272-5231(05)70433-0; Powell NB, 1999, OTOLARYNG HEAD NECK, V120, P656, DOI 10.1053/hn.1999.v120.a96956; ROCHESTER DF, 1974, AM J MED, V57, P402, DOI 10.1016/0002-9343(74)90135-1; Ryan CF, 2000, THORAX, V55, P399, DOI 10.1136/thorax.55.5.399; Sher AE, 1996, SLEEP, V19, P156, DOI 10.1093/sleep/19.2.156; Strollo PJ, 1998, CLIN CHEST MED, V19, P55, DOI 10.1016/S0272-5231(05)70431-7; SURATT PM, 1987, CHEST, V92, P631, DOI 10.1378/chest.92.4.631; THORPY M, 1994, SLEEP, V17, P372; WETTER DW, 1994, ARCH INTERN MED, V154, P2219, DOI 10.1001/archinte.154.19.2219; Woodson BT, 2000, OTOLARYNG HEAD NECK, V122, P395, DOI 10.1016/S0194-5998(00)70055-6; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705	35	9	9	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1492	1494		10.1001/jama.284.12.1492	http://dx.doi.org/10.1001/jama.284.12.1492			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000621				2022-12-01	WOS:000089379700002
J	Plancoulaine, S; Abel, L; van Beveren, M; Tregouet, DA; Joubert, M; Tortevoye, P; de The, G; Gessain, A				Plancoulaine, S; Abel, L; van Beveren, M; Tregouet, DA; Joubert, M; Tortevoye, P; de The, G; Gessain, A			Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population	LANCET			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; ESTIMATING EQUATIONS; HUMAN-HERPESVIRUS-8 INFECTION; SEXUAL TRANSMISSION; HIGH SEROPREVALENCE; SEROLOGIC EVIDENCE; HOMOSEXUAL MEN; ODDS-RATIO; ANTIBODIES	Background Transmission or human herpesvirus 8 (HHV-8), the aetiological agent of Kaposi's sarcoma, is known to occur during sex among homosexual men. However, other modes of HHV-8 transmission remain to be elucidated in endemic populations. Methods We did a population-based seroepidemiological survey in a village in French Guiana among 1337 individuals of African origin (age 2-91 years) who had reliable genealogical data. Plasma samples were taken and tested for HHV-8-specific IgG by immunofluorescence assay. Risk factors and familial correlations for HHV-8 seropositivity were modelled by logistic regression analysis by use of the estimating equations approach, which expresses familial dependences in terms of odds ratios. Familial odds ratios were also acquired by use of the distribution of all possible pairs of a given familiar dependence. Findings The overall HHV-8 seroprevalence was 13.2% with no difference according to sex. HHV-8 seropositivity was strongly age;dependent: at 1.2% under 5 years, HHV-8 seroprevalence rose up to a plateau around 15% between 15 and 40 years, and showed a seroprevalence of more than 27% in individuals older than 40 years. Strong familial aggregation in HHV-8 seroprevalence was found with high mother-child (odd ratio 2.8 [95% CI 1.6-5.0]) and sib-sib (3.8 [1.6-9.5]) correlations. By:contrast, no significant correlation between spouses (0.6 [0.2-1.9]) was seen. Interpretation This pattern of familiar aggregation, together with the variation of HHV-8 seroprevalence with age, indicate that, in endemic populations, HHV-8 transmission mainly occurs from mother to child and between siblings during childhood and adolescence.	Fac Med Necker Enfants Malad, Inst Pasteur, Unite Oncol Virale, Dept SIDA & Retrovirus,Lab Genet Humaine Malad In, F-75015 Paris, France; Fac Med Necker Enfants Malad, Inst Pasteur, CNRS,URA 1930, Lab Genet Humaine Malad Infect, F-75015 Paris, France; Fac Med Necker Enfants Malad, Inst Pasteur, INSERM,U436, Lab Genet Humaine Malad Infect, F-75015 Paris, France; Fac Med Necker Enfants Malad, Inst Pasteur, Unite Epidemiol Virus Oncogenes, Lab Genet Humaine Malad Infect, F-75015 Paris, France; INSERM, U525, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gessain, A (corresponding author), Fac Med Necker Enfants Malad, Inst Pasteur, Unite Oncol Virale, Dept SIDA & Retrovirus,Lab Genet Humaine Malad In, 28 Rue Dr Roux, F-75015 Paris, France.	agessain@pasteur.fr	Tregouet, David-Alexandre/E-3961-2016; Trégouët, David-Alexandre/P-9210-2019; Abel, Laurent/H-8888-2017; PLANCOULAINE, Sabine/E-2824-2017	Trégouët, David-Alexandre/0000-0001-9084-7800; Abel, Laurent/0000-0001-7016-6493; PLANCOULAINE, Sabine/0000-0003-0725-8306				Andreoni M, 1999, J NATL CANCER I, V91, P465, DOI 10.1093/jnci/91.5.465; Angeloni A, 1998, J INFECT DIS, V177, P1715, DOI 10.1086/517429; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Bestetti G, 1998, AIDS, V12, P541; Blackbourn DJ, 1998, J INFECT DIS, V177, P213, DOI 10.1086/517356; Blackbourn DJ, 1999, J INFECT DIS, V179, P237, DOI 10.1086/314570; Boshoff C, 1998, ADV CANCER RES, V75, P57, DOI 10.1016/S0065-230X(08)60739-3; Bourboulia D, 1998, JAMA-J AM MED ASSOC, V280, P31, DOI 10.1001/jama.280.1.31-a; Calabro M L, 1998, J Hum Virol, V1, P207; Calabro ML, 1999, J INFECT DIS, V179, P1534, DOI 10.1086/314765; Chatlynne LG, 1998, BLOOD, V92, P53, DOI 10.1182/blood.V92.1.53.413k30_53_58; de-The G, 1999, J NATL CANCER I, V91, P1888, DOI 10.1093/jnci/91.21.1888; DEMENAIS FM, 1991, AM J HUM GENET, V49, P773; Gessain A, 1999, INT J CANCER, V81, P189, DOI 10.1002/(SICI)1097-0215(19990412)81:2&lt;189::AID-IJC4&gt;3.0.CO;2-E; Kaslow, 1997, VIRAL INFECT HUMANS, P253; Kasolo FC, 1997, J GEN VIROL, V78, P847, DOI 10.1099/0022-1317-78-4-847; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Koelle DM, 1997, J INFECT DIS, V176, P94, DOI 10.1086/514045; Lennette ET, 1996, LANCET, V348, P858, DOI 10.1016/S0140-6736(96)03240-0; LIANG KY, 1991, GENET EPIDEMIOL, V8, P361, DOI 10.1002/gepi.1370080602; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; LIPSITZ SR, 1991, BIOMETRIKA, V78, P153; Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403; Mayama S, 1998, INT J CANCER, V77, P817, DOI 10.1002/(SICI)1097-0215(19980911)77:6&lt;817::AID-IJC2&gt;3.0.CO;2-X; Melbye M, 1998, INT J CANCER, V77, P543, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt;543::AID-IJC12&gt;3.0.CO;2-7; Plancoulaine S, 1998, INT J CANCER, V76, P331, DOI 10.1002/(SICI)1097-0215(19980504)76:3&lt;331::AID-IJC8&gt;3.0.CO;2-W; PRENTICE RL, 1991, BIOMETRICS, V47, P825, DOI 10.2307/2532642; Schulz TF, 1998, J GEN VIROL, V79, P1573, DOI 10.1099/0022-1317-79-7-1573; Sitas F, 1999, NEW ENGL J MED, V340, P1923, DOI 10.1056/NEJM199906173402414; Smith NA, 1999, J INFECT DIS, V180, P600, DOI 10.1086/314926; SPERDUTO RD, 1994, AM J EPIDEMIOL, V140, P555; Tregouet DA, 2000, ANN HUM GENET, V64, P1, DOI 10.1046/j.1469-1809.2000.6410001.x; Tregouet DA, 1999, GENET EPIDEMIOL, V16, P69, DOI 10.1002/(SICI)1098-2272(1999)16:1<69::AID-GEPI6>3.0.CO;2-H; Vieira J, 1997, J VIROL, V71, P7083, DOI 10.1128/JVI.71.9.7083-7087.1997; Whitby D, 1999, J INFECT DIS, V179, P234, DOI 10.1086/314563; ZHAO LP, 1990, BIOMETRIKA, V77, P642, DOI 10.1093/biomet/77.3.642; Ziegler JL, 1996, INT J CANCER, V65, P200, DOI 10.1002/(SICI)1097-0215(19960117)65:2&lt;200::AID-IJC12&gt;3.0.CO;2-H	37	189	200	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2000	356	9235					1062	1065		10.1016/S0140-6736(00)02729-X	http://dx.doi.org/10.1016/S0140-6736(00)02729-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009141				2022-12-01	WOS:000089430500010
J	Lanas, A; Bajador, E; Serrano, P; Fuentes, J; Carreno, S; Guardia, J; Sanz, M; Montoro, M; Sainz, R				Lanas, A; Bajador, E; Serrano, P; Fuentes, J; Carreno, S; Guardia, J; Sanz, M; Montoro, M; Sainz, R			Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEPTIC-ULCER DISEASE; PROPHYLACTIC ASPIRIN; CYCLOOXYGENASE; PERFORATION; PREVENTION; RAT	Background: The relation between medications that release nitric oxide, such as nitroglycerin and other nitrovasodilators, and upper gastrointestinal bleeding is uncertain. In animals, these medications reduce the gastric damage induced by nonsteroidal antiinflammatory drugs. Nitric oxide, however, inhibits platelet aggregation and may contribute to bleeding from an ulcer. Methods: We performed a case-control study to determine the risk of bleeding in patients taking nitrovasodilators, low-dose aspirin, or other nonsteroidal antiinflammatory drugs. The case group was made up of 1122 consecutive patients admitted to one of four hospitals with bleeding from a peptic lesion. The 2231 control subjects were 1109 patients hospitalized for other reasons and 1122 outpatients from the same geographic area. Results: In the week before admission, 520 (46.3 percent) of the patients with bleeding had taken a nonsteroidal antiinflammatory drug other than low-dose aspirin, 120 (10.7 percent) had taken low-dose aspirin (less than or equal to 300 mg per day), 60 (5.3 percent) a nitrovasodilator, and 135 (12.0 percent) an antisecretory agent such as a histamine H-2-receptor antagonist or a proton-pump inhibitor. In multivariate models that adjusted for age, sex, and clinical risk factors, the use of a nonsteroidal antiinflammatory drug other than low-dose aspirin was independently associated with an increased risk of bleeding from a peptic ulcer (odds ratio, 7.4; 95 percent confidence interval, 4.5 to 12.0), as was the use of low-dose aspirin alone (odds ratio, 2.4; 95 percent confidence interval, 1.8 to 3.3). The use of a nitrovasodilator was associated with a decreased risk of bleeding (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.9), as was antisecretory therapy (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.8). In patients taking any type of nonsteroidal antiinflammatory drug, the use of a nitrovasodilator or antisecretory therapy was independently associated with a decreased risk of bleeding. Conclusions: The use of nitrovasodilator drugs is independently associated with a decreased risk of upper gastrointestinal bleeding. (N Engl J Med 2000;343:834-9.) (C) 2000, Massachusetts Medical Society.	Univ Hosp, Serv Digest Dis, Zaragoza, Spain; Hosp Miguel Servet, Serv Digest Dis, Zaragoza, Spain; Hosp San Jorge, Serv Digest Dis, Huesca, Spain; Hosp San Millan, Serv Digest Dis, Logrono, Spain	Miguel Servet University Hospital; Miguel Servet University Hospital; Hospital Universidad San Jorge	Lanas, A (corresponding author), Hosp Clin Univ, Serv Aparato Digest, Zaragoza 50009, Spain.	alanas@posta.unizar.cs	Montoro, Miguel/M-3631-2013	Montoro, Miguel/0000-0001-7676-9842				BARRACHINA MD, 1995, EUR J PHARMACOL, V281, pR3, DOI 10.1016/0014-2999(95)00399-6; Donnelly MT, 1998, GASTROENTEROLOGY, V114, pA107; ELLIOTT SN, 1995, GASTROENTEROLOGY, V109, P524, DOI 10.1016/0016-5085(95)90341-0; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; Kelly JP, 1996, LANCET, V348, P1413, DOI 10.1016/S0140-6736(96)01254-8; Lanas A, 1997, GASTROENTEROLOGY, V112, P683, DOI 10.1053/gast.1997.v112.pm9041228; LANAS A, 1992, GASTROENTEROLOGY, V103, P862, DOI 10.1016/0016-5085(92)90018-T; Lanas A, 1998, J INT MED RES, V26, P120, DOI 10.1177/030006059802600302; Lanas AI, 1996, GUT, V39, P654, DOI 10.1136/gut.39.5.654; LOPEZBELMONTE J, 1993, BRIT J PHARMACOL, V108, P73, DOI 10.1111/j.1476-5381.1993.tb13442.x; MCCARTHY DM, 1995, SCAND J GASTROENTERO, V30, P24, DOI 10.3109/00365529509107758; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; PETROSKI D, 1993, CLIN THER, V15, P314; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; Rodriguez LAG, 1999, EPIDEMIOLOGY, V10, P228, DOI 10.1097/00001648-199905000-00006; Salvemini D, 1996, J CLIN INVEST, V97, P2562, DOI 10.1172/JCI118704; Singh G, 1996, ARCH INTERN MED, V156, P1530, DOI 10.1001/archinte.156.14.1530; SOLL AH, 1991, ANN INTERN MED, V114, P307, DOI 10.7326/0003-4819-114-4-307; Taha AS, 1999, GASTROENTEROLOGY, V116, P254, DOI 10.1016/S0016-5085(99)70120-4; Wallace JL, 1997, GASTROENTEROLOGY, V112, P1000, DOI 10.1053/gast.1997.v112.pm9041264; Wallace JL, 1999, THROMB RES, V93, P43, DOI 10.1016/S0049-3848(98)00134-0; WALLACE JL, 1990, AM J PHYSIOL, V259, pG462, DOI 10.1152/ajpgi.1990.259.3.G462; WALLACE JL, 1994, GASTROENTEROLOGY, V107, P173, DOI 10.1016/0016-5085(94)90074-4; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827	24	324	335	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2000	343	12					834	839		10.1056/NEJM200009213431202	http://dx.doi.org/10.1056/NEJM200009213431202			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354XB	10995862				2022-12-01	WOS:000089355600002
J	Jepsen, K; Hermanson, O; Onami, TM; Gleiberman, AS; Lunyak, V; McEvilly, RJ; Kurokawa, R; Kumar, V; Liu, F; Seto, E; Hedrick, SM; Mandel, G; Glass, CK; Rose, DW; Rosenfeld, MG				Jepsen, K; Hermanson, O; Onami, TM; Gleiberman, AS; Lunyak, V; McEvilly, RJ; Kurokawa, R; Kumar, V; Liu, F; Seto, E; Hedrick, SM; Mandel, G; Glass, CK; Rose, DW; Rosenfeld, MG			Combinatorial roles of the nuclear receptor corepressor in transcription and development	CELL			English	Article							HISTONE DEACETYLASE; N-COR; NEURONAL DIFFERENTIATION; SILENCER ELEMENT; GENE-EXPRESSION; TARGET GENES; REPRESSION; COMPLEX; MSIN3; REST	Transcriptional repression plays crucial roles in diverse aspects of metazoan development, implying critical regulatory roles for corepressors such as N-CoR and SMRT. Altered patterns of transcription in tissues and cells derived from N-CoR gene-deleted mice and the resulting block at specific points in CNS, erythrocyte, and thymocyte development indicated that N-CoR was a required component of short-term active repression by nuclear receptors and MAD and of a subset of long-term repression events mediated by REST/NRSF. Unexpectedly, N-CoR and a specific deacetylase were also required for transcriptional activation of one class of retinoic acid response element. Together, these findings suggest that specific combinations of corepressors and histone deacetylases mediate the gene-specific actions of DNA-bound repressors in development of multiple organ systems.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; SUNY Stony Brook, Howard Hughes Med Inst, Stony Brook, NY 11794 USA; Univ Calif San Diego, Div Endocrinol & Metab, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Howard Hughes Medical Institute; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Hedrick, Stephen M/E-9171-2010; Glass, Christopher/AAI-3933-2021; Kumar, Vivek/P-8749-2014; lunyak, victoria/R-3765-2017	Glass, Christopher/0000-0003-4344-3592; Hedrick, Stephen/0000-0002-6345-8751; Kumar, Vivek/0000-0001-6643-7465; Hermanson, Ola/0000-0001-9320-7921; lunyak, victoria/0000-0001-9093-2714; gleiberman, anatoli/0000-0001-8491-0826	NIDDK NIH HHS [1 RO1 DK54802-O1A1] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054802] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Bauer A, 1998, EMBO J, V17, P4291, DOI 10.1093/emboj/17.15.4291; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6; Fischer A, 1998, SCIENCE, V280, P237, DOI 10.1126/science.280.5361.237; Glass CK, 2000, GENE DEV, V14, P121; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; GREGORY CJ, 1978, BLOOD, V51, P527; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Guenther MG, 2000, GENE DEV, V14, P1048; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HERMANSON O, 1994, J HISTOCHEM CYTOCHEM, V42, P827, DOI 10.1177/42.6.7514627; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Huang EY, 2000, GENE DEV, V14, P45; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kallunki P, 1997, J CELL BIOL, V138, P1343, DOI 10.1083/jcb.138.6.1343; Kao HY, 2000, GENE DEV, V14, P55; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; NEUMAN K, 1995, J NEUROSCI RES, V41, P39, DOI 10.1002/jnr.490410106; PAIN B, 1990, New Biologist, V2, P284; RAMSDELL F, 1992, CURRENT PROTOCOLS IM; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Seol W, 1996, MOL ENDOCRINOL, V10, P1646, DOI 10.1210/me.10.12.1646; Smith WL, 1997, ACAD RADIOL, V4, P657, DOI 10.1016/S1076-6332(05)80273-9; Struhl K, 1998, COLD SPRING HARB SYM, V63, P413, DOI 10.1101/sqb.1998.63.413; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Xu JM, 1996, P NATL ACAD SCI USA, V93, P12195, DOI 10.1073/pnas.93.22.12195; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zamir I, 1996, MOL CELL BIOL, V16, P5458	55	401	409	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					753	763		10.1016/S0092-8674(00)00064-7	http://dx.doi.org/10.1016/S0092-8674(00)00064-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030619	Bronze			2022-12-01	WOS:000089395200007
J	Schoning, KU; Scholz, P; Guntha, S; Wu, X; Krishnamurthy, R; Eschenmoser, A				Schoning, KU; Scholz, P; Guntha, S; Wu, X; Krishnamurthy, R; Eschenmoser, A			Chemical etiology of nucleic acid structure: The alpha-threofuranosyl-(3 '-> 2 ') oligonucleotide system	SCIENCE			English	Article							BASE-PAIRING PROPERTIES; RNA P-RNA; PYRANOSYL-RNA; HOMO-DNA; HYBRID DUPLEXES; BUILDING-BLOCKS; PENTOSE; OLIGOMERIZATION; STABILITY; GUANIDINE	TNAs [(L)-alpha -threofuranosyl oligonucleotides] containing vicinally connected (3'-->2') phosphodiester bridges undergo informational base pairing in antiparallel strand orientation and are capable of cross-pairing with RNA and DNA. Being derived from a sugar containing only four carbons, TNA is structurally the simplest of all potentially natural oligonucleotide-type nucleic acid alternatives studied thus far. This, along with the base-pairing properties of TNA, warrants close scrutiny of the system in the context of the problem of RNA's origin.	Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Swiss Fed Inst Technol, Organ Chem Lab, CH-8092 Zurich, Switzerland	Scripps Research Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Eschenmoser, A (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	aeschen@scripps.edu	Krishnamurthy, Ramanarayanan/AAO-6030-2020	Krishnamurthy, Ramanarayanan/0000-0001-5238-610X				Beier M, 1999, SCIENCE, V283, P699, DOI 10.1126/science.283.5402.699; BOHRINGER M, 1992, HELV CHIM ACTA, V75, P1416, DOI 10.1002/hlca.19920750503; Bolli M, 1997, CHEM BIOL, V4, P309, DOI 10.1016/S1074-5521(97)90074-0; Bolli M, 1997, HELV CHIM ACTA, V80, P1901, DOI 10.1002/hlca.19970800613; Breslauer K.J., 1986, THERMODYNAMIC DATA B, P402; Cantor CR, 1980, BIOPHYSICAL CHEM 3, P1135; Damha MJ, 1998, J AM CHEM SOC, V120, P12976, DOI 10.1021/ja982325+; DEMPCY RO, 1994, P NATL ACAD SCI USA, V91, P7864, DOI 10.1073/pnas.91.17.7864; DIEDRICHSEN U, 1993, THESIS ETH ZURICH; Egger A, 1999, SYNLETT, P913; ESCHENMOSER A, 1992, HELV CHIM ACTA, V75, P218, DOI 10.1002/hlca.19920750120; Eschenmoser A, 1996, NATO ADV SCI INST SE, V320, P293; Eschenmoser A, 1999, SCIENCE, V284, P2118, DOI 10.1126/science.284.5423.2118; FISCHER RW, 1992, THESIS ETH ZURICH; Garner P, 2000, J AM CHEM SOC, V122, P2405, DOI 10.1021/ja993216d; Gatzi K, 1938, HELV CHIM ACTA, V21, P195, DOI 10.1002/hlca.19380210132; Groebke K, 1998, HELV CHIM ACTA, V81, P375, DOI 10.1002/hlca.19980810302; GROEBKE K, 1993, THESIS ETH ZURICH; GRYAZNOV SM, 1995, P NATL ACAD SCI USA, V92, P5798, DOI 10.1073/pnas.92.13.5798; HELG AG, 1994, THESIS ETH ZURICH; Herdewijn P, 1996, LIEBIGS ANN CHEM, V9, P1337; HUNZIKER J, 1993, HELV CHIM ACTA, V76, P259, DOI 10.1002/hlca.19930760119; HUNZIKER J, 1995, MODERN SYNTHETIC MET, V7, P331; Hyrup B, 1996, BIOORGAN MED CHEM, V4, P5, DOI 10.1016/0968-0896(95)00171-9; Jungmann O, 1999, ORG LETT, V1, P1527, DOI 10.1021/ol990183y; Kojima N, 2000, ORG LETT, V2, P81, DOI 10.1021/ol9912478; Kozlov IA, 2000, CHEM-EUR J, V6, P151, DOI 10.1002/(SICI)1521-3765(20000103)6:1<151::AID-CHEM151>3.3.CO;2-8; Kozlov IA, 1999, J AM CHEM SOC, V121, P5856, DOI 10.1021/ja990440u; KRISHNAMURTHY R, 1994, THESIS ETH ZURICH; LESNIK EA, 1995, BIOCHEMISTRY-US, V34, P10807, DOI 10.1021/bi00034a013; LOPEZ MG, 1992, J CARBOHYD CHEM, V11, P799, DOI 10.1080/07328309208020093; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; MULLER T, 1998, THESIS; MURRAY DH, 1967, J PHARM SCI, V56, P865, DOI 10.1002/jps.2600560716; Nelson KE, 2000, P NATL ACAD SCI USA, V97, P3868, DOI 10.1073/pnas.97.8.3868; OTTING G, 1993, HELV CHIM ACTA, V76, P2701, DOI 10.1002/hlca.19930760802; PITSCH S, 1995, HELV CHIM ACTA, V78, P1621, DOI 10.1002/hlca.19950780702; PITSCH S, 1993, HELV CHIM ACTA, V76, P2161, DOI 10.1002/hlca.19930760602; RAO AVR, 1994, J CHEM SOC CHEM COMM, P1255, DOI 10.1039/c39940001255; Reck F, 1999, ORG LETT, V1, P1531, DOI 10.1021/ol990184q; Robins MJ, 1996, J ORG CHEM, V61, P9207, DOI 10.1021/jo9617023; SCHMIDT JG, 1998, J AM CHEM SOC, V120, P4563; SCHWEIZER B, UNPUB; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tereshko V, 1998, J AM CHEM SOC, V120, P269, DOI 10.1021/ja971962h; VORBRUGGEN H, 1981, CHEM BER-RECL, V114, P1279, DOI 10.1002/cber.19811140407; ZELINSKY WS, 1987, NUCLEIC ACIDS RES, V15, P1699	47	427	456	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2000	290	5495					1347	1351		10.1126/science.290.5495.1347	http://dx.doi.org/10.1126/science.290.5495.1347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375BN	11082060				2022-12-01	WOS:000165379800046
J	Kareiva, P; Marvier, M; McClure, M				Kareiva, P; Marvier, M; McClure, M			Recovery and management options for spring/summer chinook salmon in the Columbia River Basin	SCIENCE			English	Article								Construction of four dams on the lower Snake River (in northwestern United States) between 1961 and 1975 altered salmon spawning habitat, elevated smolt and adult migration mortality, and contributed to severe declines of Snake River salmon populations. By applying a matrix model to long-term population data, we found that (i) dam passage improvements have dramatically mitigated direct mortality associated with dams; (ii) even if main stem survival were elevated to 100%, Snake River spring/summer chinook salmon (Oncorhynchus tshawytscha) would probably continue to decline toward extinction; and (iii) modest reductions in first-year mortality or estuarine mortality would reverse current population declines.	NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Santa Clara University	McClure, M (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, 2725 Montlake Blvd E, Seattle, WA 98112 USA.		Ebersole, Joseph L/A-8371-2009; McClure, Michelle M/O-7853-2015	McClure, Michelle M/0000-0003-4791-8719; Marvier, Michelle/0000-0001-8360-9265				BEAMESDERFER RCP, 1998, PLAN ANAL TESTING HY, pCH1; Caswell H., 1989, MATRIX POPULATION MO; ELMSCOCKROM TJ, 1998, SALMON SPAWNING GROU; HALLGRISWOLD J, 1988, SALMON SPAWNING GROU; MARMOREK DR, 1998, PLAN ANAL TESTING HY; *NAT MAR FISH SERV, 2000, DRAFT BIOL OP OP FED; *NAT MAR FISH SERV, 2000, SUMM RES REL TRANSP; National Research Council, 1996, UPSTR SALM SOC PAC N; Northwest Power Planning Council, 1986, COMP INF SALM STEELH; *NW POW PLANN COUN, 1989, PREL INF REP SALM ST; PETROSKY CE, 1998, PATH WEIGHT EVIDENCE; Ratner S, 1997, CONSERV BIOL, V11, P879, DOI 10.1046/j.1523-1739.1997.95457.x; RICKER WE, 1976, J FISH RES BOARD CAN, V33, P1483, DOI 10.1139/f76-191; *US ARM CORPS ENG, 1999, LOW SNAK RIV JUV SAL; Waples RS, 1995, AM FISH S S, V17, P8; WHITE M, 1989, SALMON SPAWNING GROU; WILLIAMS J, IN PRESS N AM J FISH	17	244	249	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2000	290	5493					977	979		10.1126/science.290.5493.977	http://dx.doi.org/10.1126/science.290.5493.977			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062128				2022-12-01	WOS:000165103200047
J	Kravitz, RL				Kravitz, RL			Direct-to-consumer advertising of prescription drugs: Implications for the patient-physician relationship	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Davis, CA 95616 USA	University of California System; University of California Davis	Kravitz, RL (corresponding author), Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Davis, CA 95616 USA.		Kravitz, Richard/AAF-7425-2021	Kravitz, Richard/0000-0001-5575-529X				Bell RA, 1999, J FAM PRACTICE, V48, P446; EVERETT SE, 1991, J ADVERTISING RES, V31, P43; Hoffman JR, 1999, BRIT MED J, V318, P1301, DOI 10.1136/bmj.318.7194.1301; Holmer AF, 1999, JAMA-J AM MED ASSOC, V281, P380, DOI 10.1001/jama.281.4.380; Lipsky MS, 1997, J FAM PRACTICE, V45, P495; MAGUIRE P, 1999, ACP ASIM OBSERVER, P1; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110	7	26	26	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2244	2244		10.1001/jama.284.17.2244	http://dx.doi.org/10.1001/jama.284.17.2244			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367GD	11056603	hybrid			2022-12-01	WOS:000090052600039
J	Buonomo, SBC; Clyne, RK; Fuchs, J; Loidl, J; Uhlmann, F; Nasmyth, K				Buonomo, SBC; Clyne, RK; Fuchs, J; Loidl, J; Uhlmann, F; Nasmyth, K			Disjunction of homologous chromosomes in meiosis I depends on proteolytic cleavage of the meiotic cohesin Rec8 by separin	CELL			English	Article							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; SCHIZOSACCHAROMYCES-POMBE; CONSERVED PROTEIN; SHUTTLE VECTORS; YEAST MEIOSIS; FISSION YEAST; RECOMBINATION	It has been proposed but never proven that cohesion between sister chromatids distal to chiasmata is responsible for holding homologous chromosomes together while spindles attempt to pull them toward opposite poles during metaphase of meiosis I. Meanwhile, the mechanism by which disjunction of homologs is triggered at the onset of anaphase I has remained a complete mystery. In yeast, cohesion between sister chromatid arms during meiosis depends on a meiosis-specific cohesin subunit called Rec8, whose mitotic equivalent, Scc1, is cleaved at the metaphase to anaphase transition by an endopeptidase called separin. We show here that cleavage of Rec8 by separin at one of two different sites is necessary for the resolution of chiasmata and the disjunction of homologous chromosomes during meiosis.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Vienna, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Vienna	Nasmyth, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	nasmyth@nt.imp.univie.ac.at		, Josef/0000-0002-2519-4484; Buonomo, Sara/0000-0002-0177-2884; Fuchs, Joerg/0000-0003-4171-5371; Uhlmann, Frank/0000-0002-3527-6619; Nasmyth, Kim/0000-0001-7030-4403				Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Cha RS, 2000, GENE DEV, V14, P493; Dong HJ, 2000, J CELL BIOL, V148, P417, DOI 10.1083/jcb.148.3.417; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GIROUX CN, 1989, GENOME, V31, P88, DOI 10.1139/g89-017; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P281; JIN QW, 2000, IN PRESS J CELL SCI; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KLAPHOLZ S, 1985, GENETICS, V110, P187; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Krawchuk MD, 1999, GENETICS, V153, P57; LOIDL J, 1994, J CELL BIOL, V125, P1191, DOI 10.1083/jcb.125.6.1191; LOIDL J, 1998, GENETIC MORPHOLOGICA, P257; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; MAGUIRE MP, 1974, J THEOR BIOL, V48, P485, DOI 10.1016/S0022-5193(74)80017-2; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MOLNAR M, 1995, GENETICS, V141, P61; Moore DP, 1998, CURR TOP DEV BIOL, V37, P263; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nasmyth K, 1999, TRENDS BIOCHEM SCI, V24, P98, DOI 10.1016/S0968-0004(99)01358-4; NICKLAS RB, 1977, PHILOS T ROY SOC B, V277, P267, DOI 10.1098/rstb.1977.0017; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; Orr-Weaver TL, 1999, CELL, V99, P1, DOI 10.1016/S0092-8674(00)80055-0; Parisi S, 1999, MOL CELL BIOL, V19, P3515; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; PONTICELLI AS, 1989, GENETICS, V123, P45; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; RIEDER CL, 1992, J CELL SCI, V102, P387; Rieder CL, 1999, J CELL SCI, V112, P2607; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; ROCKMILL B, 1995, GENETICS, V141, P49; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Sambrook J, 1989, MOL CLONING, V3; SIKORSKI RS, 1989, GENETICS, V122, P19; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; THIERRY A, 1995, YEAST, V11, P121, DOI 10.1002/yea.320110204; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	52	342	350	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 27	2000	103	3					387	398		10.1016/S0092-8674(00)00131-8	http://dx.doi.org/10.1016/S0092-8674(00)00131-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081626	Bronze			2022-12-01	WOS:000090144100005
J	Cockayne, DA; Hamilton, SG; Zhu, QM; Dunn, PM; Zhong, Y; Novakovic, S; Malmberg, AB; Cain, G; Berson, A; Kassotakis, L; Hedley, L; Lachnit, WG; Burnstock, G; McMahon, SB; Ford, APDW				Cockayne, DA; Hamilton, SG; Zhu, QM; Dunn, PM; Zhong, Y; Novakovic, S; Malmberg, AB; Cain, G; Berson, A; Kassotakis, L; Hedley, L; Lachnit, WG; Burnstock, G; McMahon, SB; Ford, APDW			Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X(3)-deficient mice	NATURE			English	Article							ROOT GANGLION NEURONS; P2X RECEPTORS; SENSORY NEURONS; RAT; ATP; INFLAMMATION; MICTURITION; RESPONSES	Extracellular ATP is implicated in numerous sensory processes ranging from the response to pain to the regulation of motility in visceral organs(1). The ATP receptor P2X(3) is selectively expressed on small diameter sensory neurons(2-4), supporting this hypothesis. Here we show that mice deficient in P2X(3) lose the rapidly desensitizing ATP-induced currents in dorsal root ganglion neurons. P2X(3) deficiency also causes a reduction in the sustained ATP-induced currents in nodose ganglion neurons. P2X(3)-null mice have reduced pain-related behaviour in response to injection of ATP and formalin. Significantly, P2X(3)-null mice exhibit a marked urinary bladder hyporeflexia, characterized by decreased voiding frequency and increased bladder capacity, but normal bladder pressures. Immunohistochemical studies localize P2X(3) to nerve fibres innervating the urinary bladder of wild-type mice, and show that loss of P2X(3) does not alter sensory neuron innervation density. Thus, P2X(3) is critical for peripheral pain responses and afferent pathways controlling urinary bladder volume reflexes. Antagonists to P2X(3) may therefore have therapeutic potential in the treatment of disorders of urine storage and voiding such as overactive bladder.	Roche Biosci, Neurobiol Unit, Palo Alto, CA 94304 USA; Kings Coll London, Neurosci Res Ctr, London SE1 9RT, England; UCL Royal Free & Univ Coll Med Sch, Autonom Neurosci Inst, London NW3 2PF, England	Roche Holding; University of London; King's College London; University of London; University College London; UCL Medical School	Cockayne, DA (corresponding author), Roche Biosci, Neurobiol Unit, 3401 Hillview Ave, Palo Alto, CA 94304 USA.	debra.cockayne@roche.com		McMahon, Stephen/0000-0003-4656-5536				BlandWard PA, 1997, BRIT J PHARMACOL, V122, P365, DOI 10.1038/sj.bjp.0701371; BLEEHEN T, 1977, PAIN, V3, P367, DOI 10.1016/0304-3959(77)90066-5; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; Burgard EC, 1999, J NEUROPHYSIOL, V82, P1590, DOI 10.1152/jn.1999.82.3.1590; Burnstock G, 1999, J ANAT, V194, P335, DOI 10.1046/j.1469-7580.1999.19430335.x; Burnstock G, 2000, PROG PAIN RES MANAG, V16, P63; Burnstock G, 2000, BRIT J ANAESTH, V84, P476, DOI 10.1093/oxfordjournals.bja.a013473; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; de Groat WC, 1998, BEHAV BRAIN RES, V92, P127, DOI 10.1016/S0166-4328(97)00185-X; Dmitrieva N, 1997, NEUROSCIENCE, V78, P449, DOI 10.1016/S0306-4522(96)00575-1; Elneil S., 1999, Neurourology and Urodynamics, V18, P339; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; FITZGERALD JM, 1995, BLADDER; Grubb BD, 1999, EUR J NEUROSCI, V11, P149, DOI 10.1046/j.1460-9568.1999.00426.x; Hamilton SG, 2000, BRAIN, V123, P1238, DOI 10.1093/brain/123.6.1238; Hamilton SG, 1999, BRIT J PHARMACOL, V126, P326, DOI 10.1038/sj.bjp.0702258; Ishizuka O, 1996, J UROLOGY, V156, P1853, DOI 10.1016/S0022-5347(01)65552-6; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; MCMAHON SB, 1986, PROG BRAIN RES, V67, P245; Namasivayam S, 1999, BJU INT, V84, P854; Rae MG, 1998, BRIT J PHARMACOL, V124, P176, DOI 10.1038/sj.bjp.0701803; Ralevic V, 1998, PHARMACOL REV, V50, P413; Robertson SJ, 1996, BRIT J PHARMACOL, V118, P951, DOI 10.1111/j.1476-5381.1996.tb15491.x; Thomas S, 1998, J PHYSIOL-LONDON, V509, P411, DOI 10.1111/j.1469-7793.1998.411bn.x; Tsuda M, 1999, BRIT J PHARMACOL, V128, P1497, DOI 10.1038/sj.bjp.0702960; Ueno S, 1999, BRIT J PHARMACOL, V126, P429, DOI 10.1038/sj.bjp.0702319; Vulchanova L, 1998, EUR J NEUROSCI, V10, P3470, DOI 10.1046/j.1460-9568.1998.00355.x; Zhong Y, 1998, BRIT J PHARMACOL, V125, P771, DOI 10.1038/sj.bjp.0702118	28	795	826	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2000	407	6807					1011	1015		10.1038/35039519	http://dx.doi.org/10.1038/35039519			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069181				2022-12-01	WOS:000090032500045
J	Hope, S				Hope, S			10-minute consultation - Menorrhagia	BRITISH MEDICAL JOURNAL			English	Article									The Surg, Woodstock OX20 1UD, England		Hope, S (corresponding author), The Surg, Pk Lane, Woodstock OX20 1UD, England.								0	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					935	935		10.1136/bmj.321.7266.935	http://dx.doi.org/10.1136/bmj.321.7266.935			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030684	Green Published, Bronze			2022-12-01	WOS:000089975100025
J	Thoroughman, KA; Shadmehr, R				Thoroughman, KA; Shadmehr, R			Learning of action through adaptive combination of motor primitives	NATURE			English	Article							REACHING MOVEMENTS; ARM; REPRESENTATION; DIRECTION; DYNAMICS; MODEL	Understanding how the brain constructs movements remains a fundamental challenge in neuroscience. The brain may control complex movements through flexible combination of motor primitives(1), where each primitive is an element of computation in the sensorimotor map that transforms desired limb trajectories into motor commands. Theoretical studies have shown that a system's ability to learn action depends on the shape of its primitives(2). Using a time-series analysis of error patterns, here we show that humans learn the dynamics of reaching movements through a flexible combination of primitives that have gaussian-like tuning functions encoding hand velocity. The wide tuning of the inferred primitives predicts limitations on the brain's ability to represent viscous dynamics. We find close agreement between the predicted limitations and the subjects' adaptation to new force fields. The mathematical properties of the derived primitives resemble the tuning curves of Purkinje cells in the cerebellum. The activity of these cells may encode primitives that underlie the learning of dynamics.	Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University	Shadmehr, R (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037422] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007057] Funding Source: Medline; NINDS NIH HHS [R01 NS037422-02, R01 NS037422] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; Coltz JD, 1999, J NEUROSCI, V19, P1782; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; CONRAD B, 1974, BRAIN RES, V71, P507, DOI 10.1016/0006-8993(74)90994-9; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Ghez C., 2000, NEW COGNITIVE NEUROS, P501; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Goodkin H. P., 1993, Canadian Journal of Neurological Sciences, V20, pS93; Holdefer RN, 2000, J NEUROPHYSIOL, V84, P585, DOI 10.1152/jn.2000.84.1.585; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; KAWATO M, 1989, ADV ROBOTICS, V3, P229; Lang CE, 1999, J NEUROPHYSIOL, V82, P2108, DOI 10.1152/jn.1999.82.5.2108; Martin JH, 2000, J NEUROPHYSIOL, V83, P1886, DOI 10.1152/jn.2000.83.4.1886; MATSOUKA Y, 1998, THESIS MIT; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Nezafat R., 1999, Society for Neuroscience Abstracts, V25, P2178; Sanner RM, 1999, BIOL CYBERN, V80, P369, DOI 10.1007/s004220050532; Schaal S, 1998, NEURAL COMPUT, V10, P2047, DOI 10.1162/089976698300016963; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Spoelstra J, 2000, BIOL CYBERN, V82, P321, DOI 10.1007/s004220050586; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	30	643	674	4	61	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					742	747		10.1038/35037588	http://dx.doi.org/10.1038/35037588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048720	Green Accepted			2022-12-01	WOS:000089773900042
J	Ruepp, A; Graml, W; Santos-Martinez, ML; Koretle, KK; Volker, C; Mewes, HW; Frishman, D; Stocker, S; Lupas, AN; Baumeister, W				Ruepp, A; Graml, W; Santos-Martinez, ML; Koretle, KK; Volker, C; Mewes, HW; Frishman, D; Stocker, S; Lupas, AN; Baumeister, W			The genome sequence of the thermoacidophilic scavenger Thermoplasma acidophilum	NATURE			English	Article							PROTEIN; EXPRESSION; GLUCOSE; MACHINE; VAT	Thermoplasma acidophilum is a thermoacidophilic archaeon that thrives at 59 degrees C and pH 2, which was isolated from self-heating coal refuse piles and solfatara fields(1,2). Species of the genus Thermoplasma do not possess a rigid cell wall, but are only delimited by a plasma membrane. Many macromolecular assemblies from Thermoplasma, primarily proteases and chaperones, have been pivotal in elucidating the structure and function of their more complex eukaryotic homologues(3,4). Our interest in protein folding and degradation led us to seek a more complete representation of the proteins involved in these pathways by determining the genome sequence of the organism. Here we have sequenced the 1,564,905-base-pair genome in just 7,855 sequencing reactions by using a new strategy. The 1,509 open reading frames identify Thermoplasma as a typical euryarchaeon with a substantial complement of bacteria-related genes; however, evidence indicates that there has been much lateral gene transfer between Thermoplasma and Sulfolobus solfataricus, a phylogenetically distant crenarchaeon inhabiting the same environment. At least 252 open reading frames, including a complete protein degradation pathway and various transport proteins, resemble Sulfolobus proteins most closely.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; SmithKline Beecham Pharmaceut, Bioinformat, Collegeville, PA 19426 USA; GSF Forschungszentrum Umwelt & Gesundheit, Munich Informat Ctr Prot Sequences, D-82152 Martinsried, Germany	Max Planck Society; GlaxoSmithKline; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Baumeister, W (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	baumeist@biochem.mpg.de	Frishman, Dmitrij/AAT-7815-2020; Mewes, Hans-Werner/A-8204-2019	Mewes, Hans-Werner/0000-0002-9713-6398; Santos, Leticia/0000-0002-7992-7487				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARRETT AJ, 1999, HDB PROTEOLYTIC ENZY; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; BUDGEN N, 1986, FEBS LETT, V196, P207, DOI 10.1016/0014-5793(86)80247-2; Coles M, 1999, CURR BIOL, V9, P1158, DOI 10.1016/S0960-9822(00)80017-2; DARLAND G, 1970, SCIENCE, V170, P1416, DOI 10.1126/science.170.3965.1416; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Frishman D, 1997, TRENDS GENET, V13, P415, DOI 10.1016/S0168-9525(97)01224-9; Frishman D, 1998, NUCLEIC ACIDS RES, V26, P2941, DOI 10.1093/nar/26.12.2941; Golbik R, 1999, BIOL CHEM, V380, P1049, DOI 10.1515/BC.1999.131; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; HIXON WG, 1993, BIOSYSTEMS, V29, P151, DOI 10.1016/0303-2647(93)90091-P; HUANG CJ, 1991, J BACTERIOL, V173, P1544, DOI 10.1128/jb.173.4.1544-1553.1991; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Koretke KK, 1999, PROTEINS, P141; Lopez P, 1999, MOL MICROBIOL, V32, P883, DOI 10.1046/j.1365-2958.1999.01370.x; Luebben Mathias, 1995, Biochimica et Biophysica Acta, V1229, P1; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; REE HK, 1990, NUCLEIC ACIDS RES, V18, P4471, DOI 10.1093/nar/18.15.4471; RUDOLPH J, 1995, EMBO J, V14, P667, DOI 10.1002/j.1460-2075.1995.tb07045.x; SEARCY DG, 1984, SYST APPL MICROBIOL, V5, P30; Segerer A., 1992, PROKARYOTES, P712; SMITH PF, 1975, J BACTERIOL, V124, P884, DOI 10.1128/JB.124.2.884-892.1975; STEIN DB, 1978, SCIENCE, V202, P219, DOI 10.1126/science.694528; Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; WOLF S, 1993, FEBS LETT, V326, P42, DOI 10.1016/0014-5793(93)81757-Q; YASUDA M, 1995, FEMS MICROBIOL LETT, V128, P157, DOI 10.1016/0378-1097(95)00106-F; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	30	333	706	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					508	513		10.1038/35035069	http://dx.doi.org/10.1038/35035069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029001	Bronze			2022-12-01	WOS:000089727400049
J	Fayrer-Hosken, RA; Grobler, D; Van Altena, JJ; Bertschinger, HJ; Kirkpatrick, JF				Fayrer-Hosken, RA; Grobler, D; Van Altena, JJ; Bertschinger, HJ; Kirkpatrick, JF			Immunocontraception of African elephants - A humane method to control elephant populations without behavioural side effects.	NATURE			English	Article							PORCINE ZONA-PELLUCIDA		Univ Georgia, Coll Vet Med, Athens, GA 30602 USA; Kruger Natl Pk, ZA-1350 Skukuza, South Africa; Univ Pretoria, Dept Theriogenol, ZA-0110 Onderstepoort, South Africa; ZooMontana, Billings, MT 59106 USA	University System of Georgia; University of Georgia; University of Pretoria	Fayrer-Hosken, RA (corresponding author), Univ Georgia, Coll Vet Med, Athens, GA 30602 USA.							AYRERHOSKEN RA, 1997, THERIOGENOLOGY, V47, P397; Fayrer-Hosken RA, 1999, THERIOGENOLOGY, V52, P835, DOI 10.1016/S0093-691X(99)00176-4; FayrerHosken RA, 1997, WILDLIFE SOC B, V25, P18; Kirkpatrick JF, 1997, REPROD FERT DEVELOP, V9, P105, DOI 10.1071/R96052; WILLIS P, 1994, J EQUINE VET SCI, V14, P364, DOI 10.1016/S0737-0806(06)81753-3	5	88	101	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					149	149		10.1038/35025136	http://dx.doi.org/10.1038/35025136			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001042	Bronze			2022-12-01	WOS:000089241000032
J	Jousson, O; Pawlowski, J; Zaninetti, L; Zechman, FW; Dini, F; Di Guiseppe, G; Woodfield, R; Millar, A; Meinesz, A				Jousson, O; Pawlowski, J; Zaninetti, L; Zechman, FW; Dini, F; Di Guiseppe, G; Woodfield, R; Millar, A; Meinesz, A			Invasive alga reaches California - The alga has been identified that threatens to smother Californian coastal ecosystems.	NATURE			English	Article							CAULERPA-TAXIFOLIA; MEDITERRANEAN-SEA; ORIGIN		Univ Geneva, Dept Zool & Biol Anim, CH-1224 Chene Bougeries, Switzerland; Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA; Univ Pisa, Dipartimento Etol Ecol & Evoluz, I-56126 Pisa, Italy; Merkel & Associates, San Diego, CA 92123 USA; Royal Bot Gardens, Sydney, NSW 2000, Australia; Univ Nice, Lab Environm Marin Littoral, F-06108 Nice, France	University of Geneva; California State University System; California State University Fresno; University of Pisa; UDICE-French Research Universities; Universite Cote d'Azur	Jousson, O (corresponding author), Univ Geneva, Dept Zool & Biol Anim, CH-1224 Chene Bougeries, Switzerland.		Jousson, Olivier/S-4397-2019; Jousson, Olivier/N-7000-2013	Jousson, Olivier/0000-0003-3344-7194; Di Giuseppe, Graziano/0000-0002-9999-7650				Dalton R, 2000, NATURE, V406, P447, DOI 10.1038/35020226; Jousson O, 1998, MAR ECOL PROG SER, V172, P275, DOI 10.3354/meps172275; Kaiser J, 2000, SCIENCE, V289, P222; Komatsu T, 1997, MAR ECOL PROG SER, V146, P145, DOI 10.3354/meps146145; Meinesz A, 1995, BOT MAR, V38, P499, DOI 10.1515/botm.1995.38.1-6.499; Meinesz A, 1996, CR ACAD SCI III-VIE, V319, P603; MEINESZ A, 1991, OCEANOL ACTA, V14, P415; Olsen JL, 1998, J PHYCOL, V34, P850, DOI 10.1046/j.1529-8817.1998.340850.x; PIGHINI M, 1999, 4 INT WORKSH CAUL TA	9	165	174	0	41	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					157	158		10.1038/35041623	http://dx.doi.org/10.1038/35041623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089959				2022-12-01	WOS:000165180400030
J	Whitby, FG; Masters, EI; Kramer, L; Knowlton, JR; Yao, Y; Wang, CC; Hill, CP				Whitby, FG; Masters, EI; Kramer, L; Knowlton, JR; Yao, Y; Wang, CC; Hill, CP			Structural basis for the activation of 20S proteasomes by 11S regulators	NATURE			English	Article							REG-ALPHA; ANTIGEN PRESENTATION; CLASS-I; PROTEIN; PA28; IDENTIFICATION; SUBUNIT; BETA; PURIFICATION; PA28-ALPHA	Most of the non-lysosomal proteolysis that occurs in eukaryotic cells is performed by a nonspecific and abundant barrel-shaped complex called the 20S proteasome(1). Substrates access the active sites, which are sequestered in an internal chamber, by traversing a narrow opening(2) (alpha -annulus) that is blocked in the unliganded 20S proteasome by amino-terminal sequences of alpha -subunits(3). Peptide products probably exit the 20S proteasome through the same opening. 11S regulators (also called PA26 (ref. 4), PA28 (ref. 5) and REG(6,7)) are heptamers(4,8,9) that stimulate 20S proteasome peptidase activity in vitro and may facilitate product release in vivo. Here we report the co-crystal structure of yeast 20S proteasome with the 11S regulator from Trypanosoma brucei 4 (PA26). PA26 carboxy-terminal tails provide binding affinity by inserting into pockets on the 20S proteasome, and PA26 activation loops induce conformational changes in alpha -subunits that open the gate separating the proteasome interior from the intracellular environment. The reduction in processivity expected for an open conformation of the exit gate may explain the role of 11S regulators in the production of ligands for major histocompatibility complex class I molecules(10,11).	Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco	Hill, CP (corresponding author), Univ Utah, Dept Biochem, 50 N Med Dr, Salt Lake City, UT 84132 USA.	chris@biochem.utah.edu						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BRUNGER AT, 1996, XPLOR VERSION 3 843; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Gaczynska M, 1996, J BIOL CHEM, V271, P17275, DOI 10.1074/jbc.271.29.17275; GRAY CW, 1994, J MOL BIOL, V236, P7, DOI 10.1006/jmbi.1994.1113; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hendil KB, 1998, BIOCHEM J, V332, P749, DOI 10.1042/bj3320749; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Li J, 2000, J MOL BIOL, V299, P641, DOI 10.1006/jmbi.2000.3800; MA CP, 1992, J BIOL CHEM, V267, P10515; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nussbaum AK, 1998, P NATL ACAD SCI USA, V95, P12504, DOI 10.1073/pnas.95.21.12504; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Preckel T, 1999, SCIENCE, V286, P2162, DOI 10.1126/science.286.5447.2162; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; RECHSTEINER M, 1998, UBIQUITIN BIOL CELL, P147; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; Song XL, 1997, J BIOL CHEM, V272, P27994, DOI 10.1074/jbc.272.44.27994; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Yao Y, 1999, J BIOL CHEM, V274, P33921, DOI 10.1074/jbc.274.48.33921; Zhang ZG, 1998, P NATL ACAD SCI USA, V95, P2807, DOI 10.1073/pnas.95.6.2807; Zhang ZG, 1999, BIOCHEMISTRY-US, V38, P5651, DOI 10.1021/bi990056+	30	389	413	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2000	408	6808					115	120		10.1038/35040607	http://dx.doi.org/10.1038/35040607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081519				2022-12-01	WOS:000165050400063
J	Sharp, D				Sharp, D			Shuffles	LANCET			English	Editorial Material									The Lancet, London WC1X 8RR, England		Sharp, D (corresponding author), The Lancet, London WC1X 8RR, England.							ALDER P, 1997, BRIDGE PLAYERS BEDSI, P104; FORRESTER T, 2000, DAILY TELEGRAPH 1011, P46; Trefethen LN, 2000, P ROY SOC A-MATH PHY, V456, P2561, DOI 10.1098/rspa.2000.0625	3	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1374	1374		10.1016/S0140-6736(00)02838-5	http://dx.doi.org/10.1016/S0140-6736(00)02838-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052578				2022-12-01	WOS:000089976100008
J	Wei, P; Zhang, J; Egan-Hafley, M; Liang, SG; Moore, DD				Wei, P; Zhang, J; Egan-Hafley, M; Liang, SG; Moore, DD			The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism	NATURE			English	Article							GENE; 1,4-BIS<2-(3,5-DICHLOROPYRIDYLOXY)>BENZENE; HEPATOTOXICITY; CARCINOGENS; EXPRESSION; LIVER; PXR	Organisms encounter a wide range of foreign compounds-or 'xenobiotics'-with potentially harmful consequences. The cytochrome P450 (CYP) enzymes metabolize xenobiotics and thus are a primary defence against these compounds. Increased expression of specific CYP genes in response to particular xenobiotics is a central component of this defence(1), although such induction can also increase production of toxic metabolites. Here we show that the nuclear receptor CAR mediates the response evoked by a class of xenobiotics known as the 'phenobarbital-like inducers'. The strong activation of Cyp2b10 gene expression by phenobarbital, or by the more potent TCPOBOP, is absent in mice lacking the CAR gene. These animals also show decreased metabolism of the classic CYP substrate zoxazolamine and a complete loss of the liver hypertrophic and hyperplastic responses to these inducers. Cocaine causes acute hepatotoxicity in wild-type mice previously exposed to phenobarbital-like inducers and this toxicity is also absent in the CAR-deficient animals. Thus, loss of CAR function alters sensitivity to toxins, increasing or decreasing it depending on the compound. Modulation of CAR activity in humans may significantly affect metabolism of drugs and other xenobiotics.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.							BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Bornheim LM, 1998, TOXICOL APPL PHARM, V150, P158, DOI 10.1006/taap.1998.8403; Carthew P, 1998, TOXICOL SCI, V44, P46, DOI 10.1093/toxsci/44.1.46; Choi HS, 1997, J BIOL CHEM, V272, P23565, DOI 10.1074/jbc.272.38.23565; Code EL, 1997, DRUG METAB DISPOS, V25, P985; Cunningham ML, 1996, MUTAT RES-REV GENET, V365, P59, DOI 10.1016/S0165-1110(96)90012-3; HEUBEL F, 1989, BIOCHEM PHARMACOL, V38, P1293, DOI 10.1016/0006-2952(89)90336-5; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Liang HCL, 1996, P NATL ACAD SCI USA, V93, P1671, DOI 10.1073/pnas.93.4.1671; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; POLAND A, 1980, MOL PHARMACOL, V18, P571; ROBINSON JR, 1974, MOL PHARMACOL, V10, P484; Selim K, 1999, HEPATOLOGY, V29, P1347, DOI 10.1002/hep.510290535; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116	22	551	576	4	41	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					920	923		10.1038/35038112	http://dx.doi.org/10.1038/35038112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057673				2022-12-01	WOS:000089901900056
J	Obmolova, G; Ban, C; Hsieh, P; Yang, W				Obmolova, G; Ban, C; Hsieh, P; Yang, W			Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA	NATURE			English	Article							ESCHERICHIA-COLI; REPLICATION FIDELITY; MUTATOR PHENOTYPES; THERMUS-AQUATICUS; ATP-BINDING; RECOGNITION; MUTATIONS; RECOMBINATION; HYDROLYSIS; SUBUNIT	DNA mismatch repair is critical for increasing replication fidelity in organisms ranging from bacteria to humans. MutS protein, a member of the ABC ATPase superfamily, recognizes mispaired and unpaired bases in duplex DNA and initiates mismatch repair. Mutations in human MutS genes cause a predisposition to hereditary nonpolyposis colorectal cancer as well as sporadic tumours. Here we report the crystal structures of a MutS protein and a complex of MutS with a heteroduplex DNA containing an unpaired base. The structures reveal the general architecture of members of the MutS family, an induced-fit mechanism of recognition between four domains of a MutS dimer and a heteroduplex kinked at the mismatch, a composite ATPase active site composed of residues from both MutS subunits, and a transmitter region connecting the mismatch-binding and ATPase domains. The crystal structures also provide a molecular framework for understanding hereditary nonpolyposis colorectal cancer mutations and for postulating testable roles of MutS.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NIDDKD, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	Wei.Yang@nih.gov	Yang, Wei/D-4926-2011; Ban, Changill/F-5426-2013; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036119, Z01DK036119] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAJSKI SR, 2000, MUTAT RES, V447, P49; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Ban C, 1998, EMBO J, V17, P1526, DOI 10.1093/emboj/17.5.1526; Berger JM, 1996, CURR OPIN STRUC BIOL, V6, P84, DOI 10.1016/S0959-440X(96)80099-6; Biswas I, 1999, J BIOL CHEM, V274, P23673, DOI 10.1074/jbc.274.33.23673; Biswas I, 1996, J BIOL CHEM, V271, P5040; Bjornson KP, 2000, BIOCHEMISTRY-US, V39, P3176, DOI 10.1021/bi992286u; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; Dickerson RE, 1998, NUCLEIC ACIDS RES, V26, P1906, DOI 10.1093/nar/26.8.1906; Drotschmann K, 1999, P NATL ACAD SCI USA, V96, P2970, DOI 10.1073/pnas.96.6.2970; Drotschmann K, 1999, CURR BIOL, V9, P907, DOI 10.1016/S0960-9822(99)80396-0; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; GORBALENYA AE, 1990, J MOL BIOL, V213, P583, DOI 10.1016/S0022-2836(05)80243-8; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Jiricny J, 1998, MUTAT RES-DNA REPAIR, V409, P107, DOI 10.1016/S0921-8777(98)00056-1; JONES M, 1987, GENETICS, V115, P605; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Malkov VA, 1997, J BIOL CHEM, V272, P23811, DOI 10.1074/jbc.272.38.23811; Matic I, 1996, TRENDS MICROBIOL, V4, P69, DOI 10.1016/0966-842X(96)81514-9; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nakagawa T, 1999, P NATL ACAD SCI USA, V96, P14186, DOI 10.1073/pnas.96.25.14186; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Studamire B, 1999, MOL CELL BIOL, V19, P7558; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; TERWILLIGER TC, 1997, SOLVE AUTOMATED STRU; Umar A, 1996, EUR J BIOCHEM, V238, P297, DOI 10.1111/j.1432-1033.1996.0297z.x; WU TH, 1994, J BACTERIOL, V176, P5393, DOI 10.1128/JB.176.17.5393-5400.1994; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3; Zalevsky J, 1999, GENETICS, V153, P1271	47	521	528	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					703	710		10.1038/35037509	http://dx.doi.org/10.1038/35037509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048710				2022-12-01	WOS:000089773900032
J	Benedetti-Cecchi, L				Benedetti-Cecchi, L			Variance in ecological consumer-resource interactions	NATURE			English	Article							INTERACTION STRENGTH; FOOD-WEB; COMMUNITY ORGANIZATION; INTERTIDAL ZONE; SUCCESSION; PREDATION; SIZE; VARIABILITY; DYNAMICS; ALGAE	Food-web models use the effect size of trophic interactions to predict consumer-resource dynamics(1-3). These models anticipate that strong effects of consumers increase spatial and temporal variability in abundance of species, whereas weak effects dampen fluctuations(4-6). Empirical evidence indicates that opposite patterns may occur in natural assemblages(7). Here I show that spatial variance in the distribution of resource populations is sensitive to changes in the variance of the trophic interaction, in addition to the mean effect of consumers, relative to other causes of spatial variability. Simulations indicate that both strong and weak direct effects of consumers can promote spatial variability in abundance of resources, but only trophic interactions with a large mean effect size can reduce variation. Predictions of the model agree with the results of repeated field experiments and are consistent with data from published consumer-resource interactions, proving to be robust across widely varying environmental conditions and species' life histories. Thus, food-web models that embody variance in trophic interactions may have increased capacity to explain the wide range of effects of consumers documented in empirical studies.	Dipartimento Sci Uomo Ambiente, I-56126 Pisa, Italy		Benedetti-Cecchi, L (corresponding author), Dipartimento Sci Uomo Ambiente, Via A Volta 6, I-56126 Pisa, Italy.		Benedetti-Cecchi, Lisandro/J-8225-2019	Benedetti-Cecchi, Lisandro/0000-0001-5244-5202				Anderson MJ, 1997, OECOLOGIA, V109, P442, DOI 10.1007/s004420050104; Benedetti-Cecchi L, 2000, ECOL MONOGR, V70, P45, DOI 10.1890/0012-9615(2000)070[0045:PDAIID]2.0.CO;2; Berlow EL, 1997, J EXP MAR BIOL ECOL, V214, P195, DOI 10.1016/S0022-0981(97)00023-3; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; DETHIER MN, 1988, MAR ECOL PROG SER, V50, P97, DOI 10.3354/meps050097; Dungan M.L., 1987, P188; DUNGAN ML, 1986, AM NAT, V127, P292, DOI 10.1086/284486; FAIRWEATHER PG, 1988, OIKOS, V53, P87, DOI 10.2307/3565667; Lawton J.H., 1989, P43; LUBCHENCO J, 1978, ECOL MONOGR, V48, P67, DOI 10.2307/2937360; LUBCHENCO J, 1984, J EXP MAR BIOL ECOL, V78, P23, DOI 10.1016/0022-0981(84)90069-8; MARTIN TH, 1989, ECOLOGY, V70, P1935, DOI 10.2307/1938123; May R.M., 1973, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Menconi M, 1999, J EXP MAR BIOL ECOL, V233, P1, DOI 10.1016/S0022-0981(98)00123-3; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; MENGE BA, 1986, OECOLOGIA, V71, P75, DOI 10.1007/BF00377324; MORRISON D, 1988, ECOLOGY, V69, P1367, DOI 10.2307/1941634; Navarrete SA, 1996, ECOL MONOGR, V66, P301, DOI 10.2307/2963520; Osenberg CW, 1997, AM NAT, V150, P798, DOI 10.1086/286095; PAINE RT, 1980, J ANIM ECOL, V49, P667; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; SMITH SV, 1992, ANNU REV ECOL SYST, V23, P89, DOI 10.1146/annurev.es.23.110192.000513; SOUSA WP, 1984, ECOLOGY, V65, P1918, DOI 10.2307/1937789; SOUSA WP, 1979, ECOL MONOGR, V49, P227, DOI 10.2307/1942484; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Underwood AJ, 1996, FRONTIERS OF POPULATION ECOLOGY, P369; WOOTTON JT, 1993, ECOLOGY, V74, P195, DOI 10.2307/1939514	30	57	58	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					370	374		10.1038/35030089	http://dx.doi.org/10.1038/35030089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014191				2022-12-01	WOS:000089390700045
J	Sekiyama, K; Miyauchi, S; Imaruoka, T; Egusa, H; Tashiro, T				Sekiyama, K; Miyauchi, S; Imaruoka, T; Egusa, H; Tashiro, T			Body image as a visuomotor transformation device revealed in adaptation to reversed vision	NATURE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; POSTERIOR PARIETAL CORTEX; MENTAL ROTATION; PREMOTOR CORTEX; WORKING-MEMORY; HUMAN BRAIN; MECHANISMS; NEURONS; OBJECTS; HANDS	People adapt with remarkable flexibility to reversal of the visual field caused by prism spectacles(1,2). With sufficient time, this adaptation restores visually guided behaviour and perceptual harmony between the visible and tactile worlds(1-3). Although it has been suggested that seeing one's own body is crucial for adaptation(1,2), the underlying mechanisms are unclear. Here we show that a new representation of visuomotor mapping with respect to the hands emerges in a month during adaptation to reversed vision. The subjects become bi-perceptual(3-5), or able to use both new and old representations. In a visual task designed to assess the new hand representation, subjects identified visually presented hands as left or right by matching the picture to the representation of their own hands. Functional magnetic resonance imaging showed brain activity in the left posterior frontal cortex (Broca's area) that was unique to the new hand representations of both hands, together with activation in the intraparietal sulcus and prefrontal cortex. The emergence of the new hand representation coincided with the adaptation of perceived location of visible objects in space. These results suggest that the hand representation operates as a visuomotor transformation device that provides an arm-centred frame of reference(6) for space perception.	Future Univ Hakodate, Div Cognit Psychol, Hakodate, Hokkaido 0418655, Japan; Kansai Adv Res Ctr, Commun Res Lab, Auditory & Visual Informat Sect, Kobe, Hyogo 6512492, Japan; Osaka Univ, Grad Sch Med, Suita, Osaka 5650781, Japan; Int Univ Hlth & Welf, Sch Hlth, Ohtawara 3248501, Japan; Osaka City Univ, Dept Psychol, Osaka 5588585, Japan	Future University Hakodate; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; International University of Health & Welfare; Osaka Metropolitan University	Sekiyama, K (corresponding author), Future Univ Hakodate, Div Cognit Psychol, Hakodate, Hokkaido 0418655, Japan.							Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; [Anonymous], 1993, BRAIN ACTIVATION; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Grafton ST, 1996, EXP BRAIN RES, V112, P103; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; HELD RICHARD, 1955, AMER JOUR PSYCHOL, V68, P526, DOI 10.2307/1418782; Iriki A, 1996, NEUROREPORT, V7, P2325; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Kohler I, 1964, PSYCHOL ISSUES, V3, P1; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1111/1469-8986.3520151; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; Kurata K, 1999, J NEUROPHYSIOL, V81, P1927, DOI 10.1152/jn.1999.81.4.1927; Miyauchi S, 1999, INVEST OPHTH VIS SCI, V40, pS820; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rushworth MFS, 1997, EXP BRAIN RES, V117, P292, DOI 10.1007/s002210050224; SEKIYAMA K, 1982, PERCEPT PSYCHOPHYS, V32, P89, DOI 10.3758/BF03204268; SEKIYAMA K, 1983, JPN PSYCHOL RES, V25, P95, DOI 10.4992/psycholres1954.25.95; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Stratton G.M., 1897, PSYCHOL REV, V4, P341, DOI [DOI 10.1037/H0075482, 10.1037/h0075482]; Sugita Y, 1996, NATURE, V380, P523, DOI 10.1038/380523a0; TAIRA M, 1990, EXP BRAIN RES, V83, P29; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740	29	73	73	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					374	377		10.1038/35030096	http://dx.doi.org/10.1038/35030096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	355NA	11014192				2022-12-01	WOS:000089390700046
J	Stott, LD; Berelson, W; Douglas, R; Gorsline, D				Stott, LD; Berelson, W; Douglas, R; Gorsline, D			Increased dissolved oxygen in Pacific intermediate waters due to lower rates of carbon oxidation in sediments	NATURE			English	Article							SANTA-BARBARA BASIN; NORTH PACIFIC; MONICA BASIN; SEA-FLOOR; CALIFORNIA; CLIMATE; OCEAN; DIAGENESIS; CENTURIES; RECORD	Concentrations of dissolved oxygen in the ocean seem to correlate well with climate instabilities over the past 100,000 years. For example, the concentration of dissolved oxygen in Pacific intermediate waters was considerably higher during Pleistocene glacial periods than it is today(1-4). This has been inferred from the presence of bioturbated sediments, implying that oxygen levels were sufficient for burrowing organisms to live. Today, basins in the northeastern Pacific Ocean are floored by laminated sediments implying lower oxygen levels, which may be explained by reduced ventilation(2-4). Here we report a recent return to bioturbated sediments in the northeastern Pacific Ocean since the late 1970s. From the carbon isotope composition of benthic foraminifers living in the sediment, we infer a twofold decrease in the carbon oxidation rate occurring within sediments, equivalent to an increase in dissolved oxygen concentration of 15-20 micromoles per litre. These changes, at the edges of the Santa Barbara, Santa Monica and Alfonso basins, are coincident with a change in North Pacific climate which has reduced upwelling by 20-30% and increased sea surface temperatures by 1.5-3 degrees C. This suggests that climate effects on surface productivity, reducing the supply organic matter to sediments, may have had a greater effect on benthic oxygen levels than changes in ocean circulation patterns.	Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	University of Southern California	Stott, LD (corresponding author), Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.							ALVAREZBORREGO S, 1991, MEMOIR AM ASS PETROL, V47, P555; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Berelson WM, 1996, J MAR RES, V54, P731, DOI 10.1357/0022240963213673; Biondi F, 1997, GEOPHYS RES LETT, V24, P193, DOI 10.1029/96GL03813; CHRISTENSEN CJ, 1994, MAR GEOL, V116, P399, DOI 10.1016/0025-3227(94)90054-X; DEDIEGO T, IN PRESS J FORAM RES; DOUGLAS R, 1998, ABSTR GEOL SOC AM, V30, pA55; Ebbesmeyer C. C., 1989, GEOPHYS MONOGR SER, V55, P399; GRAHAM NE, 1994, CLIM DYNAM, V10, P135, DOI 10.1007/BF00210626; JAHNKE RA, 1990, J MAR RES, V48, P413, DOI 10.1357/002224090784988773; Keigwin LD, 1990, PALEOCEANOGRAPHY, V5, P1009, DOI 10.1029/PA005i006p01009; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; LANGE CB, 1990, CLIMATIC CHANGE, V16, P319, DOI 10.1007/BF00144507; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; MCCORKLE DC, 1988, GEOCHIM COSMOCHIM AC, V52, P1169, DOI 10.1016/0016-7037(88)90270-0; NAMIAS J, 1978, MON WEATHER REV, V106, P279, DOI 10.1175/1520-0493(1978)106<0279:MCOTNA>2.0.CO;2; NAVASANCHEZ E, 1997, EOS F, V79; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; SOUTAR A, 1977, GEOL SOC AM BULL, V88, P1161, DOI 10.1130/0016-7606(1977)88<1161:SACPIT>2.0.CO;2; Stott LD, 2000, PALEOCEANOGRAPHY, V15, P161, DOI 10.1029/1999PA000375; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; VENRICK EL, 1987, SCIENCE, V238, P70, DOI 10.1126/science.238.4823.70	25	47	50	2	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					367	370		10.1038/35030084	http://dx.doi.org/10.1038/35030084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014190				2022-12-01	WOS:000089390700044
J	Taskinen, M; Saarinen-Pihkala, UM; Hovi, L; Lipsanen-Nyman, M				Taskinen, M; Saarinen-Pihkala, UM; Hovi, L; Lipsanen-Nyman, M			Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood	LANCET			English	Article							CORONARY HEART-DISEASE; LONG-TERM SURVIVORS; INSULIN-RESISTANCE; RISK-FACTORS; CHILDREN; GROWTH; ADOLESCENTS; LEUKEMIA	Background This follow-up study aimed to assess the frequency of late effects on glucose and lipid metabolism after bone-marrow transplantation in childhood. Methods 23 long-term survivors (median age 20 years) were studied 3-18 years after bone-marrow transplantation and compared with 23 healthy controls matched for age and sex and with 13 patients in remission from leukaemia. Findings 12 (52%) of the 23 bone-marrow transplantation patients had insulin resistance, including impaired glucose tolerance in six and type 2 diabetes in four. The core signs of the metabolic syndrome (hyperinsulinaemia and hypertriglyceridaemia combined), were found in nine (39%) of the bone-marrow transplantation patients compared with one (8%) of the 13 leukaemia patients and none of the healthy controls (p=0.0015). The frequency of insulin resistance increased with the time since bone-marrow transplantation. Abdominal obesity, but not overweight, was common among the patients with insulin resistance. Interpretation Long-term survivors of bone-marrow transplantation are at substantial risk of insulin resistance, impaired glucose tolerance, and type 2 diabetes even at normal weight and young age. They also develop typical signs of the metabolic syndrome. We advocate measurement of serum lipids, fasting blood glucose, and serum insulin for the follow-up of all patients who undergo transplants in childhood, to be continued regularly and possibly lifelong.	Univ Helsinki, Hosp Children & Adolescents, FIN-00290 Helsinki, Finland; Univ Kuopio, Childrens Hosp, FIN-70211 Kuopio, Finland	University of Helsinki; University of Eastern Finland	Taskinen, M (corresponding author), Univ Helsinki, Hosp Children & Adolescents, Stenbackinkatu 11, FIN-00290 Helsinki, Finland.							Akasheh M, 1999, BONE MARROW TRANSPL, V23, P199, DOI 10.1038/sj.bmt.1701544; *AM DIAB ASS, 1996, DIABETES CARE S1, V19, pS4; Cutfield WS, 2000, LANCET, V355, P610, DOI 10.1016/S0140-6736(99)04055-6; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fruhbeck G, 1998, CLIN PHYSIOL, V18, P399, DOI 10.1046/j.1365-2281.1998.00129.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138; HOVI L, 1990, BONE MARROW TRANSPL, V5, P183; Kahn R, 1998, DIABETES CARE, V21, P310; KOSKELO EK, 1991, ACTA PAEDIATR SCAND, V80, P682, DOI 10.1111/j.1651-2227.1991.tb11929.x; KUUSISTO J, 1995, CIRCULATION, V91, P831, DOI 10.1161/01.CIR.91.3.831; LAWS A, 1993, BAILLIERE CLIN ENDOC, V7, P1063, DOI 10.1016/S0950-351X(05)80245-9; LEIPER AD, 1987, BRIT J HAEMATOL, V67, P419, DOI 10.1111/j.1365-2141.1987.tb06163.x; LORINI R, 1995, BONE MARROW TRANSPL, V15, P873; Prentice AM, 1998, BRIT MED J, V317, P1401, DOI 10.1136/bmj.317.7170.1401; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RONNEMAA T, 1991, ANN MED, V23, P67, DOI 10.3109/07853899109147933; SANDERS JE, 1986, BLOOD, V68, P1129; SKLAR CA, 1982, AM J MED, V73, P688, DOI 10.1016/0002-9343(82)90411-9; SMEDMYR B, 1990, BONE MARROW TRANSPL, V6, P89; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; Talvensaari KK, 1996, J CLIN ENDOCR METAB, V81, P3051, DOI 10.1210/jc.81.8.3051; Tritos NA, 1998, J CLIN ENDOCR METAB, V83, P3025, DOI 10.1210/jc.83.9.3025; Vanhala MJ, 1998, INT J OBESITY, V22, P369, DOI 10.1038/sj.ijo.0800597	24	207	211	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					993	997		10.1016/S0140-6736(00)02717-3	http://dx.doi.org/10.1016/S0140-6736(00)02717-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041401				2022-12-01	WOS:000089293600014
J	Qian, H; Ricklefs, RE				Qian, H; Ricklefs, RE			Large-scale processes and the Asian bias in species diversity of temperate plants	NATURE			English	Article							NORTHERN HEMISPHERE; BIOGEOGRAPHY; RICHNESS; TERTIARY; AMERICA; ORIGIN	An important issue in the study of biodiversity is the extent to which global patterns of species richness reflect large-scale processes and historical contingencies(1,2). Ecological interactions in local assemblages may constrain the number of species that can coexist(3,4), but differences in diversity in similar habitats within different regions (diversity anomalies) suggest that this limit is not firm. Variation in rate of species production could influence regional and perhaps local diversity independently of the ecological capacity of an area to support coexisting species, thereby creating diversity anomalies(5,6). Temperate Zone genera of plants that are disjunct between similar environments in eastern Asia and eastern North America (EAS-ENA) have twice as many species in Asia as in North America(7). Because lineages of these genera in Asia and North America are mostly sister pairs(8), they share a common history of adaptation and ecological relationship before disjunction. Thus, the diversity anomaly in EAS-ENA genera is not an artefact of taxon or habitat sampling but reflects differences in the net diversification (speciation-extinction) of the lineages in each of the continents. Here we propose that the most probable cause of the EAS-ENA anomaly in diversity is the extreme physiographical heterogeneity of temperate eastern Asia, especially compared with eastern North America, which in conjunction with climate and sea-level change has provided abundant opportunities for evolutionary radiation through allopatric speciation.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1Z4, Canada	University of Missouri System; University of Missouri Saint Louis; University of British Columbia	Ricklefs, RE (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.							BUSH MB, 1990, QUATERNARY RES, V34, P330, DOI 10.1016/0033-5894(90)90045-M; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Goldblatt P., 1985, MONOGRAPHS SYSTEMATI, V13; Goldblatt P, 1984, MONOGRAPHS SYSTEMATI, V8; Goldblatt P., 1981, MONOGRAPHS SYSTEMATI, V5; Graham A., 1999, LATE CRETACEOUS CENO, DOI 10.1093/oso/9780195113426.001.0001; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hill M.O., 1979, TWINSPAN FORTRAN PRO; Hong D.Y., 1993, CATHAYA, V5, P1; HOOGHIEMSTRA H, 1989, PALAEOGEOGR PALAEOCL, V72, P11, DOI 10.1016/0031-0182(89)90129-6; Kartesz J. T., 1994, SYNONYMIZED CHECKLIS; Kominz MA, 1998, GEOLOGY, V26, P311, DOI 10.1130/0091-7613(1998)026<0311:LTASTG>2.3.CO;2; Latham Roger Earl, 1993, P294; Li H. L., 1952, Transactions of the American Philosophical Society, Philadelphia, V42, P371, DOI 10.2307/1005654; LI S, 1997, SPECIES POOLS SEED P; MacArthur R.H., 1972, pvii; Mai D. H., 1995, TERTIARE VEGETATIONS; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; MULLER MJ, 1982, SELECTED CLIMATE GLO; Qian H, 1999, AM NAT, V154, P160, DOI 10.1086/303230; Qian H, 1999, ANN BOT-LONDON, V83, P271, DOI 10.1006/anbo.1998.0816; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs Robert E., 1993, P215; Ricklefs Robert E., 1993, P350; Sauer J. D., 1988, PLANT MIGRATION DYNA; Schnabel A, 1998, AM J BOT, V85, P1753, DOI 10.2307/2446510; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; Wu Z. Y., 1996, FLORA CHINA, V15; Wu Z.Y., 1994, FLORA CHINA, V4; WU ZY, 1999, FLORA CHINA, V17; Xiang QY, 1998, EVOLUTION, V52, P988, DOI 10.1111/j.1558-5646.1998.tb01828.x	34	479	517	10	164	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					180	182		10.1038/35025052	http://dx.doi.org/10.1038/35025052			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001054				2022-12-01	WOS:000089241000046
J	Mocroft, A; Katlama, C; Johnson, AM; Pradier, C; Antunes, F; Mulcahy, F; Chiesi, A; Phillips, AN; Kirk, O; Lundgren, JD				Mocroft, A; Katlama, C; Johnson, AM; Pradier, C; Antunes, F; Mulcahy, F; Chiesi, A; Phillips, AN; Kirk, O; Lundgren, JD		EuroSIDA Study Grp	AIDS across Europe, 1994-98: the EuroSIDA study	LANCET			English	Article							HIV-INFECTED PATIENTS; IMMUNODEFICIENCY-VIRUS INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; DEFINING ILLNESSES; CONTROLLED TRIAL; CELL COUNTS; SURVIVAL; COHORT; COMBINATION; PROPHYLAXIS	Background The clinical presentation of HIV-1 related diseases could have changed after the introduction of highly active antiretroviral treatment (HAART). We aimed to assess changes over time in the incidence of ADIs overall and within CD4 lymphocyte count strata, the relationship with treatment and degree of immunodeficiency at diagnosis of ADIs. Methods We did a prospective observational multicentre study of over 7300 patients in 52 European HIV-1 outpatient clinics. Incidence rates per 100 patient-years of observation were calculated. Findings In total, we recorded 1667 new ADIs; the incidence of ADIs declined from 30.7 per 100 patient-years of observation during 1994 (95% CI 28.0-33.4) to 2.5 per 100 patient-years of observation during 1998 (95% CI 2.0-3.0, p<0.0001, test for trend). Median CD4 lymphocyte count at diagnosis of a new ADI increased from 28 cells/mu L to 125 cells/mu L between 1994 and 1998 (p<0.0001), yet a steep decline in the rate of ADIs was seen after stratification by latest CD4 lymphocyte count within each year (less than or equal to 50, 51-200, and >200 cells/mu L). Patients on HAART had a lower rate of ADIs than patients not on this treatment within each CD4 lymphocyte count strata. The proportion of ADIs attributable to cytomegalovirus retinitis and Mycobacterium avium complex declined over time (p=0.0058 and 0.0022, respectively), whereas the proportion of diagnoses attributable to non-Hodgkin lymphoma has increased (p<0.0001). In 1994, less than 4% of ADIs were non-Hodgkin lymphoma, in 1998 the proportion was almost 16%. This condition has become one of the most common ADIs in patients on HAART. Interpretation Our findings lend support to the idea that treatment regimens can lower the incidence of ADIs. The immediate risk of an ADI for a given CD4 lymphocyte count has declined over time and is lower among patients on HAART. Long-term follow-up of patients on combination treatment is essential to monitor the incidence of new and emerging diagnoses.	Hvidovre Univ Hosp, Dept Infect Dis, EuroSIDA Coordinating Ctr, Hvidovre, Denmark; UCL Royal Free & UCL Med Sch, Mortimer Market Ctr, London, England; Hop La Pitie Salpetriere, Paris, France; Hop Archet, Nice, France; Hosp Santa Maria, Lisbon, Portugal; St James Hosp, Dublin 8, Ireland; Ist Super Sanita, I-00161 Rome, Italy	University of Copenhagen; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Nice; Universidade de Lisboa; Hospital Santa Maria; Trinity College Dublin; Istituto Superiore di Sanita (ISS)	Lundgren, JD (corresponding author), Hvidovre Univ Hosp, Dept Infect Dis, EuroSIDA Coordinating Ctr, Hvidovre, Denmark.	eurosida@inet.uni2.dk	VALLET, Yannick/F-9979-2011; Mocroft, Amanda/C-1527-2008; Pradier, Christian/AFE-8255-2022; Mocroft, Amanda/G-8748-2011; Pradier, Christian/AAE-9669-2022; Phillips, Andrew N/B-4427-2008; kirk, ole/ABB-4746-2021; Lundgren, Jens/AAE-6876-2019	Mocroft, Amanda/0000-0001-8316-1122; Phillips, Andrew N/0000-0003-2384-4807; Antunes, Francisco/0000-0001-7932-1154; Chiesi, Antonio/0000-0002-6892-8142; Johnson, Anne/0000-0003-1330-7100; Lundgren, Jens/0000-0001-8901-7850				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; BACELLAR H, 1994, J INFECT DIS, V170, P1284, DOI 10.1093/infdis/170.5.1284; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770; EGGER M, 1998, 12 WORLD AIDS C GEN; Forrest DM, 1998, CLIN INFECT DIS, V27, P1379, DOI 10.1086/515030; Gaidano G, 1998, AM J PATHOL, V152, P623; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HANSON DL, 1995, ARCH INTERN MED, V155, P1537, DOI 10.1001/archinte.155.14.1537; HANSON DL, 1993, J ACQ IMMUN DEF SYND, V6, P624; Jacobson MA, 1997, LANCET, V349, P1443, DOI 10.1016/S0140-6736(96)11431-8; JONES J, 1999, 6 C RETR OPP INF CHI; Jones JL, 1999, J ACQ IMMUN DEF SYND, V21, pS11; Kirk O, 1998, AIDS, V12, P2031, DOI 10.1097/00002030-199815000-00015; Law MG, 1999, AIDS, V13, P263, DOI 10.1097/00002030-199902040-00015; Ledergerber B, 1999, BRIT MED J, V319, P23, DOI 10.1136/bmj.319.7201.23; Lundgren JD, 1997, J ACQ IMMUN DEF SYND, V16, P153, DOI 10.1097/00042560-199711010-00003; MACMAHON EME, 1991, LANCET, V338, P969, DOI 10.1016/0140-6736(91)91837-K; Miller V, 1999, LANCET, V353, P463, DOI 10.1016/S0140-6736(98)04954-X; MITCHELET C, 1998, AIDS, V12, P1815; Mocroft A, 1999, J ACQ IMMUN DEF SYND, V21, P401; Mocroft A, 1998, ARCH INTERN MED, V158, P491, DOI 10.1001/archinte.158.5.491; MOCROFT AJ, 1995, LANCET, V346, P12, DOI 10.1016/S0140-6736(95)92649-6; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Moore RD, 1996, ANN INTERN MED, V124, P633, DOI 10.7326/0003-4819-124-7-199604010-00003; Mouton Y, 1997, AIDS, V11, pF101, DOI 10.1097/00002030-199712000-00003; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pezzotti P, 1999, J ACQ IMMUN DEF SYND, V20, P515, DOI 10.1097/00042560-199904150-00017; PHILLIPS AN, 1991, LANCET, V337, P389; Phillips AN, 1998, J ACQ IMMUN DEF SYND, V17, P239, DOI 10.1097/00042560-199803010-00009; Spira R, 1998, J ACQ IMMUN DEF SYND, V18, P358, DOI 10.1097/00042560-199808010-00007; TURNER BJ, 1991, J ACQ IMMUN DEF SYND, V4, P1059; Weverling GJ, 1999, LANCET, V353, P1293, DOI 10.1016/S0140-6736(99)03287-0	35	337	343	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2000	356	9226					291	296		10.1016/S0140-6736(00)02504-6	http://dx.doi.org/10.1016/S0140-6736(00)02504-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MJ	11071184				2022-12-01	WOS:000088305900010
J	MITRANI, E; SHIMONI, Y				MITRANI, E; SHIMONI, Y			INDUCTION BY SOLUBLE FACTORS OF ORGANIZED AXIAL STRUCTURES IN CHICK EPIBLASTS	SCIENCE			English	Article											MITRANI, E (corresponding author), HEBREW UNIV JERUSALEM,INST LIFE SCI,DEPT ZOOL,IL-91904 JERUSALEM,ISRAEL.							ALTABA AR, 1989, NATURE, V341, P33; AZAR Y, 1979, J EMBRYOL EXP MORPH, V52, P79; AZAR Y, 1981, J EMBRYOL EXP MORPH, V61, P133; COOKE J, 1987, DEVELOPMENT, V101, P893; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; EYALGILADI H, 1984, CELL DIFFER DEV, V14, P245, DOI 10.1016/0045-6039(84)90013-7; GODSAVE SF, 1988, DEVELOPMENT, V102, P555; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; MITRANI E, 1989, DEVELOPMENT, V107, P275; MITRANI E, 1981, NATURE, V289, P800, DOI 10.1038/289800a0; MITRANI E, IN PRESS DEVELOPMENT; MITRANI E, 1982, DIFFERENTIATION, V21, P51; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P326; NICOLET G, 1970, Journal of Embryology and Experimental Morphology, V23, P79; PUTNEY M, 1973, EXPERIENTIA, V29, P466; ROSA F, 1988, SCIENCE, V239, P783, DOI 10.1126/science.3422517; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH JC, 1988, DEVELOPMENT, V103, P591; SMITH JC, 1987, DEVELOPMENT, V99, P3; SMITH JC, 1989, DEVELOPMENT, V105, P665; VAKAET L, 1962, J EMBRYOL EXP MORPH, V10, P38; WADDINGTON CH, 1932, PHILOS T R SOC LON B, V211, P179; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7	23	59	63	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 2	1990	247	4946					1092	1094		10.1126/science.11032544	http://dx.doi.org/10.1126/science.11032544			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ973	11032544				2022-12-01	WOS:A1990CQ97300046
J	Dohle, GR; Schroder, FH				Dohle, GR; Schroder, FH			Ultrasonographic assessment of the scrotum	LANCET			English	Editorial Material							TESTICULAR MICROLITHIASIS; ULTRASOUND		Univ Rotterdam Hosp, Dept Urol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Dohle, GR (corresponding author), Univ Rotterdam Hosp, Dept Urol, NL-3000 CA Rotterdam, Netherlands.							Adeyoju AB, 2000, BJU INT, V86, P87, DOI 10.1046/j.1464-410x.2000.00704.x; Furness PD, 1998, J UROLOGY, V160, P1151, DOI 10.1016/S0022-5347(01)62723-X; HOBARTH K, 1992, UROLOGY, V40, P464, DOI 10.1016/0090-4295(92)90467-B; Horstman WG, 1997, UROL CLIN N AM, V24, P653, DOI 10.1016/S0094-0143(05)70406-7; Lau MWM, 1999, BRIT J RADIOL, V72, P833, DOI 10.1259/bjr.72.861.10645188; MOLLER H, 1993, EUR UROL, V23, P8; Pierik FH, 1999, J UROLOGY, V162, P1618, DOI 10.1016/S0022-5347(05)68180-3	7	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2000	356	9242					1625	1626		10.1016/S0140-6736(00)03153-6	http://dx.doi.org/10.1016/S0140-6736(00)03153-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372TB	11089818				2022-12-01	WOS:000165249200007
J	Ims, RA; Andreassen, HP				Ims, RA; Andreassen, HP			Spatial synchronization of vole population dynamics by predatory birds	NATURE			English	Article							MICROTUS-OECONOMUS; MUSTELID PREDATORS; TRAVELING WAVES; CYCLES; HYPOTHESIS; MORTALITY; PATTERNS; MAMMALS; PHASE	Northern vole populations exhibit large-scale, spatially synchronous population dynamics(1,2). Such cases of population synchrony provide excellent opportunities for distinguishing between local intrinsic and regional extrinsic mechanisms of population regulation(3). Analyses of large-scale survey data and theoretical modelling(4-6) have indicated several plausible synchronizing mechanisms. It is difficult, however, to determine the most important one without detailed data on local demographic processes(3,7). Here we combine results from two field studies in southeastern Norway-one identifies local demographic mechanisms and landscape-level annual synchrony among 28 enclosed experimental populations and the other examines region-level multi-annual synchrony in open natural populations. Despite fences eliminating predatory mammals and vole dispersal, the growth rates of the experimental populations were synchronized and moreover, perfectly linked with vole abundance in the region. The fates of 481 radio-marked voles showed that bird predation was the synchronizing mechanism. A higher frequency of risky dispersal movements in slowly growing populations appeared to accelerate predation rate. Thus, dispersal may induce a feedback-loop between predation and population growth that enhances synchrony.	Univ Oslo, Dept Biol, Div Zool, N-0316 Oslo, Norway	University of Oslo	Ims, RA (corresponding author), NINA, Polar Environm Ctr, N-9005 Tromso, Norway.							Aars J, 1999, OIKOS, V85, P204, DOI 10.2307/3546487; Andreassen HP, 1998, J ANIM ECOL, V67, P941, DOI 10.1046/j.1365-2656.1998.6760941.x; Bjornstad ON, 1999, ECOLOGY, V80, P622, DOI 10.2307/176640; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; CLOBERT J, IN PRESS CAUSES CONS; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; HANSKI I, 1993, NATURE, V364, P232, DOI 10.1038/364232a0; HANSSON L, 1988, TRENDS ECOL EVOL, V3, P195, DOI 10.1016/0169-5347(88)90006-7; HEIKKILA J, 1994, OIKOS, V70, P245, DOI 10.2307/3545635; Ims RA, 1999, J ANIM ECOL, V68, P839, DOI 10.1046/j.1365-2656.1999.00336.x; IMS RA, 1990, OIKOS, V57, P381, DOI 10.2307/3565968; JOHANNESEN E, 1996, J MAMMAL, V78, P638; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; Korpimaki E, 1998, ECOLOGY, V79, P2448, DOI 10.2307/176834; Krebs CJ, 1996, J MAMMAL, V77, P8, DOI 10.2307/1382705; Lambin X, 1998, P ROY SOC B-BIOL SCI, V265, P1491, DOI 10.1098/rspb.1998.0462; May RM, 1999, NATURE, V398, P371, DOI 10.1038/18769; NORRDAHL K, 1995, P ROY SOC B-BIOL SCI, V261, P49, DOI 10.1098/rspb.1995.0116; Ranta E, 1997, SCIENCE, V278, P1621, DOI 10.1126/science.278.5343.1621; Ranta E, 1997, NATURE, V390, P456, DOI 10.1038/37261; REID DG, 1995, OIKOS, V73, P387, DOI 10.2307/3545963; STEEN H, 1994, ANN ZOOL FENN, V31, P271; STEEN H, 1995, OIKOS, V73, P65, DOI 10.2307/3545726; Steen H, 1996, ECOLOGY, V77, P2365, DOI 10.2307/2265738; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Wolff JO, 1997, J ANIM ECOL, V66, P1, DOI 10.2307/5959	29	178	186	0	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					194	196		10.1038/35041562	http://dx.doi.org/10.1038/35041562			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089971				2022-12-01	WOS:000165180400043
J	Kaye, J; Martin, P				Kaye, J; Martin, P			Safeguards for research using large scale DNA collections	BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND						Univ Oxford St Catherines Coll, Oxford OX1 3UJ, England; Univ Nottingham, Sch Sociol & Social Policy, Genet & Soc Unit, Nottingham NG7 2RD, England	University of Oxford; University of Nottingham	Kaye, J (corresponding author), Univ Oxford St Catherines Coll, Oxford OX1 3UJ, England.			Kaye, Jane/0000-0002-7311-4725	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abbasi K, 2000, BRIT MED J, V320, P1295; BEECHAM L, 2000, BRIT MED J, V321, P72; Frewer L, 1999, AMBIO, V28, P569; *MIN HLTH SOC SEC, 2000, OP LIC ISS ISL ERF E; *MRC, 1999, PERS INF MED RES; *MRC, 1999, REP MRC WORK GROUP D; 1999, WELLCOME NEWS Q, V3, P18	7	35	35	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1146	1149		10.1136/bmj.321.7269.1146	http://dx.doi.org/10.1136/bmj.321.7269.1146			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061743	Green Published			2022-12-01	WOS:000165219600034
J	Baldauf, SL; Roger, AJ; Wenk-Siefert, I; Doolittle, WF				Baldauf, SL; Roger, AJ; Wenk-Siefert, I; Doolittle, WF			A kingdom-level phylogeny of eukaryotes based on combined protein data	SCIENCE			English	Article							SITE RATE VARIATION; EVOLUTIONARY RELATIONSHIPS; RIBOSOMAL-RNA; ORIGINS; SUBUNIT; FAMILY; ACANTHAMOEBA; DIVERSITY; SEQUENCES; ACCURACY	Current understanding of the higher order systematics of eukaryotes relies largely on analyses of the small ribosomal subunit RNA (SSU rRNA). Independent testing of these results is still limited. We have combined the sequences of four of the most broadly taxonomically sampled proteins available to create a roughly parallel data set to that of SSU rRNA. The resulting phylogenetic tree shows a number of striking differences from SSU rRNA phylogeny, including strong support for most major groups and several major supergroups.	Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; Dalhousie Univ, Canadian Inst Adv Res, Program Evolutionary Biol, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada; Univ Zurich, Inst Pflanzenbiol, CH-8008 Zurich, Switzerland	University of York - UK; Canadian Institute for Advanced Research (CIFAR); Dalhousie University; University of Zurich	Baldauf, SL (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	slb14@york.ac.uk		Doolittle, W. Ford/0000-0002-4675-8832; Baldauf, Sandra/0000-0003-4485-6671				Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Baldauf SL, 1999, AM NAT, V154, pS178, DOI 10.1086/303292; BALDAUF SL, UNPUB; BHATTACHARYA D, 1995, ARCH PROTISTENKD, V145, P155, DOI 10.1016/S0003-9365(11)80312-X; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T., 1987, EVOLUTIONARY BIOL FU, P339; CavalierSmith T, 1996, J MOL EVOL, V43, P551, DOI 10.1007/BF02202103; DEQUEIROZ A, 1995, ANNU REV ECOL SYST, V26, P657, DOI 10.1146/annurev.es.26.110195.003301; DERIJK P, 1995, J MOL EVOL, V41, P366, DOI 10.1007/BF01215184; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Douglas SE, 1998, CURR OPIN GENET DEV, V8, P655, DOI 10.1016/S0959-437X(98)80033-6; Drouin G, 1995, J MOL EVOL, V41, P841, DOI 10.1007/BF00173163; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; *GENB, AF2769427 GENB; *GENB, AF1907712 GENB; Germot A, 1999, J EUKARYOT MICROBIOL, V46, P116, DOI 10.1111/j.1550-7408.1999.tb04594.x; Hausmann K., 1996, PROTOZOOLOGY; Hilario E, 1998, J MOL EVOL, V46, P703, DOI 10.1007/PL00006351; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; HILLIS DM, 1994, SCIENCE, V264, P671, DOI 10.1126/science.8171318; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Iwamoto M, 1998, CURR GENET, V33, P304, DOI 10.1007/s002940050341; Keeling PJ, 1996, MOL BIOL EVOL, V13, P1297, DOI 10.1093/oxfordjournals.molbev.a025576; Keeling PJ, 1998, J EUKARYOT MICROBIOL, V45, P561, DOI 10.1111/j.1550-7408.1998.tb05117.x; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Kumar S, 1996, J MOL EVOL, V42, P183, DOI 10.1007/BF02198844; Lang BF, 1999, J EUKARYOT MICROBIOL, V46, P320, DOI 10.1111/j.1550-7408.1999.tb04611.x; MACKAY R, COMMUNICATION; MADDISON WP, 1992, MMACCLADE ANAL PHYLO; Moreira D, 1999, MOL BIOL EVOL, V16, P234, DOI 10.1093/oxfordjournals.molbev.a026105; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; O'Kelly CJ, 1999, J EUKARYOT MICROBIOL, V46, P522, DOI 10.1111/j.1550-7408.1999.tb06070.x; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; ROGER AJ, 1996, THESIS DALHOUSIE U H; Sogin ML, 1997, CURR OPIN GENET DEV, V7, P792, DOI 10.1016/S0959-437X(97)80042-1; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Sullivan J, 1996, SYST BIOL, V45, P375, DOI 10.2307/2413571; SWOFFORD DL, IN PRESS PAUP PHYLOG; Van de Peer Y, 2000, GENE, V246, P1, DOI 10.1016/S0378-1119(00)00063-9; Van de Peer Y, 1997, J MOL EVOL, V45, P619, DOI 10.1007/PL00006266; Van der Auwera G, 1998, MOL PHYLOGENET EVOL, V10, P333, DOI 10.1006/mpev.1998.0544; WENKSIEFERT I, 1994, THESIS U ZURICH ZURI; Wiens JJ, 1998, SYST BIOL, V47, P625, DOI 10.1080/106351598260635	50	897	957	2	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2000	290	5493					972	977		10.1126/science.290.5493.972	http://dx.doi.org/10.1126/science.290.5493.972			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062127				2022-12-01	WOS:000165103200046
J	Ruiz, GM; Rawlings, TK; Dobbs, FC; Drake, LA; Mullady, T; Huq, A; Colwell, RR				Ruiz, GM; Rawlings, TK; Dobbs, FC; Drake, LA; Mullady, T; Huq, A; Colwell, RR			Global spread of microorganisms by ships - Ballast water discharged from vessels harbours a cocktail of potential pathogens.	NATURE			English	Article							MARINE ORGANISMS; TRANSPORT; CLIMATE; DISEASE; ECOLOGY	Ballast water discharged from vessels harbours a cocktail of potential pathogens.	Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; Univ Maryland, Dept Cell & Mol Biol, College Pk, MD 20742 USA; Old Dominion Univ, Dept Ocean Earth & Atmospher Sci, Norfolk, VA 23529 USA	Smithsonian Institution; Smithsonian Environmental Research Center; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; Old Dominion University	Ruiz, GM (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.			Ruiz, Gregory/0000-0003-2499-441X				BROCK TD, 1993, BIOL MICROORGANISMS; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; CARLTON JT, 1985, OCEANOGR MAR BIOL, V23, P313; Carlton JT, 1995, CGD1195; Colwell Rita R., 1994, P117; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Galil BS, 1997, EUR J PROTISTOL, V33, P244, DOI 10.1016/S0932-4739(97)80002-8; GRIMES DJ, 1991, ESTUARIES, V14, P345, DOI 10.2307/1352260; Hallegraeff GM, 1998, MAR ECOL PROG SER, V168, P297, DOI 10.3354/meps168297; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; MCCARTHY SA, 1994, APPL ENVIRON MICROB, V60, P2597, DOI 10.1128/AEM.60.7.2597-2601.1994; RUIZ GM, IN PRESS ANN REV ECO; Williamson M, 1996, BIOL INVASIONS	14	433	476	14	128	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2000	408	6808					49	50		10.1038/35040695	http://dx.doi.org/10.1038/35040695			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081499				2022-12-01	WOS:000165050400043
J	Henney, JE				Henney, JE			Clarification on buprenorphine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Henney, JE (corresponding author), US FDA, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2178	2178		10.1001/jama.284.17.2178	http://dx.doi.org/10.1001/jama.284.17.2178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056574				2022-12-01	WOS:000090052600005
J	Kunishima, N; Shimada, Y; Tsuji, Y; Sato, T; Yamamoto, M; Kumasaka, T; Nakanishi, S; Jingami, H; Morikawa, K				Kunishima, N; Shimada, Y; Tsuji, Y; Sato, T; Yamamoto, M; Kumasaka, T; Nakanishi, S; Jingami, H; Morikawa, K			Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor	NATURE			English	Article							PUTATIVE PHEROMONE RECEPTORS; LIGAND-BINDING DOMAIN; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; ERYTHROPOIETIN RECEPTOR; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; CALCIUM RECEPTOR; ESCHERICHIA-COLI; MGLUR4 SUBTYPE	The metabotropic glutamate receptors (mGluRs) are key receptors in the modulation of excitatory synaptic transmission in the central nervous system. Here we have determined three different crystal structures of the extracellular ligand-binding region of mGluR1-in a complex with glutamate and in two unliganded forms. They all showed disulphide-linked homodimers, whose 'active' and 'resting' conformations are modulated through the dimeric interface by a packed alpha -helical structure. The bi-lobed protomer architectures flexibly change their domain arrangements to form an 'open' or 'closed' conformation. The structures imply that glutamate binding stabilizes both the 'active' dimer and the 'closed' protomer in dynamic equilibrium. Movements of the four domains in the dimer are likely to affect the separation of the transmembrane and intracellular regions, and thereby activate the receptor. This scheme in the initial receptor activation could be applied generally to G-protein-coupled neurotransmitter receptors that possess extracellular ligand-binding sites.	Biomol Engn Res Inst, Dept Biol Struct, Osaka 5650874, Japan; Biomol Engn Res Inst, Dept Mol Biol, Osaka 5650874, Japan; RIKEN, Harima Inst, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan; Kyoto Univ, Fac Med, Dept Biol Sci, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; Kyoto University	Morikawa, K (corresponding author), Biomol Engn Res Inst, Dept Biol Struct, 6-2-3 Furuedai, Osaka 5650874, Japan.		Yamamoto, Masaki/B-7844-2015; Kumasaka, Takashi/D-7428-2018; Centeno, Patricia Pacios/O-8368-2016; Kunishima, Naoki/N-7464-2015	Yamamoto, Masaki/0000-0002-1311-1768; Kumasaka, Takashi/0000-0001-9289-1557; Kunishima, Naoki/0000-0001-9826-9902				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aritomi M, 1999, NATURE, V401, P713, DOI 10.1038/44394; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHOTHIA C, 1977, P NATL ACAD SCI USA, V74, P4130, DOI 10.1073/pnas.74.10.4130; Costantino G, 1999, J MED CHEM, V42, P5390, DOI 10.1021/jm990353c; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deller MC, 2000, CURR OPIN STRUC BIOL, V10, P213, DOI 10.1016/S0959-440X(00)00072-5; FLOR PJ, 1995, EUR J NEUROSCI, V7, P622, DOI 10.1111/j.1460-9568.1995.tb00666.x; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; Goldsmith PK, 1999, J BIOL CHEM, V274, P11303, DOI 10.1074/jbc.274.16.11303; Hampson DR, 1999, J BIOL CHEM, V274, P33488, DOI 10.1074/jbc.274.47.33488; Han GM, 1999, J BIOL CHEM, V274, P10008, DOI 10.1074/jbc.274.15.10008; Hashimoto T, 1997, EUR J NEUROSCI, V9, P1226, DOI 10.1111/j.1460-9568.1997.tb01477.x; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; KHORANA HG, 1992, J BIOL CHEM, V267, P1; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MINAKAMI R, 1994, BIOCHEM BIOPH RES CO, V199, P1136, DOI 10.1006/bbrc.1994.1349; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OH BH, 1993, J BIOL CHEM, V268, P11348; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Sugiyama S, 1996, J BIOL CHEM, V271, P9519, DOI 10.1074/jbc.271.16.9519; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; Vassylyev DG, 1998, J BIOL CHEM, V273, P17604, DOI 10.1074/jbc.273.28.17604; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	46	1018	1064	7	117	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2000	407	6807					971	977		10.1038/35039564	http://dx.doi.org/10.1038/35039564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069170				2022-12-01	WOS:000090032500034
J	Ivany, LC; Patterson, WP; Lohmann, KC				Ivany, LC; Patterson, WP; Lohmann, KC			Cooler winters as a possible cause of mass extinctions at the eocene/oligocene boundary	NATURE			English	Article							ISOTOPIC COMPOSITION; FISH OTOLITHS; EOCENE; OXYGEN; TEMPERATURES; MISSISSIPPI; PALEOGENE; PATTERNS; ALABAMA; OCEAN	The Eocene/Oligocene boundary, at about 33.7 Myr ago, marks one of the largest extinctions of marine invertebrates in the Cenozoic period(1). For example, turnover of mollusc species in the US Gulf coastal plain was over 90% at this time(2,3). A temperature change across this boundary-from warm Eocene climates to cooler conditions in the Oligocene-has been suggested as a cause of this extinction event(4), but climate reconstructions have not provided support for this hypothesis. Here we report stable oxygen isotope measurements of aragonite in fish otoliths-ear stones-collected across the Eocene/Oligocene boundary. Palaeotemperatures reconstructed from mean otolith oxygen isotope values show little change through this interval, in agreement with previous studies(5,6). From incremental microsampling of otoliths, however, we can resolve the seasonal variation in temperature, recorded as the otoliths continue to accrete new material over the life of the fish. These seasonal data suggest that winters became about 4 degrees C colder across the Eocene/Oligocene boundary. We suggest that temperature variability, rather than change in mean annual temperature, helped to cause faunal turnover during this transition.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Syracuse Univ, Dept Earth Sci, Syracuse, NY 13244 USA	University of Michigan System; University of Michigan; Syracuse University	Ivany, LC (corresponding author), Univ Michigan, Dept Geol Sci, 1006 CC Little Bldg, Ann Arbor, MI 48109 USA.	lcivany@syr.edu	, Bill/GSD-6628-2022; Patterson, William P/J-6473-2012	Lohmann, Kyger/0000-0002-0709-9192; Patterson, William/0000-0003-3387-708X				BAUM JS, 1994, GEOL SOC AM BULL, V106, P824, DOI 10.1130/0016-7606(1994)106<0824:SIEFRA>2.3.CO;2; BERGGREN WA, 1995, SEPM SPECIAL PUBLICA, V54; DETTMAN DL, 1993, GEOPH MONOG SERIES, V78, P153; Dockery D. T., 1982, MISSISSIPPI DEP NATU, V123, P1; Dockery D.T. III, 1986, Palaios, V1, P582; Frederiksen N.O., 1988, USGS PROFESSIONAL PA, V1448, P1; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; Haasl DM, 1996, PALAIOS, V11, P487, DOI 10.2307/3515214; HANSEN T A, 1987, Palaios, V2, P69, DOI 10.2307/3514573; Hansen Thor, 1992, P341; IACUMIN P, 1992, MAR BIOL, V113, P537, DOI 10.1007/BF00349696; KALISH JM, 1991, MAR ECOL PROG SER, V75, P191, DOI 10.3354/meps075191; KALISH JM, 1991, MAR BIOL, V110, P37, DOI 10.1007/BF01313090; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; MACNEIL F. S., 1984, MISSISSIPPI DEP NATU, V124, P1; Miller K.G., 1992, EOCENE OLIGOCENE CLI, P160, DOI [10.1515/9781400862924.160, DOI 10.1515/9781400862924.160]; *NOAA PMEL, 1999, WORLD OC ATL; Oboh FE, 1996, REV PALAEOBOT PALYNO, V91, P23, DOI 10.1016/0034-6667(95)00075-5; PALMER KATHERINE V. W., 1965, BULL AMER PALEONTOL, V48, P1; PALMER KATHERINE V. W., 1966, BULL AMER PALEONTOL, V48, P471; PATTERSON WP, 1993, GEOPH MONOG SERIES, V78, P191; RAUP DM, 1986, SCIENCE, V231, P833, DOI 10.1126/science.11542060; SIESSER WG, 1984, PALAEOGEOGR PALAEOCL, V47, P261, DOI 10.1016/0031-0182(84)90098-1; Valentine J. W., 1973, EVOLUTIONARY PALAEOC; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT, V3, P245, DOI 10.1017/S0094837300005352; WEIDMAN CR, 1994, J GEOPHYS RES-OCEANS, V99, P18305, DOI 10.1029/94JC01882; YANCEY TE, 1994, PALEOGENE SEQUENCE S; ZACHOS JC, 1992, GEOLOGY, V20, P569, DOI 10.1130/0091-7613(1992)020<0569:EOISEO>2.3.CO;2; ZACHOS JC, 1993, J GEOL, V101, P191, DOI 10.1086/648216; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	30	216	223	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					887	890		10.1038/35038044	http://dx.doi.org/10.1038/35038044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057663	Green Published			2022-12-01	WOS:000089901900046
J	Doyle, P; Maconochie, N; Roman, E; Davies, G; Smith, PG; Beral, V				Doyle, P; Maconochie, N; Roman, E; Davies, G; Smith, PG; Beral, V			Fetal death and congenital malformation in babies born to nuclear industry employees: report from the nuclear industry family study	LANCET			English	Article							LEVEL IONIZING-RADIATION; SPONTANEOUS-ABORTIONS; UNITED-KINGDOM; CHILDREN; REPRODUCTION; EXPOSURE; CANCER; HEALTH; STILLBIRTHS; MORTALITY	Background There is some concern about the genetic effects of exposure to low-level ionising radiation, but the evidence is sparse and conflicting. Most work has concentrated on cancer in offspring and little has been done on adverse reproductive outcome. We aimed to assess whether the offspring of men and women who are occupationally exposed to ionising radiation are at increased risk of fetal death and congenital malformation. Methods We analysed pregnancies reported by an occupational cohort of nuclear industry workers in the UK, employed at establishments operated by the Atomic Energy Authority, Atomic Weapons Establishment, and British Nuclear Fuels. Employment and radiation monitoring data supplied by employers was linked to each pregnancy. Findings 11 697 men and 1903 women reported one or more singleton pregnancy conceived after first employment within the nuclear industry, the men reporting a total of 23 676 singleton pregnancies and the women 3585. The risks of fetal death and congenital malformation were not related to whether the father had been monitored before conception or to the dose of radiation received. Among pregnancies reported by women, the risk of early (<13 weeks of gestation) miscarriage was higher if the mother had been monitored before conception (odds ratio [OR] 1.3, 95% CI 1.0-1.6), but there was no trend with dose, The risk of stillbirth was also higher if the mother had been monitored before conception (OR 2.2, 95% CI 1.0-4.6), but the finding was based on only 29 cases (13 exposed). The risk of any major malformation, or of specific groups of malformations, was not associated with maternal monitoring, or dose received, before conception. Interpretation We found no evidence of a link between exposure to low-level ionising radiation before conception and increased risk of adverse reproductive outcome in men working in the nuclear industry. Similarly for women there was no evidence of an association between monitoring before conception and malformation in offspring, The findings relating maternal preconceptual monitoring to increased risk of fetal death are equivocal and require further investigation.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Epidemiol Unit, London WC1E 7HT, England; Univ Leeds, Leukaemia Res Fund, Inst Epidemiol, Leeds LS2 9JT, W Yorkshire, England; Univ Oxford, Radcliffe Infirm, Imperial Canc Res Fund, Oxford OX2 6HE, England	University of London; London School of Hygiene & Tropical Medicine; University of Leeds; Radcliffe Infirmary; University of Oxford	Doyle, P (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Epidemiol Unit, Keppel St, London WC1E 7HT, England.		smith, peter/ABH-9627-2020	smith, peter/0000-0003-0080-7560; Roman, Eve/0000-0001-7603-3704				ALBERMAN E, 1972, ANN HUM GENET, V36, P185, DOI 10.1111/j.1469-1809.1972.tb00768.x; [Anonymous], 1992, MAN INT STAT CLASS D; Bobrow M, 1993, CHILDHOOD CANC NUCL; BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; Byrne J, 1999, TERATOLOGY, V59, P210, DOI 10.1002/(SICI)1096-9926(199904)59:4<210::AID-TERA4>3.0.CO;2-X; CARPENTER L, 1994, RADIAT RES, V138, P224, DOI 10.2307/3578592; *COMM BIOL EFF ION, 1990, BEIR, V5; CREASY MR, 1976, HUM GENET, V31, P177, DOI 10.1007/BF00296145; Draper GJ, 1997, BRIT MED J, V315, P1181, DOI 10.1136/bmj.315.7117.1181; *EUR REG CONG AN E, 1997, 7 SCI I PUBL HLTH L; GARDNER MJ, 1990, BRIT MED J, V300, P423, DOI 10.1136/bmj.300.6722.423; Goldberg MS, 1998, EPIDEMIOLOGY, V9, P271, DOI 10.1097/00001648-199805000-00010; Green LM, 1997, OCCUP ENVIRON MED, V54, P629, DOI 10.1136/oem.54.9.629; Kallen B, 1998, RADIAT RES, V149, P202, DOI 10.2307/3579931; Kline J, 1998, EPIDEMIOLOGY, V9, P231; KLINE J, 1989, CONCEPTION BIRTH; Maconochie N, 1999, OCCUP ENVIRON MED, V56, P793, DOI 10.1136/oem.56.12.793; Muirhead CR, 1999, NRPBR307; NEEL JV, 1956, EFFECTS EXPOSURE ATO; OTAKE M, 1990, RADIAT RES, V122, P1, DOI 10.2307/3577576; Parker L, 1999, LANCET, V354, P1407, DOI 10.1016/S0140-6736(99)04138-0; Roman E, 1999, BRIT MED J, V318, P1443, DOI 10.1136/bmj.318.7196.1443; Roman E, 1996, OCCUP ENVIRON MED, V53, P73, DOI 10.1136/oem.53.2.73; ROTHMAN KJ, 1995, NEW ENGL J MED, V333, P1369, DOI 10.1056/NEJM199511233332101; Sanchez JM, 1999, PRENATAL DIAG, V19, P601, DOI 10.1002/(SICI)1097-0223(199907)19:7<601::AID-PD564>3.3.CO;2-S; SEVER LE, 1991, OCCUP MED, V6, P613; SEVER LE, 1988, AM J EPIDEMIOL, V127, P226, DOI 10.1093/oxfordjournals.aje.a114799	27	52	53	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 14	2000	356	9238					1293	1299		10.1016/S0140-6736(00)02812-9	http://dx.doi.org/10.1016/S0140-6736(00)02812-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VL	11073016				2022-12-01	WOS:000089858300008
J	Takizawa, PA; DeRisi, JL; Wilhelm, JE; Vale, RD				Takizawa, PA; DeRisi, JL; Wilhelm, JE; Vale, RD			Plasma membrane compartmentalization in yeast by messenger RNA transport and a septin diffusion barrier	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MYOSIN MYO4P; LOCALIZATION; MORPHOGENESIS; PROTEINS; DEPENDS; GENE; DETERMINANT; EXPRESSION; ASH1P	Asymmetric Localization of proteins plays a key role in many cellular processes, including cell polarity and cell fate determination. Using DNA microarray analysis, we identified a plasma membrane protein-encoding mRNA (IST2) that is transported to the bud tip by an actomyosin-based process. mRNA localization created a higher concentration of IST2 protein in the bud compared with that of the mother cell, and this asymmetry was maintained by a septin-mediated membrane diffusion barrier at the mother-bud neck. These results indicate thar yeast creates distinct plasma membrane compartments, as has been described in neurons and epithelial cells.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.				PHS HHS [38496] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; DRUBIN DG, COMMUNICATION; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Munchow S, 1999, J CELL SCI, V112, P1511; NEHME CL, 1993, J CELL BIOL, V120, P687, DOI 10.1083/jcb.120.3.687; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Takizawa PA, 2000, P NATL ACAD SCI USA, V97, P5273, DOI 10.1073/pnas.080585897; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; TAKIZAWA PA, UNPUB; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	22	357	365	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					341	344		10.1126/science.290.5490.341	http://dx.doi.org/10.1126/science.290.5490.341			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030653				2022-12-01	WOS:000089818100045
J	Dodd, ME; Kellet, F; Davis, A; Simpson, JCG; Webb, AK; Haworth, CS; Niven, RM				Dodd, ME; Kellet, F; Davis, A; Simpson, JCG; Webb, AK; Haworth, CS; Niven, RM			Audit of oxygen prescribing before and after the introduction of a prescription chart	BRITISH MEDICAL JOURNAL			English	Article							NASAL		Manchester Univ Hosp NHS Trust, NW Lung Ctr, Manchester M23 9LT, Lancs, England; Stepping Hill Hosp, Stockport SK2 7JE, Lancs, England	University of Manchester	Dodd, ME (corresponding author), Manchester Univ Hosp NHS Trust, NW Lung Ctr, Manchester M23 9LT, Lancs, England.			Niven, Robert/0000-0003-2249-960X				Bateman NT, 1998, BRIT MED J, V317, P798, DOI 10.1136/bmj.317.7161.798; BAZUAYE EA, 1992, THORAX, V47, P609, DOI 10.1136/thx.47.8.609; DAVIES RJO, 1989, BRIT MED J, V299, P43, DOI 10.1136/bmj.299.6690.43; SMALL D, 1992, AM J MED, V92, P591, DOI 10.1016/0002-9343(92)90775-7; 1999, BRIT NATL FORMULARY, V37, P153	5	44	45	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 7	2000	321	7265					864	865		10.1136/bmj.321.7265.864	http://dx.doi.org/10.1136/bmj.321.7265.864			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021863	Green Published, Bronze			2022-12-01	WOS:000089857500021
J	Guttridge, DC; Mayo, MW; Madrid, LV; Wang, CY; Baldwin, AS				Guttridge, DC; Mayo, MW; Madrid, LV; Wang, CY; Baldwin, AS			NF-kappa B-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia	SCIENCE			English	Article							SKELETAL-MUSCLE; PROTEINS; DIFFERENTIATION; CANCER; MICE	MyoD regulates skeletal muscle differentiation (SMD) and is essential for repair of damaged tissue. The transcription factor nuclear factor kappa B (NF-kappa B) is activated by the cytokine tumor necrosis factor (TNF), a mediator of skeletal muscle wasting in cachexia, Here, the role of NF-kappa B in cytokine-induced muscle degeneration was explored. In differentiating C2C12 myocytes, TNF-induced activation of NF-kappa B inhibited SMD by suppressing MyoD mRNA at the post-transcriptional level. In contrast, in differentiated myotubes, TNF plus interferon-gamma (IFN-gamma) signaling was required for NF-kappa B-dependent down-regulation of MyoD and dysfunction of skeletal myofibers. MyoD mRNA was also down-regulated by TNF and IFN-gamma expression in mouse muscle in vivo. These data elucidate a possible mechanism that may underlie the skeletal muscle decay in cachexia.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Mason Farm Rd,Campus Box 7295, Chapel Hill, NC 27599 USA.			Guttridge, Denis/0000-0002-7276-6609	NATIONAL CANCER INSTITUTE [K01CA078595, R01CA072771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI035098, R01AI035098] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA78595, CA72771] Funding Source: Medline; NIAID NIH HHS [AI35098] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.3.CO;2-E; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Cooper RN, 1999, J CELL SCI, V112, P2895; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; GUTTRIDGE DC, UNPUB; Kawamura I, 1999, GENE THER, V6, P91, DOI 10.1038/sj.gt.3300819; KOISHI K, 1995, DEV DYNAM, V202, P244, DOI 10.1002/aja.1002020304; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; MOLDAWER LL, 1987, AM J PHYSIOL, V253, P766; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Szalay K, 1997, EUR J CELL BIOL, V74, P391; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; VANEYS J, 1985, ANNU REV NUTR, V5, P435, DOI 10.1146/annurev.nu.05.070185.002251	20	600	621	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2363	2366		10.1126/science.289.5488.2363	http://dx.doi.org/10.1126/science.289.5488.2363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009425	Green Submitted			2022-12-01	WOS:000089593500057
J	Li, S; Hill, CP; Sundquist, WI; Finch, JT				Li, S; Hill, CP; Sundquist, WI; Finch, JT			Image reconstructions of helical assemblies of the HIV-1CA protein	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CAPSID PROTEIN; IN-VITRO; CYCLOPHILIN-A; TYPE-1; CORE; DOMAIN; REPLICATION; TERMINUS; MODELS	The type 1 human immunodeficiency virus (HIV-1) contains a conical capsid comprising similar to 1,500 CA protein subunits, which organizes the viral RNA genome for uncoating and replication in a new host cell. In vitro, CA spontaneously assembles into helical tubes and cones that resemble authentic viral capsids(1-7). Here we describe electron cryo-microscopy and image reconstructions of CA tubes from six different helical families. In spite of their polymorphism, all tubes are composed of hexameric rings of CA arranged with approximate local p6 lattice symmetry. Crystal structures of the two CA domains were 'docked' into the reconstructed density, which showed that the amino-terminal domains form the hexameric rings and the carboxy-terminal dimerization domains connect each ring to six neighbours. We propose a molecular model for the HIV-1 capsid that follows the principles of a fullerene cone(6), in which the body of the cone is composed of curved hexagonal arrays of CA rings and the ends are closed by inclusion of 12 pentagonal 'defects'.	Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; MRC, Mol Biol Lab, Div Struct Studies, Cambridge CB2 2QH, England	Utah System of Higher Education; University of Utah; MRC Laboratory Molecular Biology	Li, S (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA.			Li, Sam/0000-0002-0210-8192				Aberham C, 1996, J VIROL, V70, P3536, DOI 10.1128/JVI.70.6.3536-3544.1996; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CREMERS AFM, 1981, J MOL BIOL, V145, P545, DOI 10.1016/0022-2836(81)90544-1; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; FRANKE EK, 1995, ADV EXP MED BIOL, V374, P217; FUKUI T, 1993, MICROSC RES TECHNIQ, V25, P335, DOI 10.1002/jemt.1070250410; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Grattinger M, 1999, VIROLOGY, V257, P247, DOI 10.1006/viro.1999.9668; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATSURA I, 1978, J MOL BIOL, V121, P71, DOI 10.1016/0022-2836(78)90263-2; Kotov A, 1999, J VIROL, V73, P8824, DOI 10.1128/JVI.73.10.8824-8830.1999; MAMMANO F, 1994, J VIROL, V68, P4927, DOI 10.1128/JVI.68.8.4927-4936.1994; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; STEVEN AC, 1986, ELECTRON MICROS, V5, P1; TOYOSHIMA C, 1990, J CELL BIOL, V111, P2623, DOI 10.1083/jcb.111.6.2623; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Zhang H, 1996, P NATL ACAD SCI USA, V93, P12519, DOI 10.1073/pnas.93.22.12519	29	409	414	0	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					409	413		10.1038/35030177	http://dx.doi.org/10.1038/35030177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014200				2022-12-01	WOS:000089390700054
J	Smith, NA; Singh, SP; Wang, MB; Stoutjesdijk, PA; Green, AG; Waterhouse, PM				Smith, NA; Singh, SP; Wang, MB; Stoutjesdijk, PA; Green, AG; Waterhouse, PM			Gene expression - Total silencing by intron-spliced hairpin RNAs	NATURE			English	Article							VIRUS-RESISTANCE; PLANTS; SENSE		CSIRO, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Smith, NA (corresponding author), CSIRO, Canberra, ACT 2601, Australia.		Green, Allan G/C-6572-2008; , Neil/U-6272-2019; singh, surinder/C-9528-2009; Green, Allan/AAM-6856-2021	singh, surinder/0000-0003-4488-8147; Green, Allan/0000-0002-3248-2089; Waterhouse, Peter/0000-0002-2812-3753				Cartea ME, 1998, PLANT SCI, V136, P181, DOI 10.1016/S0168-9452(98)00089-2; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; JORGENSEN RA, 1995, SCIENCE, V268, P689; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Rosche E, 1995, PLANT MOL BIOL, V29, P663, DOI 10.1007/BF00041157; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; STALBERG K, 1993, PLANT MOL BIOL, V23, P671, DOI 10.1007/BF00021523; Wang M. B., 1997, Journal of Genetics and Breeding, V51, P325; Waterhouse PM, 1999, TRENDS PLANT SCI, V4, P452, DOI 10.1016/S1360-1385(99)01493-4; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959	12	709	1042	0	77	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					319	320		10.1038/35030305	http://dx.doi.org/10.1038/35030305			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014180				2022-12-01	WOS:000089390700034
J	Bryk, R; Griffin, P; Nathan, C				Bryk, R; Griffin, P; Nathan, C			Peroxynitrite reductase activity of bacterial peroxiredoxins	NATURE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; SALMONELLA-TYPHIMURIUM; NITRIC-OXIDE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; REDOX REGULATION; SULFENIC ACID; AHPC; ENZYME; DECOMPOSITION	Nitric oxide (NO) is present in soil and air, and is produced by bacteria, animals and plants. Superoxide (O-2(-)) arises in all organisms inhabiting aerobic environments. Thus, many organisms are likely to encounter peroxynitrite (OONO-), a product of NO and O-2(-) that forms at near diffusion-limited rates, and rapidly decomposes upon protonation through isomerization to nitrate (NO3-; ref. 1) while generating hydroxyl radical ((OH)-O-.) and nitrogen dioxide radical ((NO2)-N-.) (refs 2, 3), both more reactive than peroxynitrite's precursors. The oxidative, inflammatory, mutagenic and cytotoxic potential (ref. 4) of peroxynitrite contrasts with the antioxidant, anti-inflammatory and tissue-protective properties ascribed to NO itself(5). Thus, the ability of cells to cope with peroxynitrite is central in determining the biological consequences of NO production. We considered whether cells might be equipped with enzymes to detoxify peroxynitrite. Peroxiredoxins have been identified in most genomes sequenced, but their functions are only partly understood. Here we show that the peroxiredoxin alkylhydroperoxide reductase subunit C (AhpC) from Salmonella typhimurium catalytically detoxifies peroxynitrite to nitrite fast enough to forestall the oxidation of bystander molecules such as DNA. Results are similar with peroxiredoxins from Mycobacterium tuberculosis and Helicobacter pylori. Thus, peroxynitrite reductase activity may be widespread among bacterial genera.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Merck Res Labs, Basic Chem Analyt Support, Rahway, NJ 07065 USA	Cornell University; Merck & Company	Nathan, C (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.	cnathan@med.cornell.edu						Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Briviba K, 1998, CHEM RES TOXICOL, V11, P1398, DOI 10.1021/tx980086y; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Coddington JW, 1999, J AM CHEM SOC, V121, P2438, DOI 10.1021/ja982887t; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658; Go YM, 1999, AM J PHYSIOL-HEART C, V277, pH1647, DOI 10.1152/ajpheart.1999.277.4.H1647; JIN DY, 2000, ANTIOXIDANT REDOX RE, P381; Kamisaki Y, 1998, P NATL ACAD SCI USA, V95, P11584, DOI 10.1073/pnas.95.20.11584; Koppenol WH, 1996, METHOD ENZYMOL, V269, P296; Merenyi G, 1998, CHEM RES TOXICOL, V11, P712, DOI 10.1021/tx980043h; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Niles JC, 1999, P NATL ACAD SCI USA, V96, P11729, DOI 10.1073/pnas.96.21.11729; OTOOLE PW, 1991, J BACTERIOL, V173, P505, DOI 10.1128/jb.173.2.505-513.1991; Pearce LL, 1999, J BIOL CHEM, V274, P35763, DOI 10.1074/jbc.274.50.35763; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; RADI R, 1991, J BIOL CHEM, V266, P4244; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; Szabo C, 1996, P NATL ACAD SCI USA, V93, P1753, DOI 10.1073/pnas.93.5.1753; Uppu RM, 1996, METHOD ENZYMOL, V269, P322; Wilson T, 1998, MICROBIOL-UK, V144, P2687, DOI 10.1099/00221287-144-10-2687; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203	29	526	545	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					211	215		10.1038/35025109	http://dx.doi.org/10.1038/35025109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001062				2022-12-01	WOS:000089241000054
J	Hansen, D; Lou, HC; Olsen, J				Hansen, D; Lou, HC; Olsen, J			Serious life events and congenital malformations: a national study with complete follow-up	LANCET			English	Article							CARDIAC NEURAL CREST; DENMARK; CORTICOSTEROIDS; PREGNANCY; TWINS; RISK	Background Emotional stress during organogenesis could, in theory, cause congenital malformations. We undertook a follow-up study to test the hypothesis that psychosocial stress increases the prevalence of malformations, particularly of the cranial neural crest. Methods We defined severe life events as death or first hospital admission for cancer or acute myocardial infarction in partners or children. From 1980 to 1992 all women exposed to severe life events during pregnancy and up to 16 months previously were identified by means of five national registers. We included 3560 exposed pregnancies and 20 299 pregnancies without such exposures randomly selected as a control cohort. Findings The frequency of cranial-neural-crest malformations was higher in pregnancies with exposure to severe life events than in those without such exposure (42 [1.18%] vs 131[0.65%]; adjusted odds ratio 1.54 [95% CI 1.05-2.27]). For other malformations, the frequencies were 3.04% and 3.26% (1.14 [0.94-1.42]). Women exposed in two consecutive pregnancies had a higher risk of cranial-neural-crest malformations (2.99 [1.06-8.43]). Death of an older child during the first trimester was associated with an adjusted odds ratio of cranial-neural-crest malformations of 4.75 (1.63-13.8). Unexpected death of a child during the first trimester was associated with adjusted odds ratios of 8.36 (2.41-29.0) for cranial-neural-crest malformations and 3.64 (1.29-10.3) for other malformations. Interpretation These findings support the hypothesis that severe emotional stress during pregnancy, especially that related to death of a child, may cause congenital malformations, particularly those of the cranial neural crest.	John F Kennedy Inst, Neuropediat Dept, DK-2600 Glostrup, Denmark; Danish Epidemiol Sci Ctr, Copenhagen, Denmark; Danish Epidemiol Sci Ctr, Aarhus, Denmark	Aarhus University; Aarhus University	Hansen, D (corresponding author), John F Kennedy Inst, Neuropediat Dept, GI Landevej 7, DK-2600 Glostrup, Denmark.							ADAMS MM, 1989, J AM COLL CARDIOL, V14, P432, DOI 10.1016/0735-1097(89)90199-X; *AM PSYCH ASS, 1987, DIAGN CRIT DSMIIIR; Basso O, 1999, AM J EPIDEMIOL, V150, P598; BLOMBERG S, 1980, ACTA PSYCHIAT SCAND, V62, P315, DOI 10.1111/j.1600-0447.1980.tb00618.x; Bohman M, 1971, Acta Paediatr Scand Suppl, V221, P1; CARLSON BM, 1996, PATTENS FDN EMBRYOLO; Carmichael SL, 2000, EPIDEMIOLOGY, V11, P30, DOI 10.1097/00001648-200001000-00008; Christensen K, 1998, DAN MED BULL, V45, P91; Czeizel AE, 1997, TERATOLOGY, V56, P335, DOI 10.1002/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W; *DANM STAT, 1998, FERT DAT GUID EXTR D, P1; DOYLE PE, 1991, J EPIDEMIOL COMMUN H, V45, P43, DOI 10.1136/jech.45.1.43; FRASER FC, 1951, PEDIATRICS, V8, P527; Hansen D, 1999, BRIT MED J, V319, P548, DOI 10.1136/bmj.319.7209.548; HULTIN M, 1971, ACTA PSYCHIAT SCAND, V221, P59; JOHNSTON MC, 1995, CRIT REV ORAL BIOL M, V6, P368, DOI 10.1177/10454411950060040601; Kallen B, 1999, OBSTET GYNECOL, V93, P392, DOI 10.1016/S0029-7844(98)00454-2; KIRBY ML, 1985, ANAT RECORD, V213, P87, DOI 10.1002/ar.1092130112; KIRBY ML, 1987, PEDIATR RES, V21, P219, DOI 10.1203/00006450-198703000-00001; KNUDSEN LB, 1986, COMMUNITY MED, V8, P29; Knudsen LB, 1998, DAN MED BULL, V45, P221; LARSEN W, 1997, J HUMAN EMBRYOLOGY; LAYDE PM, 1980, AM J HUM GENET, V32, P69; LEDOUARIN NM, 1993, DEV BIOL, V159, P24, DOI 10.1006/dbio.1993.1219; LOU HC, 1994, DEV MED CHILD NEUROL, V36, P826; OLSEN J, 1993, SCAND J SOC MED, V21, P90, DOI 10.1177/140349489302100206; POLEDNAK AP, 1976, AM J OBSTET GYNECOL, V126, P734, DOI 10.1016/0002-9378(76)90534-2; Robert E, 1994, Int J Risk Saf Med, V6, P75, DOI 10.3233/JRS-1994-6201; Rodriguez-Pinilla E, 1998, TERATOLOGY, V58, P2, DOI 10.1002/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-4; Sadler T.W., 1995, LANGMANS MED EMBRYOL, V7th; Sterling P., 1988, HDB LIFE STRESS COGN, P629, DOI DOI 10.1016/0005-7967(90)90076-U; SULIK KK, 1988, DEVELOPMENT, V103, P213; *SYG, 1981, SUNDH AKT I SYG; THOROGOOD P, 1997, EMBRYOS GENES BIRTH, P197; Torczynski E, 1989, EYE INFANCY, P9; Waldo K, 1998, DEV BIOL, V196, P129, DOI 10.1006/dbio.1998.8860	35	158	163	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					875	880		10.1016/S0140-6736(00)02676-3	http://dx.doi.org/10.1016/S0140-6736(00)02676-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036891				2022-12-01	WOS:000089259800008
J	Shigenobu, S; Watanabe, H; Hattori, M; Sakaki, Y; Ishikawa, H				Shigenobu, S; Watanabe, H; Hattori, M; Sakaki, Y; Ishikawa, H			Genome sequence of the endocellular bacterial symbiont of aphids Buchnera sp APS	NATURE			English	Article							PROTEIN-SECRETION SYSTEM; ENDOSYMBIOTIC BACTERIA; ACYRTHOSIPHON-PISUM; GENES	Almost all aphid species (Homoptera, Insecta) have 60-80 huge cells called bacteriocytes, within which are round-shaped bacteria that are designated Buchnera(1). These bacteria are maternally transmitted to eggs and embryos through host generations, and the mutualism between the host and the bacteria is so obligate that neither can reproduce independently(2). Buchnera is a close relative of Escherichia coli(3), but it contains more than 100 genomic copies per cell(4), and its genome size is only a seventh of that of E. coli(5). Here we report the complete genome sequence of Buchnera sp. strain APS, which is composed of one 640,681-base-pair chromosome and two small plasmids. There are genes for the biosyntheses of amino acids essential for the hosts in the genome, but those for non-essential amino acids are missing, indicating complementarity and syntrophy between the host and the symbiont. In addition, Buchnera lacks genes for the biosynthesis of cell-surface components, including lipopolysaccharides and phospholipids, regulator genes and genes involved in defence of the cell. These results indicate that Buchnera is completely symbiotic and viable only in its limited niche, the bacteriocyte.	RIKEN, Genome Sci Ctr, Sagamihara, Kanagawa 2288555, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 1088639, Japan	RIKEN; University of Tokyo; University of Tokyo	Sakaki, Y (corresponding author), RIKEN, Genome Sci Ctr, Kitasato 1-15-1, Sagamihara, Kanagawa 2288555, Japan.	sakai@ims.u-tokyo.ac.jp; iskw@biol.s.u-tokyo.ac.jp	Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019; Shigenobu, Shuji/B-6239-2011	Hattori, Masahira/0000-0001-9467-0344; Shigenobu, Shuji/0000-0003-4640-2323				BAUMANN P, 2000, PROKARYOTES; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Charles H, 1999, J MOL EVOL, V48, P142, DOI 10.1007/PL00006452; DOUGLAS AE, 1988, INSECT BIOCHEM, V18, P599, DOI 10.1016/0020-1790(88)90012-1; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Hattori M, 1997, NUCLEIC ACIDS RES, V25, P1802, DOI 10.1093/nar/25.9.1802; HOUK EJ, 1980, ANNU REV ENTOMOL, V25, P161, DOI 10.1146/annurev.en.25.010180.001113; Komaki K, 1999, J MOL EVOL, V48, P717, DOI 10.1007/PL00006516; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Marais A, 1996, J BACTERIOL, V178, P7003, DOI 10.1128/jb.178.23.7003-7009.1996; MITTLER TE, 1971, J NUTR, V101, P1023, DOI 10.1093/jn/101.8.1023; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; MUNSON MA, 1991, INT J SYST BACTERIOL, V41, P566, DOI 10.1099/00207713-41-4-566; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Nogueira T, 2000, CURR OPIN MICROBIOL, V3, P154, DOI 10.1016/S1369-5274(00)00068-0; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; SASAKI T, 1995, J INSECT PHYSIOL, V41, P41, DOI 10.1016/0022-1910(94)00080-Z; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Tomii K, 1998, GENOME RES, V8, P1048, DOI 10.1101/gr.8.10.1048; vanHam RCHJ, 1997, J BACTERIOL, V179, P4768, DOI 10.1128/jb.179.15.4768-4777.1997; Watanabe H, 1997, J MOL EVOL, V44, pS57, DOI 10.1007/PL00000052; WHITEHEAD LF, 1993, J GEN MICROBIOL, V139, P821, DOI 10.1099/00221287-139-4-821; Yada T, 1996, DNA Res, V3, P355, DOI 10.1093/dnares/3.6.355; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456; [No title captured]	30	970	1584	4	168	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					81	86		10.1038/35024074	http://dx.doi.org/10.1038/35024074			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993077	Bronze			2022-12-01	WOS:000089124000046
J	Aghazadeh, B; Lowry, WE; Huang, XY; Rosen, MK				Aghazadeh, B; Lowry, WE; Huang, XY; Rosen, MK			Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation	CELL			English	Article							NUCLEOTIDE EXCHANGE FACTOR; T-CELL RECEPTOR; PROTOONCOGENE PRODUCT; METHYL-GROUPS; SIGNAL-TRANSDUCTION; CHEMICAL-SHIFT; FAMILY KINASES; SRC FAMILY; B-CELLS; NMR	Rho-family GTPases transduce signals from receptors leading to changes in cell shape and motility, mitogenesis, and development. Proteins containing the Dbl homology (DH) domain are responsible for activating Rho GTPases by catalyzing the exchange of GDP for GTP, Receptor-initiated stimulation of Dbl protein Vav exchange activity involves tyrosine phosphorylation, We show through structure determination that the mVav1 DH domain is autoinhibited by an N-terminal extension, which lies in the GTPase interaction site. This extension contains the Tyr174 Src-family kinase recognition site, and phosphorylation or truncation of this peptide results in stimulation of GEF activity. NMR spectroscopy data show that the N-terminal peptide is released from the DH domain and becomes unstructured upon phosphorylation. Thus, tyrosine phosphorylation relieves autoinhibition by exposing the GTPase interaction surface of the DH domain, which is obligatory for Vav activation.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Physiol & Biophys, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Neurosci, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad program Biochem & Struct Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	Rosen, MK (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA.	rosen@mmmr1.makcc.org						Abe R, 1999, J BIOL CHEM, V274, P30410, DOI 10.1074/jbc.274.43.30410; Aghazadeh B, 1998, NAT STRUCT BIOL, V5, P1098, DOI 10.1038/4209; Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOUME HR, 1991, NATURE, V349, P117; BRUNATI AM, 1995, FEBS LETT, V367, P149, DOI 10.1016/0014-5793(95)00555-N; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bustelo XR, 1996, CRIT REV ONCOGENESIS, V7, P65, DOI 10.1615/CritRevOncog.v7.i1-2.50; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; BUSTELO XR, 1992, SCIENCE, V256, P1196, DOI 10.1126/science.256.5060.1196; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Chen YR, 2000, INT J ONCOL, V16, P651; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Downward J, 1996, CANCER SURV, V27, P87; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Gardner KH, 1996, J BIOMOL NMR, V8, P351, DOI 10.1007/BF00410333; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; KLYONO M, 2000, J BIOL CHEM, V275, P5441; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; Matsuo H, 1996, J MAGN RESON SER B, V111, P194, DOI 10.1006/jmrb.1996.0082; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Nomanbhoy TK, 1996, BIOCHEMISTRY-US, V35, P4602, DOI 10.1021/bi951743d; PASTERIS NG, 1994, CELL, V79, P669; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Szilak L, 1997, NAT STRUCT BIOL, V4, P112, DOI 10.1038/nsb0297-112; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wuthrich K., 1986, NMR PROTEINS NUCL AC; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHU K, 2000, IN PRESS J BIOL CHEM; Zwahlen C, 1998, J AM CHEM SOC, V120, P4825, DOI 10.1021/ja9742601	60	305	308	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					625	633		10.1016/S0092-8674(00)00085-4	http://dx.doi.org/10.1016/S0092-8674(00)00085-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007481	Bronze			2022-12-01	WOS:000089105200011
J	Bulaj, ZJ; Ajioka, RS; Phillips, JD; LaSalle, BA; Jorde, LB; Griffen, LM; Edwards, CQ; Kushner, JP				Bulaj, ZJ; Ajioka, RS; Phillips, JD; LaSalle, BA; Jorde, LB; Griffen, LM; Edwards, CQ; Kushner, JP			Disease-related conditions in relatives of patients with hemochromatosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEREDITARY HEMOCHROMATOSIS; EXPRESSION; GENE	Background: Hemochromatosis occurs in approximately 5 white people per 1000 and is usually due to homozygosity for mutations in the HLA-linked HFE gene. Although screening has been proposed, the proportion of homozygotes with conditions related to hemochromatosis is uncertain. Methods: We studied the prevalence of disease-related conditions among relatives of probands with hemochromatosis. We identified probands who presented to a clinic with signs or symptoms of hemochromatosis or who had elevated transferrin-saturation values. We identified homozygous relatives, mainly siblings, on the basis of HLA identity with the proband and by HFE genotyping. Disease-related conditions were cirrhosis, hepatic fibrosis, elevated aminotransferase values, and hemochromatotic arthropathy. Results: We identified 214 homozygous relatives of 291 homozygous probands. Of the 113 men in this group (mean age, 41 years), 96 (85 percent) had iron overload, and 43 (38 percent) had at least one disease-related condition. Of the 52 men over 40 years of age, 27 (52 percent) had at least one disease-related condition. Of the 101 female homozygous relatives (mean age, 44 years), 69 (68 percent) had iron overload, and 10 (10 percent) had at least one disease-related condition. Of the 43 women over 50 years of age, 7 (16 percent) had at least one disease-related condition. If the proband had a disease-related condition, relatives who were men were more likely to have morbidity than if the proband had no disease-related condition. Conclusions: A substantial number of homozygous relatives of patients with hemochromatosis - more commonly men than women - have conditions related to hemochromatosis that have yet to be detected clinically. (N Engl J Med 2000;343:1529-35.) (C) 2000, Massachusetts Medical Society.	Univ Utah, Sch Med, Dept Med, Div Hematol, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Gen Clin Res Ctr, Salt Lake City, UT 84132 USA; LDS Hosp, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kushner, JP (corresponding author), Univ Utah, Sch Med, Dept Med, Div Hematol, 4C-416,50 N Med Dr, Salt Lake City, UT 84132 USA.				NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020630, R37DK020503, R01DK020503] Funding Source: NIH RePORTER; NCI NIH HHS [CA-42014] Funding Source: Medline; NIDDK NIH HHS [DK-20503, DK-20630] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams PC, 2000, HEPATOLOGY, V31, P1160, DOI 10.1053/he.2000.6984; ADAMS PC, 1991, AM J MED, V90, P445; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; *BOLT BER NEWM, 1997, PROPHET; BOTHWELL TH, 1995, METABOLIC MOL BASES, V2, P2237; Bulaj ZJ, 2000, BLOOD, V95, P1565, DOI 10.1182/blood.V95.5.1565.005k42_1565_1571; Bulaj ZJ, 1996, NEW ENGL J MED, V335, P1799, DOI 10.1056/NEJM199612123352403; DADONE MM, 1982, AM J CLIN PATHOL, V78, P196, DOI 10.1093/ajcp/78.2.196; DANIEL WW, 1999, BIOSTATISTICS FDN AN; EDWARDS CQ, 1977, NEW ENGL J MED, V297, P7, DOI 10.1056/NEJM197707072970102; EDWARDS CQ, 1982, CLIN HAEMATOL, V11, P411; EDWARDS CQ, 1981, PROG HEMATOL, V12, P43; EDWARDS CQ, 1993, NEW ENGL J MED, V328, P1616; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; EDWARDS CQ, 1999, WINTROBES CLIN HEMAT, V1, P1056; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3; LEBOEUF RC, 1995, J LAB CLIN MED, V126, P128; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; McDonnell SM, 1999, AM J MED, V106, P619, DOI 10.1016/S0002-9343(99)00120-5; Moirand R, 1997, ANN INTERN MED, V127, P105, DOI 10.7326/0003-4819-127-2-199707150-00002; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; SCHEUER PJ, 1962, J PATHOL BACTERIOL, V84, P53, DOI 10.1002/path.1700840107; Witte DL, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P519	24	154	157	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2000	343	21					1529	1535		10.1056/NEJM200011233432104	http://dx.doi.org/10.1056/NEJM200011233432104			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375PR	11087882				2022-12-01	WOS:000165410900004
J	Zerzan, J; Stearns, S; Hanson, L				Zerzan, J; Stearns, S; Hanson, L			Access to palliative care and hospice in nursing homes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESIDENT ASSESSMENT INSTRUMENT; OF-LIFE CARE; ALZHEIMERS-DISEASE; PAIN; QUALITY; MANAGEMENT; SURVIVAL; CRITERIA; DEMENTIA; PATIENT	Nursing homes are the site of death for many elderly patients with incurable chronic illness, yet dying nursing home residents have limited access to palliative care and hospice. The probability that a nursing home will be the site of death increased from 18.7% in 1986 to 20.0% by 1993. Dying residents experience high rates of untreated pain and other symptoms. They and their family members are isolated from social and spiritual support. Hospice improves end-of-life care for dying nursing home residents by improving pain control, reducing hospitalization, and reducing use of tube feeding, but it is rarely used. For example, in 1997 only 13% of hospice enrollees were in nursing homes while 87% were in private homes, and 70% of nursing homes had no hospice patients. Hospice use varies by region, and rates of use are associated with nursing home administrators' attitudes toward hospice and contractual obligations. Current health policy discourages use of palliative care and hospice for dying nursing home residents. Quality standards and reimbursement rules provide incentives for restorative care and technologically intensive treatments rather than labor-intensive palliative care, Reimbursement incentives, contractual requirements, and concerns about health care fraud also limit its use. Changes in health policy, quality standards, and reimbursement incentives are essential to improve access to palliative care and hospice for dying nursing home residents.	Univ N Carolina, Div Gen Med, Dept Hlth Policy & Adm, Sch Publ Hlth, Chapel Hill, NC 27599 USA; Oregon Hlth Sci Univ, Dept Med, Portland, OR 97201 USA; Univ N Carolina, Dept Med, Chapel Hill, NC USA; Univ N Carolina, Ctr Hlth Eth & Policy, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Oregon Health & Science University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hanson, L (corresponding author), Univ N Carolina, Div Gen Med, Dept Hlth Policy & Adm, Sch Publ Hlth, CB 7110,5035 Old Clin Bldg, Chapel Hill, NC 27599 USA.			Hanson, Laura/0000-0001-5120-6058				Baer WM, 2000, J AM GERIATR SOC, V48, P879, DOI 10.1111/j.1532-5415.2000.tb06883.x; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; Billings J A, 1998, J Palliat Med, V1, P73, DOI 10.1089/jpm.1998.1.73; BRODER M, 1996, MED ETHICS POLICIES; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; COLLOPY B, 1991, HASTINGS CENT REP  S, V21, P1; DEGNER LF, 1991, CANCER NURS, V14, P246, DOI 10.1097/00002820-199114050-00004; FERRELL BA, 1995, ANN INTERN MED, V123, P681, DOI 10.7326/0003-4819-123-9-199511010-00007; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Fries BE, 1997, J AM GERIATR SOC, V45, P994, DOI 10.1111/j.1532-5415.1997.tb02972.x; Hanson L. C., 1999, JGIM, V14, P101; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; HAUPT BJ, 1998, ADV DATA, V299, P1; Hayley DC, 1996, ARCH INTERN MED, V156, P249, DOI 10.1001/archinte.156.3.249; *HLTH CAR FIN ADM, 1997, MED PROGR MAN STAT M; HOLTZMAN J, 1994, J AM GERIATR SOC, V42, P275, DOI 10.1111/j.1532-5415.1994.tb01751.x; Institute of Medicine, 1986, IMPR QUAL CAR NURS H; Jones B, 1997, Hosp J, V12, P41; KEAY TJ, 1994, J AM GERIATR SOC, V42, P853, DOI 10.1111/j.1532-5415.1994.tb06557.x; Keay TJ, 1998, AM FAM PHYSICIAN, V57, P491; KEMPER P, 1991, NEW ENGL J MED, V324, P595, DOI 10.1056/NEJM199102283240905; KIDDER D, 1992, HEALTH SERV RES, V27, P195; LELAND J, 1996, NURSE HOME EC, V3, P8; LINN MW, 1989, INT J AGING HUM DEV, V28, P305, DOI 10.2190/JA0E-9T0Y-H2K8-QBV6; Luchins DJ, 1997, J AM GERIATR SOC, V45, P1054, DOI 10.1111/j.1532-5415.1997.tb05966.x; McMillan A, 1990, Health Care Financ Rev, V12, P1; Miller S C, 1998, J Palliat Med, V1, P367, DOI 10.1089/jpm.1998.1.367; MILLER SC, 2000, OUTCOMES UTILIZATION; Mor V, 1997, J AM GERIATR SOC, V45, P1002, DOI 10.1111/j.1532-5415.1997.tb02973.x; Murphy K, 1997, J AM GERIATR SOC, V45, P1104, DOI 10.1111/j.1532-5415.1997.tb05974.x; *N CAR DIV FAC SER, 1997, ANN HOSP LIC DAT S 1; *NAT HOSP ORG, 1999, HOSP FACT SHEET; *NAT HOSP ORG MED, 1996, MED GUID DET PROGN S; OBRIEN LA, 1995, JAMA-J AM MED ASSOC, V274, P1775, DOI 10.1001/jama.274.22.1775; Petrisek AC, 1999, GERONTOLOGIST, V39, P279, DOI 10.1093/geront/39.3.279; Phillips CD, 1997, J AM GERIATR SOC, V45, P986, DOI 10.1111/j.1532-5415.1997.tb02971.x; SAGER MA, 1989, NEW ENGL J MED, V320, P433, DOI 10.1056/NEJM198902163200705; SENGSTAKEN EA, 1993, J AM GERIATR SOC, V41, P541, DOI 10.1111/j.1532-5415.1993.tb01892.x; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; *US DEP HHS OFF IN, 1993, OEI129200550 US DEP; *US DEP HHS OFF IN, 1997, OEI059500250 US DEP; *US DEP HHS OFF IN, 1997, OEI059500251 US DEP; *US GEN ACC OFF, 1996, GAOHEHS96145; Vladeck BC, 1996, JAMA-J AM MED ASSOC, V275, P425; VOLICER L, 1994, J AM GERIATR SOC, V42, P597, DOI 10.1111/j.1532-5415.1994.tb06856.x; von Gunten C F, 1996, Oncology (Williston Park), V10, P1070; Watt C K, 1997, Am J Hosp Palliat Care, V14, P63, DOI 10.1177/104990919701400204; Watt K, 1996, Am J Hosp Palliat Care, V13, P47, DOI 10.1177/104990919601300616; WEINER J, 1994, JAMA-J AM MED ASSOC, V271, P1525, DOI 10.1001/jama.271.19.1525; WEISSMAN DE, 1995, J PAIN SYMPTOM MANAG, V10, P292, DOI 10.1016/0885-3924(95)00006-K; Wilson SA, 1996, GERIATR NURS, V17, P6, DOI 10.1016/S0197-4572(96)80004-8; Won A, 1999, J AM GERIATR SOC, V47, P936, DOI 10.1111/j.1532-5415.1999.tb01287.x; WON A, 1999, ANN LONG TERM CARE, V7, P92; 1987, FED REG, V56, P48865	54	110	109	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2000	284	19					2489	2494		10.1001/jama.284.19.2489	http://dx.doi.org/10.1001/jama.284.19.2489			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	371MY	11074779				2022-12-01	WOS:000165183800023
J	Moret, Y; Schmid-Hempel, P				Moret, Y; Schmid-Hempel, P			Survival for immunity: The price of immune system activation for bumblebee workers	SCIENCE			English	Article							TRADE-OFFS; LIPOPOLYSACCHARIDE; RESISTANCE; HEMOLYMPH; POPULATIONS; PARASITISM; DROSOPHILA; INSECTS; COSTS; BEE	Parasites do not always harm their hosts because the immune system keeps an infection at bay. Ironically, the cost of using immune defenses could itself reduce host' fitness. This indirect cost of parasitism is often not visible because of compensatory resource intake. Here, workers of the bumblebee, Bombus terrestris, were challenged with Lipopolysaccharides and micro-latex beads to induce their immune system under starvation (i.e., not allowing compensatory intake). Compared with controls, survival of induced workers was significantly reduced (by 50 to 70%).	ETH Zurich, ETH Zentrum, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Moret, Y (corresponding author), ETH Zurich, ETH Zentrum, NW, CH-8092 Zurich, Switzerland.		Moret, Yannick/I-9282-2012					ASHIDA M, 1982, P 3 INT C INV PATH B, P81; AZUMI K, 1991, DEV COMP IMMUNOL, V15, P9, DOI 10.1016/0145-305X(91)90042-W; BOOTS M, 1993, FUNCT ECOL, V7, P528, DOI 10.2307/2390128; CARTAR RV, 1991, CAN ENTOMOL, V123, P283, DOI 10.4039/Ent123283-2; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; Demas GE, 1997, AM J PHYSIOL-REG I, V273, pR1631, DOI 10.1152/ajpregu.1997.273.5.R1631; Heinrich B., 1979, BUMBLEBEE EC; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; JOMORI T, 1990, EUR J BIOCHEM, V190, P201, DOI 10.1111/j.1432-1033.1990.tb15565.x; KATO Y, 1994, INSECT BIOCHEM MOLEC, V24, P539, DOI 10.1016/0965-1748(94)90089-2; KATO Y, 1994, INSECT BIOCHEM MOLEC, V24, P547, DOI 10.1016/0965-1748(94)90090-6; KONIG C, 1995, P ROY SOC B-BIOL SCI, V260, P225, DOI 10.1098/rspb.1995.0084; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; LENSKI RE, 1988, EVOLUTION, V42, P425, DOI 10.1111/j.1558-5646.1988.tb04149.x; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; RATTCLIFE NA, 1979, INSECT  HEMOCYTES, P331; RATTCLIFE NA, 1985, INT REV CYTOL, V97, P183; Rees JA, 1997, INSECT BIOCHEM MOLEC, V27, P413, DOI 10.1016/S0965-1748(97)00013-1; Schmid-Hempel P, 1998, MONOGRAPHS BEHAV ECO; SCHMIDHEMPEL P, 1990, INSECT SOC, V37, P14, DOI 10.1007/BF02223812; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SHYKOFF JA, 1991, APIDOLOGIE, V22, P117, DOI 10.1051/apido:19910204; SODERHALL K, 1982, DEV COMP IMMUNOL, V6, P601; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; Yan G, 1997, EVOLUTION, V51, P441, DOI [10.2307/2411116, 10.1111/j.1558-5646.1997.tb02431.x]	25	810	826	2	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2000	290	5494					1166	1168		10.1126/science.290.5494.1166	http://dx.doi.org/10.1126/science.290.5494.1166			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	372HL	11073456				2022-12-01	WOS:000165228200049
J	Covington, WW				Covington, WW			Helping western forests heal - The prognosis is poor for US forest ecosystems	NATURE			English	Editorial Material									No Arizona Univ, Ecol Restorat Inst, Flagstaff, AZ 86011 USA	Northern Arizona University	Covington, WW (corresponding author), No Arizona Univ, Ecol Restorat Inst, POB 15018, Flagstaff, AZ 86011 USA.							2000, NATURE, V407, P5	1	109	110	0	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					135	136						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089949				2022-12-01	WOS:000165180400017
J	Redeker, KR; Wang, NY; Low, JC; McMillan, A; Tyler, SC; Cicerone, RJ				Redeker, KR; Wang, NY; Low, JC; McMillan, A; Tyler, SC; Cicerone, RJ			Emissions of methyl halides and methane from rice paddies	SCIENCE			English	Article							HIGHER-PLANTS; OZONE; BROMIDE; FIELDS; VOLATILIZATION; CHLOROMETHANE; EXCHANGE; IODINE	Methyl halide gases are important sources of atmospheric inorganic halogen compounds, which in turn are central reactants in many stratospheric and tropospheric chemical processes. By observing emissions of methyl chloride, methyl bromide, and methyl iodide from flooded California rice fields, we estimate the impact of rice agriculture on the atmospheric budgets of these gases. Factors influencing methyl halide emissions are stage of rice growth, soil organic content, halide concentrations, and field-water management. Extrapolating our data implies that about 1 percent of atmospheric methyl bromide and 5 percent of methyl iodide arise from rice fields worldwide. Unplanted flooded fields emit as much methyl chloride as planted, flooded rice fields.	Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Cicerone, RJ (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.		Redeker, Kelly/AAV-3821-2020	Redeker, Kelly/0000-0002-1903-2286; McMillan, Andrew/0000-0003-4652-3360				ANDERSON JG, 1991, SCIENCE, V251, P39, DOI 10.1126/science.251.4989.39; Bossio DA, 1999, SOIL BIOL BIOCHEM, V31, P1313, DOI 10.1016/S0038-0717(99)00050-4; Carpenter LJ, 1999, J GEOPHYS RES-ATMOS, V104, P1679, DOI 10.1029/98JD02746; Chanton JP, 1997, GLOBAL BIOGEOCHEM CY, V11, P15, DOI 10.1029/96GB03761; Cicerone R. J., 1992, Global Biogeochemical Cycles, V6, P233, DOI 10.1029/92GB01412; Davis D, 1996, J GEOPHYS RES-ATMOS, V101, P2135, DOI 10.1029/95JD02727; Gan J, 1997, J ENVIRON QUAL, V26, P1107, DOI 10.2134/jeq1997.00472425002600040023x; Gan J, 1998, GEOPHYS RES LETT, V25, P3595, DOI 10.1029/98GL52697; Harper DB, 1999, NEW PHYTOL, V142, P5, DOI 10.1046/j.1469-8137.1999.00382.x; Jeffers PM, 1998, GEOPHYS RES LETT, V25, P43, DOI 10.1029/97GL03476; MURAMATSU Y, 1995, ATMOS ENVIRON, V29, P21, DOI 10.1016/1352-2310(94)00220-F; Platt U, 1995, FARADAY DISCUSS, V100, P175, DOI 10.1039/fd9950000175; Rhew RC, 2000, NATURE, V403, P292, DOI 10.1038/35002043; SAINI HS, 1995, PLANT CELL ENVIRON, V18, P1027, DOI 10.1111/j.1365-3040.1995.tb00613.x; Sander R, 1997, TELLUS B, V49, P522, DOI 10.1034/j.1600-0889.49.issue5.8.x; Sass RL, 1999, J GEOPHYS RES-ATMOS, V104, P26943, DOI 10.1029/1999JD900081; SASS RL, 1994, GLOBAL BIOGEOCHEM CY, V8, P135, DOI 10.1029/94GB00588; Saxena D, 1998, APPL ENVIRON MICROB, V64, P2831; SOLOMON S, 1994, J GEOPHYS RES-ATMOS, V99, P20491, DOI 10.1029/94JD02028; *U PHIL COLL AGR C, 1967, RICE PROD MAN, P21; vanderGon HAC, 1996, GLOBAL BIOGEOCHEM CY, V10, P1, DOI 10.1029/95GB03460; Varner RK, 1999, GEOPHYS RES LETT, V26, P2433, DOI 10.1029/1999GL900587; YUNG YL, 1980, J ATMOS SCI, V37, P339, DOI 10.1175/1520-0469(1980)037<0339:ABAOPI>2.0.CO;2	23	163	168	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2000	290	5493					966	969		10.1126/science.290.5493.966	http://dx.doi.org/10.1126/science.290.5493.966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062125	Green Published			2022-12-01	WOS:000165103200044
J	Wallenfang, MR; Seydoux, G				Wallenfang, MR; Seydoux, G			Polarization of the anterior-posterior axis of C. elegans is a microtubule-directed process	NATURE			English	Article							CAENORHABDITIS-ELEGANS; EMBRYOS; POLARITY; GRANULES; SEGREGATION; KINASE; PAR-1; LOCALIZATION; DISRUPTION; SPINDLE	In Caenorhabditis elegans, polarity along the anterior-posterior (A/P) axis is established shortly after fertilization and is determined by the sperm, whose position specifies the posterior end of the embryo(1). Although many factors required for the establishment of A/P polarity have been described(2,3), the nature of the spatial cue provided by the sperm remains unknown. Here we show that a microtubule-organizing centre is necessary and sufficient to establish several aspects of A/P polarity. In wildtype embryos, appearance of the first molecular asymmetries along the A/P axis correlates with and requires nucleation of microtubules by the sperm-derived centrosomes (sperm asters). In mutant embryos arrested in meiosis, sperm asters fail to form, and posterior is defined by the position of the persistent meiotic spindle rather than by the position of the sperm. Together, our data indicate that the primary spatial cue for A/P polarity in C. elegans derives from microtubules emanating from the sperm asters. Our findings support a parallel(4-7) between C. elegans zygotes and other cells, such as Drosophila oocytes, which rely on microtubules to regulate polarity.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Seydoux, G (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	gseydoux@jhmi.edu	SEYDOUX, Geraldine/AAA-2005-2020	Seydoux, Geraldine/0000-0001-8257-0493				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Bowerman B, 1998, CURR TOP DEV BIOL, V39, P73, DOI 10.1016/S0070-2153(08)60453-6; Boxem M, 1999, DEVELOPMENT, V126, P2227; Boyd L, 1996, DEVELOPMENT, V122, P3075; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Furuta T, 2000, MOL BIOL CELL, V11, P1401, DOI 10.1091/mbc.11.4.1401; Goldstein B, 1996, DEVELOPMENT, V122, P1467; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; HILL DP, 1990, DEVELOPMENT, V108, P159; Hird SN, 1996, DEVELOPMENT, V122, P1303; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Morris J, 2000, SCIENCE, V288, P1759, DOI 10.1126/science.288.5472.1759; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Sadler PL, 2000, DEVELOPMENT, V127, P355; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; STROME S, 1982, P NATL ACAD SCI-BIOL, V79, P1558, DOI 10.1073/pnas.79.5.1558; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Tenenhaus C, 1998, DEV BIOL, V200, P212, DOI 10.1006/dbio.1998.8940; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4	29	148	165	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2000	408	6808					89	92		10.1038/35040562	http://dx.doi.org/10.1038/35040562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081513				2022-12-01	WOS:000165050400057
J	Harland, SJ				Harland, SJ			Conundrum of the hereditary component of testicular cancer	LANCET			English	Editorial Material							CRYPTORCHIDISM; DENMARK		UCL, Dept Oncol, London W1P 8BT, England	University of London; University College London	Harland, SJ (corresponding author), UCL, Dept Oncol, London W1P 8BT, England.							Dieckmann KP, 1997, CANCER, V80, P1954, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1954::AID-CNCR12>3.0.CO;2-X; EKBOM A, 1998, NEOPLASTIC TRANSFORM, P225; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; FORMAN D, 1992, BRIT J CANCER, V65, P225; Geddes M, 1993, CANC ITALIAN MIGRANT; HARLAND SJ, 1997, GERM CELL TUMOURS, V4, P17; Heimdal K, 1996, BRIT J CANCER, V73, P964, DOI 10.1038/bjc.1996.173; *INT TEST CANC LIN, 1998, NEOPL TRANSF TEST GE, P65; LEAHY MG, 1995, HUM MOL GENET, V4, P1551, DOI 10.1093/hmg/4.9.1551; Moller H, 1996, CANCER CAUSE CONTROL, V7, P264, DOI 10.1007/BF00051302; Moller H, 1996, INT J CANCER, V66, P287, DOI 10.1002/(SICI)1097-0215(19960503)66:3<287::AID-IJC2>3.0.CO;2-V; Parkin DM, 1997, INT J CANCER, V70, P654, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;654::AID-IJC5&gt;3.0.CO;2-U; Rapley EA, 2000, NAT GENET, V24, P197, DOI 10.1038/72877; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	14	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 28	2000	356	9240					1455	1456		10.1016/S0140-6736(00)02863-4	http://dx.doi.org/10.1016/S0140-6736(00)02863-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367NA	11081522				2022-12-01	WOS:000090067300003
J	Borde, V; Goldman, ASH; Lichten, M				Borde, V; Goldman, ASH; Lichten, M			Direct coupling between meiotic DNA replication and recombination initiation	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; YEAST CHROMOSOME-III; SACCHAROMYCES-CEREVISIAE; MEIOSIS; MRE11; TIME; ACTIVATION; MUTATIONS; CHROMATIN; ORIGINS	During meiosis in Saccharomyces cerevisiae, DNA replication occurs 1.5 to 2 hours before recombination initiates by DNA double-strand break formation. We show that replication and recombination initiation are directly linked. Blocking meiotic replication prevented double-strand break formation in a replication-checkpoint-independent manner, and delaying replication of a chromosome segment specifically delayed break formation in that segment. Consequently, the time between replication and break formation was held constant in all regions. We suggest that double-strand break formation occurs as part of a process initiated by DNA replication, which thus determines when meiotic recombination initiates on a regional rather than a cell-wide basis.	NCI, Div Basic Sci, Biochem Lab, Bethesda, MD 20892 USA; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Sheffield	Lichten, M (corresponding author), NCI, Div Basic Sci, Biochem Lab, Bethesda, MD 20892 USA.		Lichten, Michael/C-5795-2013; Borde, Valerie/G-5228-2012	Lichten, Michael/0000-0001-9707-2956; Goldman, Alastair/0000-0002-0516-3197	NATIONAL CANCER INSTITUTE [Z01BC005268, ZIABC005268] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; BORDE V, UNPUB; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BUDD ME, 1989, MOL CELL BIOL, V9, P365, DOI 10.1128/MCB.9.2.365; Cha RS, 2000, GENE DEV, V14, P493; COLLINS I, 1994, MOL CELL BIOL, V14, P3524, DOI 10.1128/MCB.14.5.3524; COLLINS I, 1994, CELL, V76, P65, DOI 10.1016/0092-8674(94)90173-2; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; JOHNSTON LH, 1982, EXP CELL RES, V141, P53, DOI 10.1016/0014-4827(82)90067-2; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Ohta K, 1998, P NATL ACAD SCI USA, V95, P646, DOI 10.1073/pnas.95.2.646; REYNOLDS AE, 1989, MOL CELL BIOL, V9, P4488, DOI 10.1128/MCB.9.10.4488; Rocco V, 1996, GENES CELLS, V1, P645, DOI 10.1046/j.1365-2443.1996.00256.x; Rothstein R, 2000, GENE DEV, V14, P1; SCHILD D, 1978, CHROMOSOMA, V70, P109, DOI 10.1007/BF00292220; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SIMCHEN G, 1976, MOL GEN GENET, V144, P21, DOI 10.1007/BF00277299; SMITH K, COMMUNICATION; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x	25	191	198	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					806	809		10.1126/science.290.5492.806	http://dx.doi.org/10.1126/science.290.5492.806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052944				2022-12-01	WOS:000090067600049
J	Finney, BP; Gregory-Eaves, I; Sweetman, J; Dougas, MSV; Smol, JP				Finney, BP; Gregory-Eaves, I; Sweetman, J; Dougas, MSV; Smol, JP			Impacts of climatic change and fishing on Pacific salmon abundance over the past 300 years	SCIENCE			English	Article							BRITISH-COLUMBIA; LAKES; SEA	The effects of climate variability on Pacific salmon abundance are uncertain because historical records are short and are complicated by commercial harvesting and habitat alteration. We use Lake sediment records of delta N-15 and biological indicators to reconstruct sockeye salmon abundance in the Bristol Bay and Kodiak Island regions of Alaska over the past 300 years. Marked shifts in populations occurred over decades during this period, and some pronounced changes appear to be related to climatic change. Variations in salmon returns due to climate or harvesting can have strong impacts on sockeye nursery Lake productivity in systems where adult salmon carcasses are important nutrient sources.	Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK 99775 USA; Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada	University of Alaska System; University of Alaska Fairbanks; Queens University - Canada; University of Toronto	Finney, BP (corresponding author), Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK 99775 USA.		Gregory-Eaves, Irene/U-9325-2019; Sweetman, Jon/A-6457-2011; Smol, John P/A-8838-2015	Gregory-Eaves, Irene/0000-0002-0380-5061; Sweetman, Jon/0000-0002-9849-7355; Smol, John/0000-0002-2499-6696				ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; Anderson NJ, 1997, EUR J PHYCOL, V32, P35; [Anonymous], 1986, HDB HOLOCENE PALAEOE; BEAMISH RJ, 1993, CAN J FISH AQUAT SCI, V50, P1002, DOI 10.1139/f93-116; BELCHER JH, 1966, J ECOL, V54, P335, DOI 10.2307/2257952; Ben-David M, 1998, OIKOS, V83, P47, DOI 10.2307/3546545; BILBY RE, 1996, CAN J FISH AQUAT SCI, V53, P163; BRADBURY J P, 1988, Journal of Paleolimnology, V1, P115; Burgner R.L., 1991, P1; D'Arrigo R, 1999, GEOPHYS RES LETT, V26, P2757, DOI 10.1029/1999GL900504; ENNIS GL, 1983, CAN J BOT, V61, P1983, DOI 10.1139/b83-214; FINNEY BP, 1998, PAC ANADROMOUS FISH, V1, P388; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; Gregory-Eaves I, 1999, ARCT ANTARCT ALP RES, V31, P353, DOI 10.2307/1552584; Hall Roland I., 1999, P128; Haworth E.Y., 1986, P 8 INT DIAT S, P43; KLINE TC, 1993, CAN J FISH AQUAT SCI, V50, P2350, DOI 10.1139/f93-259; Koenings J.P., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P419; Kyle GB, 1997, FRESHWATERS ALASKA E, P205; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; PENNINGTON WINIFRED, 1961, HYDROBIOLOGIA, V17, P183, DOI 10.1007/BF00040420; REAVIE ED, 1995, J PALEOLIMNOL, V14, P49, DOI 10.1007/BF00682593; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Roppel P, 1986, SALMON KODIAK HIST S; Schmidt D.C., 1997, DEV SUSTAINING WORLD, P687; TALBOT MR, 1992, EARTH PLANET SC LETT, V110, P23, DOI 10.1016/0012-821X(92)90036-U; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; VENIAMINOV I, 1984, NOTES ISLANDS UNALAS, P39; Welch DW, 1998, CAN J FISH AQUAT SCI, V55, P937, DOI 10.1139/cjfas-55-4-937; WILES GC, 1996, CAN J FOREST RES, V26, P31; Wunsam S., 1995, MEMORIE I ITALIANO I, V53, P85	32	260	273	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					795	799		10.1126/science.290.5492.795	http://dx.doi.org/10.1126/science.290.5492.795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052941				2022-12-01	WOS:000090067600046
J	Prehoda, KE; Scott, JA; Mullins, RD; Lim, WA				Prehoda, KE; Scott, JA; Mullins, RD; Lim, WA			Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex	SCIENCE			English	Article							ACTIN-DEPOLYMERIZING PROTEIN; ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; N-WASP; PHOSPHOINOSITIDE BINDING; CYTOSKELETON; NUCLEATION; MOTILITY; DOMAINS; CDC42	The protein N-WASP [a homolog to the Wiskott-Aldrich syndrome protein (WASP)I regulates actin polymerization by stimulating the actin-nucleating activity of the actin-related protein 2/3 (Arp2/3) complex. N-WASP is tightly regulated by multiple signals: Only costimulation by Cdc42 and phosphatidylinositol (4,5)-bisphosphate (PIP2) yields potent polymerization. We found that regulation requires N-WASP's constitutively active output domain (VCA) and two regulatory domains: a Cdc42-binding domain and a previously undescribed PIP2-binding domain. In the absence of stimuli, the regulatory modules together hold the VCA-Arp2/3 complex in an inactive "closed" conformation. In this state, both the Cdc42- and PIP2-binding sites are masked. Binding of either input destabilizes the closed state and enhances binding of the other input. This cooperative activation mechanism shows how combinations of simple binding domains can be used to integrate and amplify coincident signals.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prehoda, KE (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.			Prehoda, Ken/0000-0003-4214-6158				BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Perutz M, 1990, COOPERATIVITY ALLOST; PERUTZ MF, 1978, SCI AM, V239, P92, DOI 10.1038/scientificamerican1278-92; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; PREHODA KE, UNPUB; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Stenmark H, 1999, J CELL SCI, V112, P4175; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169	29	405	413	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					801	806		10.1126/science.290.5492.801	http://dx.doi.org/10.1126/science.290.5492.801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052943				2022-12-01	WOS:000090067600048
J	Watkins, NJ; Segault, V; Charpentier, B; Nottrott, S; Fabrizio, P; Bachi, A; Wilm, M; Rosbash, M; Branlant, C; Luhrmann, R				Watkins, NJ; Segault, V; Charpentier, B; Nottrott, S; Fabrizio, P; Bachi, A; Wilm, M; Rosbash, M; Branlant, C; Luhrmann, R			A common core RNP structure shared between the small nucleoar box C/D RNPs and the spliceosomal U4 snRNP	CELL			English	Article							PRE-RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; RIBONUCLEOPROTEIN PARTICLE; BINDING PROTEIN; GUIDE SNORNAS; TRI-SNRNP; U3 SNRNA; IDENTIFICATION; SEQUENCE	The box C/D snoRNAs function in directing 2'-O-methylation and/or as chaperones in the processing of ribosomal RNA. We show here that Snu13p (15.5kD in human), a component of the U4/U6.U5 tri-snRNP, is also associated with the box C/D snoRNAs. Indeed, genetic depletion of Snu13p in yeast leads to a major defect in RNA metabolism. The box C/D motif can be folded into a stem-internal loop-stem structure, almost identical to the 15.5kD binding site in the U4 snRNA. Consistent with this, the box C/D motif binds Snu13p/15.5kD in vitro. The similarities in structure and function observed between the U4 snRNP (chaperone for U6) and the box C/D snoRNPs raises the interesting possibility that these particles may have evolved from a common ancestral RNP.	Max Planck Inst Biophys Chem, Abt Zellulare Biochem, D-37070 Gottingen, Germany; UHP Nancy 1, CNRS,Fac Sci, UMR 7567, Lab Maturat ARN & Enzymol Mol, F-54506 Vandoeuvre Les Nancy, France; Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Brandeis University; Howard Hughes Medical Institute; European Molecular Biology Laboratory (EMBL)	Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulare Biochem, Fassberg 11, D-37070 Gottingen, Germany.	luehrmann@imt.uni-marburg.de	bachi, angela/B-3527-2015	bachi, angela/0000-0003-4842-6556; Wilm, Matthias/0000-0002-5461-6834; Branlant, Christiane/0000-0003-4728-5499; CHARPENTIER, Bruno/0000-0003-2955-2987; Watkins, Nicholas/0000-0003-1256-3874				Bachellerie JP, 1997, TRENDS BIOCHEM SCI, V22, P257, DOI 10.1016/S0968-0004(97)01057-8; BASERGA SJ, 1991, EMBO J, V10, P2645, DOI 10.1002/j.1460-2075.1991.tb07807.x; FABRIZIO P, 1994, SCIENCE, V264, P261, DOI 10.1126/science.8146658; Fatica A, 2000, RNA, V6, P88, DOI 10.1017/S1355838200991623; Filipowicz W, 1999, ACTA BIOCHIM POL, V46, P377, DOI 10.18388/abp.1999_4171; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gottschalk A, 1999, EMBO J, V18, P4535, DOI 10.1093/emboj/18.16.4535; Guthrie C, 1991, METHODS ENZYMOL, V194; Hughes JMX, 1996, J MOL BIOL, V259, P645, DOI 10.1006/jmbi.1996.0346; KIMURA J, 1987, FEBS LETT, V224, P65, DOI 10.1016/0014-5793(87)80423-4; Kiss-Laszlo Z, 1998, EMBO J, V17, P797, DOI 10.1093/emboj/17.3.797; Lafontaine DLJ, 1998, TRENDS BIOCHEM SCI, V23, P383, DOI 10.1016/S0968-0004(98)01260-2; LUBBEN B, 1993, NUCLEIC ACIDS RES, V21, P5377, DOI 10.1093/nar/21.23.5377; Lyman SK, 1999, RNA, V5, P1597, DOI 10.1017/S1355838299991288; Mereau A, 1997, J MOL BIOL, V273, P552, DOI 10.1006/jmbi.1997.1320; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Narayanan A, 1999, MOL BIOL CELL, V10, P2131, DOI 10.1091/mbc.10.7.2131; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; PARKER KA, 1987, MOL CELL BIOL, V7, P2899, DOI 10.1128/MCB.7.8.2899; Samarsky DA, 1998, MOL CELL BIOL, V18, P3431, DOI 10.1128/MCB.18.6.3431; SEGAULT V, 1992, NUCLEIC ACIDS RES, V20, P3443, DOI 10.1093/nar/20.13.3443; Smith CM, 1997, CELL, V89, P669, DOI 10.1016/S0092-8674(00)80247-0; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; VANGELDER CWG, 1993, EMBO J, V12, P5191, DOI 10.1002/j.1460-2075.1993.tb06214.x; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; VORM O, 1994, BIOL MASS SPECTROM, V23, P734, DOI 10.1002/bms.1200231204; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Watkins NJ, 1998, RNA, V4, P1549, DOI 10.1017/S1355838298980761; Watkins NJ, 1998, RNA, V4, P582, DOI 10.1017/S1355838298980128; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; WISE JA, 1991, METHOD ENZYMOL, V194, P405; Xia L, 1997, RNA, V3, P17	36	283	287	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 27	2000	103	3					457	466		10.1016/S0092-8674(00)00137-9	http://dx.doi.org/10.1016/S0092-8674(00)00137-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081632	Bronze			2022-12-01	WOS:000090144100011
J	Deng, L; Wang, C; Spencer, E; Yang, LY; Braun, A; You, JX; Slaughter, C; Pickart, C; Chen, ZJ				Deng, L; Wang, C; Spencer, E; Yang, LY; Braun, A; You, JX; Slaughter, C; Pickart, C; Chen, ZJ			Activation of the I kappa B kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain	CELL			English	Article							SITE-SPECIFIC PHOSPHORYLATION; DEFECTIVE INTERLEUKIN-1; PROTEASOME PATHWAY; ALPHA; PROTEIN; OSTEOPETROSIS; PRECURSOR; INDUCTION; DOMAIN; MUTANT	TRAF6 is a signal transducer in the NF-kappa B pathway that activates I kappa B kinase (IKK) in response to proinflammatory cytokines. We have purified a heterodimeric protein complex that links TRAF6 to IKK activation. Peptide mass fingerprinting analysis reveals that this complex is composed of the ubiquitin conjugating enzyme Ubc13 and the Ubc-like protein Uev1A. We find that TRAF6, a RING domain protein, functions together with Ubc13/Uev1A to catalyze the synthesis of unique polyubiquitin chains linked through lysine-63 (K63) of ubiquitin. Blockade of this polyubiquitin chain synthesis, but not inhibition of the proteasome, prevents the activation of IKK by TRAF6. These results unveil a new regulatory function for ubiquitin, in which IKK is activated through the assembly of K63-linked polyubiquitin chains.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	Chen, ZJ (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.		Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059203, R01GM060372] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 59203, GM 60372] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHEN ZJ, 1998, UBIQUITIN BIOL CELL, P303; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothofsky ML, 1997, GENE, V195, P141, DOI 10.1016/S0378-1119(97)00097-8; Rudolph D, 2000, GENE DEV, V14, P854; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; You JX, 1999, BIOTECHNIQUES, V27, P950, DOI 10.2144/99275st01; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	39	1436	1502	6	85	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 13	2000	103	2					351	361		10.1016/S0092-8674(00)00126-4	http://dx.doi.org/10.1016/S0092-8674(00)00126-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057907	Bronze			2022-12-01	WOS:000089864300018
J	Lissy, NA; Davis, PK; Irwin, M; Kaelin, WG; Dowdy, SF				Lissy, NA; Davis, PK; Irwin, M; Kaelin, WG; Dowdy, SF			A common E2F-1 and p73 pathway mediates cell death induced by TCR activation	NATURE			English	Article							PERIPHERAL T-LYMPHOCYTES; LI-FRAUMENI; APOPTOSIS; P53; EXPRESSION; PROTEINS; GENE; MICE; COMPLEXITY; INDUCTION	Strong stimulation of the T-cell receptor (TCR) on cycling peripheral T cells causes their apoptosis by a process called TCR-activation-induced cell death (TCR-AICD)(1-3). TCR-AICD occurs from a late G1 phase cell-cycle check point(4) independently of the 'tumour suppressor' protein p53 (refs 5, 6). Disruption of the gene for the E2F-1 transcription factor(7,8), an inducer of apoptosis(9-11), causes significant increases in T-cell number and splenomegaly(12-15). Here we show that T cells undergoing TCR-AICD induce the p53-related gene p73, another mediator of apoptosis(16), which is hypermethylated in lymphomas(17,18). Introducing a dominant-negative E2F-1 protein or a dominant-negative p73 protein into T cells protects them from TCR-mediated apoptosis, whereas dominant-negative E2F-2, E2F-4 or p53 does not. Furthermore, E2F-1-null or p73-null primary T cells do not undergo TCR-mediated apoptosis either. We conclude that TCR-AICD occurs from a late G1 cell-cycle checkpoint that is dependent on both E2F-1 and p73 activities. These observations indicate that, unlike p53, p73 serves to integrate receptor-mediated apoptotic stimuli.	Washington Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Dowdy, SF (corresponding author), Washington Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, St Louis, MO 63110 USA.							ABRAMS SI, 1991, J IMMUNOL, V146, P405; Boehme SA, 1996, J IMMUNOL, V156, P4075; Corn PG, 1999, CANCER RES, V59, P3352; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Garcia I, 2000, CELL GROWTH DIFFER, V11, P91; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; JONES LA, 1990, SCIENCE, V250, P1726, DOI 10.1126/science.2125368; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; KABELITZ D, 1993, IMMUNOL TODAY, V14, P338, DOI 10.1016/0167-5699(93)90231-9; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Kawano S, 1999, BLOOD, V94, P1113; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Lissy NA, 1998, IMMUNITY, V8, P57, DOI 10.1016/S1074-7613(00)80458-6; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; Malcomson RDG, 1997, J PATHOL, V181, P166; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zhu JW, 1999, CELL GROWTH DIFFER, V10, P829	30	283	288	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					642	645		10.1038/35036608	http://dx.doi.org/10.1038/35036608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034214				2022-12-01	WOS:000089772800050
J	Luu, DT; Qin, XK; Morse, D; Cappadocia, M				Luu, DT; Qin, XK; Morse, D; Cappadocia, M			S-RNase uptake by compatible pollen tubes in gametophytic self-incompatibility	NATURE			English	Article							SOLANUM-CHACOENSE BITT; NICOTIANA-ALATA; FLOWERING PLANTS; GENETIC-ANALYSIS; GROWTH; ALLELES; POLLINATION; HYPOTHESIS; CLONING; CULTURE	Many flowering plants avoid inbreeding through a genetic mechanism termed self-incompatibility. An extremely polymorphic S-locus(1) controls the gametophytic self-incompatibility system that causes pollen rejection (that is, active arrest of pollen tube growth inside the style) when an S-allele carried by haploid pollen matches one of the S-alleles present in the diploid style. The only known product of the S-locus is an S-RNase expressed in the mature style(2). The pollen component to this cell-cell recognition system is unknown and current models(3,4) propose that it either acts as a gatekeeper allowing only its cognate S-RNase to enter the pollen tube, or as an inhibitor of non-cognate S-RNases. In the latter case, all S-RNases are presumed to enter pollen tubes; thus, the two models make diametrically opposed predictions concerning the entry of S-RNases into compatible pollen. Here we use immunocytochemical labelling of pollen tubes growing in styles to show accumulation of an S-RNase in the cytoplasm of all pollen-tube haplotypes, thus providing experimental support for the inhibitor model.	Univ Montreal, Dept Biol, Montreal, PQ H1X 2B2, Canada	Universite de Montreal	Cappadocia, M (corresponding author), Univ Montreal, Dept Biol, Montreal, PQ H1X 2B2, Canada.			Luu, Doan Trung/0000-0001-9765-2125; Morse, David/0000-0003-4131-4367				ANDERSON MA, 1986, NATURE, V321, P38, DOI 10.1038/321038a0; Certal AC, 1999, SEX PLANT REPROD, V12, P94, DOI 10.1007/s004970050177; Cheung AY, 1996, SEX PLANT REPROD, V9, P330, DOI 10.1007/BF02441951; De Nettancourt D, 1973, J Cell Sci, V12, P403; de Nettancourt D., 1977, INCOMPATIBILITY ANGI, DOI DOI 10.1007/BF00276804; DESPRES C, 1994, SEX PLANT REPROD, V7, P169, DOI 10.1007/BF00228490; Dodds PN, 1996, CELL, V85, P141, DOI 10.1016/S0092-8674(00)81090-9; Golz JF, 2000, ANN BOT-LONDON, V85, P95, DOI 10.1006/anbo.1999.1060; GRAY JE, 1991, PLANT CELL, V3, P271, DOI 10.1105/tpc.3.3.271; HESS D, 1974, Z PFLANZENPHYSIOL, V74, P371; HUANG S, 1994, PLANT CELL, V6, P1021, DOI 10.1105/tpc.6.7.1021; JAHNEN W, 1989, PLANT CELL, V1, P501, DOI 10.1105/tpc.1.5.501; Kao TH, 1996, P NATL ACAD SCI USA, V93, P12059, DOI 10.1073/pnas.93.22.12059; LEWIS D, 1961, NATURE, V190, P990, DOI 10.1038/190990a0; MARTIN FW, 1959, STAIN TECHNOL, V34, P125, DOI 10.3109/10520295909114663; Matton DP, 1997, PLANT CELL, V9, P1757, DOI 10.1105/tpc.9.10.1757; Matton DP, 1999, PLANT CELL, V11, P2087, DOI 10.1105/tpc.11.11.2087; MCCLURE B, 1989, NATURE, V32, P955; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; MCFADDEN G, 1991, ELECT MICROSCOPY PLA, P220; PANDEY KK, 1967, HEREDITY, V22, P255, DOI 10.1038/hdy.1967.31; RIVARD SR, 1994, GENOME, V37, P775, DOI 10.1139/g94-111; SABAELLEIL MK, 1994, PLANT MOL BIOL, V24, P571, DOI 10.1007/BF00023555; STEER MW, 1989, NEW PHYTOL, V111, P323, DOI 10.1111/j.1469-8137.1989.tb00697.x; Van Sint Jan V, 1996, PLANT CELL TISS ORG, V47, P9; Vandenbosch K A, 1991, ELECT MICROSCOPY PLA, P181; VERONNEAU H, 1992, PLANT CELL TISS ORG, V30, P199, DOI 10.1007/BF00040022	27	191	212	0	34	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					649	651		10.1038/35036623	http://dx.doi.org/10.1038/35036623			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034216				2022-12-01	WOS:000089772800052
J	Halfon, MS; Carmena, A; Gisselbrecht, S; Sackerson, CM; Jimenez, F; Baylies, MK; Michelson, AM				Halfon, MS; Carmena, A; Gisselbrecht, S; Sackerson, CM; Jimenez, F; Baylies, MK; Michelson, AM			Ras pathway specificity is determined by the integration of multiple signal-activated and tissue-restricted transcription factors	CELL			English	Article							GROWTH-FACTOR RECEPTOR; DROSOPHILA EMBRYONIC MESODERM; ELEGANS VULVAL INDUCTION; GENE-EXPRESSION; CELL FATES; C-ELEGANS; MUSCLE PROGENITORS; PROTEINS ACT; BOX GENES; DIFFERENTIATION	Ras signaling elicits diverse outputs, yet how Ras specificity is generated remains incompletely understood. We demonstrate that Wingless (Wg) and Decapentaplegic (Dpp) confer competence for receptor tyrosine kinase-mediated induction of a subset of Drosophila muscle and cardiac progenitors by acting both upstream of and in parallel to Pas. In addition to regulating the expression of proximal Ras pathway components, Wg and Dpp coordinate the direct effects of three signal-activated (dTCF, Mad, and Pointed-functioning in the Wg, Dpp, and Ras/MAPK pathways, respectively) and two tissue-restricted (Twist and Tinman) transcription factors on a progenitor identity gene enhancer. The integration of Pointed with the combinatorial effects of dTCF, Mad, Twist, and Tinman determines inductive Ras signaling specificity in muscle and heart development.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Dept Mol Biol, New York, NY 10021 USA; Iona Coll, Dept Biol, New Rochelle, NY 10801 USA; Univ Miguel Hernandez, Inst Neurociencias, Alicante, Spain	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Iona College; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Michelson, AM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02115 USA.		Halfon, Marc S./H-3447-2019; Carmena, Ana/H-3506-2015	Halfon, Marc S./0000-0002-4149-2705; Carmena, Ana/0000-0003-1855-7934; Gisselbrecht, Stephen/0000-0001-8723-902X	NIGMS NIH HHS [R01 GM056989, GM 56989] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056989] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Bang AG, 2000, GENE DEV, V14, P177; Bate Michael, 1993, Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie, V316, P1047; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; BODMER R, 1993, DEVELOPMENT, V118, P719; BOPP D, 1989, EMBO J, V8, P3447, DOI 10.1002/j.1460-2075.1989.tb08509.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Buff E, 1998, DEVELOPMENT, V125, P2075; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; CHEN T, 1992, DEV BIOL, V151, P176, DOI 10.1016/0012-1606(92)90225-6; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Ericson J, 1998, DEVELOPMENT, V125, P1005; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; FRASCH M, 1995, NATURE, V374, P646; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Gomez MR, 1997, DEVELOPMENT, V124, P4857; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; Hepker J, 1999, DEVELOPMENT, V126, P3669; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Imam F, 1999, GENETICS, V152, P307; Jiang LI, 1998, DEVELOPMENT, V125, P2337; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; KLAMBT C, 1993, DEVELOPMENT, V117, P163; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lawrence PA, 1995, DEVELOPMENT, V121, P4303; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Maloof JN, 1998, DEVELOPMENT, V125, P181; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Michelson AM, 1998, DEV GENET, V22, P212, DOI 10.1002/(SICI)1520-6408(1998)22:3<212::AID-DVG4>3.0.CO;2-9; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pai LM, 1997, DEVELOPMENT, V124, P2255; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Reifers F, 2000, DEVELOPMENT, V127, P225; Rommel C, 1998, CURR OPIN GENET DEV, V8, P412, DOI 10.1016/S0959-437X(98)80111-1; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Sackerson C, 1999, DEV BIOL, V211, P39, DOI 10.1006/dbio.1999.9301; SEKELSKY JJ, 1995, GENETICS, V139, P1347; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; STERN CURT, 1954, AMER SCI, V42, P213; Stern HM, 1997, DEVELOPMENT, V124, P3511; Su MT, 1999, DEVELOPMENT, V126, P3241; Szuts D, 1998, GENE DEV, V12, P2022, DOI 10.1101/gad.12.13.2022; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Tan PBO, 1999, TRENDS GENET, V15, P145, DOI 10.1016/S0168-9525(99)01694-7; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354	58	258	262	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					63	74		10.1016/S0092-8674(00)00105-7	http://dx.doi.org/10.1016/S0092-8674(00)00105-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051548	Bronze			2022-12-01	WOS:000089636400009
J	Liu, SM; Manson, JE; Stampfer, MJ; Rexrode, KM; Hu, FB; Rimm, EB; Willett, WC				Liu, SM; Manson, JE; Stampfer, MJ; Rexrode, KM; Hu, FB; Rimm, EB; Willett, WC			Whole grain consumption and risk of ischemic stroke in women - A prospective study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; FOOD-FREQUENCY QUESTIONNAIRE; DIETARY PATTERNS; POPULATION; FRUIT; MEN; REPRODUCIBILITY; POTASSIUM; MORTALITY; VALIDITY	Context Although increased intake of grain products has been recommended to prevent cardiovascular disease (CVD), prospective data examining the relation of whole grain intake to risk of ischemic stroke are sparse, especially among women. Objective To examine the hypothesis that higher whole grain intake reduces the risk of ischemic stroke in women. Design, Setting, and Participants A prospective cohort of 75521 US women aged 38 to 63 years without previous diagnosis of diabetes mellitus, coronary heart disease, stroke, or other CVDs in 1984, who completed detailed food frequency questionnaires (FFQs) in 1984, 1986, 1990, and 1994, and were followed up for 12 years as part of the Nurses' Health Study. Main Outcome Measure Incidence of ischemic stroke, confirmed by medical records, by quintile of whole grain intake according to FFQ responses. Results During 861 900 person-years of follow-up, 352 confirmed incident cases of ischemic stroke occurred. We observed an inverse association between whole grain intake and ischemic stroke risk. The age-adjusted relative risks (RRs) from the lowest to highest quintiles of whole grain intake were 1.00 (referent), 0.68 (95% confidence interval [CII, 0.49-0.94), 0.69 (95% CI, 0.51-0.95), 0.49 (95% CI, 0.35-0.69), and 0.57 (95% CI, 0.42-0.78; P=.003 for trend). Adjustment for smoking modestly attenuated this association (RR comparing extreme quintiles, 0.64; 95% CI, 0.47-0.89). This inverse association remained essentially unchanged with further adjustment for known CVD risk factors, including saturated fat and transfatty acid intake (multivariate-adjusted RR comparing extreme quintiles, 0.69; 95% Cf, 0.50-0.98). The inverse relation between whole grain intake and risk of ischemic stroke was also consistently observed among subgroups of women who never smoked, did not drink alcohol, did not exercise regularly, or who did not use postmenopausal hormones. No significant association was observed between total grain intake and risk of ischemic stroke. Conclusions tn this cohort, higher intake of whole grain foods was associated with a lower risk of ischemic stroke among women, independent of known CVD risk factors. These prospective data support the notion that higher intake of whole grains may reduce the risk of ischemic stroke.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Liu, SM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.		Liu, Simin/I-3689-2014; Rexrode, Kathryn M/I-1177-2018; Liu, Simin/GSN-4159-2022	Liu, Simin/0000-0003-2098-3844; Rexrode, Kathryn/0000-0003-3387-8429	NATIONAL CANCER INSTITUTE [R01CA040356, R37CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NCI NIH HHS [CA40356] Funding Source: Medline; NHLBI NIH HHS [HL34594, HL24704] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERTSON AM, 1995, J AM DIET ASSOC, V95, P703, DOI 10.1016/S0002-8223(95)00194-8; *AM HEART ASS, 2000, 200 HEART STROK STAT; ANDERSON GH, 1994, CRIT REV FOOD SCI, V34, P435, DOI 10.1080/10408399409527673; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; BRONNER LL, 1995, NEW ENGL J MED, V333, P1392, DOI 10.1056/NEJM199511233332106; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; GRUNDY SM, 1990, J LIPID RES, V31, P1149; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; Knekt P, 1996, BRIT MED J, V312, P478, DOI 10.1136/bmj.312.7029.478; LIU S, IN PRESS AM J CLIN N; Liu SM, 1999, AM J CLIN NUTR, V70, P412; *MMWR, 1999, MMWR-MORBID MORTAL W, V48, P649; Ness AR, 1999, J CARDIOVASC RISK, V6, P229; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Rimm EB, 1996, JAMA-J AM MED ASSOC, V275, P447, DOI 10.1001/jama.275.6.447; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Selhub J, 1996, J NUTR, V126, pS1258, DOI 10.1093/jn/126.suppl_4.1258S; Slavin J, 1997, NUTR CANCER, V27, P14, DOI 10.1080/01635589709514495; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; *USDA, 2000, NUTR YOUR HLTH DIET; Walker A, 1981, STROKE S1, V12, P113; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WILLETT WC, 1998, MODERN EPIDEMIOLOGY, P623; WOLK AM, IN PRESS BMJ	31	216	226	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1534	1540		10.1001/jama.284.12.1534	http://dx.doi.org/10.1001/jama.284.12.1534			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000647				2022-12-01	WOS:000089379700029
J	Godfrey-Faussett, P; Sonnenberg, P; Shearer, SC; Bruce, MC; Mee, C; Morris, L; Murray, J				Godfrey-Faussett, P; Sonnenberg, P; Shearer, SC; Bruce, MC; Mee, C; Morris, L; Murray, J			Tuberculosis control and molecular epidemiology in a South African gold-mining community	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FALSE-POSITIVE CULTURES; NEW-YORK-CITY; MYCOBACTERIUM-TUBERCULOSIS; STRAIN DIFFERENTIATION; RECENT TRANSMISSION; DIAGNOSIS	Background Gold miners have very high rates of tuberculosis. The :contribution of infections imported into mining communities versus transmission within them is not known and has implications for control strategies, Methods We did a prospective, population-based molecular and,conventional epidemiological study of pulmonary tuberculosis in a group of goldminers. Clusters were defined as groups of patients with Mycobacterium tuberculosis isolates with identical IS6110 DNA fingerprints. We compared the frequency of possible risk factors in the clustered and nonclustered patients whose isolates had fingerprints with more than four bands, and re-interviewed members of 45 clusters. Findings Of 448 patients, ten were excluded because they had false-positive cultures. Fingerprints were made in 419 of 438, of which 371 had more than four bands. 248 of 371 were categorised into 62 clusters. At least 50% of tuberculosis cases were due to transmission within the community. Patients who had failed treatment at entry to the study were more likely to be: in clusters (adjusted odds ratio 3.41 [95% CI 1.25-9.27]). Patients with multidrug-resistant isolates were more likely to have failed treatment but were less likely to be clustered than those with a sensitive strain(0.27 [0.09-0.83]). HIV infection was common (177 of 370 tested) but not associated with clustering. Interpretation Despite a control programme that cures 86% of new cases, most tuberculosis in this mining community is due to ongoing transmission. Persistently infectious individuals who have:previously failed treatment may be responsible for one third of tuberculosis cases. WHO targets for cure rates are not sufficient to interrupt transmission of tuberculosis in this setting. Indicators that are more closely linked to the rate of ongoing transmission are needed.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Teaching Hosp, Dept Med, ZAMBART Project, Lusaka, Zambia; Epidemiol Res Unit, Johannesburg, South Africa; Univ Witwatersrand, Dept Community Hlth, Parktown, South Africa; Gold Fields S Africa, Johannesburg, South Africa; Univ Witwatersrand, Dept Virol, Johannesburg, South Africa; Univ Witwatersrand, Natl Inst Virol, MRC, AIDS Virus Res Unit, Johannesburg, South Africa; Natl Ctr Occupat Hlth, Dept Hlth, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Zambia; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Godfrey-Faussett, P (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	peter.godfrey-faussett@lshtm.ac.uk	Morris, Lynn/V-3941-2018	Morris, Lynn/0000-0003-3961-7828; Sonnenberg, Pam/0000-0002-1067-1583				ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; Barnes PF, 1997, JAMA-J AM MED ASSOC, V278, P1159, DOI 10.1001/jama.278.14.1159; Behr MA, 1998, AM J RESP CRIT CARE, V158, P465, DOI 10.1164/ajrccm.158.2.9801062; Borgdorff MW, 1998, AM J EPIDEMIOL, V147, P187; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P321, DOI 10.1164/ajrccm.155.1.9001331; Churchyard CJ, 1999, INT J TUBERC LUNG D, V3, P791; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; DIPERRI G, 1989, LANCET, V2, P1502; Frieden TR, 1996, TUBERCLE LUNG DIS, V77, P407, DOI 10.1016/S0962-8479(96)90112-4; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; Godfrey-Faussett P, 1999, LANCET, V353, P427, DOI 10.1016/S0140-6736(98)00352-3; Harries AD, 1997, T ROY SOC TROP MED H, V91, P15, DOI 10.1016/S0035-9203(97)90376-X; International Union Against Tuberculosis and Lung Disease, 1996, TUB GUID LOW INC COU; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KOCHI A, 1991, TUBERCLE, V72, P1, DOI 10.1016/0041-3879(91)90017-M; LEGER JP, 1992, S AFR MED J, V81, P197; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; ROSS BC, 1992, J CLIN MICROBIOL, V30, P942, DOI 10.1128/JCM.30.4.942-946.1992; SMALL PM, 1993, J CLIN MICROBIOL, V31, P1677, DOI 10.1128/JCM.31.7.1677-1682.1993; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sonnenberg P, 1998, INT J TUBERC LUNG D, V2, P168; Sutherland I., 1968, TUBERCULOSIS SURVEIL; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; Warren R, 1996, S AFR MED J, V86, P45; *WHO, 1997, WHOTUBERCULOSIS97220; Wilkinson D, 1997, TROP MED INT HEALTH, V2, P747, DOI 10.1046/j.1365-3156.1997.d01-386.x	28	120	129	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2000	356	9235					1066	1071		10.1016/S0140-6736(00)02730-6	http://dx.doi.org/10.1016/S0140-6736(00)02730-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009142				2022-12-01	WOS:000089430500011
J	Carter, AP; Clemons, WM; Brodersen, DE; Morgan-Warren, RJ; Wimberly, BT; Ramakrishnan, V				Carter, AP; Clemons, WM; Brodersen, DE; Morgan-Warren, RJ; Wimberly, BT; Ramakrishnan, V			Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics	NATURE			English	Article							ESCHERICHIA-COLI RIBOSOME; AMINOACYL-TRANSFER-RNA; PEPTIDYL-TRANSFER-RNA; A-SITE; P-SITE; CONFORMATIONAL SWITCH; CROSS-LINKING; STREPTOMYCIN; BINDING; MUTATIONS	The 30S ribosomal subunit has two primary functions in protein synthesis. It discriminates against aminoacyl transfer RNAs that do not match the codon of messenger RNA, thereby ensuring accuracy in translation of the genetic message in a process called decoding. Also, it works with the 50S subunit to move the tRNAs and associated mRNA by precisely one codon, in a process called translocation. Here we describe the functional implications of the high-resolution 30S crystal structure presented in the accompanying paper, and infer details of the interactions between the 30S subunit and its tRNA and mRNA ligands. We also describe the crystal structure of the 30S subunit complexed with the antibiotics paromomycin, streptomycin and spectinomycin, which interfere with decoding and translocation. This work reveals the structural basis for the action of these antibiotics, and leads to a model for the role of the universally conserved 16S RNA residues A1492 and A1493 in the decoding process.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA	MRC Laboratory Molecular Biology; Utah System of Higher Education; University of Utah	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	brianw@mrc-lmb.cam.ac.uk; ramak@mrc-lmb.cam.ac.uk	Clemons, William M/D-1026-2009; Brodersen, Ditlev E./AAQ-5241-2020	Clemons, William M/0000-0002-0021-889X; Ramakrishnan, V/0000-0002-4699-2194; Brodersen, Ditlev/0000-0002-5413-4667; Carter, Andrew/0000-0001-7292-5430	NIGMS NIH HHS [F31 GM019384] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM019384] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; ALLEN PN, 1989, J MOL BIOL, V208, P457, DOI 10.1016/0022-2836(89)90509-3; BILGIN N, 1994, J MOL BIOL, V235, P813, DOI 10.1006/jmbi.1994.1041; BILGIN N, 1990, EMBO J, V9, P735, DOI 10.1002/j.1460-2075.1990.tb08167.x; BOCK A, 1979, FEBS LETT, V104, P317, DOI 10.1016/0014-5793(79)80842-X; BRINK MF, 1994, NUCLEIC ACIDS RES, V22, P325, DOI 10.1093/nar/22.3.325; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; Garrett R. A., 2000, RIBOSOME STRUCTURE F; GRAVEL M, 1987, BIOCHEMISTRY-US, V26, P6227, DOI 10.1021/bi00393a041; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Karimi R, 1996, EMBO J, V15, P1149, DOI 10.1002/j.1460-2075.1996.tb00453.x; KARIMI R, 1994, EUR J BIOCHEM, V226, P355, DOI 10.1111/j.1432-1033.1994.tb20059.x; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; KURLAND CG, 1996, LIMITATIONS TRANSLAT, P979; LECLERC D, 1991, NUCLEIC ACIDS RES, V19, P3973, DOI 10.1093/nar/19.14.3973; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; MELANCON P, 1984, BIOCHEMISTRY-US, V23, P6697, DOI 10.1021/bi00321a064; MELANCON P, 1988, NUCLEIC ACIDS RES, V16, P9631, DOI 10.1093/nar/16.20.9631; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MONTANDON PE, 1985, NUCLEIC ACIDS RES, V13, P4299, DOI 10.1093/nar/13.12.4299; MONTROSE L, 1986, ENGL LITERARY RENAIS, V16, P5, DOI 10.1111/j.1475-6757.1986.tb00895.x; Mueller F, 1997, J MOL BIOL, V271, P566, DOI 10.1006/jmbi.1997.1212; Mueller F, 1997, J MOL BIOL, V271, P524, DOI 10.1006/jmbi.1997.1210; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Pape T, 2000, NAT STRUCT BIOL, V7, P104; PINARD R, 1993, FASEB J, V7, P173, DOI 10.1096/fasebj.7.1.7678560; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; PRINCE JB, 1982, P NATL ACAD SCI-BIOL, V79, P5450, DOI 10.1073/pnas.79.18.5450; RUUSALA T, 1984, MOL GEN GENET, V198, P100, DOI 10.1007/BF00328707; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/BF00217518; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; VanLoock MS, 1999, J MOL BIOL, V285, P2069, DOI 10.1006/jmbi.1998.2442; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WITTMANNLIEBOLD B, 1978, FEBS LETT, V95, P91, DOI 10.1016/0014-5793(78)80059-3; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722	46	1212	1278	8	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2000	407	6802					340	348		10.1038/35030019	http://dx.doi.org/10.1038/35030019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014183				2022-12-01	WOS:000089390700037
J	Gaeta, G; De Michele, M; Cuomo, S; Guarini, P; Foglia, MC; Bond, MG; Trevisan, M				Gaeta, G; De Michele, M; Cuomo, S; Guarini, P; Foglia, MC; Bond, MG; Trevisan, M			Arterial abnormalities in the offspring of patients with premature myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; INTIMA-MEDIA THICKNESS; OXIDE SYNTHASE GENE; RISK-FACTORS; PARENTAL HISTORY; FAMILY HISTORY; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; NITRIC-OXIDE; DEPENDENT DILATATION	Background: The offspring of patients with premature coronary disease may be at increased risk for atherosclerosis. We undertook a study to determine whether changes in brachial-artery reactivity and the thickness of the carotid intima and media, two markers of early atherosclerosis, are present in adolescents and young adults with a parental history of premature myocardial infarction. Methods: We enrolled 40 healthy young people whose parents had had premature myocardial infarction (48 percent male; mean [+/-SD] age, 19.0+/-5.2 years) and 40 control subjects who were matched with the first group according to age and sex. All the subjects underwent high-resolution B-mode ultrasound examinations for the measurement of the brachial-artery vasodilatory response after arterial occlusion (i.e., reactive hyperemia) and the intima-media thickness of the distal common carotid arteries. Results: As compared with the control subjects, the offspring of patients with premature myocardial infarction had lower flow-mediated reactivity of the brachial arteries (5.7+/-5.0 percent, vs. 10.2+/-6.6 percent in the control subjects; P=0.001) and greater mean intima-media thickness of the common carotid artery (0.49+/-0.08 mm, vs. 0.44+/-0.07 mm in the control subjects; P=0.004). In the subjects with a parental history of premature myocardial infarction, an inverse association was found between brachial-artery reactivity and carotid intima-media thickness (r=-0.46, P=0.003). In a conditional logistic-regression analysis, both brachial-artery reactivity and carotid intima-media thickness were significantly and independently correlated with a parental history of premature myocardial infarction. Conclusions: Structural and functional changes are present at an early age in the arteries of persons with a parental history of premature myocardial infarction. (N Engl J Med 2000;343:840-6.) (C) 2000, Massachusetts Medical Society.	Wake Forest Univ, Bowman Gray Sch Med, Div Vasc Ultrasound Res, Winston Salem, NC 27157 USA; A Cardarelli Hosp, Div Cardiol, Naples, Italy; A Cardarelli Hosp, Clin Anal Lab, Naples, Italy; Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; S Maria di Lorcto Hosp, Div Cardiol, Naples, Italy; SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	Wake Forest University; Wake Forest Baptist Medical Center; Antonio Cardarelli Hospital; Antonio Cardarelli Hospital; University of Naples Federico II; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bond, MG (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Div Vasc Ultrasound Res, Med Ctr Blvd, Winston Salem, NC 27157 USA.		Tanaka, Gohichi/A-1684-2010	trevisan, maurizio/0000-0001-5479-0050; Crisanti, Andrea/0000-0002-2406-4426				BAO WH, 1995, CIRCULATION, V91, P365, DOI 10.1161/01.CIR.91.2.365; BARRETTCONNOR E, 1984, CIRCULATION, V69, P1065, DOI 10.1161/01.CIR.69.6.1065; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Clarkson P, 1997, CIRCULATION, V96, P3378; COOKE JP, 1994, ARTERIOSCLER THROMB, V14, P653, DOI 10.1161/01.ATV.14.5.653; De Bacquer D, 1999, J AM COLL CARDIOL, V33, P1491, DOI 10.1016/S0735-1097(99)00067-4; Enderle MD, 1998, HEART, V80, P349, DOI 10.1136/hrt.80.4.349; FREEDMAN DS, 1986, NEW ENGL J MED, V315, P721, DOI 10.1056/NEJM198609183151202; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Ghiadoni L, 1998, HYPERTENSION, V32, P25, DOI 10.1161/01.HYP.32.1.25; Greenlund KJ, 1999, CIRCULATION, V99, P2144, DOI 10.1161/01.CIR.99.16.2144; HEISS G, 1991, AM J EPIDEMIOL, V134, P250, DOI 10.1093/oxfordjournals.aje.a116078; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Jousilahti P, 1996, J CLIN EPIDEMIOL, V49, P497, DOI 10.1016/0895-4356(95)00581-1; KAPRIO J, 1993, CIRCULATION, V87, P1960, DOI 10.1161/01.CIR.87.6.1960; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; *NAT CHOL ED PROGR, 1992, PEDIATRICS, V89, P525; Neunteufl T, 1997, ATHEROSCLEROSIS, V129, P111, DOI 10.1016/S0021-9150(96)06018-2; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; PHILLIPS RL, 1974, AM J EPIDEMIOL, V100, P87, DOI 10.1093/oxfordjournals.aje.a112021; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; RILEY WA, 1986, ARTERIOSCLEROSIS, V6, P378, DOI 10.1161/01.ATV.6.4.378; SLACK J., 1966, J MED GENET, V3, P239, DOI 10.1136/jmg.3.4.239; SRINIVASAN SR, 1991, CIRCULATION, V84, P160, DOI 10.1161/01.CIR.84.1.160; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; Wood D, 1998, EUR HEART J, V19, P1434; Yataco AR, 1999, AM J CARDIOL, V83, P754, DOI 10.1016/S0002-9149(98)00984-9; Zannad F, 1998, HUM GENET, V103, P183, DOI 10.1007/s004390050804; Zureik M, 1999, ARTERIOSCL THROM VAS, V19, P366, DOI 10.1161/01.ATV.19.2.366; [No title captured]	32	135	142	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2000	343	12					840	846		10.1056/NEJM200009213431203	http://dx.doi.org/10.1056/NEJM200009213431203			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354XB	10995863	Bronze			2022-12-01	WOS:000089355600003
J	Riebesell, U; Zondervan, I; Rost, B; Tortell, PD; Zeebe, RE; Morel, FMM				Riebesell, U; Zondervan, I; Rost, B; Tortell, PD; Zeebe, RE; Morel, FMM			Reduced calcification of marine plankton in response to increased atmospheric CO2	NATURE			English	Article							TOTAL CARBON-DIOXIDE; EMILIANIA-HUXLEYI; CALCIUM-CARBONATE; COCCOLITHOPHORE; SEAWATER; SYSTEM; GROWTH; OCEAN	The formation of calcareous skeletons by marine planktonic organisms and their subsequent sinking to depth generates a continuous rain of calcium carbonate to the deep ocean and underlying sediments(1). This is important in regulating marine carbon cycling and ocean-atmosphere CO2 exchange(2). The present rise in atmospheric CO2 levels(3) causes significant changes in surface ocean pH and carbonate chemistry(4). Such changes have been shown to slow down calcification in corals and coralline macroalgae(5,6), but the majority of marine calcification occurs in planktonic organisms. Here we report reduced calcite production at increased CO2 concentrations in monospecific cultures of two dominant marine calcifying phytoplankton species, the coccolithophorids Emiliania huxleyi and Gephyrocapsa oceanica. This was accompanied by an increased proportion of malformed coccoliths and incomplete coccospheres. Diminished calcification led to a reduction in the ratio of calcite precipitation to organic matter production. Similar results were obtained in incubations of natural plankton assemblages from the north Pacific ocean when exposed to experimentally elevated CO2 levels. We suggest that the progressive increase in atmospheric CO2 concentrations may therefore slow down the production of calcium carbonate in the surface ocean. As the process of calcification releases CO2 to the atmosphere, the response observed here could potentially act as a negative feedback on atmospheric CO2 levels.	Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Princeton University; Princeton University; Columbia University	Riebesell, U (corresponding author), Alfred Wegener Inst Polar & Marine Res, POB 120161, D-27515 Bremerhaven, Germany.		Morel, Francois M M/A-8107-2008; Riebesell, Ulf/AAC-9717-2020; Rost, Bjoern/B-4447-2015	Rost, Bjoern/0000-0001-5452-5505; Tortell, Philippe/0000-0003-0212-2151; Riebesell, Ulf/0000-0002-9442-452X				[Anonymous], 1998, ORNLCDIAC105 US DEP; BOOTH BC, 1993, PROG OCEANOGR, V32, P57, DOI 10.1016/0079-6611(93)90009-3; BRADSHAW AL, 1981, EARTH PLANET SC LETT, V55, P99, DOI 10.1016/0012-821X(81)90090-X; FRANKIGNOULLE M, 1994, LIMNOL OCEANOGR, V39, P458, DOI 10.4319/lo.1994.39.2.0458; Fritz JJ, 1996, J EXP MAR BIOL ECOL, V207, P127, DOI 10.1016/S0022-0981(96)02633-0; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; GOYET C, 1989, DEEP-SEA RES, V36, P1635, DOI 10.1016/0198-0149(89)90064-2; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HARRIS RP, 1994, MAR BIOL, V119, P431, DOI 10.1007/BF00347540; Holligan PM, 1996, GLOB CHANGE BIOL, V2, P85, DOI 10.1111/j.1365-2486.1996.tb00053.x; HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731; Houghton JT., 1995, CLIMATE CHANGE 1994; JOHNSON KM, 1993, MAR CHEM, V44, P167, DOI 10.1016/0304-4203(93)90201-X; KHESHGI HS, 1991, J GEOPHYS RES-OCEANS, V96, P4957, DOI 10.1029/90JC02336; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; McConnaughey TA, 1997, EARTH-SCI REV, V42, P95, DOI 10.1016/S0012-8252(96)00036-0; McConnaughey Ted A., 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P137; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Morse J.W., 1990, DEV SEDIMENTOLOGY, V48; Nielsen MV, 1997, J PHYCOL, V33, P818, DOI 10.1111/j.0022-3646.1997.00818.x; PURDIE DA, 1994, SARSIA, V79, P379, DOI 10.1080/00364827.1994.10413569; WESTBROEK P, 1993, GLOBAL PLANET CHANGE, V8, P27, DOI 10.1016/0921-8181(93)90061-R; WESTBROEK P, 1989, J PROTOZOOL, V36, P368, DOI 10.1111/j.1550-7408.1989.tb05528.x; Westbroek P., 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P37; Winter Amos, 1994, P161; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Young Jeremy R., 1994, P63; YOUNG JR, 1994, SARSIA, V79, P417, DOI 10.1080/00364827.1994.10413573	28	995	1049	20	503	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					364	367		10.1038/35030078	http://dx.doi.org/10.1038/35030078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014189	Green Published			2022-12-01	WOS:000089390700043
J	McNew, JA; Parlati, F; Fukuda, R; Johnston, RJ; Paz, K; Paumet, F; Sollner, TH; Rothman, JE				McNew, JA; Parlati, F; Fukuda, R; Johnston, RJ; Paz, K; Paumet, F; Sollner, TH; Rothman, JE			Compartmental specificity of cellular membrane fusion encoded in SNARE proteins	NATURE			English	Article							T-SNARE; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; V-SNARE; ENDOPLASMIC-RETICULUM; TRANSPORT PATHWAYS; VESICLE TRANSPORT; COMPLEX-FORMATION; GOLGI TRANSPORT; YEAST	Membrane-enveloped vesicles travel among the compartments of the cytoplasm of eukaryotic cells, delivering their specific cargo to programmed locations by membrane fusion. The pairing of vesicle v-SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) with target membrane t-SNAREs has a central role in intracellular membrane fusion. We have tested all of the potential v-SNAREs encoded in the yeast genome for their capacity to trigger fusion by partnering with t-SNAREs that mark the Golgi, the vacuole and the plasma membrane. Here we rnd that, to a marked degree, the pattern of membrane flow in the cell is encoded and recapitulated by its isolated SNARE proteins, as predicted by the SNARE hypothesis.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Rothman, JE (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.		Zdilla, Michael J/B-4145-2011; Wunder, Stephanie L/B-5066-2012; McNew, James/ABD-8081-2020; McNew, James/AAV-4911-2020	McNew, James/0000-0001-8459-3664; Paumet, Fabienne/0000-0003-4466-6966				AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Abeliovich H, 1998, J BIOL CHEM, V273, P11719, DOI 10.1074/jbc.273.19.11719; BANFIELD DK, 1995, NATURE, V375, P806, DOI 10.1038/375806a0; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Gerst JE, 1997, J BIOL CHEM, V272, P16591, DOI 10.1074/jbc.272.26.16591; GERST JE, 1992, P NATL ACAD SCI USA, V89, P4338, DOI 10.1073/pnas.89.10.4338; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Katz L, 1998, EMBO J, V17, P6200, DOI 10.1093/emboj/17.21.6200; Lupashin VV, 1997, MOL BIOL CELL, V8, P2659, DOI 10.1091/mbc.8.12.2659; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; NEWMAN AP, 1990, MOL CELL BIOL, V10, P3405, DOI 10.1128/MCB.10.7.3405; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Nichols BJ, 1998, BBA-MOL CELL RES, V1404, P9, DOI 10.1016/S0167-4889(98)00044-5; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	50	515	529	3	63	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					153	159		10.1038/35025000	http://dx.doi.org/10.1038/35025000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001046				2022-12-01	WOS:000089241000038
J	AbdAlla, S; Lother, H; Quitterer, U				AbdAlla, S; Lother, H; Quitterer, U			AT(1)-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration	NATURE			English	Article							BRADYKININ B2 RECEPTOR; B-2 RECEPTOR; INTERNALIZATION; OVEREXPRESSION; DIMERIZATION; MECHANISMS; TERMINUS; BINDING; SYSTEM	The vasopressor angiotensin II regulates vascular contractility and blood pressure through binding to type 1 angiotensin II receptors (AT(1); refs 1, 2). Bradykinin, a vasodepressor, is a functional antagonist of angiotensin II (ref. 3). The two hormone systems are interconnected by the angiotensin-converting enzyme, which releases angiotensin II from its precursor and inactivates the vasodepressor bradykinin(4). Here we show that the AT(1) receptor and the bradykinin (B-2) receptor also communicate directly with each other. They form stable heterodimers, causing increased activation of G alpha(q) and G alpha(i) proteins, the two major signalling proteins triggered by AT(1). Furthermore, the endocytotic pathway of both receptors changed with heterodimerization. This is the first example of signal enhancement triggered by heterodimerization of two different vasoactive hormone receptors.	Inst Pharmakol, D-97078 Wurzburg, Germany; Heinrich Pette Inst, D-20251 Hamburg, Germany; Genet Engn & Biotechnol Res Inst, Alexandria, Egypt	University of Wurzburg; Heinrich Pette Institute	Quitterer, U (corresponding author), Inst Pharmakol, Versbacher Str 9, D-97078 Wurzburg, Germany.	toph029@rzbox.uni-wuerzburg.de						AbdAlla S, 1999, J BIOL CHEM, V274, P26079, DOI 10.1074/jbc.274.37.26079; AbdAlla S, 1996, J BIOL CHEM, V271, P27382, DOI 10.1074/jbc.271.44.27382; BASCANDS JL, 1994, AM J PHYSIOL-RENAL, V267, pF871, DOI 10.1152/ajprenal.1994.267.5.F871; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; DIXON BS, 1994, AM J PHYSIOL, V266, pC1406, DOI 10.1152/ajpcell.1994.266.5.C1406; DUDLEY DT, 1990, MOL PHARMACOL, V38, P370; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; MACEWAN DJ, 1995, MOL PHARMACOL, V48, P316; Masaki H, 1998, J CLIN INVEST, V101, P527, DOI 10.1172/JCI1885; Mastro R, 1999, ANAL BIOCHEM, V273, P313, DOI 10.1006/abio.1999.4224; NARDONE J, 1994, P NATL ACAD SCI USA, V91, P4417, DOI 10.1073/pnas.91.10.4417; PARRATT JR, 1994, TRENDS PHARMACOL SCI, V15, P19, DOI 10.1016/0165-6147(94)90129-5; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; Prado GN, 1997, J BIOL CHEM, V272, P14638, DOI 10.1074/jbc.272.23.14638; Quitterer U, 1999, J BIOL CHEM, V274, P14773, DOI 10.1074/jbc.274.21.14773; Quitterer U, 1999, P NATL ACAD SCI USA, V96, P10626, DOI 10.1073/pnas.96.19.10626; RANSNAS LA, 1989, P NATL ACAD SCI USA, V86, P7900, DOI 10.1073/pnas.86.20.7900; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Tsuchida S, 1999, KIDNEY INT, V56, P509, DOI 10.1046/j.1523-1755.1999.00574.x; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zhuo JL, 1998, KIDNEY INT, V54, pS22, DOI 10.1046/j.1523-1755.1998.06705.x	28	388	407	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					94	98		10.1038/35024095	http://dx.doi.org/10.1038/35024095			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993080				2022-12-01	WOS:000089124000049
J	Chang, WH; Kornberg, RD				Chang, WH; Kornberg, RD			Electron crystal structure of the transcription factor and DNA repair complex, core TFIIH	CELL			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; LIPID-LAYER CRYSTALLIZATION; TWO-DIMENSIONAL CRYSTALS; START SITE SELECTION; SACCHAROMYCES-CEREVISIAE; XERODERMA-PIGMENTOSUM; RAD3 GENE; FACTOR-B; YEAST	Core TFIIH from yeast, made up of five subunits required both for RNA polymerase II transcription and nucleotide excision DNA repair, formed 2D crystals on charged lipid layers. Diffraction from electron micrographs of the crystals in negative stain extended to about 13 Angstrom resolution, and 3D reconstruction revealed several discrete densities whose volumes corresponded well with those of individual TFIIH subunits. The structure is based on a ring of three subunits, Tfb1, Tfb2, and Tfb3, to which are appended several functional moieties: Rad3, bridged to Tfb1 by SsI1; SsI2, known to interact with Tfb2; and Kin28, known to interact with Tfb3.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.		Chang, Wei-Hau/F-1965-2015	Chang, Wei-Hau/0000-0002-2612-850X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21144] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen G, 1997, EMBO J, V16, P958, DOI 10.1093/emboj/16.5.958; Asturias FJ, 1998, ULTRAMICROSCOPY, V70, P133, DOI 10.1016/S0304-3991(97)00108-3; Asturias FJ, 1997, J MOL BIOL, V272, P536, DOI 10.1006/jmbi.1997.1273; ASTURIAS FJ, 1995, J STRUCT BIOL, V114, P60, DOI 10.1006/jsbi.1995.1005; BARDWELL AJ, 1994, MOL CELL BIOL, V14, P3569, DOI 10.1128/MCB.14.6.3569; BARDWELL L, 1994, P NATL ACAD SCI USA, V91, P3926, DOI 10.1073/pnas.91.9.3926; BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; Bushnell DA, 1996, J BIOL CHEM, V271, P20170, DOI 10.1074/jbc.271.33.20170; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; DARST SA, 1991, CELL, V66, P121, DOI 10.1016/0092-8674(91)90144-N; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; FEAVER WJ, 1991, J BIOL CHEM, V266, P19000; Feaver WJ, 2000, J BIOL CHEM, V275, P5941, DOI 10.1074/jbc.275.8.5941; Feaver WJ, 1997, J BIOL CHEM, V272, P19319, DOI 10.1074/jbc.272.31.19319; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; FRIEDBERG EC, 1992, CELL, V71, P887, DOI 10.1016/0092-8674(92)90384-O; Friedberg EC, 1996, ANNU REV BIOCHEM, V65, P15; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; Jensen P, 1998, LIT HIST-THIRD SER, V7, P1; Kornberg RD, 1991, CURR OPIN STRUC BIOL, V1, P642, DOI 10.1016/S0959-440X(05)80090-9; Leuther KK, 1996, CELL, V85, P773, DOI 10.1016/S0092-8674(00)81242-8; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; LUDWIG DS, 1986, P NATL ACAD SCI USA, V83, P8585, DOI 10.1073/pnas.83.22.8585; MATSUI P, 1995, NUCLEIC ACIDS RES, V23, P767, DOI 10.1093/nar/23.5.767; NAUMOVSKI L, 1987, MOL GEN GENET, V209, P458, DOI 10.1007/BF00331150; NAUMOVSKI L, 1986, MOL CELL BIOL, V6, P1218, DOI 10.1128/MCB.6.4.1218; Poglitsch CL, 1999, CELL, V98, P791, DOI 10.1016/S0092-8674(00)81513-5; RIBI HO, 1987, BIOCHEMISTRY-US, V26, P7974, DOI 10.1021/bi00398a064; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; SUNG P, 1987, P NATL ACAD SCI USA, V84, P6045, DOI 10.1073/pnas.84.17.6045; Sung P, 1996, J BIOL CHEM, V271, P10821, DOI 10.1074/jbc.271.18.10821; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; SVEJSTRUP JQ, 1995, CELL, V80, P21, DOI 10.1016/0092-8674(95)90447-6; Sweder KS, 1996, NUCLEIC ACIDS RES, V24, P1540, DOI 10.1093/nar/24.8.1540; UNGER VM, 1995, BIOPHYS J, V68, P1776, DOI 10.1016/S0006-3495(95)80354-1; UZGIRIS EE, 1983, NATURE, V301, P125, DOI 10.1038/301125a0; WANG ZG, 1995, MOL CELL BIOL, V15, P2288	49	79	80	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 1	2000	102	5					609	613		10.1016/S0092-8674(00)00083-0	http://dx.doi.org/10.1016/S0092-8674(00)00083-0			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007479	Bronze			2022-12-01	WOS:000089105200009
J	Revy, P; Muto, T; Levy, Y; Geissmann, F; Plebani, A; Sanal, O; Catalan, N; Forveille, M; Dufourcq-Lagelouse, R; Gennery, A; Tezcan, I; Ersoy, F; Kayserili, H; Ugazio, AG; Brousse, N; Muramatsu, M; Notarangelo, LD; Kinoshita, K; Honjo, T; Fischer, A; Durandy, A				Revy, P; Muto, T; Levy, Y; Geissmann, F; Plebani, A; Sanal, O; Catalan, N; Forveille, M; Dufourcq-Lagelouse, R; Gennery, A; Tezcan, I; Ersoy, F; Kayserili, H; Ugazio, AG; Brousse, N; Muramatsu, M; Notarangelo, LD; Kinoshita, K; Honjo, T; Fischer, A; Durandy, A			Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2)	CELL			English	Article							CLASS SWITCH RECOMBINATION; X-LINKED IMMUNODEFICIENCY; FACTOR-KAPPA-B; CD40 LIGAND; SOMATIC HYPERMUTATION; GERMINAL-CENTERS; DEFECTIVE EXPRESSION; IMMUNOGLOBULIN GENES; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR	The activation-induced cytidine deaminase (AID) gene, specifically expressed in germinal center B cells in mice, is a member of the cytidine deaminase family. We herein report mutations in the human counterpart of AID in patients with the autosomal recessive form of hyper-IgM syndrome (HIGM2). Three major abnormalities characterize AID deficiency: (1) the absence of immunoglobulin class switch recombination, (2) the lack of immunoglobulin somatic hypermutations, and (3) lymph node hyperplasia caused by the presence of giant germinal centers. The phenotype observed in HIGM2 patients (and in AID(-/-) mice) demonstrates the absolute requirement for AID in several crucial steps of B cell terminal differentiation necessary for efficient antibody responses.	Hop Necker Enfants Malad, INSERM, U429, Paris, France; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan; Hop Cochin, INSERM, U474, F-75674 Paris, France; Hop Necker Enfants Malad, Serv Anatomopathol, Paris, France; Univ Brescia, Pediat Clin, Brescia, Italy; Univ Brescia, Ist Med Mol Angelo Novicelli, Brescia, Italy; Hacettepe Univ, Div Immunol, Ihsan Dogramaci Childrens Hosp, Ankara, Turkey; Istanbul Univ, Inst Child Hlth, Istanbul, Turkey; Hop Necker Enfants Malad, Unite Immunol Hematol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Kyoto University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Brescia; University of Brescia; Hacettepe University; Istanbul University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Durandy, A (corresponding author), Hop Necker Enfants Malad, INSERM, U429, Paris, France.	durandy@necker.fr	Notarangelo, Luigi D/F-9718-2016; Revy, Patrick/H-8137-2017; Ugazio, Alberto/AAA-6092-2020; Muramatsu, Masamichi/C-4339-2015; Kayserili, Hülya/AAA-5593-2021; Honjo, Tasuku/N-4470-2016; Plebani, Alessandro/C-8593-2011; Durandy, Anne/H-7475-2017	Notarangelo, Luigi D/0000-0002-8335-0262; Muramatsu, Masamichi/0000-0002-0153-3533; Kayserili, Hülya/0000-0003-0376-499X; geissmann, frederic/0000-0001-5029-2468; Revy, Patrick/0000-0003-0758-8022; Durandy, Anne/0000-0001-7706-8466	Telethon [E.0668] Funding Source: Medline	Telethon(Fondazione Telethon)		ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BERBERICH I, 1994, J IMMUNOL, V153, P4357; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; CALLARD RE, 1994, J IMMUNOL, V153, P3295; Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494; CONLEY ME, 1994, J CLIN INVEST, V94, P1404, DOI 10.1172/JCI117476; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; DURANDY A, 1993, EUR J IMMUNOL, V23, P2294, DOI 10.1002/eji.1830230936; Durandy A, 1997, J IMMUNOL, V158, P2576; DURANDY A, 1990, J IMMUNOL, V144, P60; FACCHETTI F, 1995, J IMMUNOL, V154, P6624; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369; HU HM, 1994, J BIOL CHEM, V269, P30069; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0; Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; KRAUTER K, 1995, NATURE, V377, P321; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Lagresle C, 1996, J EXP MED, V183, P1377, DOI 10.1084/jem.183.4.1377; Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325; Lebecque S, 1997, J EXP MED, V185, P563, DOI 10.1084/jem.185.3.563; LEDERMAN S, 1992, J IMMUNOL, V149, P3817; Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9; Levy Y, 1998, P NATL ACAD SCI USA, V95, P13135, DOI 10.1073/pnas.95.22.13135; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Morris AE, 1999, J BIOL CHEM, V274, P418, DOI 10.1074/jbc.274.1.418; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; MUTO T, 2000, IN PRESS GENOMICS; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; Revy P, 1998, EUR J IMMUNOL, V28, P3648, DOI 10.1002/(SICI)1521-4141(199811)28:11<3648::AID-IMMU3648>3.3.CO;2-L; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; ROUSSET F, 1991, J EXP MED, V173, P705, DOI 10.1084/jem.173.3.705; SATO T, 1995, FEBS LETT, V358, P113, DOI 10.1016/0014-5793(94)01406-Q; SCOTT J, 1995, CELL, V81, P833, DOI 10.1016/0092-8674(95)90002-0; SIMPSON L, 1995, CELL, V81, P837, DOI 10.1016/0092-8674(95)90003-9; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; STEWART AK, 1993, J EXP MED, V177, P409, DOI 10.1084/jem.177.2.409; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tracy RB, 2000, SCIENCE, V288, P1058, DOI 10.1126/science.288.5468.1058; Wiesendanger M, 1998, CELL, V94, P415, DOI 10.1016/S0092-8674(00)81581-0; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; Zan H, 1999, J IMMUNOL, V162, P3437; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x	76	1215	1246	3	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					565	575		10.1016/S0092-8674(00)00079-9	http://dx.doi.org/10.1016/S0092-8674(00)00079-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007475	Green Published, Bronze			2022-12-01	WOS:000089105200005
J	Hindmarsh, PC; Geary, MPP; Rodeck, CH; Jackson, MR; Kingdom, JCP				Hindmarsh, PC; Geary, MPP; Rodeck, CH; Jackson, MR; Kingdom, JCP			Effect of early maternal iron stores on placental weight and structure	LANCET			English	Article							HEMOGLOBIN CONCENTRATION; BLOOD-PRESSURE; GROWTH-FACTOR; BIRTH-WEIGHT; FETAL GROWTH; PREGNANCY; ANEMIA; DEFICIENCY; ANGIOGENESIS; NEWBORN	Background Large placental size and low birthweight have been implicated as factors predicting high blood pressure in adulthood. Maternal anaemia has been suggested as a link. We investigated the interaction between maternal iron status and other factors known to influence birthweight and placental size. Methods In a prospective study of 1650 low-risk, singleton, caucasian pregnancies, we related placental size and birthweight to maternal iron status, socioeconomic status, and parity. Placental morphology was assessed in 17 randomly chosen primigravid pregnancies. Findings Parity was an important determinant of birthweight (mean standard deviation score -0.13 [SD 0.90] para 0; -0.24 [0. 90] para 1; 0.32 [1.1] para 2; 0.21 [1.1] para greater than or equal to 3; p<0.0001) and placental weight (mean 655 g [SD 130]; 679 g [122]; 675 g [139]; 694 g [157], respectively; p=0.01). Cigarette smoking influenced birthweight only. Socioeconomic status had little effect after correction for parity. In addition to parity, the factors influencing placental weight were maternal height, weight, and serum ferritin concentration at booking, but not haemoglobin concentration. Serum ferritin concentrations were associated with folate intake and parity. In the placental morphology subset, serum ferritin concentration was inversely related to overall measures of peripheral villous capillarisation. Haemoglobin concentration showed no such association. Interpretation These findings show a relation between maternal anaemia and placental size and birthweight across the normal range for these measures. Low ferritin concentrations in early pregnancy were associated with increased placental vascularisation at term. The association between ferritin concentration and folate supplementation emphasises the importance of preconceptional health, particularly in women at high risk of iron deficiency.	UCL, London Ctr Paediat Endocrinol, London, England; UCL, Dept Obstet & Gynaecol, London, England; Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Dev & Fetal Hlth, Toronto, ON M5G 1X5, Canada	University of London; University College London; University of London; University College London; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Hindmarsh, PC (corresponding author), Middlesex Hosp, Cobbold Labs, London W1N 8AA, England.	p.hindmarsh@ucl.ac.uk	Hindmarsh, P C/C-4964-2008; Kingdom, John/A-3247-2013; Kingdom, John/AAF-2145-2020					Allen LH, 1997, NUTR REV, V55, P91, DOI 10.1111/j.1753-4887.1997.tb06460.x; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Burton GJ, 1996, PLACENTA, V17, P49, DOI 10.1016/S0143-4004(05)80643-5; BUTLER NR, 1972, BMJ-BRIT MED J, V2, P127, DOI 10.1136/bmj.2.5806.127; CROWE C, 1995, J PHYSIOL-LONDON, V488, P515, DOI 10.1113/jphysiol.1995.sp020986; FENTON V, 1977, BRIT J HAEMATOL, V37, P145, DOI 10.1111/j.1365-2141.1977.tb08819.x; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; GODFREY KM, 1991, BRIT J OBSTET GYNAEC, V98, P886, DOI 10.1111/j.1471-0528.1991.tb13510.x; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Graham C. H., 1999, Placenta, V20; HOWE DT, 1995, BRIT J OBSTET GYNAEC, V102, P213, DOI 10.1111/j.1471-0528.1995.tb09096.x; JACKSON MR, 1987, PLACENTA, V8, P487, DOI 10.1016/0143-4004(87)90077-4; Kadyrov M, 1998, LANCET, V352, P1747, DOI 10.1016/S0140-6736(98)02069-8; KALTREIDER F, 1980, CLIN OBSTET GYNECOL, V23, P17; Khaliq A, 1999, LAB INVEST, V79, P151; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Kingdom JCP, 1999, ADV EXP MED BIOL, V474, P259; Lao T. T., 1999, Placenta, V20; Lao TT, 1997, PLACENTA, V18, P593, DOI 10.1016/0143-4004(77)90015-7; Moore VM, 1996, ARCH DIS CHILD, V74, P538, DOI 10.1136/adc.74.6.538; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS; PANETH N, 1995, BRIT MED J, V310, P411, DOI 10.1136/bmj.310.6977.411; RESHETNIKOVA OS, 1995, AM J OBSTET GYNECOL, V173, P724, DOI 10.1016/0002-9378(95)90330-5; Robinson S, 1998, BRIT J NUTR, V79, P249, DOI 10.1079/BJN19980042; Shore VH, 1997, PLACENTA, V18, P657, DOI 10.1016/S0143-4004(97)90007-2; Singla PN, 1997, J TROP PEDIATRICS, V43, P89, DOI 10.1093/tropej/43.2.89; STEER P, 1995, BMJ-BRIT MED J, V310, P489, DOI 10.1136/bmj.310.6978.489; STOZ F, 1987, Z GEBURTSH PERINATOL, V191, P81; WHEELER T, 1995, PLACENTA, V16, P289, DOI 10.1016/0143-4004(95)90115-9; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864	30	51	52	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 26	2000	356	9231					719	723		10.1016/S0140-6736(00)02630-1	http://dx.doi.org/10.1016/S0140-6736(00)02630-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347UU	11085691				2022-12-01	WOS:000088948200011
J	Berman, DS; Reisz, RR; Scott, D; Henrici, AC; Sumida, SS; Martens, T				Berman, DS; Reisz, RR; Scott, D; Henrici, AC; Sumida, SS; Martens, T			Early Permian bipedal reptile	SCIENCE			English	Article							KINEMATICS; HINDLIMB; SPEED	A 290-million-year-old reptilian skeleton from the Lower Permian (Asselian) of Germany provides evidence of abilities for cursorial bipedal locomotion, employing a parasagittal digitigrade posture. The skeleton is of a small bolosaurid, Eudibamus cursoris, gen. et sp. nov., and confirms the widespread distribution of Bolosauridae across Laurasia during this early stage of amniote evolution. E. cursoris is the oldest known representative of Parareptilia, a major clade of reptiles.	Univ Toronto, Dept Zool, Mississauga, ON L5L 1C6, Canada; Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA; Museum Nat Gotha, Abt Palaeontol, D-99853 Gotha, Germany	University of Toronto; University Toronto Mississauga; California State University System; California State University San Bernardino	Reisz, RR (corresponding author), Univ Toronto, Dept Zool, Mississauga, ON L5L 1C6, Canada.							Berman David S., 1997, P85, DOI 10.1016/B978-012676460-4/50005-6; CARROLL R L, 1969, Journal of Paleontology, V43, P151; CARROLL RL, 1982, J PALEONTOL, V56, P1; CARROLL RL, 1998, VERTEBRATE PALEONTOL; Clark JM, 1998, NATURE, V391, P886, DOI 10.1038/36092; Eberth DA, 2000, PALAIOS, V15, P293, DOI 10.2307/3515538; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Fieler CL, 1998, J EXP BIOL, V201, P609; HEATON M, 1980, J PALEONTOL, V54, P13; HOLMES R, 1977, J MORPHOL, V152, P101, DOI 10.1002/jmor.1051520107; Hotton Nicholas III, 1997, P207; Irschick DJ, 1999, J EXP BIOL, V202, P1047; IVACHNENKO MF, 1987, PALEONTOLOG J, P93; LAURIN M, 1995, ZOOL J LINN SOC-LOND, V113, P165, DOI 10.1111/j.1096-3642.1995.tb00932.x; LI J, 1995, PALASIATICA, V33, P17; Modesto Sean Patrick, 2000, Palaeontologia Africana, V36, P15; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; Reisz RR, 1997, TRENDS ECOL EVOL, V12, P218, DOI 10.1016/S0169-5347(97)01060-4; REISZ RR, 1981, SPEC PUBL MUS NAT HI, V7, P1; REWCASTLE SC, 1980, J ZOOL, V191, P147; ROMER AS, 1941, SPEC PAP GEOL SOC AM, V28, P1; SNYDER RC, 1952, COPEIA, P64, DOI 10.2307/1438533; SNYDER RC, 1962, AM ZOOL, V2, P191; SNYDER RC, 1949, COPEIA, P129; SNYDER RC, 1954, AM J ANAT, V95, P1, DOI 10.1002/aja.1000950102; WATSON DMS, 1954, B MUS COMP ZOOL HARV, V111, P299	26	76	78	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2000	290	5493					969	972		10.1126/science.290.5493.969	http://dx.doi.org/10.1126/science.290.5493.969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062126				2022-12-01	WOS:000165103200045
J	Zhang, L; Yu, J; Park, BH; Kinzler, KW; Vogelstein, B				Zhang, L; Yu, J; Park, BH; Kinzler, KW; Vogelstein, B			Role of BAX in the apoptotic response to anticancer agents	SCIENCE			English	Article							P53; MICE; MITOCHONDRIA; MUTATIONS; PROTEINS; CANCER; DAMAGE; P21	To assess the role of BAX in drug-induced apoptosis in human colorectal cancer cells, we generated cells that Lack functional BAX genes. Such cells were partially resistant to the apoptotic effects of the chemotherapeutic agent 5-fluorouracil, but apoptosis was not abolished. In contrast, the absence of BAX completely abolished the apoptotic response to the chemopreventive agent sulindac and other nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs inhibited the expression of the antiapoptotic protein Bcl-X-L, resulting in an altered ratio of BAX to BcL-X-L and subsequent mitochondria-mediated cell death. These results establish an unambiguous role for BAX in apoptotic processes in human epithelial cancers and may have implications for cancer chemoprevention strategies.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Ctr Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Program Human Genet, Baltimore, MD 21231 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Vogelstein, B (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Ctr Oncol, Baltimore, MD 21231 USA.		Zhang, Lin/A-7389-2009; Yu, Jian/A-8301-2009	Zhang, Lin/0000-0003-0018-3903; Yu, Jian/0000-0002-4021-1000	NATIONAL CANCER INSTITUTE [R37CA057345, R01CA057345, R37CA043460, P50CA062924, R01CA043460] Funding Source: NIH RePORTER; NCI NIH HHS [CA 43460, CA 62924, CA 57345] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Coopersmith CM, 1997, ONCOGENE, V15, P131, DOI 10.1038/sj.onc.1201176; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Huang TG, 2000, EUR J CANCER, V36, P249, DOI 10.1016/S0959-8049(99)00247-6; Ionov Y, 2000, P NATL ACAD SCI USA, V97, P10872, DOI 10.1073/pnas.190210897; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Johnson S C, 2000, Adv Intern Med, V45, P1; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Lynch HT, 1999, J MED GENET, V36, P801; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Pritchard DM, 1999, ONCOGENE, V18, P7287, DOI 10.1038/sj.onc.1203150; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Schmidt T, 1999, CELL DEATH DIFFER, V6, P873, DOI 10.1038/sj.cdd.4400562; Smith ML, 2000, EUR J CANCER, V36, P664, DOI 10.1016/S0959-8049(99)00333-0; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Williams C, 1999, ANN NY ACAD SCI, V889, P72, DOI 10.1111/j.1749-6632.1999.tb08725.x; Yamamoto Y, 1999, J BIOL CHEM, V274, P27307, DOI 10.1074/jbc.274.38.27307	23	765	798	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2000	290	5493					989	+		10.1126/science.290.5493.989	http://dx.doi.org/10.1126/science.290.5493.989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062132				2022-12-01	WOS:000165103200051
J	Vandermeer, J; de la Cerda, IG; Boucher, D; Perfecto, I; Ruiz, J				Vandermeer, J; de la Cerda, IG; Boucher, D; Perfecto, I; Ruiz, J			Hurricane disturbance and tropical tree species diversity	SCIENCE			English	Article							FOREST; NICARAGUA	The debate over the maintenance of high diversity of tree species in tropical forests centers on the role of tree-fall gaps as a primary source of disturbance. Using a 10-year data series accumulated since Hurricane loan struck the Caribbean coast of Nicaragua in 1988, we examined the pattern of species accumulation over time and with increased sampling of individuals. Our analysis shows that the pattern after a hurricane differs from the pattern after a simple tree-fall disturbance, and we conclude that pioneers are limited in Large disturbances and thus do not suppress other species the way they do in smaller disturbances.	Univ Michigan, Dept Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Univ Herbarium, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; Hood Coll, Dept Biol, Frederick, MD 21701 USA; Univ Reg Autonomas Costa Caribe Nicaraguense, Bluefields, Nicaragua	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Vandermeer, J (corresponding author), Univ Michigan, Dept Biol, Nat Sci Bldg, Ann Arbor, MI 48109 USA.	jvander@umich.edu						ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P247, DOI 10.1016/0378-1127(94)90114-7; Begon M., 1996, ECOLOGY; BELLINGHAM PJ, 1994, J ECOL, V82, P747, DOI 10.2307/2261440; Bove MC, 1998, B AM METEOROL SOC, V79, P2477, DOI 10.1175/1520-0477(1998)079<2477:EOENOO>2.0.CO;2; Brokaw N. V. L., 1985, The ecology of natural disturbance and patch dynamics, P53; BROKAW NVL, 1991, BIOTROPICA, V23, P442, DOI 10.2307/2388264; Chazdon RL, 1998, MAN BIOSPH, V20, P285; CHAZDON RL, 1999, SCIENCE, V285, P1459; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; GARWOOD NC, 1979, SCIENCE, V205, P997, DOI 10.1126/science.205.4410.997; Guariguata MR, 1997, PLANT ECOL, V132, P107, DOI 10.1023/A:1009726421352; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell S.P, 1999, SCIENCE, V285, P1459, DOI DOI 10.1126/science.285.5433.1459a; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; MILLER TE, 1982, AM NAT, V120, P533, DOI 10.1086/284009; TRENBERTH KE, 1998, CURRENT, V15, P12; VANDERMEER J, 1995, J TROP ECOL, V11, P465, DOI 10.1017/S0266467400008956; Whitmore T. C., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P549; YIH K, 1991, BIOTROPICA, V23, P106, DOI 10.2307/2388295	20	103	107	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					788	791		10.1126/science.290.5492.788	http://dx.doi.org/10.1126/science.290.5492.788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052939				2022-12-01	WOS:000090067600044
J	Vane, JR; Warner, TD				Vane, JR; Warner, TD			Nomenclature for COX-2 inhibitors	LANCET			English	Editorial Material									Univ London St Bartholomews Hosp Med Coll, Coll Med, William Harvey Res Inst, London EC1M 6BQ, England	University of London; Queen Mary University London	Vane, JR (corresponding author), Univ London St Bartholomews Hosp Med Coll, Coll Med, William Harvey Res Inst, London EC1M 6BQ, England.		Warner, Timothy D/A-1980-2009	Warner, Timothy D/0000-0003-3988-4408				BOMBADIER C, 2000, EULAR M NIC JUN 22; Dequeker J, 1998, BRIT J RHEUMATOL, V37, P946; Hawkey C, 1998, BRIT J RHEUMATOL, V37, P937; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Schoenfeld Philip, 1999, American Journal of Medicine, V107, p48S; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563	8	38	39	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1373	1374		10.1016/S0140-6736(00)02837-3	http://dx.doi.org/10.1016/S0140-6736(00)02837-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052577				2022-12-01	WOS:000089976100007
J	Steen, VD; Medsger, TA				Steen, VD; Medsger, TA			Long-term outcomes of scleroderma renal crisis	ANNALS OF INTERNAL MEDICINE			English	Article							SYSTEMIC-SCLEROSIS	Background: Although scleroderma renal crisis, a complication of systemic sclerosis, can be treated with angiotensin-converting enzyme (ACE) inhibitors, its long-term outcomes are not known. Objective: To determine outcomes, natural history, and risk factors in patients with systemic sclerosis and scleroderma renal crisis. Design: Prospective observational cohort study. Setting: University program specializing in scleroderma. Patients: 145 patients with scleroderma renal crisis who received ACE inhibitors and 662 patients with scleroderma who did not have renal crisis. Measurements: Among patients with renal crisis, the four outcomes studied were no dialysis, temporary dialysis, permanent dialysis, and early death. Demographic, clinical, and laboratory data were compared to identify risk factors for specific outcomes. Follow-up was 5 to 10 years. Results: 61% of patients with renal crisis had good outcomes (55 received no dialysis, and 34 received temporary dialysis); only 4 of these (4%) progressed to chronic renal failure and permanent dialysis. More than half of the patients who Initially required dialysis could discontinue it 3 to 18 months later. Survival of patients in the good outcome group was similar to that of patients with diffuse scleroderma who did not have renal crisis. Some patients (39%) had bad outcomes (permanent dialysis or early death). Conclusions: Renal crisis can be effectively managed when hypertension is aggressively controlled with ACE inhibitors. Patients should continue taking ACE inhibitors even after beginning dialysis in hopes of discontinuing dialysis.	Georgetown Univ, Washington, DC 20007 USA; Univ Pittsburgh, Pittsburgh, PA USA	Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Steen, VD (corresponding author), Georgetown Univ, 3800 Reservoir Rd NW,LL Gorman, Washington, DC 20007 USA.	steenv@gunet.georgetown.edu						Bunn CC, 1998, BRIT J RHEUMATOL, V37, P15; DONOHOE JF, 1992, KIDNEY INT, V41, P462, DOI 10.1038/ki.1992.65; LEROY EC, 1988, J RHEUMATOL, V15, P202; OKANO Y, 1993, ANN INTERN MED, V119, P1005, DOI 10.7326/0003-4819-119-10-199311150-00007; Rocco MV, 1996, AM J KIDNEY DIS, V28, P250, DOI 10.1016/S0272-6386(96)90308-X; STEEN VD, 1993, ARTHRITIS RHEUM, V36, pS131; Steen VD, 1999, OBSTET GYNECOL, V94, P15, DOI 10.1016/S0029-7844(99)00233-1; Steen VD, 1997, ARTHRITIS RHEUM, V40, P1146, DOI 10.1002/art.1780400620; Steen VD, 1996, RHEUM DIS CLIN N AM, V22, P861, DOI 10.1016/S0889-857X(05)70305-7; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; STEEN VD, 1990, ANN INTERN MED, V113, P352, DOI 10.7326/0003-4819-113-5-352; STEEN VD, 1984, AM J MED, V76, P779, DOI 10.1016/0002-9343(84)90986-0; WEBER J, 1993, PERITON DIALYSIS INT, V13, P224	13	208	223	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					600	603		10.7326/0003-4819-133-8-200010170-00010	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033587				2022-12-01	WOS:000089906300004
J	Spratt, BG; Greenwood, BM				Spratt, BG; Greenwood, BM			Prevention of pneumococcal disease by vaccination: does serotype replacement matter?	LANCET			English	Editorial Material							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CONJUGATE VACCINES; INVASIVE DISEASE; CLONES		Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Spratt, BG (corresponding author), Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England.		Spratt, Brian G/A-1676-2009					Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; BLACK S, 2000, 2 INT S PNEUM PNEUM; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; Crook DWM, 1998, BRIT MED BULL, V54, P595; Dagan R, 1996, J INFECT DIS, V174, P1271, DOI 10.1093/infdis/174.6.1271; DAGAN R, 2000, 2 INT S PNEUM PNEUM; DOUGLAS RM, 1986, AM J DIS CHILD, V140, P1183, DOI 10.1001/archpedi.1986.02140250109044; Enright MC, 1999, J CLIN MICROBIOL, V37, P3210, DOI 10.1128/JCM.37.10.3210-3216.1999; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Eskola J, 1999, PEDIATR INFECT DIS J, V18, P543, DOI 10.1097/00006454-199906000-00015; KIPLI T, 2000, 2 INT S PNEUM PNEUM; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Maiden MCJ, 1999, LANCET, V354, P615, DOI 10.1016/S0140-6736(99)00252-4; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Obaro SK, 2000, PEDIATR INFECT DIS J, V19, P463, DOI 10.1097/00006454-200005000-00014; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973	17	132	138	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2000	356	9237					1210	1211		10.1016/S0140-6736(00)02779-3	http://dx.doi.org/10.1016/S0140-6736(00)02779-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	361LQ	11072934				2022-12-01	WOS:000089724900005
J	Denver, DR; Morris, K; Lynch, M; Vassilieva, LL; Thomas, WK				Denver, DR; Morris, K; Lynch, M; Vassilieva, LL; Thomas, WK			High direct estimate of the mutation rate in the mitochondrial genome of Caenorhabditis elegans	SCIENCE			English	Article							HOT-SPOTS; DNA; INSTABILITY; SEQUENCES; EVOLUTION; BIAS	Mutations in the mitochondrial genome have been implicated in numerous human genetic disorders and offer important data for phylogenetic, forensic. and population genetic studies. Using a long-term series of Caenorhabditis elegans mutation accumulation lines, we performed a wide-scale screen for mutations in the mitochondrial genome that revealed a mutation rate that is two orders of magnitude higher than previous indirect estimates, a highly biased mutational spectrum, multiple mutations affecting coding function, as welt as mutational hotspots at homopolymeric nucleotide stretches.	Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; Univ Oregon, Dept Biol, Eugene, OR 97403 USA	University of Missouri System; University of Missouri Kansas City; University of Oregon	Thomas, WK (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA.				NIGMS NIH HHS [R01-GM36827] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036827] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASAKAWA S, 1991, J MOL EVOL, V32, P511, DOI 10.1007/BF02102653; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; CABOT E, 1997, EYEBALL SEQUENCE EDI; Drake JW, 1998, GENETICS, V148, P1667; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Habano W, 1998, ONCOGENE, V17, P1931, DOI 10.1038/sj.onc.1202112; Hodgkin J, 1997, GENETICS, V146, P149; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 1996, AM J HUM GENET, V59, P501; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; OKIMOTO R, 1992, GENETICS, V130, P471; Paabo S, 1996, AM J HUM GENET, V59, P493; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; PREPARATA G, 1987, J MOL EVOL, V26, P7, DOI 10.1007/BF02111277; THOMAS WK, 1991, GENETICS, V128, P269; Vassilieva LL, 1999, GENETICS, V151, P119; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WALLACE DC, 1999, NEUROMUSCULAR DISORD, V9, P9; Xia XH, 1996, J MOL EVOL, V43, P32, DOI 10.1007/BF02352297; Yokobori S, 1999, GENETICS, V153, P1851	24	228	229	6	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2342	2344		10.1126/science.289.5488.2342	http://dx.doi.org/10.1126/science.289.5488.2342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009418				2022-12-01	WOS:000089593500050
J	Nakagaki, T; Yamada, H; Toth, A				Nakagaki, T; Yamada, H; Toth, A			Maze-solving by an amoeboid organism	NATURE			English	Article							PHYSARUM PLASMODIUM; PATTERN-FORMATION; POLYCEPHALUM; WAVES		RIKEN, Biomimet Control Res Ctr, Nagoya, Aichi 4630003, Japan; RIKEN, Local Spatiotemporal Funct Lab, Wako, Saitama 3510198, Japan; Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan; Univ Szeged, Dept Phys Chem, H-6701 Szeged, Hungary	RIKEN; RIKEN; Hokkaido University; Szeged University	Nakagaki, T (corresponding author), RIKEN, Biomimet Control Res Ctr, Nagoya, Aichi 4630003, Japan.		Toth, Agota/I-4466-2015; Nakagaki, Toshiyuki/L-3049-2013	Toth, Agota/0000-0001-8254-6354; Nakagaki, Toshiyuki/0000-0002-3446-4888				DURHAM ACH, 1976, J CELL BIOL, V69, P218, DOI 10.1083/jcb.69.1.218; EPULCHRE JA, 1991, P INT C ART NEUR NET, P1265; Kuramoto, 1984, SPRINGER SERIES SYNE; MATSUMOTO K, 1986, J THEOR BIOL, V122, P339, DOI 10.1016/S0022-5193(86)80125-4; MIYAKE Y, 1994, CELL STRUCT FUNCT, V19, P363, DOI 10.1247/csf.19.363; Nakagaki T, 1999, J THEOR BIOL, V197, P497, DOI 10.1006/jtbi.1998.0890; Nakagaki T, 2000, BIOPHYS CHEM, V84, P195, DOI 10.1016/S0301-4622(00)00108-3; SEPULCHRE JA, 1993, PHYS REV E, V48, P187, DOI 10.1103/PhysRevE.48.187; STEINBOCK O, 1995, SCIENCE, V267, P868, DOI 10.1126/science.267.5199.868; Yamada H, 1999, PHYS REV E, V59, P1009, DOI 10.1103/PhysRevE.59.1009	10	607	622	13	240	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					470	470		10.1038/35035159	http://dx.doi.org/10.1038/35035159			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028990	Bronze			2022-12-01	WOS:000089727400038
J	Yu, G; Nishimura, M; Arawaka, S; Levitan, D; Zhang, LL; Tandon, A; Song, YQ; Rogaeva, E; Chen, FS; Kawaral, T; Supala, A; Levesque, L; Yu, H; Yang, DS; Holmes, E; Millman, P; Liang, Y; Zhang, DM; Xu, DH; Sato, C; Rogaev, E; Smith, M; Janus, C; Zhang, YN; Aebersold, R; Farrer, L; Sorbi, S; Bruni, A; Fraser, P; St George-Hyslop, P				Yu, G; Nishimura, M; Arawaka, S; Levitan, D; Zhang, LL; Tandon, A; Song, YQ; Rogaeva, E; Chen, FS; Kawaral, T; Supala, A; Levesque, L; Yu, H; Yang, DS; Holmes, E; Millman, P; Liang, Y; Zhang, DM; Xu, DH; Sato, C; Rogaev, E; Smith, M; Janus, C; Zhang, YN; Aebersold, R; Farrer, L; Sorbi, S; Bruni, A; Fraser, P; St George-Hyslop, P			Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and beta APP processing	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; GAMMA-SECRETASE; MISSENSE MUTATIONS; NOTCH; COMPLEX; CATENIN; COMPONENT; CLEAVAGE; RELEASE	Nicastrin, a transmembrane glycoprotein, forms high molecular weight complexes with presenilin 1 and presenilin 2. Suppression of nicastrin expression in Caenorhabditis elegans embryos induces a subset of notch/glp-1 phenotypes similar to those induced by simultaneous null mutations in both presenilin homologues of C. elegans(sel-12 and hop-1). Nicastrin also binds carboxy-terminal derivatives of beta-amyloid precursor protein (beta APP), and modulates the production of the amyloid beta-peptide (A beta) from these derivatives. Missense mutations in a conserved hydrophilic domain of nicastrin increase A beta(42) and A beta(40) peptide secretion. Deletions in this domain inhibit A beta production. Nicastrin and presenilins are therefore likely to be functional components of a multimeric complex necessary for the intramembranous proteolysis of proteins such as Notch/GLP-1 and beta APP.	Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Med Neurol, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 3H2, Canada; Schering Plough Corp, Res Inst, Dept CNS & Cardiovasc Res, Kenilworth, NJ 07033 USA; Univ Washington, Seattle, WA 98195 USA; Boston Univ, Sch Med, Genet Program, Boston, MA 02118 USA; Univ Florence, Dept Neurol, I-50134 Florence, Italy; Ctr Reg Neurogenet, USL 6, I-88046 Lamezia Terme, Italy	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Merck & Company; Schering Plough Corporation; University of Washington; University of Washington Seattle; Boston University; University of Florence	St George-Hyslop, P (corresponding author), Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Ctr Res Neurodegenerat Dis, Neurosci Bldg,6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.		Song, You-qiang/C-4401-2009; Song, You-Qiang/E-5207-2011; Farrer, Lindsay/AAS-1035-2020; Rogaev, Evgeny/AAN-7662-2020; Bruni, Amalia/K-5038-2016	Song, You-Qiang/0000-0001-9407-2256; Xu, Dazhong/0000-0001-9264-3342; Yu, Wai Haung/0000-0001-7186-6731; Bruni, Amalia/0000-0003-3471-3343; St George-Hyslop, Peter/0000-0003-0796-7209; Arawaka, Shigeki/0000-0002-1505-3012; Farrer, Lindsay/0000-0001-5533-4225				Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; CHEN F, IN PRESS J BIOL CHEM; Citron M, 1998, NEUROBIOL DIS, V5, P107, DOI 10.1006/nbdi.1998.0183; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; FELDMAN RG, 1963, NEUROLOGY, V13, P811, DOI 10.1212/WNL.13.10.811; Figeys D, 1996, NAT BIOTECHNOL, V14, P1579, DOI 10.1038/nbt1196-1579; FONCIN JF, 1985, REV NEUROL, V141, P194; Goutte C, 2000, DEVELOPMENT, V127, P2481; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Howell D.C., 2010, STAT METHODS PSYCHOL; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Levesque G, 1999, J NEUROCHEM, V72, P999, DOI 10.1046/j.1471-4159.1999.0720999.x; Li XJ, 1997, P NATL ACAD SCI USA, V94, P12204, DOI 10.1073/pnas.94.22.12204; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; PREISS JR, 1987, CELL, V51, P601; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Westlund B, 1999, P NATL ACAD SCI USA, V96, P2497, DOI 10.1073/pnas.96.5.2497; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; YU G, IN PRESS J BIOL CHEM; Zhang LL, 1999, J BIOL CHEM, V274, P8966, DOI 10.1074/jbc.274.13.8966; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054; Zubenko GS, 1998, GENOMICS, V50, P121, DOI 10.1006/geno.1998.5306	44	795	840	0	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					48	54		10.1038/35024009	http://dx.doi.org/10.1038/35024009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993067				2022-12-01	WOS:000089124000036
J	Colhoun, HM; Rubens, MB; Underwood, SR; Fuller, JH				Colhoun, HM; Rubens, MB; Underwood, SR; Fuller, JH			Cross sectional study of differences in coronary artery calcification by socioeconomic status	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UCL, Royal Free & Univ Coll Med Sch, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Royal Brompton & Harefield NHS Hosp Trust, London SW3 6NP, England	University of London; University College London; Royal Brompton & Harefield NHS Foundation Trust	Colhoun, HM (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	helen@public-health.ucl.ac.uk		Colhoun, Helen/0000-0002-8345-3288				Brunner E, 1999, J EPIDEMIOL COMMUN H, V53, P757, DOI 10.1136/jech.53.12.757; COLHOUN HM, IN PRESS J AM COLL C; Frankel S, 1999, AM J EPIDEMIOL, V150, P1081, DOI 10.1093/oxfordjournals.aje.a009932; Leeson CPM, 2000, CIRCULATION, V101, P1533, DOI 10.1161/01.CIR.101.13.1533; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175	5	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2000	321	7271					1262	1263		10.1136/bmj.321.7271.1262	http://dx.doi.org/10.1136/bmj.321.7271.1262			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	376ET	11082087	Green Published, Bronze			2022-12-01	WOS:000165445800026
J	Henney, JE				Henney, JE			New treatment for leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Henney, JE (corresponding author), US FDA, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2178	2178		10.1001/jama.284.17.2178	http://dx.doi.org/10.1001/jama.284.17.2178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056574				2022-12-01	WOS:000090052600007
J	Souslova, V; Cesare, P; Ding, YN; Akopian, AN; Stanfa, L; Suzuki, R; Carpenter, K; Dickenson, A; Boyce, S; Hill, R; Nebenius-Oosthuizen, D; Smith, AJH; Kidd, EJ; Wood, JN				Souslova, V; Cesare, P; Ding, YN; Akopian, AN; Stanfa, L; Suzuki, R; Carpenter, K; Dickenson, A; Boyce, S; Hill, R; Nebenius-Oosthuizen, D; Smith, AJH; Kidd, EJ; Wood, JN			Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X(3) receptors	NATURE			English	Article							DORSAL HORN NEURONS; SYNAPTIC TRANSMISSION; ATP; RAT; RESPONSES; NOCICEPTION; ACTIVATION	ATP activates damage-sensing neurons (nociceptors) and can evoke a sensation of pain(1). The ATP receptor P2X(3) is selectively expressed by nociceptors(2,3) and is one of seven ATP-gated, cation-selective ion channels(4-6). Here we demonstrate that ablation of the P2X(3) gene results in the loss of rapidly desensitizing ATP-gated cation currents in dorsal root ganglion neurons, and that the responses of nodose ganglion neurons to ATP show altered kinetics and pharmacology resulting from the loss of expression of P2X(2/3) heteromultimers. Null mutants have normal sensorimotor function. Behavioural responses to noxious mechanical and thermal stimuli are also normal, although formalin-induced pain behaviour is reduced. In contrast, deletion of the P2X(3) receptor causes enhanced thermal hyperalgesia in chronic inflammation. Notably, although dorsal-horn neuronal responses to mechanical and noxious heat application are normal, P2X(3)-null mice are unable to code the intensity of non-noxious 'warming' stimuli.	UCL, Dept Biol, London WC1E 6BT, England; UCL, Dept Pharmacol, London WC1E 6BT, England; Merck Sharp & Dohme Res Labs, Terlings Pk CM20 2QR, Essex, England; Univ Edinburgh, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland; Cardiff Univ, Welsh Sch Pharm, Cardiff CF1 3XF, S Glam, Wales	University of London; University College London; University of London; University College London; Merck & Company; University of Edinburgh; Cardiff University	Wood, JN (corresponding author), UCL, Dept Biol, Mortimer St, London WC1E 6BT, England.	J.Wood@ucl.ac.uk	; Kidd, Emma/N-6201-2014	Cesare, Paolo/0000-0003-1324-5974; Kidd, Emma/0000-0001-5507-1170				Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; BlandWard PA, 1997, BRIT J PHARMACOL, V122, P365, DOI 10.1038/sj.bjp.0701371; BLEEHEN T, 1977, PAIN, V3, P367, DOI 10.1016/0304-3959(77)90066-5; Cesare P, 1997, CURR OPIN NEUROBIOL, V7, P493, DOI 10.1016/S0959-4388(97)80028-1; CESARE P, 2000, P PHYSL SOC P, V523; Chapman V, 1998, PAIN, V77, P289, DOI 10.1016/S0304-3959(98)00106-7; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Grubb BD, 1999, EUR J NEUROSCI, V11, P149, DOI 10.1046/j.1460-9568.1999.00426.x; Gu JGG, 1998, NEUROSCI LETT, V253, P167, DOI 10.1016/S0304-3940(98)00632-6; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Kidd EJ, 1998, NEUROSCIENCE, V87, P533, DOI 10.1016/S0306-4522(98)00294-2; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; LI J, 1995, J NEUROSCI, V15, P3357; Li P, 1998, J NEUROPHYSIOL, V80, P3356, DOI 10.1152/jn.1998.80.6.3356; MacKenzie AB, 1999, ANN NY ACAD SCI, V868, P716, DOI 10.1111/j.1749-6632.1999.tb11351.x; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Nakamura F, 1996, P NATL ACAD SCI USA, V93, P10465, DOI 10.1073/pnas.93.19.10465; Stanfa LC, 2000, BRIT J PHARMACOL, V129, P351, DOI 10.1038/sj.bjp.0703047; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tsuda M, 1999, BRIT J PHARMACOL, V128, P1497, DOI 10.1038/sj.bjp.0702960; Ueno S, 1999, BRIT J PHARMACOL, V126, P429, DOI 10.1038/sj.bjp.0702319	21	350	373	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2000	407	6807					1015	1017		10.1038/35039526	http://dx.doi.org/10.1038/35039526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069182				2022-12-01	WOS:000090032500046
J	Tschop, M; Smiley, DL; Heiman, ML				Tschop, M; Smiley, DL; Heiman, ML			Ghrelin induces adiposity in rodents	NATURE			English	Article							HORMONE SECRETAGOGUE RECEPTOR; GROWTH-HORMONE; ARCUATE NUCLEUS; BODY-COMPOSITION; MESSENGER-RNA; RATS; PEPTIDE; EXPRESSION; METABOLISM; PITUITARY	The discovery of the peptide hormone ghrelin, an endogenous ligand for the growth hormone secretagogue (GHS) receptor(1,2), yielded the surprising result(3) that the principal site of ghrelin synthesis is the stomach and not the hypothalamus. Although ghrelin is likely to regulate pituitary growth hormone (GH) secretion(3,4) along with GH-releasing hormone and somatostatin, GHS receptors have also been identified on hypothalamic neurons(5) and in the brainstem(6). Apart from potential paracrine effects, ghrelin may thus offer an endocrine link between stomach, hypothalamus and pituitary, suggesting an involvement in regulation of energy balance. Here we show that peripheral daily administration of ghrelin caused weight gain by reducing fat utilization in mice and rats. Intracerebroventricular administration of ghrelin generated a dose-dependent increase in food intake and body weight. Rat serum ghrelin concentrations were increased by fasting and were reduced by re-feeding or oral glucose administration, but not by water ingestion. We propose that ghrelin, in addition to its role in regulating GH secretion, signals the hypothalamus when an increase in metabolic efficiency is necessary.	Lilly Res Labs, Endocrine Res & Biores Technol & Prot, Indianapolis, IN 46285 USA	Eli Lilly	Tschop, M (corresponding author), Lilly Res Labs, Endocrine Res & Biores Technol & Prot, Drop Code 0545, Indianapolis, IN 46285 USA.		Tschoep, Matthias H/I-5443-2014	Tschoep, Matthias/0000-0002-4744-371X				ATRENS DM, 1985, PHYSIOL BEHAV, V35, P15, DOI 10.1016/0031-9384(85)90165-9; Bailey ART, 1999, NEUROENDOCRINOLOGY, V70, P83, DOI 10.1159/000054462; Bailey ART, 2000, J NEUROENDOCRINOL, V12, P191; CHARLTON HM, 1988, J ENDOCRINOL, V119, P51, DOI 10.1677/joe.0.1190051; CHEN Y, IN PRESS REGUL PEPT; Elia M, 1992, World Rev Nutr Diet, V70, P68; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; FLATT JP, 1991, J NUTR BIOCHEM, V2, P193, DOI 10.1016/0955-2863(91)90016-X; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; HEIMAN ML, 1985, ENDOCRINOLOGY, V116, P410, DOI 10.1210/endo-116-1-410; Hosoda H, 2000, J BIOL CHEM, V275, P21995, DOI 10.1074/jbc.M002784200; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; HSIUNG HM, 1987, METHOD ENZYMOL, V153, P390; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kuriyama H, 2000, NEUROSCI LETT, V282, P109, DOI 10.1016/S0304-3940(00)00882-X; Luckman SM, 1999, NEUROENDOCRINOLOGY, V70, P93, DOI 10.1159/000054463; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; Okada K, 1996, ENDOCRINOLOGY, V137, P5155, DOI 10.1210/en.137.11.5155; Rose BS, 1998, J NUTR, V128, P246, DOI 10.1093/jn/128.2.246; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; SCHEURINK AJW, 1993, PHYSIOL BEHAV, V53, P879, DOI 10.1016/0031-9384(93)90264-G; Snitker S, 1998, J CLIN ENDOCR METAB, V83, P3977, DOI 10.1210/jc.83.11.3977; Vernon RG, 1996, J ENDOCRINOL, V150, P129, DOI 10.1677/joe.0.1500129; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491	24	3127	3243	1	145	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					908	913		10.1038/35038090	http://dx.doi.org/10.1038/35038090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057670				2022-12-01	WOS:000089901900053
J	Ries, S; Biederer, C; Woods, D; Shifman, O; Shirasawa, S; Sasazuki, T; McMahon, M; Oren, M; McCormick, F				Ries, S; Biederer, C; Woods, D; Shifman, O; Shirasawa, S; Sasazuki, T; McMahon, M; Oren, M; McCormick, F			Opposing effects of Ras on p53: Transcriptional activation of mdm2 and induction of p19(ARF)	CELL			English	Article							AUTOREGULATORY FEEDBACK LOOP; TUMOR-SUPPRESSOR GENE; CANCER CELL-LINES; RETINOBLASTOMA PROTEIN; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; ONCOPROTEIN MDM2; MAMMALIAN-CELLS; NIH-3T3 CELLS; WILD-TYPE	Mdm2 acts as a major regulator of the tumor suppressor p53 by targeting its destruction. Here, we show that the mdm2 gene is also regulated by the Has-driven Raf/MEK/MAP kinase pathway, in a p53-independent manner. Mdma induced by activated Raf degrades p53 in the absence of the Mdm2 inhibitor p19(ARF). This regulatory pathway accounts for the observation that cells transformed by oncogenic Ras are more resistant to p53-dependent apoptosis following exposure to DNA damage. Activation of the Ras-induced Raf/MEK/MAP kinase may therefore play a key role in suppressing p53 during tumor development and treatment. In primary cells, Raf also activates the Mdm2 inhibitor p19(ARF). Levels of p53 are therefore determined by opposing effects of Raf-induced p19(ARF) and Mdm2.	Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Kyushu Univ, Fukuoka 812, Japan	University of California System; University of California San Francisco; Weizmann Institute of Science; Kyushu University	McCormick, F (corresponding author), Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA.		McMahon, Martin/L-3303-2013	McMahon, Martin/0000-0003-2812-1042; Oren, Moshe/0000-0003-4311-7172				ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Biederer CH, 2000, J BIOL CHEM, V275, P26245, DOI 10.1074/jbc.M001430200; BOS JL, 1989, CANCER RES, V49, P4682; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cook SJ, 1999, MOL CELL BIOL, V19, P330; CORDONCARDO C, 1994, CANCER RES, V54, P794; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Esteller M, 2000, CANCER RES, V60, P129; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; FITZGERALD TJ, 1985, AM J CLIN ONCOL-CANC, V8, P517, DOI 10.1097/00000421-198512000-00012; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Haber DA, 1997, CELL, V91, P555, DOI 10.1016/S0092-8674(00)80441-9; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heimbrook DC, 1998, CURR OPIN CELL BIOL, V10, P284, DOI 10.1016/S0955-0674(98)80152-X; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; JUVEN T, 1993, ONCOGENE, V8, P3411; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lane DP, 1997, TRENDS BIOCHEM SCI, V22, P372, DOI 10.1016/S0968-0004(97)01119-5; Lebowitz PF, 1997, CANCER RES, V57, P708; LENG P, 1995, ONCOGENE, V10, P1275; Leri A, 1999, AM J PATHOL, V154, P567, DOI 10.1016/S0002-9440(10)65302-3; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; LUNA RMD, 1995, NATURE, V378, P203; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MITSUDOMI T, 1992, ONCOGENE, V7, P171; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MOSER M, 1995, DEVELOPMENT, V121, P2779; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; PIROLLO KF, 1993, RADIAT RES, V135, P234, DOI 10.2307/3578300; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; RIES SJ, 2000, IN PRESS NAT MED; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SHARMA S, 1993, CELL GROWTH DIFFER, V4, P861; Shaulian E, 1997, ONCOGENE, V15, P2717, DOI 10.1038/sj.onc.1201453; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; SKLAR MD, 1988, SCIENCE, V239, P645, DOI 10.1126/science.3277276; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	69	324	335	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 13	2000	103	2					321	330		10.1016/S0092-8674(00)00123-9	http://dx.doi.org/10.1016/S0092-8674(00)00123-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057904	Bronze			2022-12-01	WOS:000089864300015
J	Hooton, TM; Scholes, D; Stapleton, AE; Roberts, PL; Winter, C; Gupta, K; Samadpour, M; Stamm, WE				Hooton, TM; Scholes, D; Stapleton, AE; Roberts, PL; Winter, C; Gupta, K; Samadpour, M; Stamm, WE			A prospective study of asymptomatic bacteriuria in sexually active young women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: Asymptomatic bacteriuria is common in young women, but little is known about its pathogenesis, natural history, risk factors, and temporal association with symptomatic urinary tract infection. Methods: We prospectively evaluated 796 sexually active, nonpregnant women from 18 through 40 years of age over a period of six months for the occurrence of asymptomatic bacteriuria (defined as at least 10(sup 5) colony-forming units of urinary tract pathogens per milliliter). The women were patients at either a university student health center or a health maintenance organization (HMO). Periodic urine cultures were taken, daily diaries were kept, and regularly scheduled interviews were performed. Escherichia coli strains were tested for hemolysin, the papG genotype, and the ribosomal RNA type. Results: The prevalence of asymptomatic bacteriuria (the proportion of urine cultures with bacteriuria in asymptomatic women) was 5 percent (95 percent confidence interval, 4 percent to 6 percent) among women in the university group and 6 percent (95 percent confidence interval, 5 percent to 8 percent) among women in the HMO group. Persistent asymptomatic bacteriuria with the same E. coli strain was rare. Symptomatic urinary tract infection developed within one week after 8 percent of occasions on which a culture showed asymptomatic bacteriuria, as compared with 1 percent of occasions when asymptomatic bacteriuria was not found (P<0.001). Asymptomatic bacteriuria was associated with the same risk factors as for symptomatic urinary tract infection, particularly the use of a diaphragm plus spermicide and sexual intercourse. Conclusions: Asymptomatic bacteriuria in young women is common but rarely persists. It is a strong predictor of subsequent symptomatic urinary tract infection. (N Engl J Med 2000;343:992-7.) (C) 2000, Massachusetts Medical Society.	Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Environm Hlth, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Hooton, TM (corresponding author), Univ Washington, Harborview Med Ctr, 325 9th Ave,Box 359930, Seattle, WA 98104 USA.		Stapleton, Ann E/N-2428-2015	Stapleton, Ann E/0000-0003-0130-8659	NIDDK NIH HHS [DK 40045, DK 47549] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040045, R01DK047549] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))			0	170	183	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2000	343	14					992	997		10.1056/NEJM200010053431402	http://dx.doi.org/10.1056/NEJM200010053431402			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PU	11018165				2022-12-01	WOS:000089619900002
J	Jeong, H; Tombor, B; Albert, R; Oltvai, ZN; Barabasi, AL				Jeong, H; Tombor, B; Albert, R; Oltvai, ZN; Barabasi, AL			The large-scale organization of metabolic networks	NATURE			English	Article							SMALL-WORLD NETWORKS	In a cell or microorganism, the processes that generate mass, energy, information transfer and cell-fate specification are seamlessly integrated through a complex network of cellular constituents and reactions(1). However, despite the key role of these networks in sustaining cellular functions, their large-scale structure is essentially unknown. Here we present a systematic comparative mathematical analysis of the metabolic networks of 43 organisms representing all three domains of life. We show that, despite significant variation in their individual constituents and pathways, these metabolic networks have the same topological scaling properties and show striking similarities to the inherent organization of complex non-biological systems(2). This may indicate that metabolic organization is not only identical for all living organisms, but also complies with the design principles of robust and error-tolerant scale-free networks(2-5), and may represent a common blueprint for the large-scale organization of interactions among all cellular constituents.	Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA	University of Notre Dame; Northwestern University	Oltvai, ZN (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	zno008@northwestern.edu; alb@nd.edu	Jeong, Hawoong/A-2469-2009; Jeong, Hawoong/AAR-2524-2021; Barabasi, Albert-Laszlo/S-6474-2017; Albert, Reka/E-2195-2011; Jeong, Hawoong/C-1587-2011	Jeong, Hawoong/0000-0002-2491-8620; Jeong, Hawoong/0000-0002-2491-8620; Albert, Reka/0000-0002-9485-0828; Barabasi, Albert/0000-0002-4028-3522				Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; AMARAL LAN, 2000, CLASSES BEHAV SMALL; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barthelemy M, 1999, PHYS REV LETT, V82, P3180, DOI 10.1103/PhysRevLett.82.3180; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bollobas B., 1985, RANDOM GRAPHS; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; DOROGOVTSEV SN, 2000, EVOLUTION REFERENCE; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; ERDOS P, 1960, B INT STATIST INST, V38, P343; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; INGBER DE, 1993, J CELL SCI, V104, P613; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp PP, 1999, TRENDS BIOTECHNOL, V17, P275, DOI 10.1016/S0167-7799(99)01316-5; KISCHNER M, 2000, CELL, V100, P79; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	28	3381	3552	9	456	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 5	2000	407	6804					651	654		10.1038/35036627	http://dx.doi.org/10.1038/35036627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034217	Green Submitted			2022-12-01	WOS:000089772800053
J	Maghnie, M; Cosi, G; Genovese, E; Manca-Bitti, ML; Cohen, A; Zecca, S; Tinelli, C; Gallucci, M; Bernasconi, S; Boscherini, B; Severi, F; Arico, M				Maghnie, M; Cosi, G; Genovese, E; Manca-Bitti, ML; Cohen, A; Zecca, S; Tinelli, C; Gallucci, M; Bernasconi, S; Boscherini, B; Severi, F; Arico, M			Central diabetes insipidus in children and young adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LANGERHANS CELL HISTIOCYTOSIS; POSTERIOR PITUITARY-GLAND; MR; HYPOPITUITARISM; HYPOPHYSITIS; SIGNAL	Background: Central diabetes insipidus is rare in children and young adults, and up to 50 percent of cases are idiopathic. The clinical presentation and the long-term course of this disorder are largely undefined. Methods: We studied all 79 patients with central diabetes insipidus who were seen at four pediatric endocrinology units between 1970 and 1996. There were 37 male and 42 female patients whose median age at diagnosis was 7.0 years (range, 0.1 to 24.8). All patients underwent magnetic resonance imaging (MRI) and periodic studies of anterior pituitary function. The median duration of follow-up was 7.6 years (range, 1.6 to 26.2). Results: The causes of the central diabetes insipidus were Langerhans'-cell histiocytosis in 12 patients, an intracranial tumor in 18 patients, a skull fracture in 2 patients, and autoimmune polyendocrinopathy in 1 patient; 5 patients had familial disease. The cause was considered to be idiopathic in 41 patients (52 percent). In 74 patients (94 percent) the posterior pituitary was not hyperintense on the first MRI scan obtained, and 29 patients (37 percent) had thickening of the pituitary stalk. Eighteen patients had changes in the thickness of the pituitary stalk over time, ranging from normalization (six patients) or a decrease in thickness (one patient) to further thickening (seven patients) or thickening of a previously normal stalk (four patients). Anterior pituitary hormone deficiencies, primarily growth hormone deficiency, were documented in 48 patients (61 percent) a median of 0.6 year (range, 0.1 to 18.0) after the onset of central diabetes insipidus. Conclusions: Most children and young adults with acquired central diabetes insipidus have abnormal findings on MRI scans of the head, which may change over time, and at least half have anterior pituitary hormone deficiencies during follow-up. (N Engl J Med 2000;343:998-1007.) (C) 2000, Massachusetts Medical Society.	Univ Pavia, IRCCS Policlin S Matteo, Dept Pediat, I-27100 Pavia, Italy; Univ Pavia, Dept Radiol, I-27100 Pavia, Italy; Univ Pavia, Dept Biometry Sci Direct, I-27100 Pavia, Italy; Univ Roma Tor Vergata, Dept Pediat, Rome, Italy; Ist Giannina Gaslini, Ist Ricovero & Cura Carattere Sci, Genoa, Italy; Univ Aquila, Dept Radiol, I-67100 Laquila, Italy; Univ Modena, Dept Pediat, I-41100 Modena, Italy	IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; University of Pavia; University of Rome Tor Vergata; University of Genoa; IRCCS Istituto Giannina Gaslini; University of L'Aquila; Universita di Modena e Reggio Emilia	Maghnie, M (corresponding author), Univ Pavia, IRCCS Policlin S Matteo, Dept Pediat, I-27100 Pavia, Italy.		Arico, Maurizio/S-3039-2019; Bernasconi, Sergio/AAA-9419-2021	Arico, Maurizio/0000-0002-1908-6671; Tinelli, Carmine/0000-0002-8749-1978				AHMED SR, 1993, J CLIN ENDOCR METAB, V76, P1499, DOI 10.1210/jc.76.6.1499; BROOKS BS, 1989, AM J ROENTGENOL, V153, P1033, DOI 10.2214/ajr.153.5.1033; CZERNICHOW P, 1985, J PEDIATR-US, V106, P41, DOI 10.1016/S0022-3476(85)80461-3; FRASIER SD, 1967, AM J DIS CHILD, V114, P157, DOI 10.1001/archpedi.1967.02090230087009; FUJISAWA I, 1991, CANCER, V68, P1009, DOI 10.1002/1097-0142(19910901)68:5<1009::AID-CNCR2820680517>3.0.CO;2-R; Gagliardi PC, 1997, J CLIN ENDOCR METAB, V82, P3643, DOI 10.1210/jc.82.11.3643; LEGER J, 1999, J CLIN ENDOCR METAB, V84, P1974; Maghnie M, 1997, AM J NEURORADIOL, V18, P1749; MAGHNIE M, 1994, RADIOLOGY, V193, P493, DOI 10.1148/radiology.193.2.7972767; MAGHNIE M, 1993, AM J NEURORADIOL, V14, P1443; Maghnie M, 1998, J CLIN ENDOCR METAB, V83, P3089, DOI 10.1210/jc.83.9.3089; MENA W, 1993, J PEDIATR-US, V122, P911, DOI 10.1016/S0022-3476(09)90017-8; SKLAR CA, 1981, J CLIN ENDOCR METAB, V52, P9, DOI 10.1210/jcem-52-1-9; THODOU E, 1995, J CLIN ENDOCR METAB, V80, P2302, DOI 10.1210/jc.80.8.2302	14	267	279	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2000	343	14					998	1007		10.1056/NEJM200010053431403	http://dx.doi.org/10.1056/NEJM200010053431403			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PU	11018166				2022-12-01	WOS:000089619900003
J	Bruning, JC; Gautam, D; Burks, DJ; Gillette, J; Schubert, M; Orban, PC; Klein, R; Krone, W; Muller-Wieland, D; Kahn, CR				Bruning, JC; Gautam, D; Burks, DJ; Gillette, J; Schubert, M; Orban, PC; Klein, R; Krone, W; Muller-Wieland, D; Kahn, CR			Role of brain insulin receptor in control of body weight and reproduction	SCIENCE			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; FOOD-INTAKE; GENE; RAT; RESISTANCE; KNOCKOUT; NEURONS; NIDDM	Insulin receptors (IRs) and insulin signaling proteins are widely distributed throughout the central nervous system (CNS). To study the physiological role of insulin signaling in the brain, we created mice with a neuron-specific disruption of the IR gene (NIRKO mice), Inactivation of the IR had no impact on brain development or neuronal survival. However, female NIRKO mice showed increased food intake, and both male and female mice developed diet-sensitive obesity with increases in body fat and plasma leptin levels, mild insulin resistance, elevated plasma insulin Levels, and hypertriglyceridemia. NIRKO mice also exhibited impaired spermatogenesis and ovarian follicle maturation because of hypothalamic dysregulation of luteinizing hormone. Thus, IR signaling in the CNS plays an important role in regulation of energy disposal, fuel metabolism, and reproduction.	Univ Cologne, Klin & Poliklin Innere Med 2, D-50931 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany	University of Cologne; University of Cologne; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; European Molecular Biology Laboratory (EMBL)	Bruning, JC (corresponding author), Univ Cologne, Klin & Poliklin Innere Med 2, Stelzmann Str 9, D-50931 Cologne, Germany.		Klein, Ruediger/C-6147-2008; Schubert, Markus/F-5150-2010; Kahn, Ronald/AAY-2435-2021	Klein, Ruediger/0000-0002-3109-0163; Kahn, Ronald/0000-0002-7583-9228	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, R37DK031036, R01DK055326] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK55326-01A2, DK31036] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; BURKS DJ, UNPUB; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; FIGLEWICZ DP, 1995, BEHAV NEUROSCI, V109, P567, DOI 10.1037/0735-7044.109.3.567; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; GAUTAM D, UNPUB; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; NAKAMURA F, 1989, ENDOCRINOL JAPON, V36, P349; OLSON BR, 1995, NEUROENDOCRINOLOGY, V62, P155, DOI 10.1159/000127000; Porte D, 1998, DIABETOLOGIA, V41, P863, DOI 10.1007/s001250051002; ROBINSON LJ, 1994, ENDOCRINOLOGY, V135, P2568, DOI 10.1210/en.135.6.2568; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Svenningsen AF, 1996, GLIA, V18, P68, DOI 10.1002/(SICI)1098-1136(199609)18:1<68::AID-GLIA7>3.0.CO;2-#; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vento R, 1997, MOL CELL BIOCHEM, V170, P163, DOI 10.1023/A:1006813705101; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; WERTHER GA, 1987, ENDOCRINOLOGY, V121, P1562, DOI 10.1210/endo-121-4-1562; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Yura S, 2000, J CLIN INVEST, V105, P749, DOI 10.1172/JCI8353	28	1579	1637	2	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2122	2125		10.1126/science.289.5487.2122	http://dx.doi.org/10.1126/science.289.5487.2122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000114				2022-12-01	WOS:000089430900044
J	Changnon, SA; Easterling, DR				Changnon, SA; Easterling, DR			Disaster management - US policies pertaining to weather and climate extremes	SCIENCE			English	Article							UNITED-STATES; IMPACTS		NOAA, Natl Climat Data Ctr, Asheville, NC 28801 USA; Univ Illinois, Dept Geog, Champaign, IL 61820 USA	National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Illinois System; University of Illinois Urbana-Champaign	Easterling, DR (corresponding author), NOAA, Natl Climat Data Ctr, Asheville, NC 28801 USA.	deasterl@ncdc.noaa.gov						BURBY RJ, 1998, CONFRONTING NATURAL; CHANGNON S, 1999, NAT HAZARDS, V8, P290; CHANGNON S, 2000, FLOODS; CHANGNON S, 1980, 94 ILL STAT WAT; Changnon SA, 1999, CLIMATIC CHANGE, V42, P51, DOI 10.1023/A:1005408131413; Changnon SA, 1998, WATER INT, V23, P263, DOI 10.1080/02508069808686781; Changnon SA, 1999, B AM METEOROL SOC, V80, P1819, DOI 10.1175/1520-0477(1999)080<1819:IOENOG>2.0.CO;2; Changnon SA., 2000, PREDICTION SCI DECIS; HOOKE W, 2000, NAT HAZARDS REV, P1; Hooke W.H., 2000, NAT HAZARDS REV, V1, P2, DOI 10.1061/(ASCE)1527-6988(2000)1:1(2); Kunkel KE, 1999, B AM METEOROL SOC, V80, P1077, DOI 10.1175/1520-0477(1999)080<1077:TFIWAC>2.0.CO;2; KUNREUTHER H, 1999, PAYING PRICE, P1; LAMBRIGHT WH, 1989, SCI TECHNOL HUM VAL, V14, P340, DOI 10.1177/016224398901400402; PIELKE RA, 1995, HURRICANE ANDREW S F; Riebsame W.E., 1991, DROUGHT NATURAL RESO; ROTH RJ, 1996, IMPACTS RESPONSES WE, P101; RYLAND H, 1998, STEPPING SAFER FUTUR; Ryland H. G., 2000, NAT HAZARDS REV, V1, P43; SYLVES R, 1998, DISASTERS COASTAL ZO; White G, 1958, 57 U CHIC DEP GEOGR; Wright J. M., 1996, GREAT FLOOD 1993 CAU, P245	21	17	18	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2053	2055		10.1126/science.289.5487.2053	http://dx.doi.org/10.1126/science.289.5487.2053			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11032554				2022-12-01	WOS:000089430900024
J	Bishop, AC; Ubersax, JA; Petsch, DT; Matheos, DP; Gray, NS; Blethrow, J; Shimizu, E; Tsien, JZ; Schultz, PG; Rose, MD; Wood, JL; Morgan, DO; Shokat, KM				Bishop, AC; Ubersax, JA; Petsch, DT; Matheos, DP; Gray, NS; Blethrow, J; Shimizu, E; Tsien, JZ; Schultz, PG; Rose, MD; Wood, JL; Morgan, DO; Shokat, KM			A chemical switch for inhibitor-sensitive alleles of any protein kinase	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; TYROSINE KINASE; BUDDING YEAST; CRYSTAL-STRUCTURE; COMPLEX; MITOSIS; GENES; CDC28; CDK2	Protein kinases have proved to be largely resistant to the design of highly specific inhibitors, even with the aid of combinatorial chemistry(1). The lack of these reagents has complicated efforts to assign specific signalling roles to individual kinases. Here we describe a chemical genetic strategy for sensitizing protein kinases to cell-permeable molecules that do not inhibit wildtype kinases(2). From two inhibitor scaffolds, we have identified potent and selective inhibitors for sensitized kinases from five distinct subfamilies. Tyrosine and serine/threonine kinases are equally amenable to this approach. We have analysed a budding yeast strain carrying an inhibitor-sensitive form of the cyclin-dependent kinase Cdc28 (CDK1) in place of the wild-type protein. Specific inhibition of Cdc28 in vivo caused a pre-mitotic cell-cycle arrest that is distinct from the G1 arrest typically observed in temperature-sensitive cdc28 mutants(3). The mutation that confers inhibitor-sensitivity is easily identifiable from primary sequence alignments. Thus, this approach can be used to systematically generate conditional alleles of protein kinases, allowing for rapid functional characterization of members of this important gene family.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; Princeton University; Novartis; Princeton University	Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Shimizu, Eiji/K-4637-2017	Shimizu, Eiji/0000-0002-6741-9338; Morgan, David/0000-0001-8753-4416; Rose, Mark/0000-0003-1112-4765	NIGMS NIH HHS [R01 GM037739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037739] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; DOI S, 1977, ARCH MICROBIOL, V114, P287, DOI 10.1007/BF00446875; ESPINOZA FH, 1994, SCIENCE, V266, P1388, DOI 10.1126/science.7973730; Farrell A, 2000, MOL CELL BIOL, V20, P749, DOI 10.1128/MCB.20.3.749-754.2000; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; FUJIMURA HA, 1994, J CELL SCI, V107, P2617; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; KELLY PT, 1991, MOL NEUROBIOL, V5, P153, DOI 10.1007/BF02935544; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Laneuville P, 1995, Semin Immunol, V7, P255, DOI 10.1006/smim.1995.0030; Lawrie AM, 1997, NAT STRUCT BIOL, V4, P796, DOI 10.1038/nsb1097-796; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; REED SI, 1980, GENETICS, V95, P561; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sherman R., 1974, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stern B, 1996, TRENDS GENET, V12, P345; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wood JL, 1997, J AM CHEM SOC, V119, P9641, DOI 10.1021/ja9713035	30	831	847	2	99	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					395	401		10.1038/35030148	http://dx.doi.org/10.1038/35030148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014197				2022-12-01	WOS:000089390700051
J	Hanakahi, LA; Bartlet-Jones, M; Chappell, C; Pappin, D; West, SC				Hanakahi, LA; Bartlet-Jones, M; Chappell, C; Pappin, D; West, SC			Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair	CELL			English	Article							DEPENDENT PROTEIN-KINASE; V(D)J RECOMBINATION; LIGASE-IV; MYOINOSITOL HEXAPHOSPHATE; XRCC4 PROTEIN; GENE-PRODUCT; P-31 NMR; HEXAKISPHOSPHATE; INHIBITION; INTERACTS	In mammalian cells, double-strand breaks in DNA can be repaired by nonhomologous end-joining (NHEJ), a process dependent upon Ku70/80, DNA-PKcs, XRCC4, and DNA ligase IV. Starting with HeLa cell-free extracts, which promote NHEJ in a reaction dependent upon all of these proteins, we have purified a novel factor that stimulates DNA end-joining in vitro. Using a combination of phosphorus NMR, mass spectroscopy, and strong anion exchange chromatography, we identify this factor as inositol hexakisphosphate (IP6). Purified IP6 is bound by DNA-PK and specifically stimulates DNA-PK-dependent end-joining in vitro. The involvement of inositol phosphate in DNA-PK-dependent NHEJ is of particular interest since the catalytic domain of DNA-PKcs is similar to that found in the phosphatidylinositol 3 (PI 3)-kinase family.	Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Imperial Canc Res Fund, London WC2A 3PX, England	Cancer Research UK	West, SC (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	s.west@icrf.icnet.uk		Elstob, Claire/0000-0003-4252-493X; West, Stephen/0000-0001-8848-9418; Pappin, Darryl/0000-0002-8981-8401				Barrientos LG, 1996, CARBOHYD RES, V296, P39, DOI 10.1016/S0008-6215(96)00250-9; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; COSTELLO AJR, 1976, CARBOHYD RES, V46, P159, DOI 10.1016/S0008-6215(00)84287-1; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; DVIR A, 1993, J BIOL CHEM, V268, P10440; EMSLEY J, 1981, PHOSPHORUS SULFUR, V10, P401, DOI 10.1080/03086648108077394; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HAWKINS PT, 1993, BIOCHEM J, V294, P929, DOI 10.1042/bj2940929; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Larsson O, 1997, SCIENCE, V278, P471, DOI 10.1126/science.278.5337.471; Leber R, 1998, J BIOL CHEM, V273, P1794, DOI 10.1074/jbc.273.3.1794; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Modesti M, 1999, EMBO J, V18, P2008, DOI 10.1093/emboj/18.7.2008; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Rigden DJ, 1999, J MOL BIOL, V289, P691, DOI 10.1006/jmbi.1999.2848; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2000, FEBS LETT, V468, P28, DOI 10.1016/S0014-5793(00)01194-7; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; SZWERGOLD BS, 1987, BIOCHEM BIOPH RES CO, V149, P874, DOI 10.1016/0006-291X(87)90489-X; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; THEIBERT AB, 1992, J BIOL CHEM, V267, P9071; Weaver DT, 1996, CRIT REV EUKAR GENE, V6, P345, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.20; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	36	197	207	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					721	729		10.1016/S0092-8674(00)00061-1	http://dx.doi.org/10.1016/S0092-8674(00)00061-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030616	Bronze			2022-12-01	WOS:000089395200004
J	Muramatsu, M; Kinoshita, K; Fagarasan, S; Yamada, S; Shinkai, Y; Honjo, T				Muramatsu, M; Kinoshita, K; Fagarasan, S; Yamada, S; Shinkai, Y; Honjo, T			Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme	CELL			English	Article							HEAVY-CHAIN LOCUS; X-LINKED IMMUNODEFICIENCY; HYPER-IGM SYNDROME; SOMATIC HYPERMUTATION; CD40 LIGAND; IMMUNOGLOBULIN GENES; CIRCULAR DNA; B-CELLS; SACCHAROMYCES-CEREVISIAE; REGION RECOMBINATION	Induced overexpression of AID in CH12F3-2 B lymphoma cells augmented class switching from IgM to IgA without cytokine stimulation. AID deficiency caused a complete defect in class switching and showed a hyper-IgM phenotype with enlarged germinal centers containing strongly activated B cells before or after immunization. AID(-/-) spleen cells stimulated in vitro with LPS and cytokines failed to undergo class switch recombination although they expressed germline transcripts. Immunization of AID(-/-) chimera with 4-hydroxy-3-nitrophenylacetyl (NP) chicken gamma-globulin induced neither accumulation of mutations in the NP-specific variable region gene nor class switching. These results suggest that AID may be involved in regulation or catalysis of the DNA modification step of both class switching and somatic hypermutation.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; Kyoto Univ, Inst Virus Res, Dept Cell Biol, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Fagarasan, Sidonia/A-5258-2016; Shinkai, Yoichi/N-3909-2014; Muramatsu, Masamichi/C-4339-2015; Honjo, Tasuku/N-4470-2016	Fagarasan, Sidonia/0000-0003-2086-6402; Shinkai, Yoichi/0000-0002-6051-2484; Muramatsu, Masamichi/0000-0002-0153-3533; 				ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Ballantyne J, 1998, J IMMUNOL, V161, P1336; BURSTEIN HJ, 1991, J IMMUNOL, V147, P2950; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369; Holbeck SL, 1997, GENETICS, V147, P1017; Horijo T, 1995, IMMUNOGLOBULIN GENES, P235; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; KELLY BS, 1979, IMMUNOLOGY, V37, P45; Kinoshita K, 1999, COLD SPRING HARB SYM, V64, P217, DOI 10.1101/sqb.1999.64.217; Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2; Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9; LI SC, 1994, INT IMMUNOL, V6, P491, DOI 10.1093/intimm/6.4.491; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; MANTOVANI L, 1993, J IMMUNOL, V151, P473; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; MUTO T, 2000, IN PRESS GENOMICS; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Ni TT, 1999, MOL CELL, V4, P439, DOI 10.1016/S1097-2765(00)80346-9; NIKAIDO T, 1982, J BIOL CHEM, V257, P7322; Nishizawa M, 1998, ELECTROCHEM SOLID ST, V1, P10, DOI 10.1149/1.1390618; Oettinger MA, 1999, CURR OPIN CELL BIOL, V11, P325, DOI 10.1016/S0955-0674(99)80044-1; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 1999, IMMUNOL TODAY, V20, P522, DOI 10.1016/S0167-5699(99)01540-6; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; SCOTT J, 1995, CELL, V81, P833, DOI 10.1016/0092-8674(95)90002-0; Smith HC, 1996, TRENDS GENET, V12, P418, DOI 10.1016/0168-9525(96)10042-1; SOHN J, 1993, J EXP MED, V177, P493, DOI 10.1084/jem.177.2.493; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; Wabl M, 1999, CURR OPIN IMMUNOL, V11, P186, DOI 10.1016/S0952-7915(99)80031-4; Wagner SD, 1996, ANNU REV IMMUNOL, V14, P441, DOI 10.1146/annurev.immunol.14.1.441; Wilson P, 1998, IMMUNOL REV, V162, P143, DOI 10.1111/j.1600-065X.1998.tb01437.x; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x	62	2561	2618	7	315	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					553	563		10.1016/S0092-8674(00)00078-7	http://dx.doi.org/10.1016/S0092-8674(00)00078-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007474	Bronze			2022-12-01	WOS:000089105200004
J	Kaneko, A; Taleo, G; Kalkoa, M; Yamar, S; Kobayakawa, T; Bjorkman, A				Kaneko, A; Taleo, G; Kalkoa, M; Yamar, S; Kobayakawa, T; Bjorkman, A			Malaria eradication on islands	LANCET			English	Article							VANUATU ARCHIPELAGO; FALCIPARUM-MALARIA; MADAGASCAR	Background To be successful. a malaria control programme needs to be tailored to the local epidemiological characteristics. Vanuatu consists of 80 inhabited islands in the Southwest Pacific, with hypoendemic and mesoendemic malaria and suitable conditions for sustained parasite elimination. We aimed to assess whether malaria can be eliminated on isolated islands. Methods Weekly mass drug administration of chloroquine, pyrimethamine/sulfadoxine (Fansidar), and primaquine was carried out on the entire population of 718 inhabitants of Aneityum island for 9 weeks in 1991 before the onset of the rainy season. Simultaneously with the administration of drugs, permethrin-impregnated bednets were distributed to the entire population. Larvivorous fish were also introduced into several identified breeding sites of Anopheles farauti. Periodic malariometric monitoring has continued for the past 9 years. Two additional islands of Vanuatu, one with and one without malaria transmission, have been monitored for comparison. Findings High community involvement as measured by drug compliance (88.3%) and bednet provision (0.94 nets per villager) has resulted in sustained interruption of malaria transmission in Aneityum. The surveys showed complete absence of Plasmodium falciparum after mass drug administration, and P vivax disappeared from 1996 onwards, with the exception of two instances of imported infections (one mixed infection in 1993 and one P vivax infection in 1999). Interpretation Malaria can be eliminated on isolated islands with well-adapted short-term mass drug administration and sustained vector control if there is a high degree of community participation.	Tokyo Womens Med Univ, Sch Med, Dept Int Affairs & Trop Med, Shinjuku Ku, Tokyo 1628666, Japan; Dept Hlth, Malaria Sect, Port Vila, Vanuatu; Karolinska Inst, Karolinska Hosp, Infect Dis Unit, S-10401 Stockholm, Sweden	Tokyo Women's Medical University; Karolinska Institutet; Karolinska University Hospital	Kaneko, A (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Int Affairs & Trop Med, Shinjuku Ku, Tokyo 1628666, Japan.	akirak@research.twmu.ac.jp		, Akira/0000-0003-2411-3352				Arez AP, 1999, PARASITOLOGY, V118, P347, DOI 10.1017/S0031182099003972; ARNOLD J, 1954, J LAB CLIN MED, V44, P429; BELKIN JN, 1945, J PARASITOL, V31, P241, DOI 10.2307/3273001; Bruce-Chwatt L. J., 1988, Malaria: principles and practice of malariology. Volume 1., P1; Buxton P, 1927, RES POLYNESIA MELANE; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; COATNEY G. ROBERT., 1950, JOUR NATL MALARIA SOC, V9, P381; FONTENILLE D, 1990, AM J TROP MED HYG, V43, P107, DOI 10.4269/ajtmh.1990.43.107; GANCZAKOWSKI M, 1995, AM J HUM GENET, V56, P294; GARFIELD RM, 1983, LANCET, V2, P500; HII JLK, 1987, MED VET ENTOMOL, V1, P397, DOI 10.1111/j.1365-2915.1987.tb00370.x; Ishikawa H., 1996, Japanese Journal of Tropical Medicine and Hygiene, V24, P11; Kaneko A, 1998, ACTA TROP, V70, P285, DOI 10.1016/S0001-706X(98)00035-7; Laveran A, 1902, CR SOC BIOL, V54, P908; LEPERS JP, 1988, LANCET, V1, P586; Loureiro LF, 1996, ANN TROP MED PARASIT, V90, P223, DOI 10.1080/00034983.1996.11813048; MACDONALD G, 1968, B WORLD HEALTH ORGAN, V38, P743; MILLS A R, 1954, J Trop Med Hyg, V57, P99; Molineaux L., 1980, GARKI PROJECT RES EP; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; ONORI E, 1972, B WORLD HEALTH ORGAN, V47, P718; Peters W, 1987, CHEMOTHERAPY DRUG RE; REEVE PA, 1994, PAPUA NEW GUINEA MED, V37, P181; Rishikesh N., 1988, P1227; WERNSDORFER W, 1992, SE ASIAN J TROP M S4, V23, pS123; WHO, 1963, TERM MAL MAL ER	26	170	172	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2000	356	9241					1560	1564		10.1016/S0140-6736(00)03127-5	http://dx.doi.org/10.1016/S0140-6736(00)03127-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370QV	11075770				2022-12-01	WOS:000165134500012
J	Parrish-Novak, J; Dillon, SR; Nelson, A; Hammond, A; Sprecher, C; Gross, JA; Johnston, J; Madden, K; Xu, WF; West, J; Schrader, S; Burkhead, S; Heipel, M; Brandt, C; Kuijper, JL; Kramer, J; Conklin, D; Presnell, SR; Berry, J; Shiota, F; Bort, S; Hambly, K; Mudri, S; Clegg, C; Moore, M; Grant, FJ; Lofton-Day, C; Gilbert, T; Raymond, F; Ching, A; Yao, L; Smith, D; Webster, P; Whitmore, T; Maurer, M; Kaushansky, K; Holly, RD; Foster, D				Parrish-Novak, J; Dillon, SR; Nelson, A; Hammond, A; Sprecher, C; Gross, JA; Johnston, J; Madden, K; Xu, WF; West, J; Schrader, S; Burkhead, S; Heipel, M; Brandt, C; Kuijper, JL; Kramer, J; Conklin, D; Presnell, SR; Berry, J; Shiota, F; Bort, S; Hambly, K; Mudri, S; Clegg, C; Moore, M; Grant, FJ; Lofton-Day, C; Gilbert, T; Raymond, F; Ching, A; Yao, L; Smith, D; Webster, P; Whitmore, T; Maurer, M; Kaushansky, K; Holly, RD; Foster, D			Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function	NATURE			English	Article							NATURAL-KILLER-CELLS; MPL CYTOPLASMIC DOMAIN; C-MPL; SIGNAL; SUPERFAMILY; LIGAND; CD40; PROGENITOR; CYTOKINES; LOCATION	Cytokines are important in the regulation of haematopoiesis and immune responses, and can influence lymphocyte development. Here we have identified a class I cytokine receptor that is selectively expressed in lymphoid tissues and is capable of signal transduction. The full-length receptor was expressed in BaF3 cells, which created a functional assay for ligand detection and cloning. Conditioned media from activated human CD3(+) T cells supported proliferation of the assay cell line. We constructed a complementary DNA expression library from activated human CD3+ T cells, and identified a cytokine with a four-helix-bundle structure using functional cloning. This cytokine is most closely related to IL2 and IL15, and has been designated IL21 with the receptor designated IL21R. In vitro assays suggest that IL21 has a role in the proliferation and maturation of natural killer (NK) cell populations from bone marrow, in the proliferation of mature B-cell populations co-stimulated with anti-CD40, and in the proliferation of T cells co-stimulated with anti-CD3.	Zymogenet Inc, Dept Funct Cloning, Seattle, WA 98102 USA; Zymogenet Inc, Dept Immunol, Seattle, WA 98102 USA; Zymogenet Inc, Dept Prot Biochem, Seattle, WA 98102 USA; Zymogenet Inc, Dept Biol Informat, Seattle, WA 98102 USA; Zymogenet Inc, Dept Genet, Seattle, WA 98102 USA; Univ Washington, Sch Med, Div Hematol, Seattle, WA 98195 USA	Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; University of Washington; University of Washington Seattle	Foster, D (corresponding author), Zymogenet Inc, Dept Funct Cloning, 1201 Eastlake Ave E, Seattle, WA 98102 USA.							BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; CALLARD RE, 1993, IMMUNOL TODAY, V14, P559, DOI 10.1016/0167-5699(93)90188-Q; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; Drachman JG, 1997, P NATL ACAD SCI USA, V94, P2350, DOI 10.1073/pnas.94.6.2350; DZAKI K, 2000, P NATL ACAD SCI USA, V97, P14439; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; GONG JH, 1994, LEUKEMIA, V8, P652; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GURNEY AL, 1995, P NATL ACAD SCI USA, V92, P5292, DOI 10.1073/pnas.92.12.5292; HAGEKULL B, 1981, INFANT BEHAV DEV, V4, P97, DOI 10.1016/S0163-6383(81)80012-4; Kammer W, 1996, J BIOL CHEM, V271, P23634, DOI 10.1074/jbc.271.39.23634; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; Morris AE, 1997, ANIMAL CELL TECHNOLOGY, P529; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; ROBERTSON MJ, 1990, BLOOD, V76, P2421; SKODA RC, 1993, EMBO J, V12, P2645, DOI 10.1002/j.1460-2075.1993.tb05925.x; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; VIGON I, 1993, ONCOGENE, V8, P2607; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Whiteside TL, 1998, CURR TOP MICROBIOL, V230, P221; Williams NS, 1998, IMMUNOL REV, V165, P47, DOI 10.1111/j.1600-065X.1998.tb01229.x; WLODAWER A, 1993, PROTEIN SCI, V2, P1373, DOI 10.1002/pro.5560020902; Yu HX, 1998, BLOOD, V92, P3647, DOI 10.1182/blood.V92.10.3647.422k43_3647_3657; ZURAWSKI SM, 1993, EMBO J, V12, P5113, DOI 10.1002/j.1460-2075.1993.tb06206.x	29	933	1067	2	58	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2000	408	6808					57	63		10.1038/35040504	http://dx.doi.org/10.1038/35040504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081504				2022-12-01	WOS:000165050400048
J	Kordower, JH; Emborg, ME; Bloch, J; Ma, SY; Chu, YP; Leventhal, L; McBride, J; Chen, EY; Palfi, S; Roitberg, BZ; Brown, WD; Holden, JE; Pyzalski, R; Taylor, MD; Carvey, P; Ling, ZD; Trono, D; Hantraye, P; Deglon, N; Aebischer, P				Kordower, JH; Emborg, ME; Bloch, J; Ma, SY; Chu, YP; Leventhal, L; McBride, J; Chen, EY; Palfi, S; Roitberg, BZ; Brown, WD; Holden, JE; Pyzalski, R; Taylor, MD; Carvey, P; Ling, ZD; Trono, D; Hantraye, P; Deglon, N; Aebischer, P			Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease	SCIENCE			English	Article							NEUROTROPHIC FACTOR; GENE-TRANSFER; IN-VIVO; DOPAMINE; NEURONS; MONKEYS; DEGENERATION; BRAIN	Lentiviral delivery of glial cell Line-derived neurotrophic factor (Lenti-GDNF) was tested for its trophic effects upon degenerating nigrostriatal neurons in nonhuman primate models of Parkinson's disease (PD). We injected lenti-GDNF into the striatum and substantia nigra of nonlesioned aged rhesus monkeys or young adult rhesus monkeys treated 1 week prior with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Extensive GDNF expression with anterograde and retrograde transport was seen in all animals. In aged monkeys, Lenti-GDNF augmented dopaminergic function. In MPTP-treated monkeys, lenti-GDNF reversed functional deficits and completely prevented nigrostriatal degeneration. Additionally, Lenti-GDNF injections to intact rhesus monkeys revealed Long-term gene expression (8 months). In MPTP-treated monkeys, lenti-GDNF treatment reversed motor deficits in a hand-reach task. These data indicate that GDNF delivery using a Lentiviral vector system can prevent nigrostriatal degeneration and induce regeneration in primate models of PD and might be a viable therapeutic strategy for PD patients.	Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA; Univ Lausanne, Sch Med, Div Surg Res, Lausanne, Switzerland; Univ Lausanne, Sch Med, Gene Therapy Ctr, Lausanne, Switzerland; Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; Univ Geneva, Fac Med, Dept Genet & Microbiol, Geneva, Switzerland; Serv Hosp Frederic Joliot, CEA, Dept Rech Med, Direct Rech Med,CNRS,Unite Rech Associe 2210, Orsay, France; Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, CH-1015 Lausanne, Switzerland	Rush University; Rush University; University of Lausanne; University of Lausanne; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Geneva; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Kordower, JH (corresponding author), Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, 1653 W Congress Pkwy, Chicago, IL 60612 USA.	jkordowe@rush.edu	Deglon, Nicole/A-2265-2012; Aebischer, Patrick/E-1387-2013; Bloch, Jocelyne/A-9668-2017; Brown, William/GXN-2777-2022; McBride, Jodi/C-4494-2016	Deglon, Nicole/0000-0003-4475-9476; Bloch, Jocelyne/0000-0002-6405-1590; McBride, Jodi/0000-0002-4816-7569	NINDS NIH HHS [NS40578] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040578] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bjorklund A, 1997, NEUROBIOL DIS, V4, P186, DOI 10.1006/nbdi.1997.0151; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Connor B, 1999, GENE THER, V6, P1936, DOI 10.1038/sj.gt.3301033; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Eberling JL, 1999, BRAIN RES, V832, P184, DOI 10.1016/S0006-8993(99)01491-2; Emborg ME, 1998, J COMP NEUROL, V401, P253; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; GASH DM, 1998, ADV PHARMACOL, V42, P11; Honey C, 1999, CAN J NEUROL SCI, V26, pS45, DOI 10.1017/S0317167100000093; KASTNER A, 1993, BRAIN RES, V606, P341, DOI 10.1016/0006-8993(93)91005-D; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; KORDOWER JH, 1995, CELL TRANSPLANT, V4, P155, DOI 10.1016/0963-6897(95)90031-4; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Kordower JH, 1999, EXP NEUROL, V160, P1, DOI 10.1006/exnr.1999.7178; KOZLOWSKI DA, 2000, ASNTR ABSTR, V7, P25; Lapchak PA, 1997, EXP NEUROL, V144, P29, DOI 10.1006/exnr.1996.6384; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Rosenblad C, 2000, EXP NEUROL, V161, P503, DOI 10.1006/exnr.1999.7296; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; Tseng JL, 1997, J NEUROSCI, V17, P325, DOI 10.1523/JNEUROSCI.17-01-00325.1997; Wang GS, 1999, J CLIN INVEST, V104, pR55, DOI 10.1172/JCI8390	23	995	1061	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					767	773		10.1126/science.290.5492.767	http://dx.doi.org/10.1126/science.290.5492.767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052933				2022-12-01	WOS:000090067600038
J	Uhlmann, F; Wernic, D; Poupart, MA; Koonin, EV; Nasmyth, K				Uhlmann, F; Wernic, D; Poupart, MA; Koonin, EV; Nasmyth, K			Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast	CELL			English	Article							SISTER-CHROMATID SEPARATION; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; SECONDARY STRUCTURE; CUT2 PROTEOLYSIS; FISSION YEAST; BUDDING YEAST; IDENTIFICATION; INHIBITOR; CELLS	In eukaryotic cells, replicated DNA strands remain physically connected until their segregation to opposite poles of the cell during anaphase. This "sister chromatid cohesion" is essential for the alignment of chromosomes on the mitotic spindle during metaphase. Cohesion depends on the multisubunit cohesin complex, which possibly forms the physical bridges connecting sisters. Proteolytic cleavage of cohesin's Scc1 subunit at the metaphase to anaphase transition is essential for sister chromatid separation and depends on a conserved protein called separin. We show here that separin is a cysteine protease related to caspases that alone can cleave Scc1 in vitro. Cleavage of Scc1 in metaphase arrested cells is sufficient to trigger the separation of sister chromatids and their segregation to opposite cell poles.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Boehringer Ingelheim Canada Ltd, Laval, PQ H7S 2G5, Canada; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim; National Institutes of Health (NIH) - USA	Nasmyth, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	nasmyth@nt.imp.univie.ac.at		Nasmyth, Kim/0000-0001-7030-4403; Uhlmann, Frank/0000-0002-3527-6619				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; APLIN RT, 1983, INT J PEPT PROT RES, V21, P555; Barrett AJ., 2012, HDB PROTEOLYTIC ENZY; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Cai JS, 1996, P NATL ACAD SCI USA, V93, P12896, DOI 10.1073/pnas.93.23.12896; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Faleiro L, 1997, EMBO J, V16, P2271, DOI 10.1093/emboj/16.9.2271; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Griffin DK, 1996, INT REV CYTOL, V167, P263, DOI 10.1016/S0074-7696(08)61349-2; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; KRANTZ A, 1994, METHOD ENZYMOL, V244, P656; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; MAZIA D, 1961, MITOSIS PHYSL CELL D, V3; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MOLEBAJER J, 1958, CHROMOSOMA, V9, P332, DOI 10.1007/BF02568085; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; OSTERGREN G, 1973, PLANT CHROMOSOMES, V23; PARKS TD, 1995, VIROLOGY, V210, P194, DOI 10.1006/viro.1995.1331; Rose M, 1990, LAB COURSE MANUAL ME; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; YAIMA H, 1981, J AM CHEM SOC, V103, P5867; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986	52	637	655	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 27	2000	103	3					375	386		10.1016/S0092-8674(00)00130-6	http://dx.doi.org/10.1016/S0092-8674(00)00130-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081625	Bronze			2022-12-01	WOS:000090144100004
J	Greene, E; Lyon, BE; Muehter, VR; Ratcliffe, L; Oliver, SJ; Boag, PT				Greene, E; Lyon, BE; Muehter, VR; Ratcliffe, L; Oliver, SJ; Boag, PT			Disruptive sexual selection for plumage coloration in a passerine bird	NATURE			English	Article							LAZULI BUNTINGS; MATURATION; EVOLUTION; MALES; SIZE	The theory of sexual selection was developed to explain the evolution of highly exaggerated sexual ornaments(1). Now supported by vast empirical evidence(2), sexual selection is generally considered to favour individuals with the most extreme trait expression(2-4). Here we describe disruptive selection on a sexual ornament, plumage coloration, in yearling male lazuli buntings (Passerina amoena). In habitats with limited good-quality nesting cover, the dullest and the brightest yearlings were more successful in obtaining high-quality territories, pairing with females and siring offspring, than yearlings with intermediate plumage. This pattern reflects the way that territorial adult males vary levels of aggression to influence the structure of their social neighbourhood. Adult males showed less aggression towards dull yearlings than intermediate and bright ones, permitting the dull yearlings to settle on good territories nearby. Fitness comparisons based on paternity analyses showed that both the adults and dull yearlings benefited genetically from this arrangement, revealing a rare example of sexually selected male-male cooperation(5,6).	Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Boston Univ, Marine Program, Woods Hole, MA 02543 USA	University of Montana System; University of Montana; University of California System; University of California Santa Cruz; Queens University - Canada; Boston University	Greene, E (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	egreene@selway.umt.edu	Boag, Peter T/B-2907-2014; Lyon, Bruce E/E-8491-2011	Boag, Peter T/0000-0003-0050-2089; 				Andersson Malte, 1994; Birkhead TR, 1992, SPERM COMPETITON BIR; DARWIN C, 1881, DESCENT MAN SELECTIO; DAVIES NB, 1989, ANIM BEHAV, V38, P226, DOI 10.1016/S0003-3472(89)80085-5; DUGATKIN LA, 1994, BEHAV ECOL SOCIOBIOL, V35, P141, DOI 10.1007/BF00171504; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Endler J.A., 1986, Monographs in Population Biology, pviii; GIBBS HL, 1990, SCIENCE, V250, P1394, DOI 10.1126/science.250.4986.1394; GREENE E, 1996, BIRDS N AM; GROSS MR, 1985, NATURE, V313, P47, DOI 10.1038/313047a0; Hunt S, 1998, P ROY SOC B-BIOL SCI, V265, P451, DOI 10.1098/rspb.1998.0316; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LYON BE, 1986, EVOLUTION, V40, P605, DOI 10.1111/j.1558-5646.1986.tb00511.x; MCDONALD DB, 1994, SCIENCE, V266, P1030, DOI 10.1126/science.7973654; MOLLER AP, 1994, EVOLUTION, V48, P1089, DOI 10.1111/j.1558-5646.1994.tb05296.x; MORTON ES, 1990, AUK, V107, P275, DOI 10.2307/4087610; Muehter VR, 1997, BEHAV ECOL SOCIOBIOL, V41, P281, DOI 10.1007/s002650050389; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; Otter K, 1998, BEHAV ECOL SOCIOBIOL, V43, P25, DOI 10.1007/s002650050463; PRICE TD, 1984, EVOLUTION, V38, P327, DOI 10.1111/j.1558-5646.1984.tb00291.x; ROHWER S, 1988, AM NAT, V131, P556, DOI 10.1086/284806; ROHWER S, 1980, AM NAT, V115, P400, DOI 10.1086/283569; SAPPINGTON TW, 1990, P NATL ACAD SCI USA, V87, P6132, DOI 10.1073/pnas.87.16.6132; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; SMITH TB, 1993, NATURE, V363, P618, DOI 10.1038/363618a0; WAGNER RH, 1993, J THEOR BIOL, V163, P333, DOI 10.1006/jtbi.1993.1123; Yezerinac SM, 1997, P ROY SOC B-BIOL SCI, V264, P527, DOI 10.1098/rspb.1997.0075; YOUNG BE, 1991, CONDOR, V93, P236, DOI 10.2307/1368939	30	99	99	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2000	407	6807					1000	1003		10.1038/35039500	http://dx.doi.org/10.1038/35039500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069178				2022-12-01	WOS:000090032500042
J	Pellegrini, L; Burke, DF; von Delft, F; Mulloy, B; Blundell, TL				Pellegrini, L; Burke, DF; von Delft, F; Mulloy, B; Blundell, TL			Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin	NATURE			English	Article							BINDING DOMAIN; FGF; IDENTIFICATION; DIMERIZATION; MITOGENESIS; ACTIVATION; SULFATE; NMR	Fibroblast growth factors (FGFs) are a large family of structurally related proteins with a wide range of physiological and pathological activities(1). Signal transduction requires association of FGF with its receptor tyrosine kinase (FGFR)(2) and heparan sulphate proteoglycan in a specific complex on the cell surface. Direct involvement of the heparan sulphate glycosaminoglycan polysaccharide in the molecular association between FGF and its receptor is essential for biological activity(3-5). Although crystal structures of binary complexes of FGF-heparin(6,7) and FGF-FGFR(8,9) have been described, the molecular architecture of the FGF signalling complex has not been elucidated. Here we report the crystal structure of the FGFR2 ectodomain in a dimeric form that is induced by simultaneous binding to FGF1 and a heparin decasaccharide. The complex is assembled around a central heparin molecule linking two FGF1 ligands into a dimer that bridges between two receptor chains. The asymmetric heparin binding involves contacts with both FGF1 molecules but only one receptor chain. The structure of the FGF1-FGFR2-heparin ternary complex provides a structural basis for the essential role of heparan sulphate in FGF signalling.	Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England	University of Cambridge; National Institute for Biological Standards & Control	Pellegrini, L (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.		Pellegrini, Luca/AAE-2312-2022; Burke, David F/C-2091-2013	Pellegrini, Luca/0000-0002-9300-497X; Burke, David F/0000-0001-8830-3951; von Delft, Frank/0000-0003-0378-0017				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; GALZIE Z, 1997, CELL BIOL, V75, P669; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; LAFORTELLE E, 1997, METHOD ENZYMOL, V276, P472; Lin XH, 1999, DEVELOPMENT, V126, P3715; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Oldridge M, 1997, HUM MOL GENET, V6, P137, DOI 10.1093/hmg/6.1.137; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; RICE KG, 1985, ANAL BIOCHEM, V150, P325, DOI 10.1016/0003-2697(85)90518-4; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; SPRINGER BA, 1994, J BIOL CHEM, V269, P26879; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; SUDHALTER J, 1989, J BIOL CHEM, V264, P6892; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; WANG F, 1995, J BIOL CHEM, V270, P10222, DOI 10.1074/jbc.270.17.10222; Zhu HY, 1997, PROTEIN ENG, V10, P417, DOI 10.1093/protein/10.4.417; ZHU HY, 1995, J BIOL CHEM, V270, P21869, DOI 10.1074/jbc.270.37.21869; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	30	585	640	1	65	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2000	407	6807					1029	1034		10.1038/35039551	http://dx.doi.org/10.1038/35039551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069186				2022-12-01	WOS:000090032500050
J	Smaglik, P				Smaglik, P			Tissue donors use their influence in deal over gene patent terms	NATURE			English	News Item																		Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Smaglik P, 2000, NATURE, V404, P912, DOI 10.1038/35010224; 2000, NATURE, V403, P237	3	15	15	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					821	821		10.1038/35038209	http://dx.doi.org/10.1038/35038209			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057626	Bronze			2022-12-01	WOS:000089901900003
J	Angus, JA; Wright, CE; Xi, Q				Angus, JA; Wright, CE; Xi, Q			Targetting voltage-gated calcium channels in cardiovascular therapy	LANCET			English	Editorial Material							N-TYPE; CA2+ CHANNELS		Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	University of Melbourne	Angus, JA (corresponding author), Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia.		Tuluc, Petronel/C-2527-2011; Angus, James/F-6666-2014; Wright, Christine/B-2509-2012	Angus, James/0000-0002-0605-9682; Wright, Christine/0000-0002-3339-040X				BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540; Brose WG, 1997, CLIN J PAIN, V13, P256, DOI 10.1097/00002508-199709000-00012; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Furukawa T, 1997, BRIT J PHARMACOL, V121, P1136, DOI 10.1038/sj.bjp.0701226; MISHRA SK, 1994, CIRC RES, V75, P144, DOI 10.1161/01.RES.75.1.144; Molderings GJ, 2000, CIRCULATION, V101, P403, DOI 10.1161/01.CIR.101.4.403; Sarsero D, 1998, BRIT J PHARMACOL, V125, P109, DOI 10.1038/sj.bjp.0702045; Whorlow SL, 1996, CLIN EXP PHARMACOL P, V23, P16; WRIGHT CE, 1995, J CARDIOVASC PHARM, V25, P459, DOI 10.1097/00005344-199503000-00017; Wright CE, 2000, J HYPERTENS, V18, P65, DOI 10.1097/00004872-200018010-00010; XI Q, 2000, P AUST SOC EXP PHARM, V7, P98	11	15	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2000	356	9238					1287	1289		10.1016/S0140-6736(00)02807-5	http://dx.doi.org/10.1016/S0140-6736(00)02807-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VL	11073011				2022-12-01	WOS:000089858300003
J	Fukada-Tanaka, S; Inagaki, Y; Yamaguchi, T; Saito, N; Iida, S				Fukada-Tanaka, S; Inagaki, Y; Yamaguchi, T; Saito, N; Iida, S			Colour-enhancing protein in blue petals - Spectacular morning glory blooms rely on a behind-the-scenes proton exchanger.	NATURE			English	Article									Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan; Meiji Gakuin Univ, Chem Lab, Yokohama, Kanagawa 2448539, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Fukada-Tanaka, S (corresponding author), Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan.		INAGAKI, Yoshishige/B-1458-2011					Fukuda A, 1999, BBA-GENE STRUCT EXPR, V1446, P149, DOI 10.1016/S0167-4781(99)00065-2; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Iida S, 1999, ANN NY ACAD SCI, V870, P265, DOI 10.1111/j.1749-6632.1999.tb08887.x; IMAI YOSHITAKA, 1934, JOUR COLL AGRIC IMP UNIV TOKYO, V12, P479; LU TS, 1992, PHYTOCHEMISTRY, V31, P659, DOI 10.1016/0031-9422(92)90069-3; Maes T, 1999, TRENDS PLANT SCI, V4, P90, DOI 10.1016/S1360-1385(99)01375-8; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; YOSHIDA K, 1995, NATURE, V373, P291, DOI 10.1038/373291a0	8	125	143	5	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					581	581		10.1038/35036683	http://dx.doi.org/10.1038/35036683			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034195				2022-12-01	WOS:000089772800031
J	Suzuki, T; Katoh, H; Tsuchio, Y; Hasegawa, A; Kurabayashi, M; Ohira, A; Hiramori, K; Sakomura, Y; Kasanuki, H; Hori, S; Aikawa, N; Abe, S; Tei, C; Nakagawa, Y; Nobuyoshi, M; Misu, K; Sumiyoshi, T; Nagai, R				Suzuki, T; Katoh, H; Tsuchio, Y; Hasegawa, A; Kurabayashi, M; Ohira, A; Hiramori, K; Sakomura, Y; Kasanuki, H; Hori, S; Aikawa, N; Abe, S; Tei, C; Nakagawa, Y; Nobuyoshi, M; Misu, K; Sumiyoshi, T; Nagai, R			Diagnostic implications of elevated levels of smooth-muscle myosin heavy-chain protein in acute aortic dissection - The smooth muscle myosin heavy chain study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; STENT-GRAFT PLACEMENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; IMMUNOASSAY; SERUM	Background: A rapid 30-minute assay of circulating smooth-muscle myosin heavy-chain protein has been developed as a biochemical diagnostic tool for aortic dissection. Objective: To determine the sensitivity and specificity of this assay. Design: Cross-sectional study. Setting: 8 major cardiovascular centers in Japan. Patients: 95 patients with acute aortic dissection, 48 patients with acute myocardial infarction, and 131 healthy volunteers. Measurements: Levels of circulating smooth-muscle myosin heavy-chain protein. Results: Patients with acute aortic dissection who presented within 3 hours after onset had elevated levels of circulating smooth-muscle myosin heavy-chain protein, In these patients, the assay had a sensitivity of 90.9%, a specificity of 98% compared with healthy volunteers, and a specificity of 83% compared with patients who had acute myocardial infarction; the clinical decision limit was 2.5 mu g/L. All patients with proximal lesions had elevated levels of smooth-muscle myosin heavy-chain protein, and only patients with distal lesions had decreased levels (<2.5 mu g/L). Conclusions: Levels of smooth-muscle myosin heavy-chain protein can be used to diagnose aortic dissection soon after symptom onset. The assay had the greatest diagnostic value in patients with proximal lesions.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; Tokyo Womens Med Univ, Tokyo, Japan; Keio Univ, Tokyo, Japan; Sakakibara Heart Inst, Tokyo, Japan; Gunma Univ, Gunma, Japan; Iwate Med Univ, Morioka, Iwate 020, Japan; Kagoshima Univ, Kagoshima 890, Japan; Kokura Mem Hosp, Kokurakita Ku, Kokura, Japan	University of Tokyo; Tokyo Women's Medical University; Keio University; Gunma University; Iwate Medical University; Kagoshima University; Kokura Memorial Hospital	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	torusuzu-tky@umin.ac.jp						Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; DEBAKEY ME, 1955, ANN SURG, V142, P586, DOI 10.1097/00000658-195510000-00005; ERBEL R, 1989, LANCET, V1, P457; ERBEL R, 1993, CIRCULATION, V87, P1604, DOI 10.1161/01.CIR.87.5.1604; GROS BJ, 1996, CARDIOL REV, V4, P112; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; HAMM CW, 1994, NEW ENGL J MED, V331, P607, DOI 10.1056/NEJM199409013310910; ISSELBACHER EM, 1997, HEART DIS TXB CARDIO; KATOH H, 1995, J IMMUNOL METHODS, V185, P57, DOI 10.1016/0022-1759(95)00104-I; KATOH H, 1995, LANCET, V345, P191, DOI 10.1016/S0140-6736(95)90194-9; KATUS HA, 1989, J MOL CELL CARDIOL, V21, P1349, DOI 10.1016/0022-2828(89)90680-9; KERSTINGSOMMERHOFF BA, 1988, RADIOLOGY, V166, P651, DOI 10.1148/radiology.166.3.3340758; Nienaber CA, 1999, NEW ENGL J MED, V340, P1539, DOI 10.1056/NEJM199905203402003; NIENABER CA, 1992, CIRCULATION, V85, P434, DOI 10.1161/01.CIR.85.2.434; NIENABER CA, 1993, NEW ENGL J MED, V328, P1, DOI 10.1056/NEJM199301073280101; Sebastia C, 1999, RADIOGRAPHICS, V19, P45, DOI 10.1148/radiographics.19.1.g99ja0945; SPITTELL PC, 1993, MAYO CLIN PROC, V68, P642, DOI 10.1016/S0025-6196(12)60599-0; Suzuki T, 1996, CIRCULATION, V93, P1244, DOI 10.1161/01.CIR.93.6.1244; vonKodolitsch Y, 1997, Z KARDIOL, V86, P469; WHEAT MW, 1965, J THORAC CARDIOV SUR, V50, P364, DOI 10.1016/S0022-5223(19)33192-7	20	85	92	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					537	541		10.7326/0003-4819-133-7-200010030-00013	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015167				2022-12-01	WOS:000089678300006
J	Wikoff, WR; Liljas, L; Duda, RL; Tsuruta, H; Hendrix, RW; Johnson, JE				Wikoff, WR; Liljas, L; Duda, RL; Tsuruta, H; Hendrix, RW; Johnson, JE			Topologically linked protein rings in the bacteriophage HK97 capsid	SCIENCE			English	Article							3-DIMENSIONAL STRUCTURE; CONFORMATIONAL-CHANGES; BACTERIAL-VIRUS; CROSS-LINKING; MATURATION; TRANSITIONS; DEAMIDATION; ASPARAGINYL; MOLSCRIPT; RESIDUES	The crystal structure of the double-stranded DNA bacteriophage HK97 mature empty capsid was determined at 3.6 angstrom resolution. The 660 angstrom diameter icosahedral particle contains 420 subunits with a new fold. The final capsid maturation step is an autocatalytic reaction that creates 420 isopeptide bonds between proteins. Each subunit is joined to two of its neighbors by Ligation of the side-chain Lysine 169 to asparagine 356. This generates 12 pentameric and 60 hexameric rings of covalently joined subunits that loop through each other, creating protein chainmail: topologically linked protein catenanes arranged with icosahedral symmetry. Catenanes have not been previously observed in proteins and provide a stabilization mechanism for the very thin HK97 capsid.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Uppsala Univ, Ctr Biomed, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA	Scripps Research Institute; Uppsala University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Johnson, JE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Duda, Robert/0000-0002-9517-2731	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047795] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI040101, AI40101] Funding Source: Medline; NIGMS NIH HHS [GM47795, R01 GM047795] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0; Casjens S., 1988, BACTERIOPHAGES, V1, P16; CHEN JH, 1995, CELL, V80, P61, DOI 10.1016/0092-8674(95)90451-4; CONWAY JF, 1995, J MOL BIOL, V253, P86, DOI 10.1006/jmbi.1995.0538; DOKLAND T, 1993, J MOL BIOL, V233, P682, DOI 10.1006/jmbi.1993.1545; DUDA RL, 1995, J MOL BIOL, V247, P636, DOI 10.1006/jmbi.1994.0169; DUDA RL, 1995, J MOL BIOL, V247, P618, DOI 10.1016/S0022-2836(05)80143-3; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; EARNSHAW WC, 1979, J MOL BIOL, V131, P14; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gilakjan ZA, 1999, J BACTERIOL, V181, P7221, DOI 10.1128/JB.181.23.7221-7227.1999; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt G. J., 1994, P CCP4 STUD WEEK 1 M, P59; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lata R, 2000, CELL, V100, P253, DOI 10.1016/S0092-8674(00)81563-9; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; LURA R, 1988, BIOCHEMISTRY-US, V27, P7671, DOI 10.1021/bi00420a015; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POPA MP, 1991, J VIROL, V65, P3227, DOI 10.1128/JVI.65.6.3227-3237.1991; Sauvage J.-P., 1999, MOL CATENANES ROTAXA; Seeman NC, 1998, ANNU REV BIOPH BIOM, V27, P225, DOI 10.1146/annurev.biophys.27.1.225; STEVEN AC, 1992, J MOL BIOL, V228, P870, DOI 10.1016/0022-2836(92)90871-G; STEVEN AC, 1983, VIROLOGY, V124, P109, DOI 10.1016/0042-6822(83)90294-5; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; ThumanCommike PA, 1996, J MOL BIOL, V260, P85, DOI 10.1006/jmbi.1996.0383; Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0; VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0; WHITE JH, 1984, P NATL ACAD SCI-BIOL, V81, P3322, DOI 10.1073/pnas.81.11.3322; Wikoff WR, 1998, VIROLOGY, V243, P113, DOI 10.1006/viro.1998.9040; Wikoff WR, 1999, ACTA CRYSTALLOGR D, V55, P763, DOI 10.1107/S0907444998017661; Wikoff WR, 2000, ACTA CRYSTALLOGR D, V56, P890, DOI 10.1107/S0907444900005941; WIKOFF WR, UNPUB; WILLIAMS RC, 1974, J MOL BIOL, V88, P547, DOI 10.1016/0022-2836(74)90501-4; XIE ZH, 1995, J MOL BIOL, V253, P74, DOI 10.1006/jmbi.1995.0537; Yang F, 2000, NAT STRUCT BIOL, V7, P230; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296	42	534	544	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2129	2133		10.1126/science.289.5487.2129	http://dx.doi.org/10.1126/science.289.5487.2129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000116				2022-12-01	WOS:000089430900046
J	Burks, DJ; de Mora, JF; Schubert, M; Withers, DJ; Myers, MG; Towery, HH; Altamuro, SL; Flint, CL; White, MF				Burks, DJ; de Mora, JF; Schubert, M; Withers, DJ; Myers, MG; Towery, HH; Altamuro, SL; Flint, CL; White, MF			IRS-2 pathways integrate female reproduction and energy homeostasis	NATURE			English	Article							RECEPTOR SUBSTRATE FAMILY; PHOSPHOTYROSINE PROTEIN; CAENORHABDITIS-ELEGANS; INSULIN-RECEPTORS; LEPTIN RECEPTOR; FOOD-INTAKE; DB/DB MICE; SYSTEM; CELL; HYPOTHALAMUS	Severe dietary restriction, catabolic states and even short-term caloric deprivation impair fertility in mammals. Likewise, obesity is associated with infertile conditions such as polycystic ovary syndrome(1,2). The reproductive status of lower organisms such as Caenorhabditis elegans is also modulated by availability of nutrients(3,4). Thus, fertility requires the integration of reproductive and metabolic signals. Here we show that deletion of insulin receptor substrate-2 (IRS-2), a component of the insulin/insulin-like growth factor-1 signalling cascade, causes female infertility. Mice lacking IRS-2 have small, anovulatory ovaries with reduced numbers of follicles. Plasma concentrations of luteinizing hormone, prolactin and sex steroids are low in these animals. Pituitaries are decreased in size and contain reduced numbers of gonadotrophs. Females lacking IRS-2 have increased food intake and obesity, despite elevated levels of leptin. Our findings indicate that insulin, together with leptin and other neuropeptides, may modulate hypothalamic control of appetite and reproductive endocrinology. Coupled with findings on the role of insulin-signalling pathways in the regulation of fertility, metabolism and longevity in C. elegans and Drosophila(3-5), we have identified an evolutionarily conserved mechanism in mammals that regulates both reproduction and energy homeostasis.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA; Univ Salamanca, Fac Med, Ctr Invest Canc, Salamanca 37007, Spain	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	White, MF (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, 1 Joslin Pl, Boston, MA 02215 USA.		Withers, Dominic J/D-7671-2014; de Mora, Jaime Font/H-6304-2015; de Mora, Jaime Font/AAK-7591-2021; Schubert, Markus/F-5150-2010	Withers, Dominic J/0000-0002-8009-7521; de Mora, Jaime Font/0000-0002-6816-2095; de Mora, Jaime Font/0000-0002-6816-2095; 				Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Berti L, 1997, DIABETOLOGIA, V40, P606, DOI 10.1007/s001250050722; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; FOSTER LA, 1991, PHYSIOL BEHAV, V50, P745, DOI 10.1016/0031-9384(91)90012-D; Franks S, 1999, ENDOCRIN METAB CLIN, V28, P361, DOI 10.1016/S0889-8529(05)70074-8; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Legro RS, 1998, RECENT PROG HORM RES, V53, P217; McCowen KC, 1998, ENDOCRINOLOGY, V139, P4442, DOI 10.1210/en.139.11.4442; Morita Y, 1999, ENDOCRINOLOGY, V140, P941, DOI 10.1210/en.140.2.941; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Richards RG, 1996, P NATL ACAD SCI USA, V93, P12002, DOI 10.1073/pnas.93.21.12002; Schwartz MW, 1997, NEW ENGL J MED, V336, P1802, DOI 10.1056/NEJM199706193362507; Schwartz MW, 1999, AM J CLIN NUTR, V69, P584; Szanto I, 2000, P NATL ACAD SCI USA, V97, P2355, DOI 10.1073/pnas.050580497; Tissenbaum HA, 1998, GENETICS, V148, P703; Unger JW, 1997, CELL TISSUE RES, V288, P471, DOI 10.1007/s004410050833; Unger JW, 1998, HISTOL HISTOPATHOL, V13, P1215, DOI 10.14670/HH-13.1215; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Vassen L, 1999, MOL ENDOCRINOL, V13, P485; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0	30	357	372	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					377	382		10.1038/35030105	http://dx.doi.org/10.1038/35030105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014193				2022-12-01	WOS:000089390700047
J	Kollef, MH				Kollef, MH			Non-invasive ventilation for chronic obstructive pulmonary disease	LANCET			English	Editorial Material							POSITIVE PRESSURE VENTILATION; MECHANICAL VENTILATION; TRIAL		Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Kollef, MH (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.							Burdet L, 1997, AM J RESP CRIT CARE, V156, P1800, DOI 10.1164/ajrccm.156.6.9704142; Fridkin SK, 1996, INFECT CONT HOSP EP, V17, P150; Kollef MH, 1999, NEW ENGL J MED, V340, P627, DOI 10.1056/NEJM199902253400807; Kollef MH, 1997, CRIT CARE MED, V25, P567, DOI 10.1097/00003246-199704000-00004; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; SHAPIRO SH, 1992, LANCET, V340, P1425, DOI 10.1016/0140-6736(92)92620-U; THORENS JB, 1995, CRIT CARE MED, V23, P1807, DOI 10.1097/00003246-199511000-00004; Wood KA, 1998, CHEST, V113, P1339, DOI 10.1378/chest.113.5.1339	11	3	3	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					956	957		10.1016/S0140-6736(00)02708-2	http://dx.doi.org/10.1016/S0140-6736(00)02708-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041392				2022-12-01	WOS:000089293600005
J	Sandberg, S; Paton, JY; Ahola, S; McCann, DC; McGuinness, D; Hillary, CR; Oja, H				Sandberg, S; Paton, JY; Ahola, S; McCann, DC; McGuinness, D; Hillary, CR; Oja, H			The role of acute and chronic stress in asthma attacks in children	LANCET			English	Article							LIFE EVENTS; COMMON COLD; BRONCHIAL REACTIVITY; PSYCHOLOGICAL STRESS; PSYCHOSOCIAL STRESS; SUSCEPTIBILITY; CHILDHOOD; SEVERITY; ILLNESS; DISEASE	Background High levels of stress have been shown to predict the onset of asthma in children genetically at risk, and to correlate with higher asthma morbidity. Our study set out to examine whether stressful experiences actually provoke new exacerbations in children who already have asthma. Methods A group of child patients with verified chronic asthma were prospectively followed up for 18 months. We used continuous monitoring of asthma by the use of diaries and daily peak-flow values, accompanied by repeated interview assessments of life events and psychosocial experiences. The key measures included asthma exacerbations, severely negative life events, and chronic stressors. Findings Severe events, both on their own and in conjunction with high chronic stress, significantly increased the risk of new asthma attacks. The effect of severe events without accompanying chronic stress involved a small delay; they had no effect within the first 2 weeks, but significantly increased the risk in the subsequent 4 weeks (odds ratio 1.71 [95% CI 1.04-2.82], p less than or equal to 0.05 for weeks 2-4 and 2.17 [1.32-3.57], p less than or equal to 0.01 for weeks 4-6). When severe events occurred against the backdrop of high chronic stress, the risk increased sharply and almost immediately within the first fortnight (2.98 [1.20-7.38], p less than or equal to 0.05). The overall attack frequency was affected by several factors, some related to asthma and some to child characteristics. Female sex, higher baseline illness severity, three or more attacks within 6 months, autumn to winter season, and parental smoking were all related to increased risk of new exacerbations; social class and chronic stress were not. Interpretation Severely negative life events increase the risk of children's asthma attacks over the coming few weeks. This risk is magnified and brought forward in time if the child's life situation is also characterised by multiple chronic stressors.	Univ Helsinki, Hosp Children & Adolescents, FIN-00014 Helsinki, Finland; Univ Jyvaskyla, Dept Stat, SF-40351 Jyvaskyla, Finland; Univ Glasgow, Dept Child Hlth, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Dept Child & Adolescent Psychiat, Glasgow G12 8QQ, Lanark, Scotland; Univ Southampton, Dept Child Hlth, Div Allergies & Inflammat Sci, Southampton SO9 5NH, Hants, England	University of Helsinki; University of Jyvaskyla; University of Glasgow; University of Glasgow; University of Southampton	Sandberg, S (corresponding author), HYKS Inst, Tukholmankatu 8F,POB 106, FIN-00029 Helsinki, Finland.		Paton, James/B-9541-2008; Taskinen, Sara/AAD-7967-2019	Taskinen, Sara/0000-0001-9470-7258				Asher MI, 1998, EUR RESPIR J, V12, P315; AVITAL A, 1991, AM REV RESPIR DIS, V144, P36, DOI 10.1164/ajrccm/144.1.36; BOYCE WT, 1995, PSYCHOSOM MED, V57, P411, DOI 10.1097/00006842-199509000-00001; Brown GW, 1989, LIFE EVENTS ILLNESS; Clark NM, 1999, ENVIRON HEALTH PERSP, V107, P421, DOI 10.1289/ehp.99107s3421; CLOUGH JB, 1994, AM J RESP CRIT CARE, V150, P48, DOI 10.1164/ajrccm.150.1.8025771; Cobb JMT, 1996, PSYCHOSOM MED, V58, P404, DOI 10.1097/00006842-199609000-00003; Cobb JMT, 1998, J PSYCHOSOM RES, V45, P319, DOI 10.1016/S0022-3999(97)00311-5; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; Cohen S, 1999, PSYCHOSOM MED, V61, P175, DOI 10.1097/00006842-199903000-00009; COHEN S, 1993, J PERS SOC PSYCHOL, V64, P131, DOI 10.1037/0022-3514.64.1.131; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cohen S, 1998, HEALTH PSYCHOL, V17, P214, DOI 10.1037/0278-6133.17.3.214; Drummond PD, 1997, J PSYCHOSOM RES, V43, P271, DOI 10.1016/S0022-3999(97)00002-0; EISER C, 1990, J CHILD PSYCHOL PSYC, V31, P85, DOI 10.1111/j.1469-7610.1990.tb02274.x; Grey M, 1993, J Pediatr Nurs, V8, P85; Haavet Ole Rikard, 1997, Tidsskrift for den Norske Laegeforening, V117, P3644; HEISEL JS, 1973, BEHAVIORAL PEDIATRIC, V83, P119; JACOBS TJ, 1980, PSYCHOSOM MED, V42, P11, DOI 10.1097/00006842-198001000-00002; MARRIE TJ, 1993, THORAX, V48, P1, DOI 10.1136/thx.48.1.1; Mishoe SC, 1998, J ASTHMA, V35, P553, DOI 10.3109/02770909809048958; Mrazek DA, 1999, PEDIATR PULM, V27, P85, DOI 10.1002/(SICI)1099-0496(199902)27:2<85::AID-PPUL4>3.0.CO;2-B; Office of Population Censuses and Surveys, 1980, CLASS OCC; Randolph C, 1999, Curr Probl Pediatr, V29, P82, DOI 10.1016/S0045-9380(99)80041-3; SANDBERG S, 1993, J CHILD PSYCHOL PSYC, V34, P879, DOI 10.1111/j.1469-7610.1993.tb01096.x; Sarafino EP, 1998, J ASTHMA, V35, P497, DOI 10.3109/02770909809071003; SONINO N, 1993, ACTA ENDOCRINOL-COP, V128, P293, DOI 10.1530/acta.0.1280293; SONINO N, 1993, CLIN ENDOCRINOL, V38, P261, DOI 10.1111/j.1365-2265.1993.tb01004.x; Wade S, 1997, PEDIATR PULM, V24, P263, DOI 10.1002/(SICI)1099-0496(199710)24:4<263::AID-PPUL5>3.0.CO;2-L; Wright AL, 1998, EUR RESPIR J, V12, p17S	30	303	311	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2000	356	9234					982	987		10.1016/S0140-6736(00)02715-X	http://dx.doi.org/10.1016/S0140-6736(00)02715-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	353UJ	11041399	Green Accepted			2022-12-01	WOS:000089293600012
J	Bond, CT; Sprengel, R; Bissonnette, JM; Kaufmann, WA; Pribnow, D; Neelands, T; Storck, T; Baetscher, M; Jerecic, J; Maylie, J; Knaus, HG; Seeburg, PH; Adelman, JP				Bond, CT; Sprengel, R; Bissonnette, JM; Kaufmann, WA; Pribnow, D; Neelands, T; Storck, T; Baetscher, M; Jerecic, J; Maylie, J; Knaus, HG; Seeburg, PH; Adelman, JP			Respiration and parturition affected by conditional overexpression of the Ca2+-activated K+ channel subunit, SK3	SCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; SMALL-CONDUCTANCE; MYOTONIC-DYSTROPHY; SKELETAL-MUSCLE; GENE-EXPRESSION; EPILEPSY; MUTATION; DISEASE; BRAIN; RAT	In:excitable cells, small-conductance Ca2+-activated potassium channels (SK channels) are responsible for the slow after-hyperpolarization that often follows an action potential. Three SK channel subunits have been molecularly characterized. The SK3 gene was targeted by homologous recombination for the insertion of a gene switch that permitted experimental regulation of SK3 expression while retaining normal SK3 promoter function. An absence of SK3 did not-present overt phenotypic consequences. However, SK3 overexpression induced abnormal respiratory responses to hypoxia and compromised parturition. Both conditions were corrected by silencing the gene. The results implicate SK3 channels as potential therapeutic targets for disorders such as sleep apnea Or sudden infant death syndrome and for regulating uterine contractions during labor.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Univ Innsbruck, Inst Biochem Pharmacol, A-6020 Innsbruck, Austria; Max Planck Inst Med Res, Dept Mol Neurosci, D-69120 Heidelberg, Germany	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Innsbruck; Max Planck Society	Adelman, JP (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	adelman@ohsu.edu		Kaufmann, Walter Anton/0000-0001-9735-5315				ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; Adelman JP, 1995, NEURON, V15, P1449, DOI 10.1016/0896-6273(95)90022-5; BEHRENS MI, 1994, MUSCLE NERVE, V17, P1264, DOI 10.1002/mus.880171104; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; BLATZ AL, 1987, TRENDS NEUROSCI, V10, P463, DOI 10.1016/0166-2236(87)90101-9; BOND CT, UNPUB; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Chandy KG, 1998, MOL PSYCHIATR, V3, P32, DOI 10.1038/sj.mp.4000353; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; Dufour P, 1997, EUR J OBSTET GYN R B, V72, P159, DOI 10.1016/S0301-2115(96)02690-5; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gozal D, 1997, AM J RESP CRIT CARE, V155, P1755, DOI 10.1164/ajrccm.155.5.9154888; Jerecic J, 1999, ANN NY ACAD SCI, V868, P27, DOI 10.1111/j.1749-6632.1999.tb11271.x; Kaufmann WA, 1998, EUR J NEUROSCI, V10, P1084, DOI 10.1046/j.1460-9568.1998.00121.x; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Mortola JP, 1996, TISSUE OXYGEN DEPRIV, P433; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; Pribnow D, 1999, MUSCLE NERVE, V22, P742, DOI 10.1002/(SICI)1097-4598(199906)22:6<742::AID-MUS11>3.3.CO;2-T; PRIBNOW D, 1999, CURR RES ION CHANNEL, V3, P221; Ramirez JM, 1996, CURR OPIN NEUROBIOL, V6, P817, DOI 10.1016/S0959-4388(96)80033-X; RENAUD JF, 1986, NATURE, V319, P678, DOI 10.1038/319678a0; Rudnik-Schoneborn S, 1998, AM J MED GENET, V80, P314, DOI 10.1002/(SICI)1096-8628(19981204)80:4<314::AID-AJMG3>3.0.CO;2-I; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Stocker R, 1999, GLOBAL CHANGE BIOL, V5, P95, DOI 10.1046/j.1365-2486.1998.00198.x; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	28	134	138	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1942	1946		10.1126/science.289.5486.1942	http://dx.doi.org/10.1126/science.289.5486.1942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988076				2022-12-01	WOS:000089355800048
J	Fukuda, R; McNew, JA; Weber, T; Parlati, F; Engel, T; Nickel, W; Rothman, JE; Sollner, TH				Fukuda, R; McNew, JA; Weber, T; Parlati, F; Engel, T; Nickel, W; Rothman, JE; Sollner, TH			Functional architecture of an intracellular membrane t-SNARE	NATURE			English	Article							V-SNARE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; TRANSPORT PATHWAYS; VESICLE TRANSPORT; SECRETORY PATHWAY; GOLGI-APPARATUS; SNAP-25 HOMOLOG; FUSION; YEAST	Lipid bilayer fusion is mediated by SNAREs (soluble N-ethyl-maleimide-sensitive factor attachment protein receptors) located on the vesicle membrane (v-SNAREs) and the target membrane (t-SNAREs)(1,2). The assembled v-SNARE/t-SNARE complex consists of a bundle of four helices, of which one is supplied by the v-SNARE and the other three by the t-SNARE(3). For t-SNAREs on the plasma membrane, the protein syntaxin(4) supplies one helix and a SNAP-25 protein(5) contributes the other two. Although there are numerous homologues of syntaxin on intracellular membranes(6), there are only two SNAP-25-related proteins in yeast, Sec9 and Spo20, both of which are localized to the plasma membrane and function in secretion(7) and sporulation(8), respectively. What replaces SNAP-25 in t-SNAREs of intracellular membranes? Here we show that an intracellular t-SNARE is built from a `heavy chain' homologous to syntaxin and two separate nonsyntaxin `light chains'. SNAP-25 may thus be the exception rather than the rule, having been derived from genes that encoded separate light chains that fused during evolution to produce a single gene encoding one protein with two helices.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Sollner, TH (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave,Box 519, New York, NY 10021 USA.		McNew, James/AAV-4911-2020; McNew, James/ABD-8081-2020; Weber, Thomas/GLS-9125-2022; Weber, Thomas/A-2363-2008	McNew, James/0000-0001-8459-3664; Weber, Thomas/0000-0002-0494-0484; Weber, Thomas/0000-0002-0494-0484				BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Nichols BJ, 1998, BBA-MOL CELL RES, V1404, P9, DOI 10.1016/S0167-4889(98)00044-5; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Rossi G, 1997, J BIOL CHEM, V272, P16610, DOI 10.1074/jbc.272.26.16610; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEBER T, IN PESS J CELL BIOL; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	30	184	187	1	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					198	202		10.1038/35025084	http://dx.doi.org/10.1038/35025084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001059				2022-12-01	WOS:000089241000051
J	Trauger, JW; Kohli, RM; Mootz, HD; Marahiel, MA; Walsh, CT				Trauger, JW; Kohli, RM; Mootz, HD; Marahiel, MA; Walsh, CT			Peptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase	NATURE			English	Article							ERYTHROMYCIN POLYKETIDE SYNTHASE; NUCLEOTIDE-SEQUENCE; VIBRIO-HARVEYI; BIOSYNTHESIS; SUPERFAMILY	In the biosynthesis of many macrocyclic natural products by multidomain megasynthases, a carboxy-terminal thioesterase (TE) domain is involved in cyclization and product release(1,2); however, it has not been determined whether TE domains can catalyse macrocyclization (and elongation in the case of symmetric cyclic peptides) independently of upstream domains. The inability to decouple the TE cyclization step from earlier chain assembly steps has precluded determination of TE substrate specificity, which is important for the engineered biosynthesis of new compounds(1). Here we report that the excised TE domain from tyrocidine synthetase efficiently catalyses cyclization of a decapeptide-thioester to form the antibiotic tyrocidine A, and can catalyse pentapeptide-thioester dimerization followed by cyclization to form the antibiotic gramicidin S. By systematically varying the decapeptide-thioester substrate and comparing cyclization rates, we also show that only two residues (one near each end of the decapeptide) are critical for cyclization. This specificity profile indicates that the tyrocidine synthetase TE, and by analogy many other TE domains, will be able to cyclize and release a broad range of new substrates and products produced by engineered enzymatic assembly lines.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Marburg, Biochem Fachbereich Chem, D-35032 Marburg, Germany	Harvard University; Harvard Medical School; Philipps University Marburg	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.			Kohli, Rahul/0000-0002-7689-5678				AGGARWAL R, 1995, J CHEM SOC CHEM COMM, P1519, DOI 10.1039/c39950001519; Belshaw PJ, 1999, SCIENCE, V284, P486, DOI 10.1126/science.284.5413.486; Boger DL, 2000, J AM CHEM SOC, V122, P2956, DOI 10.1021/ja0001660; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; CORTES J, 1995, SCIENCE, V268, P1487, DOI 10.1126/science.7770773; deFerra F, 1997, J BIOL CHEM, V272, P25304, DOI 10.1074/jbc.272.40.25304; Gokhale RS, 1999, CHEM BIOL, V6, P117, DOI 10.1016/S1074-5521(99)80008-8; HORI K, 1989, J BIOCHEM-TOKYO, V106, P639, DOI 10.1093/oxfordjournals.jbchem.a122909; JACKSON DY, 1994, SCIENCE, V266, P243, DOI 10.1126/science.7939659; Jacobsen JR, 1997, SCIENCE, V277, P367, DOI 10.1126/science.277.5324.367; Kao CM, 1997, J AM CHEM SOC, V119, P11339, DOI 10.1021/ja972609e; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LAWSON DM, 1994, BIOCHEMISTRY-US, V33, P9382, DOI 10.1021/bi00198a003; Li J, 1996, BIOCHEMISTRY-US, V35, P9967, DOI 10.1021/bi9605292; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Mootz HD, 2000, P NATL ACAD SCI USA, V97, P5848, DOI 10.1073/pnas.100075897; ROSKOSKI R, 1970, BIOCHEMISTRY-US, V9, P4846; Shaw-Reid CA, 1999, CHEM BIOL, V6, P385, DOI 10.1016/S1074-5521(99)80050-7; STACHELHAUS T, 1995, SCIENCE, V269, P69, DOI 10.1126/science.7604280; Tang L, 2000, CHEM BIOL, V7, P77, DOI 10.1016/S1074-5521(00)00073-9; TURGAY K, 1992, MOL MICROBIOL, V6, P529, DOI 10.1111/j.1365-2958.1992.tb01498.x; Xue YQ, 2000, NATURE, V403, P571, DOI 10.1038/35000624	24	249	265	2	48	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					215	218		10.1038/35025116	http://dx.doi.org/10.1038/35025116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001063				2022-12-01	WOS:000089241000055
J	Kameyama, K; Kishi, Y; Yoshimura, M; Kanzawa, N; Sameshima, M; Tsuchiya, T				Kameyama, K; Kishi, Y; Yoshimura, M; Kanzawa, N; Sameshima, M; Tsuchiya, T			Tyrosine phosphorylation in plant bending - Puckering in a ticklish plant is controlled by dephosphorylation of its actin.	NATURE			English	Article									Sophia Univ, Fac Sci & Technol, Dept Chem, Chiyoda Ku, Tokyo 1028554, Japan; Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Dept Cell Biol, Bunkyo Ku, Tokyo 1710021, Japan	Sophia University; Tokyo Metropolitan Institute of Medical Science	Kameyama, K (corresponding author), Sophia Univ, Fac Sci & Technol, Dept Chem, Chiyoda Ku, 7-1 Kioicho, Tokyo 1028554, Japan.			Kanzawa, Nobuyuki/0000-0002-8703-6828				Barizza E, 1999, FEBS LETT, V447, P191, DOI 10.1016/S0014-5793(99)00272-0; BOYLE W J, 1992, Current Opinion in Oncology, V4, P156, DOI 10.1097/00001622-199202000-00021; DATTA M, 1957, NATURE, V179, P253, DOI 10.1038/179253a0; Eun SO, 1997, PLANT PHYSIOL, V115, P1491, DOI 10.1104/pp.115.4.1491; FLEURATLESSARD P, 1988, J EXP BOT, V39, P209, DOI 10.1093/jxb/39.2.209; HOWARD PK, 1993, SCIENCE, V259, P241, DOI 10.1126/science.7678470; Kishi Y, 1998, J CELL SCI, V111, P2923; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; TAMIYA T, 1988, J BIOCHEM-TOKYO, V104, P5, DOI 10.1093/oxfordjournals.jbchem.a122421; TORIYAMA H, 1971, CYTOLOGIA, V36, P359, DOI 10.1508/cytologia.36.359	10	100	107	1	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					37	37		10.1038/35024149	http://dx.doi.org/10.1038/35024149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993062				2022-12-01	WOS:000089124000030
J	Murch, SH				Murch, SH			Diarrhoea, diagnostic delay, and appendicitis	LANCET			English	Editorial Material									UCL Royal Free & Univ Coll Med Sch, Univ Dept Paediat Gastroenterol, London NW3 2PF, England	University of London; University College London; UCL Medical School	Murch, SH (corresponding author), UCL Royal Free & Univ Coll Med Sch, Univ Dept Paediat Gastroenterol, London NW3 2PF, England.							ANDERSSON R, 1995, INT J EPIDEMIOL, V24, P829, DOI 10.1093/ije/24.4.829; Cappendijk VC, 2000, ARCH DIS CHILD, V83, P64, DOI 10.1136/adc.83.1.64; Hashimoto H, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.1.e2; Phillips AD, 2000, GUT, V47, P377, DOI 10.1136/gut.47.3.377; Saxen H, 1996, CLIN INFECT DIS, V23, P1038, DOI 10.1093/clinids/23.5.1038; WALKERSMITH JA, 1999, DIS SMALL INTESTINE, P119	6	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					787	787		10.1016/S0140-6736(00)02650-7	http://dx.doi.org/10.1016/S0140-6736(00)02650-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022923				2022-12-01	WOS:000089101800006
J	Brunner, D; Nurse, P				Brunner, D; Nurse, P			CLIP170-like tip1p spatially organizes microtubular dynamics in fission yeast	CELL			English	Article							OSCILLATORY NUCLEAR-MOVEMENT; SCHIZOSACCHAROMYCES-POMBE; CYTOPLASMIC DYNEIN; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; MEIOTIC PROPHASE; DYNACTIN COMPLEX; BINDING PROTEIN; LIVING CELLS; CLIP-170	Rod-shaped fission yeast cells grow in a polarized manner, and unlike budding yeast, the correct positioning of the growth sites at cell ends requires interphase microtubules. Here we describe a microtubule guidance mechanism that orients microtubules in the intracellular space along the long axis of the cell, guiding them to their target region at the cell ends. This mechanism involves tip1p, a CLIP170-like protein that localizes to distal tips of cytoplasmic microtubules. In the absence of tip1p, microtubular catastrophe is no longer restricted to cell ends but occurs when microtubules reach any region of the cellular cortex. Thus, tip1p enables microtubules to discriminate different cortical regions and regulates their dynamics accordingly.	Imperial Canc Res Fund, London WC2A 3PX, England	Cancer Research UK	Nurse, P (corresponding author), Imperial Canc Res Fund, 44 Lincolns Inn Fields, London WC2A 3PX, England.	p.nurse@icrf.icnet.uk	Brunner, Damian/F-2024-2011	Brunner, Damian/0000-0001-5250-492X				Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573; BRUNNER D, 2000, IN PRESS PHILOS T B; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Ding DQ, 1998, J CELL SCI, V111, P701; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; HAGAN IM, 1988, J CELL SCI, V89, P343; Hagan IM, 1998, J CELL SCI, V111, P1603; HAROLD FM, 1990, MICROBIOL REV, V54, P381, DOI 10.1128/MMBR.54.4.381-431.1990; HIRAOKA N, 1984, PLANT CELL TISS ORG, V3, P349, DOI 10.1007/BF00043087; Hirata D, 1998, J CELL SCI, V111, P149; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Jannatipour M, 1998, BBA-GENE STRUCT EXPR, V1399, P67, DOI 10.1016/S0167-4781(98)00097-9; Joshi HC, 1998, CURR OPIN CELL BIOL, V10, P35, DOI 10.1016/S0955-0674(98)80084-7; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Mata J, 1998, TRENDS CELL BIOL, V8, P163, DOI 10.1016/S0962-8924(98)01224-0; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; MITCHISON JM, 1985, J CELL SCI, V75, P357; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Nakaseko Y, 1996, GENES CELLS, V1, P633, DOI 10.1046/j.1365-2443.1996.00253.x; NURSE P, 1994, MOL BIOL CELL, V5, P613, DOI 10.1091/mbc.5.6.613; PerezPriego MA, 1996, INSULA, V51, P7; PIERRE P, 1994, J CELL SCI, V107, P1909; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Pruyne D, 2000, J CELL SCI, V113, P365; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; SNELL V, 1993, DEVELOPMENT, P289; TODA T, 1983, J MOL BIOL, V168, P251, DOI 10.1016/S0022-2836(83)80017-5; TODA T, 1984, CELL, V37, P233, DOI 10.1016/0092-8674(84)90319-2; Tran PT, 1999, BIOL BULL, V197, P262, DOI 10.2307/1542640; UMESONO K, 1983, J MOL BIOL, V168, P271, DOI 10.1016/S0022-2836(83)80018-7; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; VASILIEV JM, 1991, J CELL SCI, V98, P1; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan KT, 1999, J CELL SCI, V112, P1437; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529; WACKER IU, 1992, J CELL BIOL, V117, P813, DOI 10.1083/jcb.117.4.813; Wadsworth P, 1999, CELL MOTIL CYTOSKEL, V42, P48, DOI 10.1002/(SICI)1097-0169(1999)42:1<48::AID-CM5>3.3.CO;2-#; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Wilson E. B., 1925, CELL DEV HEREDITY; WOODS A, 1989, J CELL SCI, V93, P491; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamashita A, 1997, GENES CELLS, V2, P155, DOI 10.1046/j.1365-2443.1997.1100307.x	56	227	230	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					695	704		10.1016/S0092-8674(00)00091-X	http://dx.doi.org/10.1016/S0092-8674(00)00091-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007487	Bronze			2022-12-01	WOS:000089105200017
J	Bristow, M				Bristow, M			Etomoxir: a new approach to treatment of chronic heart failure	LANCET			English	Editorial Material							FATTY-ACID OXIDATION; RAT-HEART; DIABETES-MELLITUS; INHIBITION; HYPERTROPHY		Univ Colorado, Hlth Sci Ctr, Dept Cardiol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Bristow, M (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Cardiol, 4200 E 9th Ave, Denver, CO 80262 USA.		bristow, michael r/G-7850-2011					ABDELALEEM S, 1994, HORM METAB RES, V26, P88, DOI 10.1055/s-2007-1000779; Bristow MR, 1998, LANCET, V352, P8; COLLIER GR, 1993, HORM METAB RES, V25, P9, DOI 10.1055/s-2007-1002035; Dillmann W H, 1986, Adv Exp Med Biol, V194, P469; Eichhorn EJ, 1996, CIRCULATION, V94, P2285, DOI 10.1161/01.CIR.94.9.2285; HEYLIGER CE, 1982, BASIC RES CARDIOL, V77, P610, DOI 10.1007/BF01908314; Lowes BD, 1998, CIRCULATION, V98, P361; Lowes Brian D., 1999, Journal of the American College of Cardiology, V33, p216A; RATHEISER K, 1991, METABOLISM, V40, P1185, DOI 10.1016/0026-0495(91)90214-H; RUPP H, 1994, MOL CELL BIOCHEM, V132, P69, DOI 10.1007/BF00925676; Schmidt-Schweda S, 2000, CLIN SCI, V99, P27, DOI 10.1042/CS19990235; SHIMOYAMA H, 1998, J CARD FAIL, V4, P121; Turcani M, 1999, BRIT J PHARMACOL, V126, P501, DOI 10.1038/sj.bjp.0702312; Turcani M, 1997, CIRCULATION, V96, P3681; ZarainHerzberg A, 1996, FASEB J, V10, P1303, DOI 10.1096/fasebj.10.11.8836044	15	59	61	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2000	356	9242					1621	1622		10.1016/S0140-6736(00)03149-4	http://dx.doi.org/10.1016/S0140-6736(00)03149-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372TB	11089814				2022-12-01	WOS:000165249200003
J	Ostrov, DA; Shi, WX; Schwartz, JCD; Almo, SC; Nathenson, SG				Ostrov, DA; Shi, WX; Schwartz, JCD; Almo, SC; Nathenson, SG			Structure of murine CTLA-4 and its role in modulating T cell responsiveness	SCIENCE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; IMMUNOLOGICAL SYNAPSE; FC FRAGMENT; PROTEIN; RESOLUTION; COMPLEX; COSTIMULATION; RECEPTOR; CD28	The effective regulation of T cell responses is dependent on opposing signals transmitted through two related cell-surface receptors, CD28 and cytotoxic T Lymphocyte-associated antigen 4 (CTLA-4). Dimerization of CTLA-4 is required for the formation of high-avidity complexes with B7 ligands and for transmission of signals that attenuate T cell activation. We determined the crystal structure of the extracellular portion of CTLA-4 to 2.0 angstrom resolution. CTLA-4 belongs to the immunoglobulin superfamily and displays a strand topology similar to Vor domains, with an unusual mode of dimerization that places the B7 binding sites distal to the dimerization interface. This organization allows each CTLA-4 dimer to bind two bivalent B7 molecules and suggests that a periodic arrangement of these components within the immunological synapse may contribute to the regulation of T cell responsiveness.	Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Nathenson, SG (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA.	nathenso@aecom.yu.edu			NATIONAL CANCER INSTITUTE [T32CA009173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI007289, R56AI007289, R01AI007289, R01AI042970] Funding Source: NIH RePORTER; NCI NIH HHS [CA09173] Funding Source: Medline; NIAID NIH HHS [AI42970, AI07289] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Bluestone JA, 1997, J IMMUNOL, V158, P1989; BODIAN DL, 1994, STRUCTURE, V2, P755, DOI 10.1016/S0969-2126(94)00076-X; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; Ikemizu S, 1999, P NATL ACAD SCI USA, V96, P4289, DOI 10.1073/pnas.96.8.4289; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Janeway C A Jr, 1996, Semin Immunol, V8, P108; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kwon ED, 1997, P NATL ACAD SCI USA, V94, P8099, DOI 10.1073/pnas.94.15.8099; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Linsley PS, 1996, CURR BIOL, V6, P398, DOI 10.1016/S0960-9822(02)00506-7; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olsson C, 1999, J BIOL CHEM, V274, P14400, DOI 10.1074/jbc.274.20.14400; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEACH RJ, 1994, J EXP MED, V180, P20498; Sayegh MH, 1999, J CLIN INVEST, V103, P1223, DOI 10.1172/JCI6952; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; [No title captured]	44	116	140	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					816	819		10.1126/science.290.5492.816	http://dx.doi.org/10.1126/science.290.5492.816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052947				2022-12-01	WOS:000090067600052
J	Berl, V; Huc, I; Khoury, RG; Krische, MJ; Lehn, JM				Berl, V; Huc, I; Khoury, RG; Krische, MJ; Lehn, JM			Interconversion of single and double helices formed from synthetic molecular strands	NATURE			English	Article							GRAMICIDIN-A; OLIGOMERS; OLIGOANTHRANILAMIDES; COMPLEXES; FAMILY; MOTIFS	Synthetic single-helical conformations are quite common, but the formation of double helices based on recognition between the two constituent strands is relatively rare. Known examples include duplex formation through base-pair-specific hydrogen bonding and stacking, as found in nucleic acids and their analogues, and polypeptides composed of amino acids with alternating L and D configurations(1,2). Some synthetic polymers(3) and self-assembled fibres(4) have double-helical winding induced by van der Waals interactions. A third mode of non-covalent interaction, coordination of organic ligands to metal ions(5-7), can give rise to double, triple and quadruple helices, although in this case the assembly is driven by the coordination geometry of the metal and the structure of the ligands, rather than by direct inter-strand complementarity. Here we describe a family of oligomeric molecules with bent conformations, which exhibit dynamic exchange between single and double molecular helices in solution, through spiral sliding of the synthetic oligomer strands. The bent conformations leading to the helical shape of the molecules result from intramolecular hydrogen bonding within 2'-pyridyl-2-pyridinecarboxamide units(8-12), with extensive intermolecular aromatic stacking stabilizing the double-stranded helices that form through dimerization.	Univ Strasbourg 1, ISIS, Lab Chim Supramol, F-67000 Strasbourg, France; Forschungszentrum Karlsruhe GmbH, Inst Nanotechnol, D-76021 Karlsruhe, Germany; ENSCPB, Inst Europeen Chim & Biol, F-33402 Talence, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Karlsruhe Institute of Technology	Huc, I (corresponding author), Univ Strasbourg 1, ISIS, Lab Chim Supramol, 4 Rue Blaise Pascal, F-67000 Strasbourg, France.			Berl, Volker/0000-0002-0665-2718				BARSUKOV IL, 1987, BIOORG KHIM+, V13, P1501; Bassani DM, 1997, ANGEW CHEM INT EDIT, V36, P1845, DOI 10.1002/anie.199718451; BELL TW, 1994, NATURE, V367, P441, DOI 10.1038/367441a0; Berl V, 2000, CHEM-EUR J, V6, P1938; Cuccia LA, 2000, ANGEW CHEM INT EDIT, V39, P233, DOI 10.1002/(SICI)1521-3773(20000103)39:1<233::AID-ANIE233>3.0.CO;2-R; DIBLASIO B, 1989, BIOPOLYMERS, V28, P203, DOI 10.1002/bip.360280122; Engelkamp H, 1999, SCIENCE, V284, P785, DOI 10.1126/science.284.5415.785; Hamuro Y, 1997, J AM CHEM SOC, V119, P10587, DOI 10.1021/ja963449u; HAMURO Y, 1994, ANGEW CHEM INT EDIT, V33, P446, DOI 10.1002/anie.199404461; Hasenknopf B, 1996, ANGEW CHEM INT EDIT, V35, P1838, DOI 10.1002/anie.199618381; KOERT U, 1990, NATURE, V346, P339, DOI 10.1038/346339a0; Kusanagi H, 1996, POLYM J, V28, P708, DOI 10.1295/polymj.28.708; LANGS DA, 1988, SCIENCE, V241, P188, DOI 10.1126/science.2455345; Mazik M, 1999, TETRAHEDRON, V55, P12771, DOI 10.1016/S0040-4020(99)00789-9; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Ohkita M, 1999, CHEM-EUR J, V5, P3471, DOI 10.1002/(SICI)1521-3765(19991203)5:12<3471::AID-CHEM3471>3.0.CO;2-5; Redmore SM, 1997, INORG CHEM, V36, P4743, DOI 10.1021/ic961534x; SYCHEV SV, 1993, EUR BIOPHYS J BIOPHY, V22, P279, DOI 10.1007/BF00180262; VEATCH WR, 1974, BIOCHEMISTRY-US, V13, P5257, DOI 10.1021/bi00723a002; Yu Q, 1999, CHEM COMMUN, P1467, DOI 10.1039/a900541b	20	595	596	2	202	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					720	723		10.1038/35037545	http://dx.doi.org/10.1038/35037545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048713				2022-12-01	WOS:000089773900035
J	[Anonymous]				[Anonymous]			Does lung cancer need a lapel ribbon?	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2000	356	9237					1205	1205						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	361LQ	11072930				2022-12-01	WOS:000089724900001
J	Nikiforova, MN; Stringer, JR; Blough, R; Medvedovic, M; Fagin, JA; Nikiforov, YE				Nikiforova, MN; Stringer, JR; Blough, R; Medvedovic, M; Fagin, JA; Nikiforov, YE			Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells	SCIENCE			English	Article							THYROID PAPILLARY CARCINOMAS; RET PROTOONCOGENE; RET/PTC1 ONCOGENE; HIGH PREVALENCE; TUMORS; CHILDREN; EXPRESSION; ACCIDENT; MODEL	Rearrangements involving the RET gene are common in radiation-associated papillary thyroid cancer (PTC). The RET/PTC1 type of rearrangement is an inversion of chromosome 10 mediated by illegitimate recombination between the RET and the H4 genes, which are 30 megabases apart. Here we ask whether despite the great linear distance between them, RET;and H4 recombination might be promoted by their proximity in the nucleus. We used two-color fluorescence in situ hybridization and three-dimensional microscopy to map the positions of the RET and H4 loci within interphase nuclei. At least one pair of RET and H4 was juxtaposed in 35% of normal human thyroid cells and in 21% of peripheral blood lymphocytes, but only in 6% of normal mammary epithelial cells. Spatial contiguity of RFT and H4 may provide a structural basis for generation of RET/PTC1 rearrangement by allowing, a single radiation track to produce a double-strand break in each gene at the same site in the nucleus.	Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Div Endocrinol & Metab, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Mol Genet, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Ctr Biostat Serv, Cincinnati, OH 45267 USA; Childrens Hosp, Med Ctr, Div Human Genet, Cytogenet Lab, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Nikiforov, YE (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.				NATIONAL CANCER INSTITUTE [R01CA072597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005652] Funding Source: NIH RePORTER; NCI NIH HHS [CA 72597] Funding Source: Medline; NIEHS NIH HHS [P01 ES 05652-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arscott PL, 1997, ENDOCRINOLOGY, V138, P5019, DOI 10.1210/en.138.11.5019; Bounacer A, 1997, ONCOGENE, V15, P1263, DOI 10.1038/sj.onc.1200206; CANNIZZARO LA, 1997, BASIC CELL CULTURE P, V75, pCH26; FUGAZZOLA L, 1995, CANCER RES, V55, P5617; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; ITO T, 1993, CANCER RES, V53, P2940; Jhiang SM, 1996, ENDOCRINOLOGY, V137, P375, DOI 10.1210/en.137.1.375; Jossart GH, 1996, CYTOGENET CELL GENET, V75, P254, DOI 10.1159/000134495; Klugbauer S, 1995, ONCOGENE, V11, P2459; Kozubek S, 1997, BLOOD, V89, P4537, DOI 10.1182/blood.V89.12.4537; Mizuno T, 1997, ONCOGENE, V15, P1455, DOI 10.1038/sj.onc.1201313; Nikiforov YE, 1999, ONCOGENE, V18, P6330, DOI 10.1038/sj.onc.1203019; Nikiforov YE, 1997, CANCER RES, V57, P1690; NIKIFOROVA MN, UNPUB; Portella G, 1996, ONCOGENE, V13, P2021; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; SANTORO M, 1993, BRIT J CANCER, V68, P460, DOI 10.1038/bjc.1993.370; SANTORO M, 1994, ONCOGENE, V9, P509; Savage JRK, 1996, MUTAT RES-REV GENET, V366, P81, DOI 10.1016/S0165-1110(96)90030-5; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; Weir B.S., 1996, GENETIC DATA ANAL; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239	22	339	354	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					138	141		10.1126/science.290.5489.138	http://dx.doi.org/10.1126/science.290.5489.138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021799				2022-12-01	WOS:000089724800052
J	Sisodia, SS				Sisodia, SS			Neuroscience - An accomplice for gamma-secretase brought into focus	SCIENCE			English	Editorial Material							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PRESENILIN		Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Sisodia, SS (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.							Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; De Strooper B, 2000, NATURE, V405, P627, DOI 10.1038/35015193; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	10	13	13	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2296	2297		10.1126/science.289.5488.2296	http://dx.doi.org/10.1126/science.289.5488.2296			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11041797				2022-12-01	WOS:000089593500036
J	Daniels, NA; Ray, B; Easton, A; Marano, N; Kahn, E; McShan, AL; Del Rosario, L; Baldwin, T; Kingsley, MA; Puhr, ND; Wells, JG; Angulo, FJ				Daniels, NA; Ray, B; Easton, A; Marano, N; Kahn, E; McShan, AL; Del Rosario, L; Baldwin, T; Kingsley, MA; Puhr, ND; Wells, JG; Angulo, FJ			Emergence of a new Vibrio parahaemolyticus serotype in raw oysters - A prevention quandary	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTROENTERITIS; SHELLFISH; INFECTIONS; OUTBREAK; CHOLERAE	Context In May and June 1998, reported Vibrio parahaemolyticus infections increased sharply in Texas. Objective To determine factors that contributed to the increase in V parahaemolyticus infections. Design, Setting, and Participants Cross-sectional survey of persons reporting gas troenteritis after eating seafood in Texas; survey of environmental conditions in Galveston Bay. Main Outcome Measures Traceback of oysters, water quality measures in harvest areas, presence of V parahaemolyticus in stool cultures; comparison of median values for environmental conditions before and during the outbreak compared with during the previous 5 years. Results Between May 31 and July 10, 1998, 416 persons in 13 states reported having gastroenteritis after eating oysters harvested from Galveston Bay. All 28 available stool specimens from affected persons yielded V parahaemolyticus serotype O3:K6 isolates. Oyster beds met current bacteriologic standards during harvest and fecal coliform counts in water samples were within acceptable limits. Median water temperature and salinity during May and June 1998 were 30.0 degrees C and 29.6 parts per thousand (ppt) compared with 28.9 degrees C and 15.6 ppt for the previous 5 years (P<.001). Conclusions This is the first reported outbreak of V parahaemolyticus serotype O3:K6 infection in the United States. The emergence of a virulent serotype and elevated seawater temperatures and salinity levels may have contributed to this large multistate outbreak of V parahaemolyticus. Bacteriologic monitoring at harvest sites did not prevent this outbreak, suggesting that current policy and regulations regarding the safety of raw oysters require reevaluation. Consumers and physicians should understand that raw or undercooked oysters can cause illness even if harvested from monitored beds. In patients who develop acute gastroenteritis within 4 days of consuming raw or undercooked oysters, a stool specimen should be tested for Vibrio species using specific media.	Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94115 USA; Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidemiol Branch, Off Smoking & Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Texas Dept Hlth, Austin, TX 78756 USA; Meharry Med Coll, Nashville, TN 37208 USA	University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Texas Department of State Health Services; Meharry Medical College	Daniels, NA (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, 1701 Divisadero,Suite 500, San Francisco, CA 94115 USA.	ndaniels@medicine.ucsf.edu		Kahn, Emily/0000-0001-7812-7958				Arakawa E, 1999, JPN J INFECT DIS, V52, P246; BARTH SS, 1999, 99 GEN M AM SOC MICR; Bej AK, 1999, J MICROBIOL METH, V36, P215, DOI 10.1016/S0167-7012(99)00037-8; CDC (Centers for Disease Control and Prevention), 2008, MMWR-MORBID MORTAL W, V47, P457; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P48; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; DOWELL SF, 1995, J INFECT DIS, V171, P1497, DOI 10.1093/infdis/171.6.1497; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; LEVINE WC, 1993, J INFECT DIS, V167, P479, DOI 10.1093/infdis/167.2.479; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; MCCARTHY SA, 1994, APPL ENVIRON MICROB, V60, P2597, DOI 10.1128/AEM.60.7.2597-2601.1994; McLaughlin James C., 1995, P465; MORRIS JG, 1985, NEW ENGL J MED, V312, P343, DOI 10.1056/NEJM198502073120604; NOLAN CM, 1984, DIAGN MICR INFEC DIS, V2, P119, DOI 10.1016/0732-8893(84)90007-5; Okuda N, 1997, J CLIN MICROBIOL, V35, P3150, DOI 10.1128/JCM.35.12.3150-3155.1997; PORTNOY BL, 1975, JAMA-J AM MED ASSOC, V233, P1065, DOI 10.1001/jama.233.10.1065; Shapiro RL, 1998, J INFECT DIS, V178, P752, DOI 10.1086/515367; THOMPSON CA, 1976, J FOOD SCI, V41, P204, DOI 10.1111/j.1365-2621.1976.tb01138.x; *USDA, 1997, GUID CONTR MOLL SHEL; WILSON R, 1981, AM J EPIDEMIOL, V114, P293, DOI 10.1093/oxfordjournals.aje.a113194; Wong HC, 1996, J CLIN MICROBIOL, V34, P1535, DOI 10.1128/JCM.34.6.1535-1539.1996; ZENYOJI H, 1970, HEALTH LAB SCI, V7, P100	24	122	132	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1541	1545		10.1001/jama.284.12.1541	http://dx.doi.org/10.1001/jama.284.12.1541			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000648	Bronze			2022-12-01	WOS:000089379700030
J	Versluis, M; Schmitz, B; von der Heydt, A; Lohse, D				Versluis, M; Schmitz, B; von der Heydt, A; Lohse, D			How snapping shrimp snap: Through cavitating bubbles	SCIENCE			English	Article							ALPHEUS-HETEROCHAELIS; DYNAMICS; ACOUSTICS	The snapping shrimp (Alpheus heterochaelis) produces a loud snapping sound by an extremely rapid closure of its snapper claw. One of the effects of the snapping is to stun or kill prey animals. During the rapid snapper claw closure, a high-velocity water jet is emitted from the claw with a speed exceeding cavitation conditions. Hydrophone measurements in conjunction with time-controlled high-speed imaging of the claw closure demonstrate that the sound is emitted at the cavitation bubble collapse and not on claw closure. A model for the bubble dynamics based on a Rayleigh-Plesset-type equation quantitatively accounts for the time dependence of the bubble radius and for the emitted sound.	Univ Twente, Dept Appl Phys, NL-7500 AE Enschede, Netherlands; Univ Twente, JM Burgers Res Ctr Fluid Dynam, NL-7500 AE Enschede, Netherlands; Tech Univ Munich, Dept Zool, D-85747 Garching, Germany; Univ Marburg, Dept Phys, D-35032 Marburg, Germany	University of Twente; University of Twente; Technical University of Munich; Philipps University Marburg	Lohse, D (corresponding author), Univ Twente, Dept Appl Phys, POB 217, NL-7500 AE Enschede, Netherlands.		Lohse, Detlef/B-4915-2013; von der Heydt, Anna S/B-9250-2008; Versluis, Michel/F-3541-2011	Lohse, Detlef/0000-0003-4138-2255; von der Heydt, Anna S/0000-0002-5557-3282; Versluis, Michel/0000-0002-2296-1860				Au WWL, 1998, J ACOUST SOC AM, V103, P41, DOI 10.1121/1.423234; Blake JR, 1998, APPL SCI RES, V58, P77, DOI 10.1023/A:1000711113941; Brennen C.E., 1995, CAVITATION BUBBLE DY, DOI [10.1017/S0022112096230599, DOI 10.1017/S0022112096230599]; Brooks WK, 1891, MEM NAT AKAD SCI WAS, V5, P319; CATO DH, 1992, MRLTR9123 DEF SCI TE; CECCIO SL, 1991, J FLUID MECH, V233, P633, DOI 10.1017/S0022112091000630; Epifanio CL, 1999, J ACOUST SOC AM, V106, P3211, DOI 10.1121/1.428175; EVEREST FA, 1948, J ACOUST SOC AM, V20, P137, DOI 10.1121/1.1906355; Hao Y, 1999, PHYS FLUIDS, V11, P2008, DOI 10.1063/1.870064; Herberholz J, 1998, BIOL BULL, V195, P156, DOI 10.2307/1542823; Herberholz J, 1999, J COMP PHYSIOL A, V185, P41, DOI 10.1007/s003590050364; Hilgenfeldt S, 1998, EUR PHYS J B, V4, P247, DOI 10.1007/s100510050375; Hilgenfeldt S, 1996, PHYS FLUIDS, V8, P2808, DOI 10.1063/1.869131; JOHNSON MW, 1947, BIOL BULL, V93, P122, DOI 10.2307/1538284; Landau L.D., 1987, FLUID MECH-SOV RES; MacGinitie G.E., 1949, NATURAL HIST MARINE, P276; PLESSET MS, 1977, ANNU REV FLUID MECH, V9, P145, DOI 10.1146/annurev.fl.09.010177.001045; PROSPERETTI A, 1977, Q APPL MATH, V34, P339, DOI 10.1090/qam/99652; PROSPERETTI A, 1986, J FLUID MECH, V168, P457, DOI 10.1017/S0022112086000460; RITZMANN RE, 1974, J COMP PHYSIOL, V95, P217, DOI 10.1007/BF00625445; SCHEIN H, 1975, Marine Behaviour and Physiology, V3, P83; SCHMITZ B, IN PRESS CRUSTACEAN; SCHMITZ B, 1998, NEW NEUROETHOLOGY MO, V2, P241; Schultz S., 1998, ZOOL-ANAL COMPLEX SY, V101, P85; Storey BD, 2000, P ROY SOC A-MATH PHY, V456, P1685, DOI 10.1098/rspa.2000.0582; TOGEL R, IN PRESS PHYS REV LE; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; VERSLUIS M, UNPUB; VOLZ P., 1938, ZEITSCHR MORPH U OKOL TIERE, V34, P272, DOI 10.1007/BF00408760	29	288	299	11	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2114	2117		10.1126/science.289.5487.2114	http://dx.doi.org/10.1126/science.289.5487.2114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000111				2022-12-01	WOS:000089430900041
J	Ciau-Uitz, A; Walmsley, M; Patient, R				Ciau-Uitz, A; Walmsley, M; Patient, R			Distinct origins of adult and embryonic blood in Xenopus	CELL			English	Article							HEMATOPOIETIC STEM-CELL; DEFINITIVE HEMATOPOIESIS; PARAAORTIC SPLANCHNOPLEURA; MOUSE EMBRYOS; FATE MAP; YOLK-SAC; IN-VIVO; LAEVIS; AORTA; LIVER	Whether embryonic and adult blood derive from a single (yolk sac) or dual (yolk sac plus intraembryonic) origin is controversial. Here, we show, in Xenopus, that the yolk sac (VBI) and intraembryonic (DLP) blood compartments derive from distinct blastomeres in the 32-cell embryo. The first adult hematopoietic stem cells (HSCs) are thought to form in association with the floor of the dorsal aorta, and we have detected such aortic clusters in Xenopus using hematopoietic markers. Lineage tracing shows that the aortic clusters derive from the blastomere that gives rise to the DLP. These observations indicate that the first adult HSCs arise independently of the embryonic lineage.	Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England	University of Nottingham	Patient, R (corresponding author), Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England.		Ciau-Uitz, Aldo/AAE-8989-2020	Ciau-Uitz, Aldo/0000-0002-0505-6607				BECHTOLD TE, 1992, J IMMUNOL, V148, P2975; Bertwistle D, 1996, MECH DEVELOP, V57, P199, DOI 10.1016/0925-4773(96)00547-3; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Cleaver O, 1997, DEV DYNAM, V210, P66, DOI 10.1002/(SICI)1097-0177(199709)210:1<66::AID-AJA7>3.3.CO;2-S; CORMIER F, 1986, DEV BIOL, V118, P167, DOI 10.1016/0012-1606(86)90084-9; CORMIER F, 1988, DEVELOPMENT, V102, P279; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; DALE L, 1987, DEVELOPMENT, V99, P527; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; Domen J, 1999, MOL MED TODAY, V5, P201, DOI 10.1016/S1357-4310(99)01464-1; Dzierzak E, 1998, IMMUNOL TODAY, V19, P228, DOI 10.1016/S0167-5699(98)01258-4; FLAJNIK MF, 1984, DEV BIOL, V104, P247, DOI 10.1016/0012-1606(84)90052-6; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; KAU CL, 1983, J IMMUNOL, V131, P2262; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Lane MC, 1999, DEVELOPMENT, V126, P423; MAENO M, 1985, DEV BIOL, V110, P503, DOI 10.1016/0012-1606(85)90108-3; MAENO M, 1985, DEV GROWTH DIFFER, V27, P137; Manaia A, 2000, DEVELOPMENT, V127, P643; Mead PE, 1998, DEVELOPMENT, V125, P2611; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Medvinsky A, 1999, BLOOD, V94, P3613; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; METCALF D, 1971, HAEMATOPOIETIC CELLS, V24; Meyer D, 1995, INT J DEV BIOL, V39, P909; Mills KR, 1999, DEV BIOL, V209, P352, DOI 10.1006/dbio.1999.9245; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; MOODY SA, 1987, DEV BIOL, V122, P300, DOI 10.1016/0012-1606(87)90296-X; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; NAKAMURA O, 1971, P JPN ACAD, V47, P407, DOI 10.2183/pjab1945.47.407; Newman CS, 1997, MECH DEVELOP, V66, P83, DOI 10.1016/S0925-4773(97)00092-0; Nieuwkoop P.D., 1994, NORMAL TABLES XENOPU; North T, 1999, DEVELOPMENT, V126, P2563; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Tavian M, 1999, DEVELOPMENT, V126, P793; TOMPKINS R, 1980, DEV DIFFERENTIATION, P25; Tracey WD, 1998, DEVELOPMENT, V125, P1371; TURPEN JB, 1982, DEV BIOL, V89, P138, DOI 10.1016/0012-1606(82)90302-5; Turpen JB, 1997, IMMUNITY, V7, P325, DOI 10.1016/S1074-7613(00)80354-4; VOLPE EP, 1981, ASPECTS DEV COMP IMM, P192; WALMSLEY ME, 1994, DEVELOPMENT, V120, P2519; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wood HB, 1997, BLOOD, V90, P2300; Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776	50	185	187	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 15	2000	102	6					787	796		10.1016/S0092-8674(00)00067-2	http://dx.doi.org/10.1016/S0092-8674(00)00067-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030622	Bronze			2022-12-01	WOS:000089395200010
J	Polejaeva, IA; Chen, SH; Vaught, TD; Page, RL; Mullins, J; Ball, S; Dai, YF; Boone, J; Walker, S; Ayares, DL; Colman, A; Campbell, KHS				Polejaeva, IA; Chen, SH; Vaught, TD; Page, RL; Mullins, J; Ball, S; Dai, YF; Boone, J; Walker, S; Ayares, DL; Colman, A; Campbell, KHS			Cloned pigs produced by nuclear transfer from adult somatic cells	NATURE			English	Article							EMBRYOS; OOCYTES; FETAL; MICE; TRANSPLANTATION; LINE	Since the first report of live mammals produced by nuclear transfer from a cultured differentiated cell population in 1995 (ref. 1), successful development has been obtained in sheep(2,3), cattle(4), mice(5) and goats(6) using a variety of somatic cell types as nuclear donors. The methodology used for embryo reconstruction in each of these species is essentially similar: diploid donor nuclei have been transplanted into enucleated MII oocytes that are activated on, or after transfer. In sheep(2) and goat(6) preactivated oocytes have also proved successful as cytoplast recipients. The reconstructed embryos are then cultured and selected embryos transferred to surrogate recipients for development to term. In pigs, nuclear transfer has been significantly less successful; a single piglet was reported after transfer of a blastomere nucleus from a four-cell embryo to an enucleated oocyte(7); however, no live offspring were obtained in studies using somatic cells such as diploid or mitotic fetal fibroblasts as nuclear donors(8,9). The development of embryos reconstructed by nuclear transfer is dependent upon a range of factors. Here we investigate some of these factors and report the successful production of cloned piglets from a cultured adult somatic cell population using a new nuclear transfer procedure.	PPL Therapeut Inc, Blacksburg, VA 24060 USA; PPL Therapeut Inc, Roslin EH25 9PP, Midlothian, Scotland		Polejaeva, IA (corresponding author), PPL Therapeut Inc, 1700 Kraft Dr, Blacksburg, VA 24060 USA.	ipolejaeva@ppl-therapeutics.com	Polejaeva, Irina/G-4881-2012	Polejaeva, Irina/0000-0002-0858-5889				Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Campbell K H, 1996, Rev Reprod, V1, P40, DOI 10.1530/ror.0.0010040; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; CANSECO RS, 1994, TRANSGENIC RES, V3, P20, DOI 10.1007/BF01976023; CHRISTENSON RK, 1971, J ANIM SCI, V32, P282; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Colman A, 1999, Cloning, V1, P185; Kwon OY, 1996, P NATL ACAD SCI USA, V93, P13010, DOI 10.1073/pnas.93.23.13010; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; MCGRATH J, 1983, J EXP ZOOL, V228, P355, DOI 10.1002/jez.1402280218; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; Ouhibi N, 1996, REPROD NUTR DEV, V36, P661; PETTERS RM, 1993, J REPROD FERTIL, P61; Platt JL, 1996, CURR OPIN IMMUNOL, V8, P721, DOI 10.1016/S0952-7915(96)80091-4; POLGE C, 1966, J REPROD FERTIL, V12, P395, DOI 10.1530/jrf.0.0120395; PRATHER RS, 1991, MOL REPROD DEV, V28, P405, DOI 10.1002/mrd.1080280413; PRATHER RS, 1989, BIOL REPROD, V41, P414, DOI 10.1095/biolreprod41.3.414; Tao T, 1999, ANIM REPROD SCI, V56, P133, DOI 10.1016/S0378-4320(99)00037-8; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wells DN, 1997, BIOL REPROD, V57, P385, DOI 10.1095/biolreprod57.2.385; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	22	904	1126	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					86	90		10.1038/35024082	http://dx.doi.org/10.1038/35024082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993078				2022-12-01	WOS:000089124000047
J	Roditi, HA; Fisher, NS; Sanudo-Wilhelmy, SA				Roditi, HA; Fisher, NS; Sanudo-Wilhelmy, SA			Uptake of dissolved organic carbon and trace elements by zebra mussels	NATURE			English	Article							WATER HUDSON RIVER; DREISSENA-POLYMORPHA; AMINO-ACIDS; FOOD; BIOACCUMULATION; INVASION; COLLOIDS; RELEASE; METALS; MATTER	Zebra mussels (Dreissena polymorpha) are widespread and abundant in major freshwater ecosystems in North America, even though the phytoplankton food resources in some of these systems seem to be too low to sustain them(1,2). Because phytoplankton biomass is greatly depleted in ecosystems with large D. polymorpha populations(3,4) and bacteria do not seem to be an important food source for this species(5), exploitation of alternative carbon sources may explain the unexpected success of D. polymorpha in such environments. Here we examine the possibility that absorption of dissolved organic carbon (DOC) from water(6-9) could provide a nutritional supplement to zebra mussels. We find that mussels absorb C-14-labelled DOC produced by cultured diatoms with an efficiency of 0.23%; this indicates that DOC in natural waters could contribute up to 50% of the carbon demand of zebra mussels. We also find that zebra mussels absorb some dissolved metals that have been complexed by the DOM; although absorption of dissolved selenium was unaffected by DOC, absorption of dissolved cadmium, silver and mercury by the mussels increased 32-, 8.7- and 3.6-fold, respectively, in the presence of high-molecular-weight DOC.	SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Fisher, NS (corresponding author), SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA.	nfisher@notes.cc.sunysb.edu						ARMSTRONG FA, 1966, NATURE, V211, P481, DOI 10.1038/211481a0; Campbell P.G.C., 1995, METAL SPECIATION BIO, P45; Caraco NF, 1997, ECOLOGY, V78, P588, DOI 10.1890/0012-9658(1997)078[0588:ZMIIAL]2.0.CO;2; Carvalho RA, 1999, LIMNOL OCEANOGR, V44, P403, DOI 10.4319/lo.1999.44.2.0403; Ciborowski JJH, 1997, J N AM BENTHOL SOC, V16, P771, DOI 10.2307/1468170; CUTTER GA, 1992, MAR CHEM, V40, P65, DOI 10.1016/0304-4203(92)90048-F; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Fahnenstiel GL, 1995, J GREAT LAKES RES, V21, P435, DOI 10.1016/S0380-1330(95)71057-7; FERGUSON JC, 1982, BIOL BULL, V162, P1, DOI 10.2307/1540965; Findlay S, 1998, MICROBIAL ECOL, V36, P131, DOI 10.1007/s002489900100; Findlay S, 1996, ESTUARIES, V19, P866, DOI 10.2307/1352303; Fisher NS, 1996, ENVIRON SCI TECHNOL, V30, P3232, DOI 10.1021/es960009u; HEDGES JI, 1994, LIMNOL OCEANOGR, V39, P743, DOI 10.4319/lo.1994.39.4.0743; HOWARTH RW, 1992, BIOGEOCHEMISTRY, V16, P83; KEPKAY PE, 1994, MAR ECOL PROG SER, V109, P293, DOI 10.3354/meps109293; KOUCH J, 1996, ENVIRON INT, V22, P585; KRYGER J, 1988, OECOLOGIA, V77, P34, DOI 10.1007/BF00380921; LEE BG, 1992, LIMNOL OCEANOGR, V37, P1345; Madon SP, 1998, CAN J FISH AQUAT SCI, V55, P401, DOI 10.1139/cjfas-55-2-401; Nichols S. Jerrine, 1993, P733; Roditi HA, 1999, LIMNOL OCEANOGR, V44, P1730, DOI 10.4319/lo.1999.44.7.1730; Santschi P.H., 1999, BIOGEOCHEMISTRY GULF, P347; SANUDOWILHELMY SA, 1996, EOS, V77, pF200; STEPHENS GC, 1964, BIOL BULL, V126, P150, DOI 10.2307/1539425; Strayer DL, 1996, CAN J FISH AQUAT SCI, V53, P1143, DOI 10.1139/cjfas-53-5-1143; WALZ N, 1978, Archiv fuer Hydrobiologie Supplement, V55, P121; Wang WX, 1996, MAR ECOL PROG SER, V140, P91, DOI 10.3354/meps140091; Wotton RS, 1996, J N AM BENTHOL SOC, V15, P127, DOI 10.2307/1467438; WRIGHT SH, 1989, ANNU REV PHYSIOL, V51, P585, DOI 10.1146/annurev.ph.51.030189.003101; WRIGHT SH, 1984, J COMP PHYSIOL, V154, P249, DOI 10.1007/BF02464404	30	126	131	3	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					78	80		10.1038/35024069	http://dx.doi.org/10.1038/35024069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993076				2022-12-01	WOS:000089124000045
J	Sachs, GA				Sachs, GA			Sometimes dying still stings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2000	284	19					2423	2423		10.1001/jama.284.19.2423	http://dx.doi.org/10.1001/jama.284.19.2423			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371MY	11074757				2022-12-01	WOS:000165183800001
J	Heath, PT; Booy, R; Azzopardi, HJ; Slack, MPE; Bowen-Morris, J; Griffiths, H; Ramsay, ME; Deeks, JJ; Moxon, ER				Heath, PT; Booy, R; Azzopardi, HJ; Slack, MPE; Bowen-Morris, J; Griffiths, H; Ramsay, ME; Deeks, JJ; Moxon, ER			Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLUENZAE TYPE-B; HAEMOPHILUS-INFLUENZAE; PRP-T; ACCELERATED IMMUNIZATION; CAPSULAR POLYSACCHARIDE; INFANT IMMUNIZATION; PROTEIN CONJUGATE; SERUM ANTIBODIES; RANDOMIZED TRIAL; DISEASE	Context The schedule for Haemophilus influenzae type b (Hib) vaccination of infants in the United Kingdom consists of 3 doses given at 2, 3, and 4 months of age. Many countries include a fourth dose (booster) of Hib vaccine in the second year of life on the basis of declining Hib antibody concentrations after the primary series. Few data are available to show that this fourth dose is actually necessary. Objective To evaluate long-term clinical protection against Hib disease and Hib antibody concentrations following primary Hib vaccination without a booster dose. Design, Setting, and Subjects Clinical protection study conducted between October 1992 and March 1999 in the United Kingdom, in which children developing invasive Hib disease despite vaccination in infancy with 3 doses of Hib conjugate vaccine were reported by pediatricians through an active, prospective, national survey. Separate antibody studies were conducted among 2 cohorts of children (n=153 and n=107) vaccinated at 2, 3, and 4 months of age with Hib conjugate vaccine and followed up to 43 and 72 months of age. Main Outcome Measures Age-specific vaccine effectiveness, derived from the observed number of true vaccine failures after 3 Hib vaccine doses compared with the number of cases expected based on the age-specific rates of invasive Hib disease obtained prior to the introduction of Hib vaccines; and proportion of children in the 2 cohorts with Hib antibody concentrations of less than 0.15 and less than 1.0 mug/mL. Results Ninety-six true vaccine failures occurring after 3 vaccine doses were detected. During the study period, an estimated 4368200 infants in the United Kingdom received 3 doses of vaccine; therefore, the vaccine failure rate was 2.2 per 100000 vaccinees (95% confidence interval, 1.8-2.7 per 100000). Although vaccine effectiveness declined significantly after the first year of life (P<.001), it remained high until the sixth year of life (99.4% in children aged 5-11 months vs 97.3% in those aged 12-71 months). The proportion of cohorts 1 and 2 with anti-PRP antibody levels of less than 0.15 <mu>g/mL increased between 12 and 72 months of age (6% at 12 months, 8% at 43 months, and 32% at 72 months; chi (2)(1)=18.25; P<.001 for trend). Conclusions Our results suggest that anti-PRP antibody levels and clinical protection against Hib disease wane over time after Hib vaccination at 2, 3, and 4 months of age without a booster dose at 2 years of age. The decline in clinical protection is minimal, however, suggesting that a booster dose of Hib vaccine following infant vaccination is not essential.	John Radcliffe Hosp, Oxford Vaccine Grp, Oxford OX3 9DU, England; John Radcliffe Hosp, Publ Hlth Lab Serv, Haemophilus Reference Lab, Oxford OX3 9DU, England; St Bartholomews & Royal London Sch Med & Dent, Dept Child Hlth, London, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; Inst Hlth Sci, Ctr Stat Med, Oxford, England	University of Oxford; University of Oxford; University of London; Queen Mary University London; Public Health England; University of Oxford	Heath, PT (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Child Hlth, Cranmer Terrace, London SW17 0RE, England.	pheath@sghms.ac.uk	Deeks, Jon/AAV-5745-2020; Ramsay, Mary Elizabeth/S-8281-2016	Deeks, Jon/0000-0002-8850-1971; Heath, Paul/0000-0002-7540-7433; Ramsay, Mary Elizabeth/0000-0002-7156-7640				Adegbola RA, 1999, LANCET, V354, P1091, DOI 10.1016/S0140-6736(99)03010-X; BOOY R, 1993, BRIT MED J, V306, P971, DOI 10.1136/bmj.306.6883.971; Booy R, 1997, LANCET, V349, P1197, DOI 10.1016/S0140-6736(96)06392-1; BOOY R, 1992, ARCH DIS CHILD, V67, P475, DOI 10.1136/adc.67.4.475; BOOY R, 1993, ARCH DIS CHILD, V69, P225, DOI 10.1136/adc.69.2.225; BOOY R, 1994, LANCET, V344, P362, DOI 10.1016/S0140-6736(94)91400-1; Booy R, 1998, LANCET, V351, P1446, DOI 10.1016/S0140-6736(98)22020-4; *BRIT PAED SURV UN, 1998, 12 ROYAL COLL PAED C, P20; CLAESSON BA, 1991, PEDIATR INFECT DIS J, V10, P560, DOI 10.1097/00006454-199108000-00002; Coen PG, 1998, EPIDEMIOL INFECT, V120, P281, DOI 10.1017/S0950268898008784; Eskola J., 1996, Reviews in Medical Microbiology, V7, P231; Eskola J, 1999, LANCET, V354, P2063, DOI 10.1016/S0140-6736(99)04377-9; ESKOLA J, 1990, NEW ENGL J MED, V323, P1381, DOI 10.1056/NEJM199011153232004; FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382, DOI 10.1128/JCM.32.10.2382-2386.1994; Galil K, 1999, J INFECT DIS, V179, P101, DOI 10.1086/314569; Goldblatt D, 1998, BMJ-BRIT MED J, V316, P1570, DOI 10.1136/bmj.316.7144.1569; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; Hargreaves RM, 1996, BRIT MED J, V312, P160; Heath PT, 1997, ARCH DIS CHILD, V77, P488, DOI 10.1136/adc.77.6.488; HEATH PT, IN PRESS CLIN INFECT; Herceg A, 1997, Commun Dis Intell, V21, P173; JONSDOTTIR KE, 1996, ICELANDIC MED J, V82, P32; KAYHTY H, 1983, J INFECT DIS, V147, P1100; Lagos R, 1996, PEDIATR INFECT DIS J, V15, P216, DOI 10.1097/00006454-199603000-00008; Lagos R, 1998, LANCET, V351, P1472, DOI 10.1016/S0140-6736(97)07456-4; MOHLEBOETANI JC, 1993, PEDIATR INFECT DIS J, V12, P589, DOI 10.1097/00006454-199307000-00009; Mulholland EK, 1998, PEDIATR INFECT DIS J, V17, pS123, DOI 10.1097/00006454-199809001-00006; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Peltola H, 1999, J INFECT DIS, V179, P223, DOI 10.1086/314535; Rothman KJ, 1986, MODERN EPIDEMIOLOGY; Scheifele DW, 1999, VACCINE, V17, P543, DOI 10.1016/S0264-410X(98)00232-1; Scheifele DW, 1996, CAN MED ASSOC J, V154, P1041; *STAT CORP, 1999, STAT STAT SOFTW REL; TAKALA AK, 1991, J INFECT DIS, V164, P982, DOI 10.1093/infdis/164.5.982; van Alphen L, 1997, J PEDIATR-US, V131, P869, DOI 10.1016/S0022-3476(97)70035-0; WEINBERG GA, 1987, J PEDIATR-US, V111, P22, DOI 10.1016/S0022-3476(87)80336-0; WENGER JD, 1997, NEW GENERATION VACCI, P489; 1998, MMWR MORB MORTAL WKL, V47, P993	38	104	106	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2000	284	18					2334	2340		10.1001/jama.284.18.2334	http://dx.doi.org/10.1001/jama.284.18.2334			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369NU	11066183	Bronze			2022-12-01	WOS:000165074500027
J	Goldmark, JP; Fazzio, TG; Estep, PW; Church, GM; Tsukiyama, T				Goldmark, JP; Fazzio, TG; Estep, PW; Church, GM; Tsukiyama, T			The Isw2 chromatin remodeling complex represses early meiotic genes upon recruitment by Ume6p	CELL			English	Article							HISTONE DEACETYLASE ACTIVITY; SWI-SNF COMPLEX; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REPRESSION; IN-VIVO; NEGATIVE REGULATOR; ACTIVATOR-BINDING; YEAST; EXPRESSION; NUCLEOSOME	The ISWI class of chromatin remodeling factors exhibits potent chromatin remodeling activities in vitro. However, the in vivo functions of this class of factors are unknown at a molecular level. We have found that S. cerevisiae Isw2 complex represses transcription of early meiotic genes during mitotic growth in a parallel pathway to Rpd3-Sin3 histone deacetylase complex. This repressor function of lsw2 complex is largely dependent upon Ume6p, which recruits the complex to target genes. Nuclease digestion analyses revealed that Isw2 complex establishes nuclease-inaccessible chromatin structure near the Ume6p binding site in vivo. Based on these findings, we propose a model for the mechanism of transcriptional repression by two distinct chromatin remodeling complexes.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Mol & Cellular Biol Program, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98109 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School	Tsukiyama, T (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	ttsukiya@fhcrc.org		church, george/0000-0001-6232-9969	NIGMS NIH HHS [GM58465-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058465] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aach J, 2000, GENOME RES, V10, P431, DOI 10.1101/gr.10.4.431; ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; ANDERSON SF, 1995, PROTEIN SCI, V4, P1832, DOI 10.1002/pro.5560040918; Belotserkovskaya R, 1999, CRIT REV EUKAR GENE, V9, P221, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.70; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; BOWDISH KS, 1995, MOL CELL BIOL, V15, P2955; BOWDISH KS, 1993, MOL CELL BIOL, V13, P2172, DOI 10.1128/MCB.13.4.2172; Cairns BR, 1998, TRENDS BIOCHEM SCI, V23, P20, DOI 10.1016/S0968-0004(97)01160-2; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; DEURING R, 2000, IN PRESS MOL CELL; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Ito T, 1996, J BIOL CHEM, V271, P25041, DOI 10.1074/jbc.271.40.25041; Jackson JC, 1996, NUCLEIC ACIDS RES, V24, P1322, DOI 10.1093/nar/24.7.1322; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kupiec M., 1997, MOL CELLULAR BIOL YE, P889; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Peterson CL, 1998, COLD SPRING HARB SYM, V63, P545, DOI 10.1101/sqb.1998.63.545; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Roberts SM, 1997, GENETICS, V147, P451; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; SMITH HE, 1990, MOL CELL BIOL, V10, P6103, DOI 10.1128/MCB.10.12.6103; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Steber CM, 1995, P NATL ACAD SCI USA, V92, P12490, DOI 10.1073/pnas.92.26.12490; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; STRICH R, 1989, P NATL ACAD SCI USA, V86, P10018, DOI 10.1073/pnas.86.24.10018; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Suka N, 1998, COLD SPRING HARB SYM, V63, P391, DOI 10.1101/sqb.1998.63.391; Sweet DH, 1997, MOL CELL BIOL, V17, P6223, DOI 10.1128/MCB.17.11.6223; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Trachtulcova P, 2000, YEAST, V16, P35, DOI 10.1002/(SICI)1097-0061(20000115)16:1<35::AID-YEA504>3.0.CO;2-0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; VIDAL M, 1991, MOL CELL BIOL, V11, P6317, DOI 10.1128/MCB.11.12.6317; Wade PA, 1999, CURR BIOL, V9, pR221, DOI 10.1016/S0960-9822(99)80134-1; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	72	203	211	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 27	2000	103	3					423	433		10.1016/S0092-8674(00)00134-3	http://dx.doi.org/10.1016/S0092-8674(00)00134-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081629	Bronze			2022-12-01	WOS:000090144100008
J	Waizenegger, IC; Hauf, S; Meinke, A; Peters, JM				Waizenegger, IC; Hauf, S; Meinke, A; Peters, JM			Two distinct pathways remove mammalian cohesin from chromosome arms in prophase and from centromeres in anaphase	CELL			English	Article							SISTER-CHROMATID SEPARATION; MATURATION-PROMOTING FACTOR; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; CYCLIN-B; MITOSIS; COMPLEX; PROTEIN; DEGRADATION	In yeast, anaphase depends on cohesin cleavage. How anaphase is controlled in vertebrates is unknown because their cohesins dissociate from chromosomes before anaphase. We show that residual amounts of the cohesin SCC1 remain associated with human centromeres until the onset of anaphase when a similarly small amount of SCC1 is cleaved. In Xenopus extracts, SCC1 cleavage depends on the anaphase-promoting complex and separin. Separin immunoprecipitates are sufficient to cleave SCC1, indicating that separin is associated with a protease activity. Separin activation coincides with securin destruction and partial separin cleavage, suggesting that several mechanisms regulate separin activity. We propose that in vertebrates, a cleavage-independent pathway removes cohesin from chromosome arms during prophase, whereas a separin-dependent pathway cleaves centromeric cohesin at the metaphase-anaphase transition.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Vienna, Dept Genet & Microbiol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Vienna	Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	peters@nt.imp.univie.ac.at	Hauf, Silke/H-7321-2012	Hauf, Silke/0000-0001-5938-721X				Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Darwiche N, 1999, GENE, V233, P39, DOI 10.1016/S0378-1119(99)00160-2; Dej KJ, 2000, TRENDS CELL BIOL, V10, P392, DOI 10.1016/S0962-8924(00)01821-3; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Koshland DE, 2000, CURR OPIN CELL BIOL, V12, P297, DOI 10.1016/S0955-0674(00)00092-2; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2000, J CELL BIOL, V150, P405, DOI 10.1083/jcb.150.3.405; MAY GS, 1992, J BIOL CHEM, V267, P15737; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Nagase T, 1996, DNA Res, V3, P43, DOI 10.1093/dnares/3.1.43; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; OSTERGREN G, 1973, STAINING KINETOCHORE, V23, P159; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; Pidoux AL, 2000, CURR OPIN CELL BIOL, V12, P308, DOI 10.1016/S0955-0674(00)00094-6; Rieder CL, 1999, J CELL SCI, V112, P2607; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; SUMARA I, 2000, IN PRESS J CELL BIOL; SUMNER AT, 1992, J CELL SCI, V103, P105; SUMNER AT, 1991, CHROMOSOMA, V100, P410, DOI 10.1007/BF00337519; Tang TTL, 1998, GENE DEV, V12, P3843, DOI 10.1101/gad.12.24.3843; TOMONOGA T, 2000, IN PRESS GENES DEV; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vorlaufer E, 1998, MOL BIOL CELL, V9, P1817, DOI 10.1091/mbc.9.7.1817; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	44	561	574	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 27	2000	103	3					399	410		10.1016/S0092-8674(00)00132-X	http://dx.doi.org/10.1016/S0092-8674(00)00132-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081627	Bronze			2022-12-01	WOS:000090144100006
J	McCarroll, L; Paton, MG; Karunaratne, SHPP; Jayasuryia, HTR; Kalpage, KSP; Hemingway, J				McCarroll, L; Paton, MG; Karunaratne, SHPP; Jayasuryia, HTR; Kalpage, KSP; Hemingway, J			Insecticides and mosquito-borne disease	NATURE			English	Article							RESISTANT CULEX-QUINQUEFASCIATUS; WUCHERERIA-BANCROFTI; SRI-LANKA; GENES		Cardiff Univ, Sch Biosci, Cardiff CF10 3TL, S Glam, Wales; Univ Peradeniya, Dept Zool, Peradeniya, Sri Lanka; Open Univ, Dept Zool, Nugegoda, Sri Lanka; Anti Filariasis Campaign, Colombo, Sri Lanka	Cardiff University; University of Peradeniya; Open University Sri Lanka	McCarroll, L (corresponding author), Cardiff Univ, Sch Biosci, Cardiff CF10 3TL, S Glam, Wales.	Hemingway@cardiff.ac.uk		Hemingway, Janet/0000-0002-3200-7173				BROGDON WG, 1990, PESTIC BIOCHEM PHYS, V37, P130, DOI 10.1016/0048-3575(90)90118-L; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hemingway J, 2000, INSECT MOL BIOL, V9, P93, DOI 10.1046/j.1365-2583.2000.00160.x; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; JAYASEKERA N, 1991, T ROY SOC TROP MED H, V85, P250, DOI 10.1016/0035-9203(91)90044-Y; Nicolas L, 1997, PARASITE, V4, P253, DOI 10.1051/parasite/1997043253; Parakrama Karunaratne S.H.P., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P460; Paton MG, 2000, BIOCHEM J, V346, P17, DOI 10.1042/0264-6021:3460017; Peiris HTR, 1996, MED VET ENTOMOL, V10, P283, DOI 10.1111/j.1365-2915.1996.tb00744.x; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Salazar C. E., 1994, Insect Molecular Biology, V3, P1, DOI 10.1111/j.1365-2583.1994.tb00145.x; Vaughan A, 1997, BIOCHEM J, V325, P359, DOI 10.1042/bj3250359	13	67	71	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2000	407	6807					961	962		10.1038/35039671	http://dx.doi.org/10.1038/35039671			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069167				2022-12-01	WOS:000090032500031
J	Huntington, JA; Read, RJ; Carrell, RW				Huntington, JA; Read, RJ; Carrell, RW			Structure of a serpin-protease complex shows inhibition by deformation	NATURE			English	Article							CRYSTAL-STRUCTURE; ALPHA-1-PROTEINASE INHIBITOR; REACTIVE CENTER; ALPHA-1-ANTITRYPSIN; PROTEINASE; TRYPSIN; ANTITHROMBIN; MECHANISM; MOLSCRIPT; INSERTION	The serpins have evolved to be the predominant family of serine-protease inhibitors in man(1,2). Their unique mechanism of inhibition involves a profound change in conformation(3), although the nature and significance of this change has been controversial. Here we report the crystallographic structure of a typical serpin-protease complex and show the mechanism of inhibition. The conformational change is initiated by reaction of the active serine of the protease with the reactive centre of the serpin. This cleaves the reactive centre, which then moves 71 Angstrom to the opposite pole of the serpin, taking the tethered protease with it. The tight linkage of the two molecules and resulting overlap of their structures does not affect the hyperstable serpin, but causes a surprising 37% loss of structure in the protease. This is induced by the plucking of the serine from its active site, together with breakage of interactions formed during zymogen activation(4). The disruption of the catalytic site prevents the release of the protease from the complex, and the structural disorder allows its proteolytic destruction(5,6). It is this ability of the conformational mechanism to crush as well as inhibit proteases that provides the serpins with their selective advantage.	Univ Cambridge, Wellcome Trust Ctr Mol Mech Dis, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England	University of Cambridge	Huntington, JA (corresponding author), Univ Cambridge, Wellcome Trust Ctr Mol Mech Dis, Cambridge Inst Med Res, Dept Haematol, Hills Rd, Cambridge CB2 2XY, England.	jah52@cam.ac.uk; rwc1000@cam.ac.uk	Read, Randy J/L-1418-2013	Read, Randy J/0000-0001-8273-0047				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; COLMAN PM, 1976, CRYSTALLOGRAPHIC COM, P248; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; ENGH R, 1989, PROTEIN ENG, V2, P407, DOI 10.1093/protein/2.6.407; Engh RA, 1995, TRENDS BIOTECHNOL, V13, P503, DOI 10.1016/S0167-7799(00)89013-7; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Fa M, 2000, STRUCT FOLD DES, V8, P397, DOI 10.1016/S0969-2126(00)00121-0; Gils A, 1998, THROMB HAEMOSTASIS, V80, P531; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; Harrop SJ, 1999, STRUCTURE, V7, P43, DOI 10.1016/S0969-2126(99)80008-2; HERVE M, 1991, ARCH BIOCHEM BIOPHYS, V285, P142, DOI 10.1016/0003-9861(91)90341-F; HOLMES WE, 1987, SCIENCE, V238, P209, DOI 10.1126/science.2958938; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; KASLIK G, 1995, FEBS LETT, V370, P179, DOI 10.1016/0014-5793(95)00816-R; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lee SL, 1997, BIOCHEMISTRY-US, V36, P13180, DOI 10.1021/bi970912m; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OLSON ST, 1995, J BIOL CHEM, V270, P30007; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Picard V, 1999, J BIOL CHEM, V274, P4586, DOI 10.1074/jbc.274.8.4586; Plotnick MI, 1996, BIOCHEMISTRY-US, V35, P7586, DOI 10.1021/bi960233w; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Stavridi ES, 1996, BIOCHEMISTRY-US, V35, P10608, DOI 10.1021/bi9605806; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; WRIGHT HT, 1995, PROTEINS, V22, P210, DOI 10.1002/prot.340220303	36	886	923	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					923	926		10.1038/35038119	http://dx.doi.org/10.1038/35038119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057674				2022-12-01	WOS:000089901900057
J	McDonald, JJ; Teder-Salejarvi, WA; Hillyard, SA				McDonald, JJ; Teder-Salejarvi, WA; Hillyard, SA			Involuntary orienting to sound improves visual perception	NATURE			English	Article							AUDIOVISUAL LINKS; ATTENTION; MECHANISMS; IDENTIFICATION; MODALITY; CUES	To perceive real-world objects and events, we need to integrate several stimulus features belonging to different sensory modalities. Although the neural mechanisms and behavioural consequences of intersensory integration have been extensively studied(1-4), the processes that enable us to pay attention to multimodal objects are still poorly understood. An important question is whether a stimulus in one sensory modality automatically attracts attention to spatially coincident stimuli that appear subsequently in other modalities, thereby enhancing their perceptual salience. The occurrence of an irrelevant sound does facilitate motor responses to a subsequent light appearing nearby(5-7). However, because participants in previous studies made speeded responses rather than psychophysical judgements, it remains unclear whether involuntary auditory attention actually affects the perceptibility of visual stimuli as opposed to postperceptual decision and response processes. Here we provide psychophysical evidence that a sudden sound improves the detectability of a subsequent flash appearing at the same location. These data show that the involuntary orienting of attention to sound enhances early perceptual processing of visual stimuli.	Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	McDonald, JJ (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.		McDonald, John/P-6966-2015					Bertelson P, 1998, PSYCHON B REV, V5, P482, DOI 10.3758/BF03208826; Driver J, 1998, CURR OPIN NEUROBIOL, V8, P245, DOI 10.1016/S0959-4388(98)80147-5; Driver J, 1998, TRENDS COGN SCI, V2, P254, DOI 10.1016/S1364-6613(98)01188-7; Dufour A, 1999, EXP BRAIN RES, V126, P215, DOI 10.1007/s002210050731; GREEN DM, 1966, SIGNAL DETECTION THE; Luck SJ, 1999, PERCEPT PSYCHOPHYS, V61, P1424, DOI 10.3758/BF03206191; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; McDonald JJ, 2000, PSYCHOL SCI, V11, P167, DOI 10.1111/1467-9280.00233; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; Mondor TA, 1998, J EXP PSYCHOL HUMAN, V24, P745, DOI 10.1037/0096-1523.24.3.745; Pashler H., 1998, PSYCHOL ATTENTION; SANTEE JL, 1982, J EXP PSYCHOL HUMAN, V8, P489, DOI 10.1037/0096-1523.8.4.489; Schmitt M, 2000, Q J EXP PSYCHOL-A, V53, P105, DOI 10.1080/027249800390691; SHIU LP, 1994, J EXP PSYCHOL HUMAN, V20, P1037, DOI 10.1037/0096-1523.20.5.1037; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; SPERLING G, 1986, HDB PERCEPTION HUMAN, V1, P2; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Stein BE., 1993, MERGING SENSES; Ward L. M., 1998, VISUAL ATTENTION, P232; Ward LM, 2000, PERCEPT PSYCHOPHYS, V62, P1258, DOI 10.3758/BF03212127; WARD LM, 1994, CAN J EXP PSYCHOL, V48, P242, DOI 10.1037/1196-1961.48.2.242; WELCH RB, 1986, HDB PERCEPTION HUMAN, V251, P25	23	338	342	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					906	908		10.1038/35038085	http://dx.doi.org/10.1038/35038085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	364PZ	11057669				2022-12-01	WOS:000089901900052
J	Glass, JI; Lefkowitz, EJ; Glass, JS; Heiner, CR; Chen, EY; Cassell, GH				Glass, JI; Lefkowitz, EJ; Glass, JS; Heiner, CR; Chen, EY; Cassell, GH			The complete sequence of the mucosal pathogen Ureaplasma urealyticum	NATURE			English	Article							MYCOPLASMA-GENITALIUM; ESCHERICHIA-COLI; PNEUMONIAE; MOLLICUTES; VIRULENCE; BACTERIA; UREASE; DNA	The comparison of the genomes of two very closely related human mucosal pathogens, Mycoplasma genitalium and Mycoplasma pneumoniae, has helped define the essential functions of a self-replicating minimal cell, as well as what constitutes a mycoplasma. Here we report the complete sequence of a more distant phylogenetic relative of those bacteria, Ureaplasma urealyticum (parvum biovar), which is also a mucosal pathogen of humans. It is the third mycoplasma to be sequenced, and has the smallest sequenced prokaryotic genome except for M. genitalium. Although the U. urealyticum genome is similar to the two sequenced mycoplasma genomes(1,2), features make this organism unique among mycoplasmas and all bacteria. Almost all ATP synthesis is the result of urea hydrolysis, which generates an energy-producing electrochemical gradient. Some highly conserved eubacterial enzymes appear not to be encoded by U. urealyticum, including the cell-division protein FtsZ, chaperonins GroES and GroEL, and ribonucleoside-diphosphate reductase. U. urealyticum has six closely related iron transporters, which apparently arose through gene duplication, suggesting that it has a kind of respiration system not present in other small genome bacteria The genome is only 25.5% G+C in nucleotide content, and the G+C content of individual genes may predict how essential those genes are to ureaplasma survival.	Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Eli Lilly & Co, Infect Dis Res & Clin Invest, Indianapolis, IN 46285 USA; Perkin Elmer Corp, Adv Ctr Genom Technol, Foster City, CA 94404 USA	University of Alabama System; University of Alabama Birmingham; Eli Lilly	Glass, JI (corresponding author), Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA.		Glass, John/A-6572-2015	Glass, John/0000-0002-3784-5301; Lefkowitz, Elliot/0000-0002-4748-4925				BAUMINGER ER, 1980, J BACTERIOL, V141, P378, DOI 10.1128/JB.141.1.378-381.1980; BRADBURY JM, 1997, INT J SYST BACTERIOL, V47, P911; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; CHEN EY, 1993, GENOMICS, V17, P651, DOI 10.1006/geno.1993.1385; DESILVA NS, 1991, J CLIN MICROBIOL, V29, P1498, DOI 10.1128/JCM.29.7.1498-1503.1991; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Heiner CR, 1998, GENOME RES, V8, P557, DOI 10.1101/gr.8.5.557; Himmelreich R, 1997, NUCLEIC ACIDS RES, V25, P701, DOI 10.1093/nar/25.4.701; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; JAYAKUMAR A, 1985, J BIOL CHEM, V260, P7528; KILIAN M, 1984, ACTA PATH MICRO IM B, V92, P61; LIGON JV, 1991, INFECT IMMUN, V59, P1170, DOI 10.1128/IAI.59.3.1170-1171.1991; MOBLEY HL, 1985, MICROBIOL REV, V59, P451; Neyrolles O, 1996, J BACTERIOL, V178, P647, DOI 10.1128/jb.178.3.647-655.1996; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; POLLACK JD, 1981, J BACTERIOL, V146, P907, DOI 10.1128/JB.146.3.907-913.1981; ROMANO N, 1986, PEDIATR INFECT DIS J, V5, P308; Shepard M.C., 1979, MYCOPLASMAS, P451; SHEPARD MC, 1966, HEALTH LAB SCI, V3, P163; Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398; SMITH DGE, 1993, J BACTERIOL, V175, P3253, DOI 10.1128/jb.175.11.3253-3258.1993; SMITH RL, 1995, J BACTERIOL, V177, P1233, DOI 10.1128/jb.177.5.1233-1238.1995; SOMERSON NL, 1965, SCIENCE, V150, P226, DOI 10.1126/science.150.3693.226; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; WILLIAMS MV, 1990, J BACTERIOL, V172, P2979, DOI 10.1128/jb.172.6.2979-2985.1990; WILLIAMS MV, 1988, DNA REPLICATION MUTA, P440; Wren BW, 1998, MICROBIOL-SGM, V144, P1205, DOI 10.1099/00221287-144-5-1205; ZHENG XT, 1995, INFECT IMMUN, V63, P891, DOI 10.1128/IAI.63.3.891-898.1995	30	271	563	0	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					757	762		10.1038/35037619	http://dx.doi.org/10.1038/35037619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048724				2022-12-01	WOS:000089773900046
J	Balsalobre, A; Brown, SA; Marcacci, L; Tronche, F; Kellendonk, C; Reichardt, HM; Schutz, G; Schibler, U				Balsalobre, A; Brown, SA; Marcacci, L; Tronche, F; Kellendonk, C; Reichardt, HM; Schutz, G; Schibler, U			Resetting of circadian time peripheral tissues by glucocorticoid signaling	SCIENCE			English	Article							DROSOPHILA CLOCK; GENE-EXPRESSION; CRYPTOCHROME; ONTOGENY; RECEPTOR; CULTURE; RHYTHMS; BRAIN	In mammals, circadian oscillators reside not only in the suprachiasmatic nucleus of the brain, which harbors the central pacemaker, but also in most peripheral tissues. Here, we show that the glucocorticoid hormone analog dexamethasone induces circadian gene expression in cultured rat-1 fibroblasts and transiently changes the phase of circadian gene expression in liver, kidney, and heart. However, dexamethasone does not affect cyclic gene expression in neurons of the suprachiasmatic nucleus. This enabled us to establish an apparent phase-shift response curve specifically for peripheral clocks in intact animals. In contrast to the central clock, circadian oscillators in peripheral tissues appear to remain responsive to phase resetting throughout the day.	Univ Geneva, Dept Biol Mol Sci 2, CH-1211 Geneva, Switzerland; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany	University of Geneva; Helmholtz Association; German Cancer Research Center (DKFZ)	Schibler, U (corresponding author), Univ Geneva, Dept Biol Mol Sci 2, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.		Brown, Steven/E-4955-2013; TRONCHE, François/F-3895-2011; Jansen, Heiko T./A-5770-2008; Reichardt, Holger/AAF-3048-2020; Kellendonk, Christoph/O-7229-2018	Jansen, Heiko T./0000-0003-0178-396X; Reichardt, Holger/0000-0003-4647-057X; Kellendonk, Christoph/0000-0003-3302-2188				Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Brown SA, 1999, CURR OPIN GENET DEV, V9, P588, DOI 10.1016/S0959-437X(99)00009-X; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery IF, 1997, P NATL ACAD SCI USA, V94, P4092, DOI 10.1073/pnas.94.8.4092; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; HASTINGS MH, 1997, CURR BIOL, V7, P670; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; LEMINH N, UNPUB; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; ROSENFELD P, 1988, DEV BRAIN RES, V42, P119, DOI 10.1016/0165-3806(88)90207-6; ROSENFELD P, 1993, CELL MOL NEUROBIOL, V13, P295, DOI 10.1007/BF00711575; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; White R, 1998, ENDOCR-RELAT CANCER, V5, P1, DOI 10.1677/erc.0.0050001; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	21	1285	1320	3	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2344	2347		10.1126/science.289.5488.2344	http://dx.doi.org/10.1126/science.289.5488.2344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009419				2022-12-01	WOS:000089593500051
J	Tamai, K; Semenov, M; Kato, Y; Spokony, R; Liu, CM; Katsuyama, Y; Hess, F; Saint-Jeannet, JP; He, X				Tamai, K; Semenov, M; Kato, Y; Spokony, R; Liu, CM; Katsuyama, Y; Hess, F; Saint-Jeannet, JP; He, X			LDL-receptor-related proteins in Wnt signal transduction	NATURE			English	Article							NEURAL CREST; MOLECULAR-CLONING; AXIS FORMATION; BETA-CATENIN; WINGLESS; FAMILY; PATHWAY; MEMBER; REQUIREMENTS; INDUCTION	The Wnt family of secreted signalling molecules are essential in embryo development and tumour formation(1). The Frizzled (Fz) family of serpentine receptors function as Wnt receptors(2-10), but how Fz proteins transduce signalling is not understood. In Drosophila, arrow phenocopies the wingless (DWnt-1) phenotype(11), and encodes a transmembrane protein(11) that is homologous to two members of the mammalian low-density lipoprotein receptor (LDLR)-related protein (LRP) family, LRP5 and LRP6 (refs 12-15). Here we report that LRP6 functions as a co-receptor for Wnt signal transduction. In Xenopus embryos, LRP6 activated Wnt-Fz signalling, and induced Wnt responsive genes, dorsal axis duplication and neural crest formation. An LRP6 mutant lacking the carboxyl intracellular domain blocked signalling by Wnt or Wnt-Fz, but not by Dishevelled or beta-catenin, and inhibited neural crest development. The extracellular domain of LRP6 bound Wnt-1 and associated with Fz in a Wnt-dependent manner. Our results indicate that LRP6 may be a component of the Wnt receptor complex.	Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol,Div Neurosci, Boston, MA 02115 USA; Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Merck Res Labs, Dept Human Genet, West Point, PA 19486 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Pennsylvania; Merck & Company	He, X (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol,Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	he_x@hub.tch.harvard.edu	Spokony, Rebecca/AAD-3014-2020					Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; Brown SP, 1998, J AGING PHYS ACTIV, V6, P248, DOI 10.1123/japa.6.3.248; Chan TYK, 1998, PHARMACOEPIDEM DR S, V7, P129, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<129::AID-PDS326>3.3.CO;2-R; Chen CM, 1999, DEVELOPMENT, V126, P5441; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Kato Y, 1999, J NEUROSCI, V19, P9364; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Muller HAJ, 1999, DEVELOPMENT, V126, P577; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	30	1038	1109	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					530	535		10.1038/35035117	http://dx.doi.org/10.1038/35035117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029007				2022-12-01	WOS:000089727400055
J	Vernino, S; Low, PA; Fealey, RD; Stewart, JD; Farrugia, G; Lennon, VA				Vernino, S; Low, PA; Fealey, RD; Stewart, JD; Farrugia, G; Lennon, VA			Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYASTHENIA-GRAVIS; TACHYCARDIA SYNDROME; NERVOUS-SYSTEM; ANTIBODIES; THYMOMA; PSEUDOOBSTRUCTION; DYSAUTONOMIA; RECOVERY; DISEASE	Background: Idiopathic autonomic neuropathy is a severe, subacute disorder with a presumed autoimmune basis. It is indistinguishable from the subacute autonomic neuropathy that may accompany lung cancer or other tumors. Autoantibodies specific for nicotinic acetylcholine receptors in the autonomic ganglia are potentially pathogenic and may serve as serologic markers of various forms of autoimmune autonomic neuropathy. Methods: We tested serum from 157 patients with a variety of types of dysautonomia. Immunoprecipitation assays with iodine-125-labeled epibatidine and solubilized human neuroblastoma acetylcholine receptors were used to detect autoantibodies that bound to or blocked ganglionic receptors. Results: Ganglionic-receptor-binding antibodies were found in 19 of 46 patients with idiopathic or paraneoplastic autonomic neuropathy (41 percent), in 6 of 67 patients with postural tachycardia syndrome, idiopathic gastrointestinal dysmotility, or diabetic autonomic neuropathy (9 percent), and in none of 44 patients with other autonomic disorders. High levels of the binding antibodies correlated with more severe autonomic dysfunction (including the presence of tonic pupils). Levels of these antibodies decreased in patients who had clinical improvement. All seven patients with ganglionic-receptor-blocking antibodies had ganglionic-receptor-binding antibodies and had idiopathic or paraneoplastic autonomic neuropathy. Conclusions: Seropositivity for antibodies that bind to or block ganglionic acetylcholine receptors identifies patients with various forms of autoimmune autonomic neuropathy and distinguishes these disorders from other types of dysautonomia. The positive correlation between high levels of ganglionic-receptor antibodies and the severity of autonomic dysfunction suggests that the antibodies have a pathogenic role in these types of neuropathy. (N Engl J Med 2000;343:847-55.) (C) 2000, Massachusetts Medical Society.	Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; McGill Univ, Montreal Neurol Hosp & Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; McGill University	Vernino, S (corresponding author), Mayo Clin & Mayo Fdn, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.	verns@mayo.edu	Vernino, Steven/AAD-5181-2020	Vernino, Steven/0000-0001-7799-8495				Anderson NE, 1996, NEUROLOGY, V47, P985, DOI 10.1212/WNL.47.4.985; BESINGER UA, 1983, NEUROLOGY, V33, P1316, DOI 10.1212/WNL.33.10.1316; Bohnen Nicolaas I., 1997, Neurology, V48, pA131; Bradbury S, 1925, AM HEART J, V1, P73, DOI 10.1016/S0002-8703(25)90007-5; CAMILLERI M, 1990, DIGEST DIS SCI, V35, P609, DOI 10.1007/BF01540409; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; FEALEY RD, 1989, MAYO CLIN PROC, V64, P617, DOI 10.1016/S0025-6196(12)65338-5; GERZANICH V, 1995, MOL PHARMACOL, V48, P774; GRIESMANN GE, 1997, MANUAL CLIN LAB IMMU, P983; Hart IK, 1997, ANN NEUROL, V41, P238, DOI 10.1002/ana.410410215; HOWARD FM, 1987, ANN NY ACAD SCI, V505, P526, DOI 10.1111/j.1749-6632.1987.tb51321.x; KHURANA RK, 1997, CLIN AUTONOMIC DISOR, P545; LENNON VA, 1995, NEW ENGL J MED, V332, P1467, DOI 10.1056/NEJM199506013322203; LENNON VA, 1991, GASTROENTEROLOGY, V100, P137, DOI 10.1016/0016-5085(91)90593-A; LENNON VA, 1996, TXB AUTOANTIBODIES, P139; Lennon Vanda A., 1997, Neurology, V48, pS23; Low PA, 1997, MUSCLE NERVE, V20, P1561, DOI 10.1002/(SICI)1097-4598(199712)20:12<1561::AID-MUS11>3.0.CO;2-3; LOW PA, 1993, J CLIN NEUROPHYSIOL, V10, P14, DOI 10.1097/00004691-199301000-00003; LOW PA, 1993, MAYO CLIN PROC, V68, P748, DOI 10.1016/S0025-6196(12)60631-4; LOW PA, 1997, CLIN AUTONOMIC DISOR, P463; Lucchinetti CF, 1998, NEUROLOGY, V50, P652, DOI 10.1212/WNL.50.3.652; RUST G, 1994, EUR J NEUROSCI, V6, P478, DOI 10.1111/j.1460-9568.1994.tb00290.x; Sandroni P, 1999, MAYO CLIN PROC, V74, P1106, DOI 10.4065/74.11.1106; SCHONDORF R, 1993, NEUROLOGY, V43, P132, DOI 10.1212/WNL.43.1_Part_1.132; SHY GM, 1960, ARCH NEUROL-CHICAGO, V2, P511, DOI 10.1001/archneur.1960.03840110025004; SKOK VI, 1987, J AUTONOM NERV SYST, V21, P91, DOI 10.1016/0165-1838(87)90012-9; Smit AAJ, 1997, MAYO CLIN PROC, V72, P333, DOI 10.4065/72.4.333; SUAREZ GA, 1994, NEUROLOGY, V44, P1675, DOI 10.1212/WNL.44.9.1675; TABBAA MA, 1986, ARCH NEUROL-CHICAGO, V43, P955, DOI 10.1001/archneur.1986.00520090079023; Venkataraman S, 1998, NEUROLOGY, V51, P1764, DOI 10.1212/WNL.51.6.1764; Vernino S, 1998, NEUROLOGY, V50, P1806, DOI 10.1212/WNL.50.6.1806; Vernino S, 2000, ANN NEUROL, V47, P297, DOI 10.1002/1531-8249(200003)47:3<297::AID-ANA4>3.3.CO;2-W; Vernino S, 1999, NEUROLOGY, V53, P1233, DOI 10.1212/WNL.53.6.1233; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; YOUNG RR, 1975, BRAIN, V98, P613, DOI 10.1093/brain/98.4.613; Yu ZY, 1999, NEW ENGL J MED, V340, P227, DOI 10.1056/NEJM199901213400311	36	443	451	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2000	343	12					847	855		10.1056/NEJM200009213431204	http://dx.doi.org/10.1056/NEJM200009213431204			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354XB	10995864				2022-12-01	WOS:000089355600004
J	Nishime, EO; Cole, CR; Blackstone, EH; Pashkow, FJ; Lauer, MS				Nishime, EO; Cole, CR; Blackstone, EH; Pashkow, FJ; Lauer, MS			Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY DISEASE; MEDICALLY TREATED PATIENTS; CHRONOTROPIC INCOMPETENCE; PROGNOSTIC INFORMATION; MYOCARDIAL-INFARCTION; VITAL STATUS; DEATH; ASSOCIATION; SURVIVAL	Context Both attenuated heart rate recovery following exercise and the Duke tread mill exercise score have been demonstrated to be independent predictors of mortality, belt their prognostic value relative to each other has not been studied. Objective To assess the associations among abnormal heart rate recovery, treadmill exercise score, and death in patients referred specifically for exercise electrocardiography. Design and Setting Prospective cohort study conducted in an academic medical center between September 1990 and December 1997, with a median follow-up of 5.2 years. Patients A total of 9454 consecutive patients (mean [SD] age, 53 [11] years; 78% male) who underwent symptom-limited exercise electrocardiographic testing. Exclusion criteria included age younger than 30 years, history of heart failure or valvular disease, pacemaker implantation, and uninterpretable electrocardiograms. Main Outcome Measures All-cause mortality, as predicted by abnormal heart rate recovery, defined as failure of heart rate to decrease by more than 12/min during the first minute after peak exercise, and by treadmill exercise score, defined as (exercise time) - (5 x maximum ST-segment deviation) - (4 x treadmill angina index). Results Three hundred twelve deaths occurred in the cohort. Abnormal heart rate recovery and intermediate- or high-risk treadmill exercise score were present in 20% (n =1852) and 21% (n =1996) of patients. respectively. in univariate analyses, death was predicted by both abnormal heart rate recovery (8% vs 2% in patients with normal heart rate recovery; hazard ratio [HR], 4.16; 95% confidence interval [CI], 3.33-5.19; chi(2)=158; P<.001) and intermediate- or high-risk treadmill exercise score (8% vs 2% in patients with low-risk scores; HR, 4.28; 95% CI, 3.43-5.35; chi(2)=164; P<.001). After adjusting for age, sex, standard cardiovascular risk factors, medication use, and other potential confounders, abnormal heart rate recovery remained predictive of death (among the 8549 patients not taking p-blockers, adjusted HR, 2.13; 95% CI, 1.63-2.78; P<.001), as did intermediate- or high-risk treadmill exercise score (adjusted HR, 1.49, 95% CI, 2.15-1.92; P=.002). There was no interaction between these 2 predictors. Conclusions in this cohort of patients referred specifically for exercise electrocardiography, both abnormal heart rate recovery and treadmill exercise score were independent predictors of mortality. Heart rate recovery appears to provide additional prognostic information to the established treadmill exercise score and should be considered for routine incorporation into exercise test interpretation.	Cleveland Clin Fdn, Dept Cardiol, Clin Res & Exercise Lab, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiothorac Surg, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Lauer, MS (corresponding author), Cleveland Clin Fdn, Dept Cardiol, Clin Res & Exercise Lab, Desk F25, Cleveland, OH 44195 USA.		Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177				ARAI Y, 1989, AM J PHYSIOL, V256, pH132, DOI 10.1152/ajpheart.1989.256.1.H132; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; BRUNELLI C, 1989, EUR HEART J, V10, P292, DOI 10.1093/oxfordjournals.eurheartj.a059486; Chen SC, 1999, ADV POLYM TECH, V18, P1, DOI 10.1002/(SICI)1098-2329(199921)18:1<1::AID-ADV1>3.0.CO;2-0; Cole CR, 2000, ANN INTERN MED, V132, P552, DOI 10.7326/0003-4819-132-7-200004040-00007; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; COX DR, 1972, J R STAT SOC B, V34, P187; CURB JD, 1985, AM J EPIDEMIOL, V121, P754, DOI 10.1093/aje/121.5.754; FLETCHER GF, 1995, CIRCULATION, V91, P580, DOI 10.1161/01.CIR.91.2.580; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; GOHLKE H, 1983, CIRCULATION, V68, P979, DOI 10.1161/01.CIR.68.5.979; HAMMERMEISTER KE, 1979, CIRCULATION, V59, P421, DOI 10.1161/01.CIR.59.3.421; HUBBARD BL, 1992, ARCH INTERN MED, V152, P309, DOI 10.1001/archinte.152.2.309; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kwok JMF, 1999, JAMA-J AM MED ASSOC, V282, P1047, DOI 10.1001/jama.282.11.1047; LADENHEIM ML, 1987, AM J CARDIOL, V59, P270, DOI 10.1016/0002-9149(87)90798-3; Lauer MS, 1997, CIRCULATION, V96, P897; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lauer MS, 1996, CIRCULATION, V93, P1520, DOI 10.1161/01.CIR.93.8.1520; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; Lauer MS, 1998, LANCET, V351, P615, DOI 10.1016/S0140-6736(97)07062-1; Lauer MS, 1998, J AM COLL CARDIOL, V32, P1280, DOI 10.1016/S0735-1097(98)00377-5; LUWAERT RJ, 1988, EUR HEART J, V9, P418, DOI 10.1093/oxfordjournals.eurheartj.a062519; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; MORROW K, 1993, ANN INTERN MED, V118, P689, DOI 10.7326/0003-4819-118-9-199305010-00005; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Pilote L, 1998, AM J CARDIOL, V81, P219, DOI 10.1016/S0002-9149(97)00871-0; Snader CE, 1997, J AM COLL CARDIOL, V30, P641, DOI 10.1016/S0735-1097(97)00217-9; WEINER DA, 1984, J AM COLL CARDIOL, V3, P772, DOI 10.1016/S0735-1097(84)80254-5; Wilkoff Bruce L., 1992, Cardiology Clinics, V10, P705; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	33	492	523	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2000	284	11					1392	1398		10.1001/jama.284.11.1392	http://dx.doi.org/10.1001/jama.284.11.1392			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352WN	10989401	Bronze			2022-12-01	WOS:000089242500033
J	Abrieu, A; Kahana, JA; Wood, KW; Cleveland, DW				Abrieu, A; Kahana, JA; Wood, KW; Cleveland, DW			CENP-E as an essential component of the mitotic checkpoint in vitro	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; CYCLOSOME/ANAPHASE-PROMOTING COMPLEX; XENOPUS EGG EXTRACTS; SACCHAROMYCES-CEREVISIAE; UNATTACHED KINETOCHORES; PROTEIN MAD2; CHROMOSOME ALIGNMENT; ANAPHASE INITIATION; BUDDING YEAST; MAP KINASE	Accurate chromatid separation is monitored by a checkpoint mechanism that delays anaphase onset until all centromeres are correctly attached to the mitotic spindle. Using Xenopus egg extracts, the kinetochore-associated microtubule motor protein CENP-E is now found to be required for establishing and maintaining this checkpoint. When CENP-E function is disrupted by immunodepletion or antibody addition, extracts fail to arrest in response to spindle damage. Mitotic arrest can be restored by addition of high levels of soluble MAD2, demonstrating that the absence of CENP-E eliminates kinetochore-dependent signaling but not the downstream steps in checkpoint signal transduction. Because it directly binds both to spindle microtubules and to the kinetochore-associated checkpoint kinase BUBR1, CENP-E is a central component in the vertebrate checkpoint that modulates signaling activity in a microtubule-dependent manner.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Abrieu, Ariane/P-3307-2019; Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682				Brown KD, 1996, J CELL SCI, V109, P961; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Chen RH, 1997, METHOD ENZYMOL, V283, P572; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; DAWSON IA, 1995, J CELL BIOL, V129, P725, DOI 10.1083/jcb.129.3.725; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Harlow ED., 1999, USING ANTIBODIES; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Jablonski SA, 1998, CHROMOSOMA, V107, P386, DOI 10.1007/s004120050322; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Martinez-Exposito MJ, 1999, P NATL ACAD SCI USA, V96, P8493, DOI 10.1073/pnas.96.15.8493; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang XM, 1997, J CELL BIOL, V137, P433, DOI 10.1083/jcb.137.2.433; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; Yu HG, 1999, J CELL BIOL, V145, P425, DOI 10.1083/jcb.145.3.425; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	41	176	179	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					817	826		10.1016/S0092-8674(00)00070-2	http://dx.doi.org/10.1016/S0092-8674(00)00070-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030625	Bronze			2022-12-01	WOS:000089395200013
J	Eid, JE; Kung, AL; Scully, R; Livingston, DM				Eid, JE; Kung, AL; Scully, R; Livingston, DM			P300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion	CELL			English	Article							SYNOVIAL SARCOMA TRANSLOCATION; TRANSCRIPTION FACTORS; PROTEINS; INTEGRINS; DIFFERENTIATION; FAMILY; SSX; CBP; TRANSFORMATION; IDENTIFICATION	Complexes containing p300, but not CBP, and the nuclear proto-oncoprotein SYT were detected in confluent cultures of G1-arrested cells but not in sparse cells or during S or G2. SYT sequences constitute the N-terminal segment of a fusion oncogene product, SYT-SSX, routinely detected in synovial sarcoma, an aggressive human tumor. SYT/p300 complex formation promotes cell adhesion to a fibronectin matrix, as reflected by compromise of this process in cells expressing SYT dl mutants that retain p300 binding activity and in the primary fibroblasts of p300 but not CBP heterozygous null mice. The mechanism linking the action of SYT/p300 complexes to adhesion function is, at least in part, transcription activation-independent and results in proper activation of beta 1 integrin, a major adhesion receptor.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Livingston, DM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Kung, Andrew L/AEU-0826-2022; Scully, Ralph/F-5008-2013; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; 	NATIONAL CANCER INSTITUTE [K01CA079576] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAYLEY ST, 1994, INT J ONCOL, V5, P425; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bazzoni G, 1998, J BIOL CHEM, V273, P6670, DOI 10.1074/jbc.273.12.6670; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Condorelli G, 1997, J CELL BIOCHEM, V67, P423, DOI 10.1002/(SICI)1097-4644(19971215)67:4<423::AID-JCB1>3.0.CO;2-U; Coppolino MG, 2000, INT J BIOCHEM CELL B, V32, P171, DOI 10.1016/S1357-2725(99)00043-6; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; dosSantos NR, 1997, HUM MOL GENET, V6, P1549, DOI 10.1093/hmg/6.9.1549; DULBECCO R, 1969, SCIENCE, V166, P962, DOI 10.1126/science.166.3908.962; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Harlow E LD, 1988, ANTIBODIES LAB MANUA, V1st; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Keely P, 1998, TRENDS CELL BIOL, V8, P101, DOI 10.1016/S0962-8924(97)01219-1; Kung AL, 2000, GENE DEV, V14, P272; LEE CA, 1995, HAEMOPHILIA, V1, P1, DOI 10.1111/j.1365-2516.1995.tb00031.x; Lee KY, 1999, MOL CELL BIOL, V19, P7724; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	36	76	79	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 15	2000	102	6					839	848		10.1016/S0092-8674(00)00072-6	http://dx.doi.org/10.1016/S0092-8674(00)00072-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030627	Bronze			2022-12-01	WOS:000089395200015
J	DiRita, VJ				DiRita, VJ			Genomics - Genomics happens	SCIENCE			English	Editorial Material							VIBRIO-CHOLERAE GENOME; PATHOGENICITY ISLAND; GENE-CLUSTER; EL-TOR; IDENTIFICATION; EPIDEMIC; BACTERIA; STRAINS; PILUS; TOXIN		Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	DiRita, VJ (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.							Akerley BJ, 1998, P NATL ACAD SCI USA, V95, P8927, DOI 10.1073/pnas.95.15.8927; BIK EM, 1995, EMBO J, V14, P209, DOI 10.1002/j.1460-2075.1995.tb06993.x; Champion GA, 1997, MOL MICROBIOL, V23, P323, DOI 10.1046/j.1365-2958.1997.2191585.x; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; FULLNER KJ, 2000, GEN M AM SOC MICR LO; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Marsh JW, 1998, MOL MICROBIOL, V29, P1481, DOI 10.1046/j.1365-2958.1998.01031.x; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Stock JB, 1996, ESCHERICHIA COLI SAL, P1103; Trucksis M, 1998, P NATL ACAD SCI USA, V95, P14464, DOI 10.1073/pnas.95.24.14464; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Watnick PI, 1999, J BACTERIOL, V181, P3606, DOI 10.1128/JB.181.11.3606-3609.1999	19	5	5	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2000	289	5484					1488	1489		10.1126/science.289.5484.1488	http://dx.doi.org/10.1126/science.289.5484.1488			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349XW	10991736				2022-12-01	WOS:000089071700031
J	Roberts, DR; Manguin, S; Mouchet, J				Roberts, DR; Manguin, S; Mouchet, J			DDT house spraying and re-emerging malaria	LANCET			English	Editorial Material							RESISTANCE; PREDICTIONS		Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Roberts, DR (corresponding author), Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	droberts@usuhs.mil	Manguin, Sylvie/G-1787-2015; Manguin, Sylvie/GOE-5338-2022	Manguin, Sylvie/0000-0002-5925-7164; Manguin, Sylvie/0000-0002-5925-7164				BROWN AWA, 1976, J MED ENTOMOL, V13, P1, DOI 10.1093/jmedent/13.1.1; Casas M, 1998, J AM MOSQUITO CONTR, V14, P410; CAVALIE P., 1962, Medecine Tropicale, V22, P95; *COMM ENV COOP, 1995, N AM REG ACT PLAN DD; Curtis CF, 2000, PARASITOL TODAY, V16, P119, DOI 10.1016/S0169-4758(99)01605-1; FARID M A, 1991, Kaohsiung Journal of Medical Sciences, V7, P243; Feighner BH, 1998, EMERG INFECT DIS, V4, P295, DOI 10.3201/eid0402.980219; Gilles HM, 1993, BRUCECHWATTS ESSENTI, V340; Litsios S., 1996, The tomorrow of malaria.; MOUCHET J, 1991, ANN SOC BELG MED TR, V71, P259; MOUCHET J, 1988, INSECT SCI APPL, V9, P297, DOI 10.1017/S1742758400006238; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; MOUCHET J, 1994, CAHIERS SANTE, V4, P257; NABARRO D, 1998, UNPUB ROLL BACK MALA; NEWSOME S, 1999, MODERN MALARIA CONTR, P100; *PAN AM HLTH ORG, 1998, 46 PAN AM HLTH ORG, P28; *PAN AM HLTH ORG, 1997, 45 PAN AM HLTH ORG, P25; *PAN AM HLTH ORG, 1994, 12 PAN AM HLTH ORG, P112; *PAN AM HLTH ORG, 1993, PEST HLTH AM, P109; REJMANKOVA E, 1995, AM J TROP MED HYG, V53, P482, DOI 10.4269/ajtmh.1995.53.482; Roberts D R, 1991, Bull Pan Am Health Organ, V25, P210; Roberts DR, 1999, EMERG INFECT DIS, V5, P310, DOI 10.3201/eid0502.990230; Roberts DR, 1996, AM J TROP MED HYG, V54, P304, DOI 10.4269/ajtmh.1996.54.304; Roberts DR, 1997, EMERG INFECT DIS, V3, P295, DOI 10.3201/eid0303.970305; ROBERTS DR, 1994, AM J TROP MED HYG, V50, P21, DOI 10.4269/ajtmh.1994.50.21; ROBERTS DR, 1999, USE REMOTE SENSORING; Rozendaal J A, 1991, Bull Pan Am Health Organ, V25, P336; STOLBERG SG, 1999, NY TIMES        0828; SUAREZ MF, 1990, J AM MOSQUITO CONTR, V6, P72; Taverne J, 1999, PARASITOL TODAY, V15, P180, DOI 10.1016/S0169-4758(99)01446-5; *WHO, 1992, WORLD HLTH STAT ANN, P349; *WHO, 1999, STRAT ROLL BACK MAL, V15; *WHO, 1994, MED VET ENTOMOL, V8, P113; *WHO, 1979, TECHN REP SER WHO, V640; *WHO, 1993, TECHN REP SER WHO, V839; *WHO, 1984, CHEM METH CONTR ARTH; *WORLD WILDL FUND, 1998, RES DDT DIL PROT BIO, P52	37	101	110	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2000	356	9226					330	332		10.1016/S0140-6736(00)02516-2	http://dx.doi.org/10.1016/S0140-6736(00)02516-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MJ	11071203				2022-12-01	WOS:000088305900038
J	Usami, T; Koyama, K; Takeuchi, O; Morozumi, K; Kimura, G				Usami, T; Koyama, K; Takeuchi, O; Morozumi, K; Kimura, G			Regional variations in the incidence of end-stage renal failure in Japan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE; HYPERTENSION; MORTALITY; SALT	Context Despite recent medical advances, the number of patients beginning dialysis annually is increasing in both the United States and Japan. The ethnically homogeneous population of Japan presents an opportunity to study the presence of factors other than race/ethnicity that might contribute to incidence of end-stage renal disease (ESRD), Objective To determine if and where regional differences exist in ESRD in Japan. Design, Setting, and Subjects Analysis of data reported by the Japanese Society for Dialysis Therapy based on the annual number of patients with ESRD beginning maintenance dialysis therapy in all 47 prefectures of Japan from 1982 to 1998. Main Outcome Measures Mean annual ESRD incidence and increasing rate of ESRD in each of 11 predefined areas making up the entire country. Results Incidence of ESRD increased approximately 3-fold in Japan during the study years, from 81.3 per 1 million in 1982 to 237.6 per 1 million in 1998. Significant regional differences were found in both measures. The mean (SEM) annual ESRD incidence (P<.01) and increasing rate of ESRD (P<.01), respectively, were significantly different across Japan. Koshinetsu (140 [11] per 1 million and 9.1 [0.6] per 1 million/y) and Hokuriku (141 [12] per 1 million and 9.7 [0.5] per 1 million/y) were the areas with the lowest incidence and increasing rate of incidence, while Okinawa (188 [17] per 1 million and 13.4 [0.6] per 1 million/y) and Kyushu (179 [15] per 1 million and 12.0 [0.6] per 1 million/y) were the areas with the highest incidence and increasing rate of incidence. Conclusions We found definite and significant regional differences in incidence and increasing rate of incidence of ESRD in Japan. Further analyses are needed to identify factors that contribute to these regional differences and thereby improve strategies for treatment of renal disease.	Nagoya City Univ, Sch Med, Dept Internal Med & Pathophysiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya City University	Usami, T (corresponding author), Nagoya City Univ, Sch Med, Dept Internal Med & Pathophysiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan.							ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; Black HR, 1997, ARCH INTERN MED, V157, P2413; DAHL LK, 1961, AM J CARDIOL, V8, P571, DOI 10.1016/0002-9149(61)90137-0; *JAP SOC DIAL THER, 1997, I MEMB DIR JAP SOC I; *JAP SOC DIAL THER, 1999, OV REG DIAL TREATM; *JAP SOC NEPHR, 1997, JAP SOC NEPHR MEMB D; JOOSSENS JV, 1983, PREV MED, V12, P53, DOI 10.1016/0091-7435(83)90171-8; Kawamura M, 1997, Hypertens Res, V20, P287, DOI 10.1291/hypres.20.287; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MacGregor GA, 1997, AM J HYPERTENS, V10, pS37; *MAN COORD AG JAP, 1998, STAT BUR STAT CTR AN; *MIN HLTH WELF, 1995, MAP NAT HLTH INS HLT; OMURA T, 1987, SOC SCI MED, V24, P401, DOI 10.1016/0277-9536(87)90212-7; SASAKI N, 1962, JPN HEART J, V3, P312; Stamler Jeremiah, 1997, American Journal of Clinical Nutrition, V65, p626S, DOI 10.1093/ajcn/65.2.626S; TANAKA H, 1982, STROKE, V13, P574, DOI 10.1161/01.STR.13.5.574; *US DEP HHS, 1999, US REN DAT SYST USRD; WHITTLE JC, 1991, ARCH INTERN MED, V151, P1359, DOI 10.1001/archinte.151.7.1359; ZATZ R, 1986, J CLIN INVEST, V77, P1925, DOI 10.1172/JCI112521	20	66	70	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	2000	284	20					2622	2624		10.1001/jama.284.20.2622	http://dx.doi.org/10.1001/jama.284.20.2622			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373NU	11086370	Bronze			2022-12-01	WOS:000165296200037
J	Silveira, MJ; DiPiero, A; Gerrity, MS; Feudtner, C				Silveira, MJ; DiPiero, A; Gerrity, MS; Feudtner, C			Patients' knowledge of options at the end of life - Ignorance in the face of death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELF-DETERMINATION ACT; ADVANCE DIRECTIVES; ELDERLY OUTPATIENTS; MEDICAL-CARE; ATTITUDES; PHYSICIANS	Context Effectiveness of legislation promoting advance directives and legalizing physician-assisted suicide depends on patients' understanding their legal options about end-of-life care. However, outpatients' understanding of their legal options at the end of life has not been studied. Objectives To estimate the percentage of outpatients who are informed about 4 areas relevant to end-of-life care: refusal and withdrawal of lifesaving treatments, physician-assisted suicide, active euthanasia, and double effect; and to determine whether authoring advance directives, experiencing illness, acting as a proxy for health care decisions, and caring for an ill loved one are associated with better knowledge in end-of-life care. Design Cross-sectional survey. Setting and Participants One thousand consecutive English-speaking, adult patients attending 1 university-based internal medicine clinic and 3 community-based, university-affiliated, mixed internal medicine and family practice clinics in Oregon during May and June 1999. Main Outcome Measures Percentage of correct responses in the 4 topic areas and total knowledge score, adjusted for demographic (eg, age, race, educational level, income level, marital status) and experiential (eg, health, proxy decision making, advance directives, and death of a loved one) factors. Results Of the 1000 patients invited to participate, 728 (73 %) consented and completed the questionnaire and were included in the analysis. A total of 69% of respondents answered correctly regarding refusal of treatment, 46% for withdrawal of treatment, 23% for assisted suicide, 32% for active euthanasia, and 41% for double effect. Sixty-two percent of respondents did not distinguish between assisted suicide and euthanasia. After adjustment for other covariates, better knowledge was significantly associated with white race (odds ratio [OR], 2.3; 95% confidence interval [CI], 1.3-4.2), having at least a college degree (OR, 3.0; 95% CI, 1.4-6.7), and having been a proxy for health care decisions (OR, 1.8, 95% CI, 1.2-2.6). Personal experience with illness (OR, 1.0; 95% CI, 0.6-1.5), death or illness of a loved one (OR, 1.6; 95% CI; 1.0-2.7), and authoring an advance directive (OR,1,3; 95% CI, 0.9-2.0) were not associated with better knowledge. Conclusions A significant proportion of outpatients at university-affiliated clinics in Oregon appear to misunderstand options in end-of-life care. Our results suggest that greater public knowledge about end-of-life care is needed, and advance care planning must be preceded by education about options in end-of-life care.	Univ Washington, Hlth Sci Ctr H220, Robert Wood Johnson Clin Scholars Program, Seattle, WA 98195 USA; Oregon Hlth Sci Univ, Dept Gen Internal Med, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; Oregon Health & Science University	Silveira, MJ (corresponding author), Univ Washington, Hlth Sci Ctr H220, Robert Wood Johnson Clin Scholars Program, Box 357183, Seattle, WA 98195 USA.		Silveira, Maria J/E-9802-2013; Feudtner, Chris/AAI-1126-2019	Feudtner, Chris/0000-0002-5879-0434; Gerrity, Martha/0000-0002-8772-4591; Silveira, Maria/0000-0002-6600-8633				*AMA POLL, 1997, AM MED NEWS     0113, P3; EDINGER W, 1992, J FAM PRACTICE, V35, P650; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; EMANUEL L, 1991, HASTINGS CENT REP, V21, pS6, DOI 10.2307/3562901; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; FINUCANE TE, 1988, J GEN INTERN MED, V3, P322, DOI 10.1007/BF02595788; GAMBLE ER, 1991, ARCH INTERN MED, V151, P277, DOI 10.1001/archinte.151.2.277; Gostin LO, 1997, JAMA-J AM MED ASSOC, V278, P1523, DOI 10.1001/jama.278.18.1523; JOHNSTON SC, 1995, ARCH INTERN MED, V155, P1025, DOI 10.1001/archinte.155.10.1025; Kane R J, 1991, J Health Hosp Law, V24, P373; LAPUMA J, 1991, JAMA-J AM MED ASSOC, V266, P402, DOI 10.1001/jama.266.3.402; MEISEL A, 1995, RIGHT DIE; PFEIFER MP, 1994, J GEN INTERN MED, V9, P82, DOI 10.1007/BF02600206; REILLY BM, 1994, ARCH INTERN MED, V154, P2299, DOI 10.1001/archinte.154.20.2299; SHMERLING RH, 1988, J GEN INTERN MED, V3, P317, DOI 10.1007/BF02595786; Smucker W D, 1993, J Am Board Fam Pract, V6, P473; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; VIRMANI J, 1994, ARCH INTERN MED, V154, P909, DOI 10.1001/archinte.154.8.909; WHITE ML, 1991, JAMA-J AM MED ASSOC, V266, P410, DOI 10.1001/jama.1991.03470030110035; 1994, TRENDS HLTH CARE LAW, V9, P29	20	127	127	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2000	284	19					2483	2488		10.1001/jama.284.19.2483	http://dx.doi.org/10.1001/jama.284.19.2483			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371MY	11074778	Bronze			2022-12-01	WOS:000165183800022
J	Langley, P				Langley, P			Why a pomegranate?	BRITISH MEDICAL JOURNAL			English	Article									British Med Assoc, London WC1H 9JP, England		Langley, P (corresponding author), British Med Assoc, London WC1H 9JP, England.							[Anonymous], SONG SOLOMON, V4, P7; *CHELS PHYS GARD C, 1997, TREES CHELS PHYS GAR, P14; CHERRY J, 1995, MYTHICAL BEASTS, P47; CHEVALLIER A, 1996, ENCY MED PLANTS, P257; COOPER JC, 1995, ILLUSTRATED ENCY TRA, P134; CURTIS VS, 1996, PERSIAN MYTHS, P54; Freeman Margaret B., 1976, UNICORN TAPESTRIES; GARRISON W, 1980, STRANGE FACTS BIBLE, P184; GOOD A, 1968, FRUITS HOLY LAND; GUNTER RT, 1934, GREEK HERBAL DIOSCOR, P80; HALL J, 1995, HALLS ILLUSTRATED DI; HERODOTUS, 1996, HISTORIES, P389; MASON AS, 1992, J ROY COLL PHYS LOND, V26, P231; Modi Jivanji Jamshedji, 1922, RELIG CEREMONIES CUS; WIGODER DE, 1988, GARDEN EDEN COOKBOOK; 1983, NEW LAROUSSE ENCY MY	16	76	82	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1153	1154		10.1136/bmj.321.7269.1153	http://dx.doi.org/10.1136/bmj.321.7269.1153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061746	Green Published			2022-12-01	WOS:000165219600037
J	Neyt, C; Jagla, K; Thisse, C; Thisse, B; Haines, L; Currie, PD				Neyt, C; Jagla, K; Thisse, C; Thisse, B; Haines, L; Currie, PD			Evolutionary origins of vertebrate appendicular muscle	NATURE			English	Article							PRECURSOR CELLS; ZEBRAFISH; SPECIFICATION; MUSCULATURE; INDUCTION; HEDGEHOG; EMBRYOS; SLOW	The evolution of terrestrial tetrapod species heralded a transition in locomotor strategies. While most fish species use the undulating contractions of the axial musculature to generate propulsive force, tetrapods also rely on the appendicular muscles of the limbs to generate movement(1,2). Despite the fossil record generating an understanding of the way in which the appendicular skeleton has evolved to provide the scaffold for tetrapod limb musculature(3), there is, by contrast, almost no information as to how this musculature arose. Here we examine fin muscle formation within two extant classes of fish. We find that in the teleost, zebrafish, fin muscles arise from migratory mesenchymal precursor cells that possess molecular and morphogenetic identity with the limb muscle precursors of tetrapod species. Chondrichthyan dogfish embryos, however, use the primitive mechanism of direct epithelial somitic extensions to derive the muscles of the fin. We conclude that the genetic mechanism controlling formation of tetrapod limb muscles evolved before the Sarcopterygian radiation.	Western Gen Hosp, MRC, Human Genet Unit, Comparat & Dev Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; INSERM, U384, F-63001 Clermont Ferrand, France; ULP, CNRS, INSERM, Inst Genet Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Currie, PD (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Comparat & Dev Genet Sect, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	petec@hgu.mrc.ac.uk	Jagla, Krzysztof/E-4144-2016	Jagla, Krzysztof/0000-0003-4965-8818; Currie, Peter/0000-0001-8874-8862; THISSE, Christine/0000-0002-8684-1681				Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Braus H., 1899, MORPHOL JB, V27, P501; Brohmann H, 2000, DEVELOPMENT, V127, P437; CHRIST B, 1977, ANAT EMBRYOL, V150, P171, DOI 10.1007/BF00316649; CHRIST B, 1983, ANAT EMBRYOL, V166, P87, DOI 10.1007/BF00317946; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Cinnamon Y, 1999, DEVELOPMENT, V126, P4305; COATES MI, 1994, DEVELOPMENT, P169; CORNING HK, 1842, MORPHOLOGISCHES JB, V22, P79; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; Denetclaw WF, 2000, DEVELOPMENT, V127, P893; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Didier Dominique A., 1995, American Museum Novitates, V3119, P1; Dietrich S, 1998, DEVELOPMENT, V125, P2235; Dohrn A., 1884, MITTEILUNGEN ZOOLOGI, V5, P161; Goodrich E.S, 1958, STUDIES STRUCTURE DE, VI; GRIM M, 1973, Folia Morphologica (Prague), V21, P197; Gross MK, 2000, DEVELOPMENT, V127, P413; Harrison RG, 1895, ARCH MIKROSK ANAT, V46, P500; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Houzelstein D, 1999, DEVELOPMENT, V126, P2689; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; Janvier P, 1999, TRENDS ECOL EVOL, V14, P298, DOI 10.1016/S0169-5347(99)01666-3; Kardong K.V., 1995, VERTEBRADOSANATOMIA; Kozlowski DJ, 1997, BIOCHEM CELL BIOL, V75, P551, DOI 10.1139/bcb-75-5-551; Mankoo BS, 1999, NATURE, V400, P69, DOI 10.1038/21892; Rasmussen AS, 1999, J MOL EVOL, V48, P118, DOI 10.1007/PL00006439; Schafer K, 1999, NAT GENET, V23, P213, DOI 10.1038/13843; Weinberg ES, 1996, DEVELOPMENT, V122, P271	30	140	142	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2000	408	6808					82	86		10.1038/35040549	http://dx.doi.org/10.1038/35040549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081511				2022-12-01	WOS:000165050400055
J	Gruchalla, RS				Gruchalla, RS			Clinical assessment of drug-induced disease	LANCET			English	Article							MAST-CELL ACTIVATION; HOSPITALIZED-PATIENTS; TRYPTASE; HYPERSENSITIVITY; SULFAMETHOXAZOLE; SULFONAMIDES; MASTOCYTOSIS; METABOLITES; TOXICITY; MARKERS	Physicians are often confronted with patients who state that they are "allergic" to a drug or drugs. Knowing which medications can be prescribed safely is therefore difficult, and care of such patients frustrating. The goal of this review is to help physicians develop management plans for patients who present with drug-induced diseases'. It provides information that allows physicians to differentiate between reactions that are truly allergic in nature and those that are not immunologically mediated. Relevant information on medical history, physical findings, and laboratory tests that may be helpful in the assessment are discussed, and guidance is provided on when and if a drug may be safely readministered. Unfortunately, however, until we are able to better understand the mechanisms responsible for drug-induced reactions, our management tools will remain limited.	Univ Texas, SW Med Ctr, Div Allergy & Immunol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Gruchalla, RS (corresponding author), Univ Texas, SW Med Ctr, Div Allergy & Immunol, Dallas, TX 75390 USA.							ADKINSON N, 1998, ALLERGY PRINCIPLES P, V2, P1212; [Anonymous], 1999, Ann Allergy Asthma Immunol, V83, P665; Araujo O E, 1984, J Emerg Med, V2, P129, DOI 10.1016/0736-4679(84)90332-9; ARKY R, 1999, PHYSICIANS DESK REFE; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; CARR A, 1993, J INFECT DIS, V167, P180, DOI 10.1093/infdis/167.1.180; Coombs R., 1975, CLIN ASPECTS IMMUNOL, P761; deShazo RD, 1997, JAMA-J AM MED ASSOC, V278, P1895, DOI 10.1001/jama.278.22.1895; EISEN HN, 1959, CELLULAR HUMORAL ASP; Gruchalla RS, 1998, J ALLERGY CLIN IMMUN, V101, P371, DOI 10.1016/S0091-6749(98)70250-7; Hess DA, 1997, ANN PHARMACOTHER, V31, P1378, DOI 10.1177/106002809703101116; LAROCHE D, 1991, ANESTHESIOLOGY, V75, P945, DOI 10.1097/00000542-199112000-00004; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEVY J, 1992, ANAPHYLACTIC REACTIO, P83; LEVY M, 1991, CLIN PEDIATR, V30, P42, DOI 10.1177/000992289103000107; LITT J, 1995, DRUG ERUPTION REFERE; MATSSON P, 1991, AGENTS ACTIONS, V33, P218, DOI 10.1007/BF01993172; MEEKINS CV, 1994, J ALLERGY CLIN IMMUN, V94, P1017, DOI 10.1016/0091-6749(94)90120-1; OSAWA J, 1990, Journal of Dermatology (Tokyo), V17, P235; PARK BK, 1992, BRIT J CLIN PHARMACO, V34, P377, DOI 10.1111/j.1365-2125.1992.tb05647.x; Pirmohamed M, 1998, BRIT MED J, V316, P1295, DOI 10.1136/bmj.316.7140.1295; PRIMOHAMED M, 1996, CLIN PHARMACOKINET, V32, P215; Rawlins MD, 1991, TXB ADVERSE DRUG REA, P18; RIEDER MJ, 1988, J PHARMACOL EXP THER, V244, P724; RILEY RJ, 1995, CLIN EXP IMMUNOL, V99, P1; ROMANO A, 1995, ALLERGY, V50, P113; Schwartz LB, 1995, J CLIN INVEST, V96, P2702, DOI 10.1172/JCI118337; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; SHEAR N, 1985, BRIT J DERMATOL, V28, pS112; SHEAR NH, 1985, CAN J PHYSIOL PHARM, V63, P1370, DOI 10.1139/y85-225; SHEAR NH, 1990, ARCH DERMATOL, V126, P94, DOI 10.1001/archderm.126.1.94; SHEAR NH, 1986, ANN INTERN MED, V105, P179, DOI 10.7326/0003-4819-105-2-179; Solensky R, 2000, ANN ALLERG ASTHMA IM, V84, P329, DOI 10.1016/S1081-1206(10)62782-2; Stitt VJ., 1988, J NATL MED ASSOC, V80, P106; VERVLOET D, 1999, DRUG ALLERGY, P323; Weiss ME, 1998, IMMUNOL ALLERGY CLIN, V18, P731, DOI 10.1016/S0889-8561(05)70035-7; *WHO, 1966, INT DRUG MON ROL HOS	37	61	63	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 28	2000	356	9240					1505	1511		10.1016/S0140-6736(00)02885-3	http://dx.doi.org/10.1016/S0140-6736(00)02885-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367NA	11081549				2022-12-01	WOS:000090067300040
J	Mitton, S				Mitton, S			Have physicists glimpsed the particle pinnacle?	LANCET			English	Editorial Material									Univ Cambridge, St Edmunds Coll, Cambridge CB3 0BN, England	University of Cambridge	Mitton, S (corresponding author), Univ Cambridge, St Edmunds Coll, Cambridge CB3 0BN, England.		Mitton, Simon A/A-5899-2012	Mitton, Simon A/0000-0003-3695-9806					0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 28	2000	356	9240					1460	1460						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367NA	11081526				2022-12-01	WOS:000090067300007
J	van Craaikamp, JCJ; Oosting, ME				van Craaikamp, JCJ; Oosting, ME			Netherlands: IVF for unmarried women, euthanasia	LANCET			English	Article								Most physicians in Europe, if asked what is very different about medicine and the law in the Netherlands, would choose euthanasia. We will discuss recent developments there but begin with a different topic-equality of access to in vitro fertilisation.	CMS Derks Star Busmann Hanotiau, Transnatl Legal Serv, NL-3584 BB Utrecht, Netherlands		Oosting, ME (corresponding author), CMS Derks Star Busmann Hanotiau, Transnatl Legal Serv, Pythagoraslaan 2, NL-3584 BB Utrecht, Netherlands.							BREWAEYS AMA, 1997, THESIS U LEIDEN; ENLERT U, 1994, HUM REPROD, V9, P1969; FORDER CJ, 1998, LEGAL POSITION SPERM; *HLTH COUNC COMM R, 1997, HLTH COUNC PUBL, V103; VERHULST FC, 1998, ADOPTION FOREIGN CHI	5	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 28	2000	356	9240					1512	1513		10.1016/S0140-6736(00)02887-7	http://dx.doi.org/10.1016/S0140-6736(00)02887-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367NA	11081550				2022-12-01	WOS:000090067300041
J	Motyka, B; Korbutt, G; Pinkoski, MJ; Heibein, JA; Caputo, A; Hobman, M; Barry, M; Shostak, I; Sawchuk, T; Holmes, CFB; Gauldie, J; Bleackley, RC				Motyka, B; Korbutt, G; Pinkoski, MJ; Heibein, JA; Caputo, A; Hobman, M; Barry, M; Shostak, I; Sawchuk, T; Holmes, CFB; Gauldie, J; Bleackley, RC			Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis	CELL			English	Article							BREAST-CANCER CELLS; 6-PHOSPHATE RECEPTOR; DNA FRAGMENTATION; TARGET-CELLS; LYTIC GRANULES; MEDIATED CYTOTOXICITY; INITIATES APOPTOSIS; CYTOSOLIC DELIVERY; SERINE PROTEASES; RAPID INDUCTION	The serine proteinase granzyme B is crucial for the rapid induction of target cell apoptosis by cytotoxic T cells. Granzyme B was recently demonstrated to enter cells in a perforin-independent manner, thus predicting the existence of a cell surface receptor(s). We now present evidence that this receptor is the cation-independent mannose 6-phosphate/insulin-like growth factor receptor (CI-MPR). Inhibition of the granzyme B-CI-MPR interaction prevented granzyme B cell surface binding, uptake, and the induction of apoptosis. Significantly, expression of the CI-MPR was essential for cytotoxic T cell-mediated apoptosis of target cells in vitro and for the rejection of allogeneic cells in vivo. These results suggest a novel target for immunotherapy and a potential mechanism used by tumors for immune evasion.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Surg, Edmonton, AB T6G 2H7, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada	University of Alberta; University of Alberta; McMaster University	Bleackley, RC (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.			Motyka, Bruce/0000-0002-8448-2777				Addison CL, 1997, J GEN VIROL, V78, P1653, DOI 10.1099/0022-1317-78-7-1653; Atkinson EA, 1998, J BIOL CHEM, V273, P21261, DOI 10.1074/jbc.273.33.21261; Bagu JR, 1997, J BIOL CHEM, V272, P5087, DOI 10.1074/jbc.272.8.5087; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Blanchard F, 1998, J BIOL CHEM, V273, P20886, DOI 10.1074/jbc.273.33.20886; Browne KA, 1999, MOL CELL BIOL, V19, P8604; BRUNETTI CR, 1994, J BIOL CHEM, V269, P17067; Caputo A, 1999, PROTEINS, V35, P415, DOI 10.1002/(SICI)1097-0134(19990601)35:4<415::AID-PROT5>3.0.CO;2-7; CAPUTO A, 1993, J BIOL CHEM, V268, P17672; Chappell SA, 1997, BRIT J CANCER, V76, P1558, DOI 10.1038/bjc.1997.596; Cieutat AM, 1998, BLOOD, V91, P1044, DOI 10.1182/blood.V91.3.1044.1044_1044_1058; CONFORT C, 1995, ENDOCRINOLOGY, V136, P3759, DOI 10.1210/en.136.9.3759; Dahms NM, 1996, BIOCHEM SOC T, V24, P136, DOI 10.1042/bst0240136; Darmon AJ, 1998, CRIT REV IMMUNOL, V18, P255, DOI 10.1615/CritRevImmunol.v18.i3.50; Darmon AJ, 1996, J BIOL CHEM, V271, P21709, DOI 10.1074/jbc.271.36.21709; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; DeLeon DD, 1996, ENDOCRINOLOGY, V137, P1851, DOI 10.1210/en.137.5.1851; DESOUZA AT, 1995, NAT GENET, V11, P447, DOI 10.1038/ng1295-447; Diamond AS, 2000, J IMMUNOL, V165, P247, DOI 10.4049/jimmunol.165.1.247; DUKE RC, 1989, J EXP MED, V170, P1451, DOI 10.1084/jem.170.4.1451; EINSTEIN R, 1991, J CELL BIOL, V112, P81, DOI 10.1083/jcb.112.1.81; FOULKES WD, 1993, BRIT J CANCER, V67, P551, DOI 10.1038/bjc.1993.101; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; GABEL CA, 1983, P NATL ACAD SCI-BIOL, V80, P775, DOI 10.1073/pnas.80.3.775; GAIDANO G, 1992, BLOOD, V80, P1781, DOI 10.1182/blood.V80.7.1781.bloodjournal8071781; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; GRIFFITHS G, 1990, J CELL SCI, V95, P441; GRIFFITHS GM, 1993, J CELL BIOL, V120, P885, DOI 10.1083/jcb.120.4.885; Heibein JA, 1999, J IMMUNOL, V163, P4683; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; KAPLAN A, 1977, J CLIN INVEST, V60, P1088, DOI 10.1172/JCI108860; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KOVACINA KS, 1989, BIOCHEM BIOPH RES CO, V160, P393, DOI 10.1016/0006-291X(89)91669-0; LAKSHMI S, 1980, BIOCHIM BIOPHYS ACTA, V614, P446, DOI 10.1016/0005-2744(80)90234-X; LOBE CG, 1986, SCIENCE, V232, P858, DOI 10.1126/science.3518058; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; MA ZM, 1992, J BIOL CHEM, V267, P19017; MA ZM, 1991, J BIOL CHEM, V266, P10589; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; MASSON D, 1987, CELL, V49, P679, DOI 10.1016/0092-8674(87)90544-7; MILLIKIN D, 1991, CANCER RES, V51, P5449; Molinari M, 1997, J BIOL CHEM, V272, P25339, DOI 10.1074/jbc.272.40.25339; MORITA R, 1991, CANCER RES, V51, P5817; MunierLehmann H, 1996, BIOCHEM SOC T, V24, P133, DOI 10.1042/bst0240133; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; Nolan C M, 1987, Adv Exp Med Biol, V225, P199; Ohashi K, 2000, NAT MED, V6, P327; OKA Y, 1986, J BIOL CHEM, V261, P9090; Page LJ, 1998, BBA-MOL CELL RES, V1401, P146, DOI 10.1016/S0167-4889(97)00138-9; Pinkoski MJ, 1998, BLOOD, V92, P1044; Sandvig K, 1996, PHYSIOL REV, V76, P949, DOI 10.1152/physrev.1996.76.4.949; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; SHI LF, 1992, J EXP MED, V176, P1521, DOI 10.1084/jem.176.6.1521; Shi LF, 1997, J EXP MED, V185, P855, DOI 10.1084/jem.185.5.855; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; STEIN M, 1987, EMBO J, V6, P2677, DOI 10.1002/j.1460-2075.1987.tb02559.x; VALENZANO KJ, 1995, J BIOL CHEM, V270, P16441, DOI 10.1074/jbc.270.27.16441; WATANABE H, 1990, P NATL ACAD SCI USA, V87, P8036, DOI 10.1073/pnas.87.20.8036; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; ZHU ZL, 1995, P NATL ACAD SCI USA, V92, P3546, DOI 10.1073/pnas.92.8.3546	65	303	326	1	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 27	2000	103	3					491	500		10.1016/S0092-8674(00)00140-9	http://dx.doi.org/10.1016/S0092-8674(00)00140-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081635	Bronze			2022-12-01	WOS:000090144100014
J	Peterson, BS; Vohr, B; Staib, LH; Cannistraci, CJ; Dolberg, A; Schneider, KC; Katz, KH; Westerveld, M; Sparrow, S; Anderson, AW; Duncan, CC; Makuch, RW; Gore, JC; Ment, LR				Peterson, BS; Vohr, B; Staib, LH; Cannistraci, CJ; Dolberg, A; Schneider, KC; Katz, KH; Westerveld, M; Sparrow, S; Anderson, AW; Duncan, CC; Makuch, RW; Gore, JC; Ment, LR			Regional brain volume abnormalities and long-term cognitive outcome in preterm infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT INFANTS; CEREBRAL BLOOD-FLOW; POSITRON EMISSION TOMOGRAPHY; SCHOOL-AGE-CHILDREN; INTRAVENTRICULAR HEMORRHAGE; PERIVENTRICULAR LEUKOMALACIA; CRANIAL ULTRASOUND; DISTINCT PATTERN; NEWBORN; RELIABILITY	Context Preterm infants have a high prevalence of long-term cognitive and behavioral disturbances. However, it is not known whether the stresses associated with premature birth disrupt regionally specific brain maturation or whether abnormalities in brain structure contribute to cognitive deficits. Objective To determine whether regional brain volumes differ between term and preterm children and to examine the association of regional brain volumes in prematurely born children with long-term cognitive outcomes. Design and Setting Case-control study conducted in 1998 and 1999 at 2 US university medical schools. Participants A consecutive sample of 25 eight-year-old preterm children recruited from a longitudinal follow-up study of preterm infants and 39 term control children who were recruited from the community and who were comparable with the preterm children in age, sex, maternal education, and minority status. Main Outcome Measures Volumes of cortical subdivisions, Ventricular system, cerebellum, basal ganglia, corpus callosum, amygdala, and hippocampus, derived from structural magnetic resonance imaging scans and compared between preterm and term children; correlations of regional brain volumes with cognitive measures (at age 8 years) and perinatal variables among preterm children. Results Regional cortical volumes were significantly smaller in the preterm children, most prominently in sensorimotor regions (difference: left, 14.6%; right, 14.3% [P<.001 for both]) but also in premotor (left, 11.2%; right, 12.6% [P<.001 for both]), midtemporal (left, 7.4% [P=.01]; right, 10.2% [P<.001]), parieto-occipital (left, 7.9% [P=.01]; right, 7.4% [P=.005]), and subgenual (left, 8.9% [P=.03]; right, 11.7% [P=.01])cortices. Preterm children's brain volumes were significantly larger (by 105.7%-271.6%) in the occipital and temporal horns of the ventricles (P<.001 for all) and smaller in the cerebellum (6.7%; P=.02), basal ganglia (11.4%-13.8%; P less than or equal to.005), amygdala (left, 20.2% [P=.001]; right, 30.0% [P<.001]), hippocampus (left, 16.0% [P=.001]; right, 12.0% [P=.007]), and corpus callosum (13.1%-35.2%; P less than or equal to.01 for all). Volumes of sensorimotor and midtemporal cortices were associated positively with full-scale, verbal, and performance IQ scores (P<.01 for all). Conclusions Our data indicate that preterm birth is associated with regionally specific, long-term reductions in brain volume and that morphological abnormalities are, in turn, associated with poorer cognitive outcome.	Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Diagnost Imaging, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; Brown Univ, Sch Med, Dept Pediat, Providence, RI 02912 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Brown University	Peterson, BS (corresponding author), Yale Univ, Ctr Child Study, 230 S Frontage Rd, New Haven, CT 06520 USA.			Staib, Lawrence/0000-0002-9516-5136	NCRR NIH HHS [RR 06022] Funding Source: Medline; NINDS NIH HHS [NS 27116, NS 35476] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035476, R01NS027116] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achenbach T M, 1991, Monogr Soc Res Child Dev, V56, P1; ALLAN WC, 1985, CLIN PERINATOL, V12, P195, DOI 10.1016/S0095-5108(18)30892-3; AZZARELLI B, 1980, CHILD BRAIN, V7, P132; Beery K. E., 2016, PEARSON; Borch K, 1998, PEDIATR RES, V43, P28, DOI 10.1203/00006450-199801000-00005; Caviness VS, 1996, J COGNITIVE NEUROSCI, V8, P566, DOI 10.1162/jocn.1996.8.6.566; CHUGANI HT, 1986, SCIENCE, V231, P840, DOI 10.1126/science.3945811; Cohen J., 1977, STAT ANAL BEHAV SCI; CONSTANTINE NA, 1987, J PEDIATR-US, V110, P921, DOI 10.1016/S0022-3476(87)80416-X; Cooke RWI, 1999, ARCH DIS CHILD-FETAL, V81, pF116, DOI 10.1136/fn.81.2.F116; DEVRIES LS, 1993, NEUROPEDIATRICS, V24, P263, DOI 10.1055/s-2008-1071554; Guo SS, 1997, EARLY HUM DEV, V47, P305, DOI 10.1016/S0378-3782(96)01793-8; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; Hack M, 1996, PEDIATRICS, V98, P931; Hegyi T, 1998, PEDIATRICS, V101, P77, DOI 10.1542/peds.101.1.77; Huppi PS, 1996, PEDIATR RES, V39, P895; Huppi PS, 1998, PEDIATR RES, V44, P584; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P27, DOI 10.1001/archneur.1990.00530010035015; Kates WR, 1997, PSYCHIAT RES-NEUROIM, V75, P31, DOI 10.1016/S0925-4927(97)00019-X; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; LOU HC, 1979, J PEDIATR-US, V95, P606, DOI 10.1016/S0022-3476(79)80779-9; LOW JA, 1993, ACTA PAEDIATR, V82, P433, DOI 10.1111/j.1651-2227.1993.tb12717.x; McCormick MC, 1996, PEDIATRICS, V97, P18; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; MENT LR, 1984, J PEDIATR-US, V104, P419, DOI 10.1016/S0022-3476(84)81109-9; Ment LR, 1999, PEDIATRICS, V104, P243, DOI 10.1542/peds.104.2.243; MENT LR, 1994, PEDIATRICS, V93, P543; MURPHY DJ, 1996, ARCH DIS CHILD, V75, P27; Olsen P, 1998, PEDIATRICS, V102, P329, DOI 10.1542/peds.102.2.329; Olsen P, 1997, ANN NEUROL, V41, P754, DOI 10.1002/ana.410410611; Pandya DN., 1986, 2 HEMISPHERES ONE BR, P47; Peterson BS, 2000, ARCH GEN PSYCHIAT, V57, P364, DOI 10.1001/archpsyc.57.4.364; PETERSON BS, IN PRESS ARCH GEN PS; PETERSON BS, IN PRESS HUM BRAIN M; PRYDS O, 1991, ANN NEUROL, V30, P321, DOI 10.1002/ana.410300302; RADEMAKERS RP, 1995, J COMPUT ASSIST TOMO, V19, P256, DOI 10.1097/00004728-199503000-00017; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAMAEKERS VT, 1990, EARLY HUM DEV, V24, P249, DOI 10.1016/0378-3782(90)90032-E; Rosenbaum JL, 1997, NEUROLOGY, V49, P1035, DOI 10.1212/WNL.49.4.1035; SCHLESSELMAN JJ, 1982, CASE CONTROL STUDIES, P105; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Sykes DH, 1997, J CHILD PSYCHOL PSYC, V38, P315, DOI 10.1111/j.1469-7610.1997.tb01516.x; VOLPE JJ, 1985, ANN NEUROL, V17, P287, DOI 10.1002/ana.410170312; VOLPE JJ, 1983, PEDIATRICS, V72, P589; Wechsler D, 1991, WISC 3 MANUAL; Whitaker AH, 1997, ARCH GEN PSYCHIAT, V54, P847; WOLKE D, 1991, J CHILD PSYCHOL PSYC, V32, P723, DOI 10.1111/j.1469-7610.1991.tb01898.x	48	718	738	0	46	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1939	1947		10.1001/jama.284.15.1939	http://dx.doi.org/10.1001/jama.284.15.1939			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	362JC	11035890	Bronze			2022-12-01	WOS:000089774000026
J	Lamers, MH; Perrakis, A; Enzlin, JH; Winterwerp, HHK; de Wind, N; Sixma, TK				Lamers, MH; Perrakis, A; Enzlin, JH; Winterwerp, HHK; de Wind, N; Sixma, TK			The crystal structure of DNA mismatch repair protein MutS binding to a G center dot T mismatch	NATURE			English	Article							ESCHERICHIA-COLI; HMUTS-ALPHA; TRANSLOCATION MECHANISM; HETERODUPLEX DNA; ATPASE ACTIVITY; RECOGNITION; COMPLEX; HYDROLYSIS; CANCER; ENDONUCLEASE	DNA mismatch repair ensures genomic integrity on DNA replication. Recognition of a DNA mismatch by a dimeric MutS protein initiates a cascade of reactions and results in repair of the newly synthesized strand; however, details of the molecular mechanism remain controversial. Here we present the crystal structure at 2.2 Angstrom of MutS from Escherichia coli bound to a G.T mismatch. The two MutS monomers have different conformations and form a heterodimer at the structural level. Only one monomer recognizes the mismatch specifically and has ADP bound. Mismatch recognition occurs by extensive minor groove interactions causing unusual base pairing and kinking of the DNA. Nonspecific major groove DNA-binding domains from both monomers embrace the DNA in a clamp-like structure. The interleaved nucleotide-binding sites are located far from the DNA. Mutations in human MutS alpha (MSH2/MSH6) that lead to hereditary predisposition for cancer, such as hereditary non-polyposis colorectal cancer, can be mapped to this crystal structure.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; European Mol Biol Lab, ILL, F-38043 Grenoble, France	Netherlands Cancer Institute; European Molecular Biology Laboratory (EMBL); Institut Laue-Langevin (ILL)	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	sixma@nki.nl	Lamers, Meindert/AGG-8911-2022; Perrakis, Anastassis/E-8704-2013	Lamers, Meindert/0000-0002-4205-1338; Perrakis, Anastassis/0000-0002-1151-6227; Sixma, Titia K/0000-0001-6180-0632				Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Biswas I, 1999, J BIOL CHEM, V274, P23673, DOI 10.1074/jbc.274.33.23673; Biswas I, 2000, BIOCHEM J, V347, P881, DOI 10.1042/0264-6021:3470881; Bjornson KP, 2000, BIOCHEMISTRY-US, V39, P3176, DOI 10.1021/bi992286u; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; Culligan KM, 2000, NUCLEIC ACIDS RES, V28, P463, DOI 10.1093/nar/28.2.463; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FISHEL RA, 1986, J MOL BIOL, V188, P147, DOI 10.1016/0022-2836(86)90300-1; Galio L, 1999, NUCLEIC ACIDS RES, V27, P2325, DOI 10.1093/nar/27.11.2325; GERSTEIN M, 1993, J MOL BIOL, V229, P494, DOI 10.1006/jmbi.1993.1048; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO;2-I; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HUNTER WN, 1992, METHOD ENZYMOL, V211, P221; Iaccarino I, 2000, J BIOL CHEM, V275, P2080, DOI 10.1074/jbc.275.3.2080; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joshi A, 2000, NUCLEIC ACIDS RES, V28, P853, DOI 10.1093/nar/28.4.853; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; Lynch HT, 1999, J MED GENET, V36, P801; Malkov VA, 1997, J BIOL CHEM, V272, P23811, DOI 10.1074/jbc.272.38.23811; Marra G, 1999, BIOCHEM J, V338, P1, DOI 10.1042/0264-6021:3380001; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANUSKA JR, 1980, J BIOL CHEM, V255, P5208; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; Takamatsu S, 1996, NUCLEIC ACIDS RES, V24, P640, DOI 10.1093/nar/24.4.640; Tsutakawa SE, 1999, CELL, V99, P615, DOI 10.1016/S0092-8674(00)81550-0; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wu TH, 1999, J BIOL CHEM, V274, P5948, DOI 10.1074/jbc.274.9.5948	50	528	537	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					711	717		10.1038/35037523	http://dx.doi.org/10.1038/35037523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048711				2022-12-01	WOS:000089773900033
J	Goldstein, JA; Demetriou, D; Grines, CL; Pica, M; Shoukfeh, M; O'Neill, WW				Goldstein, JA; Demetriou, D; Grines, CL; Pica, M; Shoukfeh, M; O'Neill, WW			Multiple complex coronary plaques in patients with acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	72nd Annual Scientific Session of the American-Heart-Association	NOV 07-10, 1999	ATLANTA, GA	Amer Heart Assoc			UNSTABLE ANGINA-PECTORIS; ATHEROSCLEROTIC PLAQUES; ANGIOGRAPHIC MORPHOLOGY; SUDDEN-DEATH; RUPTURE; THROMBOSIS; DISEASE; PROGRESSION; STENOSES; EROSION	Background: Acute myocardial infarction is believed to be caused by rupture of an unstable coronary-artery plaque that appears as a single lesion on angiography. However, plaque instability might be caused by pathophysiologic processes, such as inflammation, that exert adverse effects throughout the coronary vasculature and that therefore result in multiple unstable lesions. Methods: To document the presence of multiple unstable plaques in patients with acute myocardial infarction and determine their influence on outcome, we analyzed angiograms from 253 patients for complex coronary plaques characterized by thrombus, ulceration, plaque irregularity, and impaired flow. Results: Single complex coronary plaques were identified in 153 patients (60.5 percent) and multiple complex plaques in the other 100 patients (39.5 percent). As compared with patients with single complex plaques, those with multiple complex plaques were less likely to undergo primary angioplasty (86.0 percent vs. 94.8 percent, P=0.03) and more commonly required urgent bypass surgery (27.0 percent vs. 5.2 percent, P less/equal 0.001). During the year after myocardial infarction, the presence of multiple complex plaques was associated with an increased incidence of recurrent acute coronary syndromes (19.0 percent vs. 2.6 percent, P less/equal 0.001); repeated angioplasty (32.0 percent vs. 12.4 percent, P less/equal 0.001), particularly of non-infarct-related lesions (17.0 percent vs. 4.6 percent, P less/equal 0.001); and coronary-artery bypass graft surgery (35.0 percent vs. 11.1 percent, P less/equal 0.001). Conclusions: Patients with acute myocardial infarction may harbor multiple complex coronary plaques that are associated with adverse clinical outcomes. Plaque instability may be due to a widespread process throughout the coronary vessels, which may have implications for the management of acute ischemic heart disease. (N Engl J Med 2000;343:915-22.) (C)2000, Massachusetts Medical Society.	William Beaumont Hosp, Div Cardiol, Royal Oak, MI 48073 USA	Beaumont Health	Goldstein, JA (corresponding author), William Beaumont Hosp, Div Cardiol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.	jgoldstein@beaumont.edu						AMBROSE JA, 1985, J AM COLL CARDIOL, V5, P609, DOI 10.1016/S0735-1097(85)80384-3; AMBROSE JA, 1991, J AM COLL CARDIOL, V18, P675, DOI 10.1016/0735-1097(91)90788-B; Boden W. E., 1997, European Heart Journal, V18, P123; CHAPMAN I, 1965, ARCH PATHOL, V80, P256; CHEN LJ, 1995, CIRCULATION, V91, P2319, DOI 10.1161/01.CIR.91.9.2319; Chen LJ, 1996, J AM COLL CARDIOL, V28, P597, DOI 10.1016/0735-1097(96)00203-3; Chester MR, 1996, J AM COLL CARDIOL, V28, P604, DOI 10.1016/0735-1097(96)00235-5; DAVIES MJ, 1990, CIRCULATION, V82, P38; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; DAVIES SW, 1991, J AM COLL CARDIOL, V18, P669, DOI 10.1016/0735-1097(91)90787-A; FALK E, 1983, BRIT HEART J, V50, P127; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; FALK E, 1985, CIRCULATION, V71, P699, DOI 10.1161/01.CIR.71.4.699; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; FREEMAN MR, 1989, CIRCULATION, V80, P17, DOI 10.1161/01.CIR.80.1.17; FRINK RJ, 1994, J INVASIVE CARDIOL, V6, P173; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Garcia-Moll X, 2000, J AM COLL CARDIOL, V35, P956, DOI 10.1016/S0735-1097(99)00640-3; GERTZ SD, 1990, AM J CARDIOL, V66, P1368, DOI 10.1016/0002-9149(90)91170-B; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Guazzi MD, 1997, CIRCULATION, V96, P1145, DOI 10.1161/01.CIR.96.4.1145; HAFT JI, 1991, AM HEART J, V121, P1050, DOI 10.1016/0002-8703(91)90662-2; KASKI JC, 1995, CIRCULATION, V92, P2058, DOI 10.1161/01.CIR.92.8.2058; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; LEVIN DC, 1982, CIRCULATION, V66, P316, DOI 10.1161/01.CIR.66.2.316; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; MOISE A, 1983, NEW ENGL J MED, V309, P685, DOI 10.1056/NEJM198309223091201; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; QIAO JH, 1991, J AM COLL CARDIOL, V17, P1138, DOI 10.1016/0735-1097(91)90844-Y; REHR R, 1989, J AM COLL CARDIOL, V14, P1429, DOI 10.1016/0735-1097(89)90376-8; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; ROBERTS WC, 1972, AM J MED, V52, P425, DOI 10.1016/0002-9343(72)90033-2; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; THEROUX P, 1995, CIRCULATION, V91, P2295, DOI 10.1161/01.CIR.91.9.2295; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; WARNES CA, 1984, AM J CARDIOL, V54, P65, DOI 10.1016/0002-9149(84)90305-9	41	754	779	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2000	343	13					915	922		10.1056/NEJM200009283431303	http://dx.doi.org/10.1056/NEJM200009283431303			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	357KT	11006367				2022-12-01	WOS:000089501400003
J	Whitworth, J; Morgen, D; Quigley, M; Smith, A; Mayanja, S; Eotu, H; Omoding, N; Okongo, M; Malamba, S; Ojwiya, A				Whitworth, J; Morgen, D; Quigley, M; Smith, A; Mayanja, S; Eotu, H; Omoding, N; Okongo, M; Malamba, S; Ojwiya, A			Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMODIUM-FALCIPARUM MALARIA; INFECTION; KINSHASA; CHILDREN; MALAWI; TYPE-1; ZAIRE; POPULATION; MORTALITY	Background An association between HIV-1 and malaria is expected in theory, but has not been convincingly shown in practice. We studied the effects of HIV-1 infection and advancing immunosuppression on falciparum parasitaemia and clinical malaria. Methods HIV-1-positive and HIV-1-negative adults selected from a population-based cohort in rural Uganda were invited to attend a clinic every 3 months (routine visits) and whenever they were sick (interim visits). At each visit, information was collected on recent fever, body temperature, and malaria parasites. Participants were assigned a clinical stage at each routine visit and had regular CD4-cell measurements. Findings 484 participants made 7220 routine clinic visits between 1990 and 1998. Parasitaemia was more common at visits by HIV-1-positive individuals (328 of 2788 [11.8%] vs 231 of 3688 [6.3%], p<0.0001). At HIV-1-positive visits, lower CD4-cell counts were associated with higher parasite densities, compared with HIV-1-negative visits (p=0.0076). Clinical malaria was significantly more common at HIV-1-positive visits (55 of 2788 12.0%] vs 26 of 3688 [0.7%], p=0.0003) and the odds of having clinical malaria increased with falling CD4-cell count (p=0.0002) and advancing clinical stage (p=0.0024). Participants made 3377 interim visits. The risk of clinical malaria was significantly higher at visits by HIV-1-positive individuals than HIV-1-negative individuals (4.0% vs 1.9%, p=0.009). The risk of clinical malaria Ended to increase with falling CD4-cell counts (p=0.052). Interpretation HIV-1 infection is associated with an increased frequency of clinical malaria and parasitaemia. This association tends to become more pronounced with advancing immunosuppression, and could have important public-health implications for sub-Saharan Africa.	Uganda Virus Res Inst, MRC, AIDS Program, Entebbe, Uganda; London Sch Hyg & Trop Med, London WC1, England	Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine	Whitworth, J (corresponding author), Uganda Virus Res Inst, MRC, AIDS Program, POB 49, Entebbe, Uganda.		Smith, Adrian D/A-6336-2009	Smith, Adrian/0000-0003-0036-1490; Quigley, Maria/0000-0002-8058-6181				ALLEN S, 1991, J INFECT DIS, V164, P67, DOI 10.1093/infdis/164.1.67; ATZORI C, 1993, ANN TROP MED PARASIT, V87, P585, DOI 10.1080/00034983.1993.11812814; BLOLAND PB, 1995, AIDS, V9, P721, DOI 10.1097/00002030-199507000-00009; *CDC, 1997, WKLY EPIDEMIOL REC, V72, P285; Chandramohan D, 1998, INT J EPIDEMIOL, V27, P296, DOI 10.1093/ije/27.2.296; COLEBUNDERS R, 1990, J INFECTION, V21, P167, DOI 10.1016/0163-4453(90)91701-E; GREENBERG AE, 1991, NEW ENGL J MED, V325, P105, DOI 10.1056/NEJM199107113250206; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; Huber P.J., 1981, ROBUST STAT; Kalyesubula I, 1997, PEDIATR INFECT DIS J, V16, P876, DOI 10.1097/00006454-199709000-00011; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; LEAVER RJ, 1990, T ROY SOC TROP MED H, V84, P201, DOI 10.1016/0035-9203(90)90253-B; Migot F, 1996, PARASITE IMMUNOL, V18, P333, DOI 10.1046/j.1365-3024.1996.d01-116.x; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; MULDER DW, 1994, LANCET, V343, P1021, DOI 10.1016/S0140-6736(94)90133-3; MULLER O, 1990, T ROY SOC TROP MED H, V84, P336, DOI 10.1016/0035-9203(90)90306-Y; NGUYENDINH P, 1987, B WORLD HEALTH ORGAN, V65, P607; NIYONGABO T, 1994, ACTA TROP, V56, P299, DOI 10.1016/0001-706X(94)90101-5; SIMOOYA OO, 1988, BRIT MED J, V297, P30, DOI 10.1136/bmj.297.6640.30; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Steketee RW, 1996, AM J TROP MED HYG, V55, P24, DOI 10.4269/ajtmh.1996.55.24; Steketee RW, 1996, AM J TROP MED HYG, V55, P17, DOI 10.4269/ajtmh.1996.55.17; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; *UANIDS, 1998, UNAIDS9835; WABWIREMANGEN F, 1989, AM J TROP MED HYG, V41, P504, DOI 10.4269/ajtmh.1989.41.504; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221; Xiao LH, 1998, J INFECT DIS, V177, P437, DOI 10.1086/514212	27	309	315	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1051	1056		10.1016/S0140-6736(00)02727-6	http://dx.doi.org/10.1016/S0140-6736(00)02727-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009139				2022-12-01	WOS:000089430500008
J	Oda, K; Arakawa, H; Tanaka, T; Matsuda, K; Tanikawa, C; Mori, T; Nishimori, H; Tamai, K; Tokino, T; Nakamura, Y; Taya, Y				Oda, K; Arakawa, H; Tanaka, T; Matsuda, K; Tanikawa, C; Mori, T; Nishimori, H; Tamai, K; Tokino, T; Nakamura, Y; Taya, Y			p53AlP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53	CELL			English	Article							HUMAN GENOMIC DNA; FUNCTIONAL DOMAIN; TARGET GENE; MUTANT P53; CELL-LINES; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; PROTEIN; CANCER	Through direct cloning of p53 binding sequences from human genomic DNA, we have isolated a novel gene, designated p53AIP1 (p89-regulated Apoptosis-Inducing Protein 1), whose expression is inducible by wildtype p53. Ectopically expressed p53AIP1, which is localized within mitochondria, leads to apoptotic cell death through dissipation of mitochondrial Delta psi m. We have found that upon severe DNA damage, Ser-46 on p53 is phosphorylated and apoptosis is induced. In addition, substitution of Ser-46 inhibits the ability of p53 to induce apoptosis and selectively blocks expression of p53AIP1. Our results suggest that p53AIP1 is likely to play an important role in mediating p53-dependent apoptosis, and phosphorylation of Ser-46 regulates the transcriptional activation of this apoptosis-inducing gene.	Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, Tokyo 1088639, Japan; Natl Canc Ctr, Res Inst, Div Biol, Tokyo 1040045, Japan; Cyclex Co Ltd, Nagano 3960002, Japan; Sapporo Med Coll, Canc Res Inst, Dept Mol Biol, Chuo Ku, Sapporo, Hokkaido 0608648, Japan	University of Tokyo; National Cancer Center - Japan; Sapporo Medical University	Taya, Y (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	yusuke@ims.u-tokyo.ac.jp; ytaya@gan2.ncc.go.jp	Tamai, Katsuyuki/F-4743-2013; Tokino, Takashi/AAI-9887-2021; Arakawa, Hirofumi/L-3459-2013; Matsuda, Koichi/D-4597-2011	Tamai, Katsuyuki/0000-0003-4094-3911; Arakawa, Hirofumi/0000-0001-6077-0638; Matsuda, Koichi/0000-0001-7292-2686; Tanikawa, Chizu/0000-0003-4759-4793				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chehab NH, 2000, GENE DEV, V14, P278; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Furuhata T, 1996, ONCOGENE, V13, P1965; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GomezManzano C, 1996, CANCER RES, V56, P694; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; MITSUDOMI T, 1992, ONCOGENE, V7, P171; MIYASHITA T, 1995, CELL, V80, P293; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Ng CC, 1999, GENE CHROMOSOME CANC, V26, P329, DOI 10.1002/(SICI)1098-2264(199912)26:4<329::AID-GCC7>3.3.CO;2-3; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OREN M, 1994, SEMIN CANCER BIOL, V5, P221; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; RAMCHURREN N, 1995, INT J CANCER, V62, P237, DOI 10.1002/ijc.2910620302; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Saller E, 1999, EMBO J, V18, P4424, DOI 10.1093/emboj/18.16.4424; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; Takei Y, 1998, GENE CHROMOSOME CANC, V23, P1; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; Urano T, 1997, CANCER RES, V57, P3281; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; YEARGIN J, 1993, J CLIN INVEST, V91, P2111, DOI 10.1172/JCI116435; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	44	982	1023	3	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					849	862		10.1016/S0092-8674(00)00073-8	http://dx.doi.org/10.1016/S0092-8674(00)00073-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030628	Bronze			2022-12-01	WOS:000089395200016
J	Kolber, ZS; Van Dover, CL; Niederman, RA; Falkowski, PG				Kolber, ZS; Van Dover, CL; Niederman, RA; Falkowski, PG			Bacterial photosynthesis in surface waters of the open ocean	NATURE			English	Article							BACTERIOCHLOROPHYLL ALPHA; PACIFIC-OCEAN; PLUME WATERS; PHYTOPLANKTON; FLUORESCENCE; AUSTRALIA; COASTS	The oxidation of the global ocean by cyanobacterial oxygenic photosynthesis, about 2,100 Myr ago(1), is presumed to have limited anoxygenic bacterial photosynthesis to oceanic regions that are both anoxic and illuminated(2,3). The discovery of oxygen-requiring photosynthetic bacteria about 20 years ago(4) changed this notion, indicating that anoxygenic bacterial photosynthesis could persist under oxidizing conditions. However, the distribution of aerobic photosynthetic bacteria in the world oceans, their photosynthetic competence and their relationship to oxygenic photoautotrophs on global scales are unknown. Here we report the first biophysical evidence demonstrating that aerobic bacterial photosynthesis is widespread in tropical surface waters of the eastern Pacific Ocean and in temperate coastal waters of the northwestern Atlantic. Our results indicate that these organisms account for 2-5% of the photosynthetic electron transport in the upper ocean.	Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; William & Mary; Rutgers State University New Brunswick	Falkowski, PG (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA.							Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Binder B, 2000, J PHYCOL, V36, P120, DOI 10.1046/j.1529-8817.2000.99107.x; BLANKENSHIP RE, 1995, ANAXYGENIC PHOTOSYNT; DROOP MR, 1974, ALGAL PHYSL BIOCH, P531; Durnford DG, 1997, PHOTOSYNTH RES, V53, P229, DOI 10.1023/A:1005815725371; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Garcia D, 1998, PHOTOSYNTH RES, V55, P331, DOI 10.1023/A:1005941031263; Harashima H., 1987, AGR BIOL CHEM TOKYO, V42, P1627; Harashima K., 1989, AEROBIC PHOTOSYNTHET; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; NISBET EG, 1995, NATURE, V373, P479, DOI 10.1038/373479a0; NISHIMURA Y, 1994, J GEN APPL MICROBIOL, V40, P287, DOI 10.2323/jgam.40.287; NOGUCHI T, 1992, PHOTOSYNTH RES, V31, P21, DOI 10.1007/BF00049533; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P295, DOI DOI 10.1016/B978-0-444-89440-3.50017-5; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Schwarze C, 2000, EUR J BIOCHEM, V267, P422, DOI 10.1046/j.1432-1327.2000.01018.x; SHIBA T, 1991, APPL ENVIRON MICROB, V57, P295, DOI 10.1128/AEM.57.1.295-300.1991; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; SHIBA T, 1984, J GEN APPL MICROBIOL, V30, P1313; Shimada K., 1995, ANOXYGENIC PHOTOSYNT, P105; VanDover CL, 1996, GEOPHYS RES LETT, V23, P2049, DOI 10.1029/96GL02151; Wiessner W., 1970, P95; WOESE CR, 1984, SYST APPL MICROBIOL, V5, P315, DOI 10.1016/S0723-2020(84)80034-X; Yurkov V, 1998, APPL ENVIRON MICROB, V64, P337; YURKOV V, 1994, INT J SYST BACTERIOL, V44, P427, DOI 10.1099/00207713-44-3-427; Yurkov VV, 1999, J BACTERIOL, V181, P4517, DOI 10.1128/JB.181.15.4517-4525.1999; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998	28	246	264	3	63	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					177	179		10.1038/35025044	http://dx.doi.org/10.1038/35025044			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001053				2022-12-01	WOS:000089241000045
J	Lacoste, V; Mauclere, P; Dubreuil, G; Lewis, J; Georges-Courbot, MC; Gessain, A				Lacoste, V; Mauclere, P; Dubreuil, G; Lewis, J; Georges-Courbot, MC; Gessain, A			Virology - KSHV-like herpesviruses in chimps and gorillas	NATURE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; IDENTIFICATION		Inst Pasteur, Dept SIDA & Retrovirus, Unite Oncol Virale, F-75724 Paris 15, France; Ctr Pasteur Cameroun, Yaounde, Cameroon; Ctr Int Rech Med, Franceville, Gabon; Int Zoo Vet Grp, Keighley BD21 1AG, W Yorkshire, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre Pasteur du Cameroun; International Zoo Veterinary Group (UK)	Lacoste, V (corresponding author), Inst Pasteur, Dept SIDA & Retrovirus, Unite Oncol Virale, 25-28 Rue Dr Roux, F-75724 Paris 15, France.		LACOSTE, Vincent/V-2321-2019	LACOSTE, Vincent/0000-0002-3173-4053				CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatlynne LG, 1998, BLOOD, V92, P53, DOI 10.1182/blood.V92.1.53.413k30_53_58; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Desrosiers RC, 1997, J VIROL, V71, P9764, DOI 10.1128/JVI.71.12.9764-9769.1997; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Greensill J, 2000, J VIROL, V74, P1572, DOI 10.1128/JVI.74.3.1572-1577.2000; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; Mahieux R, 1998, J VIROL, V72, P10316, DOI 10.1128/JVI.72.12.10316-10322.1998; ROIZMANN B, 1992, ARCH VIROL, V123, P425, DOI 10.1007/BF01317276; Rose TM, 1997, J VIROL, V71, P4138, DOI 10.1128/JVI.71.5.4138-4144.1997	11	67	70	1	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					151	152		10.1038/35025145	http://dx.doi.org/10.1038/35025145			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001045				2022-12-01	WOS:000089241000036
J	Leffell, DJ				Leffell, DJ			The other side of the sun	LANCET			English	Editorial Material									Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA	Yale University	Leffell, DJ (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.							ARMSTRONG BK, 1995, DERMATOL CLIN, V13, P583, DOI 10.1016/S0733-8635(18)30064-0; Brash DE, 1996, J INVEST DERMATOL S, V1, P136; Kelly DA, 2000, J EXP MED, V191, P561, DOI 10.1084/jem.191.3.561; McMichael AJ, 1996, BRIT J CANCER, V73, P945, DOI 10.1038/bjc.1996.169; NISHIGORI C, 1996, J INVEST DERMATOL S, V1, P143; Young AR, 2000, J INVEST DERMATOL, V115, P37, DOI 10.1046/j.1523-1747.2000.00012.x	6	1	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 26	2000	356	9231					699	699		10.1016/S0140-6736(00)02625-8	http://dx.doi.org/10.1016/S0140-6736(00)02625-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347UU	11085686				2022-12-01	WOS:000088948200006
J	Kamhawi, S; Belkaid, Y; Modi, G; Rowton, E; Sacks, D				Kamhawi, S; Belkaid, Y; Modi, G; Rowton, E; Sacks, D			Protection against cutaneous Leishmaniasis resulting from bites of uninfected sand flies	SCIENCE			English	Article							EXPERIMENTAL TRANSMISSION; INTERFERON-GAMMA; VECTOR SALIVA; NATURAL MODEL; DIPTERA; MICE; IMMUNOLOGY; MODULATION; HAMSTERS; MEXICANA	Despite the fact that Leishmania are transmitted exclusively by sand flies, none of the experimental models of Leishmaniasis have established infection via sand fly bites. Here we describe a reproducible murine model of Leishmania major infection transmitted by Phlebotomus papatasi. Prior exposure of mice to bites of uninfected sand flies conferred powerful protection against Leishmania major that was associated with a strong delayed-type hypersensitivity response and with interferon-gamma production at the site of parasite delivery. These results have important implications for the epidemiology of cutaneous leishmaniasis and suggest a vaccination strategy against this and possibly other vector-borne diseases.	NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; Walter Reed Army Med Ctr, Walter Reed Army Inst Res, Dept Entomol, Washington, DC 20307 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Walter Reed National Military Medical Center	Sacks, D (corresponding author), NIAID, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	dsacks@nih.gov	Rowton, Edgar D/A-4474-2012; Rowton, Edgar D./A-1975-2011	Rowton, Edgar D./0000-0002-1979-1485; Belkaid, Yasmine/0000-0001-9962-3571	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000256, ZIAAI000256] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEACH R, 1985, AM J TROP MED HYG, V34, P278, DOI 10.4269/ajtmh.1985.34.278; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 1996, J IMMUNOL METHODS, V199, P5, DOI 10.1016/S0022-1759(96)00117-2; Brossard M, 1997, MED VET ENTOMOL, V11, P270, DOI 10.1111/j.1365-2915.1997.tb00406.x; CROSS ML, 1993, J MED ENTOMOL, V30, P725, DOI 10.1093/jmedent/30.4.725; Fayyazi A, 1999, ARCH DERMATOL RES, V291, P485, DOI 10.1007/s004030050442; Kang KF, 1996, J IMMUNOL, V156, P1402; KILLICKKENDRICK R, 1977, PROC R SOC SER B-BIO, V196, P105, DOI 10.1098/rspb.1977.0032; LAINSON R, 1977, NATURE, V266, P628, DOI 10.1038/266628a0; LAWYER PG, 1990, T ROY SOC TROP MED H, V84, P229, DOI 10.1016/0035-9203(90)90266-H; LAWYER PG, 1987, J MED ENTOMOL, V24, P458, DOI 10.1093/jmedent/24.4.458; Mbow ML, 1998, J IMMUNOL, V161, P5571; POZIO E, 1985, T ROY SOC TROP MED H, V79, P524, DOI 10.1016/0035-9203(85)90085-9; RIBEIRO JMC, 1989, EXP PARASITOL, V69, P104, DOI 10.1016/0014-4894(89)90177-X; Sugaya M, 1999, J INVEST DERMATOL, V113, P350, DOI 10.1046/j.1523-1747.1999.00697.x; Takashima A, 1996, Semin Immunol, V8, P333, DOI 10.1006/smim.1996.0044; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; Wikel SK, 1999, BIOSCIENCE, V49, P311, DOI 10.2307/1313614; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Willadsen P, 1999, PARASITOL TODAY, V15, P258, DOI 10.1016/S0169-4758(99)01472-6; Zeidner NS, 1999, PARASITE IMMUNOL, V21, P35, DOI 10.1046/j.1365-3024.1999.00199.x	22	253	267	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2000	290	5495					1351	1354		10.1126/science.290.5495.1351	http://dx.doi.org/10.1126/science.290.5495.1351			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375BN	11082061				2022-12-01	WOS:000165379800047
J	Allman, BE; McMahon, PJ; Nugent, KA; Paganin, D; Jacobson, DL; Arif, M; Werner, SA				Allman, BE; McMahon, PJ; Nugent, KA; Paganin, D; Jacobson, DL; Arif, M; Werner, SA			Imaging - Phase radiography with neutrons	NATURE			English	Article									Univ Melbourne, Sch Phys, Parkville, Vic 3010, Australia; Natl Inst Stand & Technol, Phys Lab, Gaithersburg, MD 20899 USA; Univ Missouri, Dept Phys & Astron, Columbia, MO 65211 USA	University of Melbourne; National Institute of Standards & Technology (NIST) - USA; University of Missouri System; University of Missouri Columbia	Allman, BE (corresponding author), Univ Melbourne, Sch Phys, Parkville, Vic 3010, Australia.	k.nugent@physics.unimelb.edu.au	paganin, david m/B-9717-2009; Nugent, Keith A/J-2699-2012; Nugent, Keith A/I-4154-2016	Nugent, Keith A/0000-0003-1522-8991; Nugent, Keith A/0000-0002-4281-3478; Paganin, David/0000-0002-7758-7140				Allman BE, 2000, J OPT SOC AM A, V17, P1732, DOI 10.1364/JOSAA.17.001732; Bajt S, 2000, ULTRAMICROSCOPY, V83, P67, DOI 10.1016/S0304-3991(99)00174-6; Barty A, 1998, OPT LETT, V23, P817, DOI 10.1364/OL.23.000817; Dietze M, 1996, NUCL INSTRUM METH A, V377, P320, DOI 10.1016/0168-9002(96)00203-3; GUREYEV TE, 1995, J OPT SOC AM A, V12, P1942, DOI 10.1364/JOSAA.12.001942; Nugent KA, 1996, PHYS REV LETT, V77, P2961, DOI 10.1103/PhysRevLett.77.2961; Paganin D, 1998, PHYS REV LETT, V80, P2586, DOI 10.1103/PhysRevLett.80.2586; SCHLENKER M, 1986, PHYSICA B & C, V137, P309, DOI 10.1016/0378-4363(86)90336-0; TEAGUE MR, 1983, J OPT SOC AM, V73, P1434, DOI 10.1364/JOSA.73.001434; Zernike F, 1942, PHYSICA, V9, P686, DOI 10.1016/S0031-8914(42)80035-X	10	151	159	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2000	408	6809					158	159		10.1038/35041626	http://dx.doi.org/10.1038/35041626			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089960				2022-12-01	WOS:000165180400031
J	Calignano, A; Katona, I; Desarnaud, F; Giuffrida, A; La Rana, G; Mackie, K; Freund, TF; Piomelli, D				Calignano, A; Katona, I; Desarnaud, F; Giuffrida, A; La Rana, G; Mackie, K; Freund, TF; Piomelli, D			Bidirectional control of airway responsiveness by endogenous cannabinoids	NATURE			English	Article							RAT-BRAIN MICROSOMES; GUINEA-PIG; SELECTIVE ANTAGONIST; CB1 RECEPTORS; RELEASE; COUGH; INHIBITION; ANANDAMIDE; SR141716A; NEURONS	Smoking marijuana or administration of its main active constituent, Delta (9)-tetrahydrocannabinol (Delta (9)-THC), may exert potent dilating effects on human airways(1-4). But the physiological significance of this observation and its potential therapeutic value are obscured by the fact that some asthmatic patients respond to these compounds with a paradoxical bronchospasm(3,5). The mechanisms underlying these contrasting responses remain unresolved. Here we show that the endogenous cannabinoid anandamide exerts dual effects on bronchial responsiveness in rodents: it strongly inhibits bronchospasm and cough evoked by the chemical irritant, capsaicin, but causes bronchospasm when the constricting tone exerted by the vagus nerve is removed. Both effects are mediated through peripheral CB1 cannabinoid receptors found on axon terminals of airway nerves. Biochemical analyses indicate that anandamide is synthesized in lung tissue on calcium-ion stimulation, suggesting that locally generated anandamide participates in the intrinsic control of airway responsiveness. In support of this conclusion, the CB1 antagonist SR141716A enhances capsaicin-evoked bronchospasm and cough. Our results may account for the contrasting bronchial actions of cannabis-like drugs in humans, and provide a framework for the development of more selective cannabinoid-based agents for the treatment of respiratory pathologies.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary; Univ Naples Federico II, Dept Pharmacol, I-80131 Naples, Italy; Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA	University of California System; University of California Irvine; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Naples Federico II; University of Washington; University of Washington Seattle	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	piomelli@uci.edu	Mackie, Ken/E-3715-2013; Mackie, Kenneth P/B-7358-2011; Giuffrida, Andrea/H-3770-2013; Katona, Istvan/D-9729-2011	Mackie, Ken/0000-0001-8501-6199; Giuffrida, Andrea/0000-0002-3773-0694; Katona, Istvan/0000-0003-2808-3330; CALIGNANO, Antonio/0000-0002-1742-3179				ABBOUD RT, 1976, CHEST, V70, P480, DOI 10.1378/chest.70.4.480; [Anonymous], 2000, SCI MARIJUANA; BARNES PJ, 1992, PHYSIOL REV, V72, P699, DOI 10.1152/physrev.1992.72.3.699; BOLSER DC, 1995, EUR J PHARMACOL, V276, pR1, DOI 10.1016/0014-2999(95)00118-5; Cadas H, 1997, J NEUROSCI, V17, P1226; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Coutts AA, 1997, BRIT J PHARMACOL, V121, P1557, DOI 10.1038/sj.bjp.0701301; CSIFFARY A, 1990, BRAIN RES, V506, P215, DOI 10.1016/0006-8993(90)91253-D; DESARNAUD F, 1995, J BIOL CHEM, V270, P6030, DOI 10.1074/jbc.270.11.6030; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; Ishac EJN, 1996, BRIT J PHARMACOL, V118, P2023, DOI 10.1111/j.1476-5381.1996.tb15639.x; Karlsson JA, 1999, PULM PHARMACOL THER, V12, P215, DOI 10.1006/pupt.1999.0207; Katona I, 1999, J NEUROSCI, V19, P4544; Landsman RS, 1997, EUR J PHARMACOL, V334, pR1, DOI 10.1016/S0014-2999(97)01160-6; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Rice W, 1997, EUR J PHARMACOL, V327, P227, DOI 10.1016/S0014-2999(97)89665-3; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; SAMHOUN MN, 1984, PROSTAGLANDINS, V27, P711, DOI 10.1016/0090-6980(84)90009-1; Sugiura T, 1996, EUR J BIOCHEM, V240, P53, DOI 10.1111/j.1432-1033.1996.0053h.x; Szallasi A, 1999, PHARMACOL REV, V51, P159; TASHKIN DP, 1977, AM REV RESPIR DIS, V115, P57; TASHKIN DP, 1975, AM REV RESPIR DIS, V112, P377; VACHON L, 1973, NEW ENGL J MED, V288, P985, DOI 10.1056/NEJM197305102881902; VanHoozen BE, 1997, CLIN REV ALLERG IMMU, V15, P243, DOI 10.1007/BF02737700; Widdicombe JG, 1998, RESP PHYSIOL, V114, P5, DOI 10.1016/S0034-5687(98)00076-0; Zygmunt PM, 2000, TRENDS PHARMACOL SCI, V21, P43, DOI 10.1016/S0165-6147(99)01430-3	30	139	149	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2000	408	6808					96	101		10.1038/35040576	http://dx.doi.org/10.1038/35040576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081515	Green Submitted			2022-12-01	WOS:000165050400059
J	O'Malley, PG; Jones, DL; Feuerstein, IM; Taylor, AJ				O'Malley, PG; Jones, DL; Feuerstein, IM; Taylor, AJ			Lack of correlation between psychological factors and subclinical coronary artery disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BEAM COMPUTED-TOMOGRAPHY; HEART-DISEASE; MYOCARDIAL-INFARCTION; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; PSYCHIATRIC-DISORDERS; LUMEN STENOSIS; DEPRESSION; HOSTILITY; CALCIFICATION	Background: The relation between psychological variables and clinically evident coronary artery disease has been studied extensively, although the potential mechanisms of such a relation remain speculative. We studied the relation between multiple psychological variables and subclinical coronary artery disease to assess the possible role of such variables in atherogenesis. Methods: We conducted a prospective study of 630 consecutive consenting, active-duty U.S. Army personnel, 39 to 45 years of age, without known coronary artery disease. Each participant was assessed for depression, anxiety, somatization, hostility, and stress. Subclinical coronary artery disease was identified by electron-beam computed tomography. Results: The mean (+/-SD) age of the subjects was 42+/-2 years; 82 percent were male, and 72 percent were white. The prevalence of coronary-artery calcification was 17.6 percent (mean calcification score, 10+/-49). The prevalence of prior or current psychiatric disorders was 12.7 percent. There was no correlation between the coronary-calcification score and the scores measuring depression (r=-0.07, P=0.08), anxiety (r=-0.07, P=0.10), hostility (r=-0.07, P=0.10), or stress (r=-0.002, P=0.96). Somatization (the number and severity of durable physical symptoms) was inversely correlated with calcification scores (r=-0.12, P=0.003), even after we controlled for age and sex. In multivariate logistic-regression models, a somatization score greater than 4 (out of a possible 26) was independently associated with the absence of any coronary-artery calcification (odds ratio, 0.49; 95 percent confidence interval, 0.25 to 0.96). Conclusions: Our data suggest that depression, anxiety, hostility, and stress are not related to coronary-artery calcification and that somatization is associated with the absence of calcification. (N Engl J Med 2000;343:1298-304.) (C) 2000, Massachusetts Medical Society.	Uniformed Serv Univ Hlth Sci, Dept Med EDP, Gen Internal Med Serv, Bethesda, MD 20814 USA; Walter Reed Army Med Ctr, Dept Med, Washington, DC 20307 USA; Walter Reed Army Med Ctr, Dept Radiol, Washington, DC 20307 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	O'Malley, PG (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med EDP, Gen Internal Med Serv, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	patrick.omalley@na.amedd.army.mil						AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ALMADA SJ, 1991, PSYCHOSOM MED, V53, P165, DOI 10.1097/00006842-199103000-00006; *AM PSYCH ASS, DSM4 AM PSYCH ASS; Appels A, 1997, J PSYCHOSOM RES, V43, P443, DOI 10.1016/S0022-3999(97)00158-X; BAREFOOT JC, 1989, PSYCHOSOM MED, V51, P46, DOI 10.1097/00006842-198901000-00005; Barefoot JC, 1996, CIRCULATION, V93, P1976, DOI 10.1161/01.CIR.93.11.1976; BECKER MH, 1985, MED CARE, V23, P539, DOI 10.1097/00005650-198505000-00014; BOOTHKEWLEY S, 1987, PSYCHOL BULL, V101, P343, DOI 10.1037/0033-2909.101.3.343; Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667; COSTA PT, 1993, DIAGNOSIS TREATMENT, P155; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; de Leon CFM, 1998, ARCH INTERN MED, V158, P2341; FALLAVOLLITA JA, 1994, CIRCULATION, V89, P285, DOI 10.1161/01.CIR.89.1.285; Ford DE, 1998, ARCH INTERN MED, V158, P1422, DOI 10.1001/archinte.158.13.1422; FRASURESMITH N, 1994, JAMA-J AM MED ASSOC, V271, P1082; FRIEDMAN GD, 1974, PSYCHOSOM MED, V36, P327, DOI 10.1097/00006842-197407000-00007; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; HORWITZ RI, 1993, ARCH INTERN MED, V153, P1863, DOI 10.1001/archinte.153.16.1863; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2546, DOI 10.1001/jama.283.19.2546; JENKINS CD, 1971, NEW ENGL J MED, V284, P244, DOI 10.1056/NEJM197102042840506; JENKINS CD, 1976, NEW ENGL J MED, V294, P987, DOI 10.1056/NEJM197604292941806; JULKUNEN J, 1994, PSYCHOSOM MED, V56, P519, DOI 10.1097/00006842-199411000-00007; Kajinami K, 1997, J AM COLL CARDIOL, V29, P1549, DOI 10.1016/S0735-1097(97)00090-9; Kaufmann MW, 1999, AM HEART J, V138, P549, DOI 10.1016/S0002-8703(99)70159-6; Kawachi I, 1998, CIRCULATION, V98, P405, DOI 10.1161/01.CIR.98.5.405; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; Knox SS, 1998, AM J CARDIOL, V82, P1192, DOI 10.1016/S0002-9149(98)00599-2; Kop WJ, 1996, J PSYCHOSOM RES, V40, P397, DOI 10.1016/0022-3999(95)00613-3; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Kroenke K, 1994, Arch Fam Med, V3, P774; LOUIS TA, 1986, J CHRON DIS, V39, P831, DOI 10.1016/0021-9681(86)90085-8; LOUIS TA, 1987, J CHRON DIS, V40, P369; Low KG, 1998, ANN BEHAV MED, V20, P221, DOI 10.1007/BF02884964; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; Matthews KA, 1998, PSYCHOSOM MED, V60, P633, DOI 10.1097/00006842-199809000-00021; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Miller TQ, 1996, PSYCHOL BULL, V119, P322, DOI 10.1037/0033-2909.119.2.322; O'Malley PG, 1998, J PSYCHOSOM RES, V44, P279, DOI 10.1016/S0022-3999(97)00250-X; O'Malley PG, 1998, ARCH INTERN MED, V158, P2357, DOI 10.1001/archinte.158.21.2357; O'Malley PG, 2000, AM J CARDIOL, V85, P945, DOI 10.1016/S0002-9149(99)00906-6; O'Malley PG, 1999, AM HEART J, V137, P932, DOI 10.1016/S0002-8703(99)70419-9; PICKERING TG, 1985, J BEHAV MED, V8, P203, DOI 10.1007/BF00870308; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; Rumberger JA, 1997, J AM COLL CARDIOL, V29, P1542, DOI 10.1016/S0735-1097(97)00093-4; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Sesso HD, 1998, AM J CARDIOL, V82, P851, DOI 10.1016/S0002-9149(98)00491-3; SIMON A, 1995, CIRCULATION, V92, P1414, DOI 10.1161/01.CIR.92.6.1414; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sullivan MD, 1997, AM J MED, V103, P348, DOI 10.1016/S0002-9343(97)00167-8; Taylor AJ, 1998, NEW ENGL J MED, V339, P2018, DOI 10.1056/NEJM199812313392711; TENNANT CC, 1987, PSYCHOL MED, V17, P425, DOI 10.1017/S0033291700024983; VOLLMER WM, 1986, CHEST, V90, P416, DOI 10.1378/chest.90.3.416; WARDWELL WI, 1973, J CHRON DIS, V26, P447, DOI 10.1016/0021-9681(73)90096-9; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; ZYZANSKI SJ, 1976, ARCH INTERN MED, V136, P1234, DOI 10.1001/archinte.136.11.1234	55	93	93	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2000	343	18					1298	1304		10.1056/NEJM200011023431803	http://dx.doi.org/10.1056/NEJM200011023431803			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	368RP	11058674	Bronze			2022-12-01	WOS:000090131600003
J	Majeed, A; Bardsley, M; Morgan, D; O'Sullivan, C; Bindman, AB				Majeed, A; Bardsley, M; Morgan, D; O'Sullivan, C; Bindman, AB			Cross sectional study of primary care groups in London: association of measures of socioeconomic and health status with hospital admission rates	BRITISH MEDICAL JOURNAL			English	Article							SMALL-AREA ANALYSIS; ALLOCATING RESOURCES; CLINICAL GOVERNANCE; INPATIENT SERVICES; GENERAL PRACTICES; NEW-ZEALAND; AUTHORITIES; MODEL	Objectives To calculate socioeconomic and health status measures for the primary care groups in London and to examine the association between these measures and hospital admission rates. Design Cross sectional study. Setting 66 primary care groups in London, total list size 8.0 million people. Main outcome measures Elective and emergency standardised hospital admission ratios; standardised admission rates for diabetes and asthma. Results Standardised hospital admission ratios varied from 74 to 116 for total admissions and from 50 to 124 for emergency admissions. Directly standardised admission rates for asthma varied from 152 to 801 per 100 000 (mean 364) and for diabetes from 235 to 1034 per 100 000 (mean 538). There were large differences in the mortality, socioeconomic, and general practice characteristics of the primary care groups. Hospital admission rates were significantly correlated with many of the measures of chronic illness and deprivation. The strongest correlations were with disability living allowance (R = 0.64 for total admissions and R = 0.62 for emergency admissions, P <0.0001). Practice characteristics were less strongly associated with hospital admission rates. Conclusions It is feasible to produce a range of socioeconomic, health status, and practice measures for primary care groups for use in needs assessment and in planning and monitoring health services. These measures show that primary care groups have highly variable patient and practice characteristics and that hospital admission rates are associated with chronic illness and deprivation. These variations will need to be taken into account when assessing performance.	UCL, Sch Publ Policy, London WC1H 9EZ, England; E & City London Hlth Author, Hlth Londoners Project, London E1 1RD, England; UCL Hosp NHS Trust, Res & Dev Directorate, London NW1 2LT, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Majeed, A (corresponding author), UCL, Sch Publ Policy, London WC1H 9EZ, England.	a.majeed@ucl.ac.uk	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Bardsley, Martin/0000-0002-9853-6019; Majeed, Azeem/0000-0002-2357-9858	FIC NIH HHS [F06 TW002336] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F06TW002336] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Aveyard P, 1997, J Eval Clin Pract, V3, P275, DOI 10.1046/j.1365-2753.1997.t01-1-00004.x; Baker R, 1999, BRIT MED J, V318, P779, DOI 10.1136/bmj.318.7186.779; BARDSLEY M, 2000, MAPING HLTH PRIMARY; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; CARRHILL RA, 1994, BRIT MED J, V309, P1046, DOI 10.1136/bmj.309.6961.1046; Dixon J, 1998, BRIT MED J, V317, P125, DOI 10.1136/bmj.317.7151.125; Griffiths C, 1997, BRIT MED J, V314, P482, DOI 10.1136/bmj.314.7079.482; Majeed A, 1999, BRIT MED J, V318, P772, DOI 10.1136/bmj.318.7186.772; MAJEED A, 1999, PUBLIC HLTH MED, V1, P4; MAJEED FA, 1994, BRIT MED J, V308, P1272, DOI 10.1136/bmj.308.6939.1272; MAJEED FA, 1995, BRIT MED J, V310, P1511, DOI 10.1136/bmj.310.6993.1511; Malcolm L, 1997, BRIT MED J, V314, P1890, DOI 10.1136/bmj.314.7098.1890; Malcolm L, 1999, BRIT MED J, V319, P1340, DOI 10.1136/bmj.319.7221.1340; *NHS EX, 1999, QUAL PERF NHS HIGH L; *NHS EX, 1988, EX ATTR DAT SET; Reid FDA, 1999, BRIT MED J, V319, P98, DOI 10.1136/bmj.319.7202.98; SCALLY G, 1998, BRIT MED J, V316, P39; *SECR STAT HLTH, 1997, NEW NHS; SMITH P, 1994, BRIT MED J, V309, P1050, DOI 10.1136/bmj.309.6961.1050	19	63	63	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1057	1060		10.1136/bmj.321.7268.1057	http://dx.doi.org/10.1136/bmj.321.7268.1057			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053180	Bronze, Green Published			2022-12-01	WOS:000165076800027
J	Grassme, H; Kirschnek, S; Riethmueller, J; Riehle, A; von Kurthy, G; Lang, F; Weller, M; Gulbins, E				Grassme, H; Kirschnek, S; Riethmueller, J; Riehle, A; von Kurthy, G; Lang, F; Weller, M; Gulbins, E			CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa	SCIENCE			English	Article							T-CELLS; FAS LIGAND; APOPTOSIS; MACROPHAGES; ACTIVATION; PATHWAYS; RECEPTOR; SIGNAL	Pseudomonas aeruginosa causes severe infections, particularly of the lung, that are life threatening. Here, we show that P. aeruginosa infection induces apoptosis of lung epithelial cells by activation of the endogenous CD95/CD95 ligand system. Deficiency of CD95 or CD95 ligand on epithelial cells prevented apoptosis of lung epithelial cells in vivo as well as in vitro. The importance of CD95/CD95 ligand-mediated lung epithelial cell apoptosis was demonstrated by the rapid development of sepsis in CD95- or CD95 ligand-deficient mice, but not in normal mice, after P. aeruginosa infection.	Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany; Univ Tubingen, Dept Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Gulbins, E (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Gulbins, Erich/L-6989-2014	Gulbins, Erich/0000-0002-3117-1342; Weller, Michael/0000-0002-1748-174X				Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; CIFONE MG, 1995, EMBO J, V14, P5859, DOI 10.1002/j.1460-2075.1995.tb00274.x; Fernandez-Prada C, 1998, INFECT IMMUN, V66, P3918, DOI 10.1128/IAI.66.8.3918-3924.1998; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P579, DOI 10.1128/IAI.65.2.579-586.1997; Halaas O, 1998, J IMMUNOL, V160, P4330; Kang PJ, 1997, MOL MICROBIOL, V24, P1249; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Latinis KM, 1996, BLOOD, V87, P871, DOI 10.1182/blood.V87.3.871.bloodjournal873871; Merrick JC, 1997, AM J PATHOL, V151, P785; MULLER KP, 1995, EUR J IMMUNOL, V25, P2996, DOI 10.1002/eji.1830251043; Nagata S, 1998, J HUM GENET, V43, P2, DOI 10.1007/s100380050029; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; PAYNE CM, 1995, LEUKEMIA LYMPHOMA, V19, P43, DOI 10.3109/10428199509059662; RENSINGEHL A, 1995, J INFLAMM, V45, P161; WANG ZQ, 1994, EUR J IMMUNOL, V24, P1549, DOI 10.1002/eji.1830240714; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	21	210	226	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					527	530		10.1126/science.290.5491.527	http://dx.doi.org/10.1126/science.290.5491.527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039936				2022-12-01	WOS:000089946000055
J	Vreeland, RH; Rosenzweig, WD; Powers, DW				Vreeland, RH; Rosenzweig, WD; Powers, DW			Isolation of a 250 million-year-old halotolerant bacterium from a primary salt crystal	NATURE			English	Article							SP. NOV.; DOMINICAN AMBER; NEW-MEXICO; EVAPORITES; HALOBACTERIA; DIVERSITY; ORIGIN; GENUS	Bacteria have been found associated with a variety of ancient samples(1), however few studies are generally accepted due to questions about sample quality and contamination. When Cano and Borucki(2) isolated a strain of Bacillus sphaericus from an extinct bee trapped in 25-30 million-year-old amber, careful sample selection and stringent sterilization techniques were the keys to acceptance. Here we report the isolation and growth of a previously unrecognized spore-forming bacterium (Bacillus species, designated 2-9-3) from a brine inclusion within a 250 million-year-old salt crystal from the Permian Salado Formation. Complete gene sequences of the 16S ribosomal DNA show that the organism is part of the lineage of Bacillus marismortui and Virgibacillus pantothenticus. Delicate crystal structures and sedimentary features indicate the salt has not recrystallized since formation. Samples were rejected if brine inclusions showed physical signs of possible contamination. Surfaces of salt crystal samples were sterilized with strong alkali and acid before extracting brines from inclusions. Sterilization procedures reduce the probability of contamination to less than 1 in 10(9).	W Chester Univ, Dept Biol, W Chester, PA 19383 USA	Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania	Vreeland, RH (corresponding author), W Chester Univ, Dept Biol, W Chester, PA 19383 USA.	rvreeland@wcupa.edu						Arahal DR, 1999, INT J SYST BACTERIOL, V49, P521, DOI 10.1099/00207713-49-2-521; CANO RJ, 1995, SCIENCE, V268, P1060, DOI 10.1126/science.7538699; Cournoyer B, 1999, FEMS MICROBIOL LETT, V177, P29, DOI 10.1111/j.1574-6968.1999.tb13709.x; CROFT J. S., 1978, THESIS OHIO STATE U; DENNER EBM, 1994, INT J SYST BACTERIOL, V44, P774, DOI 10.1099/00207713-44-4-774; Garabito MJ, 1997, INT J SYST BACTERIOL, V47, P735, DOI 10.1099/00207713-47-3-735; Grant WD, 1998, EXTREMOPHILES, V2, P279, DOI 10.1007/s007920050070; Greenblatt CL, 1999, MICROBIAL ECOL, V38, P58, DOI 10.1007/s002489900153; Hardie L.A., 1983, 6 INT S SALT I ALEX, V1, P11; Heyndrickx M, 1998, INT J SYST BACTERIOL, V48, P99, DOI 10.1099/00207713-48-1-99; HOLT RM, 1990, 90051 DOEWIPP US DEP, P1; HOLT RM, 1990, GEOLOGICAL HYDROLOGI, V14, P45; HUVAL JH, 1991, GEN APPL ASPECTS HAL, V201, P53; Lambert LH, 1998, INT J SYST BACTERIOL, V48, P511, DOI 10.1099/00207713-48-2-511; LOWENSTEIN TK, 1990, AM J SCI, V290, P1, DOI 10.2475/ajs.290.1.1; LOWENSTEIN TK, 1985, SEDIMENTOLOGY, V32, P627, DOI 10.1111/j.1365-3091.1985.tb00478.x; LOWENSTEIN TK, 1988, GEOL SOC AM BULL, V100, P592, DOI 10.1130/0016-7606(1988)100<0592:OODCIA>2.3.CO;2; NORTON CF, 1993, J GEN MICROBIOL, V139, P1077, DOI 10.1099/00221287-139-5-1077; ONSTOTT TC, 1995, EOS, V76, pS285; POWERS DW, 1985, J SEDIMENT PETROL, V55, P769; RENNE PR, 1998, MINERAL MAG A, V62, P1253, DOI DOI 10.1180/MINMAG.1998.62A.2.320; RENNE PR, 1996, EOS T AM GEOPHYS UN, V77, P794; ROEDDER E, 1984, AM MINERAL, V69, P413; ROSENZWEIG WD, IN PRESS GEOMICROBIO; VREELAND RH, 1984, J BACTERIOL, V160, P879, DOI 10.1128/JB.160.3.879-883.1984; Vreeland RH, 1998, EXTREMOPHILES, V2, P321, DOI 10.1007/s007920050075; Vreeland RH, 1998, MICR EXTREM UNUSUAL, P53; VREELAND RH, 1998, ENIGMATIC EXTREME MI, P387; Waino M, 1999, INT J SYST BACTERIOL, V49, P821, DOI 10.1099/00207713-49-2-821; Walter J. C. Jr., 1953, Journal of Paleontology, V27, P679	30	458	490	4	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					897	900		10.1038/35038060	http://dx.doi.org/10.1038/35038060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057666				2022-12-01	WOS:000089901900049
J	Maruyama, M; Lam, KP; Rajewsky, K				Maruyama, M; Lam, KP; Rajewsky, K			Memory B-cell persistence is independent of persisting immunizing antigen	NATURE			English	Article							IN-VIVO; T-CELLS; MICE; IMMUNOGLOBULIN; GENERATION	Immunological memory in the antibody system is generated in T-cell-dependent responses and carried by long-lived memory B cells that recognize antigen by high-affinity antibodies(1,2). But it remains controversial(1) whether these B cells represent true 'memory' cells (that is, their maintenance is independent of the immunizing antigen), or whether they are a product of a chronic immune response driven by the immunizing antigen, which can be retained in the organism for extended time periods on the surface of specialized antigen-presenting cells (follicular dendritic cells)(3). Cell transfer experiments provided evidence in favour of a role of the immunizing antigen(4,5); however, analysis of memory cells in intact animals, which showed that these cells are mostly resting(6) and can persist in the absence of detectable T-cell help(7) or follicular dendritic cells(8), argued against it. Here we show, by using a genetic switch mediated by Cre recombinase, that memory B cells switching their antibody specificity away from the immunizing antigen are indeed maintained in the animal over long periods of time, similar to cells retaining their original antigen-binding specificity.	Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117609, Singapore	University of Cologne; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Rajewsky, K (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-50931 Cologne, Germany.		MARUYAMA, MITSUO/A-7083-2016; Lam, Kong-Peng/G-5374-2012	Lam, Kong-Peng/0000-0002-1316-4333; Rajewsky, Klaus/0000-0002-6633-6370				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; ASKONAS BA, 1972, EUR J IMMUNOL, V2, P494, DOI 10.1002/eji.1830020604; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; ESSER C, 1990, ANNU REV IMMUNOL, V8, P717, DOI 10.1146/annurev.iy.08.040190.003441; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Karrer U, 2000, J IMMUNOL, V164, P768, DOI 10.4049/jimmunol.164.2.768; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lam KP, 1998, P NATL ACAD SCI USA, V95, P13171, DOI 10.1073/pnas.95.22.13171; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nemazee D, 1996, IMMUNOL TODAY, V17, P25, DOI 10.1016/0167-5699(96)80565-2; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; OKUMURA K, 1976, EUR J IMMUNOL, V6, P467, DOI 10.1002/eji.1830060704; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Torres RM, 1997, LAB PROTOCOLS CONDIT; VIEIRA P, 1990, INT IMMUNOL, V2, P487, DOI 10.1093/intimm/2.6.487; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x	30	241	249	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					636	642		10.1038/35036600	http://dx.doi.org/10.1038/35036600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034213				2022-12-01	WOS:000089772800049
J	Funnell, MM; Anderson, RM				Funnell, MM; Anderson, RM			The problem with compliance in diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT EMPOWERMENT		Univ Michigan, Michigan Diabet Res & Training Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Funnell, MM (corresponding author), Univ Michigan, Michigan Diabet Res & Training Ctr, Ann Arbor, MI 48109 USA.							Anderson RM, 2000, DIABETES EDUCATOR, V26, P597, DOI 10.1177/014572170002600405; Anderson RM, 1999, DIABETES EDUCATOR, V25, P43, DOI 10.1177/014572179902500622; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; ANDERSON RM, 1995, DIABETES CARE, V18, P412, DOI 10.2337/diacare.18.3.412; ANDERSON RM, 2000, ART EMPOWERMENT STOR; Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108; FUNNELL MM, 2000, DIABETES SPECTRUM, V13, P69; Glasgow RE, 1999, DIABETES CARE, V22, P2090, DOI 10.2337/diacare.22.12.2090	8	112	118	1	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1709	1709		10.1001/jama.284.13.1709	http://dx.doi.org/10.1001/jama.284.13.1709			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015809	hybrid			2022-12-01	WOS:000089501900038
J	Brackley, KJ; Kilby, MD; Wright, JG; Brawn, WJ; Sethia, B; Stumper, O; Holder, R; Wyldes, MP; Whittle, MJ				Brackley, KJ; Kilby, MD; Wright, JG; Brawn, WJ; Sethia, B; Stumper, O; Holder, R; Wyldes, MP; Whittle, MJ			Outcome after prenatal diagnosis of hypoplastic left-heart syndrome: a case series	LANCET			English	Article							MODIFIED NORWOOD-PROCEDURE; FETAL ECHOCARDIOGRAPHY; DISEASE; INFANTS; OBSTRUCTION; PREVALENCE; ANOMALIES; SURGERY	Background Traditionally, after prenatal diagnosis of hypoplastic left-heart syndrome (HLHS) couples have been offered termination of pregnancy or comfort care. Success of postnatal surgical options such as the Norwood procedure have been associated with survival of up to 60%. Whether survival is affected by the congenital anomaly being identified prenatally or postnatally remains uncertain. Methods We reviewed all cases of prenatally diagnosed HLHS referred to the Fetal Medicine Unit at Birmingham Women's Hospital over 6 years between 1994 and 1999. Findings 87 cases of HLHS were referred at a median gestational age (95% CI) of 23 (19-37) weeks. Of these, 53 (61%) chose prenatal karyotyping. The overall frequency of abnormal karyotype was found in seven of 59 cases (12%) and associated structural anomalies in 18 of 87 (21%). After counselling, 38 of 87 couples (44%) chose termination of pregnancy. Of the remaining 49 fetuses, 11 (23%) were not considered for postnatal surgery because of parental choice and they died after compassionate care. Of the 36 babies who had surgery postnatally, 12 survived (33%). We recorded a survival rate of 38% for the stage-1 Norwood procedure in the prenatally diagnosed HLHS in our centre. These data suggest that at the point of prenatal detection, the overall survival rate for fetuses with HLHS is 25% (if terminated pregnancies are excluded). Interpretation Fetal echocardiography allows early diagnosis of HLHS and gives clinicians the opportunity to triage this group dependent on prenatal findings, including karyotyping and the exclusion of other structural anomalies. These prospective data provide up-to-date information on the basis of which parents can make decisions.	Univ Birmingham, Birmingham Womens Hosp, Div Reprod & Child Hlth, Birmingham B15 2TG, W Midlands, England; Univ Birmingham, Childrens Hosp, Birmingham B15 2TG, W Midlands, England; Princess Diana Childrens Hosp, Div Paediat Cardiol & Cardiothorac Surg, Birmingham, W Midlands, England; St Chads Court, W Midlands Reg Congenital Anomaly Registry, Birmingham B16 9RG, W Midlands, England; Univ Birmingham, Sch Math & Stat, Birmingham B15 2TT, W Midlands, England	Birmingham Women's Hospital; University of Birmingham; University of Birmingham; University of Birmingham	Kilby, MD (corresponding author), Univ Birmingham, Birmingham Womens Hosp, Div Reprod & Child Hlth, Birmingham B15 2TG, W Midlands, England.		FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223				Allan LD, 1998, HEART, V79, P371, DOI 10.1136/hrt.79.4.371; ALLAN LD, 1991, LANCET, V337, P959, DOI 10.1016/0140-6736(91)91582-F; ALLAN LD, 1989, INT J CARDIOL, V25, P341, DOI 10.1016/0167-5273(89)90226-X; ALLAN LD, 1994, J AM COLL CARDIOL, V23, P1452, DOI 10.1016/0735-1097(94)90391-3; Bartram U, 1997, ANN THORAC SURG, V64, P1795, DOI 10.1016/S0003-4975(97)01041-2; Brace V, 2000, PRENATAL DIAG, V20, P51, DOI 10.1002/(SICI)1097-0223(200001)20:1<51::AID-PD755>3.3.CO;2-F; Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8; BULOCK FA, 1995, BRIT HEART J, V73, P456; CHANG AC, 1991, J THORAC CARDIOV SUR, V102, P841, DOI 10.1016/S0022-5223(19)33933-9; FYLER DC, 1980, PEDIATRICS S, V65, P377; GREENWOOD RD, 1975, PEDIATRICS, V55, P485; Howe DT, 1996, PRENATAL DIAG, V16, P1003, DOI 10.1002/(SICI)1097-0223(199611)16:11<1003::AID-PD995>3.0.CO;2-D; Ishino K, 1999, J THORAC CARDIOV SUR, V117, P920, DOI 10.1016/S0022-5223(99)70373-9; Kern JH, 1997, AM J CARDIOL, V80, P170, DOI 10.1016/S0002-9149(97)00313-5; Kumar RK, 1999, AM J CARDIOL, V83, P1649, DOI 10.1016/S0002-9149(99)00172-1; Montana E, 1996, J AM COLL CARDIOL, V28, P1805, DOI 10.1016/S0735-1097(96)00381-6; Munn M B, 1999, J Matern Fetal Med, V8, P147; NATOWICZ M, 1988, PEDIATRICS, V82, P698; NOONAN J A, 1958, Pediatr Clin North Am, V5, P1029; NORWOOD WI, 1980, AM J CARDIOL, V45, P87, DOI 10.1016/0002-9149(80)90224-6; OKelly SW, 1997, BRIT MED J, V314, P87, DOI 10.1136/bmj.314.7074.87; Reis PM, 1998, AM J OBSTET GYNECOL, V179, P1150, DOI 10.1016/S0002-9378(98)70123-1; VANEGMOND H, 1988, BRIT HEART J, V60, P69; WALLGREN EI, 1978, EUR J CARDIOL, V7, P15; WHITTLE MJW, 2000, P ROYAL COLL OBST GY	25	67	72	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1143	1147		10.1016/S0140-6736(00)02756-2	http://dx.doi.org/10.1016/S0140-6736(00)02756-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030293				2022-12-01	WOS:000089594300011
J	Terada, S; Kinjo, M; Hirokawa, N				Terada, S; Kinjo, M; Hirokawa, N			Oligomeric tubulin in large transporting complex is transported via kinesin in squid giant axone	CELL			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CYTOPLASMIC DYNEIN; MONOCLONAL-ANTIBODY; GROWING AXONS; LOLIGO-PEALEI; MICROTUBULES; NEURONS; AXOPLASM; MOLECULES; MYOSIN	Slow axonal transport depends on an active mechanism that conveys cytosolic proteins. To investigate its molecular mechanism, we now constructed an in vitro experimental system for observation of tubulin transport, using squid giant axons. After injecting fluorescence-labeled tubulin into the axons, we monitored the movement of fluorescence by confocal laser scanning microscopy and fluorescence correlation spectroscopy. Here, from the pharmacological experiments and the functional blocking of kinesin motor protein by anti-kinesin antibody, we show that the directional movement of fluorescent profile was dependent on kinesin motor function. The fluorescent correlation function and estimated translational diffusion time revealed that tubulin molecule was transported in a unique form of large transporting complex distinct from those of stable polymers or other cytosolic protein.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; Hokkaido Univ, Res Inst Elect Sci, Lab Supramol Biophys, Kita Ku, Sapporo, Hokkaido 0600812, Japan	University of Tokyo; Hokkaido University	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Kinjo, Masataka/F-5267-2011	Kinjo, Masataka/0000-0001-8889-8369				Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Baas PW, 1997, TRENDS CELL BIOL, V7, P380, DOI 10.1016/S0962-8924(97)01148-3; BEARER EL, 1993, P NATL ACAD SCI USA, V90, P11252, DOI 10.1073/pnas.90.23.11252; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; Campenot RB, 1996, J CELL BIOL, V135, P701, DOI 10.1083/jcb.135.3.701; Chang SH, 1999, NAT CELL BIOL, V1, P399, DOI 10.1038/15629; Dillman JF, 1996, P NATL ACAD SCI USA, V93, P141, DOI 10.1073/pnas.93.1.141; Dillman JF, 1996, J NEUROSCI, V16, P6742; EHRENBER.M, 1974, CHEM PHYS, V4, P390, DOI 10.1016/0301-0104(74)85005-6; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Funakoshi T, 1996, J CELL BIOL, V133, P1347, DOI 10.1083/jcb.133.6.1347; GALLANT PE, 1988, J NEUROSCI, V8, P1479; GILBERT SP, 1984, J CELL BIOL, V99, P445, DOI 10.1083/jcb.99.2.445; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; Hackney DD, 1996, ANNU REV PHYSIOL, V58, P731; HIGUCHI H, 1989, J BIOCHEM-TOKYO, V105, P638, DOI 10.1093/oxfordjournals.jbchem.a122717; HIRAMOTO Y, 1974, EXP CELL RES, V87, P403, DOI 10.1016/0014-4827(74)90503-5; HIRAMOTO Y, 1962, EXP CELL RES, V27, P416, DOI 10.1016/0014-4827(62)90006-X; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; Hirokawa N, 1997, TRENDS CELL BIOL, V7, P384, DOI 10.1016/S0962-8924(97)01133-1; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; KIEHART DP, 1982, METHOD CELL BIOL, V25, P13, DOI 10.1016/S0091-679X(08)61418-1; Kinjo M, 1998, ANAL CHIM ACTA, V365, P43, DOI 10.1016/S0003-2670(97)00706-X; Kinjo M, 1998, BIOTECHNIQUES, V25, P706, DOI 10.2144/98254rr01; Kinjo M, 1997, BIOIMAGING, V5, P134; KOPPEL DE, 1974, PHYS REV A, V10, P1938, DOI 10.1103/PhysRevA.10.1938; KUZNETSOV SA, 1992, NATURE, V356, P722, DOI 10.1038/356722a0; Lasek RJ, 1984, J CELL BIOL 2, V99, p212s; LIM SS, 1989, J CELL BIOL, V109, P253, DOI 10.1083/jcb.109.1.253; LIM SS, 1990, J CELL BIOL, V111, P123, DOI 10.1083/jcb.111.1.123; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753; METUZALS J, 1978, J CELL BIOL, V78, P597, DOI 10.1083/jcb.78.2.597; Miller KE, 1996, J CELL BIOL, V133, P1355, DOI 10.1083/jcb.133.6.1355; Nixon RA, 1998, CURR OPIN CELL BIOL, V10, P87, DOI 10.1016/S0955-0674(98)80090-2; OKABE S, 1992, J CELL BIOL, V117, P105, DOI 10.1083/jcb.117.1.105; OKABE S, 1993, J CELL BIOL, V120, P1177, DOI 10.1083/jcb.120.5.1177; OKABE S, 1990, NATURE, V343, P479, DOI 10.1038/343479a0; OKABE S, 1988, J CELL BIOL, V107, P651, DOI 10.1083/jcb.107.2.651; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; RIGLER R, 1992, FLUORESCENCE SPECTRO, P13; RIGLER R, 1990, BIOSCIENCE, P180; SABRY J, 1995, NEURON, V14, P1247, DOI 10.1016/0896-6273(95)90271-6; SCHNAPP BJ, 1992, J CELL BIOL, V119, P389, DOI 10.1083/jcb.119.2.389; TAKEDA S, 1995, NEURON, V14, P1257, DOI 10.1016/0896-6273(95)90272-4; Terada S, 1996, SCIENCE, V273, P784, DOI 10.1126/science.273.5276.784; TERASAKI M, 1995, P NATL ACAD SCI USA, V92, P11500, DOI 10.1073/pnas.92.25.11500; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4	53	108	112	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					141	155		10.1016/S0092-8674(00)00094-5	http://dx.doi.org/10.1016/S0092-8674(00)00094-5			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051554	Bronze			2022-12-01	WOS:000089636400015
J	Wilmoth, JR; Deegan, LJ; Lundstrom, H; Horiuchi, S				Wilmoth, JR; Deegan, LJ; Lundstrom, H; Horiuchi, S			Increase of maximum life-span in Sweden, 1861-1999	SCIENCE			English	Article							MORTALITY; LONGEVITY; VARIABILITY; COUNTRIES; AGE	A fundamental question in aging research is whether humans and other species possess an immutable life-span limit. We examined the maximum age at death in Sweden, which rose from about 101 years during the 1860s to about 108 years during the 1990s. The pace of increase was 0.44 years per decade before 1969 but accelerated to 1.11 years per decade after that date. More than 70 percent of the rise in the maximum age at death from 1861 to 1999 is attributable to reductions in death rates above age 70. The rest are due to increased numbers of survivors to old age (both larger birth cohorts and increased survivorship from infancy to age 70). The more rapid rise in the maximum age since 1969 is due to the faster pace of old-age mortality decline during recent decades.	Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA; Stat Sweden, S-10451 Stockholm, Sweden; Rockefeller Univ, Lab Populat, New York, NY 10021 USA	University of California System; University of California Berkeley; Statistics Sweden; Rockefeller University	Wilmoth, JR (corresponding author), Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA.	jrw@demog.berkeley.edu			NIA NIH HHS [R01-AG11552, K02-AG00778, R01-AG14698] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K02AG000778, R01AG014698, R01AG011552] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRILLINGER DR, 1986, BIOMETRICS, V42, P693, DOI 10.2307/2530689; Finch CE, 1996, J GERONTOL A-BIOL, V51, pB183, DOI 10.1093/gerona/51A.3.B183; Gavrilov L.A., 1991, BIOL LIFE SPAN QUANT; GUMBEL EJ, 1937, DUREE EXTREME VIE HU; Gumbel Emil Julius, 1958, STAT EXTREMES; HAYFLICK L, 1996, HOW WHY WE AGE, P66; Hill ME, 2000, DEMOGRAPHY, V37, P175, DOI 10.2307/2648119; Horiuchi S, 1991, Popul Bull UN, P38; HORIUCHI S, UNPUB; KANNISTO V, 1994, POPUL DEV REV, V20, P793, DOI 10.2307/2137662; Manton KG, 1996, J GERONTOL A-BIOL, V51, pB362, DOI 10.1093/gerona/51A.5.B362; Robine JM, 1999, MGR POPULATION AGING, V6, P145; Thatcher AR, 1998, FORCE MORTALITY AGES, P20; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Vaupel JW, 1995, EXCEPTIONAL LONGEVIT, V2; Wilmoth JR, 1999, DEMOGRAPHY, V36, P475, DOI 10.2307/2648085; Wilmoth JR, 1996, EUR J POPUL, V12, P63, DOI 10.1007/BF01797166; Wilmoth JR, 1998, SCIENCE, V280, P395, DOI 10.1126/science.280.5362.395; YASHIN AI, 1994, MECH AGEING DEV, V74, P1, DOI 10.1016/0047-6374(94)90094-9	19	162	167	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2000	289	5488					2366	2368		10.1126/science.289.5488.2366	http://dx.doi.org/10.1126/science.289.5488.2366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	359CG	11009426				2022-12-01	WOS:000089593500058
J	Hughes, AP; Jackson, JM; Callen, JP				Hughes, AP; Jackson, JM; Callen, JP			Clinical features and treatment of peristomal pyoderma grangrenosum	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLAMMATORY BOWEL-DISEASE; GANGRENOSUM	Context Peristomal pyoderma gangrenosum (PPG), an unusual Variant of pyoderma gangrenosum, has been reported almost exclusively in patients with inflammatory bowel disease (IBD) and-is frequently misdiagnosed. Objective To better characterize the clinical manifestations, diagnosis, and management of PPG. Design, Setting, and Patients Retrospective analysis of 7 patients with PPG observed in a university-affiliated community setting between 1988 and December 1999. Main Outcome Measures Clinical and histopathologic features, associated disorders, and microbiologic findings. Results Two patients had Crohn disease, 2 had ulcerative colitis, and 3 had abdominal cancer. Five patients had at least 1 relapse of PPC after initial healing. Although 3 of 4 patients with IBD had active bowel disease, a parallel course with PPG occurred in only 1 patient. Both patients whose stoma was relocated developed an ulcer at the new site. Effective therapies included topical superpotent corticosteroids; intralesional injection of triamcinolone acetonide at the ulcer margin; topical cromolyn sodium; oral dapsone, prednisone, cyclosporine, mycophenolate mofetil; and intravenous infliximab. Conclusion Our experiences demonstrate that although PPG has been most often reported in patients with IBD, it may occur in the absence of IBD. Biopsy of the skin lesion is not diagnostic but excludes other causes. Relocation of the stoma may be associated with a new ulceration and should be avoided. Trauma to the skin of a predisposed patient may elicit the pustules or ulcerations associated with pathergy.	Univ Louisville, Sch Med, Dept Med, Div Dermatol, Louisville, KY 40292 USA	University of Louisville	Callen, JP (corresponding author), 310 E Broadway, Louisville, KY 40202 USA.							Bennett ML, 2000, MEDICINE, V79, P37, DOI 10.1097/00005792-200001000-00004; Brunsting LA, 1930, ARCH DERMATOL SYPH, V22, P655, DOI 10.1001/archderm.1930.01440160053009; CAIRNS BA, 1994, ARCH SURG-CHICAGO, V129, P769; Callen JP, 1998, LANCET, V351, P581, DOI 10.1016/S0140-6736(97)10187-8; Cuttino C, 1987, J Enterostomal Ther, V14, P216; DEHIJAS CM, 1993, J AM ACAD DERMATOL, V29, P1034, DOI 10.1016/S0190-9622(08)82037-3; KELTZ M, 1992, J AM ACAD DERMATOL, V27, P360, DOI 10.1016/0190-9622(92)70200-Y; LEBWOHL MG, 1995, ATLAS SKIN SYSTEMIC, P65; Lyon CC, 2000, J AM ACAD DERMATOL, V42, P992, DOI 10.1016/S0190-9622(00)90292-5; Powell FC, 1996, J AM ACAD DERMATOL, V34, P395, DOI 10.1016/S0190-9622(96)90428-4; POWELL FC, 1985, Q J MED, V55, P173; TJANDRA JJ, 1994, DIS COLON RECTUM, V37, P938, DOI 10.1007/BF02052602; Von den Driesch P, 1997, BRIT J DERMATOL, V137, P1000, DOI 10.1046/j.1365-2133.1997.20022083.x; WILLE R, 1984, INT CLASSIF, V11, P77; WOLFSEN HC, 1990, J CLIN GASTROENTEROL, V12, P651, DOI 10.1097/00004836-199012000-00011	15	120	122	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1546	1548		10.1001/jama.284.12.1546	http://dx.doi.org/10.1001/jama.284.12.1546			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000649	Bronze			2022-12-01	WOS:000089379700031
J	Sullivan, RM; Landers, M; Yeaman, B; Wilson, DA				Sullivan, RM; Landers, M; Yeaman, B; Wilson, DA			Neurophysiology - Good memories of bad events in infancy	NATURE			English	Article									Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Sullivan, RM (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.			Wilson, Donald/0000-0001-8918-2151; Sullivan, Regina Marie/0000-0002-2406-8857	NICHD NIH HHS [R01 HD033402] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033402] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amaral DG, 1992, AMYGDALA NEUROBIOLOG, P465; Bowlby J., 1969, ATTACHMENT LOSS VOL; CAMP LL, 1989, DEV PSYCHOBIOL, V22, P25; CHAMBERS KC, 1990, ANNU REV NEUROSCI, V13, P373, DOI 10.1146/annurev.ne.13.030190.002105; DAVIS M, 1992, P255; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; HAROUTUNIAN V, 1979, SCIENCE, V205, P927, DOI 10.1126/science.472715; Hunt PS, 1997, LEARN MOTIV, P53; KUCHARSKI D, 1984, DEV PSYCHOBIOL, V17, P465, DOI 10.1002/dev.420170505; WILSON DA, 1994, BEHAV NEURAL BIOL, V61, P1, DOI 10.1016/S0163-1047(05)80039-1	10	238	238	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					38	39		10.1038/35024156	http://dx.doi.org/10.1038/35024156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993064	Green Accepted			2022-12-01	WOS:000089124000032
J	Khani-Hanjani, A; Lacaille, D; Hoar, D; Chalmers, A; Horsman, D; Anderson, M; Balshaw, R; Keown, PA				Khani-Hanjani, A; Lacaille, D; Hoar, D; Chalmers, A; Horsman, D; Anderson, M; Balshaw, R; Keown, PA			Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis	LANCET			English	Article							TUMOR-NECROSIS-FACTOR; DEPENDENT DIABETES-MELLITUS; IFN-GAMMA; FACTOR-ALPHA; POLYMORPHISM; RECEPTOR; SECRETION; INTERLEUKIN-1-BETA; METHOTREXATE; EXPRESSION	Background Rheumatoid arthritis ranges from a mild, non-deforming arthropathy with little long-term disability to severe, incapacitating, deforming arthritis which may be refractory to conventional disease-modifying agents. Epidemiological studies show an important genetic influence in rheumatoid arthritis, and MHC region genes and cytokine genes within and outside this region have been considered as candidates. We did a case-control study to test whether polymorphisms in the interferon-gamma gene are associated with severity of rheumatoid arthritis. Methods Interferon gamma dinucleotide repeat polymorphisms were examined with quantitative genescan technology, and HLA-DR alleles were identified by PCR and restriction-fragment-length polymorphism analysis. We studied 60 patients with severe rheumatoid arthritis, 39 with mild disease, and 65 normal controls. Findings Susceptibility to, and severity of, rheumatoid arthritis were related to a microsatellite polymorphism within the first intron of the interferon-gamma gene. A 126 bp allele was seen in 44 (73%) of 60 patients with severe rheumatoid arthritis, compared with eight (21%) of 39 with mild disease (odds ratio 10.66 [95% CI 4.1-24.9]), and with eight (12%) of 65 normal controls (19.59 [7.7-49.9]). Conversely, a 122 bp allele at the same locus was found in four (7%) patients with severe disease compared with 25 (64%) of those with mild disease (0.04 [0.01-0.1]) and with 52 (80%) of controls (0.018 [0.005-0.06]). Interpretation This association may be valuable for understanding the mechanism of disease progression, for predicting the course of the disease, and for guiding therapy.	Vancouver Gen Hosp, Dept Med, Immunol Lab, Vancouver, BC V5Z 1M9, Canada; Vancouver Gen Hosp, Dept Lab Med & Pathol, Vancouver, BC V5Z 1M9, Canada; Mary Pack Arthrit Ctr, Vancouver, BC, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; BC Canc Agcy, Dept Lab Med & Pathol, Vancouver, BC, Canada; Simon Fraser Univ, Dept Math & Stat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; Simon Fraser University	Keown, PA (corresponding author), Vancouver Gen Hosp, Dept Med, Immunol Lab, Vancouver, BC V5Z 1M9, Canada.			Balshaw, Robert/0000-0002-2455-8792				Abbas A. K., 1994, CELLULAR MOL IMMUNOL; ADAMS RB, 1993, J IMMUNOL, V150, P2356; ALBANI S, 1995, NAT MED, V1, P448, DOI 10.1038/nm0595-448; ALVAROGRACIA JM, 1993, J CLIN IMMUNOL, V13, P212, DOI 10.1007/BF00919974; AWATA T, 1994, DIABETOLOGIA, V37, P1159, DOI 10.1007/BF00418381; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Cantagrel A, 1999, ARTHRITIS RHEUM, V42, P1093, DOI 10.1002/1529-0131(199906)42:6<1093::AID-ANR5>3.0.CO;2-P; CASSATELLA MA, 1989, J CLIN INVEST, V83, P1570, DOI 10.1172/JCI114054; COMBE B, 1995, BRIT J RHEUMATOL, V34, P529; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; DANIS VA, 1995, DIS MARKERS, V12, P127, DOI 10.1155/1994/756247; Ebnet K, 1996, ANNU REV IMMUNOL, V14, P155, DOI 10.1146/annurev.immunol.14.1.155; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; HORNE C, 1993, TISSUE ANTIGENS, V41, P243, DOI 10.1111/j.1399-0039.1993.tb02013.x; John S, 1998, ANN RHEUM DIS, V57, P361, DOI 10.1136/ard.57.6.361; MACHOLD KP, 1992, ANN RHEUM DIS, V51, P1039, DOI 10.1136/ard.51.9.1039; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045; Mu H, 1999, ARTHRITIS RHEUM, V42, P438, DOI 10.1002/1529-0131(199904)42:3<438::AID-ANR7>3.0.CO;2-F; Nepom GT, 1996, J RHEUMATOL, V23, P5; POCIOT F, 1991, SCAND J IMMUNOL, V33, P37, DOI 10.1111/j.1365-3083.1991.tb02490.x; Pociot F, 1997, J INTERF CYTOK RES, V17, P87, DOI 10.1089/jir.1997.17.87; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Pravica V, 1999, EUR J IMMUNOGENET, V26, P1, DOI 10.1046/j.1365-2370.1999.00122.x; Reveille John D., 1998, Current Opinion in Rheumatology, V10, P187, DOI 10.1097/00002281-199805000-00007; REVEL M, 1986, TRENDS BIOCHEM SCI, V11, P166, DOI 10.1016/0968-0004(86)90134-9; RUIZLINARES A, 1993, HUM MOL GENET, V2, P1508; Schiff Michael, 1997, American Journal of Medicine, V102, p11S, DOI 10.1016/S0002-9343(97)00411-7; Siegmund T, 1998, THYROID, V8, P1013, DOI 10.1089/thy.1998.8.1013; Vandenbroeck K, 1998, ANN NEUROL, V44, P841, DOI 10.1002/ana.410440525; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weyand CM, 1997, J MOL MED-JMM, V75, P772, DOI 10.1007/s001090050167; Weyand Cornelia M., 1995, Current Opinion in Rheumatology, V7, P206, DOI 10.1097/00002281-199505000-00009; Wolfe F, 1997, AM J MED, V103, P12	35	90	93	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					820	825		10.1016/S0140-6736(00)02657-X	http://dx.doi.org/10.1016/S0140-6736(00)02657-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022930				2022-12-01	WOS:000089101800013
J	Schultz, P; Fribourg, S; Poterszman, A; Mallouh, V; Moras, D; Egly, JM				Schultz, P; Fribourg, S; Poterszman, A; Mallouh, V; Moras, D; Egly, JM			Molecular structure of human TFIIH	CELL			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTION FACTOR TFIIH; CDK-ACTIVATING KINASE; RING FINGER PROTEIN; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; XERODERMA-PIGMENTOSUM; COCKAYNE-SYNDROME; CTD KINASE	TFIIH is a multiprotein complex required for both transcription and DNA repair. Single particles of human TFIIH were revealed by electron microscopy and image processing at a resolution of 3.8 nm. TFIIH is 16 x 12.5 x 7.5 nm in size and is organized into a ring-like structure from which a large protein domain protrudes out. A subcomplex assembled from five recombinant core subunits also forms a circular architecture that can be superimposed on the ring found in human TFIIH. Immunolabeling experiments localize several subunits: p44, within the ring structure, forms the base of the protruding protein density which includes the cdk7 kinase, cyclin H, and MAT1. Within the ring structure, p44 was flanked on either side by the XPB and XPD helicases. These observations provide us with a quartenary organizational model of TFIIH.	Univ Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schultz, P (corresponding author), Univ Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries,BP 163, F-67404 Illkirch Graffenstaden, France.	pat@moorea.u-strasbg.fr	Fribourg, Sebastien/M-7418-2014	Fribourg, Sebastien/0000-0003-4112-7510; schultz, patrick/0000-0002-7310-6186; POTERSZMAN, Arnaud/0000-0002-6702-5777				AKOULITCHEV S, 1995, NATURE, V377, P557, DOI 10.1038/377557a0; Andersen G, 1997, EMBO J, V16, P958, DOI 10.1093/emboj/16.5.958; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL AJ, 1994, MOL CELL BIOL, V14, P3569, DOI 10.1128/MCB.14.6.3569; Busso D, 2000, J BIOL CHEM, V275, P22815, DOI 10.1074/jbc.M002578200; Chang WH, 2000, CELL, V102, P609, DOI 10.1016/S0092-8674(00)00083-0; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DEVAULT A, 1995, EMBO J, V14, P5027, DOI 10.1002/j.1460-2075.1995.tb00185.x; DICAPUA E, 1982, J MOL BIOL, V157, P87, DOI 10.1016/0022-2836(82)90514-9; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Faye G, 1997, MOL GEN GENET, V255, P460, DOI 10.1007/s004380050518; Feaver WJ, 2000, J BIOL CHEM, V275, P5941, DOI 10.1074/jbc.275.8.5941; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; FRIBOURG S, 2000, IN PRESS J BIOL CHEM; GERARD M, 1991, J BIOL CHEM, V266, P20940; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; HUMBERT S, 1994, EMBO J, V13, P2393, DOI 10.1002/j.1460-2075.1994.tb06523.x; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; MAKELA TP, 1995, P NATL ACAD SCI USA, V92, P5174, DOI 10.1073/pnas.92.11.5174; Marinoni JC, 1997, METHODS, V12, P235, DOI 10.1006/meth.1997.0476; MATSUI P, 1995, NUCLEIC ACIDS RES, V23, P767, DOI 10.1093/nar/23.5.767; Moreland RJ, 1999, J BIOL CHEM, V274, P22127, DOI 10.1074/jbc.274.32.22127; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; OSSIPOW V, 1995, CELL, V83, P137, DOI 10.1016/0092-8674(95)90242-2; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; Passy SI, 1999, P NATL ACAD SCI USA, V96, P4279, DOI 10.1073/pnas.96.8.4279; QIU HF, 1993, GENE DEV, V7, P2161, DOI 10.1101/gad.7.11.2161; RADERMACHER M, 1986, J MICROSC-OXFORD, V141, pRP1, DOI 10.1111/j.1365-2818.1986.tb02693.x; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Rossignol M, 1999, J BIOL CHEM, V274, P22387, DOI 10.1074/jbc.274.32.22387; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; SanMartin MC, 1997, J MOL BIOL, V268, P15, DOI 10.1006/jmbi.1997.0952; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SEROZ T, 1995, CURR OPIN GENET DEV, V5, P217, DOI 10.1016/0959-437X(95)80011-5; SEROZ T, 2000, IN PRESS J BIOL CHEM; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; Svejstrup JQ, 1996, J BIOL CHEM, V271, P643, DOI 10.1074/jbc.271.2.643; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/S0304-3991(81)80197-0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VERMEULEN W, 1994, COLD SPRING HARBOR S; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U	54	154	161	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					599	607		10.1016/S0092-8674(00)00082-9	http://dx.doi.org/10.1016/S0092-8674(00)00082-9			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007478	Bronze			2022-12-01	WOS:000089105200008
J	Shih, WM; Gryczynski, Z; Lakowicz, JR; Spudich, JA				Shih, WM; Gryczynski, Z; Lakowicz, JR; Spudich, JA			A FRET-based sensor reveals large ATP hydrolysis-induced conformational changes and three distinct states of the molecular motor myosin	CELL			English	Article							FLUORESCENCE ENERGY-TRANSFER; REGULATORY LIGHT-CHAIN; SMOOTH-MUSCLE MYOSIN; DICTYOSTELIUM-DISCOIDEUM; STRUCTURAL DYNAMICS; ATOMIC-STRUCTURE; BINDING DOMAIN; ADP RELEASE; LEVER ARM; ACTIN	The molecular motor myosin is proposed to bind to actin and swing its light-chain binding region through a large angle to produce an similar to 10 nm step in motion coupled to changes in the nucleotide state at the active site. To date, however, direct dynamic measurements have largely failed to show changes of that magnitude. Here, we use a cysteine engineering approach to create a high resolution, FRET-based sensor that reports a large, similar to 70 degree nucleotide-dependent angle change of the light-chain binding region. The combination of steady-state and time-resolved fluorescence resonance energy transfer measurements unexpectedly reveals two distinct prestroke states. The measurements also show that bound Mg.ADP.P-i, and not bound Mg.ATP, induces the myosin to adopt the prestroke states.	Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA	Stanford University; University System of Maryland; University of Maryland Baltimore	Spudich, JA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	jspudich@cmgm.stanford.edu			NCRR NIH HHS [RR-08110] Funding Source: Medline; NIAMS NIH HHS [AR42895] Funding Source: Medline; NIGMS NIH HHS [GM-35154] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S06RR008110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035154] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brust-Mascher I, 1999, BIOCHEMISTRY-US, V38, P12607, DOI 10.1021/bi9905967; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; Dayhoff MO, 1978, ATLAS PROTEIN SEQUEN, V5; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; EISENBERG E, 1980, ANNU REV PHYSIOL, V42, P293, DOI 10.1146/annurev.ph.42.030180.001453; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Getz EB, 1998, BIOPHYS J, V74, P2451, DOI 10.1016/S0006-3495(98)77953-6; Giese KC, 1997, BIOCHEMISTRY-US, V36, P8465, DOI 10.1021/bi963141f; Goldman YE, 1998, CELL, V93, P1, DOI 10.1016/S0092-8674(00)81137-X; HEIDECKER M, 1995, BIOCHEMISTRY-US, V34, P11017, DOI 10.1021/bi00035a007; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 1997, CURR BIOL, V7, pR112, DOI 10.1016/S0960-9822(06)00051-0; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Huxley AF, 1998, NATURE, V396, P317, DOI 10.1038/24503; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; LACZKO G, 1990, REV SCI INSTRUM, V61, P2331, DOI 10.1063/1.1141360; LAKOWICZ JR, 1987, BIOPHYS CHEM, V28, P35, DOI 10.1016/0301-4622(87)80073-X; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MANSTEIN DJ, 1989, SCIENCE, V246, P656, DOI 10.1126/science.2530629; Murphy CT, 1999, BIOCHEMISTRY-US, V38, P3785, DOI 10.1021/bi9826815; Palm T, 1999, BIOCHEMISTRY-US, V38, P13026, DOI 10.1021/bi991164z; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rayment I, 1996, J BIOL CHEM, V271, P15850, DOI 10.1074/jbc.271.27.15850; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; Roopnarine O, 1998, BIOCHEMISTRY-US, V37, P14428, DOI 10.1021/bi9808363; ROSENFELD SS, 2000, IN PRESS J BIOL CHEM; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Sasaki N, 1998, J BIOL CHEM, V273, P20334, DOI 10.1074/jbc.273.32.20334; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; SELLERS JR, 1995, MYOSIN, V2; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Smyczynski C, 1997, BIOCHEMISTRY-US, V36, P13201, DOI 10.1021/bi970746i; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; STIRVING M, 1995, NATURE, V375, P688; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Suzuki Y, 1998, NATURE, V396, P380, DOI 10.1038/24640; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; WERBER MM, 1992, BIOCHEMISTRY-US, V31, P7190, DOI 10.1021/bi00146a023; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; WOODWARD SK, 1995, BIOCHEMISTRY-US, V90, P8619; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; Xiao M, 1998, P NATL ACAD SCI USA, V95, P15309, DOI 10.1073/pnas.95.26.15309	54	110	112	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					683	694		10.1016/S0092-8674(00)00090-8	http://dx.doi.org/10.1016/S0092-8674(00)00090-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007486	Bronze			2022-12-01	WOS:000089105200016
J	Wilcox, AJ; Dunson, D; Baird, DD				Wilcox, AJ; Dunson, D; Baird, DD			The timing of the "fertile window" in the menstrual cycle: day specific estimates from a prospective study	BRITISH MEDICAL JOURNAL			English	Article							PROGESTERONE METABOLITES; URINARY ESTROGEN; OVULATION; PREGNANCY; CONCEPTION	Objectives To provide specific estimates of the likely occurrence of the six fertile days (the "fertile window") during the menstrual cycle. Design Prospective cohort study. Participants 221 healthy women who were planning a pregnancy. Main outcome measures The timing of ovulation in 696 menstrual cycles, estimated using urinary metabolites of oestrogen and progesterone. Results The fertile window occurred during a broad range of days in the menstrual cycle. On every day between days 6 and 21, women had a minimum of 10% probability of being in their fertile window. Women cannot predict a sporadic late ovulation; 4-6% of women whose cycles had not yet resumed were potentially fertile in the fifth week of their cycle. Conclusions In only about 30% of women is the fertile window entirely within the days of the menstrual cycle identified by clinical guidelines-that is, between days 10 and 17. Most women reach their fertile window earlier and others much later. Women should be advised that the timing of the fertile window can be highly unpredictable, even if their cycles are usually regular.	NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilcox, AJ (corresponding author), NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA.		Baird, Donna D/D-5214-2017; Wilcox, Allen J/C-7723-2019	Baird, Donna D/0000-0002-5544-2653; Wilcox, Allen J/0000-0002-3376-1311	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003, Z01ES040011, ZIAES049003, Z01ES044003, Z01ES049003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arevalo M, 1999, CONTRACEPTION, V60, P357, DOI 10.1016/S0010-7824(99)00106-7; Baird DD, 1999, FERTIL STERIL, V71, P40, DOI 10.1016/S0015-0282(98)00419-1; BAIRD DD, 1991, STAT MED, V10, P255, DOI 10.1002/sim.4780100209; BAIRD DD, 1995, EPIDEMIOLOGY, V6, P547, DOI 10.1097/00001648-199509000-00015; Beckmann C. R. B., 1998, OBSTET GYNECOLOGY; Dunson DB, 1999, HUM REPROD, V14, P1835, DOI 10.1093/humrep/14.7.1835; DUNSON DB, 2000, IN PRESS STAT MED; Guida N, 1999, FERTIL STERIL, V72, P900, DOI 10.1016/S0015-0282(99)00365-9; Lamprecht VM, 1996, CONTRACEPTION, V54, P339, DOI 10.1016/S0010-7824(96)00202-8; LENTON EA, 1984, BRIT J OBSTET GYNAEC, V91, P685, DOI 10.1111/j.1471-0528.1984.tb04831.x; Pryll W., 1916, MUENCHENER MED WOCHE, V45, P1579; ROYSTON JP, 1982, BIOMETRICS, V38, P397, DOI 10.2307/2530453; *TECHN GUID COMP W, 1996, POP REP J, V44, P14; TRELOAR AE, 1967, INT J FERTIL, V12, P77; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; WILCOX AJ, 1985, FERTIL STERIL, V44, P366; Wilcox AJ, 1998, HUM REPROD, V13, P394, DOI 10.1093/humrep/13.2.394; WILCOX AJ, 1995, NEW ENGL J MED, V333, P517	18	269	274	1	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 18	2000	321	7271					1259	1262		10.1136/bmj.321.7271.1259	http://dx.doi.org/10.1136/bmj.321.7271.1259			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	376ET	11082086	Green Published, Bronze			2022-12-01	WOS:000165445800025
J	Badovinac, VP; Tvinnereim, AR; Harty, JT				Badovinac, VP; Tvinnereim, AR; Harty, JT			Regulation of antigen-specific CD8(+) T cell homeostasis by perforin and interferon-gamma	SCIENCE			English	Article							MHC CLASS-I; LISTERIA-MONOCYTOGENES; RESPONSES; IMMUNITY; MEMORY; TNF; IMMUNODOMINANCE; MECHANISMS; EFFICIENCY; INFECTION	T cell memory depends on factors that regulate expansion and death of these cells after antigenic stimulation. Mice deficient in perforin and interferon-gamma (IFN-gamma) exhibited increased expansion, altered immunodominance, and decreased death of antigen-specific CD8(+) T cells after infection with an attenuated strain of Listeria monocytogenes, which was cleared from these mice. Expansion of CD8(+) T cells was controlled by perforin, whereas IFN-gamma regulated immunodominance and the death phase. Thus, perforin and IFN-gamma regulate distinct elements of CD8(+) T cell homeostasis independently of their role as antimicrobial effector molecules.	Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu	badovinac, Vladimir/O-7760-2015	Badovinac, Vladimir/0000-0003-3180-2439; Harty, John/0000-0001-7266-2802	NIAID NIH HHS [AI36864, AI42767, T32AI07511] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007511, R37AI042767, R21AI042767, R01AI042767, R29AI036864] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Badovinac VP, 2000, J IMMUNOL, V164, P6444, DOI 10.4049/jimmunol.164.12.6444; Badovinac VP, 2000, J IMMUNOL METHODS, V238, P107, DOI 10.1016/S0022-1759(00)00153-8; BADOVINAC VP, UNPUB; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Busch DH, 1998, J IMMUNOL, V160, P4441; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Dalton DK, 2000, J EXP MED, V192, P117, DOI 10.1084/jem.192.1.117; Fruh K, 1999, CURR OPIN IMMUNOL, V11, P76, DOI 10.1016/S0952-7915(99)80014-4; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nacy C A, 1988, Adv Exp Med Biol, V239, P1; Nguyen LT, 2000, EUR J IMMUNOL, V30, P683, DOI 10.1002/1521-4141(200002)30:2<683::AID-IMMU683>3.3.CO;2-X; PAMER EG, 1994, J IMMUNOL, V152, P686; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; Reich A, 2000, EUR J IMMUNOL, V30, P678, DOI 10.1002/1521-4141(200002)30:2<678::AID-IMMU678>3.3.CO;2-H; Sad S, 1996, J EXP MED, V184, P1543, DOI 10.1084/jem.184.4.1543; Schwarz K, 2000, J IMMUNOL, V165, P768, DOI 10.4049/jimmunol.165.2.768; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; Slifka MK, 2000, J IMMUNOL, V164, P208, DOI 10.4049/jimmunol.164.1.208; Sourdive DJD, 1998, J EXP MED, V188, P71, DOI 10.1084/jem.188.1.71; TISHON A, 1995, VIROLOGY, V212, P244, DOI 10.1006/viro.1995.1477; Vijh S, 1997, J IMMUNOL, V158, P3366; Vijh S, 1998, J IMMUNOL, V160, P3971; VILLANUEVA MS, 1994, IMMUNITY, V1, P479, DOI 10.1016/1074-7613(94)90090-6; White DW, 1999, J IMMUNOL, V162, P980; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	37	375	389	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2000	290	5495					1354	1357		10.1126/science.290.5495.1354	http://dx.doi.org/10.1126/science.290.5495.1354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375BN	11082062				2022-12-01	WOS:000165379800048
J	Young, RC				Young, RC			The sounds of silence - No news about cancer prevention is good news	NATURE			English	Editorial Material									Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Young, RC (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.								0	3	3	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					141	141		10.1038/35041645	http://dx.doi.org/10.1038/35041645			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089950	Bronze			2022-12-01	WOS:000165180400020
J	Vasquez, KM; Narayanan, L; Glazer, PM				Vasquez, KM; Narayanan, L; Glazer, PM			Specific mutations induced by triplex-forming oligonucleotides in mice	SCIENCE			English	Article							TRANSCRIPTION-COUPLED REPAIR; MAMMALIAN-CELLS; GENE-EXPRESSION; HELIX FORMATION; INSTABILITY; MUTAGENESIS; STABILITY; INVIVO	Tripler-forming oligonucleotides (TFOs) recognize and bind to specific duplex DNA sequences and have been used extensively to modify gene function in cells. Although germ line mutations can be incorporated by means of embryonic stem cell technology, little progress has been made toward introducing mutations in somatic cells of living organisms. Here we demonstrate that TFOs can induce mutations at specific genomic sites in somatic cells of adult mice. Mutation detection was facilitated by the use of transgenic mice bearing chromosomal copies of the supF and cll reporter genes. Mice treated with a supF-targeted TFO displayed about fivefold greater mutation frequencies in the supF gene compared with mice treated with a scrambled sequence control oligomer, No mutagenesis was detected in the control gene (cll) with either oligonucleotide. These results demonstrate that site-specific, TFO-directed genome modification can be accomplished in intact animals.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Therapeut Radiol, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Genet, New Haven, CT 06536 USA	Yale University; Yale University	Glazer, PM (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Therapeut Radiol, 295 Congress Ave, New Haven, CT 06536 USA.	peter.glazer@yale.edu	Glazer, Peter/S-7651-2019	Glazer, Peter/0000-0003-4525-5560	NATIONAL CANCER INSTITUTE [R01CA064186, F32CA075723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054731] Funding Source: NIH RePORTER; NCI NIH HHS [CA75723, CA64186, F32 CA075723] Funding Source: Medline; NIGMS NIH HHS [GM54731] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGRAWAL S, 1991, P NATL ACAD SCI USA, V88, P7595, DOI 10.1073/pnas.88.17.7595; Barre FX, 2000, P NATL ACAD SCI USA, V97, P3084, DOI 10.1073/pnas.050368997; Bramlage B, 1998, TRENDS BIOTECHNOL, V16, P434, DOI 10.1016/S0167-7799(98)01236-0; CHEN TS, 1990, DRUG METAB DISPOS, V18, P882; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; Famulok M, 1999, CURR OPIN STRUC BIOL, V9, P324, DOI 10.1016/S0959-440X(99)80043-8; Faruqi AF, 2000, MOL CELL BIOL, V20, P990, DOI 10.1128/MCB.20.3.990-1000.2000; Galderisi U, 1999, J CELL PHYSIOL, V181, P251, DOI 10.1002/(SICI)1097-4652(199911)181:2<251::AID-JCP7>3.0.CO;2-D; Good L, 1997, ANTISENSE NUCLEIC A, V7, P431, DOI 10.1089/oli.1.1997.7.431; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; Jakubczak JL, 1996, P NATL ACAD SCI USA, V93, P9073, DOI 10.1073/pnas.93.17.9073; Majumdar A, 1998, NAT GENET, V20, P212, DOI 10.1038/2530; MYHR BC, 1991, ENVIRON MOL MUTAGEN, V18, P308, DOI 10.1002/em.2850180420; Narayanan L, 1997, P NATL ACAD SCI USA, V94, P3122, DOI 10.1073/pnas.94.7.3122; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Vasquez KM, 1999, NUCLEIC ACIDS RES, V27, P1176, DOI 10.1093/nar/27.4.1176; Vasquez KM, 1998, TRENDS BIOCHEM SCI, V23, P4, DOI 10.1016/S0968-0004(97)01158-4; WANG G, 1995, MOL CELL BIOL, V15, P1759; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Yao X, 1999, P NATL ACAD SCI USA, V96, P6850, DOI 10.1073/pnas.96.12.6850; ZENDEGUI JG, 1992, NUCLEIC ACIDS RES, V20, P307, DOI 10.1093/nar/20.2.307	23	241	248	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2000	290	5491					530	533		10.1126/science.290.5491.530	http://dx.doi.org/10.1126/science.290.5491.530			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039937				2022-12-01	WOS:000089946000056
J	Frazier, AL; Colditz, GA; Fuchs, CS; Kuntz, KM				Frazier, AL; Colditz, GA; Fuchs, CS; Kuntz, KM			Cost-effectiveness of screening for colorectal cancer in the general population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL OCCULT-BLOOD; LARGE BOWEL; UNRESECTED POLYPS; LARGE-INTESTINE; COLON; RISK; COLONOSCOPY; SIGMOIDOSCOPY; PREVALENCE; RECURRENCE	Context A recent expert panel recommended that persons at average risk of colorectal cancer (CRC) begin screening for CRC at age 50 years using 1 of several strategies. However, many aspects of different CRC screening strategies remain uncertain. Objective To assess the consequences, costs, and cost-effectiveness of CRC screening in average-risk individuals. Design Cost-effectiveness analysis from a societal perspective using a Markov model. Subjects Hypothetical subjects representative of the 50-year-old US population at average risk for CRC. Setting Simulated clinical practice in the United States. Main Outcome Measures Discounted lifetime costs, life expectancy, and incremental cost-effectiveness (CE) ratio, compared used 22 different CRC screening strategies, including those recommended by the expert panel. Results In 1 base-case analysis, compliance was assumed to be 60% with the initial screen and 80% with follow-up or surveillance colonoscopy. The most effective strategy for white men was annual rehydrated fecal occult blood testing (FOBT) plus sigmoidoscopy (followed by colonoscopy if either a low- or high-risk polyp was found) every 5 years from age 50 to 85 years, which resulted in a 60% reduction in cancer incidence and an 80% reduction in CRC mortality compared with no screening, and an incremental CE ratio of $92 900 per year of life gained compared with annual unrehydrated FOBT plus sigmoidoscopy every 5 years. In a base-case analysis in which compliance with screening and follow-up is assumed to be 100%, screening more often than every 10 years was prohibitively expensive; annual rehydrated FOBT plus sigmoidoscopy every 5 years had an incremental CE ratio of $489 900 per life-year gained compared with the same strategy every 10 years. Other strategies recommended by the expert panel were either less effective or cost more per year of life gained than the alternatives. Colonoscopy every 10 years was less effective than the combination of annual FOBI plus sigmoidoscopy every 5 years. However, a single colonoscopy at age 55 years achieves nearly half of the reduction in CRC mortality obtainable with clolonoscopy every 10 years. Because of increased life expectancy among white women and increased cancer mortality among blacks, CRC screening was even more cost-effective in these groups than in white men. Conclusions Screening for CRC, even in the setting of imperfect compliance, significantly reduces CRC mortality at rests comparable to other cancer screening procedures. However, compliance rates significantly affect the incremental CE ratios. In this model of CRC, 60% compliance with an every 5-year schedule of screening was roughly equivalent to 100% compliance with an every 10-year schedule. Mathematical modeling used to inform clinical guidelines needs to take into account expected compliance rates.	Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Frazier, AL (corresponding author), Brigham & Womens Hosp, Channing Lab, Dept Med, 181 Longwood Ave, Boston, MA 02115 USA.		BERCHI, Célia/L-7238-2015; wang, edwin/G-5372-2010; Launoy, Guy/K-7372-2015; Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS007038] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K07CA062252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703] Funding Source: NIH RePORTER; AHRQ HHS [HS07038] Funding Source: Medline; NCI NIH HHS [5 K07 CA62252-03] Funding Source: Medline; NIDDK NIH HHS [T32DK07703] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLISON JE, 1990, ANN INTERN MED, V112, P328, DOI 10.7326/0003-4819-112-5-328; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; *AM CANC SOC, 1998, WHAT ARE KEY STAT CO; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BROWN ML, 1999, PRIM CARE CANC, V19, P15; Cockburn J, 1995, J Med Screen, V2, P79; COOPER GS, 1995, CANCER, V75, P775, DOI 10.1002/1097-0142(19950201)75:3<775::AID-CNCR2820750305>3.0.CO;2-D; DINNING JP, 1994, ARCH INTERN MED, V154, P853, DOI 10.1001/archinte.154.8.853; DISARIO JA, 1991, AM J GASTROENTEROL, V86, P941; EDDY DM, 1990, ANN INTERN MED, V113, P373, DOI 10.7326/0003-4819-113-5-373; EIDE TJ, 1978, CANCER, V42, P2839, DOI 10.1002/1097-0142(197812)42:6<2839::AID-CNCR2820420645>3.0.CO;2-Y; Geul KW, 1997, SCAND J GASTROENTERO, V32, P79; Glick S, 1998, AM J ROENTGENOL, V170, P629, DOI 10.2214/ajr.170.3.9490943; Gold MR., 1996, COST EFFECTIVENESS H; GREENBERG ER, 1994, NEW ENGL J MED, V331, P141, DOI 10.1056/NEJM199407213310301; GROSSMAN S, 1989, GASTROENTEROLOGY, V96, P299, DOI 10.1016/0016-5085(89)91551-5; HENRY LG, 1975, ANN SURG, V182, P511, DOI 10.1097/00000658-197510000-00017; HIXSON LJ, 1991, GASTROINTEST ENDOSC, V37, P125, DOI 10.1016/S0016-5107(91)70668-8; HOFF G, 1986, SCAND J GASTROENTERO, V21, P853, DOI 10.3109/00365528609011130; HOFSTAD B, 1994, SCAND J GASTROENTERO, V29, P640, DOI 10.3109/00365529409092485; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; JENTSCHURA D, 1994, SURG ENDOSC-ULTRAS, V8, P672, DOI 10.1007/BF00678564; KNOERNSCHILD H E, 1963, Surg Forum, V14, P137; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LIEBERMAN DA, 1991, AM J GASTROENTEROL, V86, P946; LO AY, 1994, J AM COLL SURGEONS, V179, P333; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MORSON B, 1974, P ROY SOC MED, V67, P451, DOI 10.1177/00359157740676P115; MORSON BC, 1985, BRIT J SURG, V72, P23; NEUGUT AI, 1985, CANCER, V55, P1586, DOI 10.1002/1097-0142(19850401)55:7<1586::AID-CNCR2820550729>3.0.CO;2-I; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; RANSOHOFF DF, 1994, AM J GASTROENTEROL, V89, P1765; RANSOHOFF DF, 1994, GASTROENTEROLOGY, V106, pA24; REX DK, 1991, GASTROENTEROLOGY, V100, P64, DOI 10.1016/0016-5085(91)90583-7; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; RIES LAG, 1994, SEER CANC STAT REV 1; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; TAPLIN SH, 1995, J NATL CANCER I, V87, P417, DOI 10.1093/jnci/87.6.417; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559; Trnka Y M, 1997, HMO Pract, V11, P130; US Bureau of the Census, 1998, STAT ABSTR US 1998; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Wagner JL, 1996, PREVENTION EARLY DET, P321; WEGENER M, 1986, DIS COLON RECTUM, V29, P383, DOI 10.1007/BF02555053; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401; ZARCHY TM, 1994, GASTROENTEROLOGY, V106, P1501, DOI 10.1016/0016-5085(94)90403-0; 1999, MMWR MORB MORTAL WKL, V48, P116	54	470	482	0	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1954	1961		10.1001/jama.284.15.1954	http://dx.doi.org/10.1001/jama.284.15.1954			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035892	Bronze			2022-12-01	WOS:000089774000028
J	Tran, J; Brenner, TJ; DiNardo, S				Tran, J; Brenner, TJ; DiNardo, S			Somatic control over the germline stem cell lineage during Drosophila spermatogenesis	NATURE			English	Article							BAG-OF-MARBLES; CONTRACTILE RING; PROLIFERATION; PROTEIN; MAINTENANCE; DIVISION; FUSOME; SIGNAL	Stem cells divide both to produce new stem cells and to generate daughter cells that can differentiate(1). The underlying mechanisms are not well understood, but conceptually are of two kinds(2). Intrinsic mechanisms may control the unequal partitioning of determinants leading to asymmetric cell divisions that yield one stem cell and one differentiated daughter cell. Alternatively, extrinsic mechanisms, involving stromal cell signals, could cause daughter cells that remain in their proper niche to stay stem cells, whereas daughter cells that leave this niche differentiate. Here we use Drosophila spermatogenesis as a model stem cell system(3) to show that there are excess stem cells and gonialblasts in testes that are deficient for Raf activity. In addition, the germline stem cell population remains active for a longer fraction of lifespan than in wild type. Finally, raf is required in somatic cells that surround germ cells. We conclude that a cell-extrinsic mechanism regulates germline stem cell behaviour.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	DiNardo, S (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 1215 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.			DiNardo, Stephen/0000-0003-4131-5511	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060804] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060804] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROSIO L, 1989, NATURE, V342, P288, DOI 10.1038/342288a0; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Fuller Margaret T., 1993, P71; GONCZY P, 1992, DEVELOPMENT, V114, P89; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Gonczy P, 1997, DEVELOPMENT, V124, P4361; HALL PA, 1989, DEVELOPMENT, V106, P619; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hime GR, 1996, J CELL SCI, V109, P2779; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Lee T, 1996, DEVELOPMENT, V122, P409; LIN HF, 1994, DEVELOPMENT, V120, P947; Matunis E, 1997, DEVELOPMENT, V124, P4383; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; TRAN T, 1998, GENETIC ANAL GERM LI, P122; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	21	190	202	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					754	757		10.1038/35037613	http://dx.doi.org/10.1038/35037613			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048723				2022-12-01	WOS:000089773900045
J	Watson, AJ; Bakker, DCE; Ridgwell, AJ; Boyd, PW; Law, CS				Watson, AJ; Bakker, DCE; Ridgwell, AJ; Boyd, PW; Law, CS			Effect of iron supply on Southern Ocean CO2 uptake and implications for glacial atmospheric CO2	NATURE			English	Article							EQUATORIAL PACIFIC-OCEAN; FERTILIZATION EXPERIMENT; MODEL; PHYTOPLANKTON; PRODUCTIVITY; DEPOSITION; SEDIMENTS; MAXIMUM; CLIMATE; GROWTH	Photosynthesis by marine phytoplankton in the Southern Ocean, and the associated uptake of carbon, is thought to be currently limited by the availability of iron(1,2). One implication of this limitation is that a larger iron supply to the region in glacial times(3) could have stimulated algal photosynthesis, leading to lower concentrations of atmospheric CO2. Similarly, it has been proposed that artificial iron fertilization of the oceans might increase future carbon sequestration. Here we report data from a whole-ecosystem test of the iron-limitation hypothesis in the Southern Ocean(4), which show that surface uptake of atmospheric CO2 and uptake ratios of silica to carbon by phytoplankton were strongly influenced by nanomolar increases of iron concentration. We use these results to inform a model of global carbon and ocean nutrients, forced with atmospheric iron fluxes to the region derived from the Vostok(3) ice-core dust record. During glacial periods, predicted magnitudes and timings of atmospheric CO2 changes match ice-core records well. At glacial terminations, the model suggests that forcing of Southern Ocean biota by iron caused the initial similar to 40 p. p. m. of glacial-interglacial CO2 change, but other mechanisms must have accounted for the remaining 40 p. p. m. increase. The experiment also confirms that modest sequestration of atmospheric CO2 by artificial additions of iron to the Southern Ocean is in principle possible, although the period and geographical extent over which sequestration would be effective remain poorly known.	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Univ Otago, NIWA, Ctr Chem & Phys Oceanog, Dept Chem, Dunedin, New Zealand; Plymouth Marine Lab, Ctr Coastal & Marine Studies, Plymouth PL1 3DH, Devon, England	University of East Anglia; University of Otago; Plymouth Marine Laboratory	Watson, AJ (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.		Ridgwell, Andy/AAD-9487-2021; Boyd, Philip W/J-7624-2014; Bakker, Dorothee C E/E-4951-2015	Ridgwell, Andy/0000-0003-2333-0128; Boyd, Philip W/0000-0001-7850-1911; Bakker, Dorothee C E/0000-0001-9234-5337; Watson, Andrew/0000-0002-9654-8147; Law, Cliff/0000-0002-7669-2475				Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; ARCHER D, 1991, J GEOPHYS RES-OCEANS, V96, P17037, DOI 10.1029/91JC01812; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Broecker WS, 1987, GLOBAL BIOGEOCHEM CY, V1, P15, DOI 10.1029/GB001i001p00015; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Cooper DJ, 1998, MAR CHEM, V60, P147, DOI 10.1016/S0304-4203(97)00082-0; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; JICKELLS TD, IN PRESS BIOGEOCHEMI; Keir RS, 1988, PALEOCEANOGRAPHY, V3, P413, DOI 10.1029/PA003i004p00413; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; Levitus S., 1994, WORLD OCEAN ATLAS 19, V3; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MORTLOCK RA, 1991, NATURE, V351, P220, DOI 10.1038/351220a0; PENG TH, 1991, NATURE, V349, P227, DOI 10.1038/349227a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Rickaby REM, 1999, PALEOCEANOGRAPHY, V14, P293, DOI 10.1029/1999PA900007; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; Sigman DM, 1999, PALEOCEANOGRAPHY, V14, P118, DOI 10.1029/1998PA900018; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291; Sohrin Y, 2000, DEEP-SEA RES PT I, V47, P55, DOI 10.1016/S0967-0637(99)00049-7; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Stevens DP, 1997, Q J ROY METEOR SOC, V123, P929, DOI 10.1002/qj.49712354008; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; WATSON A, 1991, LIMNOL OCEANOGR, V36, P1960, DOI 10.4319/lo.1991.36.8.1960	32	352	375	2	196	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					730	733		10.1038/35037561	http://dx.doi.org/10.1038/35037561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048716				2022-12-01	WOS:000089773900038
J	Edwards, IR; Aronson, JK				Edwards, IR; Aronson, JK			Adverse drug reactions: definitions, diagnosis, and management	LANCET			English	Article							EVENTS	We define an adverse drug reaction as "an appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen, or withdrawal of the product." Such reactions are currently reported by use of WHO's Adverse Reaction Terminology, which will eventually become a subset of the International Classification of Diseases. Adverse drug reactions are classified into six types (with mnemonics): dose-related (Augmented), non-dose-related (Bizarre), dose-related and time-related (Chronic), time-related (Delayed), withdrawal (End of use), and failure of therapy (Failure). Timing, the pattern of illness, the results of investigations, and rechallenge can help attribute causality to a suspected adverse drug reaction. Management includes withdrawal of the drug if possible and specific treatment of its effects. Suspected adverse drug reactions should be reported. Surveillance methods can detect reactions and prove associations.	Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England; WHO, Collaborating Ctr Int Drug Monitoring, Uppsala Monitoring Ctr, Uppsala, Sweden	Radcliffe Infirmary; World Health Organization	Aronson, JK (corresponding author), Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England.							BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bowdler J, 1997, EFFECTIVE COMMUNICAT; EDWARDS IR, 2000, MEYLERS SIDE EFFECTS, pR27; FERNER RE, 1999, SIDE EFFECTS DRUGS A, pR23; GELBERG A, 1991, DRUG INF J, V25, P19; Grahame-Smith DG, 1984, OXFORD TXB CLIN PHAR, P132; HARTIGANGO KY, IN PRESS SIDE EFFECT; LANCTOT KL, 1994, J CLIN PHARMACOL, V34, P142, DOI 10.1002/j.1552-4604.1994.tb03978.x; LAURENCE D, 1998, DICT PHARM ALLIED TO, P8; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEE A, 1997, BRIT MED J, V315, P520; Meyboom R., 1992, PHARMACOEPIDEM DR S, V1, P87; OLSSON S, IN PRESS SIDE EFFECT; Rawlins M., 1977, TXB ADVERSE DRUG REA, P10; Royer RJ, 1997, PHARMACOEPIDEM DR S, V6, pS43, DOI 10.1002/(SICI)1099-1557(199710)6:3+<S43::AID-PDS308>3.3.CO;2-U; Stephens M.D.B., 1998, DETECTION NEW ADVERS, P32; STEPHENS MBD, 1987, ADVERSE DRUG REACT, V1, P1; *WHO, 1972, TECH REP SER WHO, V498; *WHO, 1991, MIO3722A WHO; WHO Collaborating Centre for International Drug Monitoring, 1992, INT MONITORING ADVER; Wood KL, 1994, PHARMACOEPIDEM DR S, V3, P7; Wood S. M., 1993, Pharmaceutical Medicine (London), V7, P203; [No title captured]; [No title captured]	24	1635	1695	3	94	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2000	356	9237					1255	1259		10.1016/S0140-6736(00)02799-9	http://dx.doi.org/10.1016/S0140-6736(00)02799-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	361LQ	11072960				2022-12-01	WOS:000089724900041
J	Murata, K; Mitsuoka, K; Hirai, T; Walz, T; Agre, P; Heymann, JB; Engel, A; Fujiyoshi, Y				Murata, K; Mitsuoka, K; Hirai, T; Walz, T; Agre, P; Heymann, JB; Engel, A; Fujiyoshi, Y			Structural determinants of water permeation through aquaporin-1	NATURE			English	Article							INTEGRAL MEMBRANE-PROTEIN; CELL CHIP28 PROTEIN; ELECTRON CRYSTALLOGRAPHY; CHANNEL PROTEINS; 3-DIMENSIONAL STRUCTURE; RESOLUTION; PERMEABILITY; SELECTIVITY; MICROSCOPY; INHIBITION	Human red cell AQP1 is the first functionally defined member of the aquaporin family of membrane water channels. Here we describe an atomic model of AQP1 at 3.8 Angstrom resolution from electron crystallographic data. Multiple highly conserved amino-acid residues stabilize the novel fold of AQP1. The aqueous pathway is lined with conserved hydrophobic residues that permit rapid water transport, whereas the water selectivity is due to a constriction of the pore diameter to about 3 Angstrom over a span of one residue. The atomic model provides a possible molecular explanation to a longstanding puzzle in physiology-how membranes can be freely permeable to water but impermeable to protons.	Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Univ Basel, Bioctr, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins University; University of Basel	Fujiyoshi, Y (corresponding author), Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	yoshi@em.biophys.kyoto-u.ac.jp	Fujiyoshi, Yoshinori/E-5989-2012; Hirai, Teruhisa/G-2105-2015; Heymann, Bernard/H-8265-2019; Heymann, Bernard/F-6825-2011	Fujiyoshi, Yoshinori/0000-0002-8070-1493; Hirai, Teruhisa/0000-0002-2114-8149; Heymann, Bernard/0000-0002-8872-5326; Walz, Thomas/0000-0003-2606-2835				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; GUTIERREZ AM, 1995, J MEMBRANE BIOL, V143, P189; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Hirai T, 1999, J ELECTRON MICROSC, V48, P653, DOI 10.1093/oxfordjournals.jmicro.a023731; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JUNG JS, 1994, J BIOL CHEM, V269, P14648; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRIVANEK OL, 1993, ULTRAMICROSCOPY, V49, P95, DOI 10.1016/0304-3991(93)90216-K; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; MACEY RI, 1970, BIOCHIM BIOPHYS ACTA, V211, P104, DOI 10.1016/0005-2736(70)90130-6; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177; Mitsuoka K, 1997, ULTRAMICROSCOPY, V68, P109, DOI 10.1016/S0304-3991(97)00020-X; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; Pomes R, 1996, BIOPHYS J, V71, P19, DOI 10.1016/S0006-3495(96)79211-1; PRESTIDGE BR, 1994, INT J RADIAT ONCOL, V28, P17, DOI 10.1016/0360-3016(94)90136-8; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1994, J BIOL CHEM, V269, P1668; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; REIZER J, 1993, CRIT REV BIOCHEM MOL, V28, P235, DOI 10.3109/10409239309086796; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Scheuring S, 2000, J MOL BIOL, V299, P1271, DOI 10.1006/jmbi.2000.3811; Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981; SCHULZ GE, 1979, PRINCIPLES PROTEIN S, P17; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; VANHOEK AN, 1991, J BIOL CHEM, V266, P16633; WALZ T, 1994, J BIOL CHEM, V269, P1583; WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; WISTOW GJ, 1991, TRENDS BIOCHEM SCI, V16, P170, DOI 10.1016/0968-0004(91)90065-4; Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; ZHANG RB, 1993, BIOCHEMISTRY-US, V32, P2938, DOI 10.1021/bi00063a002; [No title captured]; [No title captured]; [No title captured]; [No title captured]	47	1313	1384	14	409	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2000	407	6804					599	605		10.1038/35036519	http://dx.doi.org/10.1038/35036519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034202				2022-12-01	WOS:000089772800038
J	Humke, EW; Shriver, SK; Starovasnik, MA; Fairbrother, WJ; Dixit, VM				Humke, EW; Shriver, SK; Starovasnik, MA; Fairbrother, WJ; Dixit, VM			ICEBERG: A novel inhibitor of interleukin-1 beta generation	CELL			English	Article							CASPASE RECRUITMENT DOMAIN; INDUCED-PROXIMITY MODEL; DEATH-EFFECTOR DOMAIN; CONVERTING-ENZYME; NMR STRUCTURE; CYSTEINE PROTEASE; CRYSTAL-STRUCTURE; BINDING DOMAIN; MICE DEFICIENT; GRANZYME-B	ProIL-1 beta is a proinflammatory cytokine that is proteolytically processed to its active form by caspase-1. Upon receipt of a proinflammatory stimulus, an upstream adaptor, RIP2, binds and oligomerizes caspase-1 zymogen, promoting its autoactivation. ICEBERG is a novel protein that inhibits generation of IL-1 beta by interacting with caspase-1 and preventing its association with RIP2. ICEBERG is induced by proinflammatory stimuli, suggesting that it may be part of a negative feedback loop. Consistent with this, enforced retroviral expression of ICEBERG inhibits lipopolysaccharide-induced IL-1 beta generation. The structure of ICEBERG reveals it to be a member of the death-domain-fold superfamily. The distribution of surface charge is complementary to the homologous prodomain of caspase-1, suggesting that charge-charge interactions mediate binding of ICEBERG to the prodomain of caspase-1.	Genentech Inc, Dept Prot Engn, S San Francisco, CA 94080 USA; Univ Michigan, Sch Med, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA; Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA	Roche Holding; Genentech; University of Michigan System; University of Michigan; Roche Holding; Genentech	Fairbrother, WJ (corresponding author), Genentech Inc, Dept Prot Engn, 460 Point San Bruno Blvd, S San Francisco, CA 94080 USA.		dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326	NIGMS NIH HHS [T32 GM07863] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; Cavanagh J., 1995, PROTEIN NMR SPECTROS, V2nd; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Day CL, 1999, CELL DEATH DIFFER, V6, P1125, DOI 10.1038/sj.cdd.4400584; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Duan HJ, 1996, J BIOL CHEM, V271, P1621, DOI 10.1074/jbc.271.3.1621; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; GARCIA GM, 1986, CELL, V45, P453, DOI 10.1016/0092-8674(86)90331-4; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GU Y, 1995, EMBO J, V14, P1923, DOI 10.1002/j.1460-2075.1995.tb07184.x; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hawley RG, 1996, P NATL ACAD SCI USA, V93, P10297, DOI 10.1073/pnas.93.19.10297; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Hu SM, 1997, J BIOL CHEM, V272, P9621; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KORADI R, 1996, J MOL GRAPHICS, V14, P29; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; MacCorkle RA, 1998, P NATL ACAD SCI USA, V95, P3655, DOI 10.1073/pnas.95.7.3655; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MILLER DK, 1993, J BIOL CHEM, V268, P18062; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Nicholls A., 1992, GRASP GRAPHICAL REPR; O'Reilly M, 1999, SHOCK, V12, P411, DOI 10.1097/00024382-199912000-00001; OROURKE KM, 1992, J BIOL CHEM, V267, P24921; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X; VanCriekinge W, 1996, J BIOL CHEM, V271, P27245, DOI 10.1074/jbc.271.44.27245; Vaughn DE, 1999, J MOL BIOL, V293, P439, DOI 10.1006/jmbi.1999.3177; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Yang RB, 1999, J IMMUNOL, V163, P639; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Yoza B, 1998, PROG CLIN BIOL RES, V397, P209; Zeisberger E, 1998, ANN NY ACAD SCI, V856, P116, DOI 10.1111/j.1749-6632.1998.tb08320.x; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	66	235	248	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					99	111		10.1016/S0092-8674(00)00108-2	http://dx.doi.org/10.1016/S0092-8674(00)00108-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051551	Bronze			2022-12-01	WOS:000089636400012
J	Azzam, NA; Hallenbeck, JM; Kachar, B				Azzam, NA; Hallenbeck, JM; Kachar, B			Membrane changes during hibernation - Organelle lipids undergo rapidly reversible rearrangement as body temperature drops.	NATURE			English	Article							PHASE-TRANSITIONS		NINDS, Stroke Branch, NIH, Bethesda, MD 20892 USA; Natl Inst Deafness & Other Commun Disorders, Sect Struct Cell Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Azzam, NA (corresponding author), NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	kacharb@nidcd.nih.gov			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002856, ZIANS002856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000002, ZIADC000002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALOIA RC, 1980, FED PROC, V39, P2974; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Crowe JH, 1999, CRYOBIOLOGY, V38, P180, DOI 10.1006/cryo.1998.2137; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Geiser F, 1997, J COMP PHYSIOL B, V167, P416, DOI 10.1007/s003600050091; Lyman C. P., 1982, HIBERNATION TORPOR M; WADA H, 1990, NATURE, V347, P200, DOI 10.1038/347200a0; WILLIAMS WP, 1990, PHILOS T ROY SOC B, V326, P555, DOI 10.1098/rstb.1990.0031	9	31	35	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2000	407	6802					317	318		10.1038/35030294	http://dx.doi.org/10.1038/35030294			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014177				2022-12-01	WOS:000089390700031
J	Schindler, T; Bornmann, W; Pellicena, P; Miller, WT; Clarkson, B; Kuriyan, J				Schindler, T; Bornmann, W; Pellicena, P; Miller, WT; Clarkson, B; Kuriyan, J			Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase	SCIENCE			English	Article							CRYSTAL-STRUCTURE; C-ABL; INSULIN-RECEPTOR; COMPLEX; DOMAIN; SPECIFICITY; GROWTH	The inadvertent activation of the Abelson tyrosine kinase (Abl) causes chronic myelogenous Leukemia (CML), A small-molecule inhibitor of Abl (STI-571) is effective in the treatment of CML. We report the crystal structure of the catalytic domain of Abl, complexed to a variant of STI-571. Critic:al to the binding of STI-571 is the adoption by the kinase of an inactive conformation, in which a centrally Located "activation Loop" is not phosphorylated. The conformation of this Loop is distinct from that in active protein kinases, as well as in the inactive form of the closely related Src kinases, These results suggest that compounds that exploit the distinctive inactivation mechanisms of individual protein kinases can achieve both high affinity and high specificity.	Rockefeller Univ, Labs Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Memorial Sloan Kettering Cancer Center; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Kuriyan, J (corresponding author), Rockefeller Univ, Labs Mol Biophys, 1230 York Ave, New York, NY 10021 USA.				NIGMS NIH HHS [GM29362] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029362] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; BRASHER B, UNPUB; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchdunger E., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P559; BUCHDUNGER E, 1998, 89 ANN M AM ASS CANC; DOREY K, UNPUB; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 1999, BLOOD, V94, p368A; DRUKER BJ, 1999, 41 ANN M AM SOC HEM; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; Wilson KP, 1997, CHEM BIOL, V4, P423, DOI 10.1016/S1074-5521(97)90194-0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zimmermann J, 1997, BIOORG MED CHEM LETT, V7, P187, DOI 10.1016/S0960-894X(96)00601-4	31	1491	1628	3	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1938	1942		10.1126/science.289.5486.1938	http://dx.doi.org/10.1126/science.289.5486.1938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988075				2022-12-01	WOS:000089355800047
J	Zhang, JR; Mostov, KE; Lamm, ME; Nanno, M; Shimida, S; Ohwaki, M; Tuomanen, E				Zhang, JR; Mostov, KE; Lamm, ME; Nanno, M; Shimida, S; Ohwaki, M; Tuomanen, E			The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells	CELL			English	Article							CANINE KIDNEY-CELLS; STREPTOCOCCUS-PNEUMONIAE; SECRETORY COMPONENT; IG RECEPTOR; LISTERIA-MONOCYTOGENES; CYTOKINE RESPONSES; DEFENSE-MECHANISMS; SURFACE PROTEIN; BINDING-PROTEIN; HOST-DEFENSE	The polymeric immunoglobulin receptor (plgR) plays a crucial role in mucosal immunity against microbial infection by transporting polymeric immunoglobulins (plg) across the mucosal epithelium. We report here that the human plgR (hplgR) can bind to a major pneumococcal adhesin, CbpA. Expression of hplgR in human nasopharyngeal cells and MDCK cells greatly enhanced pneumococcal adherence and invasion. The hplgR-mediated bacterial adherence and invasion were abolished by either insertional knockout of cbpA or antibodies against either hplgR or CbpA. In contrast, rabbit plgR (rplgR) did not bind to CbpA and its expression in MDCK cells did not enhance pneumococcal adherence and invasion. These results suggest that pneumococci are a novel example of a pathogen co-opting the pig transcytosis machinery to promote translocation across a mucosal barrier.	St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; Yakult Cent Inst Microbiol Res, Tokyo, Japan	St Jude Children's Research Hospital; University of California System; University of California San Francisco; Case Western Reserve University; Yakult Honsha Company, Limited	Tuomanen, E (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	elaine.tuomanen@stjude.org	Tuomanen, Elaine I/N-3081-2018	Tuomanen, Elaine I/0000-0003-0349-8716; mostov, keith/0000-0002-8123-6247	NHLBI NIH HHS [HL55980] Funding Source: Medline; NIAID NIH HHS [AI27913, AI39482] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027913, R01AI039482, R21AI039482] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AROETI B, 1993, J CELL BIOL, V123, P1149, DOI 10.1083/jcb.123.5.1149; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Blanch VJ, 1999, J IMMUNOL, V162, P1232; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; DANIELE RP, 1990, ANNU REV PHYSIOL, V52, P177; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P331, DOI 10.1016/S0928-8244(98)00153-9; Estcourt MJ, 1998, CURR OPIN MICROBIOL, V1, P411, DOI 10.1016/S1369-5274(98)80058-1; FUBARA ES, 1973, J IMMUNOL, V111, P395; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; HOEPRICH PD, 1994, INFECT DIS, P421; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; KILIAN M, 1988, MICROBIOL REV, V52, P296, DOI 10.1128/MMBR.52.2.296-303.1988; KOBAYASHI K, 1971, IMMUNOCHEMISTRY, V8, P785, DOI 10.1016/0019-2791(71)90446-0; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Luton F, 1999, MOL CELL, V4, P627, DOI 10.1016/S1097-2765(00)80213-0; Maples CJ, 1997, J BIOL CHEM, V272, P6741, DOI 10.1074/jbc.272.10.6741; MCNABB PC, 1981, ANNU REV MICROBIOL, V35, P477, DOI 10.1146/annurev.mi.35.100181.002401; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; MIZOGUCHI A, 1982, J BIOL CHEM, V257, P9612; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; MOSTOV K, 1999, MUCOSAL IMMUNOLOGY, P181; MOSTOV KE, 1982, J BIOL CHEM, V257, P1816; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; MOSTOV KE, 1995, BIOESSAYS, V17, P129, DOI 10.1002/bies.950170208; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; OVERTURF GD, 1994, INFECT DIS, P1107; PHILLIPS JO, 1990, J IMMUNOL, V145, P1740; PISKURICH JF, 1993, MOL IMMUNOL, V30, P413, DOI 10.1016/0161-5890(93)90071-I; Prasadarao NV, 1999, INFECT IMMUN, V67, P1131, DOI 10.1128/IAI.67.3.1131-1138.1999; PURKAYASTHA S, 1979, J BIOL CHEM, V254, P6583; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Shimada S, 1999, J IMMUNOL, V163, P5367; Singer KL, 1998, MOL BIOL CELL, V9, P901, DOI 10.1091/mbc.9.4.901; SOLLID LM, 1987, J IMMUNOL, V138, P4303; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4; Talbot UM, 1996, INFECT IMMUN, V64, P3772, DOI 10.1128/IAI.64.9.3772-3777.1996; TAMER CM, 1995, J IMMUNOL, V155, P707; TIRABY JG, 1973, P NATL ACAD SCI USA, V70, P3541, DOI 10.1073/pnas.70.12.3541; TOMANA M, 1978, ANAL BIOCHEM, V89, P110, DOI 10.1016/0003-2697(78)90731-5; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0; YOTHER J, 1994, J BACTERIOL, V176, P2976, DOI 10.1128/JB.176.10.2976-2985.1994; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8	51	292	312	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					827	837		10.1016/S0092-8674(00)00071-4	http://dx.doi.org/10.1016/S0092-8674(00)00071-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030626	Bronze			2022-12-01	WOS:000089395200014
J	Baumann, CA; Ribon, V; Kanzaki, M; Thurmond, DC; Mora, S; Shigematsu, S; Bickel, PE; Pessin, JE; Saltiel, AR				Baumann, CA; Ribon, V; Kanzaki, M; Thurmond, DC; Mora, S; Shigematsu, S; Bickel, PE; Pessin, JE; Saltiel, AR			CAP defines a second signalling pathway required for insulin-stimulated glucose transport	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; GLUT4 TRANSLOCATION; TYROSINE PHOSPHORYLATION; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOSE-CELLS; C-CBL; CAVEOLAE; RECEPTOR	Insulin stimulates the transport of glucose into fat and muscle cells. Although the precise molecular mechanisms involved in this process remain uncertain, insulin initiates its actions by binding to its tyrosine kinase receptor, leading to the phosphorylation of intracellular substrates. One such substrate is the Cbl protooncogene product(1). Cbl is recruited to the insulin receptor by interaction with the adapter protein CAP, through one of three adjacent SH3 domains in the carboxy terminus of CAP(2). Upon phosphorylation of Cbl, the CAP-Cbl complex dissociates from the insulin receptor and moves to a caveolin-enriched, triton-insoluble membrane fraction(3). Here, to identify a molecular mechanism underlying this subcellular redistribution, we screened a yeast two-hybrid library using the amino-terminal region of CAP and identified the caveolar protein flotillin. Flotillin forms a ternary complex with CAP and Cbl, directing the localization of the CAP-Cbl complex to a lipid raft subdomain of the plasma membrane. Expression of the N-terminal domain of CAP in 3T3-L1 adipocytes blocks the stimulation of glucose transport by insulin, without affecting signalling events that depend on phosphatidylinositol-3-OH kinase. Thus, localization of the Cbl-CAP complex to lipid rafts generates a pathway that is crucial in the regulation of glucose uptake.	Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA; Warner Lambert Co, Parke Davis Pharmaceut Res Div, Ann Arbor, MI 48105 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; Pfizer; University of Iowa; Washington University (WUSTL); Washington University (WUSTL)	Saltiel, AR (corresponding author), Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA.		Bickel, Perry/Q-9185-2019; Saltiel, Alan/L-3632-2019; Kanzaki, Makoto/H-6680-2017; Mora, Silvia/Y-3131-2019	Kanzaki, Makoto/0000-0002-6884-2955; Mora, Silvia/0000-0002-8473-1497; Saltiel, Alan/0000-0002-9726-9828				Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Corvera S, 1998, TRENDS CELL BIOL, V8, P442, DOI 10.1016/S0962-8924(98)01366-X; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; Gustavsson J, 1996, MOL MED, V2, P367, DOI 10.1007/BF03401634; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; ISAKOFF SJ, 1995, P NATL ACAD SCI USA, V92, P10247, DOI 10.1073/pnas.92.22.10247; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; KANDROR KV, 1995, J CELL BIOL, V129, P999, DOI 10.1083/jcb.129.4.999; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; KELLER SR, 1995, J BIOL CHEM, V270, P30236; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Malide D, 1997, J CELL SCI, V110, P2795; Mastick CC, 1997, J BIOL CHEM, V272, P20706, DOI 10.1074/jbc.272.33.20706; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; OKA Y, 1984, P NATL ACAD SCI-BIOL, V81, P4028, DOI 10.1073/pnas.81.13.4028; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Ribon V, 1997, BIOCHEM J, V324, P839, DOI 10.1042/bj3240839; Ribon V, 1998, MOL CELL BIOL, V18, P872, DOI 10.1128/MCB.18.2.872; Ribon V, 1998, P NATL ACAD SCI USA, V95, P14751, DOI 10.1073/pnas.95.25.14751; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; WARDZALA LJ, 1984, J BIOL CHEM, V259, P8378; WIESE RJ, 1995, J BIOL CHEM, V270, P3442, DOI 10.1074/jbc.270.7.3442	30	525	562	1	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					202	207		10.1038/35025089	http://dx.doi.org/10.1038/35025089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001060	Green Published			2022-12-01	WOS:000089241000052
J	Takamori, S; Rhee, JS; Rosenmund, C; Jahn, R				Takamori, S; Rhee, JS; Rosenmund, C; Jahn, R			Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons	NATURE			English	Article							INORGANIC-PHOSPHATE COTRANSPORTER; BRAIN SYNAPTIC VESICLES; CAENORHABDITIS-ELEGANS; FUNCTIONAL RECONSTITUTION; ENERGY-DEPENDENCE; NEUROTRANSMISSION; EXPRESSION; LOCALIZATION; PROTEINS; CLONING	Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system. Synaptic vesicles are loaded with neurotransmitter by means of specific vesicular transporters. Here we show that expression of BNPI, a vesicle-bound transporter associated with sodium-dependent phosphate transport(1-3), results in glutamate uptake by intracellular vesicles. Substrate specificity and energy dependence are very similar to glutamate uptake by synaptic vesicles. Stimulation of exocytosis-fusion of the vesicles with the cell membrane and release of their contents-resulted in quantal release of glutamate from BNPI-expressing cells. Furthermore, we expressed BNPI in neurons containing GABA (gamma-aminobutyric acid) and maintained them as cultures of single, isolated neurons that form synapses to themselves. After stimulation of these neurons, a component of the postsynaptic current is mediated by glutamate as it is blocked by a combination of the glutamate receptor antagonists, but is insensitive to a GABA(A) receptor antagonist. We conclude that BNPI functions as vesicular glutamate transporter and that expression of BNPI suffices to define a glutamatergic phenotype in neurons.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.		Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444; Jahn, Reinhard/0000-0003-1542-3498				Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Hartinger J, 1996, ANAL BIOCHEM, V240, P126, DOI 10.1006/abio.1996.0339; HELL JW, 1990, J BIOL CHEM, V265, P2111; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; HELL JW, 1994, CELL BIOL LAB HDB, P567; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; LOMBARDPLATET G, 1993, BIOTECHNIQUES, V15, P668; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; NAITO S, 1983, J BIOL CHEM, V258, P696; Ni BH, 1996, J NEUROCHEM, V66, P2227; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; PAREKH D, 1994, PANCREAS, V9, P83, DOI 10.1097/00006676-199401000-00013; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Reimer RJ, 1998, CURR OPIN NEUROBIOL, V8, P405, DOI 10.1016/S0959-4388(98)80068-8; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Takamori S, 2000, J NEUROSCI, V20, P4904	23	669	696	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					189	194		10.1038/35025070	http://dx.doi.org/10.1038/35025070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001057	Green Published			2022-12-01	WOS:000089241000049
J	Cologne, JB; Preston, DL				Cologne, JB; Preston, DL			Longevity of atomic-bomb survivors	LANCET			English	Article							REGRESSION-MODELS; MORTALITY; RADIATION	Background Conflicting claims have been made regarding biological and health consequences of exposure to low doses of radiation. Studies have suggested that certain low-dose exposed atomic-bomb survivors live longer than their peers. Earlier studies in other radiation-exposed populations demonstrated life shortening from mortality from cancer but lacked dosimetry and relied on comparison groups which may introduce bias because of lack of comparability. We have re-examined the effect of radiation on life expectancy in one cohort of survivors of the atomic bombings of Hiroshima and Nagasaki, Japan. Methods We did a prospective cohort study of 120 321 survivors. The study encompasses 45 years of mortality follow-up with radiation-dose estimates available for most cohort members. We calculated relative mortality rates and survival distribution using internal comparison (cohort-based estimation of background mortality). Findings Median life expectancy decreased with increasing radiation dose at a rate of about 1.3 years per Gy, but declined more rapidly at high doses. Median loss of life among cohort members with estimated doses below 1 Gy was about 2 months, but among the small number of cohort members with estimated doses of 1 Gy or more it was 2.6 years. Median loss of life among all individuals with greater-than-zero dose estimates was about 4 months. Interpretation These results are important in light of the recent finding that radiation significantly increases mortality rates for causes other than cancer. The results do not support claims that survivors exposed to certain doses of radiation live longer than comparable unexposed individuals. Because the cohort was intentionally constructed to contain a higher proportion of high-dose atomic-bomb survivors, average loss of life among all exposed atomic-bomb survivors would be less than the 4 months found for the study cohort.	Radiat Effects Res Fdn, Dept Stat, Minami Ku, Hiroshima 7320815, Japan	Radiation Effects Research Foundation - Japan	Cologne, JB (corresponding author), Radiat Effects Res Fdn, Dept Stat, Minami Ku, 5-2 Hijiyama Pk, Hiroshima 7320815, Japan.	cologne@rerf.or.jp		Cologne, John/0000-0003-1540-6639				Andersen PK, 2012, STAT MODELS BASED CO; BEEBE GW, 1978, LATE RADIOLOGICAL EF, P3; COX DR, 1972, J R STAT SOC B, V34, P187; *FRENCH AC SCI, 1997, 38 FRENCH AC SCI; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; HAYAKAWA N, 1989, Hiroshima Journal of Medical Sciences, V38, P53; Hendee WR, 1998, MED PHYS, V25, P1407, DOI 10.1118/1.598312; Hoel DG, 1998, HEALTH PHYS, V75, P241, DOI 10.1097/00004032-199809000-00002; Hosmer DW, 1999, APPL SURVIVAL ANAL R; KONDO S, 1993, HLTH EFFECTS LOW LEV, P27; MATSUURA M, 1992, INT CONGR SER, V1013, P67; METTLER FA, 1995, MED EFFECTRS IONIZIN, P280; MINE M, 1990, INT J RADIAT BIOL, V58, P1035, DOI 10.1080/09553009014552341; OKAJIMA S, 1985, RADIAT RES, V103, P419, DOI 10.2307/3576764; OKUMURA Y, 1997, IAEATECDOC976; Pierce DA, 1996, RADIAT RES, V146, P1, DOI 10.2307/3579391; Roesch WC, 1987, US JAPAN JOINT REASS; SELTSER R, 1965, AM J EPIDEMIOL, V81, P2, DOI 10.1093/oxfordjournals.aje.a120493; Shimizu Y, 1999, RADIAT RES, V152, P374, DOI 10.2307/3580222; SMITH PG, 1981, BRIT J RADIOL, V54, P187, DOI 10.1259/0007-1285-54-639-187; SMITH PG, 1982, BRIT MED J, V284, P449, DOI 10.1136/bmj.284.6314.449; STEHNEY AF, 1978, LATE BIOL EFFECTS IO, P333; THOMPSON D, 1997, TIME            0623, P50; THOMPSON DE, 1994, RAD RES S, V137, P17; *UN SCI COMM EFF A, 1982, 669 UN SCI COMM EFF; WARRICK J, 1997, WASHINGTON POST 0609, pA3	26	63	71	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 22	2000	356	9226					303	307		10.1016/S0140-6736(00)02506-X	http://dx.doi.org/10.1016/S0140-6736(00)02506-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MJ	11071186				2022-12-01	WOS:000088305900012
J	El-Hussein, AE; Schnell, E; Chetkovich, DM; Nicoll, RA; Bredt, DS				El-Hussein, AE; Schnell, E; Chetkovich, DM; Nicoll, RA; Bredt, DS			PSD-95 involvement in maturation of excitatory synapses	SCIENCE			English	Article							SUPPRESSOR GENE DLG; KINASE-LIKE DOMAIN; INTRAMOLECULAR INTERACTION; PROTEIN; FAMILY	PSD-95 is a neuronal PDZ protein that associates with receptors and cytoskeletal elements at synapses, but whose function is uncertain. We found that overexpression of PSD-95 in hippocampal neurons can drive maturation of glutamatergic synapses. PSD-95 expression enhanced postsynaptic clustering and activity of glutamate receptors. Postsynaptic expression of PSD-95 also enhanced maturation of the presynaptic terminal. These effects required synaptic clustering of PSD-95 but did not rely on its guanylate kinase domain. PSD-95 expression also increased the number and size of dendritic spines. These results demonstrate that PSD-95 can orchestrate synaptic development and are suggestive of roles for PSD-95 in synapse stabilization and plasticity.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bredt, DS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	bredt@itsa.ucsf.edu	Chetkovich, Dane/AAV-5457-2021	Schnell, Eric/0000-0002-5623-5015				Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Brenman JE, 1996, J NEUROSCI, V16, P7407; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Gomperts SN, 2000, J NEUROSCI, V20, P2229; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kennedy MB, 1998, BRAIN RES REV, V26, P243, DOI 10.1016/S0165-0173(97)00043-X; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; KISTNER U, 1993, J BIOL CHEM, V268, P4580; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Rao A, 1998, J NEUROSCI, V18, P1217; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000	28	928	971	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2000	290	5495					1364	1368						5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375BN	11082065				2022-12-01	WOS:000165379800051
J	Daaleman, TP; VandeCreek, L				Daaleman, TP; VandeCreek, L			Placing religion and spirituality in end-of-life care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSISTED SUICIDE; BREAST-CANCER; PHYSICIANS; ATTITUDES; BELIEFS; ADULTS; DEATH; OLDER		Univ Kansas, Med Ctr, Dept Family Med, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Dept Hist & Philosophy Med, Ctr Aging, Kansas City, KS 66160 USA; Healthcare Chaplaincy, New York, NY USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Daaleman, TP (corresponding author), Univ Kansas, Med Ctr, Dept Family Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	tdaalema@kumc.edu		Daaleman, Timothy/0000-0002-1649-4266				Antonovsky, 1987, UNRAVELING MYSTERY H; Bradshaw A, 1996, SOC SCI MED, V43, P409, DOI 10.1016/0277-9536(95)00406-8; Brady MJ, 1999, PSYCHO-ONCOLOGY, V8, P417, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<417::AID-PON398>3.3.CO;2-W; BRODY H, 1992, HEALERS POWER; BYOCK R, 1997, DYING WELL PROSPECT; CASSEL CK, 1999, PRINCIPLES CARE PATI; Cohen SR, 1996, CANCER-AM CANCER SOC, V77, P576, DOI 10.1002/(SICI)1097-0142(19960201)77:3<576::AID-CNCR22>3.0.CO;2-0; Coward D. D, 1989, NURS SCI QUART, V3, P162; Cunningham AJ, 1998, PSYCHO-ONCOL, V7, P508, DOI 10.1002/(SICI)1099-1611(199811/12)7:6<508::AID-PON376>3.0.CO;2-7; Daaleman TP, 1998, ARCH FAM MED, V7, P548, DOI 10.1001/archfami.7.6.548; DAALEMAN TP, 1997, BIOETHICS FORUM, V13, P49; Dorff Elliot N, 1991, Conserv Jud, V43, P3; Dow KH, 1996, BREAST CANCER RES TR, V39, P261, DOI 10.1007/BF01806154; DOYLE D., 1999, OXFORD TXB PALLIATIV; DUBOSE ER, 1999, PHYSICIAN ASSISTED S; ELLISON CG, 1991, J HEALTH SOC BEHAV, V32, P80, DOI 10.2307/2136801; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Emanuel EJ, 1998, JAMA-J AM MED ASSOC, V280, P507, DOI 10.1001/jama.280.6.507; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; *GEN ASS UN UN, 1988, RIGHT DIE DIGN P GEN; Holland JC, 1998, PSYCHO-ONCOL, V7, P460, DOI 10.1002/(SICI)1099-1611(199811/12)7:6<460::AID-PON328>3.0.CO;2-R; Holland JC, 1998, PSYCHO-ONCOLOGY, P790; *I MED, 1997, APPR DEATH IMPR CAR; JENKINS RA, 1988, SOC SCI MED, V26, P625, DOI 10.1016/0277-9536(88)90027-5; Kaczorowski J M, 1989, Hosp J, V5, P105; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KRAUSE N, 1989, J GERONTOL, V44, pS4, DOI 10.1093/geronj/44.1.S4; Larson DB, 1998, SCI RES SPIRITUALITY; Lazarus R.S., 1984, STRESS APPRAISAL; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; Mathew L M, 1986, Clin Geriatr Med, V2, P617; MEIER DE, 1998, NEW ENGL J MED, V338, P967; *NAT C CATH BISH, 1994, ETH REL DIR CATH HLT; Neimeyer R. A., 1994, DEATH ANXIETY HDB RE; OCONNELL LJ, 1995, WESTERN J MED, V163, P231; Pargament K.I., 1997, PSYCHOL RELIG COPING; Portenoy RK, 1997, PSYCHOSOMATICS, V38, P277, DOI 10.1016/S0033-3182(97)71465-8; POST SG, 1995, J LAW MED ETHICS, V23, P20, DOI 10.1111/j.1748-720X.1995.tb01326.x; REED PG, 1987, RES NURS HEALTH, V10, P335, DOI 10.1002/nur.4770100507; Seale C., 1998, CONSTRUCTING DEATH S, DOI [10.1017/CBO9780511583421, DOI 10.1017/CBO9780511583421]; SEIDLITZ L, 1995, J AM GERIATR SOC, V43, P993, DOI 10.1111/j.1532-5415.1995.tb05563.x; Smith Elizabeth D., 1993, Journal of Psychosocial Oncology, V11, P89; SPIEGEL D, 1989, LANCET, V2, P888; Sullivan M, 1998, J AM GERIATR SOC, V46, P1251, DOI 10.1111/j.1532-5415.1998.tb04541.x; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; THOMPSON SC, 1988, J SOC CLIN PSYCHOL, V7, P260, DOI 10.1521/jscp.1988.7.2-3.260; Van Ness Peter, 1996, SPIRITUALITY SECULAR; *WHO, 1990, TECHN REP SER WHO, V804; Wulff D. M., 1997, PSYCHOL RELIG CLASSI, V2nd; Wuthnow Robert., 1998, HEAVEN SPIRITUALITY	51	108	109	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2000	284	19					2514	2517		10.1001/jama.284.19.2514	http://dx.doi.org/10.1001/jama.284.19.2514			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	371MY	11074785				2022-12-01	WOS:000165183800028
J	Albert, CM; Mittleman, MA; Chae, CU; Lee, IM; Hennekens, CH; Manson, JE				Albert, CM; Mittleman, MA; Chae, CU; Lee, IM; Hennekens, CH; Manson, JE			Triggering of sudden death from cardiac causes by vigorous exertion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; TIME PHYSICAL-ACTIVITY; LEISURE-TIME; CASE-CROSSOVER; EXERCISE; RISK; MORTALITY; MEN; FITNESS	Background Retrospective and cross-sectional data suggest that vigorous exertion can trigger cardiac arrest or sudden death and that habitual exercise may diminish this risk. However, the role of physical activity in precipitating or preventing sudden death from cardiac causes has not been assessed prospectively in a large number of subjects. Methods We used a prospective, nested case crossover design within the Physicians Health Study to compare the risk of sudden death during and up to 30 minutes after an episode of vigorous exertion with that during periods of lighter exertion or none. We then evaluated whether habitual vigorous exercise modified the risk of sudden death that was associated with vigorous exertion. In addition, the relation of vigorous exercise to the overall risk of sudden death and nonsudden death from coronary heart disease was assessed. Results During 12 years of follow-up, 122 sudden deaths were confirmed among the 21,481 male physicians who were initially free of self-reported cardiovascular disease and who provided information on their habitual level of exercise at base line. The relative risk of sudden death during and up to 30 minutes after vigorous exertion was 16.9 (95 percent confidence interval, 10.5 to 27.0; P < 0.001). However, the absolute risk of sudden death during any particular episode of vigorous exertion was extremely low (1 sudden death per 1.51 million episodes of exertion). Habitual vigorous exercise attenuated the relative risk of sudden death that was associated with an episode of vigorous exertion (P value for trend = 0.006). The base-line level of exercise was not associated with the overall risk of subsequent sudden death. Conclusions These prospective data from a study of U.S. male physicians suggest that habitual vigorous exercise diminishes the risk of sudden death during vigorous exertion. (N Engl J Med 2000; 343:1355-61.) (C) 2000, Massachusetts Medical Society.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02215 USA; Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Miami, Sch Med, Dept Epidemiol & Publ Hlth Med, Miami, FL USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; University of Miami	Albert, CM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.		Lee, I-Min/ABD-5409-2021	Mittleman, Murray/0000-0001-9788-7274; Albert, Christine/0000-0002-2081-1121	NATIONAL CANCER INSTITUTE [R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595, K08HL003783] Funding Source: NIH RePORTER; NCI NIH HHS [CA-40360] Funding Source: Medline; NHLBI NIH HHS [1-K08-HL-03783, HL-34595] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Burke AP, 1999, JAMA-J AM MED ASSOC, V281, P921, DOI 10.1001/jama.281.10.921; CHAE CU, 1997, CIRCULATION S1, V96, P303; COBB LA, 1986, J AM COLL CARDIOL, V7, P215, DOI 10.1016/S0735-1097(86)80284-4; COX DR, 1972, J R STAT SOC B, V34, P187; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; HULL SS, 1994, CIRCULATION, V89, P548, DOI 10.1161/01.CIR.89.2.548; KANNEL WB, 1982, JAMA-J AM MED ASSOC, V248, P3143; KANNEL WB, 1982, ANN NY ACAD SCI, V382, P3, DOI 10.1111/j.1749-6632.1982.tb55203.x; KOHL HW, 1992, EPIDEMIOL REV, V14, P37, DOI 10.1093/oxfordjournals.epirev.a036091; KOHL HW, 1988, AM J EPIDEMIOL, V127, P1228, DOI 10.1093/oxfordjournals.aje.a114915; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; LEE IM, 1992, AM J EPIDEMIOL, V135, P915, DOI 10.1093/oxfordjournals.aje.a116387; Lee IM, 1999, STROKE, V30, P1, DOI 10.1161/01.STR.30.1.1; Lemaitre RN, 1999, ARCH INTERN MED, V159, P686, DOI 10.1001/archinte.159.7.686; LEON AS, 1987, JAMA-J AM MED ASSOC, V258, P2388, DOI 10.1001/jama.258.17.2388; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; MORRIS JN, 1980, LANCET, V2, P1207; MULLER JE, 1987, CIRCULATION, V75, P131, DOI 10.1161/01.CIR.75.1.131; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; PAFFENBARGER RS, 1975, NEW ENGL J MED, V292, P545, DOI 10.1056/NEJM197503132921101; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; PERONNET F, 1981, J APPL PHYSIOL, V51, P812, DOI 10.1152/jappl.1981.51.4.812; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; SICONOLFI SF, 1985, AM J EPIDEMIOL, V122, P101, DOI 10.1093/oxfordjournals.aje.a114068; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; THOMPSON PD, 1982, JAMA-J AM MED ASSOC, V247, P2535, DOI 10.1001/jama.247.18.2535; WANNAMETHEE G, 1995, CIRCULATION, V91, P1749, DOI 10.1161/01.CIR.91.6.1749; WASHBURN RA, 1990, AM J EPIDEMIOL, V132, P107, DOI 10.1093/oxfordjournals.aje.a115622; WILLICH SN, 1993, CIRCULATION, V87, P1442, DOI 10.1161/01.CIR.87.5.1442; WILLICH SN, 1993, NEW ENGL J MED, V329, P1684, DOI 10.1056/NEJM199312023292302	39	649	657	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2000	343	19					1355	1361		10.1056/NEJM200011093431902	http://dx.doi.org/10.1056/NEJM200011093431902			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZH	11070099				2022-12-01	WOS:000165152800002
J	Betts, RA				Betts, RA			Offset of the potential carbon sink from boreal forestation by decreases in surface albedo	NATURE			English	Article							CLIMATE-CHANGE; VEGETATION FEEDBACKS; GLOBAL CLIMATE; SNOW COVER; MODEL; SEQUESTRATION; WATER; GCM	Carbon uptake by forestation is one method proposed(1) to reduce net carbon dioxide emissions to the atmosphere and so limit the radiative forcing of climate change(2). But the overall impact of forestation on climate will also depend on other effects associated with the creation of new forests. In particular, the albedo of a forested landscape is generally lower than that of cultivated land, especially when snow is lying(3-9), and decreasing albedo exerts a positive radiative forcing on climate. Here I simulate the radiative forcings associated with changes in surface albedo as a result of forestation in temperate and boreal forest areas, and translate these forcings into equivalent changes in local carbon stock for comparison with estimated carbon sequestration potentials(10-12). I suggest that in many boreal forest areas, the positive forcing induced by decreases in albedo can offset the negative forcing that is expected from carbon sequestration. Some high-latitude forestation activities may therefore increase climate change, rather than mitigating it as intended.	Hadley Ctr Climate Predict & Res, Met Off, Bracknell RG12 2SY, Berks, England	Met Office - UK; Hadley Centre	Betts, RA (corresponding author), Hadley Ctr Climate Predict & Res, Met Off, Bracknell RG12 2SY, Berks, England.		Betts, Richard A/P-8976-2015	Betts, Richard A/0000-0002-4929-0307				Betts RA, 1997, NATURE, V387, P796, DOI 10.1038/42924; BONAN GB, 1995, CLIMATIC CHANGE, V29, P145, DOI 10.1007/BF01094014; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cox PM, 1999, CLIM DYNAM, V15, P183, DOI 10.1007/s003820050276; DOUVILLE H, 1997, CLIM DYNAM, V13, P57; Edwards JM, 1996, Q J ROY METEOR SOC, V122, P689, DOI 10.1002/qj.49712253107; Essery R, 1997, ANN GLACIOL, V25, P362, DOI 10.3189/S0260305500014282; Gedney N, 2000, GEOPHYS RES LETT, V27, P3053, DOI 10.1029/2000GL011794; HANSEN J, 1983, MON WEATHER REV, V111, P609, DOI 10.1175/1520-0493(1983)111<0609:ETDGMF>2.0.CO;2; Harding RJ, 1996, J CLIMATE, V9, P2778, DOI 10.1175/1520-0442(1996)009<2778:TEBOTW>2.0.CO;2; KEELING CD, 1998, NDP001 CARB DIOX INF; Kondratyev K. Ya., 1982, Land Surface Processes in Atmospheric General Circulation Models. World Climate Research Programme Study Conference, P463; Levis S, 1999, GEOPHYS RES LETT, V26, P747, DOI 10.1029/1999GL900107; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; NABUURS GJ, 1995, CAN J FOREST RES, V25, P1157, DOI 10.1139/x95-128; NILSSON S, 1995, CLIMATIC CHANGE, V30, P267, DOI 10.1007/BF01091928; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; POSEY JW, 1964, GEOFIS INT, V4, P333; ROBINSON DA, 1984, J CLIM APPL METEOROL, V23, P1626, DOI 10.1175/1520-0450(1984)023<1626:AOADSC>2.0.CO;2; SCHIMEL D, 1995, CLIMATE CHANGE 1995, P65; Sharratt BS, 1998, AGR FOREST METEOROL, V89, P269, DOI 10.1016/S0168-1923(97)00071-3; THOMAS G, 1992, Q J ROY METEOR SOC, V118, P469, DOI 10.1002/qj.49711850505; *UNFCCC, 1999, UNEPIUC992 UNFCCC; *UNFCCC, 1998, UNEPINC982 UNFCCC; Watson RT, 2000, LAND USE LAND USE CH; WILLMOTT CJ, 1985, J CLIMATOL, V5, P589, DOI 10.1002/joc.3370050602; WILSON MF, 1985, J CLIMATOL, V5, P119, DOI 10.1002/joc.3370050202; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432	30	680	710	13	247	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					187	190		10.1038/35041545	http://dx.doi.org/10.1038/35041545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089969				2022-12-01	WOS:000165180400041
J	Mann, J				Mann, J			Stemming the tide of diabetes mellitus	LANCET			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; PREVENTION; PROGRAM		Univ Otago, Dept Human Nutr, Dunedin, New Zealand; Univ Otago, Dept Med, Dunedin, New Zealand	University of Otago; University of Otago	Mann, J (corresponding author), Univ Otago, Dept Human Nutr, Dunedin, New Zealand.							Bourn DM, 1996, DIABETIC MED, V13, P938, DOI 10.1002/(SICI)1096-9136(199611)13:11<938::AID-DIA274>3.0.CO;2-P; Bray GA, 1999, DIABETES CARE, V22, P623; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; Daniel M, 1999, DIABETES CARE, V22, P1993, DOI 10.2337/diacare.22.12.1993; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; Ferrannini E, 1997, DIABETES METAB REV, V13, P81; Macaulay AC, 1997, PREV MED, V26, P779, DOI 10.1006/pmed.1997.0241; MANN JI, 2000, EUR J CLIN NUTR, V54, P353; ODEA K, 1984, DIABETES, V33, P596, DOI 10.2337/diabetes.33.6.596; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Rowley KG, 2000, DIABETES CARE, V23, P898, DOI 10.2337/diacare.23.7.898; Russell D.G., 1999, KEY RESULTS 1997 NAT; Wing RR, 1998, DIABETES CARE, V21, P350, DOI 10.2337/diacare.21.3.350; YUDKIN JS, 1990, BRIT MED J, V301, P397, DOI 10.1136/bmj.301.6749.397	14	13	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 28	2000	356	9240					1454	1455		10.1016/S0140-6736(00)02862-2	http://dx.doi.org/10.1016/S0140-6736(00)02862-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367NA	11081521				2022-12-01	WOS:000090067300002
J	Santisteban, MS; Kalashnikova, T; Smith, MM				Santisteban, MS; Kalashnikova, T; Smith, MM			Histone H2A.Z regulates transcription and is partially redundant with nucleosome remodeling complexes	CELL			English	Article							YEAST PHO5 PROMOTER; RNA-POLYMERASE-II; C-TERMINAL DOMAIN; SWI-SNF COMPLEX; SACCHAROMYCES-CEREVISIAE; IN-VIVO; TETRAHYMENA-THERMOPHILA; POSITIONED NUCLEOSOMES; CHROMATIN STRUCTURE; NEGATIVE REGULATOR	Nucleosomes impose a block to transcription that can be overcome in vivo by remodeling complexes such as SNF/SWI and histone modification complexes such as SAGA. Mutations in the major core histones relieve transcriptional repression and bypass the requirement for SNF/SWI and SAGA. We have found that the variant histone H2A.Z regulates gene transcription, and deletion of the gene encoding H2A.Z strongly increases the requirement for SNF/SWI and SAGA. This synthetic genetic interaction is seen at the level of single genes and acts downstream of promoter nucleosome reorganization. H2A.Z is preferentially crosslinked in vivo to intergenic DNA at the PHO5 and GAL1 loci, and this association changes with transcriptional activation. These results describe a novel pathway for regulating transcription using variant histones to modulate chromatin structure.	Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Smith, MM (corresponding author), Univ Virginia, Dept Microbiol, 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028920] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28920] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLIS CD, 1986, J BIOL CHEM, V261, P1941; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; ALMER A, 1986, EMBO J, V5, P2681, DOI 10.1002/j.1460-2075.1986.tb04551.x; Arenhovel H., 1991, Few-Body Systems Supplementum, P1, DOI 10.1007/978-3-7091-6701-4_1; BERGMAN LW, 1983, J BIOL CHEM, V258, P7223; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; CARLSON M, 1981, GENETICS, V98, P25; CARR AM, 1994, MOL GEN GENET, V245, P628, DOI 10.1007/BF00282226; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CLARKADAMS CD, 1988, GENE DEV, V2, P150, DOI 10.1101/gad.2.2.150; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; DOLLARD C, 1994, MOL CELL BIOL, V14, P5223, DOI 10.1128/MCB.14.8.5223; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; ERNST SG, 1987, NUCLEIC ACIDS RES, V15, P4629, DOI 10.1093/nar/15.11.4629; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; Grant PA, 1999, SEMIN CELL DEV BIOL, V10, P169, DOI 10.1006/scdb.1999.0298; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; HARVEY RP, 1983, P NATL ACAD SCI-BIOL, V80, P2819, DOI 10.1073/pnas.80.10.2819; Haswell ES, 1999, MOL CELL BIOL, V19, P2817; HATCH CL, 1983, SCIENCE, V221, P468, DOI 10.1126/science.6306766; HATCH CL, 1988, NUCLEIC ACIDS RES, V16, P1113, DOI 10.1093/nar/16.3.1113; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; Iouzalen N, 1996, NUCLEIC ACIDS RES, V24, P3947, DOI 10.1093/nar/24.20.3947; Jackson JD, 1996, TRENDS BIOCHEM SCI, V21, P466, DOI 10.1016/S0968-0004(96)20028-3; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; KRUGER W, 1995, GENE DEV, V9, P2770, DOI 10.1101/gad.9.22.2770; KRUGER W, 1991, MOL CELL BIOL, V11, P4135, DOI 10.1128/MCB.11.8.4135; Kurumizaka H, 1997, MOL CELL BIOL, V17, P6953, DOI 10.1128/MCB.17.12.6953; Leach TJ, 2000, J BIOL CHEM, V275, P23267, DOI 10.1074/jbc.M910206199; Liu XW, 1996, MOL CELL BIOL, V16, P4305; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Meluh PB, 1999, METHOD ENZYMOL, V304, P414; Mizzen C, 1998, COLD SPRING HARB SYM, V63, P469, DOI 10.1101/sqb.1998.63.469; OHNISHI ST, 1978, ANAL BIOCHEM, V88, P347, DOI 10.1016/0003-2697(78)90432-3; Perez-Martin J, 1998, MOL CELL BIOL, V18, P4157, DOI 10.1128/MCB.18.7.4157; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Recht J, 1999, EMBO J, V18, P229, DOI 10.1093/emboj/18.1.229; Roberts SM, 1997, GENETICS, V147, P451; Ryan MP, 1998, MOL CELL BIOL, V18, P1774, DOI 10.1128/MCB.18.4.1774; Santisteban MS, 1997, EMBO J, V16, P2493, DOI 10.1093/emboj/16.9.2493; SIMCHEN G, 1984, P NATL ACAD SCI-BIOL, V81, P2431, DOI 10.1073/pnas.81.8.2431; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STARGELL LA, 1993, GENE DEV, V7, P2641, DOI 10.1101/gad.7.12b.2641; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; VANDAAL A, 1990, J MOL EVOL, V30, P449, DOI 10.1007/BF02101116; VANDAAL A, 1988, NUCLEIC ACIDS RES, V16, P7487, DOI 10.1093/nar/16.15.7487; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wechser MA, 1997, EMBO J, V16, P2086, DOI 10.1093/emboj/16.8.2086; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; WHITE EM, 1988, NUCLEIC ACIDS RES, V16, P179, DOI 10.1093/nar/16.1.179; WU RS, 1982, CELL, V31, P367, DOI 10.1016/0092-8674(82)90130-1; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yona E, 1996, FEBS LETT, V382, P97, DOI 10.1016/0014-5793(96)00159-7	66	257	265	2	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 27	2000	103	3					411	422		10.1016/S0092-8674(00)00133-1	http://dx.doi.org/10.1016/S0092-8674(00)00133-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081628	Bronze			2022-12-01	WOS:000090144100007
J	Brenner, R; Perez, GJ; Bonev, AD; Eckman, DM; Kosek, JC; Wiler, SW; Patterson, AJ; Nelson, MT; Aldrich, RW				Brenner, R; Perez, GJ; Bonev, AD; Eckman, DM; Kosek, JC; Wiler, SW; Patterson, AJ; Nelson, MT; Aldrich, RW			Vasoregulation by the beta 1 subunit of the calcium-activated potassium channel	NATURE			English	Article							CA2+-ACTIVATED K+ CHANNEL; CEREBRAL-ARTERIES; SMOOTH-MUSCLE; RYANODINE RECEPTORS; MOLECULAR-BASIS; PROTEIN-KINASE; BLOOD-PRESSURE; CA CHANNELS; BK CHANNELS; WALL CA2+	Small arteries exhibit tone, a partially contracted state that is an important determinant of blood pressure. In arterial smooth muscle cells, intracellular calcium paradoxically controls both contraction and relaxation. The mechanisms by which calcium can differentially regulate diverse physiological responses within a single cell remain unresolved. Calcium-dependent relaxation is mediated by local calcium release from the sarcoplasmic reticulum. These 'calcium sparks' activate calcium-dependent potassium (BK) channels comprised of alpha and beta 1 subunits. Here we show that targeted deletion of the gene for the beta 1 subunit leads to a decrease in the calcium sensitivity of BK channels, a reduction in functional coupling of calcium sparks to BK channel activation, and increases in arterial tone and blood pressure. The beta 1 subunit of the BK channel, by tuning the channel's calcium sensitivity, is a key molecular component in translating calcium signals to the central physiological function of vasoregulation.	Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; Palo Alto Vet Adm Healthcare Syst, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Vermont; Stanford University	Aldrich, RW (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	raldrich@leland.stanford.edu	Perez, Guillermo J/D-5932-2013	Perez, Guillermo J/0000-0003-0237-2150; Nelson, Mark/0000-0002-6608-8784; Brenner, Robert/0000-0002-1036-8031				Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Berkowitz RD, 1998, J VIROL, V72, P10108, DOI 10.1128/JVI.72.12.10108-10117.1998; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Desai KH, 1997, AM J PHYSIOL-HEART C, V272, pH1053, DOI 10.1152/ajpheart.1997.272.2.H1053; Dong H, 1998, BRIT J PHARMACOL, V123, P821, DOI 10.1038/sj.bjp.0701680; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Han JX, 1998, LAB ANIM SCI, V48, P256; Hogan B., 2014, MANIPULATING MOUSE E; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; JOYNER AL, 1993, GENE TARGETING PRACT, V18, P234; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; Khan SA, 1998, J PHARMACOL EXP THER, V284, P838; KNAUS HG, 1994, J BIOL CHEM, V269, P23336; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Knot HJ, 1996, J PHYSIOL-LONDON, V492, P419, DOI 10.1113/jphysiol.1996.sp021318; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P211, DOI 10.1111/j.1469-7793.1998.211br.x; LATORRE R, 1994, MEMBRANE CHANNELS MO, P79; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meera P, 1996, FEBS LETT, V382, P84, DOI 10.1016/0014-5793(96)00151-2; MEININGER GA, 1992, AM J PHYSIOL, V263, pH647, DOI 10.1152/ajpheart.1992.263.3.H647; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Perez GJ, 1999, J GEN PHYSIOL, V113, P229, DOI 10.1085/jgp.113.2.229; Poolos NP, 1999, J NEUROSCI, V19, P5205; Riazi MA, 1999, GENOMICS, V62, P90, DOI 10.1006/geno.1999.5975; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; SIMPSON LO, 1980, PATHOLOGY, V12, P347, DOI 10.3109/00313028009077096; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Wilson PWF, 1999, CLIN CARDIOL, V22, pV1; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Xia XM, 2000, J NEUROSCI, V20, P4890; Zhou XB, 1998, PFLUG ARCH EUR J PHY, V436, P725, DOI 10.1007/s004240050695	47	653	674	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					870	876		10.1038/35038011	http://dx.doi.org/10.1038/35038011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057658				2022-12-01	WOS:000089901900041
J	Crudgington, HS; Siva-Jothy, MT				Crudgington, HS; Siva-Jothy, MT			Genital damage, kicking and early death - The battle of the sexes takes a sinister turn in the bean weevil.	NATURE			English	Article							ADAPTATION		Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Crudgington, HS (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.							ARNQVIST G, 1995, P ROY SOC B-BIOL SCI, V261, P123, DOI 10.1098/rspb.1995.0126; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BAUMANN H, 1974, J INSECT PHYSIOL, V20, P2347, DOI 10.1016/0022-1910(74)90022-5; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; EADY P, 1994, ECOL ENTOMOL, V19, P11, DOI 10.1111/j.1365-2311.1994.tb00384.x; MERRITT DJ, 1989, ZOOMORPHOLOGY, V108, P359, DOI 10.1007/BF00312276; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Simmons L.W., 1998, P341, DOI 10.1016/B978-012100543-6/50035-0; WAAGE JK, 1979, SCIENCE, V203, P916, DOI 10.1126/science.203.4383.916	10	442	455	3	197	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					855	856		10.1038/35038154	http://dx.doi.org/10.1038/35038154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057654				2022-12-01	WOS:000089901900036
J	Dalton, R				Dalton, R			US court slashes damages in polymerase-beta theft case	NATURE			English	News Item																		1998, NATURE, V393, P504	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					824	824		10.1038/35038228	http://dx.doi.org/10.1038/35038228			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057632	Bronze			2022-12-01	WOS:000089901900009
J	Williams, EJB; Hurst, LD				Williams, EJB; Hurst, LD			The proteins of linked genes evolve at similar rates	NATURE			English	Article							NONSYNONYMOUS SUBSTITUTION; POSITIVE SELECTION; EVOLUTION; GENOME; RECOMBINATION; REGIONS; MOUSE; MAMMALS	Much more variation in the rate of protein evolution occurs than is expected by chance(1). But why some proteins evolve rapidly but others slowly is poorly resolved. It was proposed, for example, that essential genes might evolve slower than dispensable ones(2), but this is not the case(3); and despite earlier claims(4), rates of evolution do not correlate with amino-acid composition(5). A few patterns have been found: proteins involved in antagonistic coevolution (for example, immune genes(3,6), parasite antigens(7) and reproductive conflict genes(8-10)) tend to be rapidly evolving, and there is a correlation between the rate of protein evolution and the mutation rate of the gene(1,11,12). Here we report a new highly statistically significant predictor of a protein's rate of evolution, and show that linked genes have similar rates of protein evolution. There is also a weaker similarity of rates of silent site evolution (see ref. 13), which appears to be, in part, a consequence of the similarity in rates of protein evolution. The similarity in rates of protein evolution is not a consequence of underlying mutational patterns. A pronounced negative correlation between the rate of protein evolution and a covariant of the recombination rate indicates that rates of protein evolution possibly reflect, in part, the local strength of stabilizing selection.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.		Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054				Averof M, 2000, SCIENCE, V287, P1283, DOI 10.1126/science.287.5456.1283; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; Caccio S, 1997, GENE, V205, P119, DOI 10.1016/S0378-1119(97)00560-X; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Casane D, 1997, J MOL EVOL, V45, P216, DOI 10.1007/PL00006223; DROUIN R, 1994, ADV HUM GENET, V22, P47; DURET L, 1994, NUCLEIC ACIDS RES, V22, P2360, DOI 10.1093/nar/22.12.2360; EYREWALKER A, 1993, P ROY SOC B-BIOL SCI, V252, P237, DOI 10.1098/rspb.1993.0071; Galtier N, 1998, GENETICS, V150, P1577; GRAUR D, 1985, J MOL EVOL, V22, P53, DOI 10.1007/BF02105805; HUGHES AL, 1991, GENETICS, V127, P345; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Hurst LD, 1998, CURR OPIN GENET DEV, V8, P701, DOI 10.1016/S0959-437X(98)80040-3; KUMA K, 1995, MOL BIOL EVOL, V12, P123, DOI 10.1093/oxfordjournals.molbev.a040181; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Makalowski W, 1998, J MOL EVOL, V47, P119, DOI 10.1007/PL00006367; Matassi G, 1999, CURR BIOL, V9, P786, DOI 10.1016/S0960-9822(99)80361-3; Nachman MW, 1996, GENETICS, V142, P537; Nordborg M, 1996, GENET RES, V67, P159, DOI 10.1017/S0016672300033619; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Silver L. M., 1995, MOUSE GENETICS; Smith NGC, 1999, GENETICS, V152, P661; Smith NGC, 1999, GENETICS, V153, P1395; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; Tsaur SC, 1997, MOL BIOL EVOL, V14, P544, DOI 10.1093/oxfordjournals.molbev.a025791; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; WOLFE KH, 1993, J MOL EVOL, V37, P441, DOI 10.1007/BF00178874; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070	29	93	93	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					900	903		10.1038/35038066	http://dx.doi.org/10.1038/35038066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057667				2022-12-01	WOS:000089901900050
J	Moore, PD				Moore, PD			Conservation biology - Seeds of doubt	NATURE			English	Editorial Material									Kings Coll London, Div Life Sci, London SE1 8WA, England	University of London; King's College London	Moore, PD (corresponding author), Kings Coll London, Div Life Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 8WA, England.	peter.moore@kcl.ac.uk						Chuine I, 2000, J ECOL, V88, P561, DOI 10.1046/j.1365-2745.2000.00468.x; EVANS EI, 1997, BR BIRDS, V90, P123; Keller M, 2000, J APPL ECOL, V37, P647, DOI 10.1046/j.1365-2664.2000.00517.x; MacDonald Ian A. W., 1994, P199; Montalvo AM, 2000, CONSERV BIOL, V14, P1034, DOI 10.1046/j.1523-1739.2000.99250.x	5	7	7	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					683	685		10.1038/35037693	http://dx.doi.org/10.1038/35037693			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048701				2022-12-01	WOS:000089773900022
J	Futran, ND; Alsarraf, R				Futran, ND; Alsarraf, R			Microvascular free-flap reconstruction in the head and neck	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANDIBLE RECONSTRUCTION; DEFECTS; EXPERIENCE; MIDFACE; BONE		Univ Washington, Sch Med, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Futran, ND (corresponding author), Univ Washington, Sch Med, Dept Otolaryngol Head & Neck Surg, Box 356515, Seattle, WA 98195 USA.	nfutran@u.washington.edu						ALLISON GR, 1987, AM J SURG, V154, P419, DOI 10.1016/0002-9610(89)90016-0; BAEK SM, 1983, PLAST RECONSTR SURG, V71, P354, DOI 10.1097/00006534-198303000-00012; BAKER SR, 1986, ARCH OTOLARYNGOL, V112, P733; BAKER SR, 1988, ARCH OTOLARYNGOL, V114, P267; BROWN KE, 1968, J PROSTHET DENT, V20, P176, DOI 10.1016/0022-3913(68)90143-1; COLEMAN JJ, 1994, CLIN PLAST SURG, V21, P113; Cordeiro PG, 1998, PLAST RECONSTR SURG, V102, P1874, DOI 10.1097/00006534-199811000-00011; Duffy FJ, 1998, J RECONSTR MICROSURG, V14, P89, DOI 10.1055/s-2007-1000149; FISHER SR, 1990, HEAD NECK-J SCI SPEC, V12, P126, DOI 10.1002/hed.2880120206; FUTRAN ND, 1994, CURRENT THERAPY OTOL, P327; HIDALGO DA, 1989, PLAST RECONSTR SURG, V84, P71, DOI 10.1097/00006534-198907000-00014; HOFFMAN HT, 1991, ARCH OTOLARYNGOL, V117, P917; KATSAROS J, 1991, PLAST RECONSTR SURG, V87, P902, DOI 10.1097/00006534-199105000-00015; KLOTCH DW, 1990, AM J SURG, V160, P396, DOI 10.1016/S0002-9610(05)80551-3; KURILOFF DB, 1993, HEAD NECK SURG OTOLA, P1949; MATIN H, 1992, ARCH SURG-CHICAGO, V44, P599; MCLEAN DH, 1972, PLAST RECONSTR SURG, V49, P268, DOI 10.1097/00006534-197203000-00005; MELAND NB, 1989, PLAST RECONSTR SURG, V83, P481, DOI 10.1097/00006534-198903000-00014; SHESTAK K C, 1988, Microsurgery, V9, P128, DOI 10.1002/micr.1920090214; Triana R J Jr, 2000, Arch Facial Plast Surg, V2, P91, DOI 10.1001/archfaci.2.2.91; URKEN ML, 1993, ARCH OTOLARYNGOL, V119, P1318; URKEN ML, 1991, LARYNGOSCOPE, V101, P257; URKEN ML, 1990, LARYNGOSCOPE, V100, P161; Urken ML, 1995, ATLAS REGIONAL FREE	24	16	17	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1761	1763		10.1001/jama.284.14.1761	http://dx.doi.org/10.1001/jama.284.14.1761			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025806				2022-12-01	WOS:000089622100002
J	Simon, AR; Vikis, HG; Stewart, S; Fanburg, BL; Cochran, BH; Guan, KL				Simon, AR; Vikis, HG; Stewart, S; Fanburg, BL; Cochran, BH; Guan, KL			Regulation of STAT3 by direct binding to the Rac1 GTPase	SCIENCE			English	Article							EPIDERMAL GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; CYTOKINE RECEPTORS; ACTIVATION; KINASE; PROTEINS; GENE; IDENTIFICATION; PATHWAY; JAKS	The signal transducers and activators of transcription (STAT) transcription factors become phosphorylated on tyrosine and translocate to the nucleus after stimulation of cells with growth factors or cytokines. We show that the Rad guanosine triphosphatase can bind to and regulate STAT3 activity. Dominant negative Rad inhibited STAT3 activation by growth factors, whereas activated Rad stimulated STAT3 phosphorylation on both tyrosine and serine residues. Moreover, activated Rad formed a complex with STAT3 in mammalian cells, Yeast two-hybrid analysis indicated that STAT3 binds directly to active but not inactive Rad and that the interaction occurs via the effector domain. Rad may serve as an alternate mechanism for targeting STAT3 to tyrosine kinase signaling complexes.	Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Tupper Res Inst, Div Pulm & Crit Care, Boston, MA 02111 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Tufts University; Tufts Medical Center; University of Michigan System; University of Michigan	Cochran, BH (corresponding author), Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA.	cochran@opal.tufts.edu	Guan, Kun-Liang/ADK-7088-2022	Cochran, Brent/0000-0002-7598-5604	NHLBI NIH HHS [K08-HL-03547] Funding Source: Medline; NIDDK NIH HHS [P30-DK34928] Funding Source: Medline; NIGMS NIH HHS [GM-54304] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054304] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe J, 1999, J BIOL CHEM, V274, P21003, DOI 10.1074/jbc.274.30.21003; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; David M, 1996, J BIOL CHEM, V271, P9185, DOI 10.1074/jbc.271.16.9185; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; HELM MH, 1995, SCIENCE, V267, P1347; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Leaman DW, 1996, MOL CELL BIOL, V16, P369; NAKAMURA K, 1993, ONCOGENE, V8, P3133; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SIMON A, UNPUB; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Vignais ML, 1996, MOL CELL BIOL, V16, P1759; Vignais ML, 1999, MOL CELL BIOL, V19, P3727; VIKIS H, UNPUB; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Wang YZ, 2000, ONCOGENE, V19, P2075, DOI 10.1038/sj.onc.1203548; Whitehead IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1; Zhang Y, 2000, J BIOL CHEM, V275, P24935, DOI 10.1074/jbc.M002383200; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	29	186	191	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					144	147		10.1126/science.290.5489.144	http://dx.doi.org/10.1126/science.290.5489.144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021801				2022-12-01	WOS:000089724800054
J	Jacob, G; Costa, F; Shannon, JR; Robertson, RM; Wathen, M; Stein, M; Biaggioni, I; Ertl, A; Black, B; Robertson, D				Jacob, G; Costa, F; Shannon, JR; Robertson, RM; Wathen, M; Stein, M; Biaggioni, I; Ertl, A; Black, B; Robertson, D			The neuropathic postural tachycardia syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITRAL-VALVE PROLAPSE; IDIOPATHIC ORTHOSTATIC INTOLERANCE; PURE AUTONOMIC FAILURE; BLOOD-PRESSURE; PLASMA NOREPINEPHRINE; HYPOTENSION; TYRAMINE; HUMANS; HYPOVOLEMIA; RESISTANCE	Background: The postural tachycardia syndrome is a common disorder that is characterized by chronic orthostatic symptoms and a dramatic increase in heart rate on standing, but that does not involve orthostatic hypotension. Several lines of evidence indicate that this disorder may result from sympathetic denervation of the legs. Methods: We measured norepinephrine spillover (the rate of entry of norepinephrine into the venous circulation) in the arms and legs both before and in response to exposure to three stimuli (the cold pressor test, sodium nitroprusside infusion, and tyramine infusion) in 10 patients with the postural tachycardia syndrome and in 8 age- and sex-matched normal subjects. Results: At base line, the mean (+/-SD) plasma norepinephrine concentration in the femoral vein was lower in the patients with the postural tachycardia syndrome than in the normal subjects (135+/-30 vs. 215+/-55 pg per milliliter [0.80+/-0.18 vs. 1.27+/-0.32 nmol per liter], P=0.001). Norepinephrine spillover in the arms increased to a similar extent in the two groups in response to each of the three stimuli, but the increases in the legs were smaller in the patients with the postural tachycardia syndrome than in the normal subjects (0.001+/-0.09 vs. 0.12+/-0.12 ng per minute per deciliter of tissue [0.006+/-0.53 vs. 0.71+/-0.71 nmol per minute per deciliter] with the cold pressor test, P=0.02; 0.02+/-0.07 vs. 0.23+/-0.17 ng per minute per deciliter [0.12+/-0.41 vs. 1.36+/-1.00 nmol per minute per deciliter] with nitroprusside infusion, P=0.01; and 0.008+/-0.09 vs. 0.19+/-0.25 ng per minute per deciliter [0.05+/-0.53 vs. 1.12+/-1.47 nmol per minute per deciliter] with tyramine infusion, P=0.04). Conclusions: The neuropathic postural tachycardia syndrome results from partial sympathetic denervation, especially in the legs. (N Engl J Med 2000;343:1008-14.) (C) 2000, Massachusetts Medical Society.	Vanderbilt Univ, Autonom Dysfunct Ctr, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Rambam Med Ctr, Jacob Recanati Autonom Dysfunct Ctr, Haifa, Israel; Rambam Med Ctr, Dept Internal Med C, Haifa, Israel	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology	Robertson, D (corresponding author), Vanderbilt Univ, Autonom Dysfunct Ctr, AA3228 MCN, Nashville, TN 37232 USA.				NCRR NIH HHS [RR-00095] Funding Source: Medline; NHLBI NIH HHS [HL-56693] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056693] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aneman A, 1996, J CLIN INVEST, V97, P1640, DOI 10.1172/JCI118590; BOUDOULAS H, 1980, CIRCULATION, V61, P1200, DOI 10.1161/01.CIR.61.6.1200; Bradbury S, 1927, AM HEART J, V3, P105, DOI 10.1016/S0002-8703(27)90177-X; CAMPBELL TJ, 1958, J LAB CLIN MED, V52, P768; CONVERTINO VA, 1980, J APPL PHYSIOL, V48, P665, DOI 10.1152/jappl.1980.48.4.665; COUSINEAU D, 1986, J APPL PHYSIOL, V60, P147, DOI 10.1152/jappl.1986.60.1.147; ESLER M, 1990, PHYSIOL REV, V70, P963, DOI 10.1152/physrev.1990.70.4.963; FOUAD FM, 1986, ANN INTERN MED, V104, P298, DOI 10.7326/0003-4819-104-3-298; FOUADTARAZI FM, 1995, AM J MED, V99, P604, DOI 10.1016/S0002-9343(99)80246-0; FROHLICH ED, 1969, ARCH INTERN MED, V123, P1, DOI 10.1001/archinte.123.1.1; FROHLICH ED, 1966, ARCH INTERN MED, V117, P614; GOLDSTEIN DS, 1988, J CLIN INVEST, V81, P213, DOI 10.1172/JCI113298; GROSSMAN E, 1991, AM J PHYSIOL, V260, pR946, DOI 10.1152/ajpregu.1991.260.5.R946; GRUCHALLA RS, 1995, AM J MED SCI, V309, P328, DOI 10.1097/00000441-199506000-00007; Hague K, 1997, ACTA NEUROPATHOL, V94, P192, DOI 10.1007/s004010050693; HICKLER RB, 1959, NEW ENGL J MED, V261, P788, DOI 10.1056/NEJM195910152611604; HOELDTKE RD, 1989, NEUROLOGY, V39, P34, DOI 10.1212/WNL.39.1.34; HOELDTKE RD, 1991, J CLIN ENDOCR METAB, V73, P132, DOI 10.1210/jcem-73-1-132; Jacob G, 1997, AM J MED, V103, P128, DOI 10.1016/S0002-9343(97)00133-2; Jacob G, 1997, CIRCULATION, V96, P575; Jacob G, 1999, CIRCULATION, V99, P1706, DOI 10.1161/01.CIR.99.13.1706; Jacob G, 1996, CIRCULATION S1, V94, P627; Jordan J, 1998, HYPERTENSION, V32, P699, DOI 10.1161/01.HYP.32.4.699; Jordan J, 1998, AM J MED, V105, P116, DOI 10.1016/S0002-9343(98)00193-4; Kanda T, 1998, ANN NEUROL, V43, P267, DOI 10.1002/ana.410430220; LOW PA, 1995, NEUROLOGY, V45, pS19; LOW PA, 1983, ANN NEUROL, V14, P573, DOI 10.1002/ana.410140513; Mosqueda-Garcia R, 1995, DISORDERS AUTONOMIC, P25; Narkiewicz K, 1998, CIRCULATION, V98, P2105, DOI 10.1161/01.CIR.98.20.2105; ONROT J, 1986, AM J MED, V80, P454, DOI 10.1016/0002-9343(86)90720-5; PASTERNAC A, 1982, AM J MED, V73, P783, DOI 10.1016/0002-9343(82)90758-6; RAPOPORT RM, 1981, PHARMACOLOGY, V23, P235; REA RF, 1990, AM J PHYSIOL, V258, pR982, DOI 10.1152/ajpregu.1990.258.4.R982; Schafers RF, 1997, N-S ARCH PHARMACOL, V355, P239, DOI 10.1007/PL00004938; SCHONDORF R, 1993, NEUROLOGY, V43, P132, DOI 10.1212/WNL.43.1_Part_1.132; SCRIVEN AJI, 1983, CLIN PHARMACOL THER, V33, P710, DOI 10.1038/clpt.1983.97; SCRIVEN AJI, 1984, J CARDIOVASC PHARM, V6, P954, DOI 10.1097/00005344-198409000-00033; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Shannon JR, 1998, CIRCULATION, V98, P336; Siggaard-Andersen J, 1970, DANISH MED B      S1, V17, P1; STREETEN DHP, 1988, J LAB CLIN MED, V111, P326; STREETEN DHP, 1990, J CLIN INVEST, V86, P1582, DOI 10.1172/JCI114878; VISSING SF, 1989, CIRC RES, V65, P1710, DOI 10.1161/01.RES.65.6.1710; WOOLEY CF, 1976, CIRCULATION, V53, P749, DOI 10.1161/01.CIR.53.5.749	44	245	253	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2000	343	14					1008	1014		10.1056/NEJM200010053431404	http://dx.doi.org/10.1056/NEJM200010053431404			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PU	11018167	Bronze			2022-12-01	WOS:000089619900004
J	Feudtner, C				Feudtner, C			Dare we go gently	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material													Feudtner, Chris/AAI-1126-2019	Feudtner, Chris/0000-0002-5879-0434					0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1621	1622		10.1001/jama.284.13.1621	http://dx.doi.org/10.1001/jama.284.13.1621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015775				2022-12-01	WOS:000089501900001
J	Wehrli, M; Dougan, ST; Caldwell, K; O'Keefe, L; Schwartz, S; Vaizel-Ohayon, D; Schejter, E; Tomlinson, A; DiNardo, S				Wehrli, M; Dougan, ST; Caldwell, K; O'Keefe, L; Schwartz, S; Vaizel-Ohayon, D; Schejter, E; Tomlinson, A; DiNardo, S			Arrow encodes an LDL-receptor-related protein essential for Wingless signalling	NATURE			English	Article							LONG-RANGE ACTION; SIGNALING PATHWAYS; MORPHOGEN GRADIENT; MOLECULAR-CLONING; DROSOPHILA LEG; POLARITY; FAMILY; EXPRESSION; PATTERN; MEMBER	The Wnt family of secreted molecules functions in cell-fate determination and morphogenesis during development in both vertebrates and invertebrates (reviewed in ref. 1). Drosophila Wingless is a founding member of this family, and many components of its signal transduction cascade have been identified, including the Frizzled class of receptor. But the mechanism by which the Wingless signal is received and transduced across the membrane is not completely understood. Here we describe a gene that is necessary for all Wingless signalling events in Drosophila. We show that arrow gene function is essential in cells receiving Wingless input and that it acts upstream of Dishevelled. arrow encodes a single-pass transmembrane protein, indicating that it may be part of a receptor complex with Frizzled class proteins. Arrow is a low-density lipoprotein (LDL)receptor-related protein (LRP), strikingly homologous to murine and human LRP5 and LRP6. Thus, our data suggests a new and conserved function for this LRP subfamily in Wingless/Wnt signal reception.	Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Columbia Univ, New York, NY 10032 USA; Rockefeller Univ, New York, NY 10021 USA; Weizmann Inst Sci, IL-76100 Rehovot, Israel	University of Pennsylvania; Columbia University; Rockefeller University; Weizmann Institute of Science	DiNardo, S (corresponding author), Univ Penn, Sch Med, BRB 2 Room 1223,421 Curie Blvd, Philadelphia, PA 19104 USA.		O'Keefe, Louise V/B-9856-2008; Dougan, Scott/B-8416-2008	Dougan, Scott/0000-0003-0214-4772; Caldwell, Kim/0000-0003-1580-6122; DiNardo, Stephen/0000-0003-4131-5511	NIGMS NIH HHS [R01 GM045747] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045747] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Chen CM, 1999, DEVELOPMENT, V126, P5441; Chen D, 1999, GENOMICS, V55, P314, DOI 10.1006/geno.1998.5688; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; DOUGAN S, 1992, NATURE, V360, P347, DOI 10.1038/360347a0; Heslip TR, 1997, DEVELOPMENT, V124, P1069; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Muller HAJ, 1999, DEVELOPMENT, V126, P577; Neumann CJ, 1997, DEVELOPMENT, V124, P871; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Penton A, 1996, NATURE, V382, P162, DOI 10.1038/382162a0; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Wehrli M, 1998, DEVELOPMENT, V125, P1421; WEHRLI M, 1995, DEVELOPMENT, V121, P2451; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	30	684	717	0	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					527	530		10.1038/35035110	http://dx.doi.org/10.1038/35035110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029006				2022-12-01	WOS:000089727400054
J	Kondo, M; Scherer, DC; Miyamoto, T; King, AG; Akashi, K; Sugamura, K; Weissman, IL				Kondo, M; Scherer, DC; Miyamoto, T; King, AG; Akashi, K; Sugamura, K; Weissman, IL			Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines	NATURE			English	Article							RECEPTOR-GAMMA-CHAIN; MOUSE BONE-MARROW; IL-2 RECEPTOR; SIGNAL-TRANSDUCTION; BETA-CHAIN; STEM-CELLS; ERYTHROPOIETIN RECEPTOR; INTERLEUKIN-2 RECEPTOR; MYELOGENOUS LEUKEMIA; GENE REARRANGEMENT	The primary role of cytokines in haemato-lymphopoiesis is thought to be the regulation of cell growth and survival(1-3). But the instructive action of cytokines in haematopoiesis has not been well addressed(4). Here we show that a clonogenic common lymphoid progenitor(5), a bone marrow-resident cell that gives rise exclusively to lymphocytes (T, B and natural killer cells), can be redirected to the myeloid lineage by stimulation through exogenously expressed interleukin (IL)-2 and GM-CSF (granulocyte/ macrophage colony-stimulating factor) receptors. Analysis of mutants of the beta-chain of the IL-2 receptor revealed that the granulocyte- and monocyte-differentiation signals are triggered by different cytoplasmic domains, showing that the signalling pathway(s) responsible for these unique developmental outcomes are separable. Finally, we show that the endogenous myelomonocytic cytokine receptors for GM-CSF and macrophage colony-stimulating factor (M-CSF) are expressed at low to moderate levels on the more primitive haematopoietic stem cells, are absent on common lymphoid progenitors, and are upregulated after myeloid lineage induction by IL-2. We conclude that cytokine signalling can regulate cell-fate decisions and propose that a critical step in lymphoid commitment is downregulation of cytokine receptors that drive myeloid cell development.	Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; Tohoku Univ, Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 9808575, Japan	Stanford University; Stanford University; Tohoku University	Kondo, M (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	motonari.kondo@stanford.edu		Fleischman, Angela/0000-0002-3701-6079				ASANO M, 1994, J IMMUNOL, V153, P5373; CHENG GY, 1986, J EXP MED, V163, P414, DOI 10.1084/jem.163.2.414; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; Ghaffari S, 1999, P NATL ACAD SCI USA, V96, P13186, DOI 10.1073/pnas.96.23.13186; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GODFREY DI, 1994, J IMMUNOL, V152, P4783; HA K, 1984, CANCER RES, V44, P4658; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HENRY C, 1981, SELECTED METHODS CEL, P138; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Metcalf D, 1999, ANN NY ACAD SCI, V872, P289, DOI 10.1111/j.1749-6632.1999.tb08473.x; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; NEMOTO T, 1995, EUR J IMMUNOL, V25, P3001, DOI 10.1002/eji.1830251102; Ogasawara K, 1998, NATURE, V392, P843, DOI 10.1038/33977; OGAWA M, 1993, BLOOD, V81, P2844; PALUMBO A, 1984, BLOOD, V64, P1059; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; WATANABE S, 1993, MOL CELL BIOL, V13, P1440, DOI 10.1128/MCB.13.3.1440; Watowich SS, 1996, ANNU REV CELL DEV BI, V12, P91, DOI 10.1146/annurev.cellbio.12.1.91	28	299	315	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2000	407	6802					383	386		10.1038/35030112	http://dx.doi.org/10.1038/35030112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014194				2022-12-01	WOS:000089390700048
J	Domeier, ME; Morse, DP; Knight, SW; Portereiko, M; Bass, BL; Mango, SE				Domeier, ME; Morse, DP; Knight, SW; Portereiko, M; Bass, BL; Mango, SE			A link between RNA interference and nonsense-mediated decay in Caenorhabditis elegans	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; GENETIC INTERFERENCE; PROTEIN; SURVEILLANCE; IDENTITY; HOMOLOG; PHA-4	Double-stranded RNA (dsRNA) inhibits expression of homologous genes by a process' involving messenger RNA degradation. To gain insight into the mechanism of degradation, we examined how RNA interference is affected by mutations in the smg genes, which are required for nonsense-mediated decay. For three of six smg genes tested, mutations resulted in animals that were initially silenced by dsRNA but then recovered; wild-type animals remained silenced. The Levels of target messenger RNAs were restored during recovery, and RNA editing and degradation of the dsRNA were identical to those of the wild type. We suggest that persistence of RNA interference relies on a subset of smg genes.	Univ Utah, Huntsman Canc Inst Ctr Children, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA; Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Mango, SE (corresponding author), Univ Utah, Huntsman Canc Inst Ctr Children, Salt Lake City, UT 84112 USA.			Mango, Susan/0000-0002-2146-3237	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NCI NIH HHS [5P30CA42014] Funding Source: Medline; PHS HHS [42014] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSON PW, COMMUNICATION; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; BRENNER S, 1974, GENETICS, V77, P71; Cali BM, 1999, GENETICS, V151, P605; Cali BM, 1998, MOL GEN GENET, V260, P176, DOI 10.1007/s004380050883; CZAPLINSKI K, 1995, RNA, V1, P610; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HODGKIN J, 1989, GENETICS, V123, P301; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; KALTENBACH L, UNPUB; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Korf I, 1998, DEVELOPMENT, V125, P2469; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Morrison M, 1997, P NATL ACAD SCI USA, V94, P9782, DOI 10.1073/pnas.94.18.9782; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Page MF, 1999, MOL CELL BIOL, V19, P5943; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; PULAK RA, 1988, MOL CELL BIOL, V8, P3748, DOI 10.1128/MCB.8.9.3748; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	32	122	154	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1928	1930		10.1126/science.289.5486.1928	http://dx.doi.org/10.1126/science.289.5486.1928			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988072				2022-12-01	WOS:000089355800044
J	Galuske, RAW; Schlote, W; Bratzke, H; Singer, W				Galuske, RAW; Schlote, W; Bratzke, H; Singer, W			Interhemispheric asymmetries of the modular structure in human temporal cortex	SCIENCE			English	Article							CAT VISUAL-CORTEX; INTRINSIC CONNECTIONS; HUMAN-BRAIN; SPEECH; ORGANIZATION; SPECIFICITY; ANATOMY; REGION; AREAS	Language-relevant processing of auditory signals is Lateralized and involve the posterior part of Brodmann area 22. We found that the functional Lateralization in this area was accompanied by interhemispheric differences in the organization of the intrinsic: microcircuitry. Neuronal tract tracing revealed a modular network of long-range intrinsic connections Linking regularly spaced clusters of neurons. Although the cluster diameter was similar in both hemispheres, their spacing was about 20 percent Larger in the Left hemisphere. Assuming similar relations between functional and anatomical architecture as in visual cortex, the present data suggest that more functionally distinct columnar systems are included per surface unit in the Left than in the right area 22.	Max Planck Inst Brain Res, Dept Neurophysiol, D-60528 Frankfurt, Germany; Goethe Univ Frankfurt, Sch Med, Edinger Inst, Neurol Inst, D-60528 Frankfurt, Germany; Goethe Univ Frankfurt, Sch Med, Inst Forens Med, D-60596 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt	Galuske, RAW (corresponding author), Max Planck Inst Brain Res, Dept Neurophysiol, Deutschordenstr 46, D-60528 Frankfurt, Germany.	galuske@mpih-frankfurt.mpg.de	Singer, Wolf/D-6874-2012					AMIR Y, 1993, J COMP NEUROL, V334, P19, DOI 10.1002/cne.903340103; Baynes K, 1990, J Cogn Neurosci, V2, P159, DOI 10.1162/jocn.1990.2.3.159; Belin P, 1998, J NEUROSCI, V18, P6388; Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Brodmann K., 1909, VERGLEICHENDE LOKALI; BURKHALTER A, 1993, J NEUROSCI, V13, P1916, DOI 10.1523/jneurosci.13-05-01916.1993; Demonet J. F., 1993, Human Brain Mapping, V1, P39, DOI 10.1002/hbm.460010105; Economo C.V., 1925, SPRINGER; Fiez JA, 1996, CEREB CORTEX, V6, P1, DOI 10.1093/cercor/6.1.1; GALABURDA AM, 1978, ARCH NEUROL-CHICAGO, V35, P812, DOI 10.1001/archneur.1978.00500360036007; Galuske RAW, 1996, CEREB CORTEX, V6, P417, DOI 10.1093/cercor/6.3.417; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1983, J NEUROSCI, V3, P1116; HOWARD D, 1992, BRAIN, V115, P1769, DOI 10.1093/brain/115.6.1769; Hutsler JJ, 1996, CEREB CORTEX, V6, P260, DOI 10.1093/cercor/6.2.260; KISVARDAY ZF, 1992, NEUROSCIENCE, V46, P275, DOI 10.1016/0306-4522(92)90050-C; LOFTUS WC, 1993, CEREB CORTEX, V3, P348; LUND JS, 1993, CEREB CORTEX, V3, P148, DOI 10.1093/cercor/3.2.148; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; RAICHLE ME, 1994, ANNU REV PSYCHOL, V45, P333, DOI 10.1146/annurev.psych.45.1.333; ROCKLAND KS, 1982, SCIENCE, V215, P1532, DOI 10.1126/science.7063863; Schmidt KE, 1997, J NEUROSCI, V17, P5480; SCHWARTZ J, 1980, SCIENCE, V207, P1380, DOI 10.1126/science.7355297; SELDON HL, 1981, BRAIN RES, V229, P277, DOI 10.1016/0006-8993(81)90994-X; SMITH A, 1975, NEUROLOGY, V25, P813, DOI 10.1212/WNL.25.9.813; TSO DY, 1986, J NEUROSCI, V6, P1160; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994	29	189	193	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2000	289	5486					1946	1949		10.1126/science.289.5486.1946	http://dx.doi.org/10.1126/science.289.5486.1946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988077				2022-12-01	WOS:000089355800049
J	Stephansson, O; Dickman, PW; Johansson, A; Cnattingius, S				Stephansson, O; Dickman, PW; Johansson, A; Cnattingius, S			Maternal hemoglobin concentration during pregnancy and risk of stillbirth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT; GESTATIONAL-AGE; PRETERM BIRTH; PLASMA-VOLUME; PRE-ECLAMPSIA; FETAL; DEATH; 2ND-TRIMESTER; HYPERTENSION; ASSOCIATION	Context High and low maternal hemoglobin concentrations during pregnancy have been reported to increase risk of small-for-gestational-age (SGA) birth, which is a predictor of stillbirth. The relationship between hemoglobin concentration during pregnancy and risk of stillbirth is unclear. Objective To study the associations among hemoglobin concentration at first measurement during antenatal care, change in hemoglobin concentration during pregnancy, and risk of stillbirth. Design, Setting, and Participants Population-based, matched case-control study of births from 1987 through 1996 in Sweden including 702 primiparous women with stillbirths occurring at 28 weeks' gestation or later and 702 primiparous women with live births. Main Outcome Measures Risk of stillbirth, classified as malformed or nonmalformed, antepartum or intrapartum, preterm or term, and SGA or non-SGA, compared by maternal hemoglobin concentration at first antenatal measurement and weekly changes in hemoglobin concentration during pregnancy, adjusted for maternal age, body mass index, height, smoking, socioeconomic status, and week of first hemoglobin measurement. Results In multivariate analyses, compared with women with hemoglobin concentrations of 126 to 135 g/L at first antenatal measurement, women with concentrations of 146 g/L or higher were at increased risk of stillbirth (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.0-3.3). This risk was slightly increased when the analysis was restricted to antepartum stillbirths without malformations (OR, 2.0; 95% CI, 1.1-3.8). When we further restricted the analyses to preterm and SCA antepartum nonmalformed stillbirths, the ORs increased to 2.7 (95% Cf, 1.1-6.4) and 4.2 (95% CI, 1.3-13.9), respectively. Excluding women with preeclampsia and eclampsia further increased these risks. Average weekly change in hemoglobin concentration during early or tate pregnancy was not significantly associated with risk of stillbirth, although a larger decrease in concentration tended to be protective. Anemia (hemoglobin concentration <110 g/L) was not significantly associated with risk of stillbirth in multivariate analyses (OR, 1.2; 95% CI, 0.5-2.7). Conclusions High hemoglobin concentration at first measurement during antenatal care appears to be associated with increased risk of stillbirth, especially preterm and SGA antepartum stillbirths.	Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Stephansson, O (corresponding author), Karolinska Inst, Dept Med Epidemiol, POB 281, SE-17177 Stockholm, Sweden.	olof.stephansson@mep.ki.se	Dickman, Paul W/B-4572-2013	Dickman, Paul W/0000-0002-5788-3380; Johansson, Anna/0000-0002-1191-7231; Stephansson, Olof/0000-0003-1528-4563				[Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1691; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; BLEKTA M, 1970, AM J OBSTET GYNECOL, V106, P10, DOI 10.1016/0002-9378(70)90120-1; CDC, 1989, MMWR-MORBID MORTAL W, V38, P400; CHESLEY LC, 1972, AM J OBSTET GYNECOL, V112, P440, DOI 10.1016/0002-9378(72)90493-0; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; GALLERY EDM, 1979, Q J MED, V48, P593; Gardosi J, 1998, BRIT J OBSTET GYNAEC, V105, P524, DOI 10.1111/j.1471-0528.1998.tb10153.x; GARN SM, 1981, SEMIN PERINATOL, V5, P155; HUISMAN A, 1986, ACTA OBSTET GYN SCAN, V65, P605, DOI 10.3109/00016348609158396; KLEBANOFF MA, 1991, AM J OBSTET GYNECOL, V164, P59, DOI 10.1016/0002-9378(91)90626-3; KNOTTNERUS JA, 1990, J CLIN EPIDEMIOL, V43, P461, DOI 10.1016/0895-4356(90)90134-B; LIEBERMAN E, 1988, AM J OBSTET GYNECOL, V159, P107, DOI 10.1016/0002-9378(88)90502-9; MAHOMED K, 1999, IRON SUPPLEMENTATION; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; MURPHY JF, 1986, LANCET, V1, P992; NAEYE RL, 1977, OBSTET GYNECOL, V50, P583; *NAT BOARD HLTH WE, 1997, HLTH CAR PREGN, P7; SAGEN N, 1984, ACTA OBSTET GYN SCAN, V63, P245, DOI 10.3109/00016348409155506; SAGEN N, 1982, BRIT J OBSTET GYNAEC, V89, P802, DOI 10.1111/j.1471-0528.1982.tb05029.x; *SAS I INC, 1997, SAS STAT SOFTW CHANG; SCHOLL TO, 1992, AM J CLIN NUTR, V55, P985, DOI 10.1093/ajcn/55.5.985; STEER P, 1995, BMJ-BRIT MED J, V310, P489, DOI 10.1136/bmj.310.6978.489; Steer PJ, 2000, AM J CLIN NUTR, V71, p1285S, DOI 10.1093/ajcn/71.5.1285s; *SWED SOC CLASS, 1995, REP STAT COORD; Whittaker PG, 1996, OBSTET GYNECOL, V88, P33, DOI 10.1016/0029-7844(96)00095-6; Winbo IGB, 1997, INT J EPIDEMIOL, V26, P1298, DOI 10.1093/ije/26.6.1298; WOOLF SH, 1993, JAMA-J AM MED ASSOC, V270, P2846	29	95	101	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	2000	284	20					2611	2617		10.1001/jama.284.20.2611	http://dx.doi.org/10.1001/jama.284.20.2611			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373NU	11086368	Bronze			2022-12-01	WOS:000165296200035
J	Sebghati, TS; Engle, JT; Goldman, WE				Sebghati, TS; Engle, JT; Goldman, WE			Intracellular parasitism by Histoplasma capsulatum: Fungal virulence and calcium dependence	SCIENCE			English	Article							TELOMERIC SEQUENCES; P388D1 MACROPHAGES; PATHOGENESIS; EXPRESSION; INFECTION; SELECTION; CELLS; GENE; DNA	Histoplasma capsulatum is an effective intracellular parasite of macrophages and causes the most prevalent fungal respiratory disease in the United States. A "dimorphic" fungus, H. capsulatum exists as a saprophytic mold in soil and converts to the parasitic yeast form after inhalation, Only the yeasts secrete a calcium-binding protein (CBP) and can grow in calcium-limiting conditions. To probe the relation between calcium Limitation and intracellular parasitism, we designed a strategy to disrupt CBP1 in H. capsulatum using a telomeric Linear plasmid and a two-step genetic selection, The resulting cbp1 yeasts no Longer grew when deprived of calcium, and they were also unable to destroy macrophages in vitro or proliferate in a mouse model of pulmonary infection.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Goldman, WE (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230, St Louis, MO 63110 USA.			Goldman, William/0000-0002-1551-6718	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025584] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07317] Funding Source: Medline; NIAID NIH HHS [AI25584] Funding Source: Medline; PHS HHS [A107172] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Batanghari JW, 1997, INFECT IMMUN, V65, P5257, DOI 10.1128/IAI.65.12.5257-5261.1997; Batanghari JW, 1998, MOL MICROBIOL, V27, P531, DOI 10.1046/j.1365-2958.1998.00697.x; BAUGHMAN RP, 1986, AM REV RESPIR DIS, V134, P771; CHARUK JHM, 1990, ANAL BIOCHEM, V188, P123, DOI 10.1016/0003-2697(90)90539-L; DEEPE GS, 1990, EUR J CLIN MICROBIOL, V9, P567, DOI 10.1007/BF01967211; EISSENBERG LG, 1991, INFECT IMMUN, V59, P1639, DOI 10.1128/IAI.59.5.1639-1646.1991; EISSENBERG LG, 1993, J EXP MED, V177, P1605, DOI 10.1084/jem.177.6.1605; EISSENBERG LG, 1988, J LEUKOCYTE BIOL, V43, P483, DOI 10.1002/jlb.43.6.483; EISSENBERG LG, 1991, CLIN MICROBIOL REV, V4, P411, DOI 10.1128/CMR.4.4.411-421.1991; GARCIAVESCOVI E, 1997, J BIOL CHEM, V272, P1440; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; GOODWIN RA, 1980, MEDICINE, V59, P1, DOI 10.1097/00005792-198001000-00001; GRAYBILL JR, 1988, J INFECT DIS, V158, P623, DOI 10.1093/infdis/158.3.623; Hogan LH, 1997, GENE, V186, P219, DOI 10.1016/S0378-1119(96)00713-5; LEVITZ SM, 1985, J INFECT DIS, V152, P938, DOI 10.1093/infdis/152.5.938; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Retallack DM, 1999, INFECT IMMUN, V67, P624, DOI 10.1128/IAI.67.2.624-629.1999; Rippon JW., 1988, MED MYCOLOGY PATHOGE, P381; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; Smith J.A., 2000, CURRENT PROTOCOLS MO; VARMA A, 1992, INFECT IMMUN, V60, P1101, DOI 10.1128/IAI.60.3.1101-1108.1992; Woods JP, 1998, J BACTERIOL, V180, P5135, DOI 10.1128/JB.180.19.5135-5143.1998; WOODS JP, 1992, MOL MICROBIOL, V6, P3603, DOI 10.1111/j.1365-2958.1992.tb01796.x; Woods JP, 1998, INFECT IMMUN, V66, P1697, DOI 10.1128/IAI.66.4.1697-1707.1998; WOODS JP, 1993, J BACTERIOL, V175, P636, DOI 10.1128/JB.175.3.636-641.1993; WORSHAM PL, 1988, MOL GEN GENET, V214, P348, DOI 10.1007/BF00337734; WORSHAM PL, 1988, J MED VET MYCOL, V26, P137	27	131	136	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2000	290	5495					1368	1372		10.1126/science.290.5495.1368	http://dx.doi.org/10.1126/science.290.5495.1368			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375BN	11082066				2022-12-01	WOS:000165379800052
J	Kaye, AH; Andrewes, D				Kaye, AH; Andrewes, D			Glasgow Outcome Scale: research scale or blunt instrument?	LANCET			English	Editorial Material							BRAIN INJURY		Univ Melbourne, Royal Melbourne Hosp, Dept Neurosurg & Surg, Parkville, Vic 3050, Australia; Univ Melbourne, Royal Melbourne Hosp, Dept Psychol, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne	Kaye, AH (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Neurosurg & Surg, Parkville, Vic 3050, Australia.			Kaye, Andrew Henry/0000-0001-5049-8861				JENNETT B, 1975, LANCET, V1, P480; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P759; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; SBORDONE RJ, 1987, REHABILITATION COGNI; SIEGAL S, 1956, NONPARAMETRIC STAT B, P201; WALSH KW, 1991, UNDERSTANDING BRAIN, P167; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; 1986, LANCET, V1, P1361	12	15	15	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 4	2000	356	9241					1540	1541		10.1016/S0140-6736(00)03121-4	http://dx.doi.org/10.1016/S0140-6736(00)03121-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370QV	11075764				2022-12-01	WOS:000165134500006
J	Gemperli, MP				Gemperli, MP			Rethinking the role of the learned intermediary: The effect of direct-to-consumer advertising on litigation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Gemperli, MP (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.							HUTTON MB, 1996, TRIAL, V32, P74; Terzian TV, 1999, AM J LAW MED, V25, P149	2	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2241	2241		10.1001/jama.284.17.2241	http://dx.doi.org/10.1001/jama.284.17.2241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056600	hybrid			2022-12-01	WOS:000090052600036
J	Goddard, J; Jarratt, J; de Castro, FR				Goddard, J; Jarratt, J; de Castro, FR			Evolution of the fire ant lesion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDOORS		Mississippi State Dept Hlth, Jackson, MS 39215 USA; Mississippi State Univ, Starkville, MS USA; Dermatopathol Reference Lab, Lexington, KY USA	Mississippi State University	Goddard, J (corresponding author), Mississippi State Dept Hlth, 2423 N State St,POB 1700, Jackson, MS 39215 USA.							BAER H, 1979, TOXICON, V17, P397, DOI 10.1016/0041-0101(79)90267-8; BUREN W F, 1972, Journal of the Georgia Entomological Society, V7, P1; DESHAZO RD, 1994, J ALLERGY CLIN IMMUN, V93, P847, DOI 10.1016/0091-6749(94)90376-X; DESHAZO RD, 1995, SOUTHERN MED J, V88, P712, DOI 10.1097/00007611-199507000-00003; deShazo RD, 1999, ANN INTERN MED, V131, P424, DOI 10.7326/0003-4819-131-6-199909210-00005; FOX RW, 1982, J ALLERGY CLIN IMMUN, V70, P120, DOI 10.1016/0091-6749(82)90239-1; GODDARD J, 2000, PHYSICIANS GUIDE ART; Levy A. L., 1998, Journal of Agromedicine, V5, P49, DOI 10.1300/J096v05n04_05; LOFGREN CS, 1975, ANNU REV ENTOMOL, V20, P1, DOI 10.1146/annurev.en.20.010175.000245; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141	10	10	12	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2162	2163		10.1001/jama.284.17.2162	http://dx.doi.org/10.1001/jama.284.17.2162			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056570				2022-12-01	WOS:000090052600002
J	Petty, TL				Petty, TL			Screening strategies for early detection of lung cancer - The time is now	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SPUTUM; OBSTRUCTION; POPULATION; TOMOGRAPHY; CARCINOMA; CELLS; RISK		Natl Lund Hlth Educ Program, Denver, CO 80218 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Rush University	Petty, TL (corresponding author), Natl Lund Hlth Educ Program, 1850 High St, Denver, CO 80218 USA.	tlpdoc@aol.com						ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; BECHTEL JJ, 1994, ARCH INTERN MED, V154, P975, DOI 10.1001/archinte.154.9.975; BECHTEL JJ, IN PRESS LUNG CANC; BURNS DM, 1998, P INT C PREV EARL DI, P164; EDDY DM, 1989, ANN INTERN MED, V111, P232, DOI 10.7326/0003-4819-111-3-232; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; FONTANA RS, 1984, AM REV RESPIR DIS, V130, P561; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Hillner BE, 1998, J CLIN ONCOL, V16, P1420, DOI 10.1200/JCO.1998.16.4.1420; Kennedy TC, 1996, CANCER RES, V56, P4673; Koike T, 1999, LUNG CANCER-J IASLC, V24, P75, DOI 10.1016/S0169-5002(99)00031-8; KUBIK A, 1990, INT J CANCER, V45, P26, DOI 10.1002/ijc.2910450107; Lam S, 1998, CHEST, V113, P696, DOI 10.1378/chest.113.3.696; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; MOON MA, 2000, INTERNAL MED NEWS, V33, P5; MOON MA, 2000, INTERNAL MED NEWS, V33, P1; Mulshine JL, 1997, ENVIRON HEALTH PERSP, V105, P935, DOI 10.2307/3433307; Petty TL, 2000, CHEST, V117, P1, DOI 10.1378/chest.117.1.1; Petty TL, 1997, JAMA-J AM MED ASSOC, V277, P246, DOI 10.1001/jama.277.3.246; PETTY TL, 1991, J RESP DIS, V12, P403; SACCOMANNO G, 1974, CANCER-AM CANCER SOC, V33, P256, DOI 10.1002/1097-0142(197401)33:1<256::AID-CNCR2820330139>3.0.CO;2-G; SAITO Y, 1992, J THORAC CARDIOV SUR, V104, P401; Salomaa ER, 1998, CHEST, V114, P1514, DOI 10.1378/chest.114.6.1514; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; Sazon DAD, 1996, AM J RESP CRIT CARE, V153, P417, DOI 10.1164/ajrccm.153.1.8542152; SHAW GL, 1998, P INT C PREV EARL DI, P221; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Smith IE, 1999, LANCET, V354, P86, DOI 10.1016/S0140-6736(99)00228-7; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Strauss GM, 1998, CHEST, V114, P1502, DOI 10.1378/chest.114.6.1502; Strauss GM, 1997, CHEST, V111, P754, DOI 10.1378/chest.111.3.754; STRAUSS GM, 1998, LUNG CANC SCREENING, P57; TOCKMAN MS, 1988, J CLIN ONCOL, V6, P1685, DOI 10.1200/JCO.1988.6.11.1685; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; TOCKMAN MS, 1986, CHEST, V89, pS324, DOI 10.1378/chest.89.4_Supplement.324S-a; *US DEP HHS, 1990, PUBL CDC	37	33	33	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1977	1980		10.1001/jama.284.15.1977	http://dx.doi.org/10.1001/jama.284.15.1977			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035898				2022-12-01	WOS:000089774000034
J	Boyd, PW; Watson, AJ; Law, CS; Abraham, ER; Trull, T; Murdoch, R; Bakker, DCE; Bowie, AR; Buesseler, KO; Chang, H; Charette, M; Croot, P; Downing, K; Frew, R; Gall, M; Hadfield, M; Hall, J; Harvey, M; Jameson, G; LaRoche, J; Liddicoat, M; Ling, R; Maldonado, MT; McKay, RM; Nodder, S; Pickmere, S; Pridmore, R; Rintoul, S; Safi, K; Sutton, P; Strzepek, R; Tanneberger, K; Turner, S; Waite, A; Zeldis, J				Boyd, PW; Watson, AJ; Law, CS; Abraham, ER; Trull, T; Murdoch, R; Bakker, DCE; Bowie, AR; Buesseler, KO; Chang, H; Charette, M; Croot, P; Downing, K; Frew, R; Gall, M; Hadfield, M; Hall, J; Harvey, M; Jameson, G; LaRoche, J; Liddicoat, M; Ling, R; Maldonado, MT; McKay, RM; Nodder, S; Pickmere, S; Pridmore, R; Rintoul, S; Safi, K; Sutton, P; Strzepek, R; Tanneberger, K; Turner, S; Waite, A; Zeldis, J			A mesoscale phytoplankton bloom in the polar Southern Ocean stimulated by iron fertilization	NATURE			English	Article							EQUATORIAL PACIFIC-OCEAN; SUB-ARCTIC PACIFIC; ANTARCTIC CIRCUMPOLAR CURRENT; MARINE-PHYTOPLANKTON; SULFUR-HEXAFLUORIDE; ATMOSPHERIC CO2; NEW-ZEALAND; CARBON; LIGHT; LIMITATION	Changes in iron supply to oceanic plankton are thought to have a significant effect on concentrations of atmospheric carbon dioxide by altering rates of carbon sequestration, a theory known as the `iron hypothesis'. For this reason, it is important to understand the response of pelagic biota to increased iron supply. Here we report the results of a mesoscale iron fertilization experiment in the polar Southern Ocean, where the potential to sequester iron-elevated algal carbon is probably greatest. Increased iron supply led to elevated phytoplankton biomass and rates of photosynthesis in surface waters, causing a large drawdown of carbon dioxide and macronutrients, and elevated dimethyl sulphide levels after 13 days. This drawdown was mostly due to the proliferation of diatom stocks. But downward export of biogenic carbon was not increased. Moreover, satellite observations of this massive bloom 30 days later, suggest that a sufficient proportion of the added iron was retained in surface waters. Our findings demonstrate that iron supply controls phytoplankton growth and community composition during summer in these polar Southern Ocean waters, but the fate of algal carbon remains unknown and depends on the interplay between the processes controlling export, remineralisation and timescales of water mass subduction.	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; Natl Inst Water & Atmosphere, Wellington, New Zealand; Univ Tasmania, Antarctic Cooperat Res Ctr, Hobart, Tas 7001, Australia; Univ Plymouth, Dept Environm Sci, Drake Circus, Plymouth PL4 8AA, Devon, England; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem MS25, Woods Hole, MA 02543 USA; Netherlands Inst Sea Res, Dept Marine Chem & Geol, NL-1790 AB Den Burg, Netherlands; Univ Otago, Dept Chem, Dunedin, New Zealand; Natl Inst Water & Atmosphere, Christchurch, New Zealand; Natl Inst Water & Atmosphere, Hamilton, New Zealand; Univ Kiel, Inst Meereskunde, D-24105 Kiel, Germany; McGill Univ, Dept Biol, Montreal, PQ H2T 2V8, Canada; Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; CSIRO, Div Marine Res, Hobart, Tas 7001, Australia; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Oceanog, Vancouver, BC V6T 1Z4, Canada; Univ Western Australia, Dept Environm Engn, Ctr Water Res, Nedlands, WA 6907, Australia	University of East Anglia; Plymouth Marine Laboratory; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Tasmania; University of Plymouth; Woods Hole Oceanographic Institution; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Otago; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Kiel; McGill University; University System of Ohio; Bowling Green State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of British Columbia; University of British Columbia; University of Western Australia	Boyd, PW (corresponding author), Univ Otago, Dept Chem, Natl Inst Water & Atmosphere, Ctr Chem & Phys Oceanog, POB 56, Dunedin, New Zealand.		Croot, Peter L/C-8460-2009; Croot, Peter/U-5296-2019; Bakker, Dorothee C E/E-4951-2015; Frew, Russell/HDN-6138-2022; Abraham, Edward R/D-7422-2011; McKay, Robert Michael/P-3759-2017; Boyd, Philip W/J-7624-2014; Charette, Matthew/I-9495-2012; LaRoche, Julie/A-1109-2010; Rintoul, Stephen R/A-1471-2012; Frew, Russell/I-5591-2012; Harvey, Mike/A-5354-2010; Bowie, Andrew/C-8677-2013; Waite, Anya M/A-5492-2015; Trull, Tom W/B-7028-2014; Strzepek, Robert/GQH-8703-2022; Strzepek, Robert Francis/A-1216-2011; Maldonado, Maria T/N-2877-2017	Croot, Peter L/0000-0003-1396-0601; Bakker, Dorothee C E/0000-0001-9234-5337; Abraham, Edward R/0000-0003-4490-6704; McKay, Robert Michael/0000-0003-2723-5371; Boyd, Philip W/0000-0001-7850-1911; Rintoul, Stephen R/0000-0002-7055-9876; Frew, Russell/0000-0002-6138-2116; Harvey, Mike/0000-0002-0979-0227; Bowie, Andrew/0000-0002-5144-7799; Waite, Anya M/0000-0003-2965-0296; Strzepek, Robert Francis/0000-0002-6442-7121; Maldonado, Maria T/0000-0001-8134-9375; LaRoche, Julie/0000-0003-4809-6411; Watson, Andrew/0000-0002-9654-8147; Law, Cliff/0000-0002-7669-2475; Sutton, Phil/0000-0003-2936-0918; Safi, Karl/0000-0002-7785-1909				Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; BANSE K, 1991, J GEOPHYS RES-OCEANS, V96, P741, DOI 10.1029/90JC02371; Behrenfeld MJ, 1998, PHOTOSYNTH RES, V58, P259, DOI 10.1023/A:1006138630573; Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; BISHOP JKB, 1991, J GEOPHYS RES-OCEANS, V96, P16839, DOI 10.1029/91JC01754; Boyd P, 1999, J GEOPHYS RES-OCEANS, V104, P13395, DOI 10.1029/1999JC900009; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; Bradford-Grieve JM, 1999, J PLANKTON RES, V21, P405, DOI 10.1093/plankt/21.3.405; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; BUESSELER KO, 1991, NATURE, V353, P420, DOI 10.1038/353420a0; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Cooper DJ, 1996, NATURE, V383, P511, DOI 10.1038/383511a0; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; DEBAAR HJW, 1999, DYNAMIC OCEAN CARBON, P61; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FITZWATER SE, 1982, LIMNOL OCEANOGR, V27, P544, DOI 10.4319/lo.1982.27.3.0544; Geider RJ, 1999, NATURE, V400, P815, DOI 10.1038/23582; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; LaRoche J, 1996, NATURE, V382, P802; LAUBSCHER RK, 1993, POLAR BIOL, V13, P471; LAW CS, 1994, MAR CHEM, V48, P57, DOI 10.1016/0304-4203(94)90062-0; Law CS, 1998, DEEP-SEA RES PT II, V45, P977, DOI 10.1016/S0967-0645(98)00022-8; Maldonado MT, 1999, DEEP-SEA RES PT II, V46, P2447, DOI 10.1016/S0967-0645(99)00071-5; Maldonado MT, 1999, DEEP-SEA RES PT II, V46, P2475, DOI 10.1016/S0967-0645(99)00072-7; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; McKay RML, 1997, PLANT PHYSIOL, V114, P615, DOI 10.1104/pp.114.2.615; MILLERO FJ, 1987, GEOCHIM COSMOCHIM AC, V51, P793, DOI 10.1016/0016-7037(87)90093-7; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662, DOI 10.4319/lo.1991.36.8.1662; MONTAGNES DJS, 1994, LIMNOL OCEANOGR, V39, P1044, DOI 10.4319/lo.1994.39.5.1044; Moore JK, 1999, GEOPHYS RES LETT, V26, P1465, DOI 10.1029/1999GL900242; Morel F., 1991, OCEANOGRAPHY, V4, P56, DOI [10.5670/oceanog.1991.03, DOI 10.5670/0CEAN0G.1991.03]; Muggli DL, 1996, MAR ECOL PROG SER, V132, P215, DOI 10.3354/meps132215; Neale PJ, 1998, NATURE, V392, P585, DOI 10.1038/33374; NELSON DM, 1991, LIMNOL OCEANOGR, V36, P1650, DOI 10.4319/lo.1991.36.8.1650; NOWLIN WD, 1986, REV GEOPHYS, V24, P469, DOI 10.1029/RG024i003p00469; Obata A, 1996, J GEOPHYS RES-OCEANS, V101, P20657, DOI 10.1029/96JC01734; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; PENG TH, 1991, LIMNOL OCEANOGR, V36, P1919, DOI 10.4319/lo.1991.36.8.1919; Popp BN, 1997, PALAEOGEOGR PALAEOCL, V132, P119, DOI 10.1016/S0031-0182(97)00061-8; Rintoul SR, 1997, DEEP-SEA RES PT I, V44, P1185, DOI 10.1016/S0967-0637(96)00125-2; Rintoul SR, 1999, DEEP-SEA RES PT I, V46, P1417, DOI 10.1016/S0967-0637(99)00013-8; SARMIENTO JL, 1991, LIMNOL OCEANOGR, V36, P1928, DOI 10.4319/lo.1991.36.8.1928; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; TRENBERTH KE, 1990, J PHYS OCEANOGR, V20, P1742, DOI 10.1175/1520-0485(1990)020<1742:TMACIG>2.0.CO;2; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; WATSON A, 1991, LIMNOL OCEANOGR, V36, P1960, DOI 10.4319/lo.1991.36.8.1960; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168; ZENTARA SJ, 1981, DEEP-SEA RES, V28, P455, DOI 10.1016/0198-0149(81)90137-0	54	1176	1239	8	675	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					695	702		10.1038/35037500	http://dx.doi.org/10.1038/35037500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048709				2022-12-01	WOS:000089773900031
J	Cooper, VS; Lenski, RE				Cooper, VS; Lenski, RE			The population genetics of ecological specialization in evolving Escherichia coli populations	NATURE			English	Article							GENOMIC MUTATION-RATE; DELETERIOUS MUTATIONS; EVOLUTIONARY-THEORIES; ADAPTATION; FITNESS; SENESCENCE	When organisms adapt genetically to one environment, they may lose fitness in other environments(1-4). Two distinct population genetic processes can produce ecological specialization-mutation accumulation and antagonistic pleiotropy(5-8). In mutation accumulation, mutations become fixed by genetic drift in genes that are not maintained by selection; adaptation to one environment and loss of adaptation to another are caused by different mutations. Antagonistic pleiotropy arises from trade-offs, such that the same mutations that are beneficial in one environment are detrimental in another. In general, it is difficult to distinguish between these processes(5-8). We analysed the decay of unused catabolic functions in 12 lines of Escherichia coli propagated on glucose for 20,000 generations(9,10). During that time, several lines evolved high mutation rates(11). If mutation accumulation is important, their unused functions should decay more than the other lines, but no significant difference was observed. Moreover, most catabolic losses occurred early in the experiment when beneficial mutations were being rapidly fixed, a pattern predicted by antagonistic pleiotropy. Thus, antagonistic pleiotropy appears more important than mutation accumulation for the decay of unused catabolic functions in these populations.	Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Michigan State University	Cooper, VS (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	cooperva@msu.edu		Lenski, Richard/0000-0002-1064-8375; Cooper, Vaughn/0000-0001-7726-0765				BENNETT AF, 1993, EVOLUTION, V47, P1, DOI 10.1111/j.1558-5646.1993.tb01194.x; *BIOL, 1993, BIOL ES MICR INSTR U; COOPER VS, 2000, THESIS MICHIGAN STAT; COOPER VS, UNPUB J BACTERIOL; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; FRY JD, 1990, AM NAT, V136, P569, DOI 10.1086/285116; Funchain P, 2000, GENETICS, V154, P959; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Guckert JB, 1996, J MICROBIOL METH, V27, P183, DOI 10.1016/S0167-7012(96)00948-7; Holt RD, 1996, EVOL ECOL, V10, P1, DOI 10.1007/BF01239342; HOULE D, 1992, NATURE, V359, P58, DOI 10.1038/359058a0; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; Kimura M., 1983, NEUTRAL THEORY MOL E; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Miller R, 1981, SIMULTANEOUS STAT IN, DOI [10.1007/978-1-4613-8122-8_1, DOI 10.1007/978-1-4613-8122-8]; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; Rose MR, 1991, EVOLUTIONARY BIOL AG; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; SZATHMARY E, 1993, GENETICS, V133, P127	24	364	371	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					736	739		10.1038/35037572	http://dx.doi.org/10.1038/35037572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048718				2022-12-01	WOS:000089773900040
J	Tong, Q; Dalgin, G; Xu, HY; Ting, CN; Leiden, JM; Hotamisligil, GS				Tong, Q; Dalgin, G; Xu, HY; Ting, CN; Leiden, JM; Hotamisligil, GS			Function of GATA transcription factors in preadipocyte-adipocyte transition	SCIENCE			English	Article							FINGER PROTEIN; PPAR-GAMMA; ADIPOGENESIS; DIFFERENTIATION; EXPRESSION; CELLS; HEMATOPOIESIS; DROSOPHILA; ISOFORMS; OBESITY	Genes that control the early stages of adipogenesis remain largely unknown. Here, we show that murine GATA-2 and GATA-3 are specifically expressed in white adipocyte precursors and that their down-regulation sets the stage for terminal differentiation. Constitutive GATA-2 and GATA-3 expression suppressed adipocyte differentiation and trapped cells at the preadipocyte stage. This effect is mediated, at least in part, through the direct suppression of peroxisome proliferator-activated receptor gamma. GATA-3-deficient embryonic stem cells exhibit an enhanced capacity to differentiate into adipocytes, and defective GATA-2 and GATA-3 expression is associated with obesity. Thus, GATA-2 and GATA-3 regulate adipocyte differentiation through molecular control of the preadipocyte-adipocyte transition.	Harvard Univ, Sch Publ Hlth, Div Biol Sci, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Div Biol Sci, 665 Huntington Ave, Boston, MA 02115 USA.			Dalgin, Gokhan/0000-0002-9696-989X	NIAID NIH HHS [R37AI29673] Funding Source: Medline; NIDDK NIH HHS [F32DK09940, DK56894] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009940, R01DK056894] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABEL T, 1993, DEVELOPMENT, V119, P623; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Dani C, 1997, J CELL SCI, V110, P1279; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; TONG QY, UNPUB; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; YANG HY, 1992, MOL CELL BIOL, V12, P4562, DOI 10.1128/MCB.12.10.4562; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	22	373	392	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					134	138		10.1126/science.290.5489.134	http://dx.doi.org/10.1126/science.290.5489.134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021798				2022-12-01	WOS:000089724800051
J	Li, M; Indra, AK; Warot, X; Brocard, J; Messaddeq, N; Kato, S; Metzger, D; Chambon, P				Li, M; Indra, AK; Warot, X; Brocard, J; Messaddeq, N; Kato, S; Metzger, D; Chambon, P			Skin abnormalities generated by temporally controlled RXR alpha mutations in mouse epidermis	NATURE			English	Article							VITAMIN-D-RECEPTOR; TRANSGENIC MICE; ACID RECEPTOR; MUTANT MICE; PPAR-ALPHA; EXPRESSION; GENE; DIFFERENTIATION; MORPHOGENESIS; MUTAGENESIS	Nuclear receptors for retinoids (RARs) and vitamin D (VDR), and for some other ligands (TRs, PPARs and LXRs), may be critical in the development and homeostasis of mammalian epidermis(1-8). It is believed that these receptors form heterodimers with retinoid X receptors (RXRs) to act as transcriptional regulators(9,10). However, most genetic approaches aimed at establishing their physiological functions in the skin have been inconclusive owing either to pleiotropic effects and redundancies between receptor isotypes in gene knockouts, or to equivocal interpretation of dominant-negative mutant studies in transgenic mice(1,13-15). Moreover, knockout of RXR alpha, the main skin RXR isotype, is lethal in utero before skin formation(11,12,16,17). Here we have resolved these problems by developing an efficient technique to create spatiotemporally controlled somatic mutations in the mouse. We used tamoxifen-inducible Cre-ER(T) recombinases(18,19) to ablate RXR alpha selectively in adult mouse keratinocytes. We show that RXR alpha has key roles in hair cycling, probably through RXR/VDR heterodimers, and in epidermal keratinocyte proliferation and differentiation.	Coll France, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan; Japan Sci & Technol, CREST, Kawaguchi, Saitama 332, Japan	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Tokyo; Japan Science & Technology Agency (JST)	Chambon, P (corresponding author), Coll France, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, France.	chambon@igbmc.u-strasbg.fr	Indra, Arup/AAG-2376-2019; Brocard, Jacques/I-3135-2017	Indra, Arup/0000-0001-6137-7555; Brocard, Jacques/0000-0002-0752-5737; Metzger, Daniel/0000-0002-5555-046X; Li, Mei/0000-0003-4225-6699				Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Feng X, 1997, GENE DEV, V11, P59, DOI 10.1101/gad.11.1.59; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Hanley K, 2000, J INVEST DERMATOL, V114, P545, DOI 10.1046/j.1523-1747.2000.00895.x; Hanley K, 2000, J BIOL CHEM, V275, P11484, DOI 10.1074/jbc.275.15.11484; Hanley K, 1997, J CLIN INVEST, V100, P705, DOI 10.1172/JCI119583; IMAKADO S, 1995, GENE DEV, V9, P317, DOI 10.1101/gad.9.3.317; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Komuves LG, 1998, J INVEST DERMATOL, V111, P429, DOI 10.1046/j.1523-1747.1998.00296.x; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mascrez B, 1998, DEVELOPMENT, V125, P4691; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; METZGER D, IN PRESS METHODS; Panteleyev AA, 1998, EXP DERMATOL, V7, P249, DOI 10.1111/j.1600-0625.1998.tb00295.x-i1; Porter RM, 1998, J INVEST DERMATOL, V110, P951, DOI 10.1046/j.1523-1747.1998.00218.x; REICHRATH J, 1994, BRIT J DERMATOL, V131, P477; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Sundberg JP, 1996, DERMATOL CLIN, V14, P619, DOI 10.1016/S0733-8635(05)70389-2; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Wendling O, 1999, P NATL ACAD SCI USA, V96, P547, DOI 10.1073/pnas.96.2.547; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	30	248	261	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					633	636		10.1038/35036595	http://dx.doi.org/10.1038/35036595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034212				2022-12-01	WOS:000089772800048
J	Maurer, MS; Karmally, W; Rivadeneira, H; Parides, MK; Bloomfield, DM				Maurer, MS; Karmally, W; Rivadeneira, H; Parides, MK; Bloomfield, DM			Upright posture and postprandial hypotension in elderly persons	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE REDUCTION; MEAL INGESTION; RESPONSES	Background: Syncope and falls are common in elderly persons and often result from the interaction of multiple clinical abnormalities. Both orthostatic hypotension and postprandial hypotension Increase in prevalence with age. Objective: To determine whether meal ingestion enhances orthostatic hypotension in elderly persons. Design: Controlled paired comparison. Setting: Clinical research center. Patients: 50 functionally independent elderly persons recruited from local senior centers (n = 47) and from patients hospitalized with an unexplained fall or syncope (n = 3) (mean age, 78 years [range, 61 to 96 years]). Twenty-five participants (50%) were taking antihypertensive medication. Measurements: sequential head-up tilt-table testing at 60 degrees was performed before and 30 minutes after ingestion of a standardized warm liquid meal that was high in carbohydrates. Heart rate and blood pressure were continuously monitored. Results: Meal ingestion (P < 0.01) and time spent upright (P < 0.001) were significantly associated with systolic blood pressure, but no significant interaction was found between meal ingestion and time spent upright (P > 0.2). These findings suggest that the association between meal ingestion and head-up tilt-table testing were additive and not synergistic. However, the proportion of participants with symptomatic hypotension increased during head-up tilt-table testing after meal ingestion (12% during preprandial testing and 22% during postprandial testing). Symptomatic hypotension tended to occur more often and sooner after meal ingestion than before meal ingestion (P = 0.03). Conclusions: Meal ingestion and head-up tilt-table testing are associated with increasing occurrences of symptomatic hypotension. After meal ingestion and head-up tilt-table testing, 22% of functionally independent elderly persons had symptomatic hypotension.	Columbia Univ, Coll Phys & Surg, Div Circulatory Physiol, New York, NY 10032 USA	Columbia University	Maurer, MS (corresponding author), Columbia Univ, Coll Phys & Surg, Div Circulatory Physiol, 177 Ft Washington Ave,MHB5-435, New York, NY 10032 USA.	msm10@columbia.edu	Parides, Michael/GON-8474-2022		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003466] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR-00645] Funding Source: Medline; NHLBI NIH HHS [HL-03466] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELLOMO G, 1988, GERONTOLOGY, V34, P311, DOI 10.1159/000212972; Fleiss JL., 1986, DESIGN ANAL CLIN EXP; Forman Daniel E., 1997, Cardiology Clinics, V15, P295; Imai C, 1998, AM J CARDIOL, V81, P1310, DOI 10.1016/S0002-9149(98)00163-5; JANSEN RW, 1986, J AM GERIATR SOC, V44, P383; JANSEN RWMM, 1995, ANN INTERN MED, V122, P286, DOI 10.7326/0003-4819-122-4-199502150-00009; JONSSON PV, 1990, ARCH INTERN MED, V150, P1518, DOI 10.1001/archinte.150.7.1518; KUIPERS HMM, 1991, J AM GERIATR SOC, V39, P181, DOI 10.1111/j.1532-5415.1991.tb01623.x; LIPSITZ LA, 1993, CIRCULATION, V87, P391, DOI 10.1161/01.CIR.87.2.391; LIPSITZ LA, 1983, NEW ENGL J MED, V309, P81, DOI 10.1056/NEJM198307143090205; LIPSITZ LA, 1986, J CHRON DIS, V39, P619, DOI 10.1016/0021-9681(86)90187-6; Ooi WL, 1997, JAMA-J AM MED ASSOC, V277, P1299, DOI 10.1001/jama.277.16.1299; VAITKEVICIUS PV, 1991, ANN INTERN MED, V115, P865, DOI 10.7326/0003-4819-115-11-865	13	36	40	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					533	536		10.7326/0003-4819-133-7-200010030-00012	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015166				2022-12-01	WOS:000089678300005
J	Hobmayer, B; Rentzsch, F; Kuhn, K; Happel, CM; von Laue, CC; Snyder, P; Rothbacher, U; Holstein, TW				Hobmayer, B; Rentzsch, F; Kuhn, K; Happel, CM; von Laue, CC; Snyder, P; Rothbacher, U; Holstein, TW			WNT signalling molecules act in axis formation in the diploblastic metazoan Hydra	NATURE			English	Article							PATTERN-FORMATION; XENOPUS EMBRYOS; BETA-CATENIN; DROSOPHILA; REGENERATION; EVOLUTION; WINGLESS; HOMOLOG	Members of the Wnt/wingless family of secreted proteins act as short-range inducers and long-range organizers during axis formation, organogenesis and tumorigenesis in many developing tissues(1). Wnt signalling pathways are conserved in nematodes, insects and vertebrates(2). Despite its developmental significance, the evolutionary origin of Wnt signalling is unclear. Here we describe the molecular characterization of members of the Wnt signalling pathwayDWnt, Dishevelled, GSK3, beta-Catenin and Tcf/Lef-in Hydra, a member of the evolutionarily old metazoan phylum Cnidaria. Wnt and Tcf are expressed in the putative Hydra head organizer, the upper part of the hypostome. Wnt, beta-Catenin and Tcf are transcriptionally upregulated when head organizers are established early in bud formation and head regeneration. Wnt and Tcf expression domains also define head organizers created by de novo pattern formation in aggregates. Our results indicate that Wnt signalling may be involved in axis formation in Hydra and support the idea that it was central in the evolution of axial differentiation in early multicellular animals.	Tech Univ Darmstadt, Inst Zool, Dept Mol Cell Biol, D-64287 Darmstadt, Germany; IBDM, Lab Genet & Physiol Dev, F-13288 Marseille 9, France	Technical University of Darmstadt; UDICE-French Research Universities; Aix-Marseille Universite	Hobmayer, B (corresponding author), Tech Univ Darmstadt, Inst Zool, Dept Mol Cell Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	hobmayer@bio.tu-darmstadt.de; holstein@bio.tu-darmstadt.de	Rothbächer, Ute/AAB-6901-2022; Rothbächer, Ute/G-2688-2013	Rothbächer, Ute/0000-0002-9989-6139; Rothbächer, Ute/0000-0002-9989-6139; Holstein, Thomas/0000-0003-0480-4674				ACHERMANN J, 1985, DEV BIOL, V107, P13, DOI 10.1016/0012-1606(85)90371-9; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Bode HR, 1984, PATTERN FORMATION PR, V1, P213; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cox RT, 1998, CURR BIOL, V8, pR140, DOI 10.1016/S0960-9822(98)70081-8; Finnerty JR, 1998, CURR OPIN GENET DEV, V8, P681, DOI 10.1016/S0959-437X(98)80037-3; Frohman Michael A., 1995, P381; Gauchat D, 2000, P NATL ACAD SCI USA, V97, P4493, DOI 10.1073/pnas.97.9.4493; GIERER A, 1972, NATURE-NEW BIOL, V239, P98, DOI 10.1038/newbio239098a0; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Hobmayer E, 1996, GENE, V172, P155, DOI 10.1016/0378-1119(96)00162-X; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Kopp A, 1999, DEVELOPMENT, V126, P3495; Kuhn K, 1999, J EXP ZOOL, V285, P63, DOI 10.1002/(SICI)1097-010X(19990415)285:1<63::AID-JEZ8>3.0.CO;2-X; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Lessing D, 1998, DEVELOPMENT, V125, P1469; MACWILLIAMS HK, 1983, DEV BIOL, V96, P239, DOI 10.1016/0012-1606(83)90325-1; MEINHARDT H, 1993, DEV BIOL, V157, P321, DOI 10.1006/dbio.1993.1138; Minobe S, 2000, DEV GENES EVOL, V210, P258, DOI 10.1007/s004270050312; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morris SC, 1998, CURR OPIN GENET DEV, V8, P662, DOI 10.1016/S0959-437X(98)80034-8; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; OTTO JJ, 1977, J EXP ZOOL, V200, P417, DOI 10.1002/jez.1402000311; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; Technau U, 1999, DEVELOPMENT, V126, P999; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Willmer P, 1990, INVERTEBRATE RELATIO; Wolpert L., 1998, PRINCIPLES DEV	30	404	422	1	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					186	189		10.1038/35025063	http://dx.doi.org/10.1038/35025063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001056				2022-12-01	WOS:000089241000048
J	Tolley, D				Tolley, D			Ureteric stents, far from ideal	LANCET			English	Editorial Material							EXPERIENCE; OBSTRUCTION		Western Gen Hosp, Dept Urol, Scottish Lithotriptor Ctr, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Tolley, D (corresponding author), Western Gen Hosp, Dept Urol, Scottish Lithotriptor Ctr, Edinburgh EH4 2XU, Midlothian, Scotland.							*ASTM SUBC, 1995, F047001 ASTM SUBC; Basu S, 2000, BJU INT S, V85, P22; DOCIMO SG, 1989, J UROLOGY, V142, P277, DOI 10.1016/S0022-5347(17)38729-3; FINNEY RP, 1978, J UROLOGY, V120, P678, DOI 10.1016/S0022-5347(17)57326-7; GIBBONS RP, 1974, J UROLOGY, V111, P594, DOI 10.1016/S0022-5347(17)60023-5; LIBBY JM, 1988, J UROLOGY, V139, P15, DOI 10.1016/S0022-5347(17)42274-9; MARDIS HK, 1988, UROL CLIN N AM, V15, P471; MCFARLANE JP, 2000, BJU INT S5, V85, P21; PAUER W, 1992, J UROLOGY, V148, P281, DOI 10.1016/S0022-5347(17)36573-4; RAMSAY JWA, 1985, BRIT J UROL, V57, P630, DOI 10.1111/j.1464-410X.1985.tb07021.x; REINBERG Y, 1994, J UROLOGY, V151, P1619, DOI 10.1016/S0022-5347(17)35319-3; Richter S, 2000, BJU INT, V85, P408, DOI 10.1046/j.1464-410x.2000.00478.x; RYAN PC, 1994, BRIT J UROL, V74, P434, DOI 10.1111/j.1464-410X.1994.tb00418.x; SALTZMAN B, 1988, UROL CLIN N AM, V15, P481; Slepian MJ, 1997, ADV DRUG DELIVER REV, V24, P11, DOI 10.1016/S0169-409X(96)00479-6; TULLOCH W S, 1952, Br J Urol, V24, P42; VALIMAA T, 1998, STENTING URINARY SYS, pCH6	17	36	37	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					872	873		10.1016/S0140-6736(00)02674-X	http://dx.doi.org/10.1016/S0140-6736(00)02674-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036889				2022-12-01	WOS:000089259800006
J	Merz, AJ; So, M; Sheetz, MP				Merz, AJ; So, M; Sheetz, MP			Pilus retraction powers bacterial twitching motility	NATURE			English	Article							NEISSERIA-GONORRHOEAE; EPITHELIAL-CELLS; IV PILI; ESCHERICHIA-COLI; PROTEIN; GENE; TRANSFORMATION; RESOLUTION; BIOGENESIS; VIRULENCE	Twitching and social gliding motility allow many Gram negative bacteria to crawl along surfaces, and are implicated in a wide range of biological functions(1). Type IV pili (Tfp) are required for twitching and social gliding, but the mechanism by which these filaments promote motility has remained enigmatic(1-4). Here we use laser tweezers(5) to show that Tfp forcefully retract. Neisseria gonorrhoeae cells that produce Tfp actively crawl on a glass surface and form adherent microcolonies. When laser tweezers are used to place and hold cells near a microcolony, retractile forces pull the cells toward the microcolony. In quantitative experiments, the Tfp of immobilized bacteria bind to latex beads and retract, pulling beads from the tweezers at forces that can exceed 80 pN. Episodes of retraction terminate with release or breakage of the Tfp tether. Both motility and retraction mediated by Tfp occur at about 1 mu m s(-1) and require protein synthesis and function of the PilT protein. Our experiments establish that Tfp filaments retract, generate substantial force and directly mediate cell movement.	Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27705 USA	Oregon Health & Science University; Duke University	Sheetz, MP (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.		So, Magdalene/ABB-8918-2020	So, Magdalene/0000-0001-8301-0674				Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; BRADLEY DE, 1972, BIOCHEM BIOPH RES CO, V47, P142, DOI 10.1016/S0006-291X(72)80021-4; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; BROSSAY L, 1994, INFECT IMMUN, V62, P2302, DOI 10.1128/IAI.62.6.2302-2308.1994; Comolli JC, 1999, INFECT IMMUN, V67, P3625, DOI 10.1128/IAI.67.7.3625-3630.1999; Coppin CM, 1996, P NATL ACAD SCI USA, V93, P1913, DOI 10.1073/pnas.93.5.1913; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; DUPUY B, 1991, J BACTERIOL, V173, P7589, DOI 10.1128/jb.173.23.7589-7598.1991; EVANS E, 1991, BIOPHYS J, V59, P838, DOI 10.1016/S0006-3495(91)82296-2; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Forest KT, 1997, GENE, V192, P165, DOI 10.1016/S0378-1119(97)00008-5; GINOCCHIO CC, 1994, CELL, V76, P717, DOI 10.1016/0092-8674(94)90510-X; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Krause S, 2000, P NATL ACAD SCI USA, V97, P3067, DOI 10.1073/pnas.050578697; Mahadevan L, 2000, SCIENCE, V288, P95, DOI 10.1126/science.288.5463.95; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; NOVOTNY CP, 1974, J BACTERIOL, V117, P1306, DOI 10.1128/JB.117.3.1306-1311.1974; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pujol C, 1999, P NATL ACAD SCI USA, V96, P4017, DOI 10.1073/pnas.96.7.4017; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; Shao JY, 1998, P NATL ACAD SCI USA, V95, P6797, DOI 10.1073/pnas.95.12.6797; SHEETZ MP, 1997, LASER TWEEZERS CELL; SWANSON J, 1978, INFECT IMMUN, V19, P320, DOI 10.1128/IAI.19.1.320-331.1978; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; WHITCHURCH CB, 1991, GENE, V101, P33, DOI 10.1016/0378-1119(91)90221-V; Wolfgang M, 1998, P NATL ACAD SCI USA, V95, P14973, DOI 10.1073/pnas.95.25.14973; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x; Yoshida T, 1999, J BACTERIOL, V181, P2038, DOI 10.1128/JB.181.7.2038-2043.1999	30	592	603	1	72	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					98	102		10.1038/35024105	http://dx.doi.org/10.1038/35024105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993081				2022-12-01	WOS:000089124000050
J	Scotet, V; de Braekeleer, M; Roussey, M; Rault, G; Parent, P; Dagorne, M; Journel, H; Lemoigne, A; Codet, JP; Catheline, M; David, V; Chaventre, A; Dugueperoux, I; Verlingue, C; Quere, I; Mercier, B; Audrezet, MP; Ferec, C				Scotet, V; de Braekeleer, M; Roussey, M; Rault, G; Parent, P; Dagorne, M; Journel, H; Lemoigne, A; Codet, JP; Catheline, M; David, V; Chaventre, A; Dugueperoux, I; Verlingue, C; Quere, I; Mercier, B; Audrezet, MP; Ferec, C			Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis	LANCET			English	Article							IMMUNOREACTIVE TRYPSINOGEN; GENE; IDENTIFICATION; POPULATION; MUTATIONS; NEWBORNS; BABIES; BLOOD; DNA	Background Neonatal screening for cystic fibrosis has been a subject of debate over the past few years. This study assesses 10 years of neonatal screening in Brittany, France, and examines its impact on prenatal screening of subsequent pregnancies in couples with an affected child. Methods The study included all the neonates screened for cystic fibrosis in Brittany from Jan 1, 1989, to Dec 31, 1998. The screening consisted of an immunoreactive trypsinogen assay from dried blood spots, plus, from 1993, mutation analysis. Data were collected on incidence of cystic fibrosis, and genotypic and biochemical characteristics. The use of prenatal screening of subsequent pregnancies in affected families was also investigated. Findings Of the 343 756 neonates screened, 118 children with cystic fibrosis were identified, giving an incidence of one in 2913. All mutated alleles were characterised: 34 different mutations resulting in 36 genotypes were detected, The introduction of DNA analysis into the protocol greatly reduced the recall rate and increased the sensitivity of the test. The mean cost of the screening programme was US$2.32 per screened child. 39 (34%) of the families identified by neonatal screening opted for subsequent prenatal diagnosis at least once. 12 couples would have benefited from this procedure while their first child was still symptom-free. 42 healthy children were born, and 18 pregnancies were terminated (therapeutic abortion rate of 100%). Interpretation We have shown the feasibility of neonatal screening for cystic fibrosis in Brittany. Through the detection of a large range of mutations, neonatal screening provides the opportunity for more reliable prenatal diagnosis and cascade screening. The neonatal screening programme described here could provide a good model for other countries intending to initiate such a scheme.	EFS Bretagne, UBO, CHU Morvan, Lab Genet Mol & Histocompatibil, F-29275 Brest, France; Lab Anthropol & Demog Genet, Bordeaux, France; INED, Paris, France; CHRU Pontchaillou, Serv Pediat & Genet Med, Rennes, France; Ctr Hello Marin, Roscoff, France; CHU Morvan, Dept Pediat & Genet Med, Brest, France; CH Beauchee, Serv Pediat & Neonatal, St Brieuc, France; CH Chubert, Serv Pediat, Vannes, France; CH Bodelio, Serv Pediat & Neonatal, Lorient, France; CHU Morvan, Nucl Med Serv, Brest, France; CHRU Pontchaillou, Serv Biochim, Rennes, France; CHRU Pontchaillou, Genet Mol Lab, Rennes, France	CHU Brest; Universite de Bretagne Occidentale; CHU Rennes; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Rennes; CHU Rennes	Ferec, C (corresponding author), EFS Bretagne, UBO, CHU Morvan, Lab Genet Mol & Histocompatibil, BP 454, F-29275 Brest, France.	claude.ferec@univ-brest.fr	Ferec, Claude/ABG-9699-2020; Quere, Isabelle/AAB-8519-2020	Ferec, Claude/0000-0002-2325-0710; Quere, Isabelle/0000-0002-1492-9764; Scotet, Virginie/0000-0002-5447-4207				AUDREZET MP, 1993, MOL CELL PROBE, V7, P497, DOI 10.1006/mcpr.1993.1073; BALNAVES ME, 1995, J MED GENET, V32, P537, DOI 10.1136/jmg.32.7.537; BOIS E, 1978, CLIN GENET, V14, P73; Castellani C, 1997, J MED GENET, V34, P297, DOI 10.1136/jmg.34.4.297; CHATFIELD S, 1991, ARCH DIS CHILD-FETAL, V66, P29, DOI 10.1136/adc.66.1_Spec_No.29; DankertRoelse JE, 1997, NEW ENGL J MED, V337, P997, DOI 10.1056/NEJM199710023371409; DANKERTROELSE JE, 1995, THORAX, V50, P712, DOI 10.1136/thx.50.7.712; DEMENAIS F, 1979, REV EPIDEMIOL SANTE, V27, P5; Dodge JA, 1998, BRIT MED J, V317, P411; Farrell P M, 1992, Adv Pediatr, V39, P35; Farrell PM, 1997, NEW ENGL J MED, V337, P963, DOI 10.1056/NEJM199710023371403; FARRELL PM, 1991, PEDIATR PULM, P11; FEREC C, 1995, HUM GENET, V96, P542, DOI 10.1007/BF00197409; FEREC C, 1992, NAT GENET, V1, P188, DOI 10.1038/ng0692-188; FEREC C, 1993, FETAL DIAGN THER, V8, P341, DOI 10.1159/000263850; GILTZELMANN R, 1981, HELV PAEDIATR ACTA, V36, P493; GREEN MR, 1993, ARCH DIS CHILD, V68, P464, DOI 10.1136/adc.68.4.464; GREGG RG, 1993, AM J HUM GENET, V52, P616; KAZAZIAN HH, 1994, HUM MUTAT, V4, P167; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lane B, 1998, BRIT MED J, V317, P411; MERELLE ME, 1999, COCHRANE LIB; MISHLER EH, 1989, WIS MED J, V88, P14; RANIERI E, 1994, BRIT MED J, V308, P1469, DOI 10.1136/bmj.308.6942.1469; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; TRAVERT G, 1983, ARCH FR PEDIATR, V40, P295; TRAVERT G, 1999, P INT C NEON SCREEN; Wald NJ, 1998, BRIT MED J, V316, P404, DOI 10.1136/bmj.316.7129.404; Waters DL, 1999, ARCH DIS CHILD-FETAL, V80, pF1, DOI 10.1136/fn.80.1.F1; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; WILCKEN B, 1985, LANCET, V2, P1319; WILCKEN B, 1995, J PEDIATR-US, V127, P965, DOI 10.1016/S0022-3476(95)70040-4; WILCKEN B, 1993, SCREENING, V2, P43	35	69	73	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2000	356	9232					789	794		10.1016/S0140-6736(00)02652-0	http://dx.doi.org/10.1016/S0140-6736(00)02652-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022925				2022-12-01	WOS:000089101800008
J	Mowat, AM				Mowat, AM			Coeliac disease - a future for peptide therapy?	LANCET			English	Editorial Material							CELIAC-DISEASE; T-CELLS; GLIADIN PEPTIDES; ORGAN-CULTURE; ALPHA-GLIADIN; A-GLIADIN; RECOGNIZE; TOXICITY		Univ Glasgow, Western Infirm, Dept Bacteriol & Immunol, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow	Mowat, AM (corresponding author), Univ Glasgow, Western Infirm, Dept Bacteriol & Immunol, Glasgow G11 6NT, Lanark, Scotland.		Mowat, Allan M/H-7932-2016	Mowat, Allan M/0000-0001-9389-3079				Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; DERITIS G, 1988, GASTROENTEROLOGY, V94, P41, DOI 10.1016/0016-5085(88)90607-5; GJERTSEN HA, 1994, HUM IMMUNOL, V39, P243, DOI 10.1016/0198-8859(94)90267-4; Lock C, 1991, Semin Immunol, V3, P247; MacDonald TT, 1999, IMMUNOL TODAY, V20, P505, DOI 10.1016/S0167-5699(99)01536-4; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; MANTZARIS G, 1991, SCAND J GASTROENTERO, V26, P392, DOI 10.3109/00365529108996500; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; MOWAT AM, 1999, MUCOSAL IMMUNOLOGY, P587; Mowat AMI, 1998, GUT, V43, P599, DOI 10.1136/gut.43.5.599; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; SHIDRAWI RG, 1995, SCAND J GASTROENTERO, V30, P758, DOI 10.3109/00365529509096324; SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910, DOI 10.1016/0016-5085(93)90912-V; STURGESS R, 1994, LANCET, V343, P758, DOI 10.1016/S0140-6736(94)91837-6; ten Dam M, 1998, CLIN EXP IMMUNOL, V114, P189; Van de Wal Y, 2000, GUT, V46, P734, DOI 10.1136/gut.46.5.734; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; vandeWal Y, 1996, IMMUNOGENETICS, V44, P246, DOI 10.1007/s002510050120	19	7	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2000	356	9226					270	271		10.1016/S0140-6736(00)02499-5	http://dx.doi.org/10.1016/S0140-6736(00)02499-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MJ	11071179				2022-12-01	WOS:000088305900005
J	Bernstein, CN; Blanchard, JF; Leslie, W; Wajda, A; Yu, BN				Bernstein, CN; Blanchard, JF; Leslie, W; Wajda, A; Yu, BN			The incidence of fracture among patients with inflammatory dowel disease - A population-based cohort study	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MINERAL DENSITY; BOWEL-DISEASE; CROHNS-DISEASE; ULCERATIVE-COLITIS; OSTEOPOROSIS; SUPPLEMENTATION; PREVENTION; DIAGNOSIS; ACCURACY	Background: The clinical significance of the high prevalence of osteopenia in inflammatory bowel disease is unclear. Objective: To determine whether persons with inflammatory bowel disease have increased incidence of fracture. Design: Population-based matched cohort study. Setting: Manitoba, Canada. Patients: Patients with inflammatory bower disease in the University of Manitoba IBD Database (n = 6027) were matched to 10 randomly selected persons in the general population without inflammatory bowel disease (n = 60 270) by year, age, sex, and postal area of residence. Measurements: The incidence of hospitalization for hip fracture was determined on the basis of hospital discharge abstracts. Outpatient medical billing records and hospital discharge abstracts were used to calculate the incidence of spine, rib, and forearm fractures. Rates were calculated on the basis of person-years of follow-up for 1984 to 1997. Results: Persons with inflammatory bower disease had significantly increased incidence of fractures at the spine (incidence rate ratio [IRR], 1.74 [95% Cl, 1.34 to 2.24]; P < 0.001), hip (IRR, 1.59 [Cl, 1.27 to 2.00]; P < 0.001), wrist/forearm (IRR, 1.33 [Cl, 1.11 to 1.58]; P = 0.001), and rib (IRR, 1.25 [Cl, 1.02 to 1.52]; P = 0.03) and of any of these fractures (IRR, 1.41 [Cl, 1.27 to 1.56]; P < 0.001). Conclusion: The incidence of fracture among persons with inflammatory bowel disease is 40% greater than that in the general population.	Univ Manitoba, Gastroenterol Sect, John Buhler Res Ctr, Winnipeg, MB R3E 3P4, Canada; Manitoba Hlth, Winnipeg, MB, Canada	University of Manitoba	Bernstein, CN (corresponding author), Univ Manitoba, Gastroenterol Sect, John Buhler Res Ctr, 804F-715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	cbernst@cc.umanitoba.ca						Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735; Bernstein CN, 1996, ALIMENT PHARM THERAP, V10, P777, DOI 10.1046/j.1365-2036.1996.63205000.x; BERNSTEIN CN, 1999, TRENDS INFLAMMATORY, P147; BERNSTEIN CN, 1997, GASTROENTEROL INT, V10, P71; CLEMENTS D, 1993, GUT, V34, P1543, DOI 10.1136/gut.34.11.1543; COMPSTON JE, 1995, ALIMENT PHARM THER, V9, P237; Fox KM, 1998, J AM GERIATR SOC, V46, P745, DOI 10.1111/j.1532-5415.1998.tb03810.x; Fries W, 1998, AM J GASTROENTEROL, V93, P2339, DOI 10.1016/S0002-9270(98)00566-8; Gennari C, 1986, Clin Rheum Dis, V12, P637; GHOSH S, 1994, GASTROENTEROLOGY, V107, P1031, DOI 10.1016/0016-5085(94)90227-5; IEZZONI LI, 1988, ANN INTERN MED, V109, P745, DOI 10.7326/0003-4819-109-9-745; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V267, P2238; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Lips Paul, 1997, American Journal of Medicine, V103, p3S, DOI 10.1016/S0002-9343(97)90021-8; Robinson RJ, 1998, ALIMENT PHARM THERAP, V12, P699; ROOS LL, 1989, SOC SCI MED, V28, P175, DOI 10.1016/0277-9536(89)90145-7; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; SILVENNOINEN JA, 1995, GUT, V37, P71, DOI 10.1136/gut.37.1.71; VOGELSANG H, 1995, EUR J GASTROEN HEPAT, V7, P609	20	341	353	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2000	133	10					795	799		10.7326/0003-4819-133-10-200011210-00012	http://dx.doi.org/10.7326/0003-4819-133-10-200011210-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374AA	11085842				2022-12-01	WOS:000165321200005
J	Macdonald, CE; Wicks, AC; Playford, RJ				Macdonald, CE; Wicks, AC; Playford, RJ			Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GASTROESOPHAGEAL REFLUX DISEASE; ESOPHAGUS; ADENOCARCINOMA; METAPLASIA	Objectives To review the benefit of an endoscopic surveillance programme for patients with Barrett's oesophagus. Design Observational study. Setting University teaching hospital. Participants 409 patients in whom Barrett's oesophagus was identified during 1984-94; 143 were entered into the annual surveillance programme. Main outcome measures Development of dysplasia and cancer and mortality. Results The average period of surveillance was 4.4 years; 55 patients were reassessed in 1994 but only eight remained in the programme in 1999, withdrawal being due to death (not from carcinoma of the oesophagus), illness, or frailty. Five of the patients who entered surveillance developed carcinoma of the oesophagus. Only one cancer was identified as a result of a surveillance endoscopy, the others being detected during endoscopy to investigate altered symptoms. Of the 266 patients who were not suitable for surveillance, one died from oesophageal cancer and 103 from other causes. Surveillance has resulted in 745 endoscopies and about 3000 biopsy specimens. Conclusion The current surveillance strategy has limited value, and it may be appropriate to restrict surveillance to patients with additional risk factors such as stricture, ulcer, or long segment (> 80 mm) Barrett's oesophagus.	Hammersmith Hosp, Dept Gastroenterol, London W12 0NN, England; Leicester Gen Hosp NHS Trust, Leicester LE5 4PW, Leics, England	Imperial College London; University Hospitals of Leicester NHS Trust; Leicester General Hospital	Playford, RJ (corresponding author), Hammersmith Hosp, Dept Gastroenterol, London W12 0NN, England.	r.playford@ic.ac.uk		Playford, Raymond/0000-0003-1235-8504				CAMERON AJ, 1985, NEW ENGL J MED, V313, P857, DOI 10.1056/NEJM198510033131404; CAMERON AJ, 1990, GASTROENTEROLOGY, V99, P918, DOI 10.1016/0016-5085(90)90607-3; Caygill CPJ, 1999, EUR J CANCER PREV, V8, P539, DOI 10.1097/00008469-199912000-00010; DENT J, 1991, J GASTROEN HEPATOL, V6, P1, DOI 10.1111/j.1440-1746.1991.tb01137.x; Jankowski JA, 1999, AM J PATHOL, V154, P965, DOI 10.1016/S0002-9440(10)65346-1; JOHNSSON F, 1987, SCAND J GASTROENTERO, V22, P714, DOI 10.3109/00365528709011148; Macdonald CE, 1997, GUT, V41, P303, DOI 10.1136/gut.41.3.303; Smith AM, 1999, BRIT J SURG, V86, P276, DOI 10.1046/j.1365-2168.1999.01015.x; Spechler SJ, 1996, GASTROENTEROLOGY, V110, P614, DOI 10.1053/gast.1996.v110.agast960614; SPECHLER SJ, 1984, GASTROENTEROLOGY, V87, P927; Wilson JMG, 1968, PRINCIPLES PRACTICE; Winters C, 1987, GASTROENTEROLOGY, V92, P118, DOI 10.1016/0016-5085(87)90847-X; Wright TA, 1996, GUT, V39, P574, DOI 10.1136/gut.39.4.574	13	166	168	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2000	321	7271					1252	1255		10.1136/bmj.321.7271.1252	http://dx.doi.org/10.1136/bmj.321.7271.1252			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	376ET	11082084	Bronze, Green Published			2022-12-01	WOS:000165445800023
J	Wilmshurst, PT; Nightingale, S; Walsh, KP; Morrison, WL				Wilmshurst, PT; Nightingale, S; Walsh, KP; Morrison, WL			Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons	LANCET			English	Article							PATENT FORAMEN OVALE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSCRANIAL DOPPLER; CRYPTOGENIC STROKE; DIVERS; SICKNESS; EMBOLISM; AUTOPSY; AURA	Background A relation between migraine with aura and cardiac right-to-left shunts has been reported. Right-to-left shunts are also associated with stroke and certain forms of decompression illness. We investigated the effect of closure of right-to-left shunts on migraine symptoms. Methods A consultant neurologist, who was unaware of information about residual shunt, undertook a structured interview with individuals who had had transcatheter closure of an atrial septal defect or patent foramen ovale to assess how the procedure affected migraine symptoms. Findings 37 of 40 consecutive patients who had had a closure procedure (to permit resumption of diving after decompression illness in 29, after stroke when paradoxical thromboembolism was suspected in four, or to close a large atrial septal defect in lour) could be contacted. 21 (57%) had a history of migraine before the procedure (with aura in 16, without aura in five). 11 individuals had fortification spectra in the period immediately after closure. During long-term follow-up, no migraine symptoms were reported by seven individuals who had previously had migraine with aura and three who had previously had migraine without aura. Eight others who had had migraine with aura before closure reported improvement in frequency and severity of migraines. Three tone migraine with aura, two migraine without aura) reported no alteration in migraine episodes. Interpretation These observations suggest a causal association between right-to-left shunts and migraine with aura. There may be a subgroup of patients who have severe migraine associated with a large right-to-left shunt in whom closure of the atrial defect may improve or abolish migraine.	Royal Shrewsbury Hosp, Dept Cardiol, Shrewsbury SY3 8XQ, Salop, England; Royal Shrewsbury Hosp, Dept Neurol, Shrewsbury SY3 8XQ, Salop, England; Our Ladys Hosp Sick Children, Dept Cardiol, Dublin 12, Ireland; Ctr Cardiothorac, Dept Cardiol, Liverpool, Merseyside, England	Our Ladys Children Hospital Crumlin	Wilmshurst, PT (corresponding author), Royal Shrewsbury Hosp, Dept Cardiol, Shrewsbury SY3 8XQ, Salop, England.							Anzola GP, 1999, NEUROLOGY, V52, P1622, DOI 10.1212/WNL.52.8.1622; CABANES L, 1993, STROKE, V24, P1865, DOI 10.1161/01.STR.24.12.1865; Del Sette M, 1998, CEREBROVASC DIS, V8, P327, DOI 10.1159/000015875; Engel GL, 1944, WAR MED, V5, P304; FERRARI MD, 1997, BLUE BOOKS PRACTICAL, P120; Germonpre P, 1998, J APPL PHYSIOL, V84, P1622, DOI 10.1152/jappl.1998.84.5.1622; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; HAUSMANN D, 1995, J AM COLL CARDIOL, V26, P1030, DOI 10.1016/0735-1097(95)00288-9; HOMMA S, 1994, STROKE, V25, P582, DOI 10.1161/01.STR.25.3.582; LANCE JW, 1993, WOLFFS HEADACHE OTHE, P59; MOON RE, 1989, LANCET, V1, P513; SANDLER M, 1972, LANCET, V1, P618; Schneider B, 1996, AM J CARDIOL, V77, P1202, DOI 10.1016/S0002-9149(96)00163-4; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; VANCAMP G, 1993, AM J CARDIOL, V71, P596, DOI 10.1016/0002-9149(93)90518-H; VIK A, 1993, UNDERSEA HYPERBAR M, V20, P121; Walsh KP, 1999, HEART, V81, P257, DOI 10.1136/hrt.81.3.257; WEBSTER MWI, 1988, LANCET, V2, P11; Wilmshurst, 1996, LANCET, V348, P1392; WILMSHURST P, 1994, CLIN SCI, V86, P297; Wilmshurst P, 2000, CLIN SCI, V99, P65, DOI 10.1042/CS19990338; Wilmshurst P, 1996, LANCET, V348, P752, DOI 10.1016/S0140-6736(05)65638-3; WILMSHURST P, IN PRESS CLIN SCI; WILMSHURST PT, 1989, LANCET, V2, P1302	24	299	321	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2000	356	9242					1648	1651		10.1016/S0140-6736(00)03160-3	http://dx.doi.org/10.1016/S0140-6736(00)03160-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372TB	11089825				2022-12-01	WOS:000165249200014
J	Holmberg, J; Clarke, DL; Frisen, J				Holmberg, J; Clarke, DL; Frisen, J			Regulation of repulsion versus adhesion by different splice forms of an Eph receptor	NATURE			English	Article							NEURAL-TUBE DEFECTS; RETINAL AXON GUIDANCE; TYROSINE KINASE; IN-VITRO; EPHRINS; IDENTIFICATION; MORPHOGENESIS; EXPRESSION; LIGANDS; GROWTH	Eph tyrosine kinase receptors and their membrane-bound ephrin ligands mediate cell interactions and participate in several developmental processes(1-4). Ligand binding to an Eph receptor results in tyrosine phosphorylation of the kinase domain, and repulsion of axonal growth cones and migrating cells. Here we report that a subpopulation of ephrin-A5 null mice display neural tube defects resembling anencephaly in man. This is caused by the failure of the neural folds to fuse in the dorsal midline, suggesting that ephrin-A5, in addition to its involvement in cell repulsion(5,6), can participate in cell adhesion. During neurulation, ephrin-A5 is coexpressed with its cognate receptor EphA7 in cells at the edges of the dorsal neural folds. Three different EphA7 splice variants(7,8), a full-length form and two truncated versions lacking kinase domains, are expressed in the neural folds. Co-expression of an endogenously expressed truncated form of EphA7 suppresses tyrosine phosphorylation of the full-length EphA7 receptor and shifts the cellular response from repulsion to adhesion in vitro. We conclude that alternative usage of different splice forms of a tyrosine kinase receptor can mediate cellular adhesion or repulsion during embryonic development.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@cmb.ki.se						Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Castellani V, 1998, J NEUROSCI, V18, P4663; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; CIOSSEK T, 1995, ONCOGENE, V10, P97; Ciossek T, 1999, MOL BRAIN RES, V74, P231, DOI 10.1016/S0169-328X(99)00285-5; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.2107; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gao PP, 2000, J NEUROSCI RES, V60, P427, DOI 10.1002/(SICI)1097-4547(20000515)60:4<427::AID-JNR1>3.3.CO;2-4; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Holder N, 1999, DEVELOPMENT, V126, P2033; Holland SJ, 1998, CURR OPIN NEUROBIOL, V8, P117, DOI 10.1016/S0959-4388(98)80015-9; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KALLEN B, 1994, TERATOLOGY, V50, P322, DOI 10.1002/tera.1420500503; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; VALENZUELA DM, 1995, ONCOGENE, V10, P1573; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wikstrom K, 1996, EXP CELL RES, V227, P360, DOI 10.1006/excr.1996.0285; Xu QL, 1996, NATURE, V381, P319, DOI 10.1038/381319a0; Xu QL, 1995, DEVELOPMENT, V121, P4005; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	30	279	290	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2000	408	6809					203	206		10.1038/35041577	http://dx.doi.org/10.1038/35041577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089974				2022-12-01	WOS:000165180400046
J	Horton, R				Horton, R			African AIDS beyond Mbeki: tripping into anarchy	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Horton, R (corresponding author), Lancet, London WC1X 8RR, England.							BERESFORD D, 2000, GUARDIAN        1025, P16; Nyazema N. Z., 2000, Central African Journal of Medicine, V46, P89; THOMAS A, 2000, DRUG DEALS MED DEV H; *UNDP, 2000, HUM DEV REP 2000, P83	4	16	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 4	2000	356	9241					1541	1542		10.1016/S0140-6736(00)03122-6	http://dx.doi.org/10.1016/S0140-6736(00)03122-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370QV	11075765				2022-12-01	WOS:000165134500007
J	Henney, JE				Henney, JE			New drug for HIV infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Henney, JE (corresponding author), US FDA, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2178	2178		10.1001/jama.284.17.2178	http://dx.doi.org/10.1001/jama.284.17.2178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056574				2022-12-01	WOS:000090052600006
J	Freitas-Junior, LH; Bottius, E; Pirrit, LA; Deitsch, KW; Scheidig, C; Guinet, F; Nehrbass, U; Wellems, TE; Scherf, A				Freitas-Junior, LH; Bottius, E; Pirrit, LA; Deitsch, KW; Scheidig, C; Guinet, F; Nehrbass, U; Wellems, TE; Scherf, A			Frequent ectopic recombination of virulence factor genes in telomeric chromosome clusters of P-falciparum	NATURE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; ANTIGENIC VARIATION; INFECTED ERYTHROCYTES; ACQUIRED-IMMUNITY; CEREBRAL MALARIA; ADHERENCE; SURFACE; TRANSCRIPTION; EXPRESSION; PHENOTYPES	Persistent and recurrent infections by Plasmodium falciparum malaria parasites result from the ability of the parasite to undergo antigenic variation and evade host immune attack(1,2). P. falciparum parasites generate high levels of variability in gene families that comprise virulence determinants of cytoadherence and antigenic variation(3-7), such as the var genes. These genes encode the major variable parasite protein (PfEMP-1), and are expressed in a mutually exclusive manner at the surface of the erythrocyte infected by P. falciparum(8-12). Here we identify a mechanism by which var gene sequences undergo recombination at frequencies much higher than those expected from homologous crossover events alone(13). These recombination events occur between sub-telomeric regions of heterologous chromosomes, which associate in clusters near the nuclear periphery in asexual blood-stage parasites or in bouquet-like configurations near one pole of the elongated nuclei in sexual parasite forms. We propose that the alignment of var genes in heterologous chromosomes facilitates gene conversion and promotes the diversity of antigenic and adhesive phenotypes. The association of virulence factors with a specific nuclear subcompartment may also have implications for variation during mitotic recombination in asexual blood stages.	Inst Pasteur, Unite Biol Interact Hote Parasite, CNRS, URA 1960, F-75724 Paris 15, France; Inst Pasteur, Lab Biol Cellulaire Noyau, CNRS, URA 1773, F-75724 Paris, France; NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Scherf, A (corresponding author), Inst Pasteur, Unite Biol Interact Hote Parasite, CNRS, URA 1960, 25 Rue Dr Roux, F-75724 Paris 15, France.		Freitas-Junior, Lucio H/C-8677-2011; Scherf, Artur/A-9674-2014	Freitas-Junior, Lucio H/0000-0002-8904-7897; Nehrbass, Ulf/0000-0002-7028-8076; Scherf, Artur/0000-0003-2411-3328	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000483, Z01AI000483] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BIGGS BA, 1992, J IMMUNOL, V149, P2047; BORST P, 1995, CELL, V82, P1, DOI 10.1016/0092-8674(95)90044-6; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Carter R, 1993, Methods Mol Biol, V21, P67; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; de Lange T, 1998, NATURE, V392, P753, DOI 10.1038/33790; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; DERNBURG AF, 1995, TELOMERES, P295; Ersfeld K, 1997, SCIENCE, V276, P611, DOI 10.1126/science.276.5312.611; Figueiredo LM, 2000, MOL BIOCHEM PARASIT, V106, P169, DOI 10.1016/S0166-6851(99)00199-1; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gupta S, 1999, PARASITOL TODAY, V15, P497, DOI 10.1016/S0169-4758(99)01559-8; Gupta S, 1999, P ROY SOC B-BIOL SCI, V266, P33, DOI 10.1098/rspb.1999.0600; HernandezRivas R, 1997, MOL CELL BIOL, V17, P604, DOI 10.1128/MCB.17.2.604; HINTERBERG K, 1994, EMBO J, V13, P4174, DOI 10.1002/j.1460-2075.1994.tb06735.x; KIMURA E, 1990, GENE, V91, P57, DOI 10.1016/0378-1119(90)90162-K; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; SCHERF A, 1988, EMBO J, V7, P1129, DOI 10.1002/j.1460-2075.1988.tb02922.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0	32	381	385	0	29	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2000	407	6807					1018	1022		10.1038/35039531	http://dx.doi.org/10.1038/35039531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069183				2022-12-01	WOS:000090032500047
J	Price, MP; Lewin, GR; McIlwrath, SL; Cheng, C; Xie, JH; Heppenstall, PA; Stucky, CL; Mannsfeldt, AG; Brennan, TJ; Drummond, HA; Qiao, J; Benson, CJ; Tarr, DE; Hrstka, RF; Yang, BL; Williamson, RA; Welsh, MJ				Price, MP; Lewin, GR; McIlwrath, SL; Cheng, C; Xie, JH; Heppenstall, PA; Stucky, CL; Mannsfeldt, AG; Brennan, TJ; Drummond, HA; Qiao, J; Benson, CJ; Tarr, DE; Hrstka, RF; Yang, BL; Williamson, RA; Welsh, MJ			The mammalian sodium channel BNC1 is required for normal touch sensation	NATURE			English	Article							ROOT GANGLION-CELLS; SENSORY NEURONS; CAENORHABDITIS-ELEGANS; NA+ CHANNEL; DEGENERIN MDEG; ION CHANNELS; HAIRY SKIN; SUBUNIT; NOCICEPTORS; PROTONS	Of the vertebrate senses, touch is the least understood at the molecular level. The ion channels that form the core of the mechanosensory complex and confer touch sensitivity remain unknown(1-3). However, the similarity of the brain sodium channel 1 (BNC1)(4-6) to nematode proteins involved in mechanotransduction indicated that it might be a part of such a mechanosensor(7,8). Here we show that disrupting the mouse BNC1 gene markedly reduces the sensitivity of a specific component of mechanosensation: low-threshold rapidly adapting mechanoreceptors. In rodent hairy skin these mechanoreceptors are excited by hair movement(2). Consistent with this function, we found BNC1 in the lanceolate nerve endings that lie adjacent to and surround the hair follicle(9). Although BNC1 has been proposed to have a role in pH sensing(10,11), the acid-evoked current in cultured sensory neurons and the response of acid-stimulated nociceptors were normal in BNC1 null mice. These data identify the BNC1 channel as essential for the normal detection of light touch and indicate that BNC1 may be a central component of a mechanosensory complex.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Anesthesia, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Max Delbruck Ctr Mol Med, Dept Neurosci, Growth Factors & Regenerat Grp, D-13092 Berlin, Germany	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Welsh, MJ (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA.		Tarr, D Ellen K/H-7295-2019; Lewin, Gary R/B-8028-2011	Tarr, D Ellen K/0000-0003-1604-4545; Benson, Christopher/0000-0001-6600-8193; Brennan, Timothy/0000-0002-0150-5145; Lewin, Gary/0000-0002-2890-6352; Welsh, Michael/0000-0002-1646-6206				Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Benson CJ, 1999, CIRC RES, V84, P921; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; DRUMMOND HA, IN PRESS BRAIN RES; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; Fricke B, 2000, CELL TISSUE RES, V299, P327; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; HALATA Z, 1993, J INVEST DERMATOL, V101, pS75, DOI 10.1111/1523-1747.ep12362877; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.neuro.15.1.227; KOERBER HR, 1988, J NEUROPHYSIOL, V60, P1584, DOI 10.1152/jn.1988.60.5.1584; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Mannsfeldt AG, 1999, MOL CELL NEUROSCI, V13, P391, DOI 10.1006/mcne.1999.0761; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; McDonald FJ, 1999, P NATL ACAD SCI USA, V96, P1727, DOI 10.1073/pnas.96.4.1727; Perl ER, 1992, SENSORY NEURONS DIVE, P3; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Rusch A, 1999, HEARING RES, V131, P170, DOI 10.1016/S0378-5955(99)00030-1; STEEN KH, 1992, J NEUROSCI, V12, P86; Stucky CL, 1999, J NEUROSCI, V19, P6497; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229	30	381	402	0	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2000	407	6807					1007	1011		10.1038/35039512	http://dx.doi.org/10.1038/35039512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366XX	11069180				2022-12-01	WOS:000090032500044
J	Jacobsen, R; Bostofte, E; Engholm, G; Hansen, J; Olsen, JH; Skakkebaek, NE; Moller, H				Jacobsen, R; Bostofte, E; Engholm, G; Hansen, J; Olsen, JH; Skakkebaek, NE; Moller, H			Risk of testicular cancer in men with abnormal semen characteristics: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GERM-CELL TUMORS; EUROPEAN COUNTRIES; CARCINOMA-INSITU; TESTIS CANCER; FERTILITY; ETIOLOGY	Objective To explore the associations between semen characteristics and subsequent risk of testicular cancer. Design Cohort study Participants 32 442 men who had a semen analysis done at the Sperm Analysis Laboratory in Copenhagen during 1963-95. Main outcome measure Standardised incidence ratios of testicular cancer compared with total population of Danish men. Results Men in couples with fertility problems were more likely to develop testicular cancer than other men (89 cases, standardised incidence ratio 1.6; 95% confidence interval 1.3 to 1.9). The risk was relatively constant with increasing time between semen analysis and cancer diagnosis. Analysis according to specific semen characteristics showed that low semen concentration (standardised incidence ratio 2.3), poor motility of the spermatozoa (2.5), and high proportion of morphologically abnormal spermatozoa (3.0) were all associated with an increased risk of testicular cancer. The only other cancer group that showed ina eased incidence was "peritoneum and other digestive organs (six cases; 3.7, 1.3 to 8.0). Of these, two cases were probably and two cases were possibly extragonadal germ cell rumours. Conclusions The results point towards the existence of common aetiological factors for low semen quality and testicular cancer. Low semen quality may also be associated with increased incidence of extragonadal germ cell tumours.	Guys Kings & St Thomas Sch Med, Thames Canc Registry, London SE1 3QD, England; Natl Univ Hosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark; Hlth Serv Phys Org, Sperm Anal, DK-1112 Copenhagen, Denmark; Danish Natl Res Fdn, Ctr Res Hlth & Social Stat, DK-2100 Copenhagen, Denmark	University of London; King's College London; Danish Cancer Society; Danmarks Grundforskningsfond	Jacobsen, R (corresponding author), Univ Copenhagen, Panum Inst, Fac Hlth Sci, Inst Publ Hlth,Dept Epidemiol, DK-2200 Copenhagen, Denmark.	RJacobsen@pubhealth.ku.dk	Lindahl-Jacobsen, Rune/J-2985-2012	Lindahl-Jacobsen, Rune/0000-0002-4622-9826; Olsen, Jorgen Helge/0000-0001-9633-5662; Moller, Henrik/0000-0001-8200-5929				ADAMI HO, 1994, INT J CANCER, V59, P33, DOI 10.1002/ijc.2910590108; Bergstrom R, 1996, J NATL CANCER I, V88, P727, DOI 10.1093/jnci/88.11.727; BERTHELSEN JG, 1983, FERTIL STERIL, V39, P68; BOSTOFTE E, 1984, FERTIL STERIL, V41, P95; BOSTOFTE E, 1990, FERTIL STERIL, V54, P1100; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; CARROLL PR, 1987, J UROLOGY, V137, P420, DOI 10.1016/S0022-5347(17)44054-7; COLEMAN M, 1986, INT J EPIDEMIOL, V15, P134, DOI 10.1093/ije/15.1.134; COLEMAN MP, 1993, IARC SCI PUBLICATION, V121; DAUGAARD G, 1987, LANCET, V2, P528; DAUGAARD G, 1992, ANN ONCOL, V3, P283, DOI 10.1093/oxfordjournals.annonc.a058180; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; FORMAN D, 1994, CANCER SURV, V20, P323; HENDERSON BE, 1979, INT J CANCER, V23, P598, DOI 10.1002/ijc.2910230503; Jacobsen R, 2000, HUM REPROD, V15, P1958, DOI 10.1093/humrep/15.9.1958; James WH, 1997, HUM REPROD, V12, P417; Moller H, 1999, BMJ-BRIT MED J, V318, P559, DOI 10.1136/bmj.318.7183.559; Moller H, 1996, CANCER CAUSE CONTROL, V7, P264, DOI 10.1007/BF00051302; MOLLER H, 1993, EUR UROL, V23, P8; Moller H, 1997, CANCER CAUSE CONTROL, V8, P904, DOI 10.1023/A:1018472530653; Moller H, 1998, APMIS, V106, P232, DOI 10.1111/j.1699-0463.1998.tb01341.x; NIJMAN JM, 1985, ARCH ANDROLOGY, V14, P239, DOI 10.3109/01485018508988306; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; SKAKKEBAEK NE, 1987, INT J ANDROL, V10, P19, DOI 10.1111/j.1365-2605.1987.tb00161.x; Storm H H, 1991, IARC Sci Publ, P220; Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228; SWERDLOW AJ, 1989, INT J CANCER, V43, P549, DOI 10.1002/ijc.2910430403; Wanderas EH, 1998, CANCER CAUSE CONTROL, V9, P475, DOI 10.1023/A:1008857702380; World Health Organization, 1999, WHO LAB MAN EX HUM S, V4th	29	258	264	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2000	321	7264					789	792		10.1136/bmj.321.7264.789	http://dx.doi.org/10.1136/bmj.321.7264.789			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009515	Green Published, Bronze			2022-12-01	WOS:000089696600020
J	Flores, GV; Duan, H; Yan, HJ; Nagaraj, R; Fu, WM; Zou, Y; Noll, M; Banerjee, U				Flores, GV; Duan, H; Yan, HJ; Nagaraj, R; Fu, WM; Zou, Y; Noll, M; Banerjee, U			Combinatorial signaling in the specification of unique cell fates	CELL			English	Article							DEVELOPING DROSOPHILA RETINA; EYE DEVELOPMENT; EGF RECEPTOR; TRANSCRIPTION FACTORS; PAX2 HOMOLOG; PATTERN-FORMATION; PIGMENT-CELLS; COMPOUND EYE; ETS DOMAIN; MAP KINASE	How multifunctional signals combine to specify unique cell fates during pattern formation is not well understood. Here, we demonstrate that together with the transcription factor Lozenge, the nuclear effecters of the EGFR and Notch signaling pathways directly regulate D-Pax2 transcription in cone cells of the Drosophila eye disc. Moreover, the specificity of D-Pax2 expression can be altered upon genetic manipulation of these inputs. Thus, a relatively small number of temporally and spatially controlled signals received by a set of pluripotent cells can create the unique combinations of activated transcription factors required to regulate target genes and ultimately specify distinct cell fates within this group. We expect that similar mechanisms may specify pattern formation in vertebrate developmental systems that involve intercellular communication.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Zurich; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.				NATIONAL EYE INSTITUTE [R01EY008152] Funding Source: NIH RePORTER; NEI NIH HHS [2R01EY08152] Funding Source: Medline; NIGMS NIH HHS [GM07195] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnone MI, 1997, DEVELOPMENT, V124, P1851; Arnosti DN, 1996, DEVELOPMENT, V122, P205; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ausubel FM., 2006, ENZYMATIC MANIPULATI; Bae SC, 1999, HISTOL HISTOPATHOL, V14, P1213, DOI 10.14670/HH-14.1213; BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K; BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; BASLER K, 1990, GENE DEV, V4, P728, DOI 10.1101/gad.4.5.728; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Crew JR, 1997, DEV GENES EVOL, V206, P481, DOI 10.1007/s004270050079; Czerny T, 1997, MECH DEVELOP, V67, P179, DOI 10.1016/S0925-4773(97)00119-6; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; DICKSON B, 1992, GENE DEV, V6, P2327, DOI 10.1101/gad.6.12a.2327; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Flores GV, 1998, DEVELOPMENT, V125, P3681; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; Fu WM, 1998, DEVELOPMENT, V125, P2943; Go MJ, 1998, DEVELOPMENT, V125, P2031; Gupta BP, 1995, J NEUROGENET, V10, P137, DOI 10.3109/01677069509083460; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; HUANG JD, 1993, GENE DEV, V7, P694, DOI 10.1101/gad.7.4.694; Ito K, 1997, DEVELOPMENT, V124, P761; KAMACHI Y, 1990, J VIROL, V64, P4808, DOI 10.1128/JVI.64.10.4808-4819.1990; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; Kavaler J, 1999, DEVELOPMENT, V126, P2261; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; Kumar J, 1997, GENE DEV, V11, P2023, DOI 10.1101/gad.11.16.2023; Kumar JP, 1998, DEVELOPMENT, V125, P3875; LAWRENCE PA, 1979, DEV BIOL, V71, P142, DOI 10.1016/0012-1606(79)90088-5; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Lindsley D.L., 1992, GENOME DROSOPHILA ME; Matsuno K, 1997, DEVELOPMENT, V124, P4265; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Tio M, 1997, DEVELOPMENT, V124, P343; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; WOLFF T, 1991, DEVELOPMENT, V113, P841; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; XU T, 1993, DEVELOPMENT, V117, P1223; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	54	201	205	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					75	85		10.1016/S0092-8674(00)00106-9	http://dx.doi.org/10.1016/S0092-8674(00)00106-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051549	Bronze, Green Published			2022-12-01	WOS:000089636400010
J	Wimberly, BT; Brodersen, DE; Clemons, WM; Morgan-Warren, RJ; Carter, AP; Vonrhein, C; Hartsch, T; Ramakrishnan, V				Wimberly, BT; Brodersen, DE; Clemons, WM; Morgan-Warren, RJ; Carter, AP; Vonrhein, C; Hartsch, T; Ramakrishnan, V			Structure of the 30S ribosomal subunit	NATURE			English	Article							THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; BINDING MOTIF; PROTEIN S15; RNA; REVEALS; MODEL; S4	Genetic information encoded in messenger RNA is translated into protein by the ribosome, which is a large nucleoprotein complex comprising two subunits, denoted 30S and 50S in bacteria. Here we report the crystal structure of the 30S subunit from Thermus thermophilus, refined to 3 Angstrom resolution. The final atomic model rationalizes over four decades of biochemical data on the ribosome, and provides a wealth of information about RNA and protein structure, protein-RNA interactions and ribosome assembly. It is also a structural basis for analysis of the functions of the 30S subunit, such as decoding, and for understanding the action of antibiotics. The structure will facilitate the interpretation in molecular terms of lower resolution structural data on several functional states of the ribosome from electron microscopy and crystallography.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA; Global Phasing Ltd, Cambridge CB3 0AX, England; Univ Gottingen, Inst Mikrobiol & Genet, Gottingen Genom Lab, D-37077 Gottingen, Germany	MRC Laboratory Molecular Biology; Utah System of Higher Education; University of Utah; Global Phasing Limited; University of Gottingen	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Clemons, William M/D-1026-2009; Brodersen, Ditlev E./AAQ-5241-2020	Clemons, William M/0000-0002-0021-889X; Carter, Andrew/0000-0001-7292-5430; Brodersen, Ditlev/0000-0002-5413-4667; Ramakrishnan, V/0000-0002-4699-2194	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM019384] Funding Source: NIH RePORTER; NIGMS NIH HHS [F31 GM019384] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1997, ACTA CRYSTALLOGR D, V53, P371, DOI 10.1107/S0907444996015272; Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; Allard P, 2000, STRUCT FOLD DES, V8, P875, DOI 10.1016/S0969-2126(00)00177-5; Berglund H, 1997, NAT STRUCT BIOL, V4, P20, DOI 10.1038/nsb0197-20; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPEL MS, 1987, SCIENCE, V238, P1403, DOI 10.1126/science.3317832; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CHOLI T, 1993, BIOL CHEM H-S, V374, P377, DOI 10.1515/bchm3.1993.374.1-6.377; Clemons WM, 1998, STRUCT FOLD DES, V6, P429, DOI 10.1016/S0969-2126(98)00045-8; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Davies C, 1998, EMBO J, V17, P4545, DOI 10.1093/emboj/17.16.4545; Davies C, 1996, STRUCTURE, V4, P1093, DOI 10.1016/S0969-2126(96)00115-3; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gabashvili IS, 1999, J MOL BIOL, V286, P1285, DOI 10.1006/jmbi.1999.2538; Garrett R. A., 2000, RIBOSOME STRUCTURE F; GLOTZ C, 1987, BIOCHEM INT, V15, P953; GOLDEN BL, 1993, BIOCHEMISTRY-US, V32, P12812, DOI 10.1021/bi00210a033; GUTELL RR, 1996, RIBOSOMAL RNA STRUCT, P111; HARTMANN RK, 1989, J BACTERIOL, V171, P2933, DOI 10.1128/jb.171.6.2933-2941.1989; HELD WA, 1974, J BIOL CHEM, V249, P3103; Helgstrand M, 1999, J MOL BIOL, V292, P1071, DOI 10.1006/jmbi.1999.3122; Hosaka H, 1997, STRUCTURE, V5, P1199, DOI 10.1016/S0969-2126(97)00270-0; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; MALHOTRA A, 1994, J MOL BIOL, V240, P308, DOI 10.1006/jmbi.1994.1448; Markus MA, 1998, EMBO J, V17, P4559, DOI 10.1093/emboj/17.16.4559; Mueller F, 1997, J MOL BIOL, V271, P524, DOI 10.1006/jmbi.1997.1210; Mueller F, 1997, J MOL BIOL, V271, P545, DOI 10.1006/jmbi.1997.1211; Nevskaya N, 1998, J MOL BIOL, V279, P233, DOI 10.1006/jmbi.1998.1758; Nikulin A, 2000, NAT STRUCT BIOL, V7, P273; NOWOTNY V, 1988, BIOCHEMISTRY-US, V27, P7051, DOI 10.1021/bi00418a057; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POWERS SE, 1994, J CONTAM HYDROL, V16, P1, DOI 10.1016/0169-7722(94)90070-1; RAMAKRISHNAN V, 1986, SCIENCE, V231, P1562, DOI 10.1126/science.3513310; RAMAKRISHNAN V, 1992, NATURE, V358, P768, DOI 10.1038/358768a0; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; STERN S, 1988, J MOL BIOL, V204, P447, DOI 10.1016/0022-2836(88)90588-8; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tocilj A, 1999, P NATL ACAD SCI USA, V96, P14252, DOI 10.1073/pnas.96.25.14252; TRAKHANOV SD, 1987, FEBS LETT, V220, P319, DOI 10.1016/0014-5793(87)80838-4; VONBOHLEN K, 1991, J MOL BIOL, V222, P11, DOI 10.1016/0022-2836(91)90730-T; WIMBERLY B, 1993, BIOCHEMISTRY-US, V32, P1078, DOI 10.1021/bi00055a013; Wimberly BT, 1997, STRUCTURE, V5, P1187, DOI 10.1016/S0969-2126(97)00269-4; YONATH A, 1988, J MOL BIOL, V203, P831, DOI 10.1016/0022-2836(88)90216-1; Yonath A, 1998, ACTA CRYSTALLOGR A, V54, P945, DOI 10.1107/S010876739800991X; YUSUPOV MM, 1988, FEBS LETT, V238, P113, DOI 10.1016/0014-5793(88)80237-0	50	1630	1708	6	164	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					327	339		10.1038/35030006	http://dx.doi.org/10.1038/35030006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014182				2022-12-01	WOS:000089390700036
J	Yaalon, DH				Yaalon, DH			Down to earth - Why soil-and soil science-matters.	NATURE			English	Editorial Material									Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Yaalon, DH (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, Givat Ram Campus, IL-91904 Jerusalem, Israel.								0	13	14	1	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					301	301		10.1038/35030260	http://dx.doi.org/10.1038/35030260			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014167	Bronze			2022-12-01	WOS:000089390700021
J	Hirschberg, JHKK; Brunsveld, L; Ramzi, A; Vekemans, JAJM; Sijbesma, RP; Meijer, EW				Hirschberg, JHKK; Brunsveld, L; Ramzi, A; Vekemans, JAJM; Sijbesma, RP; Meijer, EW			Helical self-assembled polymers from cooperative stacking of hydrogen-bonded pairs	NATURE			English	Article								The double helix of DNA epitomizes this molecule's ability to self-assemble in aqueous solutions into a complex chiral structure using hydrogen bonding and hydrophobic interactions. Noncovalently interacting molecules in organic solvents are used to design systems that similarly form controlled architectures(1-7). Peripheral chiral centres in assemblies(8,9) and chiral side chains attached to a polymer backbone(10,11) have been shown to induce chirality at the supramolecular level, and highly ordered structures stable in water are also known(12-15). However, it remains difficult to rationally exploit non-covalent interactions for the formation of chiral assemblies that are stable in water, where solvent molecules can compete effectively for hydrogen bonds. Here we describe a general strategy for the design of functionalized monomer units and their association in either water or alkanes into non-covalently linked polymeric structures with controlled helicity and chain length. The monomers consist of bifunctionalized ureidotriazine units connected by a spacer and carrying solubilizing chains at the periphery. This design allows for dimerization through self-complementary quadruple hydrogen bonding between the units and solvophobically induced stacking of the dimers into columnar polymeric architectures, whose structure and helicity can be adjusted by tuning the nature of the solubilizing side chains.	Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands; Eindhoven Univ Technol, Dutch Polymer Inst, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology; Dutch Polymer Institute; Eindhoven University of Technology	Meijer, EW (corresponding author), Eindhoven Univ Technol, Lab Macromol & Organ Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.	E.W.Meijer@tue.nl	Sijbesma, Rintje Pieter P/D-3551-2012; Meijer, E.W./K-7632-2013	Sijbesma, Rintje Pieter P/0000-0002-8975-636X; Meijer, E.W./0000-0003-4126-7492; Brunsveld, Luc/0000-0001-5675-511X				Appella DH, 1999, J AM CHEM SOC, V121, P2309, DOI 10.1021/ja983918n; Beijer FH, 1998, ANGEW CHEM INT EDIT, V37, P75, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<75::AID-ANIE75>3.0.CO;2-R; BLOKZIJL W, 1993, ANGEW CHEM INT EDIT, V32, P1545, DOI 10.1002/anie.199315451; Castellano RK, 1997, P NATL ACAD SCI USA, V94, P7132, DOI 10.1073/pnas.94.14.7132; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; Gottarelli G, 1996, HELV CHIM ACTA, V79, P220, DOI 10.1002/hlca.19960790123; GREEN MM, 1995, SCIENCE, V268, P1860, DOI 10.1126/science.268.5219.1860; KRZYWICKI TG, 1993, P NATL ACAD SCI USA, V90, P163; KUNITAKE T, 1992, ANGEW CHEM INT EDIT, V31, P709, DOI 10.1002/anie.199207091; Lydon J, 1998, CURR OPIN COLLOID IN, V3, P458, DOI 10.1016/S1359-0294(98)80019-8; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Palmans ARA, 1997, ANGEW CHEM INT EDIT, V36, P2648, DOI 10.1002/anie.199726481; Prince RB, 2000, ANGEW CHEM INT EDIT, V39, P228, DOI 10.1002/(SICI)1521-3773(20000103)39:1<228::AID-ANIE228>3.0.CO;2-B; Prins LJ, 1999, NATURE, V398, P498, DOI 10.1038/19053; Seebach D, 1996, HELV CHIM ACTA, V79, P913, DOI 10.1002/hlca.19960790402; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191	17	597	610	9	399	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					167	170		10.1038/35025027	http://dx.doi.org/10.1038/35025027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001050				2022-12-01	WOS:000089241000042
J	Franceschi, S; Munoz, N; Snijders, PJF				Franceschi, S; Munoz, N; Snijders, PJF			How strong and how wide is the link between HPV and oropharyngeal cancer?	LANCET			English	Editorial Material							UPPER AERODIGESTIVE TRACT; HUMAN-PAPILLOMAVIRUS; TONSILLAR; WORLDWIDE; RISK		Int Agcy Res Canc, Unit Field & Intervent Studies, F-69372 Lyon 08, France; Free Univ Amsterdam Hosp, Dept Pathol, Amsterdam, Netherlands	World Health Organization; International Agency for Research on Cancer (IARC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Franceschi, S (corresponding author), Int Agcy Res Canc, Unit Field & Intervent Studies, 150 Cours Albert Thomas, F-69372 Lyon 08, France.		franceschi, silvia/M-2452-2014	franceschi, silvia/0000-0003-4181-8071				BARON AE, 1993, CANCER EPIDEM BIOMAR, V2, P519; Franceschi S, 2000, ORAL ONCOL, V36, P106, DOI 10.1016/S1368-8375(99)00070-6; Franceschi S, 1996, CANCER EPIDEM BIOMAR, V5, P567; Frisch M, 1999, LANCET, V354, P1442, DOI 10.1016/S0140-6736(99)92824-6; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; HERRERO R, 2000, P 18 INT PAP C BARC, P184; *IARC, 1995, MON EV CARC RISKS HU, V64; McNeil C, 2000, J NATL CANCER I, V92, P680, DOI 10.1093/jnci/92.9.680; MUIR C, 1995, CANCER, V75, P147, DOI 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Snijders PJF, 1997, CLIN DERMATOL, V15, P415, DOI 10.1016/S0738-081X(96)00156-3; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; *WHO, 1999, WHOVB9904; Wilczynski SP, 1998, AM J PATHOL, V152, P145	15	37	37	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2000	356	9233					871	872		10.1016/S0140-6736(00)02673-8	http://dx.doi.org/10.1016/S0140-6736(00)02673-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036888				2022-12-01	WOS:000089259800005
J	Golbe, LI				Golbe, LI			Progressive supranuclear palsy in the molecular age	LANCET			English	Editorial Material							TAU-GENE; NATURAL-HISTORY; SYSTEM; ASSOCIATION; PREVALENCE; DEMENTIA		Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Golbe, LI (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08901 USA.							Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Caparros-Lefebvre D, 1999, LANCET, V354, P281, DOI 10.1016/S0140-6736(98)10166-6; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; Dickson DW, 1997, ANN NEUROL, V42, P541, DOI 10.1002/ana.410420403; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; FLAMENT S, 1991, ACTA NEUROPATHOL, V81, P591, DOI 10.1007/BF00296367; Golbe LI, 1996, NEUROLOGY, V47, P148, DOI 10.1212/WNL.47.1.148; GOLBE LI, 1988, NEUROLOGY, V38, P1031, DOI 10.1212/WNL.38.7.1031; Higgins JJ, 1999, NEUROLOGY, V53, P1421, DOI 10.1212/WNL.53.7.1421; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; LANNUZEL A, 2000, MOV DISORD S3, V15, P28; LITVAN I, 1994, ANN NEUROL, V36, P55, DOI 10.1002/ana.410360112; MAHER ER, 1986, NEUROLOGY, V36, P1005, DOI 10.1212/WNL.36.7.1005; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stanford PM, 2000, BRAIN, V123, P880, DOI 10.1093/brain/123.5.880; SWERDLOW RH, IN PRESS J NEUROCHEM	17	8	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					870	871		10.1016/S0140-6736(00)02672-6	http://dx.doi.org/10.1016/S0140-6736(00)02672-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036887				2022-12-01	WOS:000089259800004
J	Nguyen-Tran, VTB; Kubalak, SW; Minamisawa, S; Fiset, C; Wollert, KC; Brown, AB; Ruiz-Lozano, P; Barrere-Lemaire, S; Kondo, R; Norman, LW; Gourdie, RG; Rahme, MM; Feld, GK; Clark, RB; Giles, WR; Chien, KR				Nguyen-Tran, VTB; Kubalak, SW; Minamisawa, S; Fiset, C; Wollert, KC; Brown, AB; Ruiz-Lozano, P; Barrere-Lemaire, S; Kondo, R; Norman, LW; Gourdie, RG; Rahme, MM; Feld, GK; Clark, RB; Giles, WR; Chien, KR			A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages	CELL			English	Article							LONG-QT SYNDROME; HEART-FAILURE; POTASSIUM CHANNEL; OUTWARD CURRENT; ALPHA-SUBUNIT; MICE; CONNEXIN40; MUSCLE; EXPRESSION; MYOCYTES	HF-1b, an SP1-related transcription factor, is preferentially expressed in the cardiac conduction system and ventricular myocytes in the heart. Mice deficient for HF-1b survive to term and exhibit normal cardiac structure and function but display sudden cardiac death and a complete penetrance of conduction system defects, including spontaneous ventricular tachycardia and a high incidence of AV block. Continuous electrocardiographic recordings clearly documented cardiac arrhythmogenesis as the cause of death. Single-cell analysis revealed an anatomic substrate for arrhythmogenesis, including a decrease and mislocalization of connexins and a marked increase in action potential heterogeneity. Two independent markers reveal defects in the formation of ventricular Purkinje fibers. These studies identify a novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages.	Univ Calif San Diego, Salk Program Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; Univ Calgary, Calgary, AB T2N 4N1, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Medical University of South Carolina; University of Calgary	Chien, KR (corresponding author), Univ Calif San Diego, Salk Program Mol Med, La Jolla, CA 92093 USA.	kchein@ucsd.edu		Nguyen-Tran, Van/0000-0001-5678-1908; Fiset, Celine/0000-0003-2309-4823; Barrere-Lemaire, Stephanie/0000-0002-3742-6975; Minamisawa, Susumu/0000-0003-4728-2116				Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Angst BD, 1997, CIRC RES, V80, P88, DOI 10.1161/01.RES.80.1.88; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Charpentier F, 1998, BIOCHEM BIOPH RES CO, V251, P806, DOI 10.1006/bbrc.1998.9554; Chen J, 1998, DEVELOPMENT, V125, P1943; Cheng G, 1999, DEVELOPMENT, V126, P5041; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; CHIEN KR, 2000, IN PRESS NATURE, V406; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; CURRAN ME, 1999, MOL BASIS CARDIOVASC, P302; DELORME B, 1995, DEV DYNAM, V204, P358, DOI 10.1002/aja.1002040403; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Fiset C, 1997, J PHYSIOL-LONDON, V504, P557, DOI 10.1111/j.1469-7793.1997.557bd.x; Folco E, 1997, J BIOL CHEM, V272, P26505, DOI 10.1074/jbc.272.42.26505; Gourdie RG, 1999, TRENDS CARDIOVAS MED, V9, P18, DOI 10.1016/S1050-1738(98)00035-8; GOURDIE RG, 1993, J CELL SCI, V105, P985; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Jalife J, 1999, TRENDS CARDIOVAS MED, V9, P119, DOI 10.1016/S1050-1738(99)00019-5; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; KUBALAK SW, 1996, METH MOL G, V8, P470; Kupershmidt S, 1999, CIRC RES, V84, P146, DOI 10.1161/01.RES.84.2.146; Litchenberg WH, 2000, CARDIOVASC RES, V45, P379, DOI 10.1016/S0008-6363(99)00363-6; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; MARBAN E, 1999, MOL BASIS CARDIOVASC; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Roden DM, 1999, J CARDIOVASC ELECTR, V10, P1664, DOI 10.1111/j.1540-8167.1999.tb00231.x; Ross RS, 1996, DEVELOPMENT, V122, P1799; Ruiz-Lozano P, 1998, DEVELOPMENT, V125, P533; Simon AM, 1998, CURR BIOL, V8, P295, DOI 10.1016/S0960-9822(98)70113-7; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; van der Velden HMW, 1998, J CARDIOVASC ELECTR, V9, P596; Ward CA, 1997, J PHYSIOL-LONDON, V500, P631, DOI 10.1113/jphysiol.1997.sp022048; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623; Zhou J, 1998, CIRC RES, V83, P806, DOI 10.1161/01.RES.83.8.806; ZHU H, 1993, MOL CELL BIOL, V13, P4432, DOI 10.1128/MCB.13.7.4432; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	38	103	111	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					671	682		10.1016/S0092-8674(00)00089-1	http://dx.doi.org/10.1016/S0092-8674(00)00089-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007485	Bronze			2022-12-01	WOS:000089105200015
J	Pasquinelli, AE; Reinhart, BJ; Slack, F; Martindale, MQ; Kuroda, MI; Maller, B; Hayward, DC; Ball, EE; Degnan, B; Muller, P; Spring, J; Srinivasan, A; Fishman, M; Finnerty, J; Corbo, J; Levine, M; Leahy, P; Davidson, E; Ruvkun, G				Pasquinelli, AE; Reinhart, BJ; Slack, F; Martindale, MQ; Kuroda, MI; Maller, B; Hayward, DC; Ball, EE; Degnan, B; Muller, P; Spring, J; Srinivasan, A; Fishman, M; Finnerty, J; Corbo, J; Levine, M; Leahy, P; Davidson, E; Ruvkun, G			Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA	NATURE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; LIN-14	Two small RNAs regulate the timing of Caenorhabditis elegans development(1,2). Transition from the first to the second larval stage fates requires the 22-nucleotide lin-4 RNA(1,3,4), and transition from late larval to adult cell fates requires the 21-nucleotide let-7 RNA 2. The lin-4 and let-7 RNA genes are not homologous to each other, but are each complementary to sequences in the 3' untranslated regions of a set of protein-coding target genes that are normally negatively regulated by the RNAs1,2,5,6. Here we have detected let-7 RNAs of similar to 21 nucleotides in samples from a wide range of animal species, including vertebrate, ascidian, hemichordate, mollusc, annelid and arthropod, but not in RNAs from several cnidarian and poriferan species, Saccharomyces cerevisiae, Escherichia coli or Arabidopsis. We did not detect lin-4 RNA in these species. We found that let-7 temporal regulation is also conserved: let-7 RNA expression is first detected at late larval stages in C. elegans and Drosophila, at 48 hours after fertilization in zebrafish, and in adult stages of annelids and molluscs. The let-7 regulatory RNA may control late temporal transitions during development across animal phylogeny.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Hawaii, Pacific Biomed Res Ctr, Kewalo Marine Lab, Honolulu, HI 96813 USA; Baylor Univ, Howard Hughes Med Inst, Houston, TX 77030 USA; Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia; Univ Queensland, Dept Zool & Entomol, Brisbane, Qld 4072, Australia; Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Boston Univ, Dept Biol, Boston, MA 02215 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Yale University; University of Hawaii System; Baylor University; Howard Hughes Medical Institute; Australian National University; University of Queensland; University of Basel; Harvard University; Massachusetts General Hospital; Boston University; University of California System; University of California Berkeley; California Institute of Technology	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.		Ball, Eldon E/C-9261-2009	Ball, Eldon E/0000-0002-6052-1495; Hayward, David/0000-0003-2937-2425; Degnan, Bernard/0000-0001-7573-8518; Corbo, Joseph/0000-0002-9323-7140; Slack, Frank/0000-0001-8263-0409; Levine, Michael/0000-0001-7629-0081	NIAMS NIH HHS [P30 AR046032] Funding Source: Medline; NIGMS NIH HHS [R01 GM045744] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045744] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; AMBROS V, 1987, GENE DEV, V1, P398, DOI 10.1101/gad.1.4.398; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	14	1706	1912	11	194	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2000	408	6808					86	89		10.1038/35040556	http://dx.doi.org/10.1038/35040556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	11081512				2022-12-01	WOS:000165050400056
J	Ng, V; Zanazzi, G; Timpl, R; Talts, JF; Salzer, JL; Brennan, PJ; Rambukkana, A				Ng, V; Zanazzi, G; Timpl, R; Talts, JF; Salzer, JL; Brennan, PJ; Rambukkana, A			Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae	CELL			English	Article							ALPHA-DYSTROGLYCAN BINDING; SCHWANN-CELLS; G-DOMAIN; LAMININ; LEPROSY; MEMBRANE; MYELINATION; ADHESION; PERLECAN; RECEPTOR	The cell wall of pathogenic mycobacteria is abundant with complex glycolipids whose roles in disease pathogenesis are mostly unknown. Here, we provide evidence for the involvement of the specific trisaccharide unit of the phenolic glycolipid-1 (PGL-1) of Mycobacterium leprae in determining the bacterial predilection to the peripheral nerve. PGL-1 binds specifically to the native laminin-2 in the basal lamina of Schwann cell-axon units. This binding is mediated by the alpha 2LG1, alpha 2LG4, and alpha 2LG5 modules present in the naturally cleaved fragments of the peripheral nerve laminin alpha2 chain, and is inhibited by the synthetic terminal trisaccharide of PGL-1. PGL-1 is involved in the M. leprae invasion of Schwann cells through the basal lamina in a laminin-2-dependent pathway. The results indicate a novel role of a bacterial glycolipid in determining the nerve predilection of a human pathogen.	Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; NYU Med Ctr, Dept Cell Biol, New York, NY 10016 USA; NYU Med Ctr, Dept Neurol, New York, NY 10016 USA; Max Planck Inst Biochem, Dept Prot Chem, D-82152 Martinsried, Germany; Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA	Rockefeller University; New York University; New York University; Max Planck Society; Colorado State University	Rambukkana, A (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.	rambuka@rockvax.rockefeller.edu		Salzer, James/0000-0001-9126-7197; rambukkana, anura/0000-0002-6286-9145				Adams LB, 2000, INT J LEPROSY, V68, P1; Anderson RJ, 1932, PHYSIOL REV, V12, P0166, DOI 10.1152/physrev.1932.12.2.166; Aumailley M, 1998, J ANAT, V193, P1, DOI 10.1046/j.1469-7580.1998.19310001.x; BRENNAN PJ, 1984, J BIOSCIENCES, V6, P685, DOI 10.1007/BF02702710; BRENNAN PJ, 1989, REV INFECT DIS, V11, pS420; BUNGE MB, 1986, ANN NY ACAD SCI, V486, P241, DOI 10.1111/j.1749-6632.1986.tb48077.x; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; CHAN J, 1989, P NATL ACAD SCI USA, V86, P2453, DOI 10.1073/pnas.86.7.2453; CHATTERJEE D, 1989, INFECT IMMUN, V57, P322, DOI 10.1128/IAI.57.2.322-330.1989; CHATTERJEE D, 1988, CARBOHYD RES, V183, P241, DOI 10.1016/0008-6215(88)84078-3; CHURCH HJ, 1988, BIOCHEM J, V332, P491; Colognato H, 1997, J BIOL CHEM, V272, P29330, DOI 10.1074/jbc.272.46.29330; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; ENGVALL E, 1990, CELL REGUL, V1, P731, DOI 10.1091/mbc.1.10.731; Engvall E, 1996, J CELL BIOCHEM, V61, P493; FUJIWARA T, 1987, CARBOHYD RES, V163, P41, DOI 10.1016/0008-6215(87)80163-5; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; HUNTER SW, 1982, J BIOL CHEM, V257, P5072; HUNTER SW, 1981, J BACTERIOL, V147, P728, DOI 10.1128/JB.147.3.728-735.1981; JOB CK, 1989, INT J LEPROSY, V57, P532; JOHNSON PC, 1997, TXB NEUROPATHOLOGY, P1233; KOLK AHJ, 1985, ANN INST PASTEUR MIC, V136B, P217, DOI 10.1016/S0769-2609(85)80046-6; LUMSDEN CE, 1959, LEPROSY THEORY PRACT, P221; Marques MAM, 1998, INFECT IMMUN, V66, P2625, DOI 10.1128/IAI.66.6.2625-2631.1998; MEHRA V, 1984, NATURE, V308, P194, DOI 10.1038/308194a0; MUKHERJEE R, 1986, INT J LEPROSY, V54, P632; NEILL MA, 1988, J EXP MED, V167, P30, DOI 10.1084/jem.167.1.30; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3; Rambukkana A, 2000, TRENDS MICROBIOL, V8, P23, DOI 10.1016/S0966-842X(99)01647-9; RASTOGI N, 1986, CURR MICROBIOL, V13, P237, DOI 10.1007/BF01568645; Sasaki T, 1999, GUIDEBOOK EXTRACELLU, P434; SCHLESINGER LS, 1991, J EXP MED, V174, P1031, DOI 10.1084/jem.174.5.1031; Shimoji Y, 1999, P NATL ACAD SCI USA, V96, P9857, DOI 10.1073/pnas.96.17.9857; Smith WCS, 1997, LEPROSY REV, V68, P195; STONER GL, 1979, LANCET, V2, P994; Talts JF, 1999, FEBS LETT, V458, P319, DOI 10.1016/S0014-5793(99)01180-1; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Talts JF, 1998, FEBS LETT, V426, P71, DOI 10.1016/S0014-5793(98)00312-3; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; WEBSTER HDF, 1973, DEV BIOL, V32, P401, DOI 10.1016/0012-1606(73)90250-9; *WHO, 1998, WEEKLY EPIDEMIOLO S2, V76, P133; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; YOUNG DB, 1983, SCIENCE, V221, P1057, DOI 10.1126/science.6348948; YURCHENCO PD, 1994, CURR OPIN CELL BIOL, V6, P674, DOI 10.1016/0955-0674(94)90093-0	48	140	143	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 27	2000	103	3					511	524		10.1016/S0092-8674(00)00142-2	http://dx.doi.org/10.1016/S0092-8674(00)00142-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	368YB	11081637	Bronze			2022-12-01	WOS:000090144100016
J	Currie, Z; Bhan, A; Pepper, I				Currie, Z; Bhan, A; Pepper, I			Reliability of Snellen charts for testing visual acuity for driving: prospective study and postal questionnaire	BRITISH MEDICAL JOURNAL			English	Article								Objectives To assess the ability of patients with binocular 6/9 or 6/12 vision on the Snellen chart (Snellen acuity) to read a number plate at 20.5 m (the required standard for driving) and to determine how health professionals advise such patients about driving. Design Prospective study of patients and postal questionnaire to healthcare professionals. Subjects 50 patients with 6/9 vision and 50 with 6/12 vision and 100 general practitioners, 100 optometrists or opticians, and 100 ophthalmologists. Setting Ophthalmology outpatient clinics in Sheffield. Main outcome measures Ability to read a number plate at 20.5 m and health professionals' advice about driving on the basis of visual acuity. Results 26% of patients with 6/9 vision failed the number plate test, and 34% with 6/12 vision passed it Of the general practitioners advising patients with 6/9 vision, 76% said the patients could drive, 13% said they should not drive, and 11% were unsure. Of the general practitioners advising patients with 6/12 vision, 21% said the patients could drive, 54% said they should not drive, and 25% were unsure. The level of acuity at which optometrists, opticians, and ophthalmologists would advise drivers against driving ranged from 6/9(-2) (ability to read all except two letters on the 6/9 line of the Snellen chart) to less than 6/18. Conclusions Snellen acuity is a poor predictor of an individual's ability to meet the required visual standard for driving. Patients with 6/9 vision or less should be warned that they may fail to meet this standard, but those with 6/12 vision should not be assumed to be below the standard.	Royal Hallamshire Hosp, Dept Ophthalmol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Currie, Z (corresponding author), Royal Hallamshire Hosp, Dept Ophthalmol, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.							CHARMAN WN, 1985, OPHTHAL PHYSL OPT, V5, P211, DOI 10.1111/j.1475-1313.1985.tb00658.x; *DEP TRANSP, 1998, CONS TRENDS SURV; DRASDO N, 1981, OPHTHAL PHYSL OPT, V1, P39, DOI 10.1016/0275-5408(81)90060-0; *DRIV VEH LIC AUTH, 1998, GLANC GUID CURR MED, P25; MARSDEN AM, 1966, T ILLUMINATING ENG S, V31, P2; MCCAGHREY GE, 1987, OPTOMETRY TODAY, V27, P178; Shipp M D, 1995, J Am Optom Assoc, V66, P343; Taylor SP, 1997, OPHTHAL PHYSL OPT, V17, P473, DOI 10.1111/j.1475-1313.1997.tb00085.x	8	32	34	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					990	992		10.1136/bmj.321.7267.990	http://dx.doi.org/10.1136/bmj.321.7267.990			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039964	Bronze, Green Published			2022-12-01	WOS:000090035600025
J	Levin, A				Levin, A			Vaccines today	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		1997, PEDIATRICS, V100, P1015; 2000, ANN INTERN MED, V133, P489	2	5	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					661	664		10.7326/0003-4819-133-8-200010170-00102	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00102			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033609				2022-12-01	WOS:000089906300019
J	Hospers, JJ; Postma, DS; Rijcken, B; Weiss, ST; Schouten, JP				Hospers, JJ; Postma, DS; Rijcken, B; Weiss, ST; Schouten, JP			Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study	LANCET			English	Article							NONSPECIFIC BRONCHIAL RESPONSIVENESS; COMMUNITY-BASED POPULATION; SKIN-TEST REACTIVITY; RESPIRATORY SYMPTOMS; HYPERRESPONSIVENESS; DECLINE; EOSINOPHILIA; ATOPY; ADULTS; ASTHMA	Background Smoking and airway lability, which is expressed by histamine airway hyper-responsiveness, are known risk factors for development of respiratory symptoms. Smoking is also associated with increased mortality risks. We studied whether airway hyper-responsiveness is associated with increased mortality, and whether this risk was independent of smoking and reduced lung function. Methods We followed up 2008 inhabitants of the communities of Vlagtwedde, Vlaardingen, and Meppel (Netherlands), who had histamine challenge test data, from 1964-72 for 30 years. Follow-up was 99% successful (29 patients lost to follow-up) with 1453 participants alive and 526 deaths (246 died from cardiovascular disease, 54 from lung cancer, and 21 from chronic obstructive pulmonary disease [COPD]). Findings Mortality from COPD increased with more severe hyper-responsiveness; relative risks of 3.83 (95% CI 0.97-15.1), 4.40 (1.16-16.7), 4.78 (1.27-18.0), 6.69 (1.71-26.1), and 15.8 (3.72-67.1) were associated with histamine thresholds of 32 g/L, 16 g/L, 8 g/L, 4 g/L, and 1 g/L, respectively, compared with no hyper-responsiveness. These risks were adjusted for sex, age, smoking, lung function, body-mass index, positive skin tests, eosinophilia, asthma, and city of residence. Interpretation Increased histamine airway hyperresponsiveness predicts mortality from COPD. Although this trend was more pronounced in smokers, an increasing proportion of COPD deaths with increasing hyperresponsiveness was also present among individuals who had never smoked.	Univ Groningen, Dept Epidemiol & Stat, NL-9713 AV Groningen, Netherlands; Univ Groningen, Dept Pulmonol, NL-9713 AV Groningen, Netherlands; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA USA	University of Groningen; University of Groningen; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Schouten, JP (corresponding author), Univ Groningen, Dept Epidemiol & Stat, NL-9713 AV Groningen, Netherlands.	j.p.schouten@med.rug.nl			NHLBI NIH HHS [R03 HL49460] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL049460] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANNESI I, 1987, B EUR PHYSIOPATH RES, V23, P397; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; BEATY TH, 1985, J CHRON DIS, V38, P703, DOI 10.1016/0021-9681(85)90024-4; *BRIT MRC COMM RES, 1966, INSTR US QUEST RESP; Burchfiel CM, 1997, CHEST, V112, P87, DOI 10.1378/chest.112.1.87; CHAILLEUX E, 1992, REV MAL RESPIR, V9, P603; COX DR, 1972, J R STAT SOC B, V34, P187; DEVRIES K, 1962, INT ARCH ALLER A IMM, V20, P93, DOI 10.1159/000229248; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; EISER NM, 1983, B EUR PHYSIOPATH RES, V19, P495; Freund K M, 1993, Ann Epidemiol, V3, P417, DOI 10.1016/1047-2797(93)90070-K; HOPP RJ, 1990, AM REV RESPIR DIS, V141, P2, DOI 10.1164/ajrccm/141.1.2; Hospers JJ, 1999, AM J EPIDEMIOL, V150, P482; Jansen DF, 1997, RESP MED, V91, P121, DOI 10.1016/S0954-6111(97)90048-2; MACKENBACH JP, 1988, GEZONDHEIDSZORG VERM, P329; MACKENBACH JP, 1988, MORTALITY MED CARE; Mensinga Tjeert T., 1994, Annals of Epidemiology, V4, P382; MENSINGA TT, 1992, AM REV RESPIR DIS, V146, P638, DOI 10.1164/ajrccm/146.3.638; MENSINGA TT, 1990, J ALLERGY CLIN IMMUN, V86, P99, DOI 10.1016/S0091-6749(05)80129-0; OCONNOR GT, 1989, AM REV RESPIR DIS, V140, P225, DOI 10.1164/ajrccm/140.1.225; PARKER DR, 1990, AM REV RESPIR DIS, V141, P589, DOI 10.1164/ajrccm/141.3.589; POSTMA DS, 1991, AM REV RESPIR DIS, V143, P1458, DOI 10.1164/ajrccm/143.6.1458; Postma DS, 1997, EUR RESPIR REV, V7, P159; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; RIJCKEN B, 1987, AM REV RESPIR DIS, V136, P62, DOI 10.1164/ajrccm/136.1.62; RIJCKEN B, 1995, AM J RESP CRIT CARE, V151, P1377, DOI 10.1164/ajrccm.151.5.7735588; SPARROW D, 1987, AM REV RESPIR DIS, V135, P1255; VANDERLENDE R, 1972, SCAND J RESPIR DIS, V53, P218; VANDERLENDE R, 1981, CLIN RES PROC, V17, P775; VANDERLENDE R, 1969, EPIDEMIOLOGY CHRONIC; VILLAR MTA, 1995, AM J RESP CRIT CARE, V151, P656, DOI 10.1164/ajrccm/151.3_Pt_1.656; WEISS ST, 1995, AM J EPIDEMIOL, V142, P493, DOI 10.1093/oxfordjournals.aje.a117665; Xu XP, 1997, LANCET, V350, P1431, DOI 10.1016/S0140-6736(97)10041-1	33	146	155	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2000	356	9238					1313	1317		10.1016/S0140-6736(00)02815-4	http://dx.doi.org/10.1016/S0140-6736(00)02815-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VL	11073020	Bronze			2022-12-01	WOS:000089858300012
J	Lara-Tejero, M; Galan, JE				Lara-Tejero, M; Galan, JE			A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein	SCIENCE			English	Article							CYTOLETHAL DISTENDING TOXIN; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; SALMONELLA-TYPHIMURIUM; CAMPYLOBACTER-JEJUNI; HAEMOPHILUS-DUCREYI; CLONING; GENES; CDT	Many bacterial pathogens encode a multisubunit toxin, termed cytolethal distending toxin (CDT), that induces cell cycle arrest, cytoplasm distention, and, eventually, chromatin fragmentation and cell death. In one such pathogen, Campylobacter jejuni, one of the subunits of this toxin, CdtB, was shown to exhibit features of type I deoxyribonucleases. Transient expression of this subunit in cultured cells caused marked chromatin disruption. Microinjection of Low amounts of CdtB induced cytoplasmic distention and cell cycle arrest. CdtB mutants with substitutions in residues equivalent to those required for catalysis or magnesium binding in type I deoxyribonucleases did not cause chromatin disruption. CDT holotoxin containing these mutant forms of CdtB did not induce morphological changes or cell cycle arrest.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yate.edu						Collazo CM, 1996, INFECT IMMUN, V64, P3524, DOI 10.1128/IAI.64.9.3524-3531.1996; Comayras C, 1997, INFECT IMMUN, V65, P5088, DOI 10.1128/IAI.65.12.5088-5095.1997; Cope LD, 1997, P NATL ACAD SCI USA, V94, P4056, DOI 10.1073/pnas.94.8.4056; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Evans SJ, 1999, BIOCHEMISTRY-US, V38, P3902, DOI 10.1021/bi9824893; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P115, DOI 10.1016/0882-4010(88)90053-8; Jones SJ, 1996, J MOL BIOL, V264, P1154, DOI 10.1006/jmbi.1996.0703; Liu QY, 1999, ANN NY ACAD SCI, V887, P60, DOI 10.1111/j.1749-6632.1999.tb07922.x; Mayer MPA, 1999, INFECT IMMUN, V67, P1227, DOI 10.1128/IAI.67.3.1227-1237.1999; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; OKUDA J, 1995, MICROB PATHOGENESIS, V18, P167, DOI 10.1016/S0882-4010(95)90022-5; Peres SY, 1997, MOL MICROBIOL, V24, P1095, DOI 10.1046/j.1365-2958.1997.4181785.x; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; PICKETT CL, 1994, INFECT IMMUN, V62, P1046, DOI 10.1128/IAI.62.3.1046-1051.1994; Pickett CL, 1996, INFECT IMMUN, V64, P2070, DOI 10.1128/IAI.64.6.2070-2078.1996; SCOTT DA, 1994, INFECT IMMUN, V62, P244, DOI 10.1128/IAI.62.1.244-251.1994; Sert V, 1999, ONCOGENE, V18, P6296, DOI 10.1038/sj.onc.1203007; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Young VB, 2000, INFECT IMMUN, V68, P184, DOI 10.1128/IAI.68.1.184-191.2000; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	27	398	411	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2000	290	5490					354	357		10.1126/science.290.5490.354	http://dx.doi.org/10.1126/science.290.5490.354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030657				2022-12-01	WOS:000089818100049
J	Wilkins, MR; Gibbs, JSR; Shovlin, CL				Wilkins, MR; Gibbs, JSR; Shovlin, CL			A gene for primary pulmonary hypertension	LANCET			English	Editorial Material							ENDOGLIN; PROTEIN		Hammersmith Hosp, Imperial Coll, Sch Med, London W12 0NN, England	Imperial College London	Wilkins, MR (corresponding author), Hammersmith Hosp, Imperial Coll, Sch Med, London W12 0NN, England.							Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; Soda H, 1998, ANTI-CANCER DRUG, V9, P327, DOI 10.1097/00001813-199804000-00006	9	12	13	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2000	356	9237					1207	1208		10.1016/S0140-6736(00)02777-X	http://dx.doi.org/10.1016/S0140-6736(00)02777-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	361LQ	11072932				2022-12-01	WOS:000089724900003
J	Lee, JT				Lee, JT			Disruption of imprinted X inactivation by parent-of-origin effects at Tsix	CELL			English	Article							BECKWITH-WIEDEMANN-SYNDROME; METHYLATED CPG ISLAND; CHROMOSOME INACTIVATION; DNA METHYLATION; MOUSE EMBRYOS; EXPRESSED TRANSCRIPT; DOSAGE COMPENSATION; XIST EXPRESSION; CONTROL REGION; SNRPN GENE	In marsupials and in extraembryonic tissues of placental mammals, X inactivation is imprinted to occur on the paternal chromosome. Here, we find that imprinting is controlled by the antisense Xist gene, Tsix. Tsix is maternally expressed and mice carrying a Tsix deletion show normal paternal but impaired maternal transmission. Maternal inheritance occurs infrequently, with surviving progeny showing intrauterine growth retardation and reduced fertility. Transmission ratio distortion results from disrupted imprinting and postimplantation loss of mutant embryos. In contrast to effects in embryonic stem cells, deleting Tsix causes ectopic X inactivation in early male embryos and inactivation of both X chromosomes in female embryos, indicating that X chromosome counting cannot override Tsix imprinting. These results highlight differences between imprinted and random X inactivation but show that Tsix regulates both. We propose that an imprinting center lies within Tsix.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu			NIGMS NIH HHS [R01-GM58839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bielinska B, 2000, NAT GENET, V25, P74, DOI 10.1038/75629; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; Goto Y, 2000, CHROMOSOME RES, V8, P101, DOI 10.1023/A:1009234217981; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HUNT PA, 1991, DEVELOPMENT, V111, P1137; Jamieson RV, 1998, DEV BIOL, V201, P13, DOI 10.1006/dbio.1998.8972; Jones BK, 1998, GENE DEV, V12, P2200, DOI 10.1101/gad.12.14.2200; KASLOW DC, 1987, P NATL ACAD SCI USA, V84, P6210, DOI 10.1073/pnas.84.17.6210; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Latham KE, 1996, TRENDS GENET, V12, P134, DOI 10.1016/0168-9525(96)10017-2; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; LYON MF, 1971, NATURE-NEW BIOL, V232, P229, DOI 10.1038/newbio232229a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MCMAHON A, 1983, J EMBRYOL EXP MORPH, V74, P207; MIGEON BR, 1989, EXP CELL RES, V182, P597, DOI 10.1016/0014-4827(89)90262-0; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; OHNO S, 1969, ANNU REV GENET, V3, P495, DOI 10.1146/annurev.ge.03.120169.002431; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Schmidt JV, 1999, P NATL ACAD SCI USA, V96, P9733, DOI 10.1073/pnas.96.17.9733; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Solter D, 1997, GENE DEV, V11, P153, DOI 10.1101/gad.11.2.153; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tada T, 2000, DEVELOPMENT, V127, P3101; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; THORNHILL AR, 1993, DEVELOPMENT, V118, P171; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; Willard HF, 1996, CELL, V86, P5, DOI 10.1016/S0092-8674(00)80071-9; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	56	232	246	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2000	103	1					17	27		10.1016/S0092-8674(00)00101-X	http://dx.doi.org/10.1016/S0092-8674(00)00101-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051544	Bronze			2022-12-01	WOS:000089636400005
J	Parmanum, J; Field, D; Rennie, J; Steer, P				Parmanum, J; Field, D; Rennie, J; Steer, P		Brit Assoc Perinatal Med	National census of availability of neonatal intensive care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COTS	Objective To determine whether availability of neonatal intensive care cots is a problem in any or all parts of the United Kingdom. Design Three month census fi-om 1 April to 30 June 1999 comprising simple data sheets on transfers out of tertiary units. Setting The 37 largest high risk perinatal centres in the United Kingdom. Participants One obstetric specialist and one neonatal specialist in each centre. Main outcome measures Suboptimal care resulting directly from pressure on service-that is, transfers out of tertiary units (either in utero or after delivery) because the unit was "full" and not because the hospital was incapable of providing the care needed. Results All units provided data. The number of intensive care cots in each unit was between five and 16. During the three months 309 transfers occurred (equivalent to 1236 per year), of which 264 were in utero and 45 postnatal. Sixty five in utero transfers involved multiple births, hence the census related to 382 babies (1528 per year). There was considerable regional variation. The reason for transfer in most cases was "lack of neonatal beds". Conclusions Currently most major perinatal centres in the United Kingdom are regularly unable to meet in-house demand; this has implications for the service as a whole. The NHS has set no standards to help health authorities and primary care groups develop services relating to this specialty; such a step may well be an appropriate lever for change.	Univ Leicester, Dept Child Hlth, Leicester LE2 7LX, Leics, England; Kings Coll Hosp London, London SE5 9RS, England; Imperial Coll Sch Med, London W2 1PG, England	University of Leicester; King's College Hospital NHS Foundation Trust; King's College Hospital; Imperial College London	Field, D (corresponding author), Univ Leicester, Dept Child Hlth, Robert Kilpatrick Clin Sci Bldg, Leicester LE2 7LX, Leics, England.	dfield@lri.org.uk						BURTON P, 1995, J EPIDEMIOL PUBLIC H, V48, P617; *CLIN STAND ADV GR, 1993, ACC AV NEON INT CAR; *DEP EP PUBL HLTH, 1999, TRENT NEON SURV 1998; Field D, 1999, ARCH DIS CHILD-FETAL, V80, pF111, DOI 10.1136/fn.80.2.F111; FIELD DJ, 1989, BRIT MED J, V299, P1305, DOI 10.1136/bmj.299.6711.1305; MCINTOSH N, 1989, BRIT MED J, V298, P169; MCLOUGHLIN A, 1993, ARCH DIS CHILD-FETAL, V68, P597, DOI 10.1136/adc.68.5_Spec_No.597; Milligan DWA, 1997, ARCH DIS CHILD-FETAL, V76, pF197, DOI 10.1136/fn.76.3.F197; MORRIS D, 1993, ARCH DIS CHILD-FETAL, V68, P544; National Association of Health Authorities, 1993, REINV HLTH CAR NEW M; *ROYAL COLL PHYS, 1988, MED CAR NEWB ENGL WA; SIMPSON H, 1981, ARCH DIS CHILD, V56, P90, DOI 10.1136/adc.56.2.90; 1999, TIMES           0803	13	39	40	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2000	321	7263					727	729		10.1136/bmj.321.7263.727	http://dx.doi.org/10.1136/bmj.321.7263.727			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999901	Green Published			2022-12-01	WOS:000089546600018
J	Hujoel, PP; Drangsholt, M; Spiekerman, C; DeRouen, TA				Hujoel, PP; Drangsholt, M; Spiekerman, C; DeRouen, TA			Periodontal disease and coronary heart disease risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; DENTAL DISEASE; CARDIOVASCULAR-DISEASE; INFECTION; HEALTH; ATHEROSCLEROSIS; INFORMATION; MORTALITY; PATHOGENS; INVASION	Context Research has suggested a relationship between periodontal disease and coronary heart disease (CHD), but data on the association between these 2 common conditions are inconclusive due to the possibility of confounding. Objective To evaluate the risk of CHD in persons with periodontitis, gingivitis, or no periodontal disease. Design Prospective cohort study. Setting The First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, conducted in 1982-1984, 1986, 1987, and 1992. Participants A total of 8032 dentate adults aged 25 to 74 years with no reported history of cardiovascular disease, including 1859 individuals with periodontitis, 2421 with gingivitis, and 3752 with healthy periodontal tissues. Main Outcome Measure First occurrence of death from CHD or hospitalization due to CHD, or revascularization procedures, obtained from death certificates and medical records, by baseline periodontal status. Results During follow-up, 1265 individuals had at least 1 CHD event, including CHD fatality (n=468) or at least 1 hospitalization with a diagnosis of CHD (n=1022), including coronary revascularization procedures (n=155). After adjustment for known cardiovascular risk factors, gingivitis was not associated with CHD (hazard ratio, 1.05; 95% confidence interval. 0.88-1.26), while periodontitis was associated with a nonsignificant increased risk for CHD event (hazard ratio, 1.14; 95% confidence interval, 0.96-1.36). Conclusion This study did not find convincing evidence of a causal association be tween periodontal disease and CHD risk.	Univ Washington, Sch Dent, Dept Dent Publ Hlth Sci, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Dent, Dept Oral Med, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hujoel, PP (corresponding author), Univ Washington, Sch Dent, Dept Dent Publ Hlth Sci, Box 357475, Seattle, WA 98195 USA.			Hujoel, Philippe/0000-0002-4040-104X	NIDCR NIH HHS [P30-DE09743, R29-DE12190] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE012190, P30DE009743] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Albandar JM, 1999, J PERIODONTOL, V70, P30, DOI 10.1902/jop.1999.70.1.30; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Beck J D, 1998, Ann Periodontol, V3, P127, DOI 10.1902/annals.1998.3.1.127; Breslow RA, 1999, ANN EPIDEMIOL, V9, P254, DOI 10.1016/S1047-2797(98)00071-4; Christen WG, 1998, CIRCULATION, V97, P821; Danesh J, 1999, AM HEART J, V138, pS434, DOI 10.1016/S0002-8703(99)70270-X; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Deshpande RG, 1998, INFECT IMMUN, V66, P5337, DOI 10.1128/IAI.66.11.5337-5343.1998; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; Dorn BR, 1999, INFECT IMMUN, V67, P5792, DOI 10.1128/IAI.67.11.5792-5798.1999; Graubard BL, 1999, JNCI-J NATL CANCER I, V91, P1005, DOI 10.1093/jnci/91.12.1005; Herzberg M C, 1998, Ann Periodontol, V3, P151, DOI 10.1902/annals.1998.3.1.151; Herzberg MC, 1996, J PERIODONTOL, V67, P1138, DOI 10.1902/jop.1996.67.10s.1138; Joshipura K J, 1998, Ann Periodontol, V3, P175, DOI 10.1902/annals.1998.3.1.175; Joshipura KJ, 1996, J DENT RES, V75, P1631, DOI 10.1177/00220345960750090301; KISH L, 1974, J ROY STAT SOC B MET, V36, P1; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; KRONMAL RA, 1993, J ROY STAT SOC A STA, V156, P379, DOI 10.2307/2983064; KWEIDER M, 1993, SCOT MED J, V38, P73, DOI 10.1177/003693309303800304; MACHLIN SR, 1989, STAT MED, V8, P997, DOI 10.1002/sim.4780080810; MACLURE M, 1990, INT J EPIDEMIOL, V19, P782, DOI 10.1093/ije/19.4.782; MATTILA KJ, 1993, EUR HEART J, V14, P51; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Mattila KJ, 1998, CLIN INFECT DIS, V26, P719, DOI 10.1086/514570; MCLAUGHLIN JK, 1987, AM J EPIDEMIOL, V126, P144, DOI 10.1093/oxfordjournals.aje.a114647; Meyer DH, 1998, CURR OPIN MICROBIOL, V1, P88, DOI 10.1016/S1369-5274(98)80147-1; Morrison HI, 1999, J CARDIOVASC RISK, V6, P7; Newman HN, 1998, INT DENT J, V48, P173, DOI 10.1111/j.1875-595X.1998.tb00474.x; RUSSELL A. L., 1956, JOUR DENTAL RES, V35, P350, DOI 10.1177/00220345560350030401; SHAH BV, 1997, SUDAAN USERS MANUAL; Slavkin HC, 1999, J AM DENT ASSOC, V130, P109, DOI 10.14219/jada.archive.1999.0038; Slots J, 1998, J DENT RES, V77, P1764, DOI 10.1177/00220345980770100101; VALTONEN VV, 1991, ANN MED, V23, P539, DOI 10.3109/07853899109150515; WU T, 1999, CIRCULATION, V99, P8	34	293	301	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2000	284	11					1406	1410		10.1001/jama.284.11.1406	http://dx.doi.org/10.1001/jama.284.11.1406			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352WN	10989403	Bronze			2022-12-01	WOS:000089242500035
J	Dalgaard, JZ; Klar, AJS				Dalgaard, JZ; Klar, AJS			swi1 and swi3 perform imprinting, pausing, and termination of DNA replication in S-pombe	CELL			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; SWITCHING GENES; PROTEIN; CELLS; VIABILITY; MECHANISM; ASYMMETRY; BINDING	The developmental program of cell-type switching of S. pombe requires a strand-specific imprinting event at the mating-type locus (mat1). Imprinting occurs only when mat1 is replicated in a specific direction and requires several trans-acting factors. This work shows (1) that the factors swi1p and swi3p act by pausing the replication fork at the imprinting site; and (2) that swi1p and swi3p are involved in termination at the mat1-proximal polar-terminator of replication (RTS1). A genetic screen to identify termination factors identified an allele that separated pausing/imprinting and termination functions of swi1p. These results suggest that swi1p and swi3p promote imprinting in novel ways both by pausing replication at mat1 and by terminating replication at RTS1.	NCI, DHHS, Div Basic Sci,Gene Regulat & Chromosome Biol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Klar, AJS (corresponding author), NCI, DHHS, Div Basic Sci,Gene Regulat & Chromosome Biol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA.	klar@mail.ncifcfr.gov		Dalgaard, Jacob/0000-0001-9545-7254				Arcangioli B, 1998, EMBO J, V17, P4503, DOI 10.1093/emboj/17.15.4503; ARCANGIOLI B, 1994, MOL CELL BIOL, V14, P2058, DOI 10.1128/MCB.14.3.2058; ARCANGIOLI B, 1991, EMBO J, V10, P3025, DOI 10.1002/j.1460-2075.1991.tb07853.x; BEACH DH, 1983, NATURE, V305, P682, DOI 10.1038/305682a0; BEACH DH, 1984, EMBO J, V3, P603, DOI 10.1002/j.1460-2075.1984.tb01855.x; Bussiere DE, 1999, MOL MICROBIOL, V31, P1611, DOI 10.1046/j.1365-2958.1999.01287.x; Dalgaard LZ, 1999, NATURE, V400, P181, DOI 10.1038/22139; Duggin IG, 1999, J MOL BIOL, V286, P1325, DOI 10.1006/jmbi.1999.2553; EGEL R, 1984, P NATL ACAD SCI-BIOL, V81, P3481, DOI 10.1073/pnas.81.11.3481; EGEL R, 1987, CURR GENET, V12, P429, DOI 10.1007/BF00434820; Egel R., 1989, MOL BIOL FISSION YEA, P31; GUTZ H, 1985, CURR GENET, V9, P325, DOI 10.1007/BF00421601; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; KLAR AJS, 1990, EMBO J, V9, P1407, DOI 10.1002/j.1460-2075.1990.tb08256.x; KLAR AJS, 1987, NATURE, V326, P466, DOI 10.1038/326466a0; KLAR AJS, 1993, COLD SPRING HARB SYM, V58, P457, DOI 10.1101/SQB.1993.058.01.052; Klar AJS, 1998, CIBA F SYMP, V214, P87; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Lakin-Thomas PL, 2000, TRENDS GENET, V16, P135, DOI 10.1016/S0168-9525(99)01945-9; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; MEADE JH, 1975, GENETICS, V80, P711; MIYATA H, 1981, J GEN APPL MICROBIOL, V27, P365, DOI 10.2323/jgam.27.365; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORHAM SG, 1992, J BIOL CHEM, V267, P15984; NIELSEN O, 1989, EMBO J, V8, P269, DOI 10.1002/j.1460-2075.1989.tb03373.x; Park H, 1999, YEAST, V15, P35, DOI 10.1002/(SICI)1097-0061(19990115)15:1<35::AID-YEA340>3.3.CO;2-I; SCHMIDT H, 1987, MOL GEN GENET, V210, P485, DOI 10.1007/BF00327201; SCHMIDT H, 1987, CURR GENET, V11, P303, DOI 10.1007/BF00355404; SINGH J, 1993, NATURE, V361, P271, DOI 10.1038/361271a0; STYRKARSDOTTIR U, 1993, CURR GENET, V23, P184, DOI 10.1007/BF00352020; UEMURA T, 1987, NUCLEIC ACIDS RES, V15, P9727, DOI 10.1093/nar/15.23.9727	32	122	126	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					745	751		10.1016/S0092-8674(00)00063-5	http://dx.doi.org/10.1016/S0092-8674(00)00063-5			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030618	Bronze			2022-12-01	WOS:000089395200006
J	Smith, O				Smith, O			Biomedicine - Sleep, eat, and be merry	SCIENCE			English	Editorial Material							NARCOLEPSY											Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; THANNICKAL T, IN PRESS NEURON	4	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1706	1706		10.1126/science.289.5485.1706	http://dx.doi.org/10.1126/science.289.5485.1706			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	11001739				2022-12-01	WOS:000089195200036
J	Krebs, JE; Fry, CJ; Samuels, ML; Peterson, CL				Krebs, JE; Fry, CJ; Samuels, ML; Peterson, CL			Global role for chromatin remodeling enzymes in mitotic gene expression	CELL			English	Article							HISTONE ACETYLTRANSFERASE COMPLEXES; YEAST SACCHAROMYCES-CEREVISIAE; POLYMERASE-II HOLOENZYME; SWI-SNF COMPLEX; SWI/SNF COMPLEX; IN-VIVO; TRANSCRIPTION FACTOR; ACTIVATOR-BINDING; PHO5 PROMOTER; HO GENE	Regulation of eukaryotic gene expression requires ATP-dependent chromatin remodeling enzymes, such as SWI/SNF, and histone acetyltransferases, such as Gcn5p. Here we show that SWI/SNF remodeling controls recruitment of Gcn5p HAT activity to many genes in late mitosis and that these chromatin remodeling enzymes play a role in regulating mitotic exit. In contrast, interphase expression of GAL1, HIS3, PHO5, and PHO8 is accompanied by SWI/SNF-independent recruitment of Gcn5p HAT activity. Surprisingly, prearresting cells in late mitosis imposes a requirement for SWI/SNF in recruiting Gcn5p HAT activity to the GAL1 promoter, and GAL1 expression also becomes dependent on both chromatin remodeling enzymes. We propose that SWI/SNF and Gcn5p are globally required for mitotic gene expression due to the condensed state of mitotic chromatin.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Peterson, CL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.				NIGMS NIH HHS [GM49650, R01 GM049650, R37 GM049650] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049650, R37GM049650] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aerne BL, 1998, MOL BIOL CELL, V9, P945, DOI 10.1091/mbc.9.4.945; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Burns LG, 1997, MOL CELL BIOL, V17, P4811, DOI 10.1128/MCB.17.8.4811; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Drysdale CM, 1998, MOL CELL BIOL, V18, P1711, DOI 10.1128/MCB.18.3.1711; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Filetici P, 1998, BIOCHEM BIOPH RES CO, V242, P84, DOI 10.1006/bbrc.1997.7918; Fry CJ, 1999, J BIOL CHEM, V274, P15883, DOI 10.1074/jbc.274.22.15883; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Kovacech B, 1996, MOL CELL BIOL, V16, P3264; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kuo CH, 1996, IEEE SIGNAL PROC LET, V3, P269, DOI 10.1109/97.536598; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Massari ME, 1999, MOL CELL, V4, P63, DOI 10.1016/S1097-2765(00)80188-4; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; Roberts SM, 1997, GENETICS, V147, P451; SAWA H, 2000, IN PRESS MOL CELL; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Sirri V, 2000, J CELL BIOL, V148, P259, DOI 10.1083/jcb.148.2.259; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; TOONE WM, 1995, EMBO J, V14, P5824, DOI 10.1002/j.1460-2075.1995.tb00270.x; Toyn JH, 1997, GENETICS, V145, P85; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	53	189	195	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 1	2000	102	5					587	598		10.1016/S0092-8674(00)00081-7	http://dx.doi.org/10.1016/S0092-8674(00)00081-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007477	Bronze			2022-12-01	WOS:000089105200007
J	Su, Y; Swift, M				Su, Y; Swift, M			Mortality rates among carriers of ataxia-telangiectasia mutant alleles	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST-CANCER-SUSCEPTIBILITY; ATM GENE; EARLY-ONSET; CELL-CYCLE; MUTATIONS; HETEROZYGOTES; FAMILIES; RISK; PHENOTYPES; DEATH	Background: Mutations at the ataxia-telangiectasia locus cause a distinctive autosomal recessive syndrome in homozygotes and predispose heterozygotes to cancer and ischemic heart disease. Objective: To examine mortality rates among persons carrying a mutated ataxia-telangiectasia gene. Design: Retrospective cohort study. Setting: The United States and Canada. Participants: 405 grandparents of patients with ataxia-telangiectasia. Measurements: Ages at death and risk for death (from all causes, cancer, ischemic heart disease, and other causes) among carriers and noncarriers of ataxia-telangiectasia mutations. Results: Compared with noncarriers, carriers of a mutated ataxia-telangiectasia allele had a significantly increased risk for death at 20 through 79 years of age (relative risk, 1.9 [95% CI, 1.3 to 2.8]) (P < 0.001). On average, carriers died 7 to 8 years earlier than noncarriers. Cancer caused most of the excess deaths, and ischemic heart disease caused the remainder. Among carriers, relative risk for death from cancer and ischemic heart disease before 80 years of age was 2.6 (CI, 1.4 to 4.7; P = 0.002) and 2.0 (CI, 1.0 to 4.0; P = 0.062), respectively. Compared with noncarriers, carriers who died of cancer were a mean of 4 years younger (P > 0.2) and carriers who died of ischemic heart disease were a mean of 11 years younger (P = 0.006). Conclusion: Carriers of mutations at the ataxia-telangiectasia locus, who make up 1.4% to 2% of the general population, have a higher mortality rate and an earlier age at death from cancer and ischemic heart disease than noncarriers.	New York Med Coll, Inst Genet Anal Common Dis, Hawthorne, NY 10532 USA	New York Medical College	Su, Y (corresponding author), New York Med Coll, Inst Genet Anal Common Dis, 4 Skyline Dr, Hawthorne, NY 10532 USA.				NCI NIH HHS [CA 14235] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA014235] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLISON PD, 1995, SURVIVAL ANAL USING, P192; Allison PD, 1995, SURVIVAL ANAL USING, P155; Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Bebb DG, 1999, BRIT J CANCER, V80, P1979, DOI 10.1038/sj.bjc.6690630; Bishop DT, 1997, NAT GENET, V15, P226, DOI 10.1038/ng0397-226; BORRESEN AL, 1990, GENE CHROMOSOME CANC, V2, P339, DOI 10.1002/gcc.2870020412; Broeks A, 2000, AM J HUM GENET, V66, P494, DOI 10.1086/302746; Buzin CH, 2000, BIOTECHNIQUES, V28, P746, DOI 10.2144/00284rr04; Chen JD, 1998, CANCER RES, V58, P1376; Concannon P, 1997, HUM MUTAT, V10, P100, DOI 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O; CONCANNON P, 2000, ATAXIA TELANGIECTASI; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; COX DR, 1972, J R STAT SOC B, V34, P187; DORK T, 1999, AM J HUM GENET, V65, pA14; DORK T, 1999, 8 INT WORKSH AT TEL; Ederer F, 1999, J CLIN EPIDEMIOL, V52, P447, DOI 10.1016/S0895-4356(99)00016-5; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Gatti RA, 1999, MOL GENET METAB, V68, P419, DOI 10.1006/mgme.1999.2942; HANSEN ES, 1990, MUTAT RES, V239, P163, DOI 10.1016/0165-1110(90)90004-U; Inskip HM, 1999, BRIT J CANCER, V79, P1304, DOI 10.1038/sj.bjc.6690209; Izatt L, 1999, GENE CHROMOSOME CANC, V26, P286, DOI 10.1002/(SICI)1098-2264(199912)26:4<286::AID-GCC2>3.0.CO;2-X; Janin N, 1999, BRIT J CANCER, V80, P1042, DOI 10.1038/sj.bjc.6690460; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI, P122; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI, P168; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI, P189; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KELSEY JL, 1986, METHODS OBSERVATIONA; Kleinbaum D.G., 1982, EPIDEMIOLOGIC RES PR, P1; Klopper Karin, 2000, European Journal of Human Genetics, V8, P109; Larson GP, 1997, GENET TEST, V1, P165, DOI 10.1089/gte.1997.1.165; Li AR, 2000, AM J MED GENET, V92, P170, DOI 10.1002/(SICI)1096-8628(20000529)92:3<170::AID-AJMG3>3.0.CO;2-#; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; McConville CM, 1996, AM J HUM GENET, V59, P320; MEHTA CR, 1994, BIOMETRICS, V50, P1042, DOI 10.2307/2533442; Meyn MS, 1999, CLIN GENET, V55, P289, DOI 10.1034/j.1399-0004.1999.550501.x; Morgan SE, 1997, ADV CANCER RES, V71, P1, DOI 10.1016/S0065-230X(08)60095-0; MORRELL D, 1990, CANCER GENET CYTOGEN, V50, P119, DOI 10.1016/0165-4608(90)90245-6; MORRELL D, 1986, J NATL CANCER I, V77, P89; NAKAMURA T, 1992, BIOMETRICS, V48, P829, DOI 10.2307/2532348; Nakamura Y, 1998, NAT MED, V4, P1231, DOI 10.1038/3207; Nasrin N, 1997, ARTERIOSCL THROM VAS, V17, P947, DOI 10.1161/01.ATV.17.5.947; PIPPARD EC, 1988, CANCER RES, V48, P2929; Sambrook J, 1989, MOL CLONING LABORATO, p1 25; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Stankovic T, 1999, LANCET, V353, P26, DOI 10.1016/S0140-6736(98)10117-4; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; SWIFT M, 1976, CANCER RES, V36, P209; SWIFT M, 1983, LANCET, V1, P1049; SWIFT M, 1993, ADV NEUROL, V61, P115; SWIFT M, 1990, CANCER GENET CYTOGEN, V46, P21, DOI 10.1016/0165-4608(90)90004-T; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1986, AM J HUM GENET, V39, P573; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Telatar M, 1998, AM J HUM GENET, V62, P86, DOI 10.1086/301673; TERAOKA SN, 1999, 8 INT WORKSH AT TEL; Vorechovsky I, 1996, CANCER RES, V56, P2726	57	114	116	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2000	133	10					770	778		10.7326/0003-4819-133-10-200011210-00009	http://dx.doi.org/10.7326/0003-4819-133-10-200011210-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374AA	11085839				2022-12-01	WOS:000165321200002
J	Lawlor, PG; Fainsinger, RL; Bruera, ED				Lawlor, PG; Fainsinger, RL; Bruera, ED			Delirium at the end of life - Critical issues in clinical practice and research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ELDERLY HOSPITALIZED-PATIENTS; ILL CANCER-PATIENTS; COGNITIVE FAILURE; PREDICTIVE MODEL; MEDICAL PATIENTS; DIAGNOSIS; SUBTYPES; PAIN		Grey Nuns Community Hlth Ctr & Hosp, Edmonton Reg Palliat Care Program, Edmonton, AB T6L 5X8, Canada; Univ Alberta, Dept Oncol, Div Palliat Care Med, Edmonton, AB, Canada; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ Texas, Dept Symptom Control & Palliat Care, Houston, TX 77030 USA	University of Alberta; University of Texas System; UTMD Anderson Cancer Center; University of Texas System	Lawlor, PG (corresponding author), Grey Nuns Community Hlth Ctr & Hosp, Edmonton Reg Palliat Care Program, Room 5211,1100 Youville Dr W, Edmonton, AB T6L 5X8, Canada.	plawlor@gpu.srv.ualberta.ca	Bruera, Eduardo/AAA-1550-2022					AM. PSYCHIATRIC ASS'N, 1994, DIAGN STAT MAN MENT, P123; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; Breitbart W, 1996, AM J PSYCHIAT, V153, P231; Breitbart W., 1998, OXFORD TXB PALLIATIV, P933; Bruera E, 1990, J Pain Symptom Manage, V5, P218, DOI 10.1016/0885-3924(90)90014-B; BRUERA E, 1992, J PAIN SYMPTOM MANAG, V7, P192, DOI 10.1016/0885-3924(92)90074-R; BRUERA E, 1992, J PAIN SYMPTOM MANAG, V7, P267, DOI 10.1016/0885-3924(92)90060-U; BRUERA E, 1995, J PAIN SYMPTOM MANAG, V10, P348, DOI 10.1016/0885-3924(95)00052-Z; Cole MG, 1998, J GERIATR PSYCH NEUR, V11, P126, DOI 10.1177/089198879801100303; Fainsinger R, 1991, J Palliat Care, V7, P5; Fainsinger R L, 1993, J Palliat Care, V9, P4; FAINSINGER RL, 2000, TOPICS PALLIATIVE CA, V4, P261; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANCIS J, 1990, JAMA-J AM MED ASSOC, V263, P1097, DOI 10.1001/jama.263.8.1097; INOUYE SK, 1993, ANN INTERN MED, V119, P474, DOI 10.7326/0003-4819-119-6-199309150-00005; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; INOUYE SK, 1994, AM J MED, V97, P278, DOI 10.1016/0002-9343(94)90011-6; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Lawlor PG, 2000, CANCER, V88, P2859, DOI 10.1002/1097-0142(20000615)88:12<2859::AID-CNCR29>3.3.CO;2-K; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; LEVKOFF SE, 1992, ARCH INTERN MED, V152, P334, DOI 10.1001/archinte.152.2.334; LEVKOFF SE, 1988, J AM GERIATR SOC, V36, P1099, DOI 10.1111/j.1532-5415.1988.tb04396.x; LIPOWSKI ZJ, 1987, JAMA-J AM MED ASSOC, V258, P1789, DOI 10.1001/jama.258.13.1789; LIPTZIN B, 1992, BRIT J PSYCHIAT, V161, P843, DOI 10.1192/bjp.161.6.843; MASSIE MJ, 1983, AM J PSYCHIAT, V140, P1048; Meagher DJ, 1996, BRIT J PSYCHIAT, V168, P512, DOI 10.1192/bjp.168.4.512; Minagawa H, 1996, CANCER, V78, P1131, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1131::AID-CNCR26>3.3.CO;2-J; Morrison RS, 2000, JAMA-J AM MED ASSOC, V284, P47, DOI 10.1001/jama.284.1.47; O'Keeffe ST, 1999, AGE AGEING, V28, P115, DOI 10.1093/ageing/28.2.115; OKeeffe S, 1997, J AM GERIATR SOC, V45, P174, DOI 10.1111/j.1532-5415.1997.tb04503.x; POMPEI P, 1994, J AM GERIATR SOC, V42, P809, DOI 10.1111/j.1532-5415.1994.tb06551.x; Walker P, 1997, ANN ONCOL, V8, P915, DOI 10.1023/A:1008274608267	32	53	53	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2000	284	19					2427	2429		10.1001/jama.284.19.2427	http://dx.doi.org/10.1001/jama.284.19.2427			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	371MY	11074759				2022-12-01	WOS:000165183800002
J	De Maeseneer, J; Blokland, I; Willems, S; Vander Stichele, R; Meersschaut, F				De Maeseneer, J; Blokland, I; Willems, S; Vander Stichele, R; Meersschaut, F			Wet combing versus traditional scalp inspection to detect head lice in schoolchildren: observational study	BRITISH MEDICAL JOURNAL			English	Article									Community Hlth Ctr Ledeberg, B-9050 Ledeberg, Belgium; State Univ Ghent Hosp, Heymans Inst Pharmacol, B-9000 Ghent, Belgium; State Univ Ghent, Dept Gen Practice & Primary Hlth Care, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University	De Maeseneer, J (corresponding author), State Univ Ghent, Dept Gen Practice & Primary Hlth Care, 1K3 UZ, B-9000 Ghent, Belgium.		Stichele, Robert Vander/K-7203-2015; Willems, Sara/AAI-4851-2021; Willems, Sara/AFU-7707-2022	Stichele, Robert Vander/0000-0001-9118-9651; Willems, Sara/0000-0002-6349-7785				Abramson JH, 1988, MAKING SENSE DATA SE; BINGHAM P, 2000, IN PRESS PUBLIC HLTH; IBARRA J, 1994, ESTABLISHMENT BUG BU; Sackett D.L., 1985, CLIN EPIDEMIOLOGY BA	4	41	44	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 11	2000	321	7270					1187	1188		10.1136/bmj.321.7270.1187	http://dx.doi.org/10.1136/bmj.321.7270.1187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374RA	11073509	Green Published, Bronze			2022-12-01	WOS:000165357100026
J	Wong, JB; Koff, RS				Wong, JB; Koff, RS		Int Hepatitis Interventional Thera	Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C - A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article							INTERFERON-ALPHA THERAPY; QUALITY-OF-LIFE; TERM FOLLOW-UP; PREVENT HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; COMPENSATED CIRRHOSIS; SAMPLING VARIABILITY; FIBROSIS PROGRESSION; PROGNOSTIC FACTORS; RANDOMIZED TRIAL	Background: Not all patients with histologically mild chronic hepatitis C progress to cirrhosis. Objective: To compare no antiviral treatment, periodic liver biopsy with subsequent antiviral treatment for moderate hepatitis or cirrhosis, and immediate antiviral therapy. Design: Cost-effectiveness analysis. Data Sources: Clinical trial data and published studies. Target Population: Hepatitis C virus-infected patients with histologically mild hepatitis. Time Horizon: Lifetime. Perspective: Societal. Intervention: Immediate combination antiviral treatment or biopsy every 3 years plus combination antiviral therapy for moderate hepatitis or cirrhosis, Outcome Measures: Life expectancy, quality-adjusted life expectancy, and costs. Results of Base-Case Analysis: Over 20 years, biopsy every 3 years with treatment of moderate hepatitis would avoid treatment in 50% of the cohort and would result in an 18% likelihood of cirrhosis compared with 16% for immediate treatment and 27% for no antiviral therapy. Immediate antiviral treatment should increase life expectancy by 1.0 quality-adjusted life-year compared with biopsy management. Over an average lifetime, biopsy management would lead to six liver biopsies costing $6200; immediate antiviral treatment would cost $5100 less than biopsy management because of savings related to biopsy and prevention of future hepatitis C-related morbidity. Immediate therapy was cost-effective compared with biopsy management and had a cost-effectiveness ratio of $7000 compared with no antiviral therapy. Results of Sensitivity Analysis: When age, sex, genotype, and estimates of histologic progression or compliance with follow-up are varied, immediate therapy should result in an increase of at least 0.8 quality-adjusted life-year compared with biopsy management. Conclusion: For histologically mild chronic hepatitis C, initial combination treatment compared with periodic liver biopsy should reduce the future risk for cirrhosis, prolong life, and be cost-effective.	Tufts Univ, Sch Med, New England Med Ctr, Tupper Res Inst, Boston, MA 02111 USA; Univ Massachusetts, Sch Med, UMass Mem Hlth Care, Worcester, MA USA	Tufts Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Worcester	Wong, JB (corresponding author), Tufts Univ, Sch Med, New England Med Ctr, Tupper Res Inst, 750 Washington St,Box 302, Boston, MA 02111 USA.	jwong@lifespan.org		Wong, John/0000-0003-4203-9010				ABDI W, 1979, ARCH INTERN MED, V139, P667, DOI 10.1001/archinte.139.6.667; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 1997, HEPATOLOGY, V26, pS2; ASCHER NL, 1994, HEPATOLOGY, V20, pS24; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Benvegnu L, 1998, CANCER-AM CANCER SOC, V83, P901, DOI 10.1002/(SICI)1097-0142(19980901)83:5<901::AID-CNCR15>3.0.CO;2-Z; Bonis PAL, 1997, HEPATOLOGY, V26, P1035, DOI 10.1053/jhep.1997.v26.pm0009328332; Bonkovsky HL, 1999, HEPATOLOGY, V29, P264, DOI 10.1002/hep.510290124; Brunetto MR, 1998, LANCET, V351, P1535; Camma C, 1997, J HEPATOL, V26, P1187, DOI 10.1016/S0168-8278(97)80451-5; CHRISTENSEN E, 1989, SCAND J GASTROENTERO, V24, P999, DOI 10.3109/00365528909089247; COLCHER MD, 1994, HEPATOLOGY, V20, P618; DETRE KM, 1996, VIRAL HEPATITIS REV, V2, P219; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Foster GR, 1997, BRIT MED J, V315, P453, DOI 10.1136/bmj.315.7106.453; Foster GR, 1998, HEPATOLOGY, V27, P209, DOI 10.1002/hep.510270132; Gold MR., 1996, COST EFFECTIVENESS H; Grimm I, 1996, Gastroenterology, V110, P2019, DOI 10.1053/gast.1996.v110.agast962019; Harper SE, 1996, HEPATOLOGY, V23, P930; Hoofnagle JH, 1997, HEPATOLOGY, V26, pS15, DOI 10.1002/hep.510260703; Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5; Imai Y, 1998, ANN INTERN MED, V129, P94, DOI 10.7326/0003-4819-129-2-199807150-00005; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; KILPE VE, 1993, TRANSPLANTATION, V56, P554, DOI 10.1097/00007890-199309000-00012; Kim WR, 1997, ANN INTERN MED, V127, P866, DOI 10.7326/0003-4819-127-10-199711150-00002; Koretz RL, 1996, LANCET, V347, P194, DOI 10.1016/S0140-6736(96)90379-7; KUMARANAYAKE P, 2000, CAN J GASTROENTEROL, V14, pA23; Kuwana K, 1997, J GASTROEN HEPATOL, V12, P149, DOI 10.1111/j.1440-1746.1997.tb00398.x; Lau DTY, 1998, HEPATOLOGY, V28, P1121, DOI 10.1002/hep.510280430; Levine RA, 1998, ANN INTERN MED, V129, P323, DOI 10.7326/0003-4819-129-4-199808150-00010; Liu G, 1997, J CLIN ONCOL, V15, P110, DOI 10.1200/JCO.1997.15.1.110; MAHARAJ B, 1986, LANCET, V1, P523; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; MATTSSON L, 1988, LIVER, V8, P184; Mazzella G, 1996, J HEPATOL, V24, P141, DOI 10.1016/S0168-8278(96)80022-5; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; *MED EC, 1999, 1999 DRUG TOP RED BO; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Pagliaro L, 1999, ITAL J GASTROENTEROL, V31, P28; Pasta DJ, 1999, MED DECIS MAKING, V19, P353, DOI 10.1177/0272989X9901900314; Poynard T, 1998, HEPATOLOGY, V27, P1443, DOI 10.1002/hep.510270537; Poynard T, 1998, ACTA GASTRO-ENT BELG, V61, P431; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2000, HEPATOLOGY, V31, P211, DOI 10.1002/hep.510310131; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Reichard O, 1999, J HEPATOL, V30, P783, DOI 10.1016/S0168-8278(99)80129-9; Ryder SD, 1999, HEPATOLOGY, V30, p316A; SALERNO F, 1993, AM J GASTROENTEROL, V88, P514; Schalm SW, 1997, HEPATOLOGY, V26, pS128, DOI 10.1002/hep.510260722; SCHLICHTING P, 1983, SCAND J GASTROENTERO, V18, P27, DOI 10.3109/00365528309181554; SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703; Seeff LB, 1997, HEPATOLOGY, V26, pS21, DOI 10.1002/hep.510260704; Serfaty L, 1998, HEPATOLOGY, V27, P1435, DOI 10.1002/hep.510270535; Shiell A, 1999, MED J AUSTRALIA, V171, P189, DOI 10.5694/j.1326-5377.1999.tb123595.x; Shindo M, 1999, CANCER, V85, P1943, DOI 10.1002/(SICI)1097-0142(19990501)85:9<1943::AID-CNCR10>3.0.CO;2-F; Sobesky R, 1999, GASTROENTEROLOGY, V116, P378, DOI 10.1016/S0016-5085(99)70135-6; TAKAHASHI M, 1993, AM J GASTROENTEROL, V88, P240; Teramura K, 1997, J CLIN GASTROENTEROL, V25, P346, DOI 10.1097/00004836-199707000-00011; TREMOLADA F, 1992, J HEPATOL, V16, P273, DOI 10.1016/S0168-8278(05)80657-9; Ware JE, 1999, HEPATOLOGY, V30, P550, DOI 10.1002/hep.510300203; WASSERMAN Y, 1995, PHYSICIANS FEE REFER; Weinstein MC, 1980, CLIN DECISION ANAL; Wong JB, 2000, AM J GASTROENTEROL, V95, P1524; Wong JB, 1998, JAMA-J AM MED ASSOC, V280, P2088, DOI 10.1001/jama.280.24.2088; YOUSUF M, 1992, SCAND J GASTROENTERO, V27, P812, DOI 10.3109/00365529209011189	70	127	129	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2000	133	9					665	675		10.7326/0003-4819-133-9-200011070-00008	http://dx.doi.org/10.7326/0003-4819-133-9-200011070-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PC	11074899				2022-12-01	WOS:000165075300001
J	Yoshida, H; Horie, H; Matsuura, K; Miyamura, T				Yoshida, H; Horie, H; Matsuura, K; Miyamura, T			Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan	LANCET			English	Article							MONKEY KIDNEY-CELLS; NUCLEOTIDE-SEQUENCE; NONCODING REGION; POLIO VACCINE; SABIN TYPE-3; VERO CELLS; NEUROVIRULENCE; POLIOMYELITIS; POLIOVACCINE; MUTATIONS	Background A nucleotide change from U to C at position 472 in the 5' non-coding region of the type 3 poliovirus is associated with increased neurovirulence. Moreover, the proportion of type 3 polioviruses containing this mutation (472-C revertants) correlates with the neurovirulence of a particular sample. We used mutant analysis by PCR and restriction-enzyme cleavage (MAPREC) to estimate the neurovirulence of environmental samples obtained from Toyama prefecture, Japan. Methods Sewage and river water were collected between October, 1993, and September, 1995, and concentrated samples were inoculated into three different cell types. Isolated type 3 viruses were analysed to determine whether they were derived from the live oral poliovirus vaccine strain; they were then tested for neurovirulence by MAPREC. Results 29 type 3 strains were isolated-all of which were vaccine-derived. 16 (55%) comprised between 2% and 91% 472-C revertants by MAPREC and were expected to have high neurovirulence. The remaining strains included less than 0.25% revertants, and were regarded as attenuated viruses. Both types were isolated about 3 months after routine oral poliovirus vaccine administrations in May and October. Three strains isolated from river water were of the virulent type. Interpretation Our results emphasise that there is an environmental risk of vaccine-associated paralytic poliomyelitis as long as live oral poliovirus vaccine is not replaced by inactivated polio vaccine.	Natl Inst Infect Dis, Dept Virol 2, Tokyo 2080011, Japan; Japan Poliomyelitis Res Inst, Tokyo, Japan; Toyama Inst Hlth, Dept Virol, Toyama, Japan	National Institute of Infectious Diseases (NIID)	Yoshida, H (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Gakuen 4-7-1, Tokyo 2080011, Japan.			Yoshida, Hiromu/0000-0002-1488-8309				ABRAHAM R, 1993, J INFECT DIS, V168, P1105, DOI 10.1093/infdis/168.5.1105; Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; [Anonymous], 2000, JAMA, V283, P1414; BENYESHM.M, 1967, AM J EPIDEMIOL, V86, P112, DOI 10.1093/oxfordjournals.aje.a120717; Chezzi C, 1998, VACCINE, V16, P2031, DOI 10.1016/S0264-410X(98)00079-6; Chiba Y, 2000, JPN J INFECT DIS, V53, P135; Chumakov K M, 1999, Dev Biol Stand, V100, P67; CHUMAKOV KM, 1991, P NATL ACAD SCI USA, V88, P199, DOI 10.1073/pnas.88.1.199; CHUMAKOV KM, 1992, J VIROL, V66, P966, DOI 10.1128/JVI.66.2.966-970.1992; CHUMAKOV KM, 1994, J MED VIROL, V42, P79, DOI 10.1002/jmv.1890420115; Divizia M, 1999, APPL ENVIRON MICROB, V65, P3534; Dorsam V, 2000, VACCINE, V18, P2435, DOI 10.1016/S0264-410X(99)00531-9; Dragunsky E, 1996, BIOLOGICALS, V24, P77, DOI 10.1006/biol.1996.0010; DUNN G, 1990, J MED VIROL, V32, P92, DOI 10.1002/jmv.1890320205; EVANS DMA, 1985, NATURE, V314, P548, DOI 10.1038/314548a0; Hagiwara A, 1999, JPN J INFECT DIS, V52, P146; Halsey NA, 1999, PEDIATRICS, V103, P171, DOI 10.1542/peds.103.1.171; Horie H, 1998, BIOLOGICALS, V26, P289, DOI 10.1006/biol.1998.0159; Horie H, 1996, VACCINE, V14, P35, DOI 10.1016/0264-410X(95)00159-X; KAWAMURA N, 1989, J VIROL, V63, P1302, DOI 10.1128/JVI.63.3.1302-1309.1989; Lu ZB, 1996, VIROLOGY, V220, P285, DOI 10.1006/viro.1996.0316; Mallet L, 1997, J MED VIROL, V52, P50; Marker Test Subcommittee. The Japan Live Poliovaccine Research Commission, 1967, JPN J MED SCI BIOL, V20, P167; MATSUURA K, IN PRESS APPL ENV MI; POLLARD SR, 1989, J VIROL, V63, P4949, DOI 10.1128/JVI.63.11.4949-4951.1989; POYRY T, 1988, APPL ENVIRON MICROB, V54, P371; Sutter RW, 2000, PEDIATR CLIN N AM, V47, P287, DOI 10.1016/S0031-3955(05)70208-X; TAMBINI G, 1993, J INFECT DIS, V168, P1510, DOI 10.1093/infdis/168.6.1510; TATEM JM, 1991, J MED VIROL, V35, P101, DOI 10.1002/jmv.1890350206; Wood DJ, 1997, BIOLOGICALS, V25, P3, DOI 10.1006/biol.1997.0055; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347; Yoshida H, 1997, J INFECT DIS, V175, P1233, DOI 10.1086/593677	32	35	37	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 28	2000	356	9240					1461	1463		10.1016/S0140-6736(00)02868-3	http://dx.doi.org/10.1016/S0140-6736(00)02868-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367NA	11081527				2022-12-01	WOS:000090067300008
J	Chen, Q; Ghilardi, N; Wang, H; Baker, T; Xie, MH; Gurney, A; Grewal, IS; de Sauvage, FJ				Chen, Q; Ghilardi, N; Wang, H; Baker, T; Xie, MH; Gurney, A; Grewal, IS; de Sauvage, FJ			Development of Th1-type immune responses requires the type I cytokine receptor TCCR	NATURE			English	Article							T-CELL SUBSETS; INTERFERON-GAMMA; DEFICIENT MICE; TH2 CELLS; IL-4; STAT6; GENERATION; MAP	On antigen challenge, T-helper cells differentiate into two functionally distinct subsets, Th1 and Th2, characterized by the different effector cytokines that they secrete(1). Th1 cells produce interleukin (IL)-2, interferon-gamma (IFN-gamma) and lymphotoxin-beta, which mediate pro-inflammatory functions critical for the development of cell-mediated immune responses, whereas Th2 cells secrete cytokines such as IL-4, IL-5 and IL-10 that enhance humoral immunity(1,2). This process of T-helper cell differentiation is tightly regulated by cytokines. Here we report a new member of the type I cytokine receptor family, designated T-cell cytokine receptor (TCCR). When challenged in vivo with protein antigen, TCCR-deficient mice had impaired Th1 response as measured by IFN-gamma production. TCCR-deficient mice also had increased susceptibility to infection with an intracellular pathogen, Listeria monocytogenes. In addition, levels of antigen-specific immunoglobulin-gamma 2a, which are dependent on Th1 cells, were markedly reduced in these mice. Our results demonstrate the existence of a new cytokine receptor involved in regulating the adaptive immune response and critical to the generation of a Th1 response.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	de Sauvage, FJ (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	sauvage@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Ghilardi, Nico/0000-0003-4945-3097; Grewal, Iqbal S/0000-0002-4775-055X				BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Heath VL, 2000, J IMMUNOL, V164, P2861, DOI 10.4049/jimmunol.164.6.2861; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Nishikomori R, 2000, J EXP MED, V191, P847, DOI 10.1084/jem.191.5.847; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Wu CY, 1997, J IMMUNOL, V159, P1658; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8	26	326	352	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					916	920		10.1038/35038103	http://dx.doi.org/10.1038/35038103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057672				2022-12-01	WOS:000089901900055
J	Abraham, ER; Law, CS; Boyd, PW; Lavender, SJ; Maldonado, MT; Bowie, AR				Abraham, ER; Law, CS; Boyd, PW; Lavender, SJ; Maldonado, MT; Bowie, AR			Importance of stirring in the development of an iron-fertilized phytoplankton bloom	NATURE			English	Article							NORTH-ATLANTIC; SOUTHERN-OCEAN; TRACER; PATCHINESS; SEAWIFS; EVOLUTION	The growth of populations is known to be influenced by dispersal, which has often been described as purely diffusive(1,2). In the open ocean, however, the tendrils and filaments of phytoplankton populations provide evidence for dispersal by stirring(3,4). Despite the apparent importance of horizontal stirring for plankton ecology, this process remains poorly characterized. Here we investigate the development of a discrete phytoplankton bloom, which was initiated by the iron fertilization of a patch of water (7 km in diameter) in the Southern Ocean(5). Satellite images show a striking, 150-km-long bloom near the experimental site, six weeks after the initial fertilization. We argue that the ribbon-like bloom was produced from the fertilized patch through stirring, growth and diffusion, and we derive an estimate of the stirring rate. In this case, stirring acts as an important control on bloom development, mixing phytoplankton and iron out of the patch, but also entraining silicate. This may have prevented the onset of silicate limitation, and so allowed the bloom to continue for as long as there was sufficient iron. Stirring in the ocean is likely to be variable, so blooms that are initially similar may develop very differently.	Natl Inst Water & Atmospher Res, Wellington, New Zealand; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; Univ Otago, NIWA, Ctr Chem & Phys Oceanog, Dept Chem, Dunedin, New Zealand; McGill Univ, Dept Biol, Montreal, PQ H2T 2V8, Canada; Univ Plymouth, Plymouth Environm Res Ctr, Dept Environm Sci, Plymouth PL4 8AA, Devon, England	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Plymouth Marine Laboratory; University of Otago; McGill University; University of Plymouth	Abraham, ER (corresponding author), Natl Inst Water & Atmospher Res, POb 14-901, Wellington, New Zealand.	e.abraham@niwa.cri.nz	Maldonado, Maria T/N-2877-2017; Bowie, Andrew/C-8677-2013; Boyd, Philip W/J-7624-2014; Abraham, Edward R/D-7422-2011	Maldonado, Maria T/0000-0001-8134-9375; Bowie, Andrew/0000-0002-5144-7799; Boyd, Philip W/0000-0001-7850-1911; Abraham, Edward R/0000-0003-4490-6704; Lavender, Samantha/0000-0002-5181-9425; Law, Cliff/0000-0002-7669-2475				ABBOTT MR, IN PRESS DEEP SEA RE; Abraham ER, 1998, NATURE, V391, P577, DOI 10.1038/35361; Bowie AR, 1998, ANAL CHIM ACTA, V361, P189, DOI 10.1016/S0003-2670(98)00015-4; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Charette MA, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000069; COMISO JC, 1993, J GEOPHYS RES-OCEANS, V98, P2419, DOI 10.1029/92JC02505; DEBAAR HJW, 1999, INT GEOSPHERE BIOSPH, P61; GARRETT C, 1983, DYNAM ATMOS OCEANS, V7, P265, DOI 10.1016/0377-0265(83)90008-8; GOWER JFR, 1980, NATURE, V288, P157, DOI 10.1038/288157a0; HAIDVOGEL DB, 1984, DYNAM ATMOS OCEANS, V8, P1, DOI 10.1016/0377-0265(84)90002-2; HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; KIERSTEAD H, 1953, J MAR RES, V12, P141; Lavender SJ, 1999, INT J REMOTE SENS, V20, P1051, DOI 10.1080/014311699212830; Law CS, 1998, DEEP-SEA RES PT II, V45, P977, DOI 10.1016/S0967-0645(98)00022-8; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; Maldonado MT, 1999, DEEP-SEA RES PT II, V46, P2475, DOI 10.1016/S0967-0645(99)00072-7; Martin AP, 2000, J PLANKTON RES, V22, P597, DOI 10.1093/plankt/22.3.597; MARTIN AP, IN PRESS DEEP SEA RE; Moore JK, 1999, GEOPHYS RES LETT, V26, P1465, DOI 10.1029/1999GL900242; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; OKUBO A, 1971, DEEP-SEA RES, V18, P789, DOI 10.1016/0011-7471(71)90046-5; OKUBO A, 1966, J OCEANOGR SOC JAPAN, V22, P1; Okubo A., 1980, BIOMATHEMATICS, V10; OLSON RJ, IN PRESS DEEP SEA RE; Rintoul SR, 1997, DEEP-SEA RES PT I, V44, P1185, DOI 10.1016/S0967-0637(96)00125-2; Stanton TP, 1998, DEEP-SEA RES PT II, V45, P947, DOI 10.1016/S0967-0645(98)00018-6; SULLIVAN CW, 1993, SCIENCE, V262, P1832, DOI 10.1126/science.262.5141.1832; Sundermeyer MA, 1998, J GEOPHYS RES-OCEANS, V103, P21481, DOI 10.1029/98JC01999; Washburn L, 1998, DEEP-SEA RES PT I, V45, P1411, DOI 10.1016/S0967-0637(98)00023-5	30	211	216	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					727	730		10.1038/35037555	http://dx.doi.org/10.1038/35037555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048715				2022-12-01	WOS:000089773900037
J	Singh, PK; Schaefer, AL; Parsek, MR; Moninger, TO; Welsh, MJ; Greenberg, EP				Singh, PK; Schaefer, AL; Parsek, MR; Moninger, TO; Welsh, MJ; Greenberg, EP			Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA; PATHOGENESIS; EXPRESSION; GENES	The bacterium Pseudomonas aeruginosa permanently colonizes cystic fibrosis lungs despite aggressive antibiotic treatment(1-3). This suggests that P. aeruginosa might exist as biofilms-structured communities of bacteria encased in a self-produced polymeric matrix-in the cystic fibrosis lung(1,4). Consistent with this hypothesis, microscopy of cystic fibrosis sputum shows that P. aeruginosa are in biofilm-like structures. P. aeruginosa uses extracellular quorum-sensing signals (extracellular chemical signals that cue cell-density-dependent gene expression) to coordinate biofilm formation(5). Here we found that cystic fibrosis sputum produces the two principal P. aeruginosa quorum-sensing signals; however, the relative abundance of these signals was opposite to that of the standard P. aeruginosa strain PAO1 in laboratory broth culture. When P. aeruginosa sputum isolates were grown in broth, some showed quorum-sensing signal ratios like those of the laboratory strain. When we grew these isolates and PAO1 in a laboratory biofilm model, the signal ratios were like those in cystic fibrosis sputum. Our data support the hypothesis that P. aeruginosa are in a biofilm in cystic fibrosis sputum. Moreover, quorum-sensing signal profiling of specific P. aeruginosa strains may serve as a biomarker in screens to identify agents that interfere with biofilm development.	Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Northwestern Univ, Dept Civil Engn, Evanston, IL 60208 USA; Univ Iowa, Coll Med, Cent Microscopy Res Facil, Iowa City, IA 52242 USA	University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; Northwestern University; University of Iowa	Greenberg, EP (corresponding author), Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.		Schaefer, Amy/AAU-8576-2020	Greenberg, Everett/0000-0001-9474-8041; Schaefer, Amy/0000-0003-0581-054X; Welsh, Michael/0000-0002-1646-6206	NHLBI NIH HHS [K24 HL102246] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL102246] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Burns J L, 1993, Adv Pediatr Infect Dis, V8, P53; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1983, REV INFECT DIS, V5, pS867; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1984, REV INFECT DIS S3, V6, P608; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DAVIES DG, 1993, APPL ENVIRON MICROB, V59, P1181, DOI 10.1128/AEM.59.4.1181-1186.1993; HOIBY N, 1993, ANNU REV MED, V44, P1, DOI 10.1146/annurev.me.44.020193.000245; JENSEN SE, 1980, J BACTERIOL, V144, P844, DOI 10.1128/JB.144.2.844-847.1980; MENDELMAN PM, 1985, AM REV RESPIR DIS, V132, P761; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Pesci EC, 1997, TRENDS MICROBIOL, V5, P132, DOI 10.1016/S0966-842X(97)01008-1; Rumbaugh KP, 1999, J BURN CARE REHABIL, V20, P42, DOI 10.1097/00004630-199901001-00008; Schaefer AL, 2000, METHOD ENZYMOL, V305, P288; SCHAEFER AL, IN PRESS METHODS ENZ; Tang HB, 1996, INFECT IMMUN, V64, P37, DOI 10.1128/IAI.64.1.37-43.1996; WELSH MJ, 1995, METABOLIC MOL BASES, V3, P3799; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904	18	1116	1191	10	303	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					762	764		10.1038/35037627	http://dx.doi.org/10.1038/35037627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048725				2022-12-01	WOS:000089773900047
J	Irwin, M; Marin, MC; Phillips, AC; Seelan, RS; Smith, DI; Liu, WG; Flores, ER; Tsai, KY; Jacks, T; Vousden, KH; Kaelin, WG				Irwin, M; Marin, MC; Phillips, AC; Seelan, RS; Smith, DI; Liu, WG; Flores, ER; Tsai, KY; Jacks, T; Vousden, KH; Kaelin, WG			Role for the p53 homologue p73 in E2F-1-induced apoptosis	NATURE			English	Article							P53-INDEPENDENT APOPTOSIS; LI-FRAUMENI; DNA-BINDING; IN-VIVO; E2F-1; FAMILY; OVEREXPRESSION; PROTEIN; DOMAIN; CELLS	The transcription factor E2F-1 induces both cell-cycle progression and, in certain settings, apoptosis. E2F-1 uses both p53-dependent and p53-independent pathways to kill cells(1-8). The p53-dependent pathway involves the induction by E2F-1 of the human tumour-suppressor protein p14ARF, which neutralizes HDM2 (human homologue of MDM2) and thereby stabilizes the p53 protein(9). Here we show that E2F-1 induces the transcription of the p53 homologue p73. Disruption of p73 function inhibited E2F-1-induced apoptosis in p53-defective tumour cells and in p53(-/-) mouse embryo fibroblasts. We conclude that activation of p73 provides a means for E2F-1 to induce death in the absence of p53.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; NCI, Regulat Cell Growth Lab, FCRDC, Frederick, MD 21702 USA; Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Lab Med & Pathol, Rochester, MN 55905 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Howard Hughes Med Inst, Chevy Chase, MD 20185 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.		Marín Vieira, María del Carmen/B-8108-2015; Marin, Maria C/G-1040-2010	Marín Vieira, María del Carmen/0000-0002-7149-287X; Marin, Maria C/0000-0002-7149-287X; Seelan, Ratnam/0000-0002-8925-1070; Tsai, Kenneth/0000-0001-5325-212X				Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Chen YNP, 1999, P NATL ACAD SCI USA, V96, P4325, DOI 10.1073/pnas.96.8.4325; Davison TS, 1999, J BIOL CHEM, V274, P18709, DOI 10.1074/jbc.274.26.18709; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fueyo J, 1998, NAT MED, V4, P685, DOI 10.1038/nm0698-685; Holme IB, 1998, PLANT CELL TISS ORG, V53, P143, DOI 10.1023/A:1006001419989; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Hunt KK, 1997, CANCER RES, V57, P4722; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaelin WG, 1999, J NATL CANCER I, V91, P594, DOI 10.1093/jnci/91.7.594; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Krek W, 1994, CELL, V78, P1; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Nip J, 1997, MOL CELL BIOL, V17, P1049, DOI 10.1128/MCB.17.3.1049; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Weber KL, 1998, BIOTECHNIQUES, V25, P415, DOI 10.2144/98253st02; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	29	514	525	0	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					645	648		10.1038/35036614	http://dx.doi.org/10.1038/35036614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034215				2022-12-01	WOS:000089772800051
J	Emanuel, EJ; Fairclough, D; Clarridge, BC; Blum, D; Bruera, E; Penley, WC; Schnipper, LE; Mayer, RJ				Emanuel, EJ; Fairclough, D; Clarridge, BC; Blum, D; Bruera, E; Penley, WC; Schnipper, LE; Mayer, RJ			Attitudes and practices of US oncologists regarding euthanasia and physician-assisted suicide	ANNALS OF INTERNAL MEDICINE			English	Article							WASHINGTON-STATE; REQUESTS; DEATH	Background: The practices of euthanasia and physician-assisted suicide remain controversial. Objective: To achieve better understanding of attitudes and practices regarding euthanasia and physician-assisted suicide in the context of end-of-life care. Design: Cohort study. Setting: United States. Participants: 3299 oncologists who are members of the American Society of Clinical Oncology. Measurements: Responses to survey questions on attitudes toward euthanasia and physician-assisted suicide for a terminally ill patient with prostate cancer who has unremitting pain, requests for and performance of euthanasia and physician-assisted suicide, and sociodemographic characteristics. Results: Of U.S. oncologists surveyed, 22.5% supported the use of physician-assisted suicide for a terminally ill patient with unremitting pain and 6.5% supported euthanasia Oncologists who were reluctant to increase the dose of intravenous morphine for terminally ill patients in excruciating pain (odds ratio [OR], 0.61 [95% CI, 0.48 to 0.77]) and had sufficient time to talk to dying patients about end-of-life care issues (OR, 0.79 [CI, 0.71 to 0.87]) were less likely to support euthanasia or physician-assisted suicide. During their career, 3.7% of surveyed oncologists had performed euthanasia and 10.8% had performed physician-assisted suicide. Oncologists who were reluctant to increase the morphine dose for patients in excruciating pain (OR, 0.58 [CI, 0.43 to 0.79]) and those who believed that they had received adequate training in end-of-life care (OR, 0.86 [CI, 0.79 to 0.95]) were less likely to have performed euthanasia or physician-assisted suicide. Oncologists who reported not being able to obtain all the care that a dying patient needed were more likely to have performed euthanasia (P = 0.001). Conclusions: Requests for euthanasia and physician-assisted suicide are likely to decrease as training in end-of-life care improves and the ability of physicians to provide this care to their patients is enhanced.	Dana Farber Canc Inst, Dept Med Adult Oncol, Boston, MA 02115 USA; NIH, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; AMC Canc Res Ctr, Denver, CO USA; Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Canc Care Inc, New York, NY USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Baptist Hosp, Nashville, TN USA	Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; AMC Cancer Research Center; University of Massachusetts System; University of Massachusetts Boston; Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; UTMD Anderson Cancer Center; Saint Thomas Hospital	Mayer, RJ (corresponding author), Dana Farber Canc Inst, Dept Med Adult Oncol, 44 Binney St, Boston, MA 02115 USA.		Bruera, Eduardo/AAA-1550-2022					Bachman JG, 1996, NEW ENGL J MED, V334, P303, DOI 10.1056/NEJM199602013340506; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BROCK DW, 1992, HASTINGS CENT REP, V22, P10, DOI 10.2307/3562560; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; COHEN JS, 1994, NEW ENGL J MED, V331, P89, DOI 10.1056/NEJM199407143310206; DiMola G, 1996, ANN ONCOL, V7, P907, DOI 10.1093/oxfordjournals.annonc.a010792; DOUKAS DJ, 1995, J CLIN ONCOL, V13, P1055, DOI 10.1200/JCO.1995.13.5.1055; EMANUEL EJ, 1994, ARCH INTERN MED, V154, P1890, DOI 10.1001/archinte.154.17.1890; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; KINSELLA TD, 1993, CAN MED ASSOC J, V148, P1921; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2229; Portenoy RK, 1997, PSYCHOSOMATICS, V38, P277, DOI 10.1016/S0033-3182(97)71465-8; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; WARD BJ, 1994, BRIT MED J, V308, P1332, DOI 10.1136/bmj.308.6940.1332; Wolfe J, 1999, J CLIN ONCOL, V17, P1274, DOI 10.1200/JCO.1999.17.4.1274	17	115	115	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					527	532		10.7326/0003-4819-133-7-200010030-00011	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360QG	11015165				2022-12-01	WOS:000089678300004
J	Nattinger, AB; Hoffmann, RG; Kneusel, RT; Schapira, MM				Nattinger, AB; Hoffmann, RG; Kneusel, RT; Schapira, MM			Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery	LANCET			English	Article							RANDOMIZED CLINICAL-TRIAL; CONSENSUS-DEVELOPMENT-CONFERENCE; AXILLARY DISSECTION; RADIATION-THERAPY; TOTAL MASTECTOMY; CANCER-PATIENTS; OLDER WOMEN; NODE; LUMPECTOMY; SURVIVAL	Background Breast-conserving surgery is a more complex treatment than mastectomy, because a separate incision is needed for axillary lymph-node dissection, and postoperative radiotherapy is necessary. We postulated that adoption of this therapy into clinical practice might have led to discrepancies between the care recommended and that received. Methods We used records of the US national Surveillance, Epidemiology, and End Results tumour registry to study 144:759 women aged 30 years and older who underwent surgery for early-stage breast cancer between 1983 and 1995. We calculated the proportion undergoing at least the minimum appropriate primary treatment (defined, in accordance with the recommendations of a National Institutes of Health Consensus Conference in 1990, as total mastectomy with axillary node dissection or breast-conserving surgery wit axillary node dissection and radiotherapy) during each 3-month period. Findings The proportion of women receiving appropriate primary therapy fell from 88% in 1983-89 to 78% by the end of 1995. This decline was observed in all subgroups of age, race, stage, and population density. Of all women in the cohort, the proportion undergoing an inappropriate form of mastectomy remained stable at about 2.7% throughout the study period. The proportion undergoing an inappropriate form of breast-conserving surgery (omission of radiotherapy, axillary node dissection, or both) increased from 10% in 1989 to 19% at the end of 1995. Interpretation Although most women undergo appropriate care, the appropriateness of care for early-stage breast cancer in the USA declined from 1990 to 1995. Because the proportion of all women who were treated by breast-conserving surgery increased, and because this approach was more likely than was mastectomy to be applied inappropriately, the proportion of all women having inappropriate care increased.	Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Biostat, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Nattinger, AB (corresponding author), Div Gen Internal Med, FEC Med Off Bldg,Suite 4200,9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.			Nattinger, Ann/0000-0002-8189-3300				ABE O, 1995, NEW ENGL J MED, V333, P1444; BallardBarbash R, 1996, JNCI-J NATL CANCER I, V88, P716, DOI 10.1093/jnci/88.11.716; *BUR HLTH PROF, 1992, AR RES FIL SYST INF; CABANES PA, 1992, LANCET, V339, P1245, DOI 10.1016/0140-6736(92)91591-U; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Clark RM, 1996, J NATL CANCER I, V88, P1659, DOI 10.1093/jnci/88.22.1659; DECKERS PJ, 1991, J SURG ONCOL, V48, P217, DOI 10.1002/jso.2930480402; Du XL, 1999, J CLIN EPIDEMIOL, V52, P463, DOI 10.1016/S0895-4356(99)00011-6; Du XL, 1999, J GERONTOL A-BIOL, V54, pM474, DOI 10.1093/gerona/54.9.M474; FISHER B, 1995, NEW ENGL J MED, V333, P1456, DOI 10.1056/NEJM199511303332203; FISHER B, 1985, NEW ENGL J MED, V312, P674, DOI 10.1056/NEJM198503143121102; Goodwin JS, 1996, JNCI-J NATL CANCER I, V88, P1031, DOI 10.1093/jnci/88.15.1031; HARRIS JR, 1993, CANC PRINCIPLES PRAC, P1264; HOUGHTON J, 1980, LANCET, V2, P55; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; LAZOVICH D, 1991, JAMA-J AM MED ASSOC, V266, P3433, DOI 10.1001/jama.266.24.3433; Lazovich D, 1997, ARCH SURG-CHICAGO, V132, P418; Lazovich DA, 1999, CANCER-AM CANCER SOC, V86, P628, DOI 10.1002/(SICI)1097-0142(19990815)86:4<628::AID-CNCR11>3.3.CO;2-C; LEEFELDSTEIN A, 1994, JAMA-J AM MED ASSOC, V271, P1163, DOI 10.1001/jama.271.15.1163; LILJEGREN G, 1994, JNCI-J NATL CANCER I, V86, P717, DOI 10.1093/jnci/86.9.717; LIN PP, 1993, J CLIN ONCOL, V11, P1536, DOI 10.1200/JCO.1993.11.8.1536; MANN BA, 1988, JAMA-J AM MED ASSOC, V259, P3413; McMasters KM, 1998, NEW ENGL J MED, V339, P990, DOI 10.1056/NEJM199810013391410; *NAT CANC I DCPC S, 1998, SURV EP END RES PROG; Nattinger AB, 1996, NEW ENGL J MED, V335, P1035, DOI 10.1056/NEJM199610033351407; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; Nattinger AB, 1998, JAMA-J AM MED ASSOC, V279, P762; NATTINGER AB, 1992, NEW ENGL J MED, V326, P1102, DOI 10.1056/NEJM199204233261702; NATTINGER AB, 1996, MED CARE, V34, P749; Pastor R, 1998, AM J EPIDEMIOL, V148, P631, DOI 10.1093/aje/148.7.631; Riley GF, 1999, JAMA-J AM MED ASSOC, V281, P720, DOI 10.1001/jama.281.8.720; RUFFIN WK, 1995, J AM COLL SURGEONS, V180, P245; *TREATM EARL STAG, 1990, NIH CONS DEV C JUN 1, V8; White RE, 1996, J AM COLL SURGEONS, V183, P575; WINCHESTER DP, 1992, CA-CANCER J CLIN, V42, P134, DOI 10.3322/canjclin.42.3.134; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	36	142	143	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1148	1153		10.1016/S0140-6736(00)02757-4	http://dx.doi.org/10.1016/S0140-6736(00)02757-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030294				2022-12-01	WOS:000089594300012
J	Edwards, JL; Lane, MA; Nielsen, ES				Edwards, JL; Lane, MA; Nielsen, ES			Interoperability of biodiversity databases: Biodiversity information on every desktop	SCIENCE			English	Editorial Material									Natl Sci Fdn, Directorate Biol Sci, Arlington, VA 22230 USA; Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; CSIRO Entomol, Australian Natl Insect Collect, Canberra, ACT 2601, Australia	National Science Foundation (NSF); NSF - Directorate for Biological Sciences (BIO); Drexel University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Edwards, JL (corresponding author), Natl Sci Fdn, Directorate Biol Sci, 4201 Wilson Blvd, Arlington, VA 22230 USA.							Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; Hammond PM, 1995, GLOBAL BIODIVERSITY, P113; LANE MA, 1999, WEAVING WEB WEALTH B; Malakoff D, 2000, SCIENCE, V288, P1575, DOI 10.1126/science.288.5471.1575; Maurer SM, 2000, NATURE, V405, P117, DOI 10.1038/35012169; MAY RM, 1999, NATURE HUMAN SOC QUE, P30	6	158	169	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2312	2314		10.1126/science.289.5488.2312	http://dx.doi.org/10.1126/science.289.5488.2312			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009409				2022-12-01	WOS:000089593500041
J	Pai, LM; Barcelo, G; Schupbach, T				Pai, LM; Barcelo, G; Schupbach, T			D-cbl, a negative regulator of the Egfr pathway, is required for dorsoventral patterning in Drosophila oogenesis	CELL			English	Article							RECEPTOR TYROSINE KINASE; TRANSCRIPTION FACTOR CF2; GROWTH-FACTOR RECEPTOR; ALPHA-LIKE PROTEIN; FAINT-LITTLE-BALL; C-CBL; SIGNALING PATHWAYS; GENE GURKEN; GERM-LINE; EMBRYO	During Drosophila oogenesis, asymmetrically localized Gurken activates the EGF receptor (Egfr) and determines dorsal follicle cell fates. Using a mosaic follicle cell system we have identified a mutation in the D-cbl gene which causes hyperactivation of the Egfr pathway. Cbl proteins are known to downregulate activated receptors. We find that the abnormal Egfr activation is ligand dependent. Our results show that the precise regulation of Egfr activity necessary to establish different follicle cell fates requires two levels of control. The localized ligand Gurken activates Egfr to different levels in different follicle cells. In addition, Egfr activity has to be repressed through the activity of D-cbl to ensure the absence of signaling in the ventral most follicle cells.	Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University	Schupbach, T (corresponding author), Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08544 USA.				NCI NIH HHS [P01 CA41086] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA041086] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chen B, 1998, GENETICS, V149, P157; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; Deng WM, 1997, DEVELOPMENT, V124, P4639; Duffy JB, 1998, DEVELOPMENT, V125, P2263; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/S0968-0004(96)30015-7; Hsu T, 1996, GENE DEV, V10, P1411, DOI 10.1101/gad.10.11.1411; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JONGEWARD GD, 1995, GENETICS, V139, P1553; Jordan KC, 2000, NAT GENET, V24, P429, DOI 10.1038/74294; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KLINGLER M, 1988, NATURE, V335, P275, DOI 10.1038/335275a0; Kramer S, 1999, DEVELOPMENT, V126, P2515; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LEWIS EB, 1968, GENE DEV, V6, P1740; Mantrova EY, 1998, GENE DEV, V12, P1166; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; MUSSACHIO M, 1996, DEV BIOL, V178, P63; NEUMANSILBERBERG FS, 1994, DEVELOPMENT, V120, P2457; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; Nilson LA, 1998, CELL, V93, P253, DOI 10.1016/S0092-8674(00)81576-7; Perrimon N, 1997, CELL, V89, P13, DOI 10.1016/S0092-8674(00)80177-4; PRICE JV, 1989, CELL, V56, P1085, DOI 10.1016/0092-8674(89)90641-7; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Ray RP, 1996, GENE DEV, V10, P1711, DOI 10.1101/gad.10.14.1711; RAZ E, 1993, GENE DEV, V7, P1937, DOI 10.1101/gad.7.10.1937; Reich A, 1999, DEVELOPMENT, V126, P4139; RUOHOLABAKER H, 1993, CELL, V73, P953, DOI 10.1016/0092-8674(93)90273-S; SCHEJTER ED, 1989, CELL, V56, P1093, DOI 10.1016/0092-8674(89)90642-9; SCHUPBACH T, 1994, CURR OPIN GENET DEV, V4, P502, DOI 10.1016/0959-437X(94)90064-A; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Smit L, 1997, CRIT REV ONCOGENESIS, V8, P359, DOI 10.1615/CritRevOncog.v8.i4.50; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; STRECKER TR, 1989, SCIENCE, V243, P1062, DOI 10.1126/science.2922596; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Van Buskirk C, 1999, TRENDS CELL BIOL, V9, P1, DOI 10.1016/S0962-8924(98)01413-5; Wasserman JD, 1997, TRENDS CELL BIOL, V7, P431, DOI 10.1016/S0962-8924(97)01143-4; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; XU T, 1993, DEVELOPMENT, V117, P1223; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556	58	101	102	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					51	61		10.1016/S0092-8674(00)00104-5	http://dx.doi.org/10.1016/S0092-8674(00)00104-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051547	Bronze			2022-12-01	WOS:000089636400008
J	Taylor, WR; He, SG; Levick, WR; Vaney, DI				Taylor, WR; He, SG; Levick, WR; Vaney, DI			Dendritic computation of direction selectivity by retinal ganglion cells	SCIENCE			English	Article							RABBIT RETINA; AMACRINE CELLS; MECHANISM	Direction-selective ganglion cells (DSGCs) in the retina respond strongly when stimulated by image motion in a preferred direction but are only weakly excited by image motion in the opposite null direction. Such coding represents an early manifestation of complex information processing in the visual system, but the cellular locus and the synaptic mechanisms have yet to be elucidated. We recorded the synaptic activity of DSGCs using strategies to observe the asymmetric inhibitory inputs that underlie the generation of direction selectivity. The critical nonlinear interactions between the excitatory and inhibitory inputs took place postsynaptically within the dendrites of the DSGCs.	Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; Australian Natl Univ, Ctr Visual Sci, Canberra, ACT 2601, Australia; Australian Natl Univ, Dept Psychol, Canberra, ACT 2601, Australia; Univ Queensland, Sch Biomed Sci, Vis Touch & Hearing Res Ctr, Brisbane, Qld 4072, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; Australian National University; University of Queensland	Taylor, WR (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	Rowland.Taylor@anu.edu.au	LEVICK, WILLIAM R/A-9056-2008	LEVICK, WILLIAM R/0000-0002-8265-4424; Taylor, William/0000-0002-6806-3249				AMTHOR FR, 1993, J NEUROPHYSIOL, V69, P2174, DOI 10.1152/jn.1993.69.6.2174; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; He SG, 1999, J NEUROSCI, V19, P8049; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; MARCHIAFAVA PL, 1979, VISION RES, V19, P1203, DOI 10.1016/0042-6989(79)90185-8; OYSTER CW, 1993, VISION RES, V33, P579, DOI 10.1016/0042-6989(93)90181-U; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; VANEY DI, 1994, J NEUROSCI, V14, P6301; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857	16	130	134	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2347	2350		10.1126/science.289.5488.2347	http://dx.doi.org/10.1126/science.289.5488.2347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009420				2022-12-01	WOS:000089593500052
J	Simoncini, T; Hafezl-Moghadam, A; Brazil, DP; Ley, K; Chin, WW; Liao, JK				Simoncini, T; Hafezl-Moghadam, A; Brazil, DP; Ley, K; Chin, WW; Liao, JK			Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL GROWTH-FACTOR; HUMAN ESTROGEN-RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; PROTEIN; ACTIVATION; CELLS; AKT; INSULIN; PHOSPHORYLATION	Oestrogen produces diverse biological effects through binding to the oestrogen receptor (ER)(1). The ER is a steroid hormone nuclear receptor, which, when bound to oestrogen, modulates the transcriptional activity of target genes(2). Controversy exists, however, concerning whether ER has a role outside the nucleus(3), particularly in mediating the cardiovascular protective effects of oestrogen(4). Here we show that the ER isoform, ER alpha, binds in a ligand-dependent manner to the p85 alpha regulatory subunit of phosphatidylinositol-3-OH kinase (PI(3)K). Stimulation with oestrogen increases ER alpha-associated PI(3)K activity, leading to the activation of protein kinase B/Akt and endothelial nitric oxide synthase (eNOS). Recruitment and activation of PI(3)K by ligand-bound ERa are independent of gene transcription, do not involve phosphotyrosine adapter molecules or src-homology domains of p85 alpha, and extend to other steroid hormone receptors. Mice treated with oestrogen show increased eNOS activity and decreased vascular leukocyte accumulation after ischaemia and reperfusion injury. This vascular protective effect of oestrogen was abolished in the presence of PI(3)K or eNOS inhibitors. Our findings define a physiologically important non-nuclear oestrogen-signalling pathway involving the direct interaction of ERa with PI(3)K.	Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Virginia, Hlth Sci Ctr, Dept Biomed Engn, Charlottesville, VA 22908 USA; Joslin Diabet Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Virginia; Harvard University; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	Liao, JK (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 221 Longwood Ave, Boston, MA 02115 USA.		Simoncini, Tommaso/AAC-1879-2019	Simoncini, Tommaso/0000-0002-2971-0079; Brazil, Derek/0000-0003-1375-1076; Hafezi-Moghadam, Ali/0000-0002-5336-0697	NHLBI NIH HHS [P01 HL048743-090008, R01 HL070274-03, R01 HL070274, R01 HL052233, R01 HL052233-06, R01 HL052233-07, P01 HL048743-080008, R01 HL070274-02, P01 HL048743, R01 HL052233-08, R01 HL070274-05, R01 HL052233-05, R01 HL070274-01, R01 HL070274-04] Funding Source: Medline; NIDDK NIH HHS [R01 DK062729-02, R01 DK062729, R01 DK062729-05, R01 DK062729-04, R01 DK062729-03, R01 DK062729-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070274, R01HL052233, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062729] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; Gustafsson JA, 2000, J SOC GYNECOL INVEST, V7, pS8, DOI 10.1177/1071557600007001S04; Kanwar S, 1998, MICROCIRCULATION, V5, P281, DOI 10.1080/713773894; KAPELLER R, 1995, J BIOL CHEM, V270, P25985, DOI 10.1074/jbc.270.43.25985; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Stefano GB, 2000, CIRCULATION, V101, P1594, DOI 10.1161/01.CIR.101.13.1594; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871	30	1144	1175	1	35	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					538	541		10.1038/35035131	http://dx.doi.org/10.1038/35035131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029009	Green Accepted			2022-12-01	WOS:000089727400057
J	True, HL; Lindquist, SL				True, HL; Lindquist, SL			A yeast prion provides a mechanism for genetic variation and phenotypic diversity	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSLATION TERMINATION; OMNIPOTENT SUPPRESSORS; RELEASE FACTORS; PSI+ PRION; SUP35 GENE; EVOLUTION; DETERMINANT; MUTANTS; PROTEIN	A major enigma in evolutionary biology is that new forms or functions often require the concerted effects of several independent genetic changes. It is unclear how such changes might accumulate when they are likely to be deleterious individually and be lost by selective pressure. The Saccharomyces cerevisiae prion [PSI+] is an epigenetic modifier of the fidelity of translation termination, but its impact on yeast biology has been unclear. Here we show that [PSI+] provides the means to uncover hidden genetic variation and produce new heritable phenotypes. Moreover, in each of the seven genetic backgrounds tested, the constellation of phenotypes produced was unique. We propose that the epigenetic and metastable nature of [PSI+] inheritance allows yeast cells to exploit pre-existing genetic variation to thrive in fluctuating environments. Further, the capacity of [PSI+] to convert previously neutral genetic variation to a non-neutral state may facilitate the evolution of new traits.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Lindquist, SL (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, 5841 S Maryland Ave, Chicago, IL 60637 USA.		True, Heather/D-2979-2012					Adams A, 1997, METHODS YEAST GENETI; BAILEY MJ, 1981, ENZYME MICROB TECH, V3, P153, DOI 10.1016/0141-0229(81)90076-4; Budavari S., 1989, MERCK INDEX; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1992, BIOCHIMIE, V74, P455, DOI 10.1016/0300-9084(92)90086-T; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Derkatch IL, 1997, GENETICS, V147, P507; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; EUSTICE DC, 1986, J MOL BIOL, V188, P207, DOI 10.1016/0022-2836(86)90305-0; FIROOZAN M, 1991, YEAST, V7, P173, DOI 10.1002/yea.320070211; GRANT CM, 1989, MOL MICROBIOL, V3, P215, DOI 10.1111/j.1365-2958.1989.tb01810.x; HALL BG, 1983, MOL BIOL EVOL, V1, P109; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; KIKUCHI Y, 1988, GENE EXPRESSION REGU, P257; KOCH AL, 1972, GENETICS, V72, P297; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; KUSHNIROV VV, 1990, YEAST, V6, P461, DOI 10.1002/yea.320060603; KUSHNIROV VV, 1988, GENE, V66, P45, DOI 10.1016/0378-1119(88)90223-5; LEVITT RC, 1991, GENOMICS, V11, P484, DOI 10.1016/0888-7543(91)90168-E; LIEBMAN SW, 1979, J BACTERIOL, V139, P1068, DOI 10.1128/JB.139.3.1068-1071.1979; Liebman SW, 1999, J BIOL CHEM, V274, P1181, DOI 10.1074/jbc.274.3.1181; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Nadeau JH, 1997, GENETICS, V147, P1259; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; OHTA T, 1987, GENETICS, V115, P207; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Rieger KJ, 1997, YEAST, V13, P1547, DOI 10.1002/(SICI)1097-0061(199712)13:16<1547::AID-YEA230>3.0.CO;2-Y; RONCERO C, 1988, J BACTERIOL, V170, P1950, DOI 10.1128/jb.170.4.1950-1954.1988; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Seoighe C, 1999, GENE, V238, P253, DOI 10.1016/S0378-1119(99)00319-4; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Tikhomirova VL, 1996, CURR GENET, V30, P44, DOI 10.1007/s002940050098; TUITE MF, 1981, GENETICS, V98, P691; WAKEM LP, 1990, GENETICS, V124, P515; WALSH JB, 1995, GENETICS, V139, P421; WILSON SP, 1988, SEC MESS PHOSPHOPROT, V12, P1; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	49	532	548	0	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					477	483		10.1038/35035005	http://dx.doi.org/10.1038/35035005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028992				2022-12-01	WOS:000089727400040
J	Huang, P; Feng, L; Oldham, EA; Keating, MJ; Plunkett, W				Huang, P; Feng, L; Oldham, EA; Keating, MJ; Plunkett, W			Superoxide dismutase as a target for the selective killing of cancer cells	NATURE			English	Article							ENDOGENOUS MAMMALIAN METABOLITE; INHIBITS TUBULIN POLYMERIZATION; DEPENDENT FORMATION; CYTOCHROME-C; 2-METHOXYESTRADIOL; APOPTOSIS; RADICALS; CYTOTOXICITY; OXIDASE; TISSUES	Superoxide dismutases (SOD) are essential enzymes that eliminate superoxide radical (O-2(-)) and thus protect cells from damage induced by free radicals(1-3). The active O-2(-) production and low SOD activity in cancer cells(3-7) may render the malignant cells highly dependent on SOD for survival and sensitive to inhibition of SOD. Here we report that certain oestrogen derivatives selectively kill human leukaemia cells but not normal lymphocytes. Using complementary DNA microarray and biochemical approaches, we identify SOD as a target of this drug action and show that chemical modifications at the 2-carbon (2-OH, 2-OCH3) of the derivatives are essential for SOD inhibition and for apoptosis induction. Inhibition of SOD causes accumulation of cellular O-2(-) and leads to free-radical-mediated damage to mitochondrial membranes, the release of cytochrome c from mitochondria and apoptosis of the cancer cells. Our results indicate that targeting SOD may be a promising approach to the selective killing of cancer cells, and that mechanism-based combinations of SOD inhibitors with free-radical-producing agents may have clinical applications.	Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Leukaemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Huang, P (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA.			Hileman, Elizabeth/0000-0001-6822-9571				Bindokas VP, 1996, J NEUROSCI, V16, P1324; CASPARY WJ, 1979, MOL PHARMACOL, V16, P256; CUSHMAN M, 1995, J MED CHEM, V38, P2041, DOI 10.1021/jm00012a003; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P3964, DOI 10.1073/pnas.91.9.3964; DIONISI O, 1975, BIOCHIM BIOPHYS ACTA, V403, P292, DOI 10.1016/0005-2744(75)90059-5; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fujimura M, 1999, J NEUROSCI, V19, P3414; GAJEWSKI E, 1990, BIOCHEMISTRY-US, V29, P7876, DOI 10.1021/bi00486a014; GUTTERIDGE JMC, 1982, BIOCHEM J, V206, P605, DOI 10.1042/bj2060605; Halliwell B., 1985, BRIT J EXP PATHOL, DOI 10.1016/0748-5514(85)90140-0; HAMANA K, 1985, BIOCHEM INT, V10, P301; Heiden MGV, 1997, CELL, V91, P627; HUANG P, 1990, J BIOL CHEM, V265, P16617; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; MARKLUND SL, 1982, CANCER RES, V42, P1955; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Mohanty PS, 1997, SCI TECHNOL WELD JOI, V2, P133, DOI 10.1179/stw.1997.2.3.133; Mukhopadhyay T, 1998, ONCOGENE, V17, P241, DOI 10.1038/sj.onc.1201909; OBERLEY LW, 1979, CANCER RES, V39, P1141; Pervaiz S, 1999, FEBS LETT, V459, P343, DOI 10.1016/S0014-5793(99)01258-2; RIGO A, 1975, BIOCHEM BIOPH RES CO, V63, P1013, DOI 10.1016/0006-291X(75)90670-1; SHULYAKOVSKAYA T, 1993, BIOCHEM BIOPH RES CO, V195, P581, DOI 10.1006/bbrc.1993.2085; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Van Driel BEM, 1999, J HISTOCHEM CYTOCHEM, V47, P575, DOI 10.1177/002215549904700501; YOUNG RC, 1981, NEW ENGL J MED, V305, P139, DOI 10.1056/NEJM198107163050305; Zwacka RM, 1998, HUM GENE THER, V9, P1381, DOI 10.1089/hum.1998.9.9-1381	27	709	758	2	108	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					390	395		10.1038/35030140	http://dx.doi.org/10.1038/35030140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014196				2022-12-01	WOS:000089390700050
J	Kortner, G; Brigham, RM; Geiser, F				Kortner, G; Brigham, RM; Geiser, F			Metabolism - Winter torpor in a large bird	NATURE			English	Article							HIBERNATION		Univ New England, Sch Biol Sci, Armidale, NSW 2351, Australia; Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada	University of New England; University of Regina	Kortner, G (corresponding author), Univ New England, Sch Biol Sci, Armidale, NSW 2351, Australia.		Brigham, R Mark/E-6825-2010; Geiser, Fritz/O-4175-2018	Brigham, R Mark/0000-0001-6765-4250; Geiser, Fritz/0000-0001-7621-5049				BRIGHAM RM, 1992, PHYSIOL ZOOL, V65, P457, DOI 10.1086/physzool.65.2.30158263; Cossins AR, 1996, NATURE, V382, P582, DOI 10.1038/382582a0; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; Kortner G, 1999, J ZOOL, V248, P501, DOI 10.1111/j.1469-7998.1999.tb01049.x; Kortner G, 2000, OECOLOGIA, V123, P350, DOI 10.1007/s004420051021; Lyman C. P., 1982, HIBERNATION TORPOR M; Reinertsen R.E., 1983, Polar Research, V1, P269, DOI 10.1111/j.1751-8369.1983.tb00743.x	7	60	63	1	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					318	318		10.1038/35030297	http://dx.doi.org/10.1038/35030297			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014178				2022-12-01	WOS:000089390700032
J	Tumbula, DL; Becker, HD; Chang, W; Soll, D				Tumbula, DL; Becker, HD; Chang, W; Soll, D			Domain-specific recruitment of amide amino acids for protein synthesis	NATURE			English	Article							TRANSFER-RNA-SYNTHETASE; ESCHERICHIA-COLI; EVOLUTION; GENE; BIOSYNTHESIS; BACTERIA; AMIDOTRANSFERASE; TRANSLATION; RECOGNITION; ENZYME	The formation of aminoacyl-transfer RNA is a crucial step in ensuring the accuracy of protein synthesis. Despite the central importance of this process in all living organisms, it remains unknown how archaea and some bacteria synthesize Asn-tRNA and Gln-tRNA. These amide aminoacyl-tRNAs can be formed by the direct acylation of tRNA, catalysed by asparaginyl-tRNA synthetase and glutaminyl-tRNA synthetase, respectively. A separate, indirect pathway involves the formation of mis-acylated Asp-tRNA(Asn) or Glu-tRNA(Gln), and the subsequent amidation of these amino acids while they are bound to tRNA, which is catalysed by amidotransferases(1,2). Here we show that all archaea possess an archaea-specific heterodimeric amidotransferase (encoded by gatD and gatE) for Gln-tRNA formation. However, Asn-tRNA synthesis in archaea is divergent: some archaea use asparaginyl-tRNA synthetase, whereas others use a heterotrimeric amidotransferase (encoded by the gatA, gatB and gatC genes). Because bacteria primarily use transamidation(3), and the eukaryal cytoplasm uses glutaminyl-tRNA synthetase, it appears that the three domains use different mechanisms for Gln-tRNA synthesis; as such, this is the only known step in protein synthesis where all three domains have diverged. Closer inspection of the two amidotransferases reveals that each of them recruited a metabolic enzyme to aid its function; this provides direct evidence for a relationship between amino-acid metabolism and protein biosynthesis.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA	Yale University; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.			Hansen, Debra T./0000-0003-4395-8297; Becker, Hubert/0000-0002-4102-7520				BAYLEY ST, 1967, CAN J BIOCHEM, V46, P937; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Brown JR, 1999, J MOL EVOL, V49, P485, DOI 10.1007/PL00006571; Curnow AW, 1996, NATURE, V382, P589, DOI 10.1038/382589b0; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Di Giulio M, 2000, TRENDS GENET, V16, P17, DOI 10.1016/S0168-9525(99)01893-4; Fournand D, 1998, APPL ENVIRON MICROB, V64, P2844; Gagnon Y, 1996, J BIOL CHEM, V271, P14856, DOI 10.1074/jbc.271.25.14856; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Handy J, 1999, J MOL EVOL, V49, P709, DOI 10.1007/PL00006592; HAYASE Y, 1992, EMBO J, V11, P4159, DOI 10.1002/j.1460-2075.1992.tb05509.x; Ibba M, 1997, P NATL ACAD SCI USA, V94, P14383, DOI 10.1073/pnas.94.26.14383; Ibba M, 1996, P NATL ACAD SCI USA, V93, P6953, DOI 10.1073/pnas.93.14.6953; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; Kim R, 1998, BIOTECHNOL LETT, V20, P207, DOI 10.1023/A:1005305330517; Kim SI, 1997, J BACTERIOL, V179, P5625, DOI 10.1128/jb.179.17.5625-5627.1997; LUDMERER SW, 1987, J BIOL CHEM, V262, P10801; Nabholz CE, 1997, P NATL ACAD SCI USA, V94, P7903, DOI 10.1073/pnas.94.15.7903; SCHON A, 1988, NATURE, V331, P187, DOI 10.1038/331187a0; Siatecka M, 1998, EUR J BIOCHEM, V256, P80, DOI 10.1046/j.1432-1327.1998.2560080.x; Sissler M, 1999, P NATL ACAD SCI USA, V96, P8985, DOI 10.1073/pnas.96.16.8985; Soll D., 1974, ENZYMES, V10, P489; SPRING KJ, 1986, J BACTERIOL, V166, P135, DOI 10.1128/jb.166.1.135-142.1986; Stathopoulos C, 2000, SCIENCE, V287, P479, DOI 10.1126/science.287.5452.479; Weiner AM, 1999, CURR BIOL, V9, pR842, DOI 10.1016/S0960-9822(00)80041-X; WILCOX M, 1968, P NATL ACAD SCI USA, V61, P229, DOI 10.1073/pnas.61.1.229; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 1999, GENOME RES, V9, P689; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909	30	133	139	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					106	110		10.1038/35024120	http://dx.doi.org/10.1038/35024120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993083				2022-12-01	WOS:000089124000052
J	Williams, JW; Mulrow, CD; Chiquette, E; Noel, PH; Aguilar, C; Cornell, J				Williams, JW; Mulrow, CD; Chiquette, E; Noel, PH; Aguilar, C; Cornell, J			A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary	ANNALS OF INTERNAL MEDICINE			English	Review							SEROTONIN REUPTAKE INHIBITORS; NATIONAL-COMORBIDITY-SURVEY; RANDOMIZED CLINICAL-TRIALS; LONG-TERM TREATMENT; ST-JOHNS WORT; PRIMARY-CARE; DOUBLE-BLIND; MAJOR DEPRESSION; TRICYCLIC ANTIDEPRESSANTS; DISCONTINUATION RATES	Background: Depressive disorders are persistent, recurring illnesses that cause great suffering for patients and their families. Purpose: To evaluate the benefits and adverse effects of newer pharmacotherapies and herbal treatments for depressive disorders in adults and adolescents. Data Sources: English-language and non-English-language literature from 1980 to January 1998 was identified from a specialized registry of controlled trials, meta-analyses, and experts. Study Selection: Randomized trials evaluating newer antidepressants (such as serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and St. John's wort) that reported clinical outcomes were selected. Data Extraction: Two persons independently abstracted data that were then synthesized descriptively; some data were pooled by using a random-effects model. Data Synthesis: Of 315 eligible trials, most evaluated antidepressants in adults with major depression, were conducted among outpatients, and examined acute-phase treatment. Newer antidepressants were more effective than placebo for major depression (relative benefit, 1.6 [95% CI, 1.5 to 1.7]) and dysthymia (relative benefit, 1.7 [CI, 1.3 to 2.3]). They were effective among older adults and primary care patients. Efficacy did not differ among newer agents or between newer and older agents. Hypericum (St. John's wort) was more effective than placebo for mild to moderate depression (risk ratio, 1.9 [Cl, 1.2 to 2.8]), but publication bias may have inflated the estimate of benefit. Newer and older antidepressants did not differ for overall discontinuation rates, but side effect profiles varied significantly. Data were insufficient for determining the efficacy of newer antidepressants for subsyndromal depression, depression with coexisting medical or psychiatric illness, or depression in adolescents. Conclusions: Newer antidepressants are clearly effective in treating depressive disorders in diverse settings. Because of similar efficacy, both newer and older antidepressants should be considered when making treatment decisions. Better information is urgently needed on the efficacy of newer antidepressants in patients with nonmajor depression and in special populations, including adolescents.	Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio Evidence Based Practice Ctr, San Antonio, TX 78229 USA; S Texas Vet Hlth Care Syst, Audie Murphy Div, Kerrville, TX USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Williams, JW (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio Evidence Based Practice Ctr, 7703 Floyd Curl Dr,Mail Code 7879, San Antonio, TX 78229 USA.		Williams, John/AAM-4572-2020; Williams, John W/A-3696-2008	Williams, John/0000-0002-5267-5558; Williams, John W/0000-0002-5267-5558; Noel, Polly/0000-0002-1519-7489	PHS HHS [290-97-0012] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; ANDERSON IM, 1995, BMJ-BRIT MED J, V310, P1433, DOI 10.1136/bmj.310.6992.1433; ANGST J, 1995, J CLIN PSYCHOPHARM, V15, pS16, DOI 10.1097/00004714-199508001-00004; ANTON SF, 1994, PSYCHOPHARMACOL BULL, V30, P165; BEASLEY CM, 1991, BMJ-BRIT MED J, V303, P685, DOI 10.1136/bmj.303.6804.685; BEASLEY CM, 1992, INT CLIN PSYCHOPHARM, V6, P35, DOI 10.1097/00004850-199206006-00006; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERGMANN R, 1993, TW NEUROLOGIE PSYCHI, P7235; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Boyer P, 1996, EUR PSYCHIAT, V11, pS135, DOI 10.1016/0924-9338(96)85188-1; BREMNER JD, 1995, J CLIN PSYCHIAT, V56, P519; Brown C, 1995, GEN HOSP PSYCHIAT, V17, P414, DOI 10.1016/0163-8343(95)00072-0; BYRNE MM, 1989, ACTA PSYCHIAT SCAND, V80, P138, DOI 10.1111/j.1600-0447.1989.tb07194.x; CALLAHAN CM, 1994, J AM GERIATR SOC, V42, P839, DOI 10.1111/j.1532-5415.1994.tb06555.x; CHURCHILL R, 1998, SYSTEMATIC REV META, P2; CLAGHORN JL, 1992, J CLIN PSYCHIAT, V53, P434; CONTE HR, 1986, ARCH GEN PSYCHIAT, V43, P471; COYNE JC, 1994, GEN HOSP PSYCHIAT, V16, P267, DOI 10.1016/0163-8343(94)90006-X; Cucherat M, 1996, ENCEPHALE, V22, P378; DELINISTULA A, 1995, J AFFECT DISORDERS, V35, P21, DOI 10.1016/0165-0327(95)00034-K; Devane CL, 1996, J CLIN PSYCHIAT, V57, P55; DITZLER K, 1994, COMPLEMENT THER MED, V2, P5; Donoghue J, 1996, BRIT MED J, V313, P861; DUNBAR GC, 1993, ACTA PSYCHIAT SCAND, V87, P302, DOI 10.1111/j.1600-0447.1993.tb03376.x; DUNBAR GC, 1995, PHARMACOLOGY, V51, P137, DOI 10.1159/000139327; EGGER M, 1997, BRIT MED J, V314, P629; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; Entsuah AR, 1995, PSYCHOPHARMACOL BULL, V31, P759; FAWCETT J, 1995, J CLIN PSYCHIAT, V56, P37; FRANCHINI L, 1994, J AFFECT DISORDERS, V32, P225, DOI 10.1016/0165-0327(94)90085-X; Franchini L, 1997, J CLIN PSYCHIAT, V58, P104, DOI 10.4088/JCP.v58n0303; FREEMANTLE N, 1993, EFFECTIVE HLTH CARE, P5; FREEMANTLE N, 1998, SELECTIVE SEROTONIN, P2; GOLDSTEIN DJ, 1993, CLIN PHARMACOL THER, V54, P245, DOI 10.1038/clpt.1993.144; GOODNICK PJ, 1995, J CLIN PSYCHIAT, V56, P128; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P419; GREENBERG RP, 1992, J CONSULT CLIN PSYCH, V60, P664, DOI 10.1037/0022-006X.60.5.664; GREENBERG RP, 1994, J NERV MENT DIS, V182, P547, DOI 10.1097/00005053-199410000-00003; HELLERSTEIN DJ, 1993, AM J PSYCHIAT, V150, P1169; HENRY JA, 1995, BRIT MED J, V310, P221, DOI 10.1136/bmj.310.6974.221; Hoffmann J, 1979, ZFA (Stuttgart), V55, P776; HORNIG M, 1998, ALTERNATIVE MED ALER, V1, P4; Hotopf M, 1997, J EPIDEMIOL COMMUN H, V51, P354, DOI 10.1136/jech.51.4.354; Hotopf M, 1996, BRIT J PSYCHIAT, V168, P404, DOI 10.1192/bjp.168.4.404; Hotopf M, 1997, BRIT J PSYCHIAT, V170, P120, DOI 10.1192/bjp.170.2.120; HOTOPF M, 1998, SYSTEMATIC REV TREAT, P2; Hunkeler E, 1998, INT J PSYCHIAT MED, V28, P389; IBOR JJL, 1993, EUR PSYCHIAT, V8, pS17; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; KAPUR S, 1992, JAMA-J AM MED ASSOC, V268, P3441, DOI 10.1001/jama.268.24.3441; Kasper S, 1996, INT CLIN PSYCHOPHARM, V11, P35, DOI 10.1097/00004850-199609004-00005; Kasper S, 1995, INT CLIN PSYCHOPHARM, V10, P25, DOI 10.1097/00004850-199512004-00005; KATON W, 1992, MED CARE, V30, P67, DOI 10.1097/00005650-199201000-00007; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katzelnick D, 1998, INT J PSYCHIAT MED, V28, P391; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KNIEBEL R, 1988, Z ALLG MED, V64, P689; LIMA MS, 1998, COMP DRUGS VERSUS PL, P2; LIN EHB, 1995, MED CARE, V33, P67, DOI 10.1097/00005650-199501000-00006; Linde K, 1996, BRIT MED J, V313, P253, DOI 10.1136/bmj.313.7052.253; LINDE K, 1998, ST JOHNS WORT DEPRES, P2; Mandoki MW, 1997, PSYCHOPHARMACOL BULL, V33, P149; McCusker J, 1998, ARCH INTERN MED, V158, P705, DOI 10.1001/archinte.158.7.705; MONTGOMERY DE, 1995, MODAL ANAL, V10, P1; MONTGOMERY SA, 1995, INT CLIN PSYCHOPHARM, V9, P33, DOI 10.1097/00004850-199501004-00005; MONTGOMERY SA, 1994, INT CLIN PSYCHOPHARM, V9, P35, DOI 10.1097/00004850-199403001-00006; MONTGOMERY SA, 1994, INT CLIN PSYCHOPHARM, V9, P47, DOI 10.1097/00004850-199400910-00008; MONTGOMERY SA, 1993, INT CLIN PSYCHOPHARM, V8, P189, DOI 10.1097/00004850-199300830-00009; Mulrow CD, 1998, PSYCHOPHARMACOL BULL, V34, P409; MULROW CD, 1999, AHCPR PUBLICATION; Murray CJ, 1996, GLOBAL BURDEN DIS, V1996, P201; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; *N ENGL EV BAS GUI, 1998, CHOIC ANT DEPR PRIM; PARNETTI L, 1993, DRUG INVEST, V6, P181, DOI 10.1007/BF03259242; PEDEN JG, 1995, TREATMENTS PSYCHIAT, P1330; PERSAD E, 1990, CAN J PSYCHIAT, V35, P175, DOI 10.1177/070674379003500214; Persons JB, 1996, ARCH GEN PSYCHIAT, V53, P283; Philipp M, 1999, BRIT MED J, V319, P1534, DOI 10.1136/bmj.319.7224.1534; Puech A, 1997, INT CLIN PSYCHOPHARM, V12, P99, DOI 10.1097/00004850-199703000-00005; REGIER DA, 1988, ARCH GEN PSYCHIAT, V45, P977; REH C, 1992, THERAPIEWOCHE, V42, P1576; Rost K, 1998, INT J PSYCHIAT MED, V28, P398; SALZMANN E, 1995, NEUROPSYCHOBIOLOGY, V31, P68, DOI 10.1159/000119175; Schmidt U, 1993, Fortschr Med, V111, P339; SIMEON JG, 1990, PROG NEURO-PSYCHOPH, V14, P791, DOI 10.1016/0278-5846(90)90050-Q; SIMON GE, 1993, GEN HOSP PSYCHIAT, V15, P399, DOI 10.1016/0163-8343(93)90009-D; Simon GE, 1996, JAMA-J AM MED ASSOC, V275, P1897, DOI 10.1001/jama.275.24.1897; Smeraldi E, 1998, J AFFECT DISORDERS, V48, P47, DOI 10.1016/S0165-0327(97)00139-0; Sobin C, 1996, BRIT J PSYCHIAT, V169, P322, DOI 10.1192/bjp.169.3.322; SONG FJ, 1993, BMJ-BRIT MED J, V306, P683, DOI 10.1136/bmj.306.6879.683; Stahl S, 1997, ACTA PSYCHIAT SCAND, V96, P22, DOI 10.1111/j.1600-0447.1997.tb05955.x; Stassen HH, 1996, PHARMACOPSYCHIATRY, V29, P87, DOI 10.1055/s-2007-979551; Steffens D C, 1997, Depress Anxiety, V6, P10, DOI 10.1002/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO;2-9; STEGER W, 1985, Z ALLG MED, V61, P914; Szegedi A, 1997, PHARMACOPSYCHIATRY, V30, P97, DOI 10.1055/s-2007-979490; TAYLOR D, 1995, BRIT J PSYCHIAT, V167, P575, DOI 10.1192/bjp.167.5.575; Thase ME, 1996, ARCH GEN PSYCHIAT, V53, P777; Thase ME, 1997, ARCH GEN PSYCHIAT, V54, P1009; TOLLEFSON GD, 1994, J CLIN PSYCHOPHARM, V14, P163; TRINIDADE E, 1997, 19973E19974E CCOHTA; *US DEP HHS, 1993, AHCPR PUBL; Vanelle JM, 1997, BRIT J PSYCHIAT, V170, P345, DOI 10.1192/bjp.170.4.345; VANMOFFAERT M, 1989, NEW TRENDS EXPT CLIN, V5, P167; Vorbach EU, 1997, PHARMACOPSYCHIATRY, V30, P81, DOI 10.1055/s-2007-979524; VORBACH EU, 1994, J GERIATR PSYCHIA S1, V7, P519; Wagner W, 1992, Drugs, V43 Suppl 2, P48; Warshaw MG, 1996, J CLIN PSYCHIAT, V57, P158; WERNICKE JF, 1985, J CLIN PSYCHIAT, V46, P59; Wheatley D, 1997, PHARMACOPSYCHIATRY, V30, P77, DOI 10.1055/s-2007-979523; WILLIAMS JW, 1995, J GEN INTERN MED, V10, P7, DOI 10.1007/BF02599568; Williams JW, 1999, ARCH FAM MED, V8, P58, DOI 10.1001/archfami.8.1.58; WILSON K, 1998, REV ANTIDEPRESSANT D, P2; Witte B, 1995, Fortschr Med, V113, P404; 1993, AM J PSYCHIAT S4, V150, pR3	114	275	283	0	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2000	132	9					743	756		10.7326/0003-4819-132-9-200005020-00011	http://dx.doi.org/10.7326/0003-4819-132-9-200005020-00011			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	308VT	10787370				2022-12-01	WOS:000086734100010
J	Thompson, LG; Yao, T; Mosley-Thompson, E; Davis, ME; Henderson, KA; Lin, PN				Thompson, LG; Yao, T; Mosley-Thompson, E; Davis, ME; Henderson, KA; Lin, PN			A high-resolution millennial record of the South Asian Monsoon from Himalayan ice cores	SCIENCE			English	Article							EURASIAN SNOW COVER; SURFACE AIR-TEMPERATURE; TROPICAL CLIMATE; NORTH PACIFIC; RAINFALL; TRANSPORT; ENSO; DUST	A high-resolution ice core record from Dasuopu, Tibet, reveals that this site is sensitive to fluctuations in the intensity of the South Asian Monsoon. Reductions in monsoonal intensity are recorded by dust and chloride concentrations. The deeper, older sections of the Dasuopu cores suggest many other periods of drought in this region, but none have been of greater intensity than the greatest recorded drought, during 1790 to 1796 A.D. of the Last millennium. The 20th century increase in anthropogenic activity in India and Nepal, upwind from this site, is recorded by a doubling of chloride concentrations anti a fourfold increase in dust. Like other ice cores from the Tibetan Plateau, Dasuopu suggests a Large-scale, plateau-wide 20th-century warming trend that apl,ears to be amplified at higher elevations.	Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA; Chinese Acad Sci, Cold & Arid Reg Environm & Engn Inst, Lanzhou, Peoples R China; Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; Ohio State Univ, Dept Geol Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Thompson, LG (corresponding author), Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA.		Mosley-Thompson, Ellen S/Z-2100-2018					BARNETT TP, 1988, SCIENCE, V239, P504, DOI 10.1126/science.239.4839.504; BOLZAN JF, 1985, J GEOPHYS RES-ATMOS, V90, P8111, DOI 10.1029/JD090iD05p08111; Charles CD, 1997, SCIENCE, V277, P925, DOI 10.1126/science.277.5328.925; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; Cole JE, 2000, SCIENCE, V287, P617, DOI 10.1126/science.287.5453.617; DICKSON RR, 1984, J CLIM APPL METEOROL, V23, P171, DOI 10.1175/1520-0450(1984)023<0171:ESCVIM>2.0.CO;2; GAO Y, 1992, J GEOPHYS RES-ATMOS, V97, P9867, DOI 10.1029/92JD00714; GREGORY S, 1986, THEOR APPL CLIMATOL, V37, P194, DOI 10.1007/BF00867577; Grove RH, 1998, NATURE, V393, P318, DOI 10.1038/30636; HAHN DG, 1976, J ATMOS SCI, V33, P2461, DOI 10.1175/1520-0469(1976)033<2461:AARBES>2.0.CO;2; Henderson KA, 1999, J GEOPHYS RES-ATMOS, V104, P31053, DOI 10.1029/1999JD900966; JONES PD, 1994, J CLIMATE, V7, P1794, DOI 10.1175/1520-0442(1994)007<1794:HSATVA>2.0.CO;2; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Liu T.-S., 1981, GEOLOGICAL SOC AM SP, V186, P149; LIU X, IN PRESS INT J CLIMA; MERRILL JT, 1989, J GEOPHYS RES-ATMOS, V94, P8584, DOI 10.1029/JD094iD06p08584; Ortlieb L., 2000, EL NINO SO OSCILLATI, P207; PARRINGTON JR, 1983, SCIENCE, V220, P195, DOI 10.1126/science.220.4593.195; QUINN WH, 1992, NINO HIST PALEOCLIMA, P119; REEH N, 1988, J GLACIOL, V34, P46, DOI 10.3189/S0022143000009059; SIROCKO F, 1993, NATURE, V364, P322, DOI 10.1038/364322a0; SONTAKKE NA, 1993, J CLIMATE, V6, P1807, DOI 10.1175/1520-0442(1993)006<1807:COAISM>2.0.CO;2; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; THOMPSON LG, 1989, SCIENCE, V246, P474, DOI 10.1126/science.246.4929.474; THOMPSON LG, 1993, GLOBAL PLANET CHANGE, V7, P145, DOI 10.1016/0921-8181(93)90046-Q; Thompson LG, 2000, QUATERNARY SCI REV, V19, P19, DOI 10.1016/S0277-3791(99)00052-9; THOMPSON LG, 1985, SCIENCE, V229, P971, DOI 10.1126/science.229.4717.971; THOMPSON LG, 1995, SCIENCE, V269, P47; THOMPSON LG, 1997, SCIENCE, V276, P1757; TOURRE YM, 1995, J PHYS OCEANOGR, V25, P1317, DOI 10.1175/1520-0485(1995)025<1317:ESIGUO>2.0.CO;2; WALLACE JM, 1998, J GEOPHYS RES, V103, P14167; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; Yao TD, 1996, J GEOPHYS RES-ATMOS, V101, P29531, DOI 10.1029/96JD02683	33	685	806	14	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1916	1919		10.1126/science.289.5486.1916	http://dx.doi.org/10.1126/science.289.5486.1916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	11001720				2022-12-01	WOS:000089355800040
